PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Roman, TS; Marvelle, AF; Fogarty, MP; Vadlamudi, S; Gonzalez, AJ; Buchkovich, ML; Huyghe, JR; Fuchsberger, C; Jackson, AU; Wu, Y; Civelek, M; Lusis, AJ; Gaulton, KJ; Sethupathy, P; Kangas, AJ; Soininen, P; Ala-Korpela, M; Kuusisto, J; Collins, FS; Laakso, M; Boehnke, M; Mohlke, KL				Roman, Tamara S.; Marvelle, Amanda F.; Fogarty, Marie P.; Vadlamudi, Swarooparani; Gonzalez, Arlene J.; Buchkovich, Martin L.; Huyghe, Jeroen R.; Fuchsberger, Christian; Jackson, Anne U.; Wu, Ying; Civelek, Mete; Lusis, Aldons J.; Gaulton, Kyle J.; Sethupathy, Praveen; Kangas, Antti J.; Soininen, Pasi; Ala-Korpela, Mika; Kuusisto, Johanna; Collins, Francis S.; Laakso, Markku; Boehnke, Michael; Mohlke, Karen L.			Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UPSTREAM STIMULATORY FACTOR; ALPHA-D-GALACTOSAMINE; C/EBP-BETA; LIPID CONCENTRATIONS; ENDOTHELIAL LIPASE; O-GLYCOSYLATION; GENOTYPE DATA; CDNA CLONING	Genome-wide association studies (GWASs) have identified more than 150 loci associated with blood lipid and cholesterol levels; however, the functional and molecular mechanisms for many associations are unknown. We examined the functional regulatory effects of candidate variants at the GALNT2 locus associated with high-density lipoprotein cholesterol (HDL-C). Fine-mapping and conditional analyses in the METSIM study identified a single locus harboring 25 noncoding variants (r(2) > 0.7 with the lead GWAS variants) strongly associated with total cholesterol in medium-sized HDL (e.g., rs17315646, p = 3.5 x 10(-12)). We used luciferase reporter assays in HepG2 cells to test all 25 variants for allelic differences in regulatory enhancer activity. rs2281721 showed allelic differences in transcriptional activity (75-fold [T] versus 27-fold [C] more than the empty-vector control), as did a separate 780-bp segment containing rs4846913, rs2144300, and rs6143660 (49-fold [AT(-) haplotype] versus 16-fold [CC+ haplotype] more). Using electrophoretic mobility shift assays, we observed differential CEBPB binding to rs4846913, and we confirmed this binding in a native chromatin context by performing chromatin-immunoprecipitation (ChIP) assays in HepG2 and Huh-7 cell lines of differing genotypes. Additionally, sequence reads in HepG2 DNase-I-hypersensitivity and CEBPB ChIP-seq signals spanning rs4846913 showed significant allelic imbalance. Allelic-expression-imbalance assays performed with RNA from primary human hepatocyte samples and expression-quantitative-trait-locus (eQTL) data in human subcutaneous adipose tissue samples confirmed that alleles associated with increased HDL-C are associated with a modest increase in GALNT2 expression. Together, these data suggest that at least rs4846913 and rs2281721 play key roles in influencing GALNT2 expression at this HDL-C locus.	[Roman, Tamara S.; Marvelle, Amanda F.; Fogarty, Marie P.; Vadlamudi, Swarooparani; Gonzalez, Arlene J.; Buchkovich, Martin L.; Wu, Ying; Gaulton, Kyle J.; Sethupathy, Praveen; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Roman, Tamara S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Huyghe, Jeroen R.; Fuchsberger, Christian; Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Civelek, Mete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Civelek, Mete] Univ Virginia, Ctr Publ Hlth Genom, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Deparment Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gaulton, Kyle J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kangas, Antti J.; Soininen, Pasi; Ala-Korpela, Mika] Univ Oulu, Inst Hlth Sci, Computat Med, Oulu 90014, Finland; [Soininen, Pasi; Ala-Korpela, Mika] Univ Eastern Finland, Sch Pharm, Nucl Magnet Resonance Metabol Lab, Kuopio 70211, Finland; [Ala-Korpela, Mika] Oulu Univ Hosp, Oulu 90220, Finland; [Ala-Korpela, Mika] Univ Bristol, Sch Social & Community Med, Computat Med, Bristol BS8 2BN, Avon, England; [Ala-Korpela, Mika] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Virginia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Oxford; Wellcome Centre for Human Genetics; University of Oulu; University of Eastern Finland; University of Oulu; University of Bristol; University of Bristol; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	mohlke@med.unc.edu	Fuchsberger, Christian/ABD-7127-2021	Fuchsberger, Christian/0000-0002-5918-8947; Civelek, Mete/0000-0002-8141-0284; Kangas, Antti/0000-0001-7492-1732; Ala-Korpela, Mika/0000-0001-5905-1206	NIH [T32HL069768, T32GM007092, R01DK072193, R21DA027040, R01DK093757, T32GM067553, R01DK062370, K99HL121172, P01HL28481]; National Human Genome Research Institute Division of Intramural Research [Z01HG000024]; American Heart Association [13PRE16930025]; Academy of Finland [77299, 124243]; Finnish Heart Foundation; Finnish Diabetes Foundation; Finnish Funding Agency for Technology and Innovation (TEKES) [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; University of Oulu; British Heart Foundation; Wellcome Trust; Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, T32HL069768, K99HL121172] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062370, P30DK020572, R01DK072193, R01DK093757, U01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, T32GM067553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027040] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute Division of Intramural Research; American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Commission of the European Community(European Commission); University of Oulu; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by NIH grants T32HL069768 (T.S.R.), T32GM007092 (T.S.R.), R01DK072193 (K.L.M.), R21DA027040 (K.L.M.), R01DK093757 (K.L.M.), T32GM067553 (M.L.B), R01DK062370 (M.B.), K99HL121172 (M.C.), and P01HL28481 (A.J.L.) and National Human Genome Research Institute Division of Intramural Research project number Z01HG000024 (F.S.C.); American Heart Association Predoctoral Fellowship 13PRE16930025 (M.L.B.); Academy of Finland grants 77299 and 124243 (M.L.); the Finnish Heart Foundation (M.L.); the Finnish Diabetes Foundation (M.L.); Finnish Funding Agency for Technology and Innovation (TEKES) contract 1510/31/06 (M.L.); and Commission of the European Community HEALTH-F2-2007-201681 (M.L.). Applications and development of the quantitative-serum nuclear-magnetic-resonance (NMR) metabolomics platform are supported by the Academy of Finland, TEKES, Sigrid Juselius Foundation, Novo Nordisk Foundation, and Finnish Diabetes Research Foundation. A.J.K., P.S., and M.A.-K. are supported by the University of Oulu, British Heart Foundation, Wellcome Trust, and Medical Research Council. Bristol Myers Squibb supported the generation of METSIM microarray data. The authors acknowledge the GoT2D Consortium for access to the reference panel used for imputation; human organ donors whose liver samples were used in this study; the ENCODE and NIH Roadmap Epigenomics Consortia, Data Analysis and Coordination Centers, and production laboratories that generated the chromatin, histone-modification, and chromatin-immunoprecipitation (ChIP) sequencing data used for variant annotation. We thank Terry Furey and Greg Crawford for interpretating ENCODE data, Jennifer Kulzer for editing the manuscript, Yun Li and Qing Duan for providing 1000 Genomes linkage-disequilibrium data, Scott Bultman and Dallas Donohoe for providing advice on ChIP experiments, and Sumeet Khetarpal and Daniel Rader for sharing unpublished results.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bailey T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003326; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Botma GJ, 2001, ATHEROSCLEROSIS, V154, P625, DOI 10.1016/S0021-9150(00)00478-0; Buchkovich ML, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0117-x; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fogarty MP, 2010, HUM MOL GENET, V19, P1921, DOI 10.1093/hmg/ddq067; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; He HL, 2015, P NATL ACAD SCI USA, V112, P6128, DOI 10.1073/pnas.1506255112; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Jahangiri A, 2005, J LIPID RES, V46, P896, DOI 10.1194/jlr.M400212-JLR200; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Kuivenhoven JA, 2014, BBA-MOL BASIS DIS, V1842, P1993, DOI 10.1016/j.bbadis.2014.04.028; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; McCoy MG, 2002, J LIPID RES, V43, P921; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qu HQ, 2009, J IMMUNOL, V183, P5158, DOI 10.4049/jimmunol.0901337; Rahman SM, 2013, BIOCHEM BIOPH RES CO, V430, P336, DOI 10.1016/j.bbrc.2012.11.027; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Weissglas-Volkov D, 2010, CIRC-CARDIOVASC GENE, V3, P31, DOI 10.1161/CIRCGENETICS.109.908004; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xiao R, 2011, GENET EPIDEMIOL, V35, P515, DOI 10.1002/gepi.20601	64	41	41	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					801	815		10.1016/j.ajhg.2015.10.016	http://dx.doi.org/10.1016/j.ajhg.2015.10.016			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26637976	Green Published, Bronze			2022-12-18	WOS:000368437900003
J	Angebault, C; Guichet, PO; Talmat-Amar, Y; Charif, M; Gerber, S; Fares-Taie, L; Gueguen, N; Halloyn, F; Moore, D; Amati-Bonneau, P; Manes, G; Hebrard, M; Bocquet, B; Quiles, M; Piro-Megy, C; Teigell, M; Delettre, C; Rossel, M; Meunier, I; Preising, M; Lorenz, B; Carelli, V; Chinnery, PF; Yu-Wai-Man, P; Kaplan, J; Roubertie, A; Barakat, A; Bonneau, D; Reynier, P; Rozet, JM; Bomont, P; Hamel, CP; Lenaers, G				Angebault, Claire; Guichet, Pierre-Olivier; Talmat-Amar, Yasmina; Charif, Majida; Gerber, Sylvie; Fares-Taie, Lucas; Gueguen, Naig; Halloyn, Francois; Moore, David; Amati-Bonneau, Patrizia; Manes, Gael; Hebrard, Maxime; Bocquet, Beatrice; Quiles, Melanie; Piro-Megy, Camille; Teigell, Marisa; Delettre, Cecile; Rossel, Mireille; Meunier, Isabelle; Preising, Markus; Lorenz, Birgit; Carelli, Valerio; Chinnery, Patrick F.; Yu-Wai-Man, Patrick; Kaplan, Josseline; Roubertie, Agathe; Barakat, Abdelhamid; Bonneau, Dominique; Reynier, Pascal; Rozet, Jean-Michel; Bomont, Pascale; Hamel, Christian P.; Lenaers, Guy			Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL PROTEIN; ATROPHY; NOGO; OPA1; IDENTIFICATION; REGENERATION	Autosomal-recessive optic neuropathies are rare blinding conditions related to retinal ganglion cell (RGC) and optic-nerve degeneration, for which only mutations in TMEM126A and ACO2 are known. In four families with early-onset recessive optic neuropathy, we identified mutations in RTN4IP1, which encodes a mitochondrial ubiquinol oxydo-reductase. RTN4IP1 is a partner of RTN4 (also known as NOGO), and its ortholog Rad8 in C. elegans is involved in UV light response. Analysis of fibroblasts from affected individuals with a RTN4IP1 mutation showed loss of the altered protein, a deficit of mitochondrial respiratory complex I and IV activities, and increased susceptibility to UV light. Silencing of RTN4IP1 altered the number and morphogenesis of mouse RGC dendrites in vitro and the eye size, neuro-retinal development, and swimming behavior in zebrafish in vivo. Altogether, these data point to a pathophysiological mechanism responsible for RGC early degeneration and optic neuropathy and linking RTN4IP1 functions to mitochondrial physiology, response to UV light, and dendrite growth during eye maturation.	[Angebault, Claire; Guichet, Pierre-Olivier; Talmat-Amar, Yasmina; Charif, Majida; Halloyn, Francois; Manes, Gael; Hebrard, Maxime; Quiles, Melanie; Piro-Megy, Camille; Teigell, Marisa; Delettre, Cecile; Meunier, Isabelle; Roubertie, Agathe; Bomont, Pascale; Hamel, Christian P.; Lenaers, Guy] Univ Montpellier, Inst Neurosci Montpellier, INSERM U1051, F-34090 Montpellier, France; [Charif, Majida; Gueguen, Naig; Amati-Bonneau, Patrizia; Bonneau, Dominique; Reynier, Pascal; Lenaers, Guy] Univ LUNAM, Dept Biochimie & Genet, CNRS 6214, INSERM U1083, F-49933 Angers, France; [Gerber, Sylvie; Fares-Taie, Lucas; Kaplan, Josseline; Rozet, Jean-Michel] Ctr Hosp Univ, F-49933 Angers, France; [Moore, David; Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Hop Necker Enfants Malad, INSERM U1163, F-75015 Paris, France; [Bocquet, Beatrice; Meunier, Isabelle; Roubertie, Agathe; Hamel, Christian P.] Newcastle Univ, Ctr Life, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Rossel, Mireille] Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Preising, Markus; Lorenz, Birgit] CHRU Montpellier, Hop Gui Chauliac, Ctr Reference Malad Sensorielles Genet, F-34090 Montpellier, France; [Carelli, Valerio] INSERM U710, Lab MMDN EPHE, F-34090 Montpellier, France; [Carelli, Valerio] Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany; [Yu-Wai-Man, Patrick] Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna, I-40139 Bologna, Italy; [Barakat, Abdelhamid] Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40139 Bologna, Italy; [Angebault, Claire; Guichet, Pierre-Olivier; Talmat-Amar, Yasmina] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Charif, Majida; Gerber, Sylvie; Fares-Taie, Lucas] Inst Pasteur Maroc, Dept Rech Sci, Lab Genet Mol Humaine, Casablanca 20360, Morocco	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Justus Liebig University Giessen; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Newcastle University - UK	Lenaers, G (corresponding author), Univ Montpellier, Inst Neurosci Montpellier, INSERM U1051, F-34090 Montpellier, France.	guy.lenaers@inserm.fr	ROZET, Jean-Michel/E-5737-2016; Lenaers, guy/X-4727-2019; Bomont, Pascale/GLS-8721-2022; Delettre, Cécile/AAC-3096-2020; Bocquet, Beatrice/AAY-8447-2020; Naig, Gueguen/K-2699-2015; Bomont, Pascale L/Y-5517-2018; Preising, Markus/GQA-9591-2022; Hebrard, Maxime/E-4402-2016; FARES TAIE, Lucas/H-2940-2017; lenaers, guy/K-2421-2015; KAPLAN, Josseline/I-2622-2017	ROZET, Jean-Michel/0000-0001-7951-7886; Bomont, Pascale/0000-0001-7216-3261; Delettre, Cécile/0000-0003-3269-2155; Bocquet, Beatrice/0000-0002-6369-4818; Naig, Gueguen/0000-0002-3094-8121; Bomont, Pascale L/0000-0001-7216-3261; Hebrard, Maxime/0000-0003-2346-4513; GERBER, Sylvie/0000-0002-6827-1769; Halloy, Francois/0000-0003-2973-5820; FARES TAIE, Lucas/0000-0002-4613-0711; lenaers, guy/0000-0003-2736-3349; Reynier, Pascal/0000-0003-0802-4608; Bonneau, Dominique/0000-0002-6886-0969; Chinnery, Patrick/0000-0002-7065-6617; Guichet, Pierre-Olivier/0000-0003-0115-2199; Moore, David/0000-0002-0161-7390; KAPLAN, Josseline/0000-0002-1849-8658; Rossel, Mireille/0000-0003-2275-0817	Centre National de la Recherche Scientifique et Technique; Angers Loire Metropo le, Region Pays de la Loire; Centre Hospitaller Universitaire d'Angers; Fondation Maladies Rares; Fondation pour la Recherche Medicale; Retina France; Union Nationale des Aveugles et Deficients Visuels; Association Francaise contre les Myopathies; Ouvrir Les Yeux; Fight for Sight (UK); UK National Institute of Health Research as part of the Rare Diseases Translational Research Collaboration; Avenir-Atip program from INSERM; Centre National de la Recherche Scientifique; Region Languedoc-Roussillon; MRC [G0701386, G1002570, MR/K000608/1] Funding Source: UKRI; Medical Research Council [G0701386, G1002570, MR/K000608/1] Funding Source: researchfish; Fight for Sight [1479/80] Funding Source: researchfish	Centre National de la Recherche Scientifique et Technique(Centre National de la Recherche Scientifique (CNRS)); Angers Loire Metropo le, Region Pays de la Loire(Region Pays de la Loire); Centre Hospitaller Universitaire d'Angers; Fondation Maladies Rares; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Retina France; Union Nationale des Aveugles et Deficients Visuels; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ouvrir Les Yeux; Fight for Sight (UK); UK National Institute of Health Research as part of the Rare Diseases Translational Research Collaboration; Avenir-Atip program from INSERM; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	We are indebted to the Centre National de la Recherche Scientifique, INSERM, the University of Montpellier, and the University of Angers for institutional support and to the Departement des Partenariats et des Relations Exterieures from INSERM for providing a traveling INSERM and Centre National de la Recherche Scientifique et Technique grant to M.C. We are indebted to the Angers Loire Metropo le, Region Pays de la Loire, the Centre Hospitaller Universitaire d'Angers, the Fondation Maladies Rares and Fondation pour la Recherche Medicale, and the following patient associations for their financial support: Retina France, the Union Nationale des Aveugles et Deficients Visuels, the Association Francaise contre les Myopathies, and Ouvrir Les Yeux. We are indebted to Dr. Arribat, Dr. Cazevieille, Dr. Lancyre, and Dr. Pouilly for their respective contributions and to colleagues from the Institut des Neurosciences de Montpellier and from the MitoLab in Angers for generating helpful discussions. P.Y.-W.-M. receives funding from Fight for Sight (UK) and the UK National Institute of Health Research as part of the Rare Diseases Translational Research Collaboration. P.B. is supported by grants from the Avenir-Atip program from INSERM and the Centre National de la Recherche Scientifique, the Region Languedoc-Roussillon, and the Association Francaise contre les Myopathies.	Benit P, 2008, MOL CELL BIOCHEM, V314, P45, DOI 10.1007/s11010-008-9763-z; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; del Olmo-Aguado S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1346, DOI 10.1111/j.1751-1097.2012.01120.x; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Ferre M, 2015, HUM MUTAT, V36, P20, DOI 10.1002/humu.22703; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fujii M, 2011, GENES CELLS, V16, P1022, DOI 10.1111/j.1365-2443.2011.01547.x; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003; Hu WH, 2002, J NEUROCHEM, V81, P36, DOI 10.1046/j.1471-4159.2002.00788.x; Huang Y, 2009, J GUANGXI AGR MECHAN, V4, P4, DOI DOI 10.1371/J0URNAL.P0NE.0006550; ISHII N, 1993, MECH AGEING DEV, V68, P1, DOI 10.1016/0047-6374(93)90135-E; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46; Malicki J, 1996, DEVELOPMENT, V123, P263; Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Reynier P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016576; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schmandke A, 2014, NEUROSCIENTIST, V20, P372, DOI 10.1177/1073858413516800; Talmat-Amar Y, 2011, HUM MOL GENET, V20, P3738, DOI 10.1093/hmg/ddr290; Teng FYH, 2004, J NEUROCHEM, V89, P801, DOI 10.1111/j.1471-4159.2004.02366.x; Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330	26	41	43	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					754	760		10.1016/j.ajhg.2015.09.012	http://dx.doi.org/10.1016/j.ajhg.2015.09.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26593267	Bronze, Green Published			2022-12-18	WOS:000364803000011
J	Srour, M; Hamdan, FF; McKnight, DL; Davis, E; Mandel, H; Schwartzentruber, J; Martin, B; Patry, L; Nassif, C; Dionne-Laporte, A; Ospina, LH; Lemyre, E; Massicotte, C; Laframboise, R; Maranda, B; Labuda, D; Decarie, JC; Rypens, F; Goldsher, D; Fallet-Bianco, C; Soucy, JF; Laberge, AM; Maftei, C; Boycott, K; Brais, B; Boucher, RM; Rouleau, GA; Katsanis, N; Majewski, J; Elpeleg, O; Kukolich, MK; Shalev, S; Michaud, JL				Srour, Myriam; Hamdan, Fadi F.; McKnight, Diana Lee; Davis, Erica; Mandel, Hanna; Schwartzentruber, Jeremy; Martin, Brissa; Patry, Lysanne; Nassif, Christina; Dionne-Laporte, Alexandre; Ospina, Luis H.; Lemyre, Emmanuelle; Massicotte, Christine; Laframboise, Rachel; Maranda, Bruno; Labuda, Damian; Decarie, Jean-Claude; Rypens, Francoise; Goldsher, Dorith; Fallet-Bianco, Catherine; Soucy, Jean-Francois; Laberge, Anne-Marie; Maftei, Catalina; Boycott, Kym; Brais, Bernard; Boucher, Renee-Myriam; Rouleau, Guy A.; Katsanis, Nicholas; Majewski, Jacek; Elpeleg, Orly; Kukolich, Mary K.; Shalev, Stavit; Michaud, Jacques L.		Care4Rare Canada Consortium	Joubert Syndrome in French Canadians and Identification of Mutations in CEP104	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CILIARY TRANSITION ZONE; CENTROSOMAL PROTEIN; SEQUENCING DATA; MECKEL-SYNDROME; SYNDROME GENE; DISEASE; CEP290; CSPP1; CILIOGENESIS; RETARDATION	Joubert syndrome (JBTS) is a primarily autosomal-recessive disorder characterized by a distinctive mid-hindbrain and cerebellar malformation, oculomotor apraxia, irregular breathing, developmental delay, and ataxia. JBTS is a genetically heterogeneous ciliopathy. We sought to characterize the genetic landscape associated with JBTS in the French Canadian (FC) population. We studied 43 FC JBTS subjects from 35 families by combining targeted and exome sequencing. We identified pathogenic (n = 32 families) or possibly pathogenic (n = 2 families) variants in genes previously associated with JBTS in all of these subjects, except for one. In the latter case, we found a homozygous splice-site mutation (c.735+2T>C) in CEP104. Interestingly, we identified two additional non-FC JBTS subjects with mutations in CEP104; one of these subjects harbors a maternally inherited nonsense mutation (c.496C>T [p.Arg166*]) and a de novo splice-site mutation (c.2572-2A>G), whereas the other bears a homozygous frameshift mutation (c.1328_1329insT [p.Tyr444fs*3]) in CEP104. Previous studies have shown that CEP104 moves from the mother centriole to the tip of the primary cilium during ciliogenesis. Knockdown of CEP104 in retinal pigment epithelial (RPE1) cells resulted in severe defects in ciliogenesis. These observations suggest that CEP104 acts early during cilia formation by regulating the conversion of the mother centriole into the cilia basal body. We conclude that disruption of CEP104 causes JBTS. Our study also reveals that the cause of JBTS has been elucidated in the great majority of our FC subjects (33/35 [94%] families), even though JBTS shows substantial locus and allelic heterogeneity in this population.	[Srour, Myriam; Hamdan, Fadi F.; Patry, Lysanne; Nassif, Christina; Lemyre, Emmanuelle; Massicotte, Christine; Labuda, Damian; Soucy, Jean-Francois; Laberge, Anne-Marie; Maftei, Catalina; Michaud, Jacques L.] Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Srour, Myriam; Brais, Bernard; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A4, Canada; [McKnight, Diana Lee; Martin, Brissa] GeneDx, Gaithersburg, MD 20877 USA; [Davis, Erica; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Mandel, Hanna] Rambam Hlth Care Campus, Dept Pediat, Metab Unit, IL-3109601 Haifa, Israel; [Schwartzentruber, Jeremy; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Dionne-Laporte, Alexandre; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3H 2B4, Canada; [Ospina, Luis H.] Hop St Justine, Dept Ophthalmol, Montreal, PQ H3T 1C5, Canada; [Laframboise, Rachel] Ctr Hosp Univ Quebec, Div Med Genet, Quebec City, PQ G1V 4G2, Canada; [Maranda, Bruno] CHU Sherbrooke, Div Med Genet, Sherbrooke, PQ J1H 5N4, Canada; [Decarie, Jean-Claude; Rypens, Francoise] Ctr Hosp Univ St Justine, Dept Med Imaging, Montreal, PQ H3T 1C5, Canada; [Goldsher, Dorith] Technion Israel Inst Technol, MRI Unit, Rambam Med Ctr, Ruth & Baruch Rappaport Sch Med, IL-3109601 Haifa, Israel; [Fallet-Bianco, Catherine] St Justine Hosp, Dept Pathol, Montreal, PQ H3T 1C5, Canada; [Boycott, Kym] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Boucher, Renee-Myriam] Ctr Hosp Univ Quebec, Div Neurol, Quebec City, PQ G1V 4G2, Canada; [Rouleau, Guy A.] McGill Univ, Dept Human Genet, Montreal, PQ H3H 2B4, Canada; [Elpeleg, Orly] Hebrew Univ Jerusalem, Hadassah Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-9112102 Jerusalem, Israel; [Kukolich, Mary K.] Cook Childrens Med Ctr, Ft Worth, TX 76104 USA; [Michaud, Jacques L.] Technion Israel Inst Technol, Ruth & Baruch Rappaport Sch Med, IL-3525433 Haifa, Israel	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Duke University; Rambam Health Care Campus; McGill University; McGill University; Universite de Montreal; Laval University; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Rambam Health Care Campus; Technion Israel Institute of Technology; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Ottawa; Children's Hospital of Eastern Ontario; Laval University; McGill University; Hebrew University of Jerusalem; Cook Children's Medical Center; Technion Israel Institute of Technology	Shalev, S (corresponding author), Technion Israel Inst Technol, Ruth & Baruch Rappaport Sch Med, IL-3525433 Haifa, Israel.	stavit_sh@clalit.org.il; jacques.michaud@recherche-ste-justine.qc.ca	Brais, Bernard/Y-3910-2019; Fallet-Bianco, Catherine/AAP-7390-2020	Davis, Erica/0000-0002-2412-8397; Schwartzentruber, Jeremy/0000-0002-6183-2092; McKnight, Dianalee/0000-0002-7462-6300	Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Government of Canada through Genome Canada; CIHR; Ontario Genomics Institute [OGI-049]; FRSQ Reseau de Medecine Genetique Appliquee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Government of Canada through Genome Canada(Genome Canada); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; FRSQ Reseau de Medecine Genetique Appliquee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Foremost, we thank the families who generously contributed their time and materials to this research study. This work was selected for study by the Care4Rare (Enhanced Care for Rare Genetic Diseases in Canada) Canada Consortium Gene Discovery Steering Committee (Kym Boycott [lead; University of Ottawa], Alex MacKenzie [co-lead; University of Ottawa], Jacek Majewski [McGill University], Michael Brudno [University of Toronto], Dennis Bulman [University of Ottawa], and David Dyment [University of Ottawa]) and was funded in part by Genome Canada, the Canadian Institutes of Health Research (CIHR), the Ontario Genomics Institute, the Ontario Research Fund, Genome Quebec, and the Children's Hospital of Eastern Ontario Foundation. We wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre in Montreal. We thank Megan T. Cho (GeneDx) for coordinating the exchange of exome sequencing data. This work was funded by the Government of Canada through Genome Canada, the CIHR, Genome Quebec, and the Ontario Genomics Institute (OGI-049). J.L.M. is a National Scholar from the Fonds de Recherche du Quebec - Sante (FRQS). M.S. holds a CIHR clinician-scientist training award. D.L. receives financial support from the FRSQ Reseau de Medecine Genetique Appliquee.	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Bachmann-Gagescu R, 2015, HUM MUTAT, V36, P831, DOI 10.1002/humu.22821; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Czarnecki PG, 2012, TRENDS CELL BIOL, V22, P201, DOI 10.1016/j.tcb.2012.02.001; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Damseh N, 2015, J MED GENET, V52, P541, DOI 10.1136/jmedgenet-2015-103104; Damseh N, 2015, NEUROGENETICS, V16, P215, DOI 10.1007/s10048-015-0446-0; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kroes HY, 2015, EUR J HUM GENET; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Romani M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-72; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Roosing S, 2015, ELIFE, V4, DOI 10.7554/eLife.06602; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Shaheen R, 2014, AM J HUM GENET, V94, P73, DOI 10.1016/j.ajhg.2013.11.010; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srour M, 2012, J MED GENET, V49, P636, DOI 10.1136/jmedgenet-2012-101132; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Szymanska Katarzyna, 2012, Cilia, V1, P10, DOI 10.1186/2046-2530-1-10; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Thauvin-Robinet C, 2014, NAT GENET, V46, P905, DOI 10.1038/ng.3031; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111	56	41	61	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					744	753		10.1016/j.ajhg.2015.09.009	http://dx.doi.org/10.1016/j.ajhg.2015.09.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26477546	Green Published, Bronze			2022-12-18	WOS:000364803000010
J	Chan, YL; Salem, RM; Hsu, YHH; McMahon, G; Pers, TH; Vedantam, S; Esko, T; Guo, MH; Lim, ET; Franke, L; Smith, GD; Strachan, DP; Hirschhorn, JN				Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; McMahon, George; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Franke, Lude; Smith, George Davey; Strachan, David P.; Hirschhorn, Joel N.		GIANT Consortium	Genome-wide Analysis of Body Proportion Classifies Height-Associated Variants by Mechanism of Action and Implicates Genes Important for Skeletal Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR RISK-FACTORS; LEG LENGTH; ADULT HEIGHT; GROWTH; HEART; COMPONENTS; TBX2; INTEGRATION; EXPRESSION; IMPUTATION	Human height is a composite measurement, reflecting the sum of leg, spine, and head lengths. Many common variants influence total height, but the effects of these or other variants on the components of height (body proportion) remain largely unknown. We studied sitting height ratio (SHR), the ratio of sitting height to total height, to identify such effects in 3,545 African Americans and 21,590 individuals of European ancestry. We found that SHR is heritable: 26% and 39% of the total variance of SHR can be explained by common variants in European and African Americans, respectively, and global European admixture is negatively correlated with SHR in African Americans (r(2) approximate to 0.03). Six regions reached genome-wide significance (p < 5 x 10(-8)) for association with SHR and overlapped biological candidate genes, including TBX2 and IGFBP3. We found that 130 of 670 height-associated variants are nominally associated (p < 0.05) with SHR, more than expected by chance (p = 5 x 10(-40)). At these 130 loci, the height-increasing alleles are associated with either a decrease (71 loci) or increase (59 loci) in SHR, suggesting that different height loci disproportionally affect either leg length or spine/head length. Pathway analyses via DEPICT revealed that height loci affecting SHR, and especially those affecting leg length, show enrichment of different biological pathways (e.g., bone/cartilage/growth plate pathways) than do loci with no effect on SHR (e.g., embryonic development). These results highlight the value of using a pair of related but orthogonal phenotypes, in this case SHR with height, as a prism to dissect the biology underlying genetic associations in polygenic traits and diseases.	[Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Hirschhorn, Joel N.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Hirschhorn, Joel N.] Harvard Univ, Cambridge, MA 02142 USA; [Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Guo, Michael H.; Lim, Elaine T.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Chan, Yingleong; Salem, Rany M.; Hsu, Yu-Han H.; Pers, Tune H.; Vedantam, Sailaja; Esko, Tonu; Lim, Elaine T.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Chan, Yingleong] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [McMahon, George; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Smith, George Davey] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol BS8 2PR, Avon, England; [Strachan, David P.] Univ London, Populat Hlth Res Inst, London SW17 0RE, England	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Bristol; University of Tartu; University of Groningen; University of Bristol; University of London	Chan, YL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	rigel@broadinstitute.org; joelh@broadinstitute.org	Franke, Lude/P-7036-2016; Lim, Elaine/H-9032-2016; Davey Smith, George/A-7407-2013	Franke, Lude/0000-0002-5159-8802; Davey Smith, George/0000-0002-1407-8314; Pers, Tune/0000-0003-0207-4831; Lim, Teng Ting/0000-0003-3651-0654; s, hema/0000-0002-3440-9475; Salem, Rany/0000-0001-8816-6862; Esko, Tonu/0000-0003-1982-6569; Venkatasubramanian, Siddharth/0000-0002-5860-0768	NIH [R01DK075787]; March of Dimes [6-FY12-393]; NIH-NHLBI K99 award [1K99HL122515-01A1]; Juvenile Diabetes Research Foundation (JDRF) [3-APF-2014-111-A-N]; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G1001799, MC_PC_15018, MR/N01104X/1, MC_UU_12013/1] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787] Funding Source: NIH RePORTER; MRC [MC_UU_12013/1, G1001799, MR/N01104X/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NIH-NHLBI K99 award; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication is the work of the authors and Y.C. and J.N.H. will serve as guarantors for the contents of this paper. This research was specifically funded by NIH grant R01DK075787 and March of Dimes grant 6-FY12-393 to J.N.H. R.M.S. was supported by an NIH-NHLBI K99 award (#1K99HL122515-01A1) and advanced postdoctoral fellowship award from the Juvenile Diabetes Research Foundation (JDRF # 3-APF-2014-111-A-N). Acknowledgments for each of the cohorts used in this study can be found in the Supplemental Data.	Agwu JC, 1999, ARCH DIS CHILD, V80, P339, DOI 10.1136/adc.80.4.339; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballif BC, 2010, AM J HUM GENET, V86, P454, DOI 10.1016/j.ajhg.2010.01.038; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Cheng I, 2007, J CLIN ENDOCR METAB, V92, P3660, DOI 10.1210/jc.2007-0790; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Arriba Muñoz Antonio, 2013, Arch. argent. pediatr., V111, P309, DOI [10.5546/aap.2013.309, 10.5546/aap.2013.eng.309]; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Geller F, 2014, NAT GENET, V46, P957, DOI 10.1038/ng.3063; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; HERTEL NT, 1994, J PEDIATR ENDOCRINOL, V7, P155; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radio FC, 2010, AM J MED GENET A, V152A, P2061, DOI 10.1002/ajmg.a.33506; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; STOKES DC, 1988, CHEST, V93, P364, DOI 10.1378/chest.93.2.364; Strachan DP, 2007, INT J EPIDEMIOL, V36, P522, DOI 10.1093/ije/dyl309; Tilling K, 2006, AM J EPIDEMIOL, V164, P136, DOI 10.1093/aje/kwj184; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; van der Valk RJP, 2015, HUM MOL GENET, V24, P1155, DOI 10.1093/hmg/ddu510; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	54	41	41	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					695	708		10.1016/j.ajhg.2015.02.018	http://dx.doi.org/10.1016/j.ajhg.2015.02.018			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25865494	Green Published, Bronze			2022-12-18	WOS:000354189300001
J	Nakayama, T; Al-Maawali, A; El-Quessny, M; Rajab, A; Khalil, S; Stoler, JM; Tan, WH; Nasir, R; Schmitz-Abe, K; Hill, RS; Partlow, JN; Al-Saffar, M; Servattalab, S; LaCoursiere, CM; Tambunan, DE; Coulter, ME; Elhosary, PC; Gorski, G; Barkovich, AJ; Markianos, K; Poduri, A; Mochida, GH				Nakayama, Tojo; Al-Maawali, Almundher; El-Quessny, Malak; Rajab, Anna; Khalil, Samir; Stoler, Joan M.; Tan, Wen-Hann; Nasir, Ramzi; Schmitz-Abe, Klaus; Hill, R. Sean; Partlow, Jennifer N.; Al-Saffar, Muna; Servattalab, Sarah; LaCoursiere, Christopher M.; Tambunan, Dimira E.; Coulter, Michael E.; Elhosary, Princess C.; Gorski, Grzegorz; Barkovich, A. James; Markianos, Kyriacos; Poduri, Annapurna; Mochida, Ganeshwaran H.			Mutations in PYCR2, Encoding Pyrroline-5-Carboxylate Reductase 2, Cause Microcephaly and Hypomyelination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUTIS LAXA; PROTEIN; MITOCHONDRIA; METABOLISM	Despite recent advances in understanding the genetic bases of microcephaly, a large number of cases of microcephaly remain unexplained, suggesting that many microcephaly syndromes and associated genes have yet to be identified. Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral whitematter volume. Linkage mapping and wholeexome sequencing identified homozygous mutations (c.355C>T [p.Arg119Cys] and c.751C>T [p.Arg251Cys]) in PYCR2 in the affected individuals of two consanguineous families. A lymphoblastoid cell line from one affected individual showed a strong reduction in the amount of PYCR2. When mutant cDNAs were transfected into HEK293FT cells, both variant proteins retained normal mitochondrial localization but had lower amounts than the wildtype protein, suggesting that the variant proteins were less stable. A PYCR2deficient HEK293FT cell line generated by genome editing with the clustered regularly interspaced short palindromic repeat (CRISPR)Cas9 system showed that PYCR2 loss of function led to decreased mitochondrial membrane potential and increased susceptibility to apoptosis under oxidative stress. Morpholinobased knockdown of a zebrafish PYCR2 ortholog, pycr1b, recapitulated the human microcephaly phenotype, which was rescued by wildtype human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants. Hypomyelination and the absence of lax, wrinkly skin distinguishes this condition from that caused by previously reported mutations in the gene encoding PYCR2's isozyme, PYCR1, suggesting a unique and indispensable role for PYCR2 in the human CNS during development.	[Nakayama, Tojo; Al-Maawali, Almundher; El-Quessny, Malak; Stoler, Joan M.; Tan, Wen-Hann; Schmitz-Abe, Klaus; Hill, R. Sean; Partlow, Jennifer N.; Al-Saffar, Muna; Servattalab, Sarah; Coulter, Michael E.; Elhosary, Princess C.; Markianos, Kyriacos; Mochida, Ganeshwaran H.] Boston Childrens Hosp, Div Genet & Genom, Dept Med, Boston, MA 02115 USA; [Nakayama, Tojo; Al-Maawali, Almundher; El-Quessny, Malak; Schmitz-Abe, Klaus; Hill, R. Sean; Partlow, Jennifer N.; Al-Saffar, Muna; Servattalab, Sarah; Coulter, Michael E.; Elhosary, Princess C.; Markianos, Kyriacos; Mochida, Ganeshwaran H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Nakayama, Tojo; Stoler, Joan M.; Tan, Wen-Hann; Nasir, Ramzi; Schmitz-Abe, Klaus; Markianos, Kyriacos; Mochida, Ganeshwaran H.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Al-Maawali, Almundher] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Genet, Muscat 123, Oman; [Rajab, Anna] Minist Hlth, Natl Genet Ctr, Directorate Gen Hlth Affairs, Muscat 113, Oman; [Khalil, Samir] Al Makassed Islamic Charitable Soc Hosp, Dept Pediat, IL-91220 Jerusalem, Israel; [Khalil, Samir] Al Quds Univ, Fac Med, IL-90612 Jerusalem, Israel; [Nasir, Ramzi] Boston Childrens Hosp, Div Dev Med, Dept Med, Boston, MA 02115 USA; [Schmitz-Abe, Klaus; Markianos, Kyriacos] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hill, R. Sean; Partlow, Jennifer N.; Al-Saffar, Muna; Servattalab, Sarah; Coulter, Michael E.; Elhosary, Princess C.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Al-Saffar, Muna] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; [LaCoursiere, Christopher M.; Tambunan, Dimira E.; Elhosary, Princess C.; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Coulter, Michael E.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gorski, Grzegorz] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Cellular Neurosci Core, Boston, MA 02115 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Poduri, Annapurna] Boston Childrens Hosp, Epilepsy Genet Program, Boston, MA 02115 USA; [Poduri, Annapurna] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Sultan Qaboos University; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; United Arab Emirates University; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mochida, GH (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Dept Med, Boston, MA 02115 USA.	ganesh.mochida@childrens.harvard.edu	Khalil, Samir/AAW-4179-2021	Markianos, Kyriacos/0000-0003-0214-6014; El-Quessny, Malak/0000-0001-8260-4171; Tan, Wen-Hann/0000-0002-1593-6149; Schmitz-Abe, Klaus E./0000-0002-7242-8861; Al-Maawali, Almundher/0000-0002-1404-8887; Mochida, Ganeshwaran/0000-0001-7912-4097	Manton Center for Orphan Disease Research; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS035129]; NIH Fogarty International Center [R21TW008223]; Dubai Harvard Foundation for Medical Research; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; NINDS [1K23 NS069784]; Boston Children's Hospital Translational Research Program; F. Hoffmann-La Roche; Qatar National Research Fund; Boston Children's Hospital Faculty Career Development Award; Medical Research Council [099175/Z/12/Z]; Wellcome Trust [099175/Z/12/Z]; Medical Research Council [MC_PC_15004, G0700089] Funding Source: researchfish; MRC [MC_PC_15004, G0700089] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R21TW008223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, K23NS069784] Funding Source: NIH RePORTER	Manton Center for Orphan Disease Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Dubai Harvard Foundation for Medical Research; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Boston Children's Hospital Translational Research Program; F. Hoffmann-La Roche(Hoffmann-La Roche); Qatar National Research Fund(Qatar National Research Fund (QNRF)); Boston Children's Hospital Faculty Career Development Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the Manton Center for Orphan Disease Research, National Institute of Neurological Disorders and Stroke (NINDS, R01NS035129), NIH Fogarty International Center (R21TW008223), and the Dubai Harvard Foundation for Medical Research. T.N. was supported by fellowship grants from the Japan Foundation for Pediatric Research and the Japan Epilepsy Research Foundation. A.P. was supported by the NINDS (1K23 NS069784) and the Boston Children's Hospital Translational Research Program. G.H.M. was also supported by grants from F. Hoffmann-La Roche, the Qatar National Research Fund, and the Boston Children's Hospital Faculty Career Development Award. Human embryonic material was provided by the joint Medical Research Council and Wellcome Trust (grant 099175/Z/12/Z) Human Developmental Biology Resource (www.HDBR.org). We thank the families for their participation in this research, Dr. Gilad D. Evrony for help with RNA sequencing, Dr. Xiaochang Zhang, Dr. Aldo Rozzo, Dr. Byoung-Il Bae, Ms. Rachel E. Reiff, and Dr. Anthony D. Hill for technical assistance, and Dr. Christopher A. Walsh and Dr. Gerard T. Berry for helpful discussions and critical comments on the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; de Koning TJ, 2000, NEUROPEDIATRICS, V31, P287, DOI 10.1055/s-2000-12944; Dimopoulou A, 2013, MOL GENET METAB, V110, P352, DOI 10.1016/j.ymgme.2013.08.009; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GENCIC S, 1989, AM J HUM GENET, V45, P435; Guernsey DL, 2009, AM J HUM GENET, V85, P120, DOI 10.1016/j.ajhg.2009.06.008; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Pouwels PJW, 2014, ANN NEUROL, V76, P5, DOI 10.1002/ana.24194; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Sahai I, 2014, NEW ENGL J MED, V371, P847, DOI 10.1056/NEJMcpc1400833; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; Yan HL, 2006, NEUROREPORT, V17, P55, DOI 10.1097/01.wnr.0000192733.00535.b6; Yildirim Y, 2011, AM J MED GENET A, V155A, P134, DOI 10.1002/ajmg.a.33747; Ying WH, 2007, J NEUROIMMUNE PHARM, V2, P270, DOI 10.1007/s11481-007-9063-5; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	34	41	42	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					709	719		10.1016/j.ajhg.2015.03.003	http://dx.doi.org/10.1016/j.ajhg.2015.03.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25865492	Green Published, Bronze			2022-12-18	WOS:000354189300002
J	Weaver, KN; Watt, KEN; Hufnagel, RB; Acedo, JN; Linscott, LL; Sund, KL; Bender, PL; Konig, R; Lourenco, CM; Hehr, U; Hopkin, RJ; Lohmann, DR; Trainor, PA; Wieczorek, D; Saal, HM				Weaver, K. Nicole; Watt, Kristin E. Noack; Hufnagel, Robert B.; Acedo, Joaquin Navajas; Linscott, Luke L.; Sund, Kristen L.; Bender, Patricia L.; Koenig, Rainer; Lourenco, Charles M.; Hehr, Ute; Hopkin, Robert J.; Lohmann, Dietmar R.; Trainor, Paul A.; Wieczorek, Dagmar; Saal, Howard M.			Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA-POLYMERASE I; RIBOSOMAL-RNA; GENE-TRANSCRIPTION; P53; COLLINSSYNDROME,TREACHER; PATHOGENESIS; INHIBITION; BIOGENESIS; GENERATION; MUTATIONS	We report three individuals with a cranioskeletal malformation syndrome that we define as acrofacial dysostosis, Cincinnati type. Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1. All three individuals exhibit varying degrees of mandibulofacial dysostosis, and two additionally have limb anomalies. Consistent with this observation, we discovered that polr1a mutant zebrafish exhibited cranioskeletal anomalies mimicking the human phenotype. polr1a loss of function led to perturbed ribosome biogenesis and p53-dependent cell death, resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies. Our findings expand the genotypic and phenotypic heterogeneity of congenital acrofacial disorders caused by disruption of ribosome biogenesis.	[Weaver, K. Nicole; Hufnagel, Robert B.; Sund, Kristen L.; Bender, Patricia L.; Hopkin, Robert J.; Saal, Howard M.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Weaver, K. Nicole; Hufnagel, Robert B.; Sund, Kristen L.; Bender, Patricia L.; Hopkin, Robert J.; Saal, Howard M.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Watt, Kristin E. Noack; Acedo, Joaquin Navajas; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Watt, Kristin E. Noack; Trainor, Paul A.] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA; [Linscott, Luke L.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Koenig, Rainer] Univ Klinikum Frankfurt, Inst Humangenet, D-60596 Frankfurt, Germany; [Lourenco, Charles M.] Univ Sao Paulo, Neurogenet Unit, Clin Hosp Ribeirao Preto, BR-14049900 Sao Paulo, Brazil; [Hehr, Ute] Univ Klinikum Regensburg, Zentrum Humangenet, D-93053 Regensburg, Germany; [Lohmann, Dietmar R.; Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Cincinnati Children's Hospital Medical Center; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universidade de Sao Paulo; University of Regensburg; University of Duisburg Essen	Weaver, KN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, MLC 4006,3333 Burnet Ave, Cincinnati, OH 45229 USA.	kathryn.weaver@cchmc.org	Lohmann, Dietmar R./X-4895-2019; Wieczorek, Dagmar/AAU-6008-2021; Lohmann, Dietmar R/B-4041-2013	Lohmann, Dietmar R./0000-0002-2624-9889; Wieczorek, Dagmar/0000-0003-2812-6492; Lohmann, Dietmar R/0000-0002-2624-9889; Hufnagel, Robert/0000-0003-3015-3545; Navajas Acedo, Joaquin/0000-0003-2855-6660; Saal, Howard/0000-0002-0277-4777; Trainor, Paul/0000-0003-2774-3624; Linscott, Luke/0000-0001-6074-0789	German Federal Ministry of Education and Research (BMBF) [01GM1211B, 01GM1109B]; National Research Service Award F31 fellowship from the National Institute for Dental and Craniofacial Research [DE023017]; Stowers Institute for Medical Research; National Institute for Dental and Craniofacial Research [DE016082]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE023017, R01DE016082] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Research Service Award F31 fellowship from the National Institute for Dental and Craniofacial Research; Stowers Institute for Medical Research; National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to the affected individuals and their families for participating in this study. We thank Daniela Falkenstein for excellent technical assistance, Angela Newton for assistance in cloning zebrafish polr1a, and Diana Baumann and the Reptile and Aquatic Facility at the Stowers Institute for excellent zebrafish breeding, maintenance, and care. We would like to thank the Nancy Hopkins laboratory for generating the polr1a<SUP>hi3639Tg</SUP> zebrafish and Dr. Adam Amsterdam for providing primer sequences for genotyping. The sox10:gfp zebrafish were a kind gift from Dr. Thomas Schilling. This work was supported by German Federal Ministry of Education and Research (BMBF) grants 01GM1211B and 01GM1109B to D.W., a National Research Service Award F31 (DE023017) fellowship from the National Institute for Dental and Craniofacial Research to K.E.N.W., Stowers Institute for Medical Research funding to P.A.T., and National Institute for Dental and Craniofacial Research grant DE016082 to P.A.T.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hansen M, 1996, AM J MED GENET, V61, P71, DOI 10.1002/(SICI)1096-8628(19960102)61:1<71::AID-AJMG14>3.0.CO;2-T; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Neben CL, 2014, HUM MOL GENET, V23, P5659, DOI 10.1093/hmg/ddu282; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STOLL C, 1989, CLIN GENET, V35, P88; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Trainor PA, 2014, BBA-MOL BASIS DIS, V1842, P769, DOI 10.1016/j.bbadis.2013.11.010; Trainor PA, 2013, AM J MED GENET C, V163, P283, DOI 10.1002/ajmg.c.31375; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wieczorek D, 2013, CLIN GENET, V83, P499, DOI 10.1111/cge.12123; Wieczorek D, 2014, AM J HUM GENET, V95, P698, DOI 10.1016/j.ajhg.2014.10.014; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473	38	41	43	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					765	774		10.1016/j.ajhg.2015.03.011	http://dx.doi.org/10.1016/j.ajhg.2015.03.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25913037	Green Published, Bronze			2022-12-18	WOS:000354189300007
J	Cacciagli, P; Sutera-Sardo, J; Borges-Correia, A; Roux, JC; Dorboz, I; Desvignes, JP; Badens, C; Delepine, M; Lathrop, M; Cau, P; Levy, N; Girard, N; Sarda, P; Boespflug-Tanguy, O; Villard, L				Cacciagli, Pierre; Sutera-Sardo, Julie; Borges-Correia, Ana; Roux, Jean-Christophe; Dorboz, Imen; Desvignes, Jean-Pierre; Badens, Catherine; Delepine, Marc; Lathrop, Mark; Cau, Pierre; Levy, Nicolas; Girard, Nadine; Sarda, Pierre; Boespflug-Tanguy, Odile; Villard, Laurent			Mutations in BCAP31 Cause a Severe X-Linked Phenotype with Deafness, Dystonia, and Central Hypomyelination and Disorganize the Golgi Apparatus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOPLASMIC-RETICULUM; CONTIGUOUS DELETION; BAP31; PROTEIN; DEGRADATION; DISORDERS; DXS1357E; ABCD1; ER	BAP31 is one of the most abundant endoplasmic reticulum (ER) membrane proteins. It is a chaperone protein involved in several pathways, including ER-associated degradation, export of ER proteins to the Golgi apparatus, and programmed cell death. BAP31 is encoded by BCAP31, located in human Xq28 and highly expressed in neurons. We identified loss-of-function mutations in BCAP31 in seven individuals from three families. These persons suffered from motor and intellectual disabilities, dystonia, sensorineural deafness, and white-matter changes, which together define an X-linked syndrome. In the primary fibroblasts of affected individuals, we found that BCAP31 deficiency altered ER morphology and caused a disorganization of the Golgi apparatus in a significant proportion of cells. Contrary to what has been described with transient-RNA-interference experiments, we demonstrate that constitutive BCAP31 deficiency does not activate the unfolded protein response or cell-death effectors. Rather, our data demonstrate that the lack of BAP31 disturbs ER metabolism and impacts the Golgi apparatus, highlighting an important role for BAP31 in ER-to-Golgi crosstalk. These findings provide a molecular basis for a Mendelian syndrome and link intracellular protein trafficking to severe congenital brain dysfunction and deafness.	[Cacciagli, Pierre; Sutera-Sardo, Julie; Borges-Correia, Ana; Roux, Jean-Christophe; Desvignes, Jean-Pierre; Badens, Catherine; Cau, Pierre; Levy, Nicolas; Villard, Laurent] INSERM, UMR S 910, F-13385 Marseille, France; [Cacciagli, Pierre; Sutera-Sardo, Julie; Borges-Correia, Ana; Roux, Jean-Christophe; Desvignes, Jean-Pierre; Badens, Catherine; Cau, Pierre; Levy, Nicolas; Girard, Nadine; Villard, Laurent] Aix Marseille Univ, Fac Med Timone, F-13385 Marseille, France; [Cacciagli, Pierre; Badens, Catherine; Levy, Nicolas] Hop Enfants La Timone, Dept Med Genet, F-13385 Marseille, France; [Dorboz, Imen; Boespflug-Tanguy, Odile] Univ Paris Diderot, Hop Robert Debre, Sorbonne Paris Cite, INSERM,U676, F-75019 Paris, France; [Delepine, Marc; Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, F-91000 Evry, France; [Lathrop, Mark] Fdn Jean Dausset, Ctr Etude Polymorphisme Humain, F-75010 Paris, France; [Cau, Pierre] Hop Enfants La Timone, Lab Biol Cellulaire, F-13385 Marseille, France; [Girard, Nadine] Hop La Timone, Serv Neuroradiol, F-13385 Marseille, France; [Sarda, Pierre] Hop Arnaud Villeneuve, Dept Med Genet, F-34295 Montpellier, France; [Boespflug-Tanguy, Odile] Hop Robert Debre, AP HP, Ctr Reference Malad Rares Leucodystrophie, Serv Neuropediat & Malad Metabol, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Villard, L (corresponding author), INSERM, UMR S 910, F-13385 Marseille, France.	laurent.villard@univ-amu.fr	Girard, Nadine/B-7109-2017; Villard, Laurent/E-3941-2016; Cau, Pierre/M-3541-2016; , Girard/E-8537-2013; Badens, Catherine/J-8727-2016; LEVY, Nicolas/J-1632-2014; Desvignes, Jean-Pierre/I-2858-2016; Roux, Jean-Christophe/S-2563-2016	Villard, Laurent/0000-0001-6657-5008; , Girard/0000-0001-8639-9275; Badens, Catherine/0000-0001-9024-310X; LEVY, Nicolas/0000-0001-5171-6365; Desvignes, Jean-Pierre/0000-0003-3142-1994; Roux, Jean-Christophe/0000-0002-9721-8844	INSERM; Aix-Marseille Universite; European Association against Leukodystrophy (ELA) Foundation [ELA 2009-00714]; Agence Nationale de la Recherche Labex project "Medical Genomics"	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille Universite; European Association against Leukodystrophy (ELA) Foundation; Agence Nationale de la Recherche Labex project "Medical Genomics"(French National Research Agency (ANR))	We thank Pascale Fanen and Frederic Becq for the gift of the Delta F508CFTR plasmids. We thank Caroline Lacoste and the Centre de Ressources Biologiques of Hopital d'Enfants de la Timone (Karine Bertaux, Cecile Mouradian, and Andree Robaglia-Schlupp) for assistance with the cell lines used in this study. We thank Joel Courageot and Alexandre Altie from the Service Commun de Microscopie Electronique of the Faculte de Medecine de Marseille and Eleonore Eymard Pierre (Cytogenetique, Centre Hospitalier Universitaire de Clermont Ferrand, France) for providing affected-individual samples from the LeukoFrance biobank. This work was supported by funding from INSERM and Aix-Marseille Universite to L.V. and from the European Association against Leukodystrophy (ELA) Foundation (ELA 2009-00714) to O.B.T. and was supported in part by funding from Agence Nationale de la Recherche Labex project "Medical Genomics" to M.L.	Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Corzo D, 2002, AM J HUM GENET, V70, P1520, DOI 10.1086/340849; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Iwasa M, 2013, NEUROPATHOLOGY, V33, P292, DOI 10.1111/j.1440-1789.2012.01348.x; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Manley HA, 2001, J HISTOCHEM CYTOCHEM, V49, P1235, DOI 10.1177/002215540104901005; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Osaka H, 2012, MOL GENET METAB, V106, P43, DOI 10.1016/j.ymgme.2012.02.018; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Roboti P, 2009, J CELL SCI, V122, P3942, DOI 10.1242/jcs.055160; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042	19	41	42	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					579	586		10.1016/j.ajhg.2013.07.023	http://dx.doi.org/10.1016/j.ajhg.2013.07.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	24011989	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000330268900018
J	Cheung, CYK; Thompson, EA; Wijsman, EM				Cheung, Charles Y. K.; Thompson, Elizabeth A.; Wijsman, Ellen M.			GIGI: An Approach to Effective Imputation of Dense Genotypes on Large Pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; GENETIC-LINKAGE; RARE VARIANTS; MISSING GENOTYPES; COMMON DISEASE; DATA SETS; DESCENT; MARKERS; INFERENCE	Recent emergence of the common-disease-rare-variant hypothesis has renewed interest in the use of large pedigrees for identifying rare causal variants Genotyping with modem sequencing platforms is increasingly common in the search for such variants but remains expensive and often is limited to only a few subjects per pedigree. In population-based samples, genotype imputation is widely used so that additional genotyping is not needed. We now introduce an analogous approach that enables computationally efficient imputation in large pedigrees. Our approach samples inheritance vectors (IVs) from a Markov Chain Monte Carlo sampler by conditioning on genotypes from a sparse set of framework markers. Missing genotypes are probabilistically inferred from these IVs along with observed dense genotypes that are available on a subset of subjects. We implemented our approach in the Genotype Imputation Given Inheritance (GIGI) program and evaluated the approach on both simulated and real large pedigrees. With a real pedigree, we also compared imputed results obtained from this approach with those from the population-based imputation program BEAGLE. We demonstrated that our pedigree-based approach imputes many alleles with high accuracy. It is much more accurate for calling rare alleles than is population-based imputation and does not require an outside reference sample. We also evaluated the effect of varying other parameters, including the marker type and density of the framework panel, threshold for calling genotypes, and population allele frequencies. By leveraging information from existing genotypes already assayed on large pedigrees, our approach can facilitate cost-effective use of sequence data in the pursuit of rare causal variants.	[Cheung, Charles Y. K.; Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Thompson, Elizabeth A.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wijsman, EM (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	wijsman@u.washington.edu		Wijsman, Ellen/0000-0002-2725-6669	National Institutes of Health [R37GM046255, P01HL030086, P50AG05136, R01MH094293, R01MH092367]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094293, R01MH092367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from the National Institutes of Health grants R37GM046255, P01HL030086, P50AG05136, R01MH094293, and R01MH092367.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 2004, BEHAV GENET, V34, P173, DOI 10.1023/B:BEGE.0000013731.03827.69; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Baum LE, 1972, INEQUALITIES, V3, P1; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Chen WM, 2006, GENET EPIDEMIOL, V30, P471, DOI 10.1002/gepi.20160; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Daetwyler HD, 2011, GENETICS, V189, P317, DOI 10.1534/genetics.111.128082; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Elston RC, 1997, AM J HUM GENET, V60, P255; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Haldane JBS, 1919, J GENET, V8, P299; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Krithika S, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-12; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024945; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Little RJ, 1987, STAT ANAL MISSING DA; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Rosenthal EA, 2011, J LIPID RES, V52, P1837, DOI 10.1194/jlr.P016576; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thomas DC, 2009, STAT SCI, V24, P414, DOI 10.1214/09-STS288; THOMPSON EA, 1999, LECT NOTES MONOGRAPH, V33, P95; Thompson E, 2011, HUM HERED, V71, P86, DOI 10.1159/000313555; Tong LP, 2008, HUM HERED, V65, P142, DOI 10.1159/000109731; Wijsman EM, 2006, AM J HUM GENET, V79, P846, DOI 10.1086/508472; Wijsman EM, 2010, HUM GENET, V127, P705, DOI 10.1007/s00439-010-0819-2; Wijsman EM, 1998, ARTERIOSCL THROM VAS, V18, P215, DOI 10.1161/01.ATV.18.2.215; Wilcox MA, 2005, GENET EPIDEMIOL, V29, pS7, DOI 10.1002/gepi.20106	58	41	42	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					504	516		10.1016/j.ajhg.2013.02.011	http://dx.doi.org/10.1016/j.ajhg.2013.02.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23561844	Bronze, Green Published			2022-12-18	WOS:000317449700003
J	Tang, L; Wang, HF; Lu, X; Jian, XR; Jin, B; Zheng, H; Li, YQ; Wang, QY; Wu, TC; Guo, H; Liu, H; Guo, T; Yu, JM; Yang, R; Yang, Y; Hu, Y				Tang, Liang; Wang, Hua-Fang; Lu, Xuan; Jian, Xiao-Rong; Jin, Bi; Zheng, Hong; Li, Yi-Qing; Wang, Qing-Yun; Wu, Tang-Chun; Guo, Huan; Liu, Hui; Guo, Tao; Yu, Jian-Ming; Yang, Rui; Yang, Yan; Hu, Yu			Common Genetic Risk Factors for Venous Thrombosis in the Chinese Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-VEIN-THROMBOSIS; ACTIVATED PROTEIN-C; POOR ANTICOAGULANT RESPONSE; GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; LECTIN-LIKE DOMAIN; THROMBOMODULIN GENE; MYOCARDIAL-INFARCTION; PLASMA THROMBOMODULIN; BLOOD-COAGULATION	Venous thrombosis is a major medical disorder caused by both genetic and environmental factors. Little is known about the genetic background of venous thrombosis in the Chinese population. A total of 1,304 individuals diagnosed with a first venous thrombosis and 1,334 age- and sex-matched healthy participants were enrolled in this study. Resequencing of THBD (encoding thrombomodulin) in 60 individuals with venous thrombosis and 60 controls and a functional assay showed that a common variant, c.-151G>T (rs16984852), in the 5' UTR significantly reduced the gene expression and could cause a predisposition to venous thrombosis. Therefore, this variant was genotyped in a case-control study, and results indicated that heterozygotes had a 2.80-fold (95% confidence interval = 1.88-4.29) increased risk of venous thrombosis. The THBD c.-151G>T variant Was further investigated in a family analysis involving 176 first-degree relatives from 38 index families. First-degree relatives with this variant had a 3.42-fold increased risk of venous thrombosis, and their probability of remaining thrombosis-free was significantly lower than that of relatives without the variant. In addition, five rare mutations that might be deleterious were also identified in thrombophilic individuals by sequencing. This study is the largest genetic investigation of venous thrombosis in the Chinese population. Further study on genetics of thrombosis should focus on resequencing of THBD and other hemostasis genes in different populations.	[Tang, Liang; Wang, Hua-Fang; Lu, Xuan; Jian, Xiao-Rong; Wang, Qing-Yun; Liu, Hui; Guo, Tao; Yu, Jian-Ming; Yang, Rui; Yang, Yan; Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan 430022, Hunan, Peoples R China; [Jin, Bi; Zheng, Hong; Li, Yi-Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan 430022, Hunan, Peoples R China; [Wu, Tang-Chun; Guo, Huan] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ, Key Lab Environm & Hlth, Wuhan 430022, Hunan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan 430022, Hunan, Peoples R China.	dr_huyu@126.com			National Basic Scientific Research Program of China (973 Program) [2007 CB935803]; National Natural Sciences Foundation of China [30825018]; State Ministry of Health Key Clinical Construction Project [58]; Chinese National Science and Technology Major Project; Mega-Project for New Drugs Development [2011ZX09302-002-01]	National Basic Scientific Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Ministry of Health Key Clinical Construction Project; Chinese National Science and Technology Major Project; Mega-Project for New Drugs Development	We are indebted to all of the participants in the MAGIC (multiple assessments of genetic risk factors for thrombophilia in the Chinese population) study and medical assistants of our hospital. Our special thanks go to the Department of Vascular Surgery (Union Hospital) and the Ministry of Education Key Lab for Environment and Health (Tongji Medical College). This work was supported by the National Basic Scientific Research Program of China (973 Program, No. 2007 CB935803), the National Natural Sciences Foundation of China (No. 30825018), the State Ministry of Health Key Clinical Construction Project (2010 No. 58), the Chinese National Science and Technology Major Project, and the Mega-Project for New Drugs Development (No. 2011ZX09302-002-01).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aleksic N, 2003, J THROMB HAEMOST, V1, P88; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Bounameaux H, 2011, CIRCULATION, V123, P2189, DOI 10.1161/CIRCULATIONAHA.111.031690; Christiansen SC, 2006, PLOS MED, V3, P1414, DOI 10.1371/journal.pmed.0030334; Corral J, 2004, CIRCULATION, V110, P1303, DOI 10.1161/01.CIR.0000140763.51679.D9; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Doggen CJM, 1998, CIRCULATION, V97, P1037, DOI 10.1161/01.CIR.97.11.1037; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Flinterman LE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001155; Hamasaki N, 2012, J THROMB HAEMOST, V10, P2016, DOI 10.1111/j.1538-7836.2012.04893.x; Heit JA, 2011, J THROMB HAEMOST, V9, P1133, DOI 10.1111/j.1538-7836.2011.04272.x; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Horowitz NA, 2011, BLOOD, V118, P2889, DOI 10.1182/blood-2011-03-341222; Ikeda S, 2011, CIRC J, V75, P1831, DOI 10.1253/circj.CJ-11-0623; Ireland H, 1997, CIRCULATION, V96, P15; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; JACKMAN RW, 1987, P NATL ACAD SCI USA, V84, P6425, DOI 10.1073/pnas.84.18.6425; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Kubisz P, 2005, J THROMB HAEMOST, V3, P2825, DOI 10.1111/j.1538-7836.2005.01655.x; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Kunz G, 2000, BLOOD, V95, P569, DOI 10.1182/blood.V95.2.569; Le Flem L, 1999, ARTERIOSCL THROM VAS, V19, P1098, DOI 10.1161/01.ATV.19.4.1098; Le Flem L, 2001, ARTERIOSCL THROM VAS, V21, P445, DOI 10.1161/01.ATV.21.3.445; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Meltzer ME, 2008, PLOS MED, V5, P751, DOI 10.1371/journal.pmed.0050097; Morange PE, 2011, J THROMB HAEMOST, V9, P258, DOI 10.1111/j.1538-7836.2011.04311.x; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Reny JL, 2005, THROMB HAEMOSTASIS, V94, P686; Roberts LN, 2009, BRIT J HAEMATOL, V146, P369, DOI 10.1111/j.1365-2141.2009.07786.x; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sakuma M, 2009, CIRC J, V73, P305, DOI 10.1253/circj.CJ-08-0372; Salomaa V, 1999, LANCET, V353, P1729, DOI 10.1016/S0140-6736(98)09057-6; Saposnik B, 2004, BLOOD, V103, P1311, DOI 10.1182/blood-2003-07-2520; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Stein PD, 2004, AM J MED, V116, P435, DOI 10.1016/j.amjmed.2003.11.020; Sugiyama S, 2007, THROMB RES, V119, P35, DOI 10.1016/j.thromres.2005.12.012; Tang L, 2012, J THROMB HAEMOST, V10, P2019, DOI 10.1111/j.1538-7836.2012.04862.x; Tang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035773; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wason JMS, 2012, AM J HUM GENET, V90, P760, DOI 10.1016/j.ajhg.2012.03.007; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; White RH, 2005, THROMB HAEMOSTASIS, V93, P298, DOI 10.1160/TH04-08-0506; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Wu KK, 2012, BLOOD, V119, P1103, DOI 10.1182/blood-2011-12-394544; Wu KK, 2001, CIRCULATION, V103, P1386, DOI 10.1161/01.CIR.103.10.1386; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026861; Zakai NA, 2011, J THROMB HAEMOST, V9, P1877, DOI 10.1111/j.1538-7836.2011.04443.x	60	41	51	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					177	187		10.1016/j.ajhg.2012.12.013	http://dx.doi.org/10.1016/j.ajhg.2012.12.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332921	Green Published, Bronze			2022-12-18	WOS:000315179600002
J	Ionita-Laza, I; Makarov, V; Buxbaum, JD				Ionita-Laza, Iuliana; Makarov, Vlad; Buxbaum, Joseph D.		ARRA Autism Sequencing Consortium	Scan-Statistic Approach Identifies Clusters of Rare Disease Variants in LRP2, a Gene Linked and Associated with Autism Spectrum Disorders, in Three Datasets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR-RELATED PROTEIN; DNA-SEQUENCING DATA; DEVELOPMENTAL DELAY; MUTATIONS; FRAMEWORK; COMMON; CHROMOSOME-2; DISCOVERY; LINKAGE; NETWORK	Cluster-detection approaches, commonly used in epidemiology and astronomy, can be applied in the context of genetic sequence data for the identification of genetic regions significantly enriched with rare disease-risk variants (DRVs). Unlike existing association tests for sequence data, the goal of cluster-detection methods is to localize significant disease mutation clusters within a gene or region of interest. Here, we focus on a chromosome 2q replicated linkage region that is associated with autism spectrum disorder (ASD) and that has been sequenced in three independent datasets. We found that variants in one gene, LRP2, residing on 2q are associated with ASD in two datasets (the combined variable-threshold-test p value is 1.2 x 10(-5)). Using a cluster-detection method, we show that in the discovery and replication datasets, variants associated with ASD cluster preponderantly in 25 kb windows (adjusted p values are p(1) = 0.003 and p(2) = 0.002), and the two windows are highly overlapping. Furthermore, for the third dataset, a 25 kb region similar to those in the other two datasets shows significant evidence of enrichment of rare DRVs. The region implicated by all three studies is involved in ligand binding, suggesting that subtle alterations in either LRP2 expression or LRP2 primary sequence modulate the uptake of LRP2 ligands. BMP4 is a ligand of particular interest given its role in forebrain development, and modest changes in BMP4 binding, which binds to LRP2 near the mutation cluster, might subtly affect development and could lead to autism-associated phenotypes.	[Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Makarov, Vlad; Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10032 USA.	ii2135@columbia.eclu; joseph.buxbaum@mssm.edu	Sutcliffe, James S/C-1348-2012; Buxbaum, Joseph D/G-6001-2010	Sutcliffe, James S/0000-0001-5200-6007; Buxbaum, Joseph/0000-0001-8898-8313	National Science Foundation [DMS-1100279]; National Institutes of Health [R01MH095797, 1R03HG005908, MH089025]; Seaver Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG005908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089025, R01MH095797] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1100279] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The research was partially supported by National Science Foundation grant DMS-1100279 and National Institutes of Health grants R01MH095797 and 1R03HG005908 to I.I.-L. and a Seaver Foundation grant and National Institutes of Health grant MH089025 to J.D.B. The lead investigators for the ARRA Autism Sequencing Consortium are the following: Eric Boerwinkle, Joseph D. Buxbaum, Edwin H. Cook, Jr., Mark J. Daly (communicating principal investigator), Bernie Devlin, Richard Gibbs, Kathryn Roeder, Aniko Sabo, Gerard D. Schellenberg, and James S. Sutcliffe. The full list of investigators is in the Supplemental Data.	Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; BISSLER JJ, 1994, P NATL ACAD SCI USA, V91, P9622, DOI 10.1073/pnas.91.20.9622; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; DAVIES RB, 1977, BIOMETRIKA, V64, P247, DOI 10.2307/2335690; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derwinska K, 2009, EUR J HUM GENET, V17, P267, DOI 10.1038/ejhg.2008.176; Faham M, 2005, P NATL ACAD SCI USA, V102, P14717, DOI 10.1073/pnas.0506677102; Frank RAW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019011; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Joshi Priya Shirish, 2012, Dent Res J (Isfahan), V9, P100, DOI 10.4103/1735-3327.92963; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Laccone F, 2001, HUM MUTAT, V17, P183, DOI 10.1002/humu.3; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015, 10.1016/j.ajhg.2011.07.015.]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muller EA, 2012, AM J MED GENET A, V158A, P391, DOI 10.1002/ajmg.a.34216; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; WALLENSTEIN S, 1987, STAT MED, V6, P197, DOI 10.1002/sim.4780060212; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	46	41	42	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1002	1013		10.1016/j.ajhg.2012.04.010	http://dx.doi.org/10.1016/j.ajhg.2012.04.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22578327	Green Published, Bronze			2022-12-18	WOS:000305262600006
J	Allen-Brady, K; Norton, PA; Farnham, JM; Teerlink, C; Cannon-Albright, LA				Allen-Brady, Kristina; Norton, Peggy A.; Farnham, James M.; Teerlink, Craig; Cannon-Albright, Lisa A.			Significant Linkage Evidence for a Predisposition Gene for Pelvic Floor Disorders on Chromosome 9q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRESS URINARY-INCONTINENCE; ORGAN PROLAPSE; PUBOCOCCYGEUS MUSCLE; MAJOR DEPRESSION; WOMEN; EPIDEMIOLOGY; DYSFUNCTION; PREVALENCE	Predisposition factors for pelvic floor disorders (PFDs), including pelvic organ prolapse (POP), stress urinary incontinence (SUI), urge urinary incontinence (UUI), and hernias, are not well understood. We assessed linkage evidence for PFDs in mostly sister pairs who received treatment for moderate-to-severe POP. We genotyped 70 affected women of European descent from 32 eligible families with at least two affected cases by using the Illumina 1 million single-nucleotide polymorphism (SNP) marker set. Parametric linkage analysis with general dominant and recessive models was performed by the Markov chain Monte Carlo linkage analysis method, MCLINK, and a set of SNPs was formed, from which those in high linkage disequilibrium were eliminated. Significant genome-wide evidence for linkage was identified on chromosome 9q21 with a HLOD score of 3.41 under a recessive model. Seventeen pedigrees (53%) had at least nominal evidence for linkage on a by-pedigree basis at this region. These results provide evidence for a predisposition gene for PFDs on chromosome 9q.	[Allen-Brady, Kristina; Farnham, James M.; Teerlink, Craig; Cannon-Albright, Lisa A.] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84105 USA; [Norton, Peggy A.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84105 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Allen-Brady, K (corresponding author), Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84105 USA.	kristina.allen@utah.edu		Farnham, James/0000-0002-8213-949X; Teerlink, Craig/0000-0002-1992-2326; albright, lisa/0000-0003-2602-3668	Eunice Kennedy Shriver National Institute for Child Health and Human Development [R01 HD0041163]	Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank two reviewers for their insightful comments, Alun Thomas for assistance with the latent p value method, Christine Olsen and Vivien Chang with sample collection, and Kim Nguyen in the laboratory. This work was presented at the International Continence Society annual meeting at Cairo, Egypt in October 2008. Research was supported by a grant from the Eunice Kennedy Shriver National Institute for Child Health and Human Development, R01 HD0041163 (Norton).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Allen-Brady K, 2009, MOL PSYCHIATR, V14, P590, DOI 10.1038/mp.2008.14; Allen-Brady Kristina, 2007, BMC Proc, V1 Suppl 1, pS160; Altman D, 2008, EUR UROL, V54, P918, DOI 10.1016/j.eururo.2007.12.004; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Bukovsky Antonin, 2001, BMC Clin Pathol, V1, P4, DOI 10.1186/1472-6890-1-4; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Camp NJ, 2005, AM J MED GENET B, V135B, P85, DOI 10.1002/ajmg.b.30177; DIOKNO AC, 1990, UROLOGY, V36, P129, DOI 10.1016/0090-4295(90)80211-5; Duffy DL, 2006, BEHAV GENET, V36, P4, DOI 10.1007/s10519-005-9015-x; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889; Harris RL, 1998, OBSTET GYNECOL, V92, P951, DOI 10.1016/S0029-7844(98)00286-5; Hundley AF, 2006, AM J OBSTET GYNECOL, V194, P1404, DOI 10.1016/j.ajog.2006.01.049; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lawrence JM, 2008, OBSTET GYNECOL, V111, P678, DOI 10.1097/AOG.0b013e3181660c1b; Mushkat Y, 1996, AM J OBSTET GYNECOL, V174, P617, DOI 10.1016/S0002-9378(96)70437-4; Nikolova G, 2007, HUM GENET, V120, P847, DOI 10.1007/s00439-006-0267-1; Nygaard I, 2006, SEMIN PERINATOL, V30, P267, DOI 10.1053/j.semperi.2006.07.007; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; SKONER MM, 1994, NURS RES, V43, P301; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; Thompson EA, 2007, BIOMETRIKA, V94, P49, DOI 10.1093/biomet/asm001; Visco AG, 2003, AM J OBSTET GYNECOL, V189, P102, DOI 10.1067/mob.2003.372	29	41	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					678	682		10.1016/j.ajhg.2009.04.002	http://dx.doi.org/10.1016/j.ajhg.2009.04.002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19393595	Green Published, Bronze			2022-12-18	WOS:000266338800013
J	Biswas, S; Scheinfeldt, LB; Akey, JM				Biswas, Shameek; Scheinfeldt, Laura B.; Akey, Joshua M.			Genome-wide Insights into the Patterns and Determinants of Fine-Scale Population Structure in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; GENOTYPE DATA; ASSOCIATION; STRATIFICATION; DISTANCE; HISTORY; EUROPE; MODEL	Studying genomic patterns of human population structure provides important insights into human evolutionary history and the relationship among populations, and it has significant practical implications for disease-gene mapping. Here we describe a principal component (PC)-based approach to Studying intracontinental population structure in humans, identify the underlying markers mediating the observed patterns of fine-scale population structure, and infer the predominating evolutionary forces shaping local population structure. We applied this methodology to a data set of 650K SNPs genotyped in 944 unrelated individuals from 52 populations and demonstrate that, although typical PC analyses focus on the top axes of variation, substantial information about population structure is contained in lower-ranked PCs. We identified 18 significant PCs, some of which distinguish individual populations. In addition to visually representing sample clusters in PC biplots, we estimated the set of all SNPs significantly correlated with each of the most informative axes of variation. These polymorphisms, unlike ancestry-informative markers (AIMs), constitute a much larger set of loci that drive genomic signatures of population structure. The genome-wide distribution of these significantly correlated markers can largely be accounted for by the stochastic effects of genetic drift, although significant clustering does Occur in genomic regions that have been previously implicated as targets of recent adaptive evolution.	[Biswas, Shameek; Scheinfeldt, Laura B.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	akeyj@u.washington.edu		Scheinfeldt, Laura/0000-0001-6529-6701; Biswas, Shameek/0000-0002-9372-1143; Akey, Joshua/0000-0002-4411-1330	National Institutes of Health [RO1 GM078105]; Sloan Research Fellowship in Computational Biology; National Human Genome Research Institute Interdisciplinary Training in Genomic Sciences [HG00035]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Fellowship in Computational Biology(Alfred P. Sloan Foundation); National Human Genome Research Institute Interdisciplinary Training in Genomic Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the members of the Akey lab for helpful discussion. This research was supported in part by National Institutes of Health grant RO1 GM078105 and the Sloan Research Fellowship in Computational Biology to J.M.A. and by a National Human Genome Research Institute Interdisciplinary Training in Genomic Sciences grant (HG00035) to L.B.S.	Akey JM, 2003, MOL BIOL EVOL, V20, P232, DOI 10.1093/molbev/msg032; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; AKEY JM, 2009, GENOME RES IN PRESS; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Sinnott R.W., 1984, SKY TELESCOPE, V68, P158, DOI DOI 10.3758/BRM.42.1.141; Team RC., 2022, R LANG ENV STAT COMP; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu N, 2002, GENETICS, V161, P269; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	50	41	41	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					641	650		10.1016/j.ajhg.2009.04.015	http://dx.doi.org/10.1016/j.ajhg.2009.04.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19442770	Bronze, Green Published			2022-12-18	WOS:000266338800008
J	Baralle, M; Pastor, T; Bussani, E; Pagani, F				Baralle, Marco; Pastor, Tibor; Bussani, Erica; Pagani, Franco			Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXONIC SPLICING ENHANCERS; SPINAL MUSCULAR-ATROPHY; DOT-TTC REPEATS; TRIPLET REPEATS; STICKY DNA; (GAA)(N)CENTER-DOT(TTC)(N) REPEATS; REGULATORY ELEMENTS; TERMINAL DOMAIN; FRATAXIN GENE; SR-PROTEINS	The intronic GAA repeat expansion in the frataxin (FXN) gene causes the hereditary neurodegenerative disorder Friedreich ataxia. Although it is generally believed that GAA repeats block transcription elongation, direct proof in eukaryotic systems is lacking. We tested in hybrid minigenes the effect of GAA and TTC repeats on nascent transcription and pre-mRNA processing. Unexpectedly, disease-causing GAA(100) repeats did not affect transcriptional elongation in a nuclear HeLa Run On assay, nor did they affect pre-mRNA transcript abundance. However, they did result in a complex defect in pre-mRNA processing. The insertion of GAA but not TTC repeats downstream of reporter exons resulted in their partial or complete exclusion from the mature mRNAs and in the generation of a variety of aberrant splicing products. This effect of GAA repeats was observed to be position and context dependent; their insertion at different distances from the reporter exons had a variable effect on splice-site selection. In addition, GAA repeats bind to a multitude of different splicing factors and induced the accumulation of an upstream pre-mRNA splicing intermediate, which is not turned over into mature mRNA. When embedded in the homologous frataxin minigene system, the GAA repeats did not affect the pre-mRNA transcript abundance but did significantly reduce the splicing efficiency of the first intron. These data indicate an association between GAA noncoding repeats and aberrant pre-mRNA processing because binding of transcribed GAA repeats to a multitude of trans-acting splicing factors can interfere with normal turnover of intronic RNA and thus lead to its degradation and a lower abundance of mature mRNA.	[Baralle, Marco; Pastor, Tibor; Bussani, Erica; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Pagani, F (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	pagani@icgeb.org	Baralle, Marco/A-7843-2013	Baralle, Marco/0000-0002-0417-1013; Pagani, Franco/0000-0002-2678-3459	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Clark RM, 2004, GENOMICS, V83, P373, DOI 10.1016/j.ygeno.2003.09.001; Clark RM, 2006, GENOMICS, V87, P57, DOI 10.1016/j.ygeno.2005.09.006; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Filla A, 1996, AM J HUM GENET, V59, P554; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Masuyama K, 2004, GENES CELLS, V9, P959, DOI 10.1111/j.1365-2443.2004.00774.x; Masuyama K, 2007, BIOCHEM BIOPH RES CO, V359, P580, DOI 10.1016/j.bbrc.2007.05.144; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MIFFLIN RC, 1991, J BIOL CHEM, V266, P19593; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pagani F, 2003, J BIOL CHEM, V278, P26580, DOI 10.1074/jbc.M212813200; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pandolfo M, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P373; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pollard LM, 2004, NUCLEIC ACIDS RES, V32, P5962, DOI 10.1093/nar/gkh933; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; Son LS, 2006, J MOL BIOL, V360, P267, DOI 10.1016/j.jmb.2006.05.025; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Taniguchi I, 2007, P NATL ACAD SCI USA, V104, P13684, DOI 10.1073/pnas.0704922104; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304	62	41	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					77	88		10.1016/j.ajhg.2008.06.018	http://dx.doi.org/10.1016/j.ajhg.2008.06.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18597733	Green Published, Bronze			2022-12-18	WOS:000257784000009
J	Hirayasu, K; Ohashi, J; Tanaka, H; Kashiwase, K; Ogawa, A; Takanashi, M; Satake, M; Jia, GJ; Chimge, NO; Sideltseva, EW; Tokunaga, K; Yabe, T				Hirayasu, Kouyuki; Ohashi, Jun; Tanaka, Hidenori; Kashiwase, Koichi; Ogawa, Atsuko; Takanashi, Minoko; Satake, Masahiro; Jia, Guan Jun; Chimge, Nyam-Osor; Sideltseva, Elena W.; Tokunaga, Katsushi; Yabe, Toshio			Evidence for natural selection on leukocyte immunoglobulin-like receptors for HLA class I in Northeast Asians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE-SCLEROSIS; CELL-RECEPTOR; HUMAN GENOME; FAMILY; POLYMORPHISMS; HAPLOTYPES; GENE; KIR; ASSOCIATION	Human leukocyte antigen (HLA) plays a critical role in innate and adaptive immunity and is a well-known example of genes under natural selection. However, the genetic aspect of receptors recognizing HLA molecules has not yet been fully elucidated. Leukocyte immunoglobulin (Ig)-like receptors (LILRs) are a family of HLA class I-recognizing receptors comprising activating and inhibitory forms. We previously reported that the allele frequency of the 6.7 kb LILRA3 deletion is extremely high (71%) in the Japanese population, and we identified premature termination codon (PTC)-containing alleles. In this study, we observed a wide distribution of the high deletion frequency in Northeast Asians (84% in Korean Chinese, 79% in Man Chinese, 56% in Mongolian, and 76% in Buryat populations). Genotyping of the four HapMap populations revealed that LILRA3 alleles were in strong linkage disequilibrium with LILRB2 alleles in Northeast Asians. In addition, PTC-containing LILRA3 alleles were detected in Northeast Asians but not in non-Northeast Asians. Furthermore, flow-cytometric analysis revealed that the LILRB2 allele frequent in Northeast Asians was significantly associated with low levels of expression. F-ST and extended-haplotype-homozygosity analysis for the HapMap populations provided evidence of positive selection acting on the LILRA3 and LILRB2 loci. Taken together, our results suggest that both the nonfunctional LILRA3 alleles and the low-expressing LILRB2 alleles identified in our study have increased in Northeast Asians because of natural selection. Our findings, therefore, lead us to speculate that not only HLA class I ligands but also their receptors might be sensitive to the local environment.	[Hirayasu, Kouyuki; Tanaka, Hidenori; Kashiwase, Koichi; Ogawa, Atsuko; Takanashi, Minoko; Satake, Masahiro; Yabe, Toshio] Tokyo Metropolitan Red Cross Blood Ctr, Tokyo 1358639, Japan; [Hirayasu, Kouyuki; Ohashi, Jun; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Jia, Guan Jun] Harbin Red Cross Blood Ctr, Harbin 150010, Peoples R China; [Chimge, Nyam-Osor] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Sideltseva, Elena W.] Russian Acad Sci, Siberian Branch, Int Dept Irkutsk Sci Ctr, Irkutsk 664033, Russia	University of Tokyo; Yale University; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences	Yabe, T (corresponding author), Tokyo Metropolitan Red Cross Blood Ctr, Tokyo 1358639, Japan.	to-yabe@tokyo.bc.jrc	OHASHI, JUN/G-5907-2015					Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Arm JP, 1997, J IMMUNOL, V159, P2342; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Borges L, 1997, J IMMUNOL, V159, P5192; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Chimge NO, 1997, TISSUE ANTIGENS, V49, P477, DOI 10.1111/j.1399-0039.1997.tb02782.x; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Fanger NA, 1999, J LEUKOCYTE BIOL, V66, P231, DOI 10.1002/jlb.66.2.231; Heinzmann A, 2000, EUR J IMMUNOGENET, V27, P121, DOI 10.1046/j.1365-2370.2000.00214.x; Hirayasu K, 2006, HUM GENET, V119, P436, DOI 10.1007/s00439-006-0152-y; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Jiang K, 2005, TISSUE ANTIGENS, V65, P556, DOI 10.1111/j.1399-0039.2005.00412.x; Kabalaka G, 2007, ANN NY ACAD SCI, V1110, P10, DOI 10.1196/annals.1423.002; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuroki K, 2005, HUM MOL GENET, V14, P2469, DOI 10.1093/hmg/ddi247; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lichterfeld M, 2007, J EXP MED, V204, P2813, DOI 10.1084/jem.20061865; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Miyashita R, 2006, ARTHRITIS RHEUM-US, V54, P992, DOI 10.1002/art.21653; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Norman PJ, 2003, IMMUNOGENETICS, V55, P165, DOI 10.1007/s00251-003-0561-1; Ogawa A, 1998, TISSUE ANTIGENS, V51, P356; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Papanikolaou NA, 2004, HUM IMMUNOL, V65, P700, DOI 10.1016/j.humimm.2004.04.003; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389; TOKUNAGA K, 1995, TISSUE ANTIGENS, V45, P98, DOI 10.1111/j.1399-0039.1995.tb02424.x; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Tsuchiya N, 2007, CURR MED CHEM, V14, P431, DOI 10.2174/092986707779941041; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Whang DH, 2005, HUM IMMUNOL, V66, P146, DOI 10.1016/j.humimm.2004.10.013; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yabe T, 2008, BIOL BLOOD MARROW TR, V14, P75, DOI 10.1016/j.bbmt.2007.09.012; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yawata M, 2002, IMMUNOGENETICS, V54, P543, DOI 10.1007/s00251-002-0497-x; Young NT, 2001, IMMUNOGENETICS, V53, P270, DOI 10.1007/s002510100332	45	41	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1075	1083		10.1016/j.ajhg.2008.03.012	http://dx.doi.org/10.1016/j.ajhg.2008.03.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439545	Green Published, Bronze			2022-12-18	WOS:000255923600007
J	Guthery, SL; Salisbury, BA; Pungliya, MS; Stephens, JC; Bamshad, M				Guthery, Stephen L.; Salisbury, Benjamin A.; Pungliya, Manish S.; Stephens, J. Claiborne; Bamshad, Michael			The structure of common genetic variation in United States populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN-AMERICAN; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE VARIATION; NATURAL-SELECTION; INFERENCE; ASSOCIATION; POLYMORPHISMS; EPIDEMIOLOGY; ADMIXTURE; PATTERNS	The common-variant/common-disease model predicts that most risk alleles underlying complex health-related traits are common and, therefore, old and found in multiple populations, rather than being rare or population specific. Accordingly, there is widespread interest in assessing the population structure of common alleles. However, such assessments have been confounded by analysis of data sets with bias toward ascertainment of common alleles (e.g., HapMap and Perlegen) or in which a relatively small number of genes and/or populations were sampled. The aim of this study was to examine the structure of common variation ascertained in major U.S. populations, by resequencing the exons and flanking regions of 3,873 genes in 154 chromosomes from European, Latino/Hispanic, Asian, and African Americans generated by the Genaissance Resequencing Project. The frequency distributions of private and common single-nucleotide polymorphisms (SNPs) were measured, and the extent to which common SNPs were shared across populations was analyzed using several different estimators of population structure. Most SNPs that were common in one population were present in multiple populations, but SNPs common in one population were frequently not common in other populations. Moreover, SNPs that were common in two or more populations often differed significantly in frequency from one population to another, particularly in comparisons of African Americans versus other U.S. populations. These findings indicate that, even if the bulk of alleles underlying complex health-related traits are common SNPs, geographic ancestry might well be an important predictor of whether a Person carries a risk allele.	Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Utah, Dept Pediat, Salt Lake City, UT USA; Genaissance Pharmaceut, New Haven, CT USA; Motif BioSci, New York, NY USA; Univ Washington, Childrens Hosp, Reg Med Ctr, Dept Pediat,Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Bamshad, M (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Genet & Dev Med, 1959 NE Pacific St,HSB RR349, Seattle, WA 98195 USA.	mbamshad@u.washington.edu		Salisbury, Benjamin/0000-0003-0796-6492	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK069513] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI065357, AI065357, U54 AI065357-01] Funding Source: Medline; NIDDK NIH HHS [K23 DK069513, DK069513] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis Goncalo, 2007, Nat Genet, V39, P153, DOI 10.1038/ng0207-153; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Calinski T., 1974, COMMUN STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Falush D, 2003, GENETICS, V164, P1567; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Hartl DL, 1997, PRINCIPLES POPULATIO; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Kugathasan S, 2005, INFLAMM BOWEL DIS, V11, P631, DOI 10.1097/01.MIB.0000171279.05471.21; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Rebbeck TR, 2006, J CLIN ONCOL, V24, P2164, DOI 10.1200/JCO.2005.05.1656; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Rosskopf D, 2002, PHARMACOGENETICS, V12, P209, DOI 10.1097/00008571-200204000-00005; Salisbury BA, 2003, MUTAT RES-FUND MOL M, V526, P53, DOI 10.1016/S0027-5107(03)00014-9; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Tsai HJ, 2006, HUM GENET, V119, P547, DOI 10.1007/s00439-006-0169-2; Weigmann K, 2006, EMBO REP, V7, P246, DOI 10.1038/sj.embor.7400654; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	43	41	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1221	1231		10.1086/522239	http://dx.doi.org/10.1086/522239			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999361	Green Published, Bronze			2022-12-18	WOS:000251098800008
J	Yu, K; Chatterjee, N; Wheeler, W; Li, QZ; Wang, S; Rothman, N; Wacholder, S				Yu, Kai; Chatterjee, Nilanjan; Wheeler, William; Li, Qizhai; Wang, Sophia; Rothman, Nathaniel; Wacholder, Sholom			Flexible design for following up positive findings	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLE-SIZE CALCULATIONS; LIKELIHOOD RATIO TESTS; 2-STAGE DESIGNS; SELECTION BIAS; POWER; RISK; GENOMEWIDE; BOOTSTRAP	As more population-based studies suggest associations between genetic variants and disease risk, there is a need to improve the design of follow-up studies (stage II) in independent samples to confirm evidence of association observed at the initial stage (stage I). We propose to use flexible designs developed for randomized clinical trials in the calculation of sample size for follow-up studies. We apply a bootstrap procedure to correct the effect of regression to the mean, also called "winner's curse," resulting from choosing to follow up the markers with the strongest associations. We show how the results from stage I can improve sample size calculations for stage II adaptively. Despite the adaptive use of stage I data, the proposed method maintains the nominal global type I error for final analyses on the basis of either pure replication with the stage II data only or a joint analysis using information from both stages. Simulation studies show that sample-size calculations accounting for the impact of regression to the mean with the bootstrap procedure are more appropriate than is the conventional method. We also find that, in the context of flexible design, the joint analysis is generally more powerful than the replication analysis.	NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; Informat Management Serv Inc, Rockville, MD USA; Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Yu, K (corresponding author), 6120 Exevut Blvd,EPS 8050, Rockville, MD 20852 USA.	yuka@mail.nih.gov		WANG, SOPHIA/0000-0003-2597-9393	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Boffetta P, 2007, CANCER EPIDEM BIOMAR, V16, P197, DOI 10.1158/1055-9965.EPI-06-0786; CAPEN EC, 1971, J PETROL TECHNOL, V23, P641, DOI 10.2118/2993-PA; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Efron B., 1993, INTRO BOOTSTRAP; Galton F., 1886, J ANTHR I, V1, P246, DOI 10.2307%2F2841583; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hedges L.V., 2014, STAT METHODS META AN; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Muller HH, 2001, BIOMETRICS, V57, P886, DOI 10.1111/j.0006-341X.2001.00886.x; Proschan MA, 1995, BIOMETRICS, V51, P1315, DOI 10.2307/2533262; Proschan MA, 2003, STAT SINICA, V13, P163; Proschan MA, 2006, STAT BIOL HEALTH, P1; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; SAXENA KML, 1982, ANN STAT, V10, P1012, DOI 10.1214/aos/1176345892; Scherag A, 2003, HUM HERED, V56, P56, DOI 10.1159/000073733; SELF SG, 1988, BIOMETRICS, V44, P79, DOI 10.2307/2531897; SELF SG, 1992, BIOMETRICS, V48, P31, DOI 10.2307/2532736; Shieh G, 2000, BIOMETRICS, V56, P1192, DOI 10.1111/j.0006-341X.2000.01192.x; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun L, 2005, GENET EPIDEMIOL, V28, P352, DOI 10.1002/gepi.20068; Thomas D, 2004, GENET EPIDEMIOL, V27, P401, DOI 10.1002/gepi.20047; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wu LY, 2006, HUM HERED, V62, P84, DOI 10.1159/000096096; Zaykin DV, 2005, GENETICS, V171, P813, DOI 10.1534/genetics.105.044206; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	37	41	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					540	551		10.1086/520678	http://dx.doi.org/10.1086/520678			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701899	Bronze, Green Published			2022-12-18	WOS:000249128200010
J	Orru, S; Giuressi, E; Carcassi, C; Casula, M; Contu, L				Orru, S; Giuressi, E; Carcassi, C; Casula, M; Contu, L			Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-kb interval around the corneodesmosin gene (CDSN)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-C; LINKAGE DISEQUILIBRIUM; HAPLOTYPE ANALYSIS; POLYMORPHISMS; ASSOCIATION; VULGARIS; IDENTIFICATION; HLA-CW6; MARKERS; HCR	Numerous putative susceptibility loci have been described for psoriasis. Among the loci confirmed in the literature, PSORS1 ( the major histocompatibility complex at 6p21.3) has the strongest effect. Recent studies have highlighted a 200-kb candidate region. However, this region has not been well delimited, mainly because of the strong linkage equilibrium among the associated alleles. To finely map PSORS1, we set up a study using 17 polymorphic markers in a 525-kb interval around the human leucocyte antigen C locus (HLA-C). The results uncovered five loci with alleles strongly associated with psoriasis (Sidak-corrected P [P-c] values from 1.8 x 10(-7) to .003), all structured in a psoriasis-susceptibility haplotype (PSH). Subsequent analysis of extended haplotypes showed that the PSH was not only present on the traditional psoriasis-susceptibility extended haplotypes (HLA-Cw6-B57, HLA-Cw6-B37, and HLA-Cw6-B13) but also on a haplotype of Sardinian origin (HLA-Cw7-B58) found to be associated with psoriasis (P-c = .0009) because of an ancestral recombination with one of the susceptibility haplotypes carrying the HLA-Cw6 allele. Comparisons of the regions identical by descent among associated and nonassociated haplotypes highlighted a minimum region of 70 kb not recombinant with PSORS1, around the corneodesmosin (CDSN) gene.	Univ Cagliari, Genet Med Dipartimento Sci Med, Cagliari, Italy; Ctr Reg Trapianti, Cagliari, Italy	University of Cagliari	Orru, S (corresponding author), Univ Cagliari, Genet Med Dipartimento Sci Med, PO Binaghi,Via Is Guadazzonis 3, Cagliari, Italy.	sandroorru@pacs.unica.it		Carcassi, Carlo/0000-0002-9533-1579; ORRU, SANDRO/0000-0001-5085-7975				Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; BRANDRUP F, 1982, ACTA DERM-VENEREOL, V62, P229; Capon F, 2003, J MED GENET, V40, P447, DOI 10.1136/jmg.40.6.447; Chang YT, 2003, BRIT J DERMATOL, V148, P418, DOI 10.1046/j.1365-2133.2003.05166.x; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Gonzaga HFS, 1996, BRIT J DERMATOL, V135, P368, DOI 10.1046/j.1365-2133.1996.d01-1006.x; Gonzalez S, 2000, J INVEST DERMATOL, V115, P824, DOI 10.1046/j.1523-1747.2000.00133.x; Grimaldi MC, 1996, HUM IMMUNOL, V51, P89, DOI 10.1016/S0198-8859(96)00228-5; Guerrin M, 2001, TISSUE ANTIGENS, V57, P32, DOI 10.1034/j.1399-0039.2001.057001032.x; Holm SJ, 2003, EXP DERMATOL, V12, P435, DOI 10.1034/j.1600-0625.2003.00048.x; Hui J, 2002, TISSUE ANTIGENS, V60, P77, DOI 10.1034/j.1399-0039.2002.600110.x; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Orru S, 2002, TISSUE ANTIGENS, V60, P292, DOI 10.1034/j.1399-0039.2002.600403.x; Roessli D, 2000, ARLEQUIN VERSION 2 0; ROITBERGTAMBUR A, 1994, J AM ACAD DERMATOL, V31, P964, DOI 10.1016/S0190-9622(94)70265-9; Romphruk AV, 2003, TISSUE ANTIGENS, V62, P217, DOI 10.1034/j.1399-0039.2003.00056.x; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289	25	41	45	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					164	171		10.1086/426948	http://dx.doi.org/10.1086/426948			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15529278	Green Published, Bronze			2022-12-18	WOS:000225643600016
J	Chen, Q; He, G; Qin, W; Chen, QY; Zhao, XZ; Duan, SW; Liu, XM; Feng, GY; Xu, YF; St Clair, D; Li, M; Wang, JH; Xing, YL; Shi, JG; He, L				Chen, Q; He, G; Qin, W; Chen, QY; Zhao, XZ; Duan, SW; Liu, XM; Feng, GY; Xu, YF; St Clair, D; Li, M; Wang, JH; Xing, YL; Shi, JG; He, L			Family-based association study of Synapsin II and schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR DISORDER; CHROMOSOMES 3P; SUSCEPTIBILITY; POPULATION; LINKAGE; DISEASE; GENES; LOCI; 8P	Synapsin II has been proposed as a candidate gene for vulnerability to schizophrenia on the basis of its function and its location in a region of the genome implicated by linkage studies in families with schizophrenia. We recently reported positive association of synapsin II with schizophrenia in a case-control study (Chen et al. 2004). However, since case-control analyses can generate false-positive results in the presence of minor degrees of population stratification, we have performed a replication study in 366 additional Han Chinese probands and their parents by use of analyses of transmission/disequilibrium for three in/del markers and three single-nucleotide polymorphisms. Positive association was observed for rs2307981 (P = .02), rs2308169 (P = .005), rs308963 (P = .002), rs795009 (P = .02), and rs2307973 (P = .02). For transmission of six-marker haplotypes, the global P value was .0000016 (5 degrees of freedom), principally because of overtransmission of the most common haplotype, CAA/-/G/T/C/- (frequency 53.6%; chi(2) = 20.8; P = .0000051). This confirms our previous study and provides further support for the role of synapsin II variants in susceptibility to schizophrenia.	Shanghai Jiao Tong Univ, Bio X Life Sci Res Ctr, Neuropsychiat & Human Genet Grp, Shanghai 200030, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; Shanghai Inst Mental Hlth, Shanghai, Peoples R China; Soochow Univ, Sch Med, Dept Pathophysiol, Suzhou, Peoples R China; Liaoning Inst Mental Hlth, Liaoning, Peoples R China; Xian Inst Mental Hlth, Xian, Peoples R China; Univ Aberdeen, Dept Mental Hlth, Aberdeen, Scotland	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China; University of Aberdeen	He, L (corresponding author), Shanghai Jiao Tong Univ, Bio X Life Sci Res Ctr, Neuropsychiat & Human Genet Grp, Han Ran Bldg,1954 Hua Shan Rd, Shanghai 200030, Peoples R China.	helin@nhgg.org	Chen, Qi/D-3397-2009; Xu, Yifeng/AAA-2064-2021; St Clair, David/AAN-2412-2021; Duan, Shiwei/J-9633-2012; Duan, Shiwei/AAA-4782-2022; liu, xinmin/D-7017-2011	Xu, Yifeng/0000-0002-0403-1141; Duan, Shiwei/0000-0001-7682-2877; 				Chen Q, 2004, BIOL PSYCHIAT, V56, P177, DOI 10.1016/j.biopsych.2004.05.010; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; Karlin S, 2002, P NATL ACAD SCI USA, V99, P17008, DOI 10.1073/pnas.262658799; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Levinson DF, 1996, AM J MED GENET, V67, P580; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Maziade M, 2001, MOL PSYCHIATR, V6, P684, DOI 10.1038/sj.mp.4000915; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shi YY, 2004, GENOME RES, V14, P1345, DOI 10.1101/gr.1758204; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697	18	41	43	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					873	877		10.1086/425588	http://dx.doi.org/10.1086/425588			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15449241	Bronze, Green Published			2022-12-18	WOS:000224303500012
J	Herrnstadt, C; Preston, G; Howell, N				Herrnstadt, C; Preston, G; Howell, N			Errors, phantom and otherwise, in human mtDNA sequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									MitoKor Inc, San Diego, CA 92121 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Howell, N (corresponding author), MitoKor Inc, 11494 Sorrento Valley Rd, San Diego, CA 92121 USA.	howelln@mitokor.com						Arnason E, 2003, ANN HUM GENET, V67, P5, DOI 10.1046/j.1469-1809.2003.00003.x; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Dennis C, 2003, NATURE, V421, P773, DOI 10.1038/421773a; Forster R, 2003, ANN HUM GENET, V67, P2, DOI 10.1046/j.1469-1809.2003.00002.x; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Vernesi C, 2002, HUM BIOL, V74, P725, DOI 10.1353/hub.2002.0060	7	41	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1585	1586		10.1086/375406	http://dx.doi.org/10.1086/375406			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12817588	Bronze, Green Published			2022-12-18	WOS:000183275500023
J	Lin, JP; Cupples, A; Wilson, PWF; Heard-Costa, N; O'Donnell, CJ				Lin, JP; Cupples, A; Wilson, PWF; Heard-Costa, N; O'Donnell, CJ			Evidence for a gene influencing serum bilirubin on chromosome 2q telomere: A genomewide scan in the Framingham Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; RISK; TRAIT; ASSOCIATION; LIPOPROTEIN	There is an inverse relationship between serum bilirubin concentrations and risk of coronary artery disease. The strength of the association is similar to that of smoking, systolic blood pressure, and HDL cholesterol. We carried out a genomewide scan in a Framingham Heart Study. Our study sample consisted of 330 families with 1,394 sibling pairs, 681 cousin pairs, and 89 avuncular pairs. Using variance-component methods, the heritability was estimated to be 49% +/- 6%, and the genome scan demonstrated significant evidence of linkage of serum bilirubin to chromosome 2q, with a LOD score of 3.8 at location 243 cM. The peak multipoint LOD score is located 1 cM away from the uridine diphosphate glycosyltransferase 1 (UGT1A1) gene. UGT1A1 catalyzes the conjugation of bilirubin with glucuronic acid and thus enhances bilirubin elimination; therefore, it is an important candidate gene for serum bilirubin. Gilbert syndrome, a hyperbilirubinemic syndrome, has a population frequency of 2%-19% and is mainly due to a TA insertion at the promoter region of UGT1A1. Only one other region in the genome produced a multipoint LOD score >1 (LOD = 1.3). Our findings suggest that UGT1A1 may be a major gene controlling serum bilirubin levels in the population.	NHLBI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; NHLBI, Framingham Heart Study, Framingham, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lin, JP (corresponding author), NHLBI, Div Epidemiol & Clin Applicat, NIH, 6701 Rockledge Dr,Suite 8217, Bethesda, MD 20892 USA.	linj@nhlbi.nih.gov	Wilson, Peter W.F./J-2455-2016	Heard-Costa, Nancy/0000-0001-9730-0306; Cupples, L. Adrienne/0000-0003-0273-7965				Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; BREIMER LH, 1995, CLIN CHEM, V41, P1504; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Hunt SC, 1996, ARTERIOSCL THROM VAS, V16, P912, DOI 10.1161/01.ATV.16.8.912; Hunt SC, 2001, ATHEROSCLEROSIS, V154, P747, DOI 10.1016/S0021-9150(00)00420-2; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kronenberg F, 2002, EUR J HUM GENET, V10, P539, DOI 10.1038/sj.ejhg.5200842; Lamont J, 1997, CLIN CHEM, V43, P852; Levinson SS, 1997, ANN CLIN LAB SCI, V27, P185; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Schwertner HA, 2000, ATHEROSCLEROSIS, V150, P381, DOI 10.1016/S0021-9150(99)00387-1; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; te Morsche RHM, 2001, HEPATOLOGY, V33, P765, DOI 10.1053/jhep.2001.0103303le03; WALTERS MI, 1970, MICROCHEM J, V15, P231, DOI 10.1016/0026-265X(70)90045-7; WILLIAMS RR, 1991, HYPERTENSION, V17, pI69, DOI 10.1161/01.HYP.17.1_Suppl.I69; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; WU TW, 1991, BIOCHEM CELL BIOL, V69, P683, DOI 10.1139/o91-102; Yuan B, 1997, AM J HUM GENET, V60, P459	27	41	48	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1029	1034		10.1086/373964	http://dx.doi.org/10.1086/373964			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12618960	Bronze, Green Published			2022-12-18	WOS:000181972600024
J	Verhoeven, K; Villanova, M; Rossi, A; Malandrini, A; De Jonghe, P; Timmerman, V				Verhoeven, K; Villanova, M; Rossi, A; Malandrini, A; De Jonghe, P; Timmerman, V			Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-INTERNEXIN; HEREDITARY MOTOR; DISEASE TYPE-1A; NEUROPATHY; MUTATIONS; PHENOTYPE; FAMILIES; LINKAGE	Intermediate Charcot-Marie-Tooth neuropathy (CMT) is an inherited sensory motor neuropathy characterized by motor median nerve conduction velocities of 25-45 m/s. We performed a genomewide search in an Italian family with autosomal dominant intermediate CMT and mapped the locus on chromosome 10q. Analysis of key recombinants maps the gene for autosomal dominant intermediate CMT to a 10.7-Mb interval on chromosome 10q24.1-q25.1, between simple tandem repeat markers D10S1709 and D10S1795.	Univ Antwerp VIB, Born Bunge Fdn, Peripheral Neuropathy Grp,Dept Mol Genet, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Ist Ortoped Rizzoli, Bologna, Italy; Univ Siena, Inst Neurol Sci, I-53100 Siena, Italy	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; IRCCS Istituto Ortopedico Rizzoli; University of Siena	Timmerman, V (corresponding author), Univ Antwerp VIB, Born Bunge Fdn, Peripheral Neuropathy Grp,Dept Mol Genet, Universiteitspl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Timmerman, Vincent/O-7283-2019	Timmerman, Vincent/0000-0002-2162-0933				BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Ching GY, 1999, J NEUROSCI, V19, P2974; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS CJF, 1978, J GENET HUM, V26, P311; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; DEJONGHE P, 2000, NEUROMUSCULAR DIS BA; Dyck PJ, 1993, PERIPHERAL NEUROPATH, V2; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Levavasseur F, 1999, MOL BRAIN RES, V69, P104, DOI 10.1016/S0169-328X(99)00104-7; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MALANDRINI A, IN PRESS J SUBMICR C; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; NICHOLSON G, 1993, NEUROLOGY, V43, P2558, DOI 10.1212/WNL.43.12.2558; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; ROSSI A, 1985, J NEUROL, V232, P91, DOI 10.1007/BF00313907; Timmerman V, 1996, NEUROLOGY, V46, P1311, DOI 10.1212/WNL.46.5.1311; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	31	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					889	894		10.1086/323742	http://dx.doi.org/10.1086/323742			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11533914	Bronze, Green Published			2022-12-18	WOS:000171008200022
J	Richards, M; Macaulay, V				Richards, M; Macaulay, V			The mitochondrial gene tree comes of age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							SENSITIVE GEL-ELECTROPHORESIS; HOMO-SAPIENS-SAPIENS; Y-CHROMOSOME; AFRICAN POPULATIONS; PHYLOGENETIC NETWORK; SEQUENCE VARIATION; ANALYSIS REVEALS; EUROPEAN MTDNAS; HUMAN ORIGINS; NEAR-EASTERN		Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Huddersfield; University of Oxford	Richards, M (corresponding author), Univ Huddersfield, Dept Chem & Biol Sci, Queensgate, Huddersfield HD1 3DH, W Yorkshire, England.	m.b.richards@hud.ac.uk		RICHARDS, MARTIN/0000-0003-3118-0967				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; BALLINGER SW, 1992, GENETICS, V130, P139; BANDELT HJ, 1995, GENETICS, V141, P743; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; CHEN YS, 1995, AM J HUM GENET, V57, P133; CRANDALL KA, 1994, MODELS PHYLOGENETIC, P135; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; EXCOFFIER L, 1994, GENETICS, V136, P343; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Finnila S, 2001, J HUM GENET, V46, P64, DOI 10.1007/s100380170110; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; FINNILA S, IN PRESS MUTAT RES; Gamble C., 1993, TIMEWALKERS PREHISTO; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; PENNY D, 1995, MOL BIOL EVOL, V12, P863; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; STONEKING M, 1994, AM ANTHROPOL, V96, P131, DOI 10.1525/aa.1994.96.1.02a00070; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Templeton AR., 1997, CONCEPTUAL ISSUES MO, P329; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898	53	41	42	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1315	1320		10.1086/320615	http://dx.doi.org/10.1086/320615			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349234	Green Published, Bronze			2022-12-18	WOS:000169094600001
J	Whittemore, AS; Tu, IP				Whittemore, AS; Tu, IP			Detection of disease genes by use of family data. I. Likelihood-based theory	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE-RELATIVE-RISK; COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; NUCLEAR FAMILIES; PARENTAL DATA; ASSOCIATION; TESTS; TRANSMISSION; DESIGNS	We present a class of likelihood-based score statistics that accommodate genotypes of both unrelated individuals and families, thereby combining the advantages of case-control and family-based designs. The likelihood extends the one proposed by Schaid and colleagues (Schaid and Sommer 1993, 1994; Schaid 1996; Schaid and Li 1997) to arbitrary family structures with arbitrary patterns of missing data and to dense sets of multiple markers. The score statistic comprises two component test statistics. The first component statistic, the nonfounder statistic, evaluates disequilibrium in the transmission of marker alleles from parents to offspring. This statistic, when applied to nuclear families, generalizes the transmission/disequilibrium rest to arbitrary numbers of affected and unaffected siblings, with or without typed parents. The second component statistic, the founder statistic, compares observed or inferred marker genotypes in the family founders with those of controls or those of some reference population. The founder statistic generalizes the statistics commonly used for case-control data. The strengths of the approach include both the ability to assess, by comparison of nonfounder and founder statistics, the potential bias resulting from population stratification and the ability to accommodate arbitrary family structures, thus eliminating the need for many different ad hoc tests. A limitation of the approach is the potential power loss and/or bias resulting from inappropriate assumptions on the distribution of founder genotypes. The systematic likelihood-based framework provided here should be useful in the evaluation of both the relative merits of case-control and various family-based designs and the relative merits of different tests applied to the same design. It should also be useful for genotype-disease association studies done with the use of a dense set of multiple markers.	Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.			Tu, I-Ping/0000-0001-8666-8391	NCI NIH HHS [R35-CA47448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; COX RD, 1974, THEORETICAL STAT; EWENS WJ, 1995, AM J HUM GENET, V57, P455; KNAPP M, 1993, AM J HUM GENET, V52, P1085; Little RJ, 1987, STAT ANAL MISSING DA; Martin RB, 1998, GENET EPIDEMIOL, V15, P471, DOI 10.1002/(SICI)1098-2272(1998)15:5<471::AID-GEPI3>3.3.CO;2-A; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rothman N., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P762; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Schaid DJ, 1997, GENET EPIDEMIOL, V14, P1113, DOI 10.1002/(SICI)1098-2272(1997)14:6<1113::AID-GEPI92>3.0.CO;2-J; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMPSON EA, 1986, PEDIGREE ANAL HUM GE; Tu IP, 2000, AM J HUM GENET, V66, P1341, DOI 10.1086/302852; Whittaker JC, 1998, AM J HUM GENET, V63, P889, DOI 10.1086/302008; Witte JS, 1999, AM J EPIDEMIOL, V149, P693	25	41	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1328	1340		10.1086/302851	http://dx.doi.org/10.1086/302851			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739758	Green Published, Bronze			2022-12-18	WOS:000088373400015
J	Sinsheimer, JS; Blangero, J; Lange, K				Sinsheimer, JS; Blangero, J; Lange, K			Gamete-competition models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; LOCUS; GENE; ALLELE; HRG	The gamete-competition model is an application of the Bradley-Terry model for ranking of sports teams. If allele i of a marker locus is assigned parameter tau(i)> 0, then the probability that a parent with heterozygous genotype i/j transmits allele i is Pr(i/j --> i) = tau(i)/(tau(i) +/- tau(i)). Mendelian segregation corresponds to the choice tau(i)= 1 for all i. To test whether Mendelian segregation is true, one can estimate the tau(i) from pedigree data and perform a likelihaodratio test under the constraint that one tau(i) equals i. Although this procedure generates an interesting method for performance of segregation analysis with a marker locus, its real promise lies in generalization of the transmission/disequilibrium test. Quantitative as well as qualitative outcomes tan be considered. The gamete-competition model uses full pedigree data and gives an estimate of the strength of transmission distortion to affected children for each allele. Covariates are incorporated by rewriting of tau(i) exp (beta(t)x(k)), where beta is a parameter vector and x(k) is a covariate vector for the kth transmitted gamete. Examples of covariates include disease-severity indicators for the child, sex of the child, or repeat number for tandem-repeat alleles.	Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Texas Biomedical Research Institute	Sinsheimer, JS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.		Blangero, John/ABA-7175-2021		NCI NIH HHS [P30 CA016042, CA16042] Funding Source: Medline; NIDDK NIH HHS [R01 DK047482, DK42273, DK47482] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275] Funding Source: Medline; NIMH NIH HHS [R37 MH059490, R01 MH059490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042273, R01DK047482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.2307/2334029; Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Goksel DL, 1998, HUM GENET, V103, P280, DOI 10.1007/s004390050817; HENNIS BC, 1994, GENOMICS, V19, P195, DOI 10.1006/geno.1994.1046; HENNIS BC, 1995, BRIT J HAEMATOL, V89, P845; JIN K, 1994, BIOMETRICS, V50, P1189, DOI 10.2307/2533457; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; KEENER JP, 1993, SIAM REV, V35, P80, DOI 10.1137/1035004; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, IN PRESS J COMPUTATI; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; LEWIS M, 1980, ANN HUM GENET, V44, P179, DOI 10.1111/j.1469-1809.1980.tb00956.x; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	15	41	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1168	1172		10.1086/302826	http://dx.doi.org/10.1086/302826			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712230	Bronze, Green Published			2022-12-18	WOS:000088373200038
J	Stokowski, RP; Cox, DR				Stokowski, RP; Cox, DR			Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; EZRIN/RADIXIN/MOESIN ERM PROTEINS; MUTANT NF2 PROTEIN; CELL-ADHESION; ACTIN CYTOSKELETON; NA+/H+-EXCHANGER; SCHWANN-CELLS; MERLIN; PRODUCT; EZRIN	Despite intense study of the neurofibromatosis type 2 (NF2) tumor-suppressor protein merlin, the biological properties and tumor-suppressor functions of merlin are still largely unknown. In this study, we examined the molecular activities of NF2-causing mutant merlin proteins in transfected mammalian cells, to elucidate the merlin properties that are critical for tumor-suppressor function. Most important, we found that 80% of the merlin mutants studied significantly altered cell adhesion, causing cells to detach from the substratum. This finding implies a function for merlin in regulating cell-matrix attachment, and changes in cell adhesion caused by mutant protein expression may be an initial step in the pathogenesis of NF2. In addition, five different mutations in merlin caused a significant increase in detergent solubility of merlin compared to wild type, indicating a decreased ability to interact with the cytoskeleton. Although not correlated to the cell-adhesion phenotype, four missense mutations decreased the binding of merlin to the ERM-interacting protein EBP-50, implicating this interaction in merlin inhibition of cell growth. Last, we found that some NF2 point mutations in merlin most closely resembled gain-of-function alleles in their cellular phenotype, which suggests that mutant NF2 alleles may not always act in a loss-of-function manner, as had been assumed, but may include a spectrum of allelic types with different phenotypic effects on the function of the protein. In aggregate, these cellular phenotypes provide a useful assay for identifying the functional domains and molecular partners necessary for merlin tumor-suppressor activity.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Cox, DR (corresponding author), Stanford Univ, Sch Med, Dept Genet, 300 Pasteur Dr,Room M336, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07790, T32 GM007790] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ARAKAWA H, 1994, HUM MOL GENET, V3, P565, DOI 10.1093/hmg/3.4.565; Bhartur SG, 1998, BIOCHEM BIOPH RES CO, V243, P874, DOI 10.1006/bbrc.1998.8196; BOURN D, 1994, HUM MOL GENET, V3, P813, DOI 10.1093/hmg/3.5.813; Deguen B, 1998, HUM MOL GENET, V7, P217, DOI 10.1093/hmg/7.2.217; DENBAKKER MA, 1995, ONCOGENE, V10, P757; DENBAKKER MA, 1995, AM J PATHOL, V147, P1339; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; EVANS DGR, 1995, J MED GENET, V32, P470, DOI 10.1136/jmg.32.6.470; EVANS DGR, 1992, Q J MED, V84, P603; Evans WD, 1998, J INEQUAL APPL, V2, P1, DOI 10.1155/S1025583498000010; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Harwalkar JA, 1998, AM J OTOL, V19, P654; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Huynh DP, 1996, ONCOGENE, V13, P73; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; Koga H, 1998, ONCOGENE, V17, P801, DOI 10.1038/sj.onc.1202010; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LUTCHMAN M, 1995, CANCER RES, V55, P2270; MACCOLLIN M, 1994, JAMA-J AM MED ASSOC, V272, P1104; MACCOLLIN M, 1993, JAMA-J AM MED ASSOC, V270, P2316, DOI 10.1001/jama.270.19.2316; MACCOLLIN M, 1994, AM J HUM GENET, V55, P314; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; NUR EKM, 1992, J BIOL CHEM, V267, P1415; Obremski VJ, 1998, J NEUROBIOL, V37, P487, DOI 10.1002/(SICI)1097-4695(199812)37:4<487::AID-NEU1>3.3.CO;2-2; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Ritter M, 1997, EUR J CELL BIOL, V72, P222; Rosenbaum C, 1998, NEUROBIOL DIS, V5, P55, DOI 10.1006/nbdi.1998.0179; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SAINZ J, 1994, HUM MOL GENET, V3, P885, DOI 10.1093/hmg/3.6.885; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; StemmerRachamimov AO, 1997, J NEUROPATH EXP NEUR, V56, P735; Takeshima H, 1998, INT J ONCOL, V12, P1073; TAKESHIMA H, 1994, ONCOGENE, V9, P2135; TIKOO A, 1994, J BIOL CHEM, V269, P23387; Trofatter J A, 1993, Cell, V75, P826; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P10006; Zucman-Rossi J, 1998, HUM MOL GENET, V7, P2095, DOI 10.1093/hmg/7.13.2095	63	41	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					873	891		10.1086/302812	http://dx.doi.org/10.1086/302812			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712203	Bronze, Green Published			2022-12-18	WOS:000088373200011
J	Rybicki, BA; Elston, RC				Rybicki, BA; Elston, RC			The relationship between the sibling recurrence-risk ratio and genotype relative risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; LINKAGE STRATEGIES; RHEUMATOID-ARTHRITIS; SIB PAIRS; SARCOIDOSIS; SUSCEPTIBILITY; POLYMORPHISM; DISEASES; MODELS; POWER	The recurrence-risk ratio of disease in siblings, lambda(S), is a standard parameter used in genetic analysis to estimate the statistical power for detection of a disease locus. However, the relationship between the underlying risk conferred by a disease-susceptibility allele and lambda(S) has not been well described. The former is generally quantified as a genotype relative risk, gamma, and measures the ratio of disease risks between those with and those without the susceptibility genotype(s). We demonstrate that lambda(S) varies significantly more with respect to gamma and the disease-allele frequency for two-locus multiplicative models than for other two-locus and for single-locus models. For the single- and two-locus dominant-inheritance models that we studied, when a disease-susceptibility allele had a frequency greater than or equal to.2, lambda(S) had an upper limit of <10. In general, lambda(S) values >10 are possible only under recessive inheritance, dominant inheritance with relatively rare (<5%) disease-susceptibility alleles, or when two or more disease loci have alleles acting either epistatically or multiplicatively. We introduce the idea of a restricted sib recurrence-risk ratio (lambda*(S)) estimated by restriction of sibships to those ascertained through a proband who already has a putative high-risk allele. A lambda*(S) larger than the lambda(S) value estimated from randomly selected probands can serve as an indirect way of testing whether the posited susceptibility allele increases disease risk. Our results demonstrate that a lambda(S) of 2-3 may portend successful mapping for a variety of genetic models but that, for some two-locus models, a lambda(S) as high as 10 does not guarantee underlying genes easily mapped by linkage.	Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Metrohlth Med Ctr, Cleveland, OH 44106 USA	Henry Ford Health System; Henry Ford Hospital; Case Western Reserve University; MetroHealth System	Rybicki, BA (corresponding author), Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, 1 Ford Pl,3E, Detroit, MI 48202 USA.		Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	NCRR NIH HHS [P41 RR003655] Funding Source: Medline; NHLBI NIH HHS [R01 HL54306, UO1 HL60263, U01 HL060263] Funding Source: Medline; NIGMS NIH HHS [R01 GM28356, R01 GM028356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054306, U01HL060263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEATY TH, 1987, AM J MED GENET, V28, P631, DOI 10.1002/ajmg.1320280311; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Dieye A, 1997, Dakar Med, V42, P111; EDMONDSTONE WM, 1985, BRIT J DIS CHEST, V79, P27, DOI 10.1016/0007-0971(85)90004-X; Gu C, 1997, AM J HUM GENET, V61, P200, DOI 10.1086/513908; Gu C, 1997, AM J HUM GENET, V61, P211, DOI 10.1086/513909; Hall FC, 1996, QJM-MON J ASSOC PHYS, V89, P821, DOI 10.1093/qjmed/89.11.821; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Maliarik MJ, 1998, AM J RESP CRIT CARE, V158, P1566, DOI 10.1164/ajrccm.158.5.9804123; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311, DOI 10.1002/gepi.1370100504; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1987, AM J HUM GENET, V40, P1; Rybicki B A, 1998, Semin Respir Infect, V13, P166; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 1999, HUM IMMUNOL, V60, P867, DOI 10.1016/S0198-8859(99)00050-6; Rybicki BA, 1997, CLIN CHEST MED, V18, P707, DOI 10.1016/S0272-5231(05)70414-7; Scott WK, 1997, SCIENCE, V275, P1327, DOI 10.1126/science.275.5304.1327	21	41	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					593	604		10.1086/302778	http://dx.doi.org/10.1086/302778			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677319	Bronze, Green Published			2022-12-18	WOS:000088373100026
J	Vockley, J; Rogan, PK; Anderson, BD; Willard, J; Seelan, RS; Smith, DI; Liu, WG				Vockley, J; Rogan, PK; Anderson, BD; Willard, J; Seelan, RS; Smith, DI; Liu, WG			Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACYL-COA DEHYDROGENASES; MESSENGER-RNA; MEDIUM-CHAIN; SPLICE-SITE; BIOSYNTHESIS; MITOCHONDRIA; FIBROBLASTS; SEQUENCES; SPECTRUM; IMPORT	Isovaleric acidemia (IVA) is a recessive disorder caused by a deficiency of isovaleryl-CoA dehydrogenase (IVD). We have reported elsewhere nine point mutations in the ND gene in fibroblasts of patients with IVA, which lead to abnormalities in IVD protein processing and activity. In this report, we describe eight IVD gene mutations identified in seven IVA patients that result in abnormal splicing of IVD RNA. Four mutations in the coding region lead to aberrantly spliced mRNA species in patient fibroblasts. Three of these are amino acid altering point mutations, whereas one is a single-base insertion that leads to a shift in the reading frame of the mRNA. Two of the coding mutations strengthen pre-existing cryptic splice accepters adjacent to the natural splice junctions and apparently interfere with exon recognition, resulting in exon skipping. This mechanism for missplicing has not been reported elsewhere. Four other mutations alter either the conserved gt or ag dinucleotide splice sites in the IVD gene. Exon skipping and cryptic splicing were confirmed by transfection of these mutations into a Cos-7 cell line model splicing system. Several of the mutations were predicted by individual information analysis to inactivate or significantly weaken adjacent donor or acceptor sites. The high frequency of splicing mutations identified in these patients is unusual, as is the finding of missplicing associated with missense mutations in exons. These results may lead to a better understanding of the phenotypic complexity of IVA, as well as provide insight into those factors important in defining intron/ exon boundaries in vivo.	Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Childrens Mercy Hosp, Sect Med Genet & Mol Med, Kansas City, MO USA	Mayo Clinic; Mayo Clinic; Children's Mercy Hospital	Vockley, J (corresponding author), Mayo Clin & Mayo Fdn, Dept Med Genet, 200 1st St SW, Rochester, MN 55905 USA.		Vockley, Jerry/AAF-8523-2020; Rogan, Peter/B-9845-2017; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Rogan, Peter/0000-0003-2070-5254; Vockley, Jerry/0000-0002-8180-6457; Seelan, Ratnam/0000-0002-8925-1070	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045482] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK45482, R01 DK045482] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berg Mary Anne, 1992, Human Mutation, V1, P24, DOI 10.1002/humu.1380010105; CRANE F, 1955, J BIOL CHEM, V218, P717; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; IKEDA Y, 1985, BIOCHEMISTRY-US, V24, P7192, DOI 10.1021/bi00346a027; IKEDA Y, 1985, J BIOL CHEM, V260, P1326; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1986, PEDIATR RES, V20, P843, DOI 10.1203/00006450-198609000-00007; IKEDA Y, 1985, P NATL ACAD SCI USA, V82, P7081, DOI 10.1073/pnas.82.20.7081; IKEDA Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P662, DOI 10.1016/0003-9861(87)90072-5; KRAWCZAK M, 1992, HUM GENET, V90, P41; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; LIGTENBERG MJL, 1991, NUCLEIC ACIDS RES, V19, P297, DOI 10.1093/nar/19.2.297; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; PARIMOO B, 1993, GENOMICS, V15, P582, DOI 10.1006/geno.1993.1111; Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-O; Ronce N, 1997, AM J HUM GENET, V61, P233; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1997, NUCLEIC ACIDS RES, V25, P4408, DOI 10.1093/nar/25.21.4408; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; Sweetman L., 1995, METABOLIC MOL BASES, V7th, P1387; VOCKLEY J, 1992, J BIOL CHEM, V267, P2494; VOCKLEY J, 1992, PROG CLIN BIOL RES, V375, P533; VOCKLEY J, 1991, AM J HUM GENET, V49, P147	27	41	46	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					356	367		10.1086/302751	http://dx.doi.org/10.1086/302751			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677295	Bronze, Green Published			2022-12-18	WOS:000088373100002
J	Holinski-Feder, E; Reyniers, E; Uhrig, S; Golla, A; Wauters, J; Kroisel, P; Bossuyt, P; Rost, I; Jedele, K; Zierler, H; Schwab, S; Wildenauer, D; Speicher, MR; Willems, PJ; Meitinger, T; Kooy, RF				Holinski-Feder, E; Reyniers, E; Uhrig, S; Golla, A; Wauters, J; Kroisel, P; Bossuyt, P; Rost, I; Jedele, K; Zierler, H; Schwab, S; Wildenauer, D; Speicher, MR; Willems, PJ; Meitinger, T; Kooy, RF			Familial mental retardation syndrome ATR-16 due to an inherited cryptic subtelomeric translocation, t(3;16)(q29;p13.3)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-THALASSEMIA; DELETION; CHROMOSOME-16; TRISOMY-16P; FEATURES; INFANT	In the search for genetic causes of mental retardation, we have studied a five-generation family that includes 10 individuals in generations IV and V who are affected with mild-to-moderate mental retardation and mild, nonspecific dysmorphic features. The disease is inherited in a seemingly autosomal dominant fashion with reduced penetrance. The pedigree is unusual because of (1) its size and (2) the fact that individuals with the disease appear only in the last two generations, which is suggestive of anticipation. Standard clinical and laboratory screening protocols and extended cytogenetic analysis, including the use of high-resolution karyotyping and multiplex FISH (M-FISH), could not reveal the cause of the mental retardation. Therefore, a whole-genome scan was performed, by linkage analysis, with microsatellite markers. The phenotype was linked to chromosome 16p13.3, and, unexpectedly, a deletion of a part of 16pter was demonstrated in patients, similar to the deletion observed in patients with ATR-16 syndrome. Subsequent FISH analysis demonstrated that patients inherited a duplication of terminal 3q in addition to the deletion of 16p. FISH analysis of obligate carriers revealed that a balanced translocation between the terminal parts of 16p and 3q segregated in this family. This case reinforces the role of cryptic (cytogenetically invisible) subtelomeric translocations in mental retardation, which is estimated by others to be implicated in 5%-10% of cases.	Univ Antwerp, Dept Med Genet, B-2610 Wilrijk, Belgium; Univ Munich, Dept Med Genet, Munich, Germany; Univ Munich, Dept Human Genet, Munich, Germany; Graz Univ, Dept Human Genet, Graz, Austria; Univ Bonn, Dept Human Genet, D-5300 Bonn, Germany	University of Antwerp; University of Munich; University of Munich; University of Graz; University of Bonn	Kooy, RF (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Wilrijk, Belgium.		Bossuyt, Patrick M/AAR-1183-2021; Meitinger, Thomas/O-1318-2015; Bossuyt, Patrick M./B-4557-2016; Speicher, Michael R/B-5362-2013; Kooy, Frank/F-5276-2014	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; Speicher, Michael R/0000-0003-0105-955X; Kooy, Frank/0000-0003-2024-0485; Meitinger, Thomas/0000-0002-8838-8403				Altherr MR, 1997, AM J MED GENET, V71, P47, DOI 10.1002/(SICI)1096-8628(19970711)71:1<47::AID-AJMG9>3.0.CO;2-N; ARRATIA MCA, 1984, ANN GENET-PARIS, V27, P109; BRUETON LA, 1989, J MED GENET, V26, P729, DOI 10.1136/jmg.26.11.729; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Garcia-Esquivel L, 1987, J Genet Hum, V35, P299; Giraudeau F, 1997, J MED GENET, V34, P314, DOI 10.1136/jmg.34.4.314; JOKIAHO I, 1989, HUM GENET, V83, P302, DOI 10.1007/BF00285180; KONDO I, 1979, HUM GENET, V46, P141, DOI 10.1007/BF00291914; KUWANO A, 1991, AM J HUM GENET, V49, P707; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEONARD C, 1992, AM J MED GENET, V43, P621, DOI 10.1002/ajmg.1320430324; Lindor NM, 1997, AM J MED GENET, V72, P451; MONTERO MR, 1988, ANN GENET-PARIS, V31, P65; NELLIST M, 1993, CELL, V75, P1305; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; OCONNOR TA, 1992, AM J MED GENET, V42, P316, DOI 10.1002/ajmg.1320420311; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; SARGENT C, 1985, J MED GENET, V22, P39, DOI 10.1136/jmg.22.1.39; Slavotinek A, 1999, J MED GENET, V36, P405; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Uhrig S, 1999, AM J HUM GENET, V65, P448, DOI 10.1086/302508; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112	27	41	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					16	25		10.1086/302703	http://dx.doi.org/10.1086/302703			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631133	Green Published, Bronze			2022-12-18	WOS:000085033600004
J	Pearce, SHS; Vaidya, B; Imrie, H; Perros, P; Kelly, WF; Toft, AD; McCarthy, MI; Young, ET; Kendall-Taylor, P				Pearce, SHS; Vaidya, B; Imrie, H; Perros, P; Kelly, WF; Toft, AD; McCarthy, MI; Young, ET; Kendall-Taylor, P			Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							AUTOIMMUNE THYROID-DISEASE; SYSTEMIC LUPUS-ERYTHEMATOSUS; LINKAGE; GENETICS; GENES; HLA		Univ Newcastle Upon Tyne, Sch Clin Med Sci, Dept Endocrinol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Middlesbrough Gen Hosp, Diabet Care Ctr, Middlesbrough, Cleveland, England; Royal Infirm Edinburgh, Endocrine Unit, Edinburgh, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Div Med, Endocrinol Sect, London, England	Newcastle University - UK; Royal Infirmary of Edinburgh; Imperial College London	Pearce, SHS (corresponding author), Med Sch Newcastle Upon Tyne, Dept Med, 4th Floor,Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Pearce, Simon/AAB-3692-2019; Vaidya, Bijay/AAF-1947-2020; McCarthy, Mark/M-3763-2015	Pearce, Simon/0000-0001-8384-8063; Vaidya, Bijay/0000-0002-2223-0494; McCarthy, Mark/0000-0002-4393-0510; Perros, Petros/0000-0001-7320-5574				Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Davies TF, 1998, J CLIN ENDOCR METAB, V83, P3391, DOI 10.1210/jc.83.10.3391; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Farid NR, 1998, THYROID, V8, P407, DOI 10.1089/thy.1998.8.407; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; McCarthy MI, 1998, GENET EPIDEMIOL, V15, P317, DOI 10.1002/(SICI)1098-2272(1998)15:4<317::AID-GEPI1>3.0.CO;2-#; MCLACHLAN SM, 1993, J CLIN ENDOCR METAB, V77, pA605, DOI 10.1210/jcem.77.3.8370683; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Vaidya B, 1999, HUM MOL GENET, V8, P1195, DOI 10.1093/hmg/8.7.1195; WERNER SC, 1977, J CLIN ENDOCR METAB, V44, P203, DOI 10.1210/jcem-44-1-203	15	41	42	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1462	1465		10.1086/302610	http://dx.doi.org/10.1086/302610			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521315	Green Published, Bronze			2022-12-18	WOS:000083531000031
J	Beaudet, AL				Beaudet, AL			1998 ASHG Presidential Address - Making genomic medicine a reality	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HIRSCHSPRUNG-DISEASE; HEREDITARY HEMOCHROMATOSIS; GENE; MUTATION; DEFICIENCY; SEQUENCE; CANCER; RISK		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,room T619, Houston, TX 77030 USA.	abeaudet@bcm.tmc.edu						ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COX DW, 1995, METABOLIC MOL BASES, P4125; DALY AK, 1995, J MOL MED-JMM, V73, P539; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dickson D, 1998, NATURE, V395, P309, DOI 10.1038/26285; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Garrod A.G., 1931, INBORN FACTORS DIS; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Kinzler KW, 1998, GENETIC BASIS HUMAN, P565; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCRIVER CR, 1979, CIBA F SYMP, V66, P377; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; SVEGER T, 1995, ACTA PAEDIATR, V84, P815, DOI 10.1111/j.1651-2227.1995.tb13765.x; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	36	41	50	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					1	13		10.1086/302217	http://dx.doi.org/10.1086/302217			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915936	Green Published, Bronze			2022-12-18	WOS:000078477400001
J	DeStefano, AL; Baldwin, CT; Burzstyn, M; Gavras, I; Handy, DE; Joost, O; Martel, T; Nicolaou, M; Schwartz, F; Streeten, DHP; Farrer, LA; Gavras, H				DeStefano, AL; Baldwin, CT; Burzstyn, M; Gavras, I; Handy, DE; Joost, O; Martel, T; Nicolaou, M; Schwartz, F; Streeten, DHP; Farrer, LA; Gavras, H			Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; BLOOD-PRESSURE; HYPERTENSION; REGION; LOCUS; GENE	Familial orthostatic hypotensive disorder is characterized by light-headedness on standing, which may worsen to syncope, palpitations, and blue-purple ankle discoloration, and is accompanied by a marked decrease in systolic blood pressure, an increase in diastolic pressure, and tachycardia, all of which resolve when supine. We ascertained three families in which this disorder is inherited as an autosomal dominant trait with reduced penetrance. A genomewide scan was conducted in the two largest families, and three regions with multipoint LOD scores >1.5 were identified. Follow-up of these regions with additional markers in all three families yielded significant evidence of linkage at chromosome 18q. A maximum multipoint LOD score of 3.21 in the three families was observed at D18S1367, although the smallest family had negative LOD scores in the entire region. There was significant evidence of linkage in the presence of heterogeneity at 18q, with a maximum LOD score of 3.92 at D18S1367 in the two linked families. Identification of the gene responsible for orthostatic hypotensive disorder in these families may advance understanding of the general regulatory pathways involved in the continuum, from hypotension to hypertension, of blood pressure.	Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; SUNY Syracuse, Hlth Sci Ctr, Dept Med, Syracuse, NY 13210 USA	Boston University; Boston University; Boston University; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Baldwin, CT (corresponding author), Boston Univ, Sch Med, Ctr Human Genet, 80 E Concord St,W408, Boston, MA 02118 USA.		Farrer, Lindsay/AAS-1035-2020	Gavras, Irene/0000-0001-9675-9983; DeStefano, Anita/0000-0002-9335-2819; Handy, Diane/0000-0002-4310-8527; Baldwin, Clinton/0000-0002-3275-9463; Farrer, Lindsay/0000-0001-5533-4225	NHLBI NIH HHS [HL07224, P50 HL55001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055001, T32HL007224] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; ROBERTSON D, 1992, AM J HYPERTENS, V5, pS200, DOI 10.1093/ajh/5.6.200S; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; STREETEN DH, 1972, LANCET, V2, P1048; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Wu DA, 1996, J CLIN INVEST, V97, P2111, DOI 10.1172/JCI118648	15	41	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1425	1430		10.1086/302096	http://dx.doi.org/10.1086/302096			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792870	Bronze, Green Published			2022-12-18	WOS:000076985200019
J	Graham, J; Thompson, EA				Graham, J; Thompson, EA			Disequilibrium likelihoods for fine-scale mapping of a rare allele	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; POSITIONAL CLONING; SYNDROME GENE; HUNTINGTONS-DISEASE; LOCALIZATION; POPULATIONS	Genetic linkage studies based on pedigree data have limited resolution, because of the relatively small number of segregations. Disequilibrium mapping, which uses population associations to infer the location of a disease mutation, provides one possible strategy for narrowing the candidate region. The coalescent process provides a model for the ancestry of a sample of disease alleles, and recombination events between disease locus and marker may be placed on this ancestral phylogeny. These events define the recombinant classes, the sets of sampled disease copies descending from the meiosis at which a given recombination occurred. We show how Monte Carlo generation of the recombinant classes leads to a linkage likelihood for fine-scale mapping from disease haplotypes. We compare single-marker disequilibrium mapping with interval-disequilibrium mapping and discuss how the approach may be extended to multipoint-disequilibrium mapping. The method and its properties are illustrated with an example of simulated data, constructed to be typical of fine-scale mapping of a rare disease in the Japanese population. The method can take into account known features of population history, such as changing patterns of population growth.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Thompson, EA (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	thompson@stat.washington.edu	Graham, JInko/ABE-1507-2021	Graham, JInko/0000-0003-4568-1228				ARNASON A, 1977, NATURE, V268, P527, DOI 10.1038/268527a0; Benedict Ruth, 1989, CHRYSANTHEMUM SWORD; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; COX T K, 1989, American Journal of Human Genetics, V45, pA136; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EDWARDS JH, 1981, POPULATION STRUCTURE, P239; FELSENSTEIN J, 1971, Theoretical Population Biology, V2, P391, DOI 10.1016/0040-5809(71)90028-1; Fisher R., 1970, STAT METHODS RES WOR; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; GRAHAM J, 1998, THESIS U WASHINGTON; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Hanihara K., 1991, JAPAN REV, V2, P1, DOI [DOI 10.1537/ASE.102.455, 10.15055/00003292]; Harding EF., 1971, ADV APPL PROBAB, V3, P44, DOI [DOI 10.2307/1426329, 10.2307/1426329]; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; *ISEI, 1998, TEACH TXB WRIT HDB J; *JIN, 1998, CENS JAP; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; Koyama S. J., 1979, SENRI ETHNOLOGICAL S, V2, P1; Matsumoto T, 1997, HUM GENET, V100, P123, DOI 10.1007/s004390050477; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Moran P., 1962, STAT PROCESSES EVOLU; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; ROSE M, 1996, ARCHAEOLOGY, V48, P43; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMPSON EA, 1992, AM J HUM GENET, V51, P609; THOMPSON EA, 1978, NATURE, V272, P288, DOI 10.1038/272288a0; Thompson EA, 1997, AM J HUM GENET, V60, P197; vanderMeulen MA, 1997, GENETIC MAPPING OF DISEASE GENES, P115; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	35	41	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1517	1530		10.1086/302102	http://dx.doi.org/10.1086/302102			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792879	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000076985200028
J	Ashley-Koch, AE; Robinson, H; Glicksman, AE; Nolin, SL; Schwartz, CE; Brown, WT; Turner, G; Sherman, SL				Ashley-Koch, AE; Robinson, H; Glicksman, AE; Nolin, SL; Schwartz, CE; Brown, WT; Turner, G; Sherman, SL			Examination of factors associated with instability of the FMR1 CGG repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; PREMATURE OVARIAN FAILURE; FULL MUTATION; MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; I LOCUS; GENE; SIZE; EXPANSION; SEQUENCE	We examined premutation-female transmissions and premutation-male transmissions of the FMR1 CGG repeat to carrier offspring, to identify factors associated with instability of the repeat. First we investigated associations between parental and offspring repeat size. Premutation-female repeat size was positively correlated with the risk of having full-mutation offspring, confirming previous reports. Similarly, premutation-male repeat size was positively correlated with the daughter's repeat size. However, increasing paternal repeat size was associated also with both increased risk of contraction and decreased magnitude of the repeat-size change passed to the daughter. We hypothesized that the difference between the female and male transmissions was due simply to selection against full-mutation sperm. To test this hypothesis, we simulated selection against full-mutation eggs, by only examining premutation-female transmissions to their premutation offspring. Among this subset of premutation-female transmissions, associations between maternal and offspring repeat size were similar to those observed in premutation-male transmissions. This suggests that the difference between female and male transmissions may be due to selection against full-mutation sperm. Increasing maternal age was associated with increasing risk of expansion to the full mutation, possibly because of selection for smaller alleles within the offspring's soma over time; a similar effect of increasing paternal age may be due to the same selection process. Last, we have evidence that the reported association between offspring sex and risk of expansion may be due to ascertainment bias. Thus, female and male offspring are equally likely to inherit the full mutation.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30022 USA; Hunter Genet, Newcastle, NSW, Australia; New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA	Emory University; Institute for Basic Research in Developmental Disabilities; Greenwood Genetic Center	Sherman, SL (corresponding author), Emory Univ, Sch Med, Dept Genet, 1462 Clifton Rd NE, Atlanta, GA 30022 USA.		Brown, William/GXN-2777-2022	Nolin, Sarah/0000-0001-5209-289X; Ashley-Koch, Allison/0000-0001-5409-9155	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027801, P01HD035576, R01HD029909] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD27801, P01 HD35576, HD29909] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY AE, 1995, AM J HUM GENET, V57, P1414; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Ayoub N, 1997, CHROMOSOMA, V106, P1, DOI 10.1007/s004120050218; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; CONWAY GS, 1995, LANCET, V346, P309, DOI 10.1016/S0140-6736(95)92194-X; DEMUNAIN AL, 1995, J MED GENET, V32, P689, DOI 10.1136/jmg.32.9.689; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; Kaytor MD, 1997, HUM MOL GENET, V6, P2135, DOI 10.1093/hmg/6.12.2135; Kenneson A, 1997, AM J HUM GENET, V61, P1362, DOI 10.1086/301647; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MORNET E, 1993, CLIN GENET, V43, P157, DOI 10.1111/j.1399-0004.1993.tb04462.x; MORRIS A, 1995, ANN HUM GENET, V59, P283, DOI 10.1111/j.1469-1809.1995.tb00748.x; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; Nolin SL, 1996, AM J HUM GENET, V59, P1252; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; Partington MW, 1996, AM J MED GENET, V64, P370, DOI 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Rousseau F., 1994, American Journal of Human Genetics, V55, pA240; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sherman SL, 1996, AM J MED GENET, V64, P256, DOI 10.1002/(SICI)1096-8628(19960809)64:2<256::AID-AJMG4>3.0.CO;2-S; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; ViannaMorgante AM, 1996, AM J MED GENET, V64, P373, DOI 10.1002/(SICI)1096-8628(19960809)64:2<373::AID-AJMG28>3.0.CO;2-B; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1995, AM J HUM GENET, V57, P351	42	41	41	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					776	785		10.1086/302018	http://dx.doi.org/10.1086/302018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718348	Bronze, Green Published			2022-12-18	WOS:000075919000015
J	Lynch, HT; Smyrk, TC				Lynch, HT; Smyrk, TC			Classification of familial adenomatous polyposis: A diagnostic nightmare	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							ATTENUATED FORM; VARIANT		Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA; Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE 68182 USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center	Lynch, HT (corresponding author), Creighton Univ, Sch Med, Dept Prevent Med, 2500 Calif Plaza, Omaha, NE 68178 USA.							LYNCH HT, 1988, J NATL CANCER I, V80, P278, DOI 10.1093/jnci/80.4.278; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; Soravia C, 1998, AM J HUM GENET, V62, P1290, DOI 10.1086/301883; SPIRIO L, 1992, AM J HUM GENET, V51, P92; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Zwick A, 1997, GASTROENTEROLOGY, V113, P659, DOI 10.1053/gast.1997.v113.pm9247488	6	41	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1288	1289		10.1086/301890	http://dx.doi.org/10.1086/301890			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585618	Green Published, Bronze			2022-12-18	WOS:000074174700004
J	Thony, B; Neuheiser, F; Kierat, L; Blaskovics, M; Arn, PH; Ferreira, P; Rebrin, I; Ayling, J; Blau, N				Thony, B; Neuheiser, F; Kierat, L; Blaskovics, M; Arn, PH; Ferreira, P; Rebrin, I; Ayling, J; Blau, N			Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DCoH)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE/DIMERIZATION COFACTOR; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; 4A-CARBINOLAMINE DEHYDRATASE; 6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PHENYLALANINE HYDROXYLATION; DIHYDROPTERIDINE REDUCTASE; 7-SUBSTITUTED PTERINS; HOMEODOMAIN PROTEINS; WILD-TYPE; TETRAHYDROBIOPTERIN	Pterin-4a-carbinolamine dehydratase (PCD) is required for efficient tetrahydrobiopterin regeneration after phenylalanine hydroxylase activity. This catalytic function was proposed to be specifically defective in newborns with a mild form of hyperphenylalaninemia (HPA) and persistent high urinary levels of primapterin (7-biopterin). A second regulatory task of the same protein is DCoH, a coactivation of transcription by hepatocyte nuclear factor 1 alpha (HNF-1 alpha), a function that is apparently not impaired in these HPA individuals. It has been shown elsewhere that the human PCD/DCoH bifunctional protein is encoded by a single 4-exon-containing gene, PCBD, located on chromosome 10q22. We have now examined the PCBD gene for mutations at the genomic Bevel in six such HPA patients from four different families. By the use of new intron-specific primers, we detected, in all six patients, single, homozygous nucleotide alterations, in exon 4, that were inherited from their parents. These homozygous alterations predicted mutant PCD/DCoH with a single amino acid exchange, in two cases (alleles T78I), or premature stop codons, in the other four patients (alleles E86X and Q97X). Recombinant expression in Escherichia coli revealed that the mutant proteins-T78I, E8GX, and Q97X-are almost entirely in the insoluble fraction, in contrast to wild type, which is expressed as a soluble protein. These data support the proposal that HPA in combination with urinary primapterin may be due to autosomal recessive inheritance of mutations in the PCBD gene specifically affecting the dehydratase activity.	Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; Kaiser Permanente Reg Metab Lab, N Hollywood, CA USA; Nemours Childrens Clin, Jacksonville, FL USA; Univ Alberta Hosp, Edmonton Genet Clin, Edmonton, AB T6G 2B7, Canada; Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA	University of Zurich; Kaiser Permanente; University of Alberta; University of South Alabama	Thony, B (corresponding author), Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	bthony@kispi.unizh.ch		Blau, Nenad/0000-0003-4347-3230	PHS HHS [26662] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADLER C, 1992, EUR J BIOCHEM, V208, P139, DOI 10.1111/j.1432-1033.1992.tb17167.x; Arn P. H., 1994, American Journal of Human Genetics, V55, pA170; Ayling JE, 1997, CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, P565; BAILEY SW, 1993, ADV EXP MED BIOL, V338, P47; BAILEY SW, 1995, J AM CHEM SOC, V117, P10203, DOI 10.1021/ja00146a005; BLASKOVICS M, 1988, NEW ENGL J MED, V319, P1611; Blau N, 1997, CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, P719; BLAU N, 1992, J INHERIT METAB DIS, V15, P409, DOI 10.1007/BF02435990; BLAU N, 1989, J INHERIT METAB DIS, V12, P335, DOI 10.1007/BF03335415; Blau N., 1993, PTERIDINES, V4, P1; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; CURTIUS HC, 1990, BIOCHEM BIOPH RES CO, V172, P1060, DOI 10.1016/0006-291X(90)91554-6; CURTIUS HC, 1991, TECHNIQUES DIAGNOSTI, P377; DAVIS MD, 1991, P NATL ACAD SCI USA, V88, P385, DOI 10.1073/pnas.88.2.385; DHONDT JL, 1988, EUR J PEDIATR, V147, P153, DOI 10.1007/BF00442213; GIUDICI TA, 1991, PTERINS BIOGENIC AMI, P149; HANSEN LP, 1993, CURR OPIN GENET DEV, V3, P246, DOI 10.1016/0959-437X(93)90030-S; HAUER CR, 1993, J BIOL CHEM, V268, P4828; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Johnen G, 1995, P NATL ACAD SCI USA, V92, P12384, DOI 10.1073/pnas.92.26.12384; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; KOSTER S, 1995, PTERIDINES, V6, P123; KOSTER S, 1995, EUR J BIOCHEM, V231, P414, DOI 10.1111/j.1432-1033.1995.tb20714.x; Koster S, 1996, EUR J BIOCHEM, V241, P858, DOI 10.1111/j.1432-1033.1996.00858.x; LAZARUS RA, 1983, J BIOL CHEM, V258, P960; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; REBRIN I, 1995, BIOCHEMISTRY-US, V34, P5801, DOI 10.1021/bi00017a011; Sambrook J, 1989, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHALLREUTER KU, 1994, BBA-MOL BASIS DIS, V1226, P181, DOI 10.1016/0925-4439(94)90027-2; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; SCRIVER CR, 1994, ANNU REV GENET, V28, P141; SMOOKER PM, 1995, HUM MUTAT, V5, P279, DOI 10.1002/humu.1380050402; Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476; Thony B, 1997, HUM MUTAT, V10, P11; THONY B, 1995, BIOCHEM BIOPH RES CO, V210, P966, DOI 10.1006/bbrc.1995.1751; THONY B, 1993, ADV EXP MED BIOL, V338, P103; THONY B, 1994, GENOMICS, V19, P365, DOI 10.1006/geno.1994.1071; THONY B, 1994, AM J HUM GENET, V54, P782; THONY B, IN PRESS HUM GENET; WHITELEY JM, 1993, PTERIDINES, V4, P159	43	41	41	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1302	1311		10.1086/301887	http://dx.doi.org/10.1086/301887			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585615	Green Published, Bronze			2022-12-18	WOS:000074174700006
J	Ueki, Y; Naito, I; Oohashi, T; Sugimoto, M; Seki, T; Yoshioka, H; Sado, Y; Sato, H; Sawai, T; Sasaki, F; Matsuoka, M; Fukuda, S; Ninomiya, Y				Ueki, Y; Naito, I; Oohashi, T; Sugimoto, M; Seki, T; Yoshioka, H; Sado, Y; Sato, H; Sawai, T; Sasaki, F; Matsuoka, M; Fukuda, S; Ninomiya, Y			Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ALPHA-6(IV) COLLAGEN GENES; SMOOTH-MUSCLE TUMORS; MOLECULAR ANALYSIS; CHROMOSOME XQ22; RECOMBINATION; MUTATIONS; IDENTIFICATION; ALPHA-5(IV); DNA	Diffuse esophageal leiomyomatosis (DL), a benign smooth-muscle-cell tumor, is characterized by abnormal cell proliferation. DL is sometimes associated with X-linked Alport syndrome (AS), an inherited nephropathy caused by COL4A5 gene mutations. COL4A5 is tightly linked, in a head-to-head fashion, to the functionally related and coordinately regulated COL4A6 gene. No X-linked AS cases are due to COL4A6 mutations, but all DL/AS cases are always associated with deletions spanning the 5' regions of the COL4A5/COL4A6 cluster. Unlike the COL4A5 breakpoints, those of COL4A6 are clustered within intron 2 of the gene. We identified a DL/AS deletion and the first characterization of the breakpoint sequences. We show that a deletion eliminates the first coding exon of COL4A5 and the first two coding exons of COL4A6. The breakpoints share the same sequence, which, in turn, is closely homologous to the consensus sequences of topoisomerases I and II Additional DNA evidence suggested that the male patient is a somatic mosaic for the mutation. Immunohistochemical analysis using of-chain-specific monoclonal antibodies supported this conclusion, since it revealed the absence of the alpha 5(IV) and alpha 6(IV) collagen chains in most but not all of the basement membranes of the smooth-muscle-cell tumor. We also documented a similar segmental staining pattern in the glomerular basement membranes of the patient's kidney. This study is particularly relevant to the understanding of DL pathogenesis and its etiology.	Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 7008558, Japan; Shigei Med Res Inst, Div Ultrastruct Biol, Okayama, Japan; Shigei Med Res Inst, Div Immunol, Okayama, Japan; Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; Tohoku Univ, Sch Med, Dept Internal Med 2, Sendai, Miyagi 980, Japan; Hokkaido Univ, Sch Med, Dept Surg 1, Sapporo, Hokkaido 060, Japan; Kumamoto Univ, Sch Med, Dept Surg 1, Kumamoto 860, Japan; Kumamoto Rosai Hosp, Kumamoto, Japan	Okayama University; Tohoku University; Tohoku University; Hokkaido University; Kumamoto University	Ninomiya, Y (corresponding author), Okayama Univ, Sch Med, Dept Mol Biol & Biochem, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	yoshinin@ccews2.cc.okayama-u.ac.jp	Oohashi, Toshitaka/B-1599-2011	Oohashi, Toshitaka/0000-0002-9302-1913				ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; BAE YS, 1988, P NATL ACAD SCI USA, V85, P2076, DOI 10.1073/pnas.85.7.2076; BEEN MD, 1984, NUCLEIC ACIDS RES, V12, P3097, DOI 10.1093/nar/12.7.3097; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; CHAMPOUX JJ, 1988, GENETIC RECOMBINATIO, P655; Cooper D. N., 1993, HUMAN GENE MUTATION; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; GARCIATORRES R, 1993, AM J KIDNEY DIS, V22, P64; Heidet L, 1997, LAB INVEST, V76, P233; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; KAPLAN DJ, 1991, NUCLEIC ACIDS RES, V19, P4731, DOI 10.1093/nar/19.17.4731; Kendall E, 1997, GENOMICS, V43, P171, DOI 10.1006/geno.1997.4795; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; LI L, 1993, AM J HUM GENET, V53, P140; MADDALENA A, 1988, NEW ENGL J MED, V319, P999, DOI 10.1056/NEJM198810133191507; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Naito I, 1996, KIDNEY INT, V50, P304, DOI 10.1038/ki.1996.316; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; OOHASHI T, 1995, J BIOL CHEM, V270, P26863, DOI 10.1074/jbc.270.45.26863; OOHASHI T, 1994, J BIOL CHEM, V269, P7520; OTTOLENGHI S, 1982, NATURE, V300, P770, DOI 10.1038/300770a0; Renieri A, 1996, AM J HUM GENET, V58, P1192; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; SHIN RW, 1991, LAB INVEST, V64, P693; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; SUGIMOTO M, 1994, P NATL ACAD SCI USA, V91, P11679, DOI 10.1073/pnas.91.24.11679; VANBAKEL I, 1995, AM J HUM GENET, V57, P329; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	39	41	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					253	261		10.1086/301703	http://dx.doi.org/10.1086/301703			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463311	Bronze, Green Published			2022-12-18	WOS:000072416000007
J	Meschede, D; Dworniczak, B; Behre, HM; Kliesch, S; Claustres, M; Nieschlag, E; Horst, J				Meschede, D; Dworniczak, B; Behre, HM; Kliesch, S; Claustres, M; Nieschlag, E; Horst, J			CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CYSTIC-FIBROSIS; INFERTILE MALE; ABNORMALITIES; DISEASE		UNIV MUNSTER, DEPT REPROD MED, D-48149 MUNSTER, GERMANY; UNIV MUNSTER, DEPT UROL, D-48149 MUNSTER, GERMANY; INST BIOL, BIOCHIM GENET LAB, MONTPELLIER, FRANCE	University of Munster; University of Munster	Meschede, D (corresponding author), UNIV MUNSTER, INST HUMAN GENET, VESALIUSWEG 12-14, D-48149 MUNSTER, GERMANY.							Behre HM, 1995, INT J ANDROL, V18, P27; BEHRE HM, 1997, ANDROLOGY MALE REPRO, P85; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; COOPER TG, 1990, INT J ANDROL, V13, P297, DOI 10.1111/j.1365-2605.1990.tb01035.x; COSTES B, 1994, HUM MUTAT, V3, P126; De Braekeleer M, 1996, MOL HUM REPROD, V2, P669, DOI 10.1093/molehr/2.9.669; HOLSCLAW DS, 1971, J UROLOGY, V106, P568, DOI 10.1016/S0022-5347(17)61343-0; HONIG S C, 1991, Journal of Urology, V145, p326A; HONIG SC, 1994, UROL CLIN N AM, V21, P417; Kerem B, 1996, EUR J HUM GENET, V4, P65; Larsen WJ, 1993, HUMAN EMBRYOLOGY; MEACHAM RB, 1993, FERTIL STERIL, V59, P393; OLSON JR, 1969, J CLIN PATHOL, V22, P725, DOI 10.1136/jcp.22.6.725; PRYOR JP, 1991, FERTIL STERIL, V56, P725; SILBER SJ, 1995, HUM REPROD, V10, P2031, DOI 10.1093/oxfordjournals.humrep.a136231; Stern RC, 1997, NEW ENGL J MED, V336, P487, DOI 10.1056/NEJM199702133360707; STRONG TV, 1991, NEW ENGL J MED, V325, P1630, DOI 10.1056/NEJM199112053252307; TENG H, 1994, HUM MOL GENET, V3, P2249, DOI 10.1093/hmg/3.12.2249	19	41	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1200	1202		10.1086/301606	http://dx.doi.org/10.1086/301606			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345100	Green Published, Bronze			2022-12-18	WOS:A1997YH01700027
J	Burger, J; Buiting, K; Dittrich, B; Gross, S; Lich, C; Sperling, K; Horsthemke, B; Reis, A				Burger, J; Buiting, K; Dittrich, B; Gross, S; Lich, C; Sperling, K; Horsthemke, B; Reis, A			Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; PRADER-WILLI SYNDROMES; DNA METHYLATION; MOLECULAR DIAGNOSIS; CHROMOSOME REGION; FAMILIAL ANGELMAN; 15Q11-Q13; DELETIONS; MUTATIONS; DEFINE	Angelman syndrome (AS) is a neurogenetic disorder that appears to be caused by the loss of function of an imprinted gene expressed from maternal chromosome 15 only. Approximately 6% of patients have a paternal imprint on the maternal chromosome. In a few cases, this is due to an inherited microdeletion, in the 15q11-q13 imprinting center (IC), that blocks the paternal-->maternal imprint switch in the maternal germ line. We have determined the segregation of 15q11-q13 haplotypes in nine families with AS and with an imprinting defect. One family, with two affected siblings, has a microdeletion affecting the IC transcript. In the other eight patients, no mutation was found at this locus. In two families, the patient and a healthy sibling share the same maternal alleles. In one of these families and in two others, grandparental DNA samples were available, and the chromosomes with the imprinting defect were found to be of grandmaternal origin. These findings suggest that germ-line mosaicism or de novo mutations account for a significant fraction of imprinting defects, among patients who have an as-yet-undetected mutation in a cis-acting element. Alternatively, these data may indicate that some imprinting defects are caused by a failure to maintain or to reestablish the maternal imprint in the maternal germ line or by a failure to replicate the imprint postzygotically. Depending on the underlying cause of the imprinting defect, different recurrence risks need to be considered.	HUMBOLDT UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,INST HUMAN GENET,D-13353 BERLIN,GERMANY; UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,D-4300 ESSEN,GERMANY	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen			Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363				BRINK RA, 1973, ANNU REV GENET, V7, P129, DOI 10.1146/annurev.ge.07.120173.001021; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burger J, 1996, AM J MED GENET, V66, P221; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DITTRICH B, 1992, HUM GENET, V90, P313; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; FergusonSmith AC, 1996, NAT GENET, V14, P119, DOI 10.1038/ng1096-119; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kubota T, 1996, J MED GENET, V33, P1011, DOI 10.1136/jmg.33.12.1011; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; LINDEMAN R, 1991, NUCLEIC ACIDS RES, V19, P5449, DOI 10.1093/nar/19.19.5449-a; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; REIS A, 1994, AM J HUM GENET, V54, P741; REIS A, 1994, MED GENET, V6, P22; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	33	41	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					88	93		10.1086/513900	http://dx.doi.org/10.1086/513900			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245988	Bronze, Green Published			2022-12-18	WOS:A1997XM72800015
J	FaureDelanef, L; Quere, I; Chasse, JF; Guerassimenko, O; Lesaulnier, M; Bellet, H; Zittoun, J; Kamoun, P; Cohen, D				FaureDelanef, L; Quere, I; Chasse, JF; Guerassimenko, O; Lesaulnier, M; Bellet, H; Zittoun, J; Kamoun, P; Cohen, D			Methylenetetrahydrofolate reductase thermolabile variant and human longevity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RISK FACTOR; DISEASE		FDN JEAN DAUSSET,CEPH,PARIS,FRANCE; FAC MED NECKER ENFANTS MALAD,URA CNRS 1335,PARIS,FRANCE; HOP ST ELOI,SERV MED INTERNE B,MONTPELLIER,FRANCE; HOP HENRI MONDOR,SERV CENT HEMATOL BIOL,F-94010 CRETEIL,FRANCE	Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP			Quere, Isabelle/AAB-8519-2020	Quere, Isabelle/0000-0002-1492-9764				BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KANG SS, 1991, AM J HUM GENET, V48, P536; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; MICHEL E, 1996, INSEE PREMIERE, V429, P1; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; STAMFER MJ, 1992, JAMA-J AM MED ASSOC, V19, P877	11	41	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					999	1001						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106548				2022-12-18	WOS:A1997WT61400031
J	Schepers, U; Glombitza, G; Lemm, T; Hoffmann, A; Chabas, A; Ozand, P; Sandhoff, K				Schepers, U; Glombitza, G; Lemm, T; Hoffmann, A; Chabas, A; Ozand, P; Sandhoff, K			Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GM2 ACTIVATOR PROTEIN; NIEMANN-PICK DISEASE; ENDOPLASMIC-RETICULUM; SKIN FIBROBLASTS; GENE; EXPRESSION; MUTATION; GANGLIOSIDOSIS; DEGRADATION; FORMS	Lysosomal degradation of ganglioside GM2 by beta-hexosaminidase A (hex A) requires the presence of the GM2 activator protein (GM2AP) as an essential cofactor. A deficiency of the GM2 activator causes the AB variant of GM2 gangliosidosis, a recessively inherited disorder characterized by excessive neuronal accumulation of GM2 and related glycolipids. Two novel mutations in the GM2 activator gene (GM2A) have been identified by the reverse-transcriptase-PCR method-a three-base deletion, AAG(262-264) resulting in a deletion of Lys(88), and a single-base deletion, A(410), that causes a frameshift. The latter results in substitution of 33 amino acids and the loss of another 24 amino acid residues. Both patients are homoallelic for their respective mutations inherited from their parents, who are heteroallelic at the GM2A locus. Although the cultured fibroblasts of both patients produce normal levels of activator mRNA, they lack a lysosomal form of GM2AP. Pulse/chase labeling of cultured fibroblasts of the patients, in presence and absence of brefeldin A, indicates a premature degradation of both-mutant and truncated-GM2APs in the endoplasmic reticulum or Golgi. These results were supported by in vitro translation experiments and expression of the mutated proteins. When the mutated GM2APs were expressed in Escherichia coli, both mature GM2AP forms turned proved to exhibit only residual activities in an in vitro assay.	UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-53121 BONN,GERMANY; INST BIOQUIM CLIN,BARCELONA,SPAIN; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT BIOL & MED RES,RIYADH 11211,SAUDI ARABIA	University of Bonn; King Faisal Specialist Hospital & Research Center			Schepers, Ute/J-6936-2013	Schepers, Ute/0000-0002-2736-6200				Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BURG J, 1985, BIOL CHEM H-S, V366, P887, DOI 10.1515/bchm3.1985.366.2.887; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; FERLINZ K, 1995, AM J HUM GENET, V56, P1343; Fujita Kazunobu, 1995, P249; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; Henseler M, 1996, AM J HUM GENET, V58, P65; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KLIMA H, 1991, FEBS LETT, V289, P260, DOI 10.1016/0014-5793(91)81084-L; KLIMA H, 1993, BIOCHEM J, V292, P571, DOI 10.1042/bj2920571; Ledeen R.W., 1984, GANGLIOSIDE STRUCTUR; LODISH HF, 1988, J BIOL CHEM, V263, P2107; NOVAK A, 1993, BIOCHIM BIOPHYS ACTA, V1199, P209; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; SANDHOFF K, 1995, METABOLIC MOL BASES, V2, P2427; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SCHRODER M, 1991, FEBS LETT, V290, P1, DOI 10.1016/0014-5793(91)81211-P; SCHRODER M, 1993, HUM GENET, V92, P437, DOI 10.1007/BF00216446; SCHWARZMANN G, 1978, BIOCHIM BIOPHYS ACTA, V529, P106, DOI 10.1016/0005-2760(78)90108-X; SONDERFELD S, 1985, EUR J BIOCHEM, V149, P247, DOI 10.1111/j.1432-1033.1985.tb08919.x; TAKAHASHI T, 1992, J BIOL CHEM, V267, P12552; XIE B, 1992, AM J HUM GENET, V50, P1046	26	41	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1048	1056						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900233				2022-12-18	WOS:A1996VN90000012
J	DeStefano, AL; Cupples, LA; Maciel, P; Gaspar, C; Radvany, J; Dawson, DM; Sudarsky, L; Corwin, L; Coutinho, P; MacLeod, P; Sequeiros, J; Rouleau, GA; Farrer, LA				DeStefano, AL; Cupples, LA; Maciel, P; Gaspar, C; Radvany, J; Dawson, DM; Sudarsky, L; Corwin, L; Coutinho, P; MacLeod, P; Sequeiros, J; Rouleau, GA; Farrer, LA			A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-PORTUGUESE FAMILY; ATAXIA TYPE-I; SPINOCEREBELLAR ATAXIA; HUNTINGTONS-DISEASE; INTERCLASS CORRELATIONS; SYSTEM DEGENERATION; CLINICAL-FEATURES; HEREDITARY ATAXIA; GENETIC DISORDER; AZOREAN DISEASE	Machado-Joseph disease (MJD) is a late-onset, progressive, neurodegenerative disorder caused by the expansion of an unstable trinucleotide (CAG) repeat sequence in a novel gene (MJD1) on chromosome 14. Previous studies showed that age at onset is negatively correlated with the number of CAG repeat units, but only part of the variation in onset age is explained by CAG repeat length. Ages at onset and CAG repeat lengths of 136 MJD patients from 23 kindreds of Portuguese descent were analyzed, to determine whether familial factors independent of CAG repeat length modulate age at onset of MJD. Correlation among sibs for onset age adjusted for CAG repeat length was .43, which indicates that an environmental or genetic factor common to sibs influences onset age. Positive correlations were also observed for avuncular (r = .22) and first-cousin pairs (r = .28), which supports the hypothesis that a genetic factor is influencing age at onset. Commingling analysis of onset ages adjusted for CAG repeat length identified three distributions in this population of affected individuals. Further studies of a much larger sample are needed to determine whether these distributions represent the influence of a genetic or environmental factor.	BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, DEPT EPIDEMIOL & BIOSTAT, BOSTON, MA 02118 USA; BRIGHAM & WOMENS HOSP, DIV NEUROL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; MCGILL UNIV, CTR RES NEUROSCI, MONTREAL, PQ H3A 2T5, CANADA; MONTREAL GEN HOSP, RES INST, MONTREAL, PQ H3G 1A4, CANADA; ICBAS, MED GENET LAB, OPORTO, PORTUGAL; UNIV PORTO, IBMC, UNIGENE, P-4100 OPORTO, PORTUGAL; HOSP SANTO ANTONIO, SERV NEUROL, OPORTO, PORTUGAL; VET ADM MED CTR, NEUROL SERV, W ROXBURY, MA USA; HOSP ISRAELITA ALBERT EINSTEIN, SAO PAULO, BRAZIL	Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; McGill University; McGill University; Universidade do Porto; Universidade do Porto; US Department of Veterans Affairs; Veterans Health Administration (VHA); Hospital Israelita Albert Einstein			Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020; Farrer, Lindsay/AAS-1035-2020; Coutinho, Paula/K-6053-2013	Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Sequeiros, Jorge/0000-0002-9846-1037; Coutinho, Paula/0000-0002-3461-230X; Farrer, Lindsay/0000-0001-5533-4225; Cupples, L. Adrienne/0000-0003-0273-7965; DeStefano, Anita/0000-0002-9335-2819	NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NINDS NIH HHS [NS31687] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031687] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BHARUCHA NE, 1986, ARCH NEUROL-CHICAGO, V43, P142, DOI 10.1001/archneur.1986.00520020036014; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; BURT T, 1993, NEUROLOGY, V43, P1750, DOI 10.1212/WNL.43.9.1750; CANCEL G, 1995, AM J HUM GENET, V57, P809; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; HEALTON EB, 1980, NEUROLOGY, V30, P1084, DOI 10.1212/WNL.30.10.1084; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER B, 1993, J MED GENET, V30, P991, DOI 10.1136/jmg.30.12.991; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; Livingstone IR, 1984, J NEUROGENET, V1, P185, DOI 10.3109/01677068409107084; MACIEL P, 1995, AM J HUM GENET, V57, P54; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RANEN NG, 1995, AM J HUM GENET, V57, P593; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1995, AM J HUM GENET, V57, P603; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; ROSNER B, 1982, AM J EPIDEMIOL, V116, P722, DOI 10.1093/oxfordjournals.aje.a113455; ROSNER B, 1979, BIOMETRICS, V35, P461, DOI 10.2307/2530348; *SAGE, 1994, STAT AN GEN EP REL 2; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; *SAS I INC, 1992, SAS STAT SOFTW CHANG, P287; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; SEPULVEDA RL, 1994, AM J RESP CRIT CARE, V149, P620, DOI 10.1164/ajrccm.149.3.8118628; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; SEQUEIROS J, 1994, GENOMICS, V21, P645, DOI 10.1006/geno.1994.1327; Sequeiros J, 1993, HDB CEREBELLAR DISEA, P345; Silveira I, 1996, NEUROLOGY, V46, P214, DOI 10.1212/WNL.46.1.214; Snedecor GW, 1980, STAT METHODS, V7th; STEVANIN G, 1995, AM J HUM GENET, V56, P193; STGEORGEHYSLOP P, 1994, AM J HUM GENET, V55, P120; SUDARSKY L, 1992, MOVEMENT DISORD, V7, P204, DOI 10.1002/mds.870070303; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TWIST EC, 1995, J MED GENET, V31, P823; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2	43	41	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					119	127						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659514				2022-12-18	WOS:A1996VL45500017
J	Naom, I; Lee, J; Ford, D; Bowman, SJ; Lanchbury, JS; Haris, I; Hodgson, SV; Easton, D; LennardLones, J; Mathew, CG				Naom, I; Lee, J; Ford, D; Bowman, SJ; Lanchbury, JS; Haris, I; Hodgson, SV; Easton, D; LennardLones, J; Mathew, CG			Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; ULCERATIVE-COLITIS; CROHNS-DISEASE; MULTIPLE SIBLINGS; LINKAGE; JAPANESE; PREVALENCE; STRATEGIES; ANTIGEN; FAMILY	Crohn disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBDs) of unknown etiology. First-degree relatives of LED patients have a 10-fold increase in risk of developing the same disease, and distinct associations between specific HLA types and both CD and UC have been reported. We have evaluated the contribution of genes at the HLA locus to susceptibility in IBD by linkage analysis of highly informative microsatellite polymorphisms in 43 families with multiple affected cases. No evidence for linkage of HLA to IBD was obtained under any of the four models tested. Analysis of HLA haplotype sharing in affected relatives indicated that the relative risk to a sibling conferred by the HLA locus was 1.11 in UC and 0.75 in CD, with upper (95%) confidence limits of 2.41 and 1.37, respectively. This suggests that other genetic or environmental factors are responsible for most of the familial aggregation in LED.	UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOL GENET,LONDON SE1 9RT,ENGLAND; UNITED MED & DENT SCH,GUYS HOSP,MOL IMMUNOGENET UNIT,LONDON,ENGLAND; ST MARKS HOSP,LONDON EC1V 2PS,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; University of London; Institute of Cancer Research - UK			Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838				ACHORD JL, 1982, DIGEST DIS SCI, V27, P330, DOI 10.1007/BF01296752; ASAKURA H, 1982, GASTROENTEROLOGY, V82, P413; COLOMBEL JF, 1989, GASTROEN CLIN BIOL, V13, P676; COX DR, 1979, THEORETICAL STATISTI; HUGOT JP, 1994, AM J MED GENET, V52, P207, DOI 10.1002/ajmg.1320520216; JONGENEEL CV, 1991, P NATL ACAD SCI USA, V88, P9717, DOI 10.1073/pnas.88.21.9717; KOBAYASHI K, 1990, EXP CLIN IMMUNOGENET, V7, P101; KOBAYASHI K, 1990, CLIN EXP IMMUNOL, V80, P400; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396, DOI 10.1016/0016-5085(86)90193-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; MEUCCI G, 1992, GASTROENTEROLOGY, V103, P514, DOI 10.1016/0016-5085(92)90841-L; MONSEN U, 1989, CLIN GENET, V36, P411; MONSEN U, 1991, SCAND J GASTROENTERO, V26, P302, DOI 10.3109/00365529109025046; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Naom I. S., 1995, DNA CLONING COMPLEX, P195; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; ORHOLM M, 1993, BRIT MED J, V306, P20, DOI 10.1136/bmj.306.6869.20; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; RISCH N, 1990, AM J HUM GENET, V46, P229; SATSANGI J, 1994, GUT, V35, P696, DOI 10.1136/gut.35.5.696; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; TOYODA H, 1993, GASTROENTEROLOGY, V104, P741, DOI 10.1016/0016-5085(93)91009-7; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; VAUGHAN RW, 1990, TISSUE ANTIGENS, V36, P149, DOI 10.1111/j.1399-0039.1990.tb01821.x; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0; [No title captured]	31	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					226	233						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659528				2022-12-18	WOS:A1996VL45500029
J	Goldstein, AM; Goldin, LR; Dracopoli, NC; Clark, WH; Tucker, MA				Goldstein, AM; Goldin, LR; Dracopoli, NC; Clark, WH; Tucker, MA			Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELANOMA DYSPLASTIC NEVUS; FAMILIAL MELANOMA; CHROMOSOME-1P; EXCLUSION; PEDIGREES; MLM; ARM	Previous linkage analyses of 19 cutaneous malignant melanoma/dysplastic nevi (CMM/DN) kindreds showed significant evidence of linkage and heterogeneity to both chromosomes 1p and 9p, Five kindreds also showed evidence of linkage (Z > 0.7) to both regions. To further examine these findings, we conducted two-trait-locus, two-marker-locus linkage analysis. We examined one homogeneity and one heterogeneity single-locus model (SL-Hom and SL-Het), and two two-locus (2L) models: an epistatic model (Ep), in which CMM was treated as a genuine 2L disease, and a heterogeneity model (Het), in which CMM could result from disease alleles at either locus. Both loci were modeled as autosomal dominant, The LOD scores for CMM alone were highest using the SL-Het model (Z = 8.48, theta = .0). There was much stronger evidence of linkage to chromosome 9p than to 1p for CMM alone; the LOD scores were approximately two times greater on 9p than on 1p. The change in LOD scores from an evaluation of CMM atone to CMM/DN suggested that a chromosome 1p locus (or loci) contributed to both CMM and CMM/DN, whereas a 9p locus contributed more to CMM alone. For both 2L models, the LOD scores from 1p were greater for CMM/DN than for CMM alone (Ep: Z = 4.63 vs. 3.83; Het: 4.94 vs. 3.80, respectively). In contrast, for 9p, the LOD scores were substantially lower with CMM/DN than with CMM alone (Ep: 4.64 vs. 7.06; Het: 5.38 vs. 7.99, respectively). After conditioning on linkage to the other locus, only the 9p locus consistently showed significant evidence for linkage to CMM alone. Thus, the application of 2L models may be useful to help unravel the complexities of familial melanoma.	NIMH,CLIN NEUROGENET BRANCH,BETHESDA,MD 20892; SEQUANA THERAPEUT INC,LA JOLLA,CA; UNIV PENN,SCH MED,PIGMENTED LESION STUDY GRP,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT PATHOL,BOSTON,MA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Pennsylvania; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Goldstein, AM (corresponding author), NCI,GENET EPIDEMIOL BRANCH,EXECUT PLAZA N,ROOM 439,6130 EXECUT BLVD MSC 7372,BETHESDA,MD 20892, USA.		Tucker, Margaret A/B-4297-2015	Dracopoli, Nicholas/0000-0003-3962-4059				BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P6041; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P489; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Greene MH., 1979, HEREDITARY VARIANT M; GRUIS NA, 1993, MELANOMA RES, V3, P271; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KNAPP M, 1994, AM J HUM GENET, V55, P1030; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACGEOCH C, 1994, HUM MOL GENET, V3, P2195, DOI 10.1093/hmg/3.12.2195; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; Ott J., 1991, ANAL HUMAN GENETIC L; RANADE K, 1995, NAT GENET, V10, P114, DOI 10.1038/ng0595-114; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SOBEL E, IN PRESS GENETIC MAP; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; TUCKER MA, 1988, PIGMENT CELL, V9, P95; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; WALKER GJ, 1995, HUM MOL GENET, V4, P1845, DOI 10.1093/hmg/4.10.1845; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	35	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1050	1056						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651266				2022-12-18	WOS:A1996UH19200018
J	Christiano, AM; AntonLamprecht, I; Amano, S; Ebschner, U; Burgeson, RE; Uitto, J				Christiano, AM; AntonLamprecht, I; Amano, S; Ebschner, U; Burgeson, RE; Uitto, J			Compound heterozygosity for COL7A1 mutations in twins with dystrophic epidermolysis bullosa: A recessive paternal deletion insertion mutation and a dominant negative maternal glycine substitution result in a severe phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VII COLLAGEN GENE; NONSENSE MUTATIONS; ANCHORING FIBRILS; HEREDITARIA; LINKAGE; JUNCTION; FORMS	We have previously demonstrated genetic linkage between the type VII collagen gene (COL7A1) and the dominant (DDEB) and recessive (RDEB) forms of dystrophic epidermolysis bullosa (DEB) and have subsequently identified pathogenetic mutations in several families. Mutations in DDEB identified thus far are glycine substitutions in the collagenous domain of COL7A1, while the most severe forms of RDEB result from premature termination codon (PTC) mutations on both alleles. In this study, we performed mutation analysis in the COL7A1 gene in twins who displayed a severe DEB phenotype. Mutational analysis revealed a paternal 2-bp deletion/1-bp insertion in exon 56, designated 5103CC-->G, which results in a frameshift and downstream PTC. Analysis of the maternal COL7A1 allele revealed a glycine-to-arginine substitution in exon 91 (G2351R). Careful questioning of the mother revealed that she and her father had a history of shedding of toenails and occasional poorly healing erosions, consistent with a mild form of DDEB. Immunoprecipitation of type VII collagen from fibroblasts of the twins revealed a marked reduction in intracellular protein production, consistent with the drastic reduction in mRNA transcript from the paternal mutant allele, while the majority of polypeptides bearing the glycine substitution appeared to be degraded intracellularly. Thus, the severe RDEB phenotype in the probands results from compound heterozygosity for one glycine substitution and one PTC mutation in COL7A1.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL & CUTANEOUS BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON INST MOLEC MED, MOLEC DERMATOL SECT, PHILADELPHIA, PA 19107 USA; UNIV HEIDELBERG, INST ULTRASTRUKTURFORSCH HAUT, W-6900 HEIDELBERG, GERMANY; HARVARD UNIV, SCH MED, BUTANEOURS BIOL RES CTR, BOSTON, MA USA	Jefferson University; Jefferson University; Jefferson University; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School					NIAMS NIH HHS [T32-AR07561, R01-AR35689, P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, T32AR007561, R01AR035689] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANTONLAMPRECHT I, 1976, HUM GENET, V32, P69, DOI 10.1007/BF00569978; ANTONLAMPRECHT I, 1992, DIAGNOSTIC ULTRASTRU, P00459; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; Christiano A M, 1996, Adv Dermatol, V11, P199; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1995, HUM MOL GENET, V4, P1579; CHRISTIANO AM, 1994, P NATL ACAD SCI USA, V91, P3549, DOI 10.1073/pnas.91.9.3549; CHRISTIANO AM, 1995, J INVEST DERMATOL, V104, P438, DOI 10.1111/1523-1747.ep12666033; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; COOPER DN, 1993, ANN MED, V25, P11, DOI 10.3109/07853899309147851; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GEDDEDAHL T, 1990, PRINCIPLES PRACTICE, P855; GEDDEDAHL T, IN PRESS PRINCIPLES; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HASHIMOTO I, 1975, ARCH DERMATOL FORSCH, V252, P167, DOI 10.1007/BF00557916; HASHIMOTO I, 1976, ARCH DERMATOL RES, V255, P285, DOI 10.1007/BF00561499; HASHIMOTO I, 1976, ARCH DERMATOL RES, V256, P137, DOI 10.1007/BF00567360; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; LAEMMLI UK, 1970, NATURE, V338, P229; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sambrook H., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIDMAN MJ, 1986, ARCH DERMATOL, V122, P278, DOI 10.1001/archderm.122.3.278; UITTO J, 1993, SEMIN DERMATOL, V12, P191; UITTO J, 1995, P ASSOC AM PHYSICIAN, V107, P245; UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868	40	41	41	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					682	693						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644730				2022-12-18	WOS:A1996UA38000004
J	Evett, IW; Gill, PD; Scranage, JK; Weir, BS				Evett, IW; Gill, PD; Scranage, JK; Weir, BS			Establishing the robustness of short-tandem-repeat statistics for forensic applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISM; POPULATION; SCIENCE; ALLELES; LOCI; GENE	Before the introduction of a four-locus multiplex short-tandem-repeat (STR) system into casework, an extensive series of tests were carried out to determine robust procedures for assessing the evidential value of a match between crime and suspect samples. Twelve databases were analyzed from the three main ethnic groups encountered in casework in the United Kingdom: Caucasians, Afro-Caribbeans, and Asians from the Indian subcontinent. Independence tests resulted in a number of significant results, and the impact that these might have on forensic casework was investigated. It is demonstrated that previously published methods provide a simple procedure for correcting allele frequencies - and that this leads to conservative casework estimates of evidential value.	N CAROLINA STATE UNIV,DEPT STAT,PROGRAM STAT GENET,RALEIGH,NC 27695; FORENS SCI SERV INC,BIRMINGHAM,W MIDLANDS,ENGLAND	University of North Carolina; North Carolina State University; Forensic Science Service UK			Schneider, Peter M./A-6661-2011; Gill, Peter/C-3056-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45344] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; BARKER JSF, 1986, GENETICS, V112, P577; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; DEKA R, 1995, AM J HUM GENET, V56, P461; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Elder J.K., 1987, NUCLEIC ACID PROTEIN, P165; EVETT IW, 1993, AM J HUM GENET, V52, P498; FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100; GILL P, 1995, GENETICA, V96, P69, DOI 10.1007/BF01441153; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Good P.I., 1994, PERMUTATION TESTS PR; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; KIMPTON C, 1994, INT J LEGAL MED, V106, P302, DOI 10.1007/BF01224776; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; KIMPTON CP, 1993, PCR METH APPL, V3, P13; LYGO JE, 1994, INT J LEGAL MED, V107, P77, DOI 10.1007/BF01225493; MAISTE PJ, 1995, GENETICA, V96, P125, DOI 10.1007/BF01441158; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P2556, DOI 10.1073/pnas.89.7.2556; NICHOLS RA, 1991, HEREDITY, V66, P297, DOI 10.1038/hdy.1991.37; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4036; REYNOLDS J, 1983, GENETICS, V105, P767; WEIR BS, 1994, ANNU REV GENET, V28, P597; WEIR BS, 1992, GENETICS, V130, P873; Weir BS, 1990, GENETIC DATA ANAL; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0; 1993, VNTR POPULATION DATA, V1	30	41	41	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					398	407						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571967				2022-12-18	WOS:A1996TR79100017
J	Watanabe, M; Zingg, BC; Mohrenweiser, HW				Watanabe, M; Zingg, BC; Mohrenweiser, HW			Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIHYDROFOLATE-REDUCTASE PROMOTER; PROLIFERATION SPECIFIC ISOZYME; TRANSCRIPTION INITIATION; PROCESSED PSEUDOGENES; HIP1 BINDING; ENZYME; DEFICIENCY; SITE; POLYMERASE; MUTATIONS	Individuals with 50% of expected triosephosphate isomerase (TPI) enzyme activity have been previously identified in families during the screening of similar to 2,000 newborn children for quantitative variation in activity of 12 erythrocyte enzymes. The frequency of the trait was 9/1,713 individuals in the Caucasian population and 7/168 individuals among the African-American population studied. Genetic transmission of the trait was confirmed in all families. The frequency of the presumptive deficiency allele(s) at the TPI locus was greater than expected, given the reported incidence of clinical TPI deficiency. We report the molecular characterization of the variant alleles from seven African-American and three Caucasian individuals in this group of unrelated individuals. Three amino acid substitutions - a Gly-->Ala substitution at residue 72, a Val-->Met at residue 154, and a previously described Glu-->Asp substitution at residue 104 - were identified in the Caucasian individuals. The substitutions occur at residues that are not directly involved in the active site but are highly conserved through evolutionary time, suggesting important roles for these residues in maintenance of subunit structure and conformation. The variant allele in the seven African-American individuals had nucleotide changes at positions -8 and -5 (5' of) from the transcription-initiation site. In three of these individuals, an additional T-->G substitution was detected in a TATA box-like sequence located 24 nucleotides 5' of the transcription-initiation site and on the same chromosome as the -5/-8 substitutions, Thus, molecular alterations at the TPI locus were detected in 10 unrelated individuals in whom segregation of a phenotype of reduced TPI activity previously had been identified.	LAWRENCE LIVERMORE NATL LAB,BIOL & BIOTECHNOL RES PROGRAM L452,LIVERMORE,CA 94550	United States Department of Energy (DOE); Lawrence Livermore National Laboratory								AHERN TJ, 1987, P NATL ACAD SCI USA, V84, P675, DOI 10.1073/pnas.84.3.675; AINSWORTH PJ, 1991, NUCLEIC ACIDS RES, V19, P405, DOI 10.1093/nar/19.2.405; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703; BOYER TG, 1989, J BIOL CHEM, V264, P5177; BOYER TG, 1990, J BIOL CHEM, V265, P20524; BROWN JR, 1985, MOL CELL BIOL, V5, P1694, DOI 10.1128/MCB.5.7.1694; CASAL JI, 1987, BIOCHEMISTRY-US, V26, P1258, DOI 10.1021/bi00379a009; CHANG ML, 1993, AM J HUM GENET, V52, P1260; CRAIG LC, 1991, GENE, V99, P217, DOI 10.1016/0378-1119(91)90130-4; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; DECKER RS, 1986, MOL CELL BIOCHEM, V71, P31; EBER SW, 1984, HUM GENET, V67, P336, DOI 10.1007/BF00291364; ERIKSSON AE, 1993, J MOL BIOL, V229, P747, DOI 10.1006/jmbi.1993.1077; FARNHAM PJ, 1990, MOL CELL BIOL, V10, P1390, DOI 10.1128/MCB.10.4.1390; KOHL L, 1994, EUR J BIOCHEM, V220, P331, DOI 10.1111/j.1432-1033.1994.tb18629.x; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6609, DOI 10.1021/bi00480a009; MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MERKLE S, 1989, GENETICS, V123, P837; MOHRENWEISER HW, 1987, HUM GENET, V77, P241, DOI 10.1007/BF00284477; MOHRENWEISER HW, 1987, ANN HUM GENET, V51, P303, DOI 10.1111/j.1469-1809.1987.tb01065.x; MOHRENWEISER HW, 1982, PEDIATR RES, V16, P960, DOI 10.1203/00006450-198211000-00012; NEEL JV, 1988, AM J HUM GENET, V42, P663; OLD SE, 1989, MOL CELL BIOCHEM, V89, P73; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERRY BA, 1992, HUM GENET, V88, P634, DOI 10.1007/BF02265287; ROSA R, 1985, HUM GENET, V71, P235, DOI 10.1007/BF00284582; ROSE IA, 1990, BIOCHEMISTRY-US, V29, P4312, DOI 10.1021/bi00470a008; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SNAPKA RM, 1974, COMP BIOCHEM PHYSIOL, V49, P733, DOI 10.1016/0305-0491(74)90259-4; TANAKA KR, 1990, SEMIN HEMATOL, V27, P165; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WIERENGA RK, 1992, J MOL BIOL, V224, P1115, DOI 10.1016/0022-2836(92)90473-W; WIERENGA RK, 1991, J MOL BIOL, V220, P995, DOI 10.1016/0022-2836(91)90368-G; YUKSEL KU, 1986, ARCH BIOCHEM BIOPHYS, V248, P452, DOI 10.1016/0003-9861(86)90498-4; ZINGG BC, 1995, MUTAT RES-FUND MOL M, V328, P163, DOI 10.1016/0027-5107(95)00004-3	41	41	44	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					308	316						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571957				2022-12-18	WOS:A1996TR79100007
J	TAKAKUBO, F; CARTWRIGHT, P; HOOGENRAAD, N; THORBURN, DR; COLLINS, F; LITHGOW, T; DAHL, HHM				TAKAKUBO, F; CARTWRIGHT, P; HOOGENRAAD, N; THORBURN, DR; COLLINS, F; LITHGOW, T; DAHL, HHM			AN AMINO-ACID SUBSTITUTION IN THE PYRUVATE-DEHYDROGENASE E1-ALPHA GENE, AFFECTING MITOCHONDRIAL IMPORT OF THE PRECURSOR PROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-ORNITHINE TRANSCARBAMYLASE; SITE-DIRECTED MUTAGENESIS; CEREBRAL LACTIC-ACIDOSIS; LEADER PEPTIDE; PROTEOLYTIC CLEAVAGE; MESSENGER-RNA; ALPHA-SUBUNIT; RAT-LIVER; COMPLEX; DEFICIENCY	A mutation in the mitochondrial targeting sequence was characterized in a male patient with X chromosome-linked pyruvate dehydrogenase E1 alpha deficiency. The mutation was a base substitution of G by C at nucleotide 134 in the mitochondrial targeting sequence of the PDHA1 gene, resulting in an arginine-to-proline substitution at codon 10 (R1OP). Pyruvate dehydrogenase activity in cultured skin fibroblasts was 28% of the control value, and immunoblot analysis revealed a decreased level of pyruvate dehydrogenase E1 alpha immunoreactivity. Chimeric constructs in which the normal and mutant pyruvate dehydrogenase E1 alpha targeting sequences were attached to the mitochondrial matrix protein ornithine transcarbamylase were synthesized in a cell free translation system, and mitochondrial import of normal and mutant proteins was compared in vitro. The results show that ornithine transcarbamylase targeted by the mutant pyruvate dehydrogenase E1 alpha sequence was translocated into the mitochondrial matrix at a reduced rate, suggesting that defective import is responsible for the reduced pyruvate dehydrogenase level in mitochondria. The mutation was also present in an affected brother and the mildly affected mother. The clinical presentations of this X chromosome-linked disorder in affected family members are discussed. To our knowledge, this is the first report of an amino acid substitution in a mitochondrial targeting sequence resulting in a human genetic disease.	ROYAL CHILDRENS HOSP, MURDOCH INST RES BIRTH DEFECTS, MELBOURNE, VIC 3052, AUSTRALIA; LA TROBE UNIV, SCH BIOCHEM, BUNDOORA, VIC 3083, AUSTRALIA; PRINCE WALES CHILDRENS HOSP, DEPT MED GENET, RANDWICK, NSW 2031, AUSTRALIA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; La Trobe University			Lithgow, Trevor J/H-5925-2017; Thorburn, David R/G-6266-2013; Hoogenraad, Nicholas J/C-7505-2011	Lithgow, Trevor J/0000-0002-0102-7884; thorburn, david/0000-0002-7725-9470				BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BROWN GK, 1989, ANN NY ACAD SCI, V573, P360, DOI 10.1111/j.1749-6632.1989.tb15011.x; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; BROWN RM, 1990, GENOMICS, V7, P215, DOI 10.1016/0888-7543(90)90543-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOW CW, 1987, ACTA NEUROPATHOL, V74, P393, DOI 10.1007/BF00687218; CHUN K, 1995, AM J HUM GENET, V56, P558; Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203; DAHL HHM, 1992, J INHERIT METAB DIS, V15, P835, DOI 10.1007/BF01800219; DAHL HHM, 1990, AM J HUM GENET, V47, P286; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DAHL HHM, 1995, AM J HUM GENET, V56, P553; DANPURE CJ, 1993, BIOCHIMIE, V75, P309, DOI 10.1016/0300-9084(93)90091-6; DEMEIRLEIR L, 1988, J BIOL CHEM, V263, P1991; DYALLSMITH M, 1988, MOL BIOL REP BIORAD, V6, P1; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GRAF L, 1988, PROTEIN ENG, V2, P297, DOI 10.1093/protein/2.4.297; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HO L, 1989, ANN NY ACAD SCI, V573, P347, DOI 10.1111/j.1749-6632.1989.tb15010.x; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; HORWICH AL, 1985, P NATL ACAD SCI USA, V82, P4930, DOI 10.1073/pnas.82.15.4930; HURT EC, 1987, J BIOL CHEM, V262, P1420; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KIEBLER M, 1993, J MEMBRANE BIOL, V135, P191; KOIKE K, 1988, P NATL ACAD SCI USA, V85, P41, DOI 10.1073/pnas.85.1.41; KRAUS JP, 1988, P NATL ACAD SCI USA, V85, P8905, DOI 10.1073/pnas.85.23.8905; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; LEDLEY FD, 1990, P NATL ACAD SCI USA, V87, P3147, DOI 10.1073/pnas.87.8.3147; LINGELBACH KR, 1986, EUR J BIOCHEM, V161, P19, DOI 10.1111/j.1432-1033.1986.tb10119.x; MCINTYRE P, 1985, DNA-J MOLEC CELL BIO, V4, P147, DOI 10.1089/dna.1985.4.147; MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736; MULLER M, 1992, EXPERIENTIA, V48, P118; NIIDOME T, 1994, J BIOL CHEM, V269, P24719; OU WJ, 1994, J BIOL CHEM, V269, P24673; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PERALTA D, 1993, EUR J BIOCHEM, V211, P881, DOI 10.1111/j.1432-1033.1993.tb17621.x; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; PRICK M, 1981, NEUROLOGY, V31, P398; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Robinson B.H., 1989, METABOLIC BASIS INHE, P869; ROBINSON BH, 1984, J INHERIT METAB DIS, V7, P69, DOI 10.1007/BF03047378; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHATZ G, 1993, PROTEIN SCI, V2, P141; STANSBIE D, 1986, J INHERIT METAB DIS, V9, P105, DOI 10.1007/BF01799447; VANLAACK HLJM, 1988, CLIN CHIM ACTA, V171, P109; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WACHTER C, 1994, MOL BIOL CELL, V5, P465, DOI 10.1091/mbc.5.4.465; WICKING CA, 1986, BIOCHEM J, V239, P89, DOI 10.1042/bj2390089	58	41	44	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					772	780						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573035				2022-12-18	WOS:A1995RV79300005
J	DEGRAAFF, E; WILLEMSEN, R; ZHONG, N; DEDIESMULDERS, CEM; BROWN, WT; FRELING, G; OOSTRA, B				DEGRAAFF, E; WILLEMSEN, R; ZHONG, N; DEDIESMULDERS, CEM; BROWN, WT; FRELING, G; OOSTRA, B			INSTABILITY OF THE CGG REPEAT AND EXPRESSION OF THE FMR1 PROTEIN IN A MALE FRAGILE-X PATIENT WITH A LUNG-TUMOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; ABNORMAL METHYLATION; MENTAL-RETARDATION; FETAL TISSUES; FULL MUTATION; RNA-BINDING; CPG ISLAND; GENE; DIAGNOSIS; REGION	The molecular mechanism of the fragile X syndrome is based on the expansion of an CGG repeat in the 5' UTR of the FMR1 gene in the majority of fragile X patients. This repeat displays instability both between individuals and within an individual. We studied the instability of the CGG repeat and the expression of the FMR1 protein (FMRP) in several different tissues derived from a male fragile X patient. Using Southern blot analysis, only a full mutation is detected in 9 of the 11 tissues tested. The lung tumor contains a methylated premutation of 160 repeats, whereas in the testis, besides the full mutation, a premutation of 60 CGG repeats is detected. Immunohistochemistry of the testis revealed expression of FMR1 in the spermatogonia only, confirming the previous finding that, in the sperm cells of fragile X patients with a full mutation in their blood cells, only a premutation is present. Immunohistochemistry of brain and lung tissue revealed that 1% of the cells are expressing the FMRP. PCR analysis demonstrated the presence of a premutation of 160 repeats in these FMR1-expressing cells. This indicates that the tumor was derived from a lung cell containing a premutation. Remarkably, despite the methylation of the EagI and BssHII sites, FMRP expression is detected in the tumor. Methylation of both restriction sites has thus far resulted in a 100% correlation with the lack of FMR1 expression, but the results found in the tumor suggest that the CpGs in these restriction sites are not essential for regulation of FMR1 expression. This indicates a need for a more accurate study of the exact promoter of FMR1.	ERASMUS UNIV ROTTERDAM,MGC,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; NEW YORK STATE INST BASIC RES,DEPT HUMAN GENET,STATEN ISL,NY; UNIV LIMBURG,DEPT CLIN GENET,6200 MD MAASTRICHT,NETHERLANDS; UNIV LIMBURG,DEPT PATHOL,6200 MD MAASTRICHT,NETHERLANDS	Erasmus University Rotterdam; Hasselt University; Maastricht University; Hasselt University; Maastricht University			Brown, William/GXN-2777-2022; de Graaff, Esther/D-3287-2011		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029407] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 29407] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; BAKKER CE, 1994, CELL, V78, P23; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Brown W T, 1992, Mol Genet Med, V2, P39; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; DEGRAAFF E, 1995, HUM MOL GENET, V4, P45; DEVRIES BBA, 1993, J MED GENET, V30, P761, DOI 10.1136/jmg.30.9.761; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HAGERMAN RJ, 1994, AM J MED GENET, V51, P298, DOI 10.1002/ajmg.1320510404; HAGERMAN RJ, 1991, FRAGILE X SYNDROME D, P1; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; HWU WL, 1993, BIOCHEM BIOPH RES CO, V193, P324, DOI 10.1006/bbrc.1993.1627; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LI CY, 1987, J HISTOCHEM CYTOCHEM, V35, P1457, DOI 10.1177/35.12.2824601; MEIJER H, 1994, HUM MOL GENET, V3, P615; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1214; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; Oostra Ben A., 1993, V6, P45; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VANDENOUWELAND AMW, 1994, AM J MED GENET, V51, P482, DOI 10.1002/ajmg.1320510437; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WOLFL S, 1991, P NATL ACAD SCI USA, V88, P271, DOI 10.1073/pnas.88.1.271; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	54	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					609	618						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668289				2022-12-18	WOS:A1995RR60500010
J	SPRITZ, RA; FUKAI, K; HOLMES, SA; LUANDE, J				SPRITZ, RA; FUKAI, K; HOLMES, SA; LUANDE, J			FREQUENT INTRAGENIC DELETION OF THE P-GENE IN TANZANIAN PATIENTS WITH TYPE-II OCULOCUTANEOUS ALBINISM (OCA2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; SKIN; DNA	Type II oculocutaneous albinism (OCA2) is an autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in the skin, hair, and eyes. OCA2, which results from mutations of the P gene, is the most frequent type of albinism in African and African-American patients. OCA2 is especially frequent in Tanzania, where it occurs with an incidence of similar to 1/1,400. We have identified abnormalities of the P gene in each of 13 unrelated patients with OCA2 from Tanzania. One of these, a deletion of exon 7, is strongly predominant, accounting for similar to 77% of mutant alleles in this group of patients.	UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; TANZANIA TUMOR CTR,DAR ES SALAAM,TANZANIA	University of Wisconsin System; University of Wisconsin Madison	SPRITZ, RA (corresponding author), UNIV WISCONSIN,DEPT PEDIAT,GENET LAB 317,445 HENRY MALL,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-39892] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; KEDDA MA, 1994, AM J HUM GENET, V54, P1078; KROMBERG JGR, 1989, CLIN GENET, V36, P43; LEE SG, IN PRESS GENOMICS; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEE ST, 1994, HUM MOL GENET, V3, P2047; LUANDE J, 1985, CANCER, V55, P1823, DOI 10.1002/1097-0142(19850415)55:8<1823::AID-CNCR2820550830>3.0.CO;2-X; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; SPRITZ RA, 1994, ADV HUM GENET, V22, P1; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; [No title captured]	20	41	43	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1320	1323						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762554				2022-12-18	WOS:A1995RA79400009
J	THOMAS, GR; JENSSON, O; GUDMUNDSSON, G; THORSTEINSSON, L; COX, DW				THOMAS, GR; JENSSON, O; GUDMUNDSSON, G; THORSTEINSSON, L; COX, DW			WILSON DISEASE IN ICELAND - A CLINICAL AND GENETIC-STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATPASE	A survey of Wilson disease in Iceland has revealed two large kindreds with affected individuals. We have carried out studies of haplotypes of dinucleotide repeat polymorphisms (CA repeats) flanking the Wilson disease gene. The same mutation, a 7-bp deletion, is present in both families, and the clinical features are similar. The haplotype data and nature of the mutation support the existence of a founder chromosome carrying the mutation. This Icelandic mutation was not found in patients of Irish or Scottish origins, who could share some of the Icelandic ancestral genes. Although the protein function is predicted to be completely abolished by the deletion, predicting early-onset liver disease, we find that the patients present with later-onset neurological and psychiatric symptoms. We show that alternative splicing of the transcript in the region of the deletion could contribute to later onset, suggesting that alternative isoforms of the protein might have some functional significance.	HOSP SICK CHILDREN,DEPT GENET,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON M5S 1A1,CANADA; NATL UNIV HOSP REYKJAVIK,DEPT MED GENET,BLOOD BANK,REYKJAVIK,ICELAND; NATL UNIV HOSP REYKJAVIK,DEPT NEUROL,REYKJAVIK,ICELAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Landspitali National University Hospital; Landspitali National University Hospital								BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; DAS S, 1995, AM J HUM GENET, V56, P570; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; GUDMUNDSSON KR, 1969, ACTA NEUROL SCAND, V45, P114; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; HOUWEN RHJ, 1993, NETH J MED, V43, P26; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; THOMAS GR, 1994, AM J HUM GENET, V54, P71; THOMAS GR, 1995, IN PRESS AM J HUM GE, V56; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541	16	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1140	1146						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726170				2022-12-18	WOS:A1995QU58600017
J	MACCHI, P; VILLA, A; STRINA, D; SACCO, MG; MORALI, F; BRUGNONI, D; GILIANI, S; MANTUANO, E; FASTH, A; ANDERSSON, B; ZEGERS, BJM; CAVAGNI, G; REZNICK, I; LEVY, J; ZANBAR, I; PORAT, Y; AIRO, P; PLEBANI, A; VEZZONI, P; NOTARANGELO, LD				MACCHI, P; VILLA, A; STRINA, D; SACCO, MG; MORALI, F; BRUGNONI, D; GILIANI, S; MANTUANO, E; FASTH, A; ANDERSSON, B; ZEGERS, BJM; CAVAGNI, G; REZNICK, I; LEVY, J; ZANBAR, I; PORAT, Y; AIRO, P; PLEBANI, A; VEZZONI, P; NOTARANGELO, LD			CHARACTERIZATION OF 9 NOVEL MUTATIONS IN THE CD40 LIGAND GENE IN PATIENTS WITH X-LINKED HYPER IGM SYNDROME OF VARIOUS ANCESTRY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE EXPRESSION; IMMUNODEFICIENCY; GP39	X-linked immunodeficiency with hyper-IgM (HIGMX-1) is a rare disorder caused by defective expression of the CD40 ligand (CD40L) by activated T lymphocytes, resulting in inefficient T-B cell cooperation and failure of B cells to undergo immunoglobulin isotype switch. In the present work, we describe nine patients of various ancestry who bear different mutations in the X chromesome-specific CD40L gene. Two of the mutations were nonsense mutations, one each resulting in premature stop codons at amino acid residues 39 and 140. Three patients had single point missense mutations, one each at codons 126, 140, and 144. Another patient had a 4-bp genomic deletion in exon 2, resulting in a frameshift and premature termination. Three patients showed insertions, one each of 1, 2, and 4 nt, probably because of polymerase slippage, resulting in frameshift mutation and premature termination. Overall, these observations confirm the heterogeneity of mutations in HIGMX-1. However, the identification of two patients whose mutation involves codon 140 (previously shown to be altered in two other unrelated subjects) suggests that this may be a hotspot of mutation in HIGMX-1. In two additional patients with clinical and immunological features indistinguishable from canonical HIGMX-1, no mutation was detected in the coding sequence, in the 5' flanking region, or in the 3' UTR.	UNIV BRESCIA,INST CHEM,BRESCIA,ITALY; SPEDALI CIVIL BRESCIA,CLIN IMMUNOL SERV,BRESCIA,ITALY; UNIV BRESCIA,DEPT PEDIAT,BRESCIA,ITALY; GOTHENBURG UNIV,DEPT PEDIAT,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT CLIN IMMUNOL,GOTHENBURG,SWEDEN; UNIV UTRECHT,DEPT PEDIAT,UTRECHT,NETHERLANDS; CHILDRENS INST HEMATOL RES,DEPT IMMUNOL,MOSCOW,RUSSIA; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,IL-69978 TEL AVIV,ISRAEL; SOROKA HOSP,DEPT PEDIAT,BEER SHEVA,ISRAEL	University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Gothenburg; University of Gothenburg; Utrecht University; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center	MACCHI, P (corresponding author), CNR,IST TECNOL BIOMED AVANZATE,VIA AMPERE 56,I-20131 MILAN,ITALY.		Giliani, Silvia/AAX-8843-2020; Fasth, Anders/I-1109-2019; Vezzoni, Paolo/R-3416-2019; Notarangelo, Luigi D/F-9718-2016; Plebani, Alessandro/C-8593-2011; Vezzoni, Paolo/K-3197-2018; mantuano, elide/AAB-3526-2019	Giliani, Silvia/0000-0001-8137-4642; Notarangelo, Luigi D/0000-0002-8335-0262; mantuano, elide/0000-0003-1656-5543; Vezzoni, Paolo/0000-0002-6382-3923; strina, dario/0000-0002-0628-5997; Fasth, Anders/0000-0002-0033-740X; Villa, Anna/0000-0003-4428-9013; Brugnoni, Duilio/0000-0001-9420-9961	Telethon [A.014] Funding Source: Medline	Telethon(Fondazione Telethon)		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; DISANTO JP, 1994, NEW ENGL J MED, V330, P969, DOI 10.1056/NEJM199404073301404; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GAUCHAT JF, 1993, FEBS LETT, V315, P259, DOI 10.1016/0014-5793(93)81175-Y; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x; Maniatis T, 1989, DECONTAMINATION DILU; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; PILIA G, 1994, GENOMICS, V22, P249, DOI 10.1006/geno.1994.1378; RAMESH N, 1994, IMMUNOL REV, V138, P87, DOI 10.1111/j.1600-065X.1994.tb00848.x; RAMESH N, 1993, J IMMUNOL S, V1150, P26; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VILLA A, 1994, P NATL ACAD SCI USA, V91, P2110, DOI 10.1073/pnas.91.6.2110; VILLA A, 1994, HUM MUTAT, V3, P73, DOI 10.1002/humu.1380030115	19	41	43	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					898	906						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717401				2022-12-18	WOS:A1995QP66300011
J	BOGAERT, R; WILKIN, D; WILCOX, WR; LACHMAN, R; RIMOIN, D; COHN, DH; EYRE, DR				BOGAERT, R; WILKIN, D; WILCOX, WR; LACHMAN, R; RIMOIN, D; COHN, DH; EYRE, DR			EXPRESSION, IN CARTILAGE, OF A 7-AMINO-ACID DELETION IN TYPE-II COLLAGEN FROM 2 UNRELATED INDIVIDUALS WITH KNIEST-DYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STICKLER SYNDROME ARTHROOPHTHALMOPATHY; LETHAL OSTEOGENESIS IMPERFECTA; TRIPLE-HELICAL DOMAIN; GENE COL2A1; SPONDYLOEPIPHYSEAL DYSPLASIA; PROCOLLAGEN COL2A1; ALPHA-1(II) CHAIN; N-PROTEINASE; MUTATION; CLEAVAGE	Kniest dysplasia is a heritable chondrodysplasia that severely affects skeletal growth. Recent evidence suggests that the etiology is based on mutations in COL2A1, the gene for collagen type II. We report the detection and partial characterization of an identical defect in type II collagen in two unrelated patients with Kniest dysplasia. Analysis of cyanogen bromide (CB)-digested cartilage samples from both probands by SDS-PAGE revealed an abnormal band for peptide alpha 1(II)CB12. The peptide was purified and digested with endoproteinase Asp-N. Fragments unique to the Kniest tissues were identified by reverse-phase high-pressure liquid chromatography and by sequence analysis. The results established a deletion of amino acids 102-108 of the alpha 1(II) triple-helical domain, which disrupted the (gly-X-Y)n repeat needed for helix formation. This was confirmed by sequence analysis of DNA amplified from both probands, revealing the molecular basis to be a single nucleotide mutation at a CpG dinucleotide (GCG-->GTG) in the codon for alanine 102. The mutation created a new splice donor site, which would account for the absence of the last seven amino acids from the 3' end of exon 12 in alpha 1(ll)CB12. Light and electron micrographs of the probands' cartilage showed the perilacunar foamy matrix (''Swiss cheese'') characteristic of Kniest dysplasia and chondrocytes containing dilated rough endoplasmic reticulum, which earlier studies had shown were filled with type II procollagen. These two cases strengthen the concept that Kniest dysplasia is based on mutations of COL2A1 and belongs within the broad spectrum of chondrodysplasias caused by type II collagenopathies.	UNIV WASHINGTON,DEPT ORTHOPAED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ORAL BIOL,SEATTLE,WA; CEDARS SINAI MED CTR,STEVEN SPIELBERG PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL,LOS ANGELES,CA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016219] Funding Source: NIH RePORTER; NIAMS NIH HHS [R37 AR037318, AR37318, R01 AR036794] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; NIGMS NIH HHS [GM16219-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BATEMAN JF, 1986, ANAL BIOCHEM, V54, P338; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; Byers Peter H., 1993, P317; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; EYRE D, 1987, METHOD ENZYMOL, V144, P115; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; EYRE DR, 1986, AM J HUM GENET, V39, P52; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; HORTON WA, 1979, PEDIATR RES, V13, P1266, DOI 10.1203/00006450-197911000-00012; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; KATZENSTEIN PL, 1992, 56TH ANN M AM COLL R; KORKKO J, 1993, AM J HUM GENET, V53, P55; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; RIMOIN DL, 1990, PRINCIPLES PRACTICE, P895; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING, P916; SPRINGER J, 1994, EUR J PEDIATR, V153, P56; STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41; TAYBI H, 1990, RADIOLOGY SYNDROMES, P737; TILLER GE, 1993, AM J HUM GENET, V53, P209; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; VIKKULA M, 1993, GENOMICS, V16, P282, DOI 10.1006/geno.1993.1179; VISSING H, 1989, J BIOL CHEM, V264, P18265; VOGEL BE, 1988, J BIOL CHEM, V263, P19249; WALLIS GA, 1992, J BIOL CHEM, V267, P25529; WILKIN DJ, 1993, AM J HUM GENET, V53, P210; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458; WILLING MC, 1988, J BIOL CHEM, V263, P8398; WINTERPACHT A, 1993, NAT GENET, V3, P323, DOI 10.1038/ng0493-323; WINTERPACHT A, IN PRESS HUM MUTAT	40	41	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1128	1136						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977371				2022-12-18	WOS:A1994QB68400008
J	BOGHOSIANSELL, L; MEWAR, R; HARRISON, W; SHAPIRO, RM; ZACKAI, EH; CAREY, J; DAVISKEPPEN, L; HUDGINS, L; OVERHAUSER, J				BOGHOSIANSELL, L; MEWAR, R; HARRISON, W; SHAPIRO, RM; ZACKAI, EH; CAREY, J; DAVISKEPPEN, L; HUDGINS, L; OVERHAUSER, J			MOLECULAR MAPPING OF THE EDWARDS-SYNDROME PHENOTYPE TO 2 NONCONTIGUOUS REGIONS ON CHROMOSOME-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANEUPLOID PHENOTYPES; PATHOGENESIS; TRISOMY-18; ARM	In an effort to identify regions on chromosome 18 that may be critical in the appearance of the Edwards syndrome phenotype, we have analyzed six patients with partial duplication of chromosome 18. Four of the patients have duplications involving the distal half of 18q (18q21.1-qter) and are very mildly affected. The remaining two patients have most of 18q (18q12.1-qter) duplicated, are severely affected, and have been diagnosed with Edwards syndrome. We have employed FISH, using DNA probes from a chromosome 18-specific library, for the precise determination of the duplicated material in each of these patients. The clinical features and the extent of the chromosomal duplication in these patients were compared with four previously reported partial trisomy 18 patients, to identify regions of chromosome 18 that may be responsible for certain clinical features of trisomy 18. The comparative analysis confirmed that there is no single region on 18q that is sufficient to produce the trisomy 18 phenotype and identified two regions on 18q that may work in conjunction to produce the Edwards syndrome phenotype. In addition, correlative analysis indicates that duplication of 18q12.3-q22.1 may be associated with more severe mental retardation in trisomy 18 individuals.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DIV MED GENET,PHILADELPHIA,PA 19107; UNIV PENN,DEPT PSYCHIAT,PHILADELPHIA,PA 19104; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104; UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT; UNIV S DAKOTA,SCH MED,DEPT PEDIAT,SIOUX FALLS,SD; CHILDRENS HOSP & MED CTR,DIV MED GENET,SEATTLE,WA 98105	Jefferson University; Jefferson University; University of Pennsylvania; University of Pennsylvania; Utah System of Higher Education; University of Utah; University of South Dakota; Seattle Children's Hospital					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000137] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00137] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BINKERT F, 1990, HUM HERED, V40, P81, DOI 10.1159/000153910; EPSTEIN CJ, 1988, AM J MED GENET, V29, P161, DOI 10.1002/ajmg.1320290121; FRYNS JP, 1979, HUM GENET, V46, P341, DOI 10.1007/BF00273319; FRYNS JP, 1978, HUM GENET, V44, P201, DOI 10.1007/BF00295415; KLINE AD, 1993, AM J HUM GENET, V52, P895; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; LEWKONIA RM, 1980, J MED GENET, V17, P453, DOI 10.1136/jmg.17.6.453; Lyons Jones K., 1988, SMITHS RECOGNIZABLE; MARION RW, 1988, J PEDIATR-US, V113, P45, DOI 10.1016/S0022-3476(88)80526-2; MATSUOKA R, 1981, HUM GENET, V57, P78; MEUCKE J, 1982, HUM GENET, V60, P205; MEWAR R, 1993, CYTOGENET CELL GENET, V64, P1, DOI 10.1159/000133547; MEWAR R, 1993, AM J HUM GENET, V53, P1269; NEU RL, 1976, J MED GENET, V13, P520, DOI 10.1136/jmg.13.6.520; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; SHAPIRO BL, 1989, AM J MED GENET, V33, P146, DOI 10.1002/ajmg.1320330124; TURLEAU C, 1980, CLIN GENET, V18, P20; VANDYKE DC, 1990, PEDIATRICS, V85, P753; VERMA RS, 1989, HUMAN CHROMOSOMES MA; VOGEL H, 1990, DEV MED CHILD NEUROL, V32, P725; WERTELECKI W, 1971, J PEDIATR-US, V78, P44, DOI 10.1016/S0022-3476(71)80262-7; WILSON GN, 1990, AM J MED GENET, V36, P500, DOI 10.1002/ajmg.1320360426; ZUMEL RM, 1989, ANN GENET-PARIS, V32, P160	24	41	46	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					476	483						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079991				2022-12-18	WOS:A1994PF50900009
J	OLSON, JM; WIJSMAN, EM				OLSON, JM; WIJSMAN, EM			DESIGN AND SAMPLE-SIZE CONSIDERATIONS IN THE DETECTION OF LINKAGE DISEQUILIBRIUM WITH A DISEASE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; COMPLEX; REGION	The presence of linkage disequilibrium between closely linked loci can aid in the fine mapping of disease loci. We investigate the power of several designs for sampling individuals with different disease genotypes. As expected, haplotype data provide the greatest power for detecting disequilibrium, but, in the absence of parental information to resolve the phase of double heterozygotes, the most powerful design samples only individuals homozygous at the trait locus. For rare diseases, such a scheme is generally not feasible, and we also provide power and sample-size calculations for designs that sample heterozygotes. The results provide information useful in planning disequilibrium studies.	UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NCI NIH HHS [CA09168] Funding Source: Medline; NIA NIH HHS [AG05136, AG08303] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG008303, P50AG005136] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; GERSHON ES, 1989, AM J HUM GENET, V45, P578; HILL WG, 1994, AM J HUM GENET, V54, P705; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MAISTE PJ, 1992, AM J HUM GENET, V50, P1138; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Weir BS, 1990, GENETIC DATA ANAL; WIJSMAN EM, IN PRESS HDB PSYCHOP	17	41	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					574	580						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079996				2022-12-18	WOS:A1994PF50900019
J	FISHER, JM; HARVEY, JF; LINDENBAUM, RH; BOYD, PA; JACOBS, PA				FISHER, JM; HARVEY, JF; LINDENBAUM, RH; BOYD, PA; JACOBS, PA			MOLECULAR STUDIES OF TRISOMY-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; GENETIC-LINKAGE MAP; EXTRA CHROMOSOME; ENZYMATIC AMPLIFICATION; REDUCED RECOMBINATION; DNA POLYMORPHISMS; PARENTAL ORIGIN; MATERNAL AGE; NONDISJUNCTION; SEQUENCES	We have determined the parental origin of 50 cases of trisomy 18. In 48 cases the additional chromosome was maternal in origin, and in 2 cases it was paternal in origin. Seven cases, including both those with an additional paternal chromosome, appeared to be the result of a postzygotic error. In contrast to the situation in nondisjunction involving chromosomes 21 and X, there was no evidence for nullochiasmate nondisjunction.	CHURCHILL HOSP, DEPT MED GENET, OXFORD OX3 7LJ, ENGLAND; JOHN RADCLIFFE MATERN HOSP, OXFORD REG PRENATAL DIAGNOSIS SERV, OXFORD, ENGLAND	University of Oxford	FISHER, JM (corresponding author), SALISBURY DIST HOSP, WESSEX REG GENET LAB, SALISBURY SP2 8BJ, ENGLAND.							ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BABU A, 1986, AM J HUM GENET, V38, P549; DETERAWADLEIGH SD, 1987, NUCLEIC ACIDS RES, V15, P375, DOI 10.1093/nar/15.1.375; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWARDS JH, 1960, LANCET, V1, P787; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRELL RF, 1985, ANEUPLOIDY ETIOLOGY, P317; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HOOK EB, 1975, POPULATION CYTOGENET, P63; KONDOH T, 1988, HUM GENET, V79, P377; KUPKE KG, 1989, AM J HUM GENET, V45, P599; MACKENZIE MJ, 1991, AM J HUM GENET, V49, pA18; MARLHENS F, 1987, NUCLEIC ACIDS RES, V15, P1348, DOI 10.1093/nar/15.3.1348; MERRIAM JR, 1964, GENETICS, V49, P109; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORLE F, 1984, CYTOGENET CELL GENET, V37, P544; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; MORTON NE, 1988, ANN HUM GENET, V52, P227, DOI 10.1111/j.1469-1809.1988.tb01100.x; MULLER U, 1987, CYTOGENET CELL GENET, V45, P16, DOI 10.1159/000132418; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; OCONNELL P, 1987, CYTOGENET CELL GENET, V46, P671; Petersen M. B., 1992, American Journal of Human Genetics, V51, pA24; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; POLYMEROPOULOS MH, 1992, HUM MOL GENET, V1, P658, DOI 10.1093/hmg/1.8.658; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; Schinzel A, 1984, CATALOGUE UNBALANCED; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SIONS JW, 1992, HUM MOL GENET, V5, P352; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; TATEISHI H, 1986, NUCLEIC ACIDS RES, V14, P1926, DOI 10.1093/nar/14.4.1926; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P6465, DOI 10.1093/nar/18.21.6465-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2201	44	41	41	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1139	1144						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503446				2022-12-18	WOS:A1993LG13300015
J	NANCE, WE				NANCE, WE			STATEMENT OF THE AMERICAN SOCIETY OF HUMAN-GENETICS ON CYSTIC-FIBROSIS CARRIER SCREENING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											NANCE, WE (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,BOX 33,MCV STN,RICHMOND,VA 23298, USA.							1990, NEW ENGL J MED, V323, P70; 1990, AM J HUM GENET, V46, P393	2	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1443	1444						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463021				2022-12-18	WOS:A1992KC99500027
J	HOWELL, N; MCCULLOUGH, DA; KUBACKA, I; HALVORSON, S; MACKEY, D				HOWELL, N; MCCULLOUGH, DA; KUBACKA, I; HALVORSON, S; MACKEY, D			THE SEQUENCE OF HUMAN MTDNA - THE QUESTION OF ERRORS VERSUS POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-DNA MUTATION		JOHNS HOPKINS UNIV,CTR HEREDITARY EYE DIS,BALTIMORE,MD 21218; UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550	Johns Hopkins University; University of Texas System; University of Texas Medical Branch Galveston	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,GALVESTON,TX 77550, USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN MD, 1992, GENETICS, V130, P163; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1990, AM J HUM GENET, V47, P629; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393; MARZUKI S, 1991, HUM GENET, V88, P139; NOER AS, 1991, AM J HUM GENET, V49, P715; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1; SHOFFNER JM, 1991, ANN NEUROL, V30, P322; THYAGARAJAN D, 1991, ANN NEUROL, V30, P724, DOI 10.1002/ana.410300514; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YONEDA M, 1990, BIOCHEM INT, V21, P789; YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R	20	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1333	1337						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598914				2022-12-18	WOS:A1992HY65400023
J	GREENHAW, GA; HEBERT, A; DUKEWOODSIDE, ME; BUTLER, IJ; HECHT, JT; CLEAVER, JE; THOMAS, GH; HORTON, WA				GREENHAW, GA; HEBERT, A; DUKEWOODSIDE, ME; BUTLER, IJ; HECHT, JT; CLEAVER, JE; THOMAS, GH; HORTON, WA			XERODERMA-PIGMENTOSUM AND COCKAYNE SYNDROME - OVERLAPPING CLINICAL AND BIOCHEMICAL PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXCISION REPAIR; DNA-REPAIR; ULTRAVIOLET-RADIATION; PYRIMIDINE DIMERS; UV-IRRADIATION; CELLS; DEFECT; ABNORMALITIES; SENSITIVITY; FIBROBLASTS	Two siblings are described whose clinical presentation of cutaneous photosensitivity and central nervous system dysfunction is strongly reminiscent of the DeSanctis-Cacchione syndrome (DCS) variant of xeroderma pigmentosum. An extensive clinical evaluation supported a diagnosis of DCS and documented previously unreported findings. In vitro fibroblast studies showed UV sensitivity that was two to three times that of normal controls. However, neither a post-UV-irradiation DNA excision-repair defect indicative of XP nor a semiconservative DNA replication defect indicative of XP variant was found. Rather, a failure of RNA synthesis to recover to normal levels after UV exposure was observed, a biochemical abnormality seen in Cockayne syndrome (CS), one of the premature-aging syndromes with clinical UV sensitivity. These patients, therefore, clinically have XP, but their biochemical characteristics suggest CS. The reason(s) for the severe neurologic disease, in light of the relatively mild cutaneous abnormalities, is unclear. Other cases with unusual fibroblast responses to irradiation have been noted in the literature and, along with the data from our patients, reinforce the notion of the complexity of DNA maintenance and repair.	UNIV TEXAS,SCH MED,DEPT PEDIAT,POB 20708,HOUSTON,TX 77225; UNIV TEXAS,SCH MED,DEPT DERMATOL,HOUSTON,TX 77225; UNIV TEXAS,SCH MED,DEPT NEUROL,HOUSTON,TX 77225; UNIV CALIF SAN FRANCISCO,RADIOBIOL & ENVIRONM HLTH LAB,SAN FRANCISCO,CA 94143	University of Texas System; University of Texas System; University of Texas System; University of California System; University of California San Francisco								AHMED FE, 1978, BIOCHIM BIOPHYS ACTA, V521, P805, DOI 10.1016/0005-2787(78)90319-2; ANDREWS AD, 1978, P NATL ACAD SCI USA, V75, P1984, DOI 10.1073/pnas.75.4.1984; BOLSTHAUSER E, 1989, NEURORADIOLOGY, V31, P276; BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; CLEAVER JE, 1988, J INVEST DERMATOL, V90, P467, DOI 10.1111/1523-1747.ep12460917; CLEAVER JE, 1981, CYTOGENET CELL GENET, V31, P188, DOI 10.1159/000131646; CLEAVER JE, 1981, CYTOGENET CELL GENET, V29, P122, DOI 10.1159/000131559; CLEAVER JE, 1984, PHOTOCHEM PHOTOBIOL, V40, P621, DOI 10.1111/j.1751-1097.1984.tb05350.x; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; CLEAVER JE, 1975, METHOD CANCER RES, V11, P123; COOPER JR, 1986, BIOCH BASIS NEUROPHA; DUPUY JM, 1982, J INVEST DERMATOL, V78, P356; DUVOISIN RC, 1984, ADV NEUROLOGY OLIVOP; EHMANN UK, 1973, RADIAT RES, V54, P152, DOI 10.2307/3573873; KAUFMANN WK, 1981, J MOL BIOL, V149, P171, DOI 10.1016/0022-2836(81)90297-7; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; MAYNE LV, 1982, CANCER RES, V42, P1473; NISHIO H, 1988, J INHERIT METAB DIS, V11, P88, DOI 10.1007/BF01800059; OHNISHI A, 1987, MUSCLE NERVE, V10, P163, DOI 10.1002/mus.880100210; OTSUKA F, 1985, AM J DERMATOPATH, V7, P387, DOI 10.1097/00000372-198508000-00013; REED WB, 1977, ARCH DERMATOL, V113, P1561, DOI 10.1001/archderm.113.11.1561; RINALDY A, 1988, DNA-J MOLEC CELL BIO, V7, P563, DOI 10.1089/dna.1.1988.7.563; RINALDY A, 1990, P NATL ACAD SCI USA, V87, P6818, DOI 10.1073/pnas.87.17.6818; ROBBINS JH, 1989, J CHILD NEUROL, V4, P143, DOI 10.1177/088307388900400215; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SEIFERT WE, 1980, ANN NEUROL, V8, P38, DOI 10.1002/ana.410080106; SILENGO MC, 1986, PEDIATR RADIOL, V16, P264, DOI 10.1007/BF02456305; TACHI N, 1988, J CHILD NEUROL, V3, P114, DOI 10.1177/088307388800300207; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5512, DOI 10.1073/pnas.86.14.5512; TEO IA, 1983, CARCINOGENESIS, V4, P559, DOI 10.1093/carcin/4.5.559; TEO IA, 1982, MUTAT RES, V107, P371; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	37	41	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					677	689						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1372469				2022-12-18	WOS:A1992HL84800003
J	HUANG, THM; HEJTMANCIK, JF; EDWARDS, A; PETTIGREW, AL; HERRERA, CA; HAMMOND, HA; CASKEY, CT; ZOGHBI, HY; LEDBETTER, DH				HUANG, THM; HEJTMANCIK, JF; EDWARDS, A; PETTIGREW, AL; HERRERA, CA; HAMMOND, HA; CASKEY, CT; ZOGHBI, HY; LEDBETTER, DH			LINKAGE OF THE GENE FOR AN X-LINKED MENTAL-RETARDATION DISORDER TO A HYPERVARIABLE (AGAT)N REPEAT MOTIF WITHIN THE HUMAN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE (HPRT) LOCUS (XQ26)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FORSSMAN-LEHMANN SYNDROME; HUMAN GENOME; POLYMORPHISMS; DNA; LOCALIZATION; CHROMOSOME; FREQUENCY; COMMITTEE	We recently reported a new X-linked mental retardation (XLMR) disorder in a four-generation family of Dutch descent. Features included Dandy-Walker malformation, basal ganglia disease, and seizures. Twenty-six family members, including two living affected males and two obligate carriers, were available for study. No evidence of linkage was observed between the disease locus and RFLPs from several X-chromosome regions, including Xp21-p22 (13 markers), proximal Xq (four markers), and Xq28 (three markers). However, a new hypervariable short tandem repeat (STR) within the HPRT gene at Xq26 showed positive linkage to the disease locus, with a maximum lod score of 2.19 at a recombination fraction of 0. A second hypervariable marker in Xq26, the dinucleotide repeat XL90A3 (DXS425), showed a lod score of .84 at a recombination fraction of .11. Both the HPRT and DXS425 markers were typed in 40 CEPH families, and subsequent multipoint linkage analysis showed the following order: Xcen-DXS425-(HPRT,XLMR)-F9-qter. HPRT and these flanking markers are therefore useful for carrier detection and prenatal diagnosis in this family. This study illustrates that hypervariable STRs will be powerful tools for linkage analysis and genetic diagnosis, particularly when relatively small families are involved.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; NEI,BETHESDA,MD 20892	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	LEDBETTER, DH (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.			Zoghbi, Huda/0000-0002-0700-3349	NIDDK NIH HHS [DK 31428] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031428] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ARENA JF, 1991, AM J MED GENET, V38, P190, DOI 10.1002/ajmg.1320380205; ARENA JF, IN PRESS FRAGILE X; BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; Church G M, 1985, Prog Clin Biol Res, V177, P17; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GREGG RG, 1991, GENOMICS, V9, P701, DOI 10.1016/0888-7543(91)90363-J; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; LUTY JA, 1990, AM J HUM GENET, V46, P776; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MATHEWS KD, 1989, AM J MED GENET, V34, P470, DOI 10.1002/ajmg.1320340403; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NERI G, 1991, AM J MED GENET, V38, P186, DOI 10.1002/ajmg.1320380204; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; PETTIGREW AL, 1991, AM J MED GENET, V38, P200, DOI 10.1002/ajmg.1320380206; SMITH RJH, 1989, CYTOGENET CELL GENET, V50, P102, DOI 10.1159/000132733; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZULIANI G, 1990, AM J HUM GENET, V46, P963	26	41	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1312	1319						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746558				2022-12-18	WOS:A1991GU67200018
J	DEAN, M; LUCASDERSE, S; BOLOS, A; OBRIEN, SJ; KIRKNESS, EF; FRASER, CM; GOLDMAN, D				DEAN, M; LUCASDERSE, S; BOLOS, A; OBRIEN, SJ; KIRKNESS, EF; FRASER, CM; GOLDMAN, D			GENETIC-MAPPING OF THE BETA-I GABA RECEPTOR GENE TO HUMAN CHROMOSOME-4, USING A TETRANUCLEOTIDE REPEAT POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-III GENE; FUNCTIONAL EXPRESSION; SUBUNIT; SEQUENCE; HETEROGENEITY; LOCALIZATION; ANTAGONIST; DISEASE	As more coding loci for functional human genes are described, there is a growing need to identify DNA polymorphisms in specific genes. By examining DNA sequences within the introns of the beta-1 subunit of the gamma-aminobutyric acid receptor gene, GABARB1, we found a tetranucleotide repeat sequence (GATA). Amplification of this region by using PCR revealed seven alleles and a high degree of polymorphism (PIC = .75) in human populations. DNAs from the CEPH families were typed for the GABARB1 intron polymorphism and were analyzed with respect to 20 linked markers on chromosome 4. The results permit placement of GABARB1 on the linkage map of chromosome 4, between D4S104 and ALB. These results affirm that sequence analysis of noncoding segments included within or adjacent to functional genes has value as a strategy to detect highly informative polymorphisms.	PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD; NIAAA,CLIN STUDIES LAB,BETHESDA,MD; NIAAA,PHARMACOL STUDIES LAB,ROCKVILLE,MD 20852	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	DEAN, M (corresponding author), NCI,FREDERICK CANC RES CTR,VIRAL CARCINOGENESIS LAB,BLDG 560,FREDERICK,MD 21702, USA.		Goldman, David/F-9772-2010; Dean, Michael/R-7501-2019; OBRIEN, STEPHEN/ABD-1346-2020; Dean, Michael C/G-8172-2012	Goldman, David/0000-0002-1724-5405; Dean, Michael C/0000-0003-2234-0631; Fraser, Claire/0000-0003-1462-2428; OBRIEN, STEPHEN/0000-0001-7857-0757	OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DONISKELLER H, 1990, GENETIC MAPS; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; HENIKOFF S, 1987, GENETICS, V117, P711; KIRKNESS EF, IN PRESS GENOMICS; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LITT M, 1989, AM J HUM GENET, V44, P397; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Olsen RW, 1986, BENZODIAZEPINE GABA; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7198, DOI 10.1093/nar/18.23.7198-a; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V18, P7468; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; SCHOFIELD PR, 1989, FEBS LETT, V244, P361, DOI 10.1016/0014-5793(89)80563-0; SOMMER B, 1990, DNA CELL BIOL, V9, P561, DOI 10.1089/dna.1990.9.561; STEPHENSON FA, 1988, BIOCHEM J, V249, P21, DOI 10.1042/bj2490021; STRAUB TD, 1990, AM J HUM GENET, V47, pA237; SUZDAK PD, 1986, SCIENCE, V234, P1243, DOI 10.1126/science.3022383; VANAMSTEL HKP, 1990, NUCLEIC ACIDS RES, V18, P4957, DOI 10.1093/nar/18.16.4957-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4299; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958-a	29	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					621	626						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1652891				2022-12-18	WOS:A1991GE36700015
J	KREMER, EJ; YU, S; PRITCHARD, M; NAGARAJA, R; HEITZ, D; LYNCH, M; BAKER, E; HYLAND, VJ; LITTLE, RD; WADA, M; TONIOLO, D; VINCENT, A; ROUSSEAU, F; SCHLESSINGER, D; SUTHERLAND, GR; RICHARDS, RI				KREMER, EJ; YU, S; PRITCHARD, M; NAGARAJA, R; HEITZ, D; LYNCH, M; BAKER, E; HYLAND, VJ; LITTLE, RD; WADA, M; TONIOLO, D; VINCENT, A; ROUSSEAU, F; SCHLESSINGER, D; SUTHERLAND, GR; RICHARDS, RI			ISOLATION OF A HUMAN DNA-SEQUENCE WHICH SPANS THE FRAGILE-X	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; CHROMOSOMES; EXPRESSION; MUTATION; INHERITANCE	To identify the sequences involved in the expression of the fragile X and to characterize the molecular basis of the genetic lesion, we have constructed yeast artificial chromosomes (YACs) containing human DNA and have screened them with cloned DNA probes which map close to the fragile site at Xq27.3. We have isolated and partly characterized a YAC containing approximately 270 kb of human DNA from an X chromosome which expresses the fragile X. This sequence in a yeast artificial ring chromosome, XTY26, hybridizes to the two closest DNA markers, VK16 and Do33, which flank the fragile site. The human DNA sequence in XTY26 also spans the fragile site on chromosome in situ hybridization. When a restriction map of XTY26, derived by using infrequently cutting restriction enzymes, is compared with similar YAC maps derived from non-fragile-X patients, no large-scale differences are observed. This YAC, XTY26, may enable (a) the fragile site to be fully characterized at the molecular level and (b) the pathogenetic basis of the fragile-X syndrome to be determined.	ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; WASHINGTON UNIV,CTR GENET MED,SCH MED,ST LOUIS,MO 63130; UNIV STRASBOURG 1,INSERM,U184,F-67070 STRASBOURG,FRANCE; IST GENET BIOCHIM EVOLUZIONIST,PAVIA,ITALY	Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Toniolo, Daniela/AAE-2969-2019; Little, Randall/O-7172-2014; Sutherland, Grant Robert/D-2606-2012; Richards, Robert/ABE-6423-2020; Kremer, Eric J/D-3734-2013	Toniolo, Daniela/0000-0001-9545-6032; Richards, Robert Ian/0000-0002-5978-6453; Kremer, EJ/0000-0001-6114-7530; Hyland, Valentine/0000-0002-6814-2094				ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; CALLEN DF, 1990, ANN GENET-PARIS, V33, P190; CHOO KH, 1987, DNA-J MOLEC CELL BIO, V6, P297, DOI 10.1089/dna.1987.6.297; Davies KE, 1989, FRAGILE X SYNDROME; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; LAIRD CD, 1990, AM J HUM GENET, V46, P696; LAIRD CD, 1987, GENETICS, V117, P587; LEDBETTER DH, 1986, NATURE, V324, P161, DOI 10.1038/324161a0; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; OVERHAUSER J, 1989, FOCUS, V9, P8; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; REITHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEBER JL, 1989, AM J HUM GENET, V44, P388	22	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					656	661						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882843				2022-12-18	WOS:A1991GE36700019
J	PLEWINSKA, M; THUNELL, S; HOLMBERG, L; WETMUR, JG; DESNICK, RJ				PLEWINSKA, M; THUNELL, S; HOLMBERG, L; WETMUR, JG; DESNICK, RJ			DELTA-AMINOLEVULINATE DEHYDRATASE DEFICIENT PORPHYRIA - IDENTIFICATION OF THE MOLECULAR LESIONS IN A SEVERELY AFFECTED HOMOZYGOTE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN 5-AMINOLAEVULINATE DEHYDRATASE; PORPHOBILINOGEN SYNTHASE DEFECT; HEREDITARY HEPATIC PORPHYRIA; ACID DEHYDRATASE; NUCLEOTIDE-SEQUENCE; ENZYMATIC AMPLIFICATION; BOVINE LIVER; THIOL-GROUPS; ACTIVE-SITE; CDNA	delta-Aminolevulinate dehydratase deficient porphyria, a recently recognized inborn error of heme biosynthesis, results from the markedly deficient activity of the heme biosynthetic enzyme, delta-aminolevulinate dehydratase (ALA-D). The four homozygotes described to date with this disorder have remarkably distinct phenotypes, ranging from a severely affected infant with failure to thrive to an essentially asymptomatic 68-year-old male. To investigate the molecular nature of the lesions causing the severe infantile-onset form, total RNA was isolated from cultured lymphoblasts of the affected homozygote, RNA was reverse-transcribed to cDNA, and the 990-bp ALA-D-coding region was amplified by the PCR. Heterozygosity for an RsaI RFLP within the ALA-dehydratase-coding region permitted identification of the paternal and maternal mutant alleles prior to sequencing. The maternal mutation (designated G133R), a G-to-A transition of nucleotide 397, predicted a glycine-to-arginine substitution at residue 133 at the carboxyl end of the highly conserved zinc-binding site in the enzyme subunit. The G133R mutation created a PstI site and permitted the confirmation and rapid detection of this lesion in amplified genomic DNA from maternal relatives. The paternal mutation, a G-to-A transition of nucleotide 823, predicted a valine-to-methionine substitution of residue 275 (designated V275M). This mutation was confirmed in genomic DNA from family members by the competitive PCR technique. Both missense mutations, which occurred at CpG dinucleotides, resulted in the synthesis of enzyme subunits such that the activity of the homooctameric enzyme was markedly reduced, thereby causing the severe infantile-onset phenotype in the affected homozygote.	CUNY MT SINAI SCH MED,DIV MED & MOLEC GENET,5TH AVE & 100TH ST,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT MICROBIOL,NEW YORK,NY 10029; ST GORANS UNIV HOSP,DEPT CLIN CHEM,S-11281 STOCKHOLM,SWEDEN; UNIV LUND,DEPT PEDIAT,S-22101 LUND,SWEDEN	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Saint Goran's Hospital; Lund University					NCRR NIH HHS [RR00071] Funding Source: Medline; NIDDK NIH HHS [DK26824] Funding Source: Medline; NIEHS NIH HHS [ES05046] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005046] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; BISHOP TR, 1986, NUCLEIC ACIDS RES, V14, P10115, DOI 10.1093/nar/14.24.10115; BISHOP TR, 1989, NUCLEIC ACIDS RES, V17, P1775, DOI 10.1093/nar/17.4.1775; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DENT AJ, 1990, BIOCHEMISTRY-US, V29, P7822, DOI 10.1021/bi00486a007; DEVERNEUIL H, 1985, HUM GENET, V69, P174, DOI 10.1007/BF00293292; DOSS M, 1979, KLIN WOCHENSCHR, V57, P1123, DOI 10.1007/BF01481493; DOSS M, 1980, INT J BIOCHEM, V12, P823, DOI 10.1016/0020-711X(80)90170-6; ECHELARD Y, 1988, MOL GEN GENET, V214, P503, DOI 10.1007/BF00330487; FUJITA H, 1987, PEDIATRICS, V80, P880; GIBBS PNB, 1986, BIOCHEM J, V236, P447, DOI 10.1042/bj2360447; GIBBS PNB, 1985, BIOCHEM J, V225, P573, DOI 10.1042/bj2250573; HASSOUN A, 1989, J CLIN CHEM CLIN BIO, V27, P781; JAFFE EK, 1986, J BIOL CHEM, V261, P9348; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; THUNELL S, 1987, J CLIN CHEM CLIN BIO, V25, P5; TSUKAMOTO I, 1979, BIOCHIM BIOPHYS ACTA, V570, P167, DOI 10.1016/0005-2744(79)90211-0; TSUKAMOTO I, 1980, INT J BIOCHEM, V12, P751; WETMUR JG, 1986, GENE, V43, P123, DOI 10.1016/0378-1119(86)90015-6; WETMUR JG, 1986, P NATL ACAD SCI USA, V83, P7703, DOI 10.1073/pnas.83.20.7703; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	25	41	47	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					167	174						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063868				2022-12-18	WOS:A1991FW51100019
J	LABRUNE, P; MELLE, D; REY, F; BERTHELON, M; CAILLAUD, C; REY, J; MUNNICH, A; LYONNET, S				LABRUNE, P; MELLE, D; REY, F; BERTHELON, M; CAILLAUD, C; REY, J; MUNNICH, A; LYONNET, S			SINGLE-STRAND CONFORMATION POLYMORPHISM FOR DETECTION OF MUTATIONS AND BASE SUBSTITUTIONS IN PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLALANINE-HYDROXYLASE GENE; POLYMERASE CHAIN-REACTION; MOLECULAR-GENETICS; LINKAGE DISEQUILIBRIUM; RECURRENT MUTATION; POINT MUTATIONS; HAPLOTYPE; LOCUS	In the past few years, more than 20 different mutations have been reported in hyperphenylalaninemias. In southwestern Europe and Mediterranean countries, however, the mutant genotypes reported account for only a fraction (27%) of all mutant alleles at the phenylalanine hydroxylase (PAH) locus, and most of the mutations causing the disease remain unknown. In order to develop a strategy for rapid detection of mutation-containing exons, we applied the single-strand conformation-polymorphism (SSCP) technique to exons 3, 5, 7, and 12 of the PAH gene. We observed five abnormal patterns of migration in mutant PAH genes, and we consistently found base substitutions in the corresponding exons, with no false-positive results. By this procedure, two novel putative mutations were detected in the seventh exon of the PAH gene, (A259V and Y277D) and we were able to demonstrate that the DELTA-I94, R158Q, R408W, and E280K mutations were easily detectable by the SSCP technique. This procedure is therefore of particular interest for rapid detection of mutation-containing exons and for determination of further genotype-phenotype correlations in hyperphenylalaninemias.	HOP NECKER ENFANTS MALAD, INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT, 149 RUE SEVRES, F-75743 PARIS 15, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Lyonnet, Stanislas/H-5483-2017	Lyonnet, Stanislas/0000-0001-5426-9417				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; ATTREE O, 1989, GENOMICS, V4, P266, DOI 10.1016/0888-7543(89)90330-3; BERTHELON M, 1991, HUM GENET, V86, P355, DOI 10.1007/BF00201832; CAILLAUD C, IN PRESS J BIOL CHEM; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DWORNICZAK B, 1989, HUM GENET, V84, P95, DOI 10.1007/BF00210683; JOHN SWM, 1990, AM J HUM GENET, V46, P970; KOWCK SCM, 1985, BIOCHEMISTRY-US, V24, P556; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; LEVY HL, 1989, AM J HUM GENET, V45, P667; LYONNET S, 1989, AM J HUM GENET, V44, P511; OKANO Y, 1990, AM J HUM GENET, V46, P919; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; REY F, 1988, AM J HUM GENET, V43, P914; REY F, 1987, ARCH FR PEDIATR, V44, P565; WANG T, 1989, AM J HUM GENET, V45, P675; WOO SLC, 1988, AM J HUM GENET, V43, P781	23	41	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1115	1120						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035532				2022-12-18	WOS:A1991FP09200012
J	KASPERCZYK, A; DIMARTINO, NA; KRONTIRIS, TG				KASPERCZYK, A; DIMARTINO, NA; KRONTIRIS, TG			MINISATELLITE ALLELE DIVERSIFICATION - THE ORIGIN OF RARE ALLELES AT THE HRASI LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW ENGLAND MED CTR HOSP,DEPT MED HEMATOL ONCOL,BOX 245,750 WASHINGTON ST,BOSTON,MA 02111; TUFTS UNIV,SCH MED,DEPT MOLEC BIOL & MICROBIOL,BOSTON,MA 02111	Tufts Medical Center; Tufts University					NCI NIH HHS [CA45052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAXTER GD, 1989, GENET RES, V54, P149, DOI 10.1017/S0016672300028524; CHANDLER LA, 1987, CELL, V50, P711, DOI 10.1016/0092-8674(87)90329-1; ISHIKAWA J, 1987, INT J CANCER, V40, P474, DOI 10.1002/ijc.2910400407; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KASPERCZYK A, 1989, AM J HUM GENET, V46, P689; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; KRONTIRIS TG, 1987, ENVIRON HEALTH PERSP, V76, P147, DOI 10.2307/3430476; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7	16	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					854	859						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220825				2022-12-18	WOS:A1990EE94000013
J	STEVENSON, RE; GOODMAN, HO; SCHWARTZ, CE; SIMENSEN, RJ; MCLEAN, WT; HERNDON, CN				STEVENSON, RE; GOODMAN, HO; SCHWARTZ, CE; SIMENSEN, RJ; MCLEAN, WT; HERNDON, CN			ALLAN-HERNDON SYNDROME .1. CLINICAL-STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SELF MEM HOSP,GREENWOOD,SC; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,MED GENET SECT,WINSTON SALEM,NC 27103; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,NEUROL SECT,WINSTON SALEM,NC 27103	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	STEVENSON, RE (corresponding author), GREENWOOD GENET CTR,1 GREGOR MENDEL CIRCLE,GREENWOOD,SC 29646, USA.							Allan W, 1944, AM J MENT DEF, V48, P325; APAK S, 1989, AM J MED GENET, V34, P155, DOI 10.1002/ajmg.1320340203; BAAR HS, 1966, AM J MENT DEF, V71, P13; BIRCHHG, 1970, MENTAL SUBNORMALITY; BUNDEY S, 1977, DEV MED CHILD NEUROL, V19, P179; DAVIS JG, 1981, AM J HUM GENET S, V33, pA475; JOHNSTON AW, 1962, AM J HUM GENET, V14, P83; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; LEWIS EO, 1929, 19251927 HM STAT OFF; LUTZ R, 1989, CLIN GENET, V35, P417; MALAMUD N, 1958, NEUROLOGY, V8, P261, DOI 10.1212/WNL.8.4.261; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MOSER HW, 1971, BIRTH DEFECTS 7, P117; SCHMIDLEY JW, 1987, NEUROLOGY, V37, P1344, DOI 10.1212/WNL.37.8.1344; Thurmon T F, 1971, Birth Defects Orig Artic Ser, V7, P219; WIEACKER P, 1985, AM J MED GENET, V20, P597, DOI 10.1002/ajmg.1320200405; WING L, 1971, PSYCHOL MED, V1, P405, DOI 10.1017/S0033291700044792; WINTER RM, 1989, HUM GENET, V82, P367; ZATZ M, 1976, J MED GENET, V13, P217, DOI 10.1136/jmg.13.3.217	19	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					446	453						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393019				2022-12-18	WOS:A1990DX22300009
J	HOWELLS, DW; FORREST, SM; DAHL, HHM; COTTON, RGH				HOWELLS, DW; FORREST, SM; DAHL, HHM; COTTON, RGH			INSERTION OF AN EXTRA CODON FOR THREONINE IS A CAUSE OF DIHYDROPTERIDINE REDUCTASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HOWELLS, DW (corresponding author), ROYAL CHILDRENS HOSP,MURDOCH INST,OLIVE MILLER LAB,PARKVILLE,VIC 305,AUSTRALIA.			Howells, David/0000-0002-2512-7724				ARMAREGO WLF, 1984, MED RES REV, V4, P267, DOI 10.1002/med.2610040302; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CRAINE JE, 1972, J BIOL CHEM, V247, P6082; DAHL HHM, 1989, ANAL BIOCHEM, V183, P263, DOI 10.1016/0003-2697(89)90477-6; DAHL HHM, 1988, J MED GENET, V25, P25, DOI 10.1136/jmg.25.1.25; DAHL HHM, 1987, NUCLEIC ACIDS RES, V15, P1921, DOI 10.1093/nar/15.5.1921; FIRGAIRA FA, 1980, LANCET, V1, P160; FIRGAIRA FA, 1981, BIOCHEM J, V198, P677, DOI 10.1042/bj1980677; FIRGAIRA FA, 1983, PRENATAL DIAG, V3, P7, DOI 10.1002/pd.1970030103; FIRGAIRA FA, 1981, BIOCHEM J, V197, P45, DOI 10.1042/bj1970045; HOSODA S, 1966, J BIOL CHEM, V241, P192; KAUFMAN S, 1958, J BIOL CHEM, V230, P931; LAI PH, 1982, BIOCHEMISTRY-US, V21, P3284, DOI 10.1021/bi00257a006; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LOCKYER J, 1987, P NATL ACAD SCI USA, V84, P3329, DOI 10.1073/pnas.84.10.3329; SHAHBAZ M, 1987, J BIOL CHEM, V262, P16412; SMITH I, 1986, POSTGRAD MED J, V62, P113, DOI 10.1136/pgmj.62.724.113; [No title captured]	19	41	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					279	285						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2116088				2022-12-18	WOS:A1990DT87100013
J	OWEN, MJ; JAMES, LA; HARDY, JA; WILLIAMSON, R; GOATE, AM				OWEN, MJ; JAMES, LA; HARDY, JA; WILLIAMSON, R; GOATE, AM			PHYSICAL MAPPING AROUND THE ALZHEIMER-DISEASE LOCUS ON THE PROXIMAL LONG ARM OF CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											OWEN, MJ (corresponding author), IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND.		Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Goate, Alison/0000-0002-0576-2472				BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BORGAONKAR DS, 1974, CYTOGENET CELL GENET, V13, P403, DOI 10.1159/000130290; BRADLEY CM, 1986, TRISOMY, V21, P41; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COOK RH, 1979, NEUROLOGY, V29, P1402, DOI 10.1212/WNL.29.10.1402; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P633; GOATE AM, 1989, LANCET, V1, P352; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; KAPLAN JC, 1989, CYTOGENET CELL GENET, V46, P491; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; NEE LE, 1983, ARCH NEUROL-CHICAGO, V40, P203, DOI 10.1001/archneur.1983.04050040033004; NEVE RL, 1986, GENE, V49, P361, DOI 10.1016/0378-1119(86)90372-0; OATES DC, 1977, SOMAT CELL GENET, V3, P561, DOI 10.1007/BF01539066; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; POUTSKA A, 1986, TRENDS GENET, V2, P174; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; VANBROECKHOVEN C, 1988, GENETICS ALZHEIMERS, P124; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793; VANKEUREN ML, 1989, AM J MED GENET, V33, P369, DOI 10.1002/ajmg.1320330316; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6	26	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					316	322						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301399				2022-12-18	WOS:A1990CM93800012
J	RICE, T; BOUCHARD, C; BORECKI, IB; RAO, DC				RICE, T; BOUCHARD, C; BORECKI, IB; RAO, DC			COMMINGLING AND SEGREGATION ANALYSIS OF BLOOD-PRESSURE IN A FRENCH-CANADIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA; UNIV LAVAL, PHYS ACT SCI LAB, QUEBEC CITY G1K 7P4, QUEBEC, CANADA	Washington University (WUSTL); Washington University (WUSTL); Laval University	RICE, T (corresponding author), WASHINGTON UNIV, SCH MED, DIV BIOSTAT, 660 S EUCLID AVE, BOX 8067, ST LOUIS, MO 63110 USA.		Rice, Treva K/D-1385-2009; Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009	Bouchard, Claude/0000-0002-0048-491X; Rice, Treva/0000-0001-7452-2600	NHLBI NIH HHS [HL33973] Funding Source: Medline; NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HIGGINS M, 1980, AM J EPIDEMIOL, V111, P142, DOI 10.1093/oxfordjournals.aje.a112882; HIGGINS MW, 1980, HYPERTENSION, V2, pI117, DOI 10.1161/01.HYP.2.4_Pt_2.I117; HILTON PJ, 1986, NEW ENGL J MED, V314, P222, DOI 10.1056/NEJM198601233140407; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LONGINI IM, 1984, AM J EPIDEMIOL, V120, P131, DOI 10.1093/oxfordjournals.aje.a113862; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MARAZITA ML, 1987, AM J MED GENET, V26, P511, DOI 10.1002/ajmg.1320260302; McKusick V. A, 1975, MENDELIAN INHERITANC; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1979, AM J HUM GENET, V31, P161; PERUSSE L, 1989, AM J HUM GENET, V45, P240; Pickering G., 1961, NATURE ESSENTIAL HYP; PLATT ROBERT, 1967, P9; PROVINCE M A, 1985, Genetic Epidemiology, V2, P363, DOI 10.1002/gepi.1370020405; PROVINCE MA, INP PRESS AM J HUM B; RAO DC, 1980, AM J HUM GENET, V32, P620; RICE T, IN PRESS GENET EPIDE; WILLIAMS RR, 1984, GENETIC EPIDEMIOLOGY, P419	26	41	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					37	44						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294754				2022-12-18	WOS:A1990CJ04300006
J	FAIN, PR; GOLDGAR, DE; WALLACE, MR; COLLINS, FS; WRIGHT, E; NGUYEN, K; BARKER, DF				FAIN, PR; GOLDGAR, DE; WALLACE, MR; COLLINS, FS; WRIGHT, E; NGUYEN, K; BARKER, DF			REFINED PHYSICAL AND GENETIC-MAPPING OF THE NFI REGION ON CHROMOSOME-17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,MED CTR,DIV MED GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	FAIN, PR (corresponding author), UNIV UTAH,SCH MED,DEPT MED INFORMAT,RES PK,410 CHIPETA WAY,SALT LAKE CITY,UT 84108, USA.			Barker, David/0000-0002-1438-4100	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-40877] Funding Source: Medline; NINDS NIH HHS [NS-23410] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER D, 1984, AM J HUM GENET, V36, P1159; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BARKER D, IN PRESS CYTOGENET C; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FAIN P, 1988, MOL PROBES TECHNOLOG, P69; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FAIN PR, 1989, AM J HUM GENET, V44, P68; FOUNTAIN J W, 1988, American Journal of Human Genetics, V43, pA143; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; JONES GH, 1984, CONTROLLING EVENTS M, P293; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; MENON AG, 1989, GENOMICS, V5, P245, DOI 10.1016/0888-7543(89)90053-0; OCONNELL P, 1989, AM J HUM GENET, V44, P51; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; STUMPF DA, 1987, NEUROFIBROMATOSIS, V6; TSIPOURAS P, 1988, CYTOGENET CELL GENET, V47, P109, DOI 10.1159/000132523; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WAYE JS, 1986, MOL CELL BIOL, V6, P3156, DOI 10.1128/MCB.6.9.3156; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; WILLARD H F, 1987, Genomics, V1, P368, DOI 10.1016/0888-7543(87)90041-3; WILLARD HF, 1988, AM J HUM GENET S, V48, pA207	25	41	42	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					721	728						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2573276				2022-12-18	WOS:A1989AZ04900008
J	KUPKE, KG; MULLER, U				KUPKE, KG; MULLER, U			PARENTAL ORIGIN OF THE EXTRA CHROMOSOME IN TRISOMY-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Harvard Medical School	KUPKE, KG (corresponding author), CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115, USA.				NICHD NIH HHS [HD 18658, HD 24381] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658, R01HD024381] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANTONARAKIS SE, 1986, COLD SPRING HARB SYM, V51, P185, DOI 10.1101/SQB.1986.051.01.022; BABU A, 1986, AM J HUM GENET, V38, P549; CARTER PE, 1985, CLIN GENET, V27, P59; CHAKRAVARTI A, 1989, AM J HUM GENET, V44, P639; GALT J, 1989, HUM GENET, V81, P113, DOI 10.1007/BF00293885; GEITVIK GA, 1987, HUM GENET, V77, P205, DOI 10.1007/BF00284470; HARRIS P, 1987, HUM GENET, V77, P95, DOI 10.1007/BF00272372; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HODES ME, 1978, J MED GENET, V15, P48, DOI 10.1136/jmg.15.1.48; Hook EB, 1977, POPULATION CYTOGENET, P63; HOOK EB, 1983, OBSTET GYNECOL, V58, P282; ISHIKIRIYAMA S, 1984, HUM GENET, V68, P266, DOI 10.1007/BF00418400; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; KONDOH T, 1988, HUM GENET, V79, P377; LINNE T, 1979, ACTA PAEDIATR SCAND, V68, P593, DOI 10.1111/j.1651-2227.1979.tb05061.x; MAGENIS RE, 1977, HUM GENET, V37, P7, DOI 10.1007/BF00293766; MEHTA I, 1986, J MED GENET, V232, P256; MULLER U, 1987, CYTOGENET CELL GENET, V45, P16, DOI 10.1159/000132418; MULLER U, 1986, NUCLEIC ACIDS RES, V14, P1325, DOI 10.1093/nar/14.3.1325; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; OCONNELL P, 1988, GENOMICS, V3, P367, DOI 10.1016/0888-7543(88)90129-2; Schinzel A, 1984, CATALOGUE UNBALANCED; SMITH D W, 1969, Birth Defects Original Article Series, V5, P67; WILSON MG, 1980, CLIN GENET, V17, P335	27	41	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					599	605						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2577470				2022-12-18	WOS:A1989AW39500014
J	NEALE, MC; EAVES, LJ; HEWITT, JK; MACLEAN, CJ; MEYER, JM; KENDLER, KS				NEALE, MC; EAVES, LJ; HEWITT, JK; MACLEAN, CJ; MEYER, JM; KENDLER, KS			ANALYZING THE RELATIONSHIP BETWEEN AGE AT ONSET AND RISK TO RELATIVES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,RICHMOND,VA 23298	Virginia Commonwealth University	NEALE, MC (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,BOX 33,RICHMOND,VA 23298, USA.		Neale, Michael C/B-1418-2008; Kendler, Kenneth/AAF-2876-2019; Neale, Michael/AAD-5056-2020		NIA NIH HHS [AG-04954] Funding Source: Medline; NIGMS NIH HHS [GM-30250] Funding Source: Medline; NIMH NIH HHS [MH-40828] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004954] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aitken, 1934, P EDINBURGH MATH SOC, V4, P106, DOI [DOI 10.1017/S0013091500008063, 10.1017/S0013091500008063]; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; ANDERSON DE, 1972, J NATL CANCER I, V48, P1029; BAIGORRI AR, UNPUB ERROR BOUNDED; BOEHNKE M, 1984, GENETIC EPIDEMIOLOGY, P173; BUCHER KD, 1982, BIOMETRICS, V38, P249, DOI 10.2307/2530308; CLONINGER CR, 1978, ARCH GEN PSYCHIAT, V35, P941; CURNOW RN, 1972, BIOMETRICS, V28, P931, DOI 10.2307/2528630; CURNOW RN, 1974, BIOMETRICS, V30, P655, DOI 10.2307/2529230; CURNOW RN, 1975, J R STAT SOC A, V13, P131; EAVES LJ, 1983, AM J HUM GENET, V35, P1179; EAVES LJ, 1970, ASPECTS HUMAN PSYCHO; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fisher R. A., 1931, BRIT ASS MATH TABLES, V1, pxxvi; Fisher R. A., 1922, PHILOS T R SOC A, V222, P309, DOI [10.1098/rsta.1922.0009, DOI 10.1098/RSTA.1922.0009]; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HEATH AC, IN PRESS J PERS INDI; HEATH AC, 1985, NATURE, V31, P734; HEIBERG A, 1977, BRIT MED J, V2, P493, DOI 10.1136/bmj.2.6085.493; HEIMBUCH RC, 1980, AM J HUM GENET, V32, P564; HEWITT JK, IN PRESS BEHAV GENET; JABLON S, 1967, AM J HUM GENET, V19, P133; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; JOHNSON NL, 1972, DISTRIBUTIONS STATIS; KENDLER KS, 1987, ARCH GEN PSYCHIAT, V44, P881; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1551; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1413; LARSSON T, 1954, ACTA PSYCHIATRICA S, V89, P40; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MARTIN NG, 1982, BEHAV GENET, V12, P467, DOI 10.1007/BF01065638; MCGUE M, 1983, AM J HUM GENET, V35, P1161; MEYER JM, 1988, GENET EPIDEMIOL, V5, P265, DOI 10.1002/gepi.1370050408; NEALE MC, 1989, BEHAV GENET, V19, P163, DOI 10.1007/BF01065901; NEALE MC, 1986, PERS INDIV DIFFER, V7, P771, DOI 10.1016/0191-8869(86)90075-9; NEALE MC, 1988, BEHAV GENET, V18, P69, DOI 10.1007/BF01067076; Pearson K, 1900, P R SOC LONDON, V66, P316; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; PRICE RA, 1987, ARCH GEN PSYCHIAT, V44, P434; RAO DC, 1988, AM J HUM GENET, V42, P506; RAO DC, 1987, GENET EPIDEMIOL, V4, P357, DOI 10.1002/gepi.1370040505; RICE J, 1979, BIOMETRICS, V35, P451, DOI 10.2307/2530347; RICE J, 1985, Genetic Epidemiology, V2, P301, DOI 10.1002/gepi.1370020307; RIDLEY RM, 1986, PSYCHOL MED, V16, P199, DOI 10.1017/S0033291700002634; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; SMITH C, 1974, ANN HUM GENET, V37, P275, DOI 10.1111/j.1469-1809.1974.tb01835.x; Stromgren E, 1935, Z GESAMTE NEUROL PSY, V153, P784, DOI 10.1007/BF02865780; STROMGREN E, 1938, ACTA PSYCHIAT NEUROL, V19, P1; STURT E, 1986, PSYCHOL MED, V16, P583, DOI 10.1017/S0033291700010345; WEINBERG W, 1925, HDB SOZIALEN HYGIENE, P71; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; 1988, NUMERICAL ALGORITHMS; [No title captured]	54	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					226	239						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2757029				2022-12-18	WOS:A1989AK38000005
J	HATA, A; SETOYAMA, C; SHIMADA, K; TAKEDA, E; KURODA, Y; AKABOSHI, I; MATSUDA, I				HATA, A; SETOYAMA, C; SHIMADA, K; TAKEDA, E; KURODA, Y; AKABOSHI, I; MATSUDA, I			ORNITHINE TRANSCARBAMYLASE DEFICIENCY RESULTING FROM A C-TO-T SUBSTITUTION IN EXON-5 OF THE ORNITHINE TRANSCARBAMYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KUMAMOTO UNIV,SCH MED,DEPT BIOCHEM,2-2-1 HONJO,KUMAMOTO 860,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT PEDIAT,KUMAMOTO 860,JAPAN; UNIV TOKUSHIMA,SCH MED,DEPT PEDIAT,TOKUSHIMA 770,JAPAN	Kumamoto University; Kumamoto University; Tokushima University								ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; DUCHANGE N, 1986, NUCLEIC ACIDS RES, V14, P2408, DOI 10.1093/nar/14.5.2408; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HALDANE JSB, 1946, ANN EUGENIC, V13, P262; HATA A, 1988, J INHERIT METAB DIS, V11, P337, DOI 10.1007/BF01800388; HATA A, 1988, J BIOCHEM-TOKYO, V103, P302, DOI 10.1093/oxfordjournals.jbchem.a122265; HATA A, 1986, J BIOCHEM-TOKYO, V100, P717, DOI 10.1093/oxfordjournals.jbchem.a121764; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; LYON MF, 1972, BIOL REV, V47, P1; MADDALENA A, 1988, J CLIN INVEST, V82, P1353, DOI 10.1172/JCI113738; MAEDA S, 1986, MOL BIOL MED, V3, P329; MATSUDA I, 1977, CLIN CHIM ACTA, V80, P483; NUSSBAUM RL, 1986, AM J HUM GENET, V38, P149; NUSSINOV R, 1981, J MOL BIOL, V149, P125, DOI 10.1016/0022-2836(81)90264-3; ROMEO G, 1987, P NATL ACAD SCI USA, V84, P2829, DOI 10.1073/pnas.84.9.2829; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHIBASAKI Y, 1985, J CLIN INVEST, V76, P378, DOI 10.1172/JCI111973; TAKEDA E, 1983, CLIN PEDIATR, V22, P206, DOI 10.1177/000992288302200309; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; WALZER M, 1983, METABOLIC BASIS INHE, P399; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	29	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					123	127						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2741942				2022-12-18	WOS:A1989AE77900015
J	PAULS, DL; COHEN, DJ; KIDD, KK; LECKMAN, JF				PAULS, DL; COHEN, DJ; KIDD, KK; LECKMAN, JF			TOURETTE SYNDROME AND NEUROPSYCHIATRIC DISORDERS - IS THERE A GENETIC-RELATIONSHIP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									YALE UNIV, SCH MED, DEPT HUMAN GENET, NEW HAVEN, CT 06510 USA	Yale University	PAULS, DL (corresponding author), YALE UNIV, SCH MED, CTR CHILD STUDY, NEW HAVEN, CT 06510 USA.		Leckman, James/O-2426-2015					COHEN DJ, IN PRESS CHILD HIS F; COMINGS BG, 1987, AM J HUM GENET, V41, P804; COMINGS DE, 1987, AM J HUM GENET, V41, P822; COMINGS DE, 1987, AM J HUM GENET, V41, P742; COMINGS DE, 1987, AM J HUM GENET, V41, P782; COMINGS DE, 1987, AM J HUM GENET, V41, P761; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1987, AM J HUM GENET, V41, P839; COMINGS DE, 1984, AM J HUM GENET, V36, P586; KIDD KK, 1982, GILLES TOURETTE SYND, P243; Leckman J. F, 1988, TOURETTES SYNDROME T; ORVASCHEL H, 1982, J AFFECT DISORDERS, V4, P49, DOI 10.1016/0165-0327(82)90019-2; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381	14	41	41	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					206	209						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	3165247				2022-12-18	WOS:A1988P608400015
J	WEKSBERG, R; SMITH, C; ANSONCARTWRIGHT, L; MALONEY, K				WEKSBERG, R; SMITH, C; ANSONCARTWRIGHT, L; MALONEY, K			BLOOM SYNDROME - A SINGLE COMPLEMENTATION GROUP DEFINES PATIENTS OF DIVERSE ETHNIC-ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WEKSBERG, R (corresponding author), HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ALHADEFF B, 1980, CYTOGENET CELL GENET, V27, P8, DOI 10.1159/000131459; ALHADEFF B, 1984, BASIC LIFE SCI, V29, P729; ARASE S, 1980, CLIN GENET, V18, P123; BRYANT EM, 1979, NATURE, V279, P795, DOI 10.1038/279795a0; CAIRNEY AEL, 1987, J PEDIATR-US, V111, P414, DOI 10.1016/S0022-3476(87)80469-9; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; CHAN JYH, 1987, NATURE, V325, P357, DOI 10.1038/325357a0; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; FISCHER E, 1985, MUTAT RES, V145, P217, DOI 10.1016/0167-8817(85)90030-6; GERMAN J, 1965, SCIENCE, V148, P506, DOI 10.1126/science.148.3669.506; GERMAN J, 1977, AM J HUM GENET, V29, P248; GERMAN J, 1984, CLIN GENET, V25, P166; GIANNELLI F, 1977, NATURE, V265, P466, DOI 10.1038/265466a0; GRAVEL RA, 1983, HUM GENET, V65, P112, DOI 10.1007/BF00286645; Hashimoto T, 1984, Basic Life Sci, V29 Pt B, P765; HIRSCHI M, 1981, CANCER RES, V41, P2003; ISHIDA R, 1982, CANCER RES, V42, P4000; ISHIZAKI K, 1981, MUTAT RES, V80, P213, DOI 10.1016/0027-5107(81)90189-5; JASPERS NGJ, 1985, ATAXIA TELANGIECTASI, P147; KAWASHIMA H, 1980, CLIN GENET, V17, P143; KREPINSKY AB, 1980, MUTAT RES, V69, P357, DOI 10.1016/0027-5107(80)90100-1; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; RAY JH, 1984, CHROMOSOMA, V90, P383, DOI 10.1007/BF00294165; RAY JH, 1985, GENETICS, V110, P521; RAY JH, 1982, SISTER CHROMATID EXC, P553; RIVERA H, 1986, ANN GENET-PARIS, V29, P39; RUDIGER HW, 1980, AM J HUM GENET, V32, P150; TULLY JG, 1983, METHODS MICROPLASM C, V2; van Buul P P, 1978, Hum Genet, V44, P187; VANDERSCHUERENLODEWEYCKX M, 1984, AM J DIS CHILD, V138, P812, DOI 10.1001/archpedi.1984.02140470012004; VIJAYALAXMI H J E, 1983, Science (Washington D C), V221, P851; WARREN ST, 1981, P NATL ACAD SCI-BIOL, V78, P3133, DOI 10.1073/pnas.78.5.3133; WERNERFAVRE C, 1984, AM J MED GENET, V18, P215, DOI 10.1002/ajmg.1320180205; WILLIS AE, 1987, NATURE, V325, P355, DOI 10.1038/325355a0; WILLIS AE, 1987, P NATL ACAD SCI USA, V84, P8016, DOI 10.1073/pnas.84.22.8016; YOSHIDA MC, 1981, 40TH JAP CANC ASS AN	37	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					816	824						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	3163468				2022-12-18	WOS:A1988N519700003
J	COX, DW; BILLINGSLEY, GD; MANSFIELD, T				COX, DW; BILLINGSLEY, GD; MANSFIELD, T			DNA RESTRICTION-SITE POLYMORPHISMS ASSOCIATED WITH THE ALPHA1-ANTITRYPSIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University of Toronto; University of Toronto	COX, DW (corresponding author), HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.							ARNAUD P, 1977, J IMMUNOL METHODS, V16, P221, DOI 10.1016/0022-1759(77)90200-9; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; COX DW, 1987, J MED GENET, V24, P52, DOI 10.1136/jmg.24.1.52; COX DW, 1981, AM J HUM GENET, V33, P354; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1980, CLIN GENET, V17, P153; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; COX DW, 1986, LANCET, V2, P741; CRYSTAL R, 1986, 2ND INT S PULM EMPH; DARLINGTON GJ, 1982, P NATL ACAD SCI-BIOL, V79, P870, DOI 10.1073/pnas.79.3.870; HEJTMANCIK JF, 1986, LANCET, V2, P767; JEPPSSON JO, 1982, CLIN CHEM, V28, P219; KALSHEKER N, 1987, J MED GENET, V24, P47; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KURACHI K, 1981, P NATL ACAD SCI-BIOL, V78, P6826, DOI 10.1073/pnas.78.11.6826; LAI EC, 1983, AM J HUM GENET, V35, P385; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MATTESON KJ, 1985, HUM GENET, V69, P263, DOI 10.1007/BF00293037; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; PEARSON SJ, 1983, SOMATIC CELL GENET, V5, P567; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WOO SLC, 1985, SEP ALPHA1 ANT MOL M	24	41	43	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					891	906						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	2890296				2022-12-18	WOS:A1987K936100010
J	KAMHOLZ, J; SPIELMAN, R; GOGOLIN, K; MODI, W; OBRIEN, S; LAZZARINI, R				KAMHOLZ, J; SPIELMAN, R; GOGOLIN, K; MODI, W; OBRIEN, S; LAZZARINI, R			THE HUMAN MYELIN-BASIC-PROTEIN GENE - CHROMOSOMAL LOCALIZATION AND RFLP ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; NCI,VIRAL CARCINOGENESIS LAB,GENET SECT,FREDERICK,MD 21701	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KAMHOLZ, J (corresponding author), NINCDS,IRP,MOLEC GENET LAB,BLDG 36,ROOM 4A01,BETHESDA,MD 20892, USA.			OBRIEN, STEPHEN/0000-0001-7857-0757	NIGMS NIH HHS [GM32592] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BRAUN PE, 1984, MYELIN, P97; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; DEMUELENAERE A, 1981, ANN GENET-PARIS, V24, P184; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; JUNIEN C, 1980, ANN GENET-PARIS, V23, P89; KAMHOLZ J, 1986, P NATL ACAD SCI USA, V83, P4962, DOI 10.1073/pnas.83.13.4962; MANIATIS T, 1982, MOL CLONING LABORATO; NAYLOR S, 1985, CYTOGENET CELL GENET, V40, P242, DOI 10.1159/000132176; OBRIEN SJ, 1982, TECHNIQUES SOMATIC C, P513; PUCKETT C, 1985, Neurology, V35, P259; SAXE DF, 1985, CYTOGENET CELL GENET, V39, P246, DOI 10.1159/000132152; SMITH DW, 1982, RECOGNIZABLE PATTERN, P14; TAKAHASHI N, 1985, CELL, V42, P139, DOI 10.1016/S0092-8674(85)80109-4; TURLEAU C, 1977, CLIN GENET, V12, P361; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606	19	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1987	40	4					365	373						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H3196	2437795				2022-12-18	WOS:A1987H319600006
J	WATKINS, D; ROSENBLATT, DS				WATKINS, D; ROSENBLATT, DS			FAILURE OF LYSOSOMAL RELEASE OF VITAMIN-B12 - A NEW COMPLEMENTATION GROUP CAUSING METHYLMALONIC ACIDURIA (CBLF)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT PEDIAT,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT BIOL,MONTREAL H3H 1P3,QUEBEC,CANADA	McGill University; McGill University	WATKINS, D (corresponding author), MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,MRC,GENET GRP,MONTREAL H3H 1P3,QUEBEC,CANADA.							GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; ROSENBERG LE, 1983, METABOLIC BASIS INHE, P474; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; ROSENBLATT DS, 1984, J CLIN INVEST, V74, P2149, DOI 10.1172/JCI111641; ROSENBLATT DS, 1986, PEDIATRICS; SCHUH S, 1984, NEW ENGL J MED, V310, P686, DOI 10.1056/NEJM198403153101104; WILLARD HF, 1978, AM J HUM GENET, V30, P1	9	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					404	408						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766542				2022-12-18	WOS:A1986E364400013
J	COX, DW; ANDREWS, BJ; WILLS, DE				COX, DW; ANDREWS, BJ; WILLS, DE			GENETIC-POLYMORPHISM OF ALPHA-2HS-GLYCOPROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TORONTO, DEPT PAEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT GENET & MED BIOPHYS, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University of Toronto	COX, DW (corresponding author), HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA.							ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; ANDERSON NL, 1979, BIOCHEM BIOPH RES CO, V88, P258, DOI 10.1016/0006-291X(79)91724-8; BASKIES AM, 1980, CANCER, V45, P3050, DOI 10.1002/1097-0142(19800615)45:12<3050::AID-CNCR2820451229>3.0.CO;2-8; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COX D W, 1984, Genetics, V107, pS22; COX DW, 1985, HUM GENET, V70, P109, DOI 10.1007/BF00273067; COX DW, 1981, AM J HUM GENET, V33, P354; COX DW, 1983, ELECTROPHORESIS 82, P243; EIBERG H, 1983, HUMAN GENE MAPPING, V7, P461; JOHNSON AM, 1969, J CLIN INVEST, V48, P2293, DOI 10.1172/JCI106195; LAURELL CB, 1972, SCAND J CLIN LAB INV, V29, P21, DOI 10.3109/00365517209102748; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; LEWIS JG, 1980, IMMUNOLOGY, V39, P317; LEWIS JG, 1981, IMMUNOLOGY, V42, P481; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OLAISEN B, 1981, HUMAN GENE MAPPING, V6, P305; PUTNAM FW, 1975, PLASMA PROTEINS STRU, P58; SCHMID K, 1961, BIOCHIM BIOPHYS ACTA, V47, P440, DOI 10.1016/0006-3002(61)90539-X; SCHULTZE HE, 1962, NATURWISSENSCHAFTEN, V49, P15, DOI 10.1007/BF00632835; UMETSU K, 1984, HUM GENET, V67, P70, DOI 10.1007/BF00270561; WEIDINGER S, 1984, ELECTROPHORESIS 84, P487; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752; YUASA I, 1985, HUM GENET, V70, P32, DOI 10.1007/BF00389454	23	41	41	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					699	706						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3717159				2022-12-18	WOS:A1986C973000008
J	HOLZGREVE, W; GOLBUS, MS				HOLZGREVE, W; GOLBUS, MS			PRENATAL-DIAGNOSIS OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY UTILIZING FETAL LIVER-BIOPSY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco								ALLEN CM, 1964, BIOCHEMISTRY-US, V3, P1238, DOI 10.1021/bi00897a010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CATHELINEAU L, 1979, ENZYME, V18, P103; FINGER JM, 1983, AM J HUM GENET, V35, pA52; GOLBUS MS, 1974, AM J OBSTET GYNECOL, V119, P569, DOI 10.1016/0002-9378(74)90225-7; GOLBUS MS, UNPUB FETAL LIVER BI; GOLDSTEIN AS, 1974, PEDIATR RES, V8, P5, DOI 10.1203/00006450-197401000-00002; Greengard O., 1971, Essays Biochem, V7, P159; KAN YW, 1983, METABOLIC BASIS INHE, P402; LEVIN B, 1969, ARCH DIS CHILD, V44, P152, DOI 10.1136/adc.44.234.152; LEVINE RL, 1971, ANAL BIOCHEM, V42, P324, DOI 10.1016/0003-2697(71)90044-3; LONGHI R, 1981, PEDIATR RES, V15, P634, DOI 10.1203/00006450-198104001-01174; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDA I, 1971, PEDIATRICS, V48, P595; MATSUSHIMA A, 1981, J INHERIT METAB DIS, V4, P83, DOI 10.1007/BF02263602; MCINTYRE P, 1981, FEBS LETT, V135, P65, DOI 10.1016/0014-5793(81)80944-1; MIZUTANI A, 1968, J HISTOCHEM CYTOCHEM, V16, P172, DOI 10.1177/16.3.172; NAGATA N, 1980, PEDIATR RES, V14, P1370, DOI 10.1203/00006450-198012000-00022; NG WG, 1981, PEDIATRICS, V68, P448; NUSSBAUM RL, 1983, AM J HUM GENET, V35, pA59; Nuzum CT, 1976, UREA CYCLE, P325; PLOECHL E, 1981, Paediatrie und Paedologie, V16, P179; RAIHA NCR, 1968, ACTA PAEDIATR SCAND, V57, P121, DOI 10.1111/j.1651-2227.1968.tb04663.x; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; RODECK CH, 1982, LANCET, V2, P297; SCOTT CR, 1972, LANCET, V2, P1148; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; SNODGRASS PJ, 1978, PEDIATR RES, V12, P873, DOI 10.1203/00006450-197808000-00014; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; SUNSHINE P, 1972, PEDIATRICS, V50, P100; TABOR H, 1970, METHOD ENZYMOL, P286; WALSER M, 1983, METABOLIC BASIS INHE, P402; WOLFE DM, 1975, PEDIATR RES, V9, P531, DOI 10.1203/00006450-197506000-00004	33	41	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					320	328						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6711559				2022-12-18	WOS:A1984SM32400007
J	RUDDLE, FH				RUDDLE, FH			REVERSE GENETICS AND BEYOND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV, DEPT HUMAN GENET, NEW HAVEN, CT 06511 USA	Yale University	RUDDLE, FH (corresponding author), YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06511 USA.							BACCHETTI S, 1977, P NATL ACAD SCI USA, V74, P1590, DOI 10.1073/pnas.74.4.1590; BARBOSA JA, 1982, P NATL ACAD SCI-BIOL, V79, P6327, DOI 10.1073/pnas.79.20.6327; BARKER PE, 1984, P NATL ACAD SCI US; BARSKI G, 1960, CR HEBD ACAD SCI, V251, P1825; BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRADSHAW HD, 1983, P NATL ACAD SCI-BIOL, V80, P5588, DOI 10.1073/pnas.80.18.5588; BRENNARD J, 1983, J BIOL CHEM, V235, P9593; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; CREAGAN RP, 1975, CYTOGENET CELL GENET, V14, P282, DOI 10.1159/000130364; CREAGAN RP, 1977, MOL STRUCTURE HUMAN, P89; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DAVIS M, 1983, EMBO J, V2, P2281, DOI 10.1002/j.1460-2075.1983.tb01735.x; DEISSEROTH A, 1978, P NATL ACAD SCI USA, V75, P1456, DOI 10.1073/pnas.75.3.1456; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; DEMARTINVILLE B, 1983, SCIENCE, V219, P498, DOI 10.1126/science.6297001; DEMARTINVILLE B, 1981, PEDIATR RES, V15, P560, DOI 10.1203/00006450-198104001-00733; DEMARTINVILLE B, 1983, NUCLEIC ACIDS RES, V11, P5267, DOI 10.1093/nar/11.15.5267; DEUSTACHIO P, 1980, J EXP MED, V151, P1545, DOI 10.1084/jem.151.6.1545; DEUSTACHIO P, 1984, J EXP MED; EMANUEL BS, 1981, AM J HUM GENET, V33, pA103; EPHRUSSI B, 1965, P NATL ACAD SCI USA, V53, P1040, DOI 10.1073/pnas.53.5.1040; EPHRUSSI BORIS, 1964, SYMP INT SOC CELL BIOL, V3, P13; FAVERA RD, 1982, SCIENCE, V218, P686; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P319, DOI 10.1073/pnas.74.1.319; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P3937, DOI 10.1073/pnas.74.9.3937; FOURNIER REK, 1977, HUMAN CYTOGENETICS, V7, P189; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x; GEORGE DL, 1984, NUCLEIC ACIDS RES, V12, P2731, DOI 10.1093/nar/12.6.2731; GOFF SP, 1982, SCIENCE, V218, P1317, DOI 10.1126/science.6293057; GROFFEN J, 1983, NUCLEIC ACIDS RES, V11, P6331, DOI 10.1093/nar/11.18.6331; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAJEN E, 1984, NATURE, V307, P287; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARRIS LJ, 1982, P NATL ACAD SCI-BIOL, V79, P6622, DOI 10.1073/pnas.79.21.6622; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; Huttner K M, 1982, Natl Cancer Inst Monogr, V60, P63; JACOBS PA, 1981, AM J HUM GENET, V33, P513; JHANWAR SC, 1983, P NATL ACAD SCI-BIOL, V80, P4794, DOI 10.1073/pnas.80.15.4794; JOLLY DJ, 1982, P NATL ACAD SCI-BIOL, V79, P5038, DOI 10.1073/pnas.79.16.5038; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; KLOBUTCHER LA, 1981, ANNU REV BIOCHEM, V50, P533, DOI 10.1146/annurev.bi.50.070181.002533; KLOBUTCHER LA, 1980, P NATL ACAD SCI-BIOL, V77, P3610, DOI 10.1073/pnas.77.6.3610; KLOBUTCHER LA, 1979, NATURE, V280, P657, DOI 10.1038/280657a0; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KOZAK C, 1984, J VIROL, V49, P297, DOI 10.1128/JVI.49.1.297-299.1984; KOZAK CA, 1983, SCIENCE, V221, P867, DOI 10.1126/science.6308764; KOZAK CA, 1983, J VIROL, V47, P217, DOI 10.1128/JVI.47.1.217-220.1983; Kuhn L C, 1983, Mol Biol Med, V1, P335; KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0; LAU YF, 1983, P NATL ACAD SCI-BIOL, V80, P5225, DOI 10.1073/pnas.80.17.5225; LEDERBERG J, 1958, J Cell Physiol Suppl, V52, P383, DOI 10.1002/jcp.1030520418; LIN PF, 1983, P NATL ACAD SCI-BIOL, V80, P6528, DOI 10.1073/pnas.80.21.6528; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LOWY I, 1980, CELL, V22, P817, DOI 10.1016/0092-8674(80)90558-9; MAITLAND NJ, 1977, CELL, V11, P233, DOI 10.1016/0092-8674(77)90334-8; MALCOLM S, 1981, ANN HUM GENET, V45, P135, DOI 10.1111/j.1469-1809.1981.tb00315.x; MCBRIDE OW, 1983, NUCLEIC ACIDS RES, V11, P8221, DOI 10.1093/nar/11.23.8221; MCBRIDE OW, 1982, NATURE, V300, P773, DOI 10.1038/300773a0; MCBRIDE OW, 1973, P NATL ACAD SCI USA, V70, P1258, DOI 10.1073/pnas.70.4.1258; MILLER AD, 1983, P NATL ACAD SCI-BIOL, V80, P4709, DOI 10.1073/pnas.80.15.4709; MILLER RL, 1984, CYTOGENET CELL GENET, V37, P394, DOI 10.1159/000132015; MORTON CC, 1984, SCIENCE, V223, P173, DOI 10.1126/science.6691143; NEEL BG, 1982, P NATL ACAD SCI-BIOL, V79, P7842, DOI 10.1073/pnas.79.24.7842; NEVE RL, 1983, GENE, V23, P343, DOI 10.1016/0378-1119(83)90023-9; NEVE RL, 1983, GENE, V23, P355, DOI 10.1016/0378-1119(83)90024-0; OBRIEN SJ, 1983, NATURE, V302, P839, DOI 10.1038/302839a0; OKADA Y, 1958, BIKEN J, V1, P103; OUWENEEL WJ, 1976, ADV GENET, V18, P179, DOI 10.1016/S0065-2660(08)60439-3; PONTOCORVO G, 1962, BR MED B, V18, P18; PRAKASH K, 1982, P NATL ACAD SCI-BIOL, V79, P5210, DOI 10.1073/pnas.79.17.5210; PRAVTCHEVA DD, 1983, SOMAT CELL GENET, V9, P681, DOI 10.1007/BF01539473; RABIN M, 1984, CYTOGENET CELL GENET, V38, P70, DOI 10.1159/000132032; RICCIUTI F, 1973, NATURE-NEW BIOL, V241, P180, DOI 10.1038/newbio241180a0; RICCIUTI FC, 1973, GENETICS, V74, P661; ROUSSEL MF, 1983, J VIROL, V48, P770, DOI 10.1128/JVI.48.3.770-773.1983; RUDDLE F, 1972, SCIENCE, V176, P1429, DOI 10.1126/science.176.4042.1429; RUDDLE FH, 1970, NATURE, V227, P251, DOI 10.1038/227251a0; RUDDLE FH, 1973, NATURE, V242, P165, DOI 10.1038/242165a0; RUDDLE FH, 1974, SCI AM, V231, P36, DOI 10.1038/scientificamerican0774-36; RUDDLE FH, 1975, ANNU REV GENET, V9, P407, DOI 10.1146/annurev.ge.09.120175.002203; RUDDLE FH, 1968, NATL CANCER I MONOGR, P9; RUDDLE FH, 1974, CYTOGENET CELL GENET, V13, P11, DOI 10.1159/000130225; RUDDLE FH, 1981, NATURE, V294, P115, DOI 10.1038/294115a0; RUDDLE FH, 1973, HARVEY LECT, V69, P103; RUDDLE FH, 1984, GENETIC ENG, P319; RUDDLE FH, 1964, S INT SOC CELL BIOL, V3, P1273; RUDDLE FH, 1972, ADV HUM GENET, V3, P173; RYAN J, 1983, P NATL ACAD SCI-BIOL, V80, P4460, DOI 10.1073/pnas.80.14.4460; RYAN J, 1984, NUCLEIC ACIDS RES; SAKAGUCHI AY, 1983, PROG NUCLEIC ACID RE, V29, P279, DOI 10.1016/S0079-6603(08)60460-2; SAKAGUCHI AY, 1983, SOMAT CELL GENET, V9, P391, DOI 10.1007/BF01539146; SAKAGUCHI AY, 1984, P NATL ACAD SCI-BIOL, V81, P525, DOI 10.1073/pnas.81.2.525; SAKAGUCHI AY, 1983, SCIENCE, V219, P1081, DOI 10.1126/science.6823569; SCANGOS G, 1981, GENE, V14, P1, DOI 10.1016/0378-1119(81)90143-8; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SEED B, 1983, NUCLEIC ACIDS RES, V11, P2427, DOI 10.1093/nar/11.8.2427; SHEPARD JS, 1974, CANCER RES, V34, P2852; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SPARKES RS, 1984, CYTOGENET CELL GENET, V37, P1; SPURR NK, 1984, EMBO J, V3, P159, DOI 10.1002/j.1460-2075.1984.tb01777.x; STERN C, 1958, J Cell Physiol Suppl, V52, P1, DOI 10.1002/jcp.1030520404; SWAN D, 1982, J VIROL, V44, P752, DOI 10.1128/JVI.44.2.752-754.1982; SWAN D, 1979, P NATL ACAD SCI USA, V76, P2735, DOI 10.1073/pnas.76.6.2735; SWAN DC, 1982, P NATL ACAD SCI-BIOL, V79, P4691, DOI 10.1073/pnas.79.15.4691; SZYBALSKI W, 1959, P SOC EXP BIOL MED, V101, P662; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILLECKE K, 1975, P NATL ACAD SCI USA, V72, P1792, DOI 10.1073/pnas.72.5.1792; ZABEL BU, 1984, SOMAT CELL MOLEC GEN, V10, P105, DOI 10.1007/BF01534477	116	41	42	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					944	953						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6594045				2022-12-18	WOS:A1984TS30200002
J	TOMKINS, DJ; SISKEN, JE				TOMKINS, DJ; SISKEN, JE			ABNORMALITIES IN THE CELL-DIVISION CYCLE IN ROBERTS SYNDROME FIBROBLASTS - A CELLULAR BASIS FOR THE PHENOTYPIC CHARACTERISTICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV KENTUCKY,COLL MED,DEPT PATHOL,LEXINGTON,KY 40506	University of Kentucky	TOMKINS, DJ (corresponding author), MCMASTER UNIV,DEPT PEDIAT,HAMILTON L8N 3Z5,ONTARIO,CANADA.				NATIONAL CANCER INSTITUTE [R01CA027399] Funding Source: NIH RePORTER; NCI NIH HHS [CA27399] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARLOW PW, 1972, HUMANGENETIK, V14, P122, DOI 10.1007/BF00273295; FREEMAN MVR, 1974, CLIN GENET, V5, P1; GERMAN J, 1979, CLIN GENET, V16, P441; HERRMANN J, 1977, EUR J PEDIATR, V125, P117, DOI 10.1007/BF00489985; LOUIE E, 1983, J CELL BIOL, V97, pA192; McKusick V.A., 1983, MENDELIAN INHERITANC; PATON GR, 1974, HUMANGENETIK, V23, P173; QAZI QH, 1979, AM J MED GENET, V4, P231, DOI 10.1002/ajmg.1320040305; SALK D, 1981, HUM GENET, V58, P310, DOI 10.1007/BF00294930; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; SISKEN JE, 1982, J CELL PHYSIOL, V113, P219, DOI 10.1002/jcp.1041130206; SISKEN JE, 1973, CHROMOSOMA, V44, P91, DOI 10.1007/BF00372575; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; TOMKINS DJ, 1982, CLIN GENET, V22, P348; TOMKINS DJ, 1978, AM J HUM GENET, V30, pA95	15	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1332	1340						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517054				2022-12-18	WOS:A1984TZ59000014
J	MILLER, YE; JONES, C; SCOGGIN, C; MORSE, H; SELIGMAN, P				MILLER, YE; JONES, C; SCOGGIN, C; MORSE, H; SELIGMAN, P			CHROMOSOME 3Q (22-TER) ENCODES THE HUMAN TRANSFERRIN RECEPTOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FLORENCE R SABIN LABS GENET & DEV MED,DENVER,CO 80262; UNIV COLORADO,DIV PULM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,HUMAN GENET SECT,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DIV HEMATOL,DENVER,CO 80220	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	MILLER, YE (corresponding author), ELEANOR ROOSEVELT INST CANC RES INC,DENVER,CO 80262, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM027039] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA018734] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007085] Funding Source: NIH RePORTER; NCI NIH HHS [CA-18734] Funding Source: Medline; NHLBI NIH HHS [HL-07085] Funding Source: Medline; NIADDK NIH HHS [AM-27039] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; ANDERSON DW, 1981, IMMUNOL COMMUN, V10, P697, DOI 10.3109/08820138109051956; BOBROW M, 1974, NATURE, V251, P77, DOI 10.1038/251077a0; BRAMWELL ME, 1978, PROC R SOC SER B-BIO, V201, P87, DOI 10.1098/rspb.1978.0034; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; ENNS CA, 1981, J BIOL CHEM, V256; FRAZIER JL, 1982, J CLIN INVEST, V69, P853, DOI 10.1172/JCI110525; GALBRAITH RM, 1980, J CLIN INVEST, V66, P1135, DOI 10.1172/JCI109943; GOODFELLOW PN, 1982, SOMAT CELL GENET, V8, P197, DOI 10.1007/BF01538677; GOODFELLOW PN, 1981, 6TH INT WORKSH HUM G; GREENWOOD FC, 1967, MOD TRENDS ENDOCR, V3, P288; HAMILTON TA, 1979, P NATL ACAD SCI USA, V76, P6406, DOI 10.1073/pnas.76.12.6406; JONES C, 1980, CYTOGENET CELL GENET, V28, P181, DOI 10.1159/000131529; MIER JW, 1982, J IMMUNOL, V128, P1122; MILLER YE, 1982, CLIN RES, V30, pA41; OMARY BM, 1981, J BIOL CHEM, V256; PATTERSON D, 1981, P NATL ACAD SCI-BIOL, V78, P405, DOI 10.1073/pnas.78.1.405; SEABRIGH.M, 1971, LANCET, V2, P971; SELIGMAN PA, 1979, J BIOL CHEM, V254, P9943; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SULLIVAN AL, 1976, BLOOD, V47, P133; VOSS R, 1980, ANN HUM GENET, V44, P1, DOI 10.1111/j.1469-1809.1980.tb00940.x; WHANGPENG J, 1982, SCIENCE, V215, P181, DOI 10.1126/science.6274023	24	41	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					573	583						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6309000				2022-12-18	WOS:A1983RG73100003
J	DAIGER, SP; RUMMEL, DP; WANG, L; CAVALLISFORZA, LL				DAIGER, SP; RUMMEL, DP; WANG, L; CAVALLISFORZA, LL			DETECTION OF GENETIC-VARIATION WITH RADIOACTIVE LIGANDS .4. X-LINKED, POLYMORPHIC GENETIC-VARIATION OF THYROXIN-BINDING GLOBULIN (TBG)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA	Stanford University	DAIGER, SP (corresponding author), BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA.				NIGMS NIH HHS [GM-20832, GM00-295-18, GM-2045-7-03-04] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAVALLISFORZA LL, 1977, AM J HUM GENET, V29, P581; CAVALLISFORZA LL, 1971, 4TH P INT C HUM GEN, P79; DAIGER SP, BIOCH GENET; DAVIS PJ, 1971, J CLIN ENDOCR METAB, V33, P699, DOI 10.1210/jcem-33-4-699; FERRELL RE, 1978, AM J PHYS ANTHROPOL, V48, P269, DOI 10.1002/ajpa.1330480302; FERRELL RE, AM J PHYS ANTHR; FIALKOW PJ, 1970, J CLIN ENDOCR METAB, V30, P66, DOI 10.1210/jcem-30-1-66; FISHER DA, 1979, J PEDIATR-US, V94, P700, DOI 10.1016/S0022-3476(79)80133-X; FREEMAN T, 1969, CLIN CHIM ACTA, V26, P365, DOI 10.1016/0009-8981(69)90394-5; HOCMAN G, 1978, INT J BIOCHEM, V9, P639, DOI 10.1016/0020-711X(78)90088-5; HOCMAN G, 1978, INT J BIOCHEM, V9, P295, DOI 10.1016/0020-711X(78)90100-3; HOCMAN G, 1978, INT J BIOCHEM, V9, P9, DOI 10.1016/0020-711X(78)90129-5; KEATS BJB, 1979, SOURCE BOOK LINKAGE; KOBBERLING J, 1972, HUMANGENETIK, V14, P85, DOI 10.1007/BF00273290; LEIBA S, 1974, J CLIN ENDOCR METAB, V38, P569, DOI 10.1210/jcem-38-4-569; MARSHALL JS, 1972, J CLIN INVEST, V51, P3173, DOI 10.1172/JCI107144; NUSYNOWITZ ML, 1971, AM J MED, V50, P458, DOI 10.1016/0002-9343(71)90335-4; PREMACHANDRA BN, 1970, J CLIN ENDOCR METAB, V30, P752, DOI 10.1210/jcem-30-6-752; REFETOFF S, 1975, J CLIN INVEST, V56, P177, DOI 10.1172/JCI108066; REFETOFF S, 1972, J CLIN INVEST, V51, P848, DOI 10.1172/JCI106880; VERBRUGGEN R, 1975, CLIN CHEM, V21, P5	21	41	41	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					640	648						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6789676				2022-12-18	WOS:A1981LZ34800017
J	NAKATA, M; KOSHIBA, H; ETO, K; NANCE, WE				NAKATA, M; KOSHIBA, H; ETO, K; NANCE, WE			A GENETIC-STUDY OF ANODONTIA IN X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VIRGINIA COMMONWEALTH UNIV,DEPT HUMAN GENET,RICHMOND,VA 23298; KYUSHU UNIV,SCH DENT,DEPT PEDIAT DENT,FUKUOKA,JAPAN; TOKYO MED & DENT UNIV,DEPT PEDODONT,TOKYO 113,JAPAN	Virginia Commonwealth University; Kyushu University; Tokyo Medical & Dental University (TMDU)								BAILIT HL, 1975, DENT CLIN N AM, V19, P125; BERGSMA D, 1973, BIRTH DEFECTS; BROTHWELL DR, 1963, DENTAL ANTHR; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; Carter W J, 1967, J Dent Child, V34, P265; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; DARWIN C, 1892, VARIATIONS PLANTS AN; Felsher Z, 1944, ARCH DERMATOL SYPH, V49, P410, DOI 10.1001/archderm.1944.01510120024005; FRANCKE U, 1977, AM J HUM GENET, V29, P307; FRANCKE V, 1976, AM J HUM GENET, V28, P123; FRIAS JL, 1968, J PEDIATR-US, V72, P606, DOI 10.1016/S0022-3476(68)80002-2; FUJITA K, 1949, J ANTHR SOC NIPPON, V61, P27; FUJITA K, 1945, NIHON SHIKA KOHO, V2, P21; GARN SM, 1962, J DENT RES, V41, P717, DOI 10.1177/00220345620410033001; GRAHNEN H, 1956, ODONTOL REV       S3, V7, P419; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; KAPLAN E, 1968, NEW ENGL J MED, V279, P65, DOI 10.1056/NEJM196807112790203; KERR C. B., 1966, J MED GENET, V3, P169, DOI 10.1136/jmg.3.3.169; Kimura K., 1965, J ANTHROP SOC NIPPON, V72, P146, DOI [10.1537/ase1911.72.146, DOI 10.1537/ASE1911.72.146]; KOSHIBA H, 1976, JPN J PEDIATR, V14, P192; KRATZSCH R, 1972, KLIN PADIATR, V184, P328; MORTON NE, 1977, AM J HUM GENET, V29, P304; PASSARGE E, 1966, HUMANGENETIK, V3, P181, DOI 10.1007/BF00291298; PICKARD NA, 1978, NEW ENGL J MED, V299, P841, DOI 10.1056/NEJM197810192991601; Rushton M A, 1934, Proc R Soc Med, V27, P725; SEAGLE JB, 1954, J PEDIATR-US, V45, P688, DOI 10.1016/S0022-3476(54)80264-2; THURMAN J, 1948, T LONDON MED CHIR SO, V31, P71	27	41	42	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					908	919						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964	7446529				2022-12-18	WOS:A1980KT96400013
J	SCHERES, JMJC; HUSTINX, TWJ				SCHERES, JMJC; HUSTINX, TWJ			HERITABLE FRAGILE SITES AND LYMPHOCYTE CULTURE-MEDIUM CONTAINING BRDU	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											SCHERES, JMJC (corresponding author), CATHOLIC UNIV NIJMEGEN,FAC MED,DEPT HUMAN GENET,DIV CYTOGENET,NIJMEGEN,NETHERLANDS.							GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; HECHT F, 1979, AM J HUM GENET, V31, P223; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125	4	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					628	629						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395874				2022-12-18	WOS:A1980KB52200018
J	LEFRANC, G; RIVAT, L; RIVAT, C; LOISELET, J; ROPARTZ, C				LEFRANC, G; RIVAT, L; RIVAT, C; LOISELET, J; ROPARTZ, C			EVIDENCE FOR DELETED OR SILENT GENES HOMOZYGOUS AT LOCUS CODING FOR CONSTANT REGION OF GAMMA3 CHAIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FAC FRANCAISE MED & PHARM,BP 5076,BEIRUT,LEBANON; INSERM,UNIT GENET PROT HUMAINES 78,GRP RECH,BP 5,76230 BOIS GUILLAUME,FRANCE; CTR REG TRANSF SANGUINE,INT REFER CTR HUMAN IMMUNOGLOBULIN GENET MARKERS,BP 5,76230 BOIS GUILLAUME,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)								GEDDE-DAHL T JR, 1971, Clinical Genetics, V2, P356; GIBLETT ELOISE R., 1968, SER HAEMATOL, V1, P3; GOLD ER, 1967, J IMMUNOL, V99, P859; GREEN MM, 1962, GENETICA, V33, P154; HENDERSON SA, 1969, HDB MOLECULAR CYTOLO, V15, P326; KIDWELL MG, 1975, NATURE, V253, P755, DOI 10.1038/253755a0; KUNKEL HG, 1969, P NATL ACAD SCI USA, V62, P144, DOI 10.1073/pnas.62.1.144; LEFRANC G, IN PRESS; LITWIN SD, 1972, P NATL ACAD SCI USA, V69, P1739, DOI 10.1073/pnas.69.7.1739; LOBB N, 1967, NATURE, V214, P783, DOI 10.1038/214783a0; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; NATVIG JB, 1974, ANN INST PASTEUR IMM, VC125, P63; NATVIG JB, 1968, J EXP MED, V128, P763, DOI 10.1084/jem.128.4.763; NATVIG JB, 1971, J EXP MED, V133, P1004, DOI 10.1084/jem.133.5.1004; NATVIG JB, 1974, J IMMUNOL, V112, P1277; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; Ohno S., 1970, EVOLUTION GENE DUPLI; PETIT C, 1967, GENETIQUE EVOLUTION, P121; REES H, 1961, BOT REV, V27, P288, DOI 10.1007/BF02860084; RIVAT L, 1973, IMMUNOLOGY, V24, P1041; RIVAT L, 1970, NATURE, V225, P1136, DOI 10.1038/2251136a0; RIVAT L, 1970, IMMUNOLOGY, V19, P959; ROPARTZ C, 1967, UNIT IMMUNOLOGY WHO, V32; SIMCHEN G, 1969, NATURE, V222, P329, DOI 10.1038/222329a0; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STEINBERG AG, 1968, AM J HUM GENET, V20, P258; STERN H, 1973, ANNU REV GENET, V7, P37, DOI 10.1146/annurev.ge.07.120173.000345; VANLOGHEM E, 1973, VOX SANG, V24, P481; VANLOGHEM E, 1970, VOX SANG, V18, P421; WANG AC, 1974, J IMMUNOGENET, V1, P303; WANG AC, 1972, AM J HUM GENET, V24, P638; WESTERGAARD M, 1972, ANNU REV GENET, V6, P71, DOI 10.1146/annurev.ge.06.120172.000443	32	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					51	61						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1247020				2022-12-18	WOS:A1976BC88800007
J	FRIEDMAN, RD; MERRITT, AD; RIVAS, ML				FRIEDMAN, RD; MERRITT, AD; RIVAS, ML			GENETIC STUDIES OF HUMAN ACIDIC SALIVARY PROTEIN (PA)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEMPLE UNIV,SCH DENT,DEPT BIOCHEM,PHILADELPHIA,PA 19140; INDIANA UNIV,MED CTR,DEPT MED GENET,INDIANAPOLIS,IN 46202; RUTGERS STATE UNIV,DOUGLASS COLL,DEPT BIOL SCI,NEW BRUNSWICK,NJ 08903	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; Rutgers State University New Brunswick					NIGMS NIH HHS [P01 GM 19178, P01 GM 21054] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZEN EA, 1973, SCIENCE, V180, P1067, DOI 10.1126/science.180.4090.1067; AZEN EA, 1974, BIOCHEM GENET, V12, P109, DOI 10.1007/BF00487820; AZEN EA, 1972, SCIENCE, V176, P673, DOI 10.1126/science.176.4035.673; AZEN EA, 1973, BIOCHEM GENET, V9, P69, DOI 10.1007/BF00485592; FRIEDMAN RD, 1975, AM J HUM GENET, V27, P304; FRIEDMAN RD, 1973, AM J HUM GENET, V25, pA28; FRIEDMAN RD, 1972, AM J HUM GENET, V24, pA42; FRIEDMAN RM, TO BE PUBLISHED; MERRITT AD, 1973, AM J HUM GENET, V25, P510; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; SUNG M, 1969, BIOPOLYMERS, V7, P39, DOI 10.1002/bip.1969.360070105; TRUELOVE EL, 1967, J DENT RES, V46, P1400, DOI 10.1177/00220345670460064301	12	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					292	303						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803012				2022-12-18	WOS:A1975AD23600005
J	CHEN, SH; SCOTT, CR; GIBLETT, ER				CHEN, SH; SCOTT, CR; GIBLETT, ER			ADENOSINE DEAMINASE - DEMONSTRATION OF A SILENT GENE ASSOCIATED WITH COMBINED IMMUNODEFICIENCY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; KING CTY CENT BLOOD BANK,TERRY & MADISON,SEATTLE,WA 98104	University of Washington; University of Washington Seattle								Beutler E., 1971, RED CELL METABOLISM; CHEN SH, 1971, AM J HUM GENET, V23, P87; DETTER J C, 1970, Journal of Medical Genetics, V7, P356, DOI 10.1136/jmg.7.4.356; DISSING J, 1972, LANCET, V2, P1316; DISSING J, 1969, HUM HERED, V19, P375, DOI 10.1159/000152241; GIBLETT ER, 1972, LANCET, V2, P1067; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; LAMN LU, 1971, HUM HERED, V21, P63; OCHS HD, 1973, LANCET, V1, P1393; POLLARA B, 1973, PEDIATR RES, V7, P362; SCOTT CR, IN PRESS; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x	12	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					103	107						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4811750				2022-12-18	WOS:A1974S016600012
J	SCHNEIDER, RG; UEDA, S; ALPERIN, JB; BRIMHALL, B; JONES, RT				SCHNEIDER, RG; UEDA, S; ALPERIN, JB; BRIMHALL, B; JONES, RT			HEMOGLOBIN SEALY (A247HISBETA2) - A NEW VARIANT IN A JEWISH FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; DE VRIES A., 1963, BRIT JOUR HAEMATOL, V9, P484; HUEHNS E R, 1965, J Med Genet, V2, P48, DOI 10.1136/jmg.2.1.48; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; HUISMAN THJ, 1955, J LAB CLIN MED, V46, P255; JONES RT, 1964, COLD SPRING HARB SYM, V29, P297, DOI 10.1101/SQB.1964.029.01.032; JONES RT, 1966, J BIOL CHEM, V241, P2137; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; SMITHIES O, 1965, VOX SANG, V10, P359	9	41	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					151	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B2183	5643179				2022-12-18	WOS:A1968B218300007
J	LISKER, R; LORIA, A; CORDOVA, MS				LISKER, R; LORIA, A; CORDOVA, MS			STUDIES ON SEVERAL GENETIC HEMATOLOGICAL TRAITS OF MEXICAN POPULATION .8. HEMOGLOBIN S GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENTY AND OTHER CHARACTERISTICS IN A MALARIAL REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Lisker, Ruben/N-3094-2013	Lisker, Ruben/0000-0003-4272-5766; Loria, Alvar/0000-0002-4435-5319				Aguirre-Beltran G., 1958, CUIJLA ESBOZO ETNOGR; AGUIRREBELTRAN G, 1946, POBLACION NEGRA MEXI; ALLISON AC, 1961, GENETICAL VARIATION; ARENDS T, 1962, ACTA CIENT VENEZ, V13, P116; Bernstein P., 1931, COMITATO ITALIANO ST, P227; BLUMBERG BS, 1961, GENETIC POLYMORPHISM; DALAND GA, 1948, J LAB CLIN MED, V33, P1082; DENATALE A, 1955, JAMA-J AM MED ASSOC, V159, P247; GALLANGO M, 1962, 9 P C INT SOC BLOOD, P472; GALLANGO ML, 1963, HUM BIOL, V35, P361; GIBLETT ER, 1957, J LAB CLIN MED, V49, P433; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; HARRISON GA, 1961, GENETICAL VARIATION; LAYRISSE M, 1960, ANTIGENO SISTEMA SAN; LISKER R., 1962, REV INVEST CLIN, V14, P375; LISKER R, 1960, PRENSA MED MEX, V25, P2; LISKER R, IN PRESS; LISKER S, 1962, REV FRANC ETUD CLIN, V7, P76; LIVINGSTONE FB, CITED INDIRECTLY; LORIA A., 1963, GAC MED MEXICO, V93, P299; MATSON A, 1959, AM J PHYS ANTHROPOL, V17, P49; MOTULSKY Arno G., 1961, GENETIC POLYMORPHISM; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; RODRIGUEZ H, 1963, HUM BIOL, V35, P350; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SALAZER MM, 1959, SCIENCE, V130, P164; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITH SM, 1954, ANN HUM GENET, V19, P51, DOI 10.1111/j.1469-1809.1954.tb01262.x; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; SUTTON HE, 1960, AM J HUM GENET, V12, P338; VARGAS LUIS, 1960, SALUD PUBL MEXICO, V2, P257	32	41	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	2					179	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	62357	14262135				2022-12-18	WOS:A19656235700010
J	MCKEOWN, T; RECORD, RG				MCKEOWN, T; RECORD, RG			INFLUENCE OF PRE-NATAL ENVIRONMENT ON CORRELATION BETWEEN BIRTH WEIGHT AND PARENTAL HEIGHT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Calkins LA, 1937, AM J OBSTET GYNECOL, V33, P280, DOI 10.1016/S0002-9378(37)80017-4; CAWLEY RH, 1954, AM J HUM GENET, V6, P448; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; MCKEOWN T, 1952, J ENDOCRINOL, V8, P386, DOI 10.1677/joe.0.0080386; MCKEOWN T, 1954, J ENDOCRINOL, V11, P160, DOI 10.1677/joe.0.0110160; MCKEOWN T, 1953, J ENDOCRINOL, V10, P73, DOI 10.1677/joe.0.0100073; MCKEOWN T, 1953, J ENDOCRINOL, V9, P418, DOI 10.1677/joe.0.0090418; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029	8	41	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	4					457	463						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB735	14349951				2022-12-18	WOS:A1954YB73500009
J	Liu, BX; Pjanic, M; Wang, T; Nguyen, T; Gloudemans, M; Rao, A; Castano, VG; Nurnberg, S; Rader, DJ; Elwyn, S; Ingelsson, E; Montgomery, SB; Miller, CL; Quertermous, T				Liu, Boxiang; Pjanic, Milos; Wang, Ting; Nguyen, Trieu; Gloudemans, Michael; Rao, Abhiram; Castano, Victor G.; Nurnberg, Sylvia; Rader, Daniel J.; Elwyn, Susannah; Ingelsson, Erik; Montgomery, Stephen B.; Miller, Clint L.; Quertermous, Thomas			Genetic Regulatory Mechanisms of Smooth Muscle Cells Map to Coronary Artery Disease Risk Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPANDED VIEW; HEART-DISEASE; PROTEIN; EXPRESSION; DISCOVERY; VARIANT; EQTL; SEQ; ATHEROSCLEROSIS	Coronary artery disease (CAD) is the leading cause of death globally. Genome-wide association studies (GWASs) have identified more than 95 independent loci that influence CAD risk, most of which reside in non-coding regions of the genome. To interpret these loci, we generated transcriptome and whole-genome datasets using human coronary artery smooth muscle cells (HCASMCs) from 52 unrelated donors, as well as epigenomic datasets using ATAC-seq on a subset of 8 donors. Through systematic comparison with publicly available datasets from GTEx and ENCODE projects, we identified transcriptomic, epigenetic, and genetic regulatory mechanisms specific to HCASMCs. We assessed the relevance of HCASMCs to CAD risk using transcriptomic and epigenomic level analyses. By jointly modeling eQTL and GWAS datasets, we identified five genes (SIPA1, TCF21, SMAD3, FES, and PDGFRA) that may modulate CAD risk through HCASMCs, all of which have relevant functional roles in vascular remodeling. Comparison with GTEx data suggests that SIPA1 and PDGFRA influence CAD risk predominantly through HCASMCs, while other annotated genes may have multiple cell and tissue targets. Together, these results provide tissue-specific and mechanistic insights into the regulation of a critical vascular cell type associated with CAD in human populations.	[Liu, Boxiang] Stanford Univ, Dept Biol, Sch Humanities & Sci, Stanford, CA 94305 USA; [Liu, Boxiang; Pjanic, Milos; Wang, Ting; Nguyen, Trieu; Rao, Abhiram; Castano, Victor G.; Ingelsson, Erik; Montgomery, Stephen B.; Quertermous, Thomas] Stanford Sch Med, Cardiovasc Inst, 300 Pasteur Dr, Stanford, CA 94305 USA; [Pjanic, Milos; Nguyen, Trieu; Castano, Victor G.; Ingelsson, Erik; Quertermous, Thomas] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Wang, Ting; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Rao, Abhiram] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Gloudemans, Michael] Stanford Sch Med, Biomed Informat Training Program, 300 Pasteur Dr, Stanford, CA 94305 USA; [Nurnberg, Sylvia; Rader, Daniel J.; Elwyn, Susannah] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Miller, Clint L.] Univ Virginia, Ctr Publ Hlth Genom, Dept Publ Hlth Sci Biochem & Genet & Biomed Engn, Charlottesville, VA 22908 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Pennsylvania; University of Virginia	Quertermous, T (corresponding author), Stanford Sch Med, Cardiovasc Inst, 300 Pasteur Dr, Stanford, CA 94305 USA.; Quertermous, T (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	tomq1@stanford.edu	Pjanic, Milos/AAH-1262-2019; Miller, Clint/I-4370-2019; Castano, Victor/AAI-6204-2021	Pjanic, Milos/0000-0001-9746-8838; Liu, Boxiang/0000-0002-2595-4463; Nurnberg, Sylvia/0000-0002-0869-484X; Montgomery, Stephen/0000-0002-5200-3903; Gloudemans, Michael/0000-0002-9924-9943; Quertermous, Thomas/0000-0002-7645-9067	Stanford Center for Computational, Evolutionary and Human Genomics Fellowship; NIH [R01HL109512, R01HL134817, R33HL120757, R01DK107437, R01HL139478, R00HL125912]; NHLBI [R33HL120757]; NHGRI; ENCODE4 [U01HG009431]; NIH Common Fund; GTEx Program [R01MH101814]; NHGRI; Non-Coding Variants Program [R01HG008150]; Edward Mallinckrodt, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL125912, R01HL109512, R01HL134817, R01HL139478, R33HL120757] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008150, U01HG009431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101814] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Stanford Center for Computational, Evolutionary and Human Genomics Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI; ENCODE4; NIH Common Fund; GTEx Program; NHGRI; Non-Coding Variants Program; Edward Mallinckrodt, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Professor Nicolas Mermod for providing biological material and Normal Cyr for making illustrations. B.L. is supported in part by the Stanford Center for Computational, Evolutionary and Human Genomics Fellowship. T.Q. is supported by NIH grants R01HL109512, R01HL134817, R33HL120757, R01DK107437, and R01HL139478. C.L.M. is supported by R00HL125912 (NIH). S.B.M. is supported by R33HL120757 (NHLBI), U01HG009431 (NHGRI; ENCODE4), R01MH101814 (NIH Common Fund; GTEx Program), R01HG008150 (NHGRI; Non-Coding Variants Program), and the Edward Mallinckrodt, Jr. Foundation.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ahola-Olli AV, 2017, AM J HUM GENET, V100, P40, DOI 10.1016/j.ajhg.2016.11.007; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bot PT, 2011, ATHEROSCLEROSIS, V218, P33, DOI 10.1016/j.atherosclerosis.2011.05.017; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Han B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002555; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; He CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8770; Hogan NT, 2017, ELIFE, V6, DOI 10.7554/eLife.22536; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038; Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Khera AV, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2016.160; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kim JB, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006750; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; Klarin D, 2017, NAT GENET, V49, P1392, DOI 10.1038/ng.3914; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miller CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12092; Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Peterson CB, 2016, BIOINFORMATICS, V32, P2556, DOI 10.1093/bioinformatics/btw198; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shaheen R, 2016, AM J HUM GENET, V98, P643, DOI 10.1016/j.ajhg.2016.02.010; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Srivastava R, 2015, CELL REP, V13, P746, DOI 10.1016/j.celrep.2015.09.028; Steenaard RV, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0088-y; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Turner AW, 2016, ARTERIOSCL THROM VAS, V36, P972, DOI 10.1161/ATVBAHA.116.307294; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Van der Auwera G. A., 2002, FASTQ DATA HIGH CONF; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang G, 2015, J PHYSIOL-LONDON, V593, P3013, DOI 10.1113/JP270033; Won HH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005622; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	79	40	40	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					377	388		10.1016/j.ajhg.2018.08.001	http://dx.doi.org/10.1016/j.ajhg.2018.08.001			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30146127	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000443819500007
J	Burns, DT; Donkervoort, S; Muller, JS; Knierim, E; Bharucha-Goebel, D; Faqeih, EA; Bell, SK; AlFaifi, AY; Monies, D; Millan, F; Retterer, K; Dyack, S; MacKay, S; Morales-Gonzalez, S; Giunta, M; Munro, B; Hudson, G; Scavina, M; Baker, L; Massini, TC; Lek, M; Hu, Y; Ezzo, D; AlKuraya, FS; Kang, PB; Griffin, H; Foley, AR; Schuelke, M; Horvath, R; Bonnemann, CG				Burns, David T.; Donkervoort, Sandra; Muller, Juliane S.; Knierim, Ellen; Bharucha-Goebel, Diana; Faqeih, Eissa Ali; Bell, Stephanie K.; AlFaifi, Abdullah Y.; Monies, Dorota; Millan, Francisca; Retterer, Kyle; Dyack, Sarah; MacKay, Sara; Morales-Gonzalez, Susanne; Giunta, Michele; Munro, Benjamin; Hudson, Gavin; Scavina, Mena; Baker, Laura; Massini, Tara C.; Lek, Monkol; Hu, Ying; Ezzo, Daniel; AlKuraya, Fowzan S.; Kang, Peter B.; Griffin, Helen; Foley, A. Reghan; Schuelke, Markus; Horvath, Rita; Bonnemann, Carsten G.			Variants in EXOSC9 Disrupt the RNA Exosome and Result in Cerebellar Atrophy with Spinal Motor Neuronopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PONTOCEREBELLAR HYPOPLASIA TYPE-1; BIALLELIC MUTATIONS; YEAST EXOSOME; PROTEIN; GENE; DEGRADATION; SUBUNIT; COMPLEX; DNA; IDENTIFICATION	The exosome is a conserved multi-protein complex that is essential for correct RNA processing. Recessive variants in exosome components EXOSC3, EXOSC8, and RBM7 cause various constellations of pontocerebellar hypoplasia (PCH), spinal muscular atrophy (SMA), and central nervous system demyelination. Here, we report on four unrelated affected individuals with recessive variants in EXOSC9 and the effect of the variants on the function of the RNA exosome in vitro in affected individuals' fibroblasts and skeletal muscle and in vivo in zebrafish. The clinical presentation was severe, early-onset, progressive SMA-like motor neuronopathy, cerebellar atrophy, and in one affected individual, congenital fractures of the long bones. Three affected individuals of different ethnicity carried the homozygous c.41T>C (p.Leul4Pro) variant, whereas one affected individual was compound heterozygous for c.41T>C (p.Leul4Pro) and c.481C>T (p.Arg161*). We detected reduced EXOSC9 in fibroblasts and skeletal muscle and observed a reduction of the whole multi-subunit exosome complex on blue-native polyacrylamide gel electrophoresis. RNA sequencing of fibroblasts and skeletal muscle detected significant >2-fold changes in genes involved in neuronal development and cerebellar and motor neuron degeneration, demonstrating the widespread effect of the variants. Morpholino oligonucleotide knockdown and CRISPR/Cas9-mediated mutagenesis of exosc9 in zebrafish recapitulated aspects of the human phenotype, as they have in other zebrafish models of exosomal disease. Specifically, portions of the cerebellum and hindbrain were absent, and motor neurons failed to develop and migrate properly. In summary, we show that variants in EXOSC9 result in a neurological syndrome combining cerebellar atrophy and spinal motoneuronopathy, thus expanding the list of human exosomopathies.	[Burns, David T.; Muller, Juliane S.; Giunta, Michele; Munro, Benjamin; Hudson, Gavin; Griffin, Helen; Horvath, Rita] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Donkervoort, Sandra; Bharucha-Goebel, Diana; Hu, Ying; Ezzo, Daniel; Foley, A. Reghan; Bonnemann, Carsten G.] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bethesda, MD 20892 USA; [Knierim, Ellen; Morales-Gonzalez, Susanne; Schuelke, Markus] Charite, Dept Neuropediat, Charite Pl 1, D-10117 Berlin, Germany; [Knierim, Ellen; Morales-Gonzalez, Susanne; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, Charite Pl 1, D-10117 Berlin, Germany; [Bharucha-Goebel, Diana] Childrens Natl Med Ctr, Div Neurol, Washington, DC 20010 USA; [Faqeih, Eissa Ali; AlFaifi, Abdullah Y.] King Fahad Med City, Childrens Specialized Hosp, Dept Pediat Subspecialties, Sect Med Genet, Riyadh, Saudi Arabia; [Bell, Stephanie K.; Kang, Peter B.] Univ Florida, Coll Med, Dept Pediat, Div Pediat Neurol, Gainesville, FL 32610 USA; [Monies, Dorota; AlKuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Millan, Francisca; Retterer, Kyle] GeneDx, Gaithersburg, MD 20877 USA; [Dyack, Sarah] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Dyack, Sarah] Dalhousie Univ, Dept Med, Halifax, NS B3H 4R2, Canada; [MacKay, Sara] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS B3K 6R8, Canada; [Scavina, Mena] Nemours DuPont Hosp Children, Div Neurol, Wilmington, DE 19803 USA; [Baker, Laura] Nemours DuPont Hosp Children, Div Genet, Wilmington, DE 19803 USA; [Massini, Tara C.] Univ Florida, Coll Med, Dept Radiol, Gainesville, FL 32610 USA; [Lek, Monkol] Broad Inst MIT & Harvard, Program Med & Populat Genet, Ctr Mendelian Genom, Cambridge, MA 01242 USA	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Children's National Health System; King Fahad Medical City; State University System of Florida; University of Florida; King Faisal Specialist Hospital & Research Center; Dalhousie University; Dalhousie University; Dalhousie University; Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; State University System of Florida; University of Florida; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Horvath, R (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	rita.horvath@ncl.ac.uk	Horvath, Rita/AAY-7042-2020; Dyack, Sarah/AAD-4347-2020; Kang, Peter/AAV-6537-2020; Hu, Ying/GQZ-8100-2022	Giunta, Michele/0000-0002-5829-0245; Kang, Peter/0000-0002-4270-7325; Knierim, Ellen/0000-0002-4769-7322; Morales Gonzalez, Susanne/0000-0001-7279-2092; Munro, Benjamin/0000-0003-4506-7092; Schuelke, Markus/0000-0003-2824-3891; Hudson, Gavin/0000-0001-7210-2733; Griffin, Helen R/0000-0002-5288-3322; Horvath, Rita/0000-0002-9841-170X	Wellcome Centre for Mitochondrial Research [109915/Z/15/Z, 203105/Z/16/Z]; Medical Research Council (UK) [MR/N025431/1]; European Research Council [309548]; Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]; Newton Fund (UK/Turkey) [MR/N027302/1]; NIH National Institute of Neurological Disorders and Stroke; Clinical Center Genomics Opportunity - National Human Genome Research Institute; NIH; NIH Clinical Center; National Human Genome Research Institute; National Eye Institute; National Heart, Lung, and Blood Institute [UM1 HG008900]; Deutsche Forschungsgemeinschaft [SFB 665 TP C4, NeuroCure Exc 257]; MRC [G1000848, MR/N025431/2, MR/N010035/1, MR/N025431/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	Wellcome Centre for Mitochondrial Research; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust Pathfinder Scheme; Newton Fund (UK/Turkey); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical Center Genomics Opportunity - National Human Genome Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for participating and Christopher Mendoza and Gilberto ("Mike'') Averion for their help in the clinic. We would also like to thank the NIH Intramural Sequencing Center staff and Daniel MacArthur and Fengmei Zhao (Analytic and Translational Genetics Unit at Massachusetts General Hospital in collaboration with the Broad Institute of Harvard and Massachusetts Institute of Technology) for their help with exome analysis. We also thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. R.H. is a Wellcome Investigator (109915/Z/15/Z) who receives support from the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), Medical Research Council (UK) (MR/N025431/1), the European Research Council (309548), the Wellcome Trust Pathfinder Scheme (201064/Z/16/Z), and the Newton Fund (UK/Turkey, MR/N027302/1). Work in C.G. Bonnemann's laboratory is supported by intramural funds from the NIH National Institute of Neurological Disorders and Stroke. Exome sequencing was funded through the Clinical Center Genomics Opportunity, which is sponsored by the National Human Genome Research Institute, the NIH Deputy Director for Intramural Research, and the NIH Clinical Center. Sequencing analysis was provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics and was funded by the National Human Genome Research Institute, the National Eye Institute, and National Heart, Lung, and Blood Institute grant UM1 HG008900 to Daniel MacArthur and Heidi Rehm. Work in M.S.'s laboratory was supported by the Deutsche Forschungsgemeinschaft (grants SFB 665 TP C4 and NeuroCure Exc 257).	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boczonadi V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5287; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eggens VRC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-23; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Fasken MB, 2017, GENETICS, V205, P221, DOI 10.1534/genetics.116.195917; Giunta M, 2016, HUM MOL GENET, V25, P2985, DOI 10.1093/hmg/ddw149; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hrossova D, 2015, NUCLEIC ACIDS RES, V43, P4236, DOI 10.1093/nar/gkv240; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kasher PR, 2011, HUM MOL GENET, V20, P1574, DOI 10.1093/hmg/ddr034; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knierim E, 2016, AM J HUM GENET, V98, P473, DOI 10.1016/j.ajhg.2016.01.006; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005; Lardelli RM, 2017, NAT GENET, V49, P457, DOI 10.1038/ng.3762; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Noiret M, 2016, DEV BIOL, V409, P489, DOI 10.1016/j.ydbio.2015.11.002; Rudnik-Schoneborn S, 2013, NEUROLOGY, V80, P438, DOI 10.1212/WNL.0b013e31827f0f66; Sayani S, 2012, RNA, V18, P1563, DOI 10.1261/rna.033779.112; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Scholimann G, 2017, MITOCHONDRION, V37, P46, DOI 10.1016/j.mito.2017.06.007; Schwabova J, 2013, J NEUROGENET, V27, P163, DOI 10.3109/01677063.2013.814651; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sharma KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37172; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Staals RHJ, 2010, ADV EXP MED BIOL, V702, P132, DOI 10.1007/978-1-4419-7841-7_11; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Ying DG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0662-9	53	40	41	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					858	873		10.1016/j.ajhg.2018.03.011	http://dx.doi.org/10.1016/j.ajhg.2018.03.011			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727687	Green Published, hybrid			2022-12-18	WOS:000432440100011
J	Lessel, D; Schob, C; Kury, S; Reinders, MRF; Harel, T; Eldomery, MK; Coban-Akdemir, Z; Denecke, J; Edvardson, S; Colin, E; Stegmann, APA; Gerkes, EH; Tessarech, M; Bonneau, D; Barth, M; Besnard, T; Cogne, B; Revah-Politi, A; Strom, TM; Rosenfeld, JA; Yang, YP; Posey, JE; Immken, L; Oundjian, N; Helbig, KL; Meeks, N; Zegar, K; Morton, J; Schieving, JH; Claasen, A; Huentelman, M; Narayanan, V; Ramsey, K; Brunner, HG; Elpeleg, O; Mercier, S; Bezieau, S; Kubisch, C; Kleefstra, T; Kindler, S; Lupski, JR; Kreienkamp, HJ				Lessel, Davor; Schob, Claudia; Kuery, Sebastien; Reinders, Margot R. F.; Harel, Tamar; Eldomery, Mohammad K.; Coban-Akdemir, Zeynep; Denecke, Jonas; Edvardson, Shimon; Colin, Estelle; Stegmann, Alexander P. A.; Gerkes, Erica H.; Tessarech, Marine; Bonneau, Dominique; Barth, Magalie; Besnard, Thomas; Cogne, Benjamin; Revah-Politi, Anya; Strom, Tim M.; Rosenfeld, Jill A.; Yang, Yaping; Posey, Jennifer E.; Immken, LaDonna; Oundjian, Nelly; Helbig, Katherine L.; Meeks, Naomi; Zegar, Kelsey; Morton, Jenny; Schieving, Jolanda H.; Claasen, Ana; Huentelman, Matthew; Narayanan, Vinodh; Ramsey, Keri; Brunner, Han G.; Elpeleg, Orly; Mercier, Sandra; Bezieau, Stephane; Kubisch, Christian; Kleefstra, Tjitske; Kindler, Stefan; Lupski, James R.; Kreienkamp, Hans-Juergen		DDD study; C4RCD Res Grp	De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; STRESS GRANULES; RNA GRANULES; PROTEIN; HELICASE; DISEASE; GENE; DISRUPTION; FAMILY; MODULE	DHX30 is a member of the family of DExH-box helicases, which use ATP hydrolysis to unwind RNA secondary structures. Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities. While four mutations are recurrent, two are unique with one affecting the codon of one recurrent mutation. All amino acid changes are located within highly conserved helicase motifs and were found to either impair ATPase activity or RNA recognition in different in vitro assays. Moreover, protein variants exhibit an increased propensity to trigger stress granule (SG) formation resulting in global translation inhibition. Thus, our findings highlight the prominent role of translation control in development and function of the central nervous system and also provide molecular insight into how DHX30 dysfunction might cause a neurodevelopmental disorder.	[Lessel, Davor; Schob, Claudia; Kubisch, Christian; Kindler, Stefan; Kreienkamp, Hans-Juergen] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Lessel, Davor; Kubisch, Christian] Univ Med Ctr Hamburg Eppendorf UDP UKE, Undiagnosed Dis Program, Martinistr 52, D-20246 Hamburg, Germany; [Kuery, Sebastien; Besnard, Thomas; Cogne, Benjamin; Mercier, Sandra; Bezieau, Stephane] CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes, France; [Reinders, Margot R. F.; Brunner, Han G.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Harel, Tamar; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, IL-9112001 Jerusalem, Israel; [Eldomery, Mohammad K.; Coban-Akdemir, Zeynep; Rosenfeld, Jill A.; Yang, Yaping; Posey, Jennifer E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Denecke, Jonas] Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Edvardson, Shimon] Hadassah Hebrew Univ, Med Ctr, Pediat Neurol Unit, IL-9112001 Jerusalem, Israel; [Edvardson, Shimon; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-9112001 Jerusalem, Israel; [Colin, Estelle; Tessarech, Marine; Bonneau, Dominique; Barth, Magalie] Univ Hosp, Dept Biochem & Genet, F-49933 Angers 9, France; [Colin, Estelle; Tessarech, Marine; Bonneau, Dominique; Barth, Magalie] CHU Bat, IRIS IBS, Inst Mitovasc Angers, Equipe MitoLab,CNRS UMR 6015,Inserm U1083, Rue Capucins, F-49933 Angers, France; [Stegmann, Alexander P. A.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Gerkes, Erica H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Revah-Politi, Anya] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Immken, LaDonna] Clin Genet Specially Children, Austin, TX 78723 USA; [Oundjian, Nelly] Valley Hosp, Ridgewood, NJ USA; [Helbig, Katherine L.] Ambry Genet, Div Clin Gen, Aliso Viejo, CA USA; [Meeks, Naomi; Zegar, Kelsey] Univ Colorado, Sch Med, Dept Pediat, Div Clin Genet & Metab, Aurora, CO USA; [Meeks, Naomi; Zegar, Kelsey] Childrens Hosp Colorado, Clin Genet, Aurora, CO USA; [Morton, Jenny] Birmingham Womens & Childrens NHS Fdn Trust, West Midlands Reg Clin Genet Serv, Birmingham B15 2TG, W Midlands, England; [Morton, Jenny] Birmingham Womens & Childrens NHS Fdn Trust, Birmingham Hlth Partners, Birmingham B15 2TG, W Midlands, England; [Schieving, Jolanda H.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Pediat Neurol, Nijmegen, Netherlands; [Claasen, Ana; Huentelman, Matthew; Narayanan, Vinodh; Ramsey, Keri] Ctr Rare Childhood Disorders, Translat Genom Res Inst, Phoenix, AZ USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Baylor Genet Labs, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Nantes Universite; CHU de Nantes; Radboud University Nijmegen; Baylor College of Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Maastricht University; University of Groningen; Columbia University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Radboud University Nijmegen; Translational Genomics Research Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lessel, D; Kreienkamp, HJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.; Lessel, D (corresponding author), Univ Med Ctr Hamburg Eppendorf UDP UKE, Undiagnosed Dis Program, Martinistr 52, D-20246 Hamburg, Germany.	d.lessel@uke.de; kreienkamp@uke.de	Lessel, Davor/ABD-6088-2021; Kleefstra, Tjitske/G-2619-2012; Kubisch, Christian/F-1893-2011; colin, estelle/AAI-2447-2019; KÜRY, Sébastien/G-5971-2015; Mercier, Sandra/E-8922-2018; Besnard, Thomas/L-2303-2019; , WaNgtJ/AAR-7045-2020; Posey, Jennifer E./J-3048-2019; Rangasamy, Sampathkumar/B-7510-2009; Helbig, Katherine/B-7454-2012	Kubisch, Christian/0000-0003-4220-0978; KÜRY, Sébastien/0000-0001-5497-0465; Besnard, Thomas/0000-0003-4804-5147; Posey, Jennifer E./0000-0003-4814-6765; Rangasamy, Sampathkumar/0000-0003-2151-9162; Stegmann, Alexander/0000-0002-9736-7137; Helbig, Katherine/0000-0001-8249-0549; Kreienkamp, Hans-Jurgen/0000-0002-8871-9970; Bonneau, Dominique/0000-0002-6886-0969; Lessel, Davor/0000-0003-4496-244X	Forschungsforderungsfonds der Medizinischen Fakultat des Universitatsklinikums Hamburg-Eppendorf [FFM]; Deutsche Forschungsgemeinschaft [SPP1935]; US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [UM1HG006542]; NHGRI [U54HG003273, K08 HG008986]; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS05829]; French Ministry of Health; Health Regional Agency from Poitou-Charentes (HUGODIMS) [RC14_0107]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K08HG008986, UM1HG006542, U54HG003273] Funding Source: NIH RePORTER	Forschungsforderungsfonds der Medizinischen Fakultat des Universitatsklinikums Hamburg-Eppendorf [FFM]; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); French Ministry of Health; Health Regional Agency from Poitou-Charentes (HUGODIMS)(Region Nouvelle-Aquitaine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the family members for their participation and collaboration, Hans-Hinrich Honck (Institute for Human Genetics, UKE Hamburg) for excellent technical assistance and Tim Kreienkamp (Hamburg) for help with extracting eCLIP data. This work was funded in part by local funding (Forschungsforderungsfonds der Medizinischen Fakultat des Universitatsklinikums Hamburg-Eppendorf [FFM], to D.L.), Deutsche Forschungsgemeinschaft through SPP1935 "Deciphering the RNP Code'' (to H.-J.K. and S. Kindler), the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI; grant number UM1HG006542 to the Baylor-Hopkins Center for Mendelian Genomics), NHGRI grant to Baylor College of Medicine Human Genome Sequencing Center (U54HG003273) and J.E.P. (K08 HG008986), National Institute of Neurological Disorders and Stroke (NINDS) (R01NS05829 to J.R.L.), the French Ministry of Health and the Health Regional Agency from Poitou-Charentes (HUGODIMS, 2013, RC14_0107). Confocal microscopes were provided by UKE microscopic imaging facility (umif). eCLIP data were produced by the ENCODE consortium (Lab: Gene Yeo at UCSD). Acknowledgments of the DDD Study and a list of C4RCD Research Group members appear in the Supplemental Note. Baylor College of Medicine (BCM) and Miraca Holdings Inc. have formed a joint venture with shared ownership and governance of the Baylor Genetics (BG), which performs clinical exome sequencing. J.R.L. has stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron Pharmaceuticals, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. K.L.H. is a full time employee of Ambry Genetics.	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Banuelos Erika, 2017, F1000Res, V6, P553, DOI 10.12688/f1000research.10588.1; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gareau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055342; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kunde SA, 2011, HUM MOL GENET, V20, P4916, DOI 10.1093/hmg/ddr430; Kury S, 2017, AM J HUM GENET, V100, P352, DOI 10.1016/j.ajhg.2017.01.003; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mahboubi H, 2017, BBA-MOL BASIS DIS, V1863, P884, DOI 10.1016/j.bbadis.2016.12.022; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; Miroci H, 2012, J BIOL CHEM, V287, P1322, DOI 10.1074/jbc.M111.315291; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Ta-Shma A, 2017, J MED GENET, V54, P278, DOI 10.1136/jmedgenet-2016-104259; Tanaka N, 2006, BIOCHEMISTRY-US, V45, P6510, DOI 10.1021/bi052656g; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tauchert MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21510; Umate Pavan, 2011, Commun Integr Biol, V4, P118, DOI 10.4161/cib.4.1.13844; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Zheng HJ, 2015, STEM CELLS DEV, V24, P372, DOI 10.1089/scd.2014.0077	40	40	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					716	724		10.1016/j.ajhg.2017.09.014	http://dx.doi.org/10.1016/j.ajhg.2017.09.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100085	Bronze, Green Published			2022-12-18	WOS:000414251600005
J	Stankiewicz, P; Khan, TN; Szafranski, P; Slattery, L; Streff, H; Vetrini, F; Bernstein, JA; Brown, CW; Rosenfeld, JA; Rednam, S; Scollon, S; Bergstrom, KL; Parsons, DW; Plon, SE; Vieira, MW; Quaio, CRDC; Baratela, WAR; Guio, JCA; Armstrong, R; Mehta, SG; Rump, P; Pfundt, R; Lewandowski, R; Fernandes, EM; Shinde, DN; Tang, S; Hoyer, J; Zweier, C; Reis, A; Bacino, CA; Xiao, R; Breman, AM; Smith, JL; Katsanis, N; Bostwick, B; Popp, B; Davis, EE; Yang, YP				Stankiewicz, Pawel; Khan, Tahir N.; Szafranski, Przemyslaw; Slattery, Leah; Streff, Haley; Vetrini, Francesco; Bernstein, Jonathan A.; Brown, Chester W.; Rosenfeld, Jill A.; Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.; Vieira, Marta W.; Quaio, Caio R. D. C.; Baratela, Wagner A. R.; Acosta Guio, Johanna C.; Armstrong, Ruth; Mehta, Sarju G.; Rump, Patrick; Pfundt, Rolph; Lewandowski, Raymond; Fernandes, Erica M.; Shinde, Deepali N.; Tang, Sha; Hoyer, Juliane; Zweier, Christiane; Reis, Andre; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Katsanis, Nicholas; Bostwick, Bret; Popp, Bernt; Davis, Erica E.; Yang, Yaping		Deciphering Dev Disorders Study	Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIANT; TRANSCRIPTION FACTOR; INTELLECTUAL DISABILITY; COMPLEX NURF; PHD FINGER; ARRAY CGH; IN-VIVO; MUTATIONS; GENE; PROTEIN	Bromodomain PHD finger transcription factor (BPTF) is the largest subunit of nucleosome remodeling factor (NURF), a member of the ISWI chromatin-remodeling complex. However, the clinical consequences of disruption of this complex remain largely uncharacterized. BPTF is required for anterior-posterior axis formation of the mouse embryo and was shown to promote posterior neuroectodermal fate by enhancing Smad2-activated wnt8 expression in zebrafish. Here, we report eight loss-of-function and two missense variants (eight de novo and two of unknown origin) in BPTF on 17q24.2. The BPTF variants were found in unrelated individuals aged between 2.1 and 13 years, who manifest variable degrees of developmental delay/intellectual disability (10/10), speech delay (10/10), postnatal microcephaly (7/9), and dysmorphic features (9/10). Using CRISPR-Cas9 genome editing of bptf in zebrafish to induce a loss of gene function, we observed a significant reduction in head size of F0 mutants compared to control larvae. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and phospho-histone H3 (PH3) staining to assess apoptosis and cell proliferation, respectively, showed a significant increase in cell death in F0 mutants compared to controls. Additionally, we observed a substantial increase of the ceratohyal angle of the craniofacial skeleton in bptf F0 mutants, indicating abnormal craniofacial patterning. Taken together, our data demonstrate the pathogenic role of BPTF haploinsufficiency in syndromic neurodevelopmental anomalies and extend the clinical spectrum of human disorders caused by ablation of chromatin remodeling complexes.	[Stankiewicz, Pawel; Szafranski, Przemyslaw; Streff, Haley; Rosenfeld, Jill A.; Parsons, Donald W.; Plon, Sharon E.; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Bostwick, Bret; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stankiewicz, Pawel; Vetrini, Francesco; Rosenfeld, Jill A.; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Yang, Yaping] Baylor Genet, Houston, TX 77021 USA; [Khan, Tahir N.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Slattery, Leah; Bernstein, Jonathan A.] Stanford Univ, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA; [Brown, Chester W.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA; [Brown, Chester W.] Le Bonheur Childrens Hosp, Memphis, TN 38105 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Vieira, Marta W.] PUCSP, Fac Ciencias Med & Saude, BR-01221020 Sao Paulo, Brazil; [Quaio, Caio R. D. C.; Baratela, Wagner A. R.] Fleury Med & Saude, BR-04344070 Sao Paulo, Brazil; [Acosta Guio, Johanna C.] Inst Ortoped Infantil Roosevelt, Genet Med, 17-50 Bogota, Cundinamarca, Colombia; [Armstrong, Ruth; Mehta, Sarju G.] Addenbrookes Hosp, Addenbrookes Treatment Ctr, Clin Genet, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Lewandowski, Raymond; Fernandes, Erica M.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Shinde, Deepali N.; Tang, Sha] Ambry Genet, Dept Clin Gen, Aliso Viejo, CA 92656 USA; [Hoyer, Juliane; Zweier, Christiane; Reis, Andre; Popp, Bernt] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, D-91054 Erlangen, Germany	Baylor College of Medicine; Duke University; Stanford University; University of Tennessee System; University of Tennessee Health Science Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Groningen; Radboud University Nijmegen; Virginia Commonwealth University; University of Erlangen Nuremberg	Stankiewicz, P; Yang, YP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Stankiewicz, P; Yang, YP (corresponding author), Baylor Genet, Houston, TX 77021 USA.	pawels@bcm.edu; yapingy@bcm.edu	Pfundt, Rolph/L-4576-2015; Quaio, CR/H-3784-2013; Zweier, Christiane/F-2202-2015; Reis, André/D-2309-2009; , WaNgtJ/AAR-7045-2020; Quaio, Caio/GQQ-6180-2022; Popp, Bernt/M-2157-2019; Stankiewicz, Paweł/AAP-7906-2021	Quaio, CR/0000-0003-2873-2820; Zweier, Christiane/0000-0001-8002-2020; Reis, André/0000-0002-6301-6363; Popp, Bernt/0000-0002-3679-1081; Stankiewicz, Paweł/0000-0002-6456-7490; Reis, AlessanRSS/0000-0001-8486-7469; Davis, Erica/0000-0002-2412-8397; Breman, Amy/0000-0003-0299-0100; Parsons, Donald/0000-0002-8775-3501; Khan, Tahir/0000-0003-3096-8795	Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; US NIH grant [R01 MH106826]; National Institute for Health Research, through the Comprehen-sive Clinical Research Network; CHROMATIN-Net - German Federal Ministry of Education and Research (BMBF) [01GM1520A]; Rescindo Therapeutics, Inc.;  [U01HG006485]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106826] Funding Source: NIH RePORTER	Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research, through the Comprehen-sive Clinical Research Network(National Institute for Health Research (NIHR)); CHROMATIN-Net - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Rescindo Therapeutics, Inc.; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all families for participating in this study. We thank Mr. Z. Kupchinsky for zebrafish husbandry and automated imaging support. Evaluation of subject 3 was through support from U01HG006485 to S.E.P. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. E.E.D. is supported by US NIH grant R01 MH106826. The research team acknowledges the support of the National Institute for Health Research, through the Comprehen-sive Clinical Research Network. S.E.P. is a member of the Scientific Advisory Board (SAB) of Baylor Genetics Laboratories. A.R. is supported by CHROMATIN-Net funded by German Federal Ministry of Education and Research (BMBF, grant number 01GM1520A). N.K. is a paid consultant for and holds significant stock of Rescindo Therapeutics, Inc. Y.Y. is a member of the Scientific Advisory Board (SAB) of Veritas Genetics China. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered by Baylor Genetics.	Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bartnik M, 2014, J APPL GENET, V55, P125, DOI 10.1007/s13353-013-0181-x; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; Bohnsack BL, 2012, INVEST OPHTH VIS SCI, V53, P7, DOI 10.1167/iovs.11-8494; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Buganim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009657; Dai M, 2015, ONCOTARGET, V6, P33878, DOI 10.18632/oncotarget.5302; Dauber A, 2013, AM J HUM GENET, V93, P798, DOI 10.1016/j.ajhg.2013.09.010; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Erter CE, 2001, DEVELOPMENT, V128, P3571; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; French CA, 2003, CANCER RES, V63, P304; Frey WD, 2017, STEM CELL REP, V9, P23, DOI 10.1016/j.stemcr.2017.04.031; Frosk P, 2017, J MED GENET, V54, P490, DOI 10.1136/jmedgenet-2016-104296; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Goller T, 2008, MOL CELL BIOL, V28, P6819, DOI 10.1128/MCB.01058-08; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gong YC, 2017, EUR REV MED PHARMACO, V21, P102; Gordon CT, 2015, AM J HUM GENET, V96, P519, DOI 10.1016/j.ajhg.2015.01.015; Hagman KDF, 2017, GENET MED, V19, P224, DOI 10.1038/gim.2016.95; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Isrie M, 2015, AM J HUM GENET, V97, P790, DOI 10.1016/j.ajhg.2015.10.014; Jones MH, 2000, GENOMICS, V63, P35, DOI 10.1006/geno.1999.6070; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kim HT, 2011, BIOCHEM BIOPH RES CO, V409, P640, DOI 10.1016/j.bbrc.2011.05.056; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Kury S, 2017, AM J HUM GENET, V100, P352, DOI 10.1016/j.ajhg.2017.01.003; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lee JH, 2016, APMIS, V124, P425, DOI 10.1111/apm.12512; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JL, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-4; Ma YQ, 2015, J NEUROSCI, V35, P8493, DOI 10.1523/JNEUROSCI.0377-15.2015; Mayes K, 2017, ONCOTARGET, V8, P64344, DOI 10.18632/oncotarget.17834; Mayes K, 2016, CANCER RES, V76, P6183, DOI 10.1158/0008-5472.CAN-15-3125; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Naud Marie-Emmanuelle, 2017, Case Rep Genet, V2017, P7803136, DOI 10.1155/2017/7803136; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Richart L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10153; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stewart DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098686; Ta-Shma A, 2017, AM J HUM GENET, V100, P666, DOI 10.1016/j.ajhg.2017.02.007; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Vergult S, 2012, EUR J HUM GENET, V20, P534, DOI 10.1038/ejhg.2011.239; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Wang CY, 2015, TRENDS BIOCHEM SCI, V40, P468, DOI 10.1016/j.tibs.2015.06.002; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Wu B, 2016, J IMMUNOL, V197, P4325, DOI 10.4049/jimmunol.1600642; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xiao S, 2015, DIGEST DIS SCI, V60, P910, DOI 10.1007/s10620-014-3411-0; Yan KZ, 2017, AM J HUM GENET, V100, P91, DOI 10.1016/j.ajhg.2016.11.011; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	72	40	42	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					503	515		10.1016/j.ajhg.2017.08.014	http://dx.doi.org/10.1016/j.ajhg.2017.08.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28942966	Green Published, Bronze			2022-12-18	WOS:000412277300002
J	McCall, MN; Illei, PB; Halushka, MK				McCall, Matthew N.; Illei, Peter B.; Halushka, Marc K.			Complex Sources of Variation in Tissue Expression Data: Analysis of the GTEx Lung Transcriptome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; PATTERNS	The sources of gene expression variability in human tissues are thought to be a complex interplay of technical, compositional, and disease-related factors. To better understand these contributions, we investigated expression variability in a relatively homogeneous tissue expression dataset from the Genotype-Tissue Expression (GTEx) resource. In addition to identifying technical sources, such as sequencing date and post-mortem interval, we also identified several biological sources of variation. An in-depth analysis of the 175 genes with the greatest variation among 133 lung tissue samples identified five distinct clusters of highly correlated genes. One large cluster included surfactant genes (SFTPA1, SFTPA2, and SFTPC), which are expressed exclusively in type II pneumocytes, cells that proliferate in ventilator associated lung injury. High surfactant expression was strongly associated with death on a ventilator and type II pneumocyte hyperplasia. A second large cluster included dynein (DNAH9 and DNAH12) and mucin (MUCSB and MUC16) genes, which are exclusive to the respiratory epithelium and goblet cells of bronchial structures. This indicates heterogeneous bronchiole sampling due to the harvesting location in the lung. A small cluster included acute phase reactant genes (SAA1, SAA2, and SAA2-SAA4). The final two small clusters were technical and gender related. To summarize, in a collection of normal lung samples, we found that tissue heterogeneity caused by harvesting location (medial or lateral lung) and late therapeutic intervention (mechanical ventilation) were major contributors to expression variation. These unexpected sources of variation were the result of altered cell ratios in the tissue samples, an underappreciated source of expression variation.	[McCall, Matthew N.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Illei, Peter B.; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA	University of Rochester; Johns Hopkins University	McCall, MN (corresponding author), Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA.; Halushka, MK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA.	mccallm@gmail.com; mhalush1@jhmi.edu			NIH [HG006853]; Amrican Heart Association [13GRNT16420015]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG006853, R00HG006853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amrican Heart Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful to David Tabor for his assistance in obtaining the lung image and many helpful conversations. The authors are grateful to Jeff Struewing for his assistance and encouragement in this project. The authors thank Dan Arking, Alexander Baras, Dongwon Lee, and Aravinda Chakravarti for their helpful critiques of the manuscript. M.N.M. is supported by the NIH (HG006853), and M.K.H. is supported by the American Heart Association (13GRNT16420015).	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cornish Toby C, 2015, J Pathol Inform, V6, P36, DOI 10.4103/2153-3539.159213; DAMATO BE, 1984, BRIT J OPHTHALMOL, V68, P674, DOI 10.1136/bjo.68.9.674; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Gupta S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-26; Halushka MK, 2010, CARDIOVASC PATHOL, V19, P136, DOI 10.1016/j.carpath.2008.12.007; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; HOLM S, 1979, SCAND J STAT, V6, P65; Kent OA, 2014, NUCLEIC ACIDS RES, V42, P7528, DOI 10.1093/nar/gku461; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kitsiouli E, 2009, BBA-MOL BASIS DIS, V1792, P941, DOI 10.1016/j.bbadis.2009.06.007; Klambauer G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt834; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Macgregor AM, 2009, J HISTOCHEM CYTOCHEM, V57, P207, DOI 10.1369/jhc.2008.952531; Majumdar APN, 1997, P SOC EXP BIOL MED, V215, P134, DOI 10.3181/00379727-215-44120; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Quon G, 2009, BIOINFORMATICS, V25, P2882, DOI 10.1093/bioinformatics/btp378; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tong P, 2013, BIOINFORMATICS, V29, P605, DOI 10.1093/bioinformatics/bts713; TSUNO K, 1991, AM REV RESPIR DIS, V143, P1115, DOI 10.1164/ajrccm/143.5_Pt_1.1115; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145; Young B, 2006, WHEATERS FUNCTIONAL	46	40	40	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					624	635		10.1016/j.ajhg.2016.07.007	http://dx.doi.org/10.1016/j.ajhg.2016.07.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27588449	Green Published, Bronze			2022-12-18	WOS:000383114800008
J	Knierim, E; Hirata, H; Wolf, NI; Morales-Gonzalez, S; Schottmann, G; Tanaka, Y; Rudnik-Schoneborn, S; Orgeur, M; Zerres, K; Vogt, S; van Riesen, A; Gill, E; Seifert, F; Zwirner, A; Kirschner, J; Goebel, HH; Hubner, C; Stricker, S; Meierhofer, D; Stenzel, W; Schuelke, M				Knierim, Ellen; Hirata, Hiromi; Wolf, Nicole I.; Morales-Gonzalez, Susanne; Schottmann, Gudrun; Tanaka, Yu; Rudnik-Schoeneborn, Sabine; Orgeur, Mickael; Zerres, Klaus; Vogt, Stefanie; van Riesen, Anne; Gill, Esther; Seifert, Franziska; Zwirner, Angelika; Kirschner, Janbernd; Goebel, Hans Hilmar; Huebner, Christoph; Stricker, Sigmar; Meierhofer, David; Stenzel, Werner; Schuelke, Markus			Mutations in Subunits of the Activating Signal Cointegrator 1 Complex Are Associated with Prenatal Spinal Muscular Atrophy and Congenital Bone Fractures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERUM RESPONSE FACTOR; ARTHROGRYPOSIS MULTIPLEX CONGENITA; TRANSCRIPTION COACTIVATOR; INTELLECTUAL DISABILITY; NEMALINE MYOPATHY; THYROID-HORMONE; RICH PROTEIN; HUMAN BRAIN; GENE; PHENOTYPE	Transcriptional signal cointegrators associate with transcription factors or nuclear receptors and coregulate tissue-specific gene transcription. We report on recessive loss-of-function mutations in two genes (TRIP4 and ASCC1) that encode subunits of the nuclear activating signal cointegrator 1 (ASC-1) complex. We used autozygosity mapping and whole-exome sequencing to search for pathogenic mutations in four families. Affected individuals presented with prenatal-onset spinal muscular atrophy (SMA), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures. We identified homozygous and compound-heterozygous nonsense and frameshift TREP4 and ASCC1 mutations that led to a truncation or the entire absence of the respective proteins and cosegregated with the disease phenotype. Trip4 and Ascc1 have identical expression patterns in 17.5-day-old mouse embryos with high expression levels in the spinal cord, brain, paraspinal ganglia, thyroid, and submandibular glands. Antisense morpholino-mediated knockdown of either trip4 or ascc1 in zebrafish disrupted the highly patterned and coordinated process of a-motoneuron outgrowth and formation of myotomes and neuromuscular junctions and led to a swimming defect in the larvae. Immunoprecipitation of the ASC-1 complex consistently copurified cysteine and glycine rich protein 1 (CSRP1), a transcriptional cofactor, which is known to be involved in spinal cord regeneration upon injury in adult zebrafish. ASCC1 mutant fibroblasts downregulated genes associated with neurogenesis, neuronal migration, and pathfinding (SERPINF1, DAB1, SEMA3D, SEMA3A), as well as with bone development (TNFRSF11B, RASSF2, STC1). Our findings indicate that the dysfunction of a transcriptional coactivator complex can result in a clinical syndrome affecting the neuromuscular system.	[Knierim, Ellen; Morales-Gonzalez, Susanne; Schottmann, Gudrun; van Riesen, Anne; Gill, Esther; Seifert, Franziska; Zwirner, Angelika; Huebner, Christoph; Schuelke, Markus] Charite, Dept Neuropediat, D-10117 Berlin, Germany; [Knierim, Ellen; Morales-Gonzalez, Susanne; Schottmann, Gudrun; Gill, Esther; Seifert, Franziska; Zwirner, Angelika; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Hirata, Hiromi; Tanaka, Yu] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Engn, Sagamihara, Kanagawa 2525258, Japan; [Hirata, Hiromi] Japan Sci & Technol Agcy, Frontier Res Ctr, Natl Inst Genet Precursory Res Embryon Sci & Tech, Mishima, Shizuoka 4118540, Japan; [Wolf, Nicole I.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Neurosci Campus Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Rudnik-Schoeneborn, Sabine; Zerres, Klaus] Rhein Westfal TH Aachen Univ, Inst Human Genet, D-52074 Aachen, Germany; [Rudnik-Schoeneborn, Sabine; Zerres, Klaus] Rhein Westfal TH Aachen Univ, Univ Hosp, D-52074 Aachen, Germany; [Rudnik-Schoeneborn, Sabine] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Orgeur, Mickael; Stricker, Sigmar; Meierhofer, David] Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany; [Vogt, Stefanie] Med Versorgungszentrum Dr Eberhard & Partner, D-44137 Dortmund, Germany; [Kirschner, Janbernd] Univ Med Ctr Freiburg, Dept Neuropediat & Muscle Disorders, D-79106 Freiburg, Germany; [Goebel, Hans Hilmar; Stenzel, Werner] Charite, Dept Neuropathol, D-10117 Berlin, Germany; [Stricker, Sigmar] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Aoyama Gakuin University; Japan Science & Technology Agency (JST); Vrije Universiteit Amsterdam; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Medical University of Innsbruck; Max Planck Society; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Schuelke, M (corresponding author), Charite, Dept Neuropediat, D-10117 Berlin, Germany.; Schuelke, M (corresponding author), Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany.; Hirata, H (corresponding author), Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Engn, Sagamihara, Kanagawa 2525258, Japan.; Hirata, H (corresponding author), Japan Sci & Technol Agcy, Frontier Res Ctr, Natl Inst Genet Precursory Res Embryon Sci & Tech, Mishima, Shizuoka 4118540, Japan.	hihirata@chem.aoyama.ac.jp; markus.schuelke@charite.de	Wolf, Nicole I/H-3943-2014; Stricker, Sigmar/B-9169-2009; Kirschner, Janbernd/H-7418-2016; Meierhofer, David/V-4711-2019; Kirschner, Janbernd/Q-1493-2019	Wolf, Nicole I/0000-0003-1721-0728; Stricker, Sigmar/0000-0002-7174-5363; Kirschner, Janbernd/0000-0003-1618-7386; Meierhofer, David/0000-0002-0170-868X; Kirschner, Janbernd/0000-0003-1618-7386; Stenzel, Werner/0000-0002-1143-2103; Hirata, Hiromi/0000-0002-3769-7441; Schuelke, Markus/0000-0003-2824-3891; Knierim, Ellen/0000-0002-4769-7322; Morales Gonzalez, Susanne/0000-0001-7279-2092	Deutsche Forschungsgemeinschaft (DFG) [SFB 665 TP C4]; Einstein Foundation Berlin [A-2011-63]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25920008]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Suzuken Memorial Foundation; DFG [Ru746/1-2]; Interdisziplinares Zentrum fur Klinische Forschung Aachen [NP 5-4]; Planck Institute for Molecular Genetics; NeuroCure Center of Excellence [Exc 257]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Einstein Foundation Berlin; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; DFG(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung Aachen; Planck Institute for Molecular Genetics; NeuroCure Center of Excellence	We thank the parents and their children for participation at this study, Hannah Pluckhan for excellent technical assistance in electron microscopy, and Beata Lukaszewska-McGreal for LC-MS/MS sample preparation. The project was funded by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB 665 TP C4) and the Einstein Foundation Berlin (A-2011-63) to M.S., the Grant-in-Aid for Scientific Research (25920008) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and funding from the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Naito Foundation, and the Suzuken Memorial Foundation to H.H., by DFG (Ru746/1-2) and Interdisziplinares Zentrum fur Klinische Forschung Aachen (NP 5-4) grants to S.R.S., and by funding from the Planck Institute for Molecular Genetics to D.M. Additionally, M.S. is member of the NeuroCure Center of Excellence (grant no. Exc 257).	Abicht A., 2012, CONGENITAL MYASTHENI; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auboeuf D, 2004, P NATL ACAD SCI USA, V101, P2270, DOI 10.1073/pnas.0308133100; Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Colombo EA, 2014, EUR J HUM GENET, V22, P1298, DOI 10.1038/ejhg.2014.18; Courtens W, 2002, J MED GENET, V39, P74, DOI 10.1136/jmg.39.1.74; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Felderhoff-Mueser U, 2002, J CHILD NEUROL, V17, P718, DOI 10.1177/088307380201700915; Garcia-Angarita N, 2009, NEUROMUSCULAR DISORD, V19, P481, DOI 10.1016/j.nmd.2009.05.001; Garcia-Cabezas MA, 2004, ACTA NEUROPATHOL, V107, P475, DOI 10.1007/s00401-004-0825-3; GREENBERG F, 1988, AM J DIS CHILD, V142, P217, DOI 10.1001/archpedi.1988.02150020119045; Hahm JB, 2013, MOL ENDOCRINOL, V27, P840, DOI 10.1210/me.2012-1117; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; Hall JG, 2014, AM J MED GENET A, V164, P700, DOI 10.1002/ajmg.a.36395; Halliday KE, 2011, CLIN RADIOL, V66, P1049, DOI 10.1016/j.crad.2011.06.001; Hirata H, 2013, AM J HUM GENET, V92, P681, DOI 10.1016/j.ajhg.2013.03.021; Hoff JM, 2011, EUR J OBSTET GYN R B, V159, P347, DOI 10.1016/j.ejogrb.2011.09.027; Iyer LM, 2006, BIOINFORMATICS, V22, P257, DOI 10.1093/bioinformatics/bti767; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kelly TE, 1999, AM J MED GENET, V87, P65, DOI 10.1002/(SICI)1096-8628(19991105)87:1<65::AID-AJMG13>3.0.CO;2-5; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Kuehn H., 2008, CURRENT PROTOCOLS BI, DOI [http://dx.doi.org/10.1002/0471250953, DOI 10.1002/0471250953]; Laquerriere A, 2014, HUM MOL GENET, V23, P2279, DOI 10.1093/hmg/ddt618; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li H., 2013, ARXIV13033997; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Ma LP, 2012, EUR J NEUROSCI, V35, P353, DOI 10.1111/j.1460-9568.2011.07958.x; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Morgan JA, 2010, OBSTET GYNECOL SURV, V65, P249, DOI 10.1097/OGX.0b013e3181dbc50b; Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027; Naganawa Y, 2011, DEV BIOL, V355, P194, DOI 10.1016/j.ydbio.2011.04.027; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; ORIGUCHI Y, 1981, BRAIN DEV-JPN, V3, P395, DOI 10.1016/S0387-7604(81)80068-X; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Roudier MP, 2006, CLIN EXP METASTAS, V23, P167, DOI 10.1007/s10585-006-9026-x; Ruzzi L, 2001, J INVEST DERMATOL, V116, P182, DOI 10.1046/j.1523-1747.2001.00229.x; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Schmid F, 2010, INVEST OPHTH VIS SCI, V51, P1628, DOI 10.1167/iovs.09-4031; SCHRODER JM, 1978, ACTA NEUROPATHOL, V43, P169; Schuelke M, 1998, ACTA NEUROPATHOL, V95, P175, DOI 10.1007/s004010050784; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seelow D, 2012, NUCLEIC ACIDS RES, V40, pW516, DOI 10.1093/nar/gks487; Shaheen R, 2010, AM J HUM GENET, V87, P306, DOI 10.1016/j.ajhg.2010.05.020; SHIELD LK, 1986, ACTA NEUROPATHOL, V70, P60, DOI 10.1007/BF00689515; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sossi V, 2001, EUR J HUM GENET, V9, P113, DOI 10.1038/sj.ejhg.5200599; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Stern S, 2013, J NEUROSCI, V33, P18836, DOI 10.1523/JNEUROSCI.3029-13.2013; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Unterlauft JD, 2012, NEUROCHEM RES, V37, P1524, DOI 10.1007/s11064-012-0747-8; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Van Toorn R, 2002, J CHILD NEUROL, V17, P721, DOI 10.1177/088307380201700916; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Visser WE, 2010, HUM MOL GENET, V19, P4189, DOI 10.1093/hmg/ddq337; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; von Renesse A, 2014, J MED GENET, V51, P275, DOI 10.1136/jmedgenet-2013-102236; WANG XK, 1992, J BIOL CHEM, V267, P9176; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wirtz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018897; Wise GE, 2002, ARCH ORAL BIOL, V47, P247, DOI 10.1016/S0003-9969(01)00109-1	75	40	47	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					473	489		10.1016/j.ajhg.2016.01.006	http://dx.doi.org/10.1016/j.ajhg.2016.01.006			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26924529	Green Published, Bronze			2022-12-18	WOS:000372383100011
J	Palamara, PF; Francioli, LC; Wilton, PR; Genovese, G; Gusev, A; Finucane, HK; Sankararaman, S; Sunyaev, SR; de Bakker, PIW; Wakeley, J; Pe'er, I; Price, AL				Palamara, Pier Francesco; Francioli, Laurent C.; Wilton, Peter R.; Genovese, Giulio; Gusev, Alexander; Finucane, Hilary K.; Sankararaman, Sriram; Sunyaev, Shamil R.; de Bakker, Paul I. W.; Wakeley, John; Pe'er, Itsik; Price, Alkes L.		Genome Netherlands Consortium	Leveraging Distant Relatedness to Quantify Human Mutation and Gene-Conversion Rates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTITY-BY-DESCENT; DE-NOVO MUTATION; HUMAN GENOME; POPULATION HISTORY; GERMLINE MUTATIONS; SEGREGATING SITES; SEQUENCING DATA; RECOMBINATION; COALESCENT; VARIANTS	The rate at which human genomes mutate is a central biological parameter that has many implications for our ability to understand demographic and evolutionary phenomena. We present a method for inferring mutation and gene-conversion rates by using the number of sequence differences observed in identical-by-descent (IBD) segments together with a reconstructed model of recent population-size history. This approach is robust to, and can quantify, the presence of substantial genotyping error, as validated in coalescent simulations. We applied the method to 498 trio-phased sequenced Dutch individuals and inferred a point mutation rate of 1.66 x 10(-8) per base per generation and a rate of 1.26 x 10(-9) for <20 bp indels. By quantifying how estimates varied as a function of allele frequency, we inferred the probability that a site is involved in non-crossover gene conversion as 5.99 x 10(-6). We found that recombination does not have observable mutagenic effects after gene conversion is accounted for and that local gene-conversion rates reflect recombination rates. We detected a strong enrichment of recent deleterious variation among mismatching variants found within IBD regions and observed summary statistics of local sharing of IBD segments to closely match previously proposed metrics of background selection; however, we found no significant effects of selection on our mutation-rate estimates. We detected no evidence of strong variation of mutation rates in a number of genomic annotations obtained from several recent studies. Our analysis suggests that a mutation-rate estimate higher than that reported by recent pedigree-based studies should be adopted in the context of DNA-based demographic reconstruction.	[Palamara, Pier Francesco; Gusev, Alexander; Finucane, Hilary K.; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Palamara, Pier Francesco; Genovese, Giulio; Gusev, Alexander; Finucane, Hilary K.; Sankararaman, Sriram; Sunyaev, Shamil R.; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Francioli, Laurent C.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, NL-3584 CX Utrecht, Netherlands; [Wilton, Peter R.; Wakeley, John] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Genovese, Giulio] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Genovese, Giulio; Sankararaman, Sriram] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02142 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health	Palamara, PF (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ppalama@hsph.harvard.edu	Deelen, Patrick/B-3566-2013; van Leeuwen, Elisabeth/G-3382-2017; Suchiman, H. Eka D./F-5024-2017; Slagboom, P. Eline/R-4790-2016; Beekman, Marian/L-3004-2019; Wijmenga, Cisca/D-2173-2009	Deelen, Patrick/0000-0002-5654-3966; Suchiman, H. Eka D./0000-0002-7168-5516; Slagboom, P. Eline/0000-0002-2875-4723; Beekman, Marian/0000-0003-0585-6206; Willemsen, Gonneke/0000-0003-3755-0236; Karssen, Lennart C./0000-0002-1959-342X; van Enckevort, Esther/0000-0002-2440-3993; Palamara, Pier Francesco/0000-0002-7999-1972; Hehir-Kwa, Jayne/0000-0003-0837-304X; Van Duijn, Cornelia/0000-0002-2374-9204; Schonhuth, Alexander/0000-0003-3529-0856	NIH [R01 MH101244, K99 GM111744]; Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM111744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We express our gratitude to Nick Patterson, Priya Moorjani, Mark Lipson, Amy Williams, and two anonymous reviewers for useful scientific discussions and comments on an early draft and to Ilya Shlyakhter for support with the COSI2 simulator. This research was funded by NIH grant R01 MH101244. H.K.F. was supported by the Fannie and John Hertz Foundation. S.S. was supported by NIH grant K99 GM111744.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albrechtsen A, 2010, GENETICS, V186, P295, DOI 10.1534/genetics.110.113977; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbeithuber B, 2015, P NATL ACAD SCI USA, V112, P2109, DOI 10.1073/pnas.1416622112; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Besenbacher S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6969; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Harris K, 2015, P NATL ACAD SCI USA, V112, P3439, DOI 10.1073/pnas.1418652112; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; He ZW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-535; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hussin JG, 2015, NAT GENET, V47, P400, DOI 10.1038/ng.3216; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kiezun A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003301; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Lipson M., 2015, BIORXIV; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1978, GENETICS, V89, P583; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Palamara P. F., 2014, THESIS COLUMBIA U; Palamara PF, 2013, BIOINFORMATICS, V29, P180, DOI 10.1093/bioinformatics/btt239; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Shlyakhter I, 2014, BIOINFORMATICS, V30, P3427, DOI 10.1093/bioinformatics/btu562; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams AL, 2015, ELIFE, V4, DOI 10.7554/eLife.04637; Wiuf C, 2000, GENETICS, V155, P451	64	40	41	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					775	789		10.1016/j.ajhg.2015.10.006	http://dx.doi.org/10.1016/j.ajhg.2015.10.006			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26581902	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000368437900001
J	Twigg, SRF; Forecki, J; Goos, JAC; Richardson, ICA; Hoogeboom, AJM; van den Ouweland, AMW; Swagemakers, SMA; Lequin, MH; Van Antwerp, D; McGowan, SJ; Westbury, I; Miller, KA; Wall, SA; van der Spek, PJ; Mathijssen, IMJ; Pauws, E; Merzdorf, CS; Wilkie, AOM				Twigg, Stephen R. F.; Forecki, Jennifer; Goos, Jacqueline A. C.; Richardson, Ivy C. A.; Hoogeboom, A. Jeannette M.; van den Ouweland, Ans M. W.; Swagemakers, Sigrid M. A.; Lequin, Maarten H.; Van Antwerp, Daniel; McGowan, Simon J.; Westbury, Isabelle; Miller, Kerry A.; Wall, Steven A.; van der Spek, Peter J.; Mathijssen, Irene M. J.; Pauws, Erwin; Merzdorf, Christa S.; Wilkie, Andrew O. M.		WGS500 Consortium	Gain-of-Function Mutations in ZIC1 Are Associated with Coronal Craniosynostosis and Learning Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DANDY-WALKER MALFORMATION; CREST-MESODERM BOUNDARY; NEURAL CREST; XENOPUS-EMBRYOS; MUTANT MICE; MOUSE MODEL; PROTEIN; GENES; ACTIVATION; DEFECTS	Human ZIC1 (zinc finger protein of cerebellum 1), one of five homologs of the Drosophila pair-rule gene odd-paired, encodes a transcription factor previously implicated in vertebrate brain development. Heterozygous deletions of ZIC1 and its nearby paralog ZIC4 on chromosome 3q25.1 are associated with Dandy-Walker malformation of the cerebellum, and loss of the orthologous Zic1 gene in the mouse causes cerebellar hypoplasia and vertebral defects. We describe individuals from five families with heterozygous mutations located in the final (third) exon of ZIC1 (encoding four nonsense and one missense change) who have a distinct phenotype in which severe craniosynostosis, specifically involving the coronal sutures, and variable learning disability are the most characteristic features. The location of the nonsense mutations predicts escape of mutant ZIC1 transcripts from nonsense-mediated decay, which was confirmed in a cell line from an affected individual. Both nonsense and missense mutations are associated with altered and/or enhanced expression of a target gene, engrailed-2, in a Xenopus embryo assay. Analysis of mouse embryos revealed a localized domain of Zic1 expression at embryonic days 11.5-12.5 in a region overlapping the supraorbital regulatory center, which patterns the coronal suture. We conclude that the human mutations uncover a previously unsuspected role for Zic1 in early cranial suture development, potentially by regulating engrailed 1, which was previously shown to be critical for positioning of the murine coronal suture. The diagnosis of a ZIC1 mutation has significant implications for prognosis and we recommend genetic testing when common causes of coronal synostosis have been excluded.	[Twigg, Stephen R. F.; Westbury, Isabelle; Miller, Kerry A.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Clin Genet Grp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Forecki, Jennifer; Van Antwerp, Daniel; Merzdorf, Christa S.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Goos, Jacqueline A. C.; Mathijssen, Irene M. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Plast Surg, NL-3000 CA Rotterdam, Netherlands; [Richardson, Ivy C. A.; Pauws, Erwin] UCL Inst Child Hlth, Dev Biol & Canc Programme, London WC1N 1EH, England; [Hoogeboom, A. Jeannette M.; van den Ouweland, Ans M. W.] Univ Med Ctr Rotterdam, Dept Clin Genet, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Univ Med Ctr Rotterdam, Dept Bioinformat, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Lequin, Maarten H.] Univ Med Ctr Rotterdam, Dept Pediat Radiol, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [McGowan, Simon J.] Univ Oxford, John Radcliffe Hosp, Computat Biol Res Grp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Wall, Steven A.; Wilkie, Andrew O. M.] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Carniofacial Unit, Oxford OX3 9DU, England	University of Oxford; Montana State University System; Montana State University Bozeman; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Clin Genet Grp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.wilkie@imm.ox.ac.uk	McCarthy, Davis James/B-5332-2018; Knight, Julian Charles/W-2399-2019; Cazier, Jean-Baptiste/GLR-2949-2022; Wilkie, Andrew/AAC-3820-2020; Twigg, Stephen/AAU-1135-2021; Humburg, Peter/A-4191-2009; Pauws, Erwin/J-4848-2019; Kanapin, Alexander A/Q-7590-2016	McCarthy, Davis James/0000-0002-2218-6833; Knight, Julian Charles/0000-0002-0377-5536; Cazier, Jean-Baptiste/0000-0001-7581-9051; Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Humburg, Peter/0000-0002-3331-6496; Pauws, Erwin/0000-0003-1751-0317; Kanapin, Alexander A/0000-0001-9802-5297; Lise, Stefano/0000-0003-4472-6893; McGowan, Simon/0000-0001-9720-1914	National Science Foundation [DBI-1309250, IOS-0846168]; Wellcome Trust [093329, 102731]; Oxford NIHR Biomedical Research Centre; Cancer Research UK [16459] Funding Source: researchfish; Medical Research Council [MC_UU_12010/6] Funding Source: researchfish; Wellcome Trust [102731/Z/13/Z] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W0908] Funding Source: researchfish; Div Of Biological Infrastructure [1309250] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Childrens Charity; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Michael Parker and Julie Phipps for assistance with subject recruitment, Sue Butler for cell culture work, and Geoff Maher and Yan Zhou for preparing and running the PGM libraries. This work was funded by the National Science Foundation (DBI-1309250 to J.F. and IOS-0846168 to C.S.M.), the Wellcome Trust (Project Grant 093329 to A.O.M.W. and S.R.F.T., Senior Investigator award 102731 to A.O.M.W.), and the Oxford NIHR Biomedical Research Centre. Members of the 500 Whole-Genome Sequences (WGS500) Consortium are listed in the Supplemental Data.	Ali RG, 2012, INT J BIOCHEM CELL B, V44, P2065, DOI 10.1016/j.biocel.2012.08.012; Aruga J, 1999, MECH DEVELOP, V89, P141, DOI 10.1016/S0925-4773(99)00220-8; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2006, GENOMICS, V87, P783, DOI 10.1016/j.ygeno.2006.02.011; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; BRADDOCK SR, 1993, AM J MED GENET, V47, P640, DOI 10.1002/ajmg.1320470512; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Chen HX, 1998, DEV GENET, V22, P314, DOI 10.1002/(SICI)1520-6408(1998)22:4<314::AID-DVG2>3.0.CO;2-9; Cowan J, 2014, HUM MUTAT, V35, P66, DOI 10.1002/humu.22457; Deckelbaum RA, 2006, DEVELOPMENT, V133, P63, DOI 10.1242/dev.02171; Deckelbaum RA, 2012, DEVELOPMENT, V139, P1346, DOI 10.1242/dev.076729; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eley KA, 2012, PLAST RECONSTR SURG, V130, p690E, DOI 10.1097/PRS.0b013e318267d5ae; Ferraris A, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-75; Gaston-Massuet C, 2005, DEV DYNAM, V233, P1110, DOI 10.1002/dvdy.20417; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; Kuo JS, 1998, DEVELOPMENT, V125, P2867; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Li SZ, 2006, DEV DYNAM, V235, P2817, DOI 10.1002/dvdy.20896; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Sharma VP, 2013, NAT GENET, V45, P304, DOI 10.1038/ng.2531; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Ting MC, 2009, DEVELOPMENT, V136, P855, DOI 10.1242/dev.028605; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wilkinson D. G., 1998, SITU HYBRIDIZATION P; WURST W, 1994, DEVELOPMENT, V120, P2065; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	50	40	43	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					378	388		10.1016/j.ajhg.2015.07.007	http://dx.doi.org/10.1016/j.ajhg.2015.07.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26340333	Green Published, hybrid			2022-12-18	WOS:000361084700002
J	Marchegiani, S; Davis, T; Tessadori, F; van Haaften, G; Brancati, F; Hoischen, A; Huang, HG; Valkanas, E; Pusey, B; Schanze, D; Venselaar, H; Vulto-van Silfhout, AT; Wolfe, LA; Tifft, CJ; Zerfas, PM; Zambruno, G; Kariminejad, A; Sabbagh-Kermani, F; Lee, J; Tsokos, MG; Lee, CCR; Ferraz, V; da Silva, EM; Stevens, CA; Roche, N; Bartsch, O; Farndon, P; Bermejo-Sanchez, E; Brooks, BP; Maduro, V; Dallapiccola, B; Ramos, FJ; Chung, HYB; Le Caignec, C; Martins, F; Jacyk, WK; Mazzanti, L; Brunner, HG; Bakkers, J; Lin, S; Malicdan, MCV; Boerkoel, CF; Gahl, WA; de Vries, BBA; van Haelst, MM; Zenker, M; Markello, TC				Marchegiani, Shannon; Davis, Taylor; Tessadori, Federico; van Haaften, Gijs; Brancati, Francesco; Hoischen, Alexander; Huang, Haigen; Valkanas, Elise; Pusey, Barbara; Schanze, Denny; Venselaar, Hanka; Vulto-van Silfhout, Anneke T.; Wolfe, Lynne A.; Tifft, Cynthia J.; Zerfas, Patricia M.; Zambruno, Giovanna; Kariminejad, Ariana; Sabbagh-Kermani, Farahnaz; Lee, Janice; Tsokos, Maria G.; Lee, Chyi-Chia R.; Ferraz, Victor; da Silva, Eduarda Morgana; Stevens, Cathy A.; Roche, Nathalie; Bartsch, Oliver; Farndon, Peter; Bermejo-Sanchez, Eva; Brooks, Brian P.; Maduro, Valerie; Dallapiccola, Bruno; Ramos, Feliciano J.; Chung, Hon-Yin Brian; Le Caignec, Cedric; Martins, Fabiana; Jacyk, Witold K.; Mazzanti, Laura; Brunner, Han G.; Bakkers, Jeroen; Lin, Shuo; Malicdan, May Christine V.; Boerkoel, Cornelius F.; Gahl, William A.; de Vries, Bert B. A.; van Haelst, Mieke M.; Zenker, Martin; Markello, Thomas C.			Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MORPHOLOGY STANDARD TERMINOLOGY; EPITHELIAL-MESENCHYMAL TRANSITION; AUTOSOMAL-DOMINANT INHERITANCE; SAETHRE-CHOTZEN SYNDROME; SETLEIS SYNDROME; ATROPHIC SKIN; UNDIAGNOSED DISEASES; TRANSCRIPTION FACTOR; FRAMESHIFT MUTATION; FAMILIAL OCCURRENCE	Ablepharon macrostomia syndrome (AMS) and Barber-Say syndrome (BSS) are rare congenital ectodermal dysplasias characterized by similar clinical features. To establish the genetic basis of AMS and BSS, we performed extensive clinical phenotyping, whole exome and candidate gene sequencing, and functional validations. We identified a recurrent de novo mutation in TWIST2 in seven independent AMS-affected families, as well as another recurrent de novo mutation affecting the same amino acid in ten independent BSS-affected families. Moreover, a genotype-phenotype correlation was observed, because the two syndromes differed based solely upon the nature of the substituting amino acid: a lysine at TWIST2 residue 75 resulted in AMS, whereas a glutamine or alanine yielded BSS. TW1ST2 encodes a basic helix-loop-helix transcription factor that regulates the development of mesenchymal tissues. All identified mutations fell in the basic domain of TWIST2 and altered the DNA-binding pattern of Flag-1'WIST2 in HeLa cells. Comparison of wild-type and mutant TW1ST2 expressed in zebrafish identified abnormal developmental phenotypes and widespread transcriptome changes. Our results suggest that autosomal-dominant TW1ST2 mutations cause AMS or BSS by inducing protean effects on the transcription factor's DNA binding.	[Marchegiani, Shannon; Davis, Taylor; Valkanas, Elise; Pusey, Barbara; Wolfe, Lynne A.; Tifft, Cynthia J.; Maduro, Valerie; Malicdan, May Christine V.; Boerkoel, Cornelius F.; Gahl, William A.; Markello, Thomas C.] NIH, Undiagnosed Dis Program, Common Fund, Off Director, Bethesda, MD 20892 USA; [Marchegiani, Shannon; Davis, Taylor; Valkanas, Elise; Pusey, Barbara; Wolfe, Lynne A.; Tifft, Cynthia J.; Maduro, Valerie; Malicdan, May Christine V.; Boerkoel, Cornelius F.; Gahl, William A.; Markello, Thomas C.] NHGRI, NIH, Bethesda, MD 20892 USA; [Marchegiani, Shannon] Walter Reed Natl Mil Med Ctr, Dept Pediat, Bethesda, MD 20892 USA; [Tessadori, Federico; Bakkers, Jeroen] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Tessadori, Federico; Bakkers, Jeroen] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Haaften, Gijs; van Haelst, Mieke M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Brancati, Francesco] Univ G dAnnunzio Chieti & Pescara, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy; [Hoischen, Alexander; Venselaar, Hanka; Vulto-van Silfhout, Anneke T.; Brunner, Han G.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Huang, Haigen; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Schanze, Denny; Zenker, Martin] Fak Med, D-39120 Magdeburg, Germany; [Schanze, Denny; Zenker, Martin] Univ Klinikum Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany; [Wolfe, Lynne A.; Tifft, Cynthia J.; Malicdan, May Christine V.; Gahl, William A.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Zerfas, Patricia M.] NIH, Off Res Serv, Div Vet Resources, Bethesda, MD 20892 USA; [Zambruno, Giovanna] Ist Dermopat Immacolata IDI IRCCS, Lab Mol & Cell Biol, I-00167 Rome, Italy; [Kariminejad, Ariana] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Sabbagh-Kermani, Farahnaz] Kerman Univ Med Sci, Kerman 76175, Iran; [Lee, Janice] NIDCR, NIH, Bethesda, MD 20892 USA; [Tsokos, Maria G.; Lee, Chyi-Chia R.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA; [Ferraz, Victor; da Silva, Eduarda Morgana] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, BR-14049 Sao Paulo, Brazil; [Stevens, Cathy A.] TC Thompson Childrens Hosp, Dept Med Genet, Chattanooga, TN 37403 USA; [Roche, Nathalie] Univ Hosp Ghent, Dept Plast & Reconstruct Surg, B-9000 Ghent, Belgium; [Bartsch, Oliver] Johannes Gutenberg Univ Mainz, Inst Human Genet, D-55131 Mainz, Germany; [Farndon, Peter] Birmingham Womens Healthcare Trust, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England; [Bermejo-Sanchez, Eva] Inst Salud Carlos III, ECEMC Spanish Collaborat Study Congenital Malform, CIAC, IIER, Madrid 28029, Spain; [Bermejo-Sanchez, Eva] CIBER Enfermedades Raras CIBERER U724, Madrid 28029, Spain; [Brooks, Brian P.] NEI, Unit Pediat Dev & Genet Eye Dis, NIH, Bethesda, MD 20892 USA; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, Dept Med Genet, IRCCS, I-00165 Rome, Italy; [Ramos, Feliciano J.] Univ Zaragoza, GCV CIBERER Hosp Clin Univ Lozano Blesa, Serv Pediat, Unidad Genet Med,Fac Med, E-50009 Zaragoza, Spain; [Chung, Hon-Yin Brian] Univ Hong Kong, LKS Fac Med, Ctr Genom Sci, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Le Caignec, Cedric] INSERM, Fac Med, UMR957, F-44093 Nantes, France; [Martins, Fabiana] Univ Sao Paulo, Sch Dent, Dept Stomatol, Special Care Dent Ctr, BR-05508070 Sao Paulo, Brazil; [Jacyk, Witold K.] Univ Pretoria, Dept Dermatol, ZA-0028 Pretoria, South Africa; [Mazzanti, Laura] Univ Bologna, S Orsola Malpighi Hosp, Dept Pediat, I-40138 Bologna, Italy; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Walter Reed National Military Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; G d'Annunzio University of Chieti-Pescara; Radboud University Nijmegen; University of California System; University of California Los Angeles; University Hospital Magdeburg; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Kerman University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade de Sao Paulo; Ghent University; Ghent University Hospital; Johannes Gutenberg University of Mainz; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); IRCCS Bambino Gesu; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Lozano Blesa University Clinical Hospital; University of Zaragoza; University of Hong Kong; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade de Sao Paulo; University of Pretoria; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Maastricht University	Malicdan, MCV (corresponding author), NIH, Undiagnosed Dis Program, Common Fund, Off Director, Bethesda, MD 20892 USA.	malicdanm@mail.nih.gov; gahlw@helix.nih.gov	AT, Vulto-van Silfhout/H-4199-2015; Venselaar, Hanka/D-2009-2016; Bartsch, Oliver/ABE-2681-2020; Hoischen, Alexander/D-1282-2013; BERMEJO-SANCHEZ, EVA/E-8703-2012; Bakkers, Jeroen/H-5551-2011; mazzanti, laura/K-3368-2016; Roche, Nathalie/GRJ-0574-2022; Hoischen, Alexander/AGF-7293-2022; Roche, Nathalie/L-9874-2019; Brancati, Francesco/AAC-3778-2022; Boerkoel, Cornelius Franciscus/AFW-4948-2022; Brunner, Han/C-9928-2013; Zambruno, Giavanna/K-2933-2018; Malicdan, May Christine/AAK-7422-2021; Roche, Nathalie/GYQ-5132-2022; Le Caignec, Cedric/K-8467-2015; Lee, Chyi-Chia Richard/AAO-1149-2020; Ramos, Feliciano J./ABH-8920-2020; Ferraz, Victor EF/A-8774-2013; Martins, Fabiana/ABG-5745-2020; van Haaften, Gijs/G-7832-2012; Lee, Chyi-Chia/I-1938-2013; Dallapiccola, Bruno/K-8692-2016	Venselaar, Hanka/0000-0001-9824-6559; Hoischen, Alexander/0000-0002-8072-4476; BERMEJO-SANCHEZ, EVA/0000-0001-7282-2714; Bakkers, Jeroen/0000-0002-9418-0422; Hoischen, Alexander/0000-0002-8072-4476; Roche, Nathalie/0000-0001-9241-8583; Brancati, Francesco/0000-0003-3624-2354; Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Le Caignec, Cedric/0000-0002-0598-653X; Ramos, Feliciano J./0000-0002-5732-2209; Ferraz, Victor EF/0000-0003-0337-4588; Martins, Fabiana/0000-0002-4352-7959; van Haaften, Gijs/0000-0003-3033-0329; Zambruno, Giovanna/0000-0002-1295-056X; Tessadori, Federico/0000-0001-9975-0546; Lee, Chyi-Chia/0000-0002-5306-7781; Dallapiccola, Bruno/0000-0002-5031-1013; Kariminejad, Ariana/0000-0002-8467-4728; mazzanti, laura/0000-0002-7670-6494	Intramural Research Program of the NHGRI; Netherlands Organization for Health Research and Development [319 912-12-109]; Wilhelmina Children's Hospital fund; Netherlands Organization for Health Research and Development veni grant [916-12-095]; NATIONAL EYE INSTITUTE [ZIEEY000477] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200352, ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM109908] Funding Source: NIH RePORTER	Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Wilhelmina Children's Hospital fund; Netherlands Organization for Health Research and Development veni grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients, their families, and the treating physicians for their cooperation, encouragement, and interest. This work was supported by the Intramural Research Program of the NHGRI, Netherlands Organization for Health Research and Development grant 319 912-12-109 (B.B.A.d.V.), Wilhelmina Children's Hospital fund (G.v.H.), and Netherlands Organization for Health Research and Development veni grant 916-12-095 (A.H.). One AMS fibroblast cell line was from NICHD Brain and Tissue Bank for Developmental Disorders (N01-HD-4-3368/N01-HD-4-3383). We are grateful to the following: Dr. Michael Wright (Northern Genetics Service, Newcastle upon Tyne Hospitals, UK), Dr. Salmo Raskin (Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba Parana, Brazil), Dr. Donna M. McDonald-McGinn (Clinical Genetics Center, Children's Hospital of Philadelphia), Dr. Edward Cowan (NCI/NIH, Bethesda, MD), Dr. Maria Luisa Martinez-Frias (University Complutense and CIAC/ISCIII, Madrid, Spain), Dr. Elena Campione (Dermatology Unit of Tor Vergata University, Rome, Italy), Dr. Frederic Perez-Alvarez (Hospital Universitari de Girona Dr. Josep Trueta, Spain), Dra. Beatriz Lopez-Garcia (Hospital Quiron-La Floresta, Zaragoza, Spain), Dr. Anthony Liu and Dr. K.Y. Wong (QMH, Hong Kong), Dr. T.Y. Tan (Royal Children's Hospital, Melbourne, Australia), Prof. Marina Gallottini (Department of Stomatology, Dental School of USP, Brazil), Prof. Raoul C.M. Hennekam (Academic Medical Center, University of Amsterdam, the Netherlands), Prof. Wilson Araujo Silva, Jr. (Department of Genetics and Center of Genomic Medicine, Riberao Preto University/Clinical Hospital, Brazil), and Dr. Luis Rohena (San Antonio Military Medical Center, TX). The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, or U.S. Government.	Allanson JE, 2009, AM J MED GENET A, V149A, P6, DOI 10.1002/ajmg.a.32612; Amor DJ, 2001, AM J MED GENET, V103, P252, DOI 10.1002/ajmg.1540; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BARBER N, 1982, SYNDROME IDENT, V8, P6; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Biesecker LG, 2009, AM J MED GENET A, V149A, P93, DOI 10.1002/ajmg.a.32596; Brancati F, 2004, AM J MED GENET A, V127A, P96, DOI 10.1002/ajmg.a.20658; Carey JC, 2009, AM J MED GENET A, V149A, P77, DOI 10.1002/ajmg.a.32602; Cavalcanti DP, 2007, AM J MED GENET A, V143A, P241, DOI 10.1002/ajmg.a.31426; Cervantes-Barragan DE, 2011, J MED GENET, V48, P716, DOI 10.1136/jmedgenet-2011-100251; Cortes FM, 2000, GENET MOL BIOL, V23, P265, DOI 10.1590/S1415-47572000000200003; Cruz AAV, 1995, OPHTHALMIC PLAST REC, V11, P284; Cruz AAV, 2000, ARCH OPHTHALMOL-CHIC, V118, P428; Cullinane AR, 2011, J INVEST DERMATOL, V131, P2017, DOI 10.1038/jid.2011.157; DAVID A, 1991, AM J MED GENET, V39, P112, DOI 10.1002/ajmg.1320390124; Dinulos MB, 1999, AM J MED GENET, V86, P54, DOI 10.1002/(SICI)1096-8628(19990903)86:1<54::AID-AJMG10>3.0.CO;2-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ElGhouzzi V, 1997, NAT GENET, V15, P42; Ferraz VEF, 2000, AM J MED GENET, V94, P281, DOI 10.1002/1096-8628(20001002)94:4<281::AID-AJMG3>3.0.CO;2-S; Floc'h N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072490; Franco HL, 2011, INT J BIOCHEM CELL B, V43, P1523, DOI 10.1016/j.biocel.2011.07.003; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Gasparotto D, 2011, ONCOTARGET, V2, P1165; Girisha KM, 2014, INDIAN J PEDIATR, V81, P302, DOI 10.1007/s12098-013-1253-y; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Hall BD, 2009, AM J MED GENET A, V149A, P29, DOI 10.1002/ajmg.a.32597; Hennekam RCM, 2013, AM J MED GENET A, V161A, P1238, DOI 10.1002/ajmg.a.35934; Hennekam RCM, 2009, AM J MED GENET A, V149A, P61, DOI 10.1002/ajmg.a.32600; HORNBLASS A, 1985, AM J OPHTHALMOL, V99, P552, DOI 10.1016/S0002-9394(14)77956-5; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Hunter A, 2009, AM J MED GENET A, V149A, P40, DOI 10.1002/ajmg.a.32599; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; JACKSON IT, 1988, BRIT J PLAST SURG, V41, P410, DOI 10.1016/0007-1226(88)90084-7; Kallish S, 2011, AM J MED GENET A, V155A, P3060, DOI 10.1002/ajmg.a.34287; Klinger G, 2009, AM J MED GENET A, V149A, P1606, DOI 10.1002/ajmg.a.32893; Lee MS, 2000, BONE, V27, P591, DOI 10.1016/S8756-3282(00)00380-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Markello TC, 2012, MOL GENET METAB, V105, P382, DOI 10.1016/j.ymgme.2011.12.014; Martins F, 2010, AM J MED GENET A, V152A, P2569, DOI 10.1002/ajmg.a.32898; Mazzanti L, 1998, AM J MED GENET, V78, P188, DOI 10.1002/(SICI)1096-8628(19980630)78:2<188::AID-AJMG19>3.0.CO;2-J; MCCARTHY GT, 1977, DEV MED CHILD NEUROL, V19, P659; Ng JD, 2006, OPHTHAL PLAST RECONS, V22, P232, DOI 10.1097/01.iop.0000217575.01061.00; Pellegrino JE, 1996, HUM GENET, V97, P532; PRICE NJ, 1991, BRIT J OPHTHALMOL, V75, P317, DOI 10.1136/bjo.75.5.317; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roche N, 2010, AM J MED GENET A, V152A, P2563, DOI 10.1002/ajmg.a.33622; Rohena L, 2011, AM J MED GENET A, V155A, P850, DOI 10.1002/ajmg.a.33900; Rosti R.O., 2014, CLIN GENET; SANTANA SM, 1993, AM J MED GENET, V47, P20, DOI 10.1002/ajmg.1320470105; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Sod R, 1997, AM J MED GENET, V73, P366; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Sosic D, 2003, CELL CYCLE, V2, P76, DOI 10.4161/cc.2.2.338; Stemple DL, 1996, DEVELOPMENT, V123, P117; Stevens CA, 2002, AM J MED GENET, V107, P30, DOI 10.1002/ajmg.10123; Tenea D, 2006, PEDIATR DERMATOL, V23, P183, DOI 10.1111/j.1525-1470.2006.00210.x; Teng Y, 2014, CLIN EXP METASTAS, V31, P367, DOI 10.1007/s10585-013-9621-6; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; Wang T, 2014, HUM PATHOL, V45, P1839, DOI 10.1016/j.humpath.2014.05.001; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	67	40	43	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					99	110		10.1016/j.ajhg.2015.05.017	http://dx.doi.org/10.1016/j.ajhg.2015.05.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26119818	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000358189500009
J	Scheidecker, S; Etard, C; Haren, L; Stoetzel, C; Hull, S; Arno, G; Plagnol, V; Drunat, S; Passemard, S; Toutain, A; Obringer, C; Koob, M; Geoffroy, V; Marion, V; Strahle, U; Ostergaard, P; Verloes, A; Merdes, A; Moore, AT; Dollfus, H				Scheidecker, Sophie; Etard, Christelle; Haren, Laurence; Stoetzel, Corinne; Hull, Sarah; Arno, Gavin; Plagnol, Vincent; Drunat, Severine; Passemard, Sandrine; Toutain, Annick; Obringer, Cathy; Koob, Meriam; Geoffroy, Veronique; Marion, Vincent; Straehle, Uwe; Ostergaard, Pia; Verloes, Alain; Merdes, Andreas; Moore, Anthony T.; Dollfus, Helene			Mutations in TUBGCP4 Alter Microtubule Organization via the gamma-Tubulin Ring Complex in Autosomal-Recessive Microcephaly with Chorioretinopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZEBRAFISH; CENTROSOME; LYMPHEDEMA; NUCLEATION; PHENOTYPE; VARIANTS; CDK5RAP2; ROD	We have identified TUBGCP4 variants in individuals with autosomal-recessive microcephaly and chorioretinopathy. Whole-exome sequencing performed on one family with two affected siblings and independently on another family with one affected child revealed compound-heterozygous mutations in TUBGCP4. Subsequent Sanger sequencing was performed on a panel of individuals from 12 French families affected by microcephaly and ophthalmic manifestations, and one other individual was identified with compound-heterozygous mutations in TUBGCP4. One synonymous variant was common to all three families and was shown to induce exon skipping; the other mutations were frameshift mutations and a deletion. TUBGCP4 encodes gamma-tubulin complex protein 4, a component belonging to the gamma-tubulin ring complex (gamma-TuRC) and known to regulate the nucleation and organization of microtubules. Functional analysis of individual fibroblasts disclosed reduced levels of the gamma-TuRC, altered nucleation and organization of microtubules, abnormal nuclear shape, and aneuploidy. Moreover, zebrafish treated with morpholinos against tubgcp4 were found to have reduced head volume and eye developmental anomalies with chorioretinal dysplasia. In summary, the identification of TUBGCP4 mutations in individuals with microcephaly and a spectrum of anomalies in eye development, particularly photoreceptor anomalies, provides evidence of an important role for the gamma-TuRC in brain and eye development.	[Scheidecker, Sophie; Stoetzel, Corinne; Obringer, Cathy; Geoffroy, Veronique; Marion, Vincent; Dollfus, Helene] Univ Strasbourg, Strasbourg Med Sch, Inst Genet & Med Alsace, Med Genet Lab,INSERM,U1112, F-67085 Strasbourg, France; [Etard, Christelle; Straehle, Uwe] Karlsruher Inst Technol, Inst Toxikol & Genet Campus Nord, D-76344 Eggenstein Leopoldshafen, Germany; [Haren, Laurence; Merdes, Andreas] Univ Toulouse 3, Ctr Biol Dev, F-31062 Toulouse, France; [Hull, Sarah; Arno, Gavin; Moore, Anthony T.] UCL Inst Ophthalmol, Inherited Eye Dis, London EC1V 9EL, England; [Hull, Sarah; Arno, Gavin; Moore, Anthony T.] Moorfields Eye Hosp, London EC1V 2PD, England; [Plagnol, Vincent] UCL Genet Inst, London WC1E 6BT, England; [Drunat, Severine; Passemard, Sandrine; Verloes, Alain] Ctr Hosp Univ Paris, Hop Robert Debre, Unite Fonct Genet Mol, Dept Genet, F-75019 Paris, France; [Toutain, Annick] CHR Univ Tours, Dept Genet Med, F-37044 Tours, France; [Koob, Meriam] Hop Univ Strasbourg, Serv Radiopediat & Imagerie, F-67098 Strasbourg, France; [Koob, Meriam] Univ Strasbourg, Federat Med Translat Strasbourg, Lab ICube, CNRS,UMR 7357, F-67098 Strasbourg, France; [Ostergaard, Pia] St Georges Univ London, Human Genet Cardiovasc & Cell Sci Inst, London SW17 0RE, England; [Moore, Anthony T.] Great Ormond St Hosp Sick Children, Dept Ophthalmol, London WC1N 3JH, England; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Natl Affect Rares Genet Ophtalmol, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Karlsruhe Institute of Technology; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; St Georges University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dollfus, H (corresponding author), Univ Strasbourg, Strasbourg Med Sch, Inst Genet & Med Alsace, Med Genet Lab,INSERM,U1112, F-67085 Strasbourg, France.	dollfus@unistra.fr	Marion, Vincent/H-9730-2016; Ostergaard, Pia/H-8522-2019; Straehle, Uwe/K-7054-2013; /AAK-8500-2021	Ostergaard, Pia/0000-0002-2190-1356; Marion, Vincent/0000-0002-8271-7376; Toutain, Annick/0000-0002-5999-5300; Geoffroy, Veronique/0000-0002-4149-0857; Dollfus, Helene/0000-0002-2249-895X; obringer, cathy/0000-0002-7349-8749; Plagnol, Vincent/0000-0002-5597-9215; Scheidecker, Sophie/0000-0003-0902-8926	Centre Regional de Genetique Medicale de Strasbourg; Caisse d'Assurance Retraite et de la Sante au Travail Alsace-Moselle; RETINA France; National Institute for Health Research; UCL Institute of Ophthalmology (London); Fight For Sight (London); Rosetrees Trust (Edgware); Agence Nationale de la Recherche; European Commission through IP ZF-Health [FP7-HEALTH-2007-B2]; Interreg Network for Synthetic Biology in the Upper Rhine valley (NSB-Upper Rhine); Biomedical Research Centre at Moorfields Eye Hospital; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish; Fight for Sight [1317/18, 24RP131] Funding Source: researchfish	Centre Regional de Genetique Medicale de Strasbourg; Caisse d'Assurance Retraite et de la Sante au Travail Alsace-Moselle; RETINA France; National Institute for Health Research(National Institute for Health Research (NIHR)); UCL Institute of Ophthalmology (London); Fight For Sight (London); Rosetrees Trust (Edgware); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission through IP ZF-Health; Interreg Network for Synthetic Biology in the Upper Rhine valley (NSB-Upper Rhine); Biomedical Research Centre at Moorfields Eye Hospital; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	We wish to warmly thank the individuals and their families for their participation. We would like to thank Jean-Louis Mandel and the financial support of the Centre Regional de Genetique Medicale de Strasbourg, Caisse d'Assurance Retraite et de la Sante au Travail Alsace-Moselle, and RETINA France. Sequencing was performed by the IGBMC Microarray and Sequencing platform, a member of the "France Genomique'' consortium (ANR-10-INBS-0009). This work was funded in part by the National Institute for Health Research and Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology (London), Fight For Sight (London), Rosetrees Trust (Edgware), and the Agence Nationale de la Recherche (L.H. and A.M.). We are grateful for support from the European Commission through IP ZF-Health (FP7-HEALTH-2007-B2) and the Interreg Network for Synthetic Biology in the Upper Rhine valley (NSB-Upper Rhine, C.E. and U.S.). This work was approved by local ethics committees at Moorfields Eye Hospital, Hopitaux Universitaires de Strasbourg (Strasbourg University Hospital), and Robert Debre Hospital.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397; ALZIAL C, 1980, ANN GENET-PARIS, V23, P91; Biehlmaier O, 2005, EUR J NEUROSCI, V21, P59, DOI 10.1111/j.1460-9568.2004.03830.x; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bouissou A, 2014, EMBO J, V33, P114, DOI 10.1002/embj.201385967; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Issa L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-59; JARMAS AL, 1981, AM J DIS CHILD, V135, P930, DOI 10.1001/archpedi.1981.02130340036013; Jones GE, 2014, EUR J HUM GENET, V22, P881, DOI 10.1038/ejhg.2013.263; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597; Morris AC, 2005, PHYSIOL BEHAV, V86, P306, DOI 10.1016/j.physbeh.2005.08.020; Nguyen TN, 2005, CAN J OPHTHALMOL, V40, P195, DOI 10.1016/S0008-4182(05)80034-1; Novorol C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130065; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Trzupek KM, 2007, AM J MED GENET A, V143A, P1218, DOI 10.1002/ajmg.a.31717; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	28	40	41	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					666	674		10.1016/j.ajhg.2015.02.011	http://dx.doi.org/10.1016/j.ajhg.2015.02.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25817018	Bronze, Green Published			2022-12-18	WOS:000352212600014
J	Li, X; Battle, A; Karczewski, KJ; Zappala, Z; Knowles, DA; Smith, KS; Kukurba, KR; Wu, E; Simon, N; Montgomery, SB				Li, Xin; Battle, Alexis; Karczewski, Konrad J.; Zappala, Zach; Knowles, David A.; Smith, Kevin S.; Kukurba, Kim R.; Wu, Eric; Simon, Noah; Montgomery, Stephen B.			Transcriptome Sequencing of a Large Human Family Identifies the Impact of Rare Noncoding Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION VARIANTS; LOW-FREQUENCY; FUNCTIONAL VARIATION; ANNOTATION; ARCHITECTURE; ACCURATE; MUTATION; REVEALS; GENOMES; EXCESS	Recent and rapid human population growth has led to an excess of rare genetic variants that are expected to contribute to an individual's genetic burden of disease risk. To date, much of the focus has been on rare protein-coding variants, for which potential impact can be estimated from the genetic code, but determining the impact of rare noncoding variants has been more challenging. To improve our understanding of such variants, we combined high-quality genome sequencing and RNA sequencing data from a 17-individual, three-generation family to contrast expression quantitative trait loci (eQTLs) and splicing quantitative trait loci (sQTLs) within this family to eQTLs and sQTLs within a population sample. Using this design, we found that eQTLs and sQTLs with large effects in the family were enriched with rare regulatory and splicing variants (minor allele frequency < 0.01). They were also more likely to influence essential genes and genes involved in complex disease. In addition, we tested the capacity of diverse noncoding annotation to predict the impact of rare noncoding variants. We found that distance to the transcription start site, evolutionary constraint, and epigenetic annotation were considerably more informative for predicting the impact of rare variants than for predicting the impact of common variants. These results highlight that rare noncoding variants are important contributors to individual gene-expression profiles and further demonstrate a significant capability for genomic annotation to predict the impact of rare noncoding variants.	[Li, Xin; Smith, Kevin S.; Wu, Eric; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Battle, Alexis; Karczewski, Konrad J.; Zappala, Zach; Kukurba, Kim R.; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Battle, Alexis; Knowles, David A.; Montgomery, Stephen B.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Simon, Noah] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle	Li, X (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	xxli@stanford.edu; smontgom@stanford.edu	; Karczewski, Jakub/L-7326-2018	Karczewski, Konrad/0000-0003-2878-4671; Montgomery, Stephen/0000-0002-5200-3903; Li, Xin/0000-0002-2122-7461; Karczewski, Jakub/0000-0001-9322-7842	Edward Mallinckrodt, Jr. Foundation; Li Ka Shing Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation; Li Ka Shing Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank Tomas Babak, Christopher Brown, Hunter Fraser, Arend Sidow, and members of the S.B.M. lab for critical review of this work-and manuscript. This work was supported by the Edward Mallinckrodt, Jr. Foundation and the Li Ka Shing Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2010, BIOINFORMATICS, V26, pi191, DOI 10.1093/bioinformatics/btq222; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Panoutsopoulou K, 2013, HUM MOL GENET, V22, pR16, DOI 10.1093/hmg/ddt376; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537	47	40	40	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					245	256		10.1016/j.ajhg.2014.08.004	http://dx.doi.org/10.1016/j.ajhg.2014.08.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25192044	Green Published, hybrid			2022-12-18	WOS:000341404100001
J	Hildick-Smith, GJ; Cooney, JD; Garone, C; Kremer, LS; Haack, TB; Thon, JN; Miyata, N; Lieber, DS; Calvo, SE; Akman, HO; Yien, YY; Huston, NC; Branco, DS; Shah, DI; Freedman, ML; Koehler, CM; Italiano, JE; Merkenschlager, A; Beblo, S; Strom, TM; Meitinger, T; Freisinger, P; Donati, MA; Prokisch, H; Mootha, VK; DiMauro, S; Paw, BH				Hildick-Smith, Gordon J.; Cooney, Jeffrey D.; Garone, Caterina; Kremer, Laura S.; Haack, Tobias B.; Thon, Jonathan N.; Miyata, Non; Lieber, Daniel S.; Calvo, Sarah E.; Akman, H. Orhan; Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Shah, Dhvanit I.; Freedman, Matthew L.; Koehler, Carla M.; Italiano, Joseph E., Jr.; Merkenschlager, Andreas; Beblo, Skadi; Strom, Tim M.; Meitinger, Thomas; Freisinger, Peter; Donati, M. Alice; Prokisch, Holger; Mootha, Vamsi K.; DiMauro, Salvatore; Paw, Barry H.			Macrocytic Anemia and Mitochondriopathy Resulting from a Defect in Sideroflexin 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME; DISORDERS; MUTATIONS; DISEASE; PROTEIN; GENE; IDENTIFICATION; DEFICIENCY; CONSORTIUM; COBALAMIN	We used exome sequencing to identify mutations in sideroflexin 4 (SFXN4) in two children with mitochondrial disease (the more severe case also presented with macrocytic anemia). SFXN4 is an uncharacterized mitochondrial protein that localizes to the mitochondrial inner membrane. sfxn4 knockdown in zebrafish recapitulated-the mitochondrial respiratory defect observed in both individuals and the macrocytic anemia with megaloblastic features of the more severe case. In vitro and in vivo complementation studies with fibroblasts from the affected individuals and zebrafish demonstrated the requirement of SFXN4 for mitochondrial respiratory homeostasis and erythropoiesis. Our findings establish mutations in SFXN4 as a cause of mitochondriopathy and macrocytic anemia.	[Hildick-Smith, Gordon J.; Cooney, Jeffrey D.; Thon, Jonathan N.; Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Shah, Dhvanit I.; Italiano, Joseph E., Jr.; Paw, Barry H.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Hildick-Smith, Gordon J.; Cooney, Jeffrey D.; Thon, Jonathan N.; Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Shah, Dhvanit I.; Freedman, Matthew L.; Italiano, Joseph E., Jr.; Paw, Barry H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Garone, Caterina; Akman, H. Orhan; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Kremer, Laura S.; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80333 Munich, Germany; [Kremer, Laura S.; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Miyata, Non; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lieber, Daniel S.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lieber, Daniel S.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lieber, Daniel S.; Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lieber, Daniel S.; Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Merkenschlager, Andreas] Univ Leipzig, Univ Hosp Children & Adolescents, Dept Neuropediat, D-04103 Leipzig, Germany; [Beblo, Skadi] Univ Leipzig, Univ Hosp Children & Adolescents, Dept Inborn Metab Dis, D-04103 Leipzig, Germany; [Freisinger, Peter] Kinderklin Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Donati, M. Alice] Meyer Children Hosp, Unit Metab & Muscular Dis, I-50132 Florence, Italy; [Paw, Barry H.] Boston Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; [Paw, Barry H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Leipzig University; Leipzig University; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Paw, BH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	bpaw@rics.bwh.harvard.edu	Garone, Caterina/AAB-8659-2019; Prokisch, Holger/N-8964-2013; Meitinger, Thomas/O-1318-2015	Garone, Caterina/0000-0003-4928-1037; MARIA ALICE, DONATI/0000-0003-4769-5025; Shah, Dhvanit/0000-0002-3173-2402; Prokisch, Holger/0000-0003-2379-6286; Thon, Jonathan/0000-0002-7969-7001; Meitinger, Thomas/0000-0002-8838-8403; Paw, Barry/0000-0002-0492-1419; Kremer, Laura/0000-0002-1647-7538	American Heart Association; American Society of Hematology; Cooley's Anemia Foundation; March of Dimes Foundation [6-FY09-289]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; GENOMIT; Marriott Mitochondrial Disorders Clinical Research Fund; MEET; MitoNET; National Institutes of Health [K01 DK085217, T32 HL007574, F32 DK098866, R01 GM61721, R01 GM097136, P01 HD032062, R01 DK070838, P01 HL032262]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068130, P01HL032262, K99HL114719, T32HL007574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085217, F32DK098866, K01DK106156, R03DK118307, R01DK070838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM097136] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Hematology; Cooley's Anemia Foundation; March of Dimes Foundation(March of Dimes); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); GENOMIT; Marriott Mitochondrial Disorders Clinical Research Fund; MEET; MitoNET; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the individuals described in our study and families for their participation. We thank members of our respective labs (Caiyong Chen and Jacky Chung) and Samuel E. Lux IV, H. Franklin Bunn, David G. Nathan, and Ellis J. Neufeld for critical feedback on the manuscript. We thank Leonard Zon for the Tg(globin-LCR:eGFP) transgenic line, Karin Hoffmeister for the use of the fluorescence-activated cell sorting machine, Caiyong Chen for protein technical advice, Ramiro Massol for confocal microscopy imaging, and Christian Lawrence and his team for the zebrafish husbandry. Fluorescence confocal microscopy was performed at the Harvard Digestive Disease Center Imaging Facility (Boston Children's Hospital). This work was supported by grants from the American Heart Association (J.D.C.), the American Society of Hematology (G.J.H.-S., J.D.C.), Cooley's Anemia Foundation (D.I.S.), the March of Dimes Foundation (6-FY09-289, B.H.P.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (D.S.B.), GENOMIT (H.P.), the Marriott Mitochondrial Disorders Clinical Research Fund (V.K.M., S.D.), MEET (H.P.), MitoNET (H.P.), and the National Institutes of Health (K01 DK085217, D.I.S.; T32 HL007574 and F32 DK098866, Y.Y.Y.; R01 GM61721, C.M.K.; R01 GM097136, V.K.M.; P01 HD032062, S.D.M.; R01 DK070838 and P01 HL032262, B.H.P.).	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244; Blanc L, 2012, P NATL ACAD SCI USA, V109, P12099, DOI 10.1073/pnas.1204948109; Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cooney JD, 2013, DEV BIOL, V373, P431, DOI 10.1016/j.ydbio.2012.08.015; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Fay FS, 1997, EXP CELL RES, V231, P27, DOI 10.1006/excr.1996.3460; Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582; Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676; Fleming MD, 2001, GENE DEV, V15, P652, DOI 10.1101/gad.873001; Foo JN, 2012, NAT REV NEUROL, V8, P508, DOI 10.1038/nrneurol.2012.148; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hegde S, 2007, MAMM GENOME, V18, P852, DOI 10.1007/s00335-007-9074-9; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ma Y, 2012, FOOD CHEM TOXICOL, V50, P2854, DOI 10.1016/j.fct.2012.04.037; Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005; Miyake S, 2002, BIOCHEM BIOPH RES CO, V295, P463, DOI 10.1016/S0006-291X(02)00694-0; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1990, J BIOL CHEM, V265, P9452; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056985	43	40	42	2	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					906	914		10.1016/j.ajhg.2013.09.011	http://dx.doi.org/10.1016/j.ajhg.2013.09.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24119684	Bronze, Green Published			2022-12-18	WOS:000326996600011
J	Chong, JX; Ouwenga, R; Anderson, RL; Waggoner, DJ; Ober, C				Chong, Jessica X.; Ouwenga, Rebecca; Anderson, Rebecca L.; Waggoner, Darrel J.; Ober, Carole			A Population-Based Study of Autosomal-Recessive Disease-Causing Mutations in a Founder Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUTTERITE POPULATION; RESTRICTIVE DERMOPATHY; CYSTIC-FIBROSIS; GENE; COMMON; IDENTIFICATION; TRAITS; ASSOCIATION; CHROMOSOME; VARIANTS	The decreasing cost of whole-genome and whole-exome sequencing has resulted in a renaissance for identifying Mendelian disease mutations, and for the first time it is possible to survey the distribution and characteristics of these mutations in large population samples. We conducted carrier screening for all autosomal-recessive (AR) mutations known to be present in members of a founder population and revealed surprisingly high carrier frequencies for many of these mutations. By utilizing the rich demographic, genetic, and phenotypic data available on these subjects and simulations in the exact pedigree that these individuals belong to, we show that the majority of mutations were most likely introduced into the population by a single founder and then drifted to the high carrier frequencies observed. We further show that although there is an increased incidence of AR diseases overall, the mean carrier burden is likely to be lower in the Hutterites than in the general population. Finally, on the basis of simulations, we predict the presence of 30 or more undiscovered recessive mutations among these subjects, and this would at least double the number of AR diseases that have been reported in this isolated population.	[Chong, Jessica X.; Ouwenga, Rebecca; Anderson, Rebecca L.; Waggoner, Darrel J.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Waggoner, Darrel J.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Chong, JX (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jxchong@uchicago.edu; c-ober@bsd.uchicago.edu	Chong, Jessica/GZH-1625-2022	Chong, Jessica/0000-0002-1616-2448; Ober, Carole/0000-0003-4626-9809	National Heart, Lung, and Blood Institute (NHLBI);  [R01 HD21244];  [R01 HL085197]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Gerald Salen (University of Medicine and Dentistry of NJ) and David Mymin (University of Manitoba, Winnipeg) for conducting clinical studies in the individuals with sitosterolemia; Soma Das for providing PCR primers for GJB2; Mark Abney, Graeme Bell, Nancy Cox, and Lawrence Uricchio for helpful discussions; Brent Werness for mathematical assistance and suggestions; and the Hutterites for their continued participation in our studies. This research was supported in part by grants R01 HD21244 and R01 HL085197 and the National Heart, Lung, and Blood Institute (NHLBI)-funded Exome Sequencing Service at the Broad Institute.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bourgain C, 2004, GENETICS, V168, P2349, DOI 10.1534/genetics.104.031617; Boycott KM, 2008, AM J MED GENET A, V146A, P1088, DOI 10.1002/ajmg.a.32245; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; CHASE GA, 1972, AM J HUM GENET, V24, P339; Chong JX, 2011, EUR J HUM GENET, V19, P1045, DOI 10.1038/ejhg.2011.85; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Durst R, 2001, AM J HUM GENET, V68, P1172, DOI 10.1086/320123; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Frosk P, 2005, HUM MUTAT, V25, P38, DOI 10.1002/humu.20110; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Hendrickson BC, 2009, J MED GENET, V46, P641, DOI 10.1136/jmg.2009.066969; Heyer E, 1999, HUM BIOL, V71, P99; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hostetler J, 1974, HUTTERITE SOC; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Innes AM, 2010, CLIN GENET, V78, P424, DOI 10.1111/j.1399-0004.2010.01481.x; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; KIMURA M, 1963, GENETICS, V48, P1303; Kosova G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000974; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Loucks C, 2012, AM J MED GENET A, V158A, P1229, DOI 10.1002/ajmg.a.35302; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; MCKUSICK VA, 1973, ISRAEL J MED SCI, V9, P1276; Morais P, 2009, EUR J PEDIATR, V168, P1007, DOI 10.1007/s00431-008-0868-x; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; Mymin D, 2003, CIRCULATION, V107, P791, DOI 10.1161/01.CIR.0000050545.21826.AD; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OBER C, 1987, AM J HUM GENET, V41, P1145; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Peltonen L, 1997, ANN MED, V29, P553, DOI 10.3109/07853899709007481; Pichler I, 2010, EUR J HUM GENET, V18, P463, DOI 10.1038/ejhg.2009.172; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Schoser BGH, 2005, ANN NEUROL, V57, P591, DOI 10.1002/ana.20441; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; STEINBERG ARTHUR G., 1967, P267; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Stuhrmann M, 1997, CLIN GENET, V52, P240; Uricchio LH, 2012, GENET EPIDEMIOL, V36, P312, DOI 10.1002/gepi.21623; WAGENER D, 1978, AM J HUM GENET, V30, P262; Wang J, 2004, J LIPID RES, V45, P2361, DOI 10.1194/jlr.M400310-JLR200; ZIELENSKI J, 1993, AM J HUM GENET, V52, P609	56	40	43	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					608	620		10.1016/j.ajhg.2012.08.007	http://dx.doi.org/10.1016/j.ajhg.2012.08.007			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	22981120	Green Published, Bronze			2022-12-18	WOS:000309568500003
J	Ko, WY; Kaercher, KA; Giombini, E; Marcatili, P; Froment, A; Ibrahim, M; Lema, G; Nyambo, TB; Omar, SA; Wambebe, C; Ranciaro, A; Hirbo, JB; Tishkoff, SA				Ko, Wen-Ya; Kaercher, Kristin A.; Giombini, Emanuela; Marcatili, Paolo; Froment, Alain; Ibrahim, Muntaser; Lema, Godfrey; Nyambo, Thomas B.; Omar, Sabah A.; Wambebe, Charles; Ranciaro, Alessia; Hirbo, Jibril B.; Tishkoff, Sarah A.			Effects of Natural Selection and Gene Conversion on the Evolution of Human Glycophorins Coding for MNS Blood Polymorphisms in Malaria-Endemic African Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMODIUM-FALCIPARUM; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; HAPLOTYPE RECONSTRUCTION; NUCLEOTIDE SUBSTITUTION; OVERDOMINANT SELECTION; STRUCTURE PREDICTION; STATISTICAL-METHOD; DNA POLYMORPHISM; RECOMBINATION	Malaria has been a very strong selection pressure in recent human evolution, particularly in Africa. Of the one million deaths per year due to malaria, more than 90% are in sub-Saharan Africa, a region with high levels of genetic variation and population substructure. However, there have been few studies of nucleotide variation at genetic loci that are relevant to malaria susceptibility across geographically and genetically diverse ethnic groups in Africa. Invasion of erythrocytes by Plasmodium falciparum parasites is central to the pathology of malaria. Glycophorin A (GYPA) and B (GYPB), which determine MN and Ss blood types, are two major receptors that are expressed on erythrocyte surfaces and interact with parasite ligands. We analyzed nucleotide diversity of the glycophorin gene family in 15 African populations with different levels of malaria exposure. High levels of nucleotide diversity and gene conversion were found at these genes. We observed divergent patterns of genetic variation between these duplicated genes and between different extracellular domains of GYPA. Specifically, we identified fixed adaptive changes at exons 3-4 of GYPA. By contrast, we observed an allele frequency spectrum skewed toward a significant excess of intermediate-frequency alleles at GYPA exon 2 in many populations; the degree of spectrum distortion is correlated with malaria exposure, possibly because of the joint effects of gene conversion and balancing selection. We also identified a haplotype causing three amino acid changes in the extracellular domain of glycophorin B. This haplotype might have evolved adaptively in five populations with high exposure to malaria.	[Ko, Wen-Ya; Kaercher, Kristin A.; Ranciaro, Alessia; Hirbo, Jibril B.; Tishkoff, Sarah A.] Univ Penn, Sch Med, Dept Genet & Biol, Philadelphia, PA 19104 USA; [Ko, Wen-Ya; Kaercher, Kristin A.; Ranciaro, Alessia; Hirbo, Jibril B.; Tishkoff, Sarah A.] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Giombini, Emanuela; Marcatili, Paolo] Univ Roma La Sapienza, Dept Biochem Sci Rossi Fanelli, I-00185 Rome, Italy; [Froment, Alain] Museum Natl Hist Nat, Inst Rech Dev, UMR 208, F-75116 Paris, France; [Ibrahim, Muntaser] Univ Khartoum, Dept Mol Biol, Inst Endem Dis, Khartoum 15, Sudan; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Omar, Sabah A.] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi 5484000200, Kenya; [Wambebe, Charles] Int Biomed Res Afr, Abuja, Nigeria	University of Pennsylvania; University of Pennsylvania; Sapienza University Rome; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Khartoum; Muhimbili University of Health & Allied Sciences; Kenya Medical Research Institute	Tishkoff, SA (corresponding author), Univ Penn, Sch Med, Dept Genet & Biol, Philadelphia, PA 19104 USA.	tishkoff@mail.med.upenn.edu	Giombini, Emanuela/AAB-6073-2020; Marcatili, Paolo/G-9673-2016; Giombini, emanuela/K-3894-2016	Giombini, Emanuela/0000-0003-2237-9755; Giombini, emanuela/0000-0003-2237-9755; Hirbo, Jibril/0000-0002-8932-7311; Marcatili, Paolo/0000-0003-2615-5695	Human Frontiers in Science [050913-8931]; National Science Foundation [BCS 0196183, BCS-0827436]; National Institutes of Health [R01GM076637, DP1-OD-006445-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006445] Funding Source: NIH RePORTER	Human Frontiers in Science; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Andrew Clark, Char la Lambert, Joseph Lachance, and Laura Scheinfeldt for their insightful comments on the manuscript. We thank Bill Beggs and Karuna Panchapakesan for their technical assistance. We also thank Karen Carleton at the University of Maryland for her valuable suggestions on designing the real-time PCR experiments. We are grateful to Cheng-Han Huang at New York Blood Center for generously providing MM and MN blood-type DNA samples. We thank Ajit Varki for his valuable comments on the biology of sialic acids. This research is funded by Human Frontiers in Science grant 050913-8931, National Science Foundation grants BCS 0196183 and BCS-0827436, and National Institutes of Health grants R01GM076637 and DP1-OD-006445-01 to S.A.T.	Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; AKASHI H, 1995, GENETICS, V139, P1067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1984, AM NAT; ANSTEE DJ, 1990, J IMMUNOGENET, V17, P219; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLUMENFELD, 1995, HUM MUTAT, V6, P199; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Denomme GA, 2004, TRANSFUS MED REV, V18, P203, DOI 10.1016/j.tmrv.2004.03.006; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Hartl DL, 1996, J THEOR BIOL, V182, P303, DOI 10.1006/jtbi.1996.0168; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Innan H, 2003, GENETICS, V163, P803; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Kelly JK, 1997, GENETICS, V146, P1197; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Ohta T, 2000, PHILOS T R SOC B, V355, P1623, DOI 10.1098/rstb.2000.0724; Ohta T, 2010, GENES-BASEL, V1, P349, DOI 10.3390/genes1030349; Padhukasahasram B, 2004, AM J HUM GENET, V75, P386, DOI 10.1086/423451; PASVOL G, 1982, NATURE, V297, P64, DOI 10.1038/297064a0; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; REARDEN A, 1993, J BIOL CHEM, V268, P2260; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stauffer RL, 2001, J HERED, V92, P469, DOI 10.1093/jhered/92.6.469; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; *WHO, 2008, 190 WHO; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xie SS, 1997, BIOCHEM GENET, V35, P59, DOI 10.1023/A:1022212630370; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	67	40	41	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					741	754		10.1016/j.ajhg.2011.05.005	http://dx.doi.org/10.1016/j.ajhg.2011.05.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21664997	Green Published, Bronze			2022-12-18	WOS:000291768500006
J	Zhang, ML; Zhu, C; Jacomy, A; Lu, LJ; Jegga, AG				Zhang, Minlu; Zhu, Cheng; Jacomy, Alexis; Lu, Long J.; Jegga, Anil G.			The Orphan Disease Networks	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE DISEASES; GENES; DISCOVERY; DATABASE; BIOLOGY; DRUGS; TOOLS	The low prevalence rate of orphan diseases (OD) requires special combined efforts to improve diagnosis, prevention, and discovery of novel therapeutic strategies. To identify and investigate relationships based on shared genes or shared functional features, we have conducted a bioinformatic-based global analysis of all orphan diseases with known disease-causing mutant genes. Starting with a bipartite network of known OD and OD-causing mutant genes and using the human protein interactome, we first construct and topologically analyze three networks: the orphan disease network, the orphan disease-causing mutant gene network, and the orphan disease-causing mutant gene interactome. Our results demonstrate that in contrast to the common disease-causing mutant genes that are predominantly nonessential, a majority of orphan disease-causing mutant genes are essential. In confirmation of this finding, we found that OD-causing mutant genes are topologically important in the protein interactome and are ubiquitously expressed. Additionally, functional enrichment analysis of those genes in which mutations cause ODs shows that a majority result in premature death or are lethal in the orthologous mouse gene knockout models. To address the limitations of traditional gene-based disease networks, we also construct and analyze OD networks on the basis of shared enriched features (biological processes, cellular components, pathways, phenotypes, and literature citations). Analyzing these functionally-linked OD networks, we identified several additional OD-OD relations that are both phenotypically similar and phenotypically diverse. Surprisingly, we observed that the wiring of the gene-based and other feature-based OD networks are largely different; this suggests that the relationship between ODs cannot be fully captured by the gene-based network alone.	[Zhang, Minlu; Zhu, Cheng; Lu, Long J.; Jegga, Anil G.] Univ Cincinnati, Dept Comp Sci, Cincinnati, OH 45229 USA; [Lu, Long J.; Jegga, Anil G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Minlu; Lu, Long J.; Jegga, Anil G.] Cincinnati Childrens Hosp, Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Jacomy, Alexis] WebAtlas, Gephi, F-75011 Paris, France	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Jegga, AG (corresponding author), Univ Cincinnati, Dept Comp Sci, Cincinnati, OH 45229 USA.	anil.jegga@cchmc.org	Jegga, Anil/H-6140-2011; lu, lu/HGA-0894-2022; Zhu, Cheng/D-6327-2016	Jegga, Anil/0000-0002-4881-7752; 	Cincinnati Digestive Health Sciences Center [P30 DK078392]; Cincinnati Children's Hospital Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Cincinnati Digestive Health Sciences Center; Cincinnati Children's Hospital Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Orphanet team for providing us with the data. We thank Thomas Boat and John Hutton for useful comments and scientific discussions on the manuscript. We acknowledge the help of Ron Bryson for language editing. This work was supported in part by Cincinnati Digestive Health Sciences Center (Public Health Service Grant P30 DK078392) and Cincinnati Children's Hospital Medical Center.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ayme S, 2007, BUNDESGESUNDHEITSBLA, V50, P1477, DOI 10.1007/s00103-007-0381-9; Ayme Segolene, 2003, Soins, P46; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bastian M, 2009, INT AAAI C WEBLOGS S, DOI DOI 10.13140/2.1.1341.1520; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Dear JW, 2006, BRIT J CLIN PHARMACO, V62, P264, DOI 10.1111/j.1365-2125.2006.02654.x; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Field M. J., 2010, RARE DIS ORPHAN PROD; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Heemstra HE, 2009, DRUG DISCOV TODAY, V14, P1166, DOI 10.1016/j.drudis.2009.09.008; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Oti M, 2009, AM J HUM GENET, V85, P801, DOI 10.1016/j.ajhg.2009.10.026; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Remuzzi G, 2008, LANCET, V371, P1978, DOI 10.1016/S0140-6736(08)60847-8; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stolk P, 2006, B WORLD HEALTH ORGAN, V84, P745, DOI 10.2471/BLT.06.031518; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yip KY, 2006, BIOINFORMATICS, V22, P2968, DOI 10.1093/bioinformatics/btl488; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	41	40	40	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					755	766		10.1016/j.ajhg.2011.05.006	http://dx.doi.org/10.1016/j.ajhg.2011.05.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21664998	Green Published, Bronze			2022-12-18	WOS:000291768500007
J	Zhu, HW; Shang, DD; Sun, M; Choi, SJ; Liu, Q; Hao, JJ; Figuera, LE; Zhang, F; Choy, KW; Ao, Y; Liu, Y; Zhang, XL; Yue, FZ; Wang, MR; Jin, L; Patel, PI; Jing, T; Zhang, X				Zhu, Hongwen; Shang, Dandan; Sun, Miao; Choi, Sunju; Liu, Qing; Hao, Jiajie; Figuera, Luis E.; Zhang, Feng; Choy, Kwong Wai; Ao, Yang; Liu, Yang; Zhang, Xiao-Lin; Yue, Fengzhen; Wang, Ming-Rong; Jin, Li; Patel, Pragna I.; Jing, Tao; Zhang, Xue			X-Linked Congenital Hypertrichosis Syndrome Is Associated with Interchromosomal Insertions Mediated by a Human-Specific Palindrome near SOX3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE OVARIAN FAILURE; INTERSTITIAL DELETION; HUMAN GENOME; STEM-CELLS; GENE; MICE; IDENTIFICATION; TRANSLOCATION; DISEASE; TRAIT	X-linked congenital generalized hypertrichosis (CGH), an extremely rare condition characterized by universal overgrowth of terminal hair, was first mapped to chromosome Xq24-q27.1 in a Mexican family. However, the underlying genetic defect remains unknown. We ascertained a large Chinese family with an X-linked congenital hypertrichosis syndrome combining CGH, scoliosis, and spina bifida and mapped the disease locus to a 5.6 Mb critical region within the interval defined by the previously reported Mexican family. Through the combination of a high-resolution copy-number variation (CNV) scan and targeted genomic sequencing, we identified an interchromosomal insertion at Xq27.1 of a 125,577 bp intragenic fragment of COL23A1 on 5q35.3, with one X breakpoint within and the other very close to a human-specific short palindromic sequence located 82 kb downstream of SOX3. In the Mexican family, we found an interchromosomal insertion at the same Xq27.1 site of a 300,036 bp genomic fragment on 4q31.2, encompassing PRMT10 and TMEM184C and involving parts of ARHGAP10 and EDNRA. Notably, both of the two X breakpoints were within the short palindrome. The two palindrome-mediated insertions fully segregate with the CGH phenotype in each of the families, and the CNV gains of the respective autosomal genomic segments are not present in the public database and were not found in 1274 control individuals. Analysis of control individuals revealed deletions ranging from 173 bp to 9104 bp at the site of the insertions with no phenotypic consequence. Taken together, our results strongly support the pathogenicity of the identified insertions and establish X-linked congenital hypertrichosis syndrome as a genomic disorder.	[Zhu, Hongwen; Shang, Dandan; Sun, Miao; Liu, Qing; Ao, Yang; Zhang, Xiao-Lin; Zhang, Xue] Chinese Acad Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China; [Zhu, Hongwen; Shang, Dandan; Sun, Miao; Liu, Qing; Ao, Yang; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhu, Hongwen; Shang, Dandan; Sun, Miao; Liu, Qing; Ao, Yang; Zhang, Xue] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zhu, Hongwen; Yue, Fengzhen; Jing, Tao] Lanzhou Univ, Sch Basic Med Sci, Ctr Genet Med, Lanzhou 730000, Peoples R China; [Choi, Sunju; Patel, Pragna I.] Univ So Calif, Inst Genet Med, Los Angeles, CA 90033 USA; [Choi, Sunju; Patel, Pragna I.] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Hao, Jiajie; Wang, Ming-Rong] Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Hao, Jiajie; Wang, Ming-Rong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Feng; Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zhang, Feng; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Liu, Yang] China Med Univ, Res Ctr Med Gen, Shenyang 110001, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lanzhou University; University of Southern California; University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fudan University; Fudan University; Fudan University; Chinese University of Hong Kong; China Medical University	Zhang, X (corresponding author), Chinese Acad Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100005, Peoples R China.	xuezhang@pumc.edu.cn	Jin, Li/C-1468-2009; miao, sun/E-2834-2018; Choy, Richard/AAW-8230-2020; Figuera, Luis E/V-8429-2017; Zhang, Feng/C-7735-2009; Jin, Li/M-5063-2019; zhu, hongwen/AAL-6757-2021; Patel, Pragna/H-9129-2017	Jin, Li/0000-0002-4546-2415; Choy, Richard/0000-0002-3616-6200; Figuera, Luis E/0000-0002-6096-4579; Zhang, Feng/0000-0003-4556-8276; Patel, Pragna/0000-0003-3584-1072	National Natural Science Foundation of China [30730097]; State Key Laboratory Program of the Ministry of Science and Technology of China; Ministry of Education of China; 111 Project [B08007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Program of the Ministry of Science and Technology of China; Ministry of Education of China(Ministry of Education, China); 111 Project(Ministry of Education, China - 111 Project)	We thank the family members for their participation in the study. This work was supported mainly by the National Natural Science Foundation of China (fund 30730097 to X.Z. and T.J.) and the State Key Laboratory Program of the Ministry of Science and Technology of China (to X.Z.). X.Z. is a Chang Jiang Scholar of Genetic Medicine supported by the Ministry of Education of China. X.Z. is also supported by the 111 Project (B08007).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Bowl MR, 2005, J CLIN INVEST, V115, P2822, DOI 10.1172/JCI24156; Bush JO, 2004, P NATL ACAD SCI USA, V101, P7022, DOI 10.1073/pnas.0401025101; Davies K, 2007, NAT GENET, V39, P805, DOI 10.1038/ng0707-805; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; Ferreira SI, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-14; FIGUERA LE, 1995, NAT GENET, V10, P202, DOI 10.1038/ng0695-202; Fimiani G, 2006, HUM REPROD, V21, P529, DOI 10.1093/humrep/dei356; Garcia-Cruz D, 2002, CLIN GENET, V61, P321, DOI 10.1034/j.1399-0004.2002.610501.x; HALL BK, 1995, NAT GENET, V10, P126, DOI 10.1038/ng0695-126; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; Kang SHL, 2010, AM J MED GENET A, V152A, P1111, DOI 10.1002/ajmg.a.33278; Kurahashi H, 2006, DNA REPAIR, V5, P1136, DOI 10.1016/j.dnarep.2006.05.035; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MACIASFLORES MA, 1984, HUM GENET, V66, P66, DOI 10.1007/BF00275189; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Rizzolio F, 2006, HUM REPROD, V21, P1477, DOI 10.1093/humrep/dei495; Sheridan MB, 2010, AM J HUM GENET, V87, P209, DOI 10.1016/j.ajhg.2010.07.002; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sun M, 2008, J MED GENET, V45, P589, DOI 10.1136/jmg.2008.057646; Sun M, 2009, AM J HUM GENET, V84, P807, DOI 10.1016/j.ajhg.2009.04.018; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Tadin-Strapps M, 2003, CLIN GENET, V63, P418, DOI 10.1034/j.1399-0004.2003.00069.x; THARAPEL AT, 1993, AM J HUM GENET, V52, P463; Van Hemel JO, 2000, HUM GENET, V107, P415, DOI 10.1007/s004390000398; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134	33	40	43	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					819	826		10.1016/j.ajhg.2011.05.004	http://dx.doi.org/10.1016/j.ajhg.2011.05.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21636067	Bronze, Green Published			2022-12-18	WOS:000291768500014
J	Teumer, A; Rawal, R; Homuth, G; Ernst, F; Heier, M; Evert, M; Dombrowski, F; Volker, U; Nauck, M; Radke, D; Ittermann, T; Biffar, R; Doring, A; Gieger, C; Klopp, N; Wichmann, HE; Wallaschofski, H; Meisinger, C; Volzke, H				Teumer, Alexander; Rawal, Rajesh; Homuth, Georg; Ernst, Florian; Heier, Margit; Evert, Matthias; Dombrowski, Frank; Voelker, Uwe; Nauck, Matthias; Radke, Doerte; Ittermann, Till; Biffar, Reiner; Doering, Angela; Gieger, Christian; Klopp, Norman; Wichmann, H. -Erich; Wallaschofski, Henri; Meisinger, Christa; Voelzke, Henry			Genome-wide Association Study Identifies Four Genetic Loci Associated with Thyroid Volume and Goiter Risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAPPING PROTEIN; IODINE INTAKE; DISORDERS; INDUCTION; FGF10; CAPZ; ACTS; IIIB	Thyroid disorders such as goiters represent important diseases, especially in iodine-deficient areas. Sibling studies have demonstrated that genetic factors substantially contribute to the interindividual variation of thyroid volume. We performed a genome-wide association study of this phenotype by analyzing a discovery cohort consisting of 3620 participants of the Study of Health in Pomerania (SHIP). Four genetic loci were associated with thyroid volume on a genome-wide level of significance. Of these, two independent loci are located upstream of and within CAPZB, which encodes the beta subunit of the barbed-end F-actin binding protein that modulates actin polymerization, a process crucial in the colloid engulfment during thyroglobulin mobilization in the thyroid. The third locus marks FGF7, which encodes fibroblast growth factor 7. Members of this protein family have been discussed as putative signal molecules involved in the regulation of thyroid development. The fourth locus represents a "gene desert" on chromosome 16q23, located directly downstream of the predicted coding sequence LOC440389, which, however, had already been removed from the NCBI database as a result of the standard genome annotation processing at the time that this study was initiated. Experimental proof of the formerly predicted mature mRNA, however, demonstrates that LOC440389 indeed represents a real gene. All four associations were replicated in an independent sample of 1290 participants of the KORA study. These results increase the knowledge about genetic factors and physiological mechanisms influencing thyroid volume.	[Radke, Doerte; Ittermann, Till; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Teumer, Alexander; Homuth, Georg; Ernst, Florian; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Rawal, Rajesh; Doering, Angela; Gieger, Christian; Klopp, Norman; Wichmann, H. -Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Evert, Matthias; Dombrowski, Frank] Univ Med Greifswald, Inst Pathol, D-17475 Greifswald, Germany; [Evert, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Biffar, Reiner] Univ Med Greifswald, Dept Prosthet Dent Gerostomatol & Dent Mat, D-17475 Greifswald, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-80539 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Heier, Margit; Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Volzke, H (corresponding author), Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany.	voelzke@uni-greifswald.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Wichmann, Heinz Erich/AAA-5695-2022; Teumer, Alexander/S-7438-2019	Teumer, Alexander/0000-0002-8309-094X; Gieger, Christian/0000-0001-6986-9554; Volker, Uwe/0000-0002-5689-3448; Rawal, Rajesh/0000-0002-0151-9344; Meisinger, Christa/0000-0002-9026-6544	Federal Ministry of Education and Research [03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare (Erlangen, Germany); Federal State of Mecklenburg-West Pomerania; German Research Foundation [DFG Vo 955/10-1]; Federal Ministry of Nutrition, Agriculture and Comsumer's Safety; Helmholtz Center Munich; German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [NGFN-2]; Munich Center of Health Sciences (MC Health); Sanofi-Aventis	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare (Erlangen, Germany); Federal State of Mecklenburg-West Pomerania; German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Nutrition, Agriculture and Comsumer's Safety; Helmholtz Center Munich(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MC Health); Sanofi-Aventis(Sanofi-Aventis)	SHIP is part of the Community Medicine Research net of the Ernst-Moritz-Arndt-University Greifswald, Germany, which is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs, and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare (Erlangen, Germany) and the Federal State of Mecklenburg-West Pomerania. The SHIP authors are grateful to the contribution of Anja Wiechert and Astrid Petersmann in generating the SNP data and to Marc Schaffer for his assistance in the RNA analysis. The University of Greifswald is a member of the "Center of Knowledge Interchange" program of Siemens AG. Data analyses were further supported by the German Research Foundation (DFG Vo 955/10-1) and the Federal Ministry of Nutrition, Agriculture and Comsumer's Safety.; The KORA research platform was initiated and financed by the Helmholtz Center Munich, by the German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research, and by the State of Bavaria. The work of KORA is supported by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Thyroid examinations were funded by Sanofi-Aventis within the framework of the Papillon Initiative.	AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; BLAND JM, 1986, LANCET, V1, P908, DOI 10.1016/S0140-6736(86)91008-1; Brix TH, 1999, J CLIN ENDOCR METAB, V84, P3071, DOI 10.1210/jc.84.9.3071; Brix TH, 2001, THYROID, V11, P769, DOI 10.1089/10507250152484619; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; GUTEKUNST R, 1988, DEUT MED WOCHENSCHR, V113, P1109, DOI 10.1055/s-2008-1067777; Hansen PS, 2004, J CLIN ENDOCR METAB, V89, P2071, DOI 10.1210/jc.2003-031999; Homuth G, 1997, J BACTERIOL, V179, P1153, DOI 10.1128/jb.179.4.1153-1164.1997; Ittermann T, 2008, EUR J ENDOCRINOL, V159, P761, DOI 10.1530/EJE-08-0386; Kitazawa M, 2005, BIOCHEM BIOPH RES CO, V331, P181, DOI 10.1016/j.bbrc.2005.03.127; Knudsen N, 2002, THYROID, V12, P879, DOI 10.1089/105072502761016502; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Meng W, 1998, MED KLIN, V93, P347, DOI 10.1007/BF03044678; Meng W.S.A., 1998, ELIMINATION IODINE D, P21; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ornitz DM, 2001, GENOME BIOL, V2; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Volzke H, 2005, EXP CLIN ENDOCR DIAB, V113, P507, DOI 10.1055/s-2005-865741; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	35	40	41	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					664	673		10.1016/j.ajhg.2011.04.015	http://dx.doi.org/10.1016/j.ajhg.2011.04.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21565293	Bronze, Green Published			2022-12-18	WOS:000290832100016
J	Daly, SB; Urquhart, JE; Hilton, E; McKenzie, EA; Kammerer, RA; Lewis, M; Kerr, B; Stuart, H; Donnai, D; Long, DA; Burgu, B; Aydogdu, O; Derbent, M; Garcia-Minaur, S; Reardon, W; Gener, B; Shalev, S; Smith, R; Woolf, AS; Black, GC; Newman, WG				Daly, Sarah B.; Urquhart, Jill E.; Hilton, Emma; McKenzie, Edward A.; Kammerer, Richard A.; Lewis, Malcolm; Kerr, Bronwyn; Stuart, Helen; Donnai, Dian; Long, David A.; Burgu, Berk; Aydogdu, Ozgu; Derbent, Murat; Garcia-Minaur, Sixto; Reardon, Willie; Gener, Blanca; Shalev, Stavit; Smith, Rupert; Woolf, Adrian S.; Black, Graeme C.; Newman, William G.			Mutations in HPSE2 Cause Urofacial Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCHOA-SYNDROME; GENETIC HOMOGENEITY; CRITICAL REGION; BLADDER; FAMILY; SERVER	Urinary voiding dysfunction in childhood, manifesting as incontinence, dysuria, and urinary frequency, is a common condition. Urofacial syndrome (UFS) is a rare autosomal recessive disease characterized by facial grimacing when attempting to smile and failure of the urinary bladder to void completely despite a lack of anatomical bladder outflow obstruction or overt neurological damage. UFS individuals often have reflux of infected urine from the bladder to the upper renal tract, with a risk of kidney damage and renal failure. Whole-genome SNP mapping in one affected individual defined an autozygous region of 16 Mb on chromosome 10q23-q24,within which a 10 kb deletion encompassing exons 8 and 9 of HPSE2 was identified. Homozygous exonic deletions, nonsense mutations, and frameshift mutations in five further unrelated families confirmed HPSE2 as the causative gene for UPS. Mutations were not identified in tour additional UPS patients, indicating genetic heterogeneity. We show that HPSE2 is expressed in the fetal and adult central nervous system, where it might be implicated in controlling facial expression and urinary voiding, and also in bladder smooth muscle, consistent with a role in renal tract morphology and function. Our findings have broader implications for understanding the genetic basis of lower renal tract malformations and voiding dysfunction.	[Daly, Sarah B.; Urquhart, Jill E.; Hilton, Emma; Kerr, Bronwyn; Stuart, Helen; Donnai, Dian; Black, Graeme C.; Newman, William G.] Univ Manchester, Sch Biomed, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England; [McKenzie, Edward A.] Univ Manchester, Fac Life Sci, Prot Express Facil, Manchester M13 9PT, Lancs, England; [Kammerer, Richard A.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Lewis, Malcolm; Woolf, Adrian S.] Univ Manchester, Dept Paediat, Cent Manchester Fdn Natl Hlth Serv NHS Trust, Sch Biomed, Manchester M13 9WL, Lancs, England; [Lewis, Malcolm; Woolf, Adrian S.] Univ Manchester, Sch Biomed, Regenerat Med Res Grp, Manchester M13 9WL, Lancs, England; [Long, David A.] UCL Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England; [Burgu, Berk; Aydogdu, Ozgu] Ankara Univ, Sch Med, Div Paediat Urol, TR-06100 Ankara, Turkey; [Derbent, Murat] Baskent Univ, Fac Med, Dept Paediat, TR-06490 Ankara, Turkey; [Garcia-Minaur, Sixto] Univ Hosp La Paz, Inst Med & Mol Genet, Madrid 28046, Spain; [Reardon, Willie] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; [Gener, Blanca] Hosp Cruces, Baracaldo 48903, Vizcaya, Spain; [Shalev, Stavit] HaEmek Med Ctr, Inst Genet, IL-18101 Afula, Israel; [Smith, Rupert] Pennine Acute Hosp NHS Trust, Rochdale Infirm, Rochdale OL12 0NB, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of London; University College London; Ankara University; Baskent University; Hospital Universitario La Paz; Our Ladys Children Hospital Crumlin; Hospital Universitario Cruces; Emek Medical Center	Newman, WG (corresponding author), Univ Manchester, Sch Biomed, MAHSC, St Marys Hosp, Manchester M13 9WL, Lancs, England.	william.newman@manchester.ac.uk	Urquhart, Jill/G-2282-2015; Stuart, Helen/G-3535-2015; Gener, Blanca/E-4310-2012; Long, David/I-3254-2019; Woolf, Adrian S./AAZ-1075-2020	Urquhart, Jill/0000-0002-5788-5511; Stuart, Helen/0000-0003-2569-235X; Long, David/0000-0001-6580-3435; Woolf, Adrian S./0000-0001-5541-1358	National Institute of Health Research Manchester Biomedical Research Centre; University of Manchester; MAHSC; Kidney Research UK; Kidney Research UK [SF1/2008] Funding Source: researchfish	National Institute of Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); University of Manchester; MAHSC; Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	Genetic Medicine and A.S.W. are supported by the National Institute of Health Research Manchester Biomedical Research Centre, University of Manchester, and the MAHSC. D.A.I. is supported by a Senior Non-Clinical Fellowship from Kidney Research UK. Thanks to Tarkan Soygur, Fatos Yalcmkaya, and Zeynep Birsin Ozcakar for their valuable contributions in gathering the data. Thanks to Cathy Merry for helpful discussions.	Aydogdu O, 2010, EUR J PEDIATR, V169, P431, DOI 10.1007/s00431-009-1042-9; Burgu B, 2007, J UROLOGY, V177, P1552, DOI 10.1016/j.juro.2006.12.011; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chauve X, 2000, AM J MED GENET, V95, P10, DOI 10.1002/1096-8628(20001106)95:1<10::AID-AJMG3>3.0.CO;2-Z; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; Derbent M, 2009, RENAL FAILURE, V31, P589, DOI 10.1080/08860220903003370; Garcia-Minaur S, 2001, CLIN DYSMORPHOL, V10, P165, DOI 10.1097/00019605-200107000-00002; HOEBEKE P, 2002, DIALOG PEDIAT UROL, V25, P2; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; OCHOA B, 1992, J UROLOGY, V148, P580, DOI 10.1016/S0022-5347(17)36659-4; OCHOA B, 1987, AM J MED GENET, V27, P661, DOI 10.1002/ajmg.1320270320; Ochoa B, 2004, PEDIATR NEPHROL, V19, P6, DOI 10.1007/s00467-003-1291-1; Price KL, 2009, J UROLOGY, V181, P2366, DOI 10.1016/j.juro.2009.01.001; *REN ASS UK REN RE, 9 REN ASS UK REN REG; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stamps Alasdair C, 2003, J Nanobiotechnology, V1, P3, DOI 10.1186/1477-3155-1-3; Thiruchelvam N, 2003, AM J PHYSIOL-REG I, V284, pR1296, DOI 10.1152/ajpregu.00688.2002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang CY, 1999, AM J MED GENET, V84, P454, DOI 10.1002/(SICI)1096-8628(19990611)84:5<454::AID-AJMG9>3.3.CO;2-4; Wang CY, 2003, AM J MED GENET A, V119A, P9, DOI 10.1002/ajmg.a.20042	24	40	42	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					963	969		10.1016/j.ajhg.2010.05.006	http://dx.doi.org/10.1016/j.ajhg.2010.05.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT		Green Published, Bronze			2022-12-18	WOS:000278948900014
J	Liu, YT; Liu, WJ; Crooks, K; Schmidt, S; Allingham, RR; Hauser, MA				Liu, Yutao; Liu, Wenjing; Crooks, Kristy; Schmidt, Silke; Allingham, R. Rand; Hauser, Michael A.			No Evidence of Association of Heterozygous NTF4 Mutations in Patients with Primary Open-Angle Glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									[Liu, Yutao; Liu, Wenjing; Crooks, Kristy; Schmidt, Silke; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University	Hauser, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	mike.hauser@duke.edu			NEI NIH HHS [R01 EY013315, R01 EY019126] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013315, R01EY019126] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016	4	40	44	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					498	499		10.1016/j.ajhg.2009.11.018	http://dx.doi.org/10.1016/j.ajhg.2009.11.018			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20215012	Green Published, Bronze			2022-12-18	WOS:000275678800026
J	Meyer, E; Ricketts, C; Morgan, NV; Morris, MR; Pasha, S; Tee, LJ; Rahman, F; Bazin, A; Bessieres, B; Dechelotte, P; Yacoubi, MT; Al-Adnani, M; Marton, T; Tannahill, D; Trembath, RC; Fallet-Bianco, C; Cox, P; Williams, D; Maher, ER				Meyer, Esther; Ricketts, Christopher; Morgan, Neil V.; Morris, Mark R.; Pasha, Shanaz; Tee, Louise J.; Rahman, Fatimah; Bazin, Anne; Bessieres, Bettina; Dechelotte, Pierre; Yacoubi, Mohamed T.; Al-Adnani, Mudher; Marton, Tamas; Tannahill, David; Trembath, Richard C.; Fallet-Bianco, Catherine; Cox, Phillip; Williams, Denise; Maher, Eamonn R.			Mutations in FLVCR2 Are Associated with Proliferative Vasculopathy and Hydranencephaly-Hydrocephaly Syndrome (Fowler Syndrome)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AKINESIA DEFORMATION SEQUENCE; 2 SIBLINGS; EXPRESSION; IDENTIFICATION; HOMEOSTASIS; FEATURES; SUBUNIT; BLOOD; GENE	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH), also known as Fowler syndrome, is an autosomal-recessively inherited prenatal lethal disorder characterized by hydranencephaly; brain stern, basal ganglia, and spinal cord diffuse clastic ischemic lesions with calcifications; glomeruloid vasculopathy of the central nervous system and retinal vessels; and a fetal akinesia deformation sequence (FADS) with Muscular neurogenic atrophy. To identify the molecular basis for Fowler syndrome, we performed autozygosity mapping studies in three consanguineous families. The results of SNP microarrays and microsatellite marker genotyping demonstrated linkage to chromosome 14q24.3. Direct sequencing of candidate genes within the target interval revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome. FLVCR2 encodes a transmembrane transporter of the major facilitator superfamily (MFS) hypothesized to be involved in regulation of growth, calcium exchange, and homeostasis. This is the first gene to be associated with Fowler syndrome, and this finding provides a basis for further studies to elucidate the pathogenetic mechanisms and phenotypic spectrum of associated disorders.	[Meyer, Esther; Ricketts, Christopher; Morgan, Neil V.; Morris, Mark R.; Pasha, Shanaz; Tee, Louise J.; Rahman, Fatimah; Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; [Bazin, Anne; Bessieres, Bettina] Hop St Anne, Dept Fetal Pathol, F-75014 Paris, France; [Dechelotte, Pierre] Univ Auvergne, CHU Clermont Ferrand, Dept Pathol Anat, F-63058 Clermont Ferrand 1, France; [Yacoubi, Mohamed T.] CHU Farhat Hached, Dept Anat & Pathol Cytol, Sousse 4000, Tunisia; [Al-Adnani, Mudher] Sheffield Childrens NHS Fdn Trust, Western Bank, Dept Histopathol, Sheffield S10 2TH, S Yorkshire, England; [Marton, Tamas; Cox, Phillip] Birmingham Womens Hosp NHS Fdn Trust, Dept Histopathol, Birmingham B15 2TG, W Midlands, England; [Tannahill, David] Cranfield Univ, Cranfield MK43 0AL, Beds, England; [Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Fallet-Bianco, Catherine] Hop St Anne, Dept Neuropathol, F-75014 Paris, France; [Williams, Denise; Maher, Eamonn R.] Birmingham Womens Hosp NHS Fdn Trust, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England	University of Birmingham; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Universite de Sousse; Hopital Farhat Hached; Sheffield Children's NHS Foundation Trust; Birmingham Women's Hospital; Cranfield University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital	Maher, ER (corresponding author), Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	e.r.maher@bham.ac.uk	Morris, Mark/C-6413-2008; Ricketts, Christopher/AAV-9580-2020; Fallet-Bianco, Catherine/AAP-7390-2020; MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Cox, Phillip/0000-0002-4636-5668; Tannahill, David/0000-0002-3811-6864; Marton, Tamas/0000-0001-5585-2276; Morris, Mark/0000-0002-0700-355X; Trembath, Richard/0000-0003-0550-3400	Wellcome Trust; WellChild; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); WellChild; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the Wellcome Trust and WellChild for financial support. We are also grateful to the families for their help with this study.	Al-Adnani M, 2009, PEDIATR DEVEL PATHOL, V12, P68, DOI 10.2350/07-09-0348.1; Bessieres-Grattagliano B, 2009, EUR J MED GENET, V52, P386, DOI 10.1016/j.ejmg.2009.07.006; Brasier G, 2004, EXP CELL RES, V293, P31, DOI 10.1016/j.yexcr.2003.10.002; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Castro-Gago M, 2001, J CHILD NEUROL, V16, P858, DOI 10.1177/08830738010160111401; FOWLER M, 1972, DEV MED CHILD NEUROL, V14, P173; Halder Ashutosh, 2003, Indian Pediatr, V40, P418; HARDING BN, 1995, NEUROPATH APPL NEURO, V21, P61, DOI 10.1111/j.1365-2990.1995.tb01029.x; HARPER C, 1983, DEV MED CHILD NEUROL, V25, P232; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Ibrahim A, 2007, J OBSTET GYNAECOL, V27, P201, DOI 10.1080/01443610601138042; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Laurichesse-Delmas H, 2002, ULTRASOUND OBST GYN, V20, P612, DOI 10.1046/j.1469-0705.2002.00830.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; NORMAN MG, 1988, PEDIATR NEUROSCI, V14, P301, DOI 10.1159/000120409; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pimanda JE, 2008, BLOOD, V112, P4512, DOI 10.1182/blood-2008-05-157560; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Shalev Z, 2009, J VIROL, V83, P6706, DOI 10.1128/JVI.02317-08; Usta IM, 2005, PRENATAL DIAG, V25, P1019, DOI 10.1002/pd.1240; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vogt J, 2009, J MED GENET, V46, P338, DOI 10.1136/jmg.2008.065425; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; Williams D, 2010, AM J MED GENET A, V152A, P153, DOI 10.1002/ajmg.a.33094; Witters I, 2002, AM J MED GENET, V108, P41, DOI 10.1002/ajmg.10208.abs; Witters I, 2002, AM J MED GENET, V113, P23, DOI 10.1002/ajmg.10698	30	40	42	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					471	478		10.1016/j.ajhg.2010.02.004	http://dx.doi.org/10.1016/j.ajhg.2010.02.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206334	Bronze, Green Published			2022-12-18	WOS:000275678800019
J	Lee, JC; Weissglas-Volkov, D; Kyttala, M; Dastani, Z; Cantor, RM; Sobel, EM; Plaisier, CL; Engert, JC; van Greevenbroek, MMJ; Kane, JP; Malloy, MJ; Pullinger, CR; Huertas-Vazquez, A; Aguilar-Salinas, CA; Tusie-Luna, T; de Bruin, TWA; Aouizerat, BE; van der Kallen, CCJ; Croce, CM; Aqeilan, RI; Marcil, M; Viikari, JSA; Lehtimaki, T; Raitakari, OT; Kuusisto, J; Laakso, M; Taskinen, MR; Genest, J; Pajukanta, P				Lee, Jenny C.; Weissglas-Volkov, Daphna; Kyttala, Mira; Dastani, Zari; Cantor, Rita M.; Sobel, Eric M.; Plaisier, Christopher L.; Engert, James C.; van Greevenbroek, Marleen M. J.; Kane, John P.; Malloy, Mary J.; Pullinger, Clive R.; Huertas-Vazquez, Adriana; Aguilar-Salinas, Carlos A.; Tusie-Luna, Teresa; de Bruin, Tjerk W. A.; Aouizerat, Bradley E.; van der Kallen, Carla C. J.; Croce, Carlo M.; Aqeilan, Rami I.; Marcil, Michel; Viikari, Jorma S. A.; Lehtimaki, Terho; Raitakari, Olli T.; Kuusisto, Johanna; Laakso, Markku; Taskinen, Marja-Riitta; Genest, Jacques; Pajukanta, Paeivi			WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; SERUM-LIPID LEVELS; APOLIPOPROTEIN-B; LOCI; LINKAGE; REPLICATION; FAMILIES; REVEALS; RISK	Low serum HDL-cholesterol (HDL-C) is a major risk factor for coronary artery disease. We performed targeted genotyping of a 12.4 Mb linked region on 16q to test for association with low HDL-C by using a regional-tag SNP strategy. We identified one SNP, rs2548861, in the WW-domain-containing oxidoreductase (WWOX) gene with region-wide significance for low HDL-C in dyslipidemic families of Mexican and European descent and in low-HDL-C cases and controls of European descent (p = 6.9 x 10(-7)). We extended our investigation to the population level by using two independent unascertained population-based Finnish cohorts, the cross-sectional METSIM cohort of 4,463 males and the prospective Young Finns cohort of 2,265 subjects. The combined analysis provided p = 4 x 10(-4) to 2 x 10(-5). Importantly, in the prospective cohort, we observed a significant longitudinal association of rs2548861 with HDL-C levels obtained at four different time points over 21 years (p = 0.003), and the T risk allele explained 1.5% of the variance in HDL-C levels. The rs2548861 resides in a highly conserved region in intron 8 of WWOX. Results from our in vitro reporter assay and electrophoretic mobility-shift assay demonstrate that this region functions as a cis-regulatory element whose associated rs2548861 SNP has a specific allelic effect and that the region forms an allele-specific DNA-nuclear-factor complex. In conclusion, analyses of 9,798 subjects show significant association between HDL-C and a WWOX variant with an allele-specific cis-regulatory function.	[Lee, Jenny C.; Weissglas-Volkov, Daphna; Kyttala, Mira; Cantor, Rita M.; Sobel, Eric M.; Plaisier, Christopher L.; Huertas-Vazquez, Adriana; Pajukanta, Paeivi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Dastani, Zari; Marcil, Michel; Genest, Jacques] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Cardiol,Cardiovasc Genet Lab, Montreal, PQ H3A 1A1, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [van Greevenbroek, Marleen M. J.; de Bruin, Tjerk W. A.; van der Kallen, Carla C. J.] Maastricht Univ, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [van Greevenbroek, Marleen M. J.; de Bruin, Tjerk W. A.; van der Kallen, Carla C. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Kane, John P.; Malloy, Mary J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Pullinger, Clive R.; Aouizerat, Bradley E.] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Salvador Zubiran 14000, Mexico; [Tusie-Luna, Teresa] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr, Inst Invest Biomed, Mol Biol & Genom Med Unit, Salvador Zubiran 62210, Mexico; [Aouizerat, Bradley E.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Croce, Carlo M.; Aqeilan, Rami I.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Viikari, Jorma S. A.] Univ Turku, Dept Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol, FIN-20520 Turku, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-00314 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-00314 Tampere, Finland; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Taskinen, Marja-Riitta] Univ Helsinki, Cent Hosp, FIN-00290 Helsinki, Finland; [Aqeilan, Rami I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill University; Royal Victoria Hospital; McGill University; Maastricht University; Maastricht University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; University of Turku; University of Turku; Tampere University; Tampere University Hospital; Tampere University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; Hebrew University of Jerusalem	Pajukanta, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	ppajukanta@mednet.ucla.edu	Aqeilan, Rami/AAT-7785-2020; Plaisier, Christopher/HGD-5631-2022; Lehtimäki, Terho/AAD-1094-2022; Taskinen, Marja-Riitta/AAN-5432-2020; Plaisier, Christohper L/H-3238-2019; Aqeilan, Rami/R-4443-2016; Raitakari, Olli/AAQ-7389-2021; Salinas, Carlos A Aguilar/AAL-4491-2020; Young, Richard A/F-6495-2012	Lehtimäki, Terho/0000-0002-2555-4427; Taskinen, Marja-Riitta/0000-0002-6229-3588; Plaisier, Christohper L/0000-0003-3273-5717; Aqeilan, Rami/0000-0002-6034-023X; Young, Richard A/0000-0001-8855-8647; Engert, James/0000-0001-8411-4790; Sobel, Eric/0000-0002-1718-0031	National Institutes of Health [HL-28481, HL082762]; AHA [0430180N]; Kimmel Scholar Award; The Fondation Leducq; California Discovery Grant [02-10251]; Dhanem Foundation; National Human Genome Research Institute [T32 HG02536]; Academy of Finland; American Hearth Association [072523Y, 0465005Y]; Ohio Cancer Research Associates; Clinical Research Institute; Helsinki University Central Hospital; University Hospital Medical Fund; Academy of Finland [77841, 210283]; Canadian Institutes of Health Research [CIHR MOP 62834]; Fonds de la recherche en sante du Quebec (FRSQ); Tampere University Hospital Medical Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082762, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Kimmel Scholar Award; The Fondation Leducq(Leducq Foundation); California Discovery Grant; Dhanem Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Academy of Finland(Academy of Finland); American Hearth Association(American Heart Association); Ohio Cancer Research Associates; Clinical Research Institute; Helsinki University Central Hospital; University Hospital Medical Fund; Academy of Finland(Academy of Finland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Tampere University Hospital Medical Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the patients and family members for their participation in this study. We thank L. Peltonen, K. Porkka, and I. Nuotio for sample collection; E. Nikkola, M. Lupsakko, L. Riba, and I. Ruel for laboratory technical assistance; and N. Zanesi and T. Palumbo for their contribution. This research was supported by National Institutes of Health grants HL-28481 and HL082762, the AHA grant 0430180N, the Kimmel Scholar Award, The Fondation Leducq, California Discovery Grant 02-10251, and the Dhanem Foundation. D.W.-V. is supported by National Human Genome Research Institute grant T32 HG02536; M.K. by a grant from the Academy of Finland; A.H.-V. by the American Hearth Association grant 072523Y; B.E.A by the American Hearth Association grant 0465005Y; abd R.I.A by Ohio Cancer Research Associates. M.-R.T. is supported by the Clinical Research Institute, Helsinki University Central Hospital and the Finnish Heart Foundation, and T.L. is supported by the Tampere University Hospital Medical Fund. The Young Finns Study is supported by the Academy of Finland grants 77841 and 210283. J.G, M.M., and J.C.E are supported by grant CIHR MOP 62834 from the Canadian Institutes of Health Research; J.G. holds the McGill University-Novartis Chair in Medicine; M.M. and J.C.E. are recipients of a Fonds de la recherche en sante du Quebec (FRSQ) research scholarship. The authors have no competing financial interests to disclose. T.W.A.d.B. has been employed by GlaxoSmithKline. GlaxoSmithKline did not provide any financial support for this study.	Aguilar-Salinas CA, 2002, AM J MED, V113, P569, DOI 10.1016/S0002-9343(02)01314-1; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aouizerat BE, 2006, J LIPID RES, V47, P787, DOI 10.1194/jlr.M500476-JLR200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Bednarek AK, 2000, CANCER RES, V60, P2140; Cantor RM, 2004, ARTERIOSCL THROM VAS, V24, P1935, DOI 10.1161/01.ATV.0000142358.46276.a7; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Dastani Z, 2006, ARTERIOSCL THROM VAS, V26, P392, DOI 10.1161/01.ATV.0000198243.83781.a3; FRIEDLANDER Y, 1986, GENET EPIDEMIOL, V3, P95, DOI 10.1002/gepi.1370030205; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Huertas-Vazquez A, 2008, DIABETOLOGIA, V51, P62, DOI 10.1007/s00125-007-0850-6; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange K, 2001, AM J HUM GENET, V69, P504; Mahaney MC, 2003, ARTERIOSCL THROM VAS, V23, P339, DOI 10.1161/01.ATV.0000051406.14162.6A; Miller M, 2003, CURR OPIN LIPIDOL, V14, P273, DOI 10.1097/00041433-200306000-00007; Nunez MI, 2006, J MOL HISTOL, V37, P115, DOI 10.1007/s10735-006-9046-5; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Pajukanta P, 2003, AM J HUM GENET, V72, P903, DOI 10.1086/374177; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; RIFKIND BM, 1979, CIRCULATION, V60, P427; Rozen S, 2000, Methods Mol Biol, V132, P365; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soro A, 2002, AM J HUM GENET, V70, P1333, DOI 10.1086/339988; Tu IP, 2000, AM J HUM GENET, V66, P1341, DOI 10.1086/302852; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Weber M, 1997, CAN J CARDIOL, V13, P253; Weissglas-Volkov D, 2006, DIABETES, V55, P1970, DOI 10.2337/db06-0035; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	48	40	40	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					180	192		10.1016/j.ajhg.2008.07.002	http://dx.doi.org/10.1016/j.ajhg.2008.07.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674750	Bronze, Green Published			2022-12-18	WOS:000258418200003
J	Schule, B; Li, HH; Fisch-Kohl, C; Purmann, C; Francke, U				Schuele, Birgitt; Li, Hong Hua; Fisch-Kohl, Claudia; Purmann, Carolin; Francke, Uta			DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETT-SYNDROME PATIENTS; LYMPHOBLASTOID CELL-LINES; CPG-BINDING PROTEIN-2; HUMAN GENE-EXPRESSION; EPSILON-SARCOGLYCAN; MOUSE MODEL; TRANSCRIPTIONAL REPRESSOR; PATERNAL EXPRESSION; MYOCLONUS-DYSTONIA; ALLELIC VARIATION	Mutations in MECP2 and Mecp2 (encoding methyl-CpG binding protein 2 [MeCP2]) cause distinct neurological phenotypes in humans and mice, respectively, but the molecular pathology is unclear. Recent literature claimed that the developmental homeobox gene DLX5 is imprinted and that its imprinting status is modulated by MeCP2, leading to biallelic expression in Rett syndrome and twofold overexpression of Dlx5 and Dlx6 in Mecp2-null mice. The conclusion that DLX5 is a direct target of MeCP2 has implications for research on the molecular bases of Rett syndrome, autism, and genomic imprinting. Attempting to replicate the reported data, we evaluated allele-specific expression of DLX5 and DLX6 in mouse x human somatic cell hybrids, lymphoblastoid cell lines, and frontal cortex from controls and individuals with MECP2 mutations. We identified novel single-nucleotide polymorphisms in DLX5 and DLX6, enabling the first imprinting studies of DLX6. We found that DLX5 and DLX6 are biallelically expressed in somatic cell hybrids and in human cell lines and brain, with no differences between affected and control samples. We also determined expression levels of Dlx5 and Dlx6 in forebrain from seven male Mecp2-mutant mice and eight wild-type littermates by real-time quantitative reverse-transcriptase polymerase chain reaction assays. Expression of Dlx5 and Dlx6, as well as of the imprinted gene Peg3, in mouse forebrain was highly variable, with no consistent differences between Mecp2-null mutants and controls. We conclude that DLX5 and DLX6 are not imprinted in humans and are not likely to be direct targets of MeCP2 modulation. In contrast, the imprinting status of PEG3 and PEG10 is maintained in MeCP2-deficient tissues. Our results confirm that MeCP2 plays no role in the maintenance of genomic imprinting and add PEG3 and PEG10 to the list of studied imprinted genes.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University	Francke, U (corresponding author), Stanford Univ, Sch Med, Dept Genet, 279 Campus Dr, Stanford, CA 94305 USA.	ufrancke@stanford.edu		Schuele, Birgitt/0000-0002-9952-5776				Acampora D, 1999, DEVELOPMENT, V126, P3795; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Ballestar E, 2005, HUM GENET, V116, P91, DOI 10.1007/s00439-004-1200-0; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Delgado IJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-61; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Francke U, 2006, NAT CLIN PRACT NEURO, V2, P212, DOI 10.1038/ncpneuro0148; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hamilton SP, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-52; Hannula K, 2001, GENOMICS, V73, P1, DOI 10.1006/geno.2001.6502; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Inoue J, 2001, J HUM GENET, V46, P137, DOI 10.1007/s100380170101; ITABAMATSUMOTO N, 2007, IMPRINTING STATUS PA; Itoh M, 2007, J NEUROPATH EXP NEUR, V66, P117, DOI 10.1097/nen.0b013e3180302078; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Jordan C, 2006, HUM MOL GENET, V15, P2210, DOI 10.1093/hmg/ddl146; Kankirawatana P, 2006, NEUROLOGY, V67, P164, DOI 10.1212/01.wnl.0000223318.28938.45; Kimura MI, 2004, J HUM GENET, V49, P273, DOI 10.1007/s10038-004-0139-2; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Makedonski K, 2005, HUM MOL GENET, V14, P1049, DOI 10.1093/hmg/ddi097; Mcrae AF, 2007, HUM MOL GENET, V16, P364, DOI 10.1093/hmg/ddl456; Meguro M, 1997, HUM MOL GENET, V6, P2127, DOI 10.1093/hmg/6.12.2127; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Muller B, 2002, AM J HUM GENET, V71, P1303, DOI 10.1086/344531; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Perera M, 2004, MOL CELL NEUROSCI, V25, P153, DOI 10.1016/j.mcn.2003.10.004; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Rett A, 1966, Wien Med Wochenschr, V116, P723; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhou QP, 2004, NUCLEIC ACIDS RES, V32, P884, DOI 10.1093/nar/gkh233	68	40	41	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					492	506		10.1086/520063	http://dx.doi.org/10.1086/520063			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701895	Green Published, Bronze			2022-12-18	WOS:000249128200006
J	Simonaro, CM; Park, JH; Eliyahu, E; Shtraizent, N; McGovern, MM; Schuchman, EH				Simonaro, CM; Park, JH; Eliyahu, E; Shtraizent, N; McGovern, MM; Schuchman, EH			Imprinting at the SMPD1 locus: Implications for acid sphingomyelinase-deficient Niemann-Pick disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; GENE; EXPRESSION	Acid sphingomyelinase (ASM) is the lipid hydrolase that is deficient in types A and B Niemann-Pick disease (NPD). Here, we demonstrate that the gene encoding ASM (SMPD1) is paternally imprinted and that differential expression of the mutant alleles in patients with ASM-deficient NPD and in carriers influences the disease phenotype. Comparison of the results of genomic sequencing versus reverse-transcriptase polymerase chain reaction sequencing for several patients with NPD revealed preferential expression of one mutant allele. Further analysis of one family showed that the expressed allele was maternally inherited and that the distinct clinical presentations of the individual patients were correlated with the amount of residual ASM activity expressed from the maternal mutation. Treatment of NPD cell lines with 5-aza-2'-deoxycytidine enhanced the expression of the paternal SMPD1 allele, and bisulfite genomic sequencing identified which CpG dinucleotides within the SMPD1 promoter were methylated. In a related set of studies, we identified a carrier individual who had similar to 15% of normal ASM activity and clinical features of ASM-deficient NPD. DNA sequencing confirmed that this individual carried a single SMPD1 mutation and that this mutant allele was preferentially expressed. These data thus demonstrate, for the first time, imprinting at the SMPD1 gene and reveal the influence of this epigenetic modification on the presentation of ASM-deficient NPD.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Simonaro, CM (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498,1425 Madison Ave,Room 14-20A, New York, NY 10029 USA.	edward.schuchman@mssm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR021991] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR021991, K24 RR021991-01] Funding Source: Medline; NICHD NIH HHS [R01 HD028607, R01 HD28607-15] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Jaffrezou Jean-Pierre, 2004, Bull Cancer, V91, pE133; Lee CY, 2003, HUM GENET, V112, P552, DOI 10.1007/s00439-002-0893-1; LEVRAN O, 1993, HUM MUTAT, V2, P317, DOI 10.1002/humu.1380020414; PEREIRA LD, 1991, GENOMICS, V9, P229, DOI 10.1016/0888-7543(91)90246-B; Rethy Lajos A., 2000, Pathology and Oncology Research, V6, P298; Rethy Lajos A., 2000, Pathology and Oncology Research, V6, P295; SCHUCHMAN EH, 1992, GENOMICS, V12, P197, DOI 10.1016/0888-7543(92)90366-Z; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074	12	40	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					865	870		10.1086/503750	http://dx.doi.org/10.1086/503750			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642440	Green Published, Bronze			2022-12-18	WOS:000236756200011
J	Hanchard, NA; Rockett, KA; Spencer, C; Coop, G; Pinder, M; Jallow, M; Kimber, M; McVean, G; Mott, R; Kwiatkowski, DP				Hanchard, NA; Rockett, KA; Spencer, C; Coop, G; Pinder, M; Jallow, M; Kimber, M; McVean, G; Mott, R; Kwiatkowski, DP			Screening for recently selected alleles by analysis of human haplotype similarity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; STATISTICAL-METHOD; HUMAN GENOME; HISTORY; GENE	There is growing interest in the use of haplotype- based methods for detecting recent selection. Here, we describe a method that uses a sliding window to estimate similarity among the haplotypes associated with any given single-nucleotide polymorphism ( SNP) allele. We used simulations of natural selection to provide estimates of the empirical power of the method to detect recently selected alleles and found it to be comparable in power to the popular long-range haplotype test and more powerful than methods based on nucleotide diversity. We then applied the method to a recently selected allele-the sickle mutation at the HBB locus-and found it to have a signal of selection that was significantly stronger than that of simulated models both with and without strong selection. Using this method, we also evaluated 14,000 SNPs on chromosome 20, indicating the applicability of the method to regional data sets.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Oxford, Dept Paediat, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; MRC Labs, Banjul, Gambia; Tessella, Abingdon, Oxon, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology	Hanchard, NA (corresponding author), Univ W Indies, Trop Metab Res Unit, Trop Med Res Inst, Kingston 7, Jamaica.	neil.hanchard@green-oxford.com	Hanchard, Neil/AAY-9075-2021	Hanchard, Neil/0000-0003-1925-2665; Coop, Graham/0000-0001-8431-0302; Kwiatkowski, Dominic/0000-0002-5023-0176; Mott, Richard/0000-0002-1022-9330	Medical Research Council [G9505090, G19/9] Funding Source: Medline; MRC [G9505090, G19/9] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ackerman H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r24; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HUDSON RR, 1994, GENETICS, V136, P1329; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thompson EA, 1997, AM J HUM GENET, V60, P197; Toomajian C, 2003, GENETICS, V165, P287	17	40	42	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					153	159		10.1086/499252	http://dx.doi.org/10.1086/499252			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385459	Green Published, Bronze			2022-12-18	WOS:000233930400016
J	Lin, PI; McInnis, MG; Potash, JB; Willour, VL; MacKinnon, DF; Miao, KY; DePaulo, JR; Zandi, PP				Lin, PI; McInnis, MG; Potash, JB; Willour, VL; MacKinnon, DF; Miao, KY; DePaulo, JR; Zandi, PP			Assessment of the effect of age at onset on linkage to bipolar disorder: Evidence on chromosomes 18p and 21q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; MANIC-DEPRESSIVE PATIENTS; I AFFECTIVE-DISORDER; DIAGNOSTIC INTERVIEW; SUSCEPTIBILITY LOCI; NATIONAL-INSTITUTE; COMPLEX TRAITS; SIBLING PAIRS; PEDIGREES; ILLNESS	Previous evidence suggests that the inheritance of bipolar disorder (BP) may vary depending on the age at onset (AAO). Therefore, we sought to incorporate AAO as a covariate in linkage analyses of BP using two different methods, LODPAL and ordered-subset analysis (OSA), in genomewide scans of 150 multiplex pedigrees with 874 individuals. The LODPAL analysis identified two loci, on chromosomes 21q22.13 (LOD 3.29; empirical chromosomewide P value = .009) and 18p11.2 (LOD 2.83; empirical chromosomewide P = .05), with increased linkage among subjects who had early onset (AAO <= 21 years) and later onset (AAO >21 years), respectively. The finding on 21q22.13 was significant at the chromosomewide level, even after correction for multiple testing. Moreover, a similar finding was observed in an independent sample of 65 pedigrees (LOD = 2.88; empirical chromosomewide P = .025). The finding on 18p11.2 was only nominally significant and was not observed in the independent sample. However, 18p11.2 emerged as one of the strongest regions in the OSA (LOD = 2.92; empirical P = .001), in which it was the only finding to meet chromosomewide levels of significance after correction for multiple testing. These results suggest that 21q22.13 and 18p11.2 may harbor genes that increase the risks for early-onset and later-onset forms of BP, respectively. There have been previous reports of linkage on 21q22.13 and 18p11.2, but the findings have not been consistent. This inconsistency may be due to differences in the AAO characteristics of the samples examined. Future studies to fine map susceptibility genes for BP on chromosomes 21q22.13 and 18p11.2 should take AAO into account.	Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Zandi, PP (corresponding author), 624 N Broadway,8th Floor, Baltimore, MD 21205 USA.	pzandi@ihsph.edu	MacKinnon, Dean/AAG-6232-2020; Lin, Ping-I (Daniel)/O-2613-2015; McInnis, Melvin G/F-6963-2012	McInnis, Melvin G/0000-0002-0375-6247; Lin, Ping-I/0000-0002-9739-7184; Willour, Virginia/0000-0002-6639-487X; DePaulo, J Raymond/0000-0001-9221-9226	NIMH NIH HHS [K01 MH072866-01, K01 MH072866, U01 MH46280] Funding Source: Medline; PHS HHS [U01 H46274] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH072866, U01MH046280] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; *AM PSYCH ASS, 1987, DIAGN STAT MAN 3 R; Bellivier F, 2003, AM J PSYCHIAT, V160, P999, DOI 10.1176/appi.ajp.160.5.999; Bellivier F, 2001, ARCH GEN PSYCHIAT, V58, P510, DOI 10.1001/archpsyc.58.5.510; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Berrettini WH, 2000, BIOL PSYCHIAT, V47, P245, DOI 10.1016/S0006-3223(99)00226-7; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; CARLSON GA, 1977, AM J PSYCHIAT, V134, P919; Carlson GA, 2000, AM J PSYCHIAT, V157, P213, DOI 10.1176/appi.ajp.157.2.213; Carter TDC, 2003, J PSYCHIAT RES, V37, P297, DOI 10.1016/S0022-3956(03)00052-9; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Devlin B, 2002, GENET EPIDEMIOL, V22, P52, DOI 10.1002/gepi.1043; Dick DM, 2002, AM J MED GENET, V114, P407, DOI 10.1002/ajmg.10380; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; ENDICOTT J, 1979, AM J PSYCHIAT, V136, P52; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Faraone SV, 2004, AM J PSYCHIAT, V161, P625, DOI 10.1176/appi.ajp.161.4.625; GERSHON ES, 1989, GENET EPIDEMIOL, V6, P183, DOI 10.1002/gepi.1370060132; Glidden DV, 2003, GENET EPIDEMIOL, V24, P107, DOI 10.1002/gepi.10215; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Greenwood CMT, 1997, GENET EPIDEMIOL, V14, P635; Grigoroiu-Serbanescu M, 2001, AM J MED GENET, V105, P765, DOI 10.1002/ajmg.10047; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lin JP, 1997, GENET EPIDEMIOL, V14, P665, DOI 10.1002/(SICI)1098-2272(1997)14:6<665::AID-GEPI19>3.0.CO;2-O; LIN PI, IN PRESS AM J PSYCHI; Liu JJ, 2001, AM J MED GENET, V105, P189, DOI 10.1002/ajmg.1195; McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Mahony E, 2002, PSYCHOL MED, V32, P55, DOI 10.1017/S0033291701004986; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; RISCH N, 1990, AM J HUM GENET, V46, P229; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Sjoholt G, 2000, MOL PSYCHIATR, V5, P172, DOI 10.1038/sj.mp.4000681; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRATENWERTH G, 1994, PSYCHIAT PRAX, V21, P3; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; WILLOU RVL, 2003, AM J MED GENET B, V121, P21; YOUNG A, GENETIC ANAL SYSTEM; Zandi PP, 2003, AM J MED GENET B, V119B, P69, DOI 10.1002/ajmg.b.10063	50	40	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					545	555		10.1086/491602	http://dx.doi.org/10.1086/491602			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	967QS	16175501	Green Published, Bronze			2022-12-18	WOS:000232106900003
J	Niell, BL; Long, JC; Rennert, G; Gruber, SB				Niell, BL; Long, JC; Rennert, G; Gruber, SB			Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: Evidence of genetic drift within the Ashkenazim	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENOMATOUS POLYPOSIS; MUTATIONS; RISK; POLYMORPHISM; PREVALENCE; DEFICIENCY; HAPLOTYPE; ORIGIN; JEWS; AGE	The adenomatous polyposis coli (APC) I1307K allele is found in 6% of the Ashkenazi Jewish population and in 1%-2% of Sephardi Jews; it confers a relative risk of 1.5-2.0 for colorectal cancer (CRC) on all carriers. Within the Ashkenazim, the existence of numerous high-prevalence mutations, including I1307K, has sparked controversy over whether genetic drift or selection is the underlying cause. For the present population-based case-control study of CRC in Israel, we tested whether selection has operated at I1307K. We also estimated the age of the I1307K allele, to understand its origin in the context of the Jewish diasporas and subsequent founder events. We genotyped 83 matched pairs, in which one or both members of the pair carried I1307K, at three microsatellites and two SNPs. Haplotypes were statistically constructed using PHASE software. Single-marker age estimates for I1307K were calculated using the approach described by Risch et al. A common progenitor haplotype spanned across A-PC I1307K from the centromeric marker D5S135 to the telomeric marker D5S346 and was observed in individuals of Ashkenazi, Sephardi, and Arab descent. The ancestor of modern I1307K alleles existed 87.9-118 generations ago (similar to2,200-2,950 years ago). This age estimate indicates that I1307K existed at about the time of the beginning of the Jewish diaspora, explaining its presence in non-Ashkenazi populations. Our data do not indicate that selection operated at I1307K (D5S346, P = .114; D5S135, P = .373), providing compelling evidence that the high frequency of disease-susceptibility alleles in the Ashkenazim is due to genetic drift, not selection. This research underscores the importance of the migratory patterns of ancestral populations in the ethnic and geographic distribution of A-PC I1307K.	Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Carmel Hosp, Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center	Gruber, SB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, 4301 MSRB 3,Box 0638,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sgruber@umich.edu		Rennert, Gad/0000-0002-8512-068X	NCI NIH HHS [R01 CA081488, R01-CA81488] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040, T32 HG00040] Funding Source: Medline; NIGMS NIH HHS [T32 GM007863, T32 GM07863] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNAVI E, 1992, HIST ATLAS JEWISH PE; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drucker L, 2000, CANCER-AM CANCER SOC, V88, P755, DOI 10.1002/(SICI)1097-0142(20000215)88:4<755::AID-CNCR4>3.0.CO;2-7; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; GRUBER SB, 2001, METHODS MOL MED; Gryfe R, 1999, AM J HUM GENET, V64, P378, DOI 10.1086/302262; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Labuda M, 1996, AM J HUM GENET, V59, P633; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; OLSCHWANG S, 1995, AM J MED GENET, V56, P413, DOI 10.1002/ajmg.1320560413; Patael Y, 1999, EUR J HUM GENET, V7, P555, DOI 10.1038/sj.ejhg.5200325; Prior TW, 1999, GASTROENTEROLOGY, V116, P58, DOI 10.1016/S0016-5085(99)70229-5; REICH DE, 1999, MICROSATELLIES EVOLU; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; SERRE JL, 1990, HUM GENET, V84, P449; SLATKIN M, 1991, GENETICS, V129, P555; Slatkin M, 2001, GENETICS, V158, P865; Slatkin M, 2000, PHILOS T R SOC B, V355, P1663, DOI 10.1098/rstb.2000.0729; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern HS, 2001, GASTROENTEROLOGY, V120, P392, DOI 10.1053/gast.2001.21170; Weinryb Bernard, 1972, JEWS POLAND SOCIAL E; Wilson IJ, 1998, GENETICS, V150, P499	29	40	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1250	1260		10.1086/379926	http://dx.doi.org/10.1086/379926			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14624392	Bronze, Green Published			2022-12-18	WOS:000187491100003
J	Higashimoto, K; Urano, T; Sugiura, K; Yatsuki, H; Joh, K; Zhao, W; Iwakawa, M; Ohashi, H; Oshimura, M; Niikawa, N; Mukai, T; Soejima, H				Higashimoto, K; Urano, T; Sugiura, K; Yatsuki, H; Joh, K; Zhao, W; Iwakawa, M; Ohashi, H; Oshimura, M; Niikawa, N; Mukai, T; Soejima, H			Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; IMPRINTING CONTROL REGION; DNA METHYLATION; H3 METHYLTRANSFERASE; GENE-CLUSTER; MOUSE; LOCUS; H19; ACETYLATION; TRANSCRIPT	To clarify the chromatin-based imprinting mechanism of the p57(KIP2)/LIT1 subdomain at chromosome 11p15.5 and the mouse ortholog at chromosome 7F5, we investigated the histone-modification status at a differentially CpG methylated region of Lit1/LIT1 (DMR-Lit1/LIT1), which is an imprinting control region for the subdomain and is demethylated in half of patients with Beckwith-Wiedemann syndrome (BWS). Chromatin-immunoprecipitation assays revealed that, in both species, DMR-Lit1/LIT1 with the CpG-methylated, maternally derived inactive allele showed histone H3 Lys9 methylation, whereas the CpG-unmethylated, paternally active allele was acetylated on histone H3/H4 and methylated on H3 Lys4. We have also investigated the relationship between CpG methylation and histone H3 Lys9 methylation at DMR-LIT1 in patients with BWS. In a normal individual and in patients with BWS with normal DMR-LIT1 methylation, histone H3 Lys9 methylation was detected on the maternal allele; however, it disappeared completely in the patients with the DMR-LIT1 imprinting defect. These findings suggest that the histone-modification status at DMR-Lit1/LIT1 plays an important role in imprinting control within the subdomain and that loss of histone H3 Lys9 methylation, together with CpG demethylation on the maternal allele, may lead to the BWS phenotype.	Saga Med Sch, Dept Biomol Sci, Div Mol Biol & Genet, Saga 8498501, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi, Japan; Nagoya Univ, Grad Sch Med, Dept Dermatol, Div Connect Tissue Dis & Autoimmun, Nagoya, Aichi, Japan; Natl Inst Radiol Sci, Frontier Res Ctr, Chiba 260, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Yonago, Tottori, Japan; Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Japan	Saga University; Nagoya University; Nagoya University; National Institutes for Quantum Science & Technology; Saitama Children's Medical Center; Tottori University; Nagasaki University; Japan Science & Technology Agency (JST)	Soejima, H (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Mol Biol & Genet, 5-1-1 Nabeshima, Saga 8498501, Japan.	soejimah@post.saga-med.ac.jp	Sugiura, Kazumitsu/M-8913-2014	Sugiura, Kazumitsu/0000-0002-5207-4592; Soejima, Hidenobu/0000-0001-5076-6563; Urano, Takeshi/0000-0003-3383-3554				BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Higashimoto K, 2002, GENOMICS, V80, P575, DOI 10.1006/geno.2002.7006; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Li M, 1998, AM J MED GENET, V79, P253; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SHERMER R, 1997, P NATL ACAD SCI USA, V94, P10267; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thakur N, 2003, J BIOL CHEM, V278, P9514, DOI 10.1074/jbc.M212203200; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yatsuki H, 2002, GENOME RES, V12, P1860, DOI 10.1101/gr.110702; Yoshioka H, 2001, J HUM GENET, V46, P626, DOI 10.1007/s100380170013	44	40	41	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					948	956		10.1086/378595	http://dx.doi.org/10.1086/378595			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12949703	Green Published, Bronze			2022-12-18	WOS:000185676100020
J	Xing, QH; Wang, MT; Chen, XD; Feng, GY; Ji, HY; Yang, JD; Gao, JJ; Qin, W; Qian, XQ; Wu, SN; He, L				Xing, QH; Wang, MT; Chen, XD; Feng, GY; Ji, HY; Yang, JD; Gao, JJ; Qin, W; Qian, XQ; Wu, SN; He, L			A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHYDACTYLY TYPE A-1; RETICULATE ACROPIGMENTATION; XERODERMA-PIGMENTOSUM; LOD SCORES; DOHI; PIGMENTATION; MUTATIONS; FAMILY; MOUSE	Dyschromatosis symmetrica hereditaria (DSH) is a hereditary skin disease characterized by the presence of hyperpigmented and hypopigmented macules on extremities and face. The gene, or even its chromosomal location, for DSH has not yet been identified. In this study, two Chinese families with DSH were identified and subjected to a genomewide screen for linkage analysis. Two-point linkage analysis for pedigree A (maximum LOD score [Z(max)] = 7.28 at recombination fraction [theta] = 0.00) and pedigree B (Z(max) = 2.41 at theta = 0.00) mapped the locus for DSH in the two families to chromosome 6q. Subsequent multipoint analysis of the two families also provided additional support for the DSH gene being located within the region 6q24.2-q25.2, with Z(max) = 10.64. Haplotype analysis confined the locus within an interval of 10.2 Mbp, flanked by markers D6S1703 and D6S1708. The two families had no identical haplotype within the defined region, which suggests that the two families were different in origin. Further work on identification of the gene for DSH will open new avenues to exploration of the genetics of pigmentation.	Shanghai Jiao Tong Univ, BioX Life Sci Res Ctr, Shanghai 200030, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; Shanghai Med Univ 2, Shanghai Peoples Hosp 9, Shanghai, Peoples R China; Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; Shanghai Hosp Integrated Tradit & Western Med, Dept Ophthalmol, Shanghai, Peoples R China; Chinese Acad Sci, Inst Nutr Sci, Shanghai, Peoples R China; Zhengzhou Univ, Affiliated Hosp 2, Zhengzhou, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Zhengzhou University	He, L (corresponding author), Shanghai Jiao Tong Univ, BioX Life Sci Res Ctr, POB 501,Hao Ran Bldg,1954 Hua Shan Rd, Shanghai 200030, Peoples R China.	helin@sjtu.edu.cn						Alfadley A, 2000, J AM ACAD DERMATOL, V43, P113, DOI 10.1067/mjd.2000.103994; CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; Danese P, 1997, J AM ACAD DERMATOL, V37, P884, DOI 10.1016/S0190-9622(97)80018-7; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; HEMANTHKUMAR, 1997, J DERMATOL, V26, P544; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; Kono M, 2000, J DERMATOL SCI, V22, P88, DOI 10.1016/S0923-1811(99)00050-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lui W, 2001, J DENT RES, V80, P1716, DOI 10.1177/00220345010800080701; MATSUMOTO S, 1923, ACTA DERMATOL KYOTO, V2, P191; Nakamura M, 2002, J DERMATOL SCI, V28, P1, DOI 10.1016/S0923-1811(01)00158-X; Ohtoshi E, 2001, BRIT J DERMATOL, V144, P162, DOI 10.1046/j.1365-2133.2001.03968.x; Ostlere LS, 1995, CLIN EXP DERMATOL, V20, P477, DOI 10.1111/j.1365-2230.1995.tb01382.x; Oyama M, 1999, BRIT J DERMATOL, V140, P491; PATRIZI A, 1994, ACTA DERM-VENEREOL, V74, P135; SATOH Y, 1980, Journal of Dermatology (Tokyo), V7, P317; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Tan HH, 1997, PEDIATR DERMATOL, V14, P296, DOI 10.1111/j.1525-1470.1997.tb00962.x; TOMAYA I, 1929, JPN J DERMATOL, V29, P95; Urabe K, 1997, SEMIN CUTAN MED SURG, V16, P81, DOI 10.1016/S1085-5629(97)80039-9; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Yang XP, 2000, AM J HUM GENET, V66, P892, DOI 10.1086/302806	25	40	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					377	382		10.1086/377007	http://dx.doi.org/10.1086/377007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12815562	Green Published, Bronze			2022-12-18	WOS:000184223900013
J	Epstein, MP; Lin, XH; Boehnke, M				Epstein, MP; Lin, XH; Boehnke, M			A tobit variance-component method for linkage analysis of censored trait data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY CALCIFICATION; ASSESSING GENETIC-LINKAGE; SIB-PAIR ANALYSIS; QUANTITATIVE-TRAIT; ASSOCIATION; TESTS; LOCI	Variance-component (VC) methods are flexible and powerful procedures for the mapping of genes that influence quantitative traits. However, traditional VC methods make the critical assumption that the quantitative-trait data within a family either follow or can be transformed to follow a multivariate normal distribution. Violation of the multivariate normality assumption can occur if trait data are censored at some threshold value. Trait censoring can arise in a variety of ways, including assay limitation or confounding due to medication. Valid linkage analyses of censored data require the development of a modified VC method that directly models the censoring event. Here, we present such a model, which we call the "tobit VC method." Using simulation studies, we compare and contrast the performance of the traditional and tobit VC methods for linkage analysis of censored trait data. For the simulation settings that we considered, our results suggest that (1) analyses of censored data by using the traditional VC method lead to severe bias in parameter estimates and a modest increase in false-positive linkage findings, (2) analyses with the tobit VC method lead to unbiased parameter estimates and type I error rates that reflect nominal levels, and (3) the tobit VC method has a modest increase in linkage power as compared with the traditional VC method. We also apply the tobit VC method to censored data from the Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics study and provide two examples in which the tobit VC method yields noticeably different results as compared with the traditional method.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Epstein, MP (corresponding author), Emory Univ, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.	mepstein@genetics.emory.edu			NATIONAL CANCER INSTITUTE [R29CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA76404, R29 CA076404] Funding Source: Medline; NHGRI NIH HHS [R01 HG000376, R01 HG00376] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Bielak LF, 2001, RADIOLOGY, V218, P224, DOI 10.1148/radiology.218.1.r01ja34224; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Epstein MP, 2001, AM J HUM GENET, V69, P228; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Maher JE, 1996, AM J EPIDEMIOL, V144, P943, DOI 10.1093/oxfordjournals.aje.a008864; MORTON NE, 1955, AM J HUM GENET, V7, P277; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; WILLIAMS JS, 1977, BIOMETRIKA, V64, P215, DOI 10.1093/biomet/64.2.215; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6	24	40	40	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					611	620		10.1086/367924	http://dx.doi.org/10.1086/367924			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12587095	Green Published, Bronze			2022-12-18	WOS:000181152600011
J	Katoh, T; Mano, S; Ikuta, T; Munkhbat, B; Tounai, K; Ando, H; Munkhtuvshin, N; Imanishi, T; Inoko, H; Tamiya, G				Katoh, T; Mano, S; Ikuta, T; Munkhbat, B; Tounai, K; Ando, H; Munkhtuvshin, N; Imanishi, T; Inoko, H; Tamiya, G			Genetic isolates in East Asia: A study of linkage disequilibrium in the X chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISOLATED POPULATIONS; FINLAND; HISTORY; REGIONS	The background linkage disequilibrium (LD) in genetic isolates is of great interest in human genetics. Although many empirical studies have evaluated the background LD in European isolates, such as the Finnish and Sardinians, few data from other regions, such as Asia, have been reported. To evaluate the extent of background LD in East Asian genetic isolates, we analyzed the X chromosome in the Japanese population and in four Mongolian populations (Khalkh, Khoton, Uriankhai, and Zakhchin), the demographic histories of which are quite different from one another. Fisher's exact test revealed that the Japanese and Khalkh, which are the expanded populations, had the same or a relatively higher level of LD than did the Finnish, European American, and Sardinian populations. In contrast, the Khoton, Uriankhai, and Zakhchin populations, which have kept their population size constant, had a higher background LD. These results were consistent with previous genetic anthropological studies in European isolates and indicate that the Japanese and Khalkh populations could be utilized in the fine mapping of both complex and monogenic diseases, whereas the Khoton, Uriankhai, and Zakhchin populations could play an important role in the initial mapping of complex disease genes.	Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591193, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo, Japan; Natl Med Univ Mongolia, Natl Inst Hlth, Ulaanbaatar, Mongolia	Tokai University; National Institute of Advanced Industrial Science & Technology (AIST); Mongolian National University of Medical Sciences	Tamiya, G (corresponding author), Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591193, Japan.	gtamiya@is.icc.u-tokai.ac.jp	Imanishi, Tadashi/R-3076-2019; Katoh, Toru/C-7972-2012	Tamiya, Gen/0000-0002-0597-415X; MUNKHBAT, Batmunkh/0000-0002-8664-7483; Imanishi, Tadashi/0000-0002-1182-9127; Katoh, Toru/0000-0003-3376-8545				Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; BADAMKHATAN S, 1996, ETHNOGRAPHY MONGOLIA, V3; BADAMKHATAN S, 1996, ETHNOGRAPHY MONGOLIA, V2; Badamkhatan S, 1987, ETHNOGRAPHY MONGOLIA, VI; Batsuuri J, 1977, P I GEN EXPT BIOL, V12, P111; BATSUURI J, 1978, P I GEN EXPT BIOL MO, V13, P115; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hayami Akira, 2001, HIST DEMOGRAPHY PREM; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Koyama S., 1978, SENRI ETHNOL STUD, V2, P1; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lonjou C, 1999, P NATL ACAD SCI USA, V96, P1621, DOI 10.1073/pnas.96.4.1621; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Nyambuu K, 1992, INTRO ETHNOGRAPHY MO; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; *STAT BUR STAT RES, 2001, JAP STAT YB 2002; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TUMEN D, 1992, THESIS MV LOMONOSOV; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	31	40	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					395	400		10.1086/341608	http://dx.doi.org/10.1086/341608			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12082643	Green Published, Bronze			2022-12-18	WOS:000176977700017
J	Sun, L; Cox, NJ; McPeek, MS				Sun, L; Cox, NJ; McPeek, MS			A statistical method for identification of Polymorphisms that explain a linkage result	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; MODELS; CALPAIN-10; TRAITS	Suppose that many polymorphic sites have been identified and genotyped in a region showing strong linkage with a trait. A key question of interest is which site (or combination of sites) in the region influences susceptibility to the trait. We have developed a novel statistical approach to this problem, in the context of qualitative-trait mapping, in which we use linkage data to identify the polymorphic sites whose genotypes could fully explain the observed linkage to the region. The information provided by this analysis is different from that provided by tests of either linkage or association. Our approach is based on the observation that if a particular site is the only site in the region that influences the trait, then-conditional on the genotypes at that site for the affected relatives-there should be no unexplained oversharing in the region among affected individuals. We focus on the affected sib-pair study design and develop test statistics that are variations on the usual allele-sharing methods used in linkage studies. We perform hypothesis tests and derive a confidence set for the true causal polymorphic site, under the assumption that there is only one site in the region influencing the trait. Our method is appropriate under a very general model for how the site influences the trait, including epistasis with unlinked loci, correlated environmental effects within families, and gene-environment interaction. We extend our method to larger sibships and apply it to an NIDDM1 data set.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	McPeek, MS (corresponding author), Univ Chicago, Dept Stat, 5734 S Univ Ave, Chicago, IL 60637 USA.				NHGRI NIH HHS [R29 HG001645, HG01645, R01 HG001645] Funding Source: Medline; NIDDK NIH HHS [R01 DK055889, DK55889] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; BLANGERO J, 2000, GEN AN WORKSH 12 SAN; Cardon LR, 2000, BEHAV GENET, V30, P235, DOI 10.1023/A:1001970425822; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; FIMMERS R, 1989, MULTIPOINT MAPPING L, V6, P123; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HODGE SE, 1993, AM J HUM GENET, V53, P367; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Siegmund KD, 2001, GENET EPIDEMIOL, V21, pS358, DOI 10.1002/gepi.2001.21.s1.s358; Soria JM, 2000, BLOOD, V95, P2780, DOI 10.1182/blood.V95.9.2780.009k36_2780_2785; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; THOMPSON EA, 1974, BIOMETRICS, V30, P667, DOI 10.2307/2529231; Valdes AM, 1997, AM J HUM GENET, V60, P703; WHITTEMORE AS, 1996, AM J HUM GENET, V59, P276; Yang XL, 2001, MOL GENET METAB, V73, P111, DOI 10.1006/mgme.2001.3171	21	40	41	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					399	411		10.1086/338660	http://dx.doi.org/10.1086/338660			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791210	Green Published, Bronze			2022-12-18	WOS:000173254300012
J	Durst, R; Colombo, R; Shpitzen, S; Ben Avi, L; Friedlander, Y; Wexler, R; Raal, FJ; Marais, DA; Defesche, JC; Mandelshtam, MY; Kotze, MJ; Leitersdorf, E; Meiner, V				Durst, R; Colombo, R; Shpitzen, S; Ben Avi, L; Friedlander, Y; Wexler, R; Raal, FJ; Marais, DA; Defesche, JC; Mandelshtam, MY; Kotze, MJ; Leitersdorf, E; Meiner, V			Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: Positive selection is not always necessary to account for disease incidence among Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPOPROTEIN-RECEPTOR GENE; AUTOSOMAL DOMINANT INHERITANCE; IDIOPATHIC TORSION DYSTONIA; LINKAGE DISEQUILIBRIUM; APOLIPOPROTEIN-E; FRENCH-CANADIANS; PHENOTYPIC VARIATION; NONSENSE MUTATION; FOUNDER MUTATIONS; GAUCHER-DISEASE	G197del is the most prevalent LDL receptor (LDLR) mutation causing familial hypercholesterolemia (FH) in Ashkenazi Jew (AJ) individuals. The purpose of this study was to determine the origin, age, and population distribution of G197del, as well as to explore environmental and genetic effects on disease expression. Index cases from Israel (n = 46), South Africa (n = 24), Russia (n = 7), The Netherlands (n = 1), and the United States (n = 1) were enlisted. All trace their ancestry to Lithuania. A highly conserved haplotype (D19S221:104-D19S865:208-D19S413: 74) was identified in G197del chromosomes, suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the deletion was found to be 20 +/- 7 generations (the 95% confidence interval is 15-26 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 14th century. This corresponds with the founding of the Jewish community of Lithuania (1338 A.D.), as well as with the great demographic expansion of AJ individuals in eastern Europe, which followed this settlement. The penetrance of mutation-linked severe hypercholesterolemia is high (94% of heterozygotes have a baseline concentration of LDL cholesterol (LDL-C) that is >160 mg/dl), and no significant differences in the mean baseline lipid level of G197del carriers from different countries were found. Polymorphisms of apolipoprotein E and of scavenger-receptor class B type I were observed to have minor effects on the plasma lipid profile. With respect to determinative genetic influences on the biochemical phenotype, there is no evidence that could support the possibility of a selective evolutionary metabolic advantage. Therefore, the founder effect in a rapidly expanding population from a limited number of families remains a simple, parsimonious hypothesis explaining the spread of G197del-LDLR- linked FH in AJ individuals.	Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Ctr Res Prevent & Treatment Atherosclerosis, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Publ Hlth, Dept Social Med, Jerusalem, Israel; Univ Cattolica Sacro Cuore, Dept Psychol, Human Biol & Genet Res Unit, I-20123 Milan, Italy; Univ Witwatersrand, Dept Med, Carbohydrate & Lipid Metab Res Unit, ZA-2001 Johannesburg, South Africa; Univ Cape Town, Fac Hlth Sci, Cape Heart Ctr, Lipid Lab, ZA-7925 Cape Town, South Africa; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; St Petersburg Acad, Inst Expt Med, Dept Mol Genet, St Petersburg, Russia; Univ Stellenbosch, Fac Hlth Sci, Div Human Genet, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, Fac Hlth Sci, Cape Heart Res Grp, ZA-7505 Tygerberg, South Africa	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Catholic University of the Sacred Heart; University of Witwatersrand; University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Experimental Medicine; Stellenbosch University; Stellenbosch University	Leitersdorf, E (corresponding author), Hadassah Univ Hosp, Div Med, POB 12-221, IL-91120 Jerusalem, Israel.	rcolombo@mi.unicatt.it	Raal, FJ/ABD-5111-2021; Kotze, Maritha J/GMX-0989-2022; Mandelshtam, Michail/T-9993-2019	Raal, FJ/0000-0002-9170-7938; Mandelshtam, Michail/0000-0002-7135-3239; Kotze, Martha/0000-0002-6050-2876; Durst, Ronen/0000-0003-3559-1050				AALTOSETALA K, 1992, J INTERN MED, V231, P227, DOI 10.1111/j.1365-2796.1992.tb00528.x; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Ankori Zvi., 1979, GENETIC DIS ASHKENAZ, P19; BARNAVI E, 1992, HIST ATLAS JEWISH PE; BEIRNART H, 1992, ATLAS MEDIEVAL JEWIS; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BERSHADSKYI S, ENCY DICT, V11, P453; Bertolini S, 2000, ARTERIOSCL THROM VAS, V20, pE41, DOI 10.1161/01.ATV.20.9.e41; Betard C, 1996, ATHEROSCLEROSIS, V119, P43, DOI 10.1016/0021-9150(95)05627-0; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; Carmena-Ramon R, 2000, NUTR METAB CARDIOVAS, V10, P7; Colombo R, 2000, AM J HUM GENET, V66, P692, DOI 10.1086/302757; Colombo R, 2000, HUM GENET, V106, P455, DOI 10.1007/s004390000261; Couture P, 1999, ATHEROSCLEROSIS, V143, P145, DOI 10.1016/S0021-9150(98)00267-6; DALLONGEVILLE J, 1991, ARTERIOSCLER THROMB, V11, P272, DOI 10.1161/01.ATV.11.2.272; DANIEL WW, 1995, BIOSTATISTICS FDN AN, P139; DAVIES N, 1984, GODS PLAYGROUND HIST; DEKNIJFF P, 1990, ATHEROSCLEROSIS, V83, P89; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Diaz GA, 2000, AM J HUM GENET, V66, P1821, DOI 10.1086/302946; ETO M, 1988, ATHEROSCLEROSIS, V72, P123, DOI 10.1016/0021-9150(88)90072-X; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GAR J, 1971, JUDAICA ENCY, P362; GEISEL J, 1995, HUM GENET, V96, P301; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GOODMAN RM, 1979, GENETIC DIS ASHKENAZ; GUDNASON V, 1993, ARTERIOSCLER THROMB, V13, P56, DOI 10.1161/01.ATV.13.1.56; Guo SW, 1997, HUM HERED, V47, P315, DOI 10.1159/000154431; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Heath KE, 2001, ATHEROSCLEROSIS, V154, P243, DOI 10.1016/S0021-9150(00)00647-X; HIXSON JE, 1990, J LIPID RES, V31, P545; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hogenauer C, 2000, AM J HUM GENET, V67, P1422, DOI 10.1086/316911; Iwaki K, 1999, J HUM GENET, V44, P421, DOI 10.1007/s100380050193; JORDE LB, 1992, GENETIC DIVERSITY AMONG JEWS, P305; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Klein C, 1998, HUM MOL GENET, V7, P1133, DOI 10.1093/hmg/7.7.1133; KOIVISTO UM, 1992, J CLIN INVEST, V90, P219, DOI 10.1172/JCI115839; KOTZE MJ, 1991, ANN HUM GENET, V55, P115, DOI 10.1111/j.1469-1809.1991.tb00404.x; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; LANDSBERGER D, 1992, AM J HUM GENET, V50, P427; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; LEITERSDORF E, 1991, J LIPID RES, V32, P1513; Loubser O, 1999, CLIN GENET, V55, P340, DOI 10.1034/j.1399-0004.1999.550507.x; Luria SE, 1943, GENETICS, V28, P491; Mandelshtam M, 1998, HUM MUTAT, V12, P255, DOI 10.1002/(SICI)1098-1004(1998)12:4<255::AID-HUMU6>3.0.CO;2-E; MEINER V, 1991, AM J HUM GENET, V49, P443; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; MOORJANI S, 1993, LANCET, V341, P1303, DOI 10.1016/0140-6736(93)90815-X; MOTULSKY AG, 1979, GENETIC DIS ASHKENAZ, P301; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; OMALLEY JP, 1990, METABOLISM, V39, P150, DOI 10.1016/0026-0495(90)90068-N; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; Pimstone SN, 1998, ARTERIOSCL THROM VAS, V18, P309, DOI 10.1161/01.ATV.18.2.309; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; REICH DE, 1999, MICROSATELLITES EVOL, P129; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RISCH NJ, 1990, AM J HUM GENET, V46, P533; SEFTEL HC, 1989, AM J MED GENET, V34, P545, DOI 10.1002/ajmg.1320340418; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SLIMANE MN, 1993, ATHEROSCLEROSIS, V104, P153, DOI 10.1016/0021-9150(93)90186-X; STEYN K, 1989, J MED GENET, V26, P32, DOI 10.1136/jmg.26.1.32; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; TSUDA T, 1994, ANN NEUROL, V36, P97, DOI 10.1002/ana.410360118; Valente EM, 1999, ANN HUM GENET, V63, P1, DOI 10.1046/j.1469-1809.1999.6310001.x; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Ward AJ, 1996, ATHEROSCLEROSIS, V120, P83, DOI 10.1016/0021-9150(95)05685-8; WATKINS WS, 1994, AM J HUM GENET, V55, P348; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weinryb Bernard, 1972, JEWS POLAND SOCIAL E; ZOOSSMANNDISKIN A, 1995, NAT GENET, V11, P13, DOI 10.1038/ng0995-13	81	40	43	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1172	1188		10.1086/320123	http://dx.doi.org/10.1086/320123			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309683	Bronze, Green Published			2022-12-18	WOS:000168171200011
J	Shin, WS; Tanaka, M; Suzuki, J; Hemmi, C; Toyo-oka, T				Shin, WS; Tanaka, M; Suzuki, J; Hemmi, C; Toyo-oka, T			A novel homoplasmic mutation in mtDNA with a single evolutionary origin as a risk factor for cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL-DNA; ALZHEIMER-DISEASE	To clarify the relationship between variation in mtDNA and the development of cardiomyopathy (CM), the complete sequences of mtDNAs of two brothers with dilated CM were compared with those of 181 patients who had CM and with those of 168 control subjects. Five patients with CM shared a novel homoplasmic point mutation (G12192A tRNA(His)), and all of them demonstrated the evolutionarily related D-loop sequence. The results suggest that this novel mutation originated from the same ancestor and that its presence strongly predisposes carriers to CM.	Univ Tokyo, Dept Cardiovasc Med, Hlth Serv Ctr, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1130033, Japan; Gifu Int Inst Biotechnol, Gifu, Japan	University of Tokyo; University of Tokyo	Shin, WS (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Hlth Serv Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.							Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Graham RM, 1999, NEW ENGL J MED, V341, P1759, DOI 10.1056/NEJM199912023412309; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlesselman James J., 1982, CASE CONTROL STUDIES; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Suzuki J, 1999, J AM COLL CARDIOL, V33, P146, DOI 10.1016/S0735-1097(98)00527-0; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523	15	40	45	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1617	1620		10.1086/316896	http://dx.doi.org/10.1086/316896			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11038324	Green Published, Bronze			2022-12-18	WOS:000165607600030
J	Gastwirth, JL				Gastwirth, JL			The efficiency of pooling in the detection of rare mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PREVALENCE; DISEASE; HIV		NCI, Biostat Branch, Div Canc Genet & Epidemiol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gastwirth, JL (corresponding author), NCI, Biostat Branch, Div Canc Genet & Epidemiol, 6120 Execut Blvd,MS 7244, Bethesda, MD 20892 USA.				DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP010110] Funding Source: NIH RePORTER	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		Amos CI, 2000, AM J HUM GENET, V66, P1689, DOI 10.1086/302894; Brookmeyer R, 1999, BIOMETRICS, V55, P608, DOI 10.1111/j.0006-341X.1999.00608.x; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; GASTWIRTH JL, 1994, J AM STAT ASSOC, V89, P972, DOI 10.2307/2290923; GASTWIRTH JL, 1989, J STAT PLAN INFER, V22, P15, DOI 10.1016/0378-3758(89)90061-X; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; HUGHESOLIVER JM, 1994, J AM STAT ASSOC, V89, P982; Krook Anna, 1992, Human Molecular Genetics, V1, P391, DOI 10.1093/hmg/1.6.391; Munoz-Zanzi CA, 2000, J VET DIAGN INVEST, V12, P195, DOI 10.1177/104063870001200301; SOBEL M, 1975, BIOMETRIKA, V62, P181, DOI 10.2307/2334502; TU XM, 1995, BIOMETRIKA, V82, P287; Zarbl H, 1998, GENET TEST, V2, P315, DOI 10.1089/gte.1998.2.315	12	40	42	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1036	1039		10.1086/303097	http://dx.doi.org/10.1086/303097			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986050	Green Published, Bronze			2022-12-18	WOS:000089651100033
J	Cohn, DH; Shohat, T; Yahav, M; Ilan, T; Rechavi, G; King, L; Shohat, M				Cohn, DH; Shohat, T; Yahav, M; Ilan, T; Rechavi, G; King, L; Shohat, M			A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY-DISEASE; GENE	Linkage studies were performed in a large family with an autosomal dominant phenotype characterized by nephropathy and hypertension. In this family of Iraqi Jewish origin, the nephropathy develops into progressive renal failure. By performing a genomewide linkage search, we localized the disease gene to chromosome 1q21; the highest LOD score was obtained for the marker at locus D1S305, which yielded a maximum LOD score of 4.71 at a recombination fraction of 0. Recombination mapping defined an interval of similar to 11.6 cM, between the markers at loci D1S2696 and D1S2635, that contains the disease gene. Localization of the disease-causing gene in this family represents a necessary step toward isolation of the defective gene and toward a deeper understanding of the mechanisms of hypertension and progressive renal failure.	Rabin Med Ctr, Dept Med Genet, IL-49100 Petah Tiqwa, Israel; Cedars Sinai Res Inst, Ahmanson Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; Sheba Med Ctr, Israel Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel; Rabin Med Ctr, Dept Med Genet, Petah Tiqwa, Israel; FMRC, Petah Tiqwa, Israel; Chaim Sheba Med Ctr, Dept Pediat Hematol & Oncol, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chaim Sheba Medical Center; Rabin Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shohat, M (corresponding author), Rabin Med Ctr, Dept Med Genet, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.							ALBERT MS, 1969, AM J DIS CHILD, V117, P153, DOI 10.1001/archpedi.1969.02100030155006; BENISHAY D, 1967, ISRAEL J MED SCI, V3, P106; Christodoulou K, 1998, HUM MOL GENET, V7, P905, DOI 10.1093/hmg/7.5.905; DOCKHORN RJ, 1967, AM J DIS CHILD, V114, P135, DOI 10.1001/archpedi.1967.02090230065004; Faubert PF, 1997, AM J KIDNEY DIS, V30, P265, DOI 10.1016/S0272-6386(97)90062-7; GAUTHIER B, 1989, NEPHRON, V51, P502, DOI 10.1159/000185384; GOLDMAN SH, 1966, NEW ENGL J MED, V274, P984, DOI 10.1056/NEJM196605052741802; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P8327, DOI 10.1073/pnas.89.17.8327; RICHMOND JM, 1981, CLIN NEPHROL, V16, P109; Scolari F, 1999, AM J HUM GENET, V64, P1655, DOI 10.1086/302414; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WARD CJ, 1994, CELL, V77, P881; Winn MP, 1999, GENOMICS, V58, P113, DOI 10.1006/geno.1999.5828	20	40	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					647	651		10.1086/303051	http://dx.doi.org/10.1086/303051			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10930359	Green Published, Bronze			2022-12-18	WOS:000089002300011
J	Goldberg, EK; Glendening, JM; Karanjawala, Z; Sridhar, A; Walker, GJ; Hayward, NK; Rice, AJ; Kurera, D; Tebha, Y; Fountain, JW				Goldberg, EK; Glendening, JM; Karanjawala, Z; Sridhar, A; Walker, GJ; Hayward, NK; Rice, AJ; Kurera, D; Tebha, Y; Fountain, JW			Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; HUMAN PROSTATE-CANCER; CELL-LINES; ATAXIA-TELANGIECTASIA; OVARIAN-CANCER; BREAST-CANCER; PHYSICAL MAP; COLON-CANCER; LONG ARM; GENOMIC ORGANIZATION	Loss-of-heterozygosity (LOH) studies have implicated one or more chromosome 11 tumor-suppressor gene(s) in the development of cutaneous melanoma as well as a variety of other forms of human cancer. In the present study, we have identified multiple independent critical regions on this chromosome by use of homozygosity mapping of deletions (HOMOD) analysis. This method of analysis involved the use of highly polymorphic microsatellite markers and statistics to identify regions of hemizygous deletion in unmatched melanoma cell line DNAs. Regions of loss were defined by the presence of an extended region of homozygosity (ERH) at greater than or equal to 5 adjacent markers and having a statistical probability of less than or equal to.001. Significant ERHs were similar in nature to deletions identified by LOH analyses performed on uncultured melanomas, although a higher frequency of loss (24 [60%] of 40 vs. 16 [34%] of 47) was observed in the cell lines. Overall, six small regions of overlapping deletions (SROs) were identified on chromosome 11 flanked by the markers D11S1338/D11S907 (11p13-15.5 [SRO1]), D11S1344/D11S11385 (11p11.2 [SRO2]), D11S917/D11S1886 (11q21-22.3 [SRO3]), D11S927/D11S4094 (11q23 [SRO4]),AFM210ve3/D11S990 (11q24 [SR05]), and D11S1351/D11S4123 (11q24-25 [SRO6]). We propose that HOMOD analysis can be used as an adjunct to LOH analysis in the localization of tumor-suppressor genes.	Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA USA; Queensland Inst Med Res, Joint Expt Oncol Program, Queensland Canc Fund Res Unit, Herston, Qld 4006, Australia; Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia	University of Southern California; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Fountain, JW (corresponding author), NCI, Organ Syst Branch, 6116 Execut Blvd,Suite 7008,MSC 8347, Rockville, MD 20852 USA.		hayward, nicholas k/C-1367-2015; Walker, Graeme J/C-2548-2012; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; Walker, Graeme J/0000-0002-9392-8769; 	NATIONAL CANCER INSTITUTE [R01CA066021] Funding Source: NIH RePORTER; NCI NIH HHS [CA66021] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arai Y, 1996, GENOMICS, V35, P196, DOI 10.1006/geno.1996.0339; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 1997, AM J HUM GENET, V60, P121; Baysal BE, 1998, GENE, V217, P107, DOI 10.1016/S0378-1119(98)00350-3; Baysal BE, 1997, GENOMICS, V44, P214, DOI 10.1006/geno.1997.4880; BETHWAITE PB, 1995, BRIT J CANCER, V71, P814, DOI 10.1038/bjc.1995.157; BIRAN H, 1994, MED HYPOTHESES, V43, P119, DOI 10.1016/0306-9877(94)90062-0; Boland CR, 1998, CANCER RES, V58, P5248; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Castellano M, 1997, CANCER RES, V57, P4868; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Coleman WB, 1997, MOL CARCINOGEN, V19, P267, DOI 10.1002/(SICI)1098-2744(199708)19:4<267::AID-MC8>3.0.CO;2-9; Connolly KC, 1999, CANCER RES, V59, P2806; Croce CM, 1999, CANCER RES, V59, p1778S; Dahiya R, 1997, INT J CANCER, V72, P283, DOI 10.1002/(SICI)1097-0215(19970717)72:2<283::AID-IJC14>3.0.CO;2-H; Davis M, 1996, CANCER RES, V56, P741; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; EDVARDSEN K, 1994, INT J CANCER, V58, P116, DOI 10.1002/ijc.2910580119; Flores JF, 1996, CANCER RES, V56, P5023; Forozan F, 1997, AM J HUM GENET, V61, pA65; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; FOUNTAIN JW, 1998, CUTANEOUS MELANOMA, P475; Gabra H, 1996, CANCER RES, V56, P950; Gonzalgo ML, 1997, CANCER RES, V57, P5336; GUDMUNDSSON J, 1995, BRIT J CANCER, V72, P696, DOI 10.1038/bjc.1995.396; HAMPTON GM, 1994, CANCER RES, V54, P4586; HAMPTON GM, 1994, P NATL ACAD SCI USA, V91, P6953, DOI 10.1073/pnas.91.15.6953; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; Herbst RA, 1999, INT J CANCER, V80, P205, DOI 10.1002/(SICI)1097-0215(19990118)80:2<205::AID-IJC8>3.0.CO;2-J; HERBST RA, 1995, CANCER RES, V55, P2494; Horikawa I, 1995, CANCER GENET CYTOGEN, V85, P97, DOI 10.1016/0165-4608(95)00147-6; Huang CC, 1997, ONCOGENE, V15, P851, DOI 10.1038/sj.onc.1201408; Hui ABY, 1996, CANCER RES, V56, P3225; IIZUKA M, 1995, GENE CHROMOSOME CANC, V13, P40; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kawana Y, 1997, PROSTATE, V32, P205; KELDYSH PL, 1993, GENE CHROMOSOME CANC, V6, P45, DOI 10.1002/gcc.2870060109; Kohn KW, 1996, CANCER RES, V56, P5533; Koreth J, 1997, ONCOGENE, V14, P431, DOI 10.1038/sj.onc.1200847; Laake K, 1997, GENE CHROMOSOME CANC, V18, P175, DOI 10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.0.CO;2-Z; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Li RG, 1999, SCI CHINA SER C, V42, P96, DOI 10.1007/BF02881754; LIU Q, 1995, ONCOGENE, V10, P1061; Lubensky IA, 1996, CANCER RES, V56, P5272; Martin RA, 1999, J MED GENET, V36, P633; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; MISRA BC, 1989, AM J HUM GENET, V45, P565; Monaco C, 1997, GENOMICS, V46, P217, DOI 10.1006/geno.1997.5036; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MORSE HG, 1992, CANCER GENET CYTOGEN, V64, P118, DOI 10.1016/0165-4608(92)90340-E; Murakami Y, 1998, P NATL ACAD SCI USA, V95, P8153, DOI 10.1073/pnas.95.14.8153; NEGRINI M, 1995, CANCER RES, V55, P3003; Owens GC, 1998, CANCER RES, V58, P2020; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Pollock PM, 1998, HUM MUTAT, V11, P424, DOI 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.3.CO;2-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RASIO D, 1995, CANCER RES, V55, P6053; RASIO D, 1995, CANCER RES, V55, P3988; Reid LH, 1997, GENOMICS, V43, P366, DOI 10.1006/geno.1997.4826; Robertson G, 1996, CANCER RES, V56, P4487; Robertson GP, 1999, ONCOGENE, V18, P3173, DOI 10.1038/sj.onc.1202664; Robertson GP, 1998, P NATL ACAD SCI USA, V95, P9418, DOI 10.1073/pnas.95.16.9418; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; SHAW ME, 1995, GENE CHROMOSOME CANC, V13, P1, DOI 10.1002/gcc.2870130102; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tahara H, 1996, CANCER RES, V56, P599; TOMLINSON IPM, 1995, J CLIN PATHOL, V48, P424, DOI 10.1136/jcp.48.5.424; TOMLINSON IPM, 1993, GENE CHROMOSOME CANC, V7, P169, DOI 10.1002/gcc.2870070310; Tomlinson IPM, 1996, EUR J CANCER, V32A, P1797, DOI 10.1016/0959-8049(96)00198-0; TRENT JM, 1990, NEW ENGL J MED, V322, P1508, DOI 10.1056/NEJM199005243222107; Tunnacliffe A, 1999, GENOME RES, V9, P44; Uzawa K, 1996, INT J CANCER, V67, P510, DOI 10.1002/(SICI)1097-0215(19960807)67:4<510::AID-IJC8>3.3.CO;2-R; VANAGAITE L, 1995, HUM GENET, V95, P451; Walker GJ, 1999, INT J CANCER, V82, P305, DOI 10.1002/(SICI)1097-0215(19990719)82:2<305::AID-IJC24>3.0.CO;2-Z; WALKER GJ, 1995, GENE CHROMOSOME CANC, V12, P134, DOI 10.1002/gcc.2870120208; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; Wang S, 1997, AM J HUM GENET, V61, pA87; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wang SSQ, 1999, GENE CHROMOSOME CANC, V25, P154, DOI 10.1002/(SICI)1098-2264(199906)25:2<154::AID-GCC11>3.3.CO;2-N; WINQVIST R, 1995, CANCER RES, V55, P2660; Wistuba II, 1999, CLIN CANCER RES, V5, P991	91	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					417	431		10.1086/302999	http://dx.doi.org/10.1086/302999			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10877980	Green Published, Bronze			2022-12-18	WOS:000089357800017
J	Crawford, DC; Schwartz, CE; Meadows, KL; Newman, JL; Taft, LF; Gunter, C; Brown, WT; Carpenter, NJ; Howard-Peebles, PN; Monaghan, KG; Nolin, SL; Reiss, AL; Feldman, GL; Rohlfs, EM; Warren, ST; Sherman, SL				Crawford, DC; Schwartz, CE; Meadows, KL; Newman, JL; Taft, LF; Gunter, C; Brown, WT; Carpenter, NJ; Howard-Peebles, PN; Monaghan, KG; Nolin, SL; Reiss, AL; Feldman, GL; Rohlfs, EM; Warren, ST; Sherman, SL			Survey of the fragile X syndrome CGG repeat and the short-tendem-repeat and single-nucleotide-polymorphism haplotypes in an African American population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EDUCATION-NEEDS POPULATION; TRINUCLEOTIDE REPEAT; FRAXE ALLELES; FMR1 LOCUS; INSTABILITY; GENE; MUTATION; SEQUENCE; STABILITY; EXPANSION	Previous studies have shown that specific short-tandem-repeat (STR) and single-nucleotide-polymorphism (SNP)-based haplotypes within and among unaffected and fragile X white populations are found to be associated with specific CGG-repeat patterns. It has been hypothesized that these associations result from different mutational mechanisms, possibly influenced by the CGG structure and/or cis-acting factors. Alternatively, haplotype associations may result from the long mutational history of increasing instability. To understand the basis of the mutational process, we examined the CGG-repeat size, three flanking STR markers (DXS548-FRAXAC1-FRAXAC2), and one SNP (ATL1) spanning 150 kb around the CGG repeat in unaffected (n = 637) and fragile X (n = 63) African American populations and compared them with unaffected (n = 721) and fragile X (n = 102) white populations. Several important differences were found between the two ethnic groups. First, in contrast to that seen in the white population, no associations were observed among the African American intermediate or "predisposed" alleles (41-60 repeats). Second, two previously undescribed haplotypes accounted for the majority of the African American fragile X population. Third, a putative "protective" haplotype was not found among African Americans, whereas it was found among whites. Fourth, in contrast to that seen in whites, the SNP ATL1 was in linkage equilibrium among African Americans, and it did not add new information to the STR haplotypes. These data indicate that the STR- and SNP-based haplotype associations identified in whites probably reflect the mutational history of the expansion, rather than a mutational mechanism or pathway.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Howard Hughes Med Inst, Atlanta, GA USA; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Genet & IVF Inst, Fairfax, VA 22039 USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Stanford Univ, Dept Psychiat, Div Child & Adolescent Psychiat & Child Dev, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; Henry Ford Hosp, Dept Med Genet, Detroit, MI 48202 USA; HA Chapman Inst Med Genet, Tulsa, OK USA	Emory University; Emory University; Howard Hughes Medical Institute; Greenwood Genetic Center; Virginia Commonwealth University; Institute for Basic Research in Developmental Disabilities; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Henry Ford Health System; Henry Ford Hospital	Sherman, SL (corresponding author), Emory Univ, Sch Med, Dept Genet, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.		Gunter, Chris/AHA-7271-2022; Crawford, Dana/O-5578-2019; Brown, William/GXN-2777-2022; Crawford, Dana/C-1054-2012; Warren, Stephen T/A-2498-2012	Crawford, Dana/0000-0002-6437-6248; Nolin, Sarah/0000-0001-5209-289X; Gunter, Chris/0000-0001-9369-7537	NCRR NIH HHS [MO1-RR-00039, M01 RR000039] Funding Source: Medline; NICHD NIH HHS [HD29909, F31 HD008443, R01 HD029909, P01 HD035576, HD35576] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD008443, R01HD029909, P01HD035576] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arrieta I, 1999, HUM BIOL, V71, P55; Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; Brown TC, 1997, AM J MED GENET, V73, P447, DOI 10.1002/(SICI)1096-8628(19971231)73:4<447::AID-AJMG14>3.0.CO;2-R; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J HUM GENET, V58, P641; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Chiurazzi P, 1996, AM J MED GENET, V64, P209, DOI 10.1002/(SICI)1096-8628(19960712)64:1<209::AID-AJMG38>3.0.CO;2-P; Chiurazzi P, 1996, AM J MED GENET, V64, P216, DOI 10.1002/(SICI)1096-8628(19960712)64:1<216::AID-AJMG39>3.0.CO;2-O; Chiurazzi P, 1999, AM J MED GENET, V83, P347; Chiurazzi P, 1996, AM J MED GENET, V64, P203, DOI 10.1002/(SICI)1096-8628(19960712)64:1<203::AID-AJMG37>3.0.CO;2-P; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 1999, AM J HUM GENET, V64, P495, DOI 10.1086/302260; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; Destro-Bisol G, 1999, HUM GENET, V104, P149, DOI 10.1007/s004390050928; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Eichler EE, 1996, AM J MED GENET, V64, P220, DOI 10.1002/(SICI)1096-8628(19960712)64:1<220::AID-AJMG40>3.0.CO;2-M; FRANKLIN JH, 1994, SLAVERY FREEDOM HIST, P27; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; JOHNSON DM, 1981, BLACKMIGRATION AM SO; Kunst CB, 1996, AM J HUM GENET, V58, P513; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Meadows KL, 1996, AM J MED GENET, V64, P428, DOI 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.3.CO;2-7; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; NEI M, 1978, GENETICS, V89, P583; Nolin SL, 1996, AM J HUM GENET, V59, P1252; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PIERSEN WD, 1996, AFRICA AM; RICHARDS RJ, 1994, AM J MED GENET, V51, P412, DOI 10.1002/ajmg.1320510422; SCHWARTZ CE, 1988, AM J MED GENET, V30, P641, DOI 10.1002/ajmg.1320300165; SCHWARTZ CE, 1988, AM J MED GENET, V30, P531, DOI 10.1002/ajmg.1320300155; Sherman SL, 1996, AM J MED GENET, V64, P256, DOI 10.1002/(SICI)1096-8628(19960809)64:2<256::AID-AJMG4>3.0.CO;2-S; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248; ZHONG N, 1994, AM J MED GENET, V51, P417, DOI 10.1002/ajmg.1320510423; ZHONG N, 1995, AM J HUM GENET, V57, P351; Zhong N, 1996, AM J MED GENET, V64, P261, DOI 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X; [No title captured]	52	40	44	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					480	493		10.1086/302762	http://dx.doi.org/10.1086/302762			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677308	Green Published, Bronze			2022-12-18	WOS:000088373100015
J	Struewing, JP; Coriaty, ZM; Ron, E; Livoff, A; Konichezky, M; Cohen, P; Resnick, MB; Lifzchiz-Mercerl, B; Lew, S; Iscovich, J				Struewing, JP; Coriaty, ZM; Ron, E; Livoff, A; Konichezky, M; Cohen, P; Resnick, MB; Lifzchiz-Mercerl, B; Lew, S; Iscovich, J			Founder BRCA1/2 mutations among male patients with breast cancer in Israel	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FAMILIES; JEWS		NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; NCI, Radiat Epidemiol Branch, NIH, Bethesda, MD 20892 USA; Hadassah Med Org, Dept Pathol, Jerusalem, Israel; Carmel Med Ctr, Dept Pathol, Haifa, Israel; Rabin Med Ctr, Dept Pathol, Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Ichilov Med Ctr, Dept Pathol & Canc Res, Tel Aviv, Israel; Meir Hosp, Dept Pathol, Tel Aviv, Israel; Natl Inst Fertil, Raanana, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services; Carmel Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Struewing, JP (corresponding author), NCI, Lab Populat Genet, NIH, 41 Lib Dr,Room D702, Bethesda, MD 20892 USA.		Resnick, Murray/U-2986-2019; Struewing, Jeffery P/C-3221-2008; Struewing, Jeffery P/I-7502-2013	Struewing, Jeffery P/0000-0002-4848-3334				Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Csokay B, 1999, CANCER RES, V59, P995; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FRANK TS, 1998, 21 ANN SAN ANT BREAS; Friedman LS, 1997, AM J HUM GENET, V60, P313; Haraldsson K, 1998, CANCER RES, V58, P1367; Mavraki E, 1997, BRIT J CANCER, V76, P1428, DOI 10.1038/bjc.1997.574; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	12	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1800	1802		10.1086/302678	http://dx.doi.org/10.1086/302678			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577940	Green Published, Bronze			2022-12-18	WOS:000084282500041
J	Savoia, A; Del Vecchio, M; Totaro, A; Perrotta, S; Amendola, G; Moretti, A; Zelante, L; Iolascon, A				Savoia, A; Del Vecchio, M; Totaro, A; Perrotta, S; Amendola, G; Moretti, A; Zelante, L; Iolascon, A			An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WISKOTT-ALDRICH SYNDROME; PLATELET DISORDER; TRANSMISSION	The increasing number of diagnosed cases of inherited thrombocytopenias, owing to the routine practice of including platelet counts in blood tests, suggests that this condition is not so rare as expected. In the majority of cases, the molecular basis of the disease is unknown, although the defect is likely to affect thrombocytopoiesis and regulation of the normal platelet count. Here we report a genomewide search in a large Italian family affected by autosomal dominant thrombocytopenia. Patients showed a moderate thrombocytopenia with minimal symptoms characterized by normocellular bone marrow, normal medium platelet volume, and positive aggregation tests. Microsatellite analysis demonstrated that the disease locus (THC2) is linked to chromosome 10p11.1-12, within a candidate region of 6 cM between markers D10S586 and D19S1639. A maximum LOD score of 8.12 at recombination fraction .00 was obtained with the microsatellite D10S588. These data localized the first locus of an autosomal dominant thrombocytopenia, and the subsequent identification of the gene will provide new insight into the basic mechanism of megakaryocytopoiesis disorders.	Osped CSS, Serv Genet Med, IRCCS, Casa Sollievo, I-71013 Foggia, Italy; Univ Naples, Dept Pediat 2, Naples, Italy; San Leonardo Hosp Castellamare di Stabia, Naples, Italy; Univ Bari, Dept Biomed Evolut Age, Bari, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; Universita degli Studi di Bari Aldo Moro	Savoia, A (corresponding author), Osped CSS, Serv Genet Med, IRCCS, Casa Sollievo, I-71013 Foggia, Italy.		Savoia, Anna/AIC-4560-2022; Savoia, Anna/B-6463-2014; Iolascon, Achille/A-4461-2014	Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; Perrotta, Silverio/0000-0001-6149-6845; Totaro, Antonio/0000-0002-9752-8471				Bellucci S, 1997, BAILLIERE CLIN HAEM, V10, P149, DOI 10.1016/S0950-3536(97)80055-8; BITHELL TC, 1965, BLOOD-J HEMATOL, V25, P231, DOI 10.1182/blood.V25.2.231.231; BRETONGORIUS J, 1995, BLOOD, V85, P1805, DOI 10.1182/blood.V85.7.1805.bloodjournal8571805; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DOWTON SB, 1985, BLOOD, V65, P557; Fabris F, 1997, EUR J HAEMATOL, V58, P40; HO YC, 1996, BLOOD, V87, P5218; IOLASCON A, 1999, IN PRESS PEDIAT RES; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAJADO MJ, 1992, AM J HEMATOL, V39, P70, DOI 10.1002/ajh.2830390117; NAJEAN Y, 1995, SEMIN THROMB HEMOST, V21, P294, DOI 10.1055/s-2007-1000650; NAJEAN Y, 1990, BRIT J HAEMATOL, V74, P203, DOI 10.1111/j.1365-2141.1990.tb02566.x; Savoia A, 1996, HUM GENET, V97, P599; Strippoli P, 1998, BRIT J HAEMATOL, V103, P311, DOI 10.1046/j.1365-2141.1998.00991.x; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414	15	40	41	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1401	1405		10.1086/302637	http://dx.doi.org/10.1086/302637			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521306	Green Published, Bronze			2022-12-18	WOS:000083531000022
J	Slatkin, M				Slatkin, M			Disequilibrium mapping of a quantitative-trait locus in an expanding population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM	Linkage disequilibrium (LD) mapping can be successful if there is strong nonrandom association between marker alleles and an allele affecting a trait of interest. The principles of LD mapping of dichotomous traits are well understood, but less is known about LD mapping of a quantitative-trait locus (QTL). It is shown in this report that selective genotyping can increase the power to detect and map a rare allele of large effect at a QTL. Two statistical tests of the association between an allele and a quantitative character are proposed. These tests are approximately independent, so information from them can be combined. Analytic theory is developed to show that these two tests are effective in detecting the presence of a low-frequency allele with a relatively large effect on the character when the QTL is either already a candidate locus or closely linked to a marker locus that is in strong LD with the QTL. The latter situation is expected in a rapidly growing population in which the allele of large effect was present initially in one copy. Therefore, the proposed tests are useful under the same conditions as those for successful LD mapping of a dichotomous trait or disease. Simulations show that, for detection of the presence of a QTL, these tests are more powerful than a simple t-test. The tests also provide a basis for defining a measure of association, gamma, between a low-frequency allele at a putative QTL and a low-frequency allele at a marker locus.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Slatkin, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3060 Valley Life Sci Bldg, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Bulmer MG., 1979, PRINCIPLES STAT; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Krynetski EY, 1998, AM J HUM GENET, V63, P11, DOI 10.1086/301941; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; LANDER ES, 1989, GENETICS, V121, P185; LEWONTIN RC, 1964, GENETICS, V49, P49; Lynch M, 1998, GENETICS ANAL QUANTI; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Sokal R.R., 1980, BIOMETRY; Thompson EA, 1997, AM J HUM GENET, V60, P197; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	13	40	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1765	1773		10.1086/302413	http://dx.doi.org/10.1086/302413			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330364	Green Published, Bronze			2022-12-18	WOS:000080696200029
J	Fitzpatrick, JL; Hahn, C; Costa, T; Huggins, MJ				Fitzpatrick, JL; Hahn, C; Costa, T; Huggins, MJ			The duty to recontact: Attitudes of genetics service providers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDICAL GENETICS; LEGAL PERSPECTIVE; GUIDELINES	The term "duty to recontact" refers to the possible ethical and/or legal obligation of genetics service providers (GSPs) to recontact former patients about advances in research that might be relevant to them. Although currently this practice is not part of standard care, some argue that such an obligation may be established in the future. Little information is available, however, on the implications of this requirement, from the point of view of GSPs. To explore the opinions of genetics professionals on this issue, we sent a self-administered questionnaire to 1,000 randomly selected U.S. and Canadian members of the American Society of Human Genetics. We received 252 completed questionnaires. The major categories of respondents were physician geneticist (41%), Ph.D. geneticist (30%), and genetic counselor (18%); 72% of the total stated that they see patients. Respondents indicated that responsibility for staying in contact should be shared between health professionals and patients. Respondents were divided about whether recontacting patients should be the standard of care: 46% answered yes, 43% answered no, and 11% did not know. Those answering yes included 44% of physician geneticists, 53% of Ph.D. geneticists, and 31% of genetic counselors; answers were statistically independent of position or country of practice but were dependent on whether the respondent sees patients (43% answered yes) or not (54% answered yes). There also was a lack of consensus about the possible benefits and burdens of recontacting patients and about various alternative methods of informing patients about research advances. Analysis of qualitative data suggested that most respondents consider recontacting patients an ethically desirable, but not feasible, goal. Points to consider in the future development of guidelines for practice are presented.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Div Human Genet, Baltimore, MD 21201 USA; Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; IWK Grace Hlth Ctr, Dept Pediat, Halifax, NS, Canada; Dalhousie Univ, Halifax, NS, Canada; McMaster Hosp, Hamilton Hlth Sci Corp, Dept Obstet & Gynecol, Hamilton, ON L8N 3Z5, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Dalhousie University; Dalhousie University; McMaster University	Huggins, MJ (corresponding author), McMaster Hosp, Hamilton Hlth Sci Corp, Dept Obstet & Gynecol, Room 4D7,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.		Hahn, Cecil D./F-6218-2011; Hahn, Cecil/J-3372-2016	Hahn, Cecil D./0000-0002-0887-8761; Hahn, Cecil/0000-0002-0887-8761				Almqvist E, 1997, AM J HUM GENET, V61, P945, DOI 10.1086/514873; ANDREWS LB, 1991, YALE J BIOL MED, V64, P29; BERG D, 1980, SOUTHERN MED J, V73, P1041, DOI 10.1097/00007611-198008000-00025; Brook RH, 1996, LANCET, V348, P1005; Buxton Jessica L., 1996, European Journal of Human Genetics, V4, P153; Cote J. P., 1995, American Journal of Human Genetics, V57, pA293; FLETCHER JC, 1985, CLIN GENET, V27, P199; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; HANNIG VL, 1993, AM J MED GENET, V47, P257, DOI 10.1002/ajmg.1320470223; HUGGINS M, 1996, AM J HUM GENET S, V55, pA335; Patenaude AF, 1996, BEHAV SCI LAW, V14, P393, DOI 10.1002/(SICI)1099-0798(199623)14:4<393::AID-BSL248>3.0.CO;2-9; PELIAS MZ, 1992, AM J MED GENET, V42, P759, DOI 10.1002/ajmg.1320420532; PELIAS MZ, 1991, AM J MED GENET, V39, P347, DOI 10.1002/ajmg.1320390320; SHARPE NF, 1994, AM J MED GENET, V50, P234, DOI 10.1002/ajmg.1320500305; SMITH ACM, 1997, ANN BUS M AM SOC HUM	15	40	40	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					852	860		10.1086/302293	http://dx.doi.org/10.1086/302293			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053020	Green Published, Bronze			2022-12-18	WOS:000079204700023
J	Towbin, JA; Casey, B; Belmont, J				Towbin, JA; Casey, B; Belmont, J			The molecular basis of vascular disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; ALAGILLE-SYNDROME; GENE; MUTATIONS; GRIDLOCK; HEART		Texas Childrens Hosp, Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, 1 Baylor Plaza, Houston, TX 77030 USA.	jtowbin@bcm.tmc.edu	Belmont, John/AAH-6084-2021; Towbin, Jeffrey A./J-5595-2019; Belmont, John W/AAI-2494-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Belmont, John W/0000-0001-7409-3578				ANDERSON KR, 1979, BRIT HEART J, V41, P28; ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; Belmont JW, 1998, CLIN GENET, V54, P11; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; CLARK EB, 1986, GENETICS CARDIOVASCU; CLEAVER O, 1998, HEART DEV, P221; DePaepe A, 1997, AM J HUM GENET, V60, P547; FERENCZ C, 1997, GENETIC ENV RISK FAC; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Funke B, 1998, GENOMICS, V53, P146, DOI 10.1006/geno.1998.5488; GIDDINS NG, 1989, BRIT HEART J, V62, P315; Gottlieb S, 1998, AM J HUM GENET, V62, P495, DOI 10.1086/301718; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; Krantz ID, 1997, J MED GENET, V34, P152, DOI 10.1136/jmg.34.2.152; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Marchuk D A, 1998, Curr Opin Hematol, V5, P332, DOI 10.1097/00062752-199809000-00005; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Milewicz DM, 1998, CURR OPIN CARDIOL, V13, P198; Morris CA, 1998, CURR OPIN CARDIOL, V13, P214; OCONNOR WN, 1985, ARCH PATHOL LAB MED, V109, P179; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ring CJ, 1999, AM J HUM GENET, V64, P691, DOI 10.1086/302302; SCAMBLER PJ, 1993, ANN CARDIAC SURG; SCHMIDT MA, 1989, AM J MED GENET, V32, P384, DOI 10.1002/ajmg.1320320324; TOWBIN JA, 1995, NAT MED, V1, P1141, DOI 10.1038/nm1195-1141; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; WALSH K, 1998, HEART DEV, P429; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143	31	40	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					678	684		10.1086/302303	http://dx.doi.org/10.1086/302303			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053000	Bronze, Green Published			2022-12-18	WOS:000079204700002
J	Oosterwijk, JC; Knepfle, CFHM; Mesker, WE; Vrolijk, H; Sloos, WCR; Pattenier, H; Ravkin, I; van Ommen, GJB; Kanhai, HHH; Tanke, HJ				Oosterwijk, JC; Knepfle, CFHM; Mesker, WE; Vrolijk, H; Sloos, WCR; Pattenier, H; Ravkin, I; van Ommen, GJB; Kanhai, HHH; Tanke, HJ			Strategies for rare-event detection: An approach for automated fetal cell detection in maternal blood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; PERIPHERAL-BLOOD; NUCLEATED ERYTHROCYTES; FLOW-CYTOMETRY; IMAGE-ANALYSIS; DNA; CIRCULATION; AMPLIFICATION; PREGNANCIES; ENRICHMENT	This article explores the feasibility of the use of automated microscopy and image analysis to detect the presence of rare fetal nucleated red blood cells (NRBCs) circulating in maternal blood. The rationales for enrichment and for automated image analysis for "'rare-event" detection are reviewed. We also describe the application of automated image analysis to 42 maternal blood samples, using a protocol consisting of one-step enrichment followed by immunocytochemical staining for fetal hemoglobin (HbF) and FISH for X- and Y-chromosomal sequences. Automated image analysis consisted of multimode microscopy and subsequent visual evaluation of image memories containing the selected objects. The FISH results were compared with the results of conventional karyotyping of the chorionic villi. By use of manual screening, 43% of the slides were found to be positive (greater than or equal to 1 NRBC), with a mean number of 11 NRBCs (range 1-40). By automated microscopy, 52% were positive, with on average 17 NRBCs (range 1-111). There was a good correlation between both manual and automated screening, but the NRBC yield from automated image analysis was found to be superior to that from manual screening (P = .0443), particularly when the NRBC count was >15. Seven (64%) of 11 XY fetuses were correctly diagnosed by FISH analysis of automatically detected cells, and all discrepancies were restricted to the lower cell-count range. We believe that automated microscopy and image analysis reduce the screening workload, are more sensitive than manual evaluation, and can be used to detect rare HbF-containing NRBCs in maternal blood.	Leiden Univ, Ctr Med, Dept Cytochem & Cytometry, NL-2333 AL Leiden, Netherlands; Leiden Univ, Ctr Med, Dept Human Genet, Leiden, Netherlands; Leiden Univ, Ctr Med, Dept Obst & Fetal Therapy, Leiden, Netherlands; Appl Imaging Corp, Santa Clara, CA USA	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Oosterwijk, JC (corresponding author), Leiden Univ, Ctr Med, Dept Cytochem & Cytometry, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		Oosterwijk, Jan C./G-5770-2011					BHAT NM, 1993, J IMMUNOL METHODS, V158, P277, DOI 10.1016/0022-1759(93)90224-U; Bianchi DW, 1998, AM J HUM GENET, V62, P763, DOI 10.1086/301809; Bianchi DW, 1996, PRENATAL DIAG, V16, P289, DOI 10.1002/(SICI)1097-0223(199604)16:4<289::AID-PD843>3.3.CO;2-K; BIANCHI DW, 1995, J PEDIATR-US, V127, P847, DOI 10.1016/S0022-3476(95)70018-8; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; BJORKQVIST AM, 1994, ANN NY ACAD SCI, V731, P57, DOI 10.1111/j.1749-6632.1994.tb55748.x; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; CUPP JE, 1984, CYTOMETRY, V5, P138, DOI 10.1002/cyto.990050207; GANSHIRT D, 1995, CURR OPIN OBSTET GYN, V7, P103; GANSHIRTAHLERT D, 1992, AM J OBSTET GYNECOL, V166, P1350; HAMADA H, 1993, HUM GENET, V91, P427; HERZENBERG LA, 1979, P NATL ACAD SCI USA, V76, P1453, DOI 10.1073/pnas.76.3.1453; LANGLOIS S, 1993, CLIN INVEST MED, V16, P333; LEIF RC, 1983, CYTOMETRY, V3, P311, DOI 10.1002/cyto.990030416; Lewis DE, 1996, CYTOMETRY, V23, P218; LIOU JD, 1993, HUM GENET, V92, P309; LloydEvans P, 1996, TRANSFUSION, V36, P432, DOI 10.1046/j.1537-2995.1996.36596282587.x; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1993, HUM GENET, V90, P483; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; LO YMD, 1994, ANN NY ACAD SCI, V731, P229, DOI 10.1111/j.1749-6632.1994.tb55774.x; MANSI JL, 1988, J IMMUNOL METHODS, V112, P105, DOI 10.1016/0022-1759(88)90040-3; MESKER WE, 1994, CYTOMETRY, V17, P209, DOI 10.1002/cyto.990170304; Oosterwijk JC, 1998, CYTOMETRY, V32, P178, DOI 10.1002/(SICI)1097-0320(19980701)32:3<178::AID-CYTO3>3.0.CO;2-G; Oosterwijk JC, 1998, CYTOMETRY, V32, P170, DOI 10.1002/(SICI)1097-0320(19980701)32:3<170::AID-CYTO2>3.0.CO;2-O; PLOEM JS, 1986, HISTOCHEMISTRY, V84, P549, DOI 10.1007/BF00482990; PLOEMZAAIJER JJ, 1994, CYTOMETRY, V15, P199, DOI 10.1002/cyto.990150304; RAVKIN I, IN PRESS P SPIE ADV; SAUNDERS AM, 1997, LAB HEMATOL, V3, P282; SIMPSON JL, 1995, PRENATAL DIAG, V15, P907, DOI 10.1002/pd.1970151005; SIMPSON JL, 1994, ANN NY ACAD SCI, V731, P1, DOI 10.1111/j.1749-6632.1994.tb55743.x; Sohda S, 1997, PRENATAL DIAG, V17, P743, DOI 10.1002/(SICI)1097-0223(199708)17:8<743::AID-PD144>3.3.CO;2-V; SUZUMORI K, 1992, OBSTET GYNECOL, V80, P150; Tanke HJ, 1996, EARLY HUM DEV, V47, pS89, DOI 10.1016/S0378-3782(96)01829-4; THOMAS MR, 1995, PRENATAL DIAG, V15, P641, DOI 10.1002/pd.1970150709; VANDRIELKULKER AM, 1980, ANAL QUANT CYTOL, V4, P243; VERWOERD NP, 1987, CLIN CYTOMETRY HISTO, P465; ZHENG YL, 1993, J MED GENET, V30, P1051, DOI 10.1136/jmg.30.12.1051	39	40	47	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1783	1792		10.1086/302140	http://dx.doi.org/10.1086/302140			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837832	Green Published, Bronze			2022-12-18	WOS:000077707700025
J	Chang, CC; Gould, SJ				Chang, CC; Gould, SJ			Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; INTEGRAL MEMBRANE-PROTEIN; TARGETING SIGNAL; PTS2 RECEPTOR; ZELLWEGER SYNDROME; REFSUM-DISEASE; HUMAN PEX7; GENE; TRANSLATION; MUTATIONS	The peroxisome-biogenesis disorders (PBDs) are a set of often lethal genetic diseases characterized by mental retardation and defective peroxisomal matrix protein import. Mutations in PEX12 are known to underlie the disease in two patients from complementation group 3 of the PBDs. Here we show that all patients from this group carry mutations on both alleles of PEX12. A comparison between PEX12 genotypes and the clinical and cellular phenotypes of rite corresponding PBD patients suggests a relatively straightforward relationship between genotype and phenotype in this group of the PBDs, such that the loss of PEX12 function Leads to more-severe cellular and clinical phenotypes, However, one patient wire presented relatively mild clinical and cellular phenotypes was a compound heterozygote for two seemingly severe mutations on each PEX12 allele, PEX12, mRNA present in the patient's cells was derived from only one allele, the one that carried a 2-bp deletion early in the PEX12 coding region, c.26,27 Delta. The deduced protein product of this mRNA would contain only the first eight amino acids of the protein, and yet this mutant PEX12 cDNA displayed significant PEX12 activity in a functional complementation assay. Surprisingly, the PEX12/c.26,27 Delta cDNA directed the synthesis of a 29-kD PEX12 protein in vitro, a result that is consistent with translation initiation at a downstream AUG codon, Transfection studies confirmed the expression of similarly sized PEX12 proteins from the PEX12/c.26,27 Delta allele, Thus, it appears that translation initiation at internal AUG codons may modulate disease phenotypes and should be considered whenever unexpectedly mild phenotypes result from severe mutations early in the coding region.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Chang, Chia-Che/0000-0003-3509-3713	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10891] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belsham GJ, 1996, MICROBIOL REV, V60, P499, DOI 10.1128/MMBR.60.3.499-511.1996; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; deVet ECJM, 1997, BBA-LIPID LIPID MET, V1346, P25, DOI 10.1016/S0005-2760(97)00014-3; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GASPAR ML, 1991, P NATL ACAD SCI USA, V88, P8606, DOI 10.1073/pnas.88.19.8606; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MAQUAT LE, 1995, RNA, V1, P453; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; PEABODY DS, 1986, MOL CELL BIOL, V6, P2704, DOI 10.1128/MCB.6.7.2704; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; van der Klei IJ, 1997, TRENDS MICROBIOL, V5, P502, DOI 10.1016/S0966-842X(97)01156-6; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	42	40	40	1	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1294	1306		10.1086/302103	http://dx.doi.org/10.1086/302103			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792857	Bronze, Green Published			2022-12-18	WOS:000076985200006
J	Xiang, FQ; Almqvist, EW; Huq, M; Lundin, A; Hayden, MR; Edstrom, L; Anvret, M; Zhang, Z				Xiang, FQ; Almqvist, EW; Huq, M; Lundin, A; Hayden, MR; Edstrom, L; Anvret, M; Zhang, Z			A Huntington disease-like neurodegenerative disorder maps to chromosome 20p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PORPHYRIA CUTANEA-TARDA; FRONTOTEMPORAL DEMENTIA; MUTATION; LINKAGE; REPEATS; GENE	Huntington disease (HD) is an autosomal dominant neurodegenerative disorder characterized by motor disturbance, cognitive loss, and psychiatric manifestations. The disease is associated with a CAG trinucleotide-repeat expansion in the Huntington gene (IT15) on chromosome 4p16.3. One family with a history of HD was referred to us initially for predictive testing using linkage analysis. However, the chromosome 4p region was completely excluded by polymorphic markers, and later no GAG-repeat expansion in the HD gene was detected. To map the disease trait segregating in this family, whole-genome screening with highly polymorphic dinucleotide-, trinucleotide-, and tetranucleotide-repeat DNA markers was performed. A positive LOD score of 3.01 was obtained for the marker D20S482 on chromosome 20p, by two-point LOD-score analysis with the MLINK program. Haplotype analysis indicated that the gene responsible for the disease is likely located in a 2.7-cM region between the markers D20S193 and D20S895. Candidate genes from the mapping region were screened for mutations.	Karolinska Hosp, Clin Neurogenet Unit, Dept Mol Med, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Clin Neurosci, S-17176 Stockholm, Sweden; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of British Columbia; University of British Columbia	Zhang, Z (corresponding author), Karolinska Hosp, Clin Neurogenet Unit, Dept Mol Med, CMM L8-02-058, S-17176 Stockholm, Sweden.	zhiping.zhang@cmm.ki.se	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Xiang, Fengqing/0000-0003-0892-1536				ANDREW SE, 1994, AM J HUM GENET, V54, P852; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEVERNEUIL H, 1988, HUM GENET, V78, P101, DOI 10.1007/BF00291248; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GAREY JR, 1989, BLOOD, V73, P892; Heutink P, 1997, ANN NEUROL, V41, P150, DOI 10.1002/ana.410410205; HORIKAWA S, 1983, NATURE, V306, P611, DOI 10.1038/306611a0; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Prusiner SB, 1996, CURR TOP MICROBIOL, V207, P1; PUCKETT C, 1991, AM J HUM GENET, V49, P320; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Taylor TD, 1996, NAT GENET, V14, P479, DOI 10.1038/ng1296-479; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Yamaoka LH, 1996, AM J HUM GENET, V59, P1306; ZHAO ND, 1994, GENE, V145, P313	22	40	43	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1431	1438		10.1086/302093	http://dx.doi.org/10.1086/302093			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792871	Green Published, Bronze			2022-12-18	WOS:000076985200020
J	Rodriguez-Pombo, P; Hoenicka, J; Muro, S; Perez, B; Perez-Cerda, C; Richard, E; Desviat, LR; Ugarte, M				Rodriguez-Pombo, P; Hoenicka, J; Muro, S; Perez, B; Perez-Cerda, C; Richard, E; Desviat, LR; Ugarte, M			Human propionyl-CoA carboxylase beta subunit gene: Exon-intron definition and mutation spectrum in Spanish and Latin American propionic acidemia patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FULL-LENGTH CDNA; PCCB GENE; COMPLEMENTATION GROUPS; INSERTION DELETION; DEFICIENT PATIENTS; ESCHERICHIA-COLI; MESSENGER-RNAS; ALPHA-CHAIN; SEQUENCE; FIBROBLASTS	Propionyl-CoA carboxylase (PCC) is a mitochondrial biotin-dependent enzyme composed of an equal number of alpha and beta subunits. Mutations in the PCCA (alpha subunit) or PCCB (beta subunit) gene can cause the inherited metabolic disease propionic acidemia (PA), which can be life threatening in the neonatal period. Lack of data on the genomic structure of PCCB has been a significant impediment to full characterization of PCCB mutant chromosomes. In this study, we describe the genomic organization of the coding sequence of the human PCCB gene and the characterization of mutations causing PA in a total of 29 unrelated patients-21 from Spain and 8 from Latin America. The implementation of long-distance PCR has allowed us to amplify the regions encompassing the exon/intron boundaries and all the exons. The gene consists of 15 exons of 57-183 bp in size. All splice sites are consistent with the gt/ag rule. The availability of the intron sequences flanking each exon has provided the basis for implementation of screening for mutations in the PCCB gene. A total of 56/58 mutant chromosomes studied have been defined, with a total of 16 different mutations detected. The mutation spectrum includes one insertion/deletion, two insertions, 10 mis; sense mutations, one nonsense mutation, and two splicing defects. Thirteen of these mutations correspond to those not described yet in other populations. The mutation profile found in the chromosomes from the Latin American patients basically resembles that of the Spanish patients.	Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,Consejo Super Invest Cient, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Ugarte, M (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,Consejo Super Invest Cient, E-28049 Madrid, Spain.	mugarte@cbm.uam.es	Rodriguez Pombo, M Pilar/G-5231-2016; Hoenicka, Janet/B-2908-2014; DESVIAT, LOURDES R/L-3055-2013	Rodriguez Pombo, M Pilar/0000-0001-9315-5906; Hoenicka, Janet/0000-0002-6790-6988; DESVIAT, LOURDES R/0000-0003-0492-3323; Richard Rodriguez, Eva Maria/0000-0001-9711-1417				Antonarakis SE, 1998, HUM MUTAT, V11, P1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DEFILIPPIS V, 1994, PROTEIN ENG, V7, P1203, DOI 10.1093/protein/7.10.1203; DELVALLE JA, 1982, J INHERIT METAB DIS, V5, P121, DOI 10.1007/BF01800005; DESVIAT LR, 1995, AM J HUM GENET, V57, P337; Fenton W., 1995, METABOLIC MOL BASES, V7th ed., P1423; GRAVEL RA, 1994, AM J HUM GENET, V55, P51; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Hoenicka J, 1998, HUM MUTAT, pS234; HOENICKA J, 1997, MED GENETIK, V9, P4311; Kelson TL, 1996, HUM MOL GENET, V5, P331, DOI 10.1093/hmg/5.3.331; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P2047, DOI 10.1073/pnas.83.7.2047; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LAMHONWAH AM, 1994, GENOMICS, V19, P500, DOI 10.1006/geno.1994.1099; LAMHONWAH AM, 1990, GENOMICS, V8, P249, DOI 10.1016/0888-7543(90)90279-4; LAMHONWAH AM, 1989, NUCLEIC ACIDS RES, V17, P4396, DOI 10.1093/nar/17.11.4396; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; OHURA T, 1995, HUM GENET, V95, P707; OHURA T, 1993, J INHERIT METAB DIS, V16, P863, DOI 10.1007/BF00714279; OHURA T, 1993, HUM GENET, V92, P397, DOI 10.1007/BF01247343; Old JM, 1986, HUMAN GENETIC DISEAS, P1; PEREZ B, 1993, HUM MOL GENET, V2, P1289, DOI 10.1093/hmg/2.8.1289; Perez-Cerda C, 1998, EUR J PEDIATR, V157, P50, DOI 10.1007/s004310050765; PEREZCERDA C, 1994, J INHERIT METAB DIS, V17, P661, DOI 10.1007/BF00712007; Richard E, 1997, HUM GENET, V101, P93, DOI 10.1007/s004390050593; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STANKOVICS J, 1993, AM J HUM GENET, V52, P144; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; SUORMALA T, 1985, CLIN CHIM ACTA, V145, P151, DOI 10.1016/0009-8981(85)90282-7; TAHARA T, 1993, J INHERIT METAB DIS, V16, P353, DOI 10.1007/BF00710282; TAHARA T, 1990, P NATL ACAD SCI USA, V87, P1372, DOI 10.1073/pnas.87.4.1372; WAH AMLH, 1983, AM J HUM GENET, V35, P889; WOLF B, 1978, J CLIN INVEST, V62, P931, DOI 10.1172/JCI109221	34	40	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					360	369		10.1086/301970	http://dx.doi.org/10.1086/301970			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683601	Green Published, Bronze			2022-12-18	WOS:000075360800011
J	Kruglyak, L; Daly, MJ				Kruglyak, L; Daly, MJ			Linkage thresholds for two-stage genome scans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TRAITS		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Kruglyak, L (corresponding author), MIT, Whitehead Inst Biomed Res, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752				HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6	5	40	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					994	996		10.1086/301792	http://dx.doi.org/10.1086/301792			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529350	Green Published, Bronze			2022-12-18	WOS:000073514400035
J	Greenberg, DA; Hodge, SE; Vieland, VJ; Spence, MA				Greenberg, DA; Hodge, SE; Vieland, VJ; Spence, MA			Power, mode of inheritance, and type I error in LOD scores and affecteds-only methods: Reply to Kruglyak	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SINGLE-LOCUS APPROXIMATIONS; OLIGOGENIC TRAITS; LINKAGE ANALYSES; 2-LOCUS MODELS; ADEQUACY		Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Med Ctr, Dept Biomath, New York, NY 10029 USA; New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ, New York, NY USA; Univ Iowa, Coll Med, Dept Prevent Med & Environm Hlth, Iowa City, IA USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA USA; Univ Calif Irvine, Irvine Med Ctr, Dept Pediat, Orange, CA 92668 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York State Psychiatry Institute; Columbia University; University of Iowa; University of Iowa; University of California System; University of California Irvine	Greenberg, DA (corresponding author), Mt Sinai Med Ctr, Dept Psychiat, Box 1229, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH36197] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abreu PC, 1997, AM J HUM GENET, V61, pA264; Dizier MH, 1996, AM J HUM GENET, V58, P1338; Durner M, 1997, AM J HUM GENET, V61, pA274; Elston RC, 1997, AM J HUM GENET, V60, P255; Farrall M, 1997, AM J HUM GENET, V60, P735; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Greenberg DA, 1997, AM J HUM GENET, V60, P738; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; HODGE SE, IN PRESS AM J MED GE; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1997, AM J HUM GENET, V61, P254; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; Whittemore AS, 1996, AM J HUM GENET, V59, P704; WILLIAMSON JA, 1990, GENET EPIDEMIOL, V7, P309, DOI 10.1002/gepi.1370070502	17	40	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					202	204		10.1086/301690	http://dx.doi.org/10.1086/301690			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443883	Green Published, Bronze			2022-12-18	WOS:000072127900028
J	Mashima, Y; Imamura, Y; Konishi, M; Nagasawa, A; Yamada, M; Oguchi, Y; Kudoh, J; Shimizu, N				Mashima, Y; Imamura, Y; Konishi, M; Nagasawa, A; Yamada, M; Oguchi, Y; Kudoh, J; Shimizu, N			Homogeneity of kerato-epithelin codon 124 mutations in Japanese patients with either of two types of corneal stromal dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PHYLOGENETIC ANALYSIS; GRANULAR DYSTROPHY; AMYLOID DEPOSITS; CHROMOSOME-5Q; LOCUS; 5Q		Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 160, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University	Mashima, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 160, Japan.							AKIYA S, 1970, Archives of Ophthalmology, V84, P179; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; FOLBERG R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1080, DOI 10.1001/archopht.1994.01090200086027; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; GARNER A, 1969, BRIT J OPHTHALMOL, V53, P799, DOI 10.1136/bjo.53.12.799; GREGORY CY, 1995, J MED GENET, V32, P224, DOI 10.1136/jmg.32.3.224; HADDAD R, 1977, AM J OPHTHALMOL, V83, P213, DOI 10.1016/0002-9394(77)90619-5; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; HOWELL N, 1995, GENETICS, V140, P285; Konishi M, 1997, CORNEA, V16, P635; Korvatska E, 1996, EUR J HUM GENET, V4, P214; Mannis MJ, 1997, CORNEA DIAGNOSIS MAN, V2, P1043; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; OWENS SL, 1992, ARCH OPHTHALMOL-CHIC, V110, P175, DOI 10.1001/archopht.1992.01080140025015; ROSENWASSER GOD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1546, DOI 10.1001/archopht.1993.01090110112035; SAJJADI SH, 1992, OPHTHALMOLOGY, V99, P95; Small KW, 1996, AM J OPHTHALMOL, V121, P384, DOI 10.1016/S0002-9394(14)70434-9; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47	19	40	42	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1448	1450		10.1086/301649	http://dx.doi.org/10.1086/301649			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399907	Bronze, Green Published			2022-12-18	WOS:000071555900030
J	Wayne, S; Lowry, RB; McLeod, DR; Knaus, R; Farr, C; Smith, RJH				Wayne, S; Lowry, RB; McLeod, DR; Knaus, R; Farr, C; Smith, RJH			Localization of the Usher syndrome type IF (Ush1F) to chromosome 10.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Iowa, Iowa City, IA 52242 USA; Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada; Lumsden Clin, Lumsden, SK, Canada; Palliser Hlth Author, Medicine Hat, AB, Canada	University of Iowa; Alberta Childrens Hospital; University of Calgary									0	40	41	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4		S		1752	A300	A300						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YQ995					2022-12-18	WOS:000071446001753
J	Friedlander, Y; Austin, MA; Newman, B; Edwards, K; MayerDavis, EJ; King, MC				Friedlander, Y; Austin, MA; Newman, B; Edwards, K; MayerDavis, EJ; King, MC			Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-B GENE; BODY-MASS INDEX; INSULIN-RESISTANCE SYNDROME; SYSTOLIC BLOOD-PRESSURE; SEGREGATION ANALYSIS; DIETARY-FAT; FAMILIAL HYPERCHOLESTEROLEMIA; ENVIRONMENTAL-INFLUENCES; E POLYMORPHISM	Numerous studies have demonstrated genetic influences on levels of coronary heart disease (CHD) risk factors, but there also may be genetic effects on the intraindividual variation in these risk factors over time. Changes in risk factors are likely to reflect genetic- environmental interactions and may have important implications for understanding CHD risk. The present study examines the heritability of changes in CHD risk factors, using data from the two examinations by the Kaiser Permanente Women Twins Study, performed a decade apart. The sample consisted of 348 pairs of women twins who participated in both examinations, including 203 MZ pairs and 145 DZ pairs. Average ages at the two examinations were 41 and 51 years, respectively. By means of three different statistical analytic approaches, moderate heritability estimates were demonstrated for changes in LDL cholesterol (h(2) = .25 - .36) and in HDL cholesterol (h(2) = .23 - .58), some of which were statistically significant. Although small to moderate heritability estimates were found for systolic blood pressure (.18 - .37; P < .05 for some estimates), no genetic influence on changes in diastolic blood pressure was detected. Based on longitudinal twin data in women, this study demonstrates a genetic influence on changes in both lipoprotein risk factors and systolic blood pressure over a decade. In addition to environmental factors, which clearly are operating, the effect of various ''variability genes'' may be acting independently of the genetic influences on the absolute levels of these risk factors. Both mapping the gene(s) underlying intraindividual variations in these CHD risk factors and understanding their function(s) could lead to targeted intervention strategies to reduce CHD risk among genetically susceptible individuals.	HADASSAH UNIV HOSP,DEPT SOCIAL MED,SCH PUBL HLTH,IL-91120 JERUSALEM,ISRAEL; UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV N CAROLINA,SCH PUBL HLTH,DEPT EPIDEMIOL,CHAPEL HILL,NC; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PUBL HLTH SCI,WINSTON SALEM,NC 27103	Hebrew University of Jerusalem; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center				King, Mary-Claire/0000-0001-9426-1743	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041830] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41830] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbey M., 1991, NUTR METAB CARDIOVAS, V1, P10; ANNEST JL, 1979, AM J EPIDEMIOL, V110, P492, DOI 10.1093/oxfordjournals.aje.a112830; AUSTIN MA, 1992, AM J HUM GENET, V51, P829; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; AUSTIN MA, 1993, NEW ENGL J MED, V328, P353; AUSTIN MA, IN PRESS OBESITY RES; BERG K, 1988, CLIN GENET, V33, P102; BERG K, 1989, ARTERIOSCLER THROMB, V9, P150; BERG K, 1989, CLIN GENET, V35, P347; Berg K, 1994, GENETIC FACTORS CORO, P373; BLANGERO J, 1990, AM J HUM GENET, V47, P414; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BORECKI IB, 1993, AM J HUM GENET, V53, P676; Carmelli Dorit, 1994, Annals of Epidemiology, V4, P198; CHENG LSC, 1995, AM J HUM GENET, V57, P1169; CHRISTIAN JC, 1990, ARTERIOSCLEROSIS, V10, P1020, DOI 10.1161/01.ATV.10.6.1020; CHRISTIAN JC, 1995, GENET EPIDEMIOL, V12, P27, DOI 10.1002/gepi.1370120104; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1987, GENET EPIDEMIOL, V4, P443; COLETTO GMD, 1993, GENET EPIDEMIOL, V10, P533; COOK M, 1988, BIOCHEM SOC T, V16, P541, DOI 10.1042/bst0160541; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; DEMANT T, 1988, J CLIN INVEST, V82, P797, DOI 10.1172/JCI113681; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; FRIEDLANDER Y, 1995, CLIN GENET, V47, P1; FRIEDLANDER Y, 1995, AM J HUM GENET, V56, P1194; FRIEDLANDER Y, 1993, CLIN GENET, V43, P223, DOI 10.1111/j.1399-0004.1993.tb03807.x; GADDI A, 1991, AM J CLIN NUTR, V53, P1191, DOI 10.1093/ajcn/53.5.1191; GLATZ JFC, 1991, NUTR METAB CARDIOVAS, V1, P13; GROOVER ME, 1960, AM J MED SCI, V53, P133; GYLLING H, 1991, ARTERIOSCLER THROMB, V11, P1368, DOI 10.1161/01.ATV.11.5.1368; HAMM P, 1989, AM J EPIDEMIOL, V129, P312, DOI 10.1093/oxfordjournals.aje.a115135; HAVILAND MB, 1995, AM J MED GENET, V58, P315, DOI 10.1002/ajmg.1320580405; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; HONG YL, 1994, HYPERTENSION, V24, P663, DOI 10.1161/01.HYP.24.6.663; HOULSTON RS, 1988, ATHEROSCLEROSIS, V71, P81, DOI 10.1016/0021-9150(88)90305-X; HUMPHRIES SE, 1992, GENETICS CORONARY HE, P123; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; HWA JJ, 1992, J LIPID RES, V33, P711; KIRK EA, 1995, J LIPID RES, V36, P1522; KRIEGER H, 1980, HUM GENET, V53, P415, DOI 10.1007/BF00287065; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; LONGINI IM, 1984, AM J EPIDEMIOL, V120, P131, DOI 10.1093/oxfordjournals.aje.a113862; LOPEZMIRANDA J, 1994, CIRCULATION, V90, P74; LUSIS AJ, 1987, J BIOL CHEM, V262, P7594; MACCLUER JW, 1988, AM J HUM GENET, V43, P401; MACCLUER JW, 1995, CIRCULATION, V92, P3240; MAHANEY MC, 1991, METABOLISM, V40, P217; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; MATA P, 1994, ARTERIOSCLER THROMB, V14, P884, DOI 10.1161/01.ATV.14.6.884; MCCOMBS RJ, 1994, NEW ENGL J MED, V331, P706, DOI 10.1056/NEJM199409153311104; MOLL P P, 1984, Genetic Epidemiology, V1, P301, DOI 10.1002/gepi.1370010403; MONSALVE MV, 1991, CLIN GENET, V39, P260; Ordovas JM, 1995, ATHEROSCLEROSIS, V118, pS11; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; PERUSSE L, 1991, AM J HUM GENET, V49, P94; PROVINCE MA, 1989, GENET EPIDEMIOL, V6, P333, DOI 10.1002/gepi.1370060204; REILLY SL, 1991, AM J HUM GENET, V49, P1155; RICE T, 1990, AM J HUM GENET, V46, P37; RICE T, 1993, AM J HUM GENET, V52, P967; ROY M, 1995, CLIN GENET, V47, P59; *SAS I, 1985, SAS US GUID; SCHORK NJ, 1994, AM J HUM GENET, V54, P361; SELBY JV, 1993, CIRCULATION, V88, P381, DOI 10.1161/01.CIR.88.2.381; SERIES J, 1989, BIOCHIM BIOPHYS ACTA, V1003, P183, DOI 10.1016/0005-2760(89)90253-1; SIMS J, 1986, ACTA GENET MED GEMEL, V35, P7, DOI 10.1017/S0001566000006231; SING CF, 1985, AM J HUM GENET, V37, P268; SRIVASTAVA RAK, 1991, BIOCHIM BIOPHYS ACTA, V1086, P29, DOI 10.1016/0005-2760(91)90151-7; STEINMETZ A, 1989, ARTERIOSCLEROSIS, V9, P405, DOI 10.1161/01.ATV.9.3.405; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; TAMBS K, 1993, HYPERTENSION, V22, P789, DOI 10.1161/01.HYP.22.5.789; TIKKANEN MJ, 1990, CLIN GENET, V37, P327, DOI 10.1111/j.1399-0004.1990.tb03514.x; TIKKANEN MJ, 1990, ARTERIOSCLEROSIS, V10, P285, DOI 10.1161/01.ATV.10.2.285; TIRET L, 1992, GENET EPIDEMIOL, V9, P389, DOI 10.1002/gepi.1370090603; TOWNE B, 1993, GENET EPIDEMIOL, V10, P611, DOI 10.1002/gepi.1370100647; TOWNE B, 1994, AM J PHYS ANTHR S, V18, P196; WILLIAMS CJ, 1992, COMPUT METH PROG BIO, V38, P167, DOI 10.1016/0169-2607(92)90084-K; XU CF, 1990, GENET EPIDEMIOL, V7, P261, DOI 10.1002/gepi.1370070405; XU CF, 1992, NMCD, V2, P26; Zerba Kim E., 1993, Current Opinion in Lipidology, V4, P152, DOI 10.1097/00041433-199304000-00011	82	40	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1502	1512		10.1086/515462	http://dx.doi.org/10.1086/515462			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199573	Bronze, Green Published			2022-12-18	WOS:A1997XE29400030
J	Grody, WW; DunkelSchetter, C; Tatsugawa, ZH; Fox, MA; Fang, CY; Cantor, RM; Novak, JM; Bass, HN; Crandall, BF				Grody, WW; DunkelSchetter, C; Tatsugawa, ZH; Fox, MA; Fang, CY; Cantor, RM; Novak, JM; Bass, HN; Crandall, BF			PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-ANALYSIS; REGULATOR GENE; FOLLOW-UP; MODEL; IDENTIFICATION; DNA; INDIVIDUALS; EPITHELIUM; DISEASE; IMPACT	As the most common lethal autosomal recessive disorder in North America, cystic fibrosis (CF) is an obvious candidate for general population carrier screening. Although the identification of the causative gene has made detection of asymptomatic carriers possible, the extreme heterogeneity of its mutations has limited the sensitivity of the available DNA screening tests and has called into question their utility when they are applied to patients with no family history of the disease. The purpose of this study was to determine the technical feasibility, patient acceptance and understanding, and psychosocial impact of large-scale CF carrier screening in an ethnically diverse pregnant population. A total of 4,739 pregnant women attending prenatal clinics located in both an academic medical center and a large HMO were invited in person to participate. Of this group, 3,543 received CF instruction and assessments of knowledge and mood, and 3,192 underwent DNA testing for the six most common CF mutations, by means of a noninvasive PCR-based reverse-dot-blot method. Overall participation rates (ranging from 53% at the HMO to 77% at the academic center) and consent rates for DNA testing after CF instruction (>98%) exceeded those of most other American studies. The PCR-based screening method worked efficiently on large numbers of samples, and 55 carriers and one at-risk couple were identified. Understanding of residual risk, anxiety levels, and overall satisfaction with the program were acceptable across all ethnic groups. Our strategy of approaching a motivated pregnant population in person with a rapid and noninvasive testing method may provide a practical model for developing a larger CF screening program targeting appropriate high-risk groups at the national level, and may also serve as a paradigm for population-based screening of other genetically heterogeneous disorders in the future.	UNIV CALIF LOS ANGELES, SCH MED, DIV MOL PATHOL, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, DEPT PATHOL & LAB MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PSYCHOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; KAISER PERMANENTE MED CTR, LOS ANGELES, CA 90034 USA; CEDARS SINAI MED CTR, LOS ANGELES, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kaiser Permanente; Cedars Sinai Medical Center	Grody, WW (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DIV MED GENET, LOS ANGELES, CA 90095 USA.		Fang, Carolyn Y./A-2324-2008	Fang, Carolyn Y./0000-0002-0575-3867	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015750] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29337] Funding Source: Medline; NIMH NIH HHS [MH15750] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; ASCH DA, 1993, AM J OBSTET GYNECOL, V168, P1; BEAUDET AL, 1990, AM J HUM GENET, V47, P603; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; BIESECKER L, 1992, AM J HUM GENET, V50, P438; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLITZER MG, 1992, CLIN LAB MED, V12, P463, DOI 10.1016/S0272-2712(18)30500-6; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BROCK D, 1990, AM J HUM GENET, V47, P164; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CHAPPLE JC, 1987, LANCET, V1, P1189; CHEHAB FF, 1992, HUM GENET, V89, P163; CHILDS B, 1976, AM J HUM GENET, V28, P537; CHILDS B, 1976, AM J HUM GENET, V28, P550; Clayton EW, 1996, AM J HUM GENET, V58, P617; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; CURTIS A, 1993, J MED GENET, V30, P164, DOI 10.1136/jmg.30.2.164; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; *CYST FIBR FDN, 1986, REP PAT REG; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DAVIES K, 1992, NATURE, V357, pU424; DEMARCHI JM, 1994, ARCH PATHOL LAB MED, V118, P26; Doherty R., 1994, American Journal of Human Genetics, V55, pA278; FANG CY, IN PRESS WOMENS HLTH; GILBERT F, 1990, AM J HUM GENET, V46, P394; GOSTIN L, 1991, AM J LAW MED, V17, P109; GREBE TA, 1994, AM J HUM GENET, V54, P443; GREBE TA, 1992, AM J HUM GENET, V51, P736; Hannig V. L., 1994, American Journal of Human Genetics, V55, pA142; HARRIS H, 1993, BRIT MED J, V306, P1580, DOI 10.1136/bmj.306.6892.1580; HUBBARD RC, 1992, NEW ENGL J MED, V326, P812, DOI 10.1056/NEJM199203193261207; JUNG U, 1994, HUM GENET, V94, P19, DOI 10.1007/BF02272835; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1991, AM REV RESPIR DIS, V143, P457, DOI 10.1164/ajrccm/143.3.457; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; Kwok S, 1990, PCR PROTOCOLS GUIDE, P142; LIVINGSTONE J, 1994, BRIT MED J, V308, P1459, DOI 10.1136/bmj.308.6942.1459; LOADER S, 1991, AM J HUM GENET, V48, P447; Loader S, 1996, AM J HUM GENET, V59, P234; MCCRAE WM, 1973, LANCET, V2, P141; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; MENNIE ME, 1993, J MED GENET, V30, P543, DOI 10.1136/jmg.30.7.543; MENNIE ME, 1993, PRENATAL DIAG, V13, P807, DOI 10.1002/pd.1970130904; MIEDZYBRODZKA Z, 1991, LANCET, V338, P1524; MIEDZYBRODZKA ZH, 1995, BRIT MED J, V310, P353, DOI 10.1136/bmj.310.6976.353; NANCE WE, 1992, AM J HUM GENET, V51, P1443; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; SACHS L, 1982, APPLIED STATISTICS H; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHULMAN JD, 1990, AM J HUM GENET, V47, P740; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Spielberger CD, 1985, SO PSYCHOL, V2, P6; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; Tatsugawa Z H, 1994, J Genet Couns, V3, P279, DOI 10.1007/BF01412373; TENKATE LP, 1990, AM J HUM GENET, V47, P359; THOMSON DM, 1992, CLIN CHIM ACTA, V207, P169, DOI 10.1016/0009-8981(92)90116-8; WALD NJ, 1991, LANCET, V338, P1318, DOI 10.1016/0140-6736(91)92605-2; WALL J, 1995, HUM MUTAT, V5, P333, DOI 10.1002/humu.1380050411; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; WEIL J, 1991, AM J HUM GENET, V48, P145; WHITTEN CF, 1981, AM J HUM GENET, V33, P802; WHITTEN CF, 1973, NEW ENGL J MED, V288, P318, DOI 10.1056/NEJM197302082880612; WILFOND BS, 1992, MILBANK Q, V70, P629, DOI 10.2307/3350214; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WILLIAMSON R, 1993, NAT GENET, V3, P195, DOI 10.1038/ng0393-195; WITT D, 1993, AM J HUM GENET, V53, P49; Witt DR, 1996, AM J HUM GENET, V58, P823; *WORKSH POP SCREEN, 1990, NEW ENGL J MED, V323, P70; YUEN J, 1988, HEMOGLOBIN, V12, P801, DOI 10.3109/03630268808991673; ZEESMAN S, 1984, AM J MED GENET, V18, P769, DOI 10.1002/ajmg.1320180424	77	40	40	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					935	947						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106541				2022-12-18	WOS:A1997WT61400024
J	Perez, B; Desviat, LR; Ugarte, M				Perez, B; Desviat, LR; Ugarte, M			Analysis of the phenylalanine hydroxylase gene in the Spanish population: Mutation profile and association with intragenic polymorphic markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLKETONURIA MUTATION; SOUTHERN EUROPE; MOLECULAR-BASIS; LATIN-AMERICA; REGIONS; DNA; HAPLOTYPES; ALLELES; DIAGNOSIS; DELETION	The aim of this study was to characterize the phenylketonuria (PKU) alleles in the Spanish population, by both identifying the causative mutations and analyzing the RFLP haplotypes and the VNTR and short-tandem-repeat alleles associated with the phenylalanine hydroxylase (PAH) gene. We have investigated 129 independent mutant chromosomes, using denaturing gradient gel electrophoresis (DGGE) and direct sequencing. Ninety percent of the alleles were identified, and a total of 40 different mutations were detected. The mutational spectrum includes seven previously unreported mutations: P122Q, D129G, P147S, D151G, A165T, S196fs, and P407S. Seven mutations represent 43% of the Spanish PKU alleles, the most common being IVS10nt-11g-->a (14.7%), I65T (8.5%), and V388M (6.2%). The remaining 33 mutations are rare. The mutation profile and relative frequencies are markedly different from those in northern Europe, also showing unique features compared with those in other, southern European populations. The association analysis with polymorphic markers in the PAH gene provides valuable information for population-genetic studies and investigation of the origins of the mutations. This study may serve as reference in the analysis of the contemporary distributions and frequencies of the PKU mutations in related populations, with particular relevance in Latin American countries.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOL SEVERO OCHOA, FAC CIENCIAS, E-28049 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)			DESVIAT, LOURDES R/L-3055-2013	DESVIAT, LOURDES R/0000-0003-0492-3323				COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DARVASI A, 1995, EUR J HUM GENET, V3, P14; DESVIAT LR, 1995, AM J HUM GENET, V57, P337; DESVIAT LR, 1993, HUM GENET, V92, P254; DESVIAT LR, IN PRESS HUM MUTAT; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1445; GOLTSOV AA, 1992, AM J HUM GENET, V51, P627; GOLTSOV AA, 1993, HUM MOL GENET, V2, P577, DOI 10.1093/hmg/2.5.577; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GULDBERG P, 1993, HUM MOL GENET, V2, P1703, DOI 10.1093/hmg/2.10.1703; GULDBERG P, 1994, NUCLEIC ACIDS RES, V22, P880, DOI 10.1093/nar/22.5.880; GULDBERG P, 1994, J INHERIT METAB DIS, V17, P359, DOI 10.1007/BF00711830; GUTTLER F, 1993, J INHERIT METAB DIS, V16, P602, DOI 10.1007/BF00711693; Hoang L, 1996, NUCLEIC ACIDS RES, V24, P127, DOI 10.1093/nar/24.1.127; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; Kleiman Sandra, 1992, Human Mutation, V1, P344, DOI 10.1002/humu.1380010414; KONECKI DS, 1992, BIOCHEMISTRY-US, V31, P8363, DOI 10.1021/bi00150a033; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEANDRO P, 1995, HUM MUTAT, V6, P192, DOI 10.1002/humu.1380060217; LICHTERKONECKI U, 1994, HUM GENET, V94, P307; PEREZ B, 1993, HUM MOL GENET, V2, P1289, DOI 10.1093/hmg/2.8.1289; Perez B, 1996, HUM MUTAT, V8, P262, DOI 10.1002/(SICI)1098-1004(1996)8:3<262::AID-HUMU10>3.0.CO;2-0; Perez B., 1995, American Journal of Human Genetics, V57, pA170; PEREZ B, 1994, ACTA PAEDIATR, V83, P34, DOI 10.1111/j.1651-2227.1994.tb13444.x; RAMUS SJ, 1995, AM J HUM GENET, V56, P1034; Santos M, 1996, HUM HERED, V46, P128, DOI 10.1159/000154340; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; Treacy Eileen, 1993, European Journal of Human Genetics, V1, P220; Tyfield L. A., 1993, Developmental Brain Dysfunction, V6, P60; UGARTE M, 1980, J MENT DEFIC RES, V24, P119; ZSCHOCKE J, 1995, AM J HUM GENET, V57, P1311; ZSCHOCKE J, 1994, ACTA PAEDIATR, V83, P41, DOI 10.1111/j.1651-2227.1994.tb13447.x	34	40	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					95	102						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981952				2022-12-18	WOS:A1997WA81800015
J	McLaughlin, BA; Spencer, C; Eberwine, J				McLaughlin, BA; Spencer, C; Eberwine, J			CAG trinucleotide RNA repeats interact with RNA-binding proteins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; PALLIDOLUYSIAN ATROPHY DRPLA; BULBAR MUSCULAR-ATROPHY; MESSENGER-RNAS; WIDESPREAD EXPRESSION; SECONDARY STRUCTURE; NEURONS; EXPANSION; FERRITIN; PRODUCT	Genes associated with several neurological diseases are characterized by the presence of an abnormally long trinucleotide repeat sequence. By way of example, Huntington's disease (HD), is characterized by selective neuronal degeneration associated with the expansion of a polyglutamine-encoding CAG tract. Normally, this CAG tract is comprised of 11-34 repeats, but in HD it is expanded to >37 repeats in affected individuals. The mechanism by which CAG repeats cause neuronal degeneration is unknown, but it has been speculated that the expansion primarily causes abnormal protein functioning, which in turn causes HD pathology. Other mechanisms, however, have not been ruled out. Interactions between RNA and RNA-binding proteins have previously been shown to play a role in the expression of several eukaryotic genes. Herein, we report the association of cytoplasmic proteins with normal length and extended CAG repeats, using gel shift and UV crosslinking assays. Cytoplasmic protein extracts from several rat brain regions, including the striatum and cortex, sites of neuronal degeneration in HD, contain a 63-kD RNA-binding protein that specifically interacts with these GAG-repeat sequences. These protein-RNA interactions are dependent on the length of the GAG repeat, with longer repeats binding substantially more protein. Two CAG repeat-binding proteins are present in human cortex and striatum; one comigrates with the rat protein at 63 kD, while the other migrates at 49 kD. These data suggest mechanisms by which RNA-binding proteins may be involved in the pathological course of trinucleotide repeat-associated neurological diseases.	UNIV PENN, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT PSYCHIAT, PHILADELPHIA, PA 19104 USA; UNIV PENN, INST NEUROL SCI, PHILADELPHIA, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania			Eberwine, James/B-2247-2010; McLaughlin, BethAnn/D-9580-2012	McLaughlin, BethAnn/0000-0003-0228-6500	NATIONAL INSTITUTE ON AGING [R01AG009900, R37AG009900] Funding Source: NIH RePORTER; NIA NIH HHS [AG9900] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANDREWS PW, 1984, LAB INVEST, V50, P147; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; FLAGG S, IN PRESS METHODS MOL; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; HARFORD JB, 1990, ENZYME, V44, P28, DOI 10.1159/000468745; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KEW D, 1989, MOL ENDOCRINOL, V3, P1191, DOI 10.1210/mend-3-8-1191; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARCINIAK RA, 1990, P NATL ACAD SCI USA, V87, P3624, DOI 10.1073/pnas.87.9.3624; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PINOLROMA S, 1989, METHOD ENZYMOL, V180, P410; PIZZUTI A, 1993, ARCH NEUROL-CHICAGO, V50, P1173, DOI 10.1001/archneur.1993.00540110053005; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STEIN O, 1995, HUM MOL GENET, V4, P15; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; TORRE ER, 1992, J NEUROSCI, V12, P762; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VONSATTEL J, 1985, J NEUROPATHOL EXP NE, V28, P401; YOUNG AB, 1995, NEUROSCIENTIST, V1, P51; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	47	40	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					561	569						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751857				2022-12-18	WOS:A1996VN62500010
J	Paabo, S				Paabo, S			Mutational hot spots in the mitochondrial microcosm	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							MODERN HUMANS; DNA; EVOLUTION; SEQUENCE; ORIGIN				Paabo, S (corresponding author), UNIV MUNICH,INST ZOOL,LUISENSTR 14,D-8000 MUNICH 2,GERMANY.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Handt O, 1996, AM J HUM GENET, V59, P368; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HOWELL N, 1996, AM J HUM GENET, V59; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; KOCHER TD, 1991, EVOLUTION LIFE; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; LEDERBERG J, 1995, USE DNA TECHNOLOGY I; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nachman MW, 1996, GENETICS, V142, P953; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; THORNE AG, 1992, SCI AM           APR, P76; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; Watson E, 1996, AM J HUM GENET, V59, P437; WILSON MR, 1993, CRIME LAB DIGEST, V20, P68; WOLSTENHOLME DR, 1992, INT REV CYTOLOGY, V141	26	40	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					493	496						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751848				2022-12-18	WOS:A1996VN62500001
J	FANG, YY; EYRE, HJ; BOHLANDER, SK; ESTOP, A; MCPHERSON, E; TRAGER, T; RIESS, O; CALLEN, DF				FANG, YY; EYRE, HJ; BOHLANDER, SK; ESTOP, A; MCPHERSON, E; TRAGER, T; RIESS, O; CALLEN, DF			MECHANISMS OF SMALL RING FORMATION SUGGESTED BY THE MOLECULAR CHARACTERIZATION OF 2 SMALL ACCESSORY RING CHROMOSOMES DERIVED FROM CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER CHROMOSOMES; HYBRIDIZATION; ORIGIN	Molecular cloning of a microdissected small accessary ring chromosome 4 from a moderately retarded and dysmorphic patient has been performed to identify the origin of the ring chromosome. FISH was performed with cosmids identified with the cloned, microdissected products and with other markers from chromosome 4. The present study clearly demonstrates that the small ring in this patient originates from three discontinuous regions of chromosome 4: 4p13 or 14, the centromere, and 4q31. It is suggested that the origin of the ring chromosome is a ring involving the entire chromosome 4, which has then been involved in breakage and fusion events, as a consequence of DNA replication generating interlocked rings. A second severely retarded and dysmorphic patient also had a small accessary ring derived from chromosome 4. FISH studies of this ring are consistent with an origin from a contiguous region including the centromere to band 4q12. It is apparent that there are at least two mechanisms for the formation of small ring chromosomes. This adds a further complication in any attempt to ascertain common phenotypes between patients known to have morphologically similar markers derived from the same chromosome.	WOMENS & CHILDRENS HOSP, DEPT CYTOGENET & MOLEC GENET, ADELAIDE, SA 5006, AUSTRALIA; UNIV CHICAGO, HEMATOL ONCOL SECT, CHICAGO, IL 60637 USA; ALLEGHENY HLTH EDUC & RES EDUC FDN, CTR MED GENET, PITTSBURGH, PA USA; MAGEE WOMENS HOSP, DEPT GENET, PITTSBURGH, PA USA; UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT GENET, PITTSBURGH, PA USA; HAHNEMANN UNIV, MED COLL PENN, DEPT HUMAN GENET, PHILADELPHIA, PA 19102 USA; RUHR UNIV BOCHUM, DEPT MOLEC HUMAN GENET, W-4630 BOCHUM, GERMANY	Womens & Childrens Hospital Australia; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Drexel University; Ruhr University Bochum			Callen, David F/G-1975-2012	Callen, David/0000-0002-6189-9991; Bohlander, Stefan/0000-0002-2202-9088				BLENNOW E, 1993, AM J HUM GENET, V53, P433; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CALLEN DF, 1991, AM J HUM GENET, V48, P769; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CALLEN DF, 1990, ANN GENET, V4, P219; CARTER R, 1969, Journal of Medical Genetics, V6, P224, DOI 10.1136/jmg.6.2.224; CROLLA JA, 1995, HUM GENET, V95, P161; ESTOP AM, 1993, CYTOGENET CELL GENET, V63, P254; KOSZTOLANYI G, 1987, HUM GENET, V75, P174, DOI 10.1007/BF00591082; PEZZOLO A, 1993, HUM GENET, V92, P23, DOI 10.1007/BF00216140; PLATTNER R, 1993, HUM GENET, V91, P131; RAIMONDI E, 1991, J MED GENET, V28, P92, DOI 10.1136/jmg.28.2.92; RIESS O, 1994, CYTOGENET CELL GENET, V65, P238, DOI 10.1159/000133638; THANGAVELU M, 1994, PRENATAL DIAG, V14, P583, DOI 10.1002/pd.1970140712; VIERSBACH R, 1994, HUM GENET, V93, P663; WOLFF DJ, 1994, AM J HUM GENET, V55, P87	19	40	42	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1137	1142						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485165				2022-12-18	WOS:A1995TA44900021
J	KRONN, D; ODDOUX, C; PHILLIPS, J; OSTRER, A				KRONN, D; ODDOUX, C; PHILLIPS, J; OSTRER, A			PREVALENCE OF CANAVAN-DISEASE HETEROZYGOTES IN THE NEW-YORK METROPOLITAN ASHKENAZI JEWISH POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ASPARTOACYLASE				KRONN, D (corresponding author), NYU, MED CTR, HUMAN GENET PROGRAM, 550 1ST AVE, NEW YORK, NY 10016 USA.							BEAUDET AL, 1995, METABOLIC MOL BASIS, P4599; ELPELEG ON, 1994, AM J HUM GENET, V55, P287; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; KABACK MM, 1977, TAY SACHS DISEASE SC, P13; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; KAUL R, 1994, GENOMICS, V21, P364, DOI 10.1006/geno.1994.1278; Matalon R., 1994, American Journal of Human Genetics, V55, pA157; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234	9	40	41	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1250	1252						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485179				2022-12-18	WOS:A1995TA44900037
J	LUNKES, A; HARTUNG, U; MAGARINO, C; RODRIGUEZ, M; PALMERO, A; RODRIGUEZ, L; HEREDERO, L; WEISSENBACH, J; WEBER, J; AUBURGER, G				LUNKES, A; HARTUNG, U; MAGARINO, C; RODRIGUEZ, M; PALMERO, A; RODRIGUEZ, L; HEREDERO, L; WEISSENBACH, J; WEBER, J; AUBURGER, G			REFINEMENT OF THE OPA1 GENE LOCUS ON CHROMOSOME 3Q28-Q29 TO A REGION OF 2-8 CM, IN ONE CUBAN PEDIGREE WITH AUTOSOMAL-DOMINANT OPTIC ATROPHY TYPE KJER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV HOSP DUSSELDORF,DEPT NEUROL,D-40001 DUSSELDORF,GERMANY; CTR NACL GENET MED,HAVANA,CUBA; FAC CIENCIAS MED,DEPT MED GENET,SANCTI ESPIRITUS,CUBA; GENETHON,EVRY,FRANCE; MARSHFIELD MED RES FDN,CTR MED GENET,MARSHFIELD,WI 54449	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital					NHGRI NIH HHS [HG00835] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JAEGER W, 1966, J GENET HUM, V15, P312; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8; KJER P, 1959, ACTA OPHTHALMOL    S, V54, P1; LODBERG CV, 1954, OPHTHALMOLOGICA, V28, P437; Lyle WM., 1990, GENETIC RISKS; McKusick V.A., 1992, MENDELIAN INHERITANC; SMITH DP, 1972, AM J OPTOM ARCH AM A, V4, P183; WEBER JL, 1993, AM J HUM GENET, V53, P1079	11	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					968	970						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573062				2022-12-18	WOS:A1995RV79300032
J	KRAHE, R; ECKHART, M; OGUNNIYI, AO; OSUNTOKUN, BO; SICILIANO, MJ; ASHIZAWA, T				KRAHE, R; ECKHART, M; OGUNNIYI, AO; OSUNTOKUN, BO; SICILIANO, MJ; ASHIZAWA, T			DE-NOVO MYOTONIC-DYSTROPHY MUTATION IN A NIGERIAN KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNSTABLE DNA REGION; CTG REPEAT; MUSCULAR-DYSTROPHY; GENE; EXPANSION; ANTICIPATION; PHENOTYPE; SEQUENCE; CHROMOSOME-19; TRANSMISSION	An expansion of an unstable (CTG)(n) trinucleotide repeat in the 3' UTR of a gene encoding a putative serine/threonine protein kinase (DMPK) on human chromosome 19q13.3 has been shown to be specific for the myotonic dystrophy (DM) disease phenotype. In addition, a single haplotype composed of nine alleles within and flanking DMPK over a physical distance of 30 kb has been shown to be in complete linkage disequilibrium with DM. This has led to two hypotheses: (1) predisposition for (CTG)(n) instability results from a founder effect that occurred only once or a few times in human evolution; and (2) elements within the disease haplotype may predispose the (CTG)(n) repeat to instability. A detailed haplotype analysis of the DM region was conducted on a Nigerian (Yoruba) DM family, the only indigenous sub-Saharan DM case reported to date. Each affected member of this family had an expanded (CTG)(n) repeat in one of his or her DMPK alleles. However, unlike all other DM populations studied thus far, disassociation of the (CTG)(n) repeat expansion from other alleles of the putative predisposing haplotype was found. We conclude that the expanded (CTG)(n) repeat in this family is the result of an independent mutational event. Consequently, the origin of DM is unlikely to be a single mutational event, and the hypothesis that a single ancestral haplotype predisposes to repeat expansion is not compelling.	BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,GENET PROGRAM,HOUSTON,TX; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX; VET AFFAIRS MED CTR,HOUSTON,TX 77030; UNIV IBADAN,DEPT MED NEUROL,IBADAN,NIGERIA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Ibadan								ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BACHINSKI LL, 1993, AM J HUM GENET, V52, P375; BARCELO JM, 1993, HUM MOL GENET, V2, P705, DOI 10.1093/hmg/2.6.705; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; Dada T O, 1973, East Afr Med J, V50, P213; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; NOVELLI G, 1994, HUM MUTAT, V4, P79, DOI 10.1002/humu.1380040115; OHOY KL, 1993, SCIENCE, V259, P809, DOI 10.1126/science.8094260; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sambrook J., 1989, MOL CLONING LAB MANU; SHAW DJ, 1992, NEUROMUSCULAR DISORD, V2, P241, DOI 10.1016/0960-8966(92)90055-B; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SHUTLER GG, 1994, AM J HUM GENET, V54, P104; STALLINGS RL, 1988, AM J HUM GENET, V43, P144; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W; YAMAGATA H, 1994, HUM MOL GENET, V3, P819, DOI 10.1093/hmg/3.5.819; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123	42	40	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1067	1074						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726160				2022-12-18	WOS:A1995QU58600007
J	TORRONI, A; WALLACE, DC				TORRONI, A; WALLACE, DC			MTDNA HAPLOGROUPS IN NATIVE-AMERICANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA; AFFINITIES; MIGRATIONS		EMORY UNIV,SCH MED,INST MOLEC MED,ATLANTA,GA; UNIV ROMA LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOLEC,I-00185 ROME,ITALY	Emory University; Sapienza University Rome	TORRONI, A (corresponding author), EMORY UNIV,SCH MED,DEPT GENET,ATLANTA,GA, USA.		Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478				BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1994, AM J HUM GENET, V55, P7; CANN RL, 1982, THESIS U CALIFORNIA; Chen Y.-S., 1994, American Journal of Human Genetics, V55, pA148; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; PASSARINO G, 1993, AM J HUM GENET, V53, P609; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, 1994, AM J HUM GENET, V5, P760	19	40	40	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1234	1236						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726181				2022-12-18	WOS:A1995QU58600028
J	CLERMONT, O; BURLET, P; BURGLEN, L; LEFEBVRE, S; PASCAL, F; MCPHERSON, J; WASMUTH, JJ; COHEN, D; LEPASLIER, D; WEISSENBACH, J; LATHROP, M; MUNNICH, A; MELKI, J				CLERMONT, O; BURLET, P; BURGLEN, L; LEFEBVRE, S; PASCAL, F; MCPHERSON, J; WASMUTH, JJ; COHEN, D; LEPASLIER, D; WEISSENBACH, J; LATHROP, M; MUNNICH, A; MELKI, J			USE OF GENETIC AND PHYSICAL MAPPING TO LOCATE THE SPINAL MUSCULAR-ATROPHY LOCUS BETWEEN 2 NEW HIGHLY POLYMORPHIC DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; CHROMOSOME-5; MAP	The gene for autosomal recessive forms of spinal muscular atrophy (SMA) has recently been mapped to chromosome 5q13, within a 4-cM region between the blocks D5S465/D5S125 and MAP-1B/D5S112. We identified two new highly polymorphic microsatellite DNA markers-namely, AFM265wf5 (D5S629) and AFM281yh9 (D5S637)-which are the closest markers to the SMA locus. Multilocus analysis by the location-score method was used to establish the best estimate of the SMA gene location. Our data suggest that the most likely location for SMA is between locus D5S629 and the block D5S637/D5S351/MAP-1B/D5S112/D5S357. Genetic analysis of inbred SMA families, based on homozygosity by descent and physical mapping using mega-YACs, gave additional information for the loci order as follows: cen-D5S6-D5S125/D5S465-D5S435-D5S629-SMA-D5S637-D5S351-MAP-1B/D5S112-D5S357-D5S39-tel. These data give the direction for bidirectional walking in order to clone this interval and isolate the SMA gene.	HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS 15,FRANCE; CEPH,PARIS,FRANCE; INST PASTEUR,PARIS,FRANCE; INSERM,U358,PARIS,FRANCE; UNIV CALIF IRVINE,DEPT BIOCHEM,IRVINE,CA; GENETHON,EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine			Lefebvre, Suzie/D-5092-2017; McPherson, John D/D-2633-2017	McPherson, John D/0000-0001-8049-9347; Le Paslier, Denis/0000-0003-4335-9956				BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; DUBOWITZ V, 1991, NEUROMUSCULAR DISORD, V1, P47; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LIEN LL, 1991, P NATL ACAD SCI USA, V88, P7873, DOI 10.1073/pnas.88.17.7873; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1993, GENOMICS, V15, P521, DOI 10.1006/geno.1993.1103; MELKI J, 1990, NATURE, V344, P764; SHETH P, 1991, AM J HUM GENET, V48, P764; SOARES VM, 1993, GENOMICS, V15, P365, DOI 10.1006/geno.1993.1069; Westbrook C A, 1992, Cytogenet Cell Genet, V61, P225, DOI 10.1159/000133415	16	40	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					687	694						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128967				2022-12-18	WOS:A1994NC83600014
J	CAO, A				CAO, A			1993 WILLIAM-ALLAN-AWARD ADDRESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							BETA-O THALASSEMIA; ALPHA-THALASSEMIA; PRENATAL-DIAGNOSIS; DELTA-THALASSEMIA; SARDINIA; BETA-0-THALASSEMIA; MUTATION				CAO, A (corresponding author), UNIV CAGLIARI, IST CLIN & BIOL ETA EVOLUT, VIA JENNER S-N, I-09121 CAGLIARI, ITALY.							CAO A, 1981, AM J HUM GENET, V33, P592; CAO A, 1978, J MED GENET, V15, P443, DOI 10.1136/jmg.15.6.443; Cao A, 1991, CURR OPIN GENET DEV, V1, P48, DOI 10.1016/0959-437X(91)80040-S; GALANELLO R, 1990, BLOOD, V75, P1747; GALANELLO R, 1989, BLOOD, V74, P823; GALANELLO R, 1979, HEMOGLOBIN, V3, P33, DOI 10.3109/03630267909069153; GALANELLO R, 1988, CLIN GENET, V33, P151; GASPERINI D, IN PRESS HUM MUTAT; KAN YW, 1977, LANCET, V1, P269; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KAN YW, 1975, LANCET, V2, P790; MELIS MA, 1983, BLOOD, V62, P226; MOI P, 1988, BLOOD, V72, P530; PAGLIETTI E, 1986, BRIT J HAEMATOL, V63, P485, DOI 10.1111/j.1365-2141.1986.tb07525.x; PIRASTU M, 1984, J BIOL CHEM, V259, P2315; PIRASTU M, 1982, BLOOD, V60, P509; PIRASTU M, 1983, BLOOD, V62, P341; PIRASTU M, 1984, SCIENCE, V223, P929, DOI 10.1126/science.6198720; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631	21	40	40	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					397	402						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116609				2022-12-18	WOS:A1994MZ15800001
J	ANDRESEN, BS; BROSS, P; JENSEN, TG; WINTER, V; KNUDSEN, I; KOLVRAA, S; JENSEN, UB; BOLUND, L; DURAN, M; KIM, JJ; CURTIS, D; DIVRY, P; VIANEYSABAN, C; GREGERSEN, N				ANDRESEN, BS; BROSS, P; JENSEN, TG; WINTER, V; KNUDSEN, I; KOLVRAA, S; JENSEN, UB; BOLUND, L; DURAN, M; KIM, JJ; CURTIS, D; DIVRY, P; VIANEYSABAN, C; GREGERSEN, N			A RARE DISEASE-ASSOCIATED MUTATION IN THE MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD) GENE CHANGES A CONSERVED ARGININE, PREVIOUSLY SHOWN TO BE FUNCTIONALLY ESSENTIAL IN SHORT-CHAIN ACYL-COA DEHYDROGENASE (SCAD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; SUDDEN CHILD-DEATH; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; DICARBOXYLIC ACIDURIA; CULTURED FIBROBLASTS; LIVER MITOCHONDRIA; PREVALENT MUTATION; ESCHERICHIA-COLI; POINT-MUTATION	Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is a serious and potentially fatal inherited defect in the beta-oxidation of fatty acids. Approximately 80% of patients with MCAD deficiency are homozygous for a single disease-causing mutation (G985). The remaining patients (except for a few cases worldwide) are compound heterozygous with G985 in one allele. By sequencing of cloned PCR-amplified MCAD cDNA from a G985 compound heterozygous patient, we identified a C-to-T transition at position 157 as the only change in the entire coding sequence of the non-G985 allele. The presence of the T157 mutation was verified in genomic DNA from the patient and her mother by a PCR-based assay. The mutation changes a conserved arginine at position 28 (R28C) of the mature MCAD protein. The effect of the T157 mutation on MCAD protein was investigated by expression of mutant MCAD cDNA in COS-7 cells. On the basis of knowledge about the three-dimensional structure of the MCAD protein, we suggest that the mutation destroys a salt bridge between arginine'' and glutamate86, thereby affecting the formation of enzymatically active protein. Twenty-two additional families with compound heterozygous patients were tested in the PCR-based assay. The T157 mutation was identified in one of these families, which had an MCAD-deficient child who died unexpectedly in infancy. Our results indicate that the mutation is rare. It is, however, noteworthy that a homologous mutation has previously been identified in the short-chain acyl-CoA dehydrogenase (SCAD) gene of a patient with SCAD deficiency, suggesting that the conserved arginine is crucial for formation of active enzyme in the straight-chain acyl-CoA dehydrogenases.	AARHUS KOMMUNE HOSP, DEPT CLIN CHEM, MOLEC GENET LAB, DK-8000 AARHUS, DENMARK; AARHUS UNIV, INST HUMAN GENET, DK-8000 AARHUS, DENMARK; WILHELMINA CHILDRENS HOSP, METABOLE ZIEKTEN LAB, UTRECHT, NETHERLANDS; MED COLL WISCONSIN, DEPT BIOCHEM, MILWAUKEE, WI 53226 USA; CTR HUMAN GENET, SHEFFIELD, ENGLAND; HOP DEBROUSSE, CTR ETUD MALAD METAB, F-69005 LYON, FRANCE	Aarhus University; Aarhus University; Wilhelmina Kinderziekenhuis; Medical College of Wisconsin; CHU Lyon	ANDRESEN, BS (corresponding author), SKEJBY SYGEHUS, DEPT CLIN CHEM, MOLEC GENET LAB, DK-8200 AARHUS N, DENMARK.		Jensen, Uffe Birk/ABA-8306-2021; Andresen, Brage/D-2515-2012; Jensen, Uffe Birk/E-6066-2017; Bross, Peter/B-7219-2013	Jensen, Uffe Birk/0000-0002-6205-6355; Andresen, Brage/0000-0001-7488-3035; Jensen, Uffe Birk/0000-0002-6205-6355; Bross, Peter/0000-0001-9526-8525				Beinert H., 1963, ENZYMES, P447; BROSS P, 1990, J BIOL CHEM, V265, P7116; BROSS P, 1990, FLAVIN FLAVOPROTEIN, P895; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATES PM, 1992, PEDIATR RES, V31, P34, DOI 10.1203/00006450-199201000-00006; DING JH, 1992, AM J HUM GENET, V50, P229; DURAN M, 1992, PEDIATR RES, V31, P39, DOI 10.1203/00006450-199201000-00007; DURAN M, 1985, J PEDIATR-US, V107, P397, DOI 10.1016/S0022-3476(85)80514-X; DURAN M, 1986, PEDIATRICS, V78, P1052; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREGERSEN N, 1991, HUM GENET, V86, P545; GREGERSEN N, 1976, CLIN CHIM ACTA, V70, P417, DOI 10.1016/0009-8981(76)90355-7; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; INDO Y, 1991, GENOMICS, V11, P609, DOI 10.1016/0888-7543(91)90068-P; IZAI K, 1992, J BIOL CHEM, V267, P1027; JENSEN TG, 1992, BIOCHIM BIOPHYS ACTA, V1180, P65, DOI 10.1016/0925-4439(92)90028-L; KELLY DP, 1990, P NATL ACAD SCI USA, V87, P9236, DOI 10.1073/pnas.87.23.9236; KELLY DP, 1992, J INHERIT METAB DIS, V15, P171, DOI 10.1007/BF01799626; KELLY DP, 1987, P NATL ACAD SCI USA, V86, P6677; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; KOLVRAA S, 1991, HUM GENET, V87, P425; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; MARTON A, 1991, NUCLEIC ACIDS RES, V19, P2423, DOI 10.1093/nar/19.9.2423; MATSUBARA Y, 1990, LANCET, V335, P1589, DOI 10.1016/0140-6736(90)91413-5; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; NAITO E, 1990, J CLIN INVEST, V85, P1575, DOI 10.1172/JCI114607; NAITO E, 1989, J CLIN INVEST, V83, P1605, DOI 10.1172/JCI114058; NAITO E, 1989, J CLIN INVEST, V84, P1671, DOI 10.1172/JCI114346; RHEAD WJ, 1983, SCIENCE, V221, P73, DOI 10.1126/science.6857268; Roe C, 1989, METABOLIC BASIS INHE, P889; SAUDUBRAY JM, 1982, PEDIATR RES, V16, P877, DOI 10.1203/00006450-198210000-00015; STANLEY CA, 1983, PEDIATR RES, V17, P877, DOI 10.1203/00006450-198311000-00008; TANAKA K, 1990, PROG CLIN BIOL RES, V321, P577; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; YOKOTA I, 1992, J BIOL CHEM, V267, P26004; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761	42	40	41	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					730	739						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8102510				2022-12-18	WOS:A1993LU55900017
J	DIZIER, MH; ELIAOU, JF; BABRON, MC; COMBE, B; SANY, J; CLOT, J; CLERGETDARPOUX, F				DIZIER, MH; ELIAOU, JF; BABRON, MC; COMBE, B; SANY, J; CLOT, J; CLERGETDARPOUX, F			INVESTIGATION OF THE HLA COMPONENT INVOLVED IN RHEUMATOID-ARTHRITIS (RA) BY USING THE MARKER ASSOCIATION-SEGREGATION GAMMA(2) (MASC) METHOD - REJECTION OF THE UNIFYING-SHARED-EPITOPE HYPOTHESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY; INHERITANCE; DISEASES; GENETICS; IDDM; RISK; MODE; DR4	In order to investigate the HLA component involved in rheumatoid arthritis (RA), we tested genetic models by the marker association-segregation chi2 (MASC) method, using the HLA genotypic distribution observed in a sample of 97 RA patients. First we tested models assuming the involvement of a susceptibility gene linked to the DR locus. We showed that the present data are compatible with a simple model assuming the effect of a recessive allele of a biallelic locus linked to the DR locus and without any assumption of synergistic effect. Then we considered models assuming the direct involvement of the DR allele products, and we tested the unifying-shared-epitope hypothesis, which has been proposed. Under this hypothesis the DR alleles are assumed to be directly involved in the susceptibility to the disease because of the presence of similar or identical amino acid sequences in position 70-74 of the third hypervariable region of the DRBI molecules, shared by the RA-associated DR alleles DR4Dw4, DR4Dw14, and DR1. This hypothesis was strongly rejected with the present data. In the case of the direct involvement of the DR alleles, hypotheses more complex than the unifying-shared-epitope hypothesis would have to be considered.	HOP ST ELOI, IMMUNOL LAB, MONTPELLIER, FRANCE; CHU MONTPELLIER, HOP GUI CHALLIAC,INSERM,U291,SERV IMMUNORHUMATOL, MONTPELLIER, F-34059 MONTPELLIER, FRANCE; CHRU NIMES, HOP CARREMEAU, INSERM, U291, SERV RHUMATOL, NIMES, FRANCE	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes	DIZIER, MH (corresponding author), INSERM, U155, UNITE RECH EPIDEMIOL GENET, CHATEAU LONGCHAMP BOIS BOULOGNE, F-75016 PARIS, FRANCE.		Dizier, Marie-Hélène/K-8463-2018; Clerget-Darpoux, Francoise/I-4825-2017	Dizier, Marie-Hélène/0000-0001-8460-7667; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Babron, Marie-Claude/0000-0002-4100-0299				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; ELIAOU JF, IN PRESS HUM IMMUNOL; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; GAO XJ, 1990, ARTHRITIS RHEUM, V33, P939, DOI 10.1002/art.1780330704; GORONZY J, 1986, LANCET, V2, P118; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; KHAN MA, 1986, DIS MARKERS, V4, P77; MAEDA H, 1981, ANN RHEUM DIS, V40, P299, DOI 10.1136/ard.40.3.299; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NELSON JL, 1991, TISSUE ANTIGENS, V38, P145, DOI 10.1111/j.1399-0039.1991.tb01888.x; NEPOM GT, 1986, LANCET, V2, P1002; OHTA N, 1982, HUM IMMUNOL, V5, P123, DOI 10.1016/0198-8859(82)90057-X; PAYAMI H, 1986, TISSUE ANTIGENS, V27, P57; PILE KD, 1992, TISSUE ANTIGENS, V39, P138, DOI 10.1111/j.1399-0039.1992.tb01924.x; RENNINGEN KS, 1990, TISSUE ANTIGENS, V36, P235, DOI 10.1111/j.1399-0039.1990.tb01834.x; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WILLKENS RF, 1991, ARTHRITIS RHEUM, V34, P43, DOI 10.1002/art.1780340107; Winchester R. J., 1977, ARTHRITIS RHEUM, V20, P159; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; WORDWWORTH BP, 1989, P NATL ACAD SCI USA, V86, P1004; ZOSCHKE D, 1986, HUM IMMUNOL, V15, P118, DOI 10.1016/0198-8859(86)90322-8	28	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					715	721						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	7688934				2022-12-18	WOS:A1993LU55900015
J	WAGSTAFF, J; SHUGART, YY; LALANDE, M				WAGSTAFF, J; SHUGART, YY; LALANDE, M			LINKAGE ANALYSIS IN FAMILIAL ANGELMAN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; DISOMY	Familial Angelman syndrome (AS) can result from mutations in chromosome 15q11q13 that, when transmitted from father to child, result in no phenotypic abnormality but, when transmitted from mother to child, cause AS. These mutations therefore behave neither as dominant nor as recessive mutations but, rather, show an imprinted mode of inheritance. We have analyzed two sibling pairs with AS and a larger family with four AS offspring of three sisters with several recently described microsatellite polymorphisms in the AS region. AS siblings inherited the same maternal alleles at the GABRB3 and GABRA5 loci, and the unaffected siblings of AS individuals inherited the other maternal alleles at these loci. In one of the AS sibling pairs, analysis of a recombination event indicates that the mutation responsible for AS is distal to locus D15S63. This result is consistent with a previously described imprinted submicroscopic deletion causing AS, a deletion that includes loci D15S10, D15S113, and GABRB3, all distal to D15S63. The analysis of the larger AS family provides the first clear demonstration of a new mutation in nondeletion AS. Analysis of linkage of AS to GABRB3 in these three families, on the assumption of imprinted inheritance (i.e., penetrance of an AS mutation is 1 if transmitted maternally and is 0 if transmitted paternally), indicates a maximum lod score of 3.52 at theta = 0.	HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Columbia University	WAGSTAFF, J (corresponding author), CHILDRENS HOSP MED CTR,DIV GENET,ENDERS 5,300 LONGWOOD AVE,BOSTON,MA 02115, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008] Funding Source: Medline; NICHD NIH HHS [K08 HD00966] Funding Source: Medline; NINDS NIH HHS [R01 NS30628] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BARAITSER M, 1987, CLIN GENET, V31, P323; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Glatt Karen A., 1992, Human Molecular Genetics, V1, P348, DOI 10.1093/hmg/1.5.348; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PASHAYAN HM, 1982, AM J MED GENET, V13, P295, DOI 10.1002/ajmg.1320130311; REIS A, 1993, LANCET, V341, P122, DOI 10.1016/0140-6736(93)92606-T; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330	34	40	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					105	112						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317476				2022-12-18	WOS:A1993LJ38500014
J	OSTRER, H; ALLEN, W; CRANDALL, LA; MOSELEY, RE; DEWAR, MA; NYE, D; VANMCCRARY, S				OSTRER, H; ALLEN, W; CRANDALL, LA; MOSELEY, RE; DEWAR, MA; NYE, D; VANMCCRARY, S			INSURANCE AND GENETIC TESTING - WHERE ARE WE NOW	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROSIS	Basic research will spur development of genetic tests that are capable of presymptomatic prediction of disease, disability, and premature death in presently asymptomatic individuals. Concerns have been expressed about potential harms related to the use of genetic test results, especially loss of confidentiality, eugenics, and discrimination. Existing laws and administrative policies may not be sufficient to assure that genetic information is used fairly. To provide factual information and conceptual principles upon which sound social policy can be based, the Human Genome Initiative established an Ethical, Legal, and Social Issues Program. Among the first areas to be identified as a priority for study was insurance. This paper provides a review of life, health, and disability insurance systems, including basic principles, risk classification, and market and regulatory issues, and examines the potential impact of genetic information on the insurance industry.	UNIV FLORIDA,COLL MED,DEPT COMMUNITY HLTH & FAMILY MED,MED HUMANITIES PROGRAM,GAINESVILLE,FL 32611; UNIV FLORIDA,SCH BUSINESS ADM,FLORIDA INSURANCE RES CTR,GAINESVILLE,FL 32611	State University System of Florida; University of Florida; State University System of Florida; University of Florida	OSTRER, H (corresponding author), NYU MED CTR,DEPT PEDIAT,HUMAN GENET PROGRAM,550 1ST AVE,MSB-136,NEW YORK,NY 10016, USA.				NHGRI NIH HHS [HG00402] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000402] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BEAUDET AL, 1988, METABOLIC BASIS INHE, P3; BEAUREGARD K, 1991, AHCPR920016 US PHS; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CRANDALL L, 1991, NEW BIOL, V3, P1135; DEWAR MA, 1991, JAMA-J AM MED ASSOC, V267, P1208; FRIEDMAN E, 1991, JAMA-J AM MED ASSOC, V265, P2491, DOI 10.1001/jama.265.19.2491; GILBERT SK, 1986, J NATL MED ASSOC, V78, P663; GOSTIN L, 1991, AM J LAW MED, V17, P109; HARNETT B, 1990, LAW LIFE HLTH INSURA, V1; HOLAHAN J, 1986, MED TRADE OFF COST C; HOLTZMAN NA, 1992, AM J HUM GENET, V50, P457; HOLTZMAN NA, 1989, PROCEED CAUTION PRED; JUENGST ET, 1991, JAMA-J AM MED ASSOC, V266, P1835, DOI 10.1001/jama.266.13.1835; LETRENTA ND, 1990, NOV LEG SECT M AM CO; LEW EA, 1991, MED RISKS TRENDS MOR; MCKUSICK VA, 1991, HOSP PRACT, V26, P74; MEHR RI, 1987, LIFE INSURANCE THEOR; Moseley Ray, 1991, Bus Prof Ethics J, V10, P69; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; NELKIN D, 1990, DANGEROUS DIAGNOSTIC; Pokorski R J, 1992, J Insur Med, V24, P60; POKORSKI RJ, 1989, POTENTIAL ROLE GENET; REJDA GE, 1992, PRINCIPLES RISK MANA; SULLIVAN CB, 1991, HLTH AFFAIRS     SUM, P104; VAUGHAN E, 1992, FUNDAMENTALS RISK IN; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WORTHAM L, 1985, J LAW REFORM, V19, P349; 1991, JAMA-J AM MED ASSOC, V266, P1827; 1990, NEW ENGL J MED, V323, P70; 1988, OTAH384; 1985, BUSINESS WEEK   1118, P85; 1988, OTABA373 US C OFF TE; 1991, REPORT ACLI HIAA TAS; 1990, LIFE INSURANCE FACT; 1992, OTABA532; 1991, MED INFORMATION BURE; 1990, INSURANCE LAW REGULA, P356; 1983, SCREENING COUNSELING	39	40	40	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					565	577						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447322				2022-12-18	WOS:A1993KR72000014
J	LANDSVATER, RM; ROMBOUTS, AGM; TEMEERMAN, GJ; SCHILLHORNVANVEEN, JMJ; BERENDS, MJH; GEERDINK, RA; STRUYVENBERG, A; BUYS, CHCM; LIPS, CJM				LANDSVATER, RM; ROMBOUTS, AGM; TEMEERMAN, GJ; SCHILLHORNVANVEEN, JMJ; BERENDS, MJH; GEERDINK, RA; STRUYVENBERG, A; BUYS, CHCM; LIPS, CJM			THE CLINICAL IMPLICATIONS OF A POSITIVE CALCITONIN TEST FOR C-CELL HYPERPLASIA IN GENETICALLY UNAFFECTED MEMBERS OF AN MEN2A KINDRED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; MEDULLARY-THYROID CARCINOMA; TYPE-2A; CHROMOSOME-10; MARKERS; AGE; LINKAGE; GENE	C-cell hyperplasia precedes the development of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A (MEN2A). Identification of abnormal calcitonin levels after a provocative stimulus is a technique that has been widely used to diagnose this preneoplastic condition in an early stage during the development of medullary thyroid carcinoma, when total thyroidectomy is likely to be curative. In a MEN2A kindred, we identified seven individuals with abnormal calcitonin test results, whose carrier state was questionable. Five of these people were thyroidectomized, and C-cell hyperplasia was diagnosed. Four of these individuals were the offspring of a mother who is at risk for the development of MEN2A but who has had normal calcitonin test results throughout the years and of a father who is not at risk but who has had abnormal test results over a period of 10 years, without evidence of progressive elevation. None of these people developed other manifestations of MEN2A. DNA analysis using markers linked to the MEN2A gene demonstrated, with >99% likelihood, that none of the individuals who could be genotyped was a gene carrier. C-cell hyperplasia due to some mechanism other than the presence of the MEN2A gene may also occur in MEN2A kindreds. DNA analysis offers an important additional tool for proper diagnosis in the clinical management of MEN2A families.	UNIV UTRECHT HOSP,DEPT PATHOL,3584 CX UTRECHT,NETHERLANDS; UNIV GRONINGEN,DEPT MED GENET,9700 AB GRONINGEN,NETHERLANDS; WESTEINDE ZIEKENHUIS,DEPT PATHOL,THE HAGUE,NETHERLANDS	Utrecht University; Utrecht University Medical Center; University of Groningen	LANDSVATER, RM (corresponding author), UNIV UTRECHT HOSP,DEPT INTERNAL MED,HEIDELBERGLAAN 100,3584 CX UTRECHT,NETHERLANDS.							ALBORESSAAVEDRA J, 1988, HUM PATHOL, V19, P795, DOI 10.1016/S0046-8177(88)80262-4; CARSON NL, 1991, AM J HUM GENET S, V49, pA1888; EASTON DF, 1989, AM J HUM GENET, V44, P208; GAGEL RF, 1988, NEW ENGL J MED, V318, P478, DOI 10.1056/NEJM198802253180804; GAGEL RF, 1982, J PEDIATR-US, V101, P941, DOI 10.1016/S0022-3476(82)80014-0; GIBSON W, 1980, LAB INVEST, V42, P119; GIBSON WCH, 1981, AM J CLIN PATHOL, V75, P347; GIBSON WGH, 1982, AM J PATHOL, V106, P388; GOODFELLOW PJ, 1990, AM J HUM GENET, V47, P952; JACKSON CE, 1990, AM J HUM GENET S, V43, pA147; LANDSVATER RM, 1989, GENOMICS, V4, P246, DOI 10.1016/0888-7543(89)90327-3; LICHTER JB, 1992, J CLIN ENDOCR METAB, V74, P368, DOI 10.1210/jc.74.2.368; LIOU GI, 1987, NUCLEIC ACIDS RES, V15, P3196, DOI 10.1093/nar/15.7.3196; Lips C J, 1987, Henry Ford Hosp Med J, V35, P133; LIPS CJM, 1978, AM J MED, V64, P569, DOI 10.1016/0002-9343(78)90575-2; LIPS CJM, 1981, AM J MED, V70, P1051; LIVOLSI VA, 1979, AM J CLIN PATHOL, V71, P595; MATHEW CGP, 1991, LANCET, V337, P7, DOI 10.1016/0140-6736(91)93329-8; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P374, DOI 10.1093/nar/16.1.374; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1989, GENOMICS, V5, P199, DOI 10.1016/0888-7543(89)90046-3; NORUM RA, 1990, GENOMICS, V8, P313, DOI 10.1016/0888-7543(90)90287-5; OTOOLE K, 1985, HUM PATHOL, V16, P991, DOI 10.1016/S0046-8177(85)80276-8; SCHIMKE RN, 1984, ANNU REV MED, V35, P25, DOI 10.1146/annurev.me.35.020184.000325; SCOPSI L, 1991, MODERN PATHOL, V4, P297; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; TEMEERMAN GJ, 1991, THESIS STATE U GRONI; TROELSTRA C, 1992, GENOMICS, V12, P745, DOI 10.1016/0888-7543(92)90304-B; WILLIAMS ED, 1984, B CANCER, V71, P122; WILLIAMS ED, 1982, CURRENT ENDOCRINE CO, P3; WOLFE H, 1991, 4TH INT WORKSH MULT; WOLFE HJ, 1981, CLIN ENDOCRINOL META, V10, P351, DOI 10.1016/S0300-595X(81)80027-8; WU JS, 1990, AM J HUM GENET, V46, P624	34	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					335	342						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8094268				2022-12-18	WOS:A1993KN27500012
J	SHOHAT, M; BU, XD; SHOHAT, T; FISCHELGHODSIAN, N; MAGAL, N; NAKAMURA, Y; SCHWABE, AD; SCHLEZINGER, M; DANON, Y; ROTTER, JI				SHOHAT, M; BU, XD; SHOHAT, T; FISCHELGHODSIAN, N; MAGAL, N; NAKAMURA, Y; SCHWABE, AD; SCHLEZINGER, M; DANON, Y; ROTTER, JI			THE GENE FOR FAMILIAL MEDITERRANEAN FEVER IN BOTH ARMENIANS AND NON-ASHKENAZI JEWS IS LINKED TO THE ALPHA-GLOBIN COMPLEX ON 16P - EVIDENCE FOR LOCUS HOMOGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; CLUSTER; ADHESION; MARKER; FMF	Familial Mediterranean fever (FMF) is a recurrent inflammatory disorder characterized by short episodes of fever, peritonitis, pleuritis, and arthritis. While FMF has been shown to be inherited in an autosomal recessive fashion in both non-Ashkenazi Jews and Armenian families, clinical differences have raised the possibility of genetic heterogeneity. As its pathogenesis is unknown, mapping of the gene for FMF may provide the first objective method for early and accurate diagnosis of this disease. After excluding 45% of the entire human genome, we studied 14 Armenian and 9 non-Ashkenazi Jewish families with FMF and tested linkage with the alpha-globin locus on chromosome 16. Analysis of the PvuII length polymorphism of the 3' HVR (hypervariable region) probe showed significant linkage with the FMF gene (maximum lod score [lod(max)] = 9.76 at maximum recombination fraction [theta] = .076). In the Armenians, the lod(max) = 3.61 at theta = .10; and for the non-Ashkenazi Jews, lod(max) = 6.28 at theta = .06. There was no evidence for genetic heterogeneity between the Armenians and the non-Ashkenazi Jews (chi2 = 1.28; P = .26) or within either ethnic group (chi2 = .00; P = .50). Thus, the gene for FMF is linked to the alpha-globin complex on chromosome 16p in both non-Ashkenazi Jews and Armenians.	TEL AVIV UNIV,BEILINSON MED CTR,DEPT PEDIAT IMMUNOL,BASIL & GERALD FELSENSTEIN INST,IL-49100 PETAH TIQWA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL; UNIV CALIF LOS ANGELES,LEDARS SINAI MED CTR,SCH MED,DIV MED GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DIV GASTROENTEROL,LOS ANGELES,CA 90024; JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,TOKYO 170,JAPAN; BARZILAI GOVT HOSP,DEPT PEDIAT,ASHQELON,ISRAEL	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Japanese Foundation for Cancer Research; Ben Gurion University; Barzilai Medical Center	SHOHAT, M (corresponding author), TEL AVIV UNIV,BEILINSON MED CTR,DEPT MED GENET,DIV MED GENET,IL-49100 PETAH TIQWA,ISRAEL.							AKSENTIJEVICH I, 1991, AM J HUM GENET, V49, P335; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CORBI AL, 1988, J EXP MED, V167, P1597, DOI 10.1084/jem.167.5.1597; EDWARDS A, 1991, AM J HUM GENET, V49, P746; ELIAKIM M, 1981, RECURRENT POLYSEROSI, P15; GRUBERG L, 1991, CYTOGENET CELL GENET, V58, P2113; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; JARMAN AP, 1988, AM J HUM GENET, V43, P249; KASTNER DL, 1991, CYTOGENET CELL GENET, V58, P2115; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; Ott J., 1991, ANAL HUMAN GENETIC L; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; PRAS M, 1982, JOHNS HOPKINS MED J, V150, P22; Pras M, 1984, Adv Nephrol Necker Hosp, V13, P261; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; SACK GH, 1988, MOL BIOL MED, V5, P61; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; SHOHAT M, 1990, GENOMICS, V8, P83, DOI 10.1016/0888-7543(90)90228-M; SHOHAT M, 1989, AM J MED GENET, V34, P163, DOI 10.1002/ajmg.1320340205; SHOHAT T, 1990, CLIN GENET, V38, P332; SHOHAT T, 1990, TISSUE ANTIGENS, V35, P103; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; WARDLAW AJ, 1990, J EXP MED, V172, P335, DOI 10.1084/jem.172.1.335	26	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1349	1354						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463015				2022-12-18	WOS:A1992KC99500017
J	NORTHRUP, H; KWIATKOWSKI, DJ; ROACH, ES; DOBYNS, WB; LEWIS, RA; HERMAN, GE; RODRIGUEZ, E; DAIGER, SP; BLANTON, SH				NORTHRUP, H; KWIATKOWSKI, DJ; ROACH, ES; DOBYNS, WB; LEWIS, RA; HERMAN, GE; RODRIGUEZ, E; DAIGER, SP; BLANTON, SH			EVIDENCE FOR GENETIC-HETEROGENEITY IN TUBEROUS SCLEROSIS - ONE LOCUS ON CHROMOSOME-9 AND AT LEAST ONE LOCUS ELSEWHERE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; ABO BLOOD-GROUP; LINKAGE; IDENTIFICATION; PARENTS; 9Q32-34; DNA	Linkage of tuberous sclerosis complex (TSC), an autosomal dominant disorder, to markers on chromosome 9 was reported first in 1987. This assignment was confirmed by an international collaborative study that suggested more than one locus may be responsible for the phenotype. We studied 14 multigenerational TSC families (13 previously unreported) with markers for nine loci in the linked region of chromosome 9q32-q34. Our results confirm the previous reports that the genetic locus in one-third to one-half of families maps to chromosome 9. Comparison of clinical findings in the chromosome 9-linked families with those in the chromosome 9-unlinked families reveals only a higher incidence of ungual fibromata in the chromosome 9-linked families.	BRIGHAM & WOMENS HOSP, DEPT EXPTL MED, BOSTON, MA 02115 USA; UNIV TEXAS, HLTH SCI CTR, SW MED SCH, DIV PEDIAT NEUROL, DALLAS, TX 75235 USA; RILEY HOSP, DEPT NEUROL, INDIANAPOLIS, IN USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT OPHTHALMOL, HOUSTON, TX 77030 USA; UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, HOUSTON, TX 77225 USA	Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; James Whitcomb Riley Hospital Children; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	NORTHRUP, H (corresponding author), UNIV TEXAS, SCH MED,DEPT PEDIAT,DIV GENET,MSB 3 144, 6431 FANNIN ST, HOUSTON, TX 77030 USA.		Blanton, Susan Halloran/ABF-1323-2021; Dobyns, William/AAI-2768-2020; Roach, Ewell/E-3958-2011; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; 	NCRR NIH HHS [RR-02558] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002558] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CASSIDY SB, 1983, JAMA-J AM MED ASSOC, V249, P1302, DOI 10.1001/jama.249.10.1302; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CONNOR JM, 1987, J MED GENET, V24, P544, DOI 10.1136/jmg.24.9.544; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FLINTER FA, 1986, LANCET, V2, P1167; FRYER AE, 1987, LANCET, V1, P659; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gomez MR, 1988, TUBEROUS SCLEROSIS; HAINES JL, 1991, AM J HUM GENET, V49, P764; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; KANDT RS, 1989, EXP NEUROL, V104, P223, DOI 10.1016/0014-4886(89)90033-2; KANDT RS, 1991, ANN NY ACAD SCI, V615, P284; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, GENOMICS, V3, P361; LITT M, 1989, AM J HUM GENET, V44, P397; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MARTIN AO, 1988, AM J MED GENET, V31, P643, DOI 10.1002/ajmg.1320310320; NEVIN N C, 1968, Journal of Medical Genetics, V5, P273, DOI 10.1136/jmg.5.4.273; NORTHRUP H, 1987, LANCET, V2, P804; NORTHRUP H, IN PRESS J MED GENET; Ott J., 1991, ANAL HUMAN GENETIC L; OZELIUS LJ, UNPUB GENETIC LINKAG; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROACH ES, 1991, NEUROLOGY, V41, P262, DOI 10.1212/WNL.41.2_Part_1.262; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEBB DW, 1991, J MED GENET, V28, P417, DOI 10.1136/jmg.28.6.417; WEBER JL, 1989, AM J HUM GENET, V44, P388; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600; [No title captured]	37	40	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					709	720						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415216				2022-12-18	WOS:A1992JQ66700003
J	STRAUTNIEKS, S; RUTLAND, P; WINTER, RM; BARAITSER, M; MALCOLM, S				STRAUTNIEKS, S; RUTLAND, P; WINTER, RM; BARAITSER, M; MALCOLM, S			PELIZAEUS-MERZBACHER DISEASE - DETECTION OF MUTATIONS THR181-]PRO AND LEU223-]PRO IN THE PROTEOLIPID PROTEIN GENE, AND PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN; PLP; IDENTIFICATION; DISORDER	A family with an apparent history of X-linked Pelizaeus-Merzbacher disease presented for genetic counseling, requesting carrier detection and prenatal diagnosis. RFLP analysis using the proteolipid protein (PLP) gene probe was uninformative in this family. A prenatal diagnosis on a chorionic villus sample (CVS) was carried out using single-strand conformation polymorphism (SSCP) analysis of a variant in exon 4 of the PLP gene. The fetus was predicted to be unaffected. Sequencing of the exon from the CVS, the predicted-carrier mother, and the obligate-carrier grandmother revealed an A-to-C change at nucleotide 541 in the two women but not in the fetus. As this change results in a Thr-to-Pro change at amino acid 181 in a region of the gene predicted to be part of a transmembrane segment, it was concluded that this was the mutation causing the disease in this family. In addition, in a second family, an exon 5 variant band pattern on SSCP analysis was shown by sequencing to be due to a T-to-C change at nucleotide 668. This results in a Leu-to-Pro change in a carrier mother and in her two affected sons. These results provide further examples of mutations in PLP that cause Pelizaeus-Merzbacher disease and illustrate the value of SSCP in genetic analysis.	INST CHILD HLTH,MOLEC GENET UNIT,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND; HOSP SICK CHILDREN,LONDON WC1N 3JH,ENGLAND; NORTHWICK PK HOSP & CLIN RES CTR,KENNEDY GALTON CTR,MRC,CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London; Medical Research Council Clinical Trials Unit								BEGLEITER ML, 1989, AM J MED GENET, V33, P311, DOI 10.1002/ajmg.1320330305; BOLTSHAUSER E, 1988, HUM GENET, V80, P393, DOI 10.1007/BF00273659; GENCIC S, 1989, AM J HUM GENET, V45, P435; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hayashi K, 1991, PCR Methods Appl, V1, P34; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; SCHEFFER IE, 1991, NEUROPEDIATRICS, V22, P71, DOI 10.1055/s-2008-1071420; STOFFEL W, 1984, P NATL ACAD SCI-BIOL, V81, P5012, DOI 10.1073/pnas.81.16.5012; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; WILLARD HF, 1987, CYTOGENET CELL GENET, V46, P716; WU JS, 1987, NUCLEIC ACIDS RES, V15, P1882, DOI 10.1093/nar/15.4.1882	17	40	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					871	878						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1384324				2022-12-18	WOS:A1992JQ66700021
J	HOLTZMAN, NA; ROTHSTEIN, MA				HOLTZMAN, NA; ROTHSTEIN, MA			INVITED EDITORIAL - EUGENICS AND GENETIC DISCRIMINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS MED INST,DEPT HLTH MANAGEMENT,BALTIMORE,MD 21205; UNIV HOUSTON,CTR LAW,INST HLTH LAW & POLICY,HOUSTON,TX 77004	Johns Hopkins University; Johns Hopkins Medicine; University of Houston System; University of Houston	HOLTZMAN, NA (corresponding author), JOHNS HOPKINS MED INST,DEPT PEDIAT,550 N BROADWAY,SUITE 301,BALTIMORE,MD 21205, USA.							BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BLUMETHAL R, 1991, COMMUNICATION   1122; HARPER PS, 1992, AM J HUM GENET, V50, P460; HOGBEN L, 1938, SCI CITIZEN; JUENGST E, 1991, JAMA-J AM MED ASSOC, V226, P1835; Kevles D, 1985, NAME EUGENICS GENETI; Ludmerer K.M., 1972, GENETICS AM SOC HIST; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; Revo, 2022, SURG SOLUTION; ROTHSTEIN MA, 1989, MED SCREENING WORKER; SELIGMANN J, 1991, NEWSWEEK        1028, P73	11	40	40	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					457	459						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1531726				2022-12-18	WOS:A1992HH97400001
J	DOSSANTOS, MR; TANAKA, A; MIRANDA, MCS; RIBEIRO, MG; MAIA, M; SUZUKI, K				DOSSANTOS, MR; TANAKA, A; MIRANDA, MCS; RIBEIRO, MG; MAIA, M; SUZUKI, K			GM2-GANGLIOSIDOSIS-B1 VARIANT - ANALYSIS OF BETA-HEXOSAMINIDASE ALPHA-GENE MUTATIONS IN 11 PATIENTS FROM A DEFINED REGION IN PORTUGAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The G(M2)-gangliosidosis B1 variant occurs at an exceptionally high frequency in the northern part of Portugal. In most patients, the disease manifests itself as a juvenile form, as opposed to the late-infantile form described for many patients from other parts of the world. We have analyzed the beta-hexosaminidase alpha-gene in 11 patients, as well as in some relatives, in order to characterize the underlying abnormalities. They were screened for the two previously identified mutations responsible for the B1 variant phenotype (G533 --> A, also designated as the "DN allele," and C532 --> T) by PCR amplification of an 800-bp DNA fragment and subsequent dot-blot hybridization with allele-specific oligonucleotides. The fragment amplified from one patient was also subcloned and sequenced. Ten patients, constituting a clinically and biochemically homogeneous group, were found to be homozygous for the DN allele. The other, whose clinical profile more resembled the late-infantile phenotype often described in the literature, was a compound heterozygote carrying the DN allele and another, as yet unidentified, abnormal allele. Our results, corroborated by previously published data, suggest that homozygotes and compound heterozygotes for the DN allele may be distinguishable at the phenotypic level, depending on the nature of the abnormality in the other allele. A common ancestral origin for the DN allele can also be postulated.	UNIV N CAROLINA,SCH MED,BRAIN & DEV RES CTR,CB 7250,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine			Ribeiro, Maria Gil/B-6467-2013; sá Miranda, Maria Clara/K-3920-2013; Maia, Mauricio/I-5892-2015	Ribeiro, Maria Gil/0000-0001-9365-6057; sá Miranda, Maria Clara/0000-0003-0123-5525; Maia, Mauricio/0000-0002-7034-8091; Santos, Rosario/0000-0002-8594-6377	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028997, R01NS024289] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-03110] Funding Source: Medline; NINDS NIH HHS [NS-24289, NS-28997] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; DOSSANTOS MR, 1990, DEC INT WORKSH LAT O; KYTZIA HJ, 1983, EMBO J, V2, P1201, DOI 10.1002/j.1460-2075.1983.tb01567.x; MAIA M, 1990, NEUROPEDIATRICS, V21, P18, DOI 10.1055/s-2008-1071451; Maniatis T., 1982, MOL CLONING; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OHNO K, 1988, J NEUROCHEM, V50, P316, DOI 10.1111/j.1471-4159.1988.tb13266.x; RIBEIRO MG, UNPUB BIOCH CHARACTE; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUZUKI K, IN PRESS DEV NEUROSC; TANAKA A, 1990, AM J HUM GENET, V46, P329; TANAKA A, 1988, BIOCHEM BIOPH RES CO, V156, P1015, DOI 10.1016/S0006-291X(88)80945-8	13	40	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					886	890						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1832817				2022-12-18	WOS:A1991GG66500021
J	JONES, LA; SKARE, JC; HARDING, JA; COHEN, AS; MILUNSKY, A; SKINNER, M				JONES, LA; SKARE, JC; HARDING, JA; COHEN, AS; MILUNSKY, A; SKINNER, M			PROLINE AT POSITION-36 - A NEW TRANSTHYRETIN MUTATION ASSOCIATED WITH FAMILIAL AMYLOIDOTIC POLYNEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Familial amyloidotic polyneuropathy (FAP) is associated with the deposition of an abnormal transthyretin (TTR) molecule. We have studied DNA from a family of Greek descent with FAP. The proband's TTR gene was asymmetrically amplified by using PCR and then was sequenced directly, to reveal a cytosine-for-guanine substitution in codon 36. This substitution removes a recognition site for endonuclease Fnu4HI. Allele-specific PCR was employed for diagnosis of the mutation. The predicted amino acid change of alanine to proline at position 36 was confirmed by protein sequencing of the proband's plasma TTR.	BOSTON UNIV,SCH MED,CTR HUMAN GENET,DEPT PEDIAT & MICROBIOL,BOSTON,MA 02118; BOSTON CITY HOSP,CTR ARTHRITIS,DEPT MED,BOSTON,MA 02118; BOSTON CITY HOSP,THORNDIKE MEM LAB,BOSTON,MA 02118	Boston University; Boston Medical Center; Boston Medical Center				Milunsky, Aubrey/0000-0003-2114-4823	NCRR NIH HHS [RR 533] Funding Source: Medline; NIADDK NIH HHS [AM 20613, AM 07014] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM020613] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; Benson MD, 1989, METABOLIC BASIS INHE, P2439; LIDDLE CN, 1985, J PATHOL, V146, P107, DOI 10.1002/path.1711460205; NICHOLS WC, 1989, GENOMICS, V5, P535, DOI 10.1016/0888-7543(89)90020-7; RICHARDSON JS, 1981, ADV PROTEIN CHEM, V34, P243; ROBBINS J, 1978, RECENT PROG HORM RES, V34, P163; SKINNER M, 1988, AMYLOID AMYLOIDOSIS, P125	7	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					979	982						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1850191				2022-12-18	WOS:A1991FK89700017
J	KATSUBE, T; SAKAMOTO, N; KOBAYASHI, Y; SEKI, R; HIRANO, M; TANISHIMA, K; TOMODA, A; TAKAZAKURA, E; YUBISUI, T; TAKESHITA, M; SAKAKI, Y; FUKUMAKI, Y				KATSUBE, T; SAKAMOTO, N; KOBAYASHI, Y; SEKI, R; HIRANO, M; TANISHIMA, K; TOMODA, A; TAKAZAKURA, E; YUBISUI, T; TAKESHITA, M; SAKAKI, Y; FUKUMAKI, Y			EXONIC POINT MUTATIONS IN NADH-CYTOCHROME-B5 REDUCTASE GENES OF HOMOZYGOTES FOR HEREDITARY METHEMOGLOBINEMIA, TYPE-I AND TYPE-III - PUTATIVE MECHANISMS OF TISSUE-DEPENDENT ENZYME DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; RAT-LIVER MICROSOMES; AMINO-ACID SEQUENCE; CYTOCHROME B5; MENTAL-RETARDATION; HUMAN-ERYTHROCYTES; BETA-THALASSEMIA; IDENTIFICATION; DEHYDROGENASE; PARTICIPATION	We analyzed the NADH-cytochrome b5 reductase gene of hereditary methemoglobinemia type I and type III, by using PCR-related techniques. The mutation in type I is a guanine-to-adenine substitution in codon 57 of exon 3 of the NADH-cytochrome b5 reductase gene, and the sense of this codon is changed from arginine to glutamine. In type III the mutation is a thymine-to-cytosine transition in codon 148 of exon 5, causing leucine-to-proline replacement in type III. The former mutation abolishes the MspI recognition site. Homozygosity for the former mutation in a patient with type I was confirmed by restriction analysis of PCR-amplified fragments and by dot blot hybridization of amplified products with allele-specific oligonucleotide probes. The latter mutation generates a recognition site for MspI. Amplification of exon 5 by PCR followed by digestion with MspI revealed homozygosity for this mutation in patients with type III. Putative mechanisms of tissue-dependent enzyme defects in hereditary methemoglobinemia are discussed.	KYUSHU UNIV, GENET INFORMAT RES LAB, 3-1-1 MAIDASHI, HIGASHI KU, FUKUOKA 812, JAPAN; FUJITA GAKUEN UNIV HOSP, DEPT INTERNAL MED, AICHI, JAPAN; KANAZAWA UNIV, SCH MED, DEPT BIOCHEM, KANAZAWA, ISHIKAWA 920, JAPAN; KUROBE MUNICIPAL HOSP, DEPT INTERNAL MED, TOYAMA, JAPAN; MED COLL OITA, DEPT BIOCHEM, OITA 87956, JAPAN	Kyushu University; Fujita Health University; Kanazawa University; Oita University								ARNOLD H, 1978, 17TH C INT SOC HEM P; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BEUTLER E, 1968, BLOOD, V31, P131, DOI 10.1182/blood.V31.2.131.131; BEUTLER E, 1983, P NATL ACAD SCI-BIOL, V80, P3767, DOI 10.1073/pnas.80.12.3767; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; FUCHAROEN S, 1989, J BIOL CHEM, V264, P7780; FUCHAROEN S, 1989, HUM GENET, V84, P41, DOI 10.1007/BF00210668; GIBSON QH, 1948, BIOCHEM J, V42, P13, DOI 10.1042/bj0420013; GRAY GR, 1973, LANCET, V2, P530; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HIRONO H, 1980, LIPIDS, V15, P272, DOI 10.1007/BF02535839; HOLLOWAY PW, 1972, BIOCHEMISTRY-US, V11, P3689, DOI 10.1021/bi00770a005; Hultquist D E, 1978, Prog Clin Biol Res, V21, P199; KEYES SR, 1980, J BIOL CHEM, V255, P1357; KOBAYASHI Y, 1990, BLOOD, V75, P1408; LARSSON A, 1974, PEDIATR RES, V8, P852, DOI 10.1203/00006450-197410000-00007; LEROUX A, 1975, NATURE, V258, P619, DOI 10.1038/258619a0; MARSTEIN S, 1976, NEW ENGL J MED, V295, P406, DOI 10.1056/NEJM197608192950802; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; OZOLS J, 1985, J BIOL CHEM, V260, P1953; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; RICE DW, 1984, J MOL BIOL, V174, P483, DOI 10.1016/0022-2836(84)90332-2; SCOTT EM, 1959, BIOCHIM BIOPHYS ACTA, V34, P584, DOI 10.1016/0006-3002(59)90324-5; SUTTER TR, 1990, J BIOL CHEM, V265, P16428; TAKESHITA M, 1982, J MED GENET, V19, P204, DOI 10.1136/jmg.19.3.204; TAKIHARA Y, 1986, BLOOD, V67, P547; TANISHIMA K, 1985, BLOOD, V66, P1288; TOMATSU S, 1989, GENE, V80, P353; VIVESCORRONS JL, 1978, ACTA HAEMATOL-BASEL, V59, P348, DOI 10.1159/000207786; WORSTERDROUGHT C, 1953, BMJ-BRIT MED J, V2, P114, DOI 10.1136/bmj.2.4828.114; YUBISUI T, 1980, J BIOL CHEM, V255, P2454; YUBISUI T, 1986, J BIOCHEM-TOKYO, V99, P407, DOI 10.1093/oxfordjournals.jbchem.a135495; YUBISUI T, 1989, RED CELL, P107; ZENNO S, 1990, J BIOCHEM, V107, P810, DOI 10.1093/oxfordjournals.jbchem.a123130	36	40	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					799	808						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1707593				2022-12-18	WOS:A1991FK47800020
J	ROWLEY, PT; LOADER, S; SUTERA, CJ; WALDEN, M; KOZYRA, A				ROWLEY, PT; LOADER, S; SUTERA, CJ; WALDEN, M; KOZYRA, A			PRENATAL SCREENING FOR HEMOGLOBINOPATHIES .1. A PROSPECTIVE REGIONAL TRIAL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-THALASSEMIA TRAIT; SICKLE-CELL-ANEMIA; DIAGNOSIS; GENE; KNOWLEDGE; FETUS	Prenatal hemoglobinopathy screening was chosen as a model system for the study of patient receptivity to unsolicited genetic information. Providers of prenatal care in Rochester, NY, were offered free testing of all their prenatal patients and genetic counseling of women found positive. The 18,907 prenatal samples tested in a 5-year period represented 35.1% of the pregnancies in the Rochester metropolitan region. A hemoglobinopathy was found in 810 pregnancies (4.3%). Of the 21 different types of hemoglobinopathies detected, the most common were sickle cell trait (59%), hemoglobin C trait (19%), beta-thalassemia trait (11%), and hemoglobin E trait (5%). At the time of phlebotomy, 75% of the pregnancies were of less than 18 wk duration. Sixty-six percent of the pregnancies occurred in patients unaware of their diagnosis, and 80% occurred in patients unaware that they might be at risk for a child with a serious blood disorder. Of the 810 positive pregnancies, 551 (68%) occurred in patients who came for counseling. Of 453 women counseled during their first screened pregnancy, 390 (86%) said they wanted their partners tested and 254 (55%) had their partner tested. In the 77 pregnancies thus found to be at risk, the couple was too late for prenatal diagnosis in 12 cases, and the condition for which the fetus was at risk was too mild in 12 cases. Prenatal diagnosis was offered in the remaining 53 pregnancies and was accepted by 25 couples (47%). These results indicate that unselected patients in the primary care setting in this region, even though pregnant, are receptive to and utilize genetic information.	UNIV ROCHESTER,SCH MED,DEPT MED,ROCHESTER,NY 14642	University of Rochester	ROWLEY, PT (corresponding author), UNIV ROCHESTER,SCH MED,DIV GENET,BOX 641,ROCHESTER,NY 14642, USA.				NHLBI NIH HHS [HL29231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOEHM CD, 1983, NEW ENGL J MED, V308, P1054, DOI 10.1056/NEJM198305053081803; CHANG H, 1975, P NATL ACAD SCI USA, V72, P3633, DOI 10.1073/pnas.72.9.3633; CHANG JC, 1981, LANCET, V2, P1127; CHILDS B, 1976, AM J HUM GENET, V28, P537; Holtzman NA., 1989, P CAUTION PREDICTING; HUISMAN TH, 1979, J LAB CLIN MED, V86, P700; KAN YW, 1972, NEW ENGL J MED, V287, P1, DOI 10.1056/NEJM197207062870101; KAY YW, 1976, NEW ENGL J MED, V295, P1165; KAZAZIAN HH, 1980, BLOOD, V56, P926; LIPKIN M, 1986, ANN INTERN MED, V105, P115, DOI 10.7326/0003-4819-105-1-115; ORKIN SH, 1983, J CLIN INVEST, V71, P775, DOI 10.1172/JCI110826; PEARSON HA, 1973, NEW ENGL J MED, V288, P351, DOI 10.1056/NEJM197302152880706; ROWLEY PT, 1985, ANN NY ACAD SCI, V445, P408, DOI 10.1111/j.1749-6632.1985.tb17210.x; ROWLEY PT, 1979, AM J HUM GENET, V31, P718; ROWLEY PT, 1984, SCIENCE, V225, P138, DOI 10.1126/science.6729472; SCHNEIDER RG, 1975, ABNORMAL HAEMOGLOBIN, P39; WHITTEN CF, 1981, AM J HUM GENET, V33, P802	17	40	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					439	446						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998330				2022-12-18	WOS:A1991FK47000002
J	COX, NJ; MELA, AP; ZMIJEWSKI, CM; SPIELMAN, RS				COX, NJ; MELA, AP; ZMIJEWSKI, CM; SPIELMAN, RS			HLA-DR TYPING AT THE DNA LEVEL - RFLPS AND SUBTYPES DETECTED WITH A DR-BETA CDNA PROBE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT DENT & ORAL SURG,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032592] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 35047] Funding Source: Medline; NIGMS NIH HHS [GM 32592] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT ED, 1984, HISTOCOMPATIBILITY T, P4; ANDERSSON M, 1984, HUM IMMUNOL, V11, P57, DOI 10.1016/0198-8859(84)90045-4; ANGELINI G, 1986, P NATL ACAD SCI USA, V83, P4489, DOI 10.1073/pnas.83.12.4489; BELL JI, 1987, J IMMUNOL, V139, P562; BOEHME J, 1985, J IMMUNOL, V135, P2149; BOSCH ML, 1987, HUM IMMUNOL, V19, P91, DOI 10.1016/0198-8859(87)90097-8; COHEN D, 1984, P NATL ACAD SCI-BIOL, V81, P7870, DOI 10.1073/pnas.81.24.7870; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GORSKI J, 1986, NATURE, V322, P67, DOI 10.1038/322067a0; HOLBECK SL, 1986, IMMUNOGENETICS, V24, P251, DOI 10.1007/BF00364529; JAKOBSEN BK, 1986, TISSUE ANTIGENS, V27, P285; KELLER E, 1987, TISSUE ANTIGENS, V29, P154; KOHONENCORISH MRJ, 1986, HUM IMMUNOL, V15, P263, DOI 10.1016/0198-8859(86)90002-9; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LONG EO, 1983, EMBO J, V2, P389, DOI 10.1002/j.1460-2075.1983.tb01435.x; MANIATIS T, 1982, MOL CLONING LABORATO; OWERBACH D, 1983, P NATL ACAD SCI-BIOL, V80, P3758, DOI 10.1073/pnas.80.12.3758; RAY JC, 1980, NIH80545 PUBL; ROSENSHINE S, 1986, IMMUNOGENETICS, V23, P187, DOI 10.1007/BF00373820; SCHREUDER GMT, 1984, HISTOCOMPATIBILITY T, P243; SO AKL, 1984, HISTOCOMPATIBILITY T, P565; SPIELMAN RS, 1984, P NATL ACAD SCI-BIOL, V81, P3461, DOI 10.1073/pnas.81.11.3461; TILANUS MGJ, 1986, TISSUE ANTIGENS, V28, P218; TROWSDALE J, 1985, IMMUNOL REV, V85, P5, DOI 10.1111/j.1600-065X.1985.tb01129.x; TROWSDALE J, 1983, P NATL ACAD SCI-BIOL, V80, P1972, DOI 10.1073/pnas.80.7.1972; WAKE CT, 1982, NATURE, V300, P372, DOI 10.1038/300372a0	26	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					954	963						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	2904222				2022-12-18	WOS:A1988R344900017
J	DURSO, M; LUZZATTO, L; PERRONI, L; CICCODICOLA, A; GENTILE, G; PELUSO, I; PERSICO, MG; PIZZELLA, T; TONIOLO, D; VULLIAMY, TJ				DURSO, M; LUZZATTO, L; PERRONI, L; CICCODICOLA, A; GENTILE, G; PELUSO, I; PERSICO, MG; PIZZELLA, T; TONIOLO, D; VULLIAMY, TJ			AN EXTENSIVE SEARCH FOR RFLP IN THE HUMAN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE LOCUS HAS REVEALED A SILENT MUTATION IN THE CODING SEQUENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INT INST GENET & BIOPHYS,NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	DURSO, M (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND.		Toniolo, Daniela/AAE-2969-2019	Toniolo, Daniela/0000-0001-9545-6032; Ciccodicola, Alfredo/0000-0002-9924-1482				ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; Beutler E, 1983, METABOLIC BASIS INHE, P1629; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CONRAD M, 1983, BIOSYSTEMS, V16, P101, DOI 10.1016/0303-2647(83)90031-X; Foroni L, 1984, Mol Biol Med, V2, P63; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5597, DOI 10.1073/pnas.83.15.5597; HOPE R, 1987, ANN HUM GENET, V51, P1; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; KOLLER BH, 1985, J IMMUNOL, V134, P2727; LAWN RM, 1980, CELL, V21, P647, DOI 10.1016/0092-8674(80)90428-6; LUZZATTO L, 1979, BLOOD, V54, P961; LUZZATTO L, 1968, NATURE, V219, P1041, DOI 10.1038/2191041a0; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; MANIATIS T, 1982, MOL CLONING LABORATO; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MODIANO G, 1979, P NATL ACAD SCI US, V77, P6759; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P7822; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; TONIOLO D, IN PRESS P NATL ACAD; USANGA EA, 1977, ANN HUM GENET, V40, P279, DOI 10.1111/j.1469-1809.1977.tb00192.x	26	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					735	741						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	2895981				2022-12-18	WOS:A1988N143800009
J	MILLER, WL				MILLER, WL			GENE CONVERSIONS, DELETIONS, AND POLYMORPHISMS IN CONGENITAL ADRENAL-HYPERPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MILLER, WL (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,ROOM 677-S,SAN FRANCISCO,CA 94143, USA.		Miller, Walter L/J-3696-2012		NIDDK NIH HHS [DK 39773] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK039773] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; CHUNG BC, 1986, P NATL ACAD SCI USA, V83, P4243, DOI 10.1073/pnas.83.12.4243; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; EGEL R, 1981, NATURE, V290, P191, DOI 10.1038/290191a0; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; JACKSON JA, 1981, NATURE, V292, P306, DOI 10.1038/292306a0; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; MILLER WL, 1987, J PEDIATR-US, V111, P1, DOI 10.1016/S0022-3476(87)80334-7; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MOREL Y, 1986, PEDIATR RES, V20, P1200, DOI 10.1203/00006450-198611000-00158; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PALSDOTTIR A, 1987, HUM GENET, V76, P220; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; PHILLIPS JA, 1985, AM J HUM GENET, V37, pA171; RADDING CM, 1978, ANNU REV BIOCHEM, V47, P847, DOI 10.1146/annurev.bi.47.070178.004215; RUMSBY G, 1986, J MED GENET, V23, P204, DOI 10.1136/jmg.23.3.204; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; STOECKERT CJ, 1984, NUCLEIC ACIDS RES, V12, P4469, DOI 10.1093/nar/12.11.4469; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; VOUTILAINEN R, 1987, P NATL ACAD SCI USA, V84, P1590, DOI 10.1073/pnas.84.6.1590; WERKMEISTER JW, 1986, AM J HUM GENET, V39, P461; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506	29	40	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					4	7						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3276177				2022-12-18	WOS:A1988L869700001
J	ESCALLON, MH; FERRELL, RE; KAMBOH, MI				ESCALLON, MH; FERRELL, RE; KAMBOH, MI			GENETIC-STUDIES OF LOW-ABUNDANCE HUMAN-PLASMA PROTEINS .5. EVIDENCE FOR A 2ND OROSOMUCOID STRUCTURAL LOCUS (ORM2) EXPRESSED IN PLASMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,HUMAN GENET PROGRAM,PITTSBURGH,PA 15261; UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,HOUSTON,TX 77225	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health				Kamboh, M. Ilyas/0000-0002-3453-1438	NCI NIH HHS [CA29614, CA34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936, R01CA029614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER EG, 1980, H-S Z PHYSIOL CHEM, V361, P1567, DOI 10.1515/bchm2.1980.361.2.1567; BOARD PG, 1986, GENE, V44, P127, DOI 10.1016/0378-1119(86)90051-X; CHIU KM, 1977, IMMUNOLOGY, V32, P997; COOPER R, 1986, J BIOL CHEM, V261, P1849; DENTE L, 1985, NUCLEIC ACIDS RES, V13, P3941, DOI 10.1093/nar/13.11.3941; DESTGROTH SF, 1963, BIOCHIM BIOPHYS ACTA, V78, P248; EDUARDS D, 1982, CLIN PHARM THER, V31, P62; ESCALLON MH, IN PRESS HUM HERED; FRIEDMAN MJ, 1983, P NATL ACAD SCI-BIOL, V80, P5421, DOI 10.1073/pnas.80.17.5421; HANSEN JES, 1984, CLIN CHIM ACTA, V138, P41, DOI 10.1016/0009-8981(84)90352-8; JOHNSON AM, 1969, J CLIN INVEST, V48, P2293, DOI 10.1172/JCI106195; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; NIMBERG R, 1971, J BIOL CHEM, V246, P5817; REINKE R, 1985, J BIOL CHEM, V260, P4397; SARCIONE EJ, 1963, ARCH BIOCHEM BIOPHYS, V100, P516, DOI 10.1016/0003-9861(63)90120-6; SCHMID K, 1979, BIOCHIM BIOPHYS ACTA, V581, P356, DOI 10.1016/0005-2795(79)90255-1; SCHMID K, 1973, BIOCHEMISTRY-US, V12, P2711, DOI 10.1021/bi00738a026; SCHMID K, 1964, J CLIN INVEST, V43, P2347, DOI 10.1172/JCI105108; Schmid K., 1975, PLASMA PROTEINS, V1, P184; SCHWICK HG, 1984, PLASMA PROTEINS, V4, P168; TOKITA K, 1966, J CLIN INVEST, V45, P1624, DOI 10.1172/JCI105469; UMETSU K, 1985, HUM GENET, V71, P223, DOI 10.1007/BF00284578	22	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					418	427						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631077				2022-12-18	WOS:A1987K019100007
J	TOKUNAGA, K; DEWALD, G; OMOTO, K; JUJI, T				TOKUNAGA, K; DEWALD, G; OMOTO, K; JUJI, T			FAMILY STUDY ON THE POLYMORPHISMS OF THE 6TH AND 7TH COMPONENTS (C6 AND C7) OF HUMAN-COMPLEMENT - LINKAGE AND HAPLOTYPE ANALYSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									TOKYO UNIV HOSP,BLOOD TRANSFUS SERV,TOKYO,JAPAN	University of Tokyo	TOKUNAGA, K (corresponding author), UNIV TOKYO,FAC SCI,DEPT ANAT,BUNKYO KU,TOKYO 113,JAPAN.							BENDER K, 1983, J IMMUNOGENET, V10, P61; DECORDOBA SR, 1985, J EXP MED, V161, P1189, DOI 10.1084/jem.161.5.1189; ELDRIDGE PR, 1983, BIOCHEM GENET, V21, P81, DOI 10.1007/BF02395393; HOBART MJ, 1978, J IMMUNOGENET, V5, P157; HOBART MJ, 1977, J IMMUNOGENET, V4, P423; HOBART MJ, 1975, 22ND C PROT BIOL FLU, P575; LACHMANN PJ, 1978, CLIN EXP IMMUNOL, V33, P193; MORTON NE, 1955, AM J HUM GENET, V7, P277; NAKAMURA S, 1984, HUM GENET, V66, P279, DOI 10.1007/BF00286617; NAKAMURA S, 1984, HUM GENET, V68, P138, DOI 10.1007/BF00279303; NISHIMUKAI H, 1986, VOX SANG; OLVING JH, 1979, HUM GENET, V46, P181, DOI 10.1007/BF00291920; PODACK ER, 1976, J IMMUNOL, V116, P263; TOKUNAGA K, 1984, JPN J HUM GENET, V29, P415, DOI 10.1007/BF01876499; TOKUNAGA K, 1983, J IMMUNOGENET, V10, P419; WHITEHOUSE DB, 1984, BIOCHEM GENET, V22, P51, DOI 10.1007/BF00499286; WHITEHOUSE DB, 1983, ANN HUM GENET, V47, P1, DOI 10.1111/j.1469-1809.1983.tb00964.x	17	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					414	419						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766543				2022-12-18	WOS:A1986E364400015
J	RABIN, M; MCCLELLAND, A; KUHN, L; RUDDLE, FH				RABIN, M; MCCLELLAND, A; KUHN, L; RUDDLE, FH			REGIONAL LOCALIZATION OF THE HUMAN TRANSFERRIN RECEPTOR GENE TO 3Q26.2-]QTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SWISS INST EXPTL CANC RES,ISREC,CH-1066 EPALINGES,SWITZERLAND	Swiss Institute Experimental Cancer Research	RABIN, M (corresponding author), YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06511, USA.			McClelland, Alan/0000-0003-2949-3542	NIGMS NIH HHS [GM09966] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM009966, R01GM009966] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7; BROWN JP, 1982, NATURE, V296, P171, DOI 10.1038/296171a0; COX D W, 1984, Genetics, V107, pS22; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; GOUBIN G, 1983, NATURE, V302, P114, DOI 10.1038/302114a0; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; IACOPETTA BJ, 1982, BIOCHIM BIOPHYS ACTA, V687, P204, DOI 10.1016/0005-2736(82)90547-8; KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0; LARRICK JW, 1984, NEW ENGL J MED, V311, P214, DOI 10.1056/NEJM198407263110402; MILLER YE, 1983, AM J HUM GENET, V35, P573; MITELMAN F, 1984, NATURE, V310, P325, DOI 10.1038/310325a0; MORTON CC, 1984, SCIENCE, V223, P173, DOI 10.1126/science.6691143; NEWMAN R, 1982, TRENDS BIOCHEM SCI, V7, P397, DOI 10.1016/0968-0004(82)90184-0; OMARY MB, 1981, J BIOL CHEM, V256, P2888; PLOWMAN GD, 1983, NATURE, V303, P70, DOI 10.1038/303070a0; RABIN M, 1984, CYTOGENET CELL GENET, V38, P70, DOI 10.1159/000132032; RABIN M, 1984, American Journal of Human Genetics, V36, p109S; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SWEET DL, 1979, CANCER GENET CYTOGEN, V1, P33, DOI 10.1016/0165-4608(79)90008-6; SZABO P, 1977, J MOL BIOL, V115, P539, DOI 10.1016/0022-2836(77)90170-X; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; TROWBRIDGE IS, 1982, J CELL PHYSIOL, V112, P403, DOI 10.1002/jcp.1041120314; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752	25	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1112	1116						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3002171				2022-12-18	WOS:A1985AXE3600007
J	BOCK, SC; HARRIS, JF; SCHWARTZ, CE; WARD, JH; HERSHGOLD, EJ; SKOLNICK, MH				BOCK, SC; HARRIS, JF; SCHWARTZ, CE; WARD, JH; HERSHGOLD, EJ; SKOLNICK, MH			HEREDITARY THROMBOSIS IN A UTAH KINDRED IS CAUSED BY A DYSFUNCTIONAL ANTITHROMBIN-III GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,SCH MED,DEPT MED,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	BOCK, SC (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.				NHLBI NIH HHS [1-RO1-HL30712] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030712] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BISHOP DT, 1978, AM J HUM GENET, V30, pA48; BOCK SC, 1984, CYTOGENET CELL GENET, V37, P422; BOCK SC, 1982, NUCLEIC ACIDS RES, V10, P8113, DOI 10.1093/nar/10.24.8113; BOCK SC, 1983, NUCLEIC ACIDS RES, V11, P8569, DOI 10.1093/nar/11.24.8569; BOCK SC, 1985, CYTOGENET CELL GENET; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COSGRIFF TM, 1983, MEDICINE, V62, P209, DOI 10.1097/00005792-198307000-00002; GOOSSENS M, 1982, NATURE, V296, P864, DOI 10.1038/296864a0; HASSTEDT SJ, 1979, 13 U UT DEP MED BIOP; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVRIEN EW, 1978, CYTOGENET CELL GENET, V22, P319, DOI 10.1159/000130963; MAGENIS RE, 1978, CYTOGENET CELL GENET, V22, P327, DOI 10.1159/000130965; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MORTON NE, 1955, AM J HUM GENET, V7, P277; PHILLIPS JA, 1982, J CLIN INVEST, V70, P489, DOI 10.1172/JCI110640; PROCHOWNIK EV, 1983, NEW ENGL J MED, V308, P1549, DOI 10.1056/NEJM198306303082601; SKOLNICK MH, 1984, GENETIC EPIDEMIOLOGY, P271; Skolnick MH, 1980, BANBURY REPORT, P285, DOI DOI 10.1111/J.1365-2796.2006.01657.X; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THALER E, 1981, CLIN HAEMATOL, V10, P369; VONKAULL.E, 1967, AM J CLIN PATHOL, V48, P69; WINTER JH, 1982, ANN HUM GENET, V46, P29, DOI 10.1111/j.1469-1809.1982.tb00692.x	25	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					32	41						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	2983542				2022-12-18	WOS:A1985AGY5700002
J	BOEHM, CD; DOWLING, CE; ANTONARAKIS, SE; HONIG, GR; KAZAZIAN, HH				BOEHM, CD; DOWLING, CE; ANTONARAKIS, SE; HONIG, GR; KAZAZIAN, HH			EVIDENCE SUPPORTING A SINGLE ORIGIN OF THE BETA-C-GLOBIN GENE IN BLACKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ILLINOIS, COLL MED, DEPT PEDIAT, CHICAGO, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	BOEHM, CD (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, GENET UNIT, BALTIMORE, MD 21205 USA.		Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; BALLAS SK, 1982, AM J HEMATOL, V13, P37, DOI 10.1002/ajh.2830130106; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DRISCOLL MC, 1981, J CLIN INVEST, V68, P915, DOI 10.1172/JCI110346; FELDENZER J, 1979, J CLIN INVEST, V64, P751, DOI 10.1172/JCI109519; HUNT JA, 1960, BIOCHIM BIOPHYS ACTA, V42, P409, DOI 10.1016/0006-3002(60)90818-0; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KAZAZIAN HH, 1983, AM J HUM GENET, V35, P1028; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEHMANN H, 1974, MANS HAEMOGLOBINS, P302; MEARS JG, 1981, J CLIN INVEST, V68, P606, DOI 10.1172/JCI110294; MOSCHONAS N, 1982, NUCLEIC ACIDS RES, V10, P2109; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; PIRASTU M, 1983, BLOOD, V62, P341; SCHACHAT FH, 1973, COLD SPRING HARB SYM, V38, P371, DOI 10.1101/SQB.1974.038.01.040; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; Southern E, 1979, Methods Enzymol, V68, P152; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519; TUAN D, 1983, P NATL ACAD SCI-BIOL, V80, P6937, DOI 10.1073/pnas.80.22.6937; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WEATHERALL DJ, 1981, THALASSEMIA SYNDROME, P118	28	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					771	777						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556665				2022-12-18	WOS:A1985APR1800014
J	GRABOWSKI, GA; DINUR, T; OSIECKI, KM; KRUSE, JR; LEGLER, G; GATT, S				GRABOWSKI, GA; DINUR, T; OSIECKI, KM; KRUSE, JR; LEGLER, G; GATT, S			GAUCHER DISEASE TYPE-1, TYPE-2, AND TYPE-3 - DIFFERENTIAL MUTATIONS OF THE ACID BETA-GLUCOSIDASE ACTIVE-SITE IDENTIFIED WITH CONDURITOL-B EPOXIDE DERIVATIVES AND SPHINGOSINE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT MEMBRANE BIOCHEM & NEUROCHEM,IL-91010 JERUSALEM,ISRAEL; UNIV COLOGNE,INST BIOCHEM,D-5000 COLOGNE 41,FED REP GER	Hebrew University of Jerusalem; University of Cologne	GRABOWSKI, GA (corresponding author), CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED GENET,NEW YORK,NY 10029, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [K04AM001351] Funding Source: NIH RePORTER; NIADDK NIH HHS [K04-AM 01351] Funding Source: Medline; NINDS NIH HHS [NS-02967] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASU A, 1984, J BIOL CHEM, V259, P1714; Beighton P, 1982, Prog Clin Biol Res, V95, P107; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRINN L, 1962, N Y State J Med, V62, P2346; DINUR T, 1984, ANAL BIOCHEM, V136, P223, DOI 10.1016/0003-2697(84)90329-4; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; Fried K, 1958, B RES COUNCIL ISR B, V7B, P213; GATT S, 1985, ENZYME; GATT S, 1982, GAUCHER DISEASE CENT, P315; GAVER RC, 1965, J AM OIL CHEM SOC, V42, P294, DOI 10.1007/BF02540132; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GINNS EI, 1983, CLIN CHIM ACTA, V131, P283, DOI 10.1016/0009-8981(83)90097-9; GINNS EI, 1984, BIOCHEM BIOPH RES CO, V123, P574, DOI 10.1016/0006-291X(84)90268-7; Goldblatt J, 1982, Prog Clin Biol Res, V95, P95; GRABOWSKI GA, 1984, ARCH BIOCHEM BIOPHYS, V231, P144, DOI 10.1016/0003-9861(84)90371-0; GRABOWSKI GA, 1985, AM J MED GENET; HODSON P, 1979, ARCH DIS CHILD, V54, P707, DOI 10.1136/adc.54.9.707; Institute of Gaucher Disease, 2020, EP GAUCH DIS; LEGLER G, 1977, METHODS ENZYMOLOGY, P368; MALONEY AFJ, 1960, J NEUROL NEUROSUR PS, V23, P207, DOI 10.1136/jnnp.23.3.207; MEDOFF AS, 1954, ANN INTERN MED, V40, P481, DOI 10.7326/0003-4819-40-3-481; MUMFORD RA, 1976, J NEUROCHEM, V27, P943, DOI 10.1111/j.1471-4159.1976.tb05159.x; Parkin J, 1982, GAUCHER DISEASE CENT, P151; PATRICK DA, 1965, BIOCHEM J, V97, pC17; PENTCHEV PG, 1983, AM J HUM GENET, V35, P621; RAGHAVAN SS, 1973, BIOCHEM BIOPH RES CO, V54, P256, DOI 10.1016/0006-291X(73)90916-9; REISS O, 1981, AM J DIS CHILD, V43, P365; ROSE JS, 1982, AM J ROENTGENOL, V139, P1202, DOI 10.2214/ajr.139.6.1202; TURNER BM, 1978, AM J HUM GENET, V30, P346; Wenger D A, 1982, Prog Clin Biol Res, V95, P551	31	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					499	510						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	4003396				2022-12-18	WOS:A1985AKE0700006
J	DAIGER, SP; HOFFMAN, NS; WILDIN, RS; SU, TS				DAIGER, SP; HOFFMAN, NS; WILDIN, RS; SU, TS			MULTIPLE, INDEPENDENT RESTRICTION SITE POLYMORPHISMS IN HUMAN DNA DETECTED WITH A CDNA PROBE TO ARGININOSUCCINATE SYNTHETASE (AS)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine	DAIGER, SP (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225, USA.				NIADDK NIH HHS [AM30471] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BASTIESIGEAC F, 1983, HUM GENET, V63, P162, DOI 10.1007/BF00291537; BEAUDET AL, 1982, CELL, V30, P287, DOI 10.1016/0092-8674(82)90034-4; BEAUDET AL, 1983, AM J HUM GENET, V35, pA186; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; DAIGER SP, 1982, NATURE, V298, P682, DOI 10.1038/298682a0; DAIGER SP, 1982, AM J HUM GENET, V34, pA180; DAIGER SP, 1981, AM J HUM GENET, V33, pA136; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FREYTAG SO, 1984, J BIOL CHEM, V259, P3160; HOLLIS GF, 1982, NATURE, V296, P321, DOI 10.1038/296321a0; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KAHN PM, 1979, CYTOGENET CELL GENET, V25, P39; KAN YW, 1977, NEW ENGL J MED, V297, P1081, DOI 10.1056/NEJM197711172972002; KAZAZIAN HH, 1983, EVOLUTION GENES PROT; McKusick V.A., 1983, MENDELIAN INHERITANC; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; SMITH HO, 1979, SCIENCE, V205, P455, DOI 10.1126/science.377492; Southern E, 1979, Methods Enzymol, V68, P152; SU TS, 1981, J BIOL CHEM, V256, P1826; TANTRAVAHI R, 1976, Nature (London), V262, P63	22	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	4					736	749						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TJ077	6089548				2022-12-18	WOS:A1984TJ07700002
J	FEARON, ER; ANTONARAKIS, SE; MEYERS, DA; LEVINE, MA				FEARON, ER; ANTONARAKIS, SE; MEYERS, DA; LEVINE, MA			C-HA-RAS-1 ONCOGENE LIES BETWEEN BETA-GLOBIN AND INSULIN LOCI ON HUMAN CHROMOSOME-11P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA	Johns Hopkins University	FEARON, ER (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA.		Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823; Levine, Michael/0000-0003-0036-7809				ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOYER SH, UNPUB PRODUCTION F C; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; DEMARTINVILLE B, 1983, SCIENCE, V219, P498, DOI 10.1126/science.6297001; DEMARTINVILLE B, 1983, NATURE, V305, P641, DOI 10.1038/305641a0; DER CJ, 1983, CELL, V32, P201, DOI 10.1016/0092-8674(83)90510-X; DONLON TA, 1983, 7 INT HUM GEN MAPP W, P81; DOVER GJ, 1981, SCIENCE, V211, P1441, DOI 10.1126/science.6162200; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FRANKE U, 1978, AM J HUM GENET, V30, pA81; GERHARD DS, 1983, 7 INT HUM GEN MAPP W, P113; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; GUSELLA JF, 1982, P NATL ACAD SCI-BIOL, V79, P7804, DOI 10.1073/pnas.79.24.7804; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; HUERRE C, 1983, NATURE, V305, P638, DOI 10.1038/305638a0; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JHANWAR SC, 1983, P NATL ACAD SCI-BIOL, V80, P4794, DOI 10.1073/pnas.80.15.4794; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KANEKO Y, 1981, CANCER RES, V41, P4577; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEBO RV, 1983, P NATL ACAD SCI-BIOL, V80, P4808, DOI 10.1073/pnas.80.15.4808; MCBRIDE OW, 1982, NATURE, V300, P773, DOI 10.1038/300773a0; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MEYERS DA, 1979, BIRTH DEFECTS ORIG A, V14, P396; MEYERS DA, 1976, THESIS INDIANA U IND; MILES MF, 1981, J BIOL CHEM, V256, P2545; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; MORTON CC, 1983, 7 INT HUM GEN MAPP W, P201; MORTON NE, 1955, AM J HUM GENET, V7, P277; NAYLOR SL, 1982, AM J HUM GENET, V34, pA165; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; OTT J, 1974, AM J HUM GENET, V26, P588; PULCIANI S, 1982, NATURE, V300, P539, DOI 10.1038/300539a0; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHACHAT FH, 1973, COLD SPRING HARB SYM, V38, P371, DOI 10.1101/SQB.1974.038.01.040; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P383, DOI 10.1073/pnas.80.2.383; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; ULLRICH A, 1980, SCIENCE, V209, P612, DOI 10.1126/science.6248962; ULLRICH A, 1982, NUCLEIC ACIDS RES, V10, P2225, DOI 10.1093/nar/10.7.2225; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; ZABEL BU, 1982, AM J HUM GENET, V34, pA153	53	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					329	337						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6324580				2022-12-18	WOS:A1984SM32400008
J	COX, DR; GOLDBLATT, D; EPSTEIN, CJ				COX, DR; GOLDBLATT, D; EPSTEIN, CJ			CHROMOSOMAL ASSIGNMENT OF MOUSE PRGS - FURTHER EVIDENCE FOR HOMOLOGY BETWEEN MOUSE CHROMOSOME-16 AND HUMAN CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco									0	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					A145	A145						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199					2022-12-18	WOS:A1981MV19900377
J	TANIS, RJ; NEEL, JV; DEARAUZ, RT				TANIS, RJ; NEEL, JV; DEARAUZ, RT			2 MORE PRIVATE POLYMORPHISMS OF AMERINDIAN TRIBES - LDHB GUA-1 AND ACP1B GUA-1 IN GUAYMI IN PANAMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; INST NACL CULTURA,PANAMA 1,PANAMA	University of Michigan System; University of Michigan								ARENDS T, 1964, SCIENCE, V143, P367, DOI 10.1126/science.143.3604.367; BEUTLER E, 1965, LANCET, V1, P353; BEUTLER E, 1966, J LAB CLIN MED, V68, P646; HARRIS H, 1975, PRINCIPLES HUMAN BIO; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; KITAMURA M, 1971, CLIN CHIM ACTA, V34, P419; MATSON GA, 1965, AM J PHYS ANTHROPOL, V23, P123; MATSON GA, 1965, AM J PHYS ANTHROPOL, V23, P413; MESTRINER MA, 1976, AM J HUM GENET, V28, P257; MOORE MJ, 1971, BIOCHEM GENET, V5, P497, DOI 10.1007/BF00485667; NEEL JV, 1976, AM J HUM GENET, V28, P262; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; PARKER WC, 1961, ANN HUM GENET, V25, P227; PASTEWKA JV, 1973, ANAL BIOCHEM, V51, P152, DOI 10.1016/0003-2697(73)90463-6; SALZANO FM, IN PRESS; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1958, NATURE, V181, P1203, DOI 10.1038/1811203b0; SORENSEN S A, 1970, Clinical Genetics, V1, P294; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; SWALLOW DM, 1973, ANN HUM GENET, V37, P31, DOI 10.1111/j.1469-1809.1973.tb01812.x; TANIS R, 1974, ANN HUM GENET, V38, P179, DOI 10.1111/j.1469-1809.1974.tb01949.x; TANIS RJ, 1973, AM J HUM GENET, V25, P655; THYMANN M, 1975, HUM HERED, V25, P501, DOI 10.1159/000152766; TIFFANY TO, 1972, CLIN CHEM, V18, P829; WARD RH, 1975, AM J HUM GENET, V27, P1; Young Philip D., 1971, NGAWBE TRADITION CHA; [No title captured]	29	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					419	430						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DV673	900121				2022-12-18	WOS:A1977DV67300001
J	SLATIS, HM; KATZNELSON, MBM; BONNETAMIR, B				SLATIS, HM; KATZNELSON, MBM; BONNETAMIR, B			INHERITANCE OF FINGERPRINT PATTERNS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV SHEBA MED CTR,DEPT HUMAN GENET,TEL HASHOMER,ISRAEL; MICHIGAN STATE UNIV,DEPT ZOOL,E LANSING,MI 48824; TEL AVIV UNIV SACKLER SCH MED,DEPT HUMAN GENET,RAMAT AVIV,ISRAEL	Chaim Sheba Medical Center; Michigan State University; Tel Aviv University; Sackler Faculty of Medicine								BONNE B, 1970, HUM HERED, V20, P609, DOI 10.1159/000152367; BONNE B, 1971, HUM HERED, V21, P478, DOI 10.1159/000152440; DAVID TJ, 1971, HUM HERED, V21, P39, DOI 10.1159/000152381; LUDY JB, 1944, ARCH DERMAT SYPH, V49, P373; TRUBEBECKER E, 1960, ANTHROPOL ANZ, V23, P294; Walker JF, 1941, J HERED, V32, P279, DOI 10.1093/oxfordjournals.jhered.a105063	6	40	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					280	289						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	1266855				2022-12-18	WOS:A1976BS30600010
J	DIETZ, AA; RUBINSTEIN, HM; HODGES, LK; LUBRANO, T				DIETZ, AA; RUBINSTEIN, HM; HODGES, LK; LUBRANO, T			IMPROVED METHOD FOR DIFFERENTIATION OF CHOLINESTERASE VARIANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DAS P K, 1970, Journal of Medical Genetics, V7, P351, DOI 10.1136/jmg.7.4.351; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GARRY PJ, 1965, CLIN CHEM, V11, P91; GARRY PJ, 1971, CLIN CHEM, V17, P192; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HUMISTON CG, 1967, TOXICOL APPL PHARM, V10, P467, DOI 10.1016/0041-008X(67)90087-7; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KING J, 1970, BRIT J ANAESTH, V42, P698, DOI 10.1093/bja/42.8.698; KING J, 1967, CLIN BIOCHEM, V1, P42; LIDDELL J, 1963, ACTA GENET STAT MED, V13, P95; MORROW AC, 1968, J LAB CLIN MED, V71, P350; MOTULSKY ARNO G., 1964, PROGR MED GENET, V3, P49; RUBINSTEIN H M, 1970, Journal of Clinical Investigation, V49, P479, DOI 10.1172/JCI106257	14	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	1					58	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L6958	5012693				2022-12-18	WOS:A1972L695800008
J	SINNOCK, P; SING, CF				SINNOCK, P; SING, CF			ANALYSIS OF MULTILOCUS GENETIC SYSTEMS IN TECUMSEH, MICHIGAN .2. CONSIDERATION OF CORRELATION BETWEEN NONALLELES IN GAMETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Sing, Charles/0000-0001-5872-7956				BENNETT JH, 1965, AM J HUM GENET, V17, P51; BODMER JG, 1970, AM J HUM GENET, V22, P396; BODMER WF, 1967, GENETICS, V57, P237; BURROWS PJ, IN PRESS; CANNON GB, 1963, GENETICS, V48, P1201; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JF, 1972, AM J HUM GENET, V24, P1; Ewens W.J., 1969, POPULATION GENETICS; FRANKLIN I, 1970, GENETICS, V65, P707; GERSHOWITZ H, 1970, BLOOD TISSUE ANTIGEN, P33; Giblett ER., 1969, GENETIC MARKERS HUMA; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1968, 12 P INT C GEN TOKYO, V2, P140; JAIN SK, 1966, GENETICS, V53, P633; Jennings HS, 1917, GENETICS, V2, P97; KARLIN S, 1968, GENETICS, V58, P141; KIRK RL, 1971, ANN HUM GENET, V34, P329, DOI 10.1111/j.1469-1809.1971.tb00245.x; KOJIMA K, 1970, MATHEMATICAL TOPICS; KOJIMA K, 1965, COMPUTERS BIOMEDICAL, V1, P197; KOJIMA KI, 1970, BIOCHEM GENET, V4, P627, DOI 10.1007/BF00486100; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V50, P757; LEWONTIN RC, 1964, GENETICS, V49, P49; Li CC., 1955, POPULATION GENETICS; MUKAI T, 1971, P NATL ACAD SCI USA, V68, P1065, DOI 10.1073/pnas.68.5.1065; OHTA T, 1969, GENETICS, V63, P229; OHTA T, 1969, GENET RES, V13, P47, DOI 10.1017/S001667230000272X; RACE RR, 1962, BLOOD BROUPS MAN; REED TE, 1968, AM J HUM GENET, V20, P579; SHREFFLER DC, 1971, AM J HUM GENET, V23, P150; SING CF, 1971, AM J HUM GENET, V23, P164; SINNOCK P, 1972, AM J HUM GENET, V24, P381; SVED J A, 1971, Theoretical Population Biology, V2, P125; SVED JA, 1968, GENETICS, V59, P543; TURNER JRG, 1969, ANN HUM GENET, V33, P197, DOI 10.1111/j.1469-1809.1969.tb01645.x; TURNER JRG, 1967, EVOLUTION, V21, P645, DOI [10.1111/j.1558-5646.1967.tb03421.x, 10.2307/2406761]; Weinberg Wilhelm, 1908, JAHRESHEFTE VEREINS, V64, P368	38	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	4					393	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M8063	4624259				2022-12-18	WOS:A1972M806300004
J	TELFER, MA; SUGAR, M; JAEGER, EA; MULCAHY, J				TELFER, MA; SUGAR, M; JAEGER, EA; MULCAHY, J			DOMINANT PIEBALD TRAIT (WHITE FORELOCK AND LEUKODERMA) WITH NEUROLOGICAL IMPAIRMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COMMINGS DE, 1966, J AMER MED ASSOC, V195, P519; COOKE JV, 1952, J PEDIATR-US, V41, P1, DOI 10.1016/S0022-3476(52)80022-8; DEHAAS EBH, 1966, DOC OPHTHALMOL, V21, P239, DOI 10.1007/BF00184136; FROGGAT P, 1951, IRISH J MED SCI, V398, P86; HAMMERSCHLAG V, 1908, Z OHRENHEILKD, V56, P126; Horstadius S., 1950, NEURAL CREST; JAHR HM, 1954, AMA AM J DIS CHILD, V88, P481, DOI 10.1001/archpedi.1954.02050100483008; Keeler CE, 1934, J AMER MED ASSOC, V103, P0179, DOI 10.1001/jama.1934.72750290001009; MAZZINI G, 1924, RIV BIOL, V6, P413; McKusick V.A., 1968, MENDELIAN INHERITANC; REED WB, 1967, ARCH DERMATOL, V95, P176, DOI 10.1001/archderm.95.2.176; Sundfor H, 1939, J HERED, V30, P67, DOI 10.1093/oxfordjournals.jhered.a104684; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; ZIPRKOWSKI L, 1962, ARCH DERMATOL, V86, P530, DOI 10.1001/archderm.1962.01590100144027	14	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					383	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J8113	5097904				2022-12-18	WOS:A1971J811300006
J	LORAND, L; URAYAMA, T; ATENCIO, AC; HSIA, DYY				LORAND, L; URAYAMA, T; ATENCIO, AC; HSIA, DYY			INHERITANCE OF DEFICIENCY OF FIBRIN-STABILIZING FACTOR (FACTOR-13)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AMRIS CJ, 1965, THROMB DIATH HAEMORR, V14, P322; BARRY A, 1965, NEW ENGL J MED, V272, P943, DOI 10.1056/NEJM196505062721804; BOUHASIN JD, 1968, J PEDIATR-US, V72, P336, DOI 10.1016/S0022-3476(68)80205-7; BRITTEN AFH, 1967, AM J MED, V43, P751, DOI 10.1016/0002-9343(67)90117-9; DEKIEWIET JWC, TO BE PUBLISHED; DUCKERT F, 1961, THROMB DIATH HAEMO, V5, P179; EGEBERG O, 1968, THROMB DIATH HAEMOST, V20, P534, DOI 10.1055/s-0038-1651295; FISCHER M, 1968, Haematologica, V2, P79; FISHER S, 1966, BLOOD-J HEMATOL, V28, P34, DOI 10.1182/blood.V28.1.34.34; FRADERA J, IN PRESS; IKKALA EERO, 1964, SCAND J HAEMATOL, V1, P308; IKKALA F, 1962, THROMB DIATH HAEMORR, V7, P567; JOSSO F, 1964, Nouv Rev Fr Hematol, V4, P267; LEIBA H, 1969, P TELHASHOMER HOSPIT, V5; LORAND L, 1969, J CLIN INVEST, V48, P1054, DOI 10.1172/JCI106061; LORAND L, 1968, BIOCHEMISTRY-US, V7, P1214, DOI 10.1021/bi00843a043; LORAND L, 1968, BIOCHEM BIOPH RES CO, V31, P222, DOI 10.1016/0006-291X(68)90734-1; LOSOWSKY MS, 1965, LANCET, V2, P156; MANDELLI FRANCO, 1963, MED CLIN SPER, V13, P175; MASURE R, 1963, Hemostase, V3, P119; NEWCOMB TF, 1968, BLOOD, V30, P855; RATNOFF OD, 1968, LANCET, V1, P25; TSEVRENI.H, 1965, THROMB DIATH HAEMOST, V14, P325; ZAHIR M, 1969, J AMER MED ASSOC, V207, P751	24	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	1					89	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F4294	5413933				2022-12-18	WOS:A1970F429400007
J	PLATO, CC; CRUZ, MT; KURLAND, LT				PLATO, CC; CRUZ, MT; KURLAND, LT			AMYOTROPHIC LATERAL SCLEROSIS/PARKINSONISM DEMENTIA COMPLEX OF GUAM - FURTHER GENETIC INVESTIGATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CROW JF, 1965, 1163 US PUBL HEALTH; ELIZAN TS, 1966, ARCH NEUROL-CHICAGO, V14, P356, DOI 10.1001/archneur.1966.00470100012002; HIRANO A, 1966, ARCH NEUROL-CHICAGO, V15, P35, DOI 10.1001/archneur.1966.00470130039004; KURLAND LT, 1955, NEUROLOGY, V5, P182, DOI 10.1212/WNL.5.3.182; KURLAND LT, 1954, NEUROLOGY, V4, P438, DOI 10.1212/WNL.4.6.438; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; MORTON NE, 1959, AM J HUM GENET, V11, P1; NEEL JV, 1965, 1163 US PUBL HEAL ED; PLATO CC, 1967, AM J HUM GENET, V19, P722; PLATO CC, 1967, AM J HUM GENET, V19, P617; REED D, 1966, AM J EPIDEMIOL, V83, P54, DOI 10.1093/oxfordjournals.aje.a120570	11	40	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					133	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3696	5770171				2022-12-18	WOS:A1969D369600003
J	GERSHOWITZ, H; JUNQUEIRA, PC; SALZANO, FM; NEEL, JV				GERSHOWITZ, H; JUNQUEIRA, PC; SALZANO, FM; NEEL, JV			FURTHER STUDIES ON XAVANTE INDIANS .3. BLOOD GROUPS AND ABH-LEA SECRETOR TYPES IN SIMOES LOPES AND SAO MARCOS XAVANTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					ARTEAGA C, 1952, ANN EUGENIC, V16, P351; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; CEPPELLINI R, 1955, 5 P INT C BLOOD TRAN, P207; COTTERMAN CW, 1947, 33 U MICH CONTR LAB, P1; DACUNHA AB, 1961, ATAS PRIMEIRO S S ED, P315; FINNEY DJ, 1948, HEREDITY, V2, P369, DOI 10.1038/hdy.1948.22; FINNEY DJ, 1948, HEREDITY, V2, P199, DOI 10.1038/hdy.1948.11; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; GRUBB R, 1951, ACTA PATHOL MIC SC, V28, P61; LAYRISSE M, 1963, HUM BIOL, V35, P140; LAYRISSE M, 1960, AM ANTHROPOL, V62, P418, DOI 10.1525/aa.1960.62.3.02a00030; LAYRISSE M, 1963, AM ANTHROPOL, V65, P36, DOI 10.1525/aa.1963.65.1.02a00040; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1964, COLD SPRING HARB SYM, V29, P85, DOI 10.1101/SQB.1964.029.01.014; NIJENHUIS LE, 1961, THESIS U AMSTERDAM; PEDREIRA C, 1961, ATAS PRIMEIRO S SULA, P315; RACE RR, 1962, BLOOD GROUPS MAN; REYNAFARJE C, 1957, An Fac Med Lima, V40, P573; SACCHETTI A, 1953, RIV ANTROPOL, V40, P189; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SALZANO FM, 1961, AM J PHYS ANTHROPOL, V19, P391, DOI 10.1002/ajpa.1330190412; SALZANO FM, 1964, AM J HUM GENET, V16, P301; SCARO J. L., 1957, REV SOC ARGENTINA BIOL, V33, P117; SHREFFLER DC, 1967, AM J HUM GENET, V19, P514	24	40	40	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					502	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	6036271				2022-12-18	WOS:A19679857000003
J	SHREFFLER, DC; STEINBERG, AG				SHREFFLER, DC; STEINBERG, AG			FURTHER STUDIES ON XAVANTE INDIANS .4. SERUM PROTEIN GROUPS AND SC1 TRAIT OF SALIVA IN SIMOES LOPES AND SAO MARCOS XAVANTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARENDS T, 1967, P NATL ACAD SCI USA, V57, P1252, DOI 10.1073/pnas.57.5.1252; BECKMAN L, 1964, ACTA GENET STAT MED, V14, P286; CLEVE HARTWIG, 1962, PROGR MED GENET, V2, P64; GALLANGO ML, 1965, ACTA CIENT VENEZ, V16, P120; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1965, ACTA GENET STAT MED, V15, P261; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V46, P229; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1964, AM J HUM GENET, V16, P52; NISWANDER JD, 1964, ANN HUM GENET, V27, P319; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; PREER JR, 1956, J IMMUNOL, V77, P52; SALZANO FM, 1966, ACTA GENET STAT MED, V16, P242; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SALZANO FM, 1965, AM J HUM GENET, V17, P273; SHREFFLER DC, 1965, AM J HUM GENET, V17, P71; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; STEINBERG AG, 1965, AM J HUM GENET, V17, P133; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1	21	40	40	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					514	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	6036272				2022-12-18	WOS:A19679857000004
J	SIMPSON, NE; KALOW, W				SIMPSON, NE; KALOW, W			SILENT GENE FOR SERUM CHOLINESTERASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DAVIES RO, 1960, CANAD J BIOCHEM PHYS, V38, P546; HARRIS H, 1963, ANN HUM GENET, V26, P359, DOI 10.1111/j.1469-1809.1963.tb01335.x; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; HARRIS H., 1960, ACTA GENET ET STATIST MED, V10, P1; HARRIS H, 1962, NATURE, V196, P1296, DOI 10.1038/1961296a0; HARRIS H, 1962, ANN HUM GENET, V26, P59, DOI 10.1111/j.1469-1809.1962.tb01310.x; HODGKIN WE, 1963, JUL AM SOC HUM GEN; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KALOW W, 1959, ANN HUM GENET, V23, P239, DOI 10.1111/j.1469-1809.1959.tb01467.x; KALOW W, 1959, CIBA F S BIOCHEMISTR, P39; KALOW W, 1957, CAN J BIOCHEM PHYSIO, V35, P1306; Kalow Werner, 1963, PHARMACOGENETICS HER; LIDDELL J, 1962, NATURE, V193, P561, DOI 10.1038/193561a0; PARKER WC, 1963, AM J HUM GENET, V15, P159; RUBINSTEIN HM, 1963, J LAB CLIN MED, V61, P979; SIMPSON NE, 1963, AM J HUM GENET, V15, P280; SMITH SM, 1961, MATHEMATICAL TABLES; Stern C., 1960, PRINCIPLES HUMAN GEN; WOLSTENHOLME GEW, 1959, CIBA F S BIOCHEMICAL, P39	20	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	2					180	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2972A	14174799				2022-12-18	WOS:A19642972A00011
J	SUTTON, HE; KARP, GW				SUTTON, HE; KARP, GW			VARIATIONS IN HETEROZYGOUS EXPRESSION AT HAPTOGLOBIN LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLUMBERG BS, 1961, GENETIC POLYMORPHISM, P132; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; DEGROUCHY J, 1964, ANN GENET-PARIS, V7, pG25; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P232; GIBLETT ER, 1961, VOX SANG, V6, P513, DOI 10.1111/j.1423-0410.1961.tb03200.x; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; GIBLETT ER, 1961, GENETIC POLYMORPHISM, P132; GIBLETT ER, 1960, 8 P C INT SOC BLOOD, P374; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; MATSUNAGA E., 1962, JAPAN J HUMAN GENET, V7, P133; NANCE WE, 1963, SCIENCE, V141, P123, DOI 10.1126/science.141.3576.123; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; PARKER WC, 1963, NATURE, V198, P107, DOI 10.1038/198107a0; PARKER WC, 1963, AM J HUM GENET, V15, P159; SCHACHT LE, 1961, 2 P INT C HUM GEN RO, V2, P894; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, 1960, 1 T C GEN, P133; SUTTON H E, 1959, Ann Hum Genet, V23, P175; SUTTON HE, 1960, AM J HUM GENET, V12, P338; SUTTON HE, 1960, 1 T C GEN, P133	25	40	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					419	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250423				2022-12-18	WOS:A19642974A00010
J	JAMES, WH				JAMES, WH			NOTES TOWARDS AN EPIDEMIOLOGY OF SPONTANEOUS ABORTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DELHANTY JD, 1961, LANCET, V1, P1286; EDWARDS AWF, 1958, ANN HUM GENET, V23, P6, DOI 10.1111/j.1469-1809.1958.tb01437.x; EDWARDS AWF, 1960, NATURE, V186, P1074, DOI 10.1038/1861074a0; ERHARDT CL, 1956, AM J PUBLIC HEALTH N, V46, P828, DOI 10.2105/AJPH.46.7.828; Fisher R., 1930, GENETICAL THEORY NAT; FISHER RA, 1932, STATISTICAL METHODS; Gebhard Paul H., 1958, PREGNANCY BIRTH ABOR; GLASS B, 1950, AM J HUM GENET, V2, P269; GLASS B, 1949, AM J OBSTET GYNECOL, V57, P323; Greenwood M, 1914, J R STAT SOC, V77, P179, DOI 10.2307/2339801; Greenwood M, 1920, J ROY STATIST SOC  A, V83, P255; HARRIS JA, 1936, J ARTHUR HARRIS BOTA; HUDSON GS, 1945, JAMA-J AM MED ASSOC, V129, P542, DOI 10.1001/jama.1945.02860420010004; JAMES WH, 1963, AM J OBSTET GYNECOL, V85, P38; JAMES WH, 1962, J OBSTET GYN BR COMM, V69, P606; JAMES WH, 1961, ANN HUM GENET, V25, P207; JAVERT CT, 1957, SPONTANEOUS HABITUAL; KINSEY A, 1948, SEXUAL BEHAVIOUR HUM; KISER CV, 1958, MILBANK FUND Q, V36, P282, DOI 10.2307/3348556; MCCARTHY M, 1954, PARTISAN REV, V21, P34; PEARL R., 1932, HUMAN BIOL, V4, P363; PENROSE LS, 1961, LANCET, V1, P1261; RACE RR, 1942, ANN HUM GENET, V22, P165; REED T. EDWARD, 1958, ANN HUMAN GENETICS, V22, P165; RUCKER M P, 1952, J Int Coll Surg, V17, P328; SCHMID W, 1962, AMER SOCIETY HUMAN G; SCHOENECK FJ, 1953, OBSTET GYNECOL, V1, P610; SHAPIRO S, 1962, MILBANK FUND Q, V40, P7, DOI 10.2307/3348609; SILVESTRONI E, 1950, NATURE, V165, P682, DOI 10.1038/165682a0; SKELLAM JG, 1948, J ROY STAT SOC B, V10, P257; SLATER E, 1962, LANCET, V1, P69; STEVENSON AC, 1958, ANN HUMAN GENETICS, V23, P382; STOPES MC, 1927, CONTRACEPTION THEORY; SWED FS, 1943, ANN MATH STAT, V14, P83; TIETZE C, 1950, JAMA-J AM MED ASSOC, V142, P1348, DOI 10.1001/jama.1950.02910350018006; TIETZE C, 1959, AM J OBSTET GYNECOL, V78, P650, DOI 10.1016/0002-9378(59)90541-1; WARBURTON D, 1959, CLIN OBSTET GYNECOL, V2, P22, DOI 10.1097/00003081-195903000-00003; WARBURTON D, UNPUBLISHED; Westoff C.F., 1961, FAMILY GROWTH METROP; WESTOFF CF, 1957, AM J SOCIOL, V62, P491, DOI 10.1086/222079; WHITEHOUSE B, 1930, P ROY SOC MED, V23, P248; WINKELSTEIN W Jr, 1958, J Chronic Dis, V7, P273, DOI 10.1016/0021-9681(58)90085-7	42	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					223	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	13957272				2022-12-18	WOS:A19632967A00004
J	LUNDSTROM, A				LUNDSTROM, A			TOOTH MORPHOLOGY AS A BASIS FOR DISTINGUISHING MONOZYGOTIC AND DIZYGOTIC TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		KORKHAUS G, 1930, Z ANAT ENTWICKLUNGS, V91, P594; KRAUS BS, 1953, J DENT RES, V32, P554, DOI 10.1177/00220345530320041701; KRAUS BS, 1951, AM J HUM GENET, V3, P348; Kraus BS, 1959, AM J ORTHOD DENTOFAC, V45, DOI [10.1016/0002-9416(59)90076-4, DOI 10.1016/0002-9416(59)90076-4]; KRAUS BS, 1957, J FORENSIC SCI, V2, P420; LUDWIG FRED J., 1957, JOUR DENTAL RES, V36, P263; OSBORNE RH, 1959, MORPHOLOGICAL VARIAT; REIF W, 1928, THESIS BONN; SUTTON H. ELDON, 1962, AMER JOUR HUMAN GENET, V14, P52; WEITZ W, 1925, Z KLIN MED, V101, P115; WEITZ W, 1924, DEUTSCH MSCHR ZAHNHE, V5, P89; [No title captured]	12	40	41	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					34	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13931711				2022-12-18	WOS:A19632969A00007
J	SHAW, MW; GERSHOWITZ, H				SHAW, MW; GERSHOWITZ, H			A SEARCH FOR AUTOSOMAL LINKAGE IN A TRISOMIC POPULATION - BLOOD GROUP FREQUENCIES IN MONGOLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ATKINS L, 1962, NEW ENGL J MED, V266, P631, DOI 10.1056/NEJM196203292661301; BARR M L, 1960, Can Med Assoc J, V83, P979; BATEMAN AJ, 1960, LANCET, V1, P1293; Benda CE, 1939, AM J DIS CHILD, V58, P1240, DOI 10.1001/archpedi.1939.01990110104007; BUCKWALTER JA, 1957, JAMA-J AM MED ASSOC, V165, P327, DOI 10.1001/jama.1957.02980220011003; CLARKE CM, 1961, LANCET, V1, P1028; COOPER HL, 1962, NEW ENGL J MED, V266, P699, DOI 10.1056/NEJM196204052661404; ELLIS JR, 1961, ANN HUM GENET, V25, P159, DOI 10.1111/j.1469-1809.1961.tb01514.x; ENGLER M, 1949, MONGOLISM PERISTATIC, P54; FITZGERALD P, 1961, LANCET, V2, P212; FORD CE, 1959, LANCET, V1, P709; FRASER JH, 1961, LANCET, V2, P1064; HAECKEL E, 1954, AM J HUM GENET, V6, P224; HARNDEN DG, 1960, ANN HUM GENET, V24, P165; HASELHORST G, 1930, Z KONSTITUT, V15, P205; HASELHORST G, 1931, Z KONSTITUT, V16, P227; LANGBROWN H, 1953, ANN EUGENIC, V17, P307; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LENNOX B, 1961, BRIT MED BULL, V17, P196, DOI 10.1093/oxfordjournals.bmb.a069908; MANITZ HANNS, 1932, DEUTSCHE ZEITSCHR NERVENHEILK, V126, P80, DOI 10.1007/BF01760030; MILLER OJ, 1961, LANCET, V2, P78; OHNO S, 1961, EXP CELL RES, V24, P106, DOI 10.1016/0014-4827(61)90251-8; OREL H, 1927, Z KINDERHEILKD, V44, P449; PENROSE LS, 1961, ANN HUM GENET, V25, P243; Penrose LS, 1932, LANCET, V1, P394; PENROSE LS, 1957, J MENT DEFIC RES, V1, P107; REED TE, 1959, NATURE, V184, P611, DOI 10.1038/184611a0; REED TJ, TO BE PUBLISHED; ROBERTS JAF, 1959, BRIT MED BULL, V15, P129, DOI 10.1093/oxfordjournals.bmb.a069736; SHAW MW, 1962, LANCET, V1, P1407; SHAW MW, 1962, CYTOGENETICS; SLIZYNSKI BM, 1961, NATURE, V189, P683, DOI 10.1038/189683a0; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	33	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					317	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	13976965				2022-12-18	WOS:A19622965A00007
J	CATTELL, RB				CATTELL, RB			RESEARCH DESIGNS IN PSYCHOLOGICAL GENETICS WITH SPECIAL REFERENCE TO THE MULTIPLE VARIANCE METHOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANASTASI A, 1948, PSYCHOL REV, V55, P239, DOI 10.1037/h0059777; Burks B., 1928, YB NAT SOC STUD ED 1, P219; Cattell R.B., 1952, FACTOR ANAL INTRO MA; Cattell RB, 1945, J SOC PSYCHOL, V21, P3, DOI 10.1080/00224545.1945.9712295; Cattell RB, 1938, BRIT J EDUC PSYCHOL, V8, P129, DOI 10.1111/j.2044-8279.1938.tb03119.x; Cattell RB, 1950, J SOC PSYCHOL, V32, P215, DOI 10.1080/00224545.1950.9919048; Cattell RB, 1940, PEDAGOG SEMIN J GEN, V57, P31; CATTELL RB, 1938, EUGEN REV, V29, P171; CHASSELL C, 1935, RELATION BETWEEN MOR; Collins JE, 1928, J EDUC RES, V17, P157, DOI 10.1080/00220671.1928.10879827; DAHLBERG G, 1948, MATH METHODS POPULAT; DARLINGTON CD, 1950, ELEMENTS GENETICS; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; DUNN LC, 1934, HEREDITY VARIATION; EYSENCK HJ, 1951, J MENT SCI, V97, P441, DOI 10.1192/bjp.97.408.441; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FREEMAN FN, 1928, YB NATL SOC STUDY ED, P103; Gates Reginald Ruggles, 1946, HUMAN GENETICS; Gesell A, 1942, Science, V95, P446, DOI 10.1126/science.95.2470.446; Guilford J., 1936, PSYCHOMETRIC METHODS; Haggerty ME, 1924, J EDUC PSYCHOL, V15, P559, DOI 10.1037/h0073569; Haldane John Burdon Sanderson, 1938, HEREDITY POLITICS; HERMAN L, 1933, P ROY SOC EDINB, V53, P105; HOGBEN L, 1940, NATURE NURTURE; Holzinger KJ, 1935, J AM STAT ASSOC, V30, P274, DOI 10.2307/2278242; KELLY TL, 1926, INFLUENCE NURTURE NA; Lauterbach CE, 1925, GENETICS, V10, P525; LAWRENCE EM, 1931, BRIT J PSYCHOL MON S, V16; Leahy AM, 1935, J AM STAT ASSOC, V30, P281, DOI 10.2307/2278243; Leahy AM, 1935, GENETIC PSYCHOL MONO, V17, P235; LOEVINGER J, 1940, YB NAT SOC STUDY ED, P159; Loevinger J, 1943, PSYCHOL BULL, V40, P725, DOI 10.1037/h0053767; Monroe WS, 1935, J EXP EDUC, V3, P155, DOI 10.1080/00220973.1935.11009973; Newman HH., 1937, TWINS STUDY HEREDITY; NEWMAN HH, 1940, MULTIPLE HUMAN BIRTH; NEWMAN M, 1946, J GENET PSYCHOL, V68, P127; PENROSE LS, 1944, PERSONALITY BEHAVIOR, P505; PRICE B, 1950, AM J HUM GENET, V2, P293; RUNDQUIST EE, 1933, J COMP PSYCHOL, P16; SAUNDERS DR, COMMUNICATION; SCHWESINGER GC, 1933, HEREDITY ENVIRONMENT; SCOTT JP, LIFE STRESS BODILY D, pCH4; Sinnott E. W., 1950, PRINCIPLES GENETICS; Skeels HM, 1936, PEDAGOG SEMIN J GEN, V49, P91; Stern C., 1949, PRINCIPLES HUMAN GEN; STOBE SM, 1930, SCH SOC, V31, P372; STOCKARD CR, 1931, PHYSICAL BASIS PERSO; THORNDIKE EL, 1946, PSYCHOL ABSTR, P106; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; TRYON RC, 1940, YB NAT SOC STUD ED 1, P111; WOODWORTH RS, 1941, SOC SCI RES COUNC B, V47; WRIGHT S, 1923, GENETICS, V8, P238; 1928, YB NAT SOC STUDY ED, V2; 1940, YB NAT SOC STUDY ED, V2; 1940, YB NAT SOC STUDY ED, V1; 1928, YB NAT SOC STUDY ED, V1	56	40	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					76	93						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050613				2022-12-18	WOS:A1953XW62900008
J	Browning, BL; Tian, XW; Zhou, Y; Browning, SR				Browning, Brian L.; Tian, Xiaowen; Zhou, Ying; Browning, Sharon R.			Fast two-stage phasing of large-scale sequence data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; GENOTYPE IMPUTATION; POSITIVE SELECTION; WIDE ASSOCIATION; LOCAL-ANCESTRY; HAPLOTYPE; INFERENCE; DESCENT; THOUSANDS; SEGMENTS	Haplotype phasing is the estimation of haplotypes from genotype data. We present a fast, accurate, and memory-efficient haplotype phasing method that scales to large-scale SNP array and sequence data. The method uses marker windowing and composite reference haplotypes to reduce memory usage and computation time. It incorporates a progressive phasing algorithm that identifies confidently phased heterozygotes in each iteration and fixes the phase of these heterozygotes in subsequent iterations. For data with many low-frequency variants, such as whole-genome sequence data, the method employs a two-stage phasing algorithm that phases high-frequency markers via progressive phasing in the first stage and phases low-frequency markers via genotype imputation in the second stage. This haplotype phasing method is implemented in the open-source Beagle 5.2 software package. We compare Beagle 5.2 and SHAPEIT 4.2.1 by using expanding subsets of 485,301 UK Biobank samples and 38,387 TOPMed samples. Both methods have very similar accuracy and computation time for UK Biobank SNP array data. However, for TOPMed sequence data, Beagle is more than 20 times faster than SHAPEIT, achieves similar accuracy, and scales to larger sample sizes.	[Browning, Brian L.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Browning, Brian L.; Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tian, Xiaowen] AstraZeneca, Oncol Biometr, Stat Innovat, Gaithersburg, MD 20878 USA; [Zhou, Ying] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; AstraZeneca; Fred Hutchinson Cancer Center	Browning, BL (corresponding author), Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA.; Browning, BL (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Brian/ABC-4543-2021		National Human Genome Research Institute of the National Institutes of Health [HG008359]; National Heart, Lung, and Blood Institute (NHLBI); TOPMed Informatics Research Center [3R01HL117626-02S1, HHSN268201800002I]; National Institutes of Health (NIH) [R01HL104608, R01HL087699, HL104608 S1]; NHLBI [NO1-HC-25195, HHSN268201500001I, 75N92019D00031, R01 HL092577-06S1];  [R01HL-120393];  [U01HL-120393];  [HHSN268201800001I];  [HHSN268201600034I];  [U54HG003067]	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); TOPMed Informatics Research Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; 	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under award number HG008359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research has been conducted with the UK Biobank Resource under application number 19934. Molecular data for the TransOmics in Precision Medicine (TOPMed) program was supported by the National Heart, Lung, and Blood Institute (NHLBI). Core support including centralized genomic-read mapping and genotype calling along with variant quality metrics and filtering were provided by the TOPMed Informatics Research Center (3R01HL117626-02S1; contract HHSN268201800002I). Core support including phenotype harmonization, data management, sampleidentity QC, and general program coordination were provided by the TOPMed Data Coordinating Center (R01HL-120393; U01HL-120393; contract HHSN268201800001I). We gratefully acknowledge the studies and participants who provided biological samples and data for TOPMed. Funding for the Barbados Asthma Genetics Study was provided by National Institutes of Health (NIH) R01HL104608, R01HL087699, and HL104608 S1. The Framingham Heart Study was supported by contracts NO1-HC-25195, HHSN268201500001I, and 75N92019D00031 from the NHLBI and grant supplement R01 HL092577-06S1; genome sequencing was funded by HHSN268201600034I and U54HG003067. See supplemental information for acknowledgments of additional individual studies in the TOPMed data.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2020, AM J HUM GENET, V107, P895, DOI 10.1016/j.ajhg.2020.09.010; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Das S, 2018, ANNU REV GENOM HUM G, V19, P73, DOI 10.1146/annurev-genom-083117-021602; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13225-y; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hanchard NA, 2006, AM J HUM GENET, V78, P153, DOI 10.1086/499252; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Larsen LA, 1999, EUR J HUM GENET, V7, P724, DOI 10.1038/sj.ejhg.5200323; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; O'Connell J, 2016, NAT GENET, V48, P817, DOI 10.1038/ng.3583; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rubinacci S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009049; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salter-Townshend M, 2019, GENETICS, V212, P869, DOI 10.1534/genetics.119.302139; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Taliun D, 2021, NATURE, V590, DOI 10.1038/s41586-021-03205-y; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Zhang C, 2006, BIOINFORMATICS, V22, P2122, DOI 10.1093/bioinformatics/btl365; Zhou Y, 2020, AM J HUM GENET, V106, P426, DOI 10.1016/j.ajhg.2020.02.010	42	39	39	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2021	108	10					1880	1890		10.1016/j.ajhg.2021.08.005	http://dx.doi.org/10.1016/j.ajhg.2021.08.005		OCT 2021	11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE0EW	34478634	Green Published, Bronze			2022-12-18	WOS:000705304300007
J	Bashamboo, A; Eozenou, C; Jorgensen, A; Bignon-Topalovic, J; Siffroi, JP; Hyon, C; Tar, A; Nagy, P; Solyom, J; Halasz, Z; Paye-Jaouen, A; Lambert, S; Rodriguez-Buritica, D; Bertalan, R; Martinerie, L; Rajpert-De Meyts, E; Achermann, JC; McElreavey, K				Bashamboo, Anu; Eozenou, Caroline; Jorgensen, Anne; Bignon-Topalovic, Joelle; Siffroi, Jean-Pierre; Hyon, Capucine; Tar, Attila; Nagy, Peter; Solyom, Janos; Halasz, Zita; Paye-Jaouen, Annnabel; Lambert, Sophie; Rodriguez-Buritica, David; Bertalan, Rita; Martinerie, Laetitia; Rajpert-De Meyts, Ewa; Achermann, John C.; McElreavey, Ken			Loss of Function of the Nuclear Receptor NR2F2, Encoding COUP-TF2, Causes Testis Development and Cardiac Defects in 46,XX Children	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROMOTER-TRANSCRIPTION FACTOR; STEROIDOGENIC FACTOR-I; SEX DEVELOPMENT; CELL DIFFERENTIATION; OVARIAN DEVELOPMENT; TFII; HUMANS; FETAL; MUTATION; FOXL2	Emerging evidence from murine studies suggests that mammalian sex determination is the outcome of an imbalance between mutually antagonistic male and female regulatory networks that canalize development down one pathway while actively repressing the other. However, in contrast to testis formation, the gene regulatory pathways governing mammalian ovary development have remained elusive. We performed exome or Sanger sequencing on 79 46, XX SRY-negative individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs*75) mutation, while two others carried a c.97_103delCCGCCCG (p.Pro33Alafs*77) mutation. In two of three children the mutation was de novo. All three children presented with congenital heart disease (CHD), one child with congenital diaphragmatic hernia (CDH), and two children with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). The three children had androgen production, virilization of external genitalia, and biochemical or histological evidence of testicular tissue. We demonstrate a highly significant association between the NR2F2 loss-of-function mutations and this syndromic form of DSD (p = 2.44 x 10(-8)). We show that COUP-TF2 is highly abundant in a FOXL2-negative stromal cell population of the fetal human ovary. In contrast to the mouse, these data establish COUP-TF2 as a human "pro-ovary'' and "anti-testis'' sex-determining factor in female gonads. Furthermore, the data presented here provide additional evidence of the emerging importance of nuclear receptors in establishing human ovarian identity and indicate that nuclear receptors may have divergent functions in mouse and human biology.	[Bashamboo, Anu; Eozenou, Caroline; Bignon-Topalovic, Joelle; Bertalan, Rita; McElreavey, Ken] Inst Pasteur, Human Dev Genet, F-75724 Paris, France; [Jorgensen, Anne; Rajpert-De Meyts, Ewa] Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Siffroi, Jean-Pierre; Hyon, Capucine] Hosp Trousseau, APHP, Dept Med Genet, F-75012 Paris, France; [Tar, Attila] Heim Pal Childrens Hosp, H-1089 Budapest, Hungary; [Nagy, Peter] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Solyom, Janos; Halasz, Zita] Semmelweis Univ, Dept Pediat, H-1085 Budapest, Hungary; [Paye-Jaouen, Annnabel] Hop Robert Debre, Pediat & Visceral Surg & Urol, F-75019 Paris, France; [Lambert, Sophie; Martinerie, Laetitia] Hop Robert Debre, Endocrinol & Diabetol Pediat, F-75019 Paris, France; [Rodriguez-Buritica, David] Univ Texas Houston, McGovern Med Sch, Dept Pediat, Div Genet, Houston, TX 77030 USA; [Achermann, John C.] UCL GOSH Inst Child Hlth, London WC1N 1EH, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Semmelweis University; Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Health Science Center Houston; University of London; University College London	McElreavey, K (corresponding author), Inst Pasteur, Human Dev Genet, F-75724 Paris, France.	kenmce@pasteur.fr	Martinerie, Laetitia/S-7493-2018; Achermann, John/N-2906-2019; Jorgensen, Anne/S-8681-2016; Bertalan, Rita/Y-9758-2018; Rajpert-De Meyts, Ewa/H-6526-2019; Achermann, John/C-5476-2008	Achermann, John/0000-0001-8787-6272; Jorgensen, Anne/0000-0002-6409-198X; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Achermann, John/0000-0001-8787-6272; EOZENOU, Caroline/0000-0001-6968-0110	program Actions Concertees Interpasteuriennes (ACIP); European Society of Pediatric Endocrinology; EuroDSD in the European Community's Seventh Framework Programme as part of the EU [201444, 295097]; Wellcome Trust [098513/Z/12/Z, 209328/Z/17/Z]; Great Ormond Street Hospital Children's Charity [V2518]; NIHR GOSH BRC [IS-BRC-1215-20012]; COST Action DSDnet [BM1303]; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]	program Actions Concertees Interpasteuriennes (ACIP); European Society of Pediatric Endocrinology; EuroDSD in the European Community's Seventh Framework Programme as part of the EU; Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Children's Charity; NIHR GOSH BRC; COST Action DSDnet(European Cooperation in Science and Technology (COST)); Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR))	A.B. is funded in part by the program Actions Concertees Interpasteuriennes (ACIP) and a research grant from the European Society of Pediatric Endocrinology. A.B. and K. McE. are funded by a research grant from the EuroDSD in the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 201444 as well as grant no. 295097 as part of the EU call FP7-INCO-2011-6. J.C.A. is a Wellcome Trust Senior Research Fellow in Clinical Science (grant 098513/Z/12/Z, 209328/Z/17/Z) with research support from Great Ormond Street Hospital Children's Charity (grant V2518) and the NIHR GOSH BRC (IS-BRC-1215-20012). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. This work is supported by the COST Action DSDnet BM1303. The authors wish to thank Dr. Etienne Patin for comments on the manuscript. This work was funded by the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73).	Achermann JC, 2017, J CLIN INVEST, V127, P1181, DOI 10.1172/JCI88892; Al Turki S, 2014, AM J HUM GENET, V94, P574, DOI 10.1016/j.ajhg.2014.03.007; Bashamboo A, 2013, SEX DEV, V7, P126, DOI 10.1159/000342188; Bashamboo A, 2016, HUM MOL GENET, V25, P3446, DOI 10.1093/hmg/ddw186; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biason-Lauber A, 2015, SEMIN CELL DEV BIOL, V45, P59, DOI 10.1016/j.semcdb.2015.10.021; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; Del Valle Ignacio, 2017, Wellcome Open Res, V2, P25, DOI 10.12688/wellcomeopenres.11253.2; Elzaiat M, 2017, CLIN GENET, V91, P173, DOI 10.1111/cge.12862; Evtouchenko L, 1996, CELL TRANSPLANT, V5, P453, DOI 10.1016/0963-6897(96)00079-6; High FA, 2016, AM J MED GENET A, V170, P2457, DOI 10.1002/ajmg.a.37830; Hsu WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12665-0; Jorgensen A, 2015, HUM REPROD, V30, P2351, DOI 10.1093/humrep/dev194; Lee PA, 2016, HORM RES PAEDIAT, V85, P158, DOI 10.1159/000442975; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li AH, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0482-5; Li XL, 2013, MOL ENDOCRINOL, V27, P2041, DOI 10.1210/me.2013-1191; Lin FJ, 2012, ARTERIOSCL THROM VAS, V32, pE135, DOI 10.1161/ATVBAHA.112.300255; Lottrup G, 2014, HUM REPROD, V29, P1637, DOI 10.1093/humrep/deu124; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Miyado M, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0114-6; Murphy MW, 2015, NAT STRUCT MOL BIOL, V22, P442, DOI 10.1038/nsmb.3032; Ohnesorg T, 2017, CLIN GENET, V92, P347, DOI 10.1111/cge.12976; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Rastetter RH, 2014, DEV BIOL, V394, P242, DOI 10.1016/j.ydbio.2014.08.013; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Tang K, 2015, BBA-GENE REGUL MECH, V1849, P201, DOI 10.1016/j.bbagrm.2014.05.022; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Wu SP, 2016, J STEROID BIOCHEM, V157, P7, DOI 10.1016/j.jsbmb.2015.11.011; Yu CT, 2012, DEVELOPMENT, V139, P2330, DOI 10.1242/dev.076299; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010; Zhao F, 2017, SCIENCE, V357, P717, DOI 10.1126/science.aai9136	36	39	39	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					487	493		10.1016/j.ajhg.2018.01.021	http://dx.doi.org/10.1016/j.ajhg.2018.01.021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29478779	Green Published, hybrid			2022-12-18	WOS:000426469600019
J	Yin, JN; Chen, W; Chao, ES; Soriano, S; Wang, L; Wang, W; Cummock, SE; Tao, HF; Pang, KF; Liu, ZD; Pereira, FA; Samaco, RC; Zoghbi, HY; Xue, MS; Schaaf, CP				Yin, Jiani; Chen, Wu; Chao, Eugene S.; Soriano, Sirena; Wang, Li; Wang, Wei; Cummock, Steven E.; Tao, Huifang; Pang, Kaifang; Liu, Zhandong; Pereira, Fred A.; Samaco, Rodney C.; Zoghbi, Huda Y.; Xue, Mingshan; Schaaf, Christian P.			Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEVELOPMENTAL DELAY; MENTAL-RETARDATION; HOMOZYGOUS MICRODELETION; CHRNA7 CAUSES; RETT-SYNDROME; MOUSE MODELS; SINGLE-GENE; PHENOTYPES; HYPOTONIA; SEIZURES	15q13.3 microdeletion syndrome is characterized by a wide spectrum of neurodevelopmental disorders, including developmental delay, intellectual disability, epilepsy, language impairment, abnormal behaviors, neuropsychiatric disorders, and hypotonia. This syndrome is caused by a deletion on chromosome 15q, which typically encompasses six genes. Here, through studies on OTU deubiquitinase 7A (Otud7a) knockout mice, we identify OTUD7A as a critical gene responsible for many of the cardinal phenotypes associated with 15q13.3 microdeletion syndrome. Otud7a-null mice show reduced body weight, developmental delay, abnormal electroencephalography patterns and seizures, reduced ultrasonic vocalizations, decreased grip strength, impaired motor learning/motor coordination, and reduced acoustic startle. We show that OTUD7A localizes to dendritic spines and that Otud7a-null mice have decreased dendritic spine density compared to their wild-type littermates. Furthermore, frequency of miniature excitatory postsynaptic currents (mEPSCs) is reduced in the frontal cortex of Otud7a-null mice, suggesting a role of Otud7a in regulation of dendritic spine density and glutamatergic synaptic transmission. Taken together, our results suggest decreased OTUD7A dosage as a major contributor to the neurodevelopmental phenotypes associated with 15q13.3 microdeletion syndrome, through the misregulation of dendritic spine density and activity.	[Yin, Jiani; Soriano, Sirena; Wang, Li; Wang, Wei; Tao, Huifang; Samaco, Rodney C.; Zoghbi, Huda Y.; Xue, Mingshan; Schaaf, Christian P.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yin, Jiani; Soriano, Sirena; Wang, Li; Wang, Wei; Cummock, Steven E.; Tao, Huifang; Pang, Kaifang; Liu, Zhandong; Samaco, Rodney C.; Zoghbi, Huda Y.; Schaaf, Christian P.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Chen, Wu; Chao, Eugene S.; Xue, Mingshan] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Chen, Wu; Chao, Eugene S.; Xue, Mingshan] Texas Childrens Hosp, Cain Fdn Labs, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Samaco, Rodney C.] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Pang, Kaifang; Liu, Zhandong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Schaaf, CP (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Schaaf, CP (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.	schaaf@bcm.edu	Schaaf, Christian P/AAJ-7318-2021; Chen, Wu/AAO-3020-2020	Schaaf, Christian P/0000-0002-2148-7490; Chen, Wu/0000-0002-7400-0519; Soriano, Sirena/0000-0001-9967-7262; Wang, Li/0000-0001-9510-6294; Samaco, Rodney/0000-0001-5636-5314; Liu, Zhandong/0000-0002-7608-0831; Xue, Mingshan/0000-0003-1463-8884	BCM Intellectual and Developmental Disabilities Research Center Neuroconnectivity, Neurovisualization and Neurobehavioral Cores (NIH grant) [U54HD083092]; BCM Genetically Engineered Mouse Core (NIH grants) [P30CA125123, U42HG006352]; NIH [DP5OD009134, R01NS100893]; Whitehall Foundation; Citizens United for Research in Epilepsy; Joan and Stanford Alexander Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100893] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009134] Funding Source: NIH RePORTER	BCM Intellectual and Developmental Disabilities Research Center Neuroconnectivity, Neurovisualization and Neurobehavioral Cores (NIH grant); BCM Genetically Engineered Mouse Core (NIH grants); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Citizens United for Research in Epilepsy; Joan and Stanford Alexander Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by the BCM Intellectual and Developmental Disabilities Research Center Neuroconnectivity, Neurovisualization and Neurobehavioral Cores (NIH grant U54HD083092), the BCM Genetically Engineered Mouse Core (NIH grants P30CA125123, U42HG006352), NIH grant DP5OD009134 (R.C.S.), NIH grant R01NS100893 (M.X.), the Whitehall Foundation (M.X.), and Citizens United for Research in Epilepsy (M.X.). M.X. is a Caroline DeLuca Scholar. C.P.S. is generously supported by the Joan and Stanford Alexander Family. Video EEG recordings were performed by Zhenyu Wu and Dr. Jianrong Tang at the Neuroconnectivity Core and In Vivo Neurophysiology Core and Golgi-Cox staining was performed by Tao Lin at the Neuropathology Core of Jan and Dan Duncan Neurological Research Institute.	Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Drapeau E, 2014, DIS MODEL MECH, V7, P667, DOI 10.1242/dmm.013821; Endris V, 2010, AM J MED GENET A, V152A, P2908, DOI 10.1002/ajmg.a.33692; Forsingdal A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.125; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gillentine MA, 2015, BIOCHEM PHARMACOL, V97, P352, DOI 10.1016/j.bcp.2015.06.012; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hao S, 2015, NATURE, V526, P430, DOI 10.1038/nature15694; Hoppman-Chaney N, 2013, CLIN GENET, V83, P345, DOI 10.1111/j.1399-0004.2012.01925.x; LePichon JB, 2010, AM J MED GENET A, V152A, P1300, DOI 10.1002/ajmg.a.33374; Liao J, 2011, AM J MED GENET A, V155A, P2795, DOI 10.1002/ajmg.a.34237; Lowther C, 2015, GENET MED, V17, P149, DOI 10.1038/gim.2014.83; Masurel-Paulet A, 2010, CLIN GENET, V78, P149, DOI 10.1111/j.1399-0004.2010.01374.x; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Prasun P, 2014, AM J MED GENET A, V164, P1815, DOI 10.1002/ajmg.a.36535; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spielmann M, 2011, EUR J MED GENET, V54, pE441, DOI 10.1016/j.ejmg.2011.04.004; Uddin M, 2018, AM J HUM GENET, V102, P278, DOI 10.1016/j.ajhg.2018.01.006; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Yin JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep39941; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	27	39	39	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					296	308		10.1016/j.ajhg.2018.01.005	http://dx.doi.org/10.1016/j.ajhg.2018.01.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29395075	Green Published, Bronze			2022-12-18	WOS:000424407600008
J	Writzl, K; Maver, A; Kovacic, L; Martinez-Valero, P; Contreras, L; Satrustegui, J; Castori, M; Faivre, L; Lapunzina, P; van Kuilenburg, ABP; Radovic, S; Thauvin-Robinet, C; Peterlin, B; del Arco, A; Hennekam, RC				Writzl, Karin; Maver, Ales; Kovacic, Lidija; Martinez-Valero, Paula; Contreras, Laura; Satrustegui, Jorgina; Castori, Marco; Faivre, Laurence; Lapunzina, Pablo; van Kuilenburg, Andre B. P.; Radovic, Slobodanka; Thauvin-Robinet, Christel; Peterlin, Borut; del Arco, Araceli; Hennekam, Raoul C.			De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GILFORD-PROGERIA-SYNDROME; MITOCHONDRIAL PERMEABILITY TRANSITION; ADENINE-NUCLEOTIDE TRANSLOCATOR; DNA COPY NUMBER; MG/P-I CARRIER; MOLECULAR-DYNAMICS; CALCIUM-REGULATION; ADP/ATP CARRIER; IDENTIFICATION; DYSFUNCTION	A series of simplex cases have been reported under various diagnoses sharing early aging, especially evident in congenitally decreased subcutaneous fat tissue and sparse hair, bone dysplasia of the skull and fingers, a distinctive facial gestalt, and prenatal and postnatal growth retardation. For historical reasons, we suggest naming the entity Fontaine syndrome. Exome sequencing of four unrelated affected individuals showed that all carried the de novo missense variant c. 649C>T (p.Arg217Cys) or c.650G>A (p.Arg217His) in SLC25A24, a solute carrier 25 family member coding for calcium-binding mitochondrial carrier protein (SCaMC-1, also known as SLC25A24). SLC25A24 allows an electro-neutral and reversible exchange of ATP-Mg and phosphate between the cytosol and mitochondria, which is required for maintaining optimal adenine nucleotide levels in the mitochondrial matrix. Molecular dynamic simulation studies predict that p.Arg217Cys and p.Arg217His narrow the substrate cavity of the protein and disrupt transporter dynamics. SLC25A24-mutant fibroblasts and cells expressing p.Arg217Cys or p.Arg217His variants showed altered mitochondrial morphology, a decreased proliferation rate, increased mitochondrial membrane potential, and decreased ATP-linked mitochondrial oxygen consumption. The results suggest that the SLC25A24 mutations lead to impaired mitochondrial ATP synthesis and cause hyperpolarization and increased proton leak in association with an impaired energy metabolism. Our findings identify SLC25A24 mutations affecting codon 217 as the underlying genetic cause of human progeroid Fontaine syndrome.	[Writzl, Karin; Maver, Ales; Peterlin, Borut] Univ Med Ctr, Clin Inst Med Genet, Ljubljana 1000, Slovenia; [Kovacic, Lidija] Novartis Ireland Ltd, Novartis, Vista Bldg,Elm Business Pk, Dublin D04A 9N6 4, Ireland; [Martinez-Valero, Paula; Contreras, Laura; Satrustegui, Jorgina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, E-28049 Madrid, Spain; [Martinez-Valero, Paula; Contreras, Laura; Satrustegui, Jorgina; del Arco, Araceli] CSIC, Madrid 28049, Spain; [Martinez-Valero, Paula; Contreras, Laura; Satrustegui, Jorgina; del Arco, Araceli] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid 28049, Spain; [Martinez-Valero, Paula; Contreras, Laura; Satrustegui, Jorgina; del Arco, Araceli] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28049, Spain; [Castori, Marco] Ist Ricovero & Cura Carattere Sci, Div Med Genet, Casa Sollievo della Sofferenza, I-71013 Foggia, Italy; [Faivre, Laurence; Thauvin-Robinet, Christel] Ctr Hosp Univ Dijon Bourgogne, Ctr Reference Malad Rares cAnomalies Dev & Syndro, Ctr Genet, FHU TRANSLAD,Hop Enfants, F-21079 Dijon, France; [Faivre, Laurence; Thauvin-Robinet, Christel] Univ Bourgogne Franche Comte, INSERM, Genet Anomalies Dev, UMR 1231, F-21079 Dijon, France; [Lapunzina, Pablo] Ctr Invest Biomed Red Enfermedades Rares, Hosp Univ La Paz, Inst Genet Med & Mol IdiPAZ, Madrid 26128046, Spain; [van Kuilenburg, Andre B. P.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Radovic, Slobodanka] IGA Technol Serv Srl, I-33100 Udine, Italy; [del Arco, Araceli] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Fac Ciencias Ambientales & Bioquim, Toledo 45071, Spain; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University Medical Centre Ljubljana; Novartis; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; IRCCS Casa Sollievo Della Sofferenza; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Amsterdam; Academic Medical Center Amsterdam; Universidad de Castilla-La Mancha; University of Amsterdam; Academic Medical Center Amsterdam	Writzl, K (corresponding author), Univ Med Ctr, Clin Inst Med Genet, Ljubljana 1000, Slovenia.	karinwritzl@gmail.com	Contreras, Laura/ABG-7620-2021; del Arco, Araceli/R-5653-2019; Castori, Marco/K-1099-2016; Contreras, Laura/A-2296-2015; Satrustegui, Jorgina/R-6732-2019; Lapunzina, Pablo/L-7075-2014	Contreras, Laura/0000-0003-1157-4942; Castori, Marco/0000-0002-6069-0993; Faivre, Laurence/0000-0001-9770-444X; van Kuilenburg, Andre/0000-0002-7989-4910; Lapunzina, Pablo/0000-0002-6324-4825; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	Spanish Ministry of Economy and Competiveness [SAF2014-56929-R]; Ramon Areces Foundation; Slovenian Research Agency [J3-5506]; Regional Council of Burgundy (PARI); Centro de Investigacion Biomedica en Red de Enfermedades Raras; CBMSO	Spanish Ministry of Economy and Competiveness(Spanish Government); Ramon Areces Foundation; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Regional Council of Burgundy (PARI)(Region Bourgogne-Franche-Comte); Centro de Investigacion Biomedica en Red de Enfermedades Raras; CBMSO	We are pleased to thank the families for their generous cooperation. This study was financially supported by grants from the Spanish Ministry of Economy and Competiveness (SAF2014-56929-R to J.S.), Ramon Areces Foundation (to the Centro de Biologia Molecular Severo Ochoa [CBMSO]), Slovenian Research Agency (J3-5506 to B.P.), and Regional Council of Burgundy (PARI 2014). L.C. was supported by a postdoctoral contract from the Centro de Investigacion Biomedica en Red de Enfermedades Raras. We thank Barbara Sese, Luis Gonzalez-Moreno, David Marquez, and the units of Optical and Confocal Microscopy and Electron Microscopy of the CBMSO for their support.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Amigo I, 2013, J BIOL CHEM, V288, P7791, DOI 10.1074/jbc.M112.409144; Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Braddock SR, 2010, AM J MED GENET A, V152A, P1718, DOI 10.1002/ajmg.a.33468; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Castori M, 2009, AM J MED GENET A, V149A, P2193, DOI 10.1002/ajmg.a.32763; Davidson Sean M, 2007, Methods Mol Biol, V372, P421, DOI 10.1007/978-1-59745-365-3_30; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; del Arco A, 2016, BBA-MOL CELL RES, V1863, P2413, DOI 10.1016/j.bbamcr.2016.03.024; Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Faivre L, 1999, AM J MED GENET, V87, P450, DOI 10.1002/(SICI)1096-8628(19991222)87:5<450::AID-AJMG16>3.0.CO;2-T; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; FONTAINE G, 1977, J GENET HUM, V25, P109; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Heyland K., 2003, YUNIS VARON SYNDROME; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnston JJ, 2015, AM J HUM GENET, V97, P465, DOI 10.1016/j.ajhg.2015.07.009; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Llorente-Folch I, 2013, J NEUROSCI, V33, P13957, DOI 10.1523/JNEUROSCI.0929-13.2013; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Maynard S., 2015, COLD SPRING HARB PER, V5; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Delgado-Luengo WN, 2009, AM J MED GENET A, V149A, P2200, DOI 10.1002/ajmg.a.32884; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Peinado JR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008094; PETTY EM, 1990, AM J MED GENET, V35, P383, DOI 10.1002/ajmg.1320350314; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008; Rodriguez JI, 1999, AM J MED GENET, V82, P242, DOI 10.1002/(SICI)1096-8628(19990129)82:3<242::AID-AJMG9>3.3.CO;2-5; Rueda CB, 2015, J NEUROSCI, V35, P3566, DOI 10.1523/JNEUROSCI.2702-14.2015; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheibye-Knudsen M, 2014, AUTOPHAGY, V10, P1468, DOI 10.4161/auto.29321; Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sieprath T, 2015, NUCLEUS-PHILA, V6, P236, DOI 10.1080/19491034.2015.1050568; Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2011, CELL MOL LIFE SCI, V68, P1183, DOI 10.1007/s00018-010-0612-3; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Urano T, 2015, J CLIN ENDOCR METAB, V100, pE655, DOI 10.1210/jc.2014-2829; van Kuilenburg ABP, 2009, HUM GENET, V125, P581, DOI 10.1007/s00439-009-0653-6; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	56	39	39	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					844	855		10.1016/j.ajhg.2017.09.017	http://dx.doi.org/10.1016/j.ajhg.2017.09.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100094	Green Published, Bronze			2022-12-18	WOS:000414251600015
J	Guella, I; McKenzie, MB; Evans, DM; Buerki, SE; Toyota, EB; Van Allen, MI; Suri, M; Elmslie, F; Simon, MEH; van Gassen, KLI; Heron, D; Keren, B; Nava, C; Connolly, MB; Demos, M; Farrer, MJ				Guella, Ilaria; McKenzie, Marna B.; Evans, Daniel M.; Buerki, Sarah E.; Toyota, Eric B.; Van Allen, Margot I.; Suri, Mohnish; Elmslie, Frances; Simon, Marleen E. H.; van Gassen, Koen L. I.; Heron, Delphine; Keren, Boris; Nava, Caroline; Connolly, Mary B.; Demos, Michelle; Farrer, Matthew J.		Epilepsy Genomics Study; Deciphering Dev Disorders Study	De Novo Mutations in YWHAG Cause Early-Onset Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILLIAMS-BEUREN-SYNDROME; AMINO-ACID TRANSPORTER; DEVELOPING CEREBRAL-CORTEX; NEURONAL MIGRATION DELAY; 7Q11.23 CRITICAL REGION; 14-3-3 PROTEIN FAMILY; INFANTILE SPASMS; TYPICAL DELETIONS; ANION CHANNELS; ENCEPHALOPATHY	Massively parallel sequencing has revealed many de novo mutations in the etiology of developmental and epileptic encephalopathies (EEs), highlighting their genetic heterogeneity. Additional candidate genes have been prioritized in silico by their co-expression in the brain. Here, we evaluate rare coding variability in 20 candidates nominated with the use of a reference gene set of 51 established EE-associated genes. Variants within the 20 candidate genes were extracted from exome-sequencing data of 42 subjects with EE and no previous genetic diagnosis. We identified 7 rare non-synonymous variants in 7 of 20 genes and performed Sanger sequence validation in affected probands and parental samples. De novo variants were found only in SLC1A2 (aka EAAT2 or GLT1) (c.244G>A [p.Gly82Arg]) and YWHAG (aka 14-3-3g) (c.394C>T [p.Arg132Cys]), highlighting the potential cause of EE in 5% (2/42) of subjects. Seven additional subjects with de novo variants in SLC1A2 (n = 1) and YWHAG (n = 6) were subsequently identified through online tools. We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2. Hence, in silico modeling of brain co-expression is an efficient method for nominating EE-associated genes to further elucidate the disorder's etiology and genotype-phenotype correlations.	[Guella, Ilaria; McKenzie, Marna B.; Evans, Daniel M.; Farrer, Matthew J.] Univ British Columbia, Ctr Appl Neurogenet, Vancouver, BC V5R 6H8, Canada; [Buerki, Sarah E.] Inselspital Bern, Univ Childrens Hosp, Dept Neuropediat Dev & Rehabil, CH-3010 Bern, Switzerland; [Toyota, Eric B.; Connolly, Mary B.; Demos, Michelle] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6H 3V4, Canada; [Toyota, Eric B.; Connolly, Mary B.; Demos, Michelle] British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; [Van Allen, Margot I.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Suri, Mohnish] Nottingham Univ Hosp NHS Trust, Reg Clin Genet Serv, Nottingham NG5 1PB, England; [Elmslie, Frances] St Georges Univ Hosp NHS Fdn Trust, South West Thames Reg Genet Serv, London SW17 0QT, England; [Simon, Marleen E. H.; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Heron, Delphine; Keren, Boris; Nava, Caroline] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75651 Paris, France; [Heron, Delphine; Keren, Boris; Nava, Caroline] Hop La Pitie Salpetriere, AP HP, Ctr Reference Deficiences Intellectuelles Causes, F-75651 Paris, France	University of British Columbia; University of Bern; University Hospital of Bern; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; Nottingham University Hospital NHS Trust; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Farrer, MJ (corresponding author), Univ British Columbia, Ctr Appl Neurogenet, Vancouver, BC V5R 6H8, Canada.; Demos, M (corresponding author), Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6H 3V4, Canada.; Demos, M (corresponding author), British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada.	mdemos@cw.bc.ca; mfarrer@can.ubc.ca	Guella, Ilaria/AAU-1286-2020; Buerki, Sarah E./ABA-5692-2020; Guella, Ilaria/AAU-1319-2020	Adam, Shelin/0000-0002-4401-6157; Connolly, Mary/0000-0002-7784-942X; Nelson, Tanya/0000-0001-5344-3516; Buerki, Sarah Elisabeth/0000-0003-3054-1791; Nava, Caroline/0000-0003-1272-0518; Sinclair, Graham/0000-0002-3815-2005; van Gassen, Koen/0000-0001-7934-0662; McKenzie, Marna/0000-0002-0869-345X	Canada Excellence Research Chair; Alva Foundation; Rare Disease Foundation	Canada Excellence Research Chair; Alva Foundation; Rare Disease Foundation	We thank the parents and children involved. We gratefully acknowledge Dr. Suzanne Vercauteren, MD, PhD (director), Dr. William Gibson, MD, PhD (chair and member of the Biospecimen Advisory Committee), Tamsin Tarling (BioBank administrative manager), and the technical expertise of Katelin N. Townsend of the BC Children's Hospital BioBank, which is supported by Mining for Miracles through the BC Children's Hospital Foundation. We also thank the BC Children's Hospital Department of Pathology & Laboratory Medicine and the BC Children's Hospital Electroencephalogram Department. Clinical research was performed as part of the Epilepsy Genomics (EPGEN) program on the genetics of early-onset epilepsy at BC Children's Hospital and the University of British Columbia. We appreciate the support of the Canada Excellence Research Chair (M.J.F.), the Alva Foundation, and the Rare Disease Foundation.	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Cornell B, 2016, NEUROSCI LETT, V628, P40, DOI 10.1016/j.neulet.2016.06.009; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DURING MJ, 1993, LANCET, V341, P1607; Earhart BA, 2017, AM J MED GENET A, V173, P114, DOI 10.1002/ajmg.a.37966; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fusco C, 2014, EUR J HUM GENET, V22, P64, DOI 10.1038/ejhg.2013.101; GALABURDA AM, 1994, NEUROREPORT, V5, P753, DOI 10.1097/00001756-199403000-00004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAGLID KG, 1994, MOL NEUROBIOL, V9, P259, DOI 10.1007/BF02816125; Hotzy J, 2013, J BIOL CHEM, V288, P36492, DOI 10.1074/jbc.M113.489385; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; Komoike Y, 2010, GENESIS, V48, P233, DOI 10.1002/dvg.20607; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Marshall CR, 2008, AM J HUM GENET, V83, P106, DOI 10.1016/j.ajhg.2008.06.001; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mizugishi K, 1998, J HUM GENET, V43, P178, DOI 10.1007/s100380050064; Morimoto M, 2003, EPILEPSIA, V44, P1459, DOI 10.1046/j.1528-1157.2003.34703.x; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; Nefla M, 2015, J CELL SCI, V128, P3250, DOI 10.1242/jcs.169573; Nicita F, 2016, AM J MED GENET A, V170, P148, DOI 10.1002/ajmg.a.37410; Oliver KL, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000051; Oliver KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102079; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Popp B, 2016, EUR J MED GENET, V59, P549, DOI 10.1016/j.ejmg.2016.09.002; Ramocki MB, 2010, AM J HUM GENET, V87, P857, DOI 10.1016/j.ajhg.2010.10.019; Samanta D, 2017, ACTA NEUROL BELG, V117, P359, DOI 10.1007/s13760-016-0635-0; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skjevik AA, 2014, J MOL BIOL, V426, P150, DOI 10.1016/j.jmb.2013.09.012; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Valente C, 2012, NAT CELL BIOL, V14, P343, DOI 10.1038/ncb2445; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wachi T, 2016, DEV NEUROBIOL, V76, P600, DOI 10.1002/dneu.22335; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	63	39	42	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					300	310		10.1016/j.ajhg.2017.07.004	http://dx.doi.org/10.1016/j.ajhg.2017.07.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777935	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000406854800014
J	Bain, JM; Cho, MT; Telegrafi, A; Wilson, A; Brooks, S; Botti, C; Gowans, G; Autullo, LA; Krishnamurthy, V; Willing, MC; Toler, TL; Ben-Zev, B; Elpeleg, O; Shen, YF; Retterer, K; Monaghan, KG; Chung, WK				Bain, Jennifer M.; Cho, Megan T.; Telegrafi, Aida; Wilson, Ashley; Brooks, Susan; Botti, Christina; Gowans, Gordon; Autullo, Leigh Anne; Krishnamurthy, Vidya; Willing, Marcia C.; Toler, Tomi L.; Ben-Zev, Bruria; Elpeleg, Orly; Shen, Yufeng; Retterer, Kyle; Monaghan, Kristin G.; Chung, Wendy K.			Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA-BINDING PROTEINS; INTELLECTUAL DISABILITY; DROSOPHILA MODEL; MUTATIONS; DISEASE; NEURODEGENERATION; GENETICS; REPEATS; FXTAS	Via whole-exome sequencing, we identified six females from independent families with a common neurodevelopmental phenotype including developmental delay, intellectual disability, autism, hypotonia, and seizures, all with de novo predicted deleterious variants in the nuclear localization signal of Heterogeneous Nuclear Ribonucleoprotein H2, encoded by HNRNPH2, a gene located on the X chromosome. Many of the females also have seizures, psychiatric co-morbidities, and orthopedic, gastrointestinal, and growth problems as well as common dysmorphic facial features. HNRNPs are a large group of ubiquitous proteins that associate with pre-mRNAs in eukaryotic cells to produce a multitude of alternatively spliced mRNA products during development and play an important role in controlling gene expression. The failure to identify affected males, the severity of the neurodevelopmental phenotype in females, and the essential role of this gene suggests that male conceptuses with these variants may not be viable.	[Bain, Jennifer M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Cho, Megan T.; Telegrafi, Aida; Retterer, Kyle; Monaghan, Kristin G.] GeneDx, Gaithersburg, MD 20877 USA; [Wilson, Ashley; Chung, Wendy K.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Brooks, Susan; Botti, Christina] Rutgers Robert Wood Johnson Med Grp, Dept Pediat, New Brunswick, NJ 08901 USA; [Autullo, Leigh Anne] Univ Louisville, Weisskopf Child Evaluat Ctr, Louisville, KY 40202 USA; [Willing, Marcia C.; Toler, Tomi L.] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA; [Ben-Zev, Bruria] Edmond & Lily Safra Childrens Hosp Sheba, Pediat Neurol, Derech Sheba 2, Ramat Gan, Israel; [Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Shen, Yufeng] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Shen, Yufeng] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville; Washington University (WUSTL); Hebrew University of Jerusalem; Columbia University; Columbia University; Columbia University	Chung, WK (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA.; Chung, WK (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.	wkc15@columbia.edu		Toler, Tomi/0000-0002-1637-8310	Simons Foundation	Simons Foundation	We gratefully acknowledge all the individuals and their families. Funding support provided by the Simons Foundation.	Bassani S, 2013, NEUROSCIENTIST, V19, P541, DOI 10.1177/1073858413493972; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Chou MY, 1999, MOL CELL BIOL, V19, P69; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; des Portes V, 2013, HAND CLINIC, V111, P297, DOI 10.1016/B978-0-444-52891-9.00035-X; Feng DR, 2013, WIRES RNA, V4, P631, DOI 10.1002/wrna.1184; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Linder B, 2015, FEBS LETT, V589, P1598, DOI 10.1016/j.febslet.2015.04.052; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Niu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047056; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sohail M, 2015, MOL CELL BIOL, V35, P2203, DOI 10.1128/MCB.00190-15; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Van Dusen CM, 2010, MOL CELL BIOL, V30, P2552, DOI 10.1128/MCB.00230-09	27	39	40	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					728	734		10.1016/j.ajhg.2016.06.028	http://dx.doi.org/10.1016/j.ajhg.2016.06.028			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545675	Green Published, Bronze			2022-12-18	WOS:000383114800018
J	Park, JG; Tischfield, MA; Nugent, AA; Cheng, L; Di Gioia, SA; Chan, WM; Maconachie, G; Bosley, TM; Summers, CG; Hunter, DG; Robson, CD; Gottlob, I; Engle, EC				Park, Jong G.; Tischfield, Max A.; Nugent, Alicia A.; Cheng, Long; Di Gioia, Silvio Alessandro; Chan, Wai-Man; Maconachie, Gail; Bosley, Thomas M.; Summers, C. Gail; Hunter, David G.; Robson, Caroline D.; Gottlob, Irene; Engle, Elizabeth C.			Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HINDBRAIN SEGMENTATION; RETRACTION SYNDROME; BASIC DOMAIN; MUTATIONS; KREISLER; REVEALS; ROLES; MOUSE; GENE; SITE	Duane retraction syndrome (DRS) is a congenital eye-movement disorder defined by limited outward gaze and retraction of the eye on attempted inward gaze. Here, we report on three heterozygous loss-of-function MAFB mutations causing DRS and a dominant-negative MAFB mutation causing DRS and deafness. Using genotype-phenotype correlations in humans and Mafb-knockout mice, we propose a threshold model for variable loss of MAFB function. Postmortem studies of DRS have reported abducens nerve hypoplasia and aberrant innervation of the lateral rectus muscle by the oculomotor nerve. Our studies in mice now confirm this human DRS pathology. Moreover, we demonstrate that selectively disrupting abducens nerve development is sufficient to cause secondary innervation of the lateral rectus muscle by aberrant oculomotor nerve branches, which form at developmental decision regions close to target extraocular muscles. Thus, we present evidence that the primary cause of DRS is failure of the abducens nerve to fully innervate the lateral rectus muscle in early development.	[Park, Jong G.; Chan, Wai-Man; Engle, Elizabeth C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Park, Jong G.; Tischfield, Max A.; Nugent, Alicia A.; Cheng, Long; Di Gioia, Silvio Alessandro; Chan, Wai-Man; Engle, Elizabeth C.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Park, Jong G.; Tischfield, Max A.; Nugent, Alicia A.; Cheng, Long; Di Gioia, Silvio Alessandro; Chan, Wai-Man; Engle, Elizabeth C.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Park, Jong G.; Cheng, Long; Chan, Wai-Man; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Park, Jong G.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Nugent, Alicia A.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Maconachie, Gail; Gottlob, Irene] Univ Leicester, Ulverscroft Eye Unit, Leicester LE2 7LX, Leics, England; [Maconachie, Gail; Gottlob, Irene] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester LE2 7LX, Leics, England; [Bosley, Thomas M.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Summers, C. Gail] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [Summers, C. Gail] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Hunter, David G.; Engle, Elizabeth C.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Hunter, David G.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Robson, Caroline D.] Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Robson, Caroline D.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Engle, Elizabeth C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Duke University; Harvard University; Harvard Medical School; University of Leicester; University of Leicester; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Engle, EC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Engle, EC (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.; Engle, EC (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Engle, EC (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.; Engle, EC (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA.; Engle, EC (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA.; Engle, EC (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA.; Engle, EC (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	elizabeth.engle@childrens.harvard.edu		Di Gioia, Silvio Alessandro/0000-0002-7235-5682; Maconachie, Gail/0000-0001-9131-3480; Hunter, David/0000-0002-4587-4794	Research to Prevent Blindness Inc.;  [R01EY12498];  [HD018655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255, P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498] Funding Source: NIH RePORTER	Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank W.-M. Yuand L.V. Goodrich for Mafb<SUP>flox</SUP> mice; S.L. Pfaff for Isl<SUP>MN</SUP>:GFP mice; H. Ogino and S. Takahashi for the c alpha CE2 construct; and R.J. McLean, A. Mellors, M.G. Thomas, and A.-U. Haq for clinical exams. Funding support included R01EY12498 (E.C.E.), HD018655 (E.C.E.), and Research to Prevent Blindness Inc. (C.G.S.). J.G.P. is a Howard Hughes Medical Institute Medical Research Fellow, and E.C.E. is a Howard Hughes Medical Institute Investigator.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Brodsky MC, 2010, PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION, P1, DOI 10.1007/978-0-387-69069-8; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P5505, DOI 10.1167/iovs.07-0772; DEOL MS, 1964, J EMBRYOL EXP MORPH, V12, P475; DUANE A, 1905, ARCH OPHTHALMOL-CHIC, V34, P133; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; FRITZSCH B, 1995, J NEUROBIOL, V27, P457, DOI 10.1002/neu.480270403; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; HUBER A, 1974, BRIT J OPHTHALMOL, V58, P293, DOI 10.1136/bjo.58.3.293; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Kajihara M, 2001, J BIOCHEM-TOKYO, V129, P139, DOI 10.1093/oxfordjournals.jbchem.a002825; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; Miller MT, 2009, BIRTH DEFECTS RES A, V85, P667, DOI 10.1002/bdra.20609; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Parsa CF, 2013, JAMA OPHTHALMOL, V131, P439, DOI 10.1001/jamaophthalmol.2013.1111; Sadl VS, 2003, DEV DYNAM, V227, P134, DOI 10.1002/dvdy.10279; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; STRACHAN IM, 1972, BRIT J OPHTHALMOL, V56, P594, DOI 10.1136/bjo.56.8.594; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Walsh CA, 2010, NEURON, V68, P245, DOI 10.1016/j.neuron.2010.09.042; Yu WM, 2013, ELIFE, V2, DOI 10.7554/eLife.01341; Zankl A, 2012, AM J HUM GENET, V90, P494, DOI 10.1016/j.ajhg.2012.01.003	35	39	42	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1220	1227		10.1016/j.ajhg.2016.03.023	http://dx.doi.org/10.1016/j.ajhg.2016.03.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27181683	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000377286000015
J	Guo, TW; Chung, JH; Wang, T; McDonald-McGinn, DM; Kates, WR; Hawula, W; Coleman, K; Zackai, E; Emanuel, BS; Morrow, BE				Guo, Tingwei; Chung, Jonathan H.; Wang, Tao; McDonald-McGinn, Donna M.; Kates, Wendy R.; Hawula, Wanda; Coleman, Karlene; Zackai, Elaine; Emanuel, Beverly S.; Morrow, Bernice E.			Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; JMJD1C DEMETHYLATES MDC1; DIGEORGE-SYNDROME; H2A UBIQUITINATION; CELL-PROLIFERATION; SYNDROME REGION; X-INACTIVATION; COMPLEX TRAITS; H3 METHYLATION; PROTEIN	We performed whole exome sequence (WES) to identify genetic modifiers on 184 individuals with 22q11.2 deletion syndrome (22q11DS), of whom 89 case subjects had severe congenital heart disease (CHD) and 95 control subjects had normal hearts. Three genes including JMJD1C (jumonji domain containing 1C), RREB1 (Ras responsive element binding protein 1), and SEC24C (SEC24 family member C) had rare (MAF < 0.001) predicted deleterious single-nucleotide variations (rdSNVs) in seven case subjects and no control subjects (p = 0.005; Fisher exact and permutation tests). Because JMJD1C and RREB1 are involved in chromatin modification, we investigated other histone modification genes. Eighteen case subjects (20%) had rdSNVs in four genes (JMJD1C, RREB1, MINA, KDM7A) all involved in demethylation of histones (H3K9, H3K27). Overall, rdSNVs were enriched in histone modifier genes that activate transcription (Fisher exact p = 0.0004, permutations, p = 0.0003, OR = 5.16); however, rdSNVs in control subjects were not enriched. This implicates histone modification genes as influencing risk for CHD in presence of the deletion.	[Guo, Tingwei; Chung, Jonathan H.; Morrow, Bernice E.] Yeshiva Univ, Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Wang, Tao] Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine; Emanuel, Beverly S.] Univ Penn, Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine; Emanuel, Beverly S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Program Neurosci, Syracuse, NY 13210 USA; [Hawula, Wanda] Polish Mothers Mem Hosp, Res Inst, Dept Genet, PL-93338 Lodz, Poland; [Coleman, Karlene] Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Polish Mother's Memorial Hospital - Research Institute; Children's Healthcare of Atlanta (CHOA)	Morrow, BE (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.	bernice.morrow@einstein.yu.edu	McDonald-McGinn, Donna/L-8643-2019	Morrow, Bernice/0000-0002-8076-4726; McDonald-McGinn, Donna/0000-0003-4077-250X; Chung, Jonathan/0000-0003-3010-1059	National Heart, Lung, and Blood Institute [HHSN268201100037C]; NICHD at NIH [P01 HD070454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084410] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD at NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Jidong Shan, Ms. Yinghui Song, and Ms. Debbie Lewis in the Molecular Cytogenetics core lab at Einstein for technical support. We thank Emma Mclaughlin and Eugene Park for their outstanding technical support. We also appreciate the services of the Genomics Core at Einstein for Sanger DNA sequencing analysis. WES services were provided through the RS&G Service by the Northwest Genomics Center at the University of Washington, Department of Genome Sciences, under U.S. Federal Government contract number HHSN268201100037C from the National Heart, Lung, and Blood Institute. This work was supported by grant P01 HD070454 from the NICHD at NIH.	Adams EJ, 2014, J BIOL CHEM, V289, P20858, DOI 10.1074/jbc.M114.566687; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chapnik E, 2012, DEV BIOL, V362, P50, DOI 10.1016/j.ydbio.2011.11.008; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Chen ZX, 2012, J BIOL CHEM, V287, P19018, DOI 10.1074/jbc.M112.351791; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dykes IM, 2014, CIRC RES, V115, P23, DOI 10.1161/CIRCRESAHA.115.303300; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Lu J, 2013, NAT STRUCT MOL BIOL, V20, P1346, DOI 10.1038/nsmb.2729; Malik B, 2013, FEBS LETT, V587, P3038, DOI 10.1016/j.febslet.2013.07.034; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Mlynarski EE, 2015, AM J HUM GENET, V96, P753, DOI 10.1016/j.ajhg.2015.03.007; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Pastural E, 2007, ONCOGENE, V26, P1586, DOI 10.1038/sj.onc.1209959; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Petri V, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0017-8; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Racedo SE, 2015, AM J HUM GENET, V96, P235, DOI 10.1016/j.ajhg.2014.12.025; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ray SK, 2014, MOL CELL BIOL, V34, P2308, DOI 10.1128/MCB.01600-13; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	72	39	42	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					869	877		10.1016/j.ajhg.2015.10.013	http://dx.doi.org/10.1016/j.ajhg.2015.10.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26608785	Green Published, Bronze			2022-12-18	WOS:000368437900009
J	Raza, MH; Mattera, R; Morell, R; Sainz, E; Rahn, R; Gutierrez, J; Paris, E; Root, J; Solomon, B; Brewer, C; Basra, MAR; Khan, S; Riazuddin, S; Braun, A; Bonifacino, JS; Drayna, D				Raza, M. Hashim; Mattera, Rafael; Morell, Robert; Sainz, Eduardo; Rahn, Rachel; Gutierrez, Joanne; Paris, Emily; Root, Jessica; Solomon, Beth; Brewer, Carmen; Basra, M. Asim Raza; Khan, Shaheen; Riazuddin, Sheikh; Braun, Allen; Bonifacino, Juan S.; Drayna, Dennis			Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN COMPLEX; INTELLECTUAL DISABILITY; DEFICIENCY CAUSES; AP-4; MUTATIONS; ENZYME; LINKAGE; SUBUNIT; SIGNALS; LOCUS	Stuttering is a common, highly heritable neurodevelopmental disorder characterized by deficits in the volitional control of speech. Whole-exome sequencing identified two heterozygous AP4E1 coding variants, c.1549G>A (p.Val517Ile) and c.2401G>A (p.Glu801Lys), that co-segregate with persistent developmental stuttering in a large Cameroonian family, and we observed the same two variants in unrelated Cameroonians with persistent stuttering. We found 23 other rare variants, including predicted loss-of-function variants, in AP4E1 in unrelated stuttering individuals in Cameroon, Pakistan, and North America. The rate of rare variants in AP4E1 was significantly higher in unrelated Pakistani and Cameroonian stuttering individuals than in population-matched control individuals, and coding variants in this gene are exceptionally rare in the general sub-Saharan West African, South Asian, and North American populations. Clinical examination of the Cameroonian family members failed to identify any symptoms previously reported in rare individuals carrying homozygous loss-of-function mutations in this gene. AP4E1 encodes the a subunit of the heterotetrameric (epsilon-beta 4-mu 4-sigma 4) AP-4 complex, involved in protein sorting at the trans-Golgi network. We found that the mu 4 subunit of AP-4 interacts with NAGPA, an enzyme involved in the synthesis of the mannose 6-phosphate signal that targets acid hydrolases to the lysosome and the product of a gene previously associated with stuttering. These findings implicate deficits in intracellular trafficking in persistent stuttering.	[Raza, M. Hashim; Morell, Robert; Sainz, Eduardo; Rahn, Rachel; Gutierrez, Joanne; Paris, Emily; Root, Jessica; Brewer, Carmen; Braun, Allen; Drayna, Dennis] NIDCD, NIH, Bethesda, MD 20892 USA; [Mattera, Rafael; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Solomon, Beth] Clin Ctr Speech Language Pathol Serv, NIH, Bethesda, MD 20892 USA; [Basra, M. Asim Raza] Univ Punjab, Inst Chem, Lahore 54590, Pakistan; [Khan, Shaheen] Univ Punjab, Ctr Excellence Mol Biol, Lahore 54590, Pakistan; [Riazuddin, Sheikh] Alama Iqbal Med Res Ctr, Lahore 54550, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; University of Punjab; University of Punjab	Drayna, D (corresponding author), NIDCD, NIH, Bethesda, MD 20892 USA.	drayna@nidcd.nih.gov	Morell, Robert James/Q-2042-2019; , WaNgtJ/AAR-7045-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Raza, Muhammad Hashim/0000-0002-7027-5195; Basra, Muhammad Asim Raza/0000-0002-4242-0025; Bonifacino, Juan S./0000-0002-5673-6370; Rahn, Rachel/0000-0002-9943-7573; Morell, Robert/0000-0003-1537-7356	NIH National Institute of Child Health and Human Development (NICHD) [Z1A-DC000046-15, Z1A DC 000039-15, Z1A HD001607]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046, ZIADC000031, Z01DC000046, T32DC000039, ZIADC000064, Z01DC000039, ZIADC000046] Funding Source: NIH RePORTER	NIH National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH National Institute of Child Health and Human Development (NICHD) intramural grants Z1A-DC000046-15 (to D.D.), Z1A DC 000039-15 (to T.B. Friedman), and Z1A HD001607 (to J.B.). We thank the Stuttering Foundation of America, the Hollins Communications Research Institute, and the National Stuttering Association for assistance and M. Hallett, P. Friedman, S. Solomon, S. Inati, T. Lehky, L. Hathway, P. Penyakaew, S. Hove, J. Greenfield, S. Lischynsky, and H. Chow for assistance in clinical evaluations.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Bloodstein Oliver, 2021, HDB STUTTERING; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Domingues C.E., 2015, EUR J HUM GENET; Dworzynski K, 2007, AM J SPEECH-LANG PAT, V16, P169, DOI 10.1044/1058-0360(2007/021); Fagnani C, 2011, LOGOP PHONIATR VOCO, V36, P114, DOI 10.3109/14015439.2010.534503; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; KIDD KK, 1981, P NATL ACAD SCI-BIOL, V78, P606, DOI 10.1073/pnas.78.1.606; Kong XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058286; Lee SM, 2012, J CELL BIOL, V199, P799, DOI 10.1083/jcb.201204137; Lee WS, 2011, J BIOL CHEM, V286, P39786, DOI 10.1074/jbc.M111.295899; Lee WS, 2002, J BIOL CHEM, V277, P3544, DOI 10.1074/jbc.M108531200; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Rautakoski P, 2012, J FLUENCY DISORD, V37, P202, DOI 10.1016/j.jfludis.2011.12.003; Raza MH, 2013, HUM GENET, V132, P385, DOI 10.1007/s00439-012-1252-5; Raza MH, 2012, HUM GENET, V131, P311, DOI 10.1007/s00439-011-1134-2; Raza MH, 2010, HUM GENET, V128, P461, DOI 10.1007/s00439-010-0871-y; Riaz N, 2005, AM J HUM GENET, V76, P647, DOI 10.1086/429226; Riley G. D., 1994, SSI 3 STUTTERING SEV; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Sly W., 2001, METABOLIC BASES INHE; Suresh R, 2006, AM J HUM GENET, V78, P554, DOI 10.1086/501370; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; WEBSTER RL, 1980, J FLUENCY DISORD, V5, P303, DOI 10.1016/0094-730X(80)90035-2; Wittke-Thompson JK, 2007, J FLUENCY DISORD, V32, P33, DOI 10.1016/j.jfludis.2006.12.002	37	39	41	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					715	725		10.1016/j.ajhg.2015.10.007	http://dx.doi.org/10.1016/j.ajhg.2015.10.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CW2ED	26544806	Green Published, Bronze			2022-12-18	WOS:000364803000007
J	Seco, CZ; de Castro, LS; van Nierop, JW; Morin, M; Jhangiani, S; Verver, EJJ; Schraders, M; Maiwald, N; Wesdorp, M; Venselaar, H; Spruijt, L; Oostrik, J; Schoots, J; van Reeuwijk, J; Lelieveld, SH; Huygen, PLM; Insenser, M; Admiraal, RJC; Pennings, RJE; Hoefsloot, LH; Arias-Vasquez, A; de Ligt, J; Yntema, HG; Jansen, JH; Muzny, DM; Huls, G; van Rossum, MM; Lupski, JR; Moreno-Pelayo, MA; Kunst, HPM; Kremer, H				Seco, Celia Zazo; Serrao de Castro, Luciana; van Nierop, Josephine W.; Morin, Matias; Jhangiani, Shalini; Verver, Eva J. J.; Schraders, Margit; Maiwald, Nadine; Wesdorp, Mieke; Venselaar, Hanka; Spruijt, Liesbeth; Oostrik, Jaap; Schoots, Jeroen; van Reeuwijk, Jeroen; Leieveld, Stefan H.; Huygen, Patrick L. M.; Insenser, Maria; Admiraal, Ronald J. C.; Pennings, Ronald J. E.; Hoefsloot, Lies H.; Arias-Vasquez, Alejandro; de Ligt, Joep; Yntema, Helger G.; Jansen, Joop H.; Muzny, Donna M.; Huls, Gerwin; van Rossum, Michelle M.; Lupski, James R.; Angel Moreno-Pelayo, Miguel; Kunst, Henricus P. M.; Kremer, Hannie		Baylor-Hopkins Ctr Mendelian Genom	Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEM-CELL FACTOR; WHITE-SPOTTING W; C-KIT; TRANSCRIPTION FACTOR; MELANOCYTE DEVELOPMENT; SI-LOCUS; IN-VIVO; MOUSE; GENERATION; RECEPTOR	Linkage analysis combined with whole-exome sequencing in a large family with congenital and stable non-syndromic unilateral and asymmetric hearing loss (NS-UHL/AHL) revealed a heterozygous truncating mutation, c.286_303delinsT (p.Ser96Ter), in KITLG. This mutation co-segregated with NS-UHL/AHL as a dominant trait with reduced penetrance. By screening a panel of probands with NS-UHL/AHL, we found an additional mutation, c.200_202del (p.His67_Cys68delinsArg). In vitro studies revealed that the p.His67_Cys68delinsArg transmembrane isoform of KITLG is not detectable at the cell membrane, supporting pathogenicity. KITLG encodes a ligand for the KIT receptor. Also, KITLG-KIT signaling and MITF are suggested to mutually interact in melanocyte development. Because mutations in MITF are causative of Waardenburg syndrome type 2 (WS2), we screened KITLG in suspected WS2-affected probands. A heterozygous missense mutation, c.310C>G (p.Leu104Val), that segregated with WS2 was identified in a small family. In vitro studies revealed that the p.Leu104Val transmembrane isoform of KITLG is located at the cell membrane, as is wild-type KITLG. However, in culture media of transfected cells, the p.Leu104Val soluble isoform of KITLG was reduced, and no soluble p.His67_Cys68delinsArg and p.Ser96Ter KITLG could be detected. These data suggest that mutations in KITLG associated with NS-UHL/AHL have a loss-of-function effect. We speculate that the mechanism of the mutation underlying WS2 and leading to membrane incorporation and reduced secretion of KITLG occurs via a dominant-negative or gain-of-function effect. Our study unveils different phenotypes associated with KITLG, previously associated with pigmentation abnormalities, and will thereby improve the genetic counseling given to individuals with KITLG variants.	[Seco, Celia Zazo; van Nierop, Josephine W.; Verver, Eva J. J.; Schraders, Margit; Wesdorp, Mieke; Oostrik, Jaap; Huygen, Patrick L. M.; Pennings, Ronald J. E.; Kunst, Henricus P. M.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Hearing & Genes Div, NL-6525 GA Nijmegen, Netherlands; [Seco, Celia Zazo; Schraders, Margit; Wesdorp, Mieke; Oostrik, Jaap; Leieveld, Stefan H.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Serrao de Castro, Luciana; Morin, Matias; Angel Moreno-Pelayo, Miguel] Inst Ramon & Cajal Invest Sanitaria, Serv Genet, Madrid 28034, Spain; [Serrao de Castro, Luciana; Morin, Matias; Angel Moreno-Pelayo, Miguel] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28034, Spain; [van Nierop, Josephine W.; Pennings, Ronald J. E.; Kunst, Henricus P. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 GA Nijmegen, Netherlands; [Jhangiani, Shalini; Muzny, Donna M.; Lupski, James R.; Baylor-Hopkins Ctr Mendelian Genom] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Maiwald, Nadine; Spruijt, Liesbeth; Schoots, Jeroen; van Reeuwijk, Jeroen; Leieveld, Stefan H.; Hoefsloot, Lies H.; Arias-Vasquez, Alejandro; de Ligt, Joep; Yntema, Helger G.; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Insenser, Maria] Univ Alcala, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal,Dept Endocrinol & Nutr, Madrid 28034, Spain; [Admiraal, Ronald J. C.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 GA Nijmegen, Netherlands; [Jansen, Joop H.; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 GA Nijmegen, Netherlands; [Jansen, Joop H.; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 GA Nijmegen, Netherlands; [van Rossum, Michelle M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 GA Nijmegen, Netherlands; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Radboud University Nijmegen; Radboud University Nijmegen; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Radboud University Nijmegen; Baylor College of Medicine; Radboud University Nijmegen; Radboud University Nijmegen; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Baylor College of Medicine; Baylor College of Medicine	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Hearing & Genes Div, NL-6525 GA Nijmegen, Netherlands.	hannie.kremer@radboudumc.nl	Rossum, M.M./L-4614-2015; Venselaar, Hanka/D-2009-2016; Yntema, H.G./L-4771-2015; van Reeuwijk, Jeroen/P-8665-2015; Oostrik, Jaap/A-1703-2016; Insenser, María/B-9674-2014; Jansen, J.H./H-8054-2014; Huygen, P.L.M./L-4401-2015; Schraders, Margit/A-1607-2016; Pennings, Ronald JE/J-6651-2012; Kunst, Henricus P.M./J-6456-2012; van Nierop, josephine/E-5095-2016; Vasquez, Alejandro Arias/E-4762-2012; Kremer, Hannie/F-5126-2010; Seco, Celia Zazo/AAB-7636-2020; MORIN, MATIAS/H-5411-2011	Venselaar, Hanka/0000-0001-9824-6559; van Reeuwijk, Jeroen/0000-0002-0658-4399; Insenser, María/0000-0003-3168-7856; Jansen, J.H./0000-0001-9459-568X; Pennings, Ronald JE/0000-0001-5517-9683; Kunst, Henricus P.M./0000-0003-1162-6394; van Nierop, josephine/0000-0001-5523-956X; Vasquez, Alejandro Arias/0000-0002-4786-0169; Kremer, Hannie/0000-0002-0841-8693; Seco, Celia Zazo/0000-0003-3506-7611; MORIN, MATIAS/0000-0002-7985-592X; de Ligt, Joep/0000-0002-0348-419X; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	Oticon Foundation [09-3742]; ZonMw [40-00812-98-09047, 90700388]; Heinsius Houbolt Foundation; Instituto de Salud Carlos III [PI11/1215, PI14/0948]; Fundacion Ramon Areces; National Human Genome Research Institute; National Heart, Lung, and Blood Institute Baylor Hopkins Center for Mendelian Genomics [HG006542]; Programa Ciencia sem Fronteiras [201399/2012-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG006542] Funding Source: NIH RePORTER	Oticon Foundation; ZonMw(Netherlands Organization for Health Research and Development); Heinsius Houbolt Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute Baylor Hopkins Center for Mendelian Genomics; Programa Ciencia sem Fronteiras; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Mrs. Saskia van der Velde-Visser for technical assistance and Dr. Christian Gilissen for assistance in bioinformatics. We are grateful to Rafael Gonzalo-Gobemado (Microscopy Unit, Institut Ramon y Cajal de Investigacion Sanitaria) for the technical assistance and to Prof. Guy Richardson for kindly providing mRNA of mouse cochlea for RT-PCR experiments. We would like to thank Dr. Andy Beynon for the fruitful discussions about audiometric phenotypes. This work was supported by the Oticon Foundation (09-3742 to H.K.), by ZonMw (40-00812-98-09047 to H.K. and 90700388 to R.J.E.P.), by the Heinsius Houbolt Foundation (to H.K. and H.P.K.), by the Instituto de Salud Carlos III (PI11/1215 and PI14/0948 to M.A.M.-P.) and Fundacion Ramon Areces (to M.A.M.-P.), and by the National Human Genome Research Institute and National Heart, Lung, and Blood Institute Baylor Hopkins Center for Mendelian Genomics (HG006542). L.S.d.C. was supported by a post-doctoral training grant (201399/2012-1) from the Programa Ciencia sem Fronteiras and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Amyere M, 2011, J INVEST DERMATOL, V131, P1234, DOI 10.1038/jid.2011.29; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; BROWN PG, 1969, ACTA OTO-LARYNGOL, V68, P14, DOI 10.3109/00016486909121538; CABLE J, 1992, HEARING RES, V64, P6, DOI 10.1016/0378-5955(92)90164-I; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; COMMINGS DE, 1966, J AMER MED ASSOC, V195, P519; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; De Leenheer EMR, 2002, ANN OTO RHINOL LARYN, V111, P267, DOI 10.1177/000348940211100312; DEOL MS, 1970, PROC R SOC SER B-BIO, V175, P201, DOI 10.1098/rspb.1970.0019; Dikkers FG, 2005, ANN OTO RHINOL LARYN, V114, P332, DOI 10.1177/000348940511400414; EVERBERG G, 1957, Acta Otolaryngol, V47, P303, DOI 10.3109/00016485709130346; EVERBERG G, 1960, Acta Otolaryngol, V51, P615, DOI 10.3109/00016486009124539; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1988, P NATL ACAD SCI USA, V85, P9635, DOI 10.1073/pnas.85.24.9635; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; Jones MD, 1996, J BIOL CHEM, V271, P11301, DOI 10.1074/jbc.271.19.11301; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; LANGLEY KE, 1992, ARCH BIOCHEM BIOPHYS, V295, P21, DOI 10.1016/0003-9861(92)90482-C; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NISHIKAWA M, 1992, BIOCHEM BIOPH RES CO, V188, P292, DOI 10.1016/0006-291X(92)92383-9; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Pandya A, 1996, HUM MOL GENET, V5, P497, DOI 10.1093/hmg/5.4.497; Paulhe F, 2009, FASEB J, V23, P3037, DOI 10.1096/fj.09-129577; Pekelharing J, 2010, SYSMEX J INT, V20, P1; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajaraman S, 2002, GENETICS, V162, P341; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rerknimitr P, 2013, J EUR ACAD DERMATOL, V27, P460, DOI 10.1111/j.1468-3083.2012.04462.x; REYNOLDS JE, 1995, AM J MED GENET, V57, P540, DOI 10.1002/ajmg.1320570405; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; SCHROTT A, 1990, HEARING RES, V46, P1, DOI 10.1016/0378-5955(90)90134-B; Silberstein M, 2013, BIOINFORMATICS, V29, P197, DOI 10.1093/bioinformatics/bts658; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Spritz RA, 1998, AM J MED GENET, V75, P101, DOI 10.1002/(SICI)1096-8628(19980106)75:1<101::AID-AJMG20>3.0.CO;2-P; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Tabone-Eglinger S, 2014, FASEB J, V28, P4441, DOI 10.1096/fj.14-249425; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; THEUNISSEN EJJM, 1986, CLIN OTOLARYNGOL, V11, P161, DOI 10.1111/j.1365-2273.1986.tb00123.x; Wang ZQ, 2009, AM J HUM GENET, V84, P672, DOI 10.1016/j.ajhg.2009.03.019; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Wu M, 2000, GENE DEV, V14, P301; Wuyts FL, 2007, CURR OPIN NEUROL, V20, P19, DOI 10.1097/WCO.0b013e3280140808; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	59	39	42	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					647	660		10.1016/j.ajhg.2015.09.011	http://dx.doi.org/10.1016/j.ajhg.2015.09.011			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26522471	Green Published, Bronze			2022-12-18	WOS:000364803000002
J	Xi, ZR; van Blitterswijk, M; Zhang, M; McGoldrick, P; McLean, JR; Yunusova, Y; Knock, E; Moreno, D; Sato, C; McKeever, PM; Schneider, R; Keith, J; Petrescu, N; Fraser, P; Tartaglia, MC; Baker, MC; Graff-Radford, NR; Boylan, KB; Dickson, DW; Mackenzie, IR; Rademakers, R; Robertson, J; Zinman, L; Rogaeva, E				Xi, Zhengrui; van Blitterswijk, Marka; Zhang, Ming; McGoldrick, Philip; McLean, Jesse R.; Yunusova, Yana; Knock, Erin; Moreno, Danielle; Sato, Christine; McKeever, Paul M.; Schneider, Raphael; Keith, Julia; Petrescu, Nicolae; Fraser, Paul; Tartaglia, Maria Carmela; Baker, Matthew C.; Graff-Radford, Neill R.; Boylan, Kevin B.; Dickson, Dennis W.; Mackenzie, Ian R.; Rademakers, Rosa; Robertson, Janice; Zinman, Lorne; Rogaeva, Ekaterina			Jump from Pre-mutation to Pathologic Expansion in C9orf72	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; REPEAT EXPANSION; HEXANUCLEOTIDE REPEAT; CPG-ISLAND; ALS; HYPERMETHYLATION; INSIGHTS; RNA	An expanded G(4)C(2) repeat in C9orf72 represents the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). However, the lower limit for pathological expansions is unknown (the suggested cutoff is 30 repeats). It has been proposed that the expansion might have occurred only once in human history and subsequently spread throughout the population. However, our present findings support a hypothesis of multiple origins for the expansion. We report a British-Canadian family in whom a similar to 70-repeat allele from the father (unaffected by ALS or FTLD at age 89 years) expanded during parent-offspring transmission and started the first generation affected by ALS (four children carry an similar to 1,750-repeat allele). Epigenetic and RNA-expression analyses further discriminated the offspring's large expansions (which were methylated and associated with reduced C9orf72 expression) from the similar to 70-repeat allele (which was unmethylated and associated with upregulation of C9orf72). Moreover, RNA foci were only detected in fibroblasts from offspring with large expansions, but not in the father, who has the similar to 70-repeat allele. All family members with expansions were found to have an ancient known risk haplotype, although it was inherited on a unique 5-Mb genetic backbone. We conclude that small expansions (e.g., 70 repeats) might be considered "pre-mutations'' to reflect their propensity to expand in the next generation. Follow-up studies might help explain the high frequency of ALS-or FTLD-affected individuals with an expansion but without a familial history (e.g., 21% among Finnish ALS subjects).	[Xi, Zhengrui; Zhang, Ming; McGoldrick, Philip; McLean, Jesse R.; Knock, Erin; Moreno, Danielle; Sato, Christine; McKeever, Paul M.; Schneider, Raphael; Fraser, Paul; Tartaglia, Maria Carmela; Robertson, Janice; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [van Blitterswijk, Marka; Baker, Matthew C.; Dickson, Dennis W.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Yunusova, Yana; Keith, Julia; Petrescu, Nicolae; Zinman, Lorne] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Yunusova, Yana] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5G 1V7, Canada; [McKeever, Paul M.; Schneider, Raphael; Robertson, Janice] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Petrescu, Nicolae; Tartaglia, Maria Carmela; Zinman, Lorne; Rogaeva, Ekaterina] Univ Toronto, Div Neurol, Dept Med, Toronto, ON M5S 1A8, Canada; [Graff-Radford, Neill R.; Boylan, Kevin B.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z4, Canada	University of Toronto; Mayo Clinic; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Mayo Clinic; University of British Columbia	Zinman, L (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	lorne.zinman@sunnybrook.ca; ekaterina.rogaeva@utoronto.ca	van Blitterswijk, Marka/H-7274-2012; Schneider, Raphael/H-2782-2019; van Blitterswijk, Marka/AAL-4126-2021; Yunusova, Yana/E-3428-2010	van Blitterswijk, Marka/0000-0002-3054-7053; Schneider, Raphael/0000-0003-1776-2418; van Blitterswijk, Marka/0000-0002-3054-7053; Yunusova, Yana/0000-0002-2353-2275	W. Garfield Weston Foundation; James Hunter Family ALS Initiative; ALS Canada Bernice Ramsey Discovery Grant; NIH [R01 NS080882]; Alzheimer Society of Canada Doctoral Award; American ALS Association Milton Safenowitz Postdoctoral Fellowship; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080882] Funding Source: NIH RePORTER	W. Garfield Weston Foundation; James Hunter Family ALS Initiative; ALS Canada Bernice Ramsey Discovery Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Society of Canada Doctoral Award; American ALS Association Milton Safenowitz Postdoctoral Fellowship; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W. Garfield Weston Foundation (E.R., Z.X., J.R., J.K., and L.Z.), the James Hunter Family ALS Initiative (L.Z. and J.R.), an ALS Canada Bernice Ramsey Discovery Grant (Y.Y. and L.Z.), and NIH grant R01 NS080882. J.R. is a Tier 2 Canada Research Chair in ALS; P.M.M. holds an Alzheimer Society of Canada Doctoral Award; P.M. holds an American ALS Association Milton Safenowitz Postdoctoral Fellowship; J.R.M. is a James Hunter Senior Research Fellow; and M.v.B. is supported by the Milton Safenowitz Post-Doctoral Fellowship for ALS Research from the ALS Association.	Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buchman VL, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-12; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dobson-Stone C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056899, 10.1371/currents.hd.f4c66bd51e8db11f55e1701af937a419]; Dols-Icardo O, 2014, HUM MOL GENET, V23, P749, DOI 10.1093/hmg/ddt460; Fratta P., 2015, NEUROBIOL AGING, V36, pe1, DOI DOI 10.1016/J.NEUR0BI0LAGING.2014.07.037; Hardy J, 2014, EXP NEUROL, V262, P75, DOI 10.1016/j.expneurol.2013.11.006; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pliner HA, 2014, ACTA NEUROPATHOL, V127, P391, DOI 10.1007/s00401-014-1250-x; Ratti A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Smith BN, 2013, EUR J HUM GENET, V21, P102, DOI 10.1038/ejhg.2012.98; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Williams KL, 2013, J NEUROL NEUROSUR PS, V84, P931, DOI 10.1136/jnnp-2012-304529; Xi ZR, 2015, ACTA NEUROPATHOL, V129, P715, DOI 10.1007/s00401-015-1401-8; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Xi ZR, 2014, HUM MOL GENET, V23, P5630, DOI 10.1093/hmg/ddu279; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016	32	39	41	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					962	970		10.1016/j.ajhg.2015.04.016	http://dx.doi.org/10.1016/j.ajhg.2015.04.016			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26004200	Green Published, Bronze			2022-12-18	WOS:000355931200010
J	Patel, N; Khan, AO; Mansour, A; Mohamed, JY; Al-Assiri, A; Haddad, R; Jia, XF; Xiong, Y; Megarbane, A; Traboulsi, EI; Alkuraya, FS				Patel, Nisha; Khan, Arif O.; Mansour, Ahmad; Mohamed, Jawahir Y.; Al-Assiri, Abdullah; Haddad, Randa; Jia, Xiaofei; Xiong, Yong; Megarbane, Andre; Traboulsi, Elias I.; Alkuraya, Fowzan S.			Mutations in ASPH Cause Facial Dysmorphism, Lens Dislocation, Anterior-Segment Abnormalities, and Spontaneous Filtering Blebs, or Traboulsi Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ECTOPIA LENTIS; SYSTEMS; DOMAINS	We have previously described a syndrome characterized by facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs (FDLAB, or Traboulsi syndrome). In view of the consanguineous nature of the affected families and the likely autosomal-recessive inheritance pattern of this syndrome, we undertook autozygosity mapping and whole-exome sequencing to identify ASPH as the disease locus, in which we identified two homozygous mutations. ASPH encodes aspartyl/asparaginyl beta-hydroxylase (ASPH), which has been found to hydroxylate aspartic acid and asparagine residues on epidermal. growth factor (EGF)-domain-containing proteins. The truncating and missense mutations we identified are predicted to severely impair the enzymatic function of ASPH, which suggests a possible link to other forms of ectopia lentis given that many of the genes implicated in this phenotype encode proteins that harbor EGF domains. Developmental analysis of Asph revealed an expression pattern consistent with the proposed link to the human syndrome. Indeed, Asph-knockout mice had a foreshortened snout, which corresponds to the facial abnormalities in individuals with Traboulsi syndrome. These data support a genetic basis for a syndromic form of ectopia lentis and the role of aspartyl hydroxylation in human development.	[Patel, Nisha; Khan, Arif O.; Mohamed, Jawahir Y.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Patel, Nisha] King Khalid Eye Specialist Hosp, Div Pediat Ophthalmol, Riyadh 11462, Saudi Arabia; [Mansour, Ahmad; Haddad, Randa] Amer Univ Beirut, Dept Ophthalmol, Beirut 11072020, Lebanon; [Al-Assiri, Abdullah] King Khalid Eye Specialist Hosp, Div Anterior Segment, Riyadh 11462, Saudi Arabia; [Jia, Xiaofei; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Megarbane, Andre] St Joseph Univ, Med Genet Unit, Fac Med, Beirut 11042020, Lebanon; [Traboulsi, Elias I.] Cleveland Clin, Cole Eye Inst, Ctr Genet Eye Dis, Cleveland, OH 44195 USA; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Khaled Eye Specialist Hospital; American University of Beirut; King Khaled Eye Specialist Hospital; Yale University; Cleveland Clinic Foundation; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Megarbane, Andre/ABD-5574-2021; Traboulsi, Elias/AAY-7443-2020		Dubai Harvard Foundation for Medical Research; King Abdulaziz City for Science and Technology [10-BIO 1350-20]	Dubai Harvard Foundation for Medical Research; King Abdulaziz City for Science and Technology	We thank the affected individuals and their families for their enthusiastic participation. We thank Shukri Shawaf for his contributions to the collection of affected individuals in the first Lebanese pedigree affected by this syndrome. We also thank the genotyping and sequencing core facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by a collaborative research grant from the Dubai Harvard Foundation for Medical Research (to F.S.A.) and grant 10-BIO 1350-20 from King Abdulaziz City for Science and Technology.	Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; Haddad R, 2001, AM J MED GENET, V99, P185, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1156>3.0.CO;2-V; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Lachke SA, 2012, INVEST OPHTH VIS SCI, V53, P1617, DOI 10.1167/iovs.11-8839; Mansour AM, 2013, CASE REP OPHTHALM, V4, P84, DOI 10.1159/000350951; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shawaf S, 1995, OPHTHALMIC GENET, V16, P163, DOI 10.3109/13816819509057858; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; STENFLO J, 1988, J BIOL CHEM, V263, P21; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	16	39	42	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					755	759		10.1016/j.ajhg.2014.04.002	http://dx.doi.org/10.1016/j.ajhg.2014.04.002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24768550	Green Published, Bronze			2022-12-18	WOS:000335485700009
J	Marneros, AG; Beck, AE; Turner, EH; McMillin, MJ; Edwards, MJ; Field, M; Sobreira, NLD; Perez, ABA; Fortes, JAR; Lampe, AK; Uzielli, MLG; Gordon, CT; Plessis, G; Le Merrer, M; Amiel, J; Reichenberger, E; Shively, KM; Cerrato, F; Labow, BI; Tabor, HK; Smith, JD; Shendure, J; Nickerson, DA; Bamshad, MJ				Marneros, Alexander G.; Beck, Anita E.; Turner, Emily H.; McMillin, Margaret J.; Edwards, Matthew J.; Field, Michael; Sobreira, Nara Lygia de Macena; Perez, Ana Beatriz A.; Fortes, Jose A. R.; Lampe, Anne K.; Uzielli, Maria Luisa Giovannucci; Gordon, Christopher T.; Plessis, Ghislaine; Le Merrer, Martine; Amiel, Jeanne; Reichenberger, Ernst; Shively, Kathryn M.; Cerrato, Felecia; Labow, Brian I.; Tabor, Holly K.; Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.		Univ Washington	Mutations in KCTD1 Cause Scalp-Ear-Nipple Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINLAY-MARKS-SYNDROME; BTB DOMAIN; ADDITIONAL MANIFESTATIONS; FAMILY	Scalp-ear-nipple (SEN) syndrome is a rare, autosomal-dominant disorder characterized by cutis aplasia of the scalp; minor anomalies of the external ears, digits, and nails; and malformations of the breast. We used linkage analysis and exome sequencing of a multiplex family affected by SEN syndrome to identify potassium-channel tetramerization-domain-containing 1 (KCTD1) mutations that cause SEN syndrome. Evaluation of a total of ten families affected by SEN syndrome revealed KCTD1 missense mutations in each family tested. All of the mutations occurred in a KCTD1 region encoding a highly conserved bric-a-brac, tram track, and broad complex (BTB) domain that is required for transcriptional repressor activity. KCTD1 inhibits the transactivation of the transcription factor AP-2 alpha (TFAP2A) via its BTB domain, and mutations in TFAP2A cause cutis aplasia in individuals with branchiooculofacial syndrome (BOFS), suggesting a potential overlap in the pathogenesis of SEN syndrome and BOFS. The identification of KCTD1 mutations in SEN syndrome reveals a role for this BTB-domain-containing transcriptional repressor during ectodermal development.	[Marneros, Alexander G.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Beck, Anita E.; McMillin, Margaret J.; Shively, Kathryn M.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Turner, Emily H.; Smith, Joshua D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Edwards, Matthew J.] Univ Western Sydney Macarthur, Sch Med, Campbelltown, NSW 2560, Australia; [Field, Michael] Genet Learning Disabil Serv, Newcastle, NSW 2298, Australia; [Sobreira, Nara Lygia de Macena] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Perez, Ana Beatriz A.] Univ Fed Sao Paulo, Dept Morphol & Genet, Clin Genet Ctr, BR-04021001 Sao Paulo, Brazil; [Fortes, Jose A. R.] Pontificia Univ Catolica Parana, Dept Internal Med, BR-1155 Curitiba, Parana, Brazil; [Lampe, Anne K.] Western Gen Hosp, South East Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Uzielli, Maria Luisa Giovannucci] Univ Florence, Dept Genet & Mol Med, I-50132 Florence, Italy; [Gordon, Christopher T.] Hop Necker Enfants Malad, Dept Genet, INSERM, U781, F-75015 Paris, France; [Gordon, Christopher T.] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Plessis, Ghislaine; Le Merrer, Martine; Amiel, Jeanne] Hop Cote Nacre, CHU Caen, Serv Genet, F-14033 Caen 9, France; [Reichenberger, Ernst] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Cerrato, Felecia; Labow, Brian I.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Tabor, Holly K.] Treuman Katz Ctr Pediat Bioeth, Seattle Childrens Res Inst, Seattle, WA 98101 USA	Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Western Sydney University; Johns Hopkins University; Universidade Federal de Sao Paulo (UNIFESP); Pontificia Universidade Catolica do Parana; University of Edinburgh; University of Florence; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; University of Connecticut; Harvard University; Boston Children's Hospital; Seattle Children's Hospital	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@uw.edu	amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; Pérez, Ana/GQA-6861-2022; Gordon, Chris/F-1267-2017; Beck, Anita E./AAS-8775-2021; Edwards, Matthew/L-8698-2019; Shendure, Jay/AAU-3684-2021	amiel, jeanne/0000-0001-5973-4728; Gordon, Chris/0000-0002-9300-8399; Beck, Anita E./0000-0002-7965-0326; Edwards, Matthew/0000-0001-8437-8120; Turner, Emily/0000-0001-9040-9229; Marneros, Alexander/0000-0003-3866-020X; Shendure, Jay/0000-0002-1516-1865	National Institutes of Health National Human Genome Research Institute [1U54HG006493, 1RC2HG005608, 5RO1HG004316]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057331, R01HD048895] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG004316, RC2HG005608, U54HG006493, R00HG004316, U54HG006542, U54HG003273, UM1HG006493] Funding Source: NIH RePORTER	National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Life Sciences Discovery Fund; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and support; Tracy Dudding-Byth for clinical assistance; Kati Buckingham and Christa Poel for technical assistance; and Jennifer E. Below for discussion. Our work was supported in part by grants from the National Institutes of Health National Human Genome Research Institute (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., D.N., and J.S.; and 5RO1HG004316 to H.T.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation.	Aase J. M., 1988, P GREENWOOD GENET CT, V7, P177; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Al-Gazali L, 2007, CLIN DYSMORPHOL, V16, P105, DOI 10.1097/MCD.0b013e3280147217; Baris H, 2005, AM J MED GENET A, V134A, P220, DOI 10.1002/ajmg.a.30612; Ding XF, 2008, DNA CELL BIOL, V27, P257, DOI 10.1089/dna.2007.0662; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; EDWARDS MJ, 1994, AM J MED GENET, V50, P247, DOI 10.1002/ajmg.1320500307; FINLAY AY, 1978, BRIT J DERMATOL, V99, P423, DOI 10.1111/j.1365-2133.1978.tb06182.x; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Le Merrer M, 1991, Genet Couns, V2, P233; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Naik P, 2012, AM J MED GENET A, V158A, P1696, DOI 10.1002/ajmg.a.35389; Paik YS, 2010, ENT-EAR NOSE THROAT, V89, P256, DOI 10.1177/014556131008900606; Picard C, 1999, CLIN GENET, V56, P170; Plessis G, 1997, CLIN GENET, V52, P231; Sobreira NLD, 2006, AM J MED GENET A, V140A, P300, DOI 10.1002/ajmg.a.31063; Taniai H, 2004, PEDIATR INT, V46, P353, DOI 10.1111/j.1442-200x.2004.01905.x; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	19	39	42	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					621	626		10.1016/j.ajhg.2013.03.002	http://dx.doi.org/10.1016/j.ajhg.2013.03.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23541344	Green Published, Bronze			2022-12-18	WOS:000317449700015
J	Conde, L; Bracci, PM; Richardson, R; Montgomery, SB; Skibola, CF				Conde, Lucia; Bracci, Paige M.; Richardson, Rhea; Montgomery, Stephen B.; Skibola, Christine F.			Integrating GWAS and Expression Data for Functional Characterization of Disease-Associated SNPs: An Application to Follicular Lymphoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-VARIANTS; RISK; SETS	Development of post-GWAS (genome-wide association study) methods are greatly needed for characterizing the function of trait-associated SNPs. Strategies integrating various biological data sets with GWAS results will provide insights into the mechanistic role of associated SNPs. Here, we present a method that integrates RNA sequencing (RNA-seq) and allele-specific expression data with GWAS data to further characterize SNPs associated with follicular lymphoma (FL). We investigated the influence on gene expression of three established FL-associated loci-rs10484561, rs2647012, and rs6457327-by measuring their correlation with human-leukocyte-antigen (HLA) expression levels obtained from publicly available RNA-seq expression data sets from lymphoblastoid cell lines. Our results suggest that SNPs linked to the protective variant rs2647012 exert their effect by a cis-regulatory mechanism involving modulation of HLA-DQB1 expression. In contrast, no effect on HLA expression was observed for the colocalized risk variant rs10484561. The application of integrative methods, such as those presented here, to other post-GWAS investigations will help identify causal disease variants and enhance our understanding of biological disease mechanisms.	[Conde, Lucia; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Bracci, Paige M.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94118 USA; [Richardson, Rhea; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Richardson, Rhea; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Stanford University; Stanford University	Skibola, CF (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	smontgom@stanford.edu; chrisfs@berkeley.edu		Montgomery, Stephen/0000-0002-5200-3903; Conde, Lucia/0000-0001-5180-543X	National Institutes of Health [CA122663, CA154643-01A1, CA104682, CA087014]; NATIONAL CANCER INSTITUTE [R01CA104682, R01CA154643, R01CA087014, R01CA122663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA122663, CA154643-01A1, and CA104682 (to C.F.S.) and CA087014 (to P.M.B).	Berglund M, 2011, BLOOD, V118, P4489, DOI 10.1182/blood-2011-06-362921; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Skibola CF, 2012, TISSUE ANTIGENS, V79, P279, DOI 10.1111/j.1399-0039.2012.01845.x; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wrench D, 2011, BLOOD, V117, P3147, DOI 10.1182/blood-2010-10-315382	17	39	40	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					126	130		10.1016/j.ajhg.2012.11.009	http://dx.doi.org/10.1016/j.ajhg.2012.11.009			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246294	Green Published, Bronze			2022-12-18	WOS:000313759000013
J	O'hUigin, C; Kulkarni, S; Xu, YP; Deng, ZH; Kidd, J; Kidd, K; Gao, XJ; Carrington, M				O'hUigin, Colm; Kulkarni, Smita; Xu, Yunping; Deng, Zhihui; Kidd, Judith; Kidd, Kenneth; Gao, Xiaojiang; Carrington, Mary			The Molecular Origin and Consequences of Escape from miRNA Regulation by HLA-C Alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; DETERMINANTS; POLYMORPHISM; GENOME	Differential expression of human leukocyte antigen C (HLA-C) allotypes is mediated by the binding of a microRNA, miR-148a, to the 3' untranslated region of some, but not all, HLA-C alleles. The binding results in lower levels of HLA-C expression, which is associated with higher levels of HIV-1 viral load among infected individuals. The alternative set of HLA-C alleles has several substitutions in the miR-148a binding site that prevent binding and HLA-C downregulation; these high-expression alleles associate with control of HIV-1 viral load. We show that the common ancestor of all extant HLA-C alleles was suppressed by miR-148a. Substitutions that prevent miR-148a binding arose by a sequence exchange event between an HLA-C allele and an HLA-B (MIM 142830) allele of a B*07-like lineage. The event occurred 3-5 million years ago, resulting in an HLA-C variant that escape from miR-148a downregulation. We present evidence suggesting that selection played a role in the successful spread of the HLA-C escape alleles, giving rise to 7 of the 14 extant HLA-C lineages. Notably, critical peptide and KIR binding residues of the escape variants have selectively converged to resemble the sequence of their inhibited counterparts, such that the inhibited and escape groupings differ primarily by their levels of expression.	[O'hUigin, Colm; Kulkarni, Smita; Gao, Xiaojiang; Carrington, Mary] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Kulkarni, Smita; Gao, Xiaojiang; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Xu, Yunping; Deng, Zhihui] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen 518035, Guangdong, Peoples R China; [Kidd, Judith; Kidd, Kenneth] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Yale University	O'hUigin, C (corresponding author), NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA.	ohuiginc@mail.nih.gov		deng, zhihui/0000-0002-2046-1467	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010792] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank members of the Carrington group and Ram Savan for informative discussion. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Kriener K, 2000, GENOME RES, V10, P634, DOI 10.1101/gr.10.5.634; KULKARNI S, 2011, NATURE, V28, P295; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; Meyer D, 2007, P 13 INT HIST WORKSH, V1, P653; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; SATTA Y, 1993, P NATL ACAD SCI USA, V90, P7480, DOI 10.1073/pnas.90.16.7480; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xu Y, 2011, TISSUE ANTIGENS, V78, P102, DOI 10.1111/j.1399-0039.2011.01710.x; Xu Yun-Ping, 2010, Yichuan, V32, P685, DOI 10.3724/SP.J.1005.2010.00685; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937; WEBLOGO; DBMHC DIVERSITY ANTH	23	39	39	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					424	431		10.1016/j.ajhg.2011.07.024	http://dx.doi.org/10.1016/j.ajhg.2011.07.024			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907013	Green Published, Bronze			2022-12-18	WOS:000294939800007
J	Tajima, Y; Kawashima, I; Tsukimura, T; Sugawara, K; Kuroda, M; Suzuki, T; Togawa, T; Chiba, Y; Jigami, Y; Ohno, K; Fukushige, T; Kanekura, T; Itoh, K; Ohashi, T; Sakuraba, H				Tajima, Youichi; Kawashima, Ikuo; Tsukimura, Takahiro; Sugawara, Kanako; Kuroda, Mayuko; Suzuki, Toshihiro; Togawa, Tadayasu; Chiba, Yasunori; Jigami, Yoshifumi; Ohno, Kazuki; Fukushige, Tomoko; Kanekura, Takuro; Itoh, Kohji; Ohashi, Toya; Sakuraba, Hitoshi			Use of a Modified alpha-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGALSIDASE-ALPHA; ANTIBODY-FORMATION; GALACTOSIDASE-A; MICE; MODEL; BETA; FIBROBLASTS; TISSUES; ENERGY; CELLS	A modified alpha-N-acetylgalactosaminidase (NAGA) with alpha-galactosidase A (GLA)-like substrate specificity was designed on the basis of structural studies and was produced in Chinese hamster ovary cells. The enzyme acquired the ability to catalyze the degradation of 4-methylumbelliferyl-alpha-D-galactopyranoside. It retained the original NAGA's stability in plasma and N-glycans containing many mannose 6-phosphate (M6P) residues, which are advantageous for uptake by cells via M6P receptors. There was no immunological cross-reactivity between the modified NAGA and GLA, and the modified NAGA did not react to serum from a patient with Fabry disease recurrently treated with a recombinant GLA. The enzyme cleaved globotriaosylceramide (Gb3) accumulated in cultured fibroblasts from a patient with Fabry disease. Furthermore, like recombinant GLA proteins presently used for enzyme replacement therapy (ERT) for Fabry disease, the enzyme intravenously injected into Fabry model mice prevented Gb3 storage in the liver, kidneys, and heart and improved the pathological changes in these organs. Because this modified NAGA is hardly expected to cause an allergic reaction in Fabry disease patients, it is highly promising as a new and safe enzyme for ERT for Fabry disease.	[Tajima, Youichi; Kawashima, Ikuo; Sugawara, Kanako; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo 2048588, Japan; [Tsukimura, Takahiro; Kuroda, Mayuko; Suzuki, Toshihiro; Togawa, Tadayasu; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo 2048588, Japan; [Tajima, Youichi; Kawashima, Ikuo; Tsukimura, Takahiro] Tokyo Metropolitan Org Med Res, Translat Res Project, Tokyo Metropolitan Inst Med Sci, Tokyo 1568506, Japan; [Chiba, Yasunori; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Ohno, Kazuki] NPO Promot Res Intellectual Property Tokyo, Tokyo 1000005, Japan; [Fukushige, Tomoko; Kanekura, Takuro] Kagoshima Univ, Dept Dermatol, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; [Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Med Res, Dept Med Biotechnol, Tokushima 7708505, Japan; [Ohashi, Toya] Jikei Univ, Sch Med, Dept Gene Therapy, Inst DNA Med, Tokyo 1058461, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University; Tokyo Metropolitan Institute of Medical Science; National Institute of Advanced Industrial Science & Technology (AIST); Kagoshima University; Tokushima University; Jikei University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo 2048588, Japan.	sakuraba@my-pharm.ac.jp	Chiba, Yasunori/L-7993-2018	Chiba, Yasunori/0000-0002-6401-5071; Ohashi, Toya/0000-0002-9932-0631				Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; [Anonymous], 2014, METABOLIC MOL BASES; BEUTLER E, 1972, J BIOL CHEM, V247, P7195; Bodensteiner D, 2008, GENET MED, V10, P353, DOI 10.1097/GIM.0b013e318170f868; Chiba Y, 2002, GLYCOBIOLOGY, V12, P821, DOI 10.1093/glycob/cwf096; DEAN KJ, 1977, PRACTICAL ENZYMOLOGY, P173; DESNICK RJ, 2001, METABOLIC MOL BASES, P3483; DUDEK MJ, 1995, J COMPUT CHEM, V16, P791, DOI 10.1002/jcc.540160702; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; HU P, 1991, BIOCHEM BIOPH RES CO, V175, P1097, DOI 10.1016/0006-291X(91)91678-6; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Kawashima I, 2007, J HUM GENET, V52, P1018, DOI 10.1007/s10038-007-0210-x; Kong Y, 1997, J CHEM PHYS, V107, P481, DOI 10.1063/1.474409; Kornfeld S., 2001, METABOLIC MOL BASES, P3469; KOTANI M, 1994, ARCH BIOCHEM BIOPHYS, V310, P89, DOI 10.1006/abbi.1994.1144; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Ohashi T, 2008, MOL GENET METAB, V94, P313, DOI 10.1016/j.ymgme.2008.03.008; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Ohta M, 2000, GLYCOBIOLOGY, V10, P251, DOI 10.1093/glycob/10.3.251; OKUMIYA T, 1995, BIOCHEM BIOPH RES CO, V214, P1219, DOI 10.1006/bbrc.1995.2416; Pappu RV, 1998, J PHYS CHEM B, V102, P9725, DOI 10.1021/jp982255t; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Ries M, 2007, J CLIN PHARMACOL, V47, P1222, DOI 10.1177/0091270007305299; Sakuraba H, 2006, J HUM GENET, V51, P341, DOI 10.1007/s10038-006-0369-6; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Sandhoff K., 2001, METABOLIC ANDMOLECUL, P3371; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; SCHRAM AW, 1977, BIOCHIM BIOPHYS ACTA, V482, P138, DOI 10.1016/0005-2744(77)90361-8; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sugawara K, 2009, MOL GENET METAB, V96, P233, DOI 10.1016/j.ymgme.2008.12.017; Swift S., 2001, CURRENT PROTOCOLS IM; Takahashi H, 2002, P NATL ACAD SCI USA, V99, P13777, DOI 10.1073/pnas.222221899; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003	40	39	50	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					569	580		10.1016/j.ajhg.2009.09.016	http://dx.doi.org/10.1016/j.ajhg.2009.09.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853240	Bronze, Green Published			2022-12-18	WOS:000271916500005
J	Chen, WM; Manichaikul, A; Rich, SS				Chen, Wei-Min; Manichaikul, Ani; Rich, Stephen S.			A Generalized Family-Based Association Test for Dichotomous Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; COMBINED TRANSMISSION/DISEQUILIBRIUM TEST; TYPE-1 DIABETES SUSCEPTIBILITY; LINKAGE DISEQUILIBRIUM; GENETIC-MARKERS; POWER; PEDIGREES; DISEASE; RECONSTRUCTION; PARENTS	Recent advances in genotyping technology make it possible to utilize large-scale association analysis for disease-gene mapping. Powerful and robust family-based association methods are crucial for successful gene mapping. We propose a family-based association method, the generalized disequilibrium test (GDT), in which the genotype differences of all discordant relative pairs are utilized in assessing association within a family. The improvement of the GDT over existing methods is threefold: (1) information beyond first-degree relatives is incorporated efficiently, yielding substantial gains in power in comparison to existing tests; (2) the GDT statistic is implemented via a robust technique that does not rely on large sample theory resulting in further power gains, especially at high levels of significance; and (3) covariates and weights based on family size are incorporated. Advantages of the GDT over existing methods are demonstrated by extensive computer simulations and by application to recently published large-scale genome-wide linkage data from the Type 1 Diabetes Genetics Consortium (T1DGC). In our simulations, the GDT consistently outperforms other tests for a common disease and frequently outperforms other tests for a rare disease; the power improvement is > 13% in 6 out of 8 extended pedigree scenarios. All of the six strongest associations identified by the GDT have been reported by other studies, whereas only three or four of these associations can be identified by existing methods. For the T1D association at gene UBASH3A, the GDT resulted in a genome-wide significance (p = 4.3 x 10(-6)), much stronger than the published significance (p = 10(-4)).	[Chen, Wei-Min; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Chen, Wei-Min] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; [Manichaikul, Ani] Univ Virginia, Dept Publ Hlth Sci, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Chen, WM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA.	wmchen@virginia.edu	Manichaikul, Ani/B-7726-2009	Rich, Stephen/0000-0003-3872-7793; Manichaikul, Ani/0000-0002-5998-795X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF) [U01 DK062418];  [DK062418];  [DC003166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003166] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by research grants DK062418 (to S.S.R) and DC003166. We thank Goncalo Abecasis for sharing C++ source code for the GDT implementation, Josyf Mychaleckyj for several thoughtful suggestions, and two anonymous reviewers for valuable input that improved the manuscript. This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bhattacharjee S, 2008, AM J HUM GENET, V82, P567, DOI 10.1016/j.ajhg.2007.11.012; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chen WM, 2005, GENET EPIDEMIOL, V28, P11, DOI 10.1002/gepi.20034; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Knapp M, 1999, AM J HUM GENET, V65, P1208, DOI 10.1086/302591; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Liang KY, 1996, GENET EPIDEMIOL, V13, P253, DOI 10.1002/(SICI)1098-2272(1996)13:3<253::AID-GEPI3>3.0.CO;2-7; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nicodemus KK, 2007, AM J HUM GENET, V80, P178, DOI 10.1086/510498; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; RISCH N, 1996, SCIENCE, V273, P1517; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	40	39	40	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					364	376		10.1016/j.ajhg.2009.08.003	http://dx.doi.org/10.1016/j.ajhg.2009.08.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732865	Green Published, Bronze			2022-12-18	WOS:000270104500006
J	Gasper, J; Swanson, WJ				Gasper, Joe; Swanson, Willie J.			Molecular population genetics of the gene encoding the human fertilization protein zonadhesin reveals rapid adaptive evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSITIVE SELECTION; ZONA-PELLUCIDA; DNA-SEQUENCE; MAMMALIAN FERTILIZATION; DARWINIAN SELECTION; STATISTICAL-METHOD; MEMBRANE-PROTEIN; BINDING-ACTIVITY; POLYMORPHISM; SIGNATURES	A hallmark of positive selection (adaptive evolution) in protein-coding regions is a d(N)/d(S) ratio > 1, where d(N) is the number of nonsynonymous substitutions/nonsynonymous sites and d(S) is the number of synonymous substitutions/synonymous sites. Zonadhesin is a male reproductive protein localized on the sperm head, comprising many domains known to be involved in cell-cell interaction or cell adhesion. Previous studies have shown that VWD domains (homologous to the D domains of the von Willebrand factor) are involved directly in binding to the female zona pellucida (ZP) in a species-specific manner. In this study, we sequenced 47 coding exons in 12 primate species and, by using maximum-likelihood methods to determine sites under positive selection, we show that VWD2, membrane/A5 antigen mu receptor, and mucin-like domains in zonadhesin are rapidly evolving and, thus, may be involved in binding to the ZP in a species-specific manner in primates. In addition, polymorphism data from 48 human individuals revealed significant polymorphism-to-divergence heterogeneity and a significant departure from equilibrium-neutral expectations in the frequency spectrum, suggesting balancing selection and positive selection occurring in zonadhesin (ZAN) within human populations. Finally, we observe adaptive evolution in haplotypes segregating for a frameshift mutation that was previously thought to indicate that ZAN was a potential pseudogene.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Swanson, WJ (corresponding author), Univ Washington, Dept Genome Sci, Box 357739, Seattle, WA 98195 USA.	wswanson@gs.washington.edu		Swanson, Willie/0000-0002-6553-0921	NICHD NIH HHS [HD42563, HD42454, U54 HD042454, R01 HD042563] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042563] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Bonferroni CE, 1936, PUBBL R 1 SUPER SCI, V8, P3, DOI DOI 10.4135/9781412961288.N455; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fay JC, 2000, GENETICS, V155, P1405; Frank SA, 2000, EVOL ECOL RES, V2, P613; FU YX, 1993, GENETICS, V133, P693; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Garrigan D, 2001, IMMUNOGENETICS, V53, P483, DOI 10.1007/s002510100352; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goudet J., 2001, CLADISTICS; Hall T.A., 1999, NUCLC ACIDS S, V41, P95, DOI citeulike-article-id:691774; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Herlyn H, 2005, MOL PHYLOGENET EVOL, V37, P62, DOI 10.1016/j.ympev.2005.04.001; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lea IA, 2001, BIOL REPROD, V65, P1691, DOI 10.1095/biolreprod65.6.1691; McCartney MA, 2004, MOL BIOL EVOL, V21, P732, DOI 10.1093/molbev/msh071; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; McDonald JH, 1996, MOL BIOL EVOL, V13, P253, DOI 10.1093/oxfordjournals.molbev.a025562; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rozen S, 2000, Methods Mol Biol, V132, P365; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; YAN Z, 2002, MOL BIOL EVOL, V19, P908; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	61	39	41	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					820	830		10.1086/508473	http://dx.doi.org/10.1086/508473			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033959	Bronze, Green Published			2022-12-18	WOS:000241667400004
J	Fearnhead, P; Smith, NGC				Fearnhead, P; Smith, NGC			A novel method with improved power to detect recombination hotspots from polymorphism data reveals multiple hotspots in human genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; RATES; CHIMPANZEES; EVOLUTION	We introduce a new method for detection of recombination hotspots from population genetic data. This method is based on (a) defining an (approximate) penalized likelihood for how recombination rate varies with physical position and (b) maximizing this penalized likelihood over possible sets of recombination hotspots. Simulation results suggest that this is a more powerful method for detection of hotspots than are existing methods. We apply the method to data from 89 genes sequenced in African American and European American populations. We find many genes with multiple hotspots, and some hotspots show evidence of being population-specific. Our results suggest that hotspots are randomly positioned within genes and could be as frequent as one per 30 kb.	Univ Lancaster, Dept Math & Stat, Fylde Coll, Lancaster LA1 4YF, England	Lancaster University	Fearnhead, P (corresponding author), Univ Lancaster, Dept Math & Stat, Fylde Coll, Lancaster LA1 4YF, England.	p.fearnhead@lancaster.ac.uk	Fearnhead, Paul/A-1653-2008; Fearnhead, Paul/A-5938-2015	Fearnhead, Paul/0000-0002-9386-2341; Fearnhead, Paul/0000-0002-9386-2341				Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Fearnhead P, 2001, GENETICS, V159, P1299; Fearnhead P, 2002, J ROY STAT SOC B, V64, P657, DOI 10.1111/1467-9868.00355; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1992, GENETICS, V132, P583; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; SCHAFFNER SF, IN PRESS GENOME RES; SMITH NGC, 2005, GENETICS; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Webster MT, 2004, TRENDS GENET, V20, P122, DOI 10.1016/j.tig.2004.01.005; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	24	39	42	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					781	794		10.1086/497579	http://dx.doi.org/10.1086/497579			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252238	Bronze, Green Published			2022-12-18	WOS:000232569600008
J	Zheng, QP; Sebald, E; Zhou, G; Chen, YQ; Wilcox, W; Lee, B; Krakow, D				Zheng, QP; Sebald, E; Zhou, G; Chen, YQ; Wilcox, W; Lee, B; Krakow, D			Dysregulation of chondrogenesis in human cleidocranial dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; INDIAN-HEDGEHOG; BONE-DEVELOPMENT; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; CBFA1-DEFICIENT MICE; SKELETAL DEVELOPMENT; MUTATION ANALYSIS; COLLAGEN GENE	Cleidocranial dysplasia (CCD) is an autosomal dominant skeletal dysplasia caused by heterozygosity of mutations in human RUNX2. The disorder is characterized by delayed closure of the fontanel and hypoplastic clavicles that result from defective intramembranous ossification. However, additional features, such as short stature and cone epiphyses, also suggest an underlying defect in endochondral ossification. Here, we report observations of growth-plate abnormalities in a patient with a novel RUNX2 gene mutation, a single C insertion ( 1228insC), which is predicted to lead to a premature termination codon and thus to haploinsufficiency of RUNX2 and the CCD phenotype. Histological analysis of the rib and long-bone cartilages showed a markedly diminished zone of hypertrophy. Quantitative real-time reverse transcription-polymerase chain reaction analysis of limb cartilage RNA showed a 5-10-fold decrease in the hypertrophic chondrocyte molecular markers VEGF, MMP13, and COL10A1. Together, these data show that humans with CCD have altered endochondral ossification due to altered RUNX2 regulation of hypertrophic chondrocyte-specific genes during chondrocyte maturation.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 635E, Houston, TX 77030 USA.	blee@bcm.tmc.edu			NCRR NIH HHS [M01 RR000425, M01-RR00425] Funding Source: Medline; NICHD NIH HHS [P01 HD022657, P30 HD024064, HD22657, HD24064] Funding Source: Medline; NIEHS NIH HHS [P01 ES011253, ES 11253] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Cooper SC, 2001, AM J MED GENET, V104, P1, DOI 10.1002/ajmg.10024; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Hermanns P, 2001, AM J MED GENET, V106, P258, DOI 10.1002/ajmg.10231; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; JIMENEZ J, 1999, RRD MICROBIOL 1, V3, P1; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee Brendan, 2004, P331; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWE J, 1996, THEORY PRACTICE HIST, P309; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morava E, 2002, EUR J PEDIATR, V161, P619, DOI 10.1007/s00431-002-0977-x; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quack I, 1999, AM J HUM GENET, V65, P1268, DOI 10.1086/302622; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Shapiro I M, 1999, Clin Orthod Res, V2, P42; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Varghese S, 2005, J CELL PHYSIOL, V202, P391, DOI 10.1002/jcp.20130; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshida T, 2003, BLOOD CELL MOL DIS, V30, P184, DOI 10.1016/S1079-9796(03)00020-2; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Zou SJ, 2003, ARCH ORAL BIOL, V48, P673, DOI 10.1016/S0003-9969(03)00135-3	46	39	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					305	312		10.1086/432261	http://dx.doi.org/10.1086/432261			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15952089	Green Published, Bronze			2022-12-18	WOS:000230387200011
J	Zhao, JY; Boerwinkle, E; Xiong, MM				Zhao, JY; Boerwinkle, E; Xiong, MM			An entropy-based statistic for genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM TESTS; GENETIC ASSOCIATION; HAPLOTYPE BLOCKS; IDENTIFICATION; INDIVIDUALS; POPULATIONS; SIMILARITY; FUTURE	Efficient genotyping methods and the availability of a large collection of single- nucleotide polymorphisms provide valuable tools for genetic studies of human disease. The standard x 2 statistic for case- control studies, which uses a linear function of allele frequencies, has limited power when the number of marker loci is large. We introduce a novel test statistic for genetic association studies that uses Shannon entropy and a nonlinear function of allele frequencies to amplify the differences in allele and haplotype frequencies to maintain statistical power with large numbers of marker loci. We investigate the relationship between the entropy- based test statistic and the standard x(2) statistic and show that, in most cases, the power of the entropy- based statistic is greater than that of the standard x(2) statistic. The distribution of the entropy- based statistic and the type I error rates are validated using simulation studies. Finally, we apply the new entropy- based test statistic to two real data sets, one for the COMT gene and schizophrenia and one for the MMP- 2 gene and esophageal carcinoma, to evaluate the performance of the new method for genetic association studies. The results show that the entropy- based statistic obtained smaller P values than did the standard x 2 statistic.	Univ Texas, Ctr Human Genet, Ctr Hlth Sci, Houston, TX 77225 USA; Fudan Univ, Lab Theoret Syst Biol, Sch Life Sci, Shanghai 200433, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Fudan University	Xiong, MM (corresponding author), Univ Texas, Ctr Human Genet, Ctr Hlth Sci, POB 20334, Houston, TX 77225 USA.	Momiao.Xiong@uth.tmc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR044888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074735, HL74735] Funding Source: Medline; NIAMS NIH HHS [IP50AR44888, P50 AR044888] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, ES09912] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Anderson T. W, 1984, INTRO MULTIVARIATE S; Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; BOURGAIN C, 2001, ANN HUM GENET, V21, pS560; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; deVries HG, 1996, HUM GENET, V98, P304, DOI 10.1007/s004390050211; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hampe J, 2003, HUM GENET, V114, P36, DOI 10.1007/s00439-003-1017-2; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; LEHMANN EL, 1983, THEORY POINT ESTIMAT; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nothnagel M, 2002, HUM HERED, V54, P186, DOI 10.1159/000070664; NOTHNAGEL M, 2002, AM J HUM GENET S, V71; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ross S. M., 1997, INTRO PROBABILITY MO; SHANNON CE, 1948, BELL SYST TECH J, V27, P423; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Van der Meulen MA, 1997, GENET EPIDEMIOL, V14, P915, DOI 10.1002/(SICI)1098-2272(1997)14:6<915::AID-GEPI59>3.0.CO;2-P; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Xiong MM, 2003, FRONT BIOSCI, V8, pA85, DOI 10.2741/919; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Yu K, 2004, GENET EPIDEMIOL, V27, P182, DOI 10.1002/gepi.20022; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2003, AM J HUM GENET, V73, P63, DOI 10.1086/376437; Zhang SL, 2003, AM J HUM GENET, V73, P566, DOI 10.1086/378205	35	39	46	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					27	40		10.1086/431243	http://dx.doi.org/10.1086/431243			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15931594	Green Published, Bronze			2022-12-18	WOS:000229794500003
J	Bolnick, DA; Shook, BA; Campbell, L; Goddard, I				Bolnick, DA; Shook, BA; Campbell, L; Goddard, I			Problematic use of Greenberg's linguistic classification of the Americas in studies of Native American genetic variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LANGUAGE; HAPLOTYPES; AFFINITIES; ORIGIN; SINGLE		Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Univ Canterbury, Dept Linguist, Christchurch 1, New Zealand; Univ Utah, Dept Linguist, Salt Lake City, UT USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA	University of California System; University of California Davis; University of Canterbury; Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian National Museum of Natural History	Bolnick, DA (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	daweiss@ucdavis.edu						ADELAAR WFH, 1989, LINGUA, V78, P249; BERMAN H, 1992, INT J AM LINGUIST, V58, P230, DOI 10.1086/ijal.58.2.3519757; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; BRIGHT W, 1988, AM REFERENCE BOOKS A, V19, P440; CAMPBELL L, 1988, LANGUAGE, V64, P591, DOI 10.2307/414535; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Chafe W., 1987, CURR ANTHROPOL, V28, P652; Fernandez-Cobo M, 2002, AM J PHYS ANTHROPOL, V118, P154, DOI 10.1002/ajpa.10085; GODDARD I, 1990, LINGUISTICS, V28, P556; Goddard Ives, 1987, CURR ANTHROPOL, V28, P656; Goddard Ives, 1996, HDB N AM INDIANS, V17, P1; GOLLA V, 1988, AM ANTHROPOL, V90, P434, DOI 10.1525/aa.1988.90.2.02a00320; Golla V, 2000, LANG SOC, V29, P150, DOI 10.1017/S0047404500321030; Gomez-Casado E, 2003, TISSUE ANTIGENS, V61, P425, DOI 10.1034/j.1399-0039.2003.00040.x; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hill JH, 2000, AM ANTHROPOL, V102, P161, DOI 10.1525/aa.2000.102.1.161; HUNLEY K, 2004, ANN M AM ASS PHYS AN; KIMBALL G, 1992, INT J AM LINGUIST, V58, P447, DOI 10.1086/ijal.58.4.3519779; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; LEWIN R, 1988, SCIENCE, V242, P1632, DOI 10.1126/science.242.4886.1632; MATISOFF JA, 1990, LANGUAGE, V66, P106, DOI 10.2307/415281; MCMAHON AMS, 1995, T PHILOL SOC, V93, P125, DOI 10.1111/j.1467-968X.1995.tb00438.x; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; MITHUN M, 1990, ANNU REV ANTHROPOL, V19, P309; Mithun Marianne, 1999, LANGUAGES NATIVE N A; Nichols J, 1996, LANGUAGE, V72, P336, DOI 10.2307/416653; POSER WJ, 1992, INT J AM LINGUIST, V24, P174; RANKIN RL, 1992, INT J AM LINGUIST, V58, P324, DOI 10.1086/ijal.58.3.3519791; Ringe D, 2002, J LINGUIST, V38, P415; RINGE D, 1994, ANN M AM ASS ADV SCI; Roessli D, 2000, ARLEQUIN VERSION 2 0; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TORRONI A, 1993, AM J HUM GENET, V53, P563; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; [No title captured]; [No title captured]	39	39	40	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					519	522						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15284953				2022-12-18	WOS:000223272200019
J	Gargus, JJ				Gargus, JJ			Unraveling monogenic channelopathies and their implications for complex polygenic disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LONG-QT SYNDROME; POTASSIUM CHANNEL GENE; INFANT-DEATH-SYNDROME; INHERITED CARDIAC-ARRHYTHMIA; SEVERE MYOCLONIC EPILEPSY; EPISODIC ATAXIA TYPE-2; MUSCLE SODIUM-CHANNEL; HYPERKALEMIC PERIODIC PARALYSIS; FAMILIAL NEONATAL CONVULSIONS; FRONTAL-LOBE EPILEPSY	Ion channels are a large family of >1400 related proteins representing >1% of our genetic endowment; however, ion-channel diseases reflect a relatively new category of inborn error. They were first recognized in 1989, with the discovery of cystic fibrosis transmembrane conductance regulator, and rapidly advanced as positional and functional studies converged in the dissection of components of the action potential of excitable tissues. Although it remains true that diseases of excitable tissue still most clearly illustrate this family of disease, ion-channel disorders now cover the gamut of medical disciplines, causing significant pathology in virtually every organ system, producing a surprising range of often unanticipated symptoms, and providing valuable targets for pharmacological intervention. Many of the features shared among the monogenic ion-channel diseases provide a general framework for formulating a foundation for considering their intrinsically promising role in polygenic disease. Since an increasingly important approach to the identification of genes underlying polygenic disease is to identify "functional candidates" within a critical region and to test their disease association, it becomes increasingly important to appreciate how these ion-channel mechanisms can be implicated in pathophysiology.	Univ Calif Irvine, Dept Phys & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pediat, Div Human Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Gargus, JJ (corresponding author), Univ Calif Irvine, Dept Phys & Biophys, 328 Sprague Hall,839 Med Sci Court, Irvine, CA 92697 USA.				NIMH NIH HHS [MH59222] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059222] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clark JD, 1998, NEUROSCI LETT, V251, P121, DOI 10.1016/S0304-3940(98)00516-3; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Demolombe S, 1998, J BIOL CHEM, V273, P6837, DOI 10.1074/jbc.273.12.6837; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dror V, 1999, MOL PSYCHIATR, V4, P254, DOI 10.1038/sj.mp.4000508; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Engel AG, 1998, NEUROSCIENTIST, V4, P185, DOI 10.1177/107385849800400314; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2000, ANN NEUROL, V48, P647; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gargus JJ, 1998, MOL MED TODAY, V4, P518, DOI 10.1016/S1357-4310(98)01358-6; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kors EE, 2002, CURR OPIN NEUROL, V15, P311, DOI 10.1097/00019052-200206000-00014; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LEWIS TB, 1993, AM J HUM GENET, V53, P670; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; MCCLATCHEY AI, 1992, NAT GENET, V2, P148, DOI 10.1038/ng1092-148; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MORIMOTO T, 1993, EPILEPSIA, V34, P447, DOI 10.1111/j.1528-1157.1993.tb02585.x; Moslehi R, 1998, AM J MED GENET, V76, P21, DOI 10.1002/(SICI)1096-8628(19980226)76:1<21::AID-AJMG3>3.3.CO;2-D; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Phillips HA, 2001, AM J HUM GENET, V68, P225, DOI 10.1086/316946; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1994, CELL, V77, P863; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Rho JM, 1999, DEV NEUROSCI-BASEL, V21, P320, DOI 10.1159/000017381; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; Schwartz PJ, 2001, LANCET, V358, P1342, DOI 10.1016/S0140-6736(01)06450-9; Schwartz PJ, 2001, LANCET, V358, P672, DOI 10.1016/S0140-6736(01)05809-3; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shieh CC, 2000, PHARMACOL REV, V52, P557; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Spooner PM, 2001, CIRCULATION, V103, P2361; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Stoffel M, 1998, NAT GENET, V18, P6, DOI 10.1038/ng0198-6; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; TOMITA H, IN PRESS MOL PSYCHIA; Towbin JA, 2001, AM J MED, V110, P385, DOI 10.1016/S0002-9343(00)00715-4; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; van den Maagdenberg AMJM, 2002, J NEUROL, V249, P1515, DOI 10.1007/s00415-002-0860-8; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817; Zupancic JAF, 2000, J PEDIATR-US, V136, P481, DOI 10.1016/S0022-3476(00)90011-8; Zwingman TA, 2001, J NEUROSCI, V21, P1169	116	39	42	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					785	803		10.1086/374317	http://dx.doi.org/10.1086/374317			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12629596	Green Published, Bronze			2022-12-18	WOS:000181972600002
J	Watts, JA; Morley, M; Burdick, JT; Fiori, JL; Ewens, WJ; Spielman, RS; Cheung, VG				Watts, JA; Morley, M; Burdick, JT; Fiori, JL; Ewens, WJ; Spielman, RS; Cheung, VG			Gene expression phenotype in heterozygous carriers of ataxia telangiectasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IONIZING-RADIATION; BREAST-CANCER; MOLECULAR CLASSIFICATION; ATM; MUTATIONS; KINASE; RADIOSENSITIVITY; REPLICATION; CONTRIBUTE; ACTIVATION	The defining characteristic of recessive diseases is the absence of a phenotype in the heterozygous carriers. Nonetheless, subtle manifestations may be detectable by new methods, such as expression profiling. Ataxia telangiectasia (AT) is a typical recessive disease, and individual carriers cannot be reliably identified. As a group, however, carriers of an AT disease allele have been reported to have a phenotype that distinguishes them from normal control individuals: increased radiosensitivity and risk of cancer. We show here that the phenotype is also detectable, in lymphoblastoid cells from AT carriers, as changes in expression level of many genes. The differences are manifested both in baseline expression levels and in response to ionizing radiation. Our findings show that carriers of a recessive disease may have an "expression phenotype." In the particular case of AT, this suggests a new approach to the identification of carriers and enhances understanding of their increased cancer risk. More generally, we demonstrate that genomic technologies offer the opportunity to identify and study unaffected carriers, who are hundreds of times more common than affected patients.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, 3615 Civ Ctr Blvd,ARC 516, Philadelphia, PA 19104 USA.		Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070540] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002386, HG02386] Funding Source: Medline; NIDCD NIH HHS [DC00154] Funding Source: Medline; NIDDK NIH HHS [DK47481] Funding Source: Medline; NIGMS NIH HHS [R01 GM070540, R01 GM070540-04] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Callow MJ, 2000, GENOME RES, V10, P2022, DOI 10.1101/gr.10.12.2022; Chen JD, 1998, CANCER RES, V58, P1376; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Manly B. F., 1997, RANDOMIZATION BOOTST; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Telatar M, 1996, AM J HUM GENET, V59, P40; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuttle S, 2000, RADIAT RES, V153, P781, DOI 10.1667/0033-7587(2000)153[0781:GPDATO]2.0.CO;2; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; WEST CML, 1995, INT J RADIAT BIOL, V68, P197, DOI 10.1080/09553009514551101; Wright J, 1996, AM J HUM GENET, V59, P839; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	33	39	42	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					791	800		10.1086/342974	http://dx.doi.org/10.1086/342974			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12226795	Bronze, Green Published			2022-12-18	WOS:000178613800008
J	Le Caignec, C; Lefevre, M; Schott, JJ; Chaventre, A; Gayet, M; Calais, C; Moisan, JP				Le Caignec, C; Lefevre, M; Schott, JJ; Chaventre, A; Gayet, M; Calais, C; Moisan, JP			Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of Jagged 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALAGILLE-SYNDROME; JAG1 MUTATIONS; GENE; NOTCH; LIGAND; EXPRESSION; IDENTIFICATION; SPECTRUM; SERRATE; DISEASE	In the present study, we report a kindred with hearing loss, congenital heart defects, and posterior embryotoxon, segregating as autosomal dominant traits. Six of seven available affected patients manifested mild-to-severe combined hearing loss, predominantly affecting middle frequencies. Two patients were diagnosed with vestibular pathology. All patients had congenital heart defects, including tetralogy of Fallot, ventricular septal defect, or isolated peripheral pulmonic stenosis. No individual in this family met diagnostic criteria for any previously described clinical syndrome. A candidate-gene approach was undertaken and culminated in the identification of a novel Jagged 1 (JAG1) missense mutation (C234Y) in the first cysteine of the first epidermal-growth-factor-like repeat domain of the protein. JAG1 is a cell-surface ligand in the Notch signaling pathway. Mutations in JAG1 have been identified in patients with Alagille syndrome. Our findings revealed a unique phenotype with highly penetrant deafness, posterior embryotoxon, and congenital heart defects but with variable expressivity in a large kindred, which demonstrates that mutation in JAG1 can cause hearing loss.	Fac Med, Lab Etud Polymorphisme ADN, F-44035 Nantes, France; Fac Med, INSERM, U533, F-44035 Nantes, France; CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; CHU Nantes, Serv Cardiol, F-44035 Nantes 01, France; CHU Nantes, Serv Radiol, F-44035 Nantes 01, France; CHU Nantes, Serv Otorhinolaryngol, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Le Caignec, C (corresponding author), Fac Med, Lab Etud Polymorphisme ADN, 1 Rue Gaston Veil, F-44035 Nantes, France.	lecaignec@hotmail.com	Le Caignec, Cedric/K-8467-2015; Schott, jean-Jacques/F-8842-2013	Le Caignec, Cedric/0000-0002-0598-653X; Schott, jean-Jacques/0000-0002-9578-9475				ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; Crosnier C, 2000, HEPATOLOGY, V32, P574, DOI 10.1053/jhep.2000.16600; Crosnier C, 1999, GASTROENTEROLOGY, V116, P1141, DOI 10.1016/S0016-5085(99)70017-X; Crosnier C, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<72::AID-HUMU11>3.0.CO;2-U; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; Giannakudis J, 2001, EUR J HUM GENET, V9, P209, DOI 10.1038/sj.ejhg.5200613; Heritage ML, 2000, HUM MUTAT, V16, P408, DOI 10.1002/1098-1004(200011)16:5<408::AID-HUMU5>3.0.CO;2-9; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Krantz ID, 1997, J MED GENET, V34, P152, DOI 10.1136/jmg.34.2.152; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; LABRECQUE DR, 1982, HEPATOLOGY, V2, P467; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lissemore JL, 1999, MOL PHYLOGENET EVOL, V11, P308, DOI 10.1006/mpev.1998.0588; Loomes KM, 1999, HUM MOL GENET, V8, P2443, DOI 10.1093/hmg/8.13.2443; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Oda T, 1997, GENOMICS, V43, P376, DOI 10.1006/geno.1997.4820; OKUNO T, 1990, ARCH OTOLARYNGOL, V116, P217; Onouchi Y, 1999, J HUM GENET, V44, P235, DOI 10.1007/s100380050150; Pilia G, 1999, HUM MUTAT, V14, P394, DOI 10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Sun X, 1996, DEVELOPMENT, V122, P2465; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yuan ZR, 1998, HUM MOL GENET, V7, P1363, DOI 10.1093/hmg/7.9.1363	37	39	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					180	186		10.1086/341327	http://dx.doi.org/10.1086/341327			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12022040	Bronze, Green Published			2022-12-18	WOS:000176307700020
J	Betancur, C; Leboyer, M; Gillberg, C				Betancur, C; Leboyer, M; Gillberg, C			Increased rate of twins among affected sibling pairs with autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Fac Med, INSERM, U513, F-94010 Creteil, France; Assistance Publ Hop Paris, Hop Albert Chenevier & Henri Mondor, Dept Psychiat, Creteil, France; Univ Gothenburg, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Gothenburg; St Georges University London	Betancur, C (corresponding author), Fac Med, INSERM, U513, 8 Rue Gen Sarrail, F-94010 Creteil, France.		Betancur, Catalina/K-3791-2017; Leboyer, Marion/AAW-3648-2021	Betancur, Catalina/0000-0002-3327-4804; Leboyer, Marion/0000-0001-5473-3697				Greenberg DA, 2001, AM J HUM GENET, V69, P1062, DOI 10.1086/324191; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805	3	39	40	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1381	1383		10.1086/340364	http://dx.doi.org/10.1086/340364			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11951183	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000175012400032
J	Wang, K; Huang, J				Wang, K; Huang, J			A score-statistic approach for the mapping of quantitative-trait loci with sibships of arbitrary size	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR ANALYSIS; HASEMAN-ELSTON; LINKAGE ANALYSIS; DESCENT DATA; VARIANCE; IDENTITY; ROBUSTNESS; COMPONENTS	The Haseman-Elston method is widely used for the mapping of quantitative-trait loci. However, this method does not use all the information in the data, because it only considers the sib-pair trait-value difference. In addition, the Haseman-Elston method was developed for independent sib pairs; its generalization to nonindependent sib pairs is not straightforward. Here we introduce a score test statistic derived from a normal likelihood based on multiplex sibship data, conditional on identical-by-descent sharing statuses. This score test is asymptotically equivalent to the corresponding likelihood-ratio test, but it is much easier to implement. Because the proposed test uses all of the trait values, it makes more efficient use of the data than does the Haseman-Elston method. The proposed test is naturally applicable to sibships of arbitrary size. The finite-sample properties of the proposed score statistic are evaluated via simulations.	Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA 52242 USA; Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Wang, K (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, 2800 SB, Iowa City, IA 52242 USA.	kai-wang@uiowa.edu		HUANG, Jian/0000-0002-5218-9269	PHS HHS [K01-01541, R01-52841] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; COLLINS A, 1995, HUM HERED, V45, P311, DOI 10.1159/000154299; Dolan CV, 1999, AM J HUM GENET, V64, P268, DOI 10.1086/302189; Dudoit S, 1999, ANN STAT, V27, P943; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GENEST C, 1986, AM STAT, V40, P280, DOI 10.2307/2684602; Gillespie JH, 1998, POPULATION GENETICS; Goldtstein DR, 2001, GENET EPIDEMIOL, V20, P415, DOI 10.1002/gepi.1011; Gu C, 1996, GENET EPIDEMIOL, V13, P513, DOI 10.1002/(SICI)1098-2272(1996)13:6<513::AID-GEPI1>3.0.CO;2-1; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kempthorne O, 1957, INTRO GENETIC STAT; Klaassen CAJ, 1997, BERNOULLI, V3, P55, DOI 10.2307/3318652; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Sham PC, 2000, GENET EPIDEMIOL, V19, pS22, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI4>3.0.CO;2-S; Tiwari HK, 1997, ANN HUM GENET, V61, P253, DOI 10.1017/S0003480097006167; Van der Vaart A, 1998, ASYMPTOTIC STAT; Wang DL, 2001, AM J HUM GENET, V68, P1238, DOI 10.1086/320101; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	30	39	39	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					412	424		10.1086/338659	http://dx.doi.org/10.1086/338659			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791211	Bronze, Green Published			2022-12-18	WOS:000173254300013
J	Musumeci, O; Andreu, AL; Shanske, S; Bresolin, N; Comi, GP; Rothstein, R; Schon, EA; DiMauro, S				Musumeci, O; Andreu, AL; Shanske, S; Bresolin, N; Comi, GP; Rothstein, R; Schon, EA; DiMauro, S			Intragenic inversion of mtDNA: A new type of pathogenic mutation in a patient with mitochondrial myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-B GENE; EXERCISE INTOLERANCE; ENDONUCLEASE-G; NONSENSE MUTATION; LACTIC-ACIDOSIS; DNA; IDENTIFICATION; REPLICATION; GENOME; MUSCLE	We report an unusual molecular defect in the mitochondrially encoded ND1 subunit of NADH ubiquinone oxidoreductase (complex I) in a patient with mitochondrial myopathy and isolated complex I deficiency. The mutation is an inversion of seven nucleotides within the ND1 gene, which maintains the reading frame. The inversion, which alters three highly conserved amino acids in the polypeptide, was heteroplasmic in the patient's muscle but was not detectable in blood. This is the first report of a pathogenic inversion mutation in human mtDNA.	Columbia Univ Coll Phys & Surg, Dept Neurol, H Houston Merritt Ctr Muscular Dystorphy & Relate, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, H Houston Merritt Ctr Muscular Dystorphy & Relate, New York, NY 10032 USA; Univ Messina, Neurol & Neurosci Inst, Messina, Italy; Hosp Gen Valle Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona, Spain; Univ Milan, Osped Maggiore Policlin, Ist Ricovero & Cura Carattere Sci, Ctr Dino Ferrari,Ist Clin Neurol, Milan, Italy; Ist Ricovero & Cura Carattere Sci Eugenio Medea, Lecco, Italy	Columbia University; Columbia University; University of Messina; Hospital Universitari Vall d'Hebron; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Eugenio Medea	DiMauro, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, H Houston Merritt Ctr Muscular Dystorphy & Relate, 630 W 168th St,4-420, New York, NY 10032 USA.		Comi, Giacomo P/K-5702-2016	Comi, Giacomo P/0000-0002-1383-5248; Bresolin, Nereo/0000-0001-6694-3595; ANDREU, antonio luis/0000-0002-3936-3234; Rothstein, Rodney/0000-0002-4107-9654	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766, R01NS028828] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32062] Funding Source: Medline; NIGMS NIH HHS [GM5023] Funding Source: Medline; NINDS NIH HHS [NS11766, NS28828] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 1998, NEUROLOGY, V50, pA24; Andreu AL, 1999, ANN NEUROL, V45, P820, DOI 10.1002/1531-8249(199906)45:6<820::AID-ANA22>3.0.CO;2-W; Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444; Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; ATTARDI G, 1983, METHOD ENZYMOL, V97, P435; BET L, 1990, J NEUROL, V237, P399, DOI 10.1007/BF00314729; Bouzidi MF, 1998, HUM MOL GENET, V7, P385, DOI 10.1093/hmg/7.3.385; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; GERSCHENSON M, 1995, NUCLEIC ACIDS RES, V23, P88, DOI 10.1093/nar/23.1.88; Ikeda S, 1996, BIOCHEM MOL BIOL INT, V38, P1049; LYAMICHEV VI, 1986, J BIOMOL STRUCT DYN, V3, P667, DOI 10.1080/07391102.1986.10508454; Lyu YL, 1999, J MOL BIOL, V285, P1485, DOI 10.1006/jmbi.1998.2419; MORAES CT, 1992, AM J HUM GENET, V50, P934; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555	21	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1900	1904		10.1086/302927	http://dx.doi.org/10.1086/302927			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775530	Bronze, Green Published			2022-12-18	WOS:000088373800017
J	FitzPatrick, DR; Hill, A; Tolmie, JL; Thorburn, DR; Christodoulou, L				FitzPatrick, DR; Hill, A; Tolmie, JL; Thorburn, DR; Christodoulou, L			The molecular basis of malonyl-CoA decarboxylase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DECARBOXYLASE; FATTY-ACID; DOCOSAHEXAENOIC ACID; MUTATION DETECTION; CARNITINE; GENE; CARDIOMYOPATHY; LOCALIZATION; CARBOXYLASE; INHIBITION	We characterized a 2.1-kb human cDNA with a 1362-bp (454-amino acid) open reading frame showing 70.3% amino acid identity to goose malonyl-CoA decarboxylase (MCD). We have identified two different homozygous mutations in human MCD (MCD) by using RT-PCR analysis of fibroblast RNA from two previously reported consanguineous Scottish patients with MCD deficiency. The first mutation is a 442C-->G transversion resulting in a premature stop codon (S148X) in the N-terminal half of the protein. The second is a 13-bp insertion in the mature RNA, causing a frameshift with predicted protein truncation. This insertion is the result of an intronic mutation generating a novel splice acceptor sequence (IVS4-14Ad-->G). Both mutations were found to segregate appropriately within the families and were not found in 100 normal unrelated individuals. These mutations would be predicted to cause MCD deficiency, thus confirming this transcript as the hMCD ortholog. The peptide sequence of hMCD revealed a C-terminal peroxisomal targeting sequence (-SKL). This targeting signal appears to be functional in vivo, since the distribution of MCD enzymatic activity in rat liver homogenates-as measured by means of subcellular fractionation-strongly suggests that MCD is localized to peroxisomes in addition to the mitochondrial localization reported elsewhere. These data strongly support this cDNA as encoding human MCD, an important regulator of fatty acid metabolism.	Western Gen Hosp, Mol Med Ctr, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Mol Med Ctr, Clin Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Royal Childrens Hosp, Murdoch Inst, Melbourne, Vic, Australia; Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; Univ Sydney, Royal Alexandra Hosp Children, Western Sydney Genet Program, Sydney, NSW 2006, Australia; Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Edinburgh; University of Edinburgh; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Sydney; University of Sydney	FitzPatrick, DR (corresponding author), Western Gen Hosp, Mol Med Ctr, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.		Christodoulou, John/E-5866-2015; Thorburn, David R/G-6266-2013; Christodoulou, John/M-3628-2019; FitzPatrick, David R/B-8311-2008; FitzPatrick, David R/C-7301-2013	Christodoulou, John/0000-0002-8431-0641; FitzPatrick, David R./0000-0003-4861-969X; thorburn, david/0000-0002-7725-9470	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abdel-aleem S, 1998, MOL CELL BIOCHEM, V180, P95, DOI 10.1023/A:1006843107922; ABHAIRD NN, 1992, BIOCHEM J, V286, P637, DOI 10.1042/bj2860637; Aeibi H, 1974, METHOD ENZYMAT AN, P673; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON GJ, 1990, PEDIATR RES, V27, P89, DOI 10.1203/00006450-199001000-00023; Axton R, 1997, J MED GENET, V34, P279, DOI 10.1136/jmg.34.4.279; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, V2, P574, DOI 10.1016/B978-0-12-091302-2.50010-4; BROWN GK, 1984, J INHERIT METAB DIS, V7, P21, DOI 10.1007/BF01805615; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COURCHESNESMITH C, 1992, ARCH BIOCHEM BIOPHYS, V298, P576, DOI 10.1016/0003-9861(92)90452-3; DICKSON AC, 1994, NEUROCHEM RES, V19, P1271, DOI 10.1007/BF01006817; Dyck JRB, 1998, AM J PHYSIOL-HEART C, V275, pH2122, DOI 10.1152/ajpheart.1998.275.6.H2122; FOX RM, 1971, ANAL BIOCHEM, V41, P578, DOI 10.1016/0003-2697(71)90180-1; Geelen MJH, 1997, BIOCHEM BIOPH RES CO, V233, P253, DOI 10.1006/bbrc.1997.6437; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HAAN EA, 1986, EUR J PEDIATR, V144, P567, DOI 10.1007/BF00496037; Hall JL, 1996, CARDIOVASC RES, V32, P879, DOI 10.1016/S0008-6363(96)00153-8; HALLIDAY JL, 1988, BIOCHEM MED METAB B, V39, P279, DOI 10.1016/0885-4505(88)90086-2; HSIEH YJ, 1994, J BACTERIOL, V176, P714, DOI 10.1128/jb.176.3.714-724.1994; JANG SH, 1989, J BIOL CHEM, V264, P3500; KIM YS, 1978, BIOCHIM BIOPHYS ACTA, V531, P187, DOI 10.1016/0005-2760(78)90142-X; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P585, DOI 10.1016/0003-9861(78)90314-4; KOLATTUKUDY PE, 1987, ARCH BIOCHEM BIOPHYS, V256, P446, DOI 10.1016/0003-9861(87)90601-1; KRAWINKEL MB, 1994, J INHERIT METAB DIS, V17, P636, DOI 10.1007/BF00711609; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACPHEE GB, 1993, ARCH DIS CHILD, V69, P433, DOI 10.1136/adc.69.4.433; MATALON R, 1993, J INHERIT METAB DIS, V16, P571, DOI 10.1007/BF00711684; MOORE SA, 1995, J LIPID RES, V36, P2433; NYDAHL MC, 1994, AM J CLIN NUTR, V59, P115, DOI 10.1093/ajcn/59.1.115; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHOLTE HR, 1969, BIOCHIM BIOPHYS ACTA, V178, P137, DOI 10.1016/0005-2744(69)90140-5; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Shi JY, 1998, BIOCHEMISTRY-US, V37, P11033, DOI 10.1021/bi9803426; SINGH H, 1988, ARCH BIOCHEM BIOPHYS, V266, P486, DOI 10.1016/0003-9861(88)90281-0; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Yano S, 1997, EUR J PEDIATR, V156, P382, DOI 10.1007/s004310050619; Zhang SY, 1996, BIOCHEM BIOPH RES CO, V229, P701, DOI 10.1006/bbrc.1996.1868	40	39	45	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					318	326		10.1086/302492	http://dx.doi.org/10.1086/302492			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417274	Bronze, Green Published			2022-12-18	WOS:000081836900007
J	Adato, A; Kalinski, H; Weil, D; Chaib, H; Korostishevsky, M; Bonne-Tamir, B				Adato, A; Kalinski, H; Weil, D; Chaib, H; Korostishevsky, M; Bonne-Tamir, B			Possible interaction between USH1B and USH3 gene products as implied by apparent digenic deafness inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MYOSIN-VIIA GENE; UNCONVENTIONAL MYOSINS; CHROMOSOME 3Q; HEARING-LOSS; 1B SYNDROME; HAIR-CELLS; MUTATION; MOUSE		Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Ramat Aviv, Israel; Inst Pasteur, CNRS, URA 1968, Unite Genet Deficits Sensoriels, Paris, France	Tel Aviv University; Sackler Faculty of Medicine; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Adato, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Genet, IL-69978 Ramat Aviv, Israel.							Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Balciuniene J, 1998, AM J HUM GENET, V63, P786, DOI 10.1086/302012; Chen A, 1997, AM J MED GENET, V71, P467, DOI 10.1002/(SICI)1096-8628(19970905)71:4<467::AID-AJMG18>3.0.CO;2-E; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; Joensuu T, 1996, GENOMICS, V38, P255, DOI 10.1006/geno.1996.0626; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Richardson GP, 1997, J NEUROSCI, V17, P9506; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; VASILIKI K, 1998, HUM MOL GENET, V7, P1589; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202	21	39	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					261	265		10.1086/302438	http://dx.doi.org/10.1086/302438			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364543	Green Published, Bronze			2022-12-18	WOS:000081224300035
J	Devriendt, K; Jaeken, J; Matthijs, G; Van Esch, H; Debeer, P; Gewillig, M; Fryns, JP				Devriendt, K; Jaeken, J; Matthijs, G; Van Esch, H; Debeer, P; Gewillig, M; Fryns, JP			Haploinsufficiency of the HOXA gene cluster, in a patient with hand-foot-genital syndrome, velopharyngeal insufficiency, and persistent patent ductus botalli	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HOXD13		Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; Katholieke Univ Leuven Hosp, Dept Pediat, Louvain, Belgium; Katholieke Univ Leuven Hosp, Pediat Cardiol Unit, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Devriendt, K (corresponding author), Ctr Human Genet, Herestr 49, Louvain, Belgium.		Van+Esch, Hilde/AAU-5688-2020	Van Esch, Hilde/0000-0002-9604-5726; Matthijs, Gert/0000-0001-6710-1912				CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Devriendt K, 1997, J MED GENET, V34, P395, DOI 10.1136/jmg.34.5.395; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; GOODMAN FR, 1998, AM J HUM GENET, V63, pA18; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; VanLaer L, 1997, HUM GENET, V99, P831	10	39	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					249	251		10.1086/302452	http://dx.doi.org/10.1086/302452			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364539	Green Published, Bronze			2022-12-18	WOS:000081224300031
J	Olson, JM				Olson, JM			Relationship estimation by Markov-process models in a sib-pair linkage study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The results of sib-pair linkage studies may be compromised if a substantial number of putative sib pairs are not actually sib pairs. For classification of pairs in a sib-pair genome scan, I propose multipoint methods that are based on a Markov-process model of allele sharing along the chromosome. These methods can be implemented by standard algorithms that compute multipoint marker allele-sharing probabilities for sib pairs. When marker data from at least half the genome are used, misclassification rates are small. The methods will be implemented in an upcoming version of the computer software package S.A.G.E.	Case Western Reserve Univ, Metrohlth Med Ctr R255, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Olson, JM (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr R255, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	olson@darwin.cwru.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001577, R01HG001577] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03655] Funding Source: Medline; NHGRI NIH HHS [HG01577] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; CHAKRABORTY R, 1993, EXS, V67, P153; Ehm M. G., 1996, American Journal of Human Genetics, V59, pA217; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Johnson RA, 1998, APPL MULTIVARIATE ST; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Olson JM, 1998, BIOMETRICS, V54, P1266, DOI 10.2307/2533655; Parzen E., 1962, STOCHASTIC PROCESSES; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; Stivers D. N., 1996, American Journal of Human Genetics, V59, pA190; Teng J, 1998, BIOMETRICS, V54, P1247, DOI 10.2307/2533654	15	39	41	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1464	1472		10.1086/302360	http://dx.doi.org/10.1086/302360			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205280	Bronze, Green Published			2022-12-18	WOS:000080093000027
J	Hokanson, JE; Brunzell, JD; Jarvik, GP; Wijsman, EM; Austin, MA				Hokanson, JE; Brunzell, JD; Jarvik, GP; Wijsman, EM; Austin, MA			Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; FAMILIAL COMBINED HYPERLIPIDEMIA; COMPLEX SEGREGATION ANALYSIS; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; SUBCLASS PATTERNS; PARTICLE DIAMETER; MISSENSE MUTATION; INHERITED SUSCEPTIBILITY; PLASMA TRIGLYCERIDE	Small low-density lipoprotein (LDL) particles area genetically influenced coronary disease risk factor. Lipoprotein lipase (LpL) is a rate-limiting enzyme in the formation of LDL particles. The current study examined genetic linkage of LDL particle size to the LpL gene in five families with structural mutations in the LpL gene. LDL particle size was smaller among the heterozygous subjects, compared with controls, Among heterozygous subjects, 44% were classified as affected by LDL subclass phenotype B, compared with 8% of normal family members. Plasma triglyceride levels were significantly higher, and high-density lipoprotein cholesterol (HDL-C) levels were lower, in heterozygous subjects, compared with normal subjects, after age and sex adjustment. A highly significant LOD score of 6.24 at theta = 0 was obtained for linkage of LDL particle size to the LpL gene, after adjustment of LDL particle size for within-genotype variance resulting from triglyceride and HDL-C. Failure to adjust for this variance led to only a modest positive LOD score of 1.54 at theta = 0. Classifying small LDL particles as a qualitative trait (LDL subclass phenotype B) provided only suggestive evidence for linkage to the LpL gene (LOD = 1.65 at theta = 0). Thus, use of the quantitative trait adjusted for within-genotype variance, resulting from physiologic covariates, was crucial for detection of significant evidence of linkage in this study. These results indicate that heterozygous LpL deficiency may be one cause of small LDL particles and may provide a potential mechanism for the increase in coronary disease seen in heterozygous LpL deficiency. This study also demonstrates a successful strategy of genotypic specific adjustment of complex traits in mapping a quantitative trait locus.	Univ Washington, Sch Publ Hlth & Community Med, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hokanson, JE (corresponding author), Univ Washington, Sch Publ Hlth & Community Med, Dept Med, Div Metab Endocrinol & Nutr, Box 356426, Seattle, WA 98195 USA.	hokanson@u.washington.edu	Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708	NCRR NIH HHS [RR37] Funding Source: Medline; NHLBI NIH HHS [HL-46880, HL-30086] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046880, P01HL030086] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMANN G, 1996, 66 C EUR ATH SOC FDN, P29; AUSTIN MA, 1993, ARTERIOSCLER THROMB, V13, P687, DOI 10.1161/01.ATV.13.5.687; AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1995, CIRCULATION, V92, P1770, DOI 10.1161/01.CIR.92.7.1770; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Austin MA, 1998, AM J HUM GENET, V62, P406, DOI 10.1086/301712; AUSTIN MA, 1993, GENET EPIDEMIOL, V10, P599, DOI 10.1002/gepi.1370100645; Austin Melissa A., 1994, Current Opinion in Lipidology, V5, P395, DOI 10.1097/00041433-199412000-00002; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; Bredie SJH, 1996, AM J HUM GENET, V58, P812; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; BRUNZELL JD, 1973, J CLIN INVEST, V52, P1578, DOI 10.1172/JCI107334; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; CANNINGS C, 1977, CLIN GENET, V12, P208; Capell WH, 1996, ARTERIOSCL THROM VAS, V16, P1040, DOI 10.1161/01.ATV.16.8.1040; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CORESH J, 1993, J LIPID RES, V34, P1687; CROUSE JR, 1985, J LIPID RES, V26, P566; DEGRAAF J, 1992, AM J HUM GENET, V51, P1295; DEMENAIS FM, 1989, PROG CLIN BIOL RES, V329, P201; EMI M, 1990, J BIOL CHEM, V265, P5910; FISHER WR, 1983, METABOLISM, V32, P283, DOI 10.1016/0026-0495(83)90194-4; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Goddard KAB, 1995, GENET EPIDEMIOL, V12, P759, DOI 10.1002/gepi.1370120638; Graham J, 1997, GENET EPIDEMIOL, V14, P999; GRIFFIN BA, 1990, ATHEROSCLEROSIS, V83, P59, DOI 10.1016/0021-9150(90)90131-2; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOKANSON J, 1997, HDB LIPOPROTEIN TEST, V1, P267; Hokanson JE, 1997, INT J CLIN LAB RES, V27, P24, DOI 10.1007/BF02827239; Hokanson JE, 1997, ATHEROSCLEROSIS, V134, P25, DOI 10.1016/S0021-9150(97)88222-6; JAAKKOLA O, 1993, CORONARY ARTERY DIS, V4, P379, DOI 10.1097/00019501-199304000-00010; KRAUSS RM, 1982, J LIPID RES, V23, P97; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; LAMONFAVA S, 1991, ATHEROSCLEROSIS, V91, P97, DOI 10.1016/0021-9150(91)90191-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE E, 1991, P ADV STUD WORKSH SU, P237; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; MAGILL P, 1982, EUR J CLIN INVEST, V12, P113, DOI 10.1111/j.1365-2362.1982.tb00947.x; Mailly F, 1996, ATHEROSCLEROSIS, V122, P21, DOI 10.1016/0021-9150(95)05736-6; MAILLY F, 1995, ARTERIOSCL THROM VAS, V15, P468, DOI 10.1161/01.ATV.15.4.468; MARCOVINA SM, 1991, CLIN CHEM, V37, P1676; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORTON NE, 1955, AM J HUM GENET, V7, P277; Naggert JK, 1997, CLIN GENET, V51, P236; NIKKILA EA, 1978, ATHEROSCLEROSIS, V29, P497, DOI 10.1016/0021-9150(78)90178-8; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; OTT J, 1986, GENET EPIDEMIOL, P251; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; Rotter JI, 1996, AM J HUM GENET, V58, P585; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; TAYLOR KG, 1980, EUR J CLIN INVEST, V10, P133, DOI 10.1111/j.1365-2362.1980.tb02072.x; TORNVALL P, 1991, ATHEROSCLEROSIS, V90, P67, DOI 10.1016/0021-9150(91)90245-X; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WILSON DE, 1990, J CLIN INVEST, V86, P735, DOI 10.1172/JCI114770; ZAMBON A, 1993, LANCET, V341, P1119, DOI 10.1016/0140-6736(93)93129-O; Zambon A, 1996, J INVEST MED, V44, pA91; Zhang HF, 1996, BBA-LIPID LIPID MET, V1302, P159, DOI 10.1016/0005-2760(96)00059-8	63	39	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					608	618		10.1086/302234	http://dx.doi.org/10.1086/302234			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973300	Bronze, Green Published			2022-12-18	WOS:000078740600032
J	Meij, IC; Saar, K; van den Heuvel, LPWJ; Nuernberg, G; Vollmer, M; Hildebrandt, F; Reis, A; Monnens, LAH; Knoers, NVAM				Meij, IC; Saar, K; van den Heuvel, LPWJ; Nuernberg, G; Vollmer, M; Hildebrandt, F; Reis, A; Monnens, LAH; Knoers, NVAM			Hereditary isolated renal magnesium loss maps to chromosome 11q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CA2+-SENSING RECEPTOR GENE; FAMILIAL HYPOMAGNESEMIA; BARTTERS-SYNDROME; HYPOKALEMIC ALKALOSIS; AUTOSOMAL-DOMINANT; MUTATIONS; HYPERCALCIURIA; CHANNEL; TRANSLOCATION; COTRANSPORTER	Hypomagnesemia due to isolated renal magnesium loss has previously been demonstrated in two presumably unrelated Dutch families with autosomal dominant mode of inheritance. Patients with magnesium deficiency may suffer from tetany and convulsions, but the patients with hereditary renal magnesium wasting can also be clinically nonsymptomatic. In a genomewide linkage study, we first excluded a possible candidate region, on chromosome 9q, that encompasses the gene for intestinal hypomagnesemia with secondary hypocalcemia and, subsequently, found linkage to markers on chromosome 11q23. Detailed haplotype analyses identified a common haplotype segregating in both families, suggesting both their relationship through a common ancestor and the existence of a single, hypomagnesemia-causing mutation within them. The maximum two-point LOD score (Z(max)) was found for marker D11S4127 (Z(max) = 6.41 at a recombination fraction of .00),whereas a multipoint analysis gave a Z(max) of 8.24 between markers D11S4142 and D11S4171, Key recombination events define a 5.6-cM region between these two markers on chromosome 11q23. We conclude that this region encompasses a gene, involved in renal magnesium handling, that is mutated in our patients and is different from the gene involved in intestinal magnesium handling.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Max Delbruck Ctr Mol Med, Microsatellite Ctr, Berlin, Germany; Univ Hosp Freiburg, Dept Pediat, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Freiburg	Knoers, NVAM (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	N.Knoers@antrg.azn.nl	van den Heuvel, L.P.W.J./H-8044-2014; Monnens, L.A.H./L-4526-2015; van den Heuvel, Lambertus/AAM-1772-2021; Reis, André/D-2309-2009	van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Reis, André/0000-0002-6301-6363; Saar, Kathrin/0000-0002-4483-1557				Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Baron J, 1996, HUM MOL GENET, V5, P601, DOI 10.1093/hmg/5.5.601; CHERY M, 1994, HUM GENET, V93, P587; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fisher R.A., 1965, THEORY INBREEDING, V2nd ed.; FREEMAN RM, 1966, AM J MED, V41, P645, DOI 10.1016/0002-9343(66)90228-2; GEVEN WB, 1987, KIDNEY INT, V31, P1140, DOI 10.1038/ki.1987.120; GEVEN WB, 1987, CLIN GENET, V32, P398; HAIJAMAE H, 1972, ACTA PAEDIATR SCAND, V61, P591, DOI 10.1111/j.1651-2227.1972.tb15951.x; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; JANICIC N, 1995, AM J HUM GENET, V56, P880; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kelepouris E, 1998, SEMIN NEPHROL, V18, P58; KRISHNAN SN, 1995, HUM GENET, V96, P155, DOI 10.1007/BF00207372; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; MILAZZO SC, 1981, J RHEUMATOL, V8, P767; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NORDIO S, 1971, ACTA PAEDIATR SCAND, V60, P441, DOI 10.1111/j.1651-2227.1971.tb06684.x; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Rodriguez-Soriano J, 1998, PEDIATR NEPHROL, V12, P315, DOI 10.1007/s004670050461; RODRIGUEZSORIANO J, 1994, PEDIATR NEPHROL, V8, P431, DOI 10.1007/BF00856522; RUDE RK, 1983, MAGNESIUM, V2, P62; Saar K, 1997, AM J HUM GENET, V60, P605; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SMITH DL, 1993, MINER ELECTROL METAB, V19, P266; STROMME JH, 1969, ACTA PAEDIATR SCAND, V58, P433, DOI 10.1111/j.1651-2227.1969.tb04743.x; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; TOWNSEND DE, 1995, J BACTERIOL, V177, P5350, DOI 10.1128/jb.177.18.5350-5354.1995; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Walder RY, 1997, HUM MOL GENET, V6, P1491, DOI 10.1093/hmg/6.9.1491	37	39	41	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					180	188		10.1086/302199	http://dx.doi.org/10.1086/302199			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915957	Green Published, Bronze			2022-12-18	WOS:000078477400023
J	Abel, L; Muller-Myhsok, B				Abel, L; Muller-Myhsok, B			Maximum-likelihood expression of the transmission/disequilibrium test and power considerations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE DISEQUILIBRIUM		Hop La Pitie Salpetriere, INSERM, U436, F-75013 Paris, France; Bernhard Nocht Inst Trop Med, Dept Mol Genet, Hamburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Bernhard Nocht Institut fur Tropenmedizin	Abel, L (corresponding author), Hop La Pitie Salpetriere, INSERM, U436, 91 Blvd Hop, F-75013 Paris, France.		Abel, Laurent/H-8888-2017; Müller-Myhsok, Bertram/A-3289-2013	Abel, Laurent/0000-0001-7016-6493; 				Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777	6	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					664	667		10.1086/301975	http://dx.doi.org/10.1086/301975			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683606	Bronze, Green Published			2022-12-18	WOS:000075360800046
J	Shoji, Y; Koizumi, A; Kayo, T; Ohata, T; Takahashi, T; Harada, K; Takada, G				Shoji, Y; Koizumi, A; Kayo, T; Ohata, T; Takahashi, T; Harada, K; Takada, G			Evidence for linkage of human primary systemic carnitine deficiency with D5S436: A novel gene locus on chromosome 5q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE VISCERAL STEATOSIS; CARDIOMYOPATHY	Primary systemic carnitine deficiency (SCD) is a rare hereditary disorder transmitted by an autosomal recessive mode of inheritance. The disorder includes cardiomyopathy muscle weakness, hypoketotic coma with hypoglycemia, and hyperammonemia. In this study we conducted a linkage analysis of a Japanese SCD family with a proband-a 9-year-old girl-and 26 members. The serum and urinary carnitine levels were determined for all members. The entire genome was searched for linkage to the gene locus for SCD, by use of a total of similar to 300 polymorphic markers located similar to 15-20 cM apart. Ln the family, there were two significantly different phenotypes, in terms of serum free-carnitine levels: low serum free-carnitine level (29.5 +/- 5.0 mu M; n = 14) and normal serum Gee-carnitine level (46.8 +/- 6.2 mu M; n = 12). There was no correlation of urinary free-carnitine levels with the low serum-level phenotype (putative heterozygote), but in normal phenotypes (wild type) urinary levels decreased as the serum levels decreased; renal resorption of free carnitine appeared to be complete in wild-type individuals, when the serum free-carnitine level was <36 mu M. Linkage analysis using an autosomal dominant mode of inheritance of heterozygosity revealed a tight linkage between the disease allele and D5S436 on chromosome 5q, with a two-point LOD score of 4.98 and a multipoint LOD score of 5.52. The haplotype analysis revealed that the responsible genetic locus lies between D5S658 and D5S434, which we named the "SCD" locus. This region was syntenic with the jvs locus, which is responsible for murine SCD. Phylogenic conversion of the SCD locus strongly suggests involvement of a single gene, in human SCD.	Akita Univ, Sch Med, Dept Hyg, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Pediat, Akita 0108543, Japan	Akita University; Akita University	Koizumi, A (corresponding author), Akita Univ, Sch Med, Dept Hyg, Hondo 1-1-1, Akita 0108543, Japan.							ENGEL AG, 1981, NEUROLOGY, V31, P819, DOI 10.1212/WNL.31.7.819; GARAVAGLIA B, 1991, NEUROLOGY, V41, P1691, DOI 10.1212/WNL.41.10.1691; GOLPER TA, 1990, KIDNEY INT, V38, P904, DOI 10.1038/ki.1990.289; KOIZUMI T, 1988, LAB ANIM, V22, P83, DOI 10.1258/002367788780746511; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUWAJIMA M, 1991, BIOCHEM BIOPH RES CO, V174, P1090, DOI 10.1016/0006-291X(91)91532-H; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NIKAIDO H, 1995, MAMM GENOME, V6, P369, DOI 10.1007/BF00364804; Rinaldo P, 1997, J PEDIATR-US, V131, P304, DOI 10.1016/S0022-3476(97)70171-9; Roe CR, 1995, METABOLIC MOL BASES, P1508; STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512; TAKAHASHI M, 1994, CLIN CHEM, V40, P817; TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TREEM WR, 1988, NEW ENGL J MED, V319, P1331, DOI 10.1056/NEJM198811173192006; TRIPP ME, 1981, NEW ENGL J MED, V305, P385, DOI 10.1056/NEJM198108133050707	16	39	43	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					101	108		10.1086/301911	http://dx.doi.org/10.1086/301911			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634512	Bronze, Green Published			2022-12-18	WOS:000074761000016
J	Boycott, KM; Pearce, WG; Musarella, MA; Weleber, RG; Maybaum, TA; Birch, DG; Miyake, Y; Young, RSL; Bech-Hansen, NT				Boycott, KM; Pearce, WG; Musarella, MA; Weleber, RG; Maybaum, TA; Birch, DG; Miyake, Y; Young, RSL; Bech-Hansen, NT			Evidence for genetic heterogeneity in X-linked congenital stationary night blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISLAND EYE DISEASE; HETEROZYGOUS MISSENSE MUTATION; NUCLEOTIDE-EXCHANGE FACTOR; RETINITIS-PIGMENTOSA; LINKAGE ANALYSIS; INCOMPLETE TYPES; CONE DYSTROPHY; PROXIMAL XP; SHORT ARM; LOCUS	X-linked congenital stationary night blindness (CSNB) is a nonprogressive retinal disorder characterized by disturbed or absent night vision; its clinical features may also include myopia, nystagmus, and impaired visual acuity. X-linked CSNB is clinically heterogeneous, and it may also be genetically heterogeneous. We have studied 32 families with X-linked CSNB, including 11 families with the complete form of CSNB and 21 families with the incomplete form of CSNB, to identify genetic-recombination events that would refine the location of the disease genes. Critical recombination events in the set of families with complete CSNB have localized a disease gene to the region between DXS556 and DXS8083, in Xp11.4-p11.3. Critical recombination events in the set of families with incomplete CSNB have localized a disease gene to the region between DXS722 and DXS8023, in Xp11.23. Further analysis of the incomplete-CSNB families, by means of disease-associated-haplotype construction, identified 17 families, of apparent Mennonite ancestry, that share portions of an ancestral chromosome. Results of this analysis refined the location of the gene for incomplete CSNB to the region between DXS722 and DXS255, a distance of 1.2 Mb. Genetic and clinical analyses of this set of 32 families with X-linked CSNB, together with the family studies reported in the literature, strongly suggest that two loci, one for complete (CSNB1) and one for incomplete (CSNB2) X-linked CSNB, can account for all reported mapping information.	Univ Calgary, Fac Med, Dept Med Genet, Calgary, AB T2N 4N1, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2M7, Canada; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Long Isl Coll Hosp, Brooklyn, NY 11201 USA; Oregon Hlth Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Retina Fdn SW, Dallas, TX 75221 USA; Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan; Texas Tech Univ, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Lubbock, TX 79430 USA	University of Calgary; University of Alberta; University of Toronto; Long Island College Hospital; Oregon Health & Science University; Oregon Health & Science University; Retina Foundation of the Southwest; Nagoya University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Bech-Hansen, NT (corresponding author), Univ Calgary, Fac Med, Dept Med Genet, HMRB 311,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	ntbech@acs.ucalgary.ca		Birch, David/0000-0002-6594-2897				ALDRED MA, 1992, GENOMICS, V14, P99, DOI 10.1016/S0888-7543(05)80289-7; ALDRED MA, 1994, GENOMICS, V22, P255; ALITALO T, 1991, AM J HUM GENET, V48, P31; BECHHANSEN NT, 1990, HUM GENET, V84, P406; BECHHANSEN NT, 1993, AM J HUM GENET, V52, P71; BECHHANSEN NT, 1991, CYTOGENET CELL GENET, V58, P2056; BECHHANSEN NT, 1992, GENOMICS, V12, P409, DOI 10.1016/0888-7543(92)90394-8; BECHHANSEN NT, IN PRESS HUM GENET; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; BERGEN AAB, 1994, J MED GENET, V31, P580, DOI 10.1136/jmg.31.7.580; BERGEN AAB, 1993, GENOMICS, V18, P463, DOI 10.1006/geno.1993.1504; BERGER W, 1995, HUM GENET, V95, P67, DOI 10.1007/BF00225077; Boycott K. M., 1994, American Journal of Human Genetics, V55, pA255; Boycott KM, 1997, CYTOGENET CELL GENET, V76, P223, DOI 10.1159/000134555; Boycott KM, 1996, GENOMICS, V33, P488, DOI 10.1006/geno.1996.0224; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CARR R. E., 1966, INVEST OPHTHALMOL, V5, P497; CARR RE, 1974, T AM OPHTHAL SOC, V72, P449; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Epp Frank H., 1974, MENNONITES CANADA 17; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; GLASS IA, 1993, J MED GENET, V30, P1044, DOI 10.1136/jmg.30.12.1044; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Heon E, 1994, MOL GENETICS INHERIT, P277; Herrmann K., 1996, American Journal of Human Genetics, V59, pA263; HONG HK, 1994, AM J HUM GENET, V55, P1173; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KHOURI G, 1988, ARCH OPHTHALMOL-CHIC, V106, P1417, DOI 10.1001/archopht.1988.01060140581027; KRILL AE, 1977, HEREDITARY RETINAL C, V2, P391; LI Y, 1991, CYTOGENET CELL GENET, V58, P2075; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; MIYAKE Y, 1994, INVEST OPHTH VIS SCI, V35, P3770; MIYAKE Y, 1989, ARCH OPHTHALMOL-CHIC, V107, P635, DOI 10.1001/archopht.1989.01070010653009; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; MUSARELLA MA, 1992, INVEST OPHTH VIS SCI, V33, P792; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P307; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; RUTTUM MS, 1992, OPHTHALMOLOGY, V99, P747; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; SCHWARTZ M, 1991, GENOMICS, V10, P327, DOI 10.1016/0888-7543(91)90315-6; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; WEBER JL, 1990, GENOME ANAL, V1, P159; WELEBER RG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1170, DOI 10.1001/archopht.1989.01070020236032; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309	53	39	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					865	875		10.1086/301781	http://dx.doi.org/10.1086/301781			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529339	Green Published, Bronze			2022-12-18	WOS:000073514400018
J	Pellekaan, SMV; Frommer, M; Sved, JA; Boettcher, B				Pellekaan, SMV; Frommer, M; Sved, JA; Boettcher, B			Mitochondrial control-region sequence variation in aboriginal Australians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE INDEPENDENT ORIGINS; MTDNA CONTROL-REGION; GENETIC-DIFFERENCES; LENGTH MUTATIONS; MATERNAL LINEAGE; 9-BP DELETION; NEW-GUINEA; DNA; POPULATIONS; EVOLUTION	The mitochondrial D-loop hypervariable segment 1 (mt HVS1) between nucleotides 15997 and 16377 has been examined in aboriginal Australian people from the Darling River region of New South Wales (riverine) and from Yuendumu in central Australia (desert). Forty-seven unique HVS1 types were identified, varying at 49 nucleotide positions. Pairwise analysis by calculation of BEPPI (between population proportion Index) reveals statistically significant structure in the populations, although some identical HVS1 types are seen in the two contrasting regions. mt HVS1 types may reflect more-ancient distributions than do linguistic diversity and other culturally distinguishing attributes. Comparison with sequences from five published global studies reveals that these Australians demonstrate greatest divergence from some Africans, least from Papua New Guinea highlanders, and only slightly more from some Pacific groups (Indonesian, Asian, Samoan, and coastal Papua New Guinea), although the HVS1 types vary at different nucleotide sites. Construction of a median network, displaying three main groups, suggests that several hypervariable nucleotide sites within the HVS1 are likely to have undergone mutation independently, making phylogenetic comparison with global samples by conventional methods difficult. Specific nucleotide-site variants are major separators in median networks constructed from Australian HVS1 types alone and for one global selection. The distribution of these, requiring extended study, suggests that they may be signatures of different groups of prehistoric colonizers into Australia, for which the time of colonization remains elusive.	Univ Sydney, Dept Chem Sci Nursing, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Newcastle, Dept Biol Sci, Newcastle, NSW 2308, Australia	University of Sydney; University of Newcastle	Pellekaan, SMV (corresponding author), Univ Sydney, Dept Chem Sci Nursing, Sch Biol Sci, M02, Sydney, NSW 2006, Australia.	svanhols@mallett.nursing.usyd.edu.au						ABBIE AA, 1975, STUDIES PHYSICAL ANT, V2; ABBIE AA, 1979, STUDIES PHYSICAL ANT, V1; ALLEN J, 1995, ANTIQUITY, V69; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Balme Jane, 1995, Archaeology in Oceania, V30, P1; BANDELT HJ, 1995, GENETICS, V141, P743; Bell D., 1983, DAUGHTERS DREAMING; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Betty DJ, 1996, AM J HUM GENET, V58, P428; Bonatto SL, 1996, AM J HUM GENET, V59, P253; BOWLER JM, 1970, WORLD ARCHAEOL, V2, P39, DOI 10.1080/00438243.1970.9979463; BRIDSELL JB, 1993, MICROEVOLUTIONARY PA; BROWN T, 1973, AUST ABORIGINAL STUD, V49; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Donaldson T., 1980, NGIYAMBAA LANGUAGE W; Felsenstein J, 1995, PHYLIP PHYLOGENETIC; Flood, 1995, ARCHAEOLOGY DREAMTIM; Fullagar RLK, 1996, ANTIQUITY, V70, P751, DOI 10.1017/S0003598X00084040; GAO X, 1991, HUM IMMUNOL, V32, P269, DOI 10.1016/0198-8859(91)90090-V; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GRIZIOTIS G, 1987, AUST J BIOL SCI, V40, P171, DOI 10.1071/BI9870171; HARDY B, 1976, LAMENT BARKINDJE VAN; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Hercus L.A., 1993, PAAKANTYI DICT; HERCUS LA, 1982, PAC LINGUISTICS B, V67; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HOPE J, 1981, 3 AUST NAT U RES SCH; HOPE J, 1993, 24 AUSTR NAT U DEP P, P183; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; Horton David, 1994, ENCY ABORIGINAL AUST, V2; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; JACOBS P, 1991, COMPUTEREASY DRAW WI; KIRK RL, 1976, ORIGIN AUSTR, P329; LUM JK, 1994, HUM BIOL, V66, P567; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Meggitt M.J., 1962, DESERT PEOPLE STUDY; National Health and Medical Research Council Medical Research Ethics Committee, 1991, GUID ETH MATT AB TOR; NEI M, 1983, GENETICS, V105, P207; *NEW ENGL BIOL, 1993, CIRC VENT THERM CYCL; PAGE RDM, 1995, TREEVIEW WIN16 1 3; Pardoe C, 1995, ANTIQUITY, V69, P696, DOI 10.1017/S0003598X00082284; Pardoe Colin, 1994, Archaeology in Oceania, V29, P182; Pellekaan SV, 1997, ELECTROPHORESIS, V18, P1538, DOI 10.1002/elps.1150180909; PELLEKAAN SV, 1992, C P AUST BIOETH ASS, V3, P1; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1996, AM J HUM GENET, V59, P185; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Simmons R. T., 1976, ORIGIN AUSTRALIANS, P307; SMITH MA, 1993, 24 AUSTR NAT U RES S; Soodyall H, 1996, AM J HUM GENET, V58, P595; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; SYKES B, 1995, AM J HUM GENET, V57, P1463; THORNE AG, 1976, ORIGIN AUSTR, P93; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TSINTSOF AS, 1990, AM J HUM GENET, V46, P138; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WEBB SG, 1989, WILLANDRA LAKE HOMIN; White J.P., 1982, PREHISTORY AUSTR NEW; WHITE NG, 1976, NATURE, V261, P223, DOI 10.1038/261223a0; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; YENCHITSOMANUS PT, 1986, AUST J EXP BIOL MED, V64, P297, DOI 10.1038/icb.1986.31; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	80	39	39	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					435	449		10.1086/301710	http://dx.doi.org/10.1086/301710			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZA927	9463317	Green Published, Bronze			2022-12-18	WOS:000072416000027
J	Ehm, MG; Wagner, M				Ehm, MG; Wagner, M			A test statistic to detect errors in sib-pair relationships	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS	Several authors have proposed algorithms to detect Mendelian errors in human genetic linkage data. Most currently available methods use likelihood-based methods on multiplex family data to identify typing or pedigree errors. These algorithms cannot be applied in many sib-pair collections, because of lack of parental-genotype information. Nonetheless, misspecifying the relationships between individuals has serious consequences for sib-pair linkage studies: false relationships bias the statistics designed to identify linkage with disease phenotypes. To test the hypothesis that two individuals are sibs, we propose a test statistic based on the summation, over a large number of genetic markers, of the number of alleles shared identical by state by a pair of individuals, for each marker. The test statistic has an approximately normal distribution under the null hypothesis, and extreme negative values correspond to nonsib pairs. Power and significance studies show that the test statistic calculated by use of 50 unlinked markers has 96% power to detect half-sibs and has 100% power to detect unrelated individuals as not full-sib pairs, with a 5% false-positive rate. Furthermore, extreme positive values of the test statistic identify sibs as MZ twins.	Glaxo Wellcome Inc, Bioinformat Grp, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Inc, Dept Human Genet, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline	Ehm, MG (corresponding author), Glaxo Wellcome Inc, Bioinformat Grp, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.	mge37216@glaxowellcome.com						BOEHNKE M, AM J HUM GENET, V61, P42397; BOHENKE M, 1992, AM J HUM GENET S, V51, pA183; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Ehm M. G., 1996, American Journal of Human Genetics, V59, pA217; Goring H. H. H., 1995, American Journal of Human Genetics, V57, pA192; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LATHROP GM, 1983, AM J HUM GENET, V35, P241; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; Stringham HM, 1996, AM J HUM GENET, V59, P946	12	39	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					181	188		10.1086/301668	http://dx.doi.org/10.1086/301668			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443861	Green Published, Bronze			2022-12-18	WOS:000072127900023
J	Payne, AM; Downes, SM; Bessant, DAR; Bird, AC; Bhattacharya, SS				Payne, AM; Downes, SM; Bessant, DAR; Bird, AC; Bhattacharya, SS			Founder effect, seen in the British population, of the 172 peripherin/RDS mutation - and further refinement of genetic positioning of the peripherin/RDS gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RETINAL DEGENERATION; MACULAR DYSTROPHY; RDS GENE; RETINITIS-PIGMENTOSA; PATTERN DYSTROPHY; FAMILY		Inst Ophthalmol, Dept Mol Genet, London, England; Moorfields Eye Hosp, London, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Payne, AM (corresponding author), Inst Ophthalmol, Dept Mol Genet, 11-43 Bath St, London, England.		Payne, annette/F-8877-2013; Bhattacharya, Shom/N-2926-2016	Payne, annette/0000-0002-2009-0141; Bhattacharya, Shom/0000-0002-1601-6344				Keen TJ, 1996, HUM MUTAT, V8, P297; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; Nakazawa M, 1995, RETINA-J RET VIT DIS, V15, P518, DOI 10.1097/00006982-199515060-00011; Piguet B, 1996, OPHTHALMIC GENET, V17, P175, DOI 10.3109/13816819609057891; REIG C, 1995, OPHTHALMIC GENET, V16, P39, DOI 10.3109/13816819509056911; WADA Y, 1995, INVEST OPHTH VIS SCI, V36, P890; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; WROBLEWSKI JJ, 1994, OPHTHALMOLOGY, V101, P12	9	39	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					192	195		10.1086/301679	http://dx.doi.org/10.1086/301679			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443872	Bronze, Green Published			2022-12-18	WOS:000072127900025
J	Macaulay, VA; Richards, MB; Forster, P; Bendall, KE; Watson, E; Sykes, B; Bandelt, HJ				Macaulay, VA; Richards, MB; Forster, P; Bendall, KE; Watson, E; Sykes, B; Bandelt, HJ			mtDNA mutation rates - No need to panic	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUMAN MITOCHONDRIAL-DNA; SEQUENCE DIVERSITY; CONTROL REGION; POPULATIONS; ORIGIN; LINEAGES; HISTORY; EUROPE; GENOME		UNIV HAMBURG,HEINRICH PETTE INST,HAMBURG,GERMANY; UNIV HAMBURG,MATH SEMINAR,D-2000 HAMBURG,GERMANY; MASSEY UNIV,SCH BIOL SCI,PALMERSTON NORTH,NEW ZEALAND; UNIV OXFORD,INST MOL MED,OXFORD,ENGLAND	Heinrich Pette Institute; University of Hamburg; University of Hamburg; Massey University; University of Oxford			; Mackey AO, David/H-5340-2014	RICHARDS, MARTIN/0000-0003-3118-0967; Mackey AO, David/0000-0001-7914-4709				ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bellwood P, 1978, POLYNESIANS PREHISTO; Bendall KE, 1996, AM J HUM GENET, V59, P1276; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HORAI S, 1990, AM J HUM GENET, V46, P828; Howell N, 1996, AM J HUM GENET, V59, P501; Imamura K, 1996, ORIGINS SPREAD AGR P, P442; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; Meadow R.H., 1996, ORIGINS SPREAD AGR P, P390; MELTON T, 1995, AM J HUM GENET, V57, P403; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Paabo S, 1996, AM J HUM GENET, V59, P493; Phillipson DW, 1993, AFRICAN ARCHAEOLOGY; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; SHERRY ST, 1994, HUM BIOL, V66, P761; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SYKES B, 1995, AM J HUM GENET, V57, P1463; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Torroni A, 1996, GENETICS, V144, P1835; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; WAKELEY J, 1993, J MOL EVOL, V37, P613; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1996, AM J HUM GENET, V59, P437; WHITTLE A, 1985, NEOLITHIC EUROPE SUR	34	39	39	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					983	986						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382113				2022-12-18	WOS:A1997YA59100030
J	Conroy, JM; Grebe, TA; Becker, LA; Tsuchiya, K; Nicholls, RD; Buiting, K; Horsthemke, B; Cassidy, SB; Schwartz, S				Conroy, JM; Grebe, TA; Becker, LA; Tsuchiya, K; Nicholls, RD; Buiting, K; Horsthemke, B; Cassidy, SB; Schwartz, S			Balanced translocation 46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALBRIGHT HEREDITARY OSTEODYSTROPHY; HUMAN SNRPN GENE; MOLECULAR DIAGNOSIS; UNIPARENTAL DISOMY; IMPRINTING CENTER; REGION; DELETIONS; DEFINITION; 15Q11-Q13; ANGELMAN	The lack of normally active paternal genes in 15q11-q13, as an outcome of either a paternal deletion or maternal disomy, accounts for >95% of all patients with Prader-Willi syndrome. Other mechanisms, including imprinting mutations and unbalanced translocations involving pat 15q11-q13, have been described elsewhere. In this study, we present a patient with a rare balanced, de novo translocation-46,XY,t(2;15)(q37.2;q11.2)-involving breakage within the Prader-Willi/Angelman syndrome region of the paternal homologue, without an apparent deletion, The patient demonstrated several manifestations of the Prader-Willi syndrome but was clinically atypical, Cytogenetic and molecular studies of this case demonstrated the translocation breakpoint to be between SNRPN and IPW with mRNA expression of SNRPN and PAR-5 but absence of IPW and PAR-1 expression. These results suggest that disruption of either IPW expression or a nearby gene by an upstream break may contribute to the Prader-Willi syndrome phenotype and that expression of SNRPN or other upstream genes is responsible for other aspects of the classical Prader-Willi syndrome phenotype.	CASE WESTERN RESERVE UNIV,CTR HUMAN GENET LAB,SCH MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT GENET,SCH MED,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; UNIV ARIZONA,COLL MED,PHOENIX,AZ; UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,D-4300 ESSEN,GERMANY	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Arizona; University of Duisburg Essen								Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BUITING K, 1993, HUM MOL GENET, V2, P1991; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; Cassidy S B, 1984, Curr Probl Pediatr, V14, P1; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Glenn CC, 1996, AM J HUM GENET, V58, P335; HOLM VA, 1993, PEDIATRICS, V91, P398; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MICALE MA, 1995, AM J MED GENET, V57, P79, DOI 10.1002/ajmg.1320570118; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PHELAN MC, 1995, AM J MED GENET, V58, P1, DOI 10.1002/ajmg.1320580102; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Sullivan BA, 1996, AM J HUM GENET, V59, P167; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILSON LC, 1995, AM J HUM GENET, V56, P400	27	39	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					388	394		10.1086/514852	http://dx.doi.org/10.1086/514852			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311744	Bronze, Green Published			2022-12-18	WOS:A1997XX70100017
J	McIntosh, I; Clough, MV; Schaffer, AA; Puffenberger, EG; Horton, VK; Peters, K; Abbott, MH; Roig, CM; Cutone, S; Ozelius, L; Kwiatkowski, DJ; Pyeritz, RE; Brown, LJ; Pauli, RM; McCormick, MK; Francomano, CA				McIntosh, I; Clough, MV; Schaffer, AA; Puffenberger, EG; Horton, VK; Peters, K; Abbott, MH; Roig, CM; Cutone, S; Ozelius, L; Kwiatkowski, DJ; Pyeritz, RE; Brown, LJ; Pauli, RM; McCormick, MK; Francomano, CA			Fine mapping of the nail-patella syndrome locus at 9q34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; LINKAGE ANALYSIS; CHROMOSOME-9; ASSIGNMENT; 9Q31-34; MAP; ACHONDROPLASIA; LOCALIZATION; STRATEGIES; GENES	Nail-patella syndrome (NPS), or onychoosteodysplasia, is an autosomal dominant, pleiotropic disorder characterized by nail dysplasia, absent or hypoplastic patellae, iliac horns, and nephropathy. Previous studies have demonstrated linkage of the nail-patella locus to the ABO and adenylate kinase loci on human chromosome 9q34. As a first step toward isolating the NPS gene, we present linkage analysis with 13 polymorphic markers in five families with a total of 69 affected persons. Two-point linkage analysis with the program MLINK showed tight linkage of NPS and the anonymous markers D9S112 (LOD = 27.0; theta = .00) and D9S315 (LOD = 22.0; theta = .00). Informative recombination events place the NPS locus within a 1-2-cM interval between D9S60 and the adenylate kinase gene (AK1).	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; NIH, NATL CTR HUMAN GENOME RES, MED GENET BRANCH, BETHESDA, MD 20892 USA; NIH, NATL CTR HUMAN GENOME RES, LAB GENET DIS RES, BETHESDA, MD 20892 USA; UNIV WISCONSIN, DEPT PEDIAT, MADISON, WI USA; UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA; SO CALIF PERMANENTE MED GRP, DEPT MED GENET, SACRAMENTO, CA USA; MASSACHUSETTS GEN HOSP, MOL NEUROGENET UNIT, CHARLESTOWN, MA USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV EXPT MED, BOSTON, MA 02115 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	McIntosh, I (corresponding author), JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, 600 N WOLFE ST, BLALOCK 1012G, BALTIMORE, MD 21287 USA.		Pyeritz, Reed/A-1364-2010; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Puffenberger, Erik/0000-0002-6388-9148	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010293] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41135] Funding Source: Medline; NIDCR NIH HHS [DE10293] Funding Source: Medline; NIGMS NIH HHS [GM46846] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLUS GA, 1995, AM J HUM GENET, V56, P368; CAMPEAU E, 1995, AM J HUM GENET, V56, P243; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ehm MG, 1996, AM J HUM GENET, V58, P225; FIRTH ACD, 1912, BRIT J CHILD DIS, V9, P305; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GRZESCHIK KH, 1976, CYTOGENET CELL GENET, V16, P142, DOI 10.1159/000130576; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAWKINS CF, 1950, LANCET, V258, P803; JOHNSON DW, 1995, GENOMICS, V28, P356, DOI 10.1006/geno.1995.1157; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; KWIATKOWSKI DJ, 1992, NUCLEIC ACIDS RES, V20, P933; KWIATKOWSKI DJ, 1992, NUCLEIC ACIDS RES, V20, P930; KWIATKOWSKI DJ, 1992, NUCLEIC ACIDS RES, V20, P931; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVERSHA MA, 1994, 3 INT WORKSH CHROM C, V9; LITTLE EM, 1897, LANCET, V2, P781; LUCAS GL, 1966, J PEDIATR-US, V68, P273, DOI 10.1016/S0022-3476(66)80159-2; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MINO RA, 1948, AM J ROENTGENOL, V60, P633; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; OSTERREICHER W, 1931, Z MENSCHL VERERB KON, V15, P465; PERICAKVANCE MA, 1995, ANN HUM GENET, V59, P347, DOI 10.1111/j.1469-1809.1995.tb00756.x; POVEY S, 1976, ANN HUM GENET, V39, P413, DOI 10.1111/j.1469-1809.1976.tb00145.x; PUFFENBERGER EG, 1991, AM J HUM GENET, V49, P355; PUFFENBERGER EG, 1990, AM J HUM GENET S, V47, pA175; RAPLEY S, 1968, ANN HUM GENET, V31, P237, DOI 10.1111/j.1469-1809.1968.tb00554.x; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHLEUTERMANN DA, 1969, AM J HUM GENET, V21, P606; SHOVLIN CL, 1995, ANN HUM GENET, V59, P381; Turner JW, 1933, J AMER MED ASSOC, V100, P882, DOI 10.1001/jama.1933.02740120020008; VANCONG N, 1976, BIRTH DEFECTS OAS, V12, P241; WESTERVELD A, 1976, P NATL ACAD SCI USA, V73, P895, DOI 10.1073/pnas.73.3.895; WILDERVANCK L. S., 1950, GENETICA, V25, P1; [No title captured]	42	39	40	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					133	142						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981956				2022-12-18	WOS:A1997WA81800019
J	Genin, E; ClergetDarpoux, F				Genin, E; ClergetDarpoux, F			Consanguinity and the sib-pair method: An approach using identity by descent between and within individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE SUSCEPTIBILITY GENES; RECURSIVE ALGORITHM; LINKAGE; MARKER; LOCUS	To test for linkage between a trait and a marker, one can consider identical marker alleles in related individuals, for instance, sibs. For recessive diseases, it has been shown that some information may be gained from the identity by descent (IBD) of the two alleles of an affected inbred individual at the marker locus, The aim of this paper is to extend the sib-pair method of linkage analysis to the situation of sib pairs sampled from consanguineous populations. This extension takes maximum advantage of the information provided by both the IBD pattern between sibs and allelic identity within each sib of the pair. This is possible through the use of the condensed identity coefficients. Here, we propose a new test of linkage based on a chi(2). We compare the performance of this test with that of the classical chi(2) test based on the distribution of sib pairs sharing 0, 1, or 2 alleles IBD. For sib pairs from first-cousin matings, the proposed test can better detect the role of a disease-susceptibility (DS) locus. Its power is shown to be greater than that of the classical test, especially for models where the DS allele may be common and incompletely penetrant; that is to say for situations that may be encountered in multifactorial diseases. A study of the impact of inbreeding on the expected proportions of sib pairs sharing 0, 1, or 2 alleles IBD is also performed here. Ignoring inbreeding, when in fact inbreeding exists, increases the rate of type I errors in tests of linkage.	INST NATL ETUD DEMOG,F-75675 PARIS,FRANCE		Genin, E (corresponding author), INSERM,U155,UNITE RECH EPIDEMIOL GENET,CHATEAU LONGCHAMP,BOIS BOULOGNE,F-75016 PARIS,FRANCE.		Genin, Emmanuelle/C-4974-2013; Clerget-Darpoux, Francoise/I-4825-2017	Genin, Emmanuelle/0000-0003-4117-2813; Clerget-Darpoux, Francoise/0000-0003-4816-6619				BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CHEVALET C, 1984, GENET SEL EVOL, V16, P431, DOI 10.1186/1297-9686-16-4-431; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEVRIES RRP, 1976, LANCET, V2, P1328; GILLOIS M, 1964, RELATION IDENTITE GE; HAFEZ M, 1983, J MED GENET, V20, P58, DOI 10.1136/jmg.20.1.58; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Jacquard A, 1970, STRUCTURES GENETIQUE; JACUARD A, 1972, BIOMETRICS, V28, P1101; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; KARIGL G, 1982, ANN HUM GENET, V46, P83, DOI 10.1111/j.1469-1809.1982.tb00696.x; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANGE K, 1986, AM J HUM GENET, V39, P148; PENROSE LS, 1935, ANN EUGEN, V6, P133; SUAREZ BK, 1978, TISSUE ANTIGENS, V12, P87, DOI 10.1111/j.1399-0039.1978.tb01303.x; THOMPSON EA, 1974, BIOMETRICS, V30, P667, DOI 10.2307/2529231; THOMPSON EA, 1983, ANN HUM GENET, V47, P143, DOI 10.1111/j.1469-1809.1983.tb00981.x; THOMSON G, 1977, MEASURING SELECTION, P545; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	21	39	40	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1149	1162						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900245				2022-12-18	WOS:A1996VN90000024
J	Kruglyak, L; Lander, ES				Kruglyak, L; Lander, ES			Limits on fine mapping of complex traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE STRATEGIES				Kruglyak, L (corresponding author), MIT,WHITEHEAD INST BIOMED RES,CTR GENOME RES,1 KENDALL SQ,BLDG 300,CAMBRIDGE,MA 02139, USA.							KRUGLYAK L, 1995, AM J HUM GENET, V57, P212; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222	3	39	39	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1092	1093						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651271				2022-12-18	WOS:A1996UH19200023
J	Marazita, ML; Lu, H; Cooper, ME; Quinn, SM; Zhang, JB; Burmeister, JA; Califano, JV; Pandey, JP; Schenkein, HA; Tew, JG				Marazita, ML; Lu, H; Cooper, ME; Quinn, SM; Zhang, JB; Burmeister, JA; Califano, JV; Pandey, JP; Schenkein, HA; Tew, JG			Genetic segregation analyses of serum IgC2 levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS Y4; LOCALIZED JUVENILE PERIODONTITIS; EARLY-ONSET PERIODONTITIS; IMMUNODOMINANT ANTIGEN; YOUNG-ADULTS; SEROTYPE-B; ANTIBODY; LIPOPOLYSACCHARIDE; MOIETY; RACE	The aim of this study was to determine whether there was evidence for a genetic component in the immune response as measured by IgG2 levels. The study was motivated by our studies of early-onset periodontitis (EOP), a group of disorders characterized by rapid destruction of the supporting tissues of the teeth in otherwise healthy individuals. EOP has two subforms, localized juvenile periodontitis (LJP) and a generalized form (G-EOP). IgG2 Levels are elevated in LJP but not G-EOP individuals; and African-American IgG2 levels are higher than Caucasian levels regardless of EOP status. IgG2 levels were determined in 123 EOP families and in 508 unrelated non-EOP control individuals. Segregation analysis under the regressive model approach of Bonney was used to analyze IgG2 levels for evidence of major locus segregation. After adjusting for LJP status, race, sex, and age, the best-fitting model was an autosomal codominant major locus model (accounting for similar to 62% of the variance in IgG2), plus residual parent/offspring and spousal correlations. Smoking and GM23 are also known to affect IgG2 levels. If additional adjustments are made for smoking and GM23, the best-fitting model is still a codominant major Locus but with no significant residual correlations.	UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT MICROBIOL & IMMUNOL, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PERIODONT, RICHMOND, VA 23298 USA; MED UNIV S CAROLINA, DEPT MICROBIOL & IMMUNOL, CHARLESTON, SC 29425 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; Virginia Commonwealth University; Medical University of South Carolina	Marazita, ML (corresponding author), UNIV PITTSBURGH, SCH DENT MED, CLEFT PALATE CRANIOFACIAL CTR, DEPT ORAL & MAXILLOFACIAL SURG, PITTSBURGH, PA 15261 USA.				NCRR NIH HHS [1-P41-RR03655] Funding Source: Medline; NIDCR NIH HHS [DE-10703] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE010703] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BAER PN, 1971, J PERIODONTOL, V42, P516, DOI 10.1902/jop.1971.42.8.516; BAKER PJ, 1989, ORAL MICROBIOL IMMUN, V4, P98, DOI 10.1111/j.1399-302X.1989.tb00106.x; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; CALIFANO JV, 1989, INFECT IMMUN, V57, P1582, DOI 10.1128/IAI.57.5.1582-1589.1989; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Genco Robert J, 1985, J Periodontol, V56 Suppl 11S, P41, DOI 10.1902/jop.1985.56.11s.41; GRUBB R, 1995, EXP CLIN IMMUNOGENET, V12, P191; GUNSOLLEY JC, 1987, J PERIODONTOL, V58, P314, DOI 10.1902/jop.1987.58.5.314; GUNSOLLEY JC, 1988, J PERIODONTAL RES, V23, P303, DOI 10.1111/j.1600-0765.1988.tb01421.x; GUNSOLLEY JC, 1991, J PERIODONTAL RES, V26, P59, DOI 10.1111/j.1600-0765.1991.tb01627.x; HART TC, 1993, HUM GENET, V91, P416; LOE H, 1991, J PERIODONTOL, V62, P608, DOI 10.1902/jop.1991.62.10.608; *LSU MED CTR DEP B, 1994, SAGE STAT AN GEN EP; LU H, 1994, INFECT IMMUN, V62, P1677, DOI 10.1128/IAI.62.5.1677-1682.1994; LU H, 1993, INFECT IMMUN, V61, P2400, DOI 10.1128/IAI.61.6.2400-2407.1993; MANSON JD, 1974, J PERIODONTOL, V45, P636, DOI 10.1902/jop.1974.45.8.2.636; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MORELL A, 1972, J IMMUNOL, V108, P195; PAGE RC, 1991, INFECT IMMUN, V59, P3451, DOI 10.1128/IAI.59.10.3451-3462.1991; PROPERT D, 1995, EXP CLIN IMMUNOGENET, V12, P198; QUINN SM, 1995, J DENT RES, V74, P157; RANNEY RR, 1982, J PERIODONTOL, V53, P1; RAUTONEN N, 1989, EUR J IMMUNOL, V19, P817, DOI 10.1002/eji.1830190506; SCHANFIELD MS, 1986, HDB EXPT IMMUNOLOGY, V3; SORANT AJM, 1994, SAGE STAT ANAL GENET; VANDERGIESSEN M, 1973, CLIN EXP IMMUNOL, V14, P127; VYAS GN, 1968, J IMMUNOL, V100, P274; WILSON ME, 1991, INFECT IMMUN, V59, P1544, DOI 10.1128/IAI.59.4.1544-1551.1991; WILSON ME, 1992, INFECT IMMUN, V60, P1806, DOI 10.1128/IAI.60.5.1806-1812.1992	33	39	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1042	1049						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651265				2022-12-18	WOS:A1996UH19200017
J	BERAUDCOLOMB, E; ROUBIN, R; MARTIN, J; MAROC, N; GARDEISEN, A; TRABUCHET, G; GOOSSENS, M				BERAUDCOLOMB, E; ROUBIN, R; MARTIN, J; MAROC, N; GARDEISEN, A; TRABUCHET, G; GOOSSENS, M			HUMAN BETA-GLOBIN GENE POLYMORPHISMS CHARACTERIZED IN DNA EXTRACTED FROM ANCIENT BONES 12,000 YEARS OLD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							5' FLANKING REGION; SICKLE-CELL ANEMIA; MITOCHONDRIAL-DNA; ENZYMATIC AMPLIFICATION; MOLECULAR-CLONING; MUMMY DNA; SEQUENCE; REMAINS; CLUSTER; BRAIN	Analyzing the nuclear DNA from ancient human bones is an essential step to the understanding of genetic diversity in current populations, provided that such systematic studies are experimentally feasible. This article reports the successful extraction and amplification of nuclear DNA from the beta-globin region from 5 of 10 bone specimens up to 12,000 years old. These have been typed for beta-globin frameworks by sequencing through two variable positions and for a polymorphic (AT)(x)(T)(y) microsatellite 500 bp upstream of the beta-globin gene. These specimens of human remains are somewhat older than those analyzed in previous nuclear gene sequencing reports and considerably older than those used to study high-copy-number human mtDNA. These results show that the systematic study of nuclear DNA polymorphisms of ancient populations is feasible.	INST J PAOLI I CALMETTES,INSERM,U119,F-13005 MARSEILLE,FRANCE; CHU HENRI MONDOR,MOLEC GENET LAB,SERV BIOCHEM,F-94010 CRETEIL,FRANCE; CHU HENRI MONDOR,INSERM,U91,F-94010 CRETEIL,FRANCE; UNIV LYON 1,CTR GENET MOLEC & CELLULAIRE,CNRS,U106,F-69622 VILLEURBANNE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	BERAUDCOLOMB, E (corresponding author), INST J PAOLI I CALMETTES,INSERM,U406,27 BLVD JEAN MOULIN,F-13005 MARSEILLE,FRANCE.			Maroc, Nicolas/0000-0001-7285-509X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALL G, 1987, HUM EVOL, V2, P289; BERAUDCOLOMB E, 1993, MONOGRAPHIE CRA, P147; CANO RJ, 1993, NATURE, V363, P536, DOI 10.1038/363536a0; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; DELPOZZO G, 1989, NATURE, V339, P431; DESALLE R, 1992, SCIENCE, V257, P1860; DORAN GH, 1986, NATURE, V323, P803, DOI 10.1038/323803a0; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; GILL P, 1994, NAT GENET, V6, p1P30; GOLENBERG EM, 1990, NATURE, V344, P656, DOI 10.1038/344656a0; HAGELBERG E, 1989, NATURE, V342, P485, DOI 10.1038/342485a0; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; HAGELBERG E, 1994, NATURE, V370, P334; HANNI C, 1990, CR ACAD SCI III-VIE, V310, P365; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1989, P JPN ACAD B-PHYS, V65, P229, DOI 10.2183/pjab.65.229; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; HUMMEL S, 1991, NATURWISSENSCHAFTEN, V78, P266, DOI 10.1007/BF01134353; KUROSAKI K, 1993, AM J HUM GENET, V53, P638; LAWLOR DA, 1991, NATURE, V349, P786; MOSCHONAS N, 1982, NUCLEIC ACIDS RES, V10, P2109; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; ROGAN PK, 1990, YEARB PHYS ANTHROPOL, V33, P195; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SEMENZA GL, 1984, J BIOL CHEM, V259, P6045; THOMAS RH, 1989, NATURE, V340, P465, DOI 10.1038/340465a0; THOMAS WW, 1990, J MOL EVOL, V3, P101; TORRONI A, 1993, AM J HUM GENET, V53, P563; ULRICH MMW, 1987, BIOCHEM BIOPH RES CO, V149, P712, DOI 10.1016/0006-291X(87)90426-8	35	39	42	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1267	1274						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533755				2022-12-18	WOS:A1995TE65500003
J	KOBAYASHI, K; SHAHEEN, N; TERAZONO, H; SAHEKI, T				KOBAYASHI, K; SHAHEEN, N; TERAZONO, H; SAHEKI, T			MUTATIONS IN ARGININOSUCCINATE SYNTHETASE MESSENGER-RNA OF JAPANESE PATIENTS, CAUSING CLASSICAL CITRULLINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; HUMAN-LIVER; ENZYME; LOCUS; GENES; ARCHAEBACTERIA; ABNORMALITIES; DEFICIENCY; POLYMERASE; SEQUENCE	Citrullinemia is an autosomal recessive disease caused by a genetic deficiency of argininosuccinate synthetase. In order to characterize mutations in Japanese patients with classical citrullinemia, RNA isolated from 10 unrelated patients was reverse-transcribed, and cDNA amplified by PCR was cloned and sequenced. The 10 mutations identified included 6 missense mutations (A118T, A192V, R272C, G280R, R304W, and R363L), 2 mutations associated with an absence of an exon 7 or exon 13, 1 mutation with a deletion of the first 7 bp in exon 16 (which might be caused by abnormal splicing), and 1 mutation with an insertion of 37 bp within exons 15 and 16 in cDNA. The insertion mutation and the five missense mutations (R304W being excluded) are new mutations described in the present paper. These are in addition to 14 mutations (9 missense mutations, 4 mutations associated with an absence of an exon in mRNA, and 1 splicing mutation) that we identified previously in mainly American patients with neonatal citrullinemia. Two of these 20 mutations, a deletion of exon 13 sequence and a 7-bp deletion in exon 16, were common to Japanese and American populations from different ethnic backgrounds; however, other mutations were unique to each population. Furthermore, the presence of a frequent mutation-the exon 7 deletion mutation in mRNA, which accounts for 10 of 23 affected alleles-was demonstrated in Japanese citrullinemia. This differs from the situation in the United States, where there was far greater heterogeneity of mutations.			KOBAYASHI, K (corresponding author), KAGOSHIMA UNIV,FAC MED,DEPT BIOCHEM,SAKURAGAOKA 8-35-1,KAGOSHIMA 890,JAPAN.							BEAUDET AL, 1986, ADV HUM GENET, P161; BOCK HGO, 1983, NUCLEIC ACIDS RES, V11, P6505, DOI 10.1093/nar/11.18.6505; Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENNIS JA, 1989, P NATL ACAD SCI USA, V86, P7947, DOI 10.1073/pnas.86.20.7947; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; ENG CM, 1993, AM J HUM GENET, V53, P1186; IMAMURA Y, 1987, CLIN CHIM ACTA, V164, P201, DOI 10.1016/0009-8981(87)90071-4; ISASHIKI Y, 1989, Protein Sequences and Data Analysis, V2, P283; JACKSON MJ, 1989, MOL BIOL MED, V6, P179; KOBAYASHI K, 1987, HUM GENET, V76, P27; KOBAYASHI K, 1986, AM J HUM GENET, V38, P667; KOBAYASHI K, 1993, AM J HUM GENET, V53, P1024; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KOBAYASHI K, 1991, MOL BIOL MED, V8, P95; MORRIS CJ, 1988, J BACTERIOL, V170, P3125, DOI 10.1128/jb.170.7.3125-3130.1988; Nukada Osamu, 1991, Acta Paediatrica Japonica, V33, P672; OBRIEN WE, 1979, BIOCHEMISTRY-US, V18, P5353, DOI 10.1021/bi00591a015; SAHEKI T, 1987, ENZYME, V38, P227, DOI 10.1159/000469209; SAHEKI T, 1987, REV PHYSIOL BIOCH P, V108, P21, DOI 10.1007/BFb0034071; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; SAHEKI T, 1985, J INHERIT METAB DIS, V8, P155, DOI 10.1007/BF01819306; SAHEKI T, 1983, J BIOCHEM, V93, P1531, DOI 10.1093/oxfordjournals.jbchem.a134291; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SU TS, 1990, J BIOL CHEM, V265, P19716; SU TS, 1982, J CLIN INVEST, V70, P1334, DOI 10.1172/JCI110736; SURH LC, 1988, NUCLEIC ACIDS RES, V16, P9352, DOI 10.1093/nar/16.19.9352; SURH LC, 1991, GENE, V99, P181, DOI 10.1016/0378-1119(91)90125-U; VANVLIET F, 1990, GENE, V95, P99, DOI 10.1016/0378-1119(90)90419-R	30	39	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1103	1112						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977368				2022-12-18	WOS:A1994QB68400005
J	THEODOSIOU, AM; MORRISON, KE; NESBIT, AM; DANIELS, RJ; CAMPBELL, L; FRANCIS, MJ; CHRISTODOULOU, Z; DAVIES, KE				THEODOSIOU, AM; MORRISON, KE; NESBIT, AM; DANIELS, RJ; CAMPBELL, L; FRANCIS, MJ; CHRISTODOULOU, Z; DAVIES, KE			COMPLEX REPETITIVE ARRANGEMENTS OF GENE SEQUENCE IN THE CANDIDATE REGION OF THE SPINAL MUSCULAR-ATROPHY GENE IN 5Q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VII; BETA-GLUCURONIDASE; PRENATAL PREDICTION; SMA LOCUS; CHROMOSOME-5; CHILDHOOD; MAP; CONSTRUCTION; ADOLESCENCE; EXPRESSION	Childhood-onset proximal spinal muscular atrophy (SMA) is a heritable neurological disorder, which has been mapped by genetic linkage analysis to chromosome 5q13, in the interval between markers D5S435 and D5S557. Here, we present gene sequences that have been isolated from this interval, several of which show sequence homologies to exons of B-glucuronidase. These gene sequences are repeated several times across the candidate region and are also present on chromosome 5p. The arrangement of these repetitive gene motifs is polymorphic between individuals. The high degree of variability observed may have some influence on the expression of the genes in the region. Since SMA is not inherited as a classical autosomal recessive disease, novel genomic rearrangements arising from aberrant recombination events between the complex repeats may be associated with the phenotype observed.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,INST MOLEC MED,NEUROSCI GRP,OXFORD OX3 9DU,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,CTR CLIN SCI,LONDON W12 0HS,ENGLAND	University of Oxford; University of Oxford; Imperial College London				Tinsley, Louise/0000-0002-6893-2096; Morrison, Karen Elaine/0000-0003-0216-5717	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BUNDEY S, 1975, BRAIN, V98, P455, DOI 10.1093/brain/98.3.455; BUNDEY S, 1985, GENETICS NEUROLOGY, P172; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; CLERMONT O, 1994, AM J HUM GENET, V54, P687; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DANIELS RJ, 1992, J MED GENET, V29, P165, DOI 10.1136/jmg.29.3.165; Emery A E, 1991, Neuromuscul Disord, V1, P307, DOI 10.1016/0960-8966(91)90106-3; FRANK JL, 1993, SURG ONCOL, V2, P161, DOI 10.1016/0960-7404(93)90003-H; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; HAUSMANOWAPETRU.I, 1984, J MED GENET, V21, P447; HAUSMANOWAPETRU.I, 1985, J MED GENET, V22, P350; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LUND SD, 1991, MOL CELL BIOL, V11, P5426, DOI 10.1128/MCB.11.11.5426; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MELKI J, 1993, GENOMICS, V15, P521, DOI 10.1006/geno.1993.1103; MORRISON KE, 1992, AM J HUM GENET, V50, P520; MORRISON KE, 1993, HUM GENET, V92, P133; MORRISON KE, 1993, HUM MOL GENET, V2, P1753, DOI 10.1093/hmg/2.10.1753; MULLER B, 1992, AM J HUM GENET, V50, P892; MUNSAT TL, 1969, BRAIN, V92, P9, DOI 10.1093/brain/92.1.9; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Sambrook J., 1989, MOL CLONING LAB MANU; SHETH P, 1991, AM J HUM GENET, V48, P764; SHIPLEY JM, 1993, AM J HUM GENET, V52, P517; SIMNARD LR, 1994, HUM MOL GENET, V3, P459; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; SOARES VM, 1993, GENOMICS, V15, P365, DOI 10.1006/geno.1993.1069; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169; TOMATSU S, 1991, AM J HUM GENET, V48, P89; TOMATSU S, 1990, GENE, V89, P283, DOI 10.1016/0378-1119(90)90019-N; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130	37	39	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1209	1217						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977382				2022-12-18	WOS:A1994QB68400019
J	ARREDONDOVEGA, FX; SANTISTEBAN, I; KELLY, S; SCHLOSSMAN, CM; UMETSU, DT; HERSHFIELD, MS				ARREDONDOVEGA, FX; SANTISTEBAN, I; KELLY, S; SCHLOSSMAN, CM; UMETSU, DT; HERSHFIELD, MS			CORRECT SPLICING DESPITE MUTATION OF THE INVARIANT FIRST NUCLEOTIDE OF A 5' SPLICE-SITE - A POSSIBLE BASIS FOR DISPARATE CLINICAL PHENOTYPES IN SIBLINGS WITH ADENOSINE-DEAMINASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER RNA; SEVERE COMBINED IMMUNODEFICIENCY; NONSENSE MUTATIONS; JUNCTION SEQUENCES; INTRON SEQUENCES; III PROCOLLAGEN; POINT MUTATION; CLEAVAGE SITE; U1 SNRNA; GENE	Adenosine deaminase (ADA) deficiency usually causes severe combined immune deficiency in infancy. Milder phenotypes, with delayed or late onset and gradual decline in immune function, also occur and are associated with less severely impaired deoxyadenosine (dAdo) catabolism. We have characterized the mutations responsible for ADA deficiency in siblings with Striking disparity in clinical phenotype. Erythrocyte dAdo nucleotide pool size, which reflects total residual ADA activity, was lower in the older, more mildly affected sib (RG) than in her younger, more severely affected sister (EG). Cultured T cells, fibroblasts, and B lymphoblasts of RG had detectable residual ADA activity, while cells of EG did not, ADA mRNA was undetectable by northern analysis in these cells of both patients. Both sibs were found to be compound heterozygotes for the following novel splicing defects: (1) a G(+1)-->A substitution at the 5' splice site of IVS 2 and (2) a complex 17-bp rearrangement of the 3' splice site of IVS 8, which inserted a run of seven purines into the polypyrimidine tract and altered the reading frame of exon 9. PCR-amplified ADA cDNA clones with premature translation stop codons arising from aberrant pre-mRNA splicing were identified, which were consistent with these mutations. However, some cDNA clones from T cells of both patients and from fibroblasts and Epstein-Barr virus (EBV)-transformed B cells of RG, were normally spliced at both the exon 2/3 and exon 8/9 junctions. A normal coding sequence was documented for clones from both sibs. The normal cDNA clones did not appear to arise from either contamination or PCR artifact, and mosaicism seems unlikely to have been involved. These findings suggest (1) that a low level of normal pre-mRNA splicing may occur despite mutation of the invariant first nucleotide of the 5' splice donor sequence and (2) that differences in efficiency of such splicing may account for the difference in residual ADA activity, immune dysfunction, and clinical severity in these siblings.	DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; KAISER PERMANENTE MED CTR,DEPT MED GENET,SANTA CLARA,CA; KAISER PERMANENTE MED CTR,DEPT PEDIAT,SANTA CLARA,CA; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305	Duke University; Kaiser Permanente; Kaiser Permanente; Stanford University					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020902] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00070] Funding Source: Medline; NIAID NIH HHS [R01 AI26322] Funding Source: Medline; NIDDK NIH HHS [R01 DK20902] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; AKESON AL, 1989, J CELL BIOCHEM, V39, P217, DOI 10.1002/jcb.240390302; ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; COLE WG, 1990, J BIOL CHEM, V265, P17070; COULTERKARIS DE, 1989, ANN HUM GENET, V53, P169, DOI 10.1111/j.1469-1809.1989.tb01781.x; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Erlich HA., 1989, PCR TECHNOLOGY PRINC, DOI 10.1007/978-1-349-20235-5; FLETCHER JA, 1991, GENE CHROMOSOME CANC, V3, P37, DOI 10.1002/gcc.2870030107; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GEFFNER ME, 1986, AM J DIS CHILD, V140, P1194, DOI 10.1001/archpedi.1986.02140250120047; GIBLETT ER, 1972, LANCET, V2, P1067; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HERSHFIELD MS, IN PRESS MOL METABOL; HIRSCHHORN R, 1993, PEDIATR RES, V33, pS35; HIRSCHHORN R, 1990, Immunodeficiency Reviews, V2, P175; HIRSCHHORN R, 1993, AM J HUM GENET, V53, P162; HIRSCHHORN R, 1979, CIBA F S, V68, P35; KAWAMOTO H, 1993, J CELL BIOCHEM, V51, P322, DOI 10.1002/jcb.240510311; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; LEVY Y, 1988, J PEDIATR-US, V113, P312, DOI 10.1016/S0022-3476(88)80271-3; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MARKERT ML, 1987, J IMMUNOL, V138, P3203; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; MARTON A, 1991, NUCLEIC ACIDS RES, V19, P2423, DOI 10.1093/nar/19.9.2423; MCINNES B, 1992, J CLIN INVEST, V90, P306, DOI 10.1172/JCI115863; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; MORGAN G, 1987, CLIN EXP IMMUNOL, V70, P491; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NEWMAN AJ, 1985, CELL, V42, P335, DOI 10.1016/S0092-8674(85)80129-X; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PARKER R, 1985, CELL, V41, P107, DOI 10.1016/0092-8674(85)90065-0; PEEBLES CL, 1993, J BIOL CHEM, V268, P11929; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; RUBINSTEIN A, 1979, NEW ENGL J MED, V300, P387, DOI 10.1056/NEJM197902223000802; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; Sambrook J., 1989, MOL CLONING LAB MANU; SANTISTEBAN I, 1993, J CLIN INVEST, V92, P2291, DOI 10.1172/JCI116833; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; SERAPHIN B, 1990, CELL, V63, P619, DOI 10.1016/0092-8674(90)90457-P; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHOVLIN CL, 1993, LANCET, V341, P1471, DOI 10.1016/0140-6736(93)90910-9; SOKUP SW, 1991, GENE CHROMOSOME CANC, V3, P231; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; UMETSU DT, 1994, J ALLERGY CLIN IMMUN, V93, P543, DOI 10.1016/0091-6749(94)90365-4; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; WIERINGA B, 1983, NATURE, V301, P38, DOI 10.1038/301038a0; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; WIGINTON DA, 1984, NUCLEIC ACIDS RES, V12, P2439, DOI 10.1093/nar/12.5.2439; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WIGINTON DA, 1983, P NATL ACAD SCI-BIOL, V80, P7481, DOI 10.1073/pnas.80.24.7481	66	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					820	830						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178821				2022-12-18	WOS:A1994NH39400011
J	CHAKRABORTY, R; SRINIVASAN, MR; DAIGER, SP				CHAKRABORTY, R; SRINIVASAN, MR; DAIGER, SP			EVALUATION OF STANDARD ERROR AND CONFIDENCE-INTERVAL OF ESTIMATED MULTILOCUS GENOTYPE PROBABILITIES, AND THEIR IMPLICATIONS IN DNA FORENSICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VNTR LOCI; POPULATION; POLYMORPHISMS; ADMIXTURE; EVOLUTION; FREQUENCY	Multilocus genotype probabilities, estimated using the assumption of independent association of alleles within and across loci, are subject to sampling fluctuation, since allele frequencies used in such computations are derived from samples drawn from a population. We derive exact sampling variances of estimated genotype probabilities and provide simple approximation of sampling variances. Computer simulations conducted using real DNA typing data indicate that, while the sampling distribution of estimated genotype probabilities is not symmetric around the point estimate, the confidence interval of estimated (single-locus or multilocus) genotype probabilities can be obtained from the sampling of a logarithmic transformation of the estimated values. This, in turn, allows an examination of heterogeneity of estimators derived from data on different reference populations. Applications of this theory to DNA typing data at VNTR loci suggest that use of different reference population data may yield significantly different estimates. However, significant differences generally occur with rare (less than 1 in 40,000) genotype probabilities. Conservative estimates of five-locus DNA profile probabilities are always less than 1 in 1 million in an individual from the United States, irrespective of the racial/ethnic origin.			CHAKRABORTY, R (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,CTR GENET,POB 20334,HOUSTON,TX 77225, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER; NIGMS NIH HHS [IR01-GM41399] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1984, HISTOCOMPATIBILITY T; BALAZS I, 1989, AM J HUM GENET, V44, P182; Berry DA, 1992, APPL STAT, V41, P499, DOI 10.1111/j.1467-9876.1992/tb02418.x; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BUDOWLE B, 1991, CRIME LAB DIGEST, V18, P9; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1991, SCIENCE, V254, P1735, DOI 10.1126/science.1763323; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHAKRABORTY R, 1991, HUM BIOL, V63, P571; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257; CHAKRABORTY R, 1992, HUM BIOL, V56, P141; CHAKRABORTY R, IN PRESS 3RD P INT S; CHAKRABORTY R, IN PRESS GENETICS; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1991, AM J HUM GENET, V48, P662; EVETT IW, 1991, NATURE, V354, P114, DOI 10.1038/354114d0; FOREMAN L, 1991, AM J HUM GENET S, V49, P64; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; GOODMAN LA, 1962, J AM STAT ASSOC, V57, P54; Johnson NL, 1969, DISTRIBUTIONS STAT D; LI CC, 1976, 1ST COURSE POPULATIO; MOHRENWEISER HW, 1987, ANN HUM GENET, V51, P303, DOI 10.1111/j.1469-1809.1987.tb01065.x; MORRIS JW, 1989, J FORENSIC SCI, V34, P1311; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P2256; Mourant AE, 1976, DISTRIBUTION HUMAN B; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEI M, 1982, EVOL BIOL, V14, P1; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; RAO CR, 1973, LINEAR STATISTICAL I; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; ROBERTS L, 1991, SCIENCE, V254, P1721, DOI 10.1126/science.1763321; SOLOMON E, 1991, CYTOGENET CELL GENET, V52, P1; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; TILLS D, 1983, DISTRIBUTION HUMAN 1, V1; WEIR BS, 1992, GENETICS, V130, P873; Weir BS, 1990, GENETIC DATA ANAL	39	39	40	0	18	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					60	70						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434606				2022-12-18	WOS:A1993KK90800007
J	TIERCY, JM; SANCHEZMAZAS, A; EXCOFFIER, L; XIAOWEN, SI; JEANNET, M; MACH, B; LANGANEY, A				TIERCY, JM; SANCHEZMAZAS, A; EXCOFFIER, L; XIAOWEN, SI; JEANNET, M; MACH, B; LANGANEY, A			HLA-DR POLYMORPHISM IN A SENEGALESE MANDENKA POPULATION - DNA OLIGOTYPING AND POPULATION-GENETICS OF DRB1 SPECIFICITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUB-SAHARAN AFRICA; CLASS-II; OLIGONUCLEOTIDE PROBES; NUCLEOTIDE SUBSTITUTION; OVERDOMINANT SELECTION; LINKAGE DISEQUILIBRIUM; HAPLOTYPE FREQUENCIES; PROTEIN POLYMORPHISM; CHINESE POPULATION; TYPING ANALYSIS	HLA class II loci are useful markers in human population genetics, because they are extremely variable and because new molecular techniques allow large-scale analysis of DNA allele frequencies. Direct DNA typing by hybridization with sequence-specific oligonucleotide probes (HLA oligotyping) after enzymatic in vitro PCR amplification detects HLA allelic polymorphisms for all class II loci. A detailed HLA-DR oligotyping analysis of 191 individuals from a geographically, culturally, and genetically well-defined western African population, the Mandenkalu, reveals a high degree of polymorphism, with at least 24 alleles and a heterozygosity level of .884 for the DRB1 locus. The allele DRB1*1304, defined by DNA sequencing of the DRB1 first-domain exon, is the most frequent allele (27.1%). It accounts for an unusually high DR13 frequency, which is nevertheless within the neutral frequency range. The next most frequent specificities are DR11, DR3, and DR8. Among DRB3-encoded alleles, DR52b (DRB3*02) represents as much as 80.7% of all DR52 haplotypes. A survey of HLA-DR specificities in populations from different continents shows a significant positive correlation between genetic and geographic differentiation patterns. A homozygosity test for selective neutrality of DR specificities is not significant for the Mandenka population but is rejected for 20 of 24 populations. Observed high heterozygosity levels in tested populations are compatible with an overdominant model with a small selective advantage for heterozygotes.	CNR MUSEUM,URA 49,PARIS,FRANCE; HOP CANTONAL GENEVA,TRANSPLANTAT IMMUNOL UNIT,CH-1211 GENEVA 4,SWITZERLAND; UNIV GENEVA,DEPT GENET & MICROBIOL,CH-1211 GENEVA 4,SWITZERLAND; UNIV GENEVA,DEPT ANTHROPOL & ECOL,GENET & BIOMETRY LAB,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva; University of Geneva; University of Geneva			Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494; SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432				ANGELINI G, 1986, P NATL ACAD SCI USA, V83, P4489, DOI 10.1073/pnas.83.12.4489; AYED K, 1987, TISSUE ANTIGENS, V29, P225; BARBUJANI G, 1991, TRENDS ECOL EVOL, V6, P151, DOI 10.1016/0169-5347(91)90056-4; BARBUJANI G, 1991, HUM BIOL, V63, P253; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BLACK FL, 1981, AM J HUM GENET, V33, P894; BLANC M, 1990, AM J HUM GENET, V46, P383; BODMER JG, 1991, TISSUE ANTIGENS, V37, P97, DOI 10.1111/j.1399-0039.1991.tb01853.x; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; CAMBONTHOMSEN A, 1986, C INSERM, V142, P297; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHAKRABORTY R, 1978, AM J HUM GENET, V30, P550; CHAKRABORTY R, 1991, AM J HUM GENET, V49, P242; CRANE G, 1985, HUM IMMUNOL, V12, P247, DOI 10.1016/0198-8859(85)90340-4; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; DUTOIT ED, 1990, HUM IMMUNOL, V28, P406, DOI 10.1016/0198-8859(90)90035-N; DUTOIT ED, 1990, TISSUE ANTIGENS, V36, P122, DOI 10.1111/j.1399-0039.1990.tb01812.x; DUTOIT ED, 1987, TISSUE ANTIGENS, V31, P109; EWENS WJ, 1979, THEOR POPUL BIOL, V15, P205, DOI 10.1016/0040-5809(79)90035-2; EXCOFFIER L, 1991, HUM BIOL, V63, P273; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; EXCOFFIER L, 1988, THESIS U GENEVA GENE; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; FUERST PA, 1977, GENETICS, V86, P455; GAO XJ, 1991, TISSUE ANTIGENS, V38, P24, DOI 10.1111/j.1399-0039.1991.tb02031.x; GORSKI J, 1987, IMMUNOGENETICS, V25, P397, DOI 10.1007/BF00396106; HANSEN JA, 1986, HUM IMMUNOL, V16, P315, DOI 10.1016/0198-8859(86)90059-5; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P248; HELMUTH R, 1990, AM J HUM GENET, V47, P515; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, P NATL ACAD SCI USA, V89, P2277, DOI 10.1073/pnas.89.6.2277; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; JARAQUEMADA D, 1984, TISSUE ANTIGENS, V23, P23; KALIDI I, 1988, TISSUE ANTIGENS, V31, P98, DOI 10.1111/j.1399-0039.1988.tb02070.x; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; KAWAI J, 1989, J IMMUNOL, V142, P312; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KLEIN J, 1991, HUM IMMUNOL, V30, P247, DOI 10.1016/0198-8859(91)90003-R; KLITZ W, 1986, AM J HUM GENET, V39, P340; LALOUEL JM, 1976, AM J PHYS ANTHROPOL, V45, P453, DOI 10.1002/ajpa.1330450307; LANGANEY A, 1973, HUM BIOL, V45, P137; LANGANEY A, 1979, POPULATION, V34, P985, DOI 10.2307/1531429; LEE KW, 1990, J IMMUNOL, V145, P3119; LEE TD, 1990, TISSUE ANTIGENS, V35, P64, DOI 10.1111/j.1399-0039.1990.tb01758.x; LEE TD, 1988, TISSUE ANTIGENS, V32, P188, DOI 10.1111/j.1399-0039.1988.tb01656.x; MACH B, 1991, HUM IMMUNOL, V30, P278, DOI 10.1016/0198-8859(91)90007-V; MACH B, 1990, MOL BIOL HLA CLASS 2, P201; Malecot G, 1948, MATH HEREDITE; MANTEL N, 1967, CANCER RES, V27, P209; MARSH SGE, 1991, TISSUE ANTIGENS, V37, P181, DOI 10.1111/j.1399-0039.1991.tb01870.x; MEHRA NK, 1986, TISSUE ANTIGENS, V27, P64; MITTAL KK, 1982, TISSUE ANTIGENS, V20, P223; MONPLAISIR N, 1985, TISSUE ANTIGENS, V26, P1; MOREL C, 1990, HUM IMMUNOL, V29, P64, DOI 10.1016/0198-8859(90)90070-6; MORTON NE, 1972, THEOR POPUL BIOL, V2, P507; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEI M, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P222; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1984, EVOL BIOL, V17, P73; OBATA F, 1991, TISSUE ANTIGENS, V38, P124, DOI 10.1111/j.1399-0039.1991.tb02025.x; OKOYE RC, 1989, TISSUE ANTIGENS, V33, P445, DOI 10.1111/j.1399-0039.1989.tb01693.x; OLLIER W, 1985, TISSUE ANTIGENS, V25, P87; PACHOULAPAPASTERIADIS C, 1989, TISSUE ANTIGENS, V33, P488, DOI 10.1111/j.1399-0039.1989.tb01698.x; PAPIHA SS, 1985, HUM HERED, V35, P246, DOI 10.1159/000153553; PEI J, 1985, TISSUE ANTIGENS, V26, P323; PIAZZA A, 1980, HUM IMMUNOL, V4, P297; POWELL JR, 1972, EVOLUTION, V26, P553, DOI 10.1111/j.1558-5646.1972.tb01963.x; ROHLF FJ, 1990, NUMERICAL TAXONOMY S; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; SANCHEZMAZAS A, 1988, HUM GENET, V78, P161, DOI 10.1007/BF00278189; SANCHEZMAZAS A, 1990, THESIS U GENEVA GENE; Sokal R.R., 1981, BIOMETRY, V2nd ed.; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; TAKAHATA N, 1990, GENETICS, V124, P967; TIERCY JM, 1991, TISSUE ANTIGENS, V37, P161, DOI 10.1111/j.1399-0039.1991.tb01865.x; TIERCY JM, 1990, BLOOD REV, V4, P9, DOI 10.1016/0268-960X(90)90012-H; TIERCY JM, 1988, P NATL ACAD SCI USA, V85, P198, DOI 10.1073/pnas.85.1.198; TIERCY JM, 1990, EUR J IMMUNOL, V20, P237, DOI 10.1002/eji.1830200202; TIERCY JM, 1989, HUM IMMUNOL, V24, P1, DOI 10.1016/0198-8859(89)90042-6; TIERCY JM, 1991, TRANSPLANTATION, V51, P1110, DOI 10.1097/00007890-199105000-00034; TROWSDALE J, 1991, IMMUNOL TODAY, V12, P443, DOI 10.1016/0167-5699(91)90017-N; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1977, GENETICS, V85, P789; ZEMMOUR J, 1991, TISSUE ANTIGENS, V37, P174, DOI 10.1111/j.1399-0039.1991.tb01869.x	91	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					592	608						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496990				2022-12-18	WOS:A1992JJ82800017
J	KAWAME, H; ETO, Y				KAWAME, H; ETO, Y			A NEW GLUCOCEREBROSIDASE-GENE MISSENSE MUTATION RESPONSIBLE FOR NEURONOPATHIC GAUCHER DISEASE IN JAPANESE PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLUCOSIDASE GENE; ALLELES	We have identified a new T-to-A single-base substitution at nucleotide 3548 (in the genomic sequence) in exon 6 in the glucocerebrosidase gene from a patient with Gaucher disease type 3. This mutation caused a substitution of isoleucine for phenylalanine at amino acid residue 213 (of 497 residues in the mature protein). By in vitro expression study in cultured mammalian cells, this mutation resulted in deficient activity of glucocerebrosidase. By allele-specific oligonucleotide hybridization of selectively PCR-amplified DNA from eight unrelated Japanese Gaucher disease patients, this mutant allele was observed in other neuronopathic Japanese Gaucher disease patients, in moderately frequent occurrence (three of six neuronopathic patients). This observation suggests that this allele was one of several alleles which were related to the development of neurological manifestations of Gaucher disease.			KAWAME, H (corresponding author), JIKEI UNIV,DEPT PEDIAT,3-25-8 NISHI SHINBASHI,MINATO KU,TOKYO 105,JAPAN.							DAHL N, 1990, AM J HUM GENET, V47, P275; FIRON N, 1990, AM J HUM GENET, V46, P527; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; KOLODNY EH, 1990, AM J MED GENET, V36, P467, DOI 10.1002/ajmg.1320360419; LATHAM T, 1990, AM J HUM GENET, V47, P79; MASUNO M, 1990, HUM GENET, V84, P203; MUTOH K, 1988, No To Hattatsu, V20, P49; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	14	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1378	1380						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1840477				2022-12-18	WOS:A1991GU67200026
J	GARVER, KL; GARVER, B				GARVER, KL; GARVER, B			HISTORICAL PERSPECTIVES - EUGENICS - PAST, PRESENT, AND THE FUTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SURGICAL SOLUTION; GERMAN EUGENICS; HUMAN GENOME; HEALTH-CARE; GENETICS; ETHICS; AUDIT; STERILIZATION; MECHANISM; HEREDITY	During the past 20 years there has been a resurgence of interest in the history of the eugenics movements, particularly those of the United States and Germany. Unfortunately, most of these accounts have been published in nonmedical and nongenetic journals, so they are not readily available to geneticists or physicians. The authors of this article are concerned about the lack of information that geneticists, physicians, and students have concerning the origin and progress of these movements. This article provides a short history of the American and German eugenics programs and concludes with a review of their possible relations to our current practices. It is hoped that this will encourage institutions to include, in master's, Ph.D., and M.D. programs in human genetics, lectures, seminars, and journal clubs on the topic of eugenics.	UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	GARVER, KL (corresponding author), WESTERN PENN HOSP, DEPT MED GENET, 4800 FRIENDSHIP AVE, PITTSBURGH, PA 15224 USA.							ALEXANDER L, 1949, NEW ENGL J MED, V241, P39, DOI 10.1056/NEJM194907142410201; ALLAN W, 1936, SO MED SURG      AUG, P416; ALLEN G, 1979, SCI AM CONTEXT NEW P, P209; ALLEN G, 1980, PL MAGAZINE, V13, P28; ALLEN G, 1980, SCI PEOPLE       JUL, P22; ALLEN G, 1974, SCI PEOPLE       MAR, P32; ALLEN GE, 1986, OSIRIS, V2, P225, DOI 10.1086/368657; ALLEN GE, 1984, SOC RES, V51, P709; ALLEN GE, 1975, GENETICS, V79, P29; ALLEN GE, 1975, ISIS, V66, P322, DOI 10.1086/351472; ALLEN NS, 1983, POLYM DEGRAD STABIL, V5, P105, DOI 10.1016/0141-3910(83)90003-4; [Anonymous], 1988, MAPPING SEQUENCING H; Barth Karl, 1961, CHURCH DOGMATICS; BECKWITH J, 1976, ANN NY ACAD SCI, V265, P46, DOI 10.1111/j.1749-6632.1976.tb29318.x; Bird R D, 1981, J Hist Biol, V14, P339, DOI 10.1007/BF00141098; BLACKER CP, 1952, EUGENICS; BLOCH H, 1973, B HIST MED, V48, P297; BUNDEY S, 1990, LANCET, V335, P1406, DOI 10.1016/0140-6736(90)91288-L; CARTER CO, 1971, LANCET, V1, P281, DOI 10.1016/S0140-6736(71)91016-6; CARTER CO, 1974, BIRTH DEFECTS, P277; CHAPPLE JC, 1987, LANCET, V1, P1189; Chase A., 1980, LEGACY MALTHUS; CHILDS B, 1973, YALE J BIOL MED, V46, P297; CLARKE A, 1990, LANCET, V336, P120, DOI 10.1016/0140-6736(90)91637-P; CLARKE A, 1990, LANCET, V335, P1145, DOI 10.1016/0140-6736(90)91139-2; COWAN R S, 1972, Journal of the History of Biology, V5, P389, DOI 10.1007/BF00346665; COWAN RS, 1972, ISIS, V63, P509, DOI 10.1086/351000; DAVIS A, 1990, LANCET, V335, P1406; DICE LR, 1952, AM J HUM GENET, V4, P1; DUGDALE RL, 1877, JUKES STUDY CREME PA; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; DUNN LC, 1962, AM J HUM GENET, V14, P1; Fisher RA, 1924, EUGEN REV, V16, P114; FOST N C, 1990, Pediatrics, V85, P868; Galton F, 1901, NATURE, V64, P659; Galton F, 1865, MACMILLANS MAGAZINE, V12, P318; GALTON F, 1905, EUGENICS ITS DEFINIT, P45; Galton F., 1865, MACMILLANS MAGAZINE, V12; GLASS B, 1981, P AM PHILOS SOC, V125, P357; Haller Mark, 1963, EUGENICS HEREDITARIA; HOFFMEYER P, 1989, WOOD SCI TECHNOL, V23, P215, DOI 10.1007/BF00367735; HUBBARD R, 1986, INT J HEALTH SERV, V16, P227, DOI 10.2190/1YKE-PHP6-H69A-YRKV; HUBBARD R, 1985, WOMEN STUD INT FORUM, V8, P567, DOI 10.1016/0277-5395(85)90095-0; KEVLES DJ, 1985, GAME EUGENICS; KIMBALL MC, 1990, HEALTHWEEK, V4, P41; KIMBALL MC, 1990, HEALTHWEEK, V4, P1; LACHAT MR, 1975, LINACRE Q        FEB, P14; LEVINSKY NG, 1990, NEW ENGL J MED, V322, P1813, DOI 10.1056/NEJM199006213222512; LIFTON RJ, 1986, NAZI DOCTORS; LINDEMAN EC, 1936, AM EUGENICS; LUDMERER K M, 1972, Bulletin of the History of Medicine, V46, P59; LUDMERER K M, 1969, Journal of the History of Biology, V2, P337, DOI 10.1007/BF00125023; MCKUSICK VA, 1989, NEW ENGL J MED, V320, P910, DOI 10.1056/NEJM198904063201406; Mitscherlich A, 1949, DOCTORS INFAMY STORY; MODELL B, 1989, CLIN GENET, V36, P286; Motulsky A. G., 1986, HUM GENET, P3; Muller HJ, 1933, SCI MON, V37, P40; Muller-Hill B., 1988, MURDEROUS SCI; MURPHY EA, 1975, JOHNS HOPKINS MED J, V136, P98; NOAKES J, 1984, IDEAS POLITICS ASPEC, P75; OSBORN F, 1974, SOC BIOL, V21, P115, DOI 10.1080/19485565.1974.9988099; PAUL D, 1984, J HIST IDEAS, V45, P567, DOI 10.2307/2709374; PETCHESKY RP, 1979, HASTINGS CENT REP, V9, P29, DOI 10.2307/3561518; PFAAFFLIN F, 1986, MED LAW, V5, P1; POLTAWSKA W, 1964, I AM AFRAID MY DREAM; POPKIN RH, 1974, J OPER PSYCHIATR, V5, P24; Proctor R. N., 1988, RACIAL HYGIENE; Punnett RC, 1917, J HERED, V8, P464, DOI 10.1093/oxfordjournals.jhered.a111653; REED SC, 1957, AM J HUM GENET, V9, P1; REILLY P, 1983, AM J MED GENET, V16, P483, DOI 10.1002/ajmg.1320160407; REILLY P, 1983, PERSPECT BIOL MED, V26, P637; REILLY PR, 1987, Q REV BIOL, V62, P153, DOI 10.1086/415404; REITMAN MJ, 1978, PEDIATRICS, V62, P847; RELMAN AS, 1990, NEW ENGL J MED, V323, P991, DOI 10.1056/NEJM199010043231411; RELMAN AS, 1990, NEW ENGL J MED, V323, P911, DOI 10.1056/NEJM199009273231310; RUSS AR, 1976, J HIST BEHAV SCI, V12, P47; Sapp J., 1983, Journal of the History of Biology, V16, P311, DOI 10.1007/BF00582405; SEARLE GR, 1976, SOC STUD SCI, V6, P217; SEIDELMAN WE, 1989, HASTINGS CENT REP, V19, P5, DOI 10.2307/3561978; SHERLOCK R, 1987, PRESERVING LIFE PUBL; SHORT EM, 1988, AM J HUM GENET, V43, P101; SMITH JD, 1985, MINDS MADE FEEBLE; Tenenbaum J., 1956, RACE REICH STORY EPO; THIELMAN SB, 1985, PSYCHIATRY, V48, P299, DOI 10.1080/00332747.1985.11024291; TORMEY J F, 1976, Clinical Obstetrics and Gynecology, V19, P957, DOI 10.1097/00003081-197612000-00020; WEINDLING P, 1985, ANN SCI, V42, P303, DOI 10.1080/00033798500200221; Weindling P, 1989, HLTH RACE GERMAN POL; WEISS SF, 1986, ISIS, V77, P33, DOI 10.1086/354037; WEISS SF, 1987, RACE HYGIENE NATIONA; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; 1972, GENETIC AM SOC; 1953, OXFORD DICT QUOTATIO; 1991, NIH901590 PUBL	93	39	39	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1109	1118						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	GM873	1928094				2022-12-18	WOS:A1991GM87300026
J	HILTUNEN, T; KIURU, S; HONGELL, V; HELIO, T; PALO, J; PELTONEN, L				HILTUNEN, T; KIURU, S; HONGELL, V; HELIO, T; PALO, J; PELTONEN, L			FINNISH TYPE OF FAMILIAL AMYLOIDOSIS - COSEGREGATION OF ASP187-]ASN MUTATION OF GELSOLIN WITH THE DISEASE IN 3 LARGE FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORNEAL LATTICE DYSTROPHY; HEREDITARY AMYLOIDOSIS; CRANIAL NEUROPATHY; PREALBUMIN VARIANT; TRANSTHYRETIN PREALBUMIN; FIBRIL PROTEIN; INDIANA SWISS; DNA; POLYNEUROPATHY; PLASMA	Familial amyloidosis of Finnish type (FAF) is one of the familial amyloidotic polyneuropathy (FAP) syndromes, a group of inherited disorders characterized by extracellular accumulation of amyloid and by clinical symptoms and signs of polyneuropathy. FAF, an autosomal dominant trait, belongs to those rare monogenic disorders which occur with increased frequency in the Finnish population: only single FAF cases have been reported from other populations. In most types of FAP syndromes the accumulating protein is a transthyretin variant. However, recent evidence has suggested that the amyloid peptides in FAF are related to gelsolin, an actin modulating protein. The gelsolin fragments isolated from at least one patient with amyloidosis have been reported to have an amino acid substitution, with asparagine replacing aspartic acid at position 187 of the plasma gelsolin. In this study allele-specific oligonucleotides were used to analyze three large FAF families with multiple affected individuals as well as healthy family members. We found the corresponding G-A mutation in nucleotide 654 of the plasma gelsolin gene to cosegregate with the disease. The result was confirmed by sequencing and strongly suggests that the mutation has caused all the FAF cases of these families. Since the disease is clustered in restricted areas on the southern coast of Finland, this mutation most probably causes the majority, if not all, of FAF cases in Finland.	NATL PUBL HLTH INST,MOLEC GENET LAB,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND; UNIV HELSINKI,DEPT NEUROL,SF-00100 HELSINKI 10,FINLAND; UNIV HELSINKI,DEPT MED 1,SF-00100 HELSINKI 10,FINLAND; KYMENLAAKSO CENT HOSP,DEPT OPHTHALMOL,KOTKA,FINLAND	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki								ANDRADE C, 1970, ARTHRITIS RHEUM, V13, P902, DOI 10.1002/art.1780130622; BOYSEN G, 1979, J NEUROL NEUROSUR PS, V42, P1020, DOI 10.1136/jnnp.42.11.1020; COHEN AS, 1984, PERIPHERAL NEUROPATH, V2, P1866; DARRAS BT, 1986, NEUROLOGY, V36, P432, DOI 10.1212/WNL.36.3.432; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; DWULET FE, 1986, J CLIN INVEST, V78, P880, DOI 10.1172/JCI112675; HALTIA M, 1990, BIOCHEM BIOPH RES CO, V167, P927, DOI 10.1016/0006-291X(90)90612-Q; HALTIA M, 1990, AM J PATHOL, V136, P1223; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; JACOBSON DR, 1988, BIOCHEM BIOPH RES CO, V153, P198, DOI 10.1016/S0006-291X(88)81208-7; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1988, AM J HUM GENET, V42, P565; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVY E, 1990, J EXP MED, V172, P1865, DOI 10.1084/jem.172.6.1865; MAURY CPJ, 1990, FEBS LETT, V260, P85, DOI 10.1016/0014-5793(90)80072-Q; MERETOJA J, 1973, CLIN GENET, V4, P173; MERETOJA J, 1969, Annals of Clinical Research, V1, P314; MITCHELL GA, 1988, J CLIN INVEST, V81, P630, DOI 10.1172/JCI113365; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; NORDLIE M, 1988, SCAND J IMMUNOL, V27, P119, DOI 10.1111/j.1365-3083.1988.tb02329.x; NORIO R, 1973, ANN CLIN RES, V5, P109; PURCELL JJ, 1983, OPHTHALMOLOGY, V90, P1512; SACK GH, 1981, JOHNS HOPKINS MED J, V149, P239; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; SASAKI H, 1984, BIOCHEM BIOPH RES CO, V125, P636, DOI 10.1016/0006-291X(84)90586-2; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; TAWARA S, 1983, BIOCHEM BIOPH RES CO, V116, P880, DOI 10.1016/S0006-291X(83)80224-1; VALLE D, 1989, POLYM CHAIN REACTION, P63; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; VANDESAN.JH, 1973, BIOCHEMISTRY-US, V12, P5050, DOI 10.1021/bi00749a004; WALLACE MR, 1988, AM J HUM GENET, V43, P182; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; WALLACE MR, 1988, J CLIN INVEST, V81, P189, DOI 10.1172/JCI113293; WINKELMAN J E, 1971, Klinische Monatsblaetter fuer Augenheilkunde, V159, P618; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1984, J BIOL CHEM, V259, P5271	41	39	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					522	528						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1652889				2022-12-18	WOS:A1991GE36700004
J	SIEVING, PA; BINGHAM, EL; ROTH, MS; YOUNG, MR; BOEHNKE, M; KUO, CY; GINSBURG, D				SIEVING, PA; BINGHAM, EL; ROTH, MS; YOUNG, MR; BOEHNKE, M; KUO, CY; GINSBURG, D			LINKAGE RELATIONSHIP OF X-LINKED JUVENILE RETINOSCHISIS WITH XP22.1-P22.3 PROBES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT OPHTHALMOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan					NEI NIH HHS [P30-EY0700302] Funding Source: Medline; NIGMS NIH HHS [GM07863-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALITALO T, 1988, AM J HUM GENET, V43, P476; BROWN CJ, 1987, NUCLEIC ACIDS RES, V15, P9614, DOI 10.1093/nar/15.22.9614; CONDON GP, 1986, ARCH OPHTHALMOL-CHIC, V104, P576, DOI 10.1001/archopht.1986.01050160132029; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAHL N, 1988, ARCH OPHTHALMOL-CHIC, V106, P1414; DAHL N, 1988, HUM GENET, V78, P228, DOI 10.1007/BF00291666; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GELLERT G, 1988, HUM GENET, V79, P382; GIESER EP, 1961, AM J OPHTHALMOL, V51, P1193, DOI 10.1016/0002-9394(61)92457-6; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LANGE K, 1988, GENET EPIDEMIOL, V5, P461; McKusick V. A., 1986, MENDELIAN INHERITANC; ROTH MS, 1988, AM J PATHOL, V131, P331; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; WILICHOWSKI E, 1987, HUM GENET, V75, P32; WU G, 1985, OPHTHALMIC PAED GEN, V5, P13, DOI 10.3109/13816818509007850	20	39	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					616	621						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	1977307				2022-12-18	WOS:A1990EB31900005
J	MCGUFFIN, P; HUCKLE, P				MCGUFFIN, P; HUCKLE, P			SIMULATION OF MENDELISM REVISITED - THE RECESSIVE GENE FOR ATTENDING MEDICAL-SCHOOL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MCGUFFIN, P (corresponding author), UNIV COLL CARDIFF,DEPT PSYCHOL MED,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		McGuffin, Peter/A-1565-2012	McGuffin, Peter/0000-0002-9888-2907				BARNES DM, 1989, SCIENCE, V243, P313, DOI 10.1126/science.2911743; BARON M, 1987, NATURE, V326, P806; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FARMER AE, 1987, ARCH GEN PSYCHIAT, V44, P634; GERSHON ES, 1980, ACTA PSYCHIAT SCAND, V61, P319, DOI 10.1111/j.1600-0447.1980.tb00585.x; GOATE AM, 1989, LANCET, V1, P352; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; HENDERSON ND, 1982, ANNU REV PSYCHOL, V33, P403, DOI 10.1146/annurev.ps.33.020182.002155; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; KAY DWK, 1989, BRIT J PSYCHIAT, V154, P311, DOI 10.1192/bjp.154.3.311; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LALOUEL JM, 1984, AM J HUM GENET, V26, P484; LILIENFELD AM, 1959, AM J PUBLIC HEALTH N, V49, P199, DOI 10.2105/AJPH.49.2.199; MCGUFFIN P, 1988, BRIT J PSYCHIAT, V153, P591, DOI 10.1192/bjp.153.5.591; MCGUFFIN P, 1987, BRIT MED BULL, V43, P531, DOI 10.1093/oxfordjournals.bmb.a072200; MCGUFFIN P, 1986, HUM HERED, V36, P65, DOI 10.1159/000153604; MENDLEWICZ J, 1987, LANCET, V1, P1230; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P484; OTT J, 1965, ANAL HUMAN GENETIC L; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; 1988, MED DIRECTORY	32	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					994	999						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DD896	2339697				2022-12-18	WOS:A1990DD89600020
J	AUWERX, JH; BABIRAK, SP; HOKANSON, JE; STAHNKE, G; WILL, H; DEEB, SS; BRUNZELL, JD				AUWERX, JH; BABIRAK, SP; HOKANSON, JE; STAHNKE, G; WILL, H; DEEB, SS; BRUNZELL, JD			COEXISTENCE OF ABNORMALITIES OF HEPATIC LIPASE AND LIPOPROTEIN-LIPASE IN A LARGE FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT MED,DIV METAB,RG-26,SEATTLE,WA 98195; UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Max Planck Society				Auwerx, Johan/0000-0002-5065-5393	NCRR NIH HHS [RR37] Funding Source: Medline; NHLBI NIH HHS [HL30036] Funding Source: Medline; NIDDK NIH HHS [DK02456] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERS JJ, 1975, METABOLISM, V24, P1339, DOI 10.1016/0026-0495(75)90050-5; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; AUWERX JH, 1989, ARTERIOSCLEROSIS, V9, P319, DOI 10.1161/01.ATV.9.3.319; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BRECKENRIDGE WC, 1987, AM HEART J, V113, P567, DOI 10.1016/0002-8703(87)90634-X; BRECKENRIDGE WC, 1982, ATHEROSCLEROSIS, V45, P161, DOI 10.1016/0021-9150(82)90136-8; BRUNZELL JD, 1980, METABOLISM, V29, P624, DOI 10.1016/0026-0495(80)90106-7; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CARLSON LA, 1986, ACTA MED SCAND, V219, P435; DECKELBAUM RJ, 1982, J BIOL CHEM, V257, P6509; EISENBERG S, 1984, J LIPID RES, V25, P1017; ETIENNE J, 1981, BIOCHIM BIOPHYS ACTA, V663, P516, DOI 10.1016/0005-2760(81)90179-X; FAILOR RA, 1986, ATHEROSCLEROSIS, V8, P159; FISHER KL, 1987, NUCLEIC ACIDS RES, V15, P7657, DOI 10.1093/nar/15.18.7657; GOLDBERG IJ, 1982, J CLIN INVEST, V70, P1184, DOI 10.1172/JCI110717; GOLDBERG IJ, 1985, METABOLISM, V34, P832, DOI 10.1016/0026-0495(85)90107-6; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; JANSEN H, 1980, BIOCHEM BIOPH RES CO, V92, P53, DOI 10.1016/0006-291X(80)91518-1; JENSEN GL, 1980, J BIOL CHEM, V255, P1141; KINNUNEN PKJ, 1983, ATHER REV, V11, P65; KRAUSS RM, 1982, J LIPID RES, V23, P97; KUUSI T, 1980, ATHEROSCLEROSIS, V36, P589, DOI 10.1016/0021-9150(80)90251-8; LITTLE JA, 1986, LIPOPROTEIN DEFICIEN, P253; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARZETTA CA, 1986, THESIS WAKE FOREST U; MURASE T, 1981, ATHEROSCLEROSIS, V39, P293, DOI 10.1016/0021-9150(81)90015-0; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; RUBINSTEIN A, 1985, J CLIN INVEST, V75, P710, DOI 10.1172/JCI111751; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAHNKE G, 1987, DIFFERENTIATION, V35, P45, DOI 10.1111/j.1432-0436.1987.tb00150.x; TURNER PR, 1981, J CLIN INVEST, V67, P1678, DOI 10.1172/JCI110205; YAMADA N, 1979, BIOCHIM BIOPHYS ACTA, V575, P128; 1974, MANUAL LABORATORY OP, V1	34	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					470	477						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1968704				2022-12-18	WOS:A1990CT66800009
J	GROSSMAN, LI				GROSSMAN, LI			INVITED EDITORIAL - MITOCHONDRIAL-DNA IN SICKNESS AND IN HEALTH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											GROSSMAN, LI (corresponding author), WAYNE STATE UNIV,SCH MED,DEPT MOLEC BIOL & GENET,540 E CANFIELD AVE,DETROIT,MI 48201, USA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P1725; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; ERICKSON RP, 1972, AM J HUM GENET, V24, P348; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOLT IJ, 1988, LANCET, V1, P1462; LESTIENNE P, 1988, LANCET, V1, P885; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; NAKASE H, 1990, AM J HUM GENET, V46, P418; NASS MMK, 1969, SCIENCE, V165, P25, DOI 10.1126/science.165.3888.25; NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; POULTON J, 1989, LANCET, V1, P236; ROTIG A, 1988, LANCET, V2, P567; SHANSKE S, IN PRESS NEUROLOGY; SINGH S, 1989, N ENGL JMED, V320, P1300; WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	25	39	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					415	417						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2178406				2022-12-18	WOS:A1990CT66800002
J	BOEHNKE, M; ARNHEIM, N; LI, HH; COLLINS, FS				BOEHNKE, M; ARNHEIM, N; LI, HH; COLLINS, FS			FINE-STRUCTURE GENETIC-MAPPING OF HUMAN-CHROMOSOMES USING THE POLYMERASE CHAIN-REACTION ON SINGLE SPERM - EXPERIMENTAL-DESIGN CONSIDERATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Southern California	BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109, USA.			Arnheim, Norman/0000-0003-1247-1347	NIGMS NIH HHS [R01-GM36745, R29-GM41440] Funding Source: Medline; NINDS NIH HHS [R01-NS23410] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036745, R29GM041440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayala F.J., 1980, MODERN GENETICS; BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P107, DOI 10.1002/gepi.1370050206; BODMER WF, 1961, HEREDITY, V16, P485, DOI 10.1038/hdy.1961.54; BOEHNKE M, 1988, AM J HUM GENET, V43, P336; BOEHNKE M, 1989, AM J HUM GENET, V44, P216; BRIDGES CB, 1915, J EXP ZOOL, V15, P1; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; DAUSSET J, 1986, PRESSE MED, V15, P1801; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FELDMAN GL, 1988, LANCET, V2, P102; FISHER RA, 1949, HEREDITY, V3, P229, DOI 10.1038/hdy.1949.16; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LENCH N, 1988, LANCET, V1, P1356; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; MENDENHALL W, 1987, INTRO PROBABILITY ST; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OTT J, 1985, ANAL HUMAN GENETIC L; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIMCHEN G, 1969, NATURE, V222, P329, DOI 10.1038/222329a0; Thomas J.M., 1984, 8TH P INT C CAT BERL, V1, P31; THOMPSON EA, 1981, BIOMETRICS, V37, P313, DOI 10.2307/2530420; THOMPSON EA, 1988, 41 U WASH DEP STAT T; Wald A., 1947, SEQUENTIAL ANAL; WEITKAMP LR, 1973, HUM HERED, V23, P197, DOI 10.1159/000152574; WHITE R, 1987, CYTOGENET CELL GENET, V46, P715	33	39	41	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					21	32						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2568090				2022-12-18	WOS:A1989AE77900004
J	MARTINEZ, MM; GOLDIN, LR				MARTINEZ, MM; GOLDIN, LR			THE DETECTION OF LINKAGE AND HETEROGENEITY IN NUCLEAR FAMILIES FOR COMPLEX DISORDERS - ONE VERSUS 2 MARKER LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MARTINEZ, MM (corresponding author), NIMH,CLIN NEUROGENET BRANCH,BLDG 10,ROOM 3N218,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.		Martinez, Maria/B-3111-2013	Martinez, Maria/0000-0003-2180-4537				CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; CHAKRAVARTI A, 1987, GENET EPIDEMIOL, V4, P255, DOI 10.1002/gepi.1370040404; CLERGETDARPOUX F, 1987, J PSYCHIAT RES, V21, P625, DOI 10.1016/0022-3956(87)90113-0; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Meyers D A, 1986, Genet Epidemiol Suppl, V1, P99; OTT J, 1986, AM J HUM GENET, V39, P159; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x	9	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					552	559						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929598				2022-12-18	WOS:A1989T810900015
J	GODFREY, M; KEENE, DR; BLANK, E; HORI, H; SAKAI, LY; SHERWIN, LA; HOLLISTER, DW				GODFREY, M; KEENE, DR; BLANK, E; HORI, H; SAKAI, LY; SHERWIN, LA; HOLLISTER, DW			TYPE-II ACHONDROGENESIS-HYPOCHONDROGENESIS - MORPHOLOGIC AND IMMUNOHISTOPATHOLOGIC STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRINERS HOSP CRIPPLED CHILDREN,3101 SW SAM JACKSON PK RD,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT RADIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT CLIN PATHOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MED,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037272] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR37272] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOROCHOWITZ Z, 1986, AM J MED GENET, V24, P273, DOI 10.1002/ajmg.1320240208; BOROCHOWITZ Z, 1988, J PEDIATR-US, V112, P23, DOI 10.1016/S0022-3476(88)80113-6; BUENO M, 1980, ANN ESP PEDIAT, V13, P889; Burgeson RE, 1987, CONNECTIVE TISSUE DI, P3; CHEN H, 1981, AM J MED GENET, V10, P379, DOI 10.1002/ajmg.1320100411; EYRE DR, 1986, AM J HUM GENET, V39, P52; Goard K E, 1973, Pediatr Radiol, V1, P8, DOI 10.1007/BF00972818; GODFREY M, 1988, AM J HUM GENET, V43, P904; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; HENDRICKX G, 1983, EUR J PEDIATR, V140, P278, DOI 10.1007/BF00443377; HOLLISTER DW, 1982, COLLAGEN REL RES, V2, P197; HORTON WA, 1979, J PEDIATR-US, V94, P736, DOI 10.1016/S0022-3476(79)80140-7; HORTON WA, 1987, PEDIATR RES, V22, P324, DOI 10.1203/00006450-198709000-00017; HORTON WA, 1984, COLLAGEN REL RES, V4, P231; JIMENEZ RB, 1973, PEDIATRICS, V51, P1087; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; MAROTEAUX P, 1983, EUR J PEDIATR, V141, P14, DOI 10.1007/BF00445662; MAROTEAUX P, 1976, CLIN ORTHOP RELAT R, V114, P31; MURRAY L W, 1987, American Journal of Human Genetics, V41, pA12; POOLE AR, 1980, J HISTOCHEM CYTOCHEM, V28, P621, DOI 10.1177/28.7.6156200; RIMOIN D L, 1974, Birth Defects Original Article Series, V10, P274; SALDINO RM, 1971, AMER J ROENTGENOL RA, V112, P185, DOI 10.2214/ajr.112.1.185; Sheehan D.C., 1980, THEORY PRACTICE HIST, VSecond; SILLENCE DO, 1979, AM J PATHOL, V96, P813; SPRANGER J, 1985, ENDOCRINE GENETICS G, P315; Spranger J.W., 1974, BONE DYSPLASIAS ATLA; STANESCU V, 1977, ARCH FR PEDIATR, V34, pR1; WHITLEY CB, 1983, RADIOLOGY, V148, P693, DOI 10.1148/radiology.148.3.6878687; WIEDEMANN HR, 1974, Z KINDERHEILKD, V116, P223, DOI 10.1007/BF00436949; XANTHAKOS UF, 1973, J PEDIATR-US, V82, P658, DOI 10.1016/S0022-3476(73)80592-X; YANG SS, 1974, J PEDIATR-US, V85, P796, DOI 10.1016/S0022-3476(74)80343-4	32	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					894	903						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3057886				2022-12-18	WOS:A1988R344900010
J	ALITALO, T; FORSIUS, H; KARNA, J; FRANTS, RR; ERIKSSON, AW; WOOD, S; KRUSE, TA; DELACHAPELLE, A				ALITALO, T; FORSIUS, H; KARNA, J; FRANTS, RR; ERIKSSON, AW; WOOD, S; KRUSE, TA; DELACHAPELLE, A			LINKAGE RELATIONSHIPS AND GENE ORDER AROUND THE LOCUS FOR X-LINKED RETINOSCHISIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OULU,DEPT OPHTHALMOL,SF-90100 OULU 10,FINLAND; FOLKHALSAN INST GENET,HELSINKI,FINLAND; FREE UNIV AMSTERDAM,INST HUMAN GENET,1007 MC AMSTERDAM,NETHERLANDS; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS C,DENMARK	University of Oulu; Vrije Universiteit Amsterdam; University of British Columbia; Aarhus University	ALITALO, T (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,SF-00290 HELSINKI 29,FINLAND.							AHRENS P, 1986, NUCLEIC ACIDS RES, V14, P7819, DOI 10.1093/nar/14.19.7819; ALBERTSEN HM, 1987, CYTOGENET CELL GENET, V46, P569; ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALITALO T, 1987, CLIN GENET, V32, P192; BAKKER E, 1985, LANCET, V1, P655; BOMAN H, 1976, CAN J OPHTHALMOL, V10, P11; DAHL N, 1988, HUM GENET, V78, P228, DOI 10.1007/BF00291666; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; ERIKSSON AW, 1969, PROGR NEUROOPHTHALMO, V2, P360; EWING CC, 1972, CAN J OPHTHALMOLOGY, V7, P19; FORSIUS H, 1973, CAN J OPHTHALMOL, V8, P385; FORSIUS HR, 1980, POPULATION STRUCTURE, P673; HARRIS GS, 1976, CAN J OPHTHALMOL, V10, P1; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MACHLER M, 1986, HUM GENET, V73, P271, DOI 10.1007/BF00401243; McKusick V. A., 1986, MENDELIAN INHERITANC; MCMAHON TT, 1983, J AM OPTOM ASSOC, V54, P55; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; OTT J, 1974, AM J HUM GENET, V26, P588; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; STARR T, 1987, GENOME, V29, P201, DOI 10.1139/g87-034; TANINO T, 1985, DOC OPHTHALMOL, V60, P149, DOI 10.1007/BF00158030; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; VAINIOMATTILA B, 1969, ACTA OPHTHALMOL, V47, P1135; VERDAGUER J, 1982, AM J OPHTHALMOL, V93, P145, DOI 10.1016/0002-9394(82)90409-3; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111	30	39	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					476	483						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177388				2022-12-18	WOS:A1988Q473600015
J	MOREL, Y; PICADOLEONARD, J; WU, DA; CHANG, CY; MOHANDAS, TK; CHUNG, B; MILLER, WL				MOREL, Y; PICADOLEONARD, J; WU, DA; CHANG, CY; MOHANDAS, TK; CHUNG, B; MILLER, WL			ASSIGNMENT OF THE FUNCTIONAL GENE FOR HUMAN ADRENODOXIN TO CHROMOSOME 11Q13-]QTER AND OF ADRENODOXIN PSEUDOGENES TO CHROMOSOME 20CEN-]Q13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, ROOM 677-S, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA; ACAD SINICA, INST MOL BIOL, TAIPEI 115, TAIWAN; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DEPT PEDIAT, TORRANCE, CA 90509 USA; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DIV MED GENET, TORRANCE, CA 90509 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Academia Sinica - Taiwan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center			morel, yves/C-4757-2017; Miller, Walter L/J-3696-2012		FOGARTY INTERNATIONAL CENTER [F05TW003935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER; FIC NIH HHS [TW03935] Funding Source: Medline; NIDDK NIH HHS [DK37922] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN SU, 1988, DNA-J MOLEC CELL BIO, V7, P27, DOI 10.1089/dna.1988.7.27; CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; CHUNG BC, 1986, P NATL ACAD SCI USA, V83, P4243, DOI 10.1073/pnas.83.12.4243; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; DIBLASIO AM, 1987, J CLIN ENDOCR METAB, V65, P170; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HOOD L, 1975, ANNU REV GENET, V9, P305, DOI 10.1146/annurev.ge.09.120175.001513; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LIEBHABER SA, 1981, NATURE, V290, P26, DOI 10.1038/290026a0; MATTESON KJ, 1986, J CLIN ENDOCR METAB, V63, P789, DOI 10.1210/jcem-63-3-789; MCBRIDE OW, 1987, J BIOL CHEM, V262, P11163; MILLER WL, 1983, ENDOCR REV, V4, P97, DOI 10.1210/edrv-4-2-97; MILLER WL, 1987, J PEDIATR-US, V111, P1, DOI 10.1016/S0022-3476(87)80334-7; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHANDAS T, 1984, HUM GENET, V66, P292, DOI 10.1007/BF00287630; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; MOHANDAS T, 1986, SOMAT CELL MOLEC GEN, V12, P89, DOI 10.1007/BF01560731; MOREL Y, 1987, American Journal of Human Genetics, V41, pA178; PICADOLEONARD J, 1988, J BIOL CHEM, V263, P3240; PICADOLEONARD J, 1987, DNA CELL BIOL, V6, P437; RAMESH V, 1987, HUM GENET, V76, P121, DOI 10.1007/BF00284906; ROZEN R, 1987, PEDIATR RES, V21, pA294, DOI 10.1203/00006450-198704010-00760; VOUTILAINEN R, 1988, DNA-J MOLEC CELL BIO, V7, P9, DOI 10.1089/dna.1988.7.9; VOUTILAINEN R, 1988, J CLIN ENDOCR METAB, V66, P383, DOI 10.1210/jcem-66-2-383; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P202, DOI 10.1210/jcem-63-1-202; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P3556; YEN PH, 1984, SOMAT CELL MOLEC GEN, V10, P561, DOI 10.1007/BF01535221	29	39	39	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					52	59						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	2837084				2022-12-18	WOS:A1988N986300008
J	AUBOURG, PR; SACK, GH; MOSER, HW				AUBOURG, PR; SACK, GH; MOSER, HW			FREQUENT ALTERATIONS OF VISUAL PIGMENT GENES IN ADRENOLEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN F KENNEDY INST,ROOM 418,707 N BROADWAY,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NIADDK NIH HHS [AM31745-03] Funding Source: Medline; NICHD NIH HHS [HD10981-9] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM031745] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPERN M, 1971, J PHYSIOL-LONDON, V212, P211, DOI 10.1113/jphysiol.1971.sp009318; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; Farnsworth D, 1943, J OPT SOC AM, V33, P568, DOI 10.1364/JOSA.33.000568; Haupt I, 1926, J COMP PSYCHOL, V6, P291, DOI 10.1037/h0074636; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MANDEL JL, 1986, DNA PROBES, P19; MANIATIS T, 1976, CELL, V8, P163, DOI 10.1016/0092-8674(76)90001-5; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Miles W, 1929, J GEN PSYCHOL, V2, P535, DOI 10.1080/00221309.1929.9918095; MOSER HW, 1984, ANN NEUROL, V16, P628, DOI 10.1002/ana.410160603; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PORTER IH, 1962, ANN HUM GENET, V26, P107, DOI 10.1111/j.1469-1809.1962.tb01316.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772	20	39	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					408	413						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	2894755				2022-12-18	WOS:A1988M620600002
J	CLARK, AG				CLARK, AG			NEUTRALITY TESTS OF HIGHLY POLYMORPHIC RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											CLARK, AG (corresponding author), PENN STATE UNIV,DEPT BIOL,208 MUELLER LAB,UNIVERSITY PK,PA 16802, USA.			Clark, Andrew/0000-0001-7159-8511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036496] Funding Source: NIH RePORTER; NICHD NIH HHS [HD00743] Funding Source: Medline; NIGMS NIH HHS [GM36496] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIRD M, 1986, AM J HUM GENET, V39, P489; BALAZS I, 1982, P NATL ACAD SCI-BIOL, V79, P7395, DOI 10.1073/pnas.79.23.7395; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DEMARTINVILLE B, 1983, SCIENCE, V219, P498, DOI 10.1126/science.6297001; Ewens W.J., 1979, MATH POPULATION GENE; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FUERST PA, 1977, GENETICS, V86, P455; GERALD PS, 1984, CYTOGENET CELL GENET, V37, P103, DOI 10.1159/000132006; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 1986, EVOLUTIONARY PROCESS, P583; KEITH TP, 1985, MOL BIOL EVOL, V2, P206; KEITH TP, 1983, GENETICS, V105, P153; KLITZ W, 1986, AM J HUM GENET, V39, P340; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; Sokal R.R., 1981, BIOMETRY, V2nd ed.; THOMSON G, 1977, GENETICS, V85, P753; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1978, GENETICS, V88, P171; WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611; Wright S., 1978, EVOLUTION GENETICS P, V4; WYMAN A, 1984, American Journal of Human Genetics, V36, p159S; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	24	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					948	956						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	2890298				2022-12-18	WOS:A1987K936100015
J	WHITE, R; LEPPERT, M; OCONNELL, P; NAKAMURA, Y; WOODWARD, S; HOFF, M; HERBST, J; DEAN, M; VANDEWOUDE, G; LATHROP, GM; LALOUEL, JM				WHITE, R; LEPPERT, M; OCONNELL, P; NAKAMURA, Y; WOODWARD, S; HOFF, M; HERBST, J; DEAN, M; VANDEWOUDE, G; LATHROP, GM; LALOUEL, JM			FURTHER LINKAGE DATA ON CYSTIC-FIBROSIS - THE UTAH STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,CYSTIC FIBROSIS FDN RES CTR,SALT LAKE CITY,UT 84132; NCI,FREDERICK CANC RES FACIL,BASIC RES PROGRAM,LITTON BIONET INC,FREDERICK,MD 21701; UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84132; UNIV UTAH,SCH MED,HUMAN GENET,SALT LAKE CITY,UT 84132	Cystic Fibrosis Foundation; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	WHITE, R (corresponding author), UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132, USA.		Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631				BEAUDET A, 1986, LINKAGE CYSTIC FIBRO, V39, P681; Bishop YM., 2007, DISCRETE MULTIVARIAT; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; FEDER J, 1985, AM J HUM GENET, V37, P635; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	11	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					694	698						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	2879438				2022-12-18	WOS:A1986F541400002
J	OVERHAUSER, J; BEAUDET, AL; WASMUTH, JJ				OVERHAUSER, J; BEAUDET, AL; WASMUTH, JJ			A FINE-STRUCTURE PHYSICAL MAP OF THE SHORT ARM OF CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	OVERHAUSER, J (corresponding author), UNIV CALIF IRVINE,CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717, USA.				NCI NIH HHS [T32-CA-09054] Funding Source: Medline; NICHD NIH HHS [HD-18642] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018642] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACCICHETTI C, 1982, HUM GENET, V60, P389, DOI 10.1007/BF00569228; CARLOCK LR, 1985, SOMAT CELL MOLEC GEN, V11, P267, DOI 10.1007/BF01534683; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; NIEBUHR E, 1978, HUM GENET, V42, P142; OVERHAUSER J, 1986, AM J HUM GENET, V39, P1; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; WALKER JL, 1984, J MED GENET, V21, P465, DOI 10.1136/jmg.21.6.465; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397	12	39	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1986	39	5					562	572						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3032	2878609				2022-12-18	WOS:A1986F303200002
J	LEPPERT, MF; HASSTEDT, SJ; HOLM, T; OCONNELL, P; WU, L; ASH, O; WILLIAMS, RR; WHITE, R				LEPPERT, MF; HASSTEDT, SJ; HOLM, T; OCONNELL, P; WU, L; ASH, O; WILLIAMS, RR; WHITE, R			A DNA PROBE FOR THE LDL RECEPTOR GENE IS TIGHTLY LINKED TO HYPERCHOLESTEROLEMIA IN A PEDIGREE WITH EARLY CORONARY-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH, MED CTR, CARDIOVASC GENET RES CLIN, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, MED CTR, DEPT PATHOL, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, MED CTR, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	LEPPERT, MF (corresponding author), UNIV UTAH, MED CTR, HOWARD HUGHES MED INST, SALT LAKE CITY, UT 84132 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021088] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21088-09] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GOLDSTEIN JL, 1975, P NATL ACAD SCI USA, V72, P1092, DOI 10.1073/pnas.72.3.1092; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HOBBS HH, 1985, P NATL ACAD SCI USA, V82, P7651, DOI 10.1073/pnas.82.22.7651; HUMPHRIES SE, 1985, LANCET, V1, P1003; MORTON NE, 1974, CLIN CHEM, V24, P108; RAUTELA GS, 1978, CLIN CHEM, V24, P108; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219; WILLIAMS RR, 1979, UPDATE, V4, P89; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	17	39	40	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					300	306						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	2876626				2022-12-18	WOS:A1986E364400002
J	MAGENIS, RE; GUSELLA, J; WELIKY, K; OLSON, S; HAIGHT, G; TOTHFEJEL, S; SHEEHY, R				MAGENIS, RE; GUSELLA, J; WELIKY, K; OLSON, S; HAIGHT, G; TOTHFEJEL, S; SHEEHY, R			HUNTINGTON DISEASE-LINKED RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM LOCALIZED WITHIN BAND P16.1 OF CHROMOSOME-4 BY INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	MAGENIS, RE (corresponding author), OREGON HLTH SCI UNIV,DEPT MED GENET,DIV CRIPPLED CHILDRENS,PORTLAND,OR 97201, USA.				NICHD NIH HHS [HD07997] Funding Source: Medline; PHS HHS [920] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; FRANCKE U, 1977, J PEDIATR-US, V90, P250, DOI 10.1016/S0022-3476(77)80642-2; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; HARNDEN DG, 1985, CYTOGENET CELL GENET; HARNDEN DG, 1985, BIRTH DEFECTS ORIG A, V21; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HIRSCHHORN K, 1965, HUMANGENETIK, V1, P470; Huntington G., 1872, MED SURG REP, V26, P320; MCKUSICK VA, 1985, CLIN GENET, V27, P207; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P161; WOLF U, 1965, HUMANGENETIK, V1, P397	13	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					383	391						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	2876628				2022-12-18	WOS:A1986E364400010
J	GOLDMAN, D; GOLDIN, LR; RATHNAGIRI, P; OBRIEN, SJ; EGELAND, JA; MERRIL, CR				GOLDMAN, D; GOLDIN, LR; RATHNAGIRI, P; OBRIEN, SJ; EGELAND, JA; MERRIL, CR			27 PROTEIN POLYMORPHISMS BY TWO-DIMENSIONAL ELECTROPHORESIS OF SERUM, ERYTHROCYTES, AND FIBROBLASTS IN 2 PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIMH,CLIN NEUROGENET BRANCH,BETHESDA,MD 20205; NCI,VIRAL CARCINOGENESIS LAB,BETHESDA,MD 20205; UNIV MIAMI,SCH MED,DEPT PSYCHIAT,MIAMI,FL 33152	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami	GOLDMAN, D (corresponding author), NIAAA,CLIN STUDIES LAB,BETHESDA,MD 20205, USA.		Goldman, David/F-9772-2010; OBRIEN, STEPHEN/ABD-1346-2020	Goldman, David/0000-0002-1724-5405; OBRIEN, STEPHEN/0000-0001-7857-0757				ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN AJL, 1979, P NATL ACAD SCI USA, V76, P2381, DOI 10.1073/pnas.76.5.2381; COMINGS DE, 1982, CLIN CHEM, V28, P813; COMINGS DE, 1982, CLIN CHEM, V28, P805; COMINGS DE, 1977, NATURE, V277, P28; GHANGAS GS, 1977, SCIENCE, V196, P1119, DOI 10.1126/science.870972; GIOMETTI CS, 1981, J BIOL CHEM, V256, P1840; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; GOLDMAN D, 1982, CLIN CHEM, V28, P1021; HAMAGUCHI H, 1982, HUM GENET, V62, P142; HAMAGUCHI H, 1981, HUM GENET, V59, P215; HAMAGUCHI H, 1982, HUM GENET, V62, P148; HARRIS H, 1974, ANN HUM GENET, V37, P237, DOI 10.1111/j.1469-1809.1974.tb01832.x; HARRIS H, 1980, PRINCIPLES HUMAN BIO, P316; HOPKINSON DA, 1976, ANN HUM GENET, V39, P383, DOI 10.1111/j.1469-1809.1976.tb00144.x; KIDD KK, 1984, AM J PSYCHIAT, V141, P1042; KONDO I, 1984, HUM GENET, V66, P248, DOI 10.1007/BF00286611; KONDO I, 1984, HUM GENET, V66, P244, DOI 10.1007/BF00286610; LEAVITT J, 1980, J BIOL CHEM, V255, P1650; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MENZEL HJ, 1982, J LIPID RES, V23, P915; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NEEL JV, 1984, AM J HUM GENET, V36, P1135; NEI M, 1976, NATURE, V262, P491, DOI 10.1038/262491a0; OBRIEN SJ, 1983, SCIENCE, V221, P459, DOI 10.1126/science.221.4609.459; OBRIEN SJ, 1984, SCIENCE, V223; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; OLAISEN B, 1982, HUM GENET, V61, P24, DOI 10.1007/BF00291325; OTT J, 1974, AM J HUM GENET, V26, P588; ROSENBLUM BB, 1984, AM J HUM GENET, V36, P601; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; SCHAMAUN O, 1983, HUM GENET, V64, P380, DOI 10.1007/BF00292371; SMITH SC, 1980, GENETICS, V96, P967; STEINBERG RA, 1977, CELL, V10, P381, DOI 10.1016/0092-8674(77)90025-3; VANDEKERCKHOVE J, 1980, CELL, V22, P893, DOI 10.1016/0092-8674(80)90566-8; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1982, AM J HUM GENET, V34, P209; ZANNIS VI, 1980, BIOCHEM GENET, V18, P1, DOI 10.1007/BF00504356	41	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					898	911						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	3863481				2022-12-18	WOS:A1985ASD5500007
J	BLUMBERG, BD; SHULKIN, JD; ROTTER, JI; MOHANDAS, T; KABACK, MM				BLUMBERG, BD; SHULKIN, JD; ROTTER, JI; MOHANDAS, T; KABACK, MM			MINOR CHROMOSOMAL VARIANTS AND MAJOR CHROMOSOMAL-ANOMALIES IN COUPLES WITH RECURRENT ABORTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007076, R23DE007076] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-07076] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARKER PE, 1977, CLIN GENET, V11, P243; BHASIN MK, 1973, HUMANGENETIK, V18, P139, DOI 10.1007/BF00291481; BYRD JR, 1977, FERTIL STERIL, V28, P246; CARR DH, 1967, AM J OBSTET GYNECOL, V97, P283, DOI 10.1016/0002-9378(67)90488-7; CARR DH, 1963, LANCET, V2, P603; DELACHAPELLE A, 1973, INT J FERTIL, V18, P215; DIXON WJ, 1977, BMDP77 BIOMEDICAL CO; FORD J, 1977, RECORDS ADELAIDE CHI, V1, P287; GENEST P, 1979, CLIN GENET, V16, P387; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HEMMING L, 1979, J MED GENET, V16, P358, DOI 10.1136/jmg.16.5.358; HERITAGE DW, 1978, FERTIL STERIL, V29, P414; HESSLEIN P, 1980, WIEN KLIN WOCHENSC S, V92, P575; KADOTANI T, 1969, P JPN ACAD, V45, P180, DOI 10.2183/pjab1945.45.180; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; KAOSAAR ME, 1973, HUMANGENETIK, V17, P277; KARDON NB, 1980, HUM GENET, V53, P161; KIM HJ, 1975, NEW ENGL J MED, V293, P844, DOI 10.1056/NEJM197510232931703; KULAZHEN.VP, 1972, GENETIKA+, V8, P154; Lippman-hand A, 1980, HUMAN EMBRYONIC FETA, P299; MENNUTI MT, 1978, OBSTET GYNECOL, V52, P308; MILLER JF, 1980, LANCET, V2, P554; MILLER RG, 1966, SIMULTANEOUS STATIST; NEU RL, 1979, OBSTET GYNECOL, V53, P373; NIELSEN J, 1978, CLIN GENET, V13, P415; NORDENSON I, 1981, CLIN GENET, V19, P168; PATIL SR, 1977, HUM GENET, V35, P233, DOI 10.1007/BF00393975; ROBERTSON RD, 1981, CLIN RES, V29, pA116; SCHMIDT R, 1976, JAMA-J AM MED ASSOC, V236, P369, DOI 10.1001/jama.236.4.369; STENCHEVER MA, 1977, AM J OBSTET GYNECOL, V127, P143, DOI 10.1016/S0002-9378(16)33240-9; SULOVIC V, 1977, FERTIL STERIL, V28, P368; THO PT, 1979, FERTIL STERIL, V32, P389; TSENGHI C, 1976, OBSTET GYNECOL, V47, P463; WARD BE, 1980, AM J HUM GENET, V32, P549	34	39	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					948	960						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180849				2022-12-18	WOS:A1982PU21100012
J	KIHARA, H				KIHARA, H			GENETIC-HETEROGENEITY IN METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KIHARA, H (corresponding author), UNIV CALIF LOS ANGELES,LANTERMAN STATE HOSP,SCH MED,MENTAL RETARDAT RES CTR GRP,POMONA,CA 91769, USA.							ALHADEFF JA, 1978, BIOCHEM MED METAB B, V20, P357, DOI 10.1016/0006-2944(78)90083-2; ALZHEIMER A, 1910, NERVENGEWEBE NISSL A, V3, P493; AUSTIN J, 1968, ARCH NEUROL-CHICAGO, V18, P225, DOI 10.1001/archneur.1968.00470330015001; AUSTIN J, 1964, BIOCHEM J, V93, pC15, DOI 10.1042/bj0930015C; AUSTIN JH, 1959, P SOC EXP BIOL MED, V100, P361; AUSTIN JH, 1963, J NEUROCHEM, V10, P805, DOI 10.1111/j.1471-4159.1963.tb11905.x; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; BARATON G, 1977, CLIN CHIM ACTA, V76, P339, DOI 10.1016/0009-8981(77)90160-7; BERATIS NG, 1975, J PEDIATR-US, V87, P1193, DOI 10.1016/S0022-3476(75)80135-1; BRADY RO, 1970, CHEM PHYS LIPIDS, V5, P261, DOI 10.1016/0009-3084(70)90023-X; BRUNS GAP, 1978, CYTOGENET CELL GENET, V22, P182, DOI 10.1159/000130931; BUTTERWORTH J, 1978, CLIN GENET, V14, P213; CAPECCHI MR, 1974, P NATL ACAD SCI USA, V71, P4732, DOI 10.1073/pnas.71.12.4732; CHANG PL, 1980, P NATL ACAD SCI-BIOL, V77, P6166, DOI 10.1073/pnas.77.10.6166; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; CRAVIOTO H, 1967, SCIENCE, V156, P243, DOI 10.1126/science.156.3772.243; DELUCA C, 1979, P NATL ACAD SCI USA, V76, P1957, DOI 10.1073/pnas.76.4.1957; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; DUBOIS G, 1975, NEW ENGL J MED, V293, P302; DUBOIS G, 1977, AM J HUM GENET, V29, P191; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; ETO Y, 1974, ARCH NEUROL-CHICAGO, V30, P153, DOI 10.1001/archneur.1974.00490320041005; FISCHER G, 1977, BIOCHIM BIOPHYS ACTA, V481, P561, DOI 10.1016/0005-2744(77)90288-1; FISCHER G, 1975, H-S Z PHYSIOL CHEM, V356, P605, DOI 10.1515/bchm2.1975.356.1.605; FLUHARTY AL, 1978, J PEDIATR-US, V92, P782, DOI 10.1016/S0022-3476(78)80153-X; FLUHARTY AL, 1979, AM J HUM GENET, V31, P574; FLUHARTY AL, 1978, AM J HUM GENET, V30, P249; FLUHARTY AL, 1974, LIPIDS, V9, P865, DOI 10.1007/BF02532611; FLUHARTY AL, 1980, BIOCHEM J, V189, P45, DOI 10.1042/bj1890045; FLUHARTY AL, 1978, T AM SOC NEUROCHEM, V9, P163; FLUHARTY AL, 1981, T AM SOC NEUROCHEM, V12, P236; FLUHARTY AL, 1974, CLIN RES, V22, P217; FLUHARTY AL, 1979, 11 INT C BIOCH, P649; GOLDIE WD, 1980, ABSTR CHILD NEUR SOC; HAGBERG B, 1960, Acta Paediatr, V49, P135, DOI 10.1111/j.1651-2227.1960.tb07715.x; HARZER K, 1975, DEUT MED WOCHENSCHR, V100, P951; HECHTMAN P, 1980, AM J HUM GENET, V32, pA42; HELLKUHL B, 1978, CYTOGENET CELL GENET, V22, P203, DOI 10.1159/000130936; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HORWITZ AL, 1979, P NATL ACAD SCI USA, V76, P6496, DOI 10.1073/pnas.76.12.6496; JATZKEWITZ H, 1958, H-S Z PHYSIOL CHEM, V311, P279, DOI 10.1515/bchm2.1958.311.1.279; KABACK M M, 1970, New England Journal of Medicine, V282, P1336, DOI 10.1056/NEJM197006112822403; KELLY TE, 1976, CLIN GENET, V9, P540; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; KIHARA H, 1980, PEDIATR RES, V14, P890; KIHARA H, 1975, BRAIN MECHANISMS MEN, P501; KIHARA H, 1973, ENZYME THERAPY GENET, P19; LANGENBECK U, 1977, AM J HUM GENET, V29, P639; Leroy J G, 1970, Nature, V226, P553, DOI 10.1038/226553a0; LEROY JG, 1973, NEW ENGL J MED, V288, P1365, DOI 10.1056/NEJM197306282882602; LI SC, 1979, J BIOL CHEM, V254, P592; LI SC, 1976, J BIOL CHEM, V251, P1159; LOTT IT, 1976, J PEDIATR-US, V89, P438, DOI 10.1016/S0022-3476(76)80546-X; Mehl E, 1964, Hoppe Seylers Z Physiol Chem, V339, P260, DOI 10.1515/bchm2.1964.339.1.260; MRAZ W, 1976, FEBS LETT, V67, P105; NADLER HL, 1970, NEW ENGL J MED, V282, P596, DOI 10.1056/NEJM197003122821105; NEUWELT E, 1971, BIOCHIM BIOPHYS ACTA, V236, P333, DOI 10.1016/0005-2795(71)90182-6; NG WG, 1976, AM J HUM GENET, V28, P42; Nja Arne, 1946, ADA PAEDIATRICA [UPPSALA], V33, P267, DOI 10.1111/j.1651-2227.1946.tb16930.x; OKADA S, 1970, J PEDIATR-US, V77, P1063, DOI 10.1016/S0022-3476(70)80096-8; PERCY AK, 1968, SCIENCE, V161, P594, DOI 10.1126/science.161.3841.594; PERCY AK, 1971, NEW ENGL J MED, V285, P785, DOI 10.1056/NEJM197109302851407; PERCY AK, 1972, J NEUROCHEM, V19, P233, DOI 10.1111/j.1471-4159.1972.tb01273.x; PINSKY L, 1970, NATURE, V228, P1093, DOI 10.1038/2281093b0; PORTER MT, 1970, ARCH BIOCHEM BIOPHYS, V138, P646, DOI 10.1016/0003-9861(70)90392-9; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; PORTER MT, 1971, BIOCHEM BIOPH RES CO, V44, P660, DOI 10.1016/S0006-291X(71)80134-1; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; RAMAGE P, 1975, BIOCHIM BIOPHYS ACTA, V403, P473, DOI 10.1016/0005-2744(75)90075-3; RATTAZZI MC, 1977, PEDIATR RES, V11, P1030; SHAPIRA E, 1975, J PEDIATR-US, V86, P881, DOI 10.1016/S0022-3476(75)80218-6; SHAPIRO LJ, 1978, LANCET, V1, P70; SHAPIRO LJ, 1979, PEDIATR RES, V13, P1179, DOI 10.1203/00006450-197910000-00021; SIMPSON NE, 1976, CAN MED ASSOC J, V115, P739; SOURANDER P, 1966, ACTA NEUROPATHOL, V6, P231, DOI 10.1007/BF00687853; STANBURY JB, 1978, METABOLIC BASIS INHE, P2; STEVENS RL, 1981, AM J HUM GENET, V33, P900; STUMPF D, 1970, Archives of Neurology, V24, P117; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; SUZUKI Y, 1974, J PEDIATR-US, V85, P823, DOI 10.1016/S0022-3476(74)80352-5; VANDERHAGEN CB, 1973, CLIN GENET, V4, P256; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; WENGER DA, 1976, J PEDIATR-US, V88, P76, DOI 10.1016/S0022-3476(76)80732-9; WIESMANN UN, 1975, HELV PAEDIATR ACTA, V30, P31; WOOD S, 1976, J LAB CLIN MED, V88, P469; ZLOTOGORA J, 1980, PEDIATR RES, V14, P963, DOI 10.1203/00006450-198008000-00014; ZLOTOGORA J, 1980, AM J HUM GENET, V32, P663	87	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					171	181						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6122378				2022-12-18	WOS:A1982NH73200001
J	LOWRY, RB; BAIRD, PA				LOWRY, RB; BAIRD, PA			FAMILIAL GASTROSCHISIS AND OMPHALOCELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV BRITISH COLUMBIA,BRITISH COLUMBIA HLTH SURVEILLANCE REGISTRY,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia	LOWRY, RB (corresponding author), UNIV CALGARY,ALBERTA CHILDRENS HOSP,RES CTR,DEPT PAEDIATR,CALGARY T2N 1N4,ALBERTA,CANADA.							BAIRD PA, 1981, AM J HUM GENET, V33, P470; CZEIZEL A, 1979, LANCET, V2, P470; JONES DC, 1981, UNPUB FAMILY STUDIES; SALINAS CF, 1979, AM J DIS CHILD, V133, P514, DOI 10.1001/archpedi.1979.02130050058011	4	39	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					517	518						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	6211093				2022-12-18	WOS:A1982NR13300018
J	GOODMAN, SI; GALLEGOS, DA; PULLIN, CJ; HALPERN, B; TRUSCOTT, RJW; WISE, G; WILCKEN, B; RYAN, ED; WHELEN, DT				GOODMAN, SI; GALLEGOS, DA; PULLIN, CJ; HALPERN, B; TRUSCOTT, RJW; WISE, G; WILCKEN, B; RYAN, ED; WHELEN, DT			ANTENATAL DIAGNOSIS OF GLUTARIC ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WOLLONGONG,DEPT CHEM,WOLLONGONG,NSW 2500,AUSTRALIA; MCMASTER UNIV,MED CTR,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA; PRINCE WALES HOSP,RANDWICK,NSW 2031,AUSTRALIA; MCMASTER UNIV,MED CTR,DEPT PEDIAT,HAMILTON L8S 4L8,ONTARIO,CANADA; OLIVER LATHAM LABS,N RYDE,NSW,AUSTRALIA	University of Wollongong; McMaster University; McMaster University	GOODMAN, SI (corresponding author), UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT PEDIAT,DENVER,CO 80202, USA.				NICHD NIH HHS [HD-04024] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD004024] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMPOLA MG, 1975, NEW ENGL J MED, V293, P313, DOI 10.1056/NEJM197508142930701; BRANDT NJ, 1979, J PEDIATR-US, V94, P669, DOI 10.1016/S0022-3476(79)80048-7; BRANDT NJ, 1978, CLIN GENET, V13, P77; EMERY AEH, 1970, MODERN TRENDS HUMAN, V1, P267; FLEISHER LD, 1977, PEDIATR RES, V11, P455, DOI 10.1203/00006450-197704000-00512; GOODMAN SI, 1973, CLIN GENET, V4, P236; GOODMAN SI, 1975, BIOCHEM MED METAB B, V12, P12, DOI 10.1016/0006-2944(75)90091-5; GOODMAN SI, 1975, BIOCHEM MED METAB B, V13, P138, DOI 10.1016/0006-2944(75)90149-0; GOODMAN SI, 1977, J PEDIATR-US, V90, P746, DOI 10.1016/S0022-3476(77)81240-7; GOODMAN SI, 1980, PEDIATR RES, V14, P12, DOI 10.1203/00006450-198014010-00004; GOODMAN SI, 1972, ANTENATAL DIAGNOSIS, P127; GREGERSEN N, 1977, J PEDIATR-US, V90, P740, DOI 10.1016/S0022-3476(77)81239-0; KYLLERMAN M, 1977, NEUROPADIATRIE, V8, P397, DOI 10.1055/s-0028-1091535; MAHONEY MJ, 1975, ACTA PAEDIATR SCAND, V64, P44; MCNAIR HM, 1969, BASIC GAS CHROMATOGR, P150; MORROW G, 1970, J PEDIATR-US, V77, P120, DOI 10.1016/S0022-3476(70)80054-3; STOKKE O, 1975, BIOCHEM MED METAB B, V12, P386, DOI 10.1016/0006-2944(75)90071-X; SWEETMAN L, 1976, CLIN RES, V24, pA295; WHELAN DT, 1979, PEDIATRICS, V63, P88	19	39	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					695	699						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	6893520				2022-12-18	WOS:A1980KJ79500008
J	ELSTON, RC				ELSTON, RC			MAJOR LOCUS ANALYSIS FOR QUANTITATIVE TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,DEPT BIOSTAT & GENET CURRICULUM,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill								BEATY TH, 1978, THESIS U MICHIGAN AN; BERG K, 1976, 3RD INT WORKSH HUM G, P266; BLACKWELDER WC, 1977, UNC1114 U N CAR I ST; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1976, ADV APPL PROBAB, V8, P622, DOI 10.2307/1425918; ELSTON RC, 1973, BEHAV GENET, V3, P319, DOI 10.1007/BF01067609; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; ELSTON RC, 1978, ANNU REV BIOPHYS BIO, V7, P253, DOI 10.1146/annurev.bb.07.060178.001345; ELSTON RC, 1976, 3RD INT WORKSH HUM G, P294; FAIN PR, 1978, ANN HUM GENET, V42, P109, DOI 10.1111/j.1469-1809.1978.tb00935.x; GERRARD JW, 1978, AM J HUM GENET, V30, P46; GO RCP, 1978, AM J HUM GENET, V30, P28; GOLDIN LR, 1978, THESIS U N CAROLINA; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILL AP, 1975, ANN HUM GENET, V38, P439, DOI 10.1111/j.1469-1809.1975.tb00633.x; JENSEN J, 1972, AM J MED, V52, P499, DOI 10.1016/0002-9343(72)90041-1; KARLIN S, THEOR POPUL BIOL; KEMPTHORNE O, 1978, BIOMETRICS, V34, P1, DOI 10.2307/2529584; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LANGE K, 1976, AM J HUM GENET, V28, P167; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MATTHYSSE S, P NATL ACAD SCI US; Morton N. E., 1978, GENETIC EPIDEMIOLOGY; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1978, YB PHYS ANTHR; MURPHY EA, 1964, J CHRON DIS, V17, P301, DOI 10.1016/0021-9681(64)90073-6; NAMBOODIRI KK, 1977, AM J MED GENET, V1, P157, DOI 10.1002/ajmg.1320010203; OTT J, 1979, AM J HUM GENET, V31, P161; SING CF, 1979, GENETIC ANAL COMMON; SMITH CAB, 1975, ANN HUM GENET, V38, P451, DOI 10.1111/j.1469-1809.1975.tb00634.x; THOMPSON EA, 1979, GENETIC ANAL COMMON; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573	40	39	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	6					655	661						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ742	517517				2022-12-18	WOS:A1979HZ74200001
J	LACASSIE, Y; THURMON, TF; TRACY, MC; PELIAS, MZ				LACASSIE, Y; THURMON, TF; TRACY, MC; PELIAS, MZ			PIEBALD TRAIT IN A RETARDED-CHILD WITH INTERSTITIAL DELETION OF CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV CHILE,INST NUTR & FOOD TECHNOL,SANTIAGO,CHILE	Universidad de Chile								BIERDERMAN B, 1976, ANN GENET PARIS, V19, P257; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; FUNDERBURK SJ, 1974, AM J HUM GENET, V26, P715; HECHT F, 1977, 1977 BIRTH DEF C MEM; Seabright M, 1973, Lancet, V1, P1249; 1972, BIRTH DEFECTS OAS, V8	6	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					641	642						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EC270	930930				2022-12-18	WOS:A1977EC27000014
J	ROTHHAMMER, F; SPEILMAN, RS				ROTHHAMMER, F; SPEILMAN, RS			ANTHROPOMETRIC VARIATION IN AYMARA - GENETIC, GEOPRAPHIC, AND TOPOGRAPHIC CONTRIBUTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAKER PT, 1969, SCIENCE, V163, P1149, DOI 10.1126/science.163.3872.1149; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CLEGG EJ, 1970, HUM BIOL, V42, P486; CRUZ-COKE R, 1967, Revista Medica de Chile, V95, P614; CRUZCOKE R, 1966, HUM BIOL, V38, P421; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; FITCH WM, 1969, AM J HUM GENET, V21, P384; FRIEDLAENDER JS, 1971, AM J HUM GENET, V23, P253; FRISANCHO AR, 1969, HUM BIOL, V41, P365; FRISANCHO AR, 1970, AM J PHYS ANTHROPOL, V32, P279, DOI 10.1002/ajpa.1330320217; GOODMAN MM, IN PRESS; HARRISON GA, 1969, PHIL T ROY SOC     B, V256, P47; KURCZYNSKI TW, 1970, VIOMETRICS, V26, P525; Li CC., 1955, POPULATION GENETICS; PATEL KM, 1968, ANN MATH STAT, V39, P690; POST RH, 1968, BIOMEDICAL CHALLENGE, P141; REED TE, 1968, AM J HUM GENET, V20, P579; Siegel S, 1956, NONPARAMETRIC STATIS; SING GF, UNPUBLISHED NOTES; SINNETT P, 1970, ARCHAEOL PHYS ANTHRO, V5, P236; WARD RD, IN PRESS; WARD RH, 1970, AM J HUM GENET, V22, P538; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright S., 1968, EVOLUTION GENETICS P, P373	25	39	41	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	4					371	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M8063	5031980				2022-12-18	WOS:A1972M806300002
J	BENSON, PF; SOUTHGATE, J				BENSON, PF; SOUTHGATE, J			DIMINISHED ACTIVITY OF PLATELET MONOAMINE OXIDASE IN DOWNS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAZELON M, 1967, LANCET, V1, P1130; BERTACCINI G, 1960, J PHYSIOL-LONDON, V153, P239, DOI 10.1113/jphysiol.1960.sp006532; DOERY JCG, 1968, LANCET, V2, P894; HAVERBACK BJ, 1958, GASTROENTEROLOGY, V35, P570; HEATONWARD WA, 1962, J MENT SCI, V108, P865; JEROME H, 1960, CR HEBD ACAD SCI, V251, P474; JEROME H, 1962, Bull Mem Soc Med Hop Paris, V113, P168; KRAJL M, 1965, BIOCHEM PHARMACOL, V14, P1684, DOI 10.1016/0006-2952(65)90025-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANDELLI F, 1967, ACTA PAEDIATR LAT, V20, P481; McCOoy E E, 1968, J Ment Defic Res, V12, P18; OBRIEN D, 1962, ARCH DIS CHILD, V37, P17, DOI 10.1136/adc.37.191.17; RETT A, 1959, J SOC CIENC MED LI S, P265; ROBINSON DS, 1968, BIOCHEM PHARMACOL, V17, P109, DOI 10.1016/0006-2952(68)90163-9; ROSNER F, 1965, NEW ENGL J MED, V273, P1356, DOI 10.1056/NEJM196512162732503; ROSNER F, 1965, LANCET, V1, P1191; SADLER JR, 1965, J MOL BIOL, V12, P305, DOI 10.1016/S0022-2836(65)80255-8; SOUTHGATE J, 1970, J CLIN PATHOL S3, V23, P43; TISSOT R, 1966, PATHOL BIOL, V14, P312; TU JB, 1965, LANCET, V2, P715; VAZQUEZ H J, 1961, Sem Med, V118, P803	21	39	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					211	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	4253914				2022-12-18	WOS:A1971J165300008
J	FIALKOW, PJ				FIALKOW, PJ			X-CHROMOSOME INACTIVATION AND XG LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		FIALKOW PJ, 1969, SCIENCE, V163, P194, DOI 10.1126/science.163.3863.194; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; FIALKOW PT, 1970, NATURE, V226, P367, DOI 10.1038/226367a0; GORMAN JG, 1963, J LAB CLIN MED, V61, P642; GREENE ML, 1970, AM J HUM GENET, V22, P50; HENDERSON JF, 1969, AM J HUM GENET, V21, P61; KELLEY WN, 1969, ANN INTERN MED, V70, P155, DOI 10.7326/0003-4819-70-1-155; LAWLER SD, 1970, LANCET, V1, P584; LEE GR, 1968, BLOOD, V32, P59, DOI 10.1182/blood.V32.1.59.59; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Lyon M. F., 1968, Annual review of genetics. Vol. 2, P31, DOI 10.1146/annurev.ge.02.120168.000335; NYHAN WL, 1967, PEDIATR RES, V1, P5, DOI 10.1203/00006450-196701000-00001; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; Race R.R., 1968, BLOOD GROUPS MAN, P522; SANDBERG AA, 1962, BLOOD, V20, P393, DOI 10.1182/blood.V20.4.393.393; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; SHAPIRO SL, 1966, P SOC EXP BIOL MED, V122, P609; TOUGH IM, 1963, LANCET, V1, P844; TRUJILLO JM, 1962, 9 C INT SOC HEM MEX; WHANG J, 1963, BLOOD, V22, P664, DOI 10.1182/blood.V22.6.664.664	20	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					460	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	5432290				2022-12-18	WOS:A1970H022700010
J	NANCE, WE; JACKSON, CE; WITKOP, CJ				NANCE, WE; JACKSON, CE; WITKOP, CJ			AMISH ALBINISM - A DISTINCTIVE AUTOSOMAL RECESSIVE PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRDICKA R, 1966, FOLIA BIOL-PRAGUE, V12, P305; CHRISTIAN JHB, IN PRESS; CROSS HE, 1967, PEDIATRICS, V70, P398; HOSTETLER H, 1912, DESCENDANTS JACOB HO; JACKSON CE, 1968, AM J HUM GENET, V20, P522; JACKSON CE, 1968, PEDIATRICS, V41, P495; KUGELMAN TP, 1961, J INVEST DERMATOL, V37, P73, DOI 10.1038/jid.1961.84; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; MORTON NE, 1955, AM J HUM GENET, V7, P277; NANCE W E, 1969, Clinical Medicine, V17, P68; NANCE WB, IN PRESS; NANCE WE, 1970, AM J HUM GENET, V22, P453; OTTOLENG.E, 1969, P NATL ACAD SCI USA, V64, P184, DOI 10.1073/pnas.64.1.184; POPP RA, 1962, J HERED, V53, P73, DOI 10.1093/oxfordjournals.jhered.a107127; Searle A.G., 1968, COMP GENETICS COAT C; STEIN WH, 1954, J BIOL CHEM, V211, P915; TREVORROPER PD, 1952, BRIT J OPHTHALMOL, V36, P107, DOI 10.1136/bjo.36.2.107; WITKOP CJ, 1970, AM J HUM GENET, V22, P55; WITKOP CJ, IN PRESS	19	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	5					579	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H6097	5516239				2022-12-18	WOS:A1970H609700009
J	LIVINGSTONE, FB				LIVINGSTONE, FB			ASPECTS OF POPULATION DYNAMICS OF ABNORMAL HEMOGLOBIN + GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1954, ANN HUM GENET, V19, P39, DOI 10.1111/j.1469-1809.1954.tb01261.x; ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; ALLISON AC, 1955, COLD SPRING HARB SYM, V20, P239, DOI 10.1101/SQB.1955.020.01.023; ALLISON AC, 1957, ACTA GENET, V6, P430; BARNICOT NA, 1963, ANN HUM GENET, V26, P229, DOI 10.1111/j.1469-1809.1963.tb01979.x; BLUMBERG BS, 1962, P C GENETIC POLYM ED, P159; BODMER W. F., 1960, HEREDITY, V15, P283, DOI 10.1038/hdy.1960.83; FREIREMAIA N, 1961, NATURE, V189, P80, DOI 10.1038/189080a0; HALDANE JBS, 1962, NATURE, V193, P1108, DOI 10.1038/1931108a0; JACOB GF, 1958, BRIT J HAEMATOL, V4, P138, DOI 10.1111/j.1365-2141.1958.tb03844.x; JONXIS JHP, 1959, ABNORMAL HAEMOGLOBIN, P300; KIDSON CHEV, 1962, AUSTRALIAN JOUR SCI, V25, P61; KIMURA M, 1956, P NATL ACAD SCI USA, V42, P336, DOI 10.1073/pnas.42.6.336; LASKER GW, 1960, PROCESSES ONGOING HU; LEHMANN H, 1963, NATURE, V198, P492, DOI 10.1038/198492b0; LEHMANN H, 1956, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.4988.333; LEWONTIN R. C., 1958, GENETICS, V43, P419; LI CC, 1955, AM NAT, V89, P281, DOI 10.1086/281893; LIEINJO LE, 1958, BRIT MED J, V1, P1461; LIVINGST.F, 1961, HUM BIOL, V33, P205; LIVINGSTONE FB, IN PRESS; MacIVER J. E., 1958, WEST INDIAN MED JOUR, V7, P109; MANDEL S. P. H., 1959, HEREDITY, V13, P289, DOI 10.1038/hdy.1959.36; MORTON NE, 1960, AM J HUM GENET, V12, P348; MOTULSKY A, 1960, PROCESSES ONGOING HU; MOTULSKY AG, 1962, P C GENETIC POLYMORP, P159; NANCE WE, 1963, SCIENCE, V141, P123, DOI 10.1126/science.141.3576.123; NEEL JV, 1951, COLD SPRING HARB SYM, V15, P141; PENROSE LS, 1956, ANN HUM GENET, V21, P90, DOI 10.1111/j.1469-1809.1971.tb00267.x; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SMITH SM, 1954, ANN HUM GENET, V19, P51, DOI 10.1111/j.1469-1809.1954.tb01262.x; STEINBERG AG, 1961, PROGRESS MEDICAL GEN, V1, P158; VANDEPITTE JM, 1955, BLOOD, V10, P341, DOI 10.1182/blood.V10.4.341.341	34	39	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					435	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250424				2022-12-18	WOS:A19642974A00005
J	TONDO, CV; RUCKNAGEL, DL; SALZANO, FM				TONDO, CV; RUCKNAGEL, DL; SALZANO, FM			HEMOGLOBIN PORTO ALEGRE, A POSSIBLE POLYMER OF NORMAL HEMOGLOBIN IN A CAUCASIAN BRAZILIAN FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					BOYD WC, 1954, J LAB CLIN MED, V44, P235; GERALD PS, 1958, BLOOD, V13, P61, DOI 10.1182/blood.V13.1.61.61; HUISMAN THJ, 1962, J LAB CLIN MED, V60, P302; ITANO HA, 1953, ARCH BIOCHEM BIOPHYS, V47, P148, DOI 10.1016/0003-9861(53)90444-5; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; KUNKEL HG, 1958, NATIONAL RESEARCH CO, P157; LIEINJOLUANENG, 1958, BRIT MED J, V1, P1461; NEEL JV, 1959, ABNORMAL HAEMOGLOBIN; OTTESOOSER F., 1958, AN ACAD BRASIL CIENC, V30, P65; RANNEY HM, 1959, J CLIN INVEST, V38, P508, DOI 10.1172/JCI103828; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; RUCKNAGEL DL, 1962, 10 P INT C HEM MEX C; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; Tiselius A, 1939, J EXP MED, V69, P119, DOI 10.1084/jem.69.1.119; TONDO CV, 1960, SCIENCE, V132, P1893, DOI 10.1126/science.132.3443.1893; TONDO CV, 1962, AM J HUM GENET, V14, P401; TONDO CV, 1961, 2 P INT C HUM GEN RO, P69	19	39	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	3					265	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2967A	13985474				2022-12-18	WOS:A19632967A00012
J	WOOLF, CM				WOOLF, CM			PATERNAL AGE EFFECT FOR CLEFT LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Fogh-Anderson P., 1942, INHERITANCE HARELIP; FRASER F C, 1955, Acta Genet Stat Med, V5, P358; FRASER FC, 1962, CAN MED ASSOC J, V87, P683; FRASER GR, 1961, ARCH DIS CHILD, V36, P420, DOI 10.1136/adc.36.188.420; LORETZ W, 1961, AM J PUBLIC HEALTH N, V51, P873, DOI 10.2105/AJPH.51.6.873; LUBS HA, 1961, LANCET, V2, P1001; MACMAHON B, 1953, AM J HUM GENET, V5, P176; PENROSE LS, 1962, LANCET, V1, P1101; Phair GM, 1947, J SPEECH DISORD, V12, P410, DOI 10.1044/jshd.1204.410; WOOLF C M, 1963, Plast Reconstr Surg, V32, P65, DOI 10.1097/00006534-196307000-00008; WOOLF CM, 1963, AM J HUM GENET, V15, P209	11	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					389	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097233				2022-12-18	WOS:A19632968A00016
J	SLATIS, HM; HOENE, RE				SLATIS, HM; HOENE, RE			EFFECT OF CONSANGUINITY ON DISTRIBUTION OF CONTINUOUSLY VARIABLE CHARACTERISTICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DONALD H. P., 1939, PROC ROY SOC EDINBURGH, V59, P91; FLANAGAN JC, 1958, DPCITSCS; MORTON NE, 1958, AM J HUM GENET, V10, P344; MORTON NE, 1955, ANN HUM GENET, V20, P125; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; SLATIS HM, 1958, AM J HUM GENET, V10, P446	6	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	1					28	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2959A	17948464				2022-12-18	WOS:A19612959A00018
J	KNOX, WE				KNOX, WE			INBORN ERRORS OF METABOLISM .2. ALKAPTONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABDERHALDEN E, 1912, Z PHYSL CHEM, V77, P454; Albrecht H., 1902, HEILKD K, V23, P366; Bamberger E, 1903, BER DTSCH CHEM GES, V36, P2028, DOI 10.1002/cber.190303602117; Bateson W., 1902, MENDELS PRINCIPLES H, DOI 10.1017/CBO9780511694462; BATESON W, 1902, 1 EV COMM ROYAL SOC, P133; Baumann E, 1891, Z PHYSL CHEM, V15, P228; BODEKER C, 1861, ANN CHEM PHARM, V117, P98; BODEKER C, 1859, Z RATION MED, V7, P130; BRUNE B, 1887, BOSTON MED SURG J, V116, P83; BRUNE B, 1886, BOSTON MED SURG J, V115, P621; Dakin HD, 1911, J BIOL CHEM, V9, P151; DIAZ ECJ, 1939, KLIN WSCHR, V18, P965; EBSTEIN H, 1875, VIRCHOWS ARCH, V62, P554; EMBDEN H, 1893, Z PHYSL CHEM, V18, P304; Fishberg EH, 1942, J AMER MED ASSOC, V119, P882, DOI 10.1001/jama.1942.72830280001009; FLEISCHER R, 1875, BERL KLIN WSCHR, V12, P547; FLEISCHER R, 1875, BERL KLIN WSCHR, V12, P529; FRIEDMANN E, 1908, BEITR CHEM PHYSL PAT, V11, P304; FROMHERZ K, 1914, Z PHYSL CHEM, V91, P194; FROMHERZ K, 1908, THESIS FREIBURG; FURBRINGER P, 1875, BERL KLIN WCHNSCHR, V12, P330; FURBRINGER P, 1875, BERL KLIN WSCHR, V12, P390; FURBRINGER P, 1875, BERL KLIN WSCHR, V12, P313; FUTCHER TB, 1898, NEW YORK M J, V67, P69; GALDSTON M, 1952, AM J MED, V13, P432, DOI 10.1016/0002-9343(52)90298-2; Garrod A E, 1899, Med Chir Trans, V82, P367; Garrod A.E., 1909, INBORN ERRORS METABO; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; Garrod AE, 1923, INBORN ERRORS METABO; Garrod Archibald E., 1901, LANCET, V2, P1484; GOODWIN S, 1957, J AM CHEM SOC, V79, P179, DOI 10.1021/ja01558a049; Gross O, 1914, BIOCHEM Z, V61, P165; GROSS O, 1907, Z KLIN MED, V64, P359; HALL WK, 1950, J HERED, V41, P23, DOI 10.1093/oxfordjournals.jhered.a106045; HANSEMANN D, 1892, BERL KLI WCHSCHR, V29, P660; HEILE, 1900, VIRCH ARCH PATHOL AN, V160, P148; HOGBEN LANCELOT, 1932, PROC ROY SOC EDINBURGH, V52, P264; HUPPERT, 1897, Z PHYSL CHEM, V23, P412; ICHIHARA K, MED J OSAKA U; KATSCH G, 1920, DEUT ARCH KLIN MED, V134, P59; KATSCH G, 1918, DEUT ARCH KLIN MED, V127, P210; KATSCH G, 1926, DTSCH ARCH F KLIN ME, V151, P329; KENNEY FT, 1958, SCIENCE, V127, P86, DOI 10.1126/science.127.3289.86; KHACHADURIAN A, J CHRONIC DIS; KING EF, 1915, T AM UROL ASS, V9, P459; KIRK R, 1889, BMJ-BRIT MED J, V2, P1149; KIRK R, 1889, J ANAT PHYSL, V23, P69; KIRK R, 1886, BMJ-BRIT MED J, V2, P1017; KIRK R, 1888, BMJ-BRIT MED J, V2, P232; KLEIN D, 1953, CLIN GENETICS, P177; KLUYVER AJ, 1951, ANTON LEEUW INT J G, V17, P47; KNOX WE, 1955, J BIOL CHEM, V216, P479; KNOX WE, 1951, BIOCHEM J, V49, P686, DOI 10.1042/bj0490686; KNOX WE, 1956, PHYSIOL REV, V36, P164, DOI 10.1152/physrev.1956.36.2.164; KNOX WE, 1955, AMINO ACID METABOLIS, P836; KRETCHMER N, 1956, J CLIN INVEST, V35, P236, DOI 10.1172/JCI103268; LADU BN, 1958, J BIOL CHEM, V230, P251; LANGSTEIN L, 1904, BEITR CHEM PHYS PATH, V4, P145; LANYAR F, 1929, Z PHYSL CHEM, V182, P218; Lewis JH, 1926, J BIOL CHEM, V70, P659; LIEB H, 1930, Z PHYSL CHEM, V186, P111; LIN ECC, 1957, BIOCHIM BIOPHYS ACTA, V26, P85, DOI 10.1016/0006-3002(57)90057-4; LIN ECC, 1957, P SOC EXP BIOL MED, V96, P501; LUSITANUS Z, 1649, PRAXIS MEDICA ADMIRA, V3, pC134; MARSHALL J, 1887, M NEWS, V50, P35; MARTIN WJ, 1955, ANN INTERN MED, V42, P1052, DOI 10.7326/0003-4819-42-5-1052; MEYER E, 1901, DTSCH ARCH KLIN MED, V70, P443; MILCH H, 1951, J Int Coll Surg, V15, P669; MILCH RA, 1957, SCIENCE, V126, P209, DOI 10.1126/science.126.3266.209; MILCH RA, 1955, METABOLISM, V4, P513; NEUBAUER O, 1928, HDB NORM PATH PHYSL, V5, P671; NEUBERGER A, 1947, BIOCHEM J, V41, P438, DOI 10.1042/bj0410438; NIEMANN A, 1876, DTSCH ARCH KLIN MED, V18, P232; ORSI F, 1889, GAZZ MED LOMBARDA, V48, P115; Osler W, 1904, LANCET, V1, P10; Papageorge E, 1938, J BIOL CHEM, V123, P211; PICK L, 1906, BERL KLIN WCHNSCHR, V43, P556; PICK L, 1906, BERL KLIN WCHNSCHR, V43, P509; PICK L, 1906, BERL KLIN WCHNSCHR, V43, P478; PICK L, 1906, BERL KLIN WCHNSCHR, V43, P591; PIETER H, 1952, PRESSE MED, V33, P1310; PIRRUNG J, 1957, J BIOL CHEM, V229, P199; POMERANZ MM, 1941, RADIOLOGY, V37, P295; SCHENK, 1609, OBSERVACIONES MEDICA, V3, P558; SCHEPARTZ B, 1949, J BIOL CHEM, V180, P663; SCRIBONIUS GA, 1584, INSPECTIONE URINARUM, P50; SEALOCK RR, 1940, J BIOL CHEM, V123, P211; SKINSNES OK, 1948, ARCH PATHOL, V45, P552; Smith JW, 1942, J AMER MED ASSOC, V120, P1282, DOI 10.1001/jama.1942.02830510020005; SMITH W, 1882, DUBLIN J M SC, V1, P465; STEIN WD, 1955, NATURE, V175, P472, DOI 10.1038/175472a0; SUDA M, 1951, J BIOCHEM-TOKYO, V38, P297, DOI 10.1093/oxfordjournals.jbchem.a126254; TAKEDA Y, 1952, J OSAKA U, V3, P313; THANNHAUSER SJ, 1929, STOFFWECHSEL STOFFWE, P126; TOENNIESSEN E, 1922, Z INDUKT ABSTAMM, V29, P26; UMBER F, 1913, DTSCH MED WSCHR, V39, P2337; UTKIN LM, 1950, BIOCHEMISTRY-USSR+, V15, P330; Virchow R., 1866, VIRCHOWS ARCH PATHOL, V37, P212; ZDAREK E, 1902, Z HEILK, V23, P379	100	39	39	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					95	124						30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533390				2022-12-18	WOS:A1958WA21900001
J	YERGANIAN, G				YERGANIAN, G			CYTOLOGIC MAPS OF SOME ISOLATED HUMAN PACHYTENE CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GRIFFEN A. B., 1955, J MORPH, V96, P123, DOI 10.1002/jmor.1050960106; HSU TC, 1952, J HERED, V43, P167, DOI 10.1093/oxfordjournals.jhered.a106296; HUNGERFORD DAVID ALDEN, 1955, J MORPH, V97, P497, DOI 10.1002/jmor.1050970305; LEVAN A, 1953, J NATL CANCER I, V14, P1; Neel JV, 1954, HUMAN HEREDITY; SCHULTZ JACK, 1949, JOUR HEREDITY, V40, P31; SLIZYNSKI BM, 1952, J GENET, V50, P507, DOI 10.1007/BF02986845; SLIZYNSKI BM, 1949, J GENET, V49, P242, DOI 10.1007/BF02986078; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]	9	39	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	1					42	54						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA214	13410900				2022-12-18	WOS:A1957WA21400004
J	Zhang, ZH; Li, B; Fu, J; Li, R; Diao, FY; Li, CH; Chen, BB; Du, J; Zhou, Z; Mu, J; Yan, Z; Wu, L; Liu, S; Wang, WJ; Zhao, L; Dong, J; He, L; Liang, XZ; Kuang, YP; Sun, XX; Sang, Q; Wang, L				Zhang, Zhihua; Li, Bin; Fu, Jing; Li, Rong; Diao, Feiyang; Li, Caihong; Chen, Biaobang; Du, Jing; Zhou, Zhou; Mu, Jian; Yan, Zheng; Wu, Ling; Liu, Shuai; Wang, Wenjing; Zhao, Lin; Dong, Jie; He, Lin; Liang, Xiaozhen; Kuang, Yanping; Sun, Xiaoxi; Sang, Qing; Wang, Lei			Bi-allelic Missense Pathogenic Variants in TRIP13 Cause Female Infertility Characterized by Oocyte Maturation Arrest	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC RECOMBINATION; AAA-ATPASE; MUTATIONS; MEIOSIS; PROTEIN; TUBB8	Normal oocyte meiosis is a prerequisite for successful human reproduction, and abnormalities in the process will result in infertility. In 2016, we identified mutations in TUBB8 as responsible for human oocyte meiotic arrest. However, the underlying genetic factors for most affected individuals remain unknown. TRIP13, encoding an AAA-ATPase, is a key component of the spindle assembly checkpoint, and recurrent homozygous nonsense variants and a splicing variant in TRIP13 are reported to cause Wilms tumors in children. In this study, we identified homozygous and compound heterozygous missense pathogenic variants in TRIP13 responsible for female infertility mainly characterized by oocyte meiotic arrest in five individuals from four independent families. Individuals from three families suffered from oocyte maturation arrest, whereas the individual from the fourth family had abnormal zygote cleavage. All displayed only the infertility phenotype without Wilms tumors or any other abnormalities. In vitro and in vivo studies showed that the identified variants reduced the protein abundance of TRIP13 and caused its downstream molecule, HORMAD2, to accumulate in HeLa cells and in proband-derived lymphoblastoid cells. The chromosome mis-segregation assay showed that variants did not have any effects on mitosis. Injecting TRIP13 cRNA into oocytes from one affected individual was able to rescue the phenotype, which has implications for future therapeutic treatments. This study reports pathogenic variants in TRIP13 responsible for oocyte meiotic arrest, and it highlights the pivotal but different roles of TRIP13 in meiosis and mitosis. These findings also indicate that different dosage effects of mutant TRIP13 might result in two distinct human diseases.	[Zhang, Zhihua; Zhou, Zhou; Mu, Jian; Wang, Wenjing; Zhao, Lin; Dong, Jie; Sang, Qing; Wang, Lei] Fudan Univ, Int Colab Med Epigenet & Metab, Shanghai Key Lab Med Epigenet, Inst Biomed Sci,Inst Pediat,Childrens Hosp,Minist, Shanghai 200032, Peoples R China; [Zhang, Zhihua; Zhou, Zhou; Mu, Jian; Wang, Wenjing; Zhao, Lin; Dong, Jie; Sang, Qing; Wang, Lei] Fudan Univ, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Li, Bin; Yan, Zheng; Wu, Ling; Kuang, Yanping] Shanghai Jiao Tong Univ, Shanghai Hosp 9, Reprod Med Ctr, Shanghai 200011, Peoples R China; [Fu, Jing; Sun, Xiaoxi] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200011, Peoples R China; [Li, Rong] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Reprod Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Diao, Feiyang] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Peoples R China; [Li, Caihong] Shenyang Jinghua Hosp, Assisted Reprod Technol Lab, Shenyang 110005, Liaoning, Peoples R China; [Chen, Biaobang; Du, Jing] Fudan Univ, Natl Hlth Commiss Key Lab Reprod Regulat, Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China; [Liu, Shuai; Liang, Xiaozhen] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Bio X Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Wang, Lei] Shanghai Ctr Women & Childrens Hlth, Shanghai 200062, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Nanjing Medical University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University	Sang, Q; Wang, L (corresponding author), Fudan Univ, Int Colab Med Epigenet & Metab, Shanghai Key Lab Med Epigenet, Inst Biomed Sci,Inst Pediat,Childrens Hosp,Minist, Shanghai 200032, Peoples R China.; Sang, Q; Wang, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200032, Peoples R China.; Wang, L (corresponding author), Shanghai Ctr Women & Childrens Hlth, Shanghai 200062, Peoples R China.	sangqing@fudan.edu.cn; wangleiwanglei@fudan.edu.cn	Du, Jing/AAY-4092-2021; ZHAO, LIN/HGC-6923-2022; zhang, zh/GWV-4677-2022	Du, Jing/0000-0002-6767-2763; ZHAO, LIN/0000-0002-1678-7763; Chen, Biaobang/0000-0002-9921-2155	National Key Research and Development Program of China [2018YFC1003800, 2017YFC1001500, 2016YFC1000600]; National Natural Science Foundation of China [81725006, 81822019, 81771581, 81571501, 81971450, 81971382]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; Shanghai Rising-Star Program [17QA1400200]; Natural Science Foundation of Shanghai [17ZR1401900]; Capacity Building Planning Program for Shanghai Women and Children's Health Service; Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health; Foundation of Shanghai Health and Family Planning Commission [20154Y0162]; Chinese Academy of Sciences [FIRMC200507]; Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; Shanghai Rising-Star Program; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Capacity Building Planning Program for Shanghai Women and Children's Health Service; Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health; Foundation of Shanghai Health and Family Planning Commission; Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals(Ferring Pharmaceuticals)	This work was supported by the National Key Research and Development Program of China (2018YFC1003800, 2017YFC1001500, and 2016YFC1000600), the National Natural Science Foundation of China (81725006, 81822019, 81771581, 81571501, 81971450, and 81971382), the project supported by Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), the Shanghai Rising-Star Program (17QA1400200), the Natural Science Foundation of Shanghai (17ZR1401900), the Capacity Building Planning Program for Shanghai Women and Children's Health Service, the Collaborative Innovation Center Project Construction for Shanghai Women and Children's Health, the Foundation of Shanghai Health and Family Planning Commission (20154Y0162), the Strategic Collaborative Research Program of the Ferring Institute of Reproductive Medicine, Ferring Pharmaceuticals, and the Chinese Academy of Sciences (FIRMC200507).	Adhikari D, 2014, MOL CELL ENDOCRINOL, V382, P480, DOI 10.1016/j.mce.2013.07.027; Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Alfieri C, 2018, NATURE, V559, P274, DOI 10.1038/s41586-018-0281-1; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Brulotte ML, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02012-2; Chen BB, 2019, EUR J HUM GENET, V27, P300, DOI 10.1038/s41431-018-0283-3; Chen BB, 2017, AM J HUM GENET, V101, P609, DOI 10.1016/j.ajhg.2017.08.018; Chen BB, 2017, HUM REPROD, V32, P457, DOI 10.1093/humrep/dew322; Christou-Kent M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708515; Clairmont CS, 2020, NAT CELL BIOL, V22, P87, DOI 10.1038/s41556-019-0442-y; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Gao Y, 2019, J GEN VIROL, V100, P851, DOI 10.1099/jgv.0.001249; Huang LL, 2018, HUM REPROD, V33, P1183, DOI 10.1093/humrep/dey100; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Ma HT, 2016, CELL REP, V14, P1086, DOI 10.1016/j.celrep.2016.01.001; MacLennan M, 2015, SEMIN CELL DEV BIOL, V45, P68, DOI 10.1016/j.semcdb.2015.10.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Miniowitz-Shemtov S, 2015, P NATL ACAD SCI USA, V112, P11536, DOI 10.1073/pnas.1515358112; MORISHIMA I, 1975, BIOCHIM BIOPHYS ACTA, V410, P310, DOI 10.1016/0005-2744(75)90233-8; Mu J, 2019, J MED GENET, V56, P471, DOI 10.1136/jmedgenet-2018-105936; Pacheco S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005017; Rinaldi VD, 2017, MOL CELL, V67, P1026, DOI 10.1016/j.molcel.2017.07.027; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Sang Q, 2018, AM J HUM GENET, V102, P649, DOI 10.1016/j.ajhg.2018.02.015; Su YQ, 2012, SCIENCE, V335, P1496, DOI 10.1126/science.1214680; SZOLLOSI D, 1976, CURR TOPICS PATHOL, V62, P9; Wang AC, 2018, GYNECOL ENDOCRINOL, V34, P900, DOI 10.1080/09513590.2018.1464138; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024; Ye QZ, 2017, EMBO J, V36, P2419, DOI 10.15252/embj.201797291; Yost S, 2017, NAT GENET, V49, P1148, DOI 10.1038/ng.3883; Yuan P, 2018, J ASSIST REPROD GEN, V35, P1349, DOI 10.1007/s10815-018-1188-3	35	38	38	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2020	107	1					15	23		10.1016/j.ajhg.2020.05.001	http://dx.doi.org/10.1016/j.ajhg.2020.05.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH4EU	32473092	Green Published, Bronze			2022-12-18	WOS:000546685300002
J	Schlingmann, KP; Bandulik, S; Mammen, C; Tarailo-Graovac, M; Holm, R; Baumann, M; Konig, J; Lee, JJY; Drogemoller, B; Imminger, K; Beck, BB; Altmuller, J; Thiele, H; Waldegger, S; van't Hoff, W; Kleta, R; Warth, R; van Karnebeek, CDM; Vilsen, B; Bockenhauer, D; Konrad, M				Schlingmann, Karl P.; Bandulik, Sascha; Mammen, Cherry; Tarailo-Graovac, Maja; Holm, Rikke; Baumann, Matthias; Koenig, Jens; Lee, Jessica J. Y.; Drogemoller, Britt; Imminger, Katrin; Beck, Bodo B.; Altmueller, Janine; Thiele, Holger; Waldegger, Siegfried; van't Hoff, William; Kleta, Robert; Warth, Richard; van Karnebeek, Clara D. M.; Vilsen, Bente; Bockenhauer, Detlef; Konrad, Martin			Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC MUTATIONS; ALPHA-SUBUNIT; ISOFORM; NA+,K+-ATPASE; NA,K-ATPASE; SODIUM; TRPM6; HYPEREXCITABILITY; INHIBITION; TRANSPORT	Over the last decades, a growing spectrum of monogenic disorders of human magnesium homeostasis has been clinically characterized, and genetic studies in affected individuals have identified important molecular components of cellular and epithelial magnesium transport. Here, we describe three infants who are from non-consanguineous families and who presented with a disease phenotype consisting of generalized seizures in infancy, severe hypomagnesemia, and renal magnesium wasting. Seizures persisted despite magnesium supplementation and were associated with significant intellectual disability. Whole-exome sequencing and conventional Sanger sequencing identified heterozygous de novo mutations in the catalytic Na+, K+-ATPase alpha 1 subunit (ATP1A1). Functional characterization of mutant Na+, K+-ATPase alpha 1 subunits in heterologous expression systems revealed not only a loss of Na+, K+-ATPase function but also abnormal cation permeabilities, which led to membrane depolarization and possibly aggravated the effect of the loss of physiological pump activity. These findings underline the indispensable role of the alpha 1 isoform of the Na+, K+-ATPase for renal-tubular magnesium handling and cellular ion homeostasis, as well as maintenance of physiologic neuronal activity.	[Schlingmann, Karl P.; Koenig, Jens; Konrad, Martin] Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Bandulik, Sascha; Imminger, Katrin; Warth, Richard] Univ Regensburg, Med Cell Biol, D-93053 Regensburg, Germany; [Mammen, Cherry] Univ British Columbia, Div Nephrol, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Dept Biochem, Calgary, AB T2N 1N4, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Dept Mol Biol, Calgary, AB T2N 1N4, Canada; [Tarailo-Graovac, Maja] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada; [Holm, Rikke; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Baumann, Matthias; Waldegger, Siegfried] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria; [Lee, Jessica J. Y.; Drogemoller, Britt] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Beck, Bodo B.] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Beck, Bodo B.] Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Beck, Bodo B.] Ctr Rare & Hereditary Kidney Dis, D-50931 Cologne, Germany; [Altmueller, Janine; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [van't Hoff, William; Kleta, Robert; Bockenhauer, Detlef] Great Ormond St Hosp Children NHS Fdn Trust, Dept Pediat Nephrol, London WC1N 3JH, England; [Kleta, Robert; Bockenhauer, Detlef] UCL Ctr Nephrol, London NW3 2PF, England; [van Karnebeek, Clara D. M.] Univ British Columbia, Dept Pediat, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z3, Canada; [van Karnebeek, Clara D. M.] Univ Amsterdam, Med Ctr, Dept Pediat, NL-1007 Amsterdam, Netherlands; [van Karnebeek, Clara D. M.] Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 Amsterdam, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Regensburg; University of British Columbia; University of Calgary; University of Calgary; University of Calgary; Aarhus University; Medical University of Innsbruck; University of British Columbia; University of Cologne; University of Cologne; University of Cologne; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of British Columbia; University of Amsterdam; University of Amsterdam	Schlingmann, KP (corresponding author), Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany.	karlpeter.schlingmann@ukmuenster.de	Bandulik, Sascha/L-7365-2015; Warth, Richard/N-7119-2014; Thiele, Holger/ABE-6792-2020; Bockenhauer, Detlef/AAF-6495-2020	Warth, Richard/0000-0001-6084-0659; Thiele, Holger/0000-0002-0169-998X; Bockenhauer, Detlef/0000-0001-5878-941X; Tarailo-Graovac, Maja/0000-0002-4472-8584; Altmuller, Janine/0000-0003-4372-1521; Vilsen, Bente/0000-0002-4727-9382; Jordan, Katrin/0000-0001-5529-2379; Drogemoller, Britt/0000-0002-3348-5855	B.C Children's Hospital Foundation [C-II-2]; Genome British Columbia [SOF-195]; Canadian Institutes of Health Research [301221]; Michael Smith Foundation for Health Foundation Research Scholar Award; Lundbeck Foundation [R223-2016-595]; Danish Medical Research Council [7016-00193B]; Kids Kidney Research; Kidney Research UK; St Peter's Trust for Kidney Bladder and Prostate Research; David and Elaine Potter Foundation; European Union, 7th Framework Program [2012-305608]; Deutsche Forschungsgemeinschaft [BA4436/2-1, SFB699]; Hans-Joachim-Bodlee Foundation	B.C Children's Hospital Foundation; Genome British Columbia; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Foundation Research Scholar Award(Michael Smith Foundation for Health Research); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); St Peter's Trust for Kidney Bladder and Prostate Research; David and Elaine Potter Foundation; European Union, 7th Framework Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Joachim-Bodlee Foundation	We are grateful to the children and their families for their participation in this study. We would like to acknowledge the following clinicians and laboratory scientists involved in the management of the children and molecular studies: Xiaohua Han, Ruth Giesbrecht, Dora Pak, Michelle Higginson, Aisha Ghani, Colin J. Ross, and WyethW. Wasserman. Individual C-II-2 was part of the Treatable Intellectual Disability Endeavour (TIDE) with funding support from the B.C Children's Hospital Foundation as "1st Collaborative Area of Innovation'' (www.tidebc.org); Genome British Columbia (grant number SOF-195); the Canadian Institutes of Health Research (grant number 301221); and informatics infrastructure supported by Genome British Columbia and Genome Canada (ABC4DE Project). C.D.M.v.K. is a recipient of the Michael Smith Foundation for Health Foundation Research Scholar Award. The work was supported by grants to B.V. from the Lundbeck Foundation (grant number R223-2016-595) and the Danish Medical Research Council (grant number 7016-00193B). Support to D.B. and R.K. was provided by Kids Kidney Research; Kidney Research UK; St Peter's Trust for Kidney Bladder and Prostate Research; The David and Elaine Potter Foundation; and the European Union, 7th Framework Program (grant agreement 2012-305608 " European Consortium for High-Throughput Research in Rare Kidney Diseases (EURenOmics).'' S.B. and R.W. were supported by the " Deutsche Forschungsgemeinschaft'' (BA4436/2-1 to S.B. and SFB699 to R.W.). K.P.S. and M.K. received support from the Hans-Joachim-Bodlee Foundation.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bottger P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22047; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Deprez L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/j.1528-1167.2007.01415.x; DONALDSON J, 1971, CAN J BIOCHEM CELL B, V49, P1217, DOI 10.1139/o71-175; Gritz SM, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-8; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Krishnan GP, 2015, J NEUROPHYSIOL, V113, P3356, DOI 10.1152/jn.00460.2014; Larsen BR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00141; Lassuthova P, 2018, AM J HUM GENET, V102, P505, DOI 10.1016/j.ajhg.2018.01.023; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Lucking K, 1996, AM J PHYSIOL-RENAL, V271, pF253, DOI 10.1152/ajprenal.1996.271.2.F253; Marquezan BP, 2013, EPILEPSY RES, V105, P396, DOI 10.1016/j.eplepsyres.2013.03.007; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; POST RL, 1972, J BIOL CHEM, V247, P6530; Santoro L, 2011, CEPHALALGIA, V31, P808, DOI 10.1177/0333102411399351; Schlingmann KP, 2005, J AM SOC NEPHROL, V16, P3061, DOI 10.1681/ASN.2004110989; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Spadaro M, 2004, NEUROGENETICS, V5, P177, DOI 10.1007/s10048-004-0183-2; Sweadner KJ, 2003, ANN NY ACAD SCI, V986, P382, DOI 10.1111/j.1749-6632.2003.tb07218.x; Tauber P, 2016, ENDOCRINOLOGY, V157, P2489, DOI 10.1210/en.2015-2029; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; Viering DHHM, 2017, PEDIATR NEPHROL, V32, P1123, DOI 10.1007/s00467-016-3416-3; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901	37	38	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					808	816		10.1016/j.ajhg.2018.10.004	http://dx.doi.org/10.1016/j.ajhg.2018.10.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30388404	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000448942100015
J	[Anonymous]				[Anonymous]			ASHG Denounces Attempts to Link Genetics and Racial Supremacy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material																		[Anonymous], 2002, NAT BIOTECHNOL, V20, P637, DOI 10.1038/nbt0702-637; Baker JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01837-7; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Keita SOY, 2004, NAT GENET, V36, pS17, DOI 10.1038/ng1455; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; Royal CD, 2010, AM J HUM GENET, V86, P661, DOI 10.1016/j.ajhg.2010.03.011; Yudell M, 2016, SCIENCE, V351, P564, DOI 10.1126/science.aac4951	8	38	38	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					636	636		10.1016/j.ajhg.2018.10.011	http://dx.doi.org/10.1016/j.ajhg.2018.10.011			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30348456	Bronze, Green Published			2022-12-18	WOS:000448942100001
J	Ferreira, CR; Xia, ZJ; Clement, A; Parry, DA; Davids, M; Taylan, F; Sharma, P; Turgeon, CT; Blanco-Sanchez, B; Ng, BG; Logan, CV; Wolfe, LA; Solomon, BD; Cho, MT; Douglas, G; Carvalho, DR; Bratke, H; Haug, MG; Phillips, JB; Wegner, J; Tiemeyer, M; Aoki, K; Nordgren, A; Hammarsjo, A; Duker, AL; Rohena, L; Hove, HB; Ek, J; Adams, D; Tifft, CJ; Onyekweli, T; Weixel, T; Macnamara, E; Radtke, K; Powis, Z; Earl, D; Gabriel, M; Russi, AHS; Brick, L; Kozenko, M; Tham, E; Raymond, KM; Phillips, JA; Tiller, GE; Wilson, WG; Hamid, R; Malicdan, MCV; Nishimura, G; Grigelioniene, G; Jackson, A; Westerfield, M; Bober, MB; Gahl, WA; Freeze, HH				Ferreira, Carlos R.; Xia, Zhi-Jie; Clement, Aurelie; Parry, David A.; Davids, Mariska; Taylan, Fulya; Sharma, Prashant; Turgeon, Coleman T.; Blanco-Sanchez, Bernardo; Ng, Bobby G.; Logan, Clare V.; Wolfe, Lynne A.; Solomon, Benjamin D.; Cho, Megan T.; Douglas, Ganka; Carvalho, Daniel R.; Bratke, Heiko; Haug, Marte Gjol; Phillips, Jennifer B.; Wegner, Jeremy; Tiemeyer, Michael; Aoki, Kazuhiro; Nordgren, Ann; Hammarsjo, Anna; Duker, Angela L.; Rohena, Luis; Hove, Hanne Buciek; Ek, Jakob; Adams, David; Tifft, Cynthia J.; Onyekweli, Tito; Weixel, Tara; Macnamara, Ellen; Radtke, Kelly; Powis, Zoe; Earl, Dawn; Gabriel, Melissa; Russi, Alvaro H. Serrano; Brick, Lauren; Kozenko, Mariya; Tham, Emma; Raymond, Kimiyo M.; Phillips, John A., III; Tiller, George E.; Wilson, William G.; Hamid, Rizwan; Malicdan, May C. V.; Nishimura, Gen; Grigelioniene, Giedre; Jackson, Andrew; Westerfield, Monte; Bober, Michael B.; Gahl, William A.; Freeze, Hudson H.		Undiagnosed Dis Network; Scottish Genome Partnership	A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC SKELETAL DISORDERS; OLIGOMERIC GOLGI-COMPLEX; OSTEODYSPLASTIC PRIMORDIAL DWARFISM; UNDIAGNOSED DISEASES NETWORK; CONGENITAL DISORDER; BREFELDIN-A; DEFICIENCY; ZEBRAFISH; DYSPLASIA; CLASSIFICATION	The conserved oligomeric Golgi (COG) complex is involved in intracellular vesicular transport, and is composed of eight subunits distributed in two lobes, lobe A (COG1-4) and lobe B (COGS-8). We describe fourteen individuals with Saul-Wilson syndrome, a rare form of primordial dwarfism with characteristic facial and radiographic features. All affected subjects harbored heterozygous de novo variants in COG4, giving rise to the same recurrent amino acid substitution (p.Gly516Arg). Affected individuals' fibroblasts, whose COG4 mRNA and protein were not decreased, exhibited delayed anterograde vesicular trafficking from the ER to the Golgi and accelerated retrograde vesicular recycling from the Golgi to the ER. This altered steady-state equilibrium led to a decrease in Golgi volume, as well as morphologic abnormalities with collapse of the Golgi stacks. Despite these abnormalities of the Golgi apparatus, protein glycosylation in sera and fibroblasts from affected subjects was not notably altered, but decorin, a proteoglycan secreted into the extracellular matrix, showed altered Golgi-dependent glycosylation. In summary, we define a specific heterozygous COG4 substitution as the molecular basis of Saul-Wilson syndrome, a rare skeletal dysplasia distinct from biallelic COG4-CDG.	[Ferreira, Carlos R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Ferreira, Carlos R.] Childrens Natl Hlth Syst, Div Genet & Metab, Washington, DC 20010 USA; [Xia, Zhi-Jie; Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA; [Clement, Aurelie; Blanco-Sanchez, Bernardo; Phillips, Jennifer B.; Wegner, Jeremy; Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Parry, David A.; Logan, Clare V.; Jackson, Andrew] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Davids, Mariska; Sharma, Prashant; Wolfe, Lynne A.; Adams, David; Tifft, Cynthia J.; Onyekweli, Tito; Weixel, Tara; Macnamara, Ellen; Malicdan, May C. V.; Gahl, William A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Taylan, Fulya; Nordgren, Ann; Hammarsjo, Anna; Tham, Emma; Grigelioniene, Giedre] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Turgeon, Coleman T.; Raymond, Kimiyo M.] Mayo Clin, Coll Med, Biochem Genet Lab, Rochester, MN 55905 USA; [Ferreira, Carlos R.; Solomon, Benjamin D.; Cho, Megan T.; Douglas, Ganka] GeneDx, Gaithersburg, MD 20877 USA; [Carvalho, Daniel R.] SARAH Network Rehabil Hosp, Genet Unit, BR-70335901 Brasilia, DF, Brazil; [Bratke, Heiko] Haugesund Dist Hosp, SectPaediat, Dept Internal Med, Fonna Hlth Trust, N-5527 Haugesund, Norway; [Haug, Marte Gjol] St Olavs Hosp, Dept Med Genet, N-7006 Trondheim, Norway; [Tiemeyer, Michael; Aoki, Kazuhiro] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Nordgren, Ann; Hammarsjo, Anna; Tham, Emma; Grigelioniene, Giedre] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Duker, Angela L.; Bober, Michael B.] Alfred I DuPont Hosp Children, Div Orthogenet, Wilmington, DE 19803 USA; [Rohena, Luis] San Antonio Mil Med Ctr, Dept Pediat, Div Genet, Ft Sam Houston, TX 78234 USA; [Nordgren, Ann; Rohena, Luis] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Hove, Hanne Buciek] Rigshosp, Dept Pediat, Sect Rare Disorders, DK-2100 Copenhagen, Denmark; [Ek, Jakob] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Radtke, Kelly; Powis, Zoe] Ambry Genet, Aliso Viejo, CA 92656 USA; [Earl, Dawn] Seattle Childrens, Div Med Genet, Seattle, WA 98105 USA; [Gabriel, Melissa; Russi, Alvaro H. Serrano] Univ Southern Calif, Childrens Hosp Los Angeles, Div Med Genet, Los Angeles, CA 90027 USA; [Brick, Lauren; Kozenko, Mariya] McMaster Univ, McMaster Childrens Hosp, Dept Pediat, Div Genet, Hamilton, ON L8S 4J9, Canada; [Phillips, John A., III; Hamid, Rizwan] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Med Genet & Genom Med, Nashville, TN 37232 USA; [Tiller, George E.] Kaiser Permanente, Dept Genet, Los Angeles, CA 90027 USA; [Wilson, William G.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA 20903 USA; [Nishimura, Gen] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Nishimura, Gen] Saitama Med Univ Hosp, Ctr Intractable Dis, Saitama 3500495, Japan	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Sanford Burnham Prebys Medical Discovery Institute; University of Oregon; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Karolinska Institutet; Mayo Clinic; Norwegian University of Science & Technology (NTNU); University System of Georgia; University of Georgia; Karolinska Institutet; Karolinska University Hospital; Nemours Alfred I. duPont Hospital for Children; San Antonio Military Medical Center; University of Texas System; University of Texas Health San Antonio; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Seattle Children's Hospital; Children's Hospital Los Angeles; University of Southern California; McMaster University; Vanderbilt University; Kaiser Permanente; University of Virginia; RIKEN; Saitama Medical University	Ferreira, CR (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.; Ferreira, CR (corresponding author), Childrens Natl Hlth Syst, Div Genet & Metab, Washington, DC 20010 USA.	carlos.ferreira@nih.gov	Grigelioniene, Giedre/AAH-8408-2020; Nordgren, Ann C/N-4057-2013; Xia, Zhijie/J-6987-2017; Malicdan, May Christine/AAK-7422-2021; Sharma, Prashant/ABH-1968-2021; Taylan, Fulya/V-7121-2019; Bober, Michael/AAH-4553-2021; Nordgren, Ann/AAQ-9142-2021; Sharma, Prashant/ABH-2407-2021; Jackson, Andrew/D-3442-2009	Grigelioniene, Giedre/0000-0001-9601-3137; Nordgren, Ann C/0000-0003-3285-4281; Xia, Zhijie/0000-0003-3018-1925; Taylan, Fulya/0000-0002-2907-0235; Nordgren, Ann/0000-0003-3285-4281; Brown, Donna/0000-0002-8805-7225; Jackson, Andrew/0000-0002-8739-2646; Solomon, Benjamin/0000-0002-8826-1023; Bober, Michael/0000-0002-6178-1264; Parry, David/0000-0003-0376-7736; Macnamara, Ellen/0000-0002-9418-3287; BLANCO SANCHEZ, Bernardo/0000-0003-0885-2681	NHGRI; NIH [U54 NS093793, R01 DK99551, HD22486, R21 AI129873]; Rocket Fund; Stockholm County Council; Karolinska Institutet, KID; Kronprinsessan Lovisas and Axel Tiellmans Minnesfond; Barncancerfonden; Hjarnfonden; Samariten Foundation; Sallskapet Barnavard Foundation; Promobilia Foundation; Stiftelsen Frimurare Barnhuset i Stockholm; ERC [281847]; Medical Research Council Human Genetics Unit core grant (MRC) [U127580972]; Scottish Genomes Partnership; Chief Scientist Office of the Scottish Government Health Directorates [SGP/1]; Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative; Potentials Foundation; Walking With Giants Foundation; NIH-NIGMS [P41 GM103490];  [HHSN268201700060P]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200402, ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793] Funding Source: NIH RePORTER; MRC [MC_PC_U127580972] Funding Source: UKRI	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; Stockholm County Council(Stockholm County Council); Karolinska Institutet, KID; Kronprinsessan Lovisas and Axel Tiellmans Minnesfond; Barncancerfonden; Hjarnfonden; Samariten Foundation; Sallskapet Barnavard Foundation; Promobilia Foundation; Stiftelsen Frimurare Barnhuset i Stockholm; ERC(European Research Council (ERC)European Commission); Medical Research Council Human Genetics Unit core grant (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Genomes Partnership; Chief Scientist Office of the Scottish Government Health Directorates [SGP/1]; Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Potentials Foundation; Walking With Giants Foundation; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Intramural Research Program of the NHGRI, as well as NIH U54 NS093793. The Freeze lab was supported by The Rocket Fund, NIH R01 DK99551, and HHSN268201700060P. The Stockholm team has received financial support through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, KID (Karolinska Institutet's Doctoral fellowship to AH), by grants from Kronprinsessan Lovisas and Axel Tiellmans Minnesfond, Barncancerfonden, Hjarnfonden, Samariten, Sallskapet Barnavard, Promobilia Foundations, and Stiftelsen Frimurare Barnhuset i Stockholm. The Jackson lab was supported by an ERC Starter Grant (281847), by a Medical Research Council Human Genetics Unit core grant (MRC, U127580972), and the Scottish Genomes Partnership. The Scottish Genomes Partnership is funded by the Chief Scientist Office of the Scottish Government Health Directorates [SGP/1] and The Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative. The Primordial Registry at Nemours/Alfred I. duPont Hospital is supported by the Potentials Foundation and the Walking With Giants Foundation. The zebrafish lab received support from NIH HD22486 in addition to the U54, and the zebrafish glycomic analysis was supported by NIH-NIGMS (P41 GM103490 to M.T.) and the NIH Common Fund (R21 AI129873 to K.A.). We especially thank the families for their participation in research throughout the world. Without their contribution, knowledge about these rare conditions would not be as robust as it currently is.	Blanco-Sanchez B, 2014, DIS MODEL MECH, V7, P547, DOI 10.1242/dmm.014068; Bober MB, 2017, CURR OSTEOPOROS REP, V15, P61, DOI 10.1007/s11914-017-0348-1; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Burman JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009537; Chinen Y, 2015, AM J MED GENET A, V167, P2834, DOI 10.1002/ajmg.a.37278; CHOPRA RK, 1985, BIOCHEM J, V232, P277, DOI 10.1042/bj2320277; Felipe Rucian A., 2017, EUR J PAEDIATR NEURO, V21, pe140; Fernandez CJ, 1998, J BIOL CHEM, V273, P19030, DOI 10.1074/jbc.273.30.19030; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249; Garbes L, 2015, AM J HUM GENET, V96, P432, DOI 10.1016/j.ajhg.2015.01.002; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; HERSH JH, 1994, AM J MED GENET, V51, P194, DOI 10.1002/ajmg.1320510304; Izumi K, 2016, AM J HUM GENET, V99, P451, DOI 10.1016/j.ajhg.2016.06.011; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lubbehusen J, 2010, HUM MOL GENET, V19, P3623, DOI 10.1093/hmg/ddq278; Miura Y, 2005, J PEDIATR-US, V147, P851, DOI 10.1016/j.jpeds.2005.07.038; Ng BG, 2011, MOL GENET METAB, V102, P364, DOI 10.1016/j.ymgme.2010.11.161; Osipovich AB, 2008, P NATL ACAD SCI USA, V105, P16171, DOI 10.1073/pnas.0804259105; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; Peanne R, 2011, GLYCOBIOLOGY, V21, P864, DOI 10.1093/glycob/cwq176; R Core Team, 2017, R LANG ENV STAT COMP; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Reynders E, 2009, HUM MOL GENET, V18, P3244, DOI 10.1093/hmg/ddp262; SAUL RA, 1990, AM J MED GENET, V35, P388, DOI 10.1002/ajmg.1320350315; Silbert JE, 1995, BBA-REV BIOMEMBRANES, V1241, P371, DOI 10.1016/0304-4157(95)00011-9; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Stenbeck G, 2014, CURR OPIN PHARMACOL, V16, P7, DOI 10.1016/j.coph.2014.01.003; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Willett R, 2013, HISTOCHEM CELL BIOL, V140, P271, DOI 10.1007/s00418-013-1117-6; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	48	38	40	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					553	567		10.1016/j.ajhg.2018.09.003	http://dx.doi.org/10.1016/j.ajhg.2018.09.003			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30290151	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000446312200008
J	Martin, CA; Sarlos, K; Logan, CV; Thakur, RS; Parry, DA; Bizard, AH; Leitch, A; Cleal, L; Ali, NS; Al-Owain, MA; Allen, W; Altmueller, J; Aza-Carmona, M; Barakat, BAY; Barraza-Garcia, J; Begtrup, A; Bogliolo, M; Cho, MT; Cruz-Rojo, J; Dhahrabi, HAM; Elcioglu, NH; Gosgene; Gorman, GS; Jobling, R; Kesterton, I; Kishita, Y; Kohda, M; Stabej, PLQ; Malallah, AJ; Nuernberg, P; Ohtake, A; Okazaki, Y; Pujol, R; Ramirez, MJ; Revah-Politi, A; Shimura, M; Stevens, P; Taylor, RW; Turner, L; Williams, H; Wilson, C; Yigit, G; Zahavich, L; Alkuraya, FS; Surralles, J; Iglesais, A; Murayama, K; Wollnik, B; Dattani, M; Heath, KE; Hickson, ID; Jackson, AP				Martin, Carol-Anne; Sarlos, Kata; Logan, Clare V.; Thakur, Roshan Singh; Parry, David A.; Bizard, Anna H.; Leitch, Andrea; Cleal, Louise; Ali, Nadia Shaukat; Al-Owain, Mohammed A.; Allen, William; Altmueller, Janine; Aza-Carmona, Miriam; Barakat, Bushra A. Y.; Barraza-Garcia, Jimena; Begtrup, Amber; Bogliolo, Massimo; Cho, Megan T.; Cruz-Rojo, Jaime; Dhahrabi, Hassan Ali Mundi; Elcioglu, Nursel H.; GOSgene; Gorman, Grainne S.; Jobling, Rebekah; Kesterton, Ian; Kishita, Yoshihito; Kohda, Masakazu; Stabej, Polona Le Quesne; Malallah, Asam Jassim; Nuernberg, Peter; Ohtake, Akira; Okazaki, Yasushi; Pujol, Roser; Ramirez, Maria Jose; Revah-Politi, Anya; Shimura, Masaru; Stevens, Paul; Taylor, Robert W.; Turner, Lesley; Williams, Hywel; Wilson, Carolyn; Yigit, Goekhan; Zahavich, Laura; Alkuraya, Fowzan S.; Surralles, Jordi; Iglesais, Alejandro; Murayama, Kei; Wollnik, Bernd; Dattani, Mehul; Heath, Karen E.; Hickson, Ian D.; Jackson, Andrew P.			Mutations in TOP3A Cause a Bloom Syndrome-like Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOPOISOMERASE-III-ALPHA; SYNDROME GENE-PRODUCT; SYNDROME PROTEIN; CHROMOSOME SEGREGATION; ESSENTIAL COMPONENT; GROWTH FAILURE; HELICASE; BLM; RECOMBINATION; DECATENATION	Bloom syndrome, caused by biallelic mutations in BLM, is characterized by prenatal-onset growth deficiency, short stature, an erythematous photosensitive malar rash, and increased cancer predisposition. Diagnostically, a hallmark feature is the presence of increased sister chromatid exchanges (SCEs) on cytogenetic testing. Here, we describe biallelic mutations in TOP3A in ten individuals with prenatal-onset growth restriction and microcephaly. TOP3A encodes topoisomerase III alpha (TopIII alpha), which binds to BLM as part of the BTRR complex, and promotes dissolution of double Holliday junctions arising during homologous recombination. We also identify a homozygous truncating variant in RMI1, which encodes another component of the BTRR complex, in two individuals with microcephalic dwarfism. The TOP3A mutations substantially reduce cellular levels of TopIII alpha, and consequently subjects' cells demonstrate elevated rates of SCE. Unresolved DNA recombination and/or replication intermediates persist into mitosis, leading to chromosome segregation defects and genome instability that most likely explain the growth restriction seen in these subjects and in Bloom syndrome. Clinical features of mitochondrial dysfunction are evident in several individuals with biallelic TOP3A mutations, consistent with the recently reported additional function of TopIII alpha in mitochondrial DNA decatenation. In summary, our findings establish TOP3A mutations as an additional cause of prenatal-onset short stature with increased cytogenetic SCEs and implicate the decatenation activity of the BTRR complex in their pathogenesis.	[Martin, Carol-Anne; Logan, Clare V.; Parry, David A.; Leitch, Andrea; Cleal, Louise; Jackson, Andrew P.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Sarlos, Kata; Thakur, Roshan Singh; Bizard, Anna H.; Hickson, Ian D.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Chromosome Stabil & Ctr Hlth, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark; [Ali, Nadia Shaukat; Barakat, Bushra A. Y.; Dhahrabi, Hassan Ali Mundi; Malallah, Asam Jassim] Dubai Hosp, Khaleej St,Al Baraha,Box 7272, Dubai, U Arab Emirates; [Al-Owain, Mohammed A.] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Allen, William; Wilson, Carolyn] Fullerton Genet Ctr, Asheville, NC 28803 USA; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Aza-Carmona, Miriam; Barraza-Garcia, Jimena; Heath, Karen E.] Univ Autonoma Madrid, Hosp Univ La Paz, Inst Med & Mol Genet, IdiPaz, Madrid 28046, Spain; [Aza-Carmona, Miriam; Barraza-Garcia, Jimena; Heath, Karen E.] Univ Autonoma Madrid, Hosp Univ La Paz, Skeletal Dysplasia Multidisciplinary Unit, IdiPaz, Madrid 28046, Spain; [Aza-Carmona, Miriam; Barraza-Garcia, Jimena; Bogliolo, Massimo; Pujol, Roser; Ramirez, Maria Jose; Surralles, Jordi; Heath, Karen E.] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Begtrup, Amber; Cho, Megan T.] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Bogliolo, Massimo; Pujol, Roser; Ramirez, Maria Jose; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra 08193, Spain; [Cruz-Rojo, Jaime] Hosp 12 Octubre, Dept Pediat Endocrinol & Dysmorphol, E-28041 Madrid, Spain; [Elcioglu, Nursel H.] Marmara Univ, Sch Med, Dept Pediat Genet, TR-34722 Istanbul, Turkey; [GOSgene; Stabej, Polona Le Quesne; Williams, Hywel; Dattani, Mehul] UCL, Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Gorman, Grainne S.; Taylor, Robert W.] Newcastle Univ, Sch Med Educ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England; [Jobling, Rebekah; Zahavich, Laura] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kesterton, Ian; Stevens, Paul] Guys Hosp, Viapath Analyt, Cytogenet Dept, London SE1 9RT, England; [Kishita, Yoshihito; Kohda, Masakazu; Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, 38 Morohongo, Moroyama, Saitama 3500495, Japan; [Revah-Politi, Anya] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Shimura, Masaru; Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Ctr Med Genet, Midori Ku, 579-1 Heta Cho, Chiba 2660007, Japan; [Turner, Lesley] Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; [Yigit, Goekhan; Wollnik, Bernd] Univ Med Ctr Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; [Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Surralles, Jordi] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08041, Spain; [Surralles, Jordi] Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau, Barcelona 08041, Spain; [Iglesais, Alejandro] Columbia Univ, Med Ctr, Div Clin Genet, Dept Pediat, New York, NY 10032 USA	University of Edinburgh; University of Copenhagen; Dubai Hospital; King Faisal Specialist Hospital & Research Center; University of Cologne; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital Universitario 12 de Octubre; Marmara University; University of London; University College London; Newcastle University - UK; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Guy's & St Thomas' NHS Foundation Trust; Juntendo University; Saitama Medical University; Columbia University; Chiba Children's Hospital; Memorial University Newfoundland; University of Gottingen; King Faisal Specialist Hospital & Research Center; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Columbia University	Jackson, AP (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.; Hickson, ID (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Ctr Chromosome Stabil & Ctr Hlth, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	iandh@sund.ku.dk; andrew.jackson@igmm.ed.ac.uk	Williams, Hywel/AAL-2440-2021; Heath, K. E./ABG-4658-2020; Surrallés, Jordi/AAE-7667-2020; Heath, Karen Elise/K-7760-2014; Wollnik, Bernd/GRY-6062-2022; Hickson, Ian/AAJ-7548-2020; Jackson, Andrew/D-3442-2009	Williams, Hywel/0000-0001-7758-0312; Heath, K. E./0000-0002-5816-7044; Heath, Karen Elise/0000-0002-5816-7044; Wollnik, Bernd/0000-0003-2589-0364; Jackson, Andrew/0000-0002-8739-2646; Le Quesne Stabej, Polona/0000-0002-9436-5857; Thakur, Roshan/0000-0001-5284-4975; Bogliolo, Massimo/0000-0001-8240-7784; Aza-Carmona, Miriam/0000-0003-4448-9541; Kishita, Yoshihito/0000-0003-4978-1680; Ramirez de Haro, Maria Jose/0000-0003-1417-7731; Gorman, Grainne/0000-0002-7585-3409; Hickson, Ian/0000-0002-0583-566X; Horvath-Sarlos, Kata/0000-0003-3813-0209; Martin, Carol-Anne/0000-0001-5914-2757; Okazaki, Yasushi/0000-0003-3241-5502; , Jaime/0000-0002-8999-2821; Altmuller, Janine/0000-0003-4372-1521	European Research Council [281847]; MRC Human Genetics Unit [U127580972]; Danish National Research Foundation [DNRF115]; Danish Cancer Society [A10769]; Ministerio de Economia y Competitividad (MINECO) [SAF2015-66831-R, SAF2017-84646-R]; Institucio Catalana de Recerca i Estudis Avancats Academia program, MINECO [SAF2015-64152-R]; European Commission; Fondo Europeo de Desarrollo Regional "Una Manera de Hacer Europa"; Centro de Investigacion Biomedica en Red de Enfermedades Raras, an initiative of the Instituto de Salud Carlos III; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC [G0601943, G0800674]; National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; German Federal Ministry of Education and Research [01GM1404]; E-Rare network EuroMicro [01GM1404]; German Research Foundation [SFB1002]; Japan Agency for Medical Research and Development [18ek0109273, 18ek0109177]; Great Ormond Street Hospital Children's Charity; NIHR Great Ormond Street Hospital Biomedical Research Centre; NIH National Center for Advancing Translational Sciences [UL1TR001873]; MRC [MC_PC_U127580972] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001873] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Ministerio de Economia y Competitividad (MINECO); Institucio Catalana de Recerca i Estudis Avancats Academia program, MINECO; European Commission(European CommissionEuropean Commission Joint Research Centre); Fondo Europeo de Desarrollo Regional "Una Manera de Hacer Europa"; Centro de Investigacion Biomedica en Red de Enfermedades Raras, an initiative of the Instituto de Salud Carlos III; Wellcome Centre for Mitochondrial Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); E-Rare network EuroMicro; German Research Foundation(German Research Foundation (DFG)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Great Ormond Street Hospital Children's Charity; NIHR Great Ormond Street Hospital Biomedical Research Centre; NIH National Center for Advancing Translational Sciences; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the families and clinicians for their participation, the Potentials Foundation and Walking with Giants Foundation, the Medical Research Council (MRC) Institute of Genetics & Molecular Medicine core sequencing service, and G. Stewart and D. Fitzpatrick for helpful discussions. This work was supported by funding from European Research Council 281847; MRC Human Genetics Unit U127580972; and Danish National Research Foundation DNRF115 (I.D.H.); a Danish Cancer Society postdoctoral fellowship (A10769 to R.S.T.); Ministerio de Economia y Competitividad (MINECO) SAF2015-66831-R and SAF2017-84646-R (K.E.H.); the Institucio Catalana de Recerca i Estudis Avancats Academia program, MINECO SAF2015-64152-R, the European Commission, the Fondo Europeo de Desarrollo Regional "Una Manera de Hacer Europa," and the Centro de Investigacion Biomedica en Red de Enfermedades Raras, an initiative of the Instituto de Salud Carlos III (J.S.); Wellcome Centre for Mitochondrial Research 203105/Z/16/Z, MRC G0601943 and G0800674, and National Health Service Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children (R.W.T. and G.S.G.); German Federal Ministry of Education and Research 01GM1404, E-Rare network EuroMicro (01GM1404), and German Research Foundation SFB1002 project D02 (B.W.); the Practical Research Project for Rare/Intractable Diseases (18ek0109273 and 18ek0109177) from the Japan Agency for Medical Research and Development (K.M, A.O, and Y.O); the Great Ormond Street Hospital Children's Charity and NIHR Great Ormond Street Hospital Biomedical Research Centre (M.T.D.); and NIH National Center for Advancing Translational Sciences UL1TR001873 (A.R.P. and A.I.). The content and views expressed are solely the responsibility of the authors and not necessarily those of the NIH, NIHR, or Department of Health.	Ajima J, 2002, MUTAT RES-FUND MOL M, V504, P157, DOI 10.1016/S0027-5107(02)00089-1; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Bizard AH, 2018, METHODS MOL BIOL, V1672, P495, DOI 10.1007/978-1-4939-7306-4_33; BLOOM D, 1954, AMA AM J DIS CHILD, V88, P754, DOI 10.1001/archpedi.1954.02050100756008; Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; German J, 2007, HUM MUTAT, V28, P743, DOI 10.1002/humu.20501; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Hudson DF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006483; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Keller C, 1999, J PEDIATR-US, V134, P472, DOI 10.1016/S0022-3476(99)70206-4; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116; Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461; Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033; Nielsen CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9962; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rooney DE, 2001, HUMAN CYTOGENETICS M; Sanz M. M., 1993, BLOOMS SYNDROME; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	43	38	38	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					221	231		10.1016/j.ajhg.2018.07.001	http://dx.doi.org/10.1016/j.ajhg.2018.07.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30057030	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000440563700005
J	Fassad, MR; Shoemark, A; le Borgne, P; Koll, F; Patel, M; Dixon, M; Hayward, J; Richardson, C; Frost, E; Jenkins, L; Cullup, T; Chung, EMK; Lemullois, M; Aubusson-Fleury, A; Hogg, C; Mitchell, DR; Tassin, AM; Mitchison, HM				Fassad, Mahmoud R.; Shoemark, Amelia; le Borgne, Pierrick; Koll, France; Patel, Mitali; Dixon, Mellisa; Hayward, Jane; Richardson, Charlotte; Frost, Emily; Jenkins, Lucy; Cullup, Thomas; Chung, Eddie M. K.; Lemullois, Michel; Aubusson-Fleury, Anne; Hogg, Claire; Mitchell, David R.; Tassin, Anne-Marie; Mitchison, Hannah M.			C11orf70 Mutations Disrupting the Intraflagellar Transport-Dependent Assembly of Multiple Axonemal Dyneins Cause Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCING IDENTIFIES MUTATIONS; OF-FUNCTION MUTATIONS; OUTER ARM DYNEIN; MUCOCILIARY DIFFERENTIATION; CYTOPLASMIC MATURATION; FLAGELLAR; PROTEIN; DIAGNOSIS; MOTILITY; INNER	Primary ciliary dyskinesia (PCD) is a genetically and phenotypically heterogeneous disorder characterized by destructive respiratory disease and laterality abnormalities due to randomized left-right body asymmetry. PCD is mostly caused by mutations affecting the core axoneme structure of motile cilia that is essential for movement. Genes that cause PCD when mutated include a group that encode proteins essential for the assembly of the ciliary dynein motors and the active transport process that delivers them from their cytoplasmic assembly site into the axoneme. We screened a cohort of affected individuals for disease-causing mutations using a targeted next generation sequencing panel and identified two unrelated families (three affected children) with mutations in the uncharacterized C11orf70 gene (official gene name CFAP300). The affected children share a consistent PCD phenotype from early life with laterality defects and immotile respiratory cilia displaying combined loss of inner and outer dynein arms (IDA+ODA). Phylogenetic analysis shows C11orf70 is highly conserved, distributed across species similarly to proteins involved in the intraflagellar transport (IFT)-dependant assembly of axonemal dyneins. Paramecium C11orf70 RNAi knockdown led to combined loss of ciliary IDA+ODA with reduced cilia beating and swim velocity. Tagged C11orf70 in Paramecium and Chlamydomonas localizes mainly in the cytoplasm with a small amount in the ciliary component. IFT139/TTC21B (IFT-A protein) and FLA10 (IFT kinesin) depletion experiments show that its transport within cilia is IFT dependent. During ciliogenesis, C11orf70 accumulates at the ciliary tips in a similar distribution to the IFT-B protein IFT46. In summary, C11orf70 is essential for assembly of dynein arms and Cl1orf70 mutations cause defective cilia motility and PCD.	[Fassad, Mahmoud R.; Patel, Mitali; Hayward, Jane; Mitchison, Hannah M.] UCL, UCL Great Ormond St Inst Child Hlth, Genet & Genom Med Programme, London WC1N 1EH, England; [Fassad, Mahmoud R.] Alexandria Univ, Med Res Inst, Dept Human Genet, 165 El Horreya Ave, Alexandria 21561, Egypt; [Shoemark, Amelia; Dixon, Mellisa; Richardson, Charlotte; Frost, Emily; Hogg, Claire] Royal Brompton & Harefield NHS Trust, PCD Diagnost Team, London SW3 6NP, England; [Shoemark, Amelia; Dixon, Mellisa; Richardson, Charlotte; Frost, Emily; Hogg, Claire] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Shoemark, Amelia] Univ Dundee, Sch Med, Dundee, Scotland; [le Borgne, Pierrick; Koll, France; Lemullois, Michel; Aubusson-Fleury, Anne; Tassin, Anne-Marie] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France; [Jenkins, Lucy; Cullup, Thomas] Great Ormond St Hosp Children NHS Fdn Trust, Reg Mol Genet Lab, Queen Sq, London WC1N 3BH, England; [Chung, Eddie M. K.] UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England; [Mitchell, David R.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 E Adams St, Syracuse, NY 13210 USA	University of London; University College London; Egyptian Knowledge Bank (EKB); Alexandria University; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of Dundee; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mitchison, HM (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, Genet & Genom Med Programme, London WC1N 1EH, England.	h.mitchison@ucl.ac.uk	Shoemark, Amelia/I-4068-2019; Fassad, Mahmoud/J-5769-2019	Shoemark, Amelia/0000-0001-7360-6060; Fassad, Mahmoud/0000-0003-2568-8326; Mitchison, Hannah/0000-0002-3163-6293; Hayward, Jane/0000-0002-9207-9021	UK PCD Family Support Group; Action Medical Research [GN2101]; Great Ormond Street Children's Charity grant [V4515]; British Council Newton-Mosharafa Fund; Ministry of Higher Education in Egypt; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; National Institute of Health Research and Health Education England; COST Action STSM Grants [BM1407];  [V1299];  [V2217]	UK PCD Family Support Group; Action Medical Research; Great Ormond Street Children's Charity grant; British Council Newton-Mosharafa Fund; Ministry of Higher Education in Egypt(Ministry of Higher Education & Scientific Research (MHESR)); NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); National Institute of Health Research and Health Education England; COST Action STSM Grants; ; 	We are very grateful to the families who participated in this study and thank the UK PCD Family Support Group for their continued support. We thank Ms. Dani Lee and Prof. Chris O'Callaghan (UCL Great Ormond Street Institute of Child Health) for help with assessment of Paramecium motility and Dr. Dale Moulding (GOSICH Confocal Microscopy Core Facility) for experimental assistance. Funding for this study was provided by Action Medical Research (GN2101; H.M.M.) and Great Ormond Street Children's Charity grant (V4515; H.M.M.) and Leadership awards (V1299, V2217; H.M.M.). M.R.F. is supported by the British Council Newton-Mosharafa Fund and the Ministry of Higher Education in Egypt. We acknowledge support from the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (Doctoral Trainee Support Award; M.R.F.). Work by A.S. is independent research funded by a postdoctoral research fellowship from the National Institute of Health Research and Health Education England. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute of Health Research, or the Department of Health. We would like to thank C. Mathon for generating plasmid constructs, L. Shi for the IFT46 construct, J. Bonaventure for his help in RNA isolation, and C. Janke for his generous gift of PolyE antibodies. The authors acknowledge the contribution of the BEAT-PCD COST Action. The authors participate in the COST Action BEAT-PCD: Better Evidence to Advance Therapeutic options for PCD network (BM1407) and this work was supported by two BM1407 COST Action STSM Grants awarded to M.R.F. and P.L.B. The authors alone are responsible for the content and writing of the paper.	ADOUTTE A, 1980, J CELL BIOL, V84, P717, DOI 10.1083/jcb.84.3.717; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Albee AJ, 2013, G3-GENES GENOM GENET, V3, P979, DOI 10.1534/g3.113.006338; Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Aubusson-Fleury A, 2015, METHOD CELL BIOL, V127, P457, DOI 10.1016/bs.mcb.2014.12.007; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Beisson J., 2010, COLD SPRING HARB PRO, V2010, pt5362; Beisson J., 2010, COLD SPRING HARB PRO, V2010, pt5363; Bell WE, 2015, J EUKARYOT MICROBIOL, V62, P144, DOI 10.1111/jeu.12153; Bengueddach Hakim, 2017, Cilia, V6, P6, DOI 10.1186/s13630-017-0050-z; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Chilvers MA, 2003, THORAX, V58, P333, DOI 10.1136/thorax.58.4.333; Dean AB, 2015, MOL BIOL CELL, V26, P3596, DOI 10.1091/mbc.E15-05-0317; Desai PB, 2015, CYTOSKELETON, V72, P16, DOI 10.1002/cm.21206; Desai PB, 2018, DYNEINS BIOL DYNEIN, V1, P141, DOI DOI 10.1016/B978-0-12-809471-6.00004-8; Diggle CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004577; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Garrison E., 2012, ARXIV12073907QBIO; Geremek M, 2011, HUM GENET, V129, P283, DOI 10.1007/s00439-010-0922-4; Hauser K, 2000, EUR J CELL BIOL, V79, P144, DOI 10.1078/S0171-9335(04)70016-3; Hirst RA, 2010, CHEST, V138, P1441, DOI 10.1378/chest.10-0175; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2016, PAEDIATR RESPIR REV, V18, P18, DOI 10.1016/j.prrv.2015.09.001; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Hosie PH, 2015, J PAEDIATR CHILD H, V51, P722, DOI 10.1111/jpc.12791; Hou YQ, 2017, MOL BIOL CELL, V28, P2420, DOI 10.1091/mbc.E17-03-0172; Inaba Y, 2016, GENES CELLS, V21, P728, DOI 10.1111/gtc.12380; Jaffe KM, 2016, CELL REP, V14, P1841, DOI 10.1016/j.celrep.2016.01.069; KAMIYA R, 1991, J CELL BIOL, V112, P441, DOI 10.1083/jcb.112.3.441; Kang Y, 1998, MOL BIOL CELL, V9, P3085, DOI 10.1091/mbc.9.11.3085; King S. M., 2016, COLD SPRING HARB PER, V8, P8; King SM, 2015, J BIOL CHEM, V290, P7388, DOI 10.1074/jbc.M114.616425; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Leigh Margaret W, 2013, Ann Am Thorac Soc, V10, P574, DOI 10.1513/AnnalsATS.201305-110OC; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Lucas JS, 2014, PAEDIATR RESPIR REV, V15, P142, DOI 10.1016/j.prrv.2013.04.007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Milla CE, 2016, CURR OPIN PEDIATR, V28, P339, DOI 10.1097/MOP.0000000000000358; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Munye MM, 2017, AM J PHYSIOL-LUNG C, V312, pL258, DOI 10.1152/ajplung.00471.2016; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2015, AM J HUM GENET, V97, P546, DOI 10.1016/j.ajhg.2015.08.012; Olcese C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14279; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2014, J MED GENET, V51, P61, DOI 10.1136/jmedgenet-2013-101938; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Paff T, 2017, AM J HUM GENET, V100, P160, DOI 10.1016/j.ajhg.2016.11.019; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Ruiz F, 1998, MOL BIOL CELL, V9, P931, DOI 10.1091/mbc.9.4.931; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Shoemark A, 2017, AM J RESP CRIT CARE, V196, P94, DOI 10.1164/rccm.201607-1351OC; Skouri F, 1997, MOL BIOL CELL, V8, P1063; Smith Claire M, 2012, Cilia, V1, P14, DOI 10.1186/2046-2530-1-14; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Taschner M, 2017, J BIOL CHEM, V292, P7462, DOI 10.1074/jbc.M117.780155; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Trump N, 2016, J MED GENET, V53, P310, DOI 10.1136/jmedgenet-2015-103263; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	90	38	41	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					956	972		10.1016/j.ajhg.2018.03.024	http://dx.doi.org/10.1016/j.ajhg.2018.03.024			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727692	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000432440100017
J	Hoben, IM; Hjeij, R; Olbrich, H; Dougherty, GW; Nothe-Menchen, T; Aprea, I; Frank, D; Pennekamp, P; Dworniczak, B; Wallmeier, J; Raidt, J; Nielsen, KG; Philipsen, MC; Santamaria, F; Venditto, L; Amirav, I; Mussaffi, H; Prenzel, F; Wu, KM; Bakey, Z; Schmidts, M; Loges, NT; Omran, H				Hoeben, Inga M.; Hjeij, Rim; Olbrich, Heike; Dougherty, Gerard W.; Noethe-Menchen, Tabea; Aprea, Isabella; Frank, Diana; Pennekamp, Petra; Dworniczak, Bernd; Wallmeier, Julia; Raidt, Johanna; Nielsen, Kim G.; Philipsen, Maria C.; Santamaria, Francesca; Venditto, Laura; Amirav, Israel; Mussaffi, Huda; Prenzel, Freerk; Wu, Kaman; Bakey, Zeineb; Schmidts, Miriam; Loges, Niki T.; Omran, Heymut			Mutations in C11orf70 Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry Due to Defects of Outer and Inner Dynein Arms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; REGULATORY COMPLEX; EPITHELIAL-CELLS; MOTILITY; HUMANS; DYSFUNCTION; DIAGNOSIS; REVEALS; DISRUPT; CAPTURE	Primary ciliary dyskinesia (PCD) is characterized by chronic airway disease, male infertility, and randomization of the left/right body axis as a result of defects of motile cilia and sperm flagella. We identified loss-of-function mutations in the open-reading frame C11orf70 in PCD individuals from five distinct families. Transmission electron microscopy analyses and high-resolution immunofluorescence microscopy demonstrate that loss-of-function mutations in C11orf70 cause immotility of respiratory cilia and sperm flagella, respectively, as a result of the loss of axonemal outer (ODAs) and inner dynein arms (IDAs), indicating that C11orf70 is involved in cytoplasmic assembly of dynein arms. Expression analyses of C11orf70 showed that C11orf70 is expressed in ciliated respiratory cells and that the expression of C11orf70 is upregulated during ciliogenesis, similar to other previously described cytoplasmic dynein-arm assembly factors. Furthermore, C11orf70 shows an interaction with cytoplasmic ODA/IDA assembly factor DNAAF2, supporting our hypothesis that C11orf70 is a preassembly factor involved in the pathogenesis of PCD. The identification of additional genetic defects that cause PCD and male infertility is of great importance for the clinic as well as for genetic counselling.	[Hoeben, Inga M.; Hjeij, Rim; Olbrich, Heike; Dougherty, Gerard W.; Noethe-Menchen, Tabea; Aprea, Isabella; Frank, Diana; Pennekamp, Petra; Dworniczak, Bernd; Wallmeier, Julia; Raidt, Johanna; Loges, Niki T.; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Nielsen, Kim G.; Philipsen, Maria C.] Copenhagen Univ Hosp, Rigshosp, Dept Pediat & Adolescent Med, Danish PCD Ctr,Pediat Pulm Serv, DK-2100 Copenhagen, Denmark; [Santamaria, Francesca; Venditto, Laura] Univ Naples Federico II, Dept Translat Med Sci, I-80131 Naples, Italy; [Amirav, Israel] Univ Alberta, Dept Pediat, Edmonton, AB T6G 1C9, Canada; [Mussaffi, Huda] Schneider Childrens Med Ctr, IL-4920235 Petah Tiqwa, Israel; [Mussaffi, Huda] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Prenzel, Freerk] Univ Hosp Leipzig, Clin Pediat & Adolescent Med, D-04103 Leipzig, Germany; [Wu, Kaman; Bakey, Zeineb; Schmidts, Miriam] Radboud Univ Nijmegen Med Ctr, Human Genet Dept, Genome Res Div, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands; [Wu, Kaman; Bakey, Zeineb; Schmidts, Miriam] Radboud Inst Mol Life Sci, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands; [Schmidts, Miriam] Freiburg Univ, Fac Med, Ctr Pediat & Adolescent Med, Pediat Genet Div, Mathildenstr 1, D-79112 Freiburg, Germany	University of Munster; Rigshospitalet; University of Copenhagen; University of Naples Federico II; University of Alberta; Tel Aviv University; Sackler Faculty of Medicine; Leipzig University; Radboud University Nijmegen; University of Freiburg	Omran, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	heymut.omran@ukmuenster.de	Nielsen, KG/AAE-6575-2020; Noethe-Menchen, Tabea/AAW-1667-2021; Schmidts, Miriam/A-3777-2012; Amirav, Israel/I-9286-2019; Santamaria, Francesca/AAC-3503-2022	Nielsen, KG/0000-0001-5906-9449; Noethe-Menchen, Tabea/0000-0002-0571-6767; Schmidts, Miriam/0000-0002-1714-6749; Amirav, Israel/0000-0002-6917-5285; Raidt, Johanna/0000-0002-1571-2647; Omran, Heymut/0000-0003-0282-6765; Hjeij, Rim/0000-0003-1464-7289	Deutsche Forschungsgemeinschaft (DFG) [OM6/7, OM6/8, OM6/9, OM6/10, OM6/11]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Munster [Om2/009/12, Om/015/16]; European Union [305404]; project BESTCILIA; "Innovative Medical Research" of the University of Muenster Medical School [I-LO121517, I-WA121418]; Faculty of Medicine of the Westphalian Wilhelms University; Radboudumc and the Radboud Institute for Molecular Life Sciences Nijmegen (Hypatia tenure track fellowship); DFG [CRC1140 KIDGEM, KFO326, OL450/1, HJ7/1-1]; European research Council (ERC StG TREATCilia) [716344]; Chief Office of the Ministry of Health in Israel [3-6176]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Munster; European Union(European Commission); project BESTCILIA; "Innovative Medical Research" of the University of Muenster Medical School; Faculty of Medicine of the Westphalian Wilhelms University; Radboudumc and the Radboud Institute for Molecular Life Sciences Nijmegen (Hypatia tenure track fellowship); DFG(German Research Foundation (DFG)); European research Council (ERC StG TREATCilia)(European Research Council (ERC)); Chief Office of the Ministry of Health in Israel	We are grateful to all affected individuals and their family members, whose cooperation made this study possible, and we thank all referring physicians. We thank A. Dorissen, D. Ernst, S. Helms, M. Herting, A. Robbers, L. Schwiddessen, F.J. Seesing, M. Tekaat, K. Wohlgemuth, and C. Westermann for excellent technical work. We would like to thank the Genome Aggregation Database and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) OM6/7, OM6/8, OM6/9, OM6/10, OM6/11, and DFG KFO326 (H.O.), OL450/1 (H.Ol.), and HJ7/1-1 (R.H.), by the Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Munster to H.O. (Om2/009/12 and Om/015/16), the European Union seventh framework program under grant agreement 305404, project BESTCILIA (to H.O., K.G.N., and M.C.P.) and "Innovative Medical Research" of the University of Muenster Medical School (I-LO121517 to N.T.L. and I-WA121418 to J.W.) and the Faculty of Medicine of the Westphalian Wilhelms University (to J.W.). M.S. acknowledges funding from Radboudumc and the Radboud Institute for Molecular Life Sciences Nijmegen (Hypatia tenure track fellowship), DFG (CRC1140 KIDGEM), and the European research Council (ERC StG TREATCilia, grant 716344). I. Am. acknowledges the Chief Office of the Ministry of Health in Israel grant number 3-6176.	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Edelbusch C, 2017, HUM MUTAT, V38, P964, DOI 10.1002/humu.23261; El Khouri E, 2016, AM J HUM GENET, V99, P489, DOI 10.1016/j.ajhg.2016.06.022; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Frommer A, 2015, AM J RESP CELL MOL, V53, P563, DOI 10.1165/rcmb.2014-0483OC; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mirra V, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00135; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Munye MM, 2017, AM J PHYSIOL-LUNG C, V312, pL258, DOI 10.1152/ajplung.00471.2016; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2015, AM J HUM GENET, V97, P546, DOI 10.1016/j.ajhg.2015.08.012; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Olcese C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14279; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Omran H, 2009, METHOD CELL BIOL, V91, P123, DOI 10.1016/S0091-679X(08)91007-4; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Paff T, 2017, AM J HUM GENET, V100, P160, DOI 10.1016/j.ajhg.2016.11.019; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; STEEL CM, 1977, NATURE, V270, P729, DOI 10.1038/270729a0; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zietkiewicz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033667	55	38	42	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					973	984		10.1016/j.ajhg.2018.03.025	http://dx.doi.org/10.1016/j.ajhg.2018.03.025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727693	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000432440100018
J	Lassuthova, P; Rebelo, AP; Ravenscroft, G; Lamont, PJ; Davis, MR; Manganelli, F; Feely, SM; Bacon, C; Brozkova, DS; Haberlova, J; Mazanec, R; Tao, FF; Saghira, C; Abreu, L; Courel, S; Powell, E; Buglo, E; Bis, DM; Baxter, MF; Ong, RW; Marns, L; Lee, YC; Bai, YH; Isom, DG; Barro-Soria, R; Chung, KW; Scherer, SS; Larsson, HP; Laing, NG; Choi, BO; Seeman, P; Shy, ME; Santoro, L; Zuchner, S				Lassuthova, Petra; Rebelo, Adriana P.; Ravenscroft, Gianina; Lamont, Phillipa J.; Davis, Mark R.; Manganelli, Fiore; Feely, Shawna M.; Bacon, Chelsea; Brozkova, Dana Safka; Haberlova, Jana; Mazanec, Radim; Tao, Feifei; Saghira, Cima; Abreu, Lisa; Courel, Steve; Powell, Eric; Buglo, Elena; Bis, Dana M.; Baxter, Megan F.; Ong, Royston W.; Marns, Lorna; Lee, Yi-Chung; Bai, Yunhong; Isom, Daniel G.; Barro-Soria, Rene; Chung, Ki W.; Scherer, Steven S.; Larsson, H. Peter; Laing, Nigel G.; Choi, Byung-Ok; Seeman, Pavel; Shy, Michael E.; Santoro, Lucio; Zuchner, Stephan			Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; CMT NEUROPATHY SCORE; NERVOUS-SYSTEM; ALPHA-SUBUNIT; K+-ATPASE; DISEASE; NA+; NA+,K+-ATPASE; NA,K-ATPASE; EXPRESSION	Although mutations in more than 90 genes are known to cause CMT, the underlying genetic cause of CMT remains unknown in more than 50% of affected individuals. The discovery of additional genes that harbor CMT2-causing mutations increasingly depends on sharing sequence data on a global level. In this way-by combining data from seven countries on four continents-we were able to define mutations in ATP1A1, which encodes the alpha1 subunit of the Na+, K+-ATPase, as a cause of autosomal-dominant CMT2. Seven missense changes were identified that segregated within individual pedigrees: c.143T>G (p.Leu48Arg), c.1775T>C (p.Ile592Thr), c.1789G>A (p.Ala597Thr), c.1801_1802delinsTT (p.Asp601Phe), c.1798C>G (p.Pro600Ala), c.1798C>A (p.Pro600Thr), and c.2432A>C (p.Asp811Ala). Immunostaining peripheral nerve axons localized ATP1A1 to the axolemma of myelinated sensory and motor axons and to Schmidt-Lanterman incisures of myelin sheaths. Two-electrode voltage clamp measurements on Xenopus oocytes demonstrated significant reduction in Na+ current activity in some, but not all, ouabain-insensitive ATP1A1 mutants, suggesting a loss-of-function defect of the Na+, K+ pump. Five mutants fall into a remarkably narrow motif within the helical linker region that couples the nucleotide-binding and phosphorylation domains. These findings identify a CMT pathway and a potential target for therapy development in degenerative diseases of peripheral nerve axons.	[Lassuthova, Petra; Brozkova, Dana Safka; Seeman, Pavel] Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, DNA Lab, Prague 15006, Czech Republic; [Lassuthova, Petra; Brozkova, Dana Safka; Haberlova, Jana; Mazanec, Radim; Seeman, Pavel] Univ Hosp Motol, Prague 15006, Czech Republic; [Rebelo, Adriana P.; Tao, Feifei; Saghira, Cima; Abreu, Lisa; Courel, Steve; Powell, Eric; Buglo, Elena; Bis, Dana M.; Zuchner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA; [Ravenscroft, Gianina; Baxter, Megan F.; Ong, Royston W.; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Baxter, Megan F.; Ong, Royston W.; Laing, Nigel G.] Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Lamont, Phillipa J.] Royal Perth Hosp, Neurogenet Unit, Perth, WA 6000, Australia; [Davis, Mark R.; Marns, Lorna] QEII Med Ctr, PathWest Lab Med, Dept Diagnost Genom, Neurogenet Unit, Nedlands, WA 6009, Australia; [Manganelli, Fiore; Santoro, Lucio] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomathol, I-80131 Naples, Italy; [Powell, Eric] Genesis Project Fdn, Miami, FL 33136 USA; [Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Yi-Chung] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 10466, Taiwan; [Isom, Daniel G.] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pharmacol, Miami, FL 33136 USA; [Isom, Daniel G.] Univ Miami, Ctr Computat Sci, Miami, FL 33136 USA; [Scherer, Steven S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barro-Soria, Rene; Larsson, H. Peter] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 06351, South Korea; [Feely, Shawna M.; Bacon, Chelsea; Bai, Yunhong; Shy, Michael E.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Haberlova, Jana] Charles Univ Prague, Fac Med 2, Dept Pediat Neurol, Prague 15006, Czech Republic; [Chung, Ki W.] Kongju Natl Univ, Dept Biol Sci, Gongju 32588, South Korea; [Mazanec, Radim] Charles Univ Prague, Fac Med 2, Dept Neurol, Prague 15006, Czech Republic	Charles University Prague; Motol University Hospital; University of Miami; University of Western Australia; Harry Perkins Institute of Medical Research; Royal Perth Hospital; University of Western Australia; University of Naples Federico II; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Miami; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Iowa; Charles University Prague; Kongju National University; Charles University Prague	Zuchner, S (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA.	szuchner@med.miami.edu	Manganelli, Fiore/AAC-9096-2019; Lassuthova, Petra/AAA-4246-2021; Safka Brozkova, Dana/ABB-4837-2021; Lee, Yi-Chung/GZK-7162-2022; Tao, Feifei/AAI-6256-2021; Brozkova, Dana Safka/AAR-8453-2021; Lassuthova, Petra/ABB-8186-2021; Ravenscroft, Gina/H-5695-2014	Safka Brozkova, Dana/0000-0002-0572-7239; Tao, Feifei/0000-0003-4477-2304; Ravenscroft, Gina/0000-0003-3634-211X; Shy, Michael/0000-0001-8460-6971; MANGANELLI, Fiore/0000-0002-1442-9604; Laing, Nigel/0000-0001-5111-3732; Lee, Yi-Chung/0000-0003-0102-164X; Lassuthova, Petra/0000-0003-1726-5868	MH CR AZV [16-30206A]; DRO [00064203]; Australian National Health and Medical Research Council (NHMRC) Fellowship [APP1117510, APP1122952]; NHMRC [APP1080587]; NIH [RO1 NS43174, U54 NS065712, RO1 NS094388, R01 GM109762, R01 HL131461, K01 NS096778, R01NS075764, U54NS065712, U54NS092091, R35 GM119518]; Ministry of Science and Technology, Taiwan [105-2628-B-075-002-MY3]; Judy Seltzer Levenson Memorial Fund for CMT Research; Charcot-MarieTooth Association; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119518, R01GM109762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075764, U54NS065712, K01NS096778, R01NS043174, R01NS094388, U54NS092091, R01NS043259] Funding Source: NIH RePORTER	MH CR AZV; DRO; Australian National Health and Medical Research Council (NHMRC) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Judy Seltzer Levenson Memorial Fund for CMT Research; Charcot-MarieTooth Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by MH CR AZV 16-30206A and DRO 00064203 (to P.L. and P.S.); Australian National Health and Medical Research Council (NHMRC) Fellowship APP1117510 (to N.L.); Australian National Health and Medical Research Council (NHMRC) Fellowship APP1122952 (to G.R.); NHMRC Project Grant APP1080587 (to N.L.), NIH (RO1 NS43174, U54 NS065712 to S.S.S.; RO1 NS094388 to B.-O.C.; R01 GM109762, R01 HL131461 to H.P.L.; K01 NS096778 to R.B.-S.; R01NS075764, U54NS065712, and U54NS092091 to S.Z.; U54 NS065712 to M.S.; R35 GM119518 to D.G.I.), Ministry of Science and Technology, Taiwan (105-2628-B-075-002-MY3 to Y.-C.L.), the Judy Seltzer Levenson Memorial Fund for CMT Research, the Charcot-MarieTooth Association, and the Muscular Dystrophy Association. We thank C. Kleinberg and Dr. E. Arroyo for confocal images and Dr. Pressley for the rabbit antiserum against ATP1A1. We thank Dr. Pablo Artigas for the human wild-type ATP1A1 and beta1 subunits for Xenopus oocyte expression and help with Xenopus oocyte recordings.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arystarkhova E, 1996, J BIOL CHEM, V271, P23407, DOI 10.1074/jbc.271.38.23407; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dobretsov M, 2003, NEUROSCIENCE, V116, P1069, DOI 10.1016/S0306-4522(02)00922-3; Edwards IJ, 2013, J NEUROSCI, V33, P9913, DOI 10.1523/JNEUROSCI.5584-12.2013; Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826; Friedrich T, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00239; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Holm TH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00209; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kleinberg S. C., 2007, RESEARCHGATE; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x; Pareyson D, 2017, CURR OPIN NEUROL, V30, P471, DOI 10.1097/WCO.0000000000000474; Pedersen PA, 1997, FEBS LETT, V400, P206, DOI 10.1016/S0014-5793(96)01381-6; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; PRESSLEY TA, 1992, SEMIN NEPHROL, V12, P67; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Scherer SS, 2005, J NEUROSCI, V25, P1550, DOI 10.1523/JNEUROSCI.3082-04.2005; Shy ME, 2005, NEUROLOGY, V64, P1209, DOI 10.1212/01.WNL.0000156517.00615.A3; SKRE H, 1974, CLIN GENET, V6, P98; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Todt U, 2005, HUM MUTAT, V26, P315, DOI 10.1002/humu.20229; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Zhang ZS, 2016, J PHYSIOL-LONDON, V594, P39, DOI 10.1113/JP271207	31	38	38	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					505	514		10.1016/j.ajhg.2018.01.023	http://dx.doi.org/10.1016/j.ajhg.2018.01.023			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29499166	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000426469600021
J	Zhang, QL; Peng, C; Song, JP; Zhang, YC; Chen, JH; Song, ZJ; Shou, XF; Ma, ZY; Peng, H; Jian, XM; He, WQ; Ye, Z; Li, ZQ; Wang, YF; Ye, HY; Zhang, ZY; Shen, M; Tang, F; Chen, H; Shi, ZF; Chen, CJ; Chen, ZY; Shen, Y; Wang, Y; Lu, SY; Zhang, J; Li, YM; Li, SQ; Mao, Y; Zhou, LF; Yan, H; Shi, YY; Huang, CX; Zhao, Y				Zhang, Qilin; Peng, Cheng; Song, Jianping; Zhang, Yichao; Chen, Jianhua; Song, Zhijian; Shou, Xuefei; Ma, Zengyi; Peng, Hong; Jian, Xuemin; He, Wenqiang; Ye, Zhao; Li, Zhiqiang; Wang, Yongfei; Ye, Hongying; Zhang, Zhaoyun; Shen, Ming; Tang, Feng; Chen, Hong; Shi, Zhifeng; Chen, Chunjui; Chen, Zhengyuan; Shen, Yue; Wang, Ye; Lu, Shaoyong; Zhang, Jian; Li, Yiming; Li, Shiqi; Mao, Ying; Zhou, Liangfu; Yan, Hai; Shi, Yongyong; Huang, Chuanxin; Zhao, Yao			Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEARING-LOSS; USHER-SYNDROME; HAN CHINESE; AIP GENE; VARIANTS; HETEROGENEITY; DEAFNESS; COHORT; TUMORS; AGE	Pituitary adenoma (PA) is one of the most common intracranial neoplasms. Several genetic predisposing factors for PA have been identified, but they account for a small portion of cases. In this study, we sought to identify the PA genetic risk factors by focusing on causative mutations for PAs. Among the 4 affected and 17 asymptomatic members from one family with familial PA, whole-exome sequencing identified cosegregation of the PA phenotype with the heterozygous missense mutation c.4136G>T (p.Arg1379Leu) in cadherin-related 23 (CDH23). This mutation causes an amino acid substitution in the calcium-binding motif of the extracellular cadherin (EC) domains of CDH23 and is predicted to impair cell-cell adhesion. Genomic screening in a total of 12 families with familial PA (20 individuals), 125 individuals with sporadic PA, and 260 control individuals showed that 33% of the families with familial PA (4/12) and 12% of individuals with sporadic PA (15/125) harbored functional CDH23 variants. In contrast, 0.8% of the healthy control individuals (2/260) carried functional CDH23 variants. Gene-based analysis also revealed a significant association between CDH23 genotype and PA (p = 5.54 3 10(-7)). Moreover, PA individuals who did not harbor functional CDH23 variants displayed tumors that were larger in size (p = 0.005) and more invasive (p < 0.001). Therefore, mutations in CDH23 are linked with familial and sporadic PA and could play important roles in the pathogenesis of PA.	[Zhang, Qilin; Song, Jianping; Zhang, Yichao; Shou, Xuefei; Ma, Zengyi; He, Wenqiang; Ye, Zhao; Wang, Yongfei; Shen, Ming; Shi, Zhifeng; Chen, Chunjui; Chen, Zhengyuan; Shen, Yue; Wang, Ye; Li, Shiqi; Mao, Ying; Zhou, Liangfu; Zhao, Yao] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200040, Peoples R China; [Zhang, Qilin; Song, Jianping; Zhang, Yichao; Shou, Xuefei; Ma, Zengyi; He, Wenqiang; Ye, Zhao; Wang, Yongfei; Ye, Hongying; Zhang, Zhaoyun; Shen, Ming; Tang, Feng; Chen, Hong; Shi, Zhifeng; Chen, Chunjui; Chen, Zhengyuan; Shen, Yue; Wang, Ye; Li, Yiming; Li, Shiqi; Mao, Ying; Zhou, Liangfu; Zhao, Yao] Shanghai Pituitary Tumor Ctr, Shanghai 200040, Peoples R China; [Peng, Cheng; Peng, Hong; Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China; [Chen, Jianhua; Song, Zhijian; Jian, Xuemin; Li, Zhiqiang; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Inst Social Cognit & Behav Sci, Minist Educ,Key Lab Genet Dev & Neuropsychiat Dis, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Ye, Hongying; Zhang, Zhaoyun; Li, Yiming] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Endocrinol, Shanghai 200040, Peoples R China; [Tang, Feng; Chen, Hong] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Pathol, Shanghai 200040, Peoples R China; [Lu, Shaoyong; Zhang, Jian] Shanghai Jiao Tong, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Minist Educ, Shanghai 200025, Peoples R China; [Mao, Ying; Zhao, Yao] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200040, Peoples R China; [Mao, Ying; Zhao, Yao] Fudan Univ, Shanghai Med Coll, Inst Neurosurg, Shanghai 200040, Peoples R China; [Yan, Hai] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Pathol, Durham, NC 27710 USA; [Shi, Yongyong] Shanghai Jiao Tong Univ, Inst Neuropsychiat Sci & Syst Biol Med, Shanghai 200030, Peoples R China; [Shi, Yongyong] Xinjiang Med Univ, Teaching Hosp 1, Dept Psychiat, Urumqi 830054, Xinjiang, Peoples R China; [Shi, Yongyong] Qingdao Univ, Inst Biomed Sci, SJTU Bio X Inst, Qingdao Branch, Qingdao 266003, Shandong, Peoples R China; [Shi, Yongyong] Qingdao Univ, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; Duke University; Shanghai Jiao Tong University; Xinjiang Medical University; Qingdao University; Qingdao University	Zhao, Y (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200040, Peoples R China.; Zhao, Y (corresponding author), Shanghai Pituitary Tumor Ctr, Shanghai 200040, Peoples R China.; Huang, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China.; Zhao, Y (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200040, Peoples R China.; Zhao, Y (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Neurosurg, Shanghai 200040, Peoples R China.	huangcx@shsmu.edu.cn; zhaoyaohs@vip.sina.com	Zhang, Jian/GXA-1303-2022; Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; Li, Zhiqiang/AAI-4003-2021	Zhang, Jian/0000-0002-6558-791X; Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; Zhang, Qilin/0000-0002-0122-3201; Mao, Ying/0000-0001-8055-115X	China Pituitary Adenoma Specialist Council; Chang Jiang Scholars Program; National Program for Support of Top-Notch Young Professionals; Program for New-Century Excellent Talents in University [NCET-10-0356]; Shanghai Rising-Star Tracking Program [12QH1400400]; National High Technology Research and Development Program of China [2014AA020611]; National Key Basic Research Program of China (973 Program) [2015CB559100]; National Natural Science Foundation of China [31325014, 81421061, 81602191]; Program of Shanghai Academic Research Leader [15XD1502200]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; 1000 Youth Elite Program; Shanghai Pujiang Scholarship [15PJ1407400]; Natural Science Foundation; Major Basic Research Program of Shanghai [16JC1420100]	China Pituitary Adenoma Specialist Council; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Program for Support of Top-Notch Young Professionals; Program for New-Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Tracking Program; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic Research Leader; Shanghai Key Laboratory of Psychotic Disorders; 1000 Youth Elite Program; Shanghai Pujiang Scholarship(Shanghai Pujiang Program); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major Basic Research Program of Shanghai	We thank and acknowledge all of the participants in this study. We gratefully thank Mrs. Qiuwei Song and Mrs. Yun Zhang for sample collection. We thank Prof. Xingdang Liu, Prof. Yun Lu, Mrs. Jue Ji, Ms. Jie Zheng, and Mrs. Xiaolan Qin for technique support. We appreciate Dr. Daizhan Zhou for analysis consultation. We also thank Beijing Pangenomics Technology Co., Ltd. (Genetron Health) for help with the genomic data analysis. This work was supported by the China Pituitary Adenoma Specialist Council, the Chang Jiang Scholars Program (to Y. Zhao), the National Program for Support of Top-Notch Young Professionals (to Y. Zhao and Y. Shi), the Program for New-Century Excellent Talents in University (NCET-10-0356 to Y. Zhao), the Shanghai Rising-Star Tracking Program (12QH1400400 to Y. Zhao), the National High Technology Research and Development Program of China (2014AA020611 to Y.Z.), the National Key Basic Research Program of China (973 Program; 2015CB559100 to Y. Shi), the National Natural Science Foundation of China (31325014 and 81421061 to Y. Shi), the Program of Shanghai Academic Research Leader (15XD1502200 to Y. Shi), the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500 to Y.S.), the 1000 Youth Elite Program and Shanghai Pujiang Scholarship (15PJ1407400 to C.H.), the Natural Science Foundation and Major Basic Research Program of Shanghai (16JC1420100 to Y.M.), and the National Natural Science Foundation of China (81602191 to M.S.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apostolopoulou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033289; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Cai F, 2013, EUR J ENDOCRINOL, V169, P867, DOI 10.1530/EJE-13-0442; Caimari F, 2016, CLIN CANCER RES, V22, P5030, DOI 10.1158/1078-0432.CCR-16-0452; Chauvet N, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12352; Colao A, 2011, EXPERT OPIN PHARMACO, V12, P1561, DOI 10.1517/14656566.2011.568478; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Elston MS, 2009, NAT REV ENDOCRINOL, V5, P453, DOI 10.1038/nrendo.2009.126; Fougner SL, 2010, J CLIN ENDOCR METAB, V95, P2334, DOI 10.1210/jc.2009-2197; Hadjisavvas A, 2006, CLIN GENET, V69, P404, DOI 10.1111/j.1399-0004.2006.00617.x; Hwang JH, 2012, OTOLARYNG HEAD NECK, V147, P531, DOI 10.1177/0194599812446904; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lecoq AL, 2015, NAT REV ENDOCRINOL, V11, P43, DOI 10.1038/nrendo.2014.181; Manji SSM, 2011, AM J PATHOL, V179, P903, DOI 10.1016/j.ajpath.2011.04.002; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Preda V, 2014, EUR J ENDOCRINOL, V171, P659, DOI 10.1530/EJE-14-0426; Qian ZR, 2007, MODERN PATHOL, V20, P1269, DOI 10.1038/modpathol.3800965; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Schultz JM, 2011, J MED GENET, V48, P767, DOI 10.1136/jmedgenet-2011-100262; Sotomayor M, 2014, TRENDS CELL BIOL, V24, P524, DOI 10.1016/j.tcb.2014.03.007; Toledo RA, 2010, FRONT HORM RES, V38, P77, DOI 10.1159/000318497; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Ye Z, 2015, NAT GENET, V47, P793, DOI 10.1038/ng.3322; Zhou YL, 2014, MOL CELL ENDOCRINOL, V386, P16, DOI 10.1016/j.mce.2013.09.006	30	38	39	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					817	823		10.1016/j.ajhg.2017.03.011	http://dx.doi.org/10.1016/j.ajhg.2017.03.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28413019	Bronze, Green Published			2022-12-18	WOS:000400560000010
J	Harms, FL; Girisha, KM; Hardigan, AA; Koruem, F; Shukla, A; Alawi, M; Dalal, A; Brady, L; Tarnopolsky, M; Bird, LM; Ceulemans, S; Bebin, M; Bowling, KM; Hiatt, SM; Lose, EJ; Primiano, M; Chung, WK; Juusola, J; Akdemir, ZC; Bainbridge, M; Charng, WL; Drummond-Borg, M; Eldomery, MK; El-Hattab, AW; Saleh, MAM; Bezieau, S; Cogne, B; Isidor, B; Kury, S; Lupski, JR; Myers, RM; Cooper, GM; Kutsche, K				Harms, Frederike Leonie; Girisha, Katta M.; Hardigan, Andrew A.; Koruem, Fanny; Shukla, Anju; Alawi, Malik; Dalal, Ashwin; Brady, Lauren; Tarnopolsky, Mark; Bird, Lynne M.; Ceulemans, Sophia; Bebin, Martina; Bowling, Kevin M.; Hiatt, Susan M.; Lose, Edward J.; Primiano, Michelle; Chung, Wendy K.; Juusola, Jane; Akdemir, Zeynep C.; Bainbridge, Matthew; Charng, Wu-Lin; Drummond-Borg, Margaret; Eldomery, Mohammad K.; El-Hattab, Ayman W.; Saleh, Mohammed A. M.; Bezieau, Stephane; Cogne, Benjamin; Isidor, Bertrand; Kury, Sebastien; Lupski, James R.; Myers, Richard M.; Cooper, Gregory M.; Kutsche, Kerstin			Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL DIFFERENTIATION; EXPLORATORY RESEARCH; HOMOLOGY; VARIANT; GENES	From a GeneMatcher-enabled international collaboration, we identified ten individuals affected by intellectual disability, speech delay, ataxia, and facial dysmorphism and carrying a deleterious EBF3 variant detected by whole-exome sequencing. One 9-bp duplication and one splice-site, five missense, and two nonsense variants in EBF3 were found; the mutations occurred de novo in eight individuals, and the missense variant c.625C>T (p.Arg209Trp) was inherited by two affected siblings from their healthy mother, who is mosaic. EBF3 belongs to the early B cell factor family (also known as Olf, COE, or O/E) and is a transcription factor involved in neuronal differentiation and maturation. Structural assessment predicted that the five amino acid substitutions have damaging effects on DNA binding of EBF3. Transient expression of EBF3 mutant proteins in HEK293T cells revealed mislocalization of all but one mutant in the cytoplasm, as well as nuclear localization. By transactivation assays, all EBF3 mutants showed significantly reduced or no ability to activate transcription of the reporter gene CDKN1A, and in situ subcellular fractionation experiments demonstrated that EBF3 mutant proteins were less tightly associated with chromatin. Finally, in RNA-seq and ChIP-seq experiments, EBF3 acted as a transcriptional regulator, and mutant EBF3 had reduced genome-wide DNA binding and gene-regulatory activity. Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in similar to 0.1% of individuals with unexplained neurodevelopmental disorders.	[Harms, Frederike Leonie; Koruem, Fanny; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Girisha, Katta M.; Shukla, Anju] Manipal Univ, Kasturba Med Coll, Dept Med Genet, Manipal 576104, Karnataka, India; [Hardigan, Andrew A.; Bowling, Kevin M.; Hiatt, Susan M.; Myers, Richard M.; Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Hardigan, Andrew A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, D-20246 Hamburg, Germany; [Alawi, Malik] Univ Hamburg, Ctr Bioinformat, D-20246 Hamburg, Germany; [Alawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, D-20246 Hamburg, Germany; [Dalal, Ashwin] Ctr DNA Fingerprinting & Diagnost, Diagnost Div, Hyderabad 500001, Telangana, India; [Brady, Lauren; Tarnopolsky, Mark] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Bird, Lynne M.; Ceulemans, Sophia] Rady Childrens Hosp San Diego, Div Genet Dysmorphol, San Diego, CA 92123 USA; [Bebin, Martina] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Lose, Edward J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Primiano, Michelle; Chung, Wendy K.] Columbia Univ, Dept Pediat & Med, New York, NY 10032 USA; [Juusola, Jane] GeneDx, Gaithersburg, MD 20877 USA; [Akdemir, Zeynep C.; Charng, Wu-Lin; Eldomery, Mohammad K.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bainbridge, Matthew] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Drummond-Borg, Margaret] Cook Childrens Genet Clin, Ft Worth, TX 76102 USA; [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain 15258, U Arab Emirates; [Saleh, Mohammed A. M.] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh 11564, Saudi Arabia; [Bezieau, Stephane; Cogne, Benjamin; Isidor, Bertrand; Kury, Sebastien] Ctr Hosp Univ Nantes, Serv Genet Med, F-44093 Nantes 1, France; [Isidor, Bertrand] INSERM, UMR S 957, F-44035 Nantes, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Birmingham; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Heinrich Pette Institute; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); McMaster University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; Baylor College of Medicine; Baylor College of Medicine; Cook Children's Medical Center; King Fahad Medical City; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany.; Cooper, GM (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.	gcooper@hudsonalpha.org; kkutsche@uke.de	Isidor, Bertrand/AAJ-3456-2021; Bird, Lynne/AAG-9533-2021; KM, Girisha/AAK-6867-2020; KÜRY, Sébastien/G-5971-2015; DALAL, ASHWIN/GXF-0028-2022; , Malik/AAB-7437-2021; Cooper, Gregory/D-6914-2011	Isidor, Bertrand/0000-0001-6480-126X; KM, Girisha/0000-0002-0139-8239; KÜRY, Sébastien/0000-0001-5497-0465; DALAL, ASHWIN/0000-0001-5929-745X; , Malik/0000-0002-5993-7709; Harms, Frederike Leonie/0000-0003-2610-0600; Bird, Lynne/0000-0003-4833-3747; Cooper, Gregory/0000-0001-5509-9923	NIH [UM1HG007301, 1R21NS094047-01, HG006542, 5T32GM008361-21]; Simons Foundation [337701]; Deutsche Forschungsgemeinschaft [KO 4576/1-1, KO 4576/1-2, KU 1240/10-1]; Cancer Prevention & Research Institute of Texas training program [RP140102]; NATIONAL CANCER INSTITUTE [R01CA197139] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG006542, UM1HG007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Prevention & Research Institute of Texas training program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families who contributed to this study. We thank the HudsonAlpha Clinical Sequencing Exploratory Research team (Shirley Simmons, Kelly East, Whitley Kelley, Candice Finnila, David Gray, Michelle Amaral, and Michelle Thompson); Ryne Ramaker and Brian Roberts for help with data analysis; Verena Kolbe for technical assistance; Hans-Jurgen Kreienkamp for help with structural analysis and critical reading; Stefan Kindler and Claudia Schob for help with the luciferase assay; and the Microscopy Imaging Facility of the University Medical Center Hamburg-Eppendorf for technical support. We thank Martin Walsh for plasmid pGL2-p21 promoter-Luc (Addgene plasmid 33021), Stefan Kindler for pREN, and Kristoffer Rieken for LeGO-iG2-Puro+-p53. This work was supported by grants from the NIH (UM1HG007301 to HudsonAlpha, 1R21NS094047-01 to K.M.G. as co-principal investigator, HG006542 to the Baylor-Hopkins Center for Mendelian Genomics, and 5T32GM008361-21 to the University of Alabama at Birmingham), the Simons Foundation (337701 to W.K.C.), and the Deutsche Forschungsgemeinschaft (KO 4576/1-1 and KO 4576/1-2 to F.K. and KU 1240/10-1 to K.K.). W.-L.C. was supported by the Cancer Prevention & Research Institute of Texas training program (RP140102). J.J. is an employee of GeneDx. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen Inc., is a member of the scientific advisory board of Baylor Genetics, and is a co-inventor on multiple patents related to molecular diagnostics. The Baylor College of Medicine derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered at Baylor Genetics. M.B. is the founder of Codified Genomics LLC.	Alonso A., 2016, BIORXIV; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Campbell IM, 2015, TRENDS GENET, V31, P382, DOI 10.1016/j.tig.2015.03.013; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Fields S, 2008, MOL IMMUNOL, V45, P3786, DOI 10.1016/j.molimm.2008.05.018; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girisha KM, 2016, EUR J HUM GENET, V24, P1206, DOI 10.1038/ejhg.2015.261; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Liao DQ, 2009, MOL CANCER RES, V7, P1893, DOI 10.1158/1541-7786.MCR-09-0229; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McRae J. F., 2016, BIORXIV; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; Quille ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025181; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sawasdichai A., 2010, JOVE-J VIS EXP, V6, P1; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tanaka AJ, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000661; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao LY, 2006, CANCER RES, V66, P9445, DOI 10.1158/0008-5472.CAN-06-1713	43	38	39	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					117	127		10.1016/j.ajhg.2016.11.012	http://dx.doi.org/10.1016/j.ajhg.2016.11.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28017373	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000391910500010
J	Auer-Grumbach, M; Toegel, S; Schabhuttl, M; Weinmann, D; Chiari, C; Bennett, DLH; Beetz, C; Klein, D; Andersen, PM; Bohme, I; Fink-Puches, R; Gonzalez, M; Harms, MB; Motley, W; Reilly, MM; Renner, W; Rudnik-Schoneborn, S; Schlotter-Weigel, B; Themistocleous, AC; Weishaupt, JH; Ludolph, AC; Wieland, T; Tao, F; Abreu, L; Windhager, R; Zitzelsberger, M; Strom, TM; Walther, T; Scherer, SS; Zuchner, S; Martini, R; Senderek, J				Auer-Grumbach, Michaela; Toegel, Stefan; Schabhuettl, Maria; Weinmann, Daniela; Chiari, Catharina; Bennett, David L. H.; Beetz, Christian; Klein, Dennis; Andersen, Peter M.; Boehme, Ilka; Fink-Puches, Regina; Gonzalez, Michael; Harms, Matthew B.; Motley, William; Reilly, Mary M.; Renner, Wilfried; Rudnik-Schoeneborn, Sabine; Schlotter-Weigel, Beate; Themistocleous, Andreas C.; Weishaupt, Jochen H.; Ludolph, Albert C.; Wieland, Thomas; Tao, Feifei; Abreu, Lisa; Windhager, Reinhard; Zitzelsberger, Manuela; Strom, Tim M.; Walther, Thomas; Scherer, Steven S.; Zuchner, Stephan; Martini, Rudolf; Senderek, Jan			Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; HEREDITARY MOTOR NEUROPATHY; PERIPHERAL NERVOUS-SYSTEM; NEUTRAL ENDOPEPTIDASE; HEART-FAILURE; MOUSE MODEL; MUTATIONS; GENE; MICE	Axonal polyneuropathies are a frequent cause of progressive disability in the elderly. Common etiologies comprise diabetes mellitus, paraproteinaemia, and inflammatory disorders, but often the underlying causes remain elusive. Late-onset axonal Charcot-Marie-Tooth neuropathy (CMT2) is an autosomal-dominantly inherited condition that manifests in the second half of life and is genetically largely unexplained. We assumed age-dependent penetrance of mutations in a so far unknown gene causing late-onset CMT2. We screened 51 index case subjects with late-onset CMT2 for mutations by whole-exome (WES) and Sanger sequencing and subsequently queried WES repositories for further case subjects carrying mutations in the identified candidate gene. We studied nerve pathology and tissue levels and function of the abnormal protein in order to explore consequences of the mutations. Altogether, we observed heterozygous rare loss-of-function and missense mutations in MME encoding the metalloprotease neprilysin in 19 index case subjects diagnosed with axonal polyneuropathies or neurodegenerative conditions involving the peripheral nervous system. MME mutations segregated in an autosomal-dominant fashion with age-related incomplete penetrance and some affected individuals were isolated case subjects. We also found that MME mutations resulted in strongly decreased tissue availability of neprilysin and impaired enzymatic activity. Although neprilysin is known to degrade beta-amyloid, we observed no increased amyloid deposition or increased incidence of dementia in individuals with MME mutations. Detection of MME mutations is expected to increase the diagnostic yield in late-onset polyneuropathies, and it will be tempting to explore whether substances that can elevate neprilysin activity could be a rational option for treatment.	[Auer-Grumbach, Michaela; Toegel, Stefan; Schabhuettl, Maria; Weinmann, Daniela; Chiari, Catharina; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria; [Toegel, Stefan; Weinmann, Daniela; Chiari, Catharina; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed, Karl Chiari Lab Orthopaed Biol, A-1090 Vienna, Austria; [Bennett, David L. H.; Themistocleous, Andreas C.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Beetz, Christian] Jena Univ Hosp, Dept Clin Chem & Lab Med, D-07745 Jena, Germany; [Klein, Dennis; Martini, Rudolf] Univ Hosp Wurzburg, Dept Neurol, Dev Neurobiol, D-97080 Wurzburg, Germany; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden; [Boehme, Ilka] Univ Leipzig, Dept Pediat Surg, D-04103 Leipzig, Germany; [Fink-Puches, Regina] Med Univ Graz, Dept Dermatol, A-8036 Graz, Austria; [Gonzalez, Michael] Genesis Project Inc, Miami, FL USA; [Harms, Matthew B.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Motley, William; Scherer, Steven S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reilly, Mary M.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Renner, Wilfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Rudnik-Schoeneborn, Sabine] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Schlotter-Weigel, Beate; Zitzelsberger, Manuela; Senderek, Jan] Univ Munich, Friedrich Baur Inst, D-80336 Munich, Germany; [Themistocleous, Andreas C.] Univ Witwatersrand, Sch Physiol, Brain Funct Res Grp, Fac Hlth Sci, ZA-2193 Johannesburg, South Africa; [Weishaupt, Jochen H.; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [Wieland, Thomas; Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Tao, Feifei; Abreu, Lisa; Zuchner, Stephan] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Tao, Feifei; Abreu, Lisa; Zuchner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Walther, Thomas] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork T12 YT57, Ireland; [Walther, Thomas] Univ Leipzig, Dept Obstet, D-04103 Leipzig, Germany	Medical University of Vienna; Medical University of Vienna; University of Oxford; Friedrich Schiller University of Jena; University of Wurzburg; Umea University; Leipzig University; Medical University of Graz; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of London; University College London; Medical University of Graz; Medical University of Innsbruck; University of Munich; University of Witwatersrand; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Miami; University of Miami; Technical University of Munich; University College Cork; Leipzig University	Auer-Grumbach, M (corresponding author), Med Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria.; Senderek, J (corresponding author), Univ Munich, Friedrich Baur Inst, D-80336 Munich, Germany.	michaela.auer-grumbach@meduniwien.ac.at; jan.senderek@med.uni-muenchen.de	Toegel, Stefan/J-6548-2019; bennett, david/ABG-1184-2020; Tao, Feifei/AAI-6256-2021; Senderek, Jan/F-8405-2015	Toegel, Stefan/0000-0003-4317-1769; Tao, Feifei/0000-0003-4477-2304; Senderek, Jan/0000-0002-8263-1783; Reilly, Mary/0000-0003-0686-905X; Klein, Dennis/0000-0002-0476-445X; Beetz, Christian/0000-0001-7061-2895; Themistocleous, Andreas/0000-0002-1089-1543; Bennett, David/0000-0002-7996-2696; Windhager, Reinhard/0000-0002-6321-1804; Martini, Rudolf/0000-0002-5463-5592; Weinmann, Daniela/0000-0002-6298-4709	Austrian Science Fund (FWF) [P27634FW]; Friedrich-Baur-Stiftung; Fritz-Thyssen-Stiftung; NIH [U54NS065712, R01NS075764]; Judy Seltzer Levenson Memorial Fund for CMT Research; CMT Association; Genesis Project; German Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075764, U54NS065712] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Friedrich-Baur-Stiftung; Fritz-Thyssen-Stiftung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Judy Seltzer Levenson Memorial Fund for CMT Research; CMT Association; Genesis Project; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to families and study individuals for their contribution. This work was supported by the Austrian Science Fund (FWF, P27634FW to M.A.-G.), the Friedrich-Baur-Stiftung and the Fritz-Thyssen-Stiftung (to J.S.), NIH (U54NS065712 to S.Z. and S.S.S. and R01NS075764 to S.Z.), the Judy Seltzer Levenson Memorial Fund for CMT Research (to S.S.S.), the CMT Association, and "The Genesis Project." We also thank the Inherited Neuropathy Consortium for advice and general support. S.R.-S., B.S.-W., D.K., R.M., and J.S. are members of the German network on Charcot-Marie-Tooth neuropathies (CMT-NET) funded by the German Federal Ministry of Education and Research (BMBF).	Albulym OM, 2016, ANN NEUROL, V79, P419, DOI 10.1002/ana.24575; Anzini P, 1997, J NEUROSCI, V17, P4545; Auer-Grumbach M, 2003, NEUROLOGY, V61, P1435, DOI 10.1212/01.WNL.0000094197.46109.75; Azzedine H, 2012, MOL SYNDROMOL, V3, P204, DOI 10.1159/000343487; Bayes-Genis A, 2015, J AM COLL CARDIOL, V65, P657, DOI 10.1016/j.jacc.2014.11.048; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Beetz C, 2006, NEUROLOGY, V67, P1926, DOI 10.1212/01.wnl.0000244413.49258.f5; Bennett CL, 2008, NEUROLOGY, V71, P14, DOI 10.1212/01.wnl.0000304048.94023.73; Berciano J, 2011, J NEUROL, V258, P1413, DOI 10.1007/s00415-011-5947-7; Boncoraglio A, 2012, INT J BIOCHEM CELL B, V44, P1657, DOI 10.1016/j.biocel.2012.03.011; CADONI A, 1993, J NEUROIMMUNOL, V45, P61, DOI 10.1016/0165-5728(93)90164-T; Carenini S, 2001, J CELL BIOL, V152, P301, DOI 10.1083/jcb.152.2.301; Chen YC, 2015, NAT GENET, V47, P803, DOI 10.1038/ng.3308; Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1981, ANN NEUROL, V10, P222, DOI 10.1002/ana.410100304; Feltri ML, 2016, NEUROSCIENTIST, V22, P252, DOI 10.1177/1073858415572361; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; Groh J, 2012, BRAIN, V135, P88, DOI 10.1093/brain/awr283; Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269; Higuchi Y, 2016, ANN NEUROL, V79, P659, DOI 10.1002/ana.24612; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KIOUSSI C, 1995, EUR J NEUROSCI, V7, P951, DOI 10.1111/j.1460-9568.1995.tb01083.x; Kramer HH, 2009, NEUROBIOL DIS, V35, P177, DOI 10.1016/j.nbd.2008.11.002; Lam L, 2015, MUSCLE NERVE, V52, P146, DOI 10.1002/mus.24563; Lauria G, 2012, CURR OPIN NEUROL, V25, P542, DOI 10.1097/WCO.0b013e32835804c5; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Madani R, 2006, J NEUROSCI RES, V84, P1871, DOI 10.1002/jnr.21074; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mathis S, 2015, J MED GENET, V52, P681, DOI 10.1136/jmedgenet-2015-103272; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Melzig MF, 2003, PHYTOMEDICINE, V10, P494, DOI 10.1078/094471103322331449; Mohajeri MH, 2009, NEUROCHEM RES, V34, P717, DOI 10.1007/s11064-009-9919-6; Niemann A, 2014, BRAIN, V137, P668, DOI 10.1093/brain/awt371; Oberstadt M, 2016, J PERIPHER NERV SYST, V21, P111, DOI 10.1111/jns.12165; Parman Y, 2016, CURR OPIN NEUROL, V29, pS3, DOI 10.1097/WCO.0000000000000288; Plante-Bordeneuve V, 2013, HAND CLINIC, V115, P643, DOI 10.1016/B978-0-444-52902-2.00038-2; Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Schulte EC, 2013, MOVEMENT DISORD, V28, P224, DOI 10.1002/mds.25256; Seburn KL, 2014, J NEUROPATH EXP NEUR, V73, P693, DOI 10.1097/NEN.0000000000000085; Singer MA, 2012, J PERIPHER NERV SYST, V17, P43, DOI 10.1111/j.1529-8027.2012.00395.x; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; Vivarelli M, 2015, KIDNEY INT, V87, P602, DOI 10.1038/ki.2014.381; Vodovar N, 2015, JACC-HEART FAIL, V3, P629, DOI 10.1016/j.jchf.2015.03.011; Weis J, 2012, CLIN NEUROPATHOL, V31, P7, DOI 10.5414/NP300468; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zielasek J, 1996, MUSCLE NERVE, V19, P946, DOI 10.1002/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8	58	38	39	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					607	623		10.1016/j.ajhg.2016.07.008	http://dx.doi.org/10.1016/j.ajhg.2016.07.008			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27588448	Green Published, Bronze			2022-12-18	WOS:000383114800007
J	Hildebrand, MS; Griffin, NG; Damiano, JA; Cops, EJ; Burgess, R; Ozturk, E; Jones, NC; Leventer, RJ; Freeman, JL; Harvey, AS; Sadleir, LG; Scheffer, IE; Major, H; Darbro, BW; Allen, AS; Goldstein, DB; Kerrigan, JF; Berkovic, SF; Heinzen, EL				Hildebrand, Michael S.; Griffin, Nicole G.; Damiano, John A.; Cops, Elisa J.; Burgess, Rosemary; Ozturk, Ezgi; Jones, Nigel C.; Leventer, Richard J.; Freeman, Jeremy L.; Harvey, A. Simon; Sadleir, Lynette G.; Scheffer, Ingrid E.; Major, Heather; Darbro, Benjamin W.; Allen, Andrew S.; Goldstein, David B.; Kerrigan, John F.; Berkovic, Samuel F.; Heinzen, Erin L.			Mutations of the Sonic Hedgehog Pathway Underlie Hypothalamic Hamartoma with Gelastic Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC MUTATIONS; ACTIVATION; CANCER; GLI3; IDENTIFICATION; SEIZURES; WNT	Hypothalamic hamartoma (HH) with gelastic epilepsy is a well-recognized drug-resistant epilepsy syndrome of early life. 1 Surgical resection allows limited access to the small deep-seated lesions that cause the disease. Here, we report the results of a search for somatic mutations in paired hamartoma-and leukocyte-derived DNA samples from 38 individuals which we conducted by using whole-exome sequencing (WES), chromosomal microarray (CMA), and targeted resequencing (TRS) of candidate genes. Somatic mutations were identified in genes involving regulation of the sonic hedgehog (Shh) pathway in 14/38 individuals (37%). Three individuals had somatic mutations in PRKACA, which encodes a cAMP-dependent protein kinase that acts as a repressor protein in the Shh pathway, and four subjects had somatic mutations in GLI3, an Shh pathway gene associated with HH. In seven other individuals, we identified two recurrent and three single brain-tissue- specific, large copy-number or loss-of-heterozygosity (LOH) variants involving multiple Shh genes, as well as other genes without an obvious biological link to the Shh pathway. The Shh pathway genes in these large somatic lesions include the ligand itself (SHH and IHH), the receptor SMO, and several other Shh downstream pathway members, including CREBBP and GLI2. Taken together, our data implicate perturbation of the Shh pathway in at least 37% of individuals with the HH epilepsy syndrome, consistent with the concept of a developmental pathway brain disease.	[Hildebrand, Michael S.; Damiano, John A.; Cops, Elisa J.; Burgess, Rosemary; Scheffer, Ingrid E.; Berkovic, Samuel F.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Hildebrand, Michael S.; Damiano, John A.; Cops, Elisa J.; Burgess, Rosemary; Scheffer, Ingrid E.; Berkovic, Samuel F.] Austin Hlth, Heidelberg, Vic 3084, Australia; [Griffin, Nicole G.; Goldstein, David B.; Heinzen, Erin L.] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Ozturk, Ezgi; Jones, Nigel C.] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia; [Ozturk, Ezgi; Jones, Nigel C.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Leventer, Richard J.; Freeman, Jeremy L.; Harvey, A. Simon] Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Leventer, Richard J.; Harvey, A. Simon; Scheffer, Ingrid E.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Leventer, Richard J.; Harvey, A. Simon; Scheffer, Ingrid E.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Leventer, Richard J.; Harvey, A. Simon] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sadleir, Lynette G.] Univ Otago, Dept Paediat & Child Hlth, Wellington 9016, New Zealand; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Major, Heather; Darbro, Benjamin W.] Univ Iowa, Dept Pediat, Iowa City, IA 52246 USA; [Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Kerrigan, John F.] Phoenix Childrens Hosp, Barrow Neurol Inst, Div Pediat Neurol, Phoenix, AZ 85013 USA; [Heinzen, Erin L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Columbia University; University of Melbourne; Royal Melbourne Hospital; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Otago; Florey Institute of Neuroscience & Mental Health; University of Iowa; Duke University; Barrow Neurological Institute; Phoenix Children's Hospital; Columbia University	Berkovic, SF (corresponding author), Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia.; Berkovic, SF (corresponding author), Austin Hlth, Heidelberg, Vic 3084, Australia.; Heinzen, EL (corresponding author), Columbia Univ, Inst Genom Med, New York, NY 10032 USA.; Heinzen, EL (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	s.berkovic@unimelb.edu.au; eh2682@cumc.columbia.edu	Goldstein, David/AAY-8125-2020; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022	Scheffer, Ingrid E/0000-0002-2311-2174; Hildebrand, Michael/0000-0003-2739-0515; Jones, Nigel/0000-0002-1080-8439; Berkovic, Samuel/0000-0003-4580-841X; Allen, Andrew/0000-0002-7232-2143; Sadleir, Lynette/0000-0002-5355-7115; Freeman, Jeremy/0000-0002-4184-3683; Griffin, Nicole/0000-0002-8842-7492; Darbro, Benjamin/0000-0001-9279-356X	National Health and Medical Research Council (NHMRC) [628952, 1006110, 1063799]; NIH; Health Research Council of New Zealand; CURE; American Epilepsy Society; US Department of Defense; March of Dimes; Australian Research Council [13100100]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS078657] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); CURE; American Epilepsy Society; US Department of Defense(United States Department of Defense); March of Dimes(March of Dimes); Australian Research Council(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in this study, and we value the advocacy from the Hope for Hypothalamic Hamartoma Foundation (http://hopeforhh.org). Elena Aleksoska (Epilepsy Research Centre) performed genomic DNA extractions from tissues. Brett Copeland, Joshua Bridgers, and Sitharthan Kamalakaran (Institute for Genomic Medicine) provided bioinformatics support. Dr. Paul Lockhart, Greta Gillies, and Kate Pope (Murdoch Childrens Research Institute) assisted with collection of tissue, and Jeffrey Rosenfeld and Wirginia Maixner (Royal Children's Hospital, Melbourne) performed surgeries. This study was supported by a National Health and Medical Research Council (NHMRC) Program Grant (628952) to S.F.B. and I.E.S., a Practitioner Fellowship (1006110) to I.E.S, and a Career Development Fellowship (1063799) to M.S.H. I.E.S. was also funded by grants from the NIH, Australian Research Council, Health Research Council of New Zealand, CURE, American Epilepsy Society, US Department of Defense Autism Spectrum Disorder Research Program, March of Dimes, and Perpetual Charitable Trustees. E.L.H. was supported by a NIH grant (R21-NS078657). N.C.J. was supported by an Australian Research Council Future Fellowship (13100100). Acknowledgments of individuals and funding sources responsible for the samples used in this study as controls are provided in the Supplemental Data.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Berkovic SF, 2003, EPILEPSIA, V44, P969, DOI 10.1046/j.1528-1157.2003.59102.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Craig DW, 2008, AM J HUM GENET, V82, P366, DOI 10.1016/j.ajhg.2007.10.006; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Helbig I, 2013, CURR OPIN NEUROL, V26, P179, DOI 10.1097/WCO.0b013e32835ee6ff; Jamuar SS, 2014, NEW ENGL J MED, V371, P2038, DOI 10.1056/NEJMc1411784; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kebenko M, 2015, CELL SIGNAL, V27, P373, DOI 10.1016/j.cellsig.2014.11.022; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Lindhout D, 2008, BRAIN, V131, P900, DOI 10.1093/brain/awn056; Nakashima M, 2015, ANN NEUROL, V78, P375, DOI 10.1002/ana.24444; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rosenfeld JV, 2001, NEUROSURGERY, V48, P108, DOI 10.1097/00006123-200101000-00019; Saitsu H., 2016, ANN CLIN TRANSL 0324; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Sheikh A, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-29; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058; Wallace RH, 2008, NEUROLOGY, V70, P653, DOI 10.1212/01.wnl.0000284607.12906.c5; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	29	38	40	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					423	429		10.1016/j.ajhg.2016.05.031	http://dx.doi.org/10.1016/j.ajhg.2016.05.031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27453577	Green Published, Bronze			2022-12-18	WOS:000381617200013
J	Liu, CT; Raghavan, S; Maruthur, N; Kabagambe, EK; Hong, J; Ng, MCY; Hivert, MF; Lu, YC; An, P; Bentley, AR; Drolet, AM; Gaulton, KJ; Guo, XQ; Armstrong, LL; Irvin, MR; Li, M; Lipovich, L; Rybin, DV; Taylor, KD; Agyemang, C; Palmer, ND; Cade, BE; Chen, WM; Dauriz, M; Delaney, JAC; Edwards, TL; Evans, DS; Evans, MK; Lange, LA; Leong, A; Liu, JM; Liu, YM; Nayak, U; Patel, SR; Porneala, BC; Rasmussen-Torvik, LJ; Snijder, MB; Stallings, SC; Tanaka, T; Yanek, LR; Zhao, W; Becker, DM; Bielak, LF; Biggs, ML; Bottinger, EP; Bowden, DW; Chen, GJ; Correa, A; Couper, DJ; Crawford, DC; Cushman, M; Eicher, JD; Fornage, M; Franceschini, N; Fu, YP; Goodarzi, MO; Gottesman, O; Hara, K; Harris, TB; Jensen, RA; Johnson, AD; Jhun, MA; Karter, AJ; Keller, MF; Kho, AN; Kizer, JR; Krauss, RM; Langefeld, CD; Li, XH; Liang, JL; Liu, SM; Lowe, WL; Mosley, TH; North, KE; Pacheco, JA; Peyser, PA; Patrick, AL; Rice, KM; Selvin, E; Sims, M; Smith, JA; Tajuddin, SM; Vaidya, D; Wren, MP; Yao, J; Zhu, XF; Ziegler, JT; Zmuda, JM; Zonderman, AB; Zwinderman, AH; Adeyemo, A; Boerwinkle, E; Ferrucci, L; Hayes, MG; Kardia, SLR; Miljkovic, I; Pankow, JS; Rotimi, CN; Sale, MM; Wagenknecht, LE; Arnett, DK; Chen, YDI; Nalls, MA; Province, MA; Kao, WHL; Siscovick, DS; Psaty, BM; Wilson, JG; Loos, RJF; Dupuis, J; Rich, SS; Florez, JC; Rotter, JI; Morris, AP; Meigs, JB				Liu, Ching-Ti; Raghavan, Sridharan; Maruthur, Nisa; Kabagambe, Edmond Kato; Hong, Jaeyoung; Ng, Maggie C. Y.; Hivert, Marie-France; Lu, Yingchang; An, Ping; Bentley, Amy R.; Drolet, Anne M.; Gaulton, Kyle J.; Guo, Xiuqing; Armstrong, Loren L.; Irvin, Marguerite R.; Li, Man; Lipovich, Leonard; Rybin, Denis V.; Taylor, Kent D.; Agyemang, Charles; Palmer, Nicholette D.; Cade, Brian E.; Chen, Wei-Min; Dauriz, Marco; Delaney, Joseph A. C.; Edwards, Todd L.; Evans, Daniel S.; Evans, Michele K.; Lange, Leslie A.; Leong, Aaron; Liu, Jingmin; Liu, Yongmei; Nayak, Uma; Patel, Sanjay R.; Porneala, Bianca C.; Rasmussen-Torvik, Laura J.; Snijder, Marieke B.; Stallings, Sarah C.; Tanaka, Toshiko; Yanek, Lisa R.; Zhao, Wei; Becker, Diane M.; Bielak, Lawrence F.; Biggs, Mary L.; Bottinger, Erwin P.; Bowden, Donald W.; Chen, Guanjie; Correa, Adolfo; Couper, David J.; Crawford, Dana C.; Cushman, Mary; Eicher, John D.; Fornage, Myriam; Franceschini, Nora; Fu, Yi-Ping; Goodarzi, Mark O.; Gottesman, Omri; Hara, Kazuo; Harris, Tamara B.; Jensen, Richard A.; Johnson, Andrew D.; Jhun, Min A.; Karter, Andrew J.; Keller, Margaux F.; Kho, Abel N.; Kizer, Jorge R.; Krauss, Ronald M.; Langefeld, Carl D.; Li, Xiaohui; Liang, Jingling; Liu, Simin; Lowe, William L., Jr.; Mosley, Thomas H.; North, Kari E.; Pacheco, Jennifer A.; Peyser, Patricia A.; Patrick, Alan L.; Rice, Kenneth M.; Selvin, Elizabeth; Sims, Mario; Smith, Jennifer A.; Tajuddin, Salman M.; Vaidya, Dhananjay; Wren, Mary P.; Yao, Jie; Zhu, Xiaofeng; Ziegler, Julie T.; Zmuda, Joseph M.; Zonderman, Alan B.; Zwinderman, Aeilko H.; Adeyemo, Adebowale; Boerwinkle, Eric; Ferrucci, Luigi; Hayes, M. Geoffrey; Kardia, Sharon L. R.; Miljkovic, Iva; Pankow, James S.; Rotimi, Charles N.; Sale, Michele M.; Wagenknecht, Lynne E.; Arnett, Donna K.; Chen, Yii-Der Ida; Nalls, Michael A.; Province, Michael A.; Kao, W. H. Linda; Siscovick, David S.; Psaty, Bruce M.; Wilson, James G.; Loos, Ruth J. F.; Dupuis, Josee; Rich, Stephen S.; Florez, Jose C.; Rotter, Jerome I.; Morris, Andrew P.; Meigs, James B.		AAAG Consortium; CARe Consortium; COGENT-BP Consortium; eMERGE Consortium; MEDIA Consortium; MAGIC Consortium	Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES RISK; BETA-CELL FUNCTION; BODY-MASS INDEX; PLASMA-GLUCOSE; TRIGLYCERIDE LEVELS; GLYCEMIC TRAITS; LOCI; RESISTANCE; VARIANT	Knowledge of the genetic basis of the type 2 diabetes (T2D)-related quantitative traits fasting glucose (FG) and insulin (FI) in African ancestry (AA) individuals has been limited. In non-diabetic subjects of AA (n = 20,209) and European ancestry (EA; n = 57,292), we performed trans-ethnic (AA+EA) fine-mapping of 54 established EA FG or FI loci with detailed functional annotation, assessed their relevance in AA individuals, and sought previously undescribed loci through trans-ethnic (AA+EA) meta-analysis. We narrowed credible sets of variants driving association signals for 22/54 EA-associated loci; 18/22 credible sets overlapped with active islet-specific enhancers or transcription factor (TF) binding sites, and 21/22 contained at least one TF motif. Of the 54 EA-associated loci, 23 were shared between EA and AA. Replication with an additional 10,096 AA individuals identified two previously undescribed FI loci, chrX FAM133A (rs213676) and chr5 PELO (rs6450057). Trans-ethnic analyses with regulatory annotation illuminate the genetic architecture of glycemic traits and suggest gene regulation as a target to advance precision medicine for T2D. Our approach to utilize state-of-the-art functional annotation and implement trans-ethnic association analysis for discovery and fine-mapping offers a framework for further follow-up and characterization of GWAS signals of complex trait loci.	[Liu, Ching-Ti; Hong, Jaeyoung; Rybin, Denis V.; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Raghavan, Sridharan; Leong, Aaron; Porneala, Bianca C.; Meigs, James B.] Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Raghavan, Sridharan] Eastern Colorado Hlth Care Syst, Dept Vet Affairs Med Ctr, Denver, CO 80220 USA; [Raghavan, Sridharan] Univ Colorado, Sch Med, Dept Med, Div Gen Internal Med, Denver, CO 80220 USA; [Maruthur, Nisa] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21287 USA; [Maruthur, Nisa; Selvin, Elizabeth] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; [Maruthur, Nisa; Li, Man; Selvin, Elizabeth; Vaidya, Dhananjay; Kao, W. H. Linda] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Kabagambe, Edmond Kato; Edwards, Todd L.] Vanderbilt Univ, Med Ctr, Sch Med, Div Epidemiol,Dept Med, Nashville, TN 37203 USA; [Ng, Maggie C. Y.; Palmer, Nicholette D.; Bowden, Donald W.] Wake Forest Univ, Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Ng, Maggie C. Y.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC 27157 USA; [Hivert, Marie-France] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02215 USA; [Hivert, Marie-France; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Hivert, Marie-France] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1G 0A2, Canada; [Lu, Yingchang; Bottinger, Erwin P.; Gottesman, Omri; Hara, Kazuo; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [An, Ping; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63108 USA; [Bentley, Amy R.; Chen, Guanjie; Adeyemo, Adebowale; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Drolet, Anne M.; Lipovich, Leonard] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Gaulton, Kyle J.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Guo, Xiuqing; Taylor, Kent D.; Li, Xiaohui; Yao, Jie; Chen, Yii-Der Ida; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Armstrong, Loren L.; Kho, Abel N.; Lowe, William L., Jr.; Pacheco, Jennifer A.; Hayes, M. Geoffrey] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Irvin, Marguerite R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Lipovich, Leonard] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Agyemang, Charles; Snijder, Marieke B.; Zwinderman, Aeilko H.] Acad Med Ctr Amsterdam, Dept Publ Hlth, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Palmer, Nicholette D.; Bowden, Donald W.; Wren, Mary P.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Cade, Brian E.] Harvard Med Sch, Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Chen, Wei-Min; Nayak, Uma; Sale, Michele M.; Rich, Stephen S.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Dauriz, Marco] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, I-37126 Verona, Italy; [Delaney, Joseph A. C.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Evans, Daniel S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Evans, Michele K.; Tajuddin, Salman M.] NIA, Hlth Dispar Res Sect, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27607 USA; [Liu, Jingmin] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Liu, Yongmei] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Patel, Sanjay R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Rasmussen-Torvik, Laura J.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Harbor Hosp, Baltimore, MD 21225 USA; [Yanek, Lisa R.; Becker, Diane M.; Vaidya, Dhananjay] Johns Hopkins Univ, Dept Med, Div Gen Internal Med, GeneSTAR Res Program, Baltimore, MD 21287 USA; [Zhao, Wei; Bielak, Lawrence F.; Jhun, Min A.; Peyser, Patricia A.; Smith, Jennifer A.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Becker, Diane M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21287 USA; [Biggs, Mary L.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Biggs, Mary L.; Jensen, Richard A.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Sch Med, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Correa, Adolfo; Sims, Mario] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Couper, David J.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC 27514 USA; [Crawford, Dana C.] Case Western Reserve Univ, Inst Computat Biol, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Cushman, Mary] Univ Vermont, Coll Med, Dept Pathol & Med, Burlington, VT 05405 USA; [Eicher, John D.; Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Eicher, John D.; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Framingham, MA 01702 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Fu, Yi-Ping] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, NIH, Framingham, MA 01702 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Hara, Kazuo] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan; [Hara, Kazuo] Tokyo Med Univ, Dept Diabet Endocrinol & Metab, Tokyo 1630023, Japan; [Harris, Tamara B.] NIH, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Karter, Andrew J.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Keller, Margaux F.] Merck Res Labs, Dept Genet & Pharmacogen, 33 Ave Louis Pasteur, Boston, MA 02115 USA; [Kizer, Jorge R.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Kizer, Jorge R.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Langefeld, Carl D.; Ziegler, Julie T.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Publ Hlth Genom, Winston Salem, NC 27157 USA; [Langefeld, Carl D.; Ziegler, Julie T.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Liang, Jingling; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Liu, Simin] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Liu, Simin] Brown Univ, Dept Med, Providence, RI 02903 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Div Geriatr Gerontol, Jackson, MS 39216 USA; [Patrick, Alan L.] Tobago Hlth Studies Off, Scarborough, Trinidad Tobago; [Zmuda, Joseph M.; Miljkovic, Iva] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Zonderman, Alan B.] NIA, Behav Epidemiol Sect, Lab Epidemiol & Populat Sci, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne E.] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40563 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Siscovick, David S.] New York Acad Med, New York, NY 10029 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Florez, Jose C.] Broad Inst, Program Metab, Cambridge, MA 02142 USA; [Florez, Jose C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Florez, Jose C.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Stallings, Sarah C.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN 37203 USA	Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Sherbrooke; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wayne State University; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham; Wayne State University; University of Amsterdam; Academic Medical Center Amsterdam; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia; University of Verona; University of Washington; University of Washington Seattle; California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; University of Vermont; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cedars Sinai Medical Center; University of Tokyo; Tokyo Medical University; National Institutes of Health (NIH) - USA; Kaiser Permanente; Merck & Company; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Case Western Reserve University; Brown University; Brown University; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); New York Academy of Medicine; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Mississippi; University of Mississippi Medical Center; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Liverpool; Vanderbilt University	Liu, CT (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.; Meigs, JB (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.	ctliu@bu.edu; jmeigs@partners.org	Zhu, Xiaofeng/O-6874-2019; Liu, Simin/GSN-4159-2022; Lipovich, Leonard/B-2355-2019; Loos, Ruth/GON-5877-2022; Crawford, Dana/O-5578-2019; Li, Man/AAX-3400-2020; Johnson, Andrew D/G-6520-2013; Cushman, Mary/K-1157-2019; Loos, Ruth J F/Q-2862-2016; Hivert, Marie-France/GWN-0455-2022; Dauriz, Marco/S-5843-2016; Delaney, Joseph A/J-8204-2019; Liu, Simin/I-3689-2014; Rotter, Jerome/AAY-6598-2021; Vaidya, Dhananjay/AAL-5684-2020; Meigs, James/P-3927-2019; Evans, Michele Kim/AAE-4776-2019; Goodarzi, Mark/AAH-7106-2021; Cade, Brian/J-6770-2019	Lipovich, Leonard/0000-0002-0531-3570; Crawford, Dana/0000-0002-6437-6248; Li, Man/0000-0002-3839-0281; Johnson, Andrew D/0000-0001-6369-5178; Cushman, Mary/0000-0002-7871-6143; Loos, Ruth J F/0000-0002-8532-5087; Dauriz, Marco/0000-0002-5542-5941; Delaney, Joseph A/0000-0003-1771-1776; Liu, Simin/0000-0003-2098-3844; Vaidya, Dhananjay/0000-0002-7164-1601; Meigs, James/0000-0002-2439-2657; Goodarzi, Mark/0000-0001-6364-5103; Cade, Brian/0000-0003-1424-0673; Dupuis, Josee/0000-0003-2871-3603; Tajuddin, Salman M./0000-0002-7919-8528; Rasmussen-Torvik, Laura/0000-0002-0820-7300; Smith, Jennifer Ann/0000-0002-3575-5468; Rich, Stephen/0000-0003-3872-7793; Pacheco, Jennifer/0000-0001-8021-5818; Couper, David/0000-0002-4313-9235; Adeyemo, Adebowale/0000-0002-3105-3231; Pankow, James/0000-0001-7076-483X; Liu, Ching-Ti/0000-0002-0703-0742; Patel, Sanjay/0000-0002-9142-5172; Zonderman, Alan B/0000-0002-6523-4778; Zhu, Xiaofeng/0000-0003-0037-411X; Evans, Michele/0000-0002-8546-2831; Miljkovic, Iva/0000-0002-3155-9777; Hayes, M Geoffrey/0000-0002-4617-3981	Johnson Johnson; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095159, N01HC085081, N01HC095162, N01HC025195, N01HC095167, N01HC095161, N01HC085086, N01HC095166, N01HC095169, N01HC095163, N01HC095160, N01HC095168, N01HC095164] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422, UL1TR001881, UL1TR000040, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284, UL1RR025741, UL1RR025005, M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL117078, U01HL054471, U19HL069757, U01HL054481, R01HL087660, R01HL059684, R01HL103612, U01HL072518, ZIAHL006170, U01HL047902, R01HL119443, U01HL054464, R01HL087700, U01HL054472, T32HL007901, R01HL046380, R01HL059367, R01HL060944, R01HL055673, R01HL071025, R01HL105756, U01HL080295, R01HL088215, R01HL086694, R01HL087698, R21HL123677] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008673, U01HG006378, U01HG004446, U01HG008672, U01HG004603, U01HG004424, U01HG004402, ZIAHG200362, U01HG004729, R01HG003054, U01HG004609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174, R01DK089256, K24DK080140, K01DK083029, K99DK081350, U01DK078616, R01DK078616, P30DK098722, R01DK097084, P30DK063491, R01DK079888, P30DK020541, K24DK106414, R00DK081350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062106, R01AG023629, N01AG062101, R01AG032098] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.M.P. serves on the DSMB of a clinical trial for the device manufacturer Zoll LifeCor and on the Steering Committee for the Yale Open Data Access Project funded by Johnson & Johnson. D.V. is a consultant for Consumable Science, Inc. J.R.K. holds stock in Pfizer, Inc., and Gilead Sciences, Inc.	Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen CH, 2015, P NATL ACAD SCI USA, V112, P3074, DOI 10.1073/pnas.1414657112; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fesinmeyer MD, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-98; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Hong J, 2016, GENET EPIDEMIOL, V40, P284, DOI 10.1002/gepi.21963; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu CT, 2012, DIABETOLOGIA, V55, P2970, DOI 10.1007/s00125-012-2656-4; Liu CT, 2014, HUM MOL GENET, V23, P4738, DOI 10.1093/hmg/ddu183; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Ng MCY, 2013, DIABETES, V62, P965, DOI 10.2337/db12-0266; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pautsch A, 2013, BIOCHEMISTRY-US, V52, P3523, DOI 10.1021/bi4000782; Rasmussen-Torvik LJ, 2012, GENET EPIDEMIOL, V36, P384, DOI 10.1002/gepi.21632; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Spanakis EK, 2013, CURR DIABETES REP, V13, P814, DOI 10.1007/s11892-013-0421-9; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1978, EVOLUTION GENETICS P; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	61	38	38	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					56	75		10.1016/j.ajhg.2016.05.006	http://dx.doi.org/10.1016/j.ajhg.2016.05.006			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27321945	Green Published, Bronze			2022-12-18	WOS:000381616600005
J	Rebelo, AP; Abrams, AJ; Cottenie, E; Horga, A; Gonzalez, M; Bis, DM; Sanchez-Mejias, A; Pinto, M; Buglo, E; Markel, K; Prince, J; Laura, M; Houlden, H; Blake, J; Woodward, C; Sweeney, MG; Holton, JL; Hanna, M; Dallman, JE; Auer-Grumbach, M; Reilly, MM; Zuchner, S				Rebelo, Adriana P.; Abrams, Alexander J.; Cottenie, Ellen; Horga, Alejandro; Gonzalez, Michael; Bis, Dana M.; Sanchez-Mejias, Avencia; Pinto, Milena; Buglo, Elena; Markel, Kasey; Prince, Jeffrey; Laura, Matilde; Houlden, Henry; Blake, Julian; Woodward, Cathy; Sweeney, Mary G.; Holton, Janice L.; Hanna, Michael; Dallman, Julia E.; Auer-Grumbach, Michaela; Reilly, Mary M.; Zuchner, Stephan			Cryptic Amyloidogenic Elements in the 3 ' UTRs of Neurofilament Genes Trigger Axonal Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN AGGREGATION; DISEASE; MUTATIONS; ACCUMULATION; SUBUNIT; PREDICTION; GEM.APP	Abnormal protein aggregation is observed in an expanding number of neurodegenerative diseases. Here, we describe a mechanism for intracellular toxic protein aggregation induced by an unusual mutation event in families affected by axonal neuropathy. These families carry distinct frameshift variants in NEFH (neurofilament heavy), leading to a loss of the terminating codon and translation of the 3' UTR into an extra 40 amino acids. In silico aggregation prediction suggested the terminal 20 residues of the altered NEFH to be amyloidogenic, which we confirmed experimentally by serial deletion analysis. The presence of this amyloidogenic motif fused to NEFH caused prominent and toxic protein aggregates in transfected cells and disrupted motor neurons in zebrafish. We identified a similar aggregation-inducing mechanism in NEFL (neurofilament light) and FUS (fused in sarcoma), in which mutations are known to cause aggregation in Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis, respectively. In summary, we present a protein-aggregation-triggering mechanism that should be taken into consideration during the evaluation of stop-loss variants.	[Rebelo, Adriana P.; Abrams, Alexander J.; Gonzalez, Michael; Bis, Dana M.; Sanchez-Mejias, Avencia; Pinto, Milena; Buglo, Elena; Zuchner, Stephan] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Rebelo, Adriana P.; Abrams, Alexander J.; Gonzalez, Michael; Bis, Dana M.; Sanchez-Mejias, Avencia; Pinto, Milena; Buglo, Elena; Zuchner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Cottenie, Ellen; Horga, Alejandro; Laura, Matilde; Houlden, Henry; Blake, Julian; Woodward, Cathy; Holton, Janice L.; Hanna, Michael; Reilly, Mary M.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England; [Cottenie, Ellen; Horga, Alejandro; Laura, Matilde; Houlden, Henry; Woodward, Cathy; Holton, Janice L.; Hanna, Michael; Reilly, Mary M.] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England; [Markel, Kasey; Prince, Jeffrey; Dallman, Julia E.] Univ Miami, Dept Biol, Miami, FL 33146 USA; [Houlden, Henry; Sweeney, Mary G.] UCL Inst Neurol, Neurogenet Lab, Queen Sq, London WC1N 3BG, England; [Blake, Julian] Norfolk & Norwich Univ Hosp, Dept Clin Neurophysiol, Norwich NR4 7UY, Norfolk, England; [Auer-Grumbach, Michaela] Med Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria	University of Miami; University of Miami; University of London; University College London; University of London; University College London; University of Miami; University of London; University College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Medical University of Vienna	Zuchner, S (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA.; Zuchner, S (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	szuchner@med.miami.edu	Dallman, Julia/I-1414-2019; Horga, Alejandro/AAA-1086-2019; Houlden, Henry J/C-1532-2008; Dallman, Julia/AGG-3507-2022; Pinto, Milena/K-6095-2017; Holton, Janice L/F-6831-2011	Houlden, Henry J/0000-0002-2866-7777; Dallman, Julia/0000-0002-5839-807X; Pinto, Milena/0000-0001-9202-1527; Holton, Janice L/0000-0002-3882-5249; Horga, Alejandro/0000-0002-2120-2213; Hanna, Michael/0000-0003-0825-4075; Markel, Kasey/0000-0002-8285-3888; Reilly, Mary/0000-0003-0686-905X	NIH [R01NS075764, U54NS065712, U54NS092091]; Charcot-Marie-Tooth Association; Austrian Science Fund [FWF P23223-B19, P27634FW]; Muscular Dystrophy Association; Medical Research Council (MRC Centre grant) [G0601943]; National Institutes of Neurological Diseases and Stroke Office of Rare Diseases [U54NS065712]; Department of Health's National Institute for Health Research Biomedical Research Centres; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075764, U54NS065712, U54NS092091] Funding Source: NIH RePORTER; Medical Research Council [G0802760, G1001253, G0601943, MR/J004758/1, G108/638] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; MRC [G0802760, G0601943, MR/J004758/1, G108/638, G1001253] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charcot-Marie-Tooth Association; Austrian Science Fund(Austrian Science Fund (FWF)); Muscular Dystrophy Association(Muscular Dystrophy Association); Medical Research Council (MRC Centre grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Neurological Diseases and Stroke Office of Rare Diseases; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We deeply appreciate the commitment of the families who participated in this study. This work was supported by the NIH (R01NS075764, U54NS065712, and U54NS092091 to S.Z.), the Charcot-Marie-Tooth Association, the Austrian Science Fund (FWF P23223-B19 and P27634FW), and the Muscular Dystrophy Association. We also thank the Inherited Neuropathy Consortium for advice and general support. M.M.R. is grateful to the Medical Research Council (MRC Centre grant G0601943) and the National Institutes of Neurological Diseases and Stroke Office of Rare Diseases (U54NS065712) for their support. Part of this work was undertaken at University College London Hospitals, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Berciano J, 2015, J NEUROL, V262, P1289, DOI 10.1007/s00415-015-7709-4; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; Carter J, 1998, J BIOL CHEM, V273, P5101, DOI 10.1074/jbc.273.9.5101; de Groot NS, 2012, METHODS MOL BIOL, V819, P199, DOI 10.1007/978-1-61779-465-0_14; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Grill MF, 2011, BRIT J CLIN PHARMACO, V72, P381, DOI 10.1111/j.1365-2125.2011.03991.x; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hamby Stephen E., 2011, Human Genomics, V5, P241; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Huang LQ, 2015, ARCH BIOCHEM BIOPHYS, V568, P46, DOI 10.1016/j.abb.2015.01.007; Johnson-Kerner BL, 2015, HUM MOL GENET, V24, P1420, DOI 10.1093/hmg/ddu556; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kokubo Y, 1999, ARCH NEUROL-CHICAGO, V56, P1506, DOI 10.1001/archneur.56.12.1506; Kovach MJ, 2002, AM J MED GENET, V108, P295, DOI 10.1002/ajmg.10223; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Lin H, 2006, ANN NEUROL, V60, P399, DOI 10.1002/ana.20965; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Llorens J, 2013, J INTERN MED, V273, P478, DOI 10.1111/joim.12030; Perez-Olle R, 2005, J NEUROCHEM, V93, P861, DOI 10.1111/j.1471-4159.2005.03095.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Skvortsova V, 2004, EUR J HUM GENET, V12, P241, DOI 10.1038/sj.ejhg.5201144; Steiner I, 2008, J NEUROL, V255, P813, DOI 10.1007/s00415-008-0693-1; Wagner OI, 2003, J NEUROSCI, V23, P9046; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wang LN, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-52; Yum SW, 2009, ANN NEUROL, V66, P759, DOI 10.1002/ana.21728; Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272	43	38	39	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					597	614		10.1016/j.ajhg.2016.02.022	http://dx.doi.org/10.1016/j.ajhg.2016.02.022			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27040688	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000374203800001
J	Shaheen, R; Anazi, S; Ben-Omran, T; Seidahmed, MZ; Caddle, LB; Palmer, K; Ali, R; Alshidi, T; Hagos, S; Goodwin, L; Hashem, M; Wakil, SM; Abouelhoda, M; Colak, D; Murray, SA; Alkuraya, FS				Shaheen, Ranad; Anazi, Shams; Ben-Omran, Tawfeg; Seidahmed, Mohammed Zain; Caddle, L. Brianna; Palmer, Kristina; Ali, Rehab; Alshidi, Tarfa; Hagos, Samya; Goodwin, Leslie; Hashem, Mais; Wakil, Salma M.; Abouelhoda, Mohamed; Colak, Dilek; Murray, Stephen A.; Alkuraya, Fowzan S.			Mutations in SMG9, Encoding an Essential Component of Nonsense-Mediated Decay Machinery, Cause a Multiple Congenital Anomaly Syndrome in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; GENE-EXPRESSION; QUALITY-CONTROL; NMD; COMPLEX; PATHWAY; UPF1; TERMINATION; PHOSPHORYLATION; EMBRYOGENESIS	Nonsense-mediated decay (NMD) is an important process that is best known for degrading transcripts that contain premature stop codons (PTCs) to mitigate their potentially harmful consequences, although its regulatory role encompasses other classes of transcripts as well. Despite the critical role of NMD at the cellular level, our knowledge about the consequences of deficiency of its components at the organismal level is largely limited to model organisms. In this study, we report two consanguineous families in which a similar pattern of congenital anomalies was found to be most likely caused by homozygous loss-of-function mutations in SMG9, encoding an essential component of the SURF complex that generates phospho-UPF1, the single most important step in NMD. By knocking out Smg9 in mice via CRISPR/Cas9, we were able to recapitulate the major features of the SMG9-related multiple congenital anomaly syndrome we observed in humans. Surprisingly, human cells devoid of SMG9 do not appear to have reduction of PTC-containing transcripts but do display global transcriptional dysregulation. We conclude that SMG9 is required for normal human and murine development, most likely through a transcriptional regulatory role, the precise nature of which remains to be determined.	[Shaheen, Ranad; Anazi, Shams; Alshidi, Tarfa; Hagos, Samya; Hashem, Mais; Wakil, Salma M.; Abouelhoda, Mohamed; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Ben-Omran, Tawfeg; Ali, Rehab] Hamad Med Corp, Dept Genet, Doha, Qatar; [Seidahmed, Mohammed Zain] Secur Forces Hosp, Dept Pediat, Riyadh 12625, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Caddle, L. Brianna; Palmer, Kristina; Goodwin, Leslie; Murray, Stephen A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Hamad Medical Corporation; Security Forces Hospital - Saudi Arabia; King Faisal Specialist Hospital & Research Center; Jackson Laboratory; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.; Murray, SA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.; Alkuraya, FS (corresponding author), Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.	steve.murray@jax.org; falkuraya@kfshrc.edu.sa	Majid, Salma/AAT-6166-2020; Majid, Salma/AAT-2616-2020	Majid, Salma/0000-0002-7883-2515; Majid, Salma/0000-0002-1724-5405; SHAHEEN, RANAD/0000-0002-2590-1759; Colak, Dilek/0000-0001-6485-8768	King Abdulaziz City for Science and Technology (KACST) [13-BIO1113-20]; NIH [OD011185]; KACST [11-BIO2072-20]; King Salman Center for Disability Research; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011185] Funding Source: NIH RePORTER	King Abdulaziz City for Science and Technology (KACST); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KACST; King Salman Center for Disability Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families in this study for their enthusiastic participation. We thank the Sequencing Core Facility at the King Faisal Specialist Hospital and Research Center for their technical help. This study was supported by King Abdulaziz City for Science and Technology (KACST) grant 13-BIO1113-20 (F.S.A.), NIH grant OD011185 (S.A.M.), KACST grant 11-BIO2072-20 (D.C.), and the King Salman Center for Disability Research (F.S.A.).	Alkuraya F.S., 2012, CURRENT PROTOCOLS HU; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Avery P, 2011, RNA, V17, P624, DOI 10.1261/rna.2404211; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Fernandez IS, 2011, NUCLEIC ACIDS RES, V39, P347, DOI 10.1093/nar/gkq749; Guimier A, 2015, NAT GENET, V47, P1260, DOI 10.1038/ng.3376; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Metze S, 2013, RNA, V19, P1432, DOI 10.1261/rna.038893.113; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Thoren LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011650; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084321; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209	40	38	43	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					643	652		10.1016/j.ajhg.2016.02.010	http://dx.doi.org/10.1016/j.ajhg.2016.02.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27018474	Green Published, Bronze			2022-12-18	WOS:000374203800004
J	Mejlachowicz, D; Nolent, F; Maluenda, J; Ranjatoelina-Randrianaivo, H; Giuliano, F; Gut, I; Sternberg, D; Laquerriere, A; Melki, J				Mejlachowicz, Dan; Nolent, Flora; Maluenda, Jerome; Ranjatoelina-Randrianaivo, Hanitra; Giuliano, Fabienne; Gut, Ivo; Sternberg, Damien; Laquerriere, Annie; Melki, Judith			Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FETAL PHENOTYPE	Arthrogryposis multiplex congenita (AMC) is characterized by the presence of multiple joint contractures resulting from reduced or absent fetal movement. Here, we report two unrelated families affected by lethal AMC. By genetic mapping and whole-exome sequencing in a multiplex family, a heterozygous truncating MAGEL2 mutation leading to frameshift and a premature stop codon (c.1996delC, p.Gln666Serfs*36) and inherited from the father was identified in the probands. In another family, a distinct heterozygous truncating mutation leading to frameshift (c.2118delT, p.Leu708Trpfs*7) and occurring de novo on the paternal allele of MAGEL2 was identified in the affected individual. In both families, RNA analysis identified the mutated paternal MAGEL2 transcripts only in affected individuals. MAGEL2 is one of the paternally expressed genes within the Prader-Willi syndrome (PWS) locus. PWS is associated with, to varying extents, reduced fetal mobility, severe infantile hypotonia, childhood-onset obesity, hypogonadism, and intellectual disability. MAGEL2 mutations have been recently reported in affected individuals with features resembling PWS and called Schaaf-Yang syndrome. Here, we show that paternal MAGEL2 mutations are also responsible for lethal AMC, recapitulating the clinical spectrum of PWS and suggesting that MAGEL2 is a PWS-determining gene.	[Mejlachowicz, Dan; Nolent, Flora; Maluenda, Jerome; Melki, Judith] INSERM, UMR 1169, F-94276 Le Kremlin Bicetre, France; [Mejlachowicz, Dan; Nolent, Flora; Maluenda, Jerome; Melki, Judith] Univ Paris South, F-94276 Le Kremlin Bicetre, France; [Ranjatoelina-Randrianaivo, Hanitra] South Univ Hosp, Med Genet Unit, F-97448 St Pierre La Reunion, France; [Giuliano, Fabienne] Univ Hosp, Reference Ctr Dev Anomalies & Malformat, F-06000 Nice, France; [Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 080028, Spain; [Sternberg, Damien] Hop Univ Pitie Salpetriere, Serv Biochim Metabol, F-75651 Paris, France; [Sternberg, Damien] Hop Univ Pitie Salpetriere, UMR 1127 7225, F-75651 Paris, France; [Laquerriere, Annie] Univ Rouen, INSERM Team ERI28, Pathol Lab & NeoVasc Reg, Inst Res Innovat Biomed, F-76031 Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Rouen Normandie	Melki, J (corresponding author), INSERM, UMR 1169, F-94276 Le Kremlin Bicetre, France.	judith.melki@inserm.fr	Gut, Ivo/ABF-3188-2020	Gut, Ivo/0000-0001-7219-632X; STERNBERG, Damien/0000-0001-7877-7395; Maluenda, Jerome/0000-0002-6653-1336; Nolent, Flora/0000-0002-3623-690X	French Ministry of Health [AOM10181]; Association Francaise contre les Myopathies (AFM) [DAJ1891]; INSERM; Assistance Publique- Hopitaux de Paris (AP-HP)	French Ministry of Health; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Assistance Publique- Hopitaux de Paris (AP-HP)	This work was supported by grants from the French Ministry of Health (PHRC 2010, AOM10181), the Association Francaise contre les Myopathies (AFM, DAJ1891), and INSERM (to J.M.), and was sponsored by the Assistance Publique- Hopitaux de Paris (AP-HP). The authors would like to thank the Clinical Research Unit of Bicetre Hospital, the Direction of Clinical Research and Development (AP-HP), and the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bigi N, 2008, PRENATAL DIAG, V28, P796, DOI 10.1002/pd.1973; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Buiting K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-40; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Denizot S, 2004, J Perinatol, V24, P733, DOI 10.1038/sj.jp.7211185; FAHY M J, 1990, Genetic Counseling, V1, P3; Fong BF, 2003, ULTRASOUND OBST GYN, V21, P389, DOI 10.1002/uog.90; Guo L, 2012, MOL BIOL REP, V39, P147, DOI 10.1007/s11033-011-0719-0; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; Haugen G, 2009, PRENATAL DIAG, V29, P294, DOI 10.1002/pd.2207; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matarazzo V, 2013, RARE DIS, V1, DOI 10.4161/rdis.27228; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhou J, 2012, AM J HUM GENET, V91, P5, DOI 10.1016/j.ajhg.2012.05.001	20	38	41	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					616	620		10.1016/j.ajhg.2015.08.010	http://dx.doi.org/10.1016/j.ajhg.2015.08.010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26365340	Green Published, Bronze			2022-12-18	WOS:000362617300011
J	Kumar, R; Corbett, MA; van Bon, BWM; Woenig, JA; Weir, L; Douglas, E; Friend, KL; Gardner, A; Shaw, M; Jolly, LA; Tan, C; Hunter, MF; Hackett, A; Field, M; Palmer, EE; Leffler, M; Rogers, C; Boyle, J; Bienek, M; Jensen, C; Van Buggenhout, G; Van Esch, H; Hoffmann, K; Raynaud, M; Zhao, H; Reed, R; Hu, H; Haas, SA; Haan, E; Kalscheuer, VM; Gecz, J				Kumar, Raman; Corbett, Mark A.; van Bon, Bregje W. M.; Woenig, Joshua A.; Weir, Lloyd; Douglas, Evelyn; Friend, Kathryn L.; Gardner, Alison; Shaw, Marie; Jolly, Lachlan A.; Tan, Chuan; Hunter, Matthew F.; Hackett, Anna; Field, Michael; Palmer, Elizabeth E.; Leffler, Melanie; Rogers, Carolyn; Boyle, Jackie; Bienek, Melanie; Jensen, Corinna; Van Buggenhout, Griet; Van Esch, Hilde; Hoffmann, Katrin; Raynaud, Martine; Zhao, Huiying; Reed, Robin; Hu, Hao; Haas, Stefan A.; Haan, Eric; Kalscheuer, Vera M.; Gecz, Jozef			THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; GENETIC LANDSCAPE; NUCLEAR EXPORT; TREX COMPLEX; EXPRESSION; IDENTIFICATION; LOCALIZATION; PREDICTION; PROTEINS; DCPS	Export of mRNA from the cell nucleus to the cytoplasm is essential for protein synthesis, a process vital to all living eukaryotic cells. mRNA export is highly conserved and ubiquitous. Mutations affecting mRNA and mRNA processing or export factors, which cause aberrant retention of mRNAs in the nucleus, are thus emerging as contributors to an important class of human genetic disorders. Here, we report that variants in THOC2, which encodes a subunit of the highly conserved TREX mRNA-export complex, cause syndromic intellectual disability (ID). Affected individuals presented with variable degrees of ID and commonly observed features included speech delay, elevated BMI, short stature, seizure disorders, gait disturbance, and tremors. X chromosome exome sequencing revealed four missense variants in THOC2 in four families, including family MRX12, first ascertained in 1971. We show that two variants lead to decreased stability of THOCZ and its TREX-complex partners in cells derived from the affected individuals. Protein structural modeling showed that the altered amino acids are located in the RNA-binding domains of two complex THOCZ structures, potentially representing two different intermediate RNA-binding states of THOCZ during RNA transport. Our results show that disturbance of the canonical molecular pathway of mRNA export is compatible with life but results in altered neuronal development with other comorbidities.	[Kumar, Raman; Corbett, Mark A.; van Bon, Bregje W. M.; Woenig, Joshua A.; Weir, Lloyd; Gardner, Alison; Shaw, Marie; Jolly, Lachlan A.; Tan, Chuan; Haan, Eric; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5000, Australia; [van Bon, Bregje W. M.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Douglas, Evelyn; Friend, Kathryn L.] SA Pathol, Genet & Mol Pathol, Adelaide, SA 5006, Australia; [Hunter, Matthew F.] Monash Med Ctr, Monash Genet, Clayton, Vic 3168, Australia; [Hunter, Matthew F.] Monash Univ, Dept Paediat, Clayton, Vic 3168, Australia; [Hackett, Anna; Field, Michael; Palmer, Elizabeth E.; Leffler, Melanie; Rogers, Carolyn; Boyle, Jackie] Genet Learning Disabil Serv, Hunter Genet, Waratah, NSW 2298, Australia; [Bienek, Melanie; Jensen, Corinna; Hu, Hao; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Van Buggenhout, Griet; Van Esch, Hilde] Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Hoffmann, Katrin] Martin Luther Univ Halle Wittenberg, Inst Human Genet, D-06112 Halle, Germany; [Raynaud, Martine] Francois Rabelais Univ, INSERM, U930, Imaging & Brain, F-37000 Tours, France; [Raynaud, Martine] Reg Univ, Ctr Hosp, INSERM, U930,Serv Genet, F-37000 Tours, France; [Zhao, Huiying] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Reed, Robin] Harvard Univ, Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Haan, Eric] SA Pathol, South Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Robinson Research Institute; University of Adelaide; Radboud University Nijmegen; SA Pathology; Monash University; Monash University; Max Planck Society; KU Leuven; University Hospital Leuven; Martin Luther University Halle Wittenberg; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); QIMR Berghofer Medical Research Institute; Harvard University; Harvard Medical School; Max Planck Society; SA Pathology; University of Adelaide	Gecz, J (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5000, Australia.	jozef.gecz@adelaide.edu.au	Hunter, Matthew/S-7150-2019; Kumar, Raman/AHE-0538-2022; Gecz, Jozef/X-3469-2019; Palmer, Elizabeth Emma/AAD-6956-2019; Palmer, Emma/AAH-4947-2021; Corbett, Mark/A-8063-2010; van Bon, Bregje/Q-2445-2015; Raynaud, Martine/R-9811-2019; Van+Esch, Hilde/AAU-5688-2020; jolly, lachlan/B-5892-2015	Hunter, Matthew/0000-0002-2475-6545; Kumar, Raman/0000-0001-7976-8386; Gecz, Jozef/0000-0002-7884-6861; Palmer, Elizabeth Emma/0000-0003-1844-215X; Corbett, Mark/0000-0001-9298-3072; van Bon, Bregje/0000-0003-2234-0105; Raynaud, Martine/0000-0002-6888-6480; Hunter, Matthew/0000-0002-7659-1404; Kalscheuer, Vera/0000-0001-6898-3259; jolly, lachlan/0000-0003-4538-2658; Van Esch, Hilde/0000-0002-9604-5726; Haas, Stefan/0000-0003-3418-3688	National Health and Medical Research Council [628952, 1041920]; Channel 7 Children's Research Foundation; European Commission [241995]; MS McLeod Research Fellowship from the Women's and Children's Hospital Foundation; Ter Meulen Fonds stipendium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043375] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); MS McLeod Research Fellowship from the Women's and Children's Hospital Foundation; Ter Meulen Fonds stipendium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Health and Medical Research Council (grants 628952 and 1041920 to J.G.), the Channel 7 Children's Research Foundation (R.K., M.F., and J.G.), the European Commission 7th Framework Programme project Genetic and Epigenetic Networks in Cognitive Dysfunction (grant 241995 to H.H. and V.M.K.), the MS McLeod Research Fellowship from the Women's and Children's Hospital Foundation (to M.A.C.), and the Ter Meulen Fonds stipendium (to B.W.M.v.B). We thank Amanda Springer, Sharon Grosvenor, and Julie Rogerson for their help with the MRX12 family. The authors are also grateful to the families who participated in the study.	Ahmed I, 2015, HUM MOL GENET, V24, P3172, DOI 10.1093/hmg/ddv069; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beaulieu CL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-62; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Di Gregorio E, 2013, J MED GENET, V50, P543, DOI 10.1136/jmedgenet-2013-101542; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gu XX, 1996, J MED GENET, V33, P52, DOI 10.1136/jmg.33.1.52; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Hu H., 2015, MOL PSYCHIAT; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Hurt JA, 2008, DIS MODEL MECH, V1, P103, DOI 10.1242/dmm.000745; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; KERR B, 1992, AM J MED GENET, V43, P392, DOI 10.1002/ajmg.1320430160; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; Lopitz-Otsoa F, 2012, J PROTEOMICS, V75, P2998, DOI 10.1016/j.jprot.2011.12.001; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Ng CKL, 2015, HUM MOL GENET, V24, P3163, DOI 10.1093/hmg/ddv067; Nguyen LS, 2012, MOL PSYCHIATR, V17, P1103, DOI 10.1038/mp.2011.163; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266	44	38	41	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					302	310		10.1016/j.ajhg.2015.05.021	http://dx.doi.org/10.1016/j.ajhg.2015.05.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26166480	Green Published, Bronze			2022-12-18	WOS:000359328800010
J	Lou, HY; Lu, Y; Lu, DS; Fu, RQ; Wang, XJ; Feng, QD; Wu, SJ; Yang, YJ; Li, SL; Kang, LL; Guan, YQ; Hoh, BP; Chung, YJ; Jin, L; Su, B; Xu, SH				Lou, Haiyi; Lu, Yan; Lu, Dongsheng; Fu, Ruiqing; Wang, Xiaoji; Feng, Qidi; Wu, Sijie; Yang, Yajun; Li, Shilin; Kang, Longli; Guan, Yaqun; Hoh, Boon-Peng; Chung, Yeun-Jun; Jin, Li; Su, Bing; Xu, Shuhua			A 3.4-kb Copy-Number Deletion near EPAS1 Is Significantly Enriched in High-Altitude Tibetans but Absent from the Denisovan Sequence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL VARIATION; GENOME SEQUENCE; ADAPTATION; SELECTION; VARIANTS; IDENTIFICATION; MECHANISMS; INFERENCE; SITES; SIZE	Tibetan high-altitude adaptation (HAA) has been studied extensively, and many candidate genes have been reported. Subsequent efforts targeting HAA functional variants, however, have not been that successful (e.g., no functional variant has been suggested for the top candidate HAA gene, EPAS1). With WinXPCNVer, a method developed in this study, we detected in microarray data a Tibetanen-riched deletion (TED) carried by 90% of Tibetans; 50% were homozygous for the deletion, whereas only 3% carried the TED and 0% carried the homozygous deletion in 2,792 worldwide samples (p < 10(-15)). We employed long PCR and Sanger sequencing technologies to determine the exact copy number and breakpoints of the TED in 70 additional Tibetan and 182 diverse samples. The TED had identical boundaries (chr2: 46,694,276-46,697,683; hg19) and was 80 kb downstream of EPAS1. Notably, the TED was in strong linkage disequilibrium (LD; r(2) = 0.8) with EPAS1 variants associated with reduced blood concentrations of hemoglobin. It was also in complete LD with the 5-SNP motif, which was suspected to be introgressed from Denisovans, but the deletion itself was absent from the Denisovan sequence. Correspondingly, we detected that footprints of positive selection for the TED occurred 12,803 (95% confidence interval = 12,075-14,725) years ago. We further whole-genome deep sequenced (>60x) seven Tibetans and verified the TED but failed to identify any other copy-number variations with comparable patterns, giving this TED top priority for further study. We speculate that the specific patterns of the TED resulted from its own functionality in HAA of Tibetans or LD with a functional variant of EPAS1.	[Lou, Haiyi; Lu, Yan; Lu, Dongsheng; Fu, Ruiqing; Wang, Xiaoji; Feng, Qidi; Wu, Sijie; Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Independent Res Grp Populat Genom, Key Lab Computat Biol,Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Wang, Xiaoji; Xu, Shuhua] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Yang, Yajun; Li, Shilin; Jin, Li] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Key Lab Contemporary Anthropol, Minist Educ,Sch Life Sci, Shanghai 200433, Peoples R China; [Kang, Longli] Xizang Univ Nationalities, Sch Med, Xianyang 712082, Shaanxi, Peoples R China; [Guan, Yaqun] Xinjiang Med Univ, Preclin Med Coll, Dept Biochem & Mol Biol, Urumqi 830011, Peoples R China; [Hoh, Boon-Peng] UCSI Univ, Fac Med & Hlth Sci, Kuala Lumpur 56000, Malaysia; [Chung, Yeun-Jun] Catholic Univ Korea, Sch Med, Dept Microbiol, Integrated Res Ctr Genome Polymorphism, Seoul 137701, South Korea; [Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Xu, Shuhua] Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; ShanghaiTech University; Fudan University; Fudan University; Xizang Minzu University; Xinjiang Medical University; UCSI University; Catholic University of Korea; Chinese Academy of Sciences; Kunming Institute of Zoology	Xu, SH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Independent Res Grp Populat Genom, Key Lab Computat Biol,Partner Inst Computat Biol, Shanghai 200031, Peoples R China.	xushua@picb.ac.cn	XU, SHUHUA/D-5345-2009; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Xu, Shuhua/AAH-7620-2020; Hoh, Boon-Peng/H-8682-2016	XU, SHUHUA/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; Xu, Shuhua/0000-0002-1975-1002; Hoh, Boon-Peng/0000-0001-9249-4965	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB13040100]; National Natural Science Foundation of China [91331204, 31171218, 31260263, 31260252]; Science and Technology Commission of Shanghai Municipality [14YE1406800]; National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project	We thank three anonymous reviewers for their helpful comments on the manuscript. We thank Dr. Yundi Chen and his colleagues from Wuxi AppTec for their technical assistances during whole-genome sequencing. These studies were supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS; XDB13040100), by National Natural Science Foundation of China grants (91331204, 31171218, 31260263, and 31260252), and by the Science and Technology Commission of Shanghai Municipality (14YE1406800). S.X. is a Max-Planck Independent Research Group Leader and a member of the CAS Youth Innovation Promotion Association. S.X. also gratefully acknowledges the support of the National Program for Top-Notch Young Innovative Talents of the "Wanren Jihua" Project.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mokhtar SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100371; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Petousi N, 2014, J APPL PHYSIOL, V116, P893, DOI 10.1152/japplphysiol.00535.2013; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Schlattl A, 2011, GENOME RES, V21, P2004, DOI 10.1101/gr.122614.111; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001	51	38	42	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					54	66		10.1016/j.ajhg.2015.05.005	http://dx.doi.org/10.1016/j.ajhg.2015.05.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26073780	Green Published, Bronze			2022-12-18	WOS:000358189500005
J	Saunders, C; Smith, L; Wibrand, F; Ravn, K; Bross, P; Thiffault, I; Christensen, M; Atherton, A; Farrow, E; Miller, N; Kingsmore, SF; Ostergaard, E				Saunders, Carol; Smith, Laurie; Wibrand, Flemming; Ravn, Kirstine; Bross, Peter; Thiffault, Isabelle; Christensen, Mette; Atherton, Andrea; Farrow, Emily; Miller, Neil; Kingsmore, Stephen F.; Ostergaard, Elsebet			CLPB Variants Associated with Autosomal-Recessive Mitochondrial Disorder with Cataract, Neutropenia, Epilepsy, and Methylglutaconic Aciduria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3-METHYLGLUTACONIC ACIDURIA; BARTH-SYNDROME; MEVALONATE METABOLISM; CONGENITAL CATARACT; SHUNT PATHWAY; RAT-LIVER; MUTATION; HOMOLOG; HSP78; PROTEIN	3-methylglutaconic aciduria (3-MGA-uria) is a nonspecific finding associated with mitochondrial dysfunction, including defects of oxidative phosphorylation. 3-MGA-uria is classified into five groups, of which one, type IV, is genetically heterogeneous. Here we report five children with a form of type IV 3-MGA-uria characterized by cataracts, severe psychomotor regression during febrile episodes, epilepsy, neutropenia with frequent infections, and death in early childhood. Four of the individuals were of Greenlandic descent, and one was North American, of Northern European and Asian descent. Through a combination of homozygosity mapping in the Greenlandic individuals and exome sequencing in the North American, we identified biallelic variants in the caseinolytic peptidase B homolog (CLPB). The causative variants included one missense variant, c.803C>T (p.Thr268Met), and two nonsense variants, c.961A>T (p.Lys321*) and c.1249C>T (p.Arg417*). The level of CLPB protein was markedly decreased in fibroblasts and liver of affected individuals. CLPB is proposed to function as a mitochondrial chaperone involved in disaggregation of misfolded proteins, resulting from stress such as heat denaturation.	[Saunders, Carol; Smith, Laurie; Thiffault, Isabelle; Farrow, Emily; Miller, Neil; Kingsmore, Stephen F.] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Saunders, Carol; Kingsmore, Stephen F.] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Smith, Laurie; Atherton, Andrea; Farrow, Emily; Kingsmore, Stephen F.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Wibrand, Flemming; Ravn, Kirstine; Christensen, Mette; Ostergaard, Elsebet] Rigshosp, Dept Clin Genet, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Bross, Peter] Aarhus Univ, Res Unit Mol Med, DK-8200 Aarhus, Denmark; [Bross, Peter] Aarhus Univ Hosp, DK-8200 Aarhus, Denmark	Children's Mercy Hospital; Children's Mercy Hospital; Children's Mercy Hospital; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University	Saunders, C (corresponding author), Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA.	csaunders@cmh.edu; elsebet.ostergaard@dadlnet.dk	Bross, Peter/B-7219-2013	Bross, Peter/0000-0001-9526-8525; Kingsmore, Stephen/0000-0001-7180-2527	Clare Giannini Fund; Danish Council for Independent Research \ Medical Sciences [12-127702]	Clare Giannini Fund; Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	We thank the families for their participation. We thank Dr. Lili Miles for the EM studies. This work was supported by the Clare Giannini Fund and a grant from The Danish Council for Independent Research vertical bar Medical Sciences to E.O. (12-127702).	Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651; Atay Z, 2013, GENE, V515, P197, DOI 10.1016/j.gene.2012.11.044; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bross P, 2012, CURR TOP MED CHEM, V12, P2491; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Christensen JH, 2010, CELL STRESS CHAPERON, V15, P851, DOI 10.1007/s12192-010-0194-x; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Ensenauer R, 2000, J INHERIT METAB DIS, V23, P341, DOI 10.1023/A:1005670911799; Fernandes CG, 2013, MOL GENET METAB, V109, P144, DOI 10.1016/j.ymgme.2013.03.017; Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200; Gunay-Aygun M, 2005, MOL GENET METAB, V84, P1, DOI 10.1016/j.ymgme.2004.12.003; Ijlst L, 2002, AM J HUM GENET, V71, P1463, DOI 10.1086/344712; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; KELLEY RI, 1995, PEDIATR RES, V37, P671, DOI 10.1203/00006450-199505000-00020; Kratochvilova H, 2014, MITOCHONDRION, V15, P1, DOI 10.1016/j.mito.2014.02.010; Lamari F, 2013, J INHERIT METAB DIS, V36, P411, DOI 10.1007/s10545-012-9509-7; Law LK, 2003, J INHERIT METAB DIS, V26, P705, DOI 10.1023/B:BOLI.0000005603.04633.21; Leidhold C, 2006, J STRUCT BIOL, V156, P149, DOI 10.1016/j.jsb.2006.04.007; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; MARINIER E, 1987, J BIOL CHEM, V262, P16936; Mayr J. A., 2014, J INHERIT METAB DIS; Mazurova S, 2013, Prague Med Rep, V114, P139; MOCZKO M, 1995, J MOL BIOL, V254, P538, DOI 10.1006/jmbi.1995.0636; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Pedersen CB, 2010, J INHERIT METAB DIS, V33, P211, DOI 10.1007/s10545-010-9086-6; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Rauthan M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-243; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016; Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schmitt M, 1996, J CELL BIOL, V134, P1375, DOI 10.1083/jcb.134.6.1375; SCHMITT M, 1995, EMBO J, V14, P3434, DOI 10.1002/j.1460-2075.1995.tb07349.x; Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Tort F, 2013, MOL GENET METAB, V110, P73, DOI 10.1016/j.ymgme.2013.04.021; VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157; von Janowsky B, 2006, J MOL BIOL, V357, P793, DOI 10.1016/j.jmb.2006.01.008; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; WEINSTOCK SB, 1984, J BIOL CHEM, V259, P8939; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0; Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6; Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296; Wortmann SB, 2011, CLIN DYSMORPHOL, V20, P168, DOI 10.1097/MCD.0b013e328345bea8; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	47	38	41	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					258	265		10.1016/j.ajhg.2014.12.020	http://dx.doi.org/10.1016/j.ajhg.2014.12.020			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25597511	Green Published, Bronze			2022-12-18	WOS:000349276700007
J	Hause, RJ; Stark, AL; Antao, NN; Gorsic, LK; Chung, SH; Brown, CD; Wong, SS; Gill, DF; Myers, JL; To, LA; White, KP; Dolan, ME; Jones, RB				Hause, Ronald J.; Stark, Amy L.; Antao, Nirav N.; Gorsic, Lidija K.; Chung, Sophie H.; Brown, Christopher D.; Wong, Shan S.; Gill, Daniel F.; Myers, Jamie L.; To, Lida Anita; White, Kevin P.; Dolan, M. Eileen; Jones, Richard Baker			Identification and Validation of Genetic Variants that Influence Transcription Factor and Cell Signaling Protein Levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; RISK; GENERATION; ABUNDANCE; PROLIFERATION; COMPONENTS; DISCOVERY; HAPLOTYPE; COMPLEX	Many genetic variants associated with human disease have been found to be associated with alterations in mRNA expression. Although it is commonly assumed that mRNA expression changes will lead to consequent changes in protein levels, methodological challenges have limited our ability to test the degree to which this assumption holds true. Here, we further developed the micro-western array approach and globally examined relationships between human genetic variation and cellular protein levels. We collected more than 250,000 protein level measurements comprising 441 transcription factor and signaling protein isoforms across 68 Yoruba (YRI) HapMap lymphoblastoid cell lines (LCLs) and identified 12 cis and 160 trans protein level QTLs (pQTLs) at a false discovery rate (FDR) of 20%. Whereas up to two thirds of cis mRNA expression QTLs (eQTLs) were also pQTLs, many pQTLs were not associated with mRNA expression. Notably, we replicated and functionally validated a trans pQTL relationship between the KARS lysyl-tRNA synthetase locus and levels of the DIDO1 protein. This study demonstrates proof of concept in applying an antibody-based microarray approach to iteratively measure the levels of human proteins and relate these levels to human genome variation and other genomic data sets. Our results suggest that protein-based mechanisms might functionally buffer genetic alterations that influence mRNA expression levels and that pQTLs might contribute phenotypic diversity to a human population independently of influences on mRNA expression.	[Hause, Ronald J.; Chung, Sophie H.; Gill, Daniel F.; To, Lida Anita; White, Kevin P.; Dolan, M. Eileen; Jones, Richard Baker] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Hause, Ronald J.; White, Kevin P.; Dolan, M. Eileen; Jones, Richard Baker] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Hause, Ronald J.; Jones, Richard Baker] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Stark, Amy L.; Antao, Nirav N.; Gorsic, Lidija K.; Wong, Shan S.; Myers, Jamie L.; Dolan, M. Eileen] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Brown, Christopher D.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dolan, M. Eileen; Jones, Richard Baker] Univ Chicago, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; University of Chicago; University of Chicago	Dolan, ME (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu; richardbjones@gmail.com		Chung, Sophie/0000-0002-7743-4064; Hause, Ronald/0000-0002-5229-7366; Brown, Christopher/0000-0002-3785-5008	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chen F, 1998, MECH DEVELOP, V77, P49, DOI 10.1016/S0925-4773(98)00126-9; Chen Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE873, DOI 10.1152/ajpendo.00068.2011; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fonslow BR, 2013, NAT METHODS, V10, P54, DOI [10.1038/NMETH.2250, 10.1038/nmeth.2250]; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gamazon ER, 2010, PHARMACOGENET GENOM, V20, P269, DOI 10.1097/FPC.0b013e328337b8d6; Garcia-Domingo D, 1999, P NATL ACAD SCI USA, V96, P7992, DOI 10.1073/pnas.96.14.7992; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Hause RJ, 2011, EXPERT REV PROTEOMIC, V8, P565, DOI [10.1586/EPR.11.49, 10.1586/epr.11.49]; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansson A, 2013, P NATL ACAD SCI USA, V110, P4673, DOI 10.1073/pnas.1217238110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Lourdusamy A, 2012, HUM MOL GENET, V21, P3719, DOI 10.1093/hmg/dds186; Mannsperger HA, 2010, BIOINFORMATICS, V26, P2202, DOI 10.1093/bioinformatics/btq347; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sevecka M, 2006, NAT METHODS, V3, P825, DOI 10.1038/nmeth931; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TARGOFF IN, 1993, J CLIN INVEST, V91, P2556, DOI 10.1172/JCI116493; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	62	38	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					194	208		10.1016/j.ajhg.2014.07.005	http://dx.doi.org/10.1016/j.ajhg.2014.07.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25087611	Green Published, hybrid			2022-12-18	WOS:000340076000006
J	Hoover-Fong, J; Sobreira, N; Jurgens, J; Modaff, P; Blout, C; Moser, A; Kim, OH; Cho, TJ; Cho, SY; Kim, SJ; Jin, DK; Kitoh, H; Park, WY; Ling, H; Hetrick, KN; Doheny, KF; Valle, D; Pauli, RM				Hoover-Fong, Julie; Sobreira, Nara; Jurgens, Julie; Modaff, Peggy; Blout, Carrie; Moser, Ann; Kim, Ok-Hwa; Cho, Tae-Joon; Cho, Sung Yoon; Kim, Sang Jin; Jin, Dong-Kyu; Kitoh, Hiroshi; Park, Woong-Yang; Ling, Hua; Hetrick, Kurt N.; Doheny, Kimberly F.; Valle, David; Pauli, Richard M.			Mutations in PCYT1A, Encoding a Key Regulator of Phosphatidylcholine Metabolism, Cause Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; DNA-SEQUENCING DATA; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CHONDRODYSPLASIA PUNCTATA; MUSCULAR-DYSTROPHY; TARGETED DELETION; DISEASE GENE; TITIN; CTP		[Hoover-Fong, Julie; Blout, Carrie] Johns Hopkins Univ, Sch Med, Greenberg Ctr Skeletal Dysplasias, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Hoover-Fong, Julie; Valle, David] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Sobreira, Nara; Jurgens, Julie; Valle, David] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Jurgens, Julie] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Modaff, Peggy; Pauli, Richard M.] Univ Wisconsin Madison, Dept Pediat, Madison, WI 53705 USA; [Moser, Ann] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD 21205 USA; [Kim, Ok-Hwa] Ajou Univ Hosp, Dept Radiol, Suwon 443721, Kyunggi, South Korea; [Cho, Tae-Joon] Seoul Natl Univ, Childrens Hosp, Div Pediat Orthopaed, Seoul 110744, South Korea; [Cho, Sung Yoon] Hanyang Univ, Coll Med, Guri Hosp, Dept Pediat, Guri 471701, Gyeonggi Do, South Korea; [Kim, Sang Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul 135710, South Korea; [Jin, Dong-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 135710, South Korea; [Kitoh, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul 135710, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Ling, Hua; Hetrick, Kurt N.; Doheny, Kimberly F.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Inherited Dis Res, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; Kennedy Krieger Institute; Ajou University; Ajou University Hospital; Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Nagoya University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Johns Hopkins University	Hoover-Fong, J (corresponding author), Johns Hopkins Univ, Sch Med, Greenberg Ctr Skeletal Dysplasias, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA.	jhoover2@jhmi.edu	KITOH, Hiroshi/I-7256-2014; Kitoh, Hiroshi/AAC-2093-2021	Hoover-Fong, Julie/0000-0002-1242-5626; Park, Woong-Yang/0000-0003-4234-0380; Cho, Tae-Joon/0000-0001-8514-377X; Blout Zawatsky, Carrie/0000-0001-6328-0386	National Human Genome Research Institute [1U54HG006493]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007471] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the families for participating in this project. The Kathryn and Alan Greenberg Center for Skeletal Dysplasias and a grant from the National Human Genome Research Institute (1U54HG006493) provided support for this work. The authors acknowledge intellectual contributions from all members of the Baylor-Hopkins Center for Mendelian Genomics (BHCMG). We also thank Michael Bamshad for making the connection of BHCMG with W.-Y.P. and his colleagues in Korea and Japan, Gerald A. Fishman for providing fundus photographs of subject 3, and Larry Nogee and Dan Raben for helpful discussions regarding phospholipid and surfactant metabolism.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Ehara S, 1997, EUR J PEDIATR, V156, P627, DOI 10.1007/s004310050679; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herman GE, 2002, GENET MED, V4, P434, DOI 10.1097/00125817-200211000-00006; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Isidor B, 2009, AM J MED GENET A, V149A, P788, DOI 10.1002/ajmg.a.32343; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kitoh H, 2011, AM J MED GENET A, V155A, P845, DOI 10.1002/ajmg.a.33898; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopes LR, 2013, J MED GENET, V50, P228, DOI 10.1136/jmedgenet-2012-101270; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Sousa SB, 2008, AM J MED GENET A, V146A, P3186, DOI 10.1002/ajmg.a.32576; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Turell M, 2010, OPHTHALMIC GENET, V31, P12, DOI 10.3109/13816810903397812; Walters BA, 2004, AM J MED GENET A, V129A, P265, DOI 10.1002/ajmg.a.30145; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381	48	38	38	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					105	112		10.1016/j.ajhg.2013.11.018	http://dx.doi.org/10.1016/j.ajhg.2013.11.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387990	Bronze, Green Published			2022-12-18	WOS:000329888400011
J	Soong, BW; Huang, YH; Tsai, PC; Huang, CC; Pan, HC; Lu, YC; Chien, HJ; Liu, TT; Chang, MH; Lin, KP; Tu, PH; Kao, LS; Lee, YC				Soong, Bing-Wen; Huang, Yen-Hua; Tsai, Pei-Chien; Huang, Chien-Chang; Pan, Hung-Chuan; Lu, Yi-Chun; Chien, Hsin-Ju; Liu, Tze-Tze; Chang, Ming-Hong; Lin, Kon-Ping; Tu, Pang-Hsien; Kao, Lung-Sen; Lee, Yi-Chung			Exome Sequencing Identifies GNB4 Mutations as a Cause of Dominant Intermediate Charcot-Marie-Tooth Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GAMMA; EXPRESSION; PROTEINS; SUBUNITS; SUBTYPES; GENE	Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of inherited neuropathies. Mutations in approximately 45 genes have been identified as being associated with CMT. Nevertheless, the genetic etiologies of at least 30% of CMTs have yet to be elucidated. Using a genome-wide linkage study, we previously mapped a dominant intermediate CMT to chromosomal region 3q28-q29. Subsequent exome sequencing of two affected first cousins revealed heterozygous mutation c.158G>A (p.Gly53Asp) in GNB4, encoding guanine-nucleotide-binding protein subunit beta-4 (G beta(4)), to cosegregate with the CMT phenotype in the family. Further analysis of GNB4 in an additional 88 unrelated CMT individuals uncovered another de novo mutation, c.265A>G (p.Lys89Glu), in this gene in one individual. Immunohistochemistry studies revealed that G beta(4) was abundant in the axons and Schwann cells of peripheral nerves and that expression of G beta(4) was significantly reduced in the sural nerve of the two individuals carrying the c.158G>A (p.Gly53Asp) mutation. In vitro studies demonstrated that both the p.Gly53Asp and p.Lys89Glu altered proteins impaired bradykinin-induced G-protein-coupled-receptor (GPCR) signaling, which was facilitated by the wild-type G beta(4). This study identifies GNB4 mutations as a cause of CMT and highlights the importance of G beta(4)-related GPCR signaling in peripheral-nerve function in humans.	[Soong, Bing-Wen; Lu, Yi-Chun; Chien, Hsin-Ju; Lin, Kon-Ping; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei 11217, Taiwan; [Soong, Bing-Wen; Chang, Ming-Hong; Lin, Kon-Ping; Lee, Yi-Chung] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 11221, Taiwan; [Soong, Bing-Wen; Tsai, Pei-Chien; Huang, Chien-Chang; Lin, Kon-Ping; Kao, Lung-Sen; Lee, Yi-Chung] Natl Yang Ming Univ, Brain Res Ctr, Taipei 11221, Taiwan; [Soong, Bing-Wen] Natl Yang Ming Univ, Inst Neurosci, Taipei 11221, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Dept Biochem, Sch Med, Taipei 11221, Taiwan; [Huang, Yen-Hua] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 11221, Taiwan; [Huang, Chien-Chang; Kao, Lung-Sen] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Huang, Chien-Chang; Kao, Lung-Sen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Fac Med, Taipei 11221, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung 40705, Taiwan; [Liu, Tze-Tze; Kao, Lung-Sen] Natl Yang Ming Univ, Genome Res Ctr, Taipei 11221, Taiwan; [Chang, Ming-Hong] Taichung Vet Gen Hosp, Sect Neurol, Taichung 40705, Taiwan; [Tu, Pang-Hsien] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Academia Sinica - Taiwan	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei 11217, Taiwan.	lskao@ym.edu.tw; ycli@vghtpe.gov.tw	Lee, Yi-Chung/H-8813-2019; Lee, Yi-Chung/GZK-7162-2022	Lee, Yi-Chung/0000-0003-0102-164X; Tu, Pang-hsien/0000-0003-2821-7335; Soong, Bing-wen/0000-0002-3502-7153; Tsai, Pei-Chien/0000-0001-7303-0516	National Science Council, Taiwan, ROC [NSC97-2314-B-075-064-MY3, NSC98-2320-B-010-029-MY3, NSC99-2314-B-010-013-MY3, NSC100-2314-B-075-020-MY2]; Taiwan Ministry of Education Aim for the Top University Program [V100-E6-006, V101E7-005, V102E9-006]; Brain Research Center, National Yang-Ming University; High-throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan [NSC100-2319-B-010-001, NSC100-2319-B-010-002]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Education Aim for the Top University Program; Brain Research Center, National Yang-Ming University; High-throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan	The authors thank the individuals who participated in this study, as well as E.M. Ross of the University of Texas for kindly providing a human PLC beta 2 expression clone, pCMV5-PLC beta 2. This work was supported by research grants from the National Science Council, Taiwan, ROC (NSC97-2314-B-075-064-MY3, NSC98-2320-B-010-029-MY3, NSC99-2314-B-010-013-MY3, and NSC100-2314-B-075-020-MY2), the Taiwan Ministry of Education Aim for the Top University Program (V100-E6-006, V101E7-005, and V102E9-006), the Brain Research Center, National Yang-Ming University, and the High-throughput Genome Analysis Core Facility and Bioinformatics Consortium of Taiwan of the National Core Facility Program for Biotechnology, Taiwan (NSC100-2319-B-010-001 and NSC100-2319-B-010-002).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; DAVIS CJF, 1978, J GENET HUM, V26, P311; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lee YC, 2010, NEUROMUSCULAR DISORD, V20, P534, DOI 10.1016/j.nmd.2010.05.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Pen CY, 2008, J NEUROCHEM, V107, P658, DOI 10.1111/j.1471-4159.2008.05637.x; Rosskopf D, 2003, FEBS LETT, V544, P27, DOI 10.1016/S0014-5793(03)00441-1; Ruiz-Velasco V, 2002, PHYSIOL GENOMICS, V8, P41, DOI 10.1152/physiolgenomics.00085.2001; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; SHI GY, 1994, J BIOL CHEM, V269, P23204; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang YC, 2010, J BIOL CHEM, V285, P28275, DOI 10.1074/jbc.M110.141424; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	31	38	41	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					422	430		10.1016/j.ajhg.2013.01.014	http://dx.doi.org/10.1016/j.ajhg.2013.01.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23434117	Green Published, Bronze			2022-12-18	WOS:000316161700016
J	Anastasio, N; Ben-Omran, T; Teebi, A; Ha, KCH; Lalonde, E; Ali, R; Almureikhi, M; Kaloustian, VMD; Liu, JH; Rosenblatt, DS; Majewski, J; Jerome-Majewska, LA				Anastasio, Natascia; Ben-Omran, Tawfeg; Teebi, Ahmad; Ha, Kevin C. H.; Lalonde, Emilie; Ali, Rehab; Almureikhi, Mariam; Kaloustian, Vazken M. Der; Liu, Junhui; Rosenblatt, David S.; Majewski, Jacek; Jerome-Majewska, Loydie A.			Mutations in SCARF2 Are Responsible for Van Den Ende-Gupta Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL CONTRACTURES; CRANIOFACIAL ANOMALIES; CLINICAL DELINEATION; CAUDAL APPENDAGE; ABNORMAL HAIR; BLEPHAROPHIMOSIS; HETEROGENEITY; CAPTURE; GENE	Van Den Ende-Gupta syndrome (VDEGS) is an extremely rare autosomal-recessive disorder characterized by distinctive craniofacial features, which include blepharophimosis, malar and/or maxillary hypoplasia, a narrow and beaked nose, and an everted lower hp Other features are arachnodactyly, camptodactyly, peculiar skeletal abnormalities, and normal development and intelligence. We present molecular data on four VDEGS patients from three consanguineous Qatari families belonging to the same highly inbred Bedouin tribe. The patients were genotyped with SNP microarrays, and a 2 4 Mb homozygous region was found on chromosome 22q11 in an area overlapping the DiGeorge critical region. This region contained 44 genes, including SCARF2, a gene that is expressed during development in a number of mouse tissues relevant to the symptoms described above Sanger sequencing identified a missense change, c 773G>A (p C258Y), in exon 4 in the two closely related patients and a 2 bp deletion in exon 8, c.1328_1329delTG (p.V4431DfsX83), in two unrelated individuals In parallel with the candidate gene approach, complete exome sequencing was used to confirm that SCARF2 was the gene responsible for VDEGS. SCARF2 contains putative epidermal growth factor-like domains in its extracellular domain, along with a number of positively charged residues in its intracellular domain, indicating that it may be involved in intracellular signaling However, the function of SCAM:2 has not been characterized, and this study reports that phenotypic effects can be associated with defects in the scavenger receptor F family of genes	[Anastasio, Natascia; Ha, Kevin C. H.; Lalonde, Emilie; Kaloustian, Vazken M. Der; Liu, Junhui; Rosenblatt, David S.; Majewski, Jacek; Jerome-Majewska, Loydie A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Ben-Omran, Tawfeg; Ali, Rehab; Almureikhi, Mariam] Hamad Med Corp, Sect Clin & Metab Genet, Dept Pediat, Doha, Qatar; [Ben-Omran, Tawfeg; Teebi, Ahmad] Weill Cornell Med Coll, Dept Pediat & Genet Med, New York, NY USA; [Ben-Omran, Tawfeg; Teebi, Ahmad] Weill Cornell Med Coll, Dept Pediat & Genet Med, Doha, Qatar; [Ha, Kevin C. H.; Lalonde, Emilie; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Ha, Kevin C. H.; Lalonde, Emilie; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Kaloustian, Vazken M. Der; Rosenblatt, David S.; Jerome-Majewska, Loydie A.] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; Hamad Medical Corporation; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; McGill University; McGill University	Majewski, J (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.			Ha, Kevin/0000-0001-5746-4365; Lalonde, Emilie/0000-0002-8573-1966; Anastasio, Natascia/0000-0003-0818-0678	Canadian Institutes of Health Research; Canada Research Chair; Fonds de la Recherche en Sante Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec)	The authors would like to gratefully thank all patients and their families for their consent to publish this data. We thank the staff of the Genome Quebec Genotyping and Sequencing platforms, with specific mention of Joana Dias, Francois Bacot, Pierre Lepage, and Alexandre Montpetit for active involvement in the project. We would like to thank Laura Dempsey-Nunez and Margaret Illson for laboratory support and Marc Tischkowitz and Fatma Almesalfri for assistance in acquiring control samples We would also like to thank Dieter Reinhardt for helpful discussion and editing This work was supported by grants from the Canadian Institutes of Health Research to D S.R, L.A.J.-M., and J M and a Canada Research Chair award to J M. L.A J -M. and D.S.R are members of the Research Institute of the McGill University Health Centre, which is supported in part by the Fonds de la Recherche en Sante Quebec.	ALI R, 2010, AM J MED GE IN PRESS; BISTRITZER T, 1993, CLIN GENET, V44, P15; Carr CW, 2007, AM J MED GENET A, V143A, P2706, DOI 10.1002/ajmg.a.32007; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; FROSTER UG, 1993, AM J MED GENET, V47, P717, DOI 10.1002/ajmg.1320470527; Guerra D, 2005, AM J MED GENET A, V136A, P377, DOI 10.1002/ajmg.a.30665; GUPTA A, 1995, J MED GENET, V32, P809, DOI 10.1136/jmg.32.10.809; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Leal GF, 2009, AM J MED GENET A, V149A, P1293, DOI 10.1002/ajmg.a.32871; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Phadke SR, 1998, AM J MED GENET, V77, P16, DOI 10.1002/(SICI)1096-8628(19980428)77:1<16::AID-AJMG4>3.0.CO;2-J; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Schweitzer DN, 2003, AM J MED GENET A, V118A, P267, DOI 10.1002/ajmg.a.10143; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Sukhanov S, 2003, BIOCHEM BIOPH RES CO, V306, P443, DOI 10.1016/S0006-291X(03)00990-2; TEEBI AS, 1989, AM J MED GENET, V33, P58, DOI 10.1002/ajmg.1320330107; VANDENENDE JJ, 1992, AM J MED GENET, V42, P467, DOI 10.1002/ajmg.1320420411; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200	24	38	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					553	559		10.1016/j.ajhg.2010.09.005	http://dx.doi.org/10.1016/j.ajhg.2010.09.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20887961	Bronze, Green Published			2022-12-18	WOS:000283037600012
J	Li, L; Nakaya, N; Chavali, VRM; Ma, ZW; Jiao, XD; Sieving, PA; Riazuddin, S; Tomarev, SI; Ayyagari, R; Riazuddin, SA; Hejtmancik, JF				Li, Lin; Nakaya, Naoki; Chavali, Venkata R. M.; Ma, Zhiwei; Jiao, Xiaodong; Sieving, Paul A.; Riazuddin, Sheikh; Tomarev, Stanislav I.; Ayyagari, Radha; Riazuddin, S. Amer; Hejtmancik, J. Fielding			A Mutation in ZNF513, a Putative Regulator of Photoreceptor Development, Causes Autosomal-Recessive Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACULAR DEGENERATION; MOLECULAR-GENETICS; CRX; ROD; TRANSCRIPTION; PROTEIN; GENES; REGENERATION; DYSTROPHIES; PREVALENCE	Retinitis pigmentosa (RP) is a phenotypically and genetically heterogeneous group of inherited retinal degenerations characterized clinically by night blindness, progressive constriction of the visual fields, and loss of vision, and pathologically by progressive loss of rod and then cone photoreceptors. Autosomal-recessive RP (arRP) in a consanguineous Pakistani family previously linked to chromosome 2p22.3-p24.1 is shown to result from a homozygous missense mutation (c.1015T>C [p.C33912]) in ZNF513, encoding a presumptive transcription factor. znf513 is expressed in the retina, especially in the outer nuclear layer, inner nuclear layer, and photoreceptors. Knockdown of znf513 in zebrafish reduces eye size, retinal thickness, and expression of rod and cone opsins and causes specific loss of photoreceptors. These effects are rescued by coinjection with wild-type (WT) but not p.C339R-znf5/3 mRNA. Both normal and p.C339R mutant ZNF513 proteins expressed in COS-7 cells localize to the nucleus. ChIP analysis shows that only the wild-type but not the mutant ZNF513 binds to the Pax6, Sp4, Arr3, Irbp, and photoreceptor opsin promoters. These results suggest that the ZNF513 p.C339R mutation is responsible for RP in this family and that ZNF513 plays a key role in the regulation of photoreceptor-specific genes in retinal development and photoreceptor maintenance.	[Li, Lin; Ma, Zhiwei; Jiao, Xiaodong; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Nakaya, Naoki; Tomarev, Stanislav I.] NEI, Sect Mol Mech Glaucoma, Lab Mol & Dev Biol, NIH, Bethesda, MD 20892 USA; [Li, Lin] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Chavali, Venkata R. M.; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92037 USA; [Riazuddin, Sheikh; Riazuddin, S. Amer] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Riazuddin, Sheikh] Allama lqbal Med Coll, Lahore 54550, Pakistan; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sun Yat Sen University; University of California System; University of California San Diego; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Johns Hopkins University; Johns Hopkins Medicine	Hejtmancik, JF (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov			National Eye Institute [EY13198]; Foundation Fighting Blindness; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [ZIAEY000311, R01EY013198, ZIAEY000272] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. David Hyde and Dr. James Fadool for the generous gifts of zebrafish cone opsin and 1D1 monoclonal antibodies, respectively. Supported by National Eye Institute Grant EY13198 (R.A.); Foundation Fighting Blindness (R.A.); and Research to Prevent Blindness, Inc. (R.A.).	Ambasudhan R, 2004, GENOMICS, V83, P615, DOI 10.1016/j.ygeno.2003.10.004; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BOUGHMAN JA, 1982, CLIN STRUCTURAL BIOC, P147; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Garelli A, 2006, INVEST OPHTH VIS SCI, V47, P3017, DOI 10.1167/iovs.05-1659; GRONDAHL J, 1987, CLIN GENET, V31, P255; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hims MM, 2003, DEV OPHTHALMOL, V37, P109; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Inglehearn CF, 1998, EYE, V12, P571, DOI 10.1038/eye.1998.147; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; Lerner LE, 2002, J BIOL CHEM, V277, P25877, DOI 10.1074/jbc.M201407200; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morris AC, 2008, DEV NEUROBIOL, V68, P605, DOI 10.1002/dneu.20610; Naz S, 2010, AM J OPHTHALMOL, V149, P861, DOI 10.1016/j.ajo.2009.12.034; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sera T, 2009, ADV DRUG DELIVER REV, V61, P513, DOI 10.1016/j.addr.2009.03.012; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Vasireddy V, 2005, MOL VIS, V11, P665; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wilkinson D. G., 1998, SITU HYBRIDIZATION P	33	38	40	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					400	409		10.1016/j.ajhg.2010.08.003	http://dx.doi.org/10.1016/j.ajhg.2010.08.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20797688	Bronze, Green Published			2022-12-18	WOS:000281923500010
J	Polito, VA; Cosma, MP				Polito, Vinicia Assunta; Cosma, Maria Pia			IDS Crossing of the Blood-Brain Barrier Corrects CNS Defects in MPSII Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENZYME-REPLACEMENT-THERAPY; MULTIPLE SULFATASE DEFICIENCY; MUCOPOLYSACCHARIDOSIS TYPE-II; ADENOASSOCIATED-VIRUS; HUNTER-SYNDROME; GENE-TRANSFER; MOUSE MODEL; VII; MUTATIONS; DELIVERY	Mucopolysaccharidosis type 11 (M I'S I I), or Hunter syndrome, arises from a deficiency in iduronate 2-sulfatase (IDS), and it is characterized by progressive somatic and neurological involvement. The MPSII mouse model reproduces the features of MPSII patients. Systemic administration of the AAV2/5CMV-hIDS vector in MPSII mouse pups results in the full correction of glycosaminoglycan (GAG) accumulation in visceral organs and in the rescue of the defects and GAG accumulation in the central nervous system (CNS). Remarkably, in treated MPSII animals, this CNS correction arises from the crossing of the blood-brain barrier by the IDS enzyme itself, not from the brain transduction. Thus, we show here that early treatment of MPSII mice with one systemic injection of AAV2/5CMV-hIDS results in prolonged and high levels of circulating IDS that can efficiently and simultaneously rescue both visceral and CNS defects for up to 18 months after therapy.	[Polito, Vinicia Assunta; Cosma, Maria Pia] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Polito, Vinicia Assunta; Cosma, Maria Pia] CNR, Inst Genet & Biophys IGB, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Cosma, MP (corresponding author), Telethon Inst Genet & Med TIGEM, Via P Castellino 111, I-80131 Naples, Italy.	cosma@tigem.it	Cosma, Maria Pia/E-8731-2015; Polito, Vinicia Assunta/AAA-5219-2020	Cosma, Maria Pia/0000-0003-4207-5097; Polito, Vinicia Assunta/0000-0002-5698-7778	Telethon Foundation; MPS Society; SEMM (European School of Molecular Medicine)	Telethon Foundation(Fondazione Telethon); MPS Society; SEMM (European School of Molecular Medicine)	The authors thank A. Auricchio, A. Ballabio, N. Brunetti, and M. E. Haskins for critical reading of the manuscript; S. Abbondante for technical suggestions; M. Doria for providing reagents; E. Nusco and R. Salvia for technical support; and AAV vector core for vector preparation. We are grateful for financial Support from the Telethon Foundation and from the MPS Society. We thank SEMM (European School of Molecular Medicine) for support to V.A.P.	Auricchio A, 2002, J CLIN INVEST, V110, P499, DOI 10.1172/JCI200215780; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hildinger M, 2001, J VIROL, V75, P6199, DOI 10.1128/JVI.75.13.6199-6203.2001; HOPWOOD JJ, 1993, HUM MUTAT, V2, P435, DOI 10.1002/humu.1380020603; Matzner U, 2009, MOL THER, V17, P600, DOI 10.1038/mt.2008.305; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Neufeld EF., 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Roces DP, 2004, HUM MOL GENET, V13, P1979, DOI 10.1093/hmg/ddh220; Sferra TJ, 2004, MOL THER, V10, P478, DOI 10.1016/j.ymthe.2004.05.029; Suzuki K, 2007, ACTA NEUROPATHOL, V114, P481, DOI 10.1007/s00401-007-0264-z; Vogler C, 2005, P NATL ACAD SCI USA, V102, P14777, DOI 10.1073/pnas.0506892102	16	38	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					296	301		10.1016/j.ajhg.2009.07.011	http://dx.doi.org/10.1016/j.ajhg.2009.07.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19679226	Green Published, Bronze			2022-12-18	WOS:000269332900019
J	Fernandez, T; Morgan, T; Davis, N; Klin, A; Morris, A; Farhi, A; Lifton, RP; State, MW				Fernandez, Thomas; Morgan, Thomas; Davis, Nicole; Klin, Ami; Morris, Ashley; Farhi, Anita; Lifton, Richard P.; State, Matthew W.			Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome (vol 74, pg 1286, 2004)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction							CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2					Matthew.state@yale.edu	State, Matthew/W-2256-2019; Fernandez, Thomas V/D-4295-2009	Fernandez, Thomas V/0000-0003-0830-022X; State, Matthew/0000-0003-1624-8302				Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; ROOHI J, 2008, J MED GENET IN PRESS; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773	4	38	53	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1385	1385		10.1016/j.ajhg.2008.04.021	http://dx.doi.org/10.1016/j.ajhg.2008.04.021			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18551756	Green Published, Bronze			2022-12-18	WOS:000256647000017
J	Haeuptle, MA; Pujol, FM; Neupert, C; Winchester, B; Kastaniotis, AJ; Aebi, M; Hennet, T				Haeuptle, Micha A.; Pujol, Francois M.; Neupert, Christine; Winchester, Bryan; Kastaniotis, Alexander J.; Aebi, Markus; Hennet, Thierry			Human RFT1 deficiency leads to a disorder of N-linked glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSES CONGENITAL DISORDER; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ALG9 GENE; IN-VIVO; TRANSFERASE; MANNOSYLTRANSFERASE; IDENTIFICATION; MUTATION; PATHWAY	N-linked glycosylation is an essential posttranslational modification of proteins in eukaryotes. The substrate of N-linked glycosylation, dolichol pyrophosphate (DolPP)-GlcNAc(2)Man(9)Glc(3), is assembled through a complex series of ordered reactions requiring the translocation of the intermediate DolPP-GlcNAc(2)Man(5) structure across the endoplasmic-reticulum membrane. A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-G1cNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene. The c.199C -> T mutation introduced the amino acid substitution p.R67C. The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum. Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Delta rft1 yeast cells. The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA. The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes. RFTI deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.	[Haeuptle, Micha A.; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Haeuptle, Micha A.; Hennet, Thierry] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Pujol, Francois M.; Kastaniotis, Alexander J.] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Pujol, Francois M.; Kastaniotis, Alexander J.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Winchester, Bryan] UCL, Inst Child Hlth, Biochem Res Grp, London WC1N 1EH, England; [Neupert, Christine; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hennet, T (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thennet@access.uzh.ch		Kastaniotis, Alexander/0000-0003-3624-9214				Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Aebi M, 1999, Glycoconj J, V16, P669; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; Chantret I, 2003, J BIOL CHEM, V278, P9962, DOI 10.1074/jbc.M211950200; Frank CG, 2004, AM J HUM GENET, V75, P146, DOI 10.1086/422367; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grubenmann CE, 2004, HUM MOL GENET, V13, P535, DOI 10.1093/hmg/ddh050; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Imbach T, 1999, P NATL ACAD SCI USA, V96, P6982, DOI 10.1073/pnas.96.12.6982; Imtiaz F, 2000, J INHERIT METAB DIS, V23, P162, DOI 10.1023/A:1005669900330; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; Korner C, 1999, EMBO J, V18, P6816, DOI 10.1093/emboj/18.23.6816; Kranz C, 2001, J CLIN INVEST, V108, P1613, DOI 10.1172/JCI200113635; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Schenk B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419; Stibler H, 1998, SCAND J CLIN LAB INV, V58, P55, DOI 10.1080/00365519850186832; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	30	38	41	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					600	606		10.1016/j.ajhg.2007.12.021	http://dx.doi.org/10.1016/j.ajhg.2007.12.021			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18313027	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000254067800005
J	Kimmel, G; Jordan, MI; Halperin, E; Shamir, R; Karp, RM				Kimmel, Gad; Jordan, Michael I.; Halperin, Eran; Shamir, Ron; Karp, Richard M.			A Randomization test for controlling population stratification in whole-genome association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; IMPACT; MODEL	Population stratification can be a serious obstacle in the analysis of genomewide association studies. We propose a method for evaluating the significance of association scores in whole-genome cohorts with stratification. Our approach is a randomization test akin to a standard permutation test. It conditions on the genotype matrix and thus takes into account not only the population structure but also the complex linkage disequilibrium structure of the genome. As we show in simulation experiments, our method achieves higher power and significantly better control over false-positive rates than do existing methods. In addition, it can be easily applied to whole-genome association studies.	Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Int Comp Sci Inst, Berkeley, CA 94704 USA; Tel Aviv Univ, Sackler Fac Exact Sci, Sch Comp Sci, IL-69978 Tel Aviv, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tel Aviv University	Kimmel, G (corresponding author), Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA.	kimmel@cs.berkeley.edu	Shamir, Ron/E-6514-2011; Jordan, Michael I/C-5253-2013	Shamir, Ron/0000-0003-1889-9870; Jordan, Michael/0000-0001-8935-817X	NHGRI NIH HHS [R33 HG003070] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HUDSON RR, 1992, GENETICS, V132, P583; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Kalos M. H., 1986, MONTE CARLO METHODS; Kimmel G, 2006, AM J HUM GENET, V79, P481, DOI 10.1086/507317; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li N, 2003, GENETICS, V165, P2213; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; STRANGER BE, 2007, BIOL GEN M COLD SPRI; SUTTER NB, 2007, PLOS GENET, V316, P112; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	24	38	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					895	905		10.1086/521372	http://dx.doi.org/10.1086/521372			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924333	Green Published, Bronze			2022-12-18	WOS:000250480900003
J	Liu, JF; Liu, YJ; Liu, XG; Deng, HW				Liu, Jianfeng; Liu, Yongjun; Liu, Xiaogang; Deng, Hong-Wen			Bayesian mapping of quantitative trait loci for multiple complex traits with the use of variance components	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN MONTE-CARLO; HASTINGS ACCEPTANCE PROBABILITY; LINKAGE ANALYSIS; BONE MASS; GENETIC-MARKERS; VOLUMETRIC DENSITY; PRIOR KNOWLEDGE; OSTEOPOROSIS; INFORMATION; PREDICTION	Complex traits important for humans are often correlated phenotypically and genetically. joint mapping of quantitativetrait loci (QTLs) for multiple correlated traits plays an important role in unraveling the genetic architecture of complex traits. Compared with single-trait analysis, joint mapping addresses more questions and has advantages for power of QTL detection and precision of parameter estimation. Some statistical methods have been developed to map QTLs underlying multiple traits, most of which are based on m aximum-likelihood methods. We develop here a multivariate version of the Bayes methodology for joint mapping of QTLs, using the Markov chain-Monte Carlo (MCMC) algorithm. We adopt a variance-components method to model complex traits in outbred populations (e.g., humans). The method is robust, can deal with an arbitrary number of alleles with arbitrary patterns of gene actions (such as additive and dominant), and allows for multiple phenotype data of various types in the joint analysis (e.g., multiple continuous traits and mixtures of continuous traits and discrete traits). Under a Bayesian framework, parameters-including the number of QTLs-are estimated on the basis of their marginal posterior samples, which are generated through two samplers, the Gibbs sampler and the reversible-jump MCMC. In addition, we calculate the Bayes factor related to each identified QTL, to test coincident linkage versus pleiotropy. The performance of our method is evaluated in simulations with full-sib families. The results show that our proposed Bayesian joint-mapping method performs well for mapping multiple QTLs in situations of either bivariate continuous traits or mixed data types. Compared with the analysis for each trait separately, Bayesian joint mapping improves statistical power, provides stronger evidence of QTL detection, and increases precision in estimation of parameter and QTL position. We also applied the proposed method to a set of real data and detected a coincident linkage responsible for determining bone mineral density and areal bone size of wrist in humans.	Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha 410081, Hunan, Peoples R China; Univ Missouri, Sch Med, Dept Orthoped Surg, Kansas City, MO 64108 USA; Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; Xian Jiaotong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; Xian Jiaotong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Peoples R China	Hunan Normal University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University	Deng, HW (corresponding author), Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, 36 Lushan Rd, Changsha 410081, Hunan, Peoples R China.	dengh@umkc.edu	Liu, Yong/GWQ-6163-2022	Deng, Hong-Wen/0000-0002-0387-8818; Liu, Jian-Feng/0000-0002-5766-7864	NIAMS NIH HHS [K01 AR002170, R01 AR050496, K01 AR 02170] Funding Source: Medline; NIA NIH HHS [R21 AG027110, R01 AG026564, R21 AG 027110] Funding Source: Medline; NIGMS NIH HHS [R01 GM 60402, R01 GM060402] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, K01AR002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Augat P, 1996, J BONE MINER RES, V11, P1356; BULMER MG, 1980, MATH THEORY QUALITAT; Chan JSK, 1997, BIOMETRICS, V53, P86, DOI 10.2307/2533099; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; Deng HW, 2000, J BONE MINER RES, V15, P1243, DOI 10.1359/jbmr.2000.15.7.1243; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; Dunson DB, 2001, AM J EPIDEMIOL, V153, P1222, DOI 10.1093/aje/153.12.1222; Falconer DS, 1996, INTRO QUANTITATIVE G; Garcia-Cortes LA, 2001, GENET SEL EVOL, V33, P3, DOI 10.1051/gse:2001107; Gelman A, 2013, BAYESIAN DATA ANAL; Gilbert H, 2003, GENET SEL EVOL, V35, P281, DOI [10.1051/gse:2003009, 10.1186/1297-9686-35-3-281]; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Henshall JM, 1999, GENETICS, V151, P885; HOESCHELE I, 1993, THEOR APPL GENET, V85, P946, DOI 10.1007/BF00215033; HOESCHELE I, 1993, THEOR APPL GENET, V85, P953, DOI 10.1007/BF00215034; Huang JA, 2003, AM J HUM GENET, V72, P949, DOI 10.1086/374568; Jannink JL, 2004, GENETICS, V166, P641, DOI 10.1534/genetics.166.1.641; JIANG CJ, 1995, GENETICS, V140, P1111; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knott SA, 2000, GENETICS, V156, P899; Lange C, 2001, GENETICS, V159, P1325; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Lund MS, 2003, GENETICS, V163, P405; Mangin B, 1998, BIOMETRICS, V54, P88, DOI 10.2307/2533998; Mao Y, 2005, HEREDITY, V94, P305, DOI 10.1038/sj.hdy.6800564; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Meuwissen THE, 2004, GENET SEL EVOL, V36, P261, DOI 10.1051/gse:2004001; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Meuwissen THE, 2002, GENETICS, V161, P373; Neath A.A., 2006, J DATA SCI, V4, P131, DOI [10.6339/JDS.2006.04(2).266, DOI 10.6339/JDS.2006.04(2).266]; Raftery A. E., 1992, BAYESIAN STAT; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Satagopan JM, 1996, GENETICS, V144, P805; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; Sillanpaa MJ, 1999, GENETICS, V151, P1605; Sillanpaa MJ, 2004, GENETICS, V167, P1037, DOI 10.1534/genetics.103.025320; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Uimari P, 1996, GENETICS, V143, P1831; Uimari P, 1997, GENETICS, V146, P735; Varona L, 2004, GENETICS, V166, P1025, DOI 10.1534/genetics.166.2.1025; von Rohr P, 2002, GENET SEL EVOL, V34, P1, DOI [10.1051/gse:2001001, 10.1186/1297-9686-34-1-1]; Wang H, 2005, GENETICS, V170, P465, DOI 10.1534/genetics.104.039354; Wang T, 1998, GENETICS, V148, P507; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Williamson G., 1999, NUTR FOOD SCI, V1, P6; Xu CW, 2005, GENETICS, V169, P1045, DOI 10.1534/genetics.103.019406; Xu SZ, 1998, GENET RES, V71, P73, DOI 10.1017/S0016672398003115; Xu SZ, 2003, GENETICS, V163, P789; Yi NJ, 2000, GENETICS, V155, P1391; Yi NJ, 2004, GENETICS, V167, P967, DOI 10.1534/genetics.104.026286; Yi NJ, 2004, BEHAV GENET, V34, P3, DOI 10.1023/B:BEGE.0000009473.43185.43; Yi NJ, 2003, GENETICS, V165, P867; Yi NJ, 2003, GENETICS, V164, P1129; Yi NJ, 2001, GENETICS, V157, P1759; Yi NJ, 2000, GENETICS, V156, P411; [No title captured]	65	38	40	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					304	320		10.1086/519495	http://dx.doi.org/10.1086/519495			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668380	Green Published, Bronze			2022-12-18	WOS:000248540400010
J	Shi, M; Umbach, DM; Weinberg, CR				Shi, Min; Umbach, David M.; Weinberg, Clarice R.			Identification of risk-related haplotypes with the use of multiple SNPs from nuclear families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; TRANSMISSION TEST; TESTS; GENOTYPE; POLYMORPHISMS; TRAITS; FETAL	Family-based association studies offer robustness to population stratification and can provide insight into maternally mediated and parent-of-origin effects. Usually, such studies investigate multiple markers covering a gene or chromosomal region of interest. We propose a simple and general method to test the association of a disease trait with multiple, possibly linked SNP markers and, subsequently, to nominate a set of "risk-haplotype-tagging alleles." Our test, the max_Z(2) test, uses only the genotypes of affected individuals and their parents without requiring the user to either know or assign haplotypes and their phases. It also accommodates sporadically missing SNP data. In the spirit of the pedigree disequilibrium test, our procedure requires only a vector of differences with expected value 0 under the null hypothesis. To enhance power against a range of alternatives when genotype data are complete, we also consider a method for combining multiple tests; here, we combine max_ Z(2) and Hotelling's T-2. To facilitate discovery of risk-related haplotypes, we develop a simple procedure for nominating risk-haplotype-tagging alleles. Our procedures can also be used to study maternally mediated genetic effects and to explore imprinting. We compare the statistical power of several competing testing procedures through simulation studies of case-parents triads, whose diplotypes are simulated on the basis of draws from the HapMap-based known haplotypes of four genes. In our simulations, the max_ Z(2) test and the max_TDT (transmission/ disequilibrium test) proposed by McIntyre et al. perform almost identically, but max_ Z2, unlike max_ TDT, extends directly to the investigation of maternal effects. As an illustration, we reanalyze data from a previously reported orofacial cleft study, to now investigate both fetal and maternal effects of the IRF6 gene.	Natl Inst Environm Hlth Sci, Biostat Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weinberg, CR (corresponding author), Natl Inst Environm Hlth Sci, Biostat Branch, NIH, Dept Hlth & Human Serv, Mail Drop A3-03 101-A315, Res Triangle Pk, NC 27709 USA.	weinber2@niehs.nih.gov	Shi, Min/GXM-3977-2022	Weinberg, Clarice/0000-0002-7713-8556	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES040007, Z01ES040007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen AS, 2007, GENET EPIDEMIOL, V31, P211, DOI 10.1002/gepi.20203; Becker T, 2004, AM J HUM GENET, V75, P561, DOI 10.1086/424390; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chung RH, 2006, HUM HERED, V61, P189, DOI 10.1159/000094774; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Fan RZ, 2005, ANN HUM GENET, V69, P187, DOI 10.1046/j.1529-8817.2004.00151.x; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Hadi AS, 1998, AM STAT, V52, P15, DOI 10.2307/2685559; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lee WC, 2003, AM J EPIDEMIOL, V158, P1036, DOI 10.1093/aje/kwg268; Lee WC, 2003, AM J EPIDEMIOL, V158, P1023, DOI 10.1093/aje/kwg266; Lee WC, 2002, EPIDEMIOLOGY, V13, P545, DOI 10.1097/00001648-200209000-00010; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Mitchell LE, 1997, AM J HUM GENET, V60, P1006; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Weinberg C, 2003, AM J EPIDEMIOL, V158, P1033, DOI 10.1093/aje/kwg267; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	29	38	38	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					53	66		10.1086/518670	http://dx.doi.org/10.1086/518670			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564963	Bronze, Green Published			2022-12-18	WOS:000247039700005
J	Kimmel, G; Shamir, R				Kimmel, Gad; Shamir, Ron			A fast method for computing high-significance disease association in large population-based studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAG SNP SELECTION; LINKAGE DISEQUILIBRIUM; GENOTYPE DATA; LARGE-SCALE; GENETIC ASSOCIATIONS; WHOLE-GENOME; INFERENCE; HAPLOTYPES; RESOLUTION; TRAITS	Because of rapid progress in genotyping techniques, many large-scale, genomewide disease-association studies are now under way. Typically, the disorders examined are multifactorial, and, therefore, researchers seeking association must consider interactions among loci and between loci and other factors. One of the challenges of large disease-association studies is obtaining accurate estimates of the significance of discovered associations. The linkage disequilibrium between SNPs makes the tests highly dependent, and dependency worsens when interactions are tested. The standard way of assigning significance ( P value) is by a permutation test. Unfortunately, in large studies, it is prohibitively slow to compute low P values by this method. We present here a faster algorithm for accurately calculating low P values in case-control association studies. Unlike with several previous methods, we do not assume a specific distribution of the traits, given the genotypes. Our method is based on importance sampling and on accounting for the decay in linkage disequilibrium along the chromosome. The algorithm is dramatically faster than the standard permutation test. On data sets mimicking medium-to-large association studies, it speeds up computation by a factor of 5,000 - 100,000, sometimes reducing running times from years to minutes. Thus, our method significantly increases the problem-size range for which accurate, meaningful association results are attainable.	Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Kimmel, G (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	kgad@post.tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870				ARNOLD SF, 1990, MATH STAT, P487; BALDING DJ, 2001, HDB STAT GENETICS PO; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Couzin J, 2005, SCIENCE, V309, P81, DOI 10.1126/science.309.5731.81; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gilks W. R., 1994, MARKOV CHAIN MONTE C; Halperin E, 2005, BIOINFORMATICS, V21, pI195, DOI 10.1093/bioinformatics/bti1021; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Kalos M. H., 1986, MONTE CARLO METHODS; Kimmel G, 2005, J COMPUT BIOL, V12, P1243, DOI 10.1089/cmb.2005.12.1243; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kimmel G, 2004, P 8 ANN INT C RES CO, P2, DOI [10.1145/974614.974616, DOI 10.1145/974614.974616]; Li N, 2003, GENETICS, V165, P2213; Lin DY, 2006, AM J HUM GENET, V78, P505, DOI 10.1086/500812; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; OLSON JM, 1994, AM J HUM GENET, V55, P574; Pritchard JK, 2000, GENETICS, V155, P945; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shi MM, 2001, CLIN CHEM, V47, P164; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404	38	38	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					481	492		10.1086/507317	http://dx.doi.org/10.1086/507317			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909386	Green Published, Bronze			2022-12-18	WOS:000239830700010
J	Ekelund, E; Saaf, A; Tengvall-Linder, M; Melen, E; Link, J; Barker, J; Reynolds, NJ; Meggitt, SJ; Kere, J; Wahlgren, CF; Pershagen, G; Wickman, M; Nordenskjold, M; Kockum, I; Bradley, M				Ekelund, E.; Saaf, A.; Tengvall-Linder, M.; Melen, E.; Link, J.; Barker, J.; Reynolds, N. J.; Meggitt, S. J.; Kere, J.; Wahlgren, C. -F.; Pershagen, G.; Wickman, M.; Nordenskjold, M.; Kockum, I.; Bradley, M.			Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; HAPLOTYPES; PROGRAM	In a systematic analysis of global gene-expression patterns, we found that SOCS3 messenger RNA was significantly more highly expressed in skin from patients with atopic dermatitis than in skin from healthy controls, and immunohistochemical analysis confirmed a similar elevation of SOCS3 protein. Furthermore, we found a genetic association between atopic dermatitis and a haplotype in the SOCS3 gene in two independent groups of patients (P < .02 and P < .03). These results strongly suggest that SOCS3, located in a chromosomal region previously linked to the disease (17q25), is a susceptibility gene for atopic dermatitis.	Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; Karolinska Inst, Dermatol Unit, Stockholm, Sweden; Karolinska Inst, Dept Med, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Stockholm, Sweden; Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; Karolinska Inst, Dept Biosci, Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; Stockholm Cty Council, Dept Occupat & Environm Hlth, Stockholm, Sweden; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Univ London Kings Coll, St Johns Inst Dermatol, London WC2R 2LS, England; Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm County Council; Stanford University; University of London; King's College London; Newcastle University - UK; Newcastle University - UK	Bradley, M (corresponding author), Karolinska Univ Hosp, Dept Mol Med & Surg, CMM 02, SE-17176 Stockholm, Sweden.	maria.bradley@cmm.ki.se	Link, Jenny/J-1629-2012; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Kockum, Ingrid/O-8781-2018	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Kockum, Ingrid/0000-0002-0867-4726; Barker, Jonathan/0000-0002-9030-183X; Bradley, Maria/0000-0001-7192-5041; Link, Jenny/0000-0002-6134-9404; Reynolds, Nick/0000-0002-6484-825X; Pershagen, Goran/0000-0002-9701-1130; Nordenskjold, Magnus/0000-0002-4974-425X				Bohme M, 2002, ACTA DERM-VENEREOL, V82, P98, DOI 10.1080/00015550252948112; Bradley M, 2000, ACTA DERM-VENEREOL, V80, P106; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Ehlting C, 2005, BIOCHEM J, V387, P737, DOI 10.1042/BJ20041101; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Haagerup A, 2004, ACTA DERM-VENEREOL, V84, P346, DOI 10.1080/00015550410034426; HANIFIN JM, 1992, DERMATOLOGY; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leung DYM, 1998, MOL GENET METAB, V63, P157, DOI 10.1006/mgme.1998.2682; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Melen E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023135; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veal CD, 2005, J INVEST DERMATOL, V125, P399, DOI 10.1111/j.0022-202X.2005.23828.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	22	38	40	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1060	1065		10.1086/504272	http://dx.doi.org/10.1086/504272			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685656	Bronze, Green Published			2022-12-18	WOS:000237553800015
J	Li, YH; Rowland, C; Schrodi, S; Laird, W; Tacey, K; Ross, D; Leong, D; Catanese, J; Sninsky, J; Grupe, A				Li, Yonghong; Rowland, Charles; Schrodi, Steven; Laird, Walter; Tacey, Kristina; Ross, David; Leong, Diane; Catanese, Joseph; Sninsky, John; Grupe, Andrew			A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ONSET; GENE; AGE		Celera Diagnost, Alameda, CA 94502 USA		Li, YH (corresponding author), Celera Diagnost, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	yonghong.li@celeradiagnostics.com	Sander-Effron, Samuel/AAX-2231-2020; Schrodi, Steven J./O-4288-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022	Schrodi, Steven J./0000-0003-2304-8528; Li, Yonghong/0000-0001-7326-0717				Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383	9	38	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1090	1092		10.1086/504725	http://dx.doi.org/10.1086/504725			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685663	Green Published, Bronze			2022-12-18	WOS:000237553800022
J	Chen, ZH; Zheng, G; Ghosh, K; Li, ZH				Chen, ZH; Zheng, G; Ghosh, K; Li, ZH			Linkage disequilibrium mapping of quantitative-trait loci by selective genotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION; PAIRS	The principles of linkage disequilibrium mapping of dichotomous diseases can be well applied to the mapping of quantitative-trait loci through the method of selective genotyping. In 1999, M. Slatkin considered a truncation selection (TS) approach. We propose in this report an extended TS approach and an extreme-rank-selection (ERS) approach. The properties of these selection approaches are studied analytically. By using a simulation study, we demonstrate that both the extended TS approach and the ERS approach provide remarkable improvements over Slatkin's original TS approach.	Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117543, Singapore; NHLBI, Div Epidemiol & Clin Applicat, Off Biostat Res, Bethesda, MD 20892 USA; George Washington Univ, Dept Stat, Washington, DC USA; NCI, Biostat Branch, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv,NIH, Washington, DC USA	National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, ZH (corresponding author), Natl Univ Singapore, Dept Stat & Appl Probabil, 3 Sci Dr 2, Singapore 117543, Singapore.	stachenz@nus.edu.sg		Chen, Zehua/0000-0003-2127-7829	NATIONAL EYE INSTITUTE [R01EY014478] Funding Source: NIH RePORTER; NEI NIH HHS [EY014478, R01 EY014478] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; LANDER ES, 1989, GENETICS, V121, P185; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Slatkin M, 1999, AM J HUM GENET, V64, P1765, DOI 10.1086/302413; Szatkiewicz JP, 2004, AM J HUM GENET, V75, P906, DOI 10.1086/425523; Thompson EA, 1997, AM J HUM GENET, V60, P197; Xiong MM, 2002, HUM HERED, V53, P158, DOI 10.1159/000064978; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405	13	38	40	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					661	669		10.1086/491658	http://dx.doi.org/10.1086/491658			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175512	Bronze, Green Published			2022-12-18	WOS:000232106900014
J	Weller, S; Cajigas, I; Morrell, J; Obie, C; Steel, G; Gould, SJ; Valle, D				Weller, S; Cajigas, I; Morrell, J; Obie, C; Steel, G; Gould, SJ; Valle, D			Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION GROUP; ZELLWEGER-SYNDROME; TARGETING SIGNALS; CYCLING RECEPTOR; MOLECULAR-BASIS; PROTEIN IMPORT; PTS1 RECEPTOR; COMMON-CAUSE; AAA-ATPASE; IDENTIFICATION	Matsumoto and colleagues recently identified PEX26 as the gene responsible for complementation group 8 of the peroxisome biogenesis disorders and showed that it encodes an integral peroxisomal membrane protein with a single C-terminal transmembrane domain and a cytosolic N-terminus that interacts with the PEX1/PEX6 heterodimer through direct binding to the latter. They proposed that PEX26 functions as the peroxisomal docking factor for the PEX1/PEX6 heterodimer. Here, we identify new PEX26 disease alleles, localize the PEX6-binding domain to the N-terminal half of the protein (aa 29-174), and show that, at the cellular level, PEX26 deficiency impairs peroxisomal import of both PTS1- and PTS2-targeted matrix proteins. Also, we find that PEX26 undergoes alternative splicing to produce several splice forms-including one, PEX26-Delta ex5, that maintains frame and encodes an isoform lacking the transmembrane domain of full-length PEX26 (PEX26-FL). Despite its cytosolic location, PEX26-Delta ex5 rescues peroxisome biogenesis in PEX26-deficient cells as efficiently as does PEX26-FL. To test our observation that a peroxisomal location is not required for PEX26 function, we made a chimeric protein (PEX26-Mito) with PEX26 as its N-terminus and the targeting segment of a mitochondrial outer membrane protein (OMP25) at its C-terminus. We found PEX26-Mito localized to the mitochondria and directed all detectable PEX6 and a fraction of PEX1 to this extraperoxisomal location; yet PEX26-Mito retains the full ability to rescue peroxisome biogenesis in PEX26-deficient cells. On the basis of these observations, we suggest that a peroxisomal localization of PEX26 and PEX6 is not required for their function and that the interaction of PEX6 with PEX1 is dynamic. This model predicts that, once activated in an extraperoxisomal location, PEX1 moves to the peroxisome and completes the function of the PEX1/6 heterodimer.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Summer Internship Program, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 519 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	dvalle@jhmi.edu	Grønborg, Sabine/AAA-4565-2020	Gronborg, Sabine/0000-0002-2113-9023				BELL GI, 1986, NUCLEIC ACIDS RES, V14, P5561; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRODY LC, 1992, J BIOL CHEM, V267, P3302; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chang CC, 1999, J CELL SCI, V112, P1579; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Faber KN, 1998, METH MOL B, V103, P121; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Geisbrecht BV, 1998, P NATL ACAD SCI USA, V95, P8630, DOI 10.1073/pnas.95.15.8630; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gould SJ., 2001, METABOLIC MOL BASES, P3181; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Hahn SH, 1999, J PEDIATR-US, V135, P250, DOI 10.1016/S0022-3476(99)70030-2; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; Jones JM, 2001, J CELL BIOL, V153, P1141, DOI 10.1083/jcb.153.6.1141; Kiel JAKW, 1999, YEAST, V15, P1059, DOI 10.1002/(SICI)1097-0061(199908)15:11<1059::AID-YEA434>3.0.CO;2-I; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; Liu YF, 1999, AM J HUM GENET, V65, P621, DOI 10.1086/302534; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Matsumoto N, 2003, AM J HUM GENET, V73, P233, DOI 10.1086/377004; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Shimozawa N, 2004, HUM MUTAT, V23, P552, DOI 10.1002/humu.20032; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; Steinberg S, 2004, MOL GENET METAB, V83, P252, DOI 10.1016/j.ymgme.2004.08.008; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wanders RJA, 2004, AM J MED GENET A, V126A, P355, DOI 10.1002/ajmg.a.20661; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	59	38	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					987	1007		10.1086/430637	http://dx.doi.org/10.1086/430637			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15858711	Green Published, Bronze			2022-12-18	WOS:000229047900006
J	Edamura, KN; Leonard, MR; Pearson, CE				Edamura, KN; Leonard, MR; Pearson, CE			Role of replication and CpG methylation in fragile X syndrome CGG deletions in primate cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEATS; FULL MUTATION; DELAYED REPLICATION; TRIPLET REPEATS; TRANSGENIC MICE; FETAL TISSUES; FMR1 MUTATION; IN-VIVO; DNA; EXPANSION	Instability of the fragile X CGG repeat involves both maternally derived expansions and deletions in the gametes of full-mutation males. It has also been suggested that the absence of aberrant CpG methylation may enhance repeat deletions through an unknown process. The effect of CGG tract length, DNA replication direction, location of replication initiation, and CpG methylation upon CGG stability were investigated using an SV40 primate replication system. Replication-dependant deletions with 53 CGG repeats were observed when replication was initiated proximal to the repeat, with CGG as the lagging-strand template. When we initiated replication further from the repeat, while maintaining CGG as the lagging-strand template or using CCG as the lagging-strand template, significant instability was not observed. CpG methylation of the unstable template stabilized the repeat, decreasing both the frequency and the magnitude of deletion events. Furthermore, CpG methylation slowed the efficiency of replication for all templates. Interestingly, replication forks displayed no evidence of a block at the CGG repeat tract, regardless of replication direction or CpG methylation status. Templates with 20 CGG repeats were stable under all circumstances. These results reveal that CGG deletions occur during replication and are sensitive to replication-fork dynamics, tract length, and CpG methylation.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Program Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave,Elm Wing 11-135, Toronto, ON M5G 1X8, Canada.	cepearson@genet.sickkids.on.ca		Pearson, Christopher/0000-0001-9545-4205				Astolfi P, 2003, GENE, V317, P117, DOI 10.1016/S0378-1119(03)00659-0; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOWELL RT, 1982, HUM GENET, V62, P282, DOI 10.1007/BF00333538; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; Krasilnikova Maria M., 2004, V277, P19; Lavedan C, 1998, GENOMICS, V50, P229, DOI 10.1006/geno.1998.5299; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; MARTORELL L, 1995, J MED GENET, V32, P593, DOI 10.1136/jmg.32.8.593; MATSUO K, 1994, NUCLEIC ACIDS RES, V22, P5354, DOI 10.1093/nar/22.24.5354; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; Nichol K, 2002, GENOME RES, V12, P1246, DOI 10.1101/gr.74502; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Pearson CE, 1998, BIOCHEMISTRY-US, V37, P2701, DOI 10.1021/bi972546c; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; Peier AM, 2002, GENOMICS, V80, P423, DOI 10.1006/geno.2002.6849; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Reyniers E, 1999, AM J MED GENET, V84, P245, DOI 10.1002/(SICI)1096-8628(19990528)84:3<245::AID-AJMG16>3.0.CO;2-U; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; Rife M, 2004, MOL HUM REPROD, V10, P773, DOI 10.1093/molehr/gah102; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sasaki T, 1999, MOL CELL BIOL, V19, P547; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Sutton KA, 2000, REV REPROD, V5, P93, DOI 10.1530/revreprod/5.2.93; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Tassone F, 1999, AM J MED GENET, V84, P240, DOI 10.1002/(SICI)1096-8628(19990528)84:3<240::AID-AJMG15>3.3.CO;2-2; Taylor AK, 1999, AM J MED GENET, V84, P233, DOI 10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14>3.0.CO;2-6; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wohrle D, 1998, J MED GENET, V35, P103, DOI 10.1136/jmg.35.2.103; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147	41	38	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					302	311		10.1086/427928	http://dx.doi.org/10.1086/427928			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15625623	Green Published, Bronze			2022-12-18	WOS:000226215100015
J	Shete, S; Zhou, XJ; Amos, CI				Shete, S; Zhou, XJ; Amos, CI			Genomic imprinting and linkage test for quantitative-trait loci in extended pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE	Genomic imprinting is a mechanism in which only one of the two copies of a gene is expressed. Some genes that affect development and behavior in mammals are known to be imprinted. Deregulation of imprinted genes has been found in a number of human diseases. Incorporating imprinting information into linkage analysis results in a more powerful test for linkage. Here, we propose an efficient method to test for linkage and imprinting of quantitative traits in extended pedigrees. We compared the results obtained by using the extended-pedigree-analysis approach proposed in this study with other existing approaches. We found that the proposed method is more powerful and uses extended-pedigree information most efficiently.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Box 189,1515 Holcombe Blvd, Houston, TX 77030 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002275, HG 02275] Funding Source: Medline; NIEHS NIH HHS [ES 09912, R01 ES009912] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 1997, GENETICS ANAL QUANTI; Etzel CJ, 2003, HUM HERED, V55, P108, DOI 10.1159/000072315; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; SHETE S, IN PRESS BEHAV GENET; Sobel E, 1996, AM J HUM GENET, V58, P1323; SORANT AJM, 1994, SUBROUTINE PACKAGE F; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Walter J, 2003, SEMIN CELL DEV BIOL, V14, P101, DOI 10.1016/S1084-9521(02)00142-8; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S	19	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					933	938		10.1086/378592	http://dx.doi.org/10.1086/378592			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	13680523	Green Published, Bronze			2022-12-18	WOS:000185676100018
J	Tabiner, M; Youings, S; Dennis, N; Baldwin, D; Buis, C; Mayers, A; Jacobs, PA; Crolla, JA				Tabiner, M; Youings, S; Dennis, N; Baldwin, D; Buis, C; Mayers, A; Jacobs, PA; Crolla, JA			Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Investigation of the co-occurrence of panic and phobic disorders with joint laxity led to the identification of various forms of interstitial duplications involving human chromosome 15q24-q26 (named "DUP25") in a Spanish population. DUP25 was observed in 68 of 70 (97%) patients assigned the diagnosis panic disorder/agoraphobia. DUP25 was also found in 14 of 189 (7%) control individuals. In the present study, we replicated the experimental conditions described by Gratacos and colleagues in which fluorescence in situ hybridization was used to examine metaphase chromosomes of patients with panic disorder/social phobia and of control individuals from a southern region of the United Kingdom, the primary aim being to determine the prevalence of this chromosomal rearrangement in a geographically and ethnically distinct population. DUP25 was not observed in any of our 16 patients or 40 control samples or in three previously reported DUP25-positive control (Centre d'Etude du Polymorphisme Humain) cell lines, indicating a highly significant difference in the frequency of DUP25 between the study by Gratacos and colleagues and the present investigation.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Royal S Hants Hosp, Univ Dept Psychiat, Southampton SO9 4PE, Hants, England	Salisbury District Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital	Crolla, JA (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.			Baldwin, David/0000-0003-3343-0907; Mayers, Andrew/0000-0003-2298-498X				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BEIGHTON P, 1983, ASSESSMENT HYPERMOBI, P9; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; Crolla JA, 1997, J MED GENET, V34, P207, DOI 10.1136/jmg.34.3.207; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi	8	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					535	538		10.1086/367777	http://dx.doi.org/10.1086/367777			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12548501	Bronze, Green Published			2022-12-18	WOS:000181152600003
J	Nebel, A; Landau-Tasseron, E; Filon, D; Oppenheim, A; Faerman, M				Nebel, A; Landau-Tasseron, E; Filon, D; Oppenheim, A; Faerman, M			Genetic evidence for the expansion of Arabian tribes into the Southern Levant and North Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							JEWS		Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Lab Biol Anthropol & Ancient DNA, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel; Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Asian & African Studies, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Faerman, M (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Lab Biol Anthropol & Ancient DNA, IL-91120 Jerusalem, Israel.		Nebel, Almut/E-4196-2010					Abun-Nasr J.M, 1987, HIST MAGHRIB ISLAMIC; BEESTON AFL, 1995, ENCY ISLAM, V8, P663; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; CASKEL W, 1966, GAMHARAT AN NASAB, V1; Dussaud Rene, 1955, PENETRATION ARABES S; Ephal Israel, 1984, ANCIENT ARABS; Fagnan E, 1898, IBN ATHIR; Goldziher Ignaz, 1967, MUSLIM STUDIES, VI; GROHMANN A, 1960, ENCY ISLAM, V1, P524; IBNKHALLIKAN, 1972, WAFAYAT AL AYAN, V7; LEWICKI T, 1986, ENCY ISLAM, V5, P652; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Peters F. E., 1999, FDN CLASSICAL ISLAMI, V3; RENTZ G, 1960, ENCY ISLAM, V1, P533; RICCI L, 1984, ARABIE SUD, V1, P239; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749	18	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1594	1596		10.1086/340669	http://dx.doi.org/10.1086/340669			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992266	Bronze, Green Published			2022-12-18	WOS:000175445700022
J	Rubes, J; Vozdova, M; Robbins, WA; Rezacova, O; Perreault, SD; Wyrobek, AJ				Rubes, J; Vozdova, M; Robbins, WA; Rezacova, O; Perreault, SD; Wyrobek, AJ			Stable variants of sperm aneuploidy among healthy men show associations between germinal and somatic aneuploidy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; SEX-CHROMOSOME ANEUPLOIDY; HUMAN MITOTIC MUTANT; LIFE-STYLE FACTORS; MULTICOLOR FISH; PATERNAL AGE; Y-CHROMOSOME; DIPLOIDY RATES; INFERTILE MEN; X-CHROMOSOME	Repeated semen specimens from healthy men were analyzed by sperm fluorescence in situ hybridization (FISH), to identify men who consistently produced elevated frequencies of aneuploid sperm and to determine whether men who were identified as stable variants of sperm aneuploidy also exhibited higher frequencies of aneuploidy in their peripheral blood lymphocytes. Seven semen specimens were provided by each of 15 men over a 2-year period and were evaluated by the X-Y-8 multicolor sperm FISH method (i.e., similar to1,050,000 sperm were analyzed from 105 specimens). Three men were identified as stable aneuploidy variants producing significantly higher frequencies of XY, disomy X, disomy Y, disomy 8, and/or diploid sperm over time. In addition, one man and three men were identified as sperm-morphology and sperm-motility variants, respectively. Strong correlations were found between the frequencies of sperm with autosomal and sex-chromosome aneuploidies and between the two types of meiosis II diploidy; but not between sperm aneuploidy and semen quality. A significant association was found between the frequencies of sex-chromosome aneuploidies in sperm and lymphocytes in a subset of 10 men (r(2) = 0.67 P = .004), especially between XY sperm and sex-chromosome aneuploidy in lymphocytes (r(2) = 0.70, P = .003). These findings suggest that certain apparently healthy men can produce significantly higher frequencies of both aneuploid sperm and lymphocytes. Serious long-term somatic and reproductive health consequences may include increased risks of aneuploidy-related somatic diseases and of having children with paternally transmitted aneuploidies, such as Klinefelter, Turner, triple-X, and XYY syndromes.	Vet Res Inst, CS-62132 Brno, Czech Republic; Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; Univ Calif Los Angeles, Ctr Environm & Occupat Hlth, Los Angeles, CA USA; US EPA, Off Res & Dev, Natl Inst & Environm Effects Res Lab, Res Triangle Pk, NC USA; Lawrence Livermore Natl Lab, Biol & Biotechnol Res Prog, Livermore, CA USA	Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of California System; University of California Los Angeles; United States Environmental Protection Agency; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Rubes, J (corresponding author), Vet Res Inst, Hudcova 70, CS-62132 Brno, Czech Republic.		Darney, Sally P/X-6289-2018; Kopecna, Olga/E-1730-2012; Vozdova, Miluse/E-1376-2012	Darney, Sally P/0000-0002-0315-1774; Vozdova, Miluse/0000-0001-9076-8221; Wyrobek, Andrew/0000-0002-5921-5298	NIEHS NIH HHS [P42 ES004705] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abruzzo MA, 1996, HUM GENET, V97, P819; Amalfitano G, 2000, CANCER GENET CYTOGEN, V116, P6, DOI 10.1016/S0165-4608(99)00089-8; Baumgartner A, 1999, ENVIRON MOL MUTAGEN, V33, P49, DOI 10.1002/(SICI)1098-2280(1999)33:1<49::AID-EM6>3.0.CO;2-F; Baumgartner A, 2001, MUTAT RES-GEN TOX EN, V490, P11, DOI 10.1016/S1383-5718(00)00141-8; Bielanska M, 2000, HUM REPROD, V15, P440, DOI 10.1093/humrep/15.2.440; Blanco J, 1998, AM J HUM GENET, V63, P1067, DOI 10.1086/302058; Brandriff B.F., 1990, BIOL MAMMALIAN GERM, P183; CATALAN J, 1995, CYTOGENET CELL GENET, V68, P11, DOI 10.1159/000133879; Colombero LT, 1999, FERTIL STERIL, V72, P90, DOI 10.1016/S0015-0282(99)00158-2; Dasari VK, 2001, J UROLOGY, V165, P1335, DOI 10.1016/S0022-5347(01)69895-1; De Mas P, 2001, HUM REPROD, V16, P1204, DOI 10.1093/humrep/16.6.1204; Devi AS, 1998, FERTIL STERIL, V70, P89, DOI 10.1016/S0015-0282(98)00122-8; Downie SE, 1997, MOL HUM REPROD, V3, P815, DOI 10.1093/molehr/3.9.815; Duesberg P, 2000, CELL MOTIL CYTOSKEL, V47, P81; Duesberg P, 1999, ANTICANCER RES, V19, P4887; Eskenazi B, 2002, HUM REPROD, V17, P576, DOI 10.1093/humrep/17.3.576; Fait G, 2001, FERTIL STERIL, V75, P828, DOI 10.1016/S0015-0282(00)01793-3; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; Gazvani MR, 2000, FERTIL STERIL, V73, P51, DOI 10.1016/S0015-0282(99)00467-7; Gazvani MR, 2000, FERTIL STERIL, V74, P251, DOI 10.1016/S0015-0282(00)00603-8; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hamilton Lawrence C., 1998, STAT STATA, V5; Harkonen K, 1999, ENVIRON MOL MUTAGEN, V34, P39, DOI 10.1002/(SICI)1098-2280(1999)34:1<39::AID-EM6>3.0.CO;2-F; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Kinakin B, 1997, CYTOGENET CELL GENET, V78, P116, DOI 10.1159/000134641; Lim AST, 1999, HUM GENET, V104, P405, DOI 10.1007/s004390050975; Lim AST, 1999, FERTIL STERIL, V72, P121, DOI 10.1016/S0015-0282(99)00194-6; LOWE X, 1995, MUTAT RES-DNAGING G, V338, P59, DOI 10.1016/0921-8734(95)00012-U; Lowe X, 2001, AM J HUM GENET, V69, P1046, DOI 10.1086/323763; Marchetti F, 2001, P NATL ACAD SCI USA, V98, P3952, DOI 10.1073/pnas.061404598; MARTIN RH, 1995, MOL REPROD DEV, V42, P89, DOI 10.1002/mrd.1080420112; MARTIN RH, 1990, CYTOGENET CELL GENET, V53, P103, DOI 10.1159/000132905; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; MARTIN RH, 1994, CYTOGENET CELL GENET, V65, P95, DOI 10.1159/000133608; Martinez-Pasarell O, 1999, HUM GENET, V104, P345, DOI 10.1007/s004390050964; Morel F, 2000, MOL HUM REPROD, V6, P566, DOI 10.1093/molehr/6.6.566; Morel F, 1998, FERTIL STERIL, V69, P1122, DOI 10.1016/S0015-0282(98)00058-2; NASH RN, 1997, J MED GENET, V34, P63; Pang MG, 1999, HUM REPROD, V14, P1266, DOI 10.1093/humrep/14.5.1266; PAPI L, 1989, ANN HUM GENET, V53, P243, DOI 10.1111/j.1469-1809.1989.tb01791.x; Pfeffer J, 1999, FERTIL STERIL, V72, P472, DOI 10.1016/S0015-0282(99)00279-4; Rives N, 2000, MOL HUM REPROD, V6, P107, DOI 10.1093/molehr/6.2.107; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1995, REPROD FERT DEVELOP, V7, P799, DOI 10.1071/RD9950799; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robbins WA, 1996, MUTAT RES-FUND MOL M, V355, P235, DOI 10.1016/0027-5107(96)00030-9; Robbins WA, 1997, ENVIRON MOL MUTAGEN, V30, P175, DOI 10.1002/(SICI)1098-2280(1997)30:2<175::AID-EM10>3.0.CO;2-A; Robbins Wendie A., 1999, Environmental Epidemiology and Toxicology, V1, P125; Rubes J, 1998, FERTIL STERIL, V70, P715, DOI 10.1016/S0015-0282(98)00261-1; Schmid TE, 2001, MUTAGENESIS, V16, P189, DOI 10.1093/mutage/16.3.189; Schultz H, 2000, INT J ANDROL, V23, P300, DOI 10.1046/j.1365-2605.2000.00241.x; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P887, DOI 10.2307/3434998; Sen S, 2000, CURR OPIN ONCOL, V12, P82, DOI 10.1097/00001622-200001000-00014; Shi Q, 2000, CYTOGENET CELL GENET, V90, P219, DOI 10.1159/000056773; Shi Q, 2000, CYTOGENET CELL GENET, V90, P79, DOI 10.1159/000015668; Shi QH, 2001, MOL REPROD DEV, V59, P417, DOI 10.1002/mrd.1048; Sloter ED, 2000, AM J HUM GENET, V67, P862, DOI 10.1086/303088; Soares SR, 2001, HUM GENET, V108, P134, DOI 10.1007/s004390000449; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; TOLMIE JL, 1988, HUM GENET, V80, P197, DOI 10.1007/BF00702872; VanHummelen P, 1997, AM J HUM GENET, V61, P651; VanHummelen P, 1996, HUM GENET, V98, P608; Vegetti W, 2000, HUM REPROD, V15, P351, DOI 10.1093/humrep/15.2.351; VERMA RS, 1989, HUMAN CHROMOSOMES MA, P4; Wang JY, 2000, MOL HUM REPROD, V6, P665, DOI 10.1093/molehr/6.7.665; World Health Organization, 1992, WHO LAB MAN EX HUM S, V3rd; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Wyrobek AJ, 1996, ENVIRON MOL MUTAGEN, V28, P254; WYROBEK AJ, 2000, HUMAN MONITORING ENV, P134; Yamaki H, 2001, ANTICANCER RES, V21, P985	70	38	40	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1507	1519		10.1086/340791	http://dx.doi.org/10.1086/340791			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992257	Green Published, Bronze			2022-12-18	WOS:000175445700012
J	Schuermann, MJ; Otto, E; Becker, A; Saar, K; Ruschendorf, F; Polak, BC; Ala-Mello, S; Hoefele, J; Wiedensohler, A; Haller, M; Omran, H; Nurnberg, P; Hildebrandt, F				Schuermann, MJ; Otto, E; Becker, A; Saar, K; Ruschendorf, F; Polak, BC; Ala-Mello, S; Hoefele, J; Wiedensohler, A; Haller, M; Omran, H; Nurnberg, P; Hildebrandt, F			Mapping of gene loci for nephronophthisis type 4 and Senior-Loken syndrome, to chromosome 1p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC KIDNEY-DISEASE; LINKAGE ANALYSIS; MAP; CHILDREN; PROTEIN	For nephronophthisis (NPHP), the primary genetic cause of chronic renal failure in young adults, three loci have been mapped. To identify a new locus for NPHP, we here report on total-genome linkage analysis in seven families with NPHP, in whom we had excluded linkage to all three known NPHP loci. LOD scores >1 were obtained at nine loci, which were then fine mapped at 1-cM intervals. Extensive total-genome haplotype analysis revealed homozygosity in one family, in the region of the PCLN1 gene. Subsequent mutational analysis in this gene revealed PCLN1 mutations, thereby allowing exclusion of this family as a phenocopy. Multipoint linkage analysis for the remaining six families with NPHP together yielded a maximum LOD score (Z(max)) of 8.9 (at D1S253). We thus identified a new locus, NPHP4, for nephronophthisis. Markers D1S2660 and D1S2642 are flanking NPHP4 at a 2.9-cM critical interval. In one family with NPHP4, extensive genealogical studies were conducted, revealing consanguinity during the 17th century. On the basis of haplotype sharing by descent, we obtained a multipoint Z(max) of 5.8 for D1S253 in this kindred alone. In addition, we were able to localize to the NPHP4 locus a new locus for Senior-Loken syndrome, an NPHP variant associated with retinitis pigmentosa.	Univ Freiburg, Univ Childrens Hosp, D-79106 Freiburg, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Ophthalmol, Amsterdam, Netherlands; Family Federat Finland, Helsinki, Finland	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; Vrije Universiteit Amsterdam; Family Federation of Finland	Hildebrandt, F (corresponding author), Univ Freiburg, Univ Childrens Hosp, Mathildenstr 1, D-79106 Freiburg, Germany.		Hoefele, Julia/AAB-6448-2020	Hoefele, Julia/0000-0002-7917-7129; Omran, Heymut/0000-0003-0282-6765; Otto, Edgar/0000-0002-2387-9973; Saar, Kathrin/0000-0002-4483-1557				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; Barnes KC, 2001, GENOMICS, V71, P246, DOI 10.1006/geno.2000.6430; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 2000, J AM SOC NEPHROL, V11, P1753, DOI 10.1681/ASN.V1191753; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2001, KIDNEY INT, V59, P434, DOI 10.1046/j.1523-1755.2001.059002434.x; HILDEBRANDT F, 1999, PEDIAT NEPHROLOGY; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; Maniatis T., 1987, MOL CLONING LAB MANU; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Ott J., 1991, ANAL HUMAN GENETIC L; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; POLAK BCP, 1983, AM J OPHTHALMOL, V95, P487, DOI 10.1016/0002-9394(83)90269-6; POTTER DE, 1980, KIDNEY INT, V18, P103, DOI 10.1038/ki.1980.115; Saar K, 1997, AM J HUM GENET, V60, P605; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; SMITH CH, 1945, AM J DIS CHILD, V69, P369; STEEL CM, 1977, NATURE, V270, P729, DOI 10.1038/270729a0; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668	32	38	39	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1240	1246		10.1086/340317	http://dx.doi.org/10.1086/340317			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11920287	Green Published, Bronze			2022-12-18	WOS:000175012400013
J	Bourgain, C; Genin, E; Holopainen, P; Mustalahti, K; Maki, M; Partanen, J; Clerget-Darpoux, F				Bourgain, C; Genin, E; Holopainen, P; Mustalahti, K; Maki, M; Partanen, J; Clerget-Darpoux, F			Use of closely related affected individuals for the genetic study of complex diseases in founder populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM	We propose a method, the maximum identity length contrast (MILC) statistic, to locate genetic risk factors for complex diseases in founder populations. The MILC approach compares the identity length of parental haplotypes that are transmitted to affected offspring with the identity length of those that are not transmitted to affected offspring. Initially, the statistical properties of the method were assessed using randomly selected affected individuals with unknown relationship. Because both nuclear families with multiple affected sibs and large pedigrees are often available in founder populations, we performed simulations to investigate the properties of the MILC statistic in the presence of closely related affected individuals. The simulation showed that the use of closely related affected individuals greatly enhances the power of the statistic. For a given sample size and type I error, the use of affected sib pairs, instead of affected individuals randomly selected from the population, could increase the power by a factor of two. This increase was related to an increase of kinship-coefficient contrast between haplotype groups when closely related individuals were considered. The MILC approach allows the simultaneous use of affected individuals from a founder population and affected individuals with any kind of relationship, close or remote. We used the MILC approach to analyze the role of HLA in celiac disease and showed that the effect of HLA may be detected with the MILC approach by typing only 11 affected individuals, who were part of a single large Finnish pedigree.	INSERM, U535, Unite Rech Epidemiol Genet, F-94276 Le Kremlin Bicetre, France; FRC Blood Transfus Serv, Dept Tissue Typing, Helsinki, Finland; Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); Tampere University; Tampere University; Tampere University Hospital	Bourgain, C (corresponding author), INSERM, U535, Unite Rech Epidemiol Genet, Batiment Gregory Pincus,80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	bourgain@kb.inserm.fr	Saavalainen, Päivi M/E-8621-2011; Genin, Emmanuelle/C-4974-2013; Partanen, Jukka/B-7207-2014; Bourgain, Catherine/L-1505-2017; Clerget-Darpoux, Francoise/I-4825-2017	Genin, Emmanuelle/0000-0003-4117-2813; Partanen, Jukka/0000-0001-6681-4734; Clerget-Darpoux, Francoise/0000-0003-4816-6619				Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; CLERGETDARPOUX F, 1994, CR ACAD SCI III-VIE, V317, P931; Foissac A, 1998, TISSUE ANTIGENS, V52, P318, DOI 10.1111/j.1399-0039.1998.tb03054.x; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Karell K, 2000, TISSUE ANTIGENS, V56, P45, DOI 10.1034/j.1399-0039.2000.560106.x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; MAZZILLI MC, 1992, HUM IMMUNOL, V33, P133, DOI 10.1016/0198-8859(92)90064-T; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; QUESNEVILLE H, 1997, ANN HUM GENET, V61, P543; Roks Gerwin, 2000, European Journal of Human Genetics, V8, P169; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; VARILO T, 1999, THESIS U HELSINKI HE	18	38	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					154	159		10.1086/316933	http://dx.doi.org/10.1086/316933			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11102286	Green Published, Bronze			2022-12-18	WOS:000166399900014
J	Hogenauer, C; Santa Ana, CA; Porter, JL; Millard, M; Gelfand, A; Rosenblatt, RL; Prestidge, CB; Fordtran, JS				Hogenauer, C; Santa Ana, CA; Porter, JL; Millard, M; Gelfand, A; Rosenblatt, RL; Prestidge, CB; Fordtran, JS			Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADVANTAGE HYPOTHESIS; CHOLERA-TOXIN; TRANSPORT; GENE; ENTEROTOXIN; JEJUNUM	To explain the very high frequency of cystic fibrosis (CF) mutations in most populations of European descent, it has been proposed that CF heterozygotes have a survival advantage when infected with Vibrio cholerae or Escherichia coli, the toxins of which induce diarrhea by stimulation of active intestinal chloride secretion. Two assumptions underlie this hypothesis: (1) chloride conductance by the CF transmembrane conductance regulator (CFTR) is the rate-limiting step for active intestinal chloride secretion at all levels of expression, from approximately zero in patients with CF to normal levels in people who are not carriers of a mutation; and (2) heterozygotes have smaller amounts of functional intestinal CFTR than do people who are not carriers, and heterozygotes therefore secrete less chloride when exposed to secretagogues. The authors used an intestinal perfusion technique to measure in vivo basal and prostaglandin-stimulated jejunal chloride secretion in normal subjects, CF heterozygotes, and patients with CE Patients with CF had essentially no active chloride secretion in the basal state, and secretion was not stimulated by a prostaglandin analogue. However, CF heterozygotes secreted chloride at the same rate as did people without a CF mutation. If heterozygotes are assumed to have less-than-normal intestinal CFTR function, these results mean that CFTR expression is not rate limiting for active chloride secretion in heterozygotes. The results do not support the theory that the very high frequency of CF mutations is due to a survival advantage that is conferred on heterozygotes who contract diarrheal illnesses mediated by intestinal hypersecretion of chloride.	Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX 75246 USA; Childrens Med Ctr, Cyst Fibrosis Clin, Dallas, TX 75235 USA	Baylor University; Baylor University Medical Center	Fordtran, JS (corresponding author), Baylor Univ, Med Ctr, Dept Internal Med, 2nd Floor HOB,3500 Gaston Ave, Dallas, TX 75246 USA.			Hogenauer, Christoph/0000-0003-4566-0806	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037172] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK37172-14] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANWELL JG, 1970, J CLIN INVEST, V49, P183, DOI 10.1172/JCI106217; BAXTER PS, 1988, NATURE, V335, P211, DOI 10.1038/335211a0; BAXTER PS, 1989, LANCET, V1, P464; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; BERTRANPETIT J, 1996, DIBA FDN S 197, P97; Bienvenu T, 1996, HUM HERED, V46, P168, DOI 10.1159/000154347; CASTAGLIUOLO I, 1994, GASTROENTEROLOGY, V107, P657, DOI 10.1016/0016-5085(94)90112-0; Chang E.B., 1991, DIARRHEAL DIS, P49; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CUTHBERT AW, 1995, J PHYSIOL-LONDON, V482, P449, DOI 10.1113/jphysiol.1995.sp020531; DAVIS GR, 1980, J CLIN INVEST, V66, P1326, DOI 10.1172/JCI109985; FIELD M, 1993, ANNU REV PHYSIOL, V55, P631, DOI 10.1146/annurev.ph.55.030193.003215; FONTELO P, 1995, SCIENCE, V267, P440, DOI 10.1126/science.7529941; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gaginella T. S., 1990, Textbook of secretory diarrhea., P15; Grubb BR, 1997, AM J PHYSIOL-GASTR L, V273, pG258, DOI 10.1152/ajpgi.1997.273.2.G258; HAMER DH, 1998, SLEISENGER FORDTRANS, P1594; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; HITCHIN BW, 1991, GUT, V32, P893, DOI 10.1136/gut.32.8.893; JORDE LB, 1988, AM J HUM GENET, V42, P808; Knowles MR, 1999, CYSTIC FIBROSIS IN ADULTS, P27; KOPELMAN HR, 1993, PEDIAT GASTROINTESTI, P854; LUNDGREN O, 1989, DIGEST DIS SCI, V34, P264, DOI 10.1007/BF01536062; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; OLOUGHLIN EV, 1991, AM J PHYSIOL, V260, pG758, DOI 10.1152/ajpgi.1991.260.5.G758; PETRITSCH W, 1992, GUT, V33, P1174, DOI 10.1136/gut.33.9.1174; QUINTON PM, 1994, CURR BIOL, V4, P742, DOI 10.1016/S0960-9822(00)00166-4; QUINTON PM, 1982, FLUID ELECTROLYTE AB, P53; READ NW, 1979, GASTROENTEROLOGY, V76, P932; RODMAN DM, 1991, MED HYPOTHESES, V36, P253, DOI 10.1016/0306-9877(91)90144-N; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; Romey MC, 1999, HUM GENET, V105, P145, DOI 10.1007/s004390051077; Schiller LR, 1997, GASTROENTEROLOGY, V112, P1529, DOI 10.1016/S0016-5085(97)70034-9	34	38	41	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1422	1427		10.1086/316911	http://dx.doi.org/10.1086/316911			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11055897	Bronze, Green Published			2022-12-18	WOS:000165607600007
J	Capon, F; Tacconelli, A; Giardina, E; Sciacchitano, S; Bruno, R; Tassi, V; Trischitta, V; Filetti, S; Dallapiccola, B; Noveili, G				Capon, F; Tacconelli, A; Giardina, E; Sciacchitano, S; Bruno, R; Tassi, V; Trischitta, V; Filetti, S; Dallapiccola, B; Noveili, G			Mapping a dominant form of multinodular goiter to chromosome Xp22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IODOTHYRONINE DEIODINASE; CONGENITAL GOITER; PENDRED SYNDROME; NA+/I SYMPORTER; GENE; MUTATION; THYROGLOBULIN; EXPRESSION; CLONING; HYPOTHYROIDISM	Multinodular goiter (MNG) is a common disorder characterized by a nodular enlargement of the thyroid gland and occurring with a female:male ratio of 5:1. This article reports the analysis of an Italian three-generation pedigree MNG, including 10 affected females and 2 affected males. After linkage to candidate regions previously implicated in various forms of goiter was excluded, a novel MNG locus was searched. Because no male-to-male transmission was present in the study pedigree, an X-linked autosomal dominant pattern of inheritance was hypothesized. Therefore, 18 markers spaced at 10-cM intervals on the ii chromosome were examined. A significant LOD score was observed in the Xp22 region, where marker DXS1226 generated a maximum LOD score of 4.73 at a recombination fraction of 0. Analysis of six flanking microsatellites confirmed these data, and haplotype inspection delimited a 9.6-cM interval lying between DXS1052 and DXS8033.	Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy; Univ Rome La Sapienza, Dept Expt Med & Pathol, Rome, Italy; Hosp Tinchi Matera, San Giovanni Rotondo, Foggia, Italy; Casa Sollievo Sofferenza, Ist Ricovero & Cura Caraterre Sci, Endocrinol Unit, San Giovanni Rotondo, Foggia, Italy; Univ Catanzaro, Dept Expt Med, Rome, Italy; Casa Sollievo Sofferenza, Mendel Inst, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; Magna Graecia University of Catanzaro; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel	Noveili, G (corresponding author), Fac Med, Cattedra Genet, Ed E Nord Piano Terra,Via Tor Vergata 135, I-00133 Rome, Italy.		Novelli, Giuseppe/GQB-3329-2022; Sciacchitano, Salvatore/AAM-5895-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Trischitta, Vincenzo/K-1487-2016; Giardina, Emiliano/J-1965-2012; Capon, Francesca/F-4763-2011; Dallapiccola, Bruno/K-8692-2016	Novelli, Giuseppe/0000-0002-7781-602X; Sciacchitano, Salvatore/0000-0003-1492-5365; Novelli, Giuseppe/0000-0002-7781-602X; Trischitta, Vincenzo/0000-0003-1174-127X; Capon, Francesca/0000-0003-2432-5793; giardina, emiliano/0000-0002-2741-5009; Tassi, Vittorio/0000-0003-3536-4480; Dallapiccola, Bruno/0000-0002-5031-1013	Telethon [E.1031] Funding Source: Medline	Telethon(Fondazione Telethon)		ABRAMOWICZ MJ, 1992, J CLIN INVEST, V90, P1200, DOI 10.1172/JCI115981; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; CORRAL J, 1993, LANCET, V341, P462, DOI 10.1016/0140-6736(93)90209-Y; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Fujiwara H, 1997, NAT GENET, V16, P124, DOI 10.1038/ng0697-124; GREIG WR, 1967, Q J MED, V36, P175; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108; INGBAR SH, 1968, TEXTBOOK ENDOCRINOLO, P105; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; MURRAY IPC, 1966, J CLIN ENDOCR METAB, V26, P1039, DOI 10.1210/jcem-26-10-1039; Neumann S, 1999, J CLIN ENDOCR METAB, V84, P3750, DOI 10.1210/jc.84.10.3750; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; VANSANDE J, 1995, J CLIN ENDOCR METAB, V80, P2577, DOI 10.1210/jc.80.9.2577; *WHO, 1993, 1 WHO NUTR UN	18	38	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1004	1007		10.1086/303095	http://dx.doi.org/10.1086/303095			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986044	Bronze, Green Published			2022-12-18	WOS:000089651100025
J	O'Connell, JR; Weeks, DE				O'Connell, JR; Weeks, DE			An optimal algorithm for automatic genotype elimination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; PEDIGREE ANALYSIS; COMPUTATIONS; EXTENSIONS	In an effort to accelerate likelihood computations on pedigrees, Lange and Goradia defined a genotype-elimination algorithm that aims to identify those genotypes that need not be considered during the likelihood computation. For pedigrees without loops, they showed that their algorithm was optimal, in the sense that it identified all genotypes that lead to a Mendelian inconsistency. Their algorithm, however, is not optimal for pedigrees with loops, which continue to pose daunting computational challenges. We present here a simple extension of the Lange-Goradia algorithm that we prove is optimal on pedigrees with loops, and we give examples of how our new algorithm can be used to detect genotyping errors. We also introduce a more efficient and faster algorithm for carrying out the fundamental step in the Lange-Goradia algorithm-namely, genotype elimination within a nuclear family. Finally, we improve a common algorithm for computing the likelihood of a pedigree with multiple loops. This algorithm breaks each loop by duplicating a person in that loop and then carrying out a separate likelihood calculation for each vector of possible genotypes of the loop breakers. This algorithm, however, does unnecessary computations when the loop-breaker vector is inconsistent. In this paper we present a new recursive loop breaker-elimination algorithm that solves this problem and illustrate its effectiveness on a pedigree with six loops.	Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics	O'Connell, JR (corresponding author), Univ Pittsburgh, Dept Human Genet, Crabtree Hall A310,130 DeSoto St, Pittsburgh, PA 15261 USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NHGRI NIH HHS [HG00932] Funding Source: Medline; NIA NIH HHS [AG16992-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016992] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Jones AC, 1998, AM J HUM GENET, V63, P80, DOI 10.1086/301937; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LANGE K, 1987, AM J HUM GENET, V40, P250; LATHROP GM, 1988, AM J HUM GENET, V42, P498; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SOBEL E, 1995, GENETIC MAPPING DNA; Xie X., 1992, American Journal of Human Genetics, V51, pA206	13	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1733	1740		10.1086/302663	http://dx.doi.org/10.1086/302663			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577928	Bronze, Green Published			2022-12-18	WOS:000084282500029
J	Horwitz, M; Wiernik, PH				Horwitz, M; Wiernik, PH			Pseudoautosomal linkage of Hodgkin disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; COMPLEX INHERITANCE; REGION; SUSCEPTIBILITY; HLA; DYSCHONDROSTEOSIS; CONCORDANCE; LYMPHOMA; MUTATIONS; RELATIVES	Heritable factors appear to account for much of the risk for Hodgkin disease (HD). There is evidence for an HLA-linked gene, but other predisposing loci remain unaccounted for. The observation of a family coinheriting both HD and Leri-Weill dyschondrosteosis (LWD) suggests that a gene conferring risk for HD resides adjacent to the LWD locus. The gene responsible for LWD, SHOX, localizes to the short-arm pseudoautosomal region (PAR) of the X and Y chromosomes. A unique segregation pattern for PAR-linked genes has been predicted-that affected sibs will tend to be same sex. An excess of sex-concordant affected sib pairs with HD has been noted but has been attributed to an environmental etiology. These two observations-sex concordance in sib pairs with HD and cosegregation of HD and LWD-impelled a test of the hypothesis that there is a PAR-localized gene for HD. By first scoring recombinations dissociating sex from phenotype in individuals from pedigrees with LWD, we determined a male maximum recombination frequency (theta(max)) of .405. This places SHOX near the short-arm telomeres of the sex chromosome and supports the prediction that PAR recombination is obligatory for spermatogenesis. By inferring recombinations between HD and sexual phenotype in sib pairs, we predict, for the postulated HD gene, a male theta(max) as high as .254, which places it in proximity to SHOX. Morton's nonparametric affected-sib-pair "beta" model was used in the evaluation of linkage between HD and phenotypic sex and gave a LOD score of 2.41. Using this approach, we reevaluated evidence for HLA linkage in HD in haplotyped sib pairs and found a LOD score of 2.00. The resulting beta values indicate that the putative PAR- and HLA-linked loci account for 29% and 40%, respectively, of the heritability of HD in an American population.	Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; New York Med Coll, Ctr Comprehens Canc, Bronx, NY USA	University of Washington; University of Washington Seattle; New York Medical College	Horwitz, M (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 357720, Seattle, WA 98195 USA.			Horwitz, Marshall/0000-0002-1683-1680				Anton JI, 1938, ANN SURG, V108, P411, DOI 10.1097/00000658-193809000-00006; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; BERBERICH FR, 1983, HUM IMMUNOL, V6, P207, DOI 10.1016/0198-8859(83)90094-0; BOWERS TK, 1977, VOX SANG, V33, P273, DOI 10.1111/j.1423-0410.1977.tb04474.x; CARTER AR, 1974, BRIT J RADIOL, V47, P634, DOI 10.1259/0007-1285-47-562-634; CHAKRAVARTI A, 1986, GENET EPIDEMIOL, V3, P407, DOI 10.1002/gepi.1370030605; CIMINO G, 1988, EUR J CANCER CLIN ON, V24, P1595, DOI 10.1016/0277-5379(88)90051-X; Collins A, 1996, P NATL ACAD SCI USA, V93, P9177, DOI 10.1073/pnas.93.17.9177; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CREAGAN ET, 1972, LANCET, V2, P547; CROW TJ, 1994, BRIT J PSYCHIAT, V164, P159, DOI 10.1192/bjp.164.2.159; DEVORE JW, 1957, ANN INTERN MED, V47, P300, DOI 10.7326/0003-4819-47-2-300; DONHUIJSENANT R, 1988, ANN INTERN MED, V109, P946, DOI 10.7326/0003-4819-109-12-946; DUROSINMI M A, 1989, African Journal of Medicine and Medical Sciences, V18, P219; ESPIRITU C, 1975, AM J DIS CHILD, V129, P375, DOI 10.1001/archpedi.1975.02120400075020; FELMAN AH, 1969, RADIOLOGY, V93, P1037, DOI 10.1148/93.5.1037; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; FRYNS JP, 1979, HUM GENET, V46, P21, DOI 10.1007/BF00278898; GOEPP CE, 1978, AM J HUM GENET, V30, pA52; GOKHALE DA, 1995, LEUKEMIA, V9, P826; GREENE MH, 1979, INT J CANCER, V23, P777, DOI 10.1002/ijc.2910230607; GRUFFERMAN S, 1977, NEW ENGL J MED, V296, P248, DOI 10.1056/NEJM197702032960504; HAFEZ M, 1985, FAM CANCER, P175; HAIM N, 1982, CANCER, V49, P2197, DOI 10.1002/1097-0142(19820515)49:10<2197::AID-CNCR2820491036>3.0.CO;2-9; HERDMAN RC, 1966, J PEDIATR-US, V68, P432, DOI 10.1016/S0022-3476(66)80247-0; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; HORS J, 1985, HISTOCOMPATIBILITY T, P411; HORWITZ M, IN PRESS GENETIC BAS; KAJII T, 1968, CANCER, V22, P218, DOI 10.1002/1097-0142(196807)22:1<218::AID-CNCR2820220125>3.0.CO;2-S; KREMER E, 1993, BLOOD, V82, P22, DOI 10.1182/blood.V82.1.22.bloodjournal82122; KVALOY K, 1994, HUM MOL GENET, V3, P771, DOI 10.1093/hmg/3.5.771; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LI L, 1995, HUM MOL GENET, V4, P2013, DOI 10.1093/hmg/4.11.2013; LICHTENSTEIN JR, 1980, J MED GENET, V17, P41, DOI 10.1136/jmg.17.1.41; Lio P, 1997, P NATL ACAD SCI USA, V94, P5344, DOI 10.1073/pnas.94.10.5344; LISKER R, 1972, CLIN GENET, V3, P154; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; MCBRIDE A, 1977, EUR J CANCER, V13, P549, DOI 10.1016/0014-2964(77)90116-5; MERZ H, 1991, AM J PATHOL, V139, P1173; Morton NE, 1996, P NATL ACAD SCI USA, V93, P3471, DOI 10.1073/pnas.93.8.3471; NAGEL GA, 1978, INT J CANCER, V22, P675, DOI 10.1002/ijc.2910220606; NUNEZROLDAN A, 1979, TISSUE ANTIGENS, V13, P377; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; Penrose LS, 1942, J MENT SCI, V88, P308; RAZIS DV, 1959, ANN INTERN MED, V51, P933, DOI 10.7326/0003-4819-51-5-933; RIGBY PG, 1966, JAMA-J AM MED ASSOC, V197, P95; ROBERTSON SJ, 1987, CANCER, V59, P1314, DOI 10.1002/1097-0142(19870401)59:7<1314::AID-CNCR2820590714>3.0.CO;2-V; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; RULLIER J, 1968, Semaine des Hopitaux de Paris, V44, P2474; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; SHUGART Y, 1998, AM J HUM GENET S, V63, pA87; VIANNA NJ, 1974, LANCET, V2, P854; Weintraub M, 1996, ONCOGENE, V12, P687	54	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1413	1422		10.1086/302608	http://dx.doi.org/10.1086/302608			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521308	Green Published, Bronze			2022-12-18	WOS:000083531000024
J	Roby, P; Eyre, S; Worthington, J; Ramesar, R; Cilliers, H; Beighton, P; Grant, M; Wallis, G				Roby, P; Eyre, S; Worthington, J; Ramesar, R; Cilliers, H; Beighton, P; Grant, M; Wallis, G			Autosomal dominant (Beukes) premature degenerative osteoarthropathy of the hip joint maps to an 11-cM region on chromosome 4q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ Manchester, Arthrit Res Campaign, Epidemiol Res Unit, Manchester M13 9PT, Lancs, England; Univ Manchester, Dept Med, Manchester M13 9PL, Lancs, England; Univ Cape Town, Dept Human Genet, ZA-7925 Cape Town, South Africa; Univ Bloemfontein, Bloemfontein, South Africa	University of Manchester; University of Manchester; University of Manchester; University of Cape Town	Wallis, G (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.		eyre, stephen/K-3776-2017; Ramesar, Raj S/I-6941-2015; Worthington, Jane/M-9770-2014	eyre, stephen/0000-0002-1251-6974; Ramesar, Raj S/0000-0001-5688-1634; Worthington, Jane/0000-0003-0544-042X				ALALI M, 1994, INT J EXP PATHOL, V75, pA71; BEIGHTON P, 1994, AM J MED GENET, V53, P348, DOI 10.1002/ajmg.1320530408; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; CILLIERS HJ, 1990, AM J MED GENET, V36, P386, DOI 10.1002/ajmg.1320360403; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460	7	38	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					904	908		10.1086/302291	http://dx.doi.org/10.1086/302291			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053028	Green Published, Bronze			2022-12-18	WOS:000079204700031
J	Balciuniene, J; Dahl, N; Borg, E; Samuelsson, E; Koisti, MJ; Pettersson, U; Jazin, EE				Balciuniene, J; Dahl, N; Borg, E; Samuelsson, E; Koisti, MJ; Pettersson, U; Jazin, EE			Evidence for digenic inheritance of nonsyndromic hereditary hearing loss in a Swedish family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MYOSIN-VIIA GENE; LINKAGE ANALYSIS; DEAFNESS; MUTATIONS; MAPS; IMPAIRMENT; POU3F4; LOCI	We investigated a Swedish family with nonsyndromic progressive bilateral sensorineural hearing loss. Thirteen candidate loci for autosomal dominant nonsyndromic hearing loss were tested for linkage in this family. We found significant LOD scores (>3) for markers at candidate locus DFNA12 (11q22-q24) and suggestive LOD scores (>2) for markers at locus DFNA2 (1p32). Our results for markers on chromosome 11 narrowed down the candidate region for the DFNA12 locus. A detailed analysis of the phenotypes and haplotypes shared by the affected individuals supported the notion that two genes segregated together with hearing impairment in the family. Severely affected family members had haplotypes linked to the disease allele on both chromosomes 1 and 11, whereas individuals with milder hearing loss had haplotypes linked to the disease allele on either chromosome 1 or chromosome 11. These observations suggest an additive effect of two genes, each gene resulting in a mild and sometimes undiagnosed phenotype, but both together resulting in a more severe phenotype.	Uppsala Univ, Dept Genet & Pathol, Unit Med Genet, S-75123 Uppsala, Sweden; Uppsala Univ, Dept Genet & Pathol, Clin Genet Unit, S-75123 Uppsala, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; Orebro Med Ctr Hosp, Audiol Clin, Res Unit, Orebro, Sweden	Uppsala University; Uppsala University; Karolinska Institutet	Jazin, EE (corresponding author), Uppsala Univ, Dept Genet & Pathol, Unit Med Genet, Box 589, S-75123 Uppsala, Sweden.	elena.jazin@medgen.uu.se		Jazin, Elena/0000-0002-0363-3466				Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Benlian P, 1996, HUM MUTAT, V7, P340, DOI 10.1002/(SICI)1098-1004(1996)7:4<340::AID-HUMU8>3.0.CO;2-C; Chen A, 1997, AM J MED GENET, V71, P467, DOI 10.1002/(SICI)1096-8628(19970905)71:4<467::AID-AJMG18>3.0.CO;2-E; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; GORLIN RJ, 1995, HEREDITARY HEARING L, P43; Hollway GE, 1998, LANCET, V351, P877, DOI 10.1016/S0140-6736(98)24012-8; Jacobs HT, 1997, ANN MED, V29, P483, DOI 10.3109/07853899709007472; JOHNSON WG, 1980, AM J HUM GENET, V32, P374; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lindqvist AKB, 1996, GENOME RES, V6, P1170, DOI 10.1101/gr.6.12.1170; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nye JS, 1998, AM J MED GENET, V75, P401, DOI 10.1002/(SICI)1096-8628(19980203)75:4<401::AID-AJMG10>3.0.CO;2-S; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VanCamp G, 1997, AM J HUM GENET, V60, P758; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; VANOMMEN GJ, 1995, NAT MED, V1, P412; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weiler T, 1996, AM J HUM GENET, V59, P872	35	38	38	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					786	793		10.1086/302012	http://dx.doi.org/10.1086/302012			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718342	Bronze, Green Published			2022-12-18	WOS:000075919000016
J	Sakuntabhai, A; Hammami-Hauasli, N; Bodemer, C; Rochat, A; Prost, C; Barrandon, Y; de Prost, Y; Lathrop, M; Wojnarowska, F; Bruckner-Tuderman, L; Hovnanian, A				Sakuntabhai, A; Hammami-Hauasli, N; Bodemer, C; Rochat, A; Prost, C; Barrandon, Y; de Prost, Y; Lathrop, M; Wojnarowska, F; Bruckner-Tuderman, L; Hovnanian, A			Deletions within COL7A1 exons distant from consensus splice sites alter splicing and produce shortened polypeptides in dominant dystrophic epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VII COLLAGEN GENE; TRIPLE-HELICAL DOMAIN; GLYCINE SUBSTITUTION MUTATIONS; PREMATURE TERMINATION CODONS; TO-ARGININE SUBSTITUTION; GROWTH-FACTOR-BETA; PRE-MESSENGER-RNA; ANCHORING FIBRILS; OSTEOGENESIS IMPERFECTA; AUTOSOMAL-DOMINANT	We describe two familial cases of dominant dystrophic epidermolysis bullosa (DDEB) that are heterozygous for deletions in COL7A1 that alter splicing, despite intact consensus splice-site sequences. One patient shows a 28-bp genomic deletion (6081del28) in exon 73 associated with the activation of a cryptic donor splice site within this exon; the combination of both defects restores the phase and replaces the last 11 Gly-X-Y repeats of exon 73 by a noncollagenous sequence, Glu-Ser-Leu. The second patient demonstrates a 27-bp deletion in exon 87 (6847del27), causing in-frame skipping of this exon; consensus splice sites, putative branch sites, and introns flanking exons 73 and 87 showed a normal sequence. Keratinocytes from the probands synthesized normal and shortened type VII collagen polypeptides and showed intracellular accumulation of type VII procollagen molecules. This first report of genomic deletions in COL7A1 in DDEB suggests a role for exonic sequences in the control of splicing of COL7A1 pre-mRNA and provides evidence that shortened type VII collagen polypeptides can alter, in a dominant manner, anchoring-fibril formation and can cause DDEB of differing severity.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxford Radcliffe Hosp, Dept Dermatol, Oxford, England; Univ Munster, Dept Dermatol, D-4400 Munster, Germany; Necker Hosp, Dept Dermatol, Paris, France; Ecole Normale Super, Lab Cellular Differentiat, F-75231 Paris, France; Hop St Louis, Dept Histol, Paris, France	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Munster; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Hovnanian, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Hovnanian, Alain/I-4711-2017	Hovnanian, Alain/0000-0003-3412-7512	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; Ashkenas J, 1997, AM J HUM GENET, V61, P267, DOI 10.1086/514865; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Bruckner-Tuderman Leena, 1993, P507; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; Christiano AM, 1997, J INVEST DERMATOL, V109, P390, DOI 10.1111/1523-1747.ep12336276; CHRISTIANO AM, 1995, HUM MOL GENET, V4, P1579; CHRISTIANO AM, 1994, P NATL ACAD SCI USA, V91, P3549, DOI 10.1073/pnas.91.9.3549; Christiano AM, 1997, J INVEST DERMATOL, V109, P811, DOI 10.1111/1523-1747.ep12341013; CHRISTIANO AM, 1995, J INVEST DERMATOL, V104, P438, DOI 10.1111/1523-1747.ep12666033; Christiano AM, 1996, AM J HUM GENET, V58, P671; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; Christiano AM, 1996, J INVEST DERMATOL, V106, P778, DOI 10.1111/1523-1747.ep12346304; Christiano AM, 1997, HUM MUTAT, V10, P408, DOI 10.1002/(SICI)1098-1004(1997)10:5<408::AID-HUMU12>3.3.CO;2-B; Christiano AM, 1996, AM J HUM GENET, V58, P682; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Dunnill MGS, 1996, J INVEST DERMATOL, V107, P171, DOI 10.1111/1523-1747.ep12329570; DUNNILL MGS, 1994, J MED GENET, V31, P745, DOI 10.1136/jmg.31.10.745; Eady R. A. J., 1985, METHODS SKIN RES, P1; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HammamiHauasli N, 1997, J INVEST DERMATOL, V109, P384, DOI 10.1111/1523-1747.ep12336264; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; Hovnanian A, 1997, AM J HUM GENET, V61, P599, DOI 10.1086/515495; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; Jarvikallio A, 1997, HUM MUTAT, V10, P338; Kon A, 1997, J INVEST DERMATOL, V108, P224, DOI 10.1111/1523-1747.ep12335324; Kon A, 1997, J INVEST DERMATOL, V109, P684, DOI 10.1111/1523-1747.ep12338093; KONIG A, 1992, J INVEST DERMATOL, V99, P808, DOI 10.1111/1523-1747.ep12614773; KONIG A, 1992, J CELL BIOL, V117, P679, DOI 10.1083/jcb.117.3.679; KRAWCZAK M, 1991, HUM GENET, V86, P425; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; Lee JYY, 1997, J INVEST DERMATOL, V108, P947; MATSUO M, 1992, BIOCHEM BIOPH RES CO, V182, P495, DOI 10.1016/0006-291X(92)91759-J; MCCONKEY EH, 1995, HUMAN GENETICS MOL R, P148; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; MORRIS NP, 1986, J BIOL CHEM, V261, P5638; NAEYAERT JM, 1995, J INVEST DERMATOL, V104, P803, DOI 10.1111/1523-1747.ep12606999; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SONNENBERG A, 1991, EXP CELL RES, V197, P234, DOI 10.1016/0014-4827(91)90428-W; TIDMAN MJ, 1985, J INVEST DERMATOL, V84, P374, DOI 10.1111/1523-1747.ep12265460; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919; ZHUANG JP, 1993, HUM GENET, V91, P210; Zuker M., 1994, COMPUTER ANAL SEQUEN, P267	68	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					737	748		10.1086/302029	http://dx.doi.org/10.1086/302029			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718359	Green Published, Bronze			2022-12-18	WOS:000075919000011
J	Krakow, D; Reinker, K; Powell, B; Cantor, R; Priore, MA; Garber, A; Lachman, RS; Rimoin, DL; Cohn, DH				Krakow, D; Reinker, K; Powell, B; Cantor, R; Priore, MA; Garber, A; Lachman, RS; Rimoin, DL; Cohn, DH			Localization of a multiple synostoses syndrome disease gene to chromosome 17q21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; MAP; SYMPHALANGISM	Multiple synostoses syndrome is an autosomal dominant disorder characterized by premature onset of joint fusions, which initially affect the interphalangeal joints, by characteristic facies, and by deafness. We performed linkage analysis on a large Hawaiian family with multiple synostoses syndrome. Because another autosomal dominant disorder, proximal symphalangism, shares some clinical symptoms with multiple synostoses syndrome and has been linked to markers at loci at chromosome 17q21-22, we tested the hypothesis that multiple synostoses syndrome is linked to the same chromosomal region. Using polymorphic markers from the proximal symphalangism interval, we conducted linkage analysis and showed that the multiple synostoses-syndrome phenotype is linked to the same chromosomal region. A maximum LOD score of 3.98 at recombination fraction of .00 was achieved for the marker at locus D17S787. Further genetic analysis identified individuals with recombinant genotypes, allowing localization of the disease gene within the interval D17S931-D17S792, a 16-cM region. These data provide evidence that multiple synostoses syndrome and proximal symphalangism may be allelic disorders.	Univ Calif Los Angeles, Sch Med, Ahmanson Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med,Dept Obstet & Gynecol, Burns & Allen Cedars Sinai Res Inst, Steven Spielberg Pediat Res Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Radiol, Los Angeles, CA USA; Univ Hawaii, Shriners Hosp, Dept Orthoped, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Dept Pediat & Genet, Honolulu, HI 96822 USA; Kapiolani Med Ctr Women & Children, Honolulu, HI USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Hawaii System; University of Hawaii System	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.		Reinker, Kent/R-5231-2019		NICHD NIH HHS [HD 01205, HD-22657, RSDP-HD0084908] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FUHRMANN W, 1966, HUMANGENETIK, V3, P64, DOI 10.1007/BF00273020; Gaal S A, 1987, Hawaii Med J, V46, P305; Herrmann J, 1974, Birth Defects Orig Artic Ser, V10, P23; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; HURVITZ SA, 1985, CLIN GENET, V28, P61; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MAROTEAUX P, 1972, NOUV PRESSE MED, V1, P3041; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; POLYMEROPOULOS MH, 1995, GENOMICS, V27, P225, DOI 10.1006/geno.1995.1035; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; STRASBURGER AK, 1965, B JOHNS HOPKINS HOSP, V117, P108	14	38	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					120	124		10.1086/301921	http://dx.doi.org/10.1086/301921			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634519	Green Published, Bronze			2022-12-18	WOS:000074761000018
J	Brkanac, Z; Cody, JD; Leach, RJ; DuPont, BR				Brkanac, Z; Cody, JD; Leach, RJ; DuPont, BR			Identification of cryptic rearrangements in patients with 18q- deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; PHENOTYPE; REGION; DEFINITION; GENE	The majority of patients with 18q- syndrome appear cytogenetically to have a terminal deletion of the long arm of chromosome 18. These 18q- patients are diagnosed by use of standard cytogenetic banding techniques, which have resolution insufficient for precise genotyping. In our effort to obtain a thorough genotype, we have analyzed the DNA from 35 patients who originally were diagnosed as having de novo terminal deletions of chromosome 18. Molecular analysis was performed with polymorphic markers throughout the 18q-region. Cytogenetic FISH was performed with two human 18q telomeric probes, a chromosome 18-specific alpha-satellite probe, and whole chromosome 18-specific paint. Of 35 patients previously reported to have terminal deletions of 18q, we found that 5 (14%) have more-complex cryptic rearrangements and that 3 (9%) retain the most distal portion of 18q, consistent with an interstitial rather than a terminal deletion. These findings indicate that a standard karyotype can lead to insufficient characterization in 18q- syndrome. This has important ramifications for phenotype mapping of this syndrome, as well as for proper prognosis.	Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	DuPont, BR (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.			Leach, Robin/0000-0002-3201-5579				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; CHUDLEY AE, 1992, AM J MED GENET, V43, P535, DOI 10.1002/ajmg.1320430307; DE GROUCHY J, 1964, Pathol Biol, V12, P579; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRACOPOLI NC, 1994, CURRENT PROTOCOLS; GIBAS LM, 1985, KARYOGRAM, V11, P91; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; JOSIFEK K, 1991, APPL CYTOGENET, V17, P101; KLINE AD, 1993, AM J HUM GENET, V52, P895; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KRASIKOV N, 1992, AM J MED GENET, V43, P531, DOI 10.1002/ajmg.1320430306; MILLER G, 1990, AM J MED GENET, V37, P128, DOI 10.1002/ajmg.1320370130; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PENNY LA, 1995, AM J HUM GENET, V56, P676; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P611; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; STRATHDEE G, 1994, AM J HUM GENET, V54, P1085; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; WILSON MG, 1979, AM J MED GENET, V3, P155, DOI 10.1002/ajmg.1320030207	24	38	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1500	1506		10.1086/301854	http://dx.doi.org/10.1086/301854			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585582	Bronze, Green Published			2022-12-18	WOS:000074174700028
J	Ahmad, W; Brancolini, V; ul Haque, MF; Lam, H; ul Haque, S; Haider, M; Maimon, A; Aita, VM; Owen, J; Brown, D; Zegarelli, DJ; Ahmad, M; Ott, J; Christiano, AM				Ahmad, W; Brancolini, V; ul Haque, MF; Lam, H; ul Haque, S; Haider, M; Maimon, A; Aita, VM; Owen, J; Brown, D; Zegarelli, DJ; Ahmad, M; Ott, J; Christiano, AM			A locus for autosomal recessive hypodontia with associated dental anomalies maps to chromosome 16q12.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							EXPRESSION PATTERNS; TOOTH DEVELOPMENT; SIGNALING CENTER; HOMEOBOX GENE; INVITRO; TEETH; EGF		Rockefeller Univ, Dept Dermatol, New York, NY 10027 USA; Rockefeller Univ, Dept Genet & Dev, New York, NY 10027 USA; Rockefeller Univ, Sch Dent & Oral Surg, New York, NY 10027 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Quaid I Azam Univ, Dept Biol Sci, Islamabad, Pakistan; Abbassi Shaheed Hosp, Karachi, Pakistan; Res Genet Inc, Huntsville, AL 35801 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Quaid I Azam University	Christiano, AM (corresponding author), Columbia Univ, Coll Physicians & Surgeons, Dept Dermatol, 630 W 168th St,VC151526, New York, NY 10032 USA.		Ahmad, Wasim/E-9713-2015; Ahmad, Wasim/GSD-8904-2022	Brown, Donna/0000-0002-8805-7225; Brancolini, Valeria/0000-0003-0871-537X	NHGRI NIH HHS [HG-00008] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BURZYNSKI NJ, 1983, BIRTH DEFECTS-ORIG, V19, P95; Grahnen H., 1961, ODONT REVY, V12, P348; KRONMILLER JE, 1991, DEV BIOL, V147, P485, DOI 10.1016/0012-1606(91)90307-O; LEWIN DI, 1997, J NIH RES, V9, P75; MACKENZIE A, 1991, DEVELOPMENT, V111, P269; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; PARTANEN AM, 1985, DEV BIOL, V111, P84, DOI 10.1016/0012-1606(85)90437-3; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Schulze C., 1970, THOMAS ORAL PATHOLOG, P96; SVINHUFVUD E, 1988, CLIN GENET, V34, P373; Thesleff I, 1996, NAT GENET, V13, P379, DOI 10.1038/ng0896-379; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/0092-8674(93)90678-J; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417	15	38	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					987	991		10.1086/301799	http://dx.doi.org/10.1086/301799			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529357	hybrid, Green Published			2022-12-18	WOS:000073514400033
J	Pekkarinen, P; Hovatta, I; Hakola, P; Jarvi, O; Kestila, M; Lenkkeri, U; Adolfsson, R; Holmgren, G; Nylander, PO; Tranebjaerg, L; Terwilliger, JD; Lonnqvist, J; Peltonen, L				Pekkarinen, P; Hovatta, I; Hakola, P; Jarvi, O; Kestila, M; Lenkkeri, U; Adolfsson, R; Holmgren, G; Nylander, PO; Tranebjaerg, L; Terwilliger, JD; Lonnqvist, J; Peltonen, L			Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; MULTILOCUS LINKAGE ANALYSIS; CYTOCHROME-C OXIDASE; NASU-HAKOLA DISEASE; MEMBRANOUS LIPODYSTROPHY; SCLEROSING LEUKOENCEPHALOPATHY; HUMAN GENOME; NUCLEOTIDE-SEQUENCE; POINT MUTATIONS; GENE	PLO-SL (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy) is a recessively inherited disorder characterized by systemic bone cysts and progressive presenile frontal-lobe dementia, resulting in death at <50 years of age, Since the 1960s, similar to 160 cases have been reported, mainly in Japan and Finland, The pathogenesis of the disease is unknown. In this article, we report the assignment of the locus for PLO-SL, by random genome screening using a modification of the haplotype-sharing method, in patients from a genetically isolated population. By screening five patient samples from 2 Finnish families, followed by linkage analysis of 12 Finnish families, 3 Swedish families, and 1 Norwegian family, we were able to assign the PLO-SL locus to a 9-cM interval between markers D19S191 and D19S420 on chromosome 19q13. The critical region was further restricted, to similar to 1.8 Mb, by linkage-disequilibrium analysis of the Finnish families. According to the haplotype analysis, one Swedish and one Norwegian PLO-SL family are nor linked to the chromosome 19 locus, suggesting that PLO-SL isa heterogeneous disease. In this chromosomal region, one potential candidate gene for PLO-SL, the gene encoding amyloid precursor-like protein 1, was analyzed, but no mutations were detected in the coding region.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Univ Helsinki, Inst Biomed, Dept Human Mol Genet, FIN-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland; Univ Kuopio, Dept Forens Psychiat, FIN-70211 Kuopio, Finland; Univ Turku, Dept Pathol, Turku, Finland; Univ Oulu, Bioctr, Oulu, Finland; Univ Oulu, Dept Biochem, Oulu, Finland; Umea Univ, Dept Psychiat, Umea, Sweden; Umea Univ, Dept Clin Genet, Umea, Sweden; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA	Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Turku; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Umea University; Umea University; UiT The Arctic University of Tromso; University Hospital of North Norway; Columbia University; Columbia University	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	leena.peltonen@ktl.fi	Hovatta, Iiris/D-6871-2012; Ijäs, Petra/F-8280-2015	Hovatta, Iiris/0000-0002-5990-7892; Ijäs, Petra/0000-0002-7292-1971; Adolfsson, Rolf/0000-0001-9785-8473				ADOLFSSON R, 1978, LANCET, V1, P1209; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BIRD TD, 1983, NEUROLOGY, V33, P81, DOI 10.1212/WNL.33.1.81; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BROWN J, 1995, HUM MOL GENET, V4, P1625, DOI 10.1093/hmg/4.9.1625; DEISENHAMMER F, 1993, NERVENARZT, V64, P263; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Deldinne M, 1996, J Belge Radiol, V79, P267; DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EDVARDSEN P, 1983, INT ORTHOP, V7, P99; FABRIZI GM, 1989, NUCLEIC ACIDS RES, V17, P7107, DOI 10.1093/nar/17.17.7107; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; HAKOLA HPA, 1993, ACTA NEUROL SCAND, V88, P370, DOI 10.1111/j.1600-0404.1993.tb05360.x; HAKOLA HPA, 1990, PSYCHIAT FENNICA MON, V17; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; IANNACCONE S, 1992, CLIN NEUROPATHOL, V11, P49; IIVANAINEN M, 1984, J COMPUT ASSIST TOMO, V8, P940, DOI 10.1097/00004728-198410000-00025; IKONEN E, 1991, P NATL ACAD SCI USA, V88, P11222, DOI 10.1073/pnas.88.24.11222; ISOLA J, 1994, AM J PATHOL, V145, P1301; JARVI OH, 1995, FINSKA LAKARESALLSKA, V155, P39; JARVI OH, 1968, 7TH INT C INT AC PAT, P291; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KALIMO H, 1994, ACTA NEUROL SCAND, V89, P353; KAUPPINEN R, 1992, MOL CELL PROBE, V6, P527, DOI 10.1016/0890-8508(92)90050-8; KESTILA M, IN PRESS MOL CELL; KIM TW, 1995, MOL BRAIN RES, V32, P36, DOI 10.1016/0169-328X(95)00328-P; KITAJIMA I, 1989, J NEUROL SCI, V91, P35, DOI 10.1016/0022-510X(89)90074-9; KOCER N, 1994, SKELETAL RADIOL, V23, P577; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LENKKERI U, IN PRESS HUM GENET; MAEDA M, 1990, J BIOL CHEM, V265, P9027; MAKELA P, 1982, SKELETAL RADIOL, V8, P51; Malandrini A, 1996, BRAIN DEV-JPN, V18, P59, DOI 10.1016/0387-7604(95)00098-4; MANNIKKO M, 1995, AM J HUM GENET, V57, P1377; MATSUSHITA M, 1981, ACTA NEUROPATHOL, V54, P89, DOI 10.1007/BF00689400; Miller BL, 1997, BRIT J PSYCHIAT, V171, P1, DOI 10.1192/bjp.171.1.1; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; NIKALI K, 1995, AM J HUM GENET, V56, P1088; NORIO R, 1973, ANN CLIN RES, V5, P109; Nylander PO, 1996, CLIN GENET, V50, P353; NYLANDER PO, 1991, HUM HERED, V41, P157, DOI 10.1159/000153995; OHNO S, 1986, NUCLEIC ACIDS RES, V14, P5559; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1986, GENET EPIDEMIOL, P251; PAZZAGLIA UE, 1986, SKELETAL RADIOL, V15, P474, DOI 10.1007/BF00355109; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Penetrance Ott J., 1991, ANAL HUMAN GENETIC L, P146; PREZIUSO L, 1992, Chirurgia degli Organi di Movimento, V77, P205; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sourander P, 1981, INT S LEUK ALL DIS K, P87; STUBGEN JP, 1992, S AFR MED J, V81, P620; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; TAANMAN JW, 1989, NUCLEIC ACIDS RES, V17, P1766, DOI 10.1093/nar/17.4.1766; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; TERAYAMA K, 1961, J JPN ORTHOP ASSOC, V35, P626; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 1996, AM J HUM GENET, V58, P1095; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TRAM KKT, 1993, BIOCHEM MOL BIOL INT, V29, P981; VIRTAMA PEJ, 1990, PSYCHIAT FENNICA MON, V17; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Wijker M, 1996, HUM MOL GENET, V5, P151, DOI 10.1093/hmg/5.1.151; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; WOOD C, 1978, ARCH PATHOL LAB MED, V102, P22; Yamaoka LH, 1996, AM J HUM GENET, V59, P1306	73	38	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					362	372		10.1086/301722	http://dx.doi.org/10.1086/301722			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463329	Green Published, hybrid			2022-12-18	WOS:000072416000020
J	Brown, S; Yu, CC; Lanzano, P; Heller, D; Thomas, L; Warburton, D; Kitajewski, J; Stadtmauer, L				Brown, S; Yu, CC; Lanzano, P; Heller, D; Thomas, L; Warburton, D; Kitajewski, J; Stadtmauer, L			A de novo mutation (Gln2Stop) at the 5 ' end of the SRY gene leads to sex reversal with partial ovarian function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TESTIS-DETERMINING GENE; HMG BOX; GONADAL-DYSGENESIS; XY FEMALES; MISSENSE MUTATIONS; NONSENSE MUTATION; REGION		Columbia Univ, Dept Obstet & Gynecol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA; CUNY, Presbyterian Hosp, New York, NY USA; Harlem Hosp, Dept Pathol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; City University of New York (CUNY) System; NewYork-Presbyterian Hospital	Brown, S (corresponding author), Columbia Univ, Dept Obstet & Gynecol, PH 16,630 W 168th St, New York, NY 10032 USA.	brown@cuccfa.ccc.columbia.edu						AFFARA NA, 1993, HUM MOL GENET, V2, P785, DOI 10.1093/hmg/2.6.785; Epstein C.J, 1986, CONSEQUENCES CHROMOS; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; HALL JG, 1982, WESTERN J MED, V137, P32; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; HAWKINS JR, 1992, AM J HUM GENET, V51, P979; HAWKINS JR, 1994, HUM MOL GENET, V3, P1463, DOI 10.1093/hmg/3.suppl_1.1463; IIDA T, 1994, HUM MOL GENET, V3, P1437; JAGER RJ, 1992, HUM GENET, V90, P350; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; MCELREAVEY KD, 1992, GENOMICS, V13, P838, DOI 10.1016/0888-7543(92)90164-N; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; PAGE LA, 1990, PEDIATR RES, V28, P514, DOI 10.1203/00006450-199011000-00020; PALMER CG, 1976, HUM GENET, V35, P35, DOI 10.1007/BF00295617; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POULAT F, 1994, HUM MUTAT, V3, P200, DOI 10.1002/humu.1380030305; SCHMITT-NEY M, 1995, AM J HUM GENET, V56, P862; TAJIMA T, 1994, HUM MOL GENET, V3, P1187, DOI 10.1093/hmg/3.7.1187; ZENG YT, 1993, J MED GENET, V30, P655, DOI 10.1136/jmg.30.8.655	20	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					189	192		10.1086/301684	http://dx.doi.org/10.1086/301684			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443877	hybrid, Green Published			2022-12-18	WOS:000072127900024
J	Brown, MR; Tomek, MS; VanLaer, L; Smith, S; Kenyon, JB; VanCamp, G; Smith, RJH				Brown, MR; Tomek, MS; VanLaer, L; Smith, S; Kenyon, JB; VanCamp, G; Smith, RJH			A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA13, maps to chromosome 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE POU3F4; DEAFNESS	Nonsyndromic hearing loss (NSHL) is the most common type of hearing impairment in the elderly. Environmental and hereditary factors play an etiologic role, although the relative contribution of each is unknown. To date, 39 NSHL genes have been localized. Twelve produce autosomal dominant hearing loss, most frequently postlingual in onset and progressive in nature. We have ascertained a large, multigenerational family in which a gene for autosomal dominant NSHL is segregating. Affected individuals experience progressive hearing loss beginning in the 2d-4th decades, eventually making the use of amplification mandatory. A novel locus, DFNA13, was identified on chromosome 6p; the disease gene maps to a 4-cM interval flanked by D6S1663 and D6S1691, with a maximum two-point LOD score of 6.409 at D6S299.	DEPT OTORHINOLARYNGOL HEAD & NECK SURG, MOL OTOLARYNGOL RES LABS, IOWA CITY, IA USA; DEPT MED GENET, ANTWERP, BELGIUM; BOYS TOWN NATL RES HOSP, OMAHA, NE 68131 USA	Boys Town National Research Hospital			Van Camp, Guy/F-3386-2013	Van Camp, Guy/0000-0001-5105-9000; Smith, Richard/0000-0003-1201-6731				BRUNNER HG, 1994, HUM MOL GENET, V3, P1561, DOI 10.1093/hmg/3.9.1561; Cao MY, 1996, ANN OTO RHINOL LARYN, V105, P628; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; GREINWALD JH, IN PRESS GENOME RES; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GUILLAUDEUX T, 1993, CYTOGENET CELL GENET, V63, P212, DOI 10.1159/000133537; HANSON IM, 1989, GENOMICS, V5, P925, DOI 10.1016/0888-7543(89)90135-3; KIRSCHHOFER K, 1996, 2 WORKSH EUR WORKGR; LYON MF, 1990, GENETIC VARIANTS STR; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; VanCamp G, 1997, AM J HUM GENET, V60, P758; Verhoeven K, 1997, AM J HUM GENET, V60, P1168	19	38	39	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					924	927		10.1086/514892	http://dx.doi.org/10.1086/514892			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382104	Bronze, Green Published			2022-12-18	WOS:A1997YA59100020
J	Elston, RC				Elston, RC			Algorithms and inferences: The challenge of multifactorial diseases 1996 WILLIAM ALLAN AWARD ADDRESS - Algorithms and inferences: The challenge of multifactorial diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX TRAITS; LINKAGE		CASE WESTERN RESERVE UNIV,DEPT EPIDEMIOL & BIOSTAT,RAMMELKAMP CTR EDUC & RES,CLEVELAND,OH 44106	Case Western Reserve University; MetroHealth System					NCRR NIH HHS [RR03655] Funding Source: Medline; NIGMS NIH HHS [GM 28356] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNARD GA, 1949, J R STAT SOC B, V11, P116; Blangero J, 1995, GENET EPIDEMIOL, V12, P689, DOI 10.1002/gepi.1370120628; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, BEHAV GENET, V3, P101, DOI 10.1007/BF01067650; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1996, NAT GENET, V12, P355; MALECOT G, 1947, ANN U LYON, V10, P43; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1985, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; SMITH CAB, 1959, AM J HUM GENET, V11, P289; WHITTEMORE AS, 1996, AM J HUM GENET, V59, P519; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355	16	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					255	262						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012396				2022-12-18	WOS:A1997WE93100002
J	Bowen, T; Guy, C; Speight, G; Jones, L; Cardno, A; Murphy, K; McGuffin, P; Owen, MJ; ODonovan, MC				Bowen, T; Guy, C; Speight, G; Jones, L; Cardno, A; Murphy, K; McGuffin, P; Owen, MJ; ODonovan, MC			Expansion of 50 CAG/CTG repeats excluded in schizophrenia by application of a highly efficient approach using repeat expansion detection and a PCR screening set	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE	Studies of the transmission of schizophrenia in families with affected members in several generations have suggested that an expanded trinucleotide repeat mechanism may contribute to the genetic inheritance of this disorder. Using repeat expansion detection (RED), we and others have previously found that the distribution of CAG/CTG repeat size is larger in patients with schizophrenia than in controls. In an attempt to identify the specific expanded CAG/CTG locus or loci associated with schizophrenia, we have now used an approach based on a CAG/CTG PCR screening set combined with RED data. This has allowed us to minimize genotyping while excluding 43 polymorphic autosomal loci and 7 X-chromosomal loci from the screening set as candidates for expansion in schizophrenia with a very high degree of confidence.	UNIV WALES COLL CARDIFF,COLL MED,DEPT PSYCHOL MED,CARDIFF CF4 4XN,S GLAM,WALES; UNIV WALES COLL CARDIFF,COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES	Cardiff University; Cardiff University			O'Donovan, Michael C/P-7005-2018; McGuffin, Peter/A-1565-2012	O'Donovan, Michael C/0000-0001-7073-2379; McGuffin, Peter/0000-0002-9888-2907; Murphy, Kieran/0000-0003-2930-4465	MRC [G9309834] Funding Source: UKRI; Medical Research Council [G9309834] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; GASTIER JM, 1996, GENOMICS, V32, P74; Haaf T, 1996, NAT GENET, V12, P183, DOI 10.1038/ng0296-183; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Margolis RL, 1996, HUM MOL GENET, V5, P607, DOI 10.1093/hmg/5.5.607; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; MORRISON PJ, 1993, LANCET, V342, P385; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ODonovan MC, 1996, PSYCHOL MED, V26, P1, DOI 10.1017/S0033291700033663; ODONOVAN MC, IN PRESS PSYCHOL MED; PENROSE LS, 1991, EUR ARCH CLIN NEUROS, V240, P314; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; STALLINGS RL, 1994, GENOMICS, V21, P116, DOI 10.1006/geno.1994.1232; Vincent JB, 1996, MOL PSYCHIATR, V1, P141; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; XU Y, 1995, COMPUT APPL BIOSCI, V11, P117	18	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					912	917						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808608				2022-12-18	WOS:A1996VL28300022
J	Anderson, TI; Borresen, AL; Moller, P				Anderson, TI; Borresen, AL; Moller, P			A common BRCA1 mutation in Norwegian breast and ovarian cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT GENET,N-0310 OSLO,NORWAY; NORWEGIAN RADIUM HOSP,DEPT ONCOL,UNIT MED GENET,N-0310 OSLO,NORWAY	University of Oslo; University of Oslo								COUCH FJ, IN PRESS HUM MUTAT; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOLLER P, 1993, J CANC CARE, V2, P94; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198	5	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					486	487						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755943				2022-12-18	WOS:A1996VM28800033
J	Paterson, AD; Kennedy, JL; Petronis, A				Paterson, AD; Kennedy, JL; Petronis, A			Evidence for genetic anticipation in non-mendelian diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							BREAST-OVARIAN CANCER; FAMILIAL ALZHEIMER-DISEASE; DEPENDENT DIABETES-MELLITUS; CHROMOSOME REGION 17Q12-Q21; NONPOLYPOSIS COLON-CANCER; LINKAGE ANALYSIS; COLORECTAL-CANCER; BRCA1; MARKERS; LOCUS		CLARKE INST PSYCHIAT, NEUROGENET SECT, TORONTO, ON M5T 1R8, CANADA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada			Paterson, Andrew D/A-4088-2011; Petronis, Art/AAD-4491-2019	Paterson, Andrew D/0000-0002-9169-118X; 				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; ARASON A, 1993, AM J HUM GENET, V52, P711; BASSETT AS, 1994, AM J HUM GENET, V54, P864; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; COHEN BB, 1993, AM J HUM GENET, V52, P723; COOK RH, 1979, NEUROLOGY, V29, P1402, DOI 10.1212/WNL.29.10.1402; DAI ZH, 1991, CHIN J NEUROL PSYCHI, V24, P111; DEIGHTON C, 1994, ANN RHEUM DIS, V53, P833, DOI 10.1136/ard.53.12.833; DEVILEE P, 1993, AM J HUM GENET, V52, P730; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FITCH N, 1988, ANN NEUROL, V23, P14, DOI 10.1002/ana.410230104; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GREEN RC, 1994, AM J HUM GENET, V54, P1067; Gregor P, 1992, Cor Vasa, V34, P218; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALTIA M, 1994, ANN NEUROL, V36, P362, DOI 10.1002/ana.410360307; HANSON RL, 1995, AM J HUM GENET, V57, P160; INOUE R, 1994, JPN J CANCER RES, V85, P1233, DOI 10.1111/j.1349-7006.1994.tb02935.x; KAMINO K, 1992, AM J HUM GENET, V51, P998; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LINDBLOM A, 1993, AM J HUM GENET, V52, P749; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; LYNCH HT, 1991, SEMIN ONCOL, V18, P337; LYNCH HT, 1991, CANCER GENET CYTOGEN, V52, P161; MANDEL JL, 1994, NAT GENET, V7, P453, DOI 10.1038/ng0894-453; MAZOYER S, 1993, AM J HUM GENET, V52, P754; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MCINNIS MG, 1994, AM J HUM GENET, V55, P590; Mott FW, 1911, LANCET, V1, P1251; NAROD SA, 1995, AM J HUM GENET, V56, P254; PAYAMI H, 1995, NEUROLOGY, V45, P135, DOI 10.1212/WNL.45.1.135; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PETRONIS A, 1995, CLIN NEUROSCI, V3, P76; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; RAPHAEL SA, 1993, AM J DIS CHILD, V147, P842, DOI 10.1001/archpedi.1993.02160320044017; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1993, AM J HUM GENET, V52, P767; SOLTESZ G, 1994, NATO ADV SCI INST SE, V270, P47; SORBI S, 1993, NAT GENET, V4, P10, DOI 10.1038/ng0593-10; SPURR NK, 1993, AM J HUM GENET, V52, P777; TEARE MD, 1993, AM J HUM GENET, V52, P786; TONIN P, 1994, HUM MOL GENET, V3, P1679, DOI 10.1093/hmg/3.9.1679; VANDERMEY AGL, 1989, LANCET, V2, P1291; VANDUIJN CM, 1994, AM J HUM GENET, V55, P714; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; ZUPPAN P, 1991, AM J HUM GENET, V48, P1065	52	38	38	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					264	268						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659536				2022-12-18	WOS:A1996VL45500038
J	Delahunty, C; Ankener, W; Deng, Q; Eng, J; Nickerson, DA				Delahunty, C; Ankener, W; Deng, Q; Eng, J; Nickerson, DA			Testing the feasibility of DNA typing for human identification by PCR and an oligonucleotide ligation assay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; GENETIC-LINKAGE MAP; TANDEM REPEAT LOCI; AMPLIFICATION; MARKERS; POLYMORPHISMS; FINGERPRINTS; POPULATION; SAMPLES; EXPERIENCE	The use of DNA typing in human genome analysis is increasing and finding widespread application in the area of forensic and paternity testing. In this report, we explore the feasibility of typing single nucleotide polymorphisms (SNPs) by using a semiautomated method for analyzing human DNA samples. In this approach, PCR is used to amplify segments of human DNA containing a common SNP. Allelic nucleotides in the amplified product are then typed by a colorimetric implementation of the oligonucleotide ligation assay (OLA). The results of the combined assay, PCR/OLA, are read directly by a spectrophotometer; the absorbances are compiled; and the genotypes are automatically determined. A panel of 20 markers has been developed for DNA typing and has been tested using a sample panel from the CEPH pedigrees (CEPH parents). The results of this typing, as well as the potential to apply this method to larger populations, are discussed.	UNIV WASHINGTON,DEPT MOLEC BIOTECHNOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle			Eng, Jimmy K/I-4202-2012	Eng, Jimmy K/0000-0001-6352-6737	NHGRI NIH HHS [HG-00464] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000464] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARTELS CF, 1990, NUCLEIC ACIDS RES, V18, P6171, DOI 10.1093/nar/18.20.6171-a; BLAKE E, 1992, J FORENSIC SCI, V37, P700; BOCK SC, 1983, NUCLEIC ACIDS RES, V11, P8569, DOI 10.1093/nar/11.24.8569; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COMEY CT, 1993, J FORENSIC SCI, V38, P239; COSSO S, 1995, J FORENSIC SCI, V40, P424; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GILL P, 1994, FORENSIC SCI INT, V65, P51, DOI 10.1016/0379-0738(94)90299-2; GREEN P, 1992, AM J HUM GENET, V50, P440; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; HANSEN HE, 1993, FORENSIC SCI INT, V60, P23, DOI 10.1016/0379-0738(93)90089-S; HANSEN T, 1992, SCAND J IMMUNOL, V36, P285, DOI 10.1111/j.1365-3083.1992.tb03101.x; HILTUNEN T, 1994, BIOTECHNIQUES, V17, P240; HOCHMEISTER MN, 1991, INT J LEGAL MED, V104, P229, DOI 10.1007/BF01369812; HOCHMEISTER MN, 1995, J FORENSIC SCI, V40, P649; HOCHMEISTER MN, 1991, J FORENSIC SCI, V36, P1649; HOLGERSSON S, 1994, ELECTROPHORESIS, V15, P890, DOI 10.1002/elps.11501501127; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1986, AM J HUM GENET, V39, P11; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; KIMPTON CP, 1993, PCR METH APPL, V3, P13; KUNKEL GR, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961-a; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LANDER ES, 1994, NATURE, V371, P735, DOI 10.1038/371735a0; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LANGE K, 1993, AM J HUM GENET, V52, P305; LEE JCI, 1992, J FORENSIC SCI, V37, P1269; LEITERSDORF E, 1988, NUCLEIC ACIDS RES, V16, P7215, DOI 10.1093/nar/16.14.7215; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; MARCHETTI G, 1993, HUM MOL GENET, V2, P1055, DOI 10.1093/hmg/2.7.1055; MCEWEN JE, 1994, AM J HUM GENET, V54, P941; MONSON KL, 1993, J FORENSIC SCI, V38, P1037; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; MURRAY V, 1993, NUCLEIC ACIDS RES, V21, P2395, DOI 10.1093/nar/21.10.2395; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; OWEN F, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; PENA SDJ, 1994, TRENDS GENET, V10, P204, DOI 10.1016/0168-9525(94)90257-7; PERLIN MW, 1995, AM J HUM GENET, V57, P1199; REYNOLDS R, 1991, ANAL CHEM, V63, P2, DOI 10.1021/ac00001a002; ROEWER L, 1992, FORENSIC SCI INT, V53, P163, DOI 10.1016/0379-0738(92)90193-Z; SAJANTILA A, 1991, FORENSIC SCI INT, V51, P23, DOI 10.1016/0379-0738(91)90203-U; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; SCHNEIDER PM, 1993, INT J LEGAL MED, V105, P295, DOI 10.1007/BF01370388; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; SYVANEN AC, 1994, HUM MUTAT, V3, P172, DOI 10.1002/humu.1380030303; TSUNEYOSHI T, 1991, NUCLEIC ACIDS RES, V19, P4571, DOI 10.1093/nar/19.16.4571-a; WALSH PS, 1991, J FORENSIC SCI, V36, P1551; WESTWOOD SA, 1990, FORENSIC SCI INT, V45, P201, DOI 10.1016/0379-0738(90)90176-Y; WHITAKER JP, 1995, BIOTECHNIQUES, V18, P670; YANDELL DW, 1989, AM J HUM GENET, V45, P547	61	38	51	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1239	1246						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651301				2022-12-18	WOS:A1996UM27100017
J	Virtaneva, K; Miao, JM; Traskelin, AL; Stone, N; Warrington, JA; Weissenbach, J; Myers, RM; Cox, DR; Sistonen, P; delaChapelle, A; Lehesjoki, AE				Virtaneva, K; Miao, JM; Traskelin, AL; Stone, N; Warrington, JA; Weissenbach, J; Myers, RM; Cox, DR; Sistonen, P; delaChapelle, A; Lehesjoki, AE			Progressive myoclonus epilepsy EPM1 locus maps to a 175-kb interval in distal 21q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNVERRICHT-LUNDBORG; GENE; LINKAGE; CHROMOSOME-21; LOCALIZATION; POPULATIONS; FINLAND	The EPM1 locus responsible for progressive myoclonus epilepsy of Unverricht-Lundborg type (MIM 254800) maps to a region in distal chromosome 21q where positional cloning has been hampered by the lack of physical and genetic mapping resolution. We here report the use of a recently constituted contig of cosmid, BAC, and P1 clones that allowed new polymorphic markers to be positioned. These were typed in 53 unrelated disease families from an isolated Finnish population in which a putative single ancestral EPM1 mutation has segregated for an estimated 100 generations. By thus exploiting historical recombinations in haplotype analysis, EPM1 could be assigned to the similar to 175-kb interval between the markers D21S2040 and D21S1259.	HELSINKI UNIV,DEPT MED GENET,FIN-00014 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,HELSINKI,FINLAND; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305; GENETHON SA,CNRS,URA 1922,EVRY,FRANCE	University of Helsinki; Stanford University; Centre National de la Recherche Scientifique (CNRS)					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031831] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00206] Funding Source: Medline; NICHD NIH HHS [HD24610] Funding Source: Medline; NINDS NIH HHS [NS31831] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Faham M, 1995, GENOME RES, V5, P474, DOI 10.1101/gr.5.5.474; GARDINER K, 1995, GENOMICS, V30, P376, DOI 10.1006/geno.1995.0035; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V57, P1486; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; KOSKINIEMI M, 1990, PAEDIATRIC EPILEPSY, P137; LEHESJOKI AE, 1992, NEUROLOGY, V42, P1545, DOI 10.1212/WNL.42.8.1545; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEHESJOKI AE, 1993, NEUROLOGY, V43, P2384, DOI 10.1212/WNL.43.11.2384; MANNIKKO M, 1995, AM J HUM GENET, V57, P1377; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NIKALI K, 1995, AM J HUM GENET, V56, P1088; NORIO R, 1979, CLIN GENET, V15, P382; Norio R., 1981, BIOCULTURAL ASPECTS, P359; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517; Stone NE, 1996, GENOME RES, V6, P218, DOI 10.1101/gr.6.3.218; SULISALO T, 1994, AM J HUM GENET, V55, P937; Tahvanainen E, 1995, GENOMICS, V30, P409, DOI 10.1006/geno.1995.1258; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777	26	38	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1247	1253						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651302				2022-12-18	WOS:A1996UM27100018
J	Wiggs, JL; Damji, KF; Haines, JL; PericakVance, MA; Allingham, RR				Wiggs, JL; Damji, KF; Haines, JL; PericakVance, MA; Allingham, RR			The distinction between juvenile and adult-onset primary open-angle glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE		TUFTS UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02111; TUFTS UNIV,SACKLER SCH GRAD BIOMED SCI,DIV GENET,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02114; DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT OPHTHALMOL,DURHAM,NC 27710	Tufts University; Tufts University; Harvard University; Massachusetts General Hospital; Duke University; Duke University					NEI NIH HHS [R01 EY009847] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARMALY MF, 1969, ARCH OPHTHALMOL-CHIC, V81, P25, DOI 10.1001/archopht.1969.00990010027005; ARMALY MF, 1962, INVEST OPHTH VISUAL, V1, P618; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Wiggs JL, 1995, OPHTHALMOLOGY, V102, P1782, DOI 10.1016/S0161-6420(95)30793-2; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269	8	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					243	244						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554064				2022-12-18	WOS:A1996TL69700031
J	SILVERMAN, GA; SCHNEIDER, SS; MASSA, HF; FLINT, A; LALANDE, M; LEONARD, JC; OVERHAUSER, J; VANDENENGH, G; TRASK, BJ				SILVERMAN, GA; SCHNEIDER, SS; MASSA, HF; FLINT, A; LALANDE, M; LEONARD, JC; OVERHAUSER, J; VANDENENGH, G; TRASK, BJ			THE 18Q(-) SYNDROME - ANALYSIS OF CHROMOSOMES BY BIVARIATE FLOW KARYOTYPING AND THE PCR REVEALS A SUCCESSIVE SET OF DELETION BREAKPOINTS WITHIN 18Q21.2-Q22.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTIGUOUS GENE SYNDROMES; SHIVERER MUTATION; LONG ARM; MYELIN; EXPRESSION; LINKAGE; BRAIN; CELL; BCL2	The 18q(-) syndrome is one of several terminal deletion disorders that occur in humans. Previous G-banding studies suggest that the loss of a critical band, 18q21.3, results in mental retardation, craniofacial anomalies, and metabolic defects. However, it is difficult to reconcile the consistent loss of a single region with the large variability in clinical phenotype. The purpose of this study was to reassess the extent of chromosomal loss in a cohort of 17 18q(-) syndrome patients by using fluorescent-activated chromosome sorting, PCR, and FISH. Bivariate now karyotypes revealed heterogeneity among the deletions; they ranged in size from 9 to 26 Mb. To confirm this heterogeneity at a molecular level, deleted and normal chromosomes 18 of six patients were collected by now sorting, preamplified by random priming, and assayed for marker content by the PCR. This analysis defined five unique breakpoints among the six patients. We conclude that the terminal deletions in the 18q(-) syndrome occur over a broad region spanning the interval from 18q21.2 to 18q22.2. Our results suggest that the variability in clinical phenotype may be more representative of a contiguous-gene syndrome with a baseline deficit of 18q22.2-qter than of the loss of a single critical region within 18q21.3.	HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; UNIV WASHINGTON, DEPT MOLEC BIOTECHNOL, SEATTLE, WA 98195 USA; CORIELL INST MED RES, CAMDEN, NJ USA; THOMAS JEFFERSON UNIV, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA	Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Coriell Institute for Medical Research; Jefferson University			Silverman, Gary/AAJ-1269-2020		NICHD NIH HHS [HD18655, HD28475] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028475, R29HD028475] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARBARESE E, 1983, J NEUROCHEM, V40, P1680, DOI 10.1111/j.1471-4159.1983.tb08142.x; BRACKWERNER R, 1989, GENOMICS, V4, P68, DOI 10.1016/0888-7543(89)90316-9; BRENNER DA, 1992, AM J HUM GENET, V50, P1203; CAMMER W, 1984, J NEUROCHEM, V42, P1372, DOI 10.1111/j.1471-4159.1984.tb02797.x; CHASALOW FI, 1986, STEROIDS, V47, P421, DOI 10.1016/0039-128X(86)90057-7; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; DE GROUCHY J, 1964, Pathol Biol, V12, P579; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FELDING I, 1987, CLIN GENET, V31, P206; FINLEY S C, 1969, Journal of Medical Genetics, V6, P388, DOI 10.1136/jmg.6.4.388; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HENROT B, 1989, ARCH FR PEDIATR, V46, P729; HINDI A, 1986, J MED GENET, V23, P263, DOI 10.1136/jmg.23.3.263; HUI SM, IN PRESS GENOMICS; KLINE AD, 1993, AM J HUM GENET, V52, P895; KRISTJANSSON K, 1994, NAT GENET, V6, P19, DOI 10.1038/ng0194-19; KROISEL PM, 1994, CYTOGENET CELL GENET, V65, P97, DOI 10.1159/000133609; LEBEAU MM, 1993, CYTOGENET CELL GENET, V63, P77, DOI 10.1159/000133508; LEJEUNE J, 1966, ANN GENET-PARIS, V9, pG32; LURIE IW, 1972, HUMANGENETIK, V15, P203, DOI 10.1007/BF00702354; MAGNESS ST, 1994, HUM MOL GENET, V3, P1695, DOI 10.1093/hmg/3.9.1695; MILLER G, 1990, AM J MED GENET, V37, P128, DOI 10.1002/ajmg.1320370130; NAYLOR EW, 1978, J MED GENET, V15, P157, DOI 10.1136/jmg.15.2.157; Overhauser Joan, 1993, V384, P175; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; SCHINZEL A, 1975, HUMANGENETIK, V26, P123; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Schreck R. R., 1994, CURRENT PROTOCOLS HU; SILVERMAN GA, 1991, GENOMICS, V9, P219, DOI 10.1016/0888-7543(91)90245-A; SILVERMAN GA, 1993, GENOMICS, V15, P442, DOI 10.1006/geno.1993.1086; SILVERMAN GA, 1993, MOL CELL BIOL, V13, P5469, DOI 10.1128/MCB.13.9.5469; STRATHDEE G, 1994, AM J HUM GENET, V54, P1085; STRICKER RB, 1982, JAMA-J AM MED ASSOC, V248, P1359, DOI 10.1001/jama.248.11.1359; SUGDEN B, 1977, J VIROL, V23, P503, DOI 10.1128/JVI.23.3.503-508.1977; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; TRASK B, 1989, AM J HUM GENET, V45, P739; TRASK B, 1990, CYTOMETRY, V11, P184, DOI 10.1002/cyto.990110121; TRASK BJ, 1991, FUNCTIONAL ORG NUCL, P3; VANDEVANTER DR, 1994, P NATL ACAD SCI USA, V91, P5858, DOI 10.1073/pnas.91.13.5858; VANKESSEL AG, 1994, CYTOGENET CELL GENET, V65, P142; VOGEL H, 1990, DEV MED CHILD NEUROL, V32, P732; WERTELECKI W, 1971, J PEDIATR-US, V78, P44, DOI 10.1016/S0022-3476(71)80262-7; WILSON MG, 1979, AM J MED GENET, V3, P155, DOI 10.1002/ajmg.1320030207; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	48	38	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					926	937						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717403				2022-12-18	WOS:A1995QP66300014
J	FRIDOVICHKEIL, JL; LANGLEY, SD; MAZUR, LA; LENNON, JC; DEMBURE, PP; ELSAS, LJ				FRIDOVICHKEIL, JL; LANGLEY, SD; MAZUR, LA; LENNON, JC; DEMBURE, PP; ELSAS, LJ			IDENTIFICATION AND FUNCTIONAL-ANALYSIS OF 3 DISTINCT MUTATIONS IN THE HUMAN GALACTOSE-1-PHOSPHATE URIDYLTRANSFERASE GENE ASSOCIATED WITH GALACTOSEMIA IN A SINGLE-FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URIDYL TRANSFERASE; URIDYLYLTRANSFERASE	We have identified three mutations associated with transferase-deficiency galactosemia in a three-generation family including affected members in two generations and have modeled all three mutations in a yeast-expression system. A sequence of pedigree, biochemical, and molecular analyses of the galactose-l-phosphate uridyltransferase (GALT) enzyme and genetic locus in both affected and carrier individuals revealed three distinct base substitutions in this family, two (Q188R and S135L) that had been reported previously and one (V151A) that was novel. Biochemical analyses of red-blood-cell lysates from the relevant family members suggested that each of these mutations was associated with dramatic impairment of GALT activity in these cells. While this observation was consistent with our previous findings concerning the Q188R mutation expressed both in humans and in a yeast-model system, it was at odds with a report by Reichardt and colleagues, indicating that in their COS cell-expression system the S135L substitution behaved as a neutral polymorphism. To address this apparent paradox, as well as to investigate the functional significance of the newly identified V151A substitution, all three mutations were recreated by site-directed mutagenesis of the otherwise wild-type human GALT sequence and were expressed both individually and in the appropriate allelic combinations in a GALT-deficient strain of the yeast Saccharomyces cerevisiae. The results of these yeast-modeling studies were fully consistent with the patient data, leading us to conclude that, at least within the context of the cell types studied, in the homozygous state Q188R is a mutation that eliminates GALT activity, and S135L and V151A are both mutations that impair GALT activity to <6% of wild-type values.	EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA	Emory University	FRIDOVICHKEIL, JL (corresponding author), EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ROOM 429B,1462 CLIFTON RD NE,ATLANTA,GA 30322, USA.				NCRR NIH HHS [MO1-RR00039] Funding Source: Medline; NICHD NIH HHS [P01-1-HD-29847-0] Funding Source: Medline; NIDDK NIH HHS [1-R29-DK46403-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD029847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046403] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 1965, LANCET, V1, P353; BEUTLER E, 1966, J LAB CLIN MED, V68, P137; ELSAS LJ, 1995, AM J HUM GENET, V56, P630; ELSAS LJ, 1994, AM J HUM GENET, V54, P1030; ELSAS LJ, IN PRESS EUR J PEDIA; Elsas LJ, 1993, INT PEDIATR, V8, P101; FLACH JE, 1990, MOL BIOL MED, V7, P365; FRIDOVICHKEIL JL, 1993, P NATL ACAD SCI USA, V90, P398, DOI 10.1073/pnas.90.2.398; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P199; LEE JES, 1982, CLIN CHIM ACTA, V124, P351, DOI 10.1016/0009-8981(82)90429-6; LESLIE ND, 1992, GENOMICS, V14, P474, DOI 10.1016/S0888-7543(05)80244-7; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; MELLMAN WJ, 1965, J LAB CLIN MED, V66, P980; NG WG, 1967, CLIN CHIM ACTA, V15, P489, DOI 10.1016/0009-8981(67)90014-9; REICHARDT JKV, 1988, MOL BIOL MED, V5, P107; REICHARDT JKV, 1991, AM J HUM GENET, V49, P860; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; REICHARDT JKV, 1992, GENOMICS, V12, P596, DOI 10.1016/0888-7543(92)90453-Y; Sambrook J., 1989, MOL CLONING LAB MANU; Segal S, 1989, METABOLIC BASIS INHE, P453; VANKAMPEN EJ, 1974, CLIN CHEM PRINCIPLES, P1131	22	38	40	2	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					640	646						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887417				2022-12-18	WOS:A1995QK91800012
J	ESTOP, AM; MARQUEZ, C; MUNNE, S; NAVARRO, J; CIEPLY, K; VANKIRK, V; MARTORELL, MR; BENET, J; TEMPLADO, C				ESTOP, AM; MARQUEZ, C; MUNNE, S; NAVARRO, J; CIEPLY, K; VANKIRK, V; MARTORELL, MR; BENET, J; TEMPLADO, C			AN ANALYSIS OF HUMAN SPERM CHROMOSOME BREAKPOINTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT-LETHAL MUTATIONS; HUMAN SPERMATOZOA; MOUSE EGGS; NORMAL MEN; MALE-MICE; ABNORMALITIES; INVITRO; REPAIR; TRANSLOCATION; CAPACITATION	Sperm chromosome analysis of 19 sperm donors with either normal or balanced karyotypes was carried out in order to explore the nature of sperm chromosome structural aberrations. A total of 2,389 cells (range 36-298/donor) were karyotyped after in vitro penetration of hamster eggs. The median percentage of sperm structural aberrations was 9.3% (SD +/- 4.7; range 0% +/- 17.8%), with a total of 247 breakpoints, of which 220 could be characterized fully. Two sets of donors were studied in two different centers: center 1 (United States) and center 2 (Spain). The frequencies of nonrejoined and rejoined chromosome-type aberrations were very similar between center 1 and center 2: 83.6% and 10.0%, and 75.0% and 10.3%, respectively. Chromatid-type aberrations were more frequent in center 2 (14.7%) than in center 1 (6.4%) (P = .037). Chromosome 4 had less than the expected number of breakpoints (P < .001). A positive significant correlation was found between sperm breakpoints reported in this study and sites of balanced chromosome de novo rearrangements detected at prenatal diagnosis and reported in the literature (P = .0001).	WESTERN PENN HOSP,DEPT MED GENET,PITTSBURGH,PA 15224; UNIV AUTONOMA BARCELONA,DEPT CELL BIOL,E-08193 BARCELONA,SPAIN	West Penn Hospital; Autonomous University of Barcelona	ESTOP, AM (corresponding author), UNIV PITTSBURGH,ALLEGHENY SINGER RES INST,DEPT HUMAN GENET,320 E N AVE,PITTSBURGH,PA 15212, USA.		Benet, Jordi/I-1690-2017; Moreno, Victor/A-1697-2010	Benet, Jordi/0000-0001-6185-2555; Moreno, Victor/0000-0002-2818-5487; Templado, Cristina/0000-0002-4602-9488; Navarro, Joaquima/0000-0002-9245-2260; Munne, Santiago/0000-0002-1088-5565				AULA P, 1976, HUM GENET, V32, P143, DOI 10.1007/BF00291497; BENET J, 1992, HUM GENET, V89, P176; BENET J, 1991, HUM REPROD, V6, P369, DOI 10.1093/oxfordjournals.humrep.a137342; BENET J, 1989, HUM GENET, V81, P239; BRANDRIFF BF, 1988, CYTOGENET CELL GENET, V47, P29, DOI 10.1159/000132500; EHLING UH, 1988, MUTAT RES, V199, P21, DOI 10.1016/0027-5107(88)90226-6; EHLING UH, 1988, MUTAT RES, V199, P191; ESTOP AM, 1991, HUM GENET, V87, P447; ESTOP AM, 1992, HUM GENET, V89, P425; GENESCA A, 1992, HUM GENET, V89, P181; LUBS H, 1985, INT SYSTEM HUMAN CYT; MAGENIS RE, 1985, Y CHROMOSOME A, P537; MARTIN RH, 1987, AM J HUM GENET, V41, P484; MARTIN RH, 1983, CYTOGENET CELL GENET, V35, P252, DOI 10.1159/000131876; MARTIN RH, 1992, BIOL REPROD, V47, P268, DOI 10.1095/biolreprod47.2.268; MATSUDA Y, 1989, MUTAT RES, V210, P35, DOI 10.1016/0027-5107(89)90042-0; MATSUDA Y, 1988, MUTAT RES, V198, P131, DOI 10.1016/0027-5107(88)90048-6; MATTEI MG, 1979, CYTOGENET CELL GENET, V23, P95, DOI 10.1159/000131309; MIKAMO K, 1983, RAD INDUCED CHROMOSO, P432; MUNNE S, 1991, HUM REPROD, V6, P703, DOI 10.1093/oxfordjournals.humrep.a137412; MUNNE S, 1993, HUM REPROD, V8, P581, DOI 10.1093/oxfordjournals.humrep.a138100; NAVARRO J, 1993, AM J HUM GENET, V53, P214; OLSON SB, 1988, CYTOGENETICS MAMMALI, P583; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SANTALO J, 1986, J IN VITRO FERTIL EM, V2, P99; SEGA GA, 1976, MUTAT RES, V38, P217; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; TEMPLADO C, 1990, HUM GENET, V84, P159; TEMPLADO C, 1988, HUM GENET, V79, P24, DOI 10.1007/BF00291704; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WORKING PK, 1984, ENVIRON MUTAGEN, V6, P273, DOI 10.1002/em.2860060304; 1985, CYTOGENET CELL GENET, V21, P309; 1991, CYTOGENET CELL GENET, V58, P986	33	38	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					452	460						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847382				2022-12-18	WOS:A1995QF42300015
J	KETTERLING, RP; VIELHABER, E; SOMMER, SS				KETTERLING, RP; VIELHABER, E; SOMMER, SS			THE RATES OF C-C-]T-A AND G-C-]C-G TRANSVERSIONS AT CPG DINUCLEOTIDES IN THE HUMAN FACTOR-IX GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOPHILIA-B; NUCLEAR EXTRACTS; G.T MISPAIRS; HUMAN-CELLS; MUTATIONS; DELETIONS; DNA	We have identified eight independent transversions at CpG in 290 consecutive families with hemophilia B. These eight transversions account for 16.3% of all independent transversions in our sample, yet the expected frequency of CpG transversions at random in the factor IX gene is only 2.6% (P<.01). The aggregate data suggest that the two types of CpG transversions (G:C-->T:A and G:C-->C:G) possess similar mutation rates (24.8 X 10(-10) and 20.6 x 10(-10), respectively), which are about fivefold greater than the comparable rates for transversions at non-CpG dinucleotides. The enhancement of transversions at CpG suggests that the model by which mutations occur at CpG may need to be reevaluated. The relationship, if any, between deamination of 5-methyl cytosine and enhancement of transversions at CpG remains to be defined.	MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic				Ketterling, Rhett/0000-0001-6479-7897	NHLBI NIH HHS [R01 HL39762] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOTTEMA CDK, 1993, HUM GENET, V91, P496; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P839; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DIEM K, 1970, BINOMIAL DISTRIBUTIO, P85; DUTTON CM, 1993, HUM MUTAT, V2, P468, DOI 10.1002/humu.1380020607; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; GIANNELLI F, 1993, NUCLEIC ACIDS RES, V21, P3075, DOI 10.1093/nar/21.13.3075; GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; JACOBSON DP, 1993, AM J HUM GENET, V53, P443; KETTERLING RP, 1991, HUM GENET, V87, P333; KETTERLING RP, 1991, GENOMICS, V10, P1093, DOI 10.1016/0888-7543(91)90207-U; KNOLL A, UNPUB EVIDENCE PATTE; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; SARKAR G, 1991, NUCLEIC ACIDS RES, V19, P631, DOI 10.1093/nar/19.3.631; SOMMER SS, 1992, FASEB J, V6, P2767, DOI 10.1096/fasebj.6.10.1634040; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; VIELHABER E, UNPUB SPONTANEOUS NO; VOGEL F, 1975, ADV HUM GENET, V5, P223; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	28	38	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					831	835						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178822				2022-12-18	WOS:A1994NH39400012
J	KETTERLING, RP; VIELHABER, EL; LIND, TJ; THORLAND, EC; SOMMER, SS				KETTERLING, RP; VIELHABER, EL; LIND, TJ; THORLAND, EC; SOMMER, SS			THE RATES AND PATTERNS OF DELETIONS IN THE HUMAN FACTOR-IX GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOPHILIA-B; NUCLEOTIDE-SEQUENCE; MISSENSE MUTATIONS; MUSCULAR-DYSTROPHY; POINT MUTATIONS; MOLECULAR-BASIS; HUMAN GENOME; RECOMBINATION; DNA; POLYMORPHISMS	Deletions are commonly observed in genes with either segments of highly homologous sequences or excessive gene length. However, in the factor IX gene and in most genes, deletions (of greater than or equal to 21 bp) are uncommon. We have analyzed DNA from 290 families with hemophilia B (203 independent mutations) and have found 12 deletions >20 bp. Eleven of these are >2 kb (range >3-163 kb), and one is 1.1 kb. The junctions of the four deletions that are completely contained within the factor IX gene have been determined. A novel mutation occurred in patient HB128: the data suggest that a 26.8-kb deletion occurred between two segments of alternating purines and pyrimidines and that a 2.3-kb sense strand segment derived from the deleted region was inserted. For our sample of 203 independent mutations, we estimate the ''baseline'' rates of deletional mutation per base pair per generation as a function of size. The rate for large (>2 kb) deletions is exceedingly low. For every mutational event in which a given base is at the junction of a large deletion, there are an estimated 58 microdeletions (<20 bp) and 985 single-base substitutions at that base. Analysis of the nine reported deletion junctions in the factor IX gene literature reveals that (i) five are associated with inversions, orphan sequences, or sense strand insertions; (ii) four are simple deletions that display an excess of short direct repeats at their junctions; (iii) there is no dramatic clustering of junctions within the gene; and (iv) with the exception of alternating purines and pyrimidines, deletion junctions are not preferentially associated with repetitive DNA.	MAYO CLIN FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA	Mayo Clinic				Ketterling, Rhett/0000-0001-6479-7897	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL39762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANSON DS, 1988, EMBO J, V7, P2795, DOI 10.1002/j.1460-2075.1988.tb03134.x; ARIGA T, 1990, GENOMICS, V8, P607, DOI 10.1016/0888-7543(90)90246-Q; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BARRAI I, 1985, AM J HUM GENET, V37, P680; BERKVENS TM, 1990, GENOMICS, V7, P486, DOI 10.1016/0888-7543(90)90190-6; BLAHO JA, 1989, PROG NUCLEIC ACID RE, V37, P107; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; CHEN SH, 1990, AM J HUM GENET, V47, P1020; Diem K., 1970, SCI TABLES, VSeventh; DUTTON C, IN PRESS HUM GENET; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; GREEN PM, 1988, MOL BIOL MED, V5, P95; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HENTHORN PS, 1990, GENOMICS, V6, P226, DOI 10.1016/0888-7543(90)90561-8; HIGGS DR, 1989, BLOOD, V73, P1081; JURKA J, 1990, NUCLEIC ACIDS RES, V18, P137, DOI 10.1093/nar/18.1.137; KAPLAN DJ, 1991, NUCLEIC ACIDS RES, V19, P4731, DOI 10.1093/nar/19.17.4731; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KETTERLING RP, 1991, GENOMICS, V10, P1093, DOI 10.1016/0888-7543(91)90207-U; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KETTERLING RP, 1993, HUM MUTAT, V2, P53, DOI 10.1002/humu.1380020110; KILIMANN MW, 1992, HUM GENET, V89, P253; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LARSSON SA, 1982, ACTA MED SCAND, V212, P195; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LUDWIG M, 1992, AM J HUM GENET, V50, P164; MANDEL JL, 1989, NATURE, V339, P584, DOI 10.1038/339584a0; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NIEMANNSEYDE S, 1992, HUM GENET, V90, P65; NOGUCHI T, 1988, ONCOGENE, V3, P709; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; Peake IR, 1989, BRIT J HAEMATOL, V71, P1; PULAK RA, 1988, MOL CELL BIOL, V8, P3748, DOI 10.1128/MCB.8.9.3748; RICKE DO, 1992, NUCLEIC ACIDS RES, V20, P5233, DOI 10.1093/nar/20.19.5233; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; ROTHSTEIN R, 1987, MOL CELL BIOL, V7, P1198, DOI 10.1128/MCB.7.3.1198; SARKAR G, 1991, NUCLEIC ACIDS RES, V19, P631, DOI 10.1093/nar/19.3.631; SCULLEY DG, 1992, HUM GENET, V90, P195; SOLERA J, 1992, AM J HUM GENET, V50, P434; SOMMER SS, 1993, AM J HUM GENET, V52, P1016; SOMMER SS, 1992, FASEB J, V6, P2767, DOI 10.1096/fasebj.6.10.1634040; SOMMER SS, 1992, HUM GENET, V89, P295; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; Thompson A R, 1991, Prog Hemost Thromb, V10, P175; VNENCAKJONES CL, 1990, SCIENCE, V250, P1745, DOI 10.1126/science.1980158; VOGEL F, 1975, ADV HUM GENET, V5, P223; WINSHIP PR, 1989, LANCET, V1, P631; WOODSSAMUELS P, 1991, GENOMICS, V10, P94, DOI 10.1016/0888-7543(91)90489-2; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; ZHANG M, 1989, HUM GENET, V82, P283, DOI 10.1007/BF00291171	58	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					201	213						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304338				2022-12-18	WOS:A1994MU31500005
J	SCHWARTZ, CE				SCHWARTZ, CE			X-LINKED MENTAL-RETARDATION - IN PURSUIT OF A GENE MAP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							FORSSMAN-LEHMANN SYNDROME; ALLAN-HERNDON SYNDROME; MACRO-ORCHIDISM; GROWTH-RETARDATION; HUMAN-CHROMOSOMES; FRAGILE SITES; MARTIN-BELL; HYDROCEPHALUS; LOCALIZATION; DEFICIENCY				SCHWARTZ, CE (corresponding author), GREENWOOD GENET CTR, 1 GREGOR MENDEL CIRCLE, GREENWOOD, SC 29646 USA.							Allan W, 1944, AM J MENT DEF, V48, P325; Arena J. F., 1992, American Journal of Human Genetics, V51, pA181; Ash WM, 1922, BRIT MED J, V1922, P558, DOI 10.1136/bmj.1.3197.558; BIALER MG, 1992, AM J MED GENET, V43, P491, DOI 10.1002/ajmg.1320430173; BIEDERMAN B, 1977, BD OAS, V13, P224; Birch HG, 1970, MENTAL SUBNORMALITY; BORJESON M, 1962, ACTA MED SCAND, V171, P13; BOWEN P, 1978, AM J MED GENET, V2, P409, DOI 10.1002/ajmg.1320020410; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; DUNN HG, 1963, AM J MENT DEF, V67, P827; ESCALANTE JA, 1971, J GENET HUM, V19, P137; FOX P, 1980, AM J MED GENET, V7, P491, DOI 10.1002/ajmg.1320070409; FREZAL J, 1992, AM J MED GENET, V44, P854, DOI 10.1002/ajmg.1320440637; FRIED K, 1973, J MED GENET, V10, P17, DOI 10.1136/jmg.10.1.17; FRIED K, 1972, CLIN GENET, V3, P258; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; GLASS IA, 1991, J MED GENET, V28, P361, DOI 10.1136/jmg.28.6.361; GUSTAVSON KH, 1993, AM J MED GENET, V45, P654, DOI 10.1002/ajmg.1320450527; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; HOWARDPEEBLES PN, 1979, HUM GENET, V50, P247, DOI 10.1007/BF00399389; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; JENNINGS M, 1980, AM J MED GENET, V7, P417, DOI 10.1002/ajmg.1320070404; JUBERG RC, 1980, AM J HUM GENET, V32, P714; KERR B, 1991, J MED GENET, V28, P378, DOI 10.1136/jmg.28.6.378; LEWIS EO, 1929, REPORT INVESTIGATION; LOSOWSKY MS, 1961, J MENT DEFIC RES, V5, P60, DOI 10.1111/jir.1961.5.1.60; LUBS HA, 1969, AM J HUM GENET, V21, P231; LUJAN JE, 1984, AM J MED GENET, V17, P311, DOI 10.1002/ajmg.1320170124; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MATHEWS KD, 1989, AM J MED GENET, V34, P470, DOI 10.1002/ajmg.1320340403; MATTEI JF, 1983, CLIN GENET, V23, P70; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLEY JC, 1992, AM J MED GENET, V43, P383, DOI 10.1002/ajmg.1320430159; NERI G, 1991, AM J MED GENET, V38, P186, DOI 10.1002/ajmg.1320380204; NERI G, 1992, AM J MED GENET, V43, P373, DOI 10.1002/ajmg.1320430158; NORDSTROM AM, 1992, HUM GENET, V90, P263, DOI 10.1007/BF00220075; OPITZ JM, 1986, AM J MED GENET, V23, P1, DOI 10.1002/ajmg.1320230102; OPITZ JM, 1984, AM J MED GENET, V17, P5, DOI 10.1002/ajmg.1320170103; OPITZ JM, 1987, AM J MED GENET, V26, P37; PENROSE LS, 1938, SPECIAL REP SER, V229; PETTIGREW AL, 1991, AM J MED GENET, V38, P200, DOI 10.1002/ajmg.1320380206; Porteous M. E. M., 1992, American Journal of Human Genetics, V51, pA106; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; RICHARDS BW, 1981, J MENT DEFIC RES, V25, P253; Roberts JAF, 1937, BMJ-BRIT MED J, V1937, P1213; RUVALCABA RHA, 1977, JAMA-J AM MED ASSOC, V238, P1646, DOI 10.1001/jama.238.15.1646; SAMANNS C, 1991, AM J MED GENET, V38, P224, DOI 10.1002/ajmg.1320380210; SAUGIERVEBER P, 1993, AM J HUM GENET, V52, P1040; SCHWARTZ CE, 1990, AM J HUM GENET, V47, P454; SCHWARTZ CE, 1992, AM J MED GENET, V43, P467, DOI 10.1002/ajmg.1320430170; SCHWARTZ CE, 1991, BIOL PSYCHIAT, V2, P481; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; STEVENSON RE, 1990, AM J HUM GENET, V47, P446; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, HUM GENET, V48, P117, DOI 10.1007/BF00273283; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; Tranebjaerg L., 1992, American Journal of Human Genetics, V51, pA47; TURNER G, 1978, NEW ENGL J MED, V299, P1472; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; TURNER G, 1974, J MED GENET, V11, P109, DOI 10.1136/jmg.11.2.109; TURNER G, 1975, J MED GENET, V12, P367, DOI 10.1136/jmg.12.4.367; TURNER G, 1992, AM J MED GENET, V44, P855, DOI 10.1002/ajmg.1320440638; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VASQUEZ SB, 1979, J PEDIATR-US, V94, P56, DOI 10.1016/S0022-3476(79)80350-9; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILSON M, 1991, AM J MED GENET, V40, P406, DOI 10.1002/ajmg.1320400405; WING L, 1971, PSYCHOL MED, V1, P405, DOI 10.1017/S0033291700044792; YARBROUGH KM, 1976, CLIN GENET, V9, P125	74	38	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1025	1031						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503437				2022-12-18	WOS:A1993LG13300001
J	WANG, J; ZHOU, J; TODOROVIC, SM; FEERO, WG; BARANY, F; CONWIT, R; HAUSMANOWAPETRUSEWICZ, I; FIDZIANSKA, A; ARAHATA, K; WESSEL, HB; SILLEN, A; MARKS, HG; HARTLAGE, P; GALLOWAY, G; RICKER, K; LEHMANNHORN, F; HAYAKAWA, H; HOFFMAN, EP				WANG, J; ZHOU, J; TODOROVIC, SM; FEERO, WG; BARANY, F; CONWIT, R; HAUSMANOWAPETRUSEWICZ, I; FIDZIANSKA, A; ARAHATA, K; WESSEL, HB; SILLEN, A; MARKS, HG; HARTLAGE, P; GALLOWAY, G; RICKER, K; LEHMANNHORN, F; HAYAKAWA, H; HOFFMAN, EP			MOLECULAR-GENETIC AND GENETIC CORRELATIONS IN SODIUM CHANNELOPATHIES - LACK OF FOUNDER EFFECT AND EVIDENCE FOR A 2ND GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; CHANNEL ALPHA-SUBUNIT; PARAMYOTONIA-CONGENITA; LINKAGE; CHROMOSOME-17; POLYMORPHISMS; MYOTONIA; MUTATION; LOCUS	We present a correlation of molecular genetic data (mutations) and genetic data (dinucleotide-repeat polymorphisms) for a cohort of seven hyperkalemic periodic paralysis (HyperPP) and two paramyotonia congenita (PC) families from diverse ethnic backgrounds. We found that each of three previously identified point mutations of the adult skeletal muscle sodium-channel gene occurred on two different dinucleotide-repeat haplotypes. These results indicate that dinucleotide-repeat haplotypes are not predictive of allelic heterogeneity in sodium channelopathies, contrary to previous suggestions. In addition, we identified a HyperPP pedigree in which the dominant disorder was not linked to the sodium-channel gene. Thus, a second locus can give rise to a similar clinical phenotype. Some individuals in this pedigree exhibited a base change causing the nonconservative substitution of an evolutionarily conserved amino acid. Because this change was not present in 240 normal chromosomes and was near another HyperPP mutation, it fulfilled the most commonly used criteria for being a mutation rather than a polymorphism. However, linkage studies using single-strand conformation polymorphism-derived and sequence-derived haplotypes excluded this base change as a causative mutation: these data serve as a cautionary example of potential pitfalls in the delineation of change-of-function point mutations.	UNIV PITTSBURGH, SCH MED, DEPT MOLEC GENET & BIOCHEM, BIOMED SCI TOWER W1211, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROL, PITTSBURGH, PA 15261 USA; CHILDRENS HOSP, PITTSBURGH, PA 15213 USA; UNIV BELGRADE, PEDIAT NEUROL & PSYCHIAT CLIN, BELGRADE, YUGOSLAVIA; CORNELL UNIV, MED CTR, COLL MED, DEPT MICROBIOL, NEW YORK, NY 10021 USA; POLISH ACAD SCI, NEUROMUSCULAR UNIT, WARSAW 42, POLAND; NATL INST NEUROSCI, DIV NEUROMUSCULAR RES, TOKYO, JAPAN; UNIV UPPSALA HOSP, DEPT CLIN GENET, S-75014 UPPSALA, SWEDEN; DUPONT CO INC, DEPT NEUROL, WILMINGTON, DE 19898 USA; MED COLL GEORGIA, AUGUSTA, GA 30912 USA; UNIV WURZBURG, NEUROL CLIN, W-8700 WURZBURG, GERMANY; UNIV ULM, DEPT PHYSIOL, W-7900 ULM, GERMANY; HITACHI GEN HOSP, PEDIAT CLIN, HITACHI, JAPAN	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Belgrade; Cornell University; Polish Academy of Sciences; National Center for Neurology & Psychiatry - Japan; Uppsala University; Uppsala University Hospital; DuPont; University System of Georgia; Augusta University; University of Wurzburg; Ulm University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; DAVIES K, 1992, NAT GENET, V1, P231; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; EULENBURG A, 1886, ZENTRALBL NEUROL, V5, P508; FEERO WG, IN PRESS NEUROLOGY; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; HARDY J, 1992, NAT GENET, V1, P233, DOI 10.1038/ng0792-233; HIGUCHI R, 1989, AMPLIFICATIONS FORUM; JONES CT, 1992, NAT GENET, V1, P306, DOI 10.1038/ng0792-306; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KOCH MC, 1991, J MED GENET, V28, P583, DOI 10.1136/jmg.28.9.583; LEHMANNHORN F, 1981, MUSCLE NERVE, V4, P396, DOI 10.1002/mus.880040508; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1991, PFLUG ARCH EUR J PHY, V418, P297, DOI 10.1007/BF00370530; LEHMANNHORN F, UNPUB SAME SCN4A MUT; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MCCLATCHEY AI, 1992, NAT GENET, V2, P148, DOI 10.1038/ng1092-148; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RICH EC, 1894, MED NEWS, V65, P210; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1986, MYOLOGY, P1297; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; RUDOLPH JA, 1992, ANIM GENET, V23, P241, DOI 10.1111/j.1365-2052.1992.tb00136.x; Sambrook J., 1989, MOL CLONING LAB MANU; SPIER SJ, 1990, J AM VET MED ASSOC, V197, P1009; WANG JZ, 1992, BIOCHEM BIOPH RES CO, V182, P794, DOI 10.1016/0006-291X(92)91802-W; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256	35	38	42	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1074	1084						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8389097				2022-12-18	WOS:A1993LG13300008
J	WU, JK; YE, Z; DARRAS, BT				WU, JK; YE, Z; DARRAS, BT			SENSITIVITY OF SINGLE-STRAND CONFORMATION POLYMORPHISM (SSCP) ANALYSIS IN DETECTING P53 POINT MUTATIONS IN TUMORS WITH MIXED CELL-POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							POLYMERASE; DNA		TUFTS UNIV NEW ENGLAND MED CTR,DEPT PEDIAT,BOSTON,MA 02111; TUFTS UNIV NEW ENGLAND MED CTR,DEPT NEUROL,BOSTON,MA 02111; TUFTS UNIV,SCH MED,BOSTON,MA 02111	Tufts Medical Center; Tufts Medical Center; Tufts University	WU, JK (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR,DEPT NEUROSURG,BOSTON,MA 02111, USA.			Darras, Basil/0000-0002-1536-8145	NINDS NIH HHS [K08-NS01367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		FULTS D, 1992, CANCER RES, V52, P674; MASHIYAMA S, 1991, ONCOGENE, V6, P1313; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OHGAKI H, 1991, CANCER RES, V51, P6202; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875	6	38	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1273	1275						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503457				2022-12-18	WOS:A1993LG13300032
J	GOLDGAR, DE; CANNONALBRIGHT, LA; OLIPHANT, A; WARD, JH; LINKER, G; SWENSEN, J; TRAN, TD; FIELDS, P; UHARRIET, P; SKOLNICK, MH				GOLDGAR, DE; CANNONALBRIGHT, LA; OLIPHANT, A; WARD, JH; LINKER, G; SWENSEN, J; TRAN, TD; FIELDS, P; UHARRIET, P; SKOLNICK, MH			CHROMOSOME-17Q LINKAGE STUDIES OF 18 UTAH BREAST-CANCER KINDREDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								In this paper we present linkage results from the analysis of 18 Utah breast cancer kindreds, for three 17q markers. Four kindreds had LOD scores greater than 1.0 for at least one of the marker loci. One of these kindreds has a LOD score of 6.07 with D17S579, and we believe it to be the most informative 17q family reported to date. Among the kindreds which appear unlinked to 17q were an early-onset breast cancer family, a large breast-ovarian family, and a kindred with mixed age at onset. Analysis of individual recombinants in the linked families localizes the BRCA1 gene between THRA1 and D17S579 (Mfd188). A comparison of the Cancer and Steroid Hormone Study (CASH) model and a model which assumes a rare dominant susceptibility locus with low penetrance and no phenocopies stresses the difficulties in assessing linkage if the assumptions of the CASH model in terms of age at onset of breast cancer are not appropriate for the BRCA1 locus. A hypothetical breast cancer pedigree is used to calculate gene carrier probabilities under the CASH model, thereby illustrating some of our concerns regarding the use of this model to detect and exclude 17q linkage in breast cancer families.			GOLDGAR, DE (corresponding author), UNIV UTAH,GENET EPIDEMIOL GRP,420 CHIPETA WAY,SUITE 180,SALT LAKE CITY,UT 84108, USA.			albright, lisa/0000-0003-2602-3668	NCI NIH HHS [CN-05222, CA-48711] Funding Source: Medline; NCRR NIH HHS [RR-00064] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA048711] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DE, 1972, J NATL CANCER I, V48, P1029; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1993, AM J HUM GENET, V52, P678; FAIN PR, 1992, CYTOGENET CELL GENET, V60, P178; FUTREAL PA, 1992, HUM MOL GENET, V1, P66, DOI 10.1093/hmg/1.1.66-a; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; LATHROP GM, 1985, AM J HUM GENET, V37, P482; NAROD SA, 1991, LANCET, V338, P82; OLIPHANT AR, 1991, NUCLEIC ACIDS RES, V19, P4794; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; Skolnick MH, 1980, BANBURY REPORT, P285, DOI DOI 10.1111/J.1365-2796.2006.01657.X; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	13	38	39	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					743	748						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460640				2022-12-18	WOS:A1993KY05900012
J	CHAMBERLAIN, S; FARRALL, M; SHAW, J; WILKES, D; CARVAJAL, J; HILLERMAN, R; DOUDNEY, K; HARDING, AE; WILLIAMSON, R; SIRUGO, G; FUJITA, R; KOENIG, M; MANDEL, JL; PALAU, F; MONROS, E; VILCHEZ, J; PRIETO, F; RICHTER, A; VANASSE, M; MELANCON, S; COCOZZA, S; REDOLFI, E; CAVALCANTI, F; PIANESE, L; FILLA, A; DIDONATO, S; PANDOLFO, M				CHAMBERLAIN, S; FARRALL, M; SHAW, J; WILKES, D; CARVAJAL, J; HILLERMAN, R; DOUDNEY, K; HARDING, AE; WILLIAMSON, R; SIRUGO, G; FUJITA, R; KOENIG, M; MANDEL, JL; PALAU, F; MONROS, E; VILCHEZ, J; PRIETO, F; RICHTER, A; VANASSE, M; MELANCON, S; COCOZZA, S; REDOLFI, E; CAVALCANTI, F; PIANESE, L; FILLA, A; DIDONATO, S; PANDOLFO, M			GENETIC-RECOMBINATION EVENTS WHICH POSITION THE FRIEDREICH ATAXIA LOCUS PROXIMAL TO THE D9S15/D9S5 LINKAGE GROUP ON CHROMOSOME-9Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCE; PRENATAL-DIAGNOSIS; LINKED MARKERS; CPG ISLANDS; IDENTIFICATION; D9S5; DISEQUILIBRIUM; LOCALIZATION; POLYMORPHISM; CONFIRMATION	The absence of recombination between the mutation causing Friedreich ataxia and the two loci which originally assigned the disease locus to chromosome 9 has slowed attempts to isolate and characterize the genetic defect underlying this neurodegenerative disorder. A proximity of less than 1 cM to the linkage group has been proved by the generation of high maximal lod score (Z) to each of the two tightly linked markers D9S15 (Z = 96.69; recombination fraction [theta] = .01) and D9S5 (Z = 98.22; theta = .01). We report here recombination events which indicate that the FRDA locus is located centromeric to the D9S15/D9S5 linkage group, with the most probable order being cen-FRDA-D9S5-D9S15-qter. However, orientation of the markers with respect to the centromere, critical to the positional cloning strategy, remains to be resolved definitively.	ROYAL POSTGRAD MED SCH,MRC,MOLEC MED GRP,LONDON W12 0HS,ENGLAND; INST NEUROL,LONDON WC1N 3BG,ENGLAND; INST CHIM BIOL,GENET LAB,STRASBOURG,FRANCE; HOSP LA FE,UNIDAD GENET,VALENCIA,SPAIN; HOP ST JUSTINE,SERV GENET MED,MONTREAL H3T 1C5,QUEBEC,CANADA; HOP ST JUSTINE,SERV NEUROL,MONTREAL H3T 1C5,QUEBEC,CANADA; UNIV NAPOLI FEDERICO 2,DEPT CELLULAR & MOLEC PATHOL & BIOL,NAPLES,ITALY; UNIV NAPOLI FEDERICO 2,DEPT NEUROL,NAPLES,ITALY; INST NATL NEUROL CARLO BESTA,DIV BIOCHEM & GENET NERVOUS SYST,MILAN,ITALY	Imperial College London; University of London; University College London; Hospital Universitari i Politecnic La Fe; Universite de Montreal; Universite de Montreal; University of Naples Federico II; University of Naples Federico II; IRCCS Istituto Neurologico Besta	CHAMBERLAIN, S (corresponding author), ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND.		Carvajal, Jaime J/O-3681-2014; Sirugo, Giorgio/N-9056-2019; Cavalcanti, Francesca/N-3901-2019; Pandolfo, Massimo/B-2853-2010; Cocozza, Sergio/F-6488-2010; Palau, Francesc/A-9391-2014; Di Donato, Stefano/B-9717-2012; Doudney, Kit/Q-9728-2019; Sirugo, Giorgio/L-1628-2016; CAVALCANTI, FRANCESCA/I-3651-2014	Carvajal, Jaime J/0000-0002-7277-0317; Cavalcanti, Francesca/0000-0001-5769-4582; Palau, Francesc/0000-0002-8635-5421; Doudney, Kit/0000-0002-0089-1152; CAVALCANTI, FRANCESCA/0000-0001-5769-4582; Shaw, Jacqui/0000-0003-4227-503X; Fujita, Ricardo/0000-0002-9617-5109; Vilchez, Juan J/0000-0002-0532-2872; Redolfi, Elena Maria/0000-0003-1919-5744	Telethon [148] Funding Source: Medline	Telethon(Fondazione Telethon)		CARLSON M, 1987, NUCLEIC ACIDS RES, V15, P10614, DOI 10.1093/nar/15.24.10614-a; CHAMBERLAIN S, 1989, CYTOGENET CELL GENET, V51, P975; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; FUJITA R, 1989, CYTOGENET CELL GENET, V51, P1001; FUJITA R, 1991, GENOMICS, V10, P915, DOI 10.1016/0888-7543(91)90179-I; FUJITA R, 1992, HUM GENET, V89, P531, DOI 10.1007/BF00219179; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HANAUER A, 1990, LANCET, V335, P1102, DOI 10.1016/0140-6736(90)92679-C; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1983, QJ MED, V208, P489; KEATS BJB, 1989, AM J MED GENET, V33, P266, DOI 10.1002/ajmg.1320330224; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MONROS E, UNPUB FRIEDREICH ATA; ORZECHOWSKI HD, 1987, NUCLEIC ACIDS RES, V15, P6310, DOI 10.1093/nar/15.15.6310; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; RICHTER A, 1989, CYTOGENET CELL GENET, V51, P1066; RICHTER A, 1990, AM J HUM GENET S, V47, pA144; SHAW J, 1990, CYTOGENET CELL GENET, V53, P221, DOI 10.1159/000132936; SIRUGO G, 1992, AM J HUM GENET, V50, P559; WALLIS J, 1989, NUCLEIC ACIDS RES, V17, P4904, DOI 10.1093/nar/17.12.4904; WALLIS J, 1989, AM J MED GENET, V34, P458, DOI 10.1002/ajmg.1320340327; WALLIS J, 1990, HUM GENET, V85, P98; WILKES D, 1991, GENOMICS, V9, P90, DOI 10.1016/0888-7543(91)90224-3; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; YOSHIDA A, 1989, HUM GENET, V83, P204, DOI 10.1007/BF00286722	30	38	38	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					99	109						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434613				2022-12-18	WOS:A1993KK90800013
J	PANGALOS, C; THEOPHILE, D; SINET, PM; MARKS, A; STAMBOULIEHABAZIS, D; CHETTOUH, Z; PRIEUR, M; VERELLEN, C; RETHORE, MO; LEJEUNE, J; DELABAR, JM				PANGALOS, C; THEOPHILE, D; SINET, PM; MARKS, A; STAMBOULIEHABAZIS, D; CHETTOUH, Z; PRIEUR, M; VERELLEN, C; RETHORE, MO; LEJEUNE, J; DELABAR, JM			NO SIGNIFICANT EFFECT OF MONOSOMY FOR DISTAL 21Q22.3 ON THE DOWN-SYNDROME PHENOTYPE IN MIRROR DUPLICATIONS OF CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOWNS-SYNDROME; MOLECULAR DEFINITION; REPEAT POLYMORPHISM; DNA-SEQUENCES; BETA-SUBUNIT; CDNA CLONE; REGION; GENE; MAP	Three Down syndrome patients for whom karyotypic analysis showed a ''mirror'' (reverse tandem) duplication of chromosome 21 were studied by phenotypic, cytogenetic, and molecular methods. On high-resolution R-banding analysis performed in two cases, the size of the fusion 21q22.3 band was apparently less than twice the size of the normal 21q22.3, suggesting a partial deletion of distal 21q. The evaluation of eight chromosome 21 single-copy sequences of the 21q22 region-namely, SOD1, D21S15, D21S42, CRYA1, PFKL, CD18, COL6A1, and S100B-by a slot blot method showed in all three cases a partial deletion of 21q22.3 and partial monosomy. The translocation breakpoints were different in each patient, and in two cases the rearranged chromosome was found to be asymmetrical. The molecular definition of the monosomy 21 in each patient was, respectively, COL6A1-S100B, CD18-S100B, and PFKL-S100B. DNA polymorphism analysis indicated in all cases a homozygosity of the duplicated material. The duplicated region was maternal in two patients and paternal in one patient. These data suggest that the reverse tandem chromosomes did not result from a telomeric fusion between chromosomes 21 but from a translocation between sister chromatids. The phenotypes of these patients did not differ significantly from that of individuals with full trisomy 21, except in one case with large ears with an unfolded helix. The fact that monosomy of distal 21q22.3 in these patients resulted in a phenotype very similar to Down syndrome suggests that the duplication of the genes located in this part of chromosome 21 is not necessary for the pathogenesis of the Down syndrome features observed in these patients, including most of the facial and hand features, muscular hypotonia, cardiopathy of the Fallot tetralogy type, and part of the mental retardation.	HOP NECKER ENFANTS MALAD,BIOCHIM GENET LAB,CNRS,URA 1335,149 RUE SEVRES,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,INST PROGENESE,F-75743 PARIS 15,FRANCE; UNIV TORONTO,BANTING & BEST DEPT MED RES,TORONTO M5S 1A1,ONTARIO,CANADA; DIAGNOST GENET CTR,ATHENS,GREECE; UCL,CTR GENET HUMAINE,BRUSSELS,BELGIUM	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; Universite Catholique Louvain	SINET, PM (corresponding author), HOP NECKER ENFANTS MALAD,BIOCHIM GENET LAB,CNRS,URA 1335,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.							ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; BARTSCHSANDHOFF M, 1973, HUMANGENETIK, V18, P329, DOI 10.1007/BF00291130; BERG JM, 1980, J MED GENET, V17, P144, DOI 10.1136/jmg.17.2.144; BLOUIN JL, 1990, AM J HUM GENET, V46, P518; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CANTU JM, 1980, ANN GENET-PARIS, V23, P183; CHETTOUH Z, 1991, AM J HUM GENET S, V49, pA1430; COHEN MM, 1967, CYTOGENETICS, V6, P321, DOI 10.1159/000154936; COX DR, 1990, CYTOGENET CELL GENET, V55, P235, DOI 10.1159/000133017; CRETE N, 1991, ADV MOL GENET, V4, P325; DALLAPICCOLA B, 1986, HUM GENET, V73, P218, DOI 10.1007/BF00401230; DELABAR JM, 1992, GENOMICS, V13, P887, DOI 10.1016/0888-7543(92)90177-T; EPSTEIN CJ, 1990, AM J MED GENET S, V7, P31; Garson O M, 1970, Aust Paediatr J, V6, P53; GUO Z, 1990, NUCLEIC ACIDS RES, V18, P4967, DOI 10.1093/nar/18.16.4967-a; HAGEMEIJER A, 1977, HUM GENET, V38, P15, DOI 10.1007/BF00295803; HARVEY J, 1977, J MED GENET, V14, P152, DOI 10.1136/jmg.14.2.152; JACKSON JF, 1976, CLIN GENET, V9, P483; KADOTANI T, 1970, P JPN ACAD, V46, P858, DOI 10.2183/pjab1945.46.858; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KORENBERG J R, 1989, American Journal of Human Genetics, V45, pA79; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; KORENBERG JR, 1990, AM J HUM GENET S, V47, pA31; Lejeune J, 1965, Ann Genet, V8, P60; LEVANON D, 1987, BIOCHEM BIOPH RES CO, V147, P1182, DOI 10.1016/S0006-291X(87)80194-8; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MCDEVITT DS, 1986, EXP EYE RES, V43, P285, DOI 10.1016/S0014-4835(86)80098-7; MCGINNISS MJ, 1992, AM J HUM GENET, V50, P15; MCINNIS MG, 1991, GENOMICS, V11, P573, DOI 10.1016/0888-7543(91)90064-L; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PELLISSIER MC, 1987, HUM GENET, V75, P95; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PETERSEN MB, 1990, AM J MED GENET S, V7, P104; PHELAN MC, 1988, AM J HUM GENET, V43, P511; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RAHMANI Z, 1990, AM J MED GENET, V7, P98; RICHARDS BW, 1965, J MENT DEFIC RES, V9, P118; SACHDEVA S, 1971, J MENT DEFIC RES, V15, P181; SCHUH BE, 1974, J MED GENET, V11, P297, DOI 10.1136/jmg.11.3.297; SINET PM, 1991, AM J HUM GENET S, V49, pA1528; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TANZI RE, 1992, AM J HUM GENET, V50, P551; TURLEAU C, 1980, ANN GENET-PARIS, V23, P187; VOGEL W, 1972, HUMANGENETIK, V14, P255, DOI 10.1007/BF00278046; WANG D, 1992, P NATL ACAD SCI USA, V89, P3222, DOI 10.1073/pnas.89.8.3222; WARKANY J, 1963, J PEDIATR-US, V62, P890, DOI 10.1016/S0022-3476(63)80103-1; WEIL D, 1988, AM J HUM GENET, V42, P435; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; ZELLWEGER H, 1963, J PEDIATR-US, V62, P225, DOI 10.1016/S0022-3476(63)80396-0	54	38	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1240	1250						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463008				2022-12-18	WOS:A1992KC99500007
J	WEIFFENBACH, B; BAGLEY, R; FALLS, K; HYSER, C; STORVICK, D; JACOBSEN, SJ; SCHULTZ, P; MENDELL, J; VANDIJK, KW; MILNER, ECB; GRIGGS, R				WEIFFENBACH, B; BAGLEY, R; FALLS, K; HYSER, C; STORVICK, D; JACOBSEN, SJ; SCHULTZ, P; MENDELL, J; VANDIJK, KW; MILNER, ECB; GRIGGS, R			LINKAGE ANALYSES OF 5 CHROMOSOME-4 MARKERS LOCALIZES THE FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) GENE TO DISTAL 4Q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG ARM; MAP; TRANSLOCATION; LOCUS; RFLP	The genetic locus for facioscapulohumeral muscular dystrophy (FSHD) has been mapped to chromosome 4. We have examined linkage to five chromosome 4q DNA markers in 22 multigenerational FSHD families. Multipoint linkage analyses of the segregation of four markers in the FSHD families and in 40 multigenerational mapping families from the Centre d'Etude du Polymorphisme Humaine enabled these loci and FSHD to be placed in the following order: cen-D4S171-factor XI-D4S163-D4S139-FSHD-qter. One interval, D4S171-FSHD, showed significant sex-specific differences in recombination. Homogeneity tests supported linkage of FSHD to these 4q DNA markers in all of the families we studied. The position of FSHD is consistent with that generated by other groups as members of an international FSHD consortium.	UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY 14627; UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,FAC NEUROSCI,LA JOLLA,CA 92093; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; VIRGINIA MASON RES CTR,SEATTLE,WA 98101	University of Rochester; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; Ohio State University; Virginia Mason Medical Center	WEIFFENBACH, B (corresponding author), COLLABORAT RES INC,1365 MAIN ST,WALTHAM,MA 02154, USA.		van Dijk, Ko Willems/AAT-4681-2021; van Dijk, Ko Willems/A-1798-2008	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Griggs, Robert/0000-0001-7988-4854				ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; BOWDEN DW, 1989, GENOMICS, V5, P718, DOI 10.1016/0888-7543(89)90113-4; BUETOW KH, 1990, GENOMICS, V8, P13, DOI 10.1016/0888-7543(90)90220-O; BUETOW KH, 1991, AM J HUM GENET, V48, P911; BUTLER MG, 1990, NUCLEIC ACIDS RES, V18, P5327, DOI 10.1093/nar/18.17.5327-a; DISTECHE CM, 1986, HUM GENET, V74, P372, DOI 10.1007/BF00280488; GILBERT JR, 1992, AM J HUM GENET, V51, P424; JACOBSEN SJ, 1990, AM J HUM GENET, V47, P376; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; MATHEWS KD, 1992, AM J HUM GENET, V51, P428; MILLS KA, 1992, AM J HUM GENET, V51, P432; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; OTT J, 1985, ANAL HUMAN GENETIC L; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; UPADHYAYA M, 1992, AM J HUM GENET, V51, P404; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; WEIFFENBACH B, IN PRESS MAMMALIAN G; WIJMENGA C, 1992, AM J HUM GENET, V51, P411; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; [No title captured]	29	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					416	423						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642240				2022-12-18	WOS:A1992JF77600023
J	GIACALONE, JP; FRANCKE, U				GIACALONE, JP; FRANCKE, U			COMMON SEQUENCE MOTIFS AT THE REARRANGEMENT SITES OF A CONSTITUTIONAL-X AUTOSOME TRANSLOCATION AND ASSOCIATED DELETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; X-AUTOSOME TRANSLOCATIONS; CHROMOSOME REARRANGEMENTS; PARENTAL ORIGIN; DMD GENE; DNA; LOCUS; FRAGMENTS; CLONING; FEMALE	Reciprocal chromosome translocations are common de novo rearrangements that occur randomly throughout the human genome. To learn about causative mechanisms, we have cloned and sequenced the breakpoints of a cytologically balanced constitutional reciprocal translocation, t(X;4)(p21.2;q31.22), present in a girl with Duchenne muscular dystrophy (DMD). Physical mapping of the derivative chromosomes, after their separation in somatic cell hybrids, reveals that the translocation disrupts the DMD gene in Xp21 within the 18-kb intron 16. Restriction mapping and sequencing of clones that span both translocation breakpoints as well as the corresponding normal regions indicate the loss of approximately 5 kb in the formation of the derivative X chromosome, with 4-6 bp deleted from chromosome 4. RFLP and Southern analyses indicate that the de novo translocations is of paternal origin and that the father's X chromosome contains the DNA that is deleted in the derivative X. Most likely, deletion and translocation arose simultaneously from a complex rearrangement event that involves three chromosomal breakpoints. Short regions of sequence homology were present at the three sites. A 5-bp sequence, GGAAT, found exactly at the translocation breakpoints on both normal chromosomes X and 4, has been preserved only on the der(4) chromosome. It is likely that the X-derived sequence GGAATCA has been lost in the formation of the der(X) chromosome, as it matches an inverted GAATCA sequence present on the opposite strand exactly at the other end of the deleted 5-kb fragment. These findings suggest a possible mechanism which may have juxtaposed the three sites and mediated sequence-specific breakage and recombination between nonhomologous chromosomes in male meiosis.	STANFORD UNIV, MED CTR, HOWARD HUGHES MED INST, BECKMAN CTR, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University								BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BLONDEN LAJ, 1991, GENOMICS, V10, P631, DOI 10.1016/0888-7543(91)90445-K; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BOUE A, 1985, ADV HUM GENET, V14, P1; BOYD Y, 1988, CYTOGENET CELL GENET, V48, P28, DOI 10.1159/000132581; BOYD Y, 1986, CLIN GENET, V29, P108; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; CHANDLEY AC, 1981, ANN GENET-PARIS, V24, P5; CHANDLEY AC, 1988, PROGR TOPICS CYTOGEN, V8, P361; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1989, AM J HUM GENET, V45, P63; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1981, CYTOGENET CELL GENET, V31, P24, DOI 10.1159/000131622; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S; HALUSKA FG, 1987, TRENDS GENET, V3, P11, DOI 10.1016/0168-9525(87)90155-7; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; KEAN VM, 1986, J MED GENET, V23, P491, DOI 10.1136/jmg.23.6.491; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KRAWCZAK M, 1991, HUM GENET, V86, P425; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LOVE DR, 1991, GENOMICS, V10, P57, DOI 10.1016/0888-7543(91)90484-V; MARTIN RH, 1988, PROGR TOPICS CYTOGEN, V8, P397; MOHANDAS T, 1982, AM J HUM GENET, V34, P811; MONACO AP, 1987, TRENDS GENET, V3, P33, DOI 10.1016/0168-9525(87)90163-6; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; NIELSEN LB, 1984, ANN GENET-PARIS, V27, P173; OLSON SB, 1988, PROGR TOPICS CYTOGEN, V8, P583; PAI GS, 1980, CLIN GENET, V18, P436; POUSTKA A, 1984, P NATL ACAD SCI-BIOL, V81, P4129, DOI 10.1073/pnas.81.13.4129; QUACK B, 1988, CYTOGENET CELL GENET, V48, P43, DOI 10.1159/000132583; RIBEIRO MCM, 1986, AM J MED GENET, V25, P231, DOI 10.1002/ajmg.1320250205; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; ROBINSON DO, 1990, GENET RES, V56, P135, DOI 10.1017/S0016672300035217; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALENGHE F, 1981, CHROMOSOMA, V82, P205, DOI 10.1007/BF00286105; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WARBURTON D, 1984, PRENATAL DIAG, V4, P69, DOI 10.1002/pd.1970040706	52	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					725	741						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1347968				2022-12-18	WOS:A1992HL84800008
J	JIN, WD; JACKSON, CE; DESNICK, RJ; SCHUCHMAN, EH				JIN, WD; JACKSON, CE; DESNICK, RJ; SCHUCHMAN, EH			MUCOPOLYSACCHARIDOSIS TYPE-VI - IDENTIFICATION OF 3 MUTATIONS IN THE ARYLSULFATASE-B GENE OF PATIENTS WITH THE SEVERE AND MILD PHENOTYPES PROVIDES MOLECULAR EVIDENCE FOR GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAROTEAUX-LAMY SYNDROME; DEFICIENCY; SULFATASE; DIAGNOSIS; CLONING; CDNA; DNA	Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy disease) results from the deficient activity of the lysosomal enzyme, arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase E.C.3.1.6.1). The enzymatic defect leads to the accumulation of the glycosaminoglycan, dermatan sulfate, primarily in connective tissue and reticuloendothelial cell lysosomes. Although MPS VI patients have normal intelligence and no neurologic abnormalities, the disease is clinically heterogeneous: severely affected individuals expire in childhood or early adolescence while those with the mild or intermediate phenotypes have a slower, milder disease course and a longer life span. The recent isolation of the full-length cDNA-encoding human ASB permitted an investigation of the molecular lesions underlying the phenotypic heterogeneity in MPS VI. The ASB cDNA-coding sequences were determined from two unrelated MPS VI patients with the severe (proband 1) and mild (proband 2) phenotypes. These patients had about 2% and 7% of normal ASB activity in cultured fibroblasts, respectively. Proband 1 was homoallelic for a T-to-C transition in nucleotide (nt) 349, which predicted a cysteine-to-arginine substitution in the ASB polypeptide at residue 117 (C117R). Proband 2 was heteroallelic, having a T-to-C transition in nt 707, which predicted a leucine-to-proline replacement at ASB residue 236 (L236P), and having a G-to-A transition in nt 1214, which predicted a cysteine-to-tyrosine substitution at ASB residue 405 (C405Y). These mutations did not occur in three other unrelated MPS VI patients or in 120 ASB alleles from normal individuals, indicating that they were not polymorphisms. The identification of these three ASB mutations documents the first evidence of molecular heterogeneity in MPS VI and provides an initial basis for genotype/phenotype correlations in this lysosomal storage disease.	CUNY MT SINAI SCH MED, DIV MED & MOLEC GENET, 100TH ST & 5TH AVE, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025759] Funding Source: NIH RePORTER; NCRR NIH HHS [5 MO1 RR00071] Funding Source: Medline; NICHD NIH HHS [5 T32 HD-70105] Funding Source: Medline; NIDDK NIH HHS [5 RO1 DK25759] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN E, 1968, BIOCHIM BIOPHYS ACTA, V168, P243, DOI 10.1016/0005-2795(68)90147-5; BROOKS DA, 1991, AM J HUM GENET, V48, P710; FLUHARTY AL, 1975, BIOCHEM BIOPH RES CO, V64, P955, DOI 10.1016/0006-291X(75)90140-0; GIBSON GJ, 1987, BIOCHEM J, V248, P755, DOI 10.1042/bj2480755; GNOITSZULZYCHKA J, 1972, ACTA BIOCHIM POL, V19, P181; HOPWOOD JJ, 1986, BIOCHEM J, V234, P507, DOI 10.1042/bj2340507; HUMBEL R, 1976, CLIN CHIM ACTA, V68, P339, DOI 10.1016/0009-8981(76)90401-0; ITAKURA K, 1984, ANNU REV BIOCHEM, V53, P323; JIN WD, 1991, NUCLEIC ACIDS RES, V19, P4305, DOI 10.1093/nar/19.15.4305-a; KOLODNY EH, 1976, CURRENT TRENDS SPHIN, P239; MAROTEAUX P, 1963, PRESSE MED, V71, P1849; MATALON R, 1974, BIOCHEM BIOPH RES CO, V61, P1450, DOI 10.1016/S0006-291X(74)80446-8; MCGOVERN MM, 1982, J BIOL CHEM, V257, P2605; MCGOVERN MM, 1981, ENZYME, V26, P206, DOI 10.1159/000459176; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PETERS C, 1990, J BIOL CHEM, V265, P3374; QUIGLEY HA, 1974, AM J OPHTHALMOL, V77, P809, DOI 10.1016/0002-9394(74)90383-3; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; SHAPIRA E, 1975, ARCH BIOCHEM BIOPHYS, V170, P179, DOI 10.1016/0003-9861(75)90109-5; STECKEL F, 1983, J BIOL CHEM, V258, P4322; STUMPF DA, 1973, AM J DIS CHILD, V126, P747, DOI 10.1001/archpedi.1973.02110190597003; WALD SL, 1984, ANN NEUROL, V8, P336; WICKER G, 1991, J BIOL CHEM, V266, P21386	26	38	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					795	800						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550123				2022-12-18	WOS:A1992HL84800015
J	DALESSIO, M; RAMIREZ, F; BLUMBERG, BD; WIRTZ, MK; RAO, VH; GODFREY, MD; HOLLISTER, DW				DALESSIO, M; RAMIREZ, F; BLUMBERG, BD; WIRTZ, MK; RAO, VH; GODFREY, MD; HOLLISTER, DW			CHARACTERIZATION OF A COLIAI SPLICING DEFECT IN A CASE OF EHLERS-DANLOS SYNDROME TYPE-VII - FURTHER EVIDENCE OF MOLECULAR HOMOGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE; PRO-ALPHA-2(I) CHAIN; AMINO-ACIDS; PATIENT; MUTATION; PROCOLLAGEN; DELETION; VARIANT; REGION; EXON	A child affected by the type VII form of Ehlers-Danlos syndrome (EDS VII) was shown to have a heterozygous structural defect in the amino-terminus of pro-alpha-1(I) collagen. As a result, type I procollagen trimers containing defective subunits are not converted to mature collagen molecules. To identify the cause of the protein abnormality, specifically primed cDNAs and genomic DNA were PCR amplified and sequenced. This analysis disclosed that the protein structural defect is caused by a single base substitution (A for G) at position - 1 of the splice donor site of intron 6 of the pro-alpha-1(I) collagen gene (COL1A1). The affected allele produces (a) transcripts lacking exon 6 sequences and (b), in lesser amount, normally spliced transcripts. Furthermore, the rate of exon 6 skipping is temperature dependent, for it appears to decrease substantially when the patient's fibroblasts are incubated at 31-degrees-C. These findings are similar to those we previously reported for other unrelated EDS VII cases and, therefore, reemphasize the molecular homogeneity of this rare connective tissue disorder.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,POB 1126,1 GUSTAVE LEVY PL,NEW YORK,NY 10029; PERMANENTE MED GRP INC,SAN FRANCISCO,CA; OREGON HLTH SCI UNIV,DEPT OPHTHALMOL,PORTLAND,OR 97201; UNIV NEBRASKA,MED CTR,MEYER REHABIL INST,MUNROE CTR HUMAN GENET,OMAHA,NE 68105; UNIV NEBRASKA,MED CTR,DEPT PEDIAT,OMAHA,NE 68105	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Permanente Medical Groups; Oregon Health & Science University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center			D'Alessio, Marina/AAA-1306-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040046, R01AR038648, R37AR038648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-40046, AR-38648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BYERS PH, 1983, PRINCIPLES PRACTICE, P836; COLE WG, 1986, J BIOL CHEM, V261, P5496; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; EYRE DR, 1985, J BIOL CHEM, V260, P1322; KAWASAKI ES, 1989, PCR TECHNOLOGY PRINC, P89; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; LEE B, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P173; LEE BL, 1991, J BIOL CHEM, V286, P5256; LICHTENSTEIN JR, 1973, SCIENCE, V182, P298, DOI 10.1126/science.182.4109.298; STEINMANN B, 1980, J BIOL CHEM, V255, P8887; VASAN NS, 1991, AM J HUM GENET, V48, P305; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; WIRTZ MK, 1990, J BIOL CHEM, V265, P6312; WIRTZ MK, 1987, J BIOL CHEM, V262, P16376; ZAGURSKY RJ, 1986, GENE ANAL TECH, V2, P232	20	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					400	406						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867198				2022-12-18	WOS:A1991GA86600017
J	HAVILAND, MB; KESSLING, AM; DAVIGNON, J; SING, CF				HAVILAND, MB; KESSLING, AM; DAVIGNON, J; SING, CF			ESTIMATION OF HARDY-WEINBERG AND PAIRWISE DISEQUILIBRIUM IN THE APOLIPOPROTEIN AL-CIII-AIV GENE-CLUSTER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY DISEASE; RANDOMLY MATING POPULATIONS; C-III GENES; LINKAGE DISEQUILIBRIUM; DNA POLYMORPHISMS; HEART-DISEASE; I GENE; PREMATURE ATHEROSCLEROSIS; CHOLESTEROL CONCENTRATION	Departures from Hardy-Weinberg (HW) equilibria and pairwise disequilibria were estimated in a sample of unrelated healthy individuals typed for six RFLPs in the apo AI-CIII-AIV gene region. The sample was composed of males and females, selected for health, from two populations, those of exclusively French-Canadian (FC) and those of some non-French-Canadian (NFC) ancestry. An approach suggested by Weir and Cockerham, which includes estimates of nonrandom association (disequilibria) between three and four alleles at two loci as well as the traditional associations between two alleles, at two loci was used. The pattern of departures from HW equilibria suggested that the genetic structures of the FC and NFC are different. Departure from HW equilibrium at an RFLP locus could not be predicted from information about other loci in the same gene region. Nonrandom associations were also evident from the pairwise analyses. Two pairs of loci had significant diallelic disequilibria, while two other pairs had significant triallelic disequilibria. All of the RFLP pairs had at least one measure of disequilibrium at its maximum value determined by allele frequencies. Inferences about pairwise disequilibria depended on the statistical approach used. Sizes of the pairwise disequilibria were not correlated with the physical distance between loci. The impact of these disequilibria on RFLP-phenotype association studies is discussed.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON,ENGLAND; INST RECH CLIN MONTREAL,MONTREAL H2W 1R7,QUEBEC,CANADA	Imperial College London; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	SING, CF (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.			Sing, Charles/0000-0001-5872-7956	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39107] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABURATANI H, 1988, JPN J MED, V27, P56, DOI 10.2169/internalmedicine1962.27.56; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BERG K, 1983, PROG MED GENET, V5, P35; BODMER W, 1977, HLA DISEASE, P280; BORRESEN AL, 1988, HUM GENET, V78, P216, DOI 10.1007/BF00291664; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; CHAKRABORTY R, 1986, American Journal of Human Genetics, V39, pA231; COHEN T, 1986, NUCLEIC ACIDS RES, V14, P1924, DOI 10.1093/nar/14.4.1924; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; DAVIGNON J, 1983, HYPERTENSION PHYSIOP, P810; FERNS GAA, 1986, HUM GENET, V73, P245, DOI 10.1007/BF00401237; FERNS GAA, 1985, LANCET, V2, P300; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FISHER EA, 1989, ANNU REV NUTR, V9, P139, DOI 10.1146/annurev.nu.09.070189.001035; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GOTTO AM, 1986, METHOD ENZYMOL, V128, P3; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HANIS CL, 1991, ARTERIOSCLER THROMB, V11, P362, DOI 10.1161/01.ATV.11.2.362; HEGELE RA, 1990, GENET EPIDEMIOL, V7, P69, DOI 10.1002/gepi.1370070114; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; HIGGINS MW, 1989, INT J EPIDEMIOL S, V1, pS1; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; ISNG CF, IN PRESS EUR J EPIDE; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; KARATHANASIS SK, 1983, NATURE, V305, P823, DOI 10.1038/305823a0; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; KESSLING AM, 1986, CLIN GENET, V29, P485; KESSLING AM, 1988, AM J HUM GENET, V42, P458; KESSLING AM, 1988, HUM GENET, V78, P237, DOI 10.1007/BF00291668; KESSLING AM, 1985, CLIN GENET, V28, P296; KESSLING AM, UNPUB PATTERNS ASS G; KOTTKE BA, 1986, AM J CARDIOL, V57, pC11, DOI 10.1016/0002-9149(86)91021-0; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; LABERGE C, 1966, B JOHNS HOPKINS HOSP, V118, P52; LAW SW, 1984, BIOCHEM BIOPH RES CO, V118, P934, DOI 10.1016/0006-291X(84)91485-2; LITT M, 1986, AM J HUM GENET, V39, P166; LUSIS AJ, 1988, J LIPID RES, V29, P397; LUSSIERCACAN S, UNPUB ESTIMATES DIST; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MILLER NE, 1983, ATHEROSCLEROSIS MECH, P153; MONSALVE MV, 1989, CLIN SCI, V76, P22; OETTGEN P, 1986, NUCLEIC ACIDS RES, V14, P5571, DOI 10.1093/nar/14.13.5571; ORAM JF, 1981, J BIOL CHEM, V256, P8348; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PAUL H, 1987, HUM GENET, V75, P264, DOI 10.1007/BF00281071; PAULWEBER B, 1988, ATHEROSCLEROSIS, V73, P125, DOI 10.1016/0021-9150(88)90033-0; POWNALL HJ, 1983, ATHEROSCLEROSIS MECH, P125; REES A, 1985, ATHEROSCLEROSIS, V58, P269, DOI 10.1016/0021-9150(85)90072-3; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; REES A, 1983, LANCET, V1, P444; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHAEFER EJ, 1978, J LIPID RES, V19, P667; SCHAMAUN O, 1984, HUM GENET, V68, P181, DOI 10.1007/BF00279311; SCHULL WJ, 1990, ANNU REV PUBL HEALTH, V11, P105; SCHWARTZ RC, 1990, AM J HUM GENET, V46, P1214; SHOULDERS CC, 1986, LANCET, V2, P1286; SING CF, 1990, ANNU REV GENET, V24, P171; SINNOCK P, 1972, AM J HUM GENET, V24, P393; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1988, GENETICS, V120, P1145; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; WILE DB, 1989, ATHEROSCLEROSIS, V78, P9, DOI 10.1016/0021-9150(89)90153-6; XHIGNESSE M, IN PRESS ARTERIOSCLE; ZERBA KE, IN PRESS GENETICS; 1985, SAS IML USERS GUIDE; [No title captured]	71	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					350	365						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678249				2022-12-18	WOS:A1991GA86600011
J	GORSKI, JL; BURRIGHT, EN; HARNDEN, CE; STEIN, CK; GLOVER, TW; REYNER, EL				GORSKI, JL; BURRIGHT, EN; HARNDEN, CE; STEIN, CK; GLOVER, TW; REYNER, EL			LOCALIZATION OF DNA-SEQUENCES TO A REGION WITHIN XP11.21 BETWEEN INCONTINENTIA PIGMENTI (IPI) X-CHROMOSOMAL TRANSLOCATION BREAKPOINTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; LOCUS; GENE; HETEROGENEITY; DISEASE; ASSIGNMENT; FRAGMENTS; MARKERS; CLONING; WALKING	Incontinentia pigmenti (IP) is an X-linked dominant disorder characterized by developmental anomalies of the tissues and organs derived from embryonic ectoderm and neuroectoderm. An IP locus, designated IP1, probably resides in Xp11.21, since five unrelated patients with nonfamilial IP have been identified who possess constitutional de novo reciprocal X;autosome translocations involving Xp11.21. We have used a series of somatic cell hybrids containing the rearranged chromosomes derived from three of the five IP1 patients, along with other hybrid cell lines, to map probes in the vicinity of the IP1 locus. Five anonymous DNA loci-DXS422, DXS14, DXS343, DXS429, and DXS370-have been mapped to a region within Xp11.21, between two IP1 X-chromosomal translocation breakpoints; the IP1 t(X;17) breakpoint is proximal (centromeric) to this region, and the IP1 t(X;13) and t(X;9) X-chromosomal breakpoints lie distal to it. While no IP1 translocation breakpoint has yet been identified by pulsed-field gel electrophoretic (PFGE) analysis, an overlap between three probes-p58-1, 7P(SH)3.5, and cpX210-has been detected, placing these probes within 125 kb. Four probes-p58-1, 7P(SH)3.5, cpX210, and 30C(E)2.8-have been helpful in constructing a 1,250-kb PFGE map of the region between the breakpoints; these results suggest that the IP1 X-chromosomal translocation breakpoints are separated by at least this distance. The combined somatic cell hybrid and PFGE analyses we report here favor the probe order DXS323-(IP1 t(X;13), IP1 t(X;9))-(DXS422, DXS14, DXS343, DXS429, DXS370)-(IP1 t(X;17), DXZ1). These sequences provide a starting point for identifying overlapping genomic sequences that span the IP1 translocation breakpoints; the availability of IP1 translocation breakpoints should now assist the cloning of this locus.	UNIV MICHIGAN,MED CTR,SCH MED,DEPT COMMUNICABLE DIS,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,GRAD PROGRAM CELLULAR & MOLEC BIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	GORSKI, JL (corresponding author), UNIV MICHIGAN,MED CTR,SCH MED,DEPT PEDIAT,DIV PEDIAT GENET,D1109 MED PROFESS BLDG,BOX 0718,ANN ARBOR,MI 48109, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007544] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-23768] Funding Source: Medline; NIGMS NIH HHS [2-T32-GM07863-11, 5-T32-GM07544-11] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANAND R, 1988, GENOMICS, V3, P177, DOI 10.1016/0888-7543(88)90077-8; BARKER DF, 1989, CYTOGENET CELL GENET, V51, P957; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BOYD Y, 1987, CLIN GENET, V31, P265; CANNIZZARO LA, 1987, CLIN GENET, V32, P66; CARNEY RG, 1976, ARCH DERMATOL, V112, P535, DOI 10.1001/archderm.112.4.535; CHEN JD, 1989, AM J HUM GENET, V45, P401; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COX DR, 1989, GENOMICS, V4, P397, DOI 10.1016/0888-7543(89)90347-9; CROLLA JA, 1989, HUM GENET, V81, P269, DOI 10.1007/BF00279002; DEGROUCHY J, 1985, ANN GENET-PARIS, V28, P86; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; ELEJALDE BR, 1983, CYTOGENETICS X CHROM, P225; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; FRANCKE U, 1990, NATURE, V343, P692, DOI 10.1038/343692a0; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GILGENKRANTZ S, 1985, ANN GENET-PARIS, V28, P90; GORSKI JL, 1989, CYTOGENET CELL GENET, V52, P90, DOI 10.1159/000132849; HARNDEN DG, 1985, ISCN INT SYSTEM HUMA; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HODGSON SV, 1985, HUM GENET, V71, P231, DOI 10.1007/BF00284581; KAJII T, 1985, ANN GENET-PARIS, V28, P219; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOUFOS A, 1989, AM J HUM GENET, V44, P711; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LAFRENIERE RG, 1989, CYTOGENET CELL GENET, V51, P1028; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Maniatis T., 1982, MOL CLONING; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROMEO G, 1988, LANCET, V2, P8; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SEFIANI A, 1989, GENOMICS, V4, P427, DOI 10.1016/0888-7543(89)90350-9; SEFIANI A, 1989, ANN GENET-PARIS, V32, P149; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; SYBERT VP, 1990, J PEDIATR-US, V116, P581, DOI 10.1016/S0022-3476(05)81606-3; THOMAS IT, 1989, AM J HUM GENET, V45, P193; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472	49	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					53	64						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985463				2022-12-18	WOS:A1991ET18800008
J	PATEL, PI; GARCIA, C; DEOCALUNA, RM; MALAMUT, RI; FRANCO, B; SLAUGENHAUPT, S; CHAKRAVARTI, A; LUPSKI, JR				PATEL, PI; GARCIA, C; DEOCALUNA, RM; MALAMUT, RI; FRANCO, B; SLAUGENHAUPT, S; CHAKRAVARTI, A; LUPSKI, JR			ISOLATION OF A MARKER LINKED TO THE CHARCOT-MARIE-TOOTH DISEASE TYPE-IA GENE BY DIFFERENTIAL ALU-PCR OF HUMAN-CHROMOSOME 17-RETAINING HYBRIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV,DEPT PEDIAT,HOUSTON,TX 77030; LOUISIANA STATE UNIV,MED CTR,DEPT NEUROL,NEW ORLEANS,LA 70112; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260	Baylor University; Louisiana State University System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	PATEL, PI (corresponding author), BAYLOR UNIV,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		FRANCO, Brunella/S-2882-2018; Patel, Pragna/H-9129-2017	FRANCO, Brunella/0000-0001-5588-4569; Patel, Pragna/0000-0003-3584-1072	NICHD NIH HHS [HD24064-02] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline; NINDS NIH HHS [R01 NS-27042] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BALLABIO A, IN PRESS GENOMICS; BIRD TD, 1982, AM J HUM GENET, V34, P388; Charcot JM, 1886, REV MED-PARIS, V6, P97; FRANCO B, UNPUB; LEDBETTER SA, 1990, GENOMICS, V6, P475, DOI 10.1016/0888-7543(90)90477-C; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PATEL PI, 1990, AM J HUM GENET, V46, P801; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANTUINEN P, 1988, AM J HUM GENET, V43, P587	18	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					926	934						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978559				2022-12-18	WOS:A1990EK40000007
J	WARD, K; OCONNELL, P; CAREY, JC; LEPPERT, M; JOLLEY, S; PLAETKE, R; OGDEN, B; WHITE, R				WARD, K; OCONNELL, P; CAREY, JC; LEPPERT, M; JOLLEY, S; PLAETKE, R; OGDEN, B; WHITE, R			DIAGNOSIS OF NEUROFIBROMATOSIS-I BY USING TIGHTLY LINKED, FLANKING DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84132; UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	WARD, K (corresponding author), UNIV UTAH,SCH MED,DEPT OBSTET & GYNECOL,50 N MED DR,ROOM 2B-200,SALT LAKE CITY,UT 84132, USA.							[Anonymous], 1987, NEUROFIBROMATOSIS, V6, P1; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; CAREY JC, 1987, ANN NY ACAD SCI, V486, P45; Crowe FW, 1956, CLIN PATHOLOGICAL GE; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HOLM S, 1979, SCAND J STAT, V6, P65; KOBRIN JL, 1979, SURV OPHTHALMOL, V24, P45, DOI 10.1016/0039-6257(79)90147-4; KOPF AW, 1985, ARCH DERMATOL, V121, P766, DOI 10.1001/archderm.121.6.766; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEWONTIN RC, 1964, GENETICS, V49, P49; MOODIE P, 1988, BRIT J HAEMATOL, V70, P77, DOI 10.1111/j.1365-2141.1988.tb02437.x; OCONNELL P, 1989, AM J HUM GENET, V44, P51; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	21	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					943	949						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971145				2022-12-18	WOS:A1990DD89600012
J	RASMUSSEN, SA; MULINARE, J; KHOURY, MJ; MALONEY, EK				RASMUSSEN, SA; MULINARE, J; KHOURY, MJ; MALONEY, EK			EVALUATION OF BIRTH-DEFECT HISTORIES OBTAINED THROUGH MATERNAL INTERVIEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,ATLANTA,GA 30333; UNIV FLORIDA,COLL MED,GAINESVILLE,FL 32611; COMP SERV CORP,HUNTSVILLE,AL	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida					NHLBI NIH HHS [HLO748908] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANESHENSEL CS, 1982, AM J PUBLIC HEALTH, V72, P1017, DOI 10.2105/AJPH.72.9.1017; AXELSSON G, 1984, INT J EPIDEMIOL, V13, P94, DOI 10.1093/ije/13.1.94; CARTWRIGHT A, 1979, J BIOSOC SCI, V11, P49, DOI 10.1017/S0021932000012049; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; ERICKSON JD, 1984, JAMA-J AM MED ASSOC, V252, P903, DOI 10.1001/jama.252.7.903; Fletcher R., 1982, CLIN EPIDEMIOLOGY ES; GODDARD KE, 1961, PEDIATRICS, V28, P1011; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; HOEKELMAN RA, 1976, CLIN PEDIATR, V15, P261, DOI 10.1177/000992287601500305; MITCHELL AA, 1986, AM J EPIDEMIOL, V123, P670, DOI 10.1093/oxfordjournals.aje.a114286; WILCOX AJ, 1984, AM J EPIDEMIOL, V120, P727, DOI 10.1093/oxfordjournals.aje.a113940; 1985, SAS USERS GUIDE STAT	12	38	42	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					478	485						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309699				2022-12-18	WOS:A1990CT66800010
J	GRIMM, T; MULLER, B; DREIER, M; KIND, E; BETTECKEN, T; MENG, G; MULLER, CR				GRIMM, T; MULLER, B; DREIER, M; KIND, E; BETTECKEN, T; MENG, G; MULLER, CR			HOT SPOT OF RECOMBINATION WITHIN DXS164 IN THE DUCHENNE MUSCULAR-DYSTROPHY GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GRIMM, T (corresponding author), UNIV WURZBURG,INST HUMAN GENET,KOELLIKERSTR 2,D-8700 WURZBURG,FED REP GER.		Müller-Myhsok, Bertram/A-3289-2013					BAKKER E, 1985, LANCET, V1, P655; BURGOYNE PS, 1986, NATURE, V319, P258, DOI 10.1038/319258a0; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHEN JD, 1989, GENOMICS, V4, P105, DOI 10.1016/0888-7543(89)90322-4; DAVIES KE, 1985, HUM GENET, V70, P249; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HAMERTON JL, 1971, HUMANCYTOGENETICS, V1; HAMERTON JL, 1971, HUMANCYTOGENETICS, V2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINDLOF M, 1987, ANN HUM GENET, V51, P317, DOI 10.1111/j.1469-1809.1987.tb01066.x; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1987, TRENDS GENET, V3, P33, DOI 10.1016/0168-9525(87)90163-6; MORTON NE, 1982, HUM GENET, V62, P266, DOI 10.1007/BF00333534; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; OTT J, 1985, Genetic Epidemiology, V2, P79, DOI 10.1002/gepi.1370020108; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; RUSSO A, 1987, HUM GENET, V76, P230; SCHWENN O, 1988, THESIS U WURZBURG; SZABO P, 1984, P NATL ACAD SCI-BIOL, V81, P7855, DOI 10.1073/pnas.81.24.7855; TRECO D, 1985, MOL CELL BIOL, V5, P2029, DOI 10.1128/MCB.5.8.2029; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WILCOX DE, 1985, HUM GENET, V70, P365, DOI 10.1007/BF00295379	27	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					368	372						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2570527				2022-12-18	WOS:A1989AN87900005
J	GRIFFITHS, LR; ZWI, MB; MCLEOD, JG; NICHOLSON, GA				GRIFFITHS, LR; ZWI, MB; MCLEOD, JG; NICHOLSON, GA			CHROMOSOME-I LINKAGE STUDIES IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SYDNEY,CONCORD HOSP,DEPT MED,CONCORD,AUSTRALIA	Concord Repatriation General Hospital; University of Sydney	GRIFFITHS, LR (corresponding author), UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA.			Griffiths, Lyn/0000-0002-6774-5475				BAKKER E, 1985, LANCET, V1, P655; BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1982, AM J HUM GENET, V34, P388; BIRD TD, 1983, ANN NEUROL, V14, P679, DOI 10.1002/ana.410140612; BISHOP DT, 1982, CYTOGENET CELL GENET, V32, P255; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOCK SC, 1985, CYTOGENET CELL GENET, V39, P67, DOI 10.1159/000132105; BOCK SC, 1984, CYTOGENET CELL GENET, V37, P423; CHANCE PF, 1987, NEUROLOGY, V37, P325, DOI 10.1212/WNL.37.2.325; CHANDRA T, 1983, P NATL ACAD SCI-BIOL, V80, P1845, DOI 10.1073/pnas.80.7.1845; CONNEALLY PM, 1978, CYTOGENET CELL GENET, V22, P295, DOI 10.1159/000130957; COOK PJL, 1978, CYTOGENET CELL GENET, V22, P378, DOI 10.1159/000130976; DARBY JK, 1985, CYTOGENET CELL GENET, V39, P158, DOI 10.1159/000132127; DARBY JK, 1985, AM J HUM GENET, V37, P52; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; DYCK PJ, 1983, MAYO CLIN PROC, V58, P430; DYCK PJ, 1975, PERIPHERAL NEUROPATH, V2, P825; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P4380, DOI 10.1093/nar/14.10.4380; GRIFFITHS LR, 1987, CYTOGENET CELL GENET, V45, P231, DOI 10.1159/000132459; GUILOFF RJ, 1982, J NEUROL NEUROSUR PS, V45, P669, DOI 10.1136/jnnp.45.8.669; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HARDMAN JA, 1984, DNA-J MOLEC CELL BIO, V3, P457, DOI 10.1089/dna.1.1984.3.457; HILL CJ, 1972, NATURE, V235, P162, DOI 10.1038/235162a0; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; MEISLER MH, 1986, MOL CELLULAR BASIS D, P457; MORTON NE, 1956, AM J HUM GENET, V8, P80; MUNKE M, 1985, CYTOGENET CELL GENET, V40, P705; OTT J, 1974, AM J HUM GENET, V26, P588; PROCHOWNIK EV, 1983, J BIOL CHEM, V258, P8389; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RIVAS ML, 1975, CYTOGENET CELL GENET, V16, P347; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; TRICOLI JV, 1984, CYTOGENET CELL GENET, V37, P597; WINTER JH, 1982, ANN HUM GENET, V46, P29, DOI 10.1111/j.1469-1809.1982.tb00692.x; ZABEL BU, 1984, CYTOGENET CELL GENET, V37, P615	38	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					756	771						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	2895983				2022-12-18	WOS:A1988N143800012
J	BABU, A; AGARWAL, AK; VERMA, RS				BABU, A; AGARWAL, AK; VERMA, RS			A NEW APPROACH IN RECOGNITION OF HETEROCHROMATIC REGIONS OF HUMAN-CHROMOSOMES BY MEANS OF RESTRICTION ENDONUCLEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY HLTH SCI CTR,LONG ISL COLL HOSP,DIV GENET,BROOKLYN,NY 11201; CUNY MT SINAI SCH MED,BETH ISRAEL MED CTR,DIV MED GENET,NEW YORK,NY 10029; CUNY,JOHN JAY COLL,DEPT SCI,NEW YORK,NY 10021	Long Island College Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System								BABU A, 1986, HISTOCHEM J, V18, P329, DOI 10.1007/BF01675211; BABU A, 1986, AM J HUM GENET, V38, P549; BABU A, 1987, CHROMOSOMA, V95, P163, DOI 10.1007/BF00330345; BABU A, 1986, CYTOGENET CELL GENET, V41, P60, DOI 10.1159/000132199; BABU A, 1987, INT REV CYTOL, V108, P1, DOI 10.1016/S0074-7696(08)61435-7; BABU A, 1986, CAN J GENET CYTOL, V28, P631, DOI 10.1139/g86-093; BABU A, IN PRESS MOL GEN GEN; BABU KA, 1985, KARYOGRAM, V11, P23; BIANCHI MS, 1985, CHROMOSOMA, V91, P131, DOI 10.1007/BF00294057; BIANCHI NO, 1984, CHROMOSOMA, V90, P133, DOI 10.1007/BF00292450; Jacobs P A, 1977, Prog Med Genet, V2, P251; KAELBLING M, 1984, CHROMOSOMA, V90, P128, DOI 10.1007/BF00292449; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MEZZANOTTE R, 1983, CYTOGENET CELL GENET, V36, P562, DOI 10.1159/000131973; MILLER DA, 1983, SCIENCE, V219, P395, DOI 10.1126/science.6294832; MILLER DA, 1984, EXP CELL RES, V155, P294, DOI 10.1016/0014-4827(84)90793-6; OLSON SB, 1986, AM J HUM GENET, V38, P235; PHILLIPS RB, 1980, J MED GENET, V17, P380, DOI 10.1136/jmg.17.5.380; Verma R S, 1980, Int Rev Cytol, V62, P361; Verma RS, 1988, HETEROCHROMATIN MOL; ZABEAU M, 1979, MOL GENET, P1	21	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					60	65						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2827464				2022-12-18	WOS:A1988L869700008
J	TRENT, RJ; MICKLESON, KNP; WILKINSON, T; YAKAS, J; DIXON, MW; HILL, PJ; KRONENBERG, H				TRENT, RJ; MICKLESON, KNP; WILKINSON, T; YAKAS, J; DIXON, MW; HILL, PJ; KRONENBERG, H			GLOBIN GENES IN POLYNESIANS HAVE MANY REARRANGEMENTS INCLUDING A RECENTLY DESCRIBED GAMMA-GAMMA-GAMMA-GAMMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MIDDLEMORE HOSP, DEPT HAEMATOL, AUCKLAND 6, NEW ZEALAND; MIDDLEMORE HOSP, DEPT NEONATAL PAEDIAT, AUCKLAND 6, NEW ZEALAND; NATL WOMENS HOSP, AUCKLAND, NEW ZEALAND; ROYAL PRINCE ALFRED HOSP, DEPT HAEMATOL, CAMPERDOWN, NSW 2050, AUSTRALIA	University of Sydney	TRENT, RJ (corresponding author), UNIV SYDNEY, CLIN IMMUNOL RES CTR, MOLEC BIOL LAB, SYDNEY, NSW 2006, AUSTRALIA.							[Anonymous], 1980, ESSENTIAL MALARIOLOG; Bellwood P, 1978, POLYNESIANS PREHISTO; BOWDEN DK, 1985, LANCET, V2, P1025; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; GROSSBELLARD M, 1973, EUR J BIOCHEM, V36, P21; HARANO K, 1985, FEBS LETT, V190, P45, DOI 10.1016/0014-5793(85)80424-5; Higgs D R, 1983, Curr Top Hematol, V4, P37; HIGGS DR, 1986, P NATL ACAD SCI US; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1986, BLOOD; HILL AVS, 1983, SAUDI MED J, V4, P221; LIEINJO LE, 1981, NUCLEIC ACIDS RES, V9, P3707, DOI 10.1093/nar/9.15.3707; LIEINJO LE, 1985, HUM GENET, V70, P116, DOI 10.1007/BF00273068; MICHELSON AM, 1983, J BIOL CHEM, V258, P5245; MICKLESON KNP, 1985, NEW ZEAL MED J, V98, P1036; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; OPPENHEIMER SJ, 1984, LANCET, V1, P424; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PEMBREY ME, 1972, J CLIN PATHOL, V25, P738, DOI 10.1136/jcp.25.8.738; THEIN SL, 1984, BRIT J HAEMATOL, V57, P349; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; TRENT RJ, 1981, BRIT J HAEMATOL, V49, P149, DOI 10.1111/j.1365-2141.1981.tb07207.x; TRENT RJ, 1985, AM J HEMATOL, V18, P431, DOI 10.1002/ajh.2830180414; WAINSCOAT JS, 1983, AM J HUM GENET, V35, P1086; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853	26	38	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1986	39	3					350	360						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E3644	3766541				2022-12-18	WOS:A1986E364400007
J	HANASH, SM; NEEL, JV; BAIER, LJ; ROSENBLUM, BB; NIEZGODA, W; MARKEL, D				HANASH, SM; NEEL, JV; BAIER, LJ; ROSENBLUM, BB; NIEZGODA, W; MARKEL, D			GENETIC-ANALYSIS OF 33 PLATELET POLYPEPTIDES DETECTED IN TWO-DIMENSIONAL POLYACRYLAMIDE GELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan	HANASH, SM (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48104, USA.			Markel, Dorene/0000-0002-3382-6779	NATIONAL CANCER INSTITUTE [P01CA026803, R01CA032146] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA-32146, P01-CA-26803] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLEMETSON KJ, 1979, BIOCHIM BIOPHYS ACTA, V553, P11, DOI 10.1016/0005-2736(79)90027-0; COMINGS DE, 1982, CLIN CHEM, V28, P798; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; HAMAGUCHI H, 1982, HUM GENET, V62, P142; HAMAGUCHI H, 1981, HUM GENET, V59, P215; HAMAGUCHI H, 1982, HUM GENET, V60, P176, DOI 10.1007/BF00569708; HAMAGUCHI H, 1982, HUM GENET, V62, P148; LEAVITT J, 1982, CLIN CHEM, V28, P850; LONG MW, UNPUB HUMAN PLATELET; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MCGREGOR JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P473, DOI 10.1016/0005-2736(80)90192-3; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NEEL JV, 1984, METHODS APPLICATIONS, P259; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ROSENBLUM BB, 1984, AM J HUM GENET, V36, P601; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303; SMITH SC, 1980, GENETICS, V96, P967; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1982, AM J HUM GENET, V34, P209; WILSON JM, 1983, P NATL ACAD SCI-BIOL, V80, P870, DOI 10.1073/pnas.80.3.870	21	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					352	360						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3953575				2022-12-18	WOS:A1986A578100009
J	DARBY, JK; FEDER, J; SELBY, M; RICCARDI, V; FERRELL, R; SIAO, D; GOSLIN, K; RUTTER, W; SHOOTER, EM; CAVALLISFORZA, LL				DARBY, JK; FEDER, J; SELBY, M; RICCARDI, V; FERRELL, R; SIAO, D; GOSLIN, K; RUTTER, W; SHOOTER, EM; CAVALLISFORZA, LL			A DISCORDANT SIBSHIP ANALYSIS BETWEEN BETA-NGF AND NEUROFIBROMATOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,HORMONE RES LAB,SAN FRANCISCO,CA 94143; BAYLOR COLL MED,NEUROFIBROMATOSIS PROGRAM,HOUSTON,TX 77030; UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,GENE MARKER LAB,HOUSTON,TX 77025	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	DARBY, JK (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM-28428] Funding Source: Medline; NINDS NIH HHS [1FS-NS-07004-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BREAKEFIELD XO, 1983, BIOCH CLIN ASPECTS N; DAVIS M, 1983, AUG GEN MAPP WORKSH; DESCHRYVERKECSKEMETI K, 1983, NEW ENGL J MED, V308, P635, DOI 10.1056/NEJM198303173081106; FABRICANT RN, 1981, ARCH NEUROL-CHICAGO, V38, P401, DOI 10.1001/archneur.1981.00510070035003; FRANCKE U, 1983, SCIENCE, V222, P1248, DOI 10.1126/science.6648531; GORIN PD, 1980, DEV BIOL, V80, P313, DOI 10.1016/0012-1606(80)90407-8; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MARTINVILLE B, 1983, AUG HUM GEN MAPP C U; PEARSON J, 1974, ANN NY ACAD SCI, V228, P288, DOI 10.1111/j.1749-6632.1974.tb20517.x; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHENKEIN I, 1974, NEW ENGL J MED, V290, P613, DOI 10.1056/NEJM197403142901108; SCHWARTZ JP, 1980, P NATL ACAD SCI-BIOL, V77, P1154, DOI 10.1073/pnas.77.2.1154; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; Server A C, 1977, Adv Protein Chem, V31, P339, DOI 10.1016/S0065-3233(08)60221-1; SIGGERS DC, 1976, NEW ENGL J MED, V295, P629, DOI 10.1056/NEJM197609162951201; SIGGERS DC, 1975, NEW ENGL J MED, V292, P1134; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE MA, 1983, J MED GENET, V20, P334, DOI 10.1136/jmg.20.5.334; STEFFEN D, 1978, CELL, V15, P1003, DOI 10.1016/0092-8674(78)90284-2; SUTTER A, 1979, J BIOL CHEM, V254, P1516; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; VARON S, 1967, BIOCHEMISTRY-US, V6, P2202, DOI 10.1021/bi00859a043; ZABEL BU, 1983, AUG GEN MAPP WORKSH	25	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					52	59						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	2983544				2022-12-18	WOS:A1985AGY5700006
J	DRACOPOLI, NC; RETTIG, WJ; ALBINO, AP; ESPOSITO, D; ARCHIDIACONO, N; ROCCHI, M; SINISCALCO, M; OLD, LJ				DRACOPOLI, NC; RETTIG, WJ; ALBINO, AP; ESPOSITO, D; ARCHIDIACONO, N; ROCCHI, M; SINISCALCO, M; OLD, LJ			GENES-CONTROLLING GP25/30 CELL-SURFACE MOLECULES MAP TO CHROMOSOME-X AND CHROMOSOME-Y AND ESCAPE X-INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TRIESTE, DEPT MED GENET, I-34127 TRIESTE, ITALY	University of Trieste	DRACOPOLI, NC (corresponding author), MEM SLOAN KETTERING CANC CTR, 1275 YORK AVE, NEW YORK, NY 10021 USA.			Dracopoli, Nicholas/0000-0003-3962-4059; archidiacono, nicoletta/0000-0002-1439-9521	NCI NIH HHS [CA-08748] Funding Source: Medline; NIA NIH HHS [AG-00541] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000541] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARCHIDIACONO N, 1979, HUM GENET, V52, P69; DIPPOLD WG, 1980, P NATL ACAD SCI-BIOL, V77, P6114, DOI 10.1073/pnas.77.10.6114; DRACOPOLI NC, 1984, SOMAT CELL MOLEC GEN, V10, P475, DOI 10.1007/BF01534852; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GOODFELLOW P, 1980, SOMAT CELL GENET, V6, P777, DOI 10.1007/BF01538976; HAMERTON JL, 1984, CYTOGENET CELL GENET, V37, P3, DOI 10.1159/000132001; HOPE RM, 1982, CYTOGENET CELL GENET, V33, P204, DOI 10.1159/000131756; KAHAN B, 1975, P NATL ACAD SCI USA, V72, P1510, DOI 10.1073/pnas.72.4.1510; KAHAN B, 1980, SOMAT CELL GENET, V6, P309, DOI 10.1007/BF01542785; KHAN PM, 1971, AM J HUM GENET, V23, P614; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; MARCUS M, 1976, NATURE, V262, P63, DOI 10.1038/262063a0; MATTES MJ, 1984, P NATL ACAD SCI-BIOL, V81, P568, DOI 10.1073/pnas.81.2.568; RETTIG WJ, 1984, SOMAT CELL MOLEC GEN, V10, P297, DOI 10.1007/BF01535251; RETTIG WJ, 1984, P NATL ACAD SCI-BIOL, V81, P6437, DOI 10.1073/pnas.81.20.6437; Siniscalco M, 1982, Prog Clin Biol Res, V103 Pt A, P103; UEDA R, 1981, P NATL ACAD SCI-BIOL, V78, P5122, DOI 10.1073/pnas.78.8.5122; WILLARD HF, 1976, AM J HUM GENET, V28, P213	19	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					199	207						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	4038849				2022-12-18	WOS:A1985AGY5700020
J	MAEKAWA, M; KANDA, S; SUDO, K; KANNO, T				MAEKAWA, M; KANDA, S; SUDO, K; KANNO, T			ESTIMATION OF THE GENE-FREQUENCY OF LACTATE-DEHYDROGENASE SUBUNIT DEFICIENCIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MAEKAWA, M (corresponding author), HAMAMATSU UNIV,SCH MED,DEPT LAB MED,HANDA CHO 3600,HAMAMATSU,SHIZUOKA 43131,JAPAN.							BOONE C, 1972, P NATL ACAD SCI USA, V69, P510, DOI 10.1073/pnas.69.2.510; CHEN TR, 1973, AM J HUM GENET, V25, P200; KANNO T, 1980, CLIN CHIM ACTA, V108, P267; KITAMURA M, 1971, CLIN CHIM ACTA, V34, P419; KITAMURA M, 1975, ISOZYMES, V2, P97; MARKERT CL, 1959, P NATL ACAD SCI USA, V45, P753, DOI 10.1073/pnas.45.5.753; MOHRENWEISER HW, 1982, BIOCHIM BIOPHYS ACTA, V702, P90, DOI 10.1016/0167-4838(82)90030-9; MOHRENWEISER HW, 1981, P NATL ACAD SCI-BIOL, V78, P5046, DOI 10.1073/pnas.78.8.5046; NEEL JV, 1949, AM J HUM GENET, V1, P156; SATOH C, 1983, AM J HUM GENET, V35, P656; Shioya M, 1971, Rinsho Byori, V19, P469; TANIS RJ, 1977, AM J HUM GENET, V29, P419; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210	13	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1204	1214						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517049				2022-12-18	WOS:A1984TZ59000005
J	EAVES, LJ				EAVES, LJ			ERRORS OF INFERENCE IN THE DETECTION OF MAJOR GENE EFFECTS ON PSYCHOLOGICAL TEST-SCORES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											EAVES, LJ (corresponding author), MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23233, USA.				NIGMS NIH HHS [1R01-GM30250-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030250] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBAUM A, 1979, STATISTICAL THEORIES; ELSTON RC, 1979, AM J HUM GENET, V31, P655; GERRARD JW, 1978, AM J HUM GENET, V30, P46; GO RCP, 1978, AM J HUM GENET, V30, P28; LORD FM, 1979, STATISTICAL THEORIES; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; Mather K, 1982, BIOMETRICAL GENETICS; MORTON NE, 1974, AM J HUM GENET, V26, P489; 1982, LIBRARY MANUAL, V3	9	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1179	1189						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RU705	6650501				2022-12-18	WOS:A1983RU70500012
J	SCHNEIDER, NR; CHAGANTI, SR; GERMAN, J; CHAGANTI, RSK				SCHNEIDER, NR; CHAGANTI, SR; GERMAN, J; CHAGANTI, RSK			FAMILIAL PREDISPOSITION TO CANCER AND AGE AT ONSET OF DISEASE IN RANDOMLY SELECTED CANCER-PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MEM SLOAN KETTERING CANC CTR,CANC GENET & CYTOGENET LAB,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; UNIV TEXAS,PARLAND MEM HOSP,SW MED SCH,DEPT PATHOL,DALLAS,TX 75235; NEW YORK BLOOD CTR,HUMAN GENET LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; New York Blood Center								ALBERT S, 1978, AM J EPIDEMIOL, V108, P373, DOI 10.1093/oxfordjournals.aje.a112634; ALBERT S, 1977, CANCER, V40, P1674, DOI 10.1002/1097-0142(197710)40:4<1674::AID-CNCR2820400442>3.0.CO;2-C; ANDERSON DE, 1977, CANCER-AM CANCER SOC, V40, P1855, DOI 10.1002/1097-0142(197710)40:4+<1855::AID-CNCR2820400814>3.0.CO;2-1; ANDERSON VE, 1958, VARIABLES RELATED HU; BUTLIN HT, 1887, BRIT MED J, V1, P436; CHRISTINE B, 1972, CONN HLTH B, V88, P127; CLEMMESEN JOHANNES, 1965, ACTA PATHOL MICROBIOL SCAND SUPPL, V174, P1; Crabtree JA, 1941, AM J PUBLIC HEALTH N, V31, P49, DOI 10.2105/AJPH.31.1.49; CUTLER SJ, 1975, NCI MONOGRAPH, V41; Dorn HF, 1941, AM J HYG, V34, P12, DOI 10.1093/oxfordjournals.aje.a118723; EISENBERG H, 1966, CANCER CONNECTICUT I; ENGEL LW, 1980, AM J EPIDEMIOL, V111, P99, DOI 10.1093/oxfordjournals.aje.a112879; EWING J, 1922, NEOPLASTIC DISEASES, P105; Fraumeni Jr J. F., 1977, GENETICS HUMAN CANCE, P223; GOVER M, 1939, PUBLIC HLTH B, V248; HILL ID, 1972, BRIT J PREV SOC MED, V26, P132; HILLIER WT, 1904, ARCH MIDDLESEX HOSP, V2, P104; Jacobsen O., 1946, HEREDITY BREAST CANC; KNUDSON AG, 1973, PROG MED GENET, V9, P113; KNUDSON AG, 1981, CANCER ACHIEVEMENTS, P381; LILIENFELD A, 1967, CANCER EPIDEMIOLOGY; LIPKIN M, 1981, CLIN BULL, V11, P13; LYNCH HT, 1979, JAMA-J AM MED ASSOC, V242, P1268, DOI 10.1001/jama.242.12.1268; LYNCH HT, 1976, JAMA-J AM MED ASSOC, V236, P582, DOI 10.1001/jama.236.6.582; LYNCH HT, 1976, CANCER GENETICS, P389; MACKLIN MT, 1959, J NATL CANCER I, V22, P927, DOI 10.1093/jnci/22.5.927; MACMAHON B, 1970, EPIDEMIOLOGY PRINCIP, P218; MOERTEL CG, 1966, RECENT RESULTS CANCE, V7; MONSON RR, 1974, COMPUT BIOMED RES, V7, P325, DOI 10.1016/0010-4809(74)90010-X; SCHIMKE RN, 1978, GENETICS CANCER MAN; SCHOTTENFELD D, 1975, CANCER EPIDEMIOL, P3; SMITHERS DW, 1948, BRIT J CANCER, V2, P163, DOI 10.1038/bjc.1948.24; STEINBERG AG, 1960, CANCER, V13, P985, DOI 10.1002/1097-0142(196009/10)13:5<985::AID-CNCR2820130520>3.0.CO;2-J; STRONG LC, 1981, AM J HUM GENET, V33, pA68; Wells HG, 1923, J AMER MED ASSOC, V81, P1017, DOI 10.1001/jama.1923.26510120005012; WOOLF CHARLES M., 1955, UNIV CALIFORNIA PUBL PUBLIC HEALTH, V2, P265; 1981, CANCER FACTS FIGURES	37	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					454	467						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6859041				2022-12-18	WOS:A1983QS16000011
J	HU, DN; LI, JH; CHEN, HY; CHANG, HS; WU, BX; LU, ZK; WANG, DZ; LIU, XG				HU, DN; LI, JH; CHEN, HY; CHANG, HS; WU, BX; LU, ZK; WANG, DZ; LIU, XG			GENETICS OF CLEFT-LIP AND CLEFT-PALATE IN CHINA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHANGHAI SOC GENET,SHANGHAI,PEOPLES R CHINA; INT PEACE MATERN & INFANT HOSP,SHANGHAI,PEOPLES R CHINA; SHANGHAI SECOND MED COLL,NINTH PEOPLE HOSP,SHANGHAI,PEOPLES R CHINA; SHADONG MED COLL,SHADUNG,PEOPLES R CHINA; JIAOTONG UNIV,SHANGHAI,PEOPLES R CHINA	Shanghai Jiao Tong University; Shanghai Jiao Tong University								CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; CZEIZEL E, 1977, MED GENETICS, P411; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FOUGANDERSEN P, 1942, INHERITANCE HARELIP; FRASER FC, 1970, AM J HUM GENET, V22, P336; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; WOOLF CM, 1963, AM J HUM GENET, V15, P209	10	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					999	1002						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180854				2022-12-18	WOS:A1982PU21100018
J	MASAKI, M; HIGURASHI, M; IIJIMA, K; ISHIKAWA, N; TANAKA, F; FUJII, T; KUROKI, Y; MATSUI, I; IINUMA, K; MATSUO, N; TAKESHITA, K; HASHIMOTO, S				MASAKI, M; HIGURASHI, M; IIJIMA, K; ISHIKAWA, N; TANAKA, F; FUJII, T; KUROKI, Y; MATSUI, I; IINUMA, K; MATSUO, N; TAKESHITA, K; HASHIMOTO, S			MORTALITY AND SURVIVAL FOR DOWN SYNDROME IN JAPAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TOKYO,FAC MED,SCH HLTH SCI,DEPT MATERNAL & CHILD HLTH,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT PEDIAT,TOKYO 113,JAPAN; TSUKUJI MATERNAL & CHILDREN HOSP,TOKYO 104,JAPAN; KANAGAWA CHILDRENS MED CTR,YOKOHAMA 233,JAPAN; SHIZUOKA CHILDRENS HOSP,SHIZUOKA 420,JAPAN; NATL CHILDRENS HOSP,TOKYO 154,JAPAN; TOTTORI UNIV,NEUROL SCI RES INST,YONAGO,TOTTORI 683,JAPAN; MIYAKO HLTH CTR,MIYAKO 027,JAPAN	University of Tokyo; University of Tokyo; National Center for Child Health & Development - Japan; Tottori University	MASAKI, M (corresponding author), UNIV TOKYO,FAC MED,SCH HLTH SCI,DEPT HUMAN ECOL,TOKYO 113,JAPAN.							CARTER CO, 1958, J MENT DEFIC RES, V2, P64, DOI 10.1111/j.1365-2788.1958.tb00388.x; COLLMANN RD, 1963, J MENT DEFIC RES, V7, P60; FABIA J, 1970, J MENT DEFIC RES, V14, P235; FRYERS T, 1979, EARLY HUM DEV, V3, P29, DOI 10.1016/0378-3782(79)90018-5; GALLAGHER RP, 1975, J MENT DEFIC RES, V19, P157; KABUTO M, 1979, SEISHIN EISEI KENKYU, V26, P57; NARUTOMI N, 1970, SHONI HOKEN KENKYU, V35, P366; OSTER J, 1975, ACTA PAEDIATR SCAND, V64, P322, DOI 10.1111/j.1651-2227.1975.tb03842.x; Record RG, 1955, BRIT J PREV SOC MED, V9, P10; REED LJ, 1939, AM J HYG, V30, P33; RICHARDS BW, 1969, J MENT DEFIC RES, V13, P276; TSUDA K, 1978, SHONIKA SHINRYO, V42, P993; 1971, 13TH LIFE TABLES	13	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					629	639						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6455063				2022-12-18	WOS:A1981LZ34800016
J	ORIOL, R; LEPENDU, J; SPARKES, RS; SPARKES, MC; CRIST, M; GALE, RP; TERASAKI, PI; BERNOCO, M				ORIOL, R; LEPENDU, J; SPARKES, RS; SPARKES, MC; CRIST, M; GALE, RP; TERASAKI, PI; BERNOCO, M			INSIGHTS INTO THE EXPRESSION OF ABH AND LEWIS ANTIGENS THROUGH HUMAN-BONE MARROW TRANSPLANTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,DIV MED GENET,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,TISSUE TYPING LAB,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,BONE MARROW TRANSPLANTAT UNIT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	ORIOL, R (corresponding author), HOP BROUSSAIS,INST IMMUNOBIOL,F-75674 PARIS 14,FRANCE.		Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387				BARIETY J, 1980, KIDNEY INT, V17, P820, DOI 10.1038/ki.1980.94; BIRD GWG, 1976, J MED GENET, V13, P70, DOI 10.1136/jmg.13.1.70; CROOKSTON MC, 1970, LANCET, V2, P1110; CROOKSTON MC, 1980, IMMUNOBIOLOGY ERYTHR; FIORI A, 1971, J CHROMATOGR, V55, P351, DOI 10.1016/S0021-9673(01)82560-7; GARRETTA M, 1974, BIOMED EXPRESS, V21, P114; Giblett ER., 1969, GENETIC MARKERS HUMA; GLYNN LE, 1957, LANCET, V2, P1083; GRAHAM HA, 1977, HUMAN BLOOD GROUPS, P257; HAKOMORI S, 1977, HUMAN BLOOD GROUPS, P150; HINGLAIS N, J ULTRASTRUCT RES; HOLBURN AM, 1974, BRIT J HAEMATOL, V28, P157; ISSIT PD, 1975, APPLIED BLOOD GROUP; KIMBERLING WJ, 1979, J IMMUNOGENET, V6, P75; MARCELLIBARGE A, 1976, VOX SANG, V30, P81, DOI 10.1111/j.1423-0410.1976.tb02798.x; MARCUS DM, 1969, SCIENCE, V164, P553, DOI 10.1126/science.164.3879.553; MAYR WR, 1976, J IMMUNOGENET, V3, P367; MAYR WR, 1980, HLA ANTIGENS CLIN ME, P68; MOLLISON PL, 1979, BLOOD TRANSFUSION CL, P246; ORIOL R, 1980, HUM IMMUNOL, V1, P195, DOI 10.1016/0198-8859(80)90014-2; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1980, TRANSPLANTATION, V29, P184, DOI 10.1097/00007890-198003000-00003; PICARD J, 1978, J CLIN LAB IMMUNOL, V1, P119; RACHKEWICH RA, 1978, J IMMUNOGENET, V5, P25; RENTON PH, 1962, VOX SANG, V7, P33, DOI 10.1111/j.1423-0410.1962.tb03226.x; ROUGER P, 1980, TRANSFUSION, V20, P536, DOI 10.1046/j.1537-2995.1980.20581034506.x; SNEATH JS, 1955, NATURE, V176, P172, DOI 10.1038/176172a0; SPARKES MC, 1977, VOX SANG, V33, P202, DOI 10.1111/j.1423-0410.1977.tb04464.x; SWANSON J, 1971, LANCET, V1, P396; SZULMAN AE, 1973, LAB INVEST, V28, P565; SZULMAN AE, 1960, J EXP MED, V111, P785, DOI 10.1084/jem.111.6.785; SZYMANSKI IO, 1977, J MED GENET, V14, P279, DOI 10.1136/jmg.14.4.279; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; TERASAKI PI, 1978, AM J CLIN PATHOL, V69, P103; TILLEY CA, 1975, VOX SANG, V28, P25, DOI 10.1111/j.1423-0410.1975.tb02737.x; WATANABE K, 1979, J BIOL CHEM, V254, P3221; Watkins W M, 1980, Adv Hum Genet, V10, P1; WROBEL DM, 1974, VOX SANG, V27, P395, DOI 10.1111/j.1423-0410.1974.tb02436.x; YAMASHITA K, 1976, NATURE, V262, P702, DOI 10.1038/262702a0; YUNIS JJ, 1969, BIOCH METHODS RED CE	40	38	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					551	560						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6167165				2022-12-18	WOS:A1981LZ34800008
J	JUBERG, RC; MARSIDI, I				JUBERG, RC; MARSIDI, I			A NEW FORM OF X-LINKED MENTAL-RETARDATION WITH GROWTH-RETARDATION, DEAFNESS, AND MICROGENITALISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WRIGHT STATE UNIV,SCH MED,DEPT PEDIAT,DAYTON,OH 45435	University System of Ohio; Wright State University Dayton	JUBERG, RC (corresponding author), CHILDRENS MED CTR,DEPT MED GENET & BIRTH DEFECTS,DAYTON,OH 45404, USA.				BHP HRSA HHS [5D28-PE-15199] Funding Source: Medline	BHP HRSA HHS		BAAR HS, 1966, AM J MENT DEF, V71, P13; BORJESON M, 1962, ACTA MED SCAND, V171, P13; CHRISTIAN JC, 1977, CLIN GENET, V11, P128; DEROOVER J, 1977, ANN GENET-PARIS, V20, P263; DUNN HG, 1963, AM J MENT DEF, V67, P827; FRIED K, 1972, CLIN GENET, V3, P258; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; JACOBS PA, 1979, NEW ENGL J MED, V300, P737; JENNINGS MT, 1979, AM J HUM GENET, V31, pA91; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1978, MED J AUSTRALIA, V2, P624; TURNER G, 1978, NEW ENGL J MED, V299, P1472; TURNER G, 1975, J MED GENET, V12, P367, DOI 10.1136/jmg.12.4.367; VANDENBERGHE H, 1978, CLIN GENET, V13, P106; VASQUEZ SB, 1979, J PEDIATR-US, V94, P56, DOI 10.1016/S0022-3476(79)80350-9; YARBROUGH KM, 1976, CLIN GENET, V9, P125	19	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					714	722						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	KJ795	6107045				2022-12-18	WOS:A1980KJ79500010
J	SISTONEN, P; EHNHOLM, C				SISTONEN, P; EHNHOLM, C			HERITABILITY OF SERUM HIGH-DENSITY LIPOPROTEIN IN TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CENT PUBL HLTH LAB,LONDON NW9 5HT,ENGLAND	Public Health England	SISTONEN, P (corresponding author), FINNISH RED CROSS BLOOD TRANSFUS SERV,HELSINKI,FINLAND.							ALBERS JJ, 1976, METABOLISM, V25, P633, DOI 10.1016/0026-0495(76)90060-3; BERG K, 1976, LANCET, V1, P499; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; CHRISTIAN JC, 1976, ACTA GENET MED GEMEL, V25, P145, DOI 10.1017/S000156600001401X; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1977, AM J HUM GENET, V20, P462; COREY LA, 1976, AM J HUM GENET, V28, P433; Eisenberg S, 1975, Adv Lipid Res, V13, P1; Falconer D.S., 1960, INTRO QUANTITATIVE G; GLUECK CJ, 1977, ATHEROSCLEROSIS, V27, P387, DOI 10.1016/0021-9150(77)90159-9; HASEMAN JK, 1970, BEHAV GENET, V1, P11, DOI 10.1007/BF01067367; KANG KW, 1974, HUM HERED, V24, P363, DOI 10.1159/000152672; KEMPTHORNE O, 1961, AM J HUM GENET, V13, P320; LEVY RI, 1976, LIPOPROTEIN METABOLI, P56; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; SARNA S, 1978, HUM HERED, V28, P241, DOI 10.1159/000152964; VANGENT CM, 1978, CLIN CHIM ACTA, V88, P155, DOI 10.1016/0009-8981(78)90163-8	19	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					1	7						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7189093				2022-12-18	WOS:A1980JH29600001
J	RAUM, D; GLASS, D; CARPENTER, CB; SCHUR, PH; ALPER, CA				RAUM, D; GLASS, D; CARPENTER, CB; SCHUR, PH; ALPER, CA			MAPPING OF THE STRUCTURAL GENE FOR THE 2ND COMPONENT OF COMPLEMENT WITH RESPECT TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ROBERT B BRIGHAM HOSP,BOSTON,MA 02120; PETER BENT BRIGHAM HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	RAUM, D (corresponding author), CTR BLOOD RES,BOSTON,MA 02115, USA.							ALBERT ED, 1975, HISTOCOMPATIBILITY T, P941; ALLEN FH, 1974, VOX SANG, V27, P382, DOI 10.1111/j.1423-0410.1974.tb02433.x; ALPER CA, 1976, J EXP MED, V144, P1111, DOI 10.1084/jem.144.4.1111; ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; ARNASON A, 1977, NATURE, V268, P527, DOI 10.1038/268527a0; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; DAY NK, 1975, J EXP MED, V141, P1464, DOI 10.1084/jem.141.6.1464; DEMANT P, 1973, P NATL ACAD SCI USA, V70, P863, DOI 10.1073/pnas.70.3.863; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRIEND PS, 1975, IMMUNOGENETICS, V2, P569, DOI 10.1007/BF01572325; FU SM, 1974, J EXP MED, V140, P1108, DOI 10.1084/jem.140.4.1108; GIBSON DJ, 1976, J IMMUNOL, V116, P1065; GLASS D, 1976, J CLIN INVEST, V58, P853, DOI 10.1172/JCI108538; GLASS D, 1976, ARTHRITIS RHEUM, V19, P945, DOI 10.1002/art.1780190519; HAUPTMANN G, 1976, TISSUE ANTIGENS, V7, P52; HOBART MJ, 1976, TRANSPLANT REV, V32, P26; KRONKE M, 1977, IMMUNOGENETICS, V5, P461, DOI 10.1007/BF01570505; LAMM LU, 1974, HUM HERED, V24, P273, DOI 10.1159/000152660; LAMM LU, 1976, TISSUE ANTIGENS, V7, P122; LAMM LU, 1977, TISSUE ANTIGENS, V10, P394; MEO T, 1976, EUR J IMMUNOL, V6, P916, DOI 10.1002/eji.1830061216; MEO T, 1977, P NATL ACAD SCI USA, V74, P1672, DOI 10.1073/pnas.74.4.1672; MITTAL KK, 1968, TRANSPLANTATION, V6, P913, DOI 10.1097/00007890-196811000-00006; OLAISEN B, 1975, HUMANGENETIK, V30, P291, DOI 10.1007/BF00275141; OTT J, 1976, ANN HUM GENET, V40, P191, DOI 10.1111/j.1469-1809.1976.tb00179.x; PARISER KM, J IMMUNOL; RAUM D, 1976, J CLIN INVEST, V58, P1240, DOI 10.1172/JCI108578; SCHUR PH, 1975, CLINICS RHEUMATIC DI, V1, P519; ZIEGLER JB, 1975, NATURE, V254, P609, DOI 10.1038/254609a0	29	38	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					35	41						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	312013				2022-12-18	WOS:A1979GR11500004
J	WINSOR, EJT; WELCH, JP				WINSOR, EJT; WELCH, JP			GENETIC AND DEMOGRAPHIC ASPECTS OF NOVA-SCOTIA NIEMANN-PICK DISEASE (TYPE-D)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WINSOR, EJT (corresponding author), DALHOUSIE UNIV, DEPT PEDIAT, HALIFAX B3H 4H7, NS, CANADA.							CALLAHAN JW, 1974, BIOCHEM BIOPH RES CO, V58, P384, DOI 10.1016/0006-291X(74)90376-3; CRAWLEY FM, 1971, THESIS DALHOUSIE U; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; CROCKER AC, 1961, J NEUROCHEM, V7, P69, DOI 10.1111/j.1471-4159.1961.tb13499.x; CUMINGS JH, 1962, CEREBRAL SPHINGOLIPI; DUNN HC, 1971, NEUROLOGY, V21, P442; EMERY JM, 1972, AM J OPHTHALMOL, V74, P1144, DOI 10.1016/0002-9394(72)90736-2; FOX JT, 1967, DIS NERV SYST, V28, P194; FREDRICKSON DS, 1972, METABOLIC BASIS INHE, P783; GALFI I, 1967, ACTA PAEDIATR HUNG, V8, P355; LABERGE C, 1967, CAN MED ASSOC J, V97, P1099; LOWDEN JA, 1967, ARCH NEUROL-CHICAGO, V17, P230, DOI 10.1001/archneur.1967.00470270008002; MANGE AP, 1964, AM J HUM GENET, V16, P484; MANGE AP, 1969, COMPUTER APPLICATION; MCKUSICK VA, 1964, COLD SPRING HARB SYM, V29, P99, DOI 10.1101/SQB.1964.029.01.015; MCKUSICK VA, 1968, RECORD LINKAGE MEDIC, P263; NEVILLE BGR, 1973, BRAIN, V96, P97, DOI 10.1093/brain/96.1.97; NORMAN RM, 1967, ARCH DIS CHILD, V42, P91, DOI 10.1136/adc.42.221.91; OPPENHEIMER DR, 1967, J NEUROL SCI, V5, P575, DOI 10.1016/0022-510X(67)90093-7; PHILIPPART M, 1969, ARCH NEUROL-CHICAGO, V20, P227, DOI 10.1001/archneur.1969.00480090015001; PORGES E, 1966, J NEUROCHEM, V13, P879, DOI 10.1111/j.1471-4159.1966.tb05884.x; RABINOWICZ T, 1968, Pathologia Europaea, V3, P154; RAO BG, 1977, ANN NEUROL, V1, P385, DOI 10.1002/ana.410010410; TIBBLES JA, 1972, PEDIATR RES, V6, P364; VETHAMANY VG, 1972, ARCH PATHOL, V93, P537; WENGER DA, 1977, AM J DIS CHILD, V131, P955, DOI 10.1001/archpedi.1977.02120220021002	26	38	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					530	538						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA288	736041				2022-12-18	WOS:A1978GA28800006
J	DAIGER, SP; CAVALLISFORZA, LL				DAIGER, SP; CAVALLISFORZA, LL			DETECTION OF GENETIC-VARIATION WITH RADIOACTIVE LIGANDS .2. GENETIC-VARIANTS OF VITAMIN-D-LABELED GROUP-SPECIFIC COMPONENT (GC) PROTEINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV HOSP,MED CTR,DEPT GENET,STANFORD,CA 94305	Stanford University								BELSEY R, 1974, AM J MED, V57, P50, DOI 10.1016/0002-9343(74)90767-0; BLUMBERG BS, 1964, NATURE, V202, P561, DOI 10.1038/202561a0; BOUILLON R, 1976, EUR J BIOCHEM, V66, P285, DOI 10.1111/j.1432-1033.1976.tb10518.x; CAVALLISFORZA LL, 1977, AM J HUM GENET, V29, P581; CAVALLISFORZA LL, 1969, AM J HUM GENET, V21, P252; CAVALLISFORZA LL, 1971, 4TH P INT C HUM GEN, P79; CLEVE H, 1973, ISRAEL J MED SCI, V9, P1133; CLEVE H, 1970, HUMANGENETIK, V9, P26, DOI 10.1007/BF00696010; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; DAIGER SP, 1976, THESIS STANFORD U; HADDAD GJ, 1976, J BIOL CHEM, V16, P4803; HENNIG W, 1965, VOX SANG, V10, P214, DOI 10.1111/j.1423-0410.1965.tb04341.x; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; IMAWARI M, 1977, J CLIN INVEST, V59, P432, DOI 10.1172/JCI108657; JOHNSON AM, 1975, AM J HUM GENET, V27, P728; KIRK RL, 1963, ACTA GENET STAT MED, V13, P140; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; MCDERMID EM, 1972, HUM HERED, V22, P249, DOI 10.1159/000152494; NAKAJIMA H, 1971, HUM HERED, V21, P362, DOI 10.1159/000152427; REINSKOU T, 1965, ACTA GENET STAT MED, V15, P248; RITNER CH, 1969, VOX SANG, V10, P510; SPEISER P, 1972, HUMANGENETIK, V17, P81, DOI 10.1007/BF01789606; WADE T, 1966, JPN J HUM GENET, V10, P157	23	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					593	604						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	73350				2022-12-18	WOS:A1977EC27000007
J	NAVON, R; GEIGER, B; YOSEPH, YB; RATTAZZI, MC				NAVON, R; GEIGER, B; YOSEPH, YB; RATTAZZI, MC			LOW-LEVELS OF BETA-HEXOSAMINIDASE-A IN HEALTHY INDIVIDUALS WITH APPARENT DEFICIENCY OF THIS ENZYME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY BUFFALO,CHILDRENS HOSP,DEPT PEDIAT,DIV HUMAN GENET,BUFFALO,NY; TEL AVIV UNIV,SCH MED,SHEBA MED CTR,DEPT HUMAN GENET,TEL HASHOMER,ISRAEL; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,REHOVOTH,ISRAEL	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chaim Sheba Medical Center; Tel Aviv University; Weizmann Institute of Science								BACH G, 1975, J BIOL CHEM, V250, P1328; BARTHOLOMEW WR, 1974, INT ARCH ALLER A IMM, V46, P512, DOI 10.1159/000231154; BENYOSEPH Y, 1975, IMMUNOCHEMISTRY, V12, P221, DOI 10.1016/0019-2791(75)90235-9; CANTZ M, 1974, EUR J BIOCHEM, V47, P581, DOI 10.1111/j.1432-1033.1974.tb03729.x; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; GEIGER B, 1974, FEBS LETT, V45, P276, DOI 10.1016/0014-5793(74)80861-6; GEIGER B, 1975, EUR J BIOCHEM, V56, P311, DOI 10.1111/j.1432-1033.1975.tb02235.x; KOLODNY EH, 1969, BIOCHEM BIOPH RES CO, V37, P526, DOI 10.1016/0006-291X(69)90947-4; LI YT, 1973, J BIOL CHEM, V248, P7512; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; NADLER HL, 1968, BIOCHEM GENET, V2, P119, DOI 10.1007/BF01458711; NAVON R, 1973, AM J HUM GENET, V25, P287; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PADEH B, 1971, ISRAEL J MED SCI, V7, P259; RATTAZZI MC, 1976, AM J HUM GENET, V28, P143; RATTAZZI MC, 1975, ISOZYMES, V2, P439; RATTAZZI MC, 1972, ANTENATAL DIAGNOSIS, P207; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1971, H-S Z PHYSIOL CHEM, V352, P1119, DOI 10.1515/bchm2.1971.352.2.1119; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; TALLMAN JF, 1974, NATURE, V252, P254, DOI 10.1038/252254a0; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; VIDGOFF J, 1974, AM J HUM GENET, V26, pA89; WENGER DA, 1972, ARCH BIOCHEM BIOPHYS, V153, P116, DOI 10.1016/0003-9861(72)90427-4	27	38	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					339	349						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	941901				2022-12-18	WOS:A1976BX34500003
J	NAKASHIM.K; MIWA, S; ODA, S; ODA, E; MATSUMOT.N; FUKUMOTO, Y; YAMADA, T				NAKASHIM.K; MIWA, S; ODA, S; ODA, E; MATSUMOT.N; FUKUMOTO, Y; YAMADA, T			ELECTROPHORETIC AND KINETIC STUDIES OF GLUCOSEPHOSPHATE ISOMERASE (GPI) IN 2 DIFFERENT JAPANESE FAMILIES WITH GPI DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YAMAGUCHI UNIV,SCH MED,THIRD DEPT INTERN MED,UBE,YAMAGUCHI 755,JAPAN; NARITA RED CROSS HOSP,DEPT PEDIAT,NARITA,JAPAN; SHINSHU UNIV,SCH MED,INST ADAPTATION MED,DEPT MED,MATSUMOTO,JAPAN	Yamaguchi University; Shinshu University								ARNOLD H, 1970, KLIN WOCHENSCHR, V48, P1299, DOI 10.1007/BF01485522; BAUGHAN MA, 1968, BLOOD, V32, P236, DOI 10.1182/blood.V32.2.236.236; Beutler E., 1971, RED CELL METABOLISM; BLUME KG, 1972, J LAB CLIN MED, V79, P942; CARTER ND, 1969, BIOCHIM BIOPHYS ACTA, V181, P12, DOI 10.1016/0005-2795(69)90222-0; DACIE JV, 1967, NATURE, V216, P663, DOI 10.1038/216663a0; DETTER JC, 1968, ANN HUM GENET, V31, P329, DOI 10.1111/j.1469-1809.1968.tb00565.x; Giblett ER., 1969, GENETIC MARKERS HUMA; MIWA S, IN PRESS; MIWA S, 1969, SOGORINSHO, V18, P1743; OSKI F, 1971, CLIN RES, V19, P427; PAGLIA DE, 1969, NEW ENGL J MED, V280, P66, DOI 10.1056/NEJM196901092800203; SCHROTER W, 1971, BRIT J HAEMATOL, V20, P249, DOI 10.1111/j.1365-2141.1971.tb07036.x; SHROTER W, 1970, EUROP J CLIN INVEST, V1, P145; 1967, WHO366 TECHN REP	15	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					294	301						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704861				2022-12-18	WOS:A1973P918200009
J	NISWANDER, JD				NISWANDER, JD			FURTHER STUDIES ON XAVANTE INDIANS .7. ORAL STATUS OF XAVANTES OF SIMOES LOPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSON GM, 1960, PRACTICAL ORTHODONTI; Angel J. L., 1944, HUMAN BIOL, V16, P283; ARCHARD HO, 1965, ORAL SURG ORAL MED O, V20, P201, DOI 10.1016/0030-4220(65)90192-1; BARRETT JJ, 1953, AUSTRALIAN J DENT, V57, P127; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P298, DOI 10.1016/0002-9416(54)90092-5; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P373, DOI 10.1016/0002-9416(54)90035-4; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P517, DOI 10.1016/0002-9416(54)90103-7; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P462, DOI 10.1016/0002-9416(54)90118-9; BORSANYI S, 1960, JAMA-J AM MED ASSOC, V174, P20, DOI 10.1001/jama.1960.03030010022005; BRASH IC, 1956, AETIOLOGY IRREGULARI; BROTHWELL DR, 1963, DENTAL ANTHROPOLO ED; BROTHWELL DR, 1963, DENTAL ANTHROPOLOGY; Campbell, 1925, THESIS U ADELAIDE AD; CARBONELL VM, 1963, DENTAL ANTHROPOLOGY; CRAN JA, 1955, AUSTRALIAN J DENT, V59, P356; DAHLBERG AA, 1963, DENTAL ANTHROPOLOGY; DUMMETT C O, 1957, J Am Dent Assoc, V54, P49; DUNKEL IC, UNPUBLISHED MANUSCRI; EVELETH PB, 1966, HUM BIOL, V38, P60; FARAGO C, 1964, Med J Aust, V2, P218; FINN SB, 1952, SURVEY LITERATURE DE; FINN SB, 1952, 225 NAT AC SCIENC NA; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; HUNT EE, 1961, AMER J ORTHODONT, V17, P406; KEITH A, 1924, GROWTH JAWS NORMAL A; KROGMAN WILTON MARION, 1938, ZEITSCHR RASSENK, V7, P41; LEIGH RW, 1928, AM ARCHAEOL ETHNOL, V23, P399; LIMA PE, 1950, B MUSEU NACIONAL, V11, P1; Maybury-Lewis D, 1965, SAVAGE INNOCENT; MAYBURYLEWIS D, IN PRESS; McINTOSH W G, 1949, J Can Dent Assoc (Tor), V15, P69; MILLS JRE, 1963, DENTAL ANTHROPOLOGY; Moorrees C.F.A., 1957, ALEUT DENTITION; NEEL JV, 1964, AM J HUM GENET, V16, P52; NISWANDER JD, 1963, AM J PHYS ANTHROPOL, V21, P569, DOI 10.1002/ajpa.1330210413; OBERG K, 1953, 15 I SOC ANTHR PUBL; POLUNIN I., 1953, MED JOUR MALAYA, V8-8, P55; RABKIN S, 1937, J D RES, V16, P203; RIHAN HY, 1932, INT J ORTHOD ORAL, V18, P708; RUSSELL A. L., 1956, JOUR DENTAL RES, V35, P350, DOI 10.1177/00220345560350030401; RUSSELL AL, 1965, ENVIRONMENTAL VARIAB; SALZANO FM, 1967, AM J HUM GENET, V19, P463; SCHERP HW, 1964, J AM DENT ASSOC, V68, P667, DOI 10.14219/jada.archive.1964.0147; Schull WJ, 1965, EFFECTS INBREEDING J; SEDWICK HJ, 1936, J AM DENT ASSOC, V23, P764; SILVERMAN M, 1966, ANN INTERN MED, V64, P842, DOI 10.7326/0003-4819-64-4-842; STEGGERDA M., 1942, AMER JOUR ORTHODONT AND ORAL SURG, V28, P361, DOI 10.1016/S0096-6347(42)90608-2; TOVERUD G, 1952, 225 NAT AC SCIENC NA; WEINSTEIN ED, 1967, AM J HUM GENET, V19, P532; 1960, ECUADOR NUTRITION SU; 1965, 1000 US PUBL HEAL 11	51	38	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					543	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	4382497				2022-12-18	WOS:A19679857000007
J	WARBURTON, D; MILLER, DA; MILLER, OJ; BREG, WR; DECAPOA, A; SHAW, MW				WARBURTON, D; MILLER, DA; MILLER, OJ; BREG, WR; DECAPOA, A; SHAW, MW			DISTINCTION BETWEEN CHROMOSOME 4 AND CHROMOSOME 5 BY REPLICATION PATTERN AND LENGTH OF LONG AND SHORT ARMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BADER S, 1963, EXP CELL RES, V31, P100, DOI 10.1016/0014-4827(63)90159-9; BETTECKEN F, 1965, DEUT MED WOCHENSCHR, V90, P2008, DOI 10.1055/s-0028-1113464; GERMAN J, 1964, CYTOGENETICS, V3, P347, DOI 10.1159/000129824; GERMAN JL, 1964, CYTOGENETICS CELLS C; GIANNELLI F, 1966, CYTOGENETICS, V5, P186, DOI 10.1159/000129897; GINDILIS VM, 1966, CYTOLOGY, V8, P144; HARRIS RJC, 1964, CYTOGENETICS CELL ED; MILLER OJ, 1966, LANCET, V2, P105; MILLER OJ, 1966, CYTOGENETICS, V5, P137, DOI 10.1159/000129893; PATAU K, 1965, HUMAN CHROMOSOME MET; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SHAW MW, 1965, AM J HUM GENET, V17, P54; Siegel S, 1956, NONPARAMETRIC STATIS; STEELE MW, 1966, CYTOGENETICS, V5, P419, DOI 10.1159/000129917; WOLF U, 1965, HUMANGENETIK, V1, P397; YUNIS JJ, 1965, HUMAN CHROMOSOME  ED; 1966, B WORLD HEALTH ORG, V34, P765; 1966, CYTOGENETICS, V5, P361	18	38	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					399	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026933				2022-12-18	WOS:A19679607400005
J	VANDYKE, HE; VALDMANIS, A; MANN, JD				VANDYKE, HE; VALDMANIS, A; MANN, JD			PROBABLE DELETION OF SHORT ARM OF CHROMOSOME 18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BECKER KL, 1963, MAYO CLIN PROC, V38, P261; BIESELE JJ, 1962, AM J HUM GENET, V14, P125; BOEOEK JA, 1961, LANCET, V1, P167; BRODIE HR, 1962, CAN MED ASSOC J, V87, P559; BUHLER EM, 1964, LANCET, V1, P170; de Grouchy J., 1963, CR HEBD ACAD SCI, V258, P1028; De LOZZIO C. B., 1963, LANCET, V1, P1106; EDWARDS JH, 1960, LANCET, V1, P787; FERGUSONSMITH MA, 1963, ANN HUM GENET, V27, P143, DOI 10.1111/j.1469-1809.1963.tb00207.x; GUNZ FW, 1962, BRIT MED J, P1097, DOI 10.1136/bmj.2.5312.1097; HAUSCHKA TS, 1962, AM J HUM GENET, V14, P22; HECHT F, 1963, LANCET, V1, P114; JACOBS PA, 1961, LANCET, V1, P1183; LELE KP, 1963, ANN HUM GENET, V27, P171, DOI 10.1111/j.1469-1809.1963.tb00209.x; LUCAS M, 1963, ANN HUM GENET, V27, P189, DOI 10.1111/j.1469-1809.1963.tb00212.x; MANN JD, 1962, LANCET, V1, P8; MERCER ROBERT D., 1963, CLEVELAND CLIN QUART, V30, P225; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NOWELL PC, 1960, SCIENCE, V132, P1497; ROHDE RA, 1963, LANCET, V2, P1309; RUSSELL LB, 1962, PROGRESS MEDICAL GEN, V2; SMITH DW, 1962, J PEDIATR-US, V60, P513, DOI 10.1016/S0022-3476(62)80112-7; STEIKER DD, 1961, J PEDIATR-US, V58, P321, DOI 10.1016/S0022-3476(61)80262-X; STEINBERG AG, 1962, PROGRESS MEDICAL GEN, V2; TRUJILLO JM, 1961, LANCET, V1, P560; VISLIE H, 1962, LANCET, V2, P76; WANG HC, 1962, NATURE, V195, P733, DOI 10.1038/195733a0	27	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	3					364	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2973A	14207551				2022-12-18	WOS:A19642973A00010
J	GIBLETT, ER; WAXMAN, SH; GARTLER, SM				GIBLETT, ER; WAXMAN, SH; GARTLER, SM			BLOOD GROUP STUDIES ON FAMILY OF AN XX/XY HERMAPHRODITE WITH GENERALIZED TISSUE MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMSTRONG CN, 1957, BRIT MED J, V2, P605, DOI 10.1136/bmj.2.5045.605; BOOTH PB, 1957, BRIT MED J, V1, P1456, DOI 10.1136/bmj.1.5033.1456; CLEGHORN TE, PERSONAL COMMUNICATI; DUNSFORD I, 1953, BRIT MED J, V2, P81, DOI 10.1136/bmj.2.4827.81; GARTLER SM, 1962, P NATL ACAD SCI USA, V48, P332, DOI 10.1073/pnas.48.3.332; MANN JD, 1962, LANCET, V1, P8; MOLLISON PL, 1961, BLOOD TRANSFUSION CL, P135; NICHOLAS JW, 1957, BRIT MED J, V1, P1458, DOI 10.1136/bmj.1.5033.1458; RACE RR, 1958, BLOOD GROUPS MAN, P63; SANGER R, 1955, VOX SANG, V5, P73; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; WAXMAN SH, 1962, J PEDIATR-US, V60, P540, DOI 10.1016/S0022-3476(62)80115-2; WOODRUFF MF, 1962, LANCET, V1, P192; WOODRUFF MFA, 1953, BRIT MED J, V2, P1103, DOI 10.1136/bmj.2.4845.1103-c	14	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					62	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13947709				2022-12-18	WOS:A19632969A00002
J	STEINBERG, A; SINGH, RB; VOS, GH; LAI, LYC; LIM, TW				STEINBERG, A; SINGH, RB; VOS, GH; LAI, LYC; LIM, TW			GENETIC AND POPULATION STUDIES OF BLOOD TYPES AND SERUM FACTORS AMONG INDIANS AND CHINESE FROM MALAYA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GIBLETT ER, 1960, AM J HUM GENET, V12, P160; KIRK RL, 1960, NATURE, V185, P185, DOI 10.1038/185185a0; LAI L. Y. C., 1961, AUSTRALIAN JOUR SCI, V23, P228; MOURANT AE, 1958, ABO BLLODGROUPS; MOURANT AE, 1954, DISTRIBUTIONS HUMAN; OTTENSOOSER F, 1961, LANCET; Race Robert Russell, 1958, BLOOD GROUPS MAN; ROPARTZ CL, 1961, REV FRANC ET CL BIOL; SIMMONS R T, 1950, Med J Aust, V2, P917; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0	12	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	4					355	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2962A	13916666				2022-12-18	WOS:A19612962A00006
J	KODANI, M				KODANI, M			SUPERNUMERARY CHROMOSOME OF MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDRES AH, 1936, P MAXIM GORKY MED GE, V4, P506; BENDER MA, 1957, SCIENCE, V126, P974, DOI 10.1126/science.126.3280.974; Cooper KW, 1944, GENETICS, V29, P537; DARLINGTON CD, 1955, NATURE, V175, P32, DOI 10.1038/175032a0; EVANS HERBERT M., 1929, MEM UNIV CALIFORNIA, V9, P1; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; HSU TC, 1952, J HERED, V43, P167, DOI 10.1093/oxfordjournals.jhered.a106296; KODANI M, 1957, P NATL ACAD SCI USA, V43, P285, DOI 10.1073/pnas.43.3.285; KODANI M, 1957, 1956 P INT GEN S TOK, P103; KOLLER PC, 1937, P ROY SOC EDINB B, V57, P194; MELANDER Y, 1950, HEREDITAS, V36, P261; MINOUCHI OSAMU, 1934, CYTOLOGIA, V5, P472; MITTWOCH U, 1952, ANN EUGENIC, V17, P37; Painter TS, 1923, J EXP ZOOL, V37, P291, DOI 10.1002/jez.1400370303; RAY-CHANDHURI S. P., 1955, JOUR GENETICS, V53, P363, DOI 10.1007/BF02981665; ROTHFELS KH, 1950, J MORPHOL, V87, P287, DOI 10.1002/jmor.1050870205; Schrader F, 1940, P NATL ACAD SCI USA, V26, P634, DOI 10.1073/pnas.26.11.634; SHIWAGO P. I., 1932, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELL FORSCH U MIKROSK ANAT, V16, P413, DOI 10.1007/BF00390956; Stern C., 1949, PRINCIPLES HUMAN GEN; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; Van Winiwarter H., 1912, ARCH BIOL, V27, P91; WAHRMAN J, 1955, NATURE, V175, P600, DOI 10.1038/175600b0; WHITE MJD, 1951, ADV GENET, V4, P267, DOI 10.1016/S0065-2660(08)60238-2; White MJD., 1954, ANIMAL CYTOLOGY EVOL, V2; WINIWARTER HD, 1925, COMPT REND ASS ANAT, P1	25	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					125	140						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533391				2022-12-18	WOS:A1958WA21900002
J	SACHS, L; BATMIRIAM, M				SACHS, L; BATMIRIAM, M			GENETICS OF JEWISH POPULATIONS .1. FINGER PRINT PATTERNS IN JEWISH POPULATIONS IN ISRAEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COON CS, 1948, RACES EUROPE; CUMMINS H, 1943, FINGER PRINTS PALMS; DA CUNHA A. XAVIER, 1954, CONT ANTHROPOL PORTULSA, V5, P315; HOLT SB, 1949, ANN EUGENIC, V14, P329; Mourant A., 1954, DISTRIBUTION HUMAN B; RIFE DC, 1953, AM J HUM GENET, V5, P389	6	38	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	2					117	126						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA215	13444249				2022-12-18	WOS:A1957WA21500003
J	WOOLF, CM				WOOLF, CM			A FURTHER STUDY ON THE FAMILIAL ASPECTS OF CARCINOMA OF THE STOMACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROBECH O, 1949, HEREDITY UTERINE CAN; BUSK T, 1948, ANN EUGENIC, V14, P213; CLEMMESEN J, 1949, BRIT J CANCER, V3, P474, DOI 10.1038/bjc.1949.50; GORER PA, 1953, CLIN GENETICS, pCH29; HAGY GW, 1954, AM J HUM GENET, V6, P434; IASON AH, 1953, GASTRIC CANCER; Jacobsen O., 1946, HEREDITY BREAST CANC; MACKLIN MT, 1953, EUGEN NEWS, V35, P112; MACKLIN MT, 1952, AM J HUMAN GENET, V4, P377; MOSBECH J, 1955, J NATL CANCER I, V15, P1665; MURPHY DP, 1952, HEREDITY UTERINE CAN; OBERLING C, 1944, RIDDLE CANCER; PENROSE LS, 1948, ANN EUGENIC, V14, P234; SMITHERS DW, 1948, BRIT J CANCER, V2, P163, DOI 10.1038/bjc.1948.24; Stocks P, 1933, ANN EUGENIC, V5, P237, DOI 10.1111/j.1469-1809.1933.tb02094.x; VIDEBAEK A, 1954, ACTA MED SCAND, V149, P137; WOOLF CHARLES M., 1955, UNIV CALIFORNIA PUBL PUBLIC HEALTH, V2, P265	17	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	2					102	109						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF069	13313520				2022-12-18	WOS:A1956WF06900004
J	SUTTON, HE; CLARK, PJ; SCHULL, WJ				SUTTON, HE; CLARK, PJ; SCHULL, WJ			USE OF MULTI-ALLELE GENETIC CHARACTERS IN THE DIAGNOSIS OF TWIN ZYGOSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COTTERMAN CW, 1951, AM J HUM GENET, V3, P362; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; Mourant A., 1954, DISTRIBUTION HUMAN B; RACE RR, 1954, BLOOD GROUPS MAN; STRANDSKOV HH, 1946, GENETICS, V31, P438; Wiener AS, 1940, GENETICS, V25, P0187; WIENER AS, 1952, AM J HUM GENET, V4, P37	7	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	2					180	188						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA211	14388005				2022-12-18	WOS:A1955WA21100007
J	MYRIANTHOPOULOS, NC; BROWN, IA				MYRIANTHOPOULOS, NC; BROWN, IA			A GENETIC STUDY OF PROGRESSIVE SPINAL MUSCULAR ATROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Aring CD, 1935, MEDICINE, V14, P77, DOI 10.1097/00005792-193502000-00002; BEAUMONT WM, 1900, T OPHTHAL SOC UK, V20, P258; BERNHARDT M, 1889, VIRCHOWS ARCH PATH A, V115, P197; BEST F, 1931, KURZES HDB OPHTHALMO, V6; Boeters H, 1938, Z GESAMTE NEUROL PSY, V160, P455, DOI 10.1007/BF02877992; BRADBURNE AA, 1912, T OPHTHAL SOC UK, V32, P142; Bremer FW, 1922, ARCH PSYCHIAT NERVEN, V66, P477, DOI 10.1007/BF01910510; BROWN MR, 1951, NEW ENGL J MED, V245, P645, DOI 10.1056/NEJM195110252451704; Cooper H, 1910, BRIT MED J, V1910, P917, DOI 10.1136/bmj.1.2572.917; DUKEELDER W, 1949, TXB OPHTHALMOLOGY, V4; EICHHORST H, 1873, BERL KLIN WOCHENSCHR, V10, P511; EICHHORST H, 1873, BERL KLIN WOCH, V10, P397; FAGIN ID, 1942, AM J OPHTHALMOL, V23, P968; FRIEDENWALD H, 1922, P AM OPHTH SOC, V20, P200; FURST T, 1929, ARCH RASSENBIOL, V21, P424; Gates R. R., 1946, HUMAN GENETICS, VII; GOWERS WR, 1903, MANUAL DISEASES NERV, V1; GRINKER RR, 1945, NEUROLOGY, P1034; HASSIN GB, 1945, J NEUROPATH EXP NEUR, V4, P240, DOI 10.1097/00005072-194504030-00003; HEARD CF, 1901, OPHTH REC, V10, P404; HOFFMANN M, 1916, THESIS KIEL, P22; KOLLARITS J, 1906, DTSCH Z NERVENHEILK, V30, P293; Langdon HM, 1928, BRAIN, V51, P321, DOI 10.1093/brain/51.3.321; Lovell HW, 1932, ARCH NEURO PSYCHIATR, V28, P394, DOI 10.1001/archneurpsyc.1932.02240020146010; MCKINLEY JC, 1939, OUTLINE NEUROPSYCHIA; Milhorat AT, 1938, ARCH NEURO PSYCHIATR, V40, P663, DOI 10.1001/archneurpsyc.1938.02270100035002; MOLEEN GA, 1932, ARCH NEUROL PSYCHIAT, V27, P645; OSLER W, 1880, ARCH MED, V4, P316; ROBERTSON EE, 1953, AMA ARCH NEUROL PSY, V69, P197, DOI 10.1001/archneurpsyc.1953.02320260055004; SANDERS J., 1934, GENETICA, V16, P365, DOI 10.1007/BF02071503; STEINTHAL MARGARETE, 1929, ARCH RASS U GES BIOL, V21, P425; WALSH FB, 1947, CLIN NEURO OPHTH, P277; WECHSLER IS, 1952, TXB CLIN NEUROLOGY; WILBRAND H, 1900, NEUROLOGIE AUGES, V1; WILSON SAK, 1940, NEUROLOGY, V2, P1006	35	38	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1954	6	4					387	411						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB735	14349945				2022-12-18	WOS:A1954YB73500003
J	SLATIS, HM				SLATIS, HM			SEASONAL VARIATION IN THE AMERICAN LIVE BIRTH SEX RATIO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Ciocco A., 1938, HUM BIOL, V10, P36; Huntington E., 1938, SEASON BIRTH; ORWIG GH, 1948, THESIS U CHICAGO; STRANDSKOV HERLUF H., 1942, HUMAN BIOL, V14, P85; 1922, BIRTH STILLBIRTH INF; 1915, BIRTH STATISTICS REG; 1942, VITAL STATISTICS US	7	38	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					21	33						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050607				2022-12-18	WOS:A1953XW62900002
J	Cakici, JA; Dimmock, DP; Caylor, SA; Gaughran, M; Clarke, C; Triplett, C; Clark, MM; Kingsmore, SF; Bloss, CS				Cakici, Julie A.; Dimmock, David P.; Caylor, Sara A.; Gaughran, Mary; Clarke, Christina; Triplett, Cynthia; Clark, Michelle M.; Kingsmore, Stephen F.; Bloss, Cinnamon S.			A Prospective Study of Parental Perceptions of Rapid Whole-Genome and -Exome Sequencing among Seriously Ill Infants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTITUDES	Rapid diagnostic genomic sequencing recently became feasible for infants in intensive care units (ICUs). However, research regarding parents' perceived utility, adequacy of consent, and potential harms and benefits is lacking. Herein we report results of parental surveys of these domains from the second Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT2) study, a randomized, controlled trial of rapid diagnostic genomic sequencing of infants in regional ICUs. More than 90% of parents reported feeling adequately informed to consent to diagnostic genomic sequencing. Despite only 23% (27) of 117 infants receiving genomic diagnoses, 97% (156) of 161 parents reported that testing was at least somewhat useful and 50.3% (88/161) reported no decisional regret (median 0, mean 10, range 0-100). Five of 117 families (4.3%) reported harm. Upon follow-up, one (1%) confirmed harm to child and parent related to negative results/no diagnosis, two (2%) reported stress or confusion, and two (2%) denied harm. In 81% (89) of 111 infants, families and clinicians agreed that genomic results were useful. Of the families for whom clinicians perceived harm from genomic testing, no parents reported harm. Positive tests/genomic diagnosis were more frequently perceived to be useful by parents, to benefit their infant, and to help manage potential symptoms (p <.05). In summary, the large majority of parents felt that first-tier, rapid, diagnostic genomic sequencing was beneficial for infants lacking etiologic diagnoses in ICUs. Most parents in this study perceived being adequately informed to consent, understood their child's results, and denied regret or harm from undergoing sequencing.	[Cakici, Julie A.; Bloss, Cinnamon S.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA; [Cakici, Julie A.; Dimmock, David P.; Caylor, Sara A.; Gaughran, Mary; Clarke, Christina; Clark, Michelle M.; Kingsmore, Stephen F.] Rady Childrens Hosp, Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Cakici, Julie A.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Triplett, Cynthia] Univ Calif San Diego, Qualcomm Inst, Calit2, La Jolla, CA 92093 USA; [Bloss, Cinnamon S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Bloss, CS (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92093 USA.; Bloss, CS (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA.	cbloss@ucsd.edu	Cakici, Julie/ABC-3574-2021	Cakici, Julie/0000-0001-5672-3396; Bloss, Cinnamon/0000-0003-1315-8387	Eunice Kennedy Shriver NICHD [U19HD077693]; NHGRI [HG008753]; NCATS [UL1TR002550]; NHGRI	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Michele Feddock, Christian Hansen, Josh Braun, and the staff at Rady Children's Institute for Genomic Medicine. This study was supported by grant U19HD077693 from Eunice Kennedy Shriver NICHD and NHGRI to S.F.K., grant UL1TR002550 from NCATS to E.J. Topol, grant HG008753 from NHGRI to C.S.B., and gifts from the Liguori Family, John Motter and Effie Simanikas, Ernest and Evelyn Rady, and RCHSD.	Berrios C, 2020, GENET MED, V22, P416, DOI 10.1038/s41436-019-0644-5; Boeldt DL, 2017, PERS MED, V14, P17, DOI 10.2217/pme-2016-0050; Botkin JR, 2015, AM J HUM GENET, V97, P6, DOI 10.1016/j.ajhg.2015.05.022; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Butterfield RM, 2019, GENET MED, V21, P409, DOI 10.1038/s41436-018-0061-1; Cacioppo CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153597; Carroll J, 2020, J PERINATOL, V40, P1007, DOI 10.1038/s41372-020-0697-y; Ceyhan-Birsoy O, 2019, AM J HUM GENET, V104, P76, DOI 10.1016/j.ajhg.2018.11.016; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Dimmock DP, 2020, AM J HUM GENET, V107, P942, DOI 10.1016/j.ajhg.2020.10.003; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; Frankel LA, 2016, PEDIATRICS, V137, pS24, DOI 10.1542/peds.2015-3731F; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Kingsmore SF, 2019, AM J HUM GENET, V105, P719, DOI 10.1016/j.ajhg.2019.08.009; Knapp B, 2019, PEDIATRICS, V143, pS54, DOI 10.1542/peds.2018-1099J; Knoppers BM, 2012, PAED CHILD HEALT-CAN, V17, P190, DOI 10.1093/pch/17.4.190; Malek J, 2019, GENET MED, V21, P2791, DOI 10.1038/s41436-019-0570-6; MARKEL H, 1992, AM J MED, V93, P209, DOI 10.1016/0002-9343(92)90052-D; Mello Michelle M, 2004, Pediatr Crit Care Med, V5, P40, DOI 10.1097/01.PCC.0000102413.32891.E5; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Mollison L, 2020, GENET MED, V22, P752, DOI 10.1038/s41436-019-0730-8; Pereira S, 2019, PEDIATRICS, V143, pS6, DOI 10.1542/peds.2018-1099C; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Reiff M, 2012, GENET MED, V14, P250, DOI 10.1038/gim.2011.52; RTeam, 2014, R LANG ENV STAT COMP; Sanderson SC, 2017, AM J HUM GENET, V100, P414, DOI 10.1016/j.ajhg.2017.01.021; Skinner D, 2016, SOCIOL HEALTH ILL, V38, P1303, DOI 10.1111/1467-9566.12460; Strong KA, 2014, AM J BIOETHICS, V14, P24, DOI 10.1080/15265161.2013.879959; Stuttgen K, 2020, J PERS MED, V10, DOI 10.3390/jpm10020024; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Wynn J, 2018, CLIN GENET, V93, P1039, DOI 10.1111/cge.13200	33	37	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2020	107	5					953	962		10.1016/j.ajhg.2020.10.004	http://dx.doi.org/10.1016/j.ajhg.2020.10.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OP1QL	33157008	Bronze, Green Published			2022-12-18	WOS:000587855200013
J	Girardi, L; Serdarogullari, M; Patassini, C; Poli, M; Fabiani, M; Caroselli, S; Coban, O; Findikli, N; Boynukalin, FK; Bahceci, M; Chopra, R; Canipari, R; Cimadomo, D; Rienzi, L; Ubaldi, F; Hoffmann, E; Rubio, C; Simon, C; Capalbo, A				Girardi, Laura; Serdarogullari, Munevver; Patassini, Cristina; Poli, Maurizio; Fabiani, Marco; Caroselli, Silvia; Coban, Onder; Findikli, Necati; Boynukalin, Fazilet Kubra; Bahceci, Mustafa; Chopra, Rupali; Canipari, Rita; Cimadomo, Danilo; Rienzi, Laura; Ubaldi, Filippo; Hoffmann, Eva; Rubio, Carmen; Simon, Carlos; Capalbo, Antonio			Incidence, Origin, and Predictive Model for the Detection and Clinical Management of Segmental Aneuploidies in Human Embryos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INNER CELL MASS; IN-VITRO FERTILIZATION; BLASTOCYST BIOPSY; CHROMOSOME SEGREGATION; MOSAICISM; IMPLANTATION; OUTCOMES; TROPHECTODERM; REPLICATION; DERIVATION	Despite next-generation sequencing, which now allows for the accurate detection of segmental aneuploidies from in vitro fertilization embryo biopsies, the origin and characteristics of these aneuploidies are still relatively unknown. Using a multifocal biopsy approach (four trophectoderms [TEs] and one inner cell mass [ICM] analyzed per blastocyst; n = 390), we determine the origin of the aneuploidy and the diagnostic predictive value of segmental aneuploidy detection in TE biopsies toward the ICM's chromosomal constitution. Contrary to the prevalent meiotic origin of whole-chromosome aneuploidies, we show that sub-chromosomal abnormalities in human blastocysts arise from mitotic errors in around 70% of cases. As a consequence, the positive-predictive value toward ICM configuration was significantly lower for segmental as compared to whole-chromosome aneuploidies (70.8% versus 97.18%, respectively). In order to enhance the clinical utility of reporting segmental findings in clinical TE biopsies, we have developed and clinically verified a risk stratification model based on a second TE biopsy confirmation and segmental length; this model can significantly improve the prediction of aneuploidy risk in the ICM in over 86% of clinical cases enrolled. In conclusion, we provide evidence of the predominant mitotic origin of segmental aneuploidies in preimplantation embryos and develop a risk stratification model that can help post-test genetic counseling and that facilitates the decision-making process on clinical utilization of these embryos.	[Girardi, Laura; Patassini, Cristina; Poli, Maurizio; Fabiani, Marco; Caroselli, Silvia; Capalbo, Antonio] Igenomix Italy, I-36063 Marostica, Italy; [Serdarogullari, Munevver; Coban, Onder] British Cyprus IVF Hosp, CY-2681 Nicosia, Cyprus; [Findikli, Necati] Bahceci Fulya IVF Ctr, Embryol Lab, TR-34394 Istanbul, Turkey; [Findikli, Necati] Beykent Univ, Dept Biomed Engn, Hadim Koruyolu Cd 19, TR-34398 Sariyer, Turkey; [Boynukalin, Fazilet Kubra; Bahceci, Mustafa] Infertil Clin, Bahceci Fulya IVF Ctr, TR-34394 Istanbul, Turkey; [Chopra, Rupali] Igenomix FZ LLC, Dubai Hlth Care City, Unit 501-502,Bldg 40,POB 66566, Dubai, U Arab Emirates; [Canipari, Rita; Capalbo, Antonio] Sapienza Univ Rome, Unit Histol & Med Embryol, DAHFMO, I-00161 Rome, Italy; [Cimadomo, Danilo; Rienzi, Laura; Ubaldi, Filippo] Ctr Reprod Med Clin Valle Giulia, Genera, I-00197 Rome, Italy; [Hoffmann, Eva] Univ Copenhagen, DRNF Ctr Chromosome Stabil, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Rubio, Carmen; Simon, Carlos; Capalbo, Antonio] Igenomix Fdn, Valencia 46980, Spain; [Simon, Carlos] Univ Valencia, Dept Obstet & Gynecol, Valencia 46010, Spain; [Simon, Carlos] INCLIVA, Valencia 46010, Spain; [Simon, Carlos] Harvard Univ, Harvard Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA	Bahceci Health Group; Beykent University; Bahceci Health Group; Sapienza University Rome; University of Copenhagen; University of Valencia; Harvard University; Harvard Medical School	Capalbo, A (corresponding author), Igenomix Italy, I-36063 Marostica, Italy.; Capalbo, A (corresponding author), Sapienza Univ Rome, Unit Histol & Med Embryol, DAHFMO, I-00161 Rome, Italy.; Capalbo, A (corresponding author), Igenomix Fdn, Valencia 46980, Spain.	antonio.capalbo@igenomix.com	Fabiani, Marco/AAR-7348-2021; Capalbo, Antonio/ABE-9842-2020; Serdarogullari, Munevver/ABE-1887-2020; Simon, Carlos/G-2186-2014; hoffmann, eva/AAM-6594-2020; Rubio, Carmen/D-7753-2018; Findikli, Necati/I-4924-2018	Simon, Carlos/0000-0003-0902-9531; hoffmann, eva/0000-0002-2588-0652; Findikli, Necati/0000-0001-9362-5912; Poli, Maurizio/0000-0003-0996-807X; Fabiani, Marco/0000-0002-8763-0114; Capalbo, Antonio/0000-0003-0109-323X	Novo Nordisk Foundation [16662]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	E.H. is the recipient of a Novo Nordisk Foundation grant (16662).	Babariya D, 2017, HUM REPROD, V32, P2549, DOI 10.1093/humrep/dex324; Capalbo A, 2019, HUM REPROD, V34, P2311, DOI 10.1093/humrep/dez175; Capalbo A, 2017, HUM REPROD UPDATE, V23, P706, DOI 10.1093/humupd/dmx026; Capalbo A, 2017, FERTIL STERIL, V107, P1098, DOI 10.1016/j.fertnstert.2017.03.023; Capalbo A, 2017, FERTIL STERIL, V107, P12, DOI 10.1016/j.fertnstert.2016.11.002; Capalbo A, 2016, HUM REPROD, V31, P199, DOI 10.1093/humrep/dev294; Capalbo A, 2015, EUR J HUM GENET, V23, P901, DOI 10.1038/ejhg.2014.222; Capalbo A, 2014, HUM REPROD, V29, P1173, DOI 10.1093/humrep/deu033; Capalbo A, 2013, HUM REPROD, V28, P2298, DOI 10.1093/humrep/det245; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chuang TH, 2018, MOL HUM REPROD, V24, P593, DOI 10.1093/molehr/gay043; Cimadomo D, 2018, HUM REPROD, V33, P1839, DOI 10.1093/humrep/dey282; Dumont M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102924; Escriba MJ, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0515-6; Ferreira JCP, 2016, PRENATAL DIAG, V36, P1146, DOI 10.1002/pd.4951; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Fragouli E, 2019, HUM REPROD UPDATE, V25, P15, DOI 10.1093/humupd/dmy036; Fragouli E, 2017, HUM GENET, V136, P805, DOI 10.1007/s00439-017-1797-4; Goodrich D, 2016, J ASSIST REPROD GEN, V33, P1473, DOI 10.1007/s10815-016-0784-3; Hovatta O, 2006, REPROD FERT DEVELOP, V18, P823, DOI 10.1071/RD06075; Kort DH, 2016, HUM REPROD, V31, P312, DOI 10.1093/humrep/dev281; Kubicek D, 2019, REPROD BIOMED ONLINE, V38, P330, DOI 10.1016/j.rbmo.2018.11.023; Lai HH, 2017, MOL CYTOGENET, V10, DOI 10.1186/s13039-017-0315-7; Lawrenz B, 2019, HUM REPROD, V34, P998, DOI 10.1093/humrep/dez055; Malvestiti F, 2015, PRENATAL DIAG, V35, P1117, DOI 10.1002/pd.4656; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Munne S, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103741; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Popovic M, 2018, HUM REPROD, V33, P1342, DOI 10.1093/humrep/dey106; Putnam CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11256; Rubio C, 2019, BIOL REPROD, V101, P1083, DOI 10.1093/biolre/ioz019; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Somigliana E, 2019, FERTIL STERIL, V111, P1169, DOI 10.1016/j.fertnstert.2019.01.025; Sox H.C., 1989, CLIN CHEM, V35, P2020; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Trockman A, 2018, PROCEEDINGS 2018 IEEE/ACM 40TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE), P511, DOI 10.1145/3180155.3180209; Van der Aa N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1352; Vera-Rodriguez M, 2016, FERTIL STERIL, V105, P1047, DOI 10.1016/j.fertnstert.2015.12.022; Victor AR, 2019, HUM REPROD, V34, P181, DOI 10.1093/humrep/dey327; Vogel I, 2019, BIOINFORMATICS, V35, P5055, DOI 10.1093/bioinformatics/btz412	42	37	37	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2020	106	4					525	534		10.1016/j.ajhg.2020.03.005	http://dx.doi.org/10.1016/j.ajhg.2020.03.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ5MJ	32220293	Green Published, Bronze			2022-12-18	WOS:000523306000009
J	Prive, F; Vilhjalmsson, BJ; Aschard, H; Blum, MGB				Prive, Florian; Vilhjalmsson, Bjarni J.; Aschard, Hugues; Blum, Michael G. B.			Making the Most of Clumping and Thresholding for Polygenic Scores	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; RISK PREDICTION; DISEASE; MODELS; REGRESSION	Polygenic prediction has the potential to contribute to precision medicine. Clumping and thresholding (C+T) is a widely used method to derive polygenic scores. When using C+T, several p value thresholds are tested to maximize predictive ability of the derived polygenic scores. Along with this p value threshold, we propose to tune three other hyper-parameters for C+T. We implement an efficient way to derive thousands of different C+T scores corresponding to a grid over four hyper-parameters. For example, it takes a few hours to derive 123K different C+T scores for 300K individuals and 1M variants using 16 physical cores. We find that optimizing over these four hyperparameters improves the predictive performance of C+T in both simulations and real data applications as compared to tuning only the p value threshold. A particularly large increase can be noted when predicting depression status, from an AUC of 0.557 (95% CI: [0.544-0.569]) when tuning only the p value threshold to an AUC of 0.592 (95% CI: [0.580-0.604]) when tuning all four hyper-parameters we propose for C+T. We further propose stacked clumping and thresholding (SCT), a polygenic score that results from stacking all derived C+T scores. Instead of choosing one set of hyper-parameters that maximizes prediction in some training set, SCT learns an optimal linear combination of all C+T scores by using an efficient penalized regression. We apply SCT to eight different case-control diseases in the UK biobank data and find that SCT substantially improves prediction accuracy with an average AUC increase of 0.035 over standard C+T.	[Prive, Florian; Blum, Michael G. B.] Univ Grenoble Alpes, CNRS, Lab TIMC IMAG, UMR 5525, La Tronche, France; [Prive, Florian; Vilhjalmsson, Bjarni J.] Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business Econ, Aarhus, Denmark; [Aschard, Hugues] Inst Pasteur, C3BI, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Aarhus University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Prive, F; Blum, MGB (corresponding author), Univ Grenoble Alpes, CNRS, Lab TIMC IMAG, UMR 5525, La Tronche, France.; Prive, F (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business Econ, Aarhus, Denmark.	florian.prive.21@gmail.com; michael.blum@univ-grenoble-alpes.fr	Vilhjálmsson, Bjarni/ABC-1369-2020	Vilhjálmsson, Bjarni/0000-0003-2277-9249; Aschard, Hugues/0000-0002-7554-6783	LabEx PERSYVAL-Lab [ANR-11-LABX-0025-01]; ANR project FROGH [ANR-16-CE12-0033]; French National Research Agency under the "Investissements d'avenir" program [ANR-15-IDEX-02]; Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH [R248-2017-2003]; MRC [MC_PC_12028] Funding Source: UKRI	LabEx PERSYVAL-Lab; ANR project FROGH(French National Research Agency (ANR)); French National Research Agency under the "Investissements d'avenir" program(French National Research Agency (ANR)); Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Shing Wan Choi for helpful discussions about lassosum. We are grateful to the two anonymous reviewers who contributed to improving this paper. F.P. and M.G.B.B. acknowledge LabEx PERSYVAL-Lab (ANR-11-LABX-0025-01) and ANR project FROGH (ANR-16-CE12-0033). F.P. and M.G.B.B. also acknowledge the Grenoble Alpes Data Institute that is supported by the French National Research Agency under the "Investissements d'avenir" program (ANR-15-IDEX-02). F.P. and B.J.V. acknowledge Niels Bohr Professorship from the Danish National Research Foundation to Prof. John J. McGrath, and the Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH (R248-2017-2003). This research has been conducted using the UK Biobank Resource under Application Number 25589.	Allegrini AG, 2019, MOL PSYCHIATR, V24, P819, DOI 10.1038/s41380-019-0394-4; Breiman L, 1996, MACH LEARN, V24, P49; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Censin JC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002362; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Choi SW, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz082; Choi SW., 2018, BIORXIV, DOI [DOI 10.1257/aer.100.2.234, 10.1101/416545, DOI 10.1101/416545]; Chun S., 2019, BIORXIV, DOI [10.1101/370064, DOI 10.1101/370064]; Chung W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08535-0; COX DR, 1972, J R STAT SOC B, V34, P187; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Ge T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09718-5; Hughey J.J., 2019, BIORXIV, DOI [10.1101/599910, DOI 10.1101/599910]; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Krapohl E, 2018, MOL PSYCHIATR, V23, P1368, DOI 10.1038/mp.2017.163; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lloyd-Jones L.R., 2019, BIORXIV, DOI [10.1101/522961, DOI 10.1101/522961]; Mak TSH, 2017, GENET EPIDEMIOL, V41, P469, DOI 10.1002/gepi.22050; Marquez-Luna C., 2018, MODELING FUNCTIONAL, DOI [10.1101/375337, DOI 10.1101/375337]; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palmer C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006091; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Prive F, 2019, GENETICS, V212, P65, DOI 10.1534/genetics.119.302019; Prive F, 2018, BIOINFORMATICS, V34, P2781, DOI 10.1093/bioinformatics/bty185; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2018, R LANG ENV STAT COMP; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Tibshirani R, 2012, J R STAT SOC B, V74, P245, DOI 10.1111/j.1467-9868.2011.01004.x; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Zheng G, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4614-2245-7	45	37	37	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1213	1221		10.1016/j.ajhg.2019.11.001	http://dx.doi.org/10.1016/j.ajhg.2019.11.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31761295	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000500935400011
J	Flex, E; Martinelli, S; Van Dijck, A; Ciolfi, A; Cecchetti, S; Coluzzi, E; Pannone, L; Andreoli, C; Radio, FC; Pizzi, S; Carpentieri, G; Bruselles, A; Catanzaro, G; Pedace, L; Miele, E; Carcarino, E; Ge, X; Chijiwa, C; Lewis, MS; Meuwissen, M; Kenis, S; Van der Aa, N; Larson, A; Brown, K; Wasserstein, MP; Skotko, BG; Begtrup, A; Person, R; Karayiorgou, M; Roos, JL; Van Gassen, KL; Koopmans, M; Bijlsma, EK; Santen, GWE; Barge-Schaapveld, DQCM; Ruivenkamp, CAL; Hoffer, MJV; Lalani, SR; Streff, H; Craigen, WJ; Graham, BH; van den Elzen, APM; Kamphuis, DJ; Ounap, K; Reinson, K; Pajusalu, S; Wojcik, MH; Viberti, C; Di Gaetano, C; Bertini, E; Petrucci, S; De Luca, A; Rota, R; Ferretti, E; Matullo, G; Dallapiccola, B; Sgura, A; Walkiewicz, M; Kooy, RF; Tartaglia, M				Flex, Elisabetta; Martinelli, Simone; Van Dijck, Anke; Ciolfi, Andrea; Cecchetti, Serena; Coluzzi, Elisa; Pannone, Luca; Andreoli, Cristina; Radio, Francesca Clementina; Pizzi, Simone; Carpentieri, Giovanna; Bruselles, Alessandro; Catanzaro, Giuseppina; Pedace, Lucia; Miele, Evelina; Carcarino, Elena; Ge, Xiaoyan; Chijiwa, Chieko; Lewis, Me Suzanne; Meuwissen, Marije; Kenis, Sandra; Van der Aa, Nathalie; Larson, Austin; Brown, Kathleen; Wasserstein, Melissa P.; Skotko, Brian G.; Begtrup, Amber; Person, Richard; Karayiorgou, Maria; Roos, J. Louw; Van Gassen, Koen L.; Koopmans, Marije; Bijlsma, Emilia K.; Santen, Gijs W. E.; Barge-Schaapveld, Daniela Q. C. M.; Ruivenkamp, Claudia A. L.; Hoffer, Mariette J., V; Lalani, Seema R.; Streff, Haley; Craigen, William J.; Graham, Brett H.; van den Elzen, Annette P. M.; Kamphuis, Daan J.; Ounap, Katrin; Reinson, Karit; Pajusalu, Sander; Wojcik, Monica H.; Viberti, Clara; Di Gaetano, Cornelia; Bertini, Enrico; Petrucci, Simona; De Luca, Alessandro; Rota, Rossella; Ferretti, Elisabetta; Matullo, Giuseppe; Dallapiccola, Bruno; Sgura, Antonella; Walkiewicz, Magdalena; Kooy, R. Frank; Tartaglia, Marco			Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							H1 LINKER HISTONES; CHROMATIN-STRUCTURE; DNA-DAMAGE; MAMMALIAN DEVELOPMENT; BIALLELIC MUTATIONS; PHOSPHORYLATION; SUBTYPES; LAMINS; GAMMA-H2AX; LANDSCAPE	Histones mediate dynamic packaging of nuclear DNA in chromatin, a process that is precisely controlled to guarantee efficient compaction of the genome and proper chromosomal segregation during cell division and to accomplish DNA replication, transcription, and repair. Due to the important structural and regulatory roles played by histones, it is not surprising that histone functional dysregulation or aberrant levels of histones can have severe consequences for multiple cellular processes and ultimately might affect development or contribute to cell transformation. Recently, germline frameshift mutations involving the C-terminal tail of HIST1H1E, which is a widely expressed member of the linker histone family and facilitates higher-order chromatin folding, have been causally linked to an as-yet poorly defined syndrome that includes intellectual disability. We report that these mutations result in stable proteins that reside in the nucleus, bind to chromatin, disrupt proper compaction of DNA, and are associated with a specific methylation pattern. Cells expressing these mutant proteins have a dramatically reduced proliferation rate and competence, hardly enter into the S phase, and undergo accelerated senescence. Remarkably, clinical assessment of a relatively large cohort of subjects sharing these mutations revealed a premature aging phenotype as a previously unrecognized feature of the disorder. Our findings identify a direct link between aberrant chromatin remodeling, cellular senescence, and accelerated aging.	[Flex, Elisabetta; Martinelli, Simone; Pannone, Luca; Carpentieri, Giovanna; Bruselles, Alessandro] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [Van Dijck, Anke; Meuwissen, Marije; Van der Aa, Nathalie; Kooy, R. Frank] Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium; [Van Dijck, Anke; Kenis, Sandra] Antwerp Univ Hosp, Dept Neurol, B-2650 Edegem, Belgium; [Ciolfi, Andrea; Pannone, Luca; Radio, Francesca Clementina; Pizzi, Simone; Carpentieri, Giovanna; Bertini, Enrico; Dallapiccola, Bruno; Tartaglia, Marco] IRCCS, Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Core Facil, Microscopy Area, I-00161 Rome, Italy; [Coluzzi, Elisa; Sgura, Antonella] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy; [Andreoli, Cristina] Ist Super Sanita, Dept Environm & Hlth, I-00161 Rome, Italy; [Catanzaro, Giuseppina; Ferretti, Elisabetta] Sapienza Univ, Dept Expt Med, I-00161 Rome, Italy; [Pedace, Lucia; Miele, Evelina; Carcarino, Elena; Rota, Rossella] IRCCS, Osped Pediat Bambino Gesu, Dept Pediat Oncohematol & Cell & Gene Therapy, I-00146 Rome, Italy; [Ge, Xiaoyan; Lalani, Seema R.; Streff, Haley; Craigen, William J.; Graham, Brett H.; Walkiewicz, Magdalena] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Chijiwa, Chieko; Lewis, Me Suzanne] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Larson, Austin; Brown, Kathleen] Univ Colorado, Dept Pediat, Sect Clin Genet & Metab, Sch Med, Aurora, CO 80045 USA; [Flex, Elisabetta; Wasserstein, Melissa P.] Childrens Hosp Montefiore, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Skotko, Brian G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Div Med Genet & Metab, Boston, MA 02114 USA; [Skotko, Brian G.] Harvard Med Sch, Dept Pediat, Boston, MA 02114 USA; [Begtrup, Amber; Person, Richard] GeneDx, Gaithersburg, MD 20877 USA; [Karayiorgou, Maria] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10032 USA; [Roos, J. Louw] Univ Pretoria, Weskoppies Hosp, Dept Psychiat, ZA-0001 Pretoria, South Africa; [Van Gassen, Koen L.; Koopmans, Marije] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Bijlsma, Emilia K.; Santen, Gijs W. E.; Barge-Schaapveld, Daniela Q. C. M.; Ruivenkamp, Claudia A. L.; Hoffer, Mariette J., V] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Graham, Brett H.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [van den Elzen, Annette P. M.] Reinier Graaf Ziekenhuis, Dept Pediat, NL-2600 GA Delft, Netherlands; [Kamphuis, Daan J.] Reinier Graaf Ziekenhuis, Dept Neurol, NL-2600 GA Delft, Netherlands; [Ounap, Katrin; Reinson, Karit; Pajusalu, Sander] Tartu Univ Hosp, United Labs, Dept Clin Genet, EE-50406 Tartu, Estonia; [Ounap, Katrin; Reinson, Karit; Pajusalu, Sander] Univ Tartu, Inst Clin Med, EE-50406 Tartu, Estonia; [Pajusalu, Sander] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Wojcik, Monica H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Viberti, Clara; Di Gaetano, Cornelia; Matullo, Giuseppe] Univ Turin, Dept Med Sci, I-10126 Turin, Italy; [Viberti, Clara; Di Gaetano, Cornelia; Matullo, Giuseppe] Italian Inst Genom Med, I-10126 Turin, Italy; [Petrucci, Simona] Sapienza Univ, Dept Clin & Mol Med, I-00189 Rome, Italy; [Petrucci, Simona; De Luca, Alessandro] Casa Sollievo Sofferenza Hosp, IRCCS, Div Med Genet, I-71013 San Giovanni Rotondo, Italy; [Ferretti, Elisabetta] IRCCS, Ist Neuromed, I-86077 Pozzilli, Italy; [Carcarino, Elena] Sorbonne Univ, Inserm 1138, Cordeliers Res Ctr, F-75006 Paris, France; [Ge, Xiaoyan] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Walkiewicz, Magdalena] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Istituto Superiore di Sanita (ISS); University of Antwerp; University of Antwerp; IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University; Istituto Superiore di Sanita (ISS); Sapienza University Rome; IRCCS Bambino Gesu; Baylor College of Medicine; University of British Columbia; University of Colorado System; University of Colorado Anschutz Medical Campus; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; University of Pretoria; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Indiana University System; Indiana University Bloomington; Reinier de Graaf Hospital; Reinier de Graaf Hospital; University of Tartu; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Turin; Italian Institute for Genomic Medicine (IIGM); Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; IRCCS Neuromed; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kooy, RF (corresponding author), Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium.; Tartaglia, M (corresponding author), IRCCS, Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	frank.kooy@uantwerpen.be; marco.tartaglia@opbg.net	Kooy, Frank/F-5276-2014; Ciolfi, Andrea/J-4954-2018; PANNONE, LUCA/AAC-1528-2021; Miele, Evelina/ABB-7545-2021; Barge, Daniela/AAC-4967-2022; Larson, Austin/GZG-9853-2022; Skotko, Brian G/D-1375-2013; Flex, Elisabetta/A-5958-2017; Cecchetti, Serena/N-1061-2015; Tartaglia, Marco/K-2955-2018; Bertini, Enrico/ABG-1278-2020; Reinson, Karit/AAJ-3939-2021; Rota, Rossella/AAB-2497-2019; Miele, Evelina/AAK-1963-2021; Larson, Austin/AAN-8673-2021; Di Gaetano, Cornelia/AAA-5477-2019; Pedace, Lucia/ABF-1102-2021; Lalani, Seema/AAI-5090-2020; Pajusalu, Sander/U-1739-2019; Pizzi, Simone/AAI-1767-2019; Andreoli, Cristina/I-9050-2014; Carpentieri, Giovanna/AAT-9814-2021; catanzaro, giuseppina/AGZ-8080-2022; De Luca, Alessandro/B-2179-2017; Bruselles, Alessandro/M-6012-2019; Martinelli, Simone/J-9432-2018; Pajusalu, Sander/HDO-6793-2022; Bertini, Enrico/A-2284-2014; OUNAP, KATRIN/Q-1103-2016; Dallapiccola, Bruno/K-8692-2016; Ferretti, Elisabetta/G-5413-2013	Kooy, Frank/0000-0003-2024-0485; Ciolfi, Andrea/0000-0002-6191-0978; PANNONE, LUCA/0000-0001-7027-8196; Miele, Evelina/0000-0002-4747-1032; Barge, Daniela/0000-0003-4461-4293; Skotko, Brian G/0000-0002-5232-9882; Flex, Elisabetta/0000-0002-6802-1356; Cecchetti, Serena/0000-0002-3601-176X; Tartaglia, Marco/0000-0001-7736-9672; Rota, Rossella/0000-0002-9408-7711; Larson, Austin/0000-0002-2079-6929; Di Gaetano, Cornelia/0000-0001-8938-7093; Pajusalu, Sander/0000-0002-5435-0781; Andreoli, Cristina/0000-0003-3724-0668; Carpentieri, Giovanna/0000-0001-5526-6015; catanzaro, giuseppina/0000-0001-8427-9691; De Luca, Alessandro/0000-0002-4408-8062; Bruselles, Alessandro/0000-0002-1556-4998; Martinelli, Simone/0000-0002-5843-419X; Bertini, Enrico/0000-0001-9276-4590; Van Dijck, Anke/0000-0002-6713-2943; Lewis, Suzanne/0000-0002-6300-5381; OUNAP, KATRIN/0000-0002-4594-6364; Dallapiccola, Bruno/0000-0002-5031-1013; Ferretti, Elisabetta/0000-0001-7265-6429	Fondazione Bambino Gesu (Vite Coraggiose); Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG21390, IG21614]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Dipartimenti di Eccellenza (miur) [D15D18000410001]; National Human Genome Research Institute [UM1 HG008900]; National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program; National Eye Institute; National Institutes of Health (NIH) [T32GM007748]; European Research Area Network (ERA-NET) NEURONthrough the Research Foundation-Flanders (FWO); Estonian Research Council [PRG471, PUTJD827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER	Fondazione Bambino Gesu (Vite Coraggiose); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Dipartimenti di Eccellenza (miur)(Estonian Research Council); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Area Network (ERA-NET) NEURONthrough the Research Foundation-Flanders (FWO)(FWO); Estonian Research Council(Estonian Research Council); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and their families for their participation in this study, and Serenella Venanzi (Istituto Superiore di Sanita, Rome) for technical support. This project was supported, in part, by Fondazione Bambino Gesu (Vite Coraggiose to M.T.), the Italian Ministry of Health (Ricerca Corrente 2017 and 2018 to A.C. and M.T.), Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG21390 to G.M. and IG21614 to M.T.) and Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Dipartimenti di Eccellenza (miur)(Project D15D18000410001) to the Department of Medical Sciences, University of Turin, Italy. M.T. acknowledges Consorsio Interuniversitario per il Calcolo Automatico (CINECA) for the computational resources. The Broad Center for Mendelian Genomics (UM1 HG008900) is funded by the National Human Genome Research Institute with supplemental funding provided by the National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program and the National Eye Institute. M.H.W. is supported by National Institutes of Health (NIH) grant T32GM007748. R.F.K. and A.V.D. are supported by grants from the European Research Area Network (ERA-NET) NEURONthrough the Research Foundation-Flanders (FWO). K.O ., S.P., and K.R. are supported by Estonian Research Council grants PRG471 and PUTJD827.	AJIRO K, 1981, BIOCHEMISTRY-US, V20, P1445, DOI 10.1021/bi00509a007; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Andreoli C, 1997, MUTAT RES-FUND MOL M, V377, P95, DOI 10.1016/S0027-5107(97)00065-1; Aref-Eshghi E, 2019, AM J HUM GENET, V104, P685, DOI 10.1016/j.ajhg.2019.03.008; Bauer CK, 2018, AM J HUM GENET, V103, P621, DOI 10.1016/j.ajhg.2018.09.001; Bayona-Feliu A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00338-5; Berardinelli F, 2013, ENVIRON MOL MUTAGEN, V54, P172, DOI 10.1002/em.21761; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Catanzaro G, 2018, NEUROPATH APPL NEURO, V44, P687, DOI 10.1111/nan.12479; Cau P, 2014, SEMIN CELL DEV BIOL, V29, P125, DOI 10.1016/j.semcdb.2014.03.021; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Crane-Robinson C, 2016, BBA-GENE REGUL MECH, V1859, P431, DOI 10.1016/j.bbagrm.2015.10.008; Criscione SW, 2016, TRENDS GENET, V32, P751, DOI 10.1016/j.tig.2016.09.005; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dorboz I, 2017, BRAIN, V140, P2550, DOI [10.1093/brain/awx215, 10.1093/brain/awx314, 10.1093/brain/awx207]; Downey M, 2006, CELL CYCLE, V5, P1376, DOI 10.4161/cc.5.13.2899; Duffney LJ, 2018, AM J MED GENET B, V177, P426, DOI 10.1002/ajmg.b.32631; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flex E, 2016, AM J HUM GENET, V99, P962, DOI 10.1016/j.ajhg.2016.08.003; Fuentes EN, 2014, COMP BIOCHEM PHYS B, V176, P48, DOI 10.1016/j.cbpb.2014.07.003; Geeven G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0857-0; Gonzalez-Suarez I, 2010, NUCLEUS-PHILA, V1, P129, DOI 10.4161/nucl.1.2.10797; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Guarrera S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0164-3; GURLEY LR, 1975, J BIOL CHEM, V250, P3936; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Happel N, 2009, CELL CYCLE, V8, P2226, DOI 10.4161/cc.8.14.8982; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Helsmoortel C, 2015, CLIN GENET, V88, P140, DOI 10.1111/cge.12470; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Herrera RE, 1996, P NATL ACAD SCI USA, V93, P11510, DOI 10.1073/pnas.93.21.11510; HOHMANN P, 1976, J BIOL CHEM, V251, P3685; Izzo A, 2013, CELL REP, V3, P2142, DOI 10.1016/j.celrep.2013.05.003; Kalashnikova AA, 2016, BBA-GENE REGUL MECH, V1859, P455, DOI 10.1016/j.bbagrm.2015.10.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao RQ, 2016, BBA-GENE REGUL MECH, V1859, P476, DOI 10.1016/j.bbagrm.2015.11.012; Lidzbarsky G, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00104; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MATSUMOTO YI, 1980, NATURE, V284, P181, DOI 10.1038/284181a0; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Padeken J, 2014, CURR OPIN CELL BIOL, V28, P54, DOI 10.1016/j.ceb.2014.03.001; Pan CY, 2016, BBA-GENE REGUL MECH, V1859, P496, DOI 10.1016/j.bbagrm.2015.12.002; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Perner S, 2003, AM J PATHOL, V163, P1751, DOI 10.1016/S0002-9440(10)63534-1; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Roque A, 2016, BBA-GENE REGUL MECH, V1859, P444, DOI 10.1016/j.bbagrm.2015.09.009; Rossiello F, 2014, CURR OPIN GENET DEV, V26, P89, DOI 10.1016/j.gde.2014.06.009; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Takenouchi T, 2018, AM J MED GENET A, V176, P712, DOI 10.1002/ajmg.a.38616; Tatton-Brown K, 2017, AM J HUM GENET, V100, P725, DOI 10.1016/j.ajhg.2017.03.010; Tessadori F, 2017, NAT GENET, V49, P1642, DOI 10.1038/ng.3956; Tsekrekou M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071411; Vandeweyer G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0074-6; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wolffe AP., 1998, CHROMATIN STRUCTURE; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yuen BTK, 2013, CANCER CELL, V24, P567, DOI 10.1016/j.ccr.2013.09.015; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	75	37	37	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					493	508		10.1016/j.ajhg.2019.07.007	http://dx.doi.org/10.1016/j.ajhg.2019.07.007			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31447100	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000484435700005
J	Lam, M; Hill, WD; Trampush, JW; Yu, J; Knowles, E; Davies, G; Stahl, E; Huckins, L; Liewald, DC; Djurovic, S; Melle, I; Sundet, K; Christoforou, A; Reinvang, I; DeRosse, P; Lundervold, AJ; Steen, VM; Espeseth, T; Raikkonen, K; Widen, E; Palotie, A; Eriksson, JG; Giegling, I; Konte, B; Hartmann, AM; Roussos, P; Giakoumaki, S; Burdick, KE; Payton, A; Ollier, W; Chiba-Falek, O; Attix, DK; Need, AC; Cirulli, ET; Voineskos, AN; Stefanis, NC; Avramopoulos, D; Hatzimanolis, A; Arking, DE; Smyrnis, N; Bilder, RM; Freimer, NA; Cannon, TD; London, E; Poldrack, RA; Sabb, FW; Congdon, E; Conley, ED; Scult, MA; Dickinson, D; Straub, RE; Donohoe, G; Morris, D; Corvin, A; Gill, M; Hariri, AR; Weinberger, DR; Pendleton, N; Bitsios, P; Rujescu, D; Lahti, J; Le Hellard, S; Keller, MC; Andreassen, OA; Deary, IJ; Glahn, DC; Malhotra, AK; Lencz, T				Lam, Max; Hill, W. David; Trampush, Joey W.; Yu, Jin; Knowles, Emma; Davies, Gail; Stahl, Eli; Huckins, Laura; Liewald, David C.; Djurovic, Srdjan; Melle, Ingrid; Sundet, Kjetil; Christoforou, Andrea; Reinvang, Ivar; DeRosse, Pamela; Lundervold, Astri J.; Steen, Vidar M.; Espeseth, Thomas; Raikkonen, Katri; Widen, Elisabeth; Palotie, Aarno; Eriksson, Johan G.; Giegling, Ina; Konte, Bettina; Hartmann, Annette M.; Roussos, Panos; Giakoumaki, Stella; Burdick, Katherine E.; Payton, Antony; Ollier, William; Chiba-Falek, Ornit; Attix, Deborah K.; Need, Anna C.; Cirulli, Elizabeth T.; Voineskos, Aristotle N.; Stefanis, Nikos C.; Avramopoulos, Dimitrios; Hatzimanolis, Alex; Arking, Dan E.; Smyrnis, Nikolaos; Bilder, Robert M.; Freimer, Nelson A.; Cannon, Tyrone D.; London, Edythe; Poldrack, Russell A.; Sabb, Fred W.; Congdon, Eliza; Conley, Emily Drabant; Scult, Matthew A.; Dickinson, Dwight; Straub, Richard E.; Donohoe, Gary; Morris, Derek; Corvin, Aiden; Gill, Michael; Hariri, Ahmad R.; Weinberger, Daniel R.; Pendleton, Neil; Bitsios, Panos; Rujescu, Dan; Lahti, Jari; Le Hellard, Stephanie; Keller, Matthew C.; Andreassen, Ole A.; Deary, Ian J.; Glahn, David C.; Malhotra, Anil K.; Lencz, Todd			Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DE-NOVO MUTATIONS; DNA-DAMAGE; 1ST-EPISODE SCHIZOPHRENIA; BIPOLAR DISORDER; GENE-EXPRESSION; POLYGENIC RISK; CHD8; AUTISM; LOCI	Susceptibility to schizophrenia is inversely correlated with general cognitive ability at both the phenotypic and the genetic level. Paradoxically, a modest but consistent positive genetic correlation has been reported between schizophrenia and educational attainment, despite the strong positive genetic correlation between cognitive ability and educational attainment. Here we leverage published genome-wide association studies (GWASs) in cognitive ability, education, and schizophrenia to parse biological mechanisms underlying these results. Association analysis based on subsets (ASSET), a pleiotropic meta-analytic technique, allowed jointly associated loci to be identified and characterized. Specifically, we identified subsets of variants associated in the expected ("concordant") direction across all three phenotypes (i.e., greater risk for schizophrenia, lower cognitive ability, and lower educational attainment); these were contrasted with variants that demonstrated the counterintuitive ("discordant") relationship between education and schizophrenia (i.e., greater risk for schizophrenia and higher educational attainment). ASSET analysis revealed 235 independent loci associated with cognitive ability, education, and/or schizophrenia at p < 5 x 10(-8). Pleiotropic analysis successfully identified more than 100 loci that were not significant in the input GWASs. Many of these have been validated by larger, more recent single-phenotype GWASs. Leveraging the joint genetic correlations of cognitive ability, education, and schizophrenia, we were able to dissociate two distinct biological mechanisms-early neurodevelopmental pathways that characterize concordant allelic variation and adulthood synaptic pruning pathways-that were linked to the paradoxical positive genetic association between education and schizophrenia. Furthermore, genetic correlation analyses revealed that these mechanisms contribute not only to the etiopathogenesis of schizophrenia but also to the broader biological dimensions implicated in both general health outcomes and psychiatric illness.	[Lam, Max] Inst Mental Hlth, Singapore 539747, Singapore; [Lam, Max; Yu, Jin; DeRosse, Pamela; Malhotra, Anil K.; Lencz, Todd] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY 11004 USA; [Lam, Max] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Hill, W. David; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Hill, W. David; Davies, Gail; Liewald, David C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Trampush, Joey W.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Knowles, Emma; Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Stahl, Eli; Huckins, Laura; Roussos, Panos; Burdick, Katherine E.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Stahl, Eli; Huckins, Laura; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Stahl, Eli; Huckins, Laura; Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Djurovic, Srdjan] Univ Bergen, Oslo Univ Hosp, Dept Med Genet, N-4956 Bergen, Nydalen, Norway; [Djurovic, Srdjan; Melle, Ingrid; Steen, Vidar M.; Le Hellard, Stephanie; Andreassen, Ole A.] Univ Bergen, Norsk Senter Forskning Mentale Lidelser, KG Jebsen Ctr Psychosis Res, N-4956 Bergen, Nydalen, Norway; [Melle, Ingrid; Sundet, Kjetil; Espeseth, Thomas; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, N-1039 Oslo, Blindern, Norway; [Sundet, Kjetil; Reinvang, Ivar; Espeseth, Thomas] Univ Oslo, Dept Psychol, N-1094 Oslo, Blindem, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, N-7804 Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, N-7807 Bergen, Norway; [Raikkonen, Katri; Lahti, Jari] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland; [Widen, Elisabeth; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki 00014, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki 00014, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00290, Finland; [Giegling, Ina; Konte, Bettina; Hartmann, Annette M.; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Roussos, Panos; Burdick, Katherine E.] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN 2, Bronx, NY 10468 USA; [Giakoumaki, Stella] Univ Crete, Dept Psychol, Iraklion 74100, Greece; [Burdick, Katherine E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Payton, Antony] Univ Manchester, Sch Hlth Sci, Div Informat Imaging & Data Sci, Manchester M13 9NT, Lancs, England; [Ollier, William] Univ Manchester, Ctr Epidemiol, Hlth Serv Res & Primary Care, Div Populat Hlth, Manchester M13 9PL, Lancs, England; [Ollier, William] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England; [Chiba-Falek, Ornit; Attix, Deborah K.] Duke Univ, Med Ctr, Dept Neurol, Bryan Alzheimer Dis Res Ctr, Durham, NC 27705 USA; [Chiba-Falek, Ornit; Attix, Deborah K.] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27705 USA; [Attix, Deborah K.] Duke Univ, Med Ctr, Div Med Psychol, Psychiat & Behav Sci, Durham, NC 27708 USA; [Attix, Deborah K.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA; [Need, Anna C.] Imperial Coll, Dept Med, Div Brain Sci, London W12 0NN, England; [Cirulli, Elizabeth T.] Helix Inc, San Diego, CA 92121 USA; [Voineskos, Aristotle N.; Hatzimanolis, Alex; Smyrnis, Nikolaos] Univ Toronto, Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Inst, Toronto, ON M6J 1H4, Canada; [Stefanis, Nikos C.; Hatzimanolis, Alex; Smyrnis, Nikolaos] Natl & Kapodistrian Univ Athens, Eginit Hosp, Dept Psychiat, Med Sch, Athens, Greece; [Stefanis, Nikos C.; Hatzimanolis, Alex] Univ Mental Hlth Res Inst, Athens 11527, Greece; [Stefanis, Nikos C.] Theodor Theohari Cozzika Fdn, Neurobiol Res Inst, Athens, Greece; [Avramopoulos, Dimitrios; Arking, Dan E.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Avramopoulos, Dimitrios; Bilder, Robert M.; Freimer, Nelson A.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [London, Edythe; Congdon, Eliza] UCLA, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Yale Univ, Dept Psychol, New Haven, CT 06511 USA; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94305 USA; [Sabb, Fred W.] Univ Oregon, Robert & Beverly Lewis Ctr Neuroimaging, Eugene, OR 97401 USA; [Conley, Emily Drabant] 23andMe Inc, Mountain View, CA 94041 USA; [Scult, Matthew A.; Hariri, Ahmad R.] Duke Univ, Dept Psychol & Neurosci, Lab NeuroGenet, Durham, NC 27708 USA; [Dickinson, Dwight] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20814 USA; [Straub, Richard E.; Weinberger, Daniel R.] Johns Hopkins Univ, Lieber Inst Brain Dev, Med Campus, Baltimore, MD 21205 USA; [Pendleton, Neil] Univ Manchester, Salford Royal NHS Fdn Trust, Div Neurosci & Expt Psychol, Sch Biol Sci,Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Sch Psychol & Discipline Biochem, Neuroimaging Cognit & Genom Ctr, Galway, Ireland; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Bitsios, Panos] Univ Crete, Fac Med, Dept Psychiat & Behav Sci, GR-71003 Iraklion, Greece; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, FIN-00014 Helsinki, Finland; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80303 USA; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Malhotra, Anil K.; Lencz, Todd] Zucker Sch Med Hofstra Northwell, Dept Psychiat, Hempstead, NY 11549 USA; [Malhotra, Anil K.; Lencz, Todd] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA	Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Edinburgh; University of Edinburgh; University of Southern California; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bergen; University of Bergen; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Folkhalsan Research Center; Martin Luther University Halle Wittenberg; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Crete; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Manchester; University of Manchester; Manchester Metropolitan University; Duke University; Duke University; Duke University; Duke University; Imperial College London; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; National & Kapodistrian University of Athens; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; Yale University; Stanford University; University of Oregon; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Salford Royal NHS Foundation Trust; University of Manchester; Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin; University of Crete; University of Helsinki; University of Colorado System; University of Colorado Boulder; University of Oslo; Northwell Health	Lencz, T (corresponding author), Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY 11004 USA.; Lencz, T (corresponding author), Zucker Sch Med Hofstra Northwell, Dept Psychiat, Hempstead, NY 11549 USA.; Lencz, T (corresponding author), Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA.	tlencz@northwell.edu	Morris, Derek/AAW-8343-2021; Konte, Bettina/AAT-1142-2021; Rujescu, Dan/GRS-3875-2022; Hartmann, Annette/AAS-6331-2021; Giegling, Ina/ABA-3677-2021; Andreassen, Ole A./AAY-7531-2020; Huckins, Laura/GPX-8325-2022; Donohoe, Gary/J-6481-2013; Bilder, Robert M/A-8894-2008; Smyrnis, Nikolaos/AAA-3783-2020; Lencz, Todd/J-3418-2014; Lam, Max/AAM-4946-2021; Hatzimanolis, Alex/GOG-7992-2022; Lahti, Jari/P-7987-2018; Yu, Jin/E-3732-2013; Pendleton, Neil/F-2333-2015	Morris, Derek/0000-0002-3413-570X; Konte, Bettina/0000-0001-5287-308X; Huckins, Laura/0000-0002-5369-6502; Donohoe, Gary/0000-0003-3037-7426; Bilder, Robert M/0000-0001-5085-7852; Lencz, Todd/0000-0001-8586-338X; Voineskos, Aristotle/0000-0003-0156-0395; Lahti, Jari/0000-0002-4310-5297; Palotie, Aarno/0000-0002-2527-5874; Raikkonen, Katri/0000-0003-3124-3470; Yu, Jin/0000-0002-2990-6602; Lam, Max/0000-0002-4256-7844; Poldrack, Russell/0000-0001-6755-0259; Payton, Antony/0000-0003-0335-152X; Cirulli Rogers, Liz/0000-0001-7808-2809; Koltai, Deborah/0000-0002-4254-9902; Trampush, Joey/0000-0003-0830-508X; Pendleton, Neil/0000-0003-0794-2386	BBSRC [BB/F022441/1, BB/F019394/1] Funding Source: UKRI; MRC [G0901461, G0600237, G0100594] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100141, R01MH117646, ZIAMH002717] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bansal V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05510-z; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Bilder RM, 2006, J CLIN EXP NEUROPSYC, V28, P270, DOI 10.1080/13803390500360554; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15705-x; Chong SA, 2009, SOC PSYCH PSYCH EPID, V44, P999, DOI 10.1007/s00127-009-0027-3; Cornblatt B, 1999, DEV PSYCHOPATHOL, V11, P487, DOI 10.1017/S0954579499002175; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Deneve S, 2017, NEURON, V94, P969, DOI 10.1016/j.neuron.2017.05.016; Dobbyn A, 2018, AM J HUM GENET, V102, P1169, DOI 10.1016/j.ajhg.2018.04.011; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; Evans LM, 2018, NAT GENET, V50, P737, DOI 10.1038/s41588-018-0108-x; Fernandez E, 2017, CELL REP, V21, P679, DOI 10.1016/j.celrep.2017.09.045; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gale CR, 2013, MOL PSYCHIATR, V18, P190, DOI 10.1038/mp.2012.26; Gamazon ER, 2018, NAT GENET, V50, P956, DOI 10.1038/s41588-018-0154-4; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gaspar H., 2016, BIORXIV; Gaspar HA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12325-3; Ghaloul-Gonzalez L, 2016, MOL GENET METAB, V118, P296, DOI 10.1016/j.ymgme.2016.06.005; Glahn DC, 2007, AM J MED GENET B, V144B, P242, DOI 10.1002/ajmg.b.30446; Goldberg TE, 2009, SCHIZOPHR RES, V107, P262, DOI 10.1016/j.schres.2008.11.003; Gompers AL, 2017, NAT NEUROSCI, V20, P1062, DOI 10.1038/nn.4592; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Hauberg ME, 2017, AM J HUM GENET, V100, P885, DOI 10.1016/j.ajhg.2017.04.016; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hill WD, 2019, MOL PSYCHIATR, V24, P169, DOI 10.1038/s41380-017-0001-5; Hill WD, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.114; Hill WD, 2019, CURR OPIN PSYCHOL, V27, P25, DOI 10.1016/j.copsyc.2018.07.007; Hill WD, 2018, MOL PSYCHIATR, V23, P2347, DOI 10.1038/s41380-017-0005-1; Hill WD, 2016, BIOL PSYCHIAT, V80, P266, DOI 10.1016/j.biopsych.2015.08.033; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keefe RSE, 2008, WORLD PSYCHIATRY, V7, P22; Keulemans JLM, 1996, J MED GENET, V33, P458, DOI 10.1136/jmg.33.6.458; Kimura H, 2016, SCHIZOPHR RES, V178, P104, DOI 10.1016/j.schres.2016.08.023; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lam M, 2018, JAMA PSYCHIAT, V75, P929, DOI 10.1001/jamapsychiatry.2018.1668; Lam M, 2017, CELL REP, V21, P2597, DOI 10.1016/j.celrep.2017.11.028; Le Hellard S, 2017, SCHIZOPHRENIA BULL, V43, P654, DOI 10.1093/schbul/sbw085; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu QS, 2017, AM J HUM GENET, V101, P939, DOI 10.1016/j.ajhg.2017.11.001; MacCabe JH, 2008, PSYCHOL MED, V38, P1133, DOI 10.1017/S0033291707002048; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; McDermott JE, 2018, MOL CELL NEUROSCI, V92, P50, DOI 10.1016/j.mcn.2018.06.008; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Reichenberg A, 2002, AM J PSYCHIAT, V159, P2027, DOI 10.1176/appi.ajp.159.12.2027; Reichenberg A, 2005, ARCH GEN PSYCHIAT, V62, P1297, DOI 10.1001/archpsyc.62.12.1297; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Senthil G, 2017, MOL PSYCHIATR, V22, P1659, DOI 10.1038/mp.2017.29; Shiwaku H, 2015, CURR MOL MED, V15, P119, DOI 10.2174/1566524015666150303002556; Singh T, 2017, NAT GENET, V49, P1167, DOI 10.1038/ng.3903; Smeland OB, 2017, JAMA PSYCHIAT, V74, P1065, DOI 10.1001/jamapsychiatry.2017.1986; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Su YJ, 2015, CELL RES, V25, P993, DOI 10.1038/cr.2015.85; Suetterlin P, 2018, CEREB CORTEX, V28, P2192, DOI 10.1093/cercor/bhy058; Trampush JW, 2017, MOL PSYCHIATR, V22, P336, DOI 10.1038/mp.2016.244; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Turley P, 2018, NAT GENET, V50, P229, DOI 10.1038/s41588-017-0009-4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhu ZZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193256	90	37	38	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					334	350		10.1016/j.ajhg.2019.06.012	http://dx.doi.org/10.1016/j.ajhg.2019.06.012			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	IM5GK	31374203	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-18	WOS:000478022200008
J	Logan, CV; Murray, JE; Parry, DA; Robertson, A; Bellelli, R; Tarnauskaite, Z; Challis, R; Cleal, L; Bore, V; Fluteau, A; Santoyo-Lopez, J; Aitman, T; Barroso, I; Basel, D; Bicknell, LS; Goe, H; Hu, H; Huff, C; Hutchison, M; Joyce, C; Knox, R; Lacroix, AE; Langlois, S; McCandless, S; McCarrier, J; Metcalfe, KA; Morrissey, R; Murphy, N; Netchine, I; O'connell, SM; Olney, AH; Paria, N; Rosenfeld, JA; Sherlock, M; Syverson, E; White, PC; Wise, C; Yu, Y; Zacharin, M; Banerjee, I; Reijns, M; Bober, MB; Semple, RK; Boulton, SJ; Rios, JJ; Jackson, AP				Logan, Clare, V; Murray, Jennie E.; Parry, David A.; Robertson, Andrea; Bellelli, Roberto; Tarnauskaite, Zygimante; Challis, Rachel; Cleal, Louise; Bore, Valerie; Fluteau, Adeline; Santoyo-Lopez, Javier; Aitman, Tim; Barroso, Ines; Basel, Donald; Bicknell, Louise S.; Goe, Himanshu; Hu, Hao; Huff, Chad; Hutchison, Michele; Joyce, Caroline; Knox, Rachel; Lacroix, Amy E.; Langlois, Sylvie; McCandless, Shawn; McCarrier, Julie; Metcalfe, Kay A.; Morrissey, Rose; Murphy, Nuala; Netchine, Irene; O'connell, Susan M.; Olney, Ann Haskins; Paria, Nandina; Rosenfeld, Jill A.; Sherlock, Mark; Syverson, Erin; White, Perrin C.; Wise, Carol; Yu, Yao; Zacharin, Margaret; Banerjee, Indraneel; Reijns, Martin; Bober, Michael B.; Semple, Robert K.; Boulton, Simon J.; Rios, Jonathan J.; Jackson, Andrew P.		SGP Consortium	DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN RECOGNITION COMPLEX; REPLICATION STRESS; GROWTH-RETARDATION; SHORT STATURE; MUTATIONS; INHIBITOR; DOMAIN	During genome replication, polymerase epsilon (Pol epsilon) acts as the major leading-strand DNA polymerase. Here we report the identification of biallelic mutations in POLE, encoding the Pol epsilon catalytic subunit POLE1, in 15 individuals from 12 families. Phenotypically, these individuals had clinical features closely resembling IMAGe syndrome (intrauterine growth restriction [IUGR], metaphyseal dysplasia, adrenal hypoplasia congenita, and genitourinary anomalies in males), a disorder previously associated with gain-of-function mutations in CDKN1C. POLE1-deficient individuals also exhibited distinctive facial features and variable immune dysfunction with evidence of lymphocyte deficiency. All subjects shared the same intronic variant (c.1686+32C>G) as part of a common haplotype, in combination with different loss-of-function variants in trans. The intronic variant alters splicing, and together the biallelic mutations lead to cellular deficiency of Pol epsilon and delayed S-phase progression. In summary, we establish POLE as a second gene in which mutations cause IMAGe syndrome. These findings add to a growing list of disorders due to mutations in DNA replication genes that manifest growth restriction alongside adrenal dysfunction and/or immunodeficiency, consolidating these as replisome phenotypes and highlighting a need for future studies to understand the tissue-specific development roles of the encoded proteins.	[Logan, Clare, V; Murray, Jennie E.; Parry, David A.; Robertson, Andrea; Tarnauskaite, Zygimante; Challis, Rachel; Cleal, Louise; Fluteau, Adeline; Reijns, Martin; Jackson, Andrew P.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Murray, Jennie E.; Challis, Rachel; Cleal, Louise] Western Gen Hosp, South East Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Bellelli, Roberto; Bore, Valerie; Boulton, Simon J.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Santoyo-Lopez, Javier] Univ Edinburgh, Roslin Inst, Edinburgh Genom Clin Div, Edinburgh EH25 9RG, Midlothian, Scotland; [Aitman, Tim] Univ Edinburgh, MRC Ctr Genom & Expt Med, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Barroso, Ines] Wellcome Sanger Inst, Cambridge CB10 1SA, England; [Basel, Donald; McCarrier, Julie; Syverson, Erin] Childrens Hosp Wisconsin, Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bicknell, Louise S.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9016, New Zealand; [Goe, Himanshu] Hunter Genet, Waratah, NSW 2305, Australia; [Goe, Himanshu] Univ Newcastle, Callaghan, NSW 2308, Australia; [Hu, Hao; Huff, Chad; Yu, Yao] MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hutchison, Michele] Univ Arkansas, Dept Pediat, Little Rock, AR 72205 USA; [Joyce, Caroline] Cork Univ Hosp, Dept Clin Biochem, Cork, Ireland; [Knox, Rachel; Semple, Robert K.] Univ Cambridge, MRC Metab Dis Unit, Cambridge CB2 0QQ, England; [Lacroix, Amy E.; Olney, Ann Haskins] Univ Nebraska, Med Ctr, Omaha, NE 68918 USA; [Langlois, Sylvie] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [McCandless, Shawn] UH Cleveland Med Ctr, Pediat Genet, Cleveland, OH 44106 USA; [Metcalfe, Kay A.] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Metcalfe, Kay A.] Univ Manchester, Inst Human Dev, Manchester M13 9WL, Lancs, England; [Morrissey, Rose] Cork Univ Hosp, Dept Paediat & Child Hlth, Cork, Ireland; [Murphy, Nuala; O'connell, Susan M.] Childrens Univ Hosp, UCD Sch Med, Temple St, Dublin, Ireland; [Netchine, Irene] Sorbonne Univ, Hosp Trousseau, AP HP, INSEAM,UMR S938, F-75012 Paris, France; [Paria, Nandina; Wise, Carol; Rios, Jonathan J.] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Rosenfeld, Jill A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sherlock, Mark] Beaumont Hosp, Dept Endocrinol, Dublin, Ireland; [White, Perrin C.; Wise, Carol; Rios, Jonathan J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wise, Carol; Rios, Jonathan J.] Univ Texas Southwestern Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX 75390 USA; [Wise, Carol; Rios, Jonathan J.] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Zacharin, Margaret] Royal Childrens Hosp, Div Med, Melbourne, Vic 3052, Australia; [Banerjee, Indraneel] Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Dept Paediat Endocrinol, Manchester M13 9WU, Lancs, England; [Bober, Michael B.] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Semple, Robert K.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Francis Crick Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Wellcome Trust Sanger Institute; Children's Hospital of Wisconsin; Medical College of Wisconsin; University of Otago; University of Newcastle; University of Texas System; UTMD Anderson Cancer Center; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University College Cork; University of Cambridge; University of Nebraska System; University of Nebraska Medical Center; University of British Columbia; University of Manchester; University College Cork; Childrens University Hospital - Temple Street; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Texas Scottish Rite Hospital for Children; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Children's Hospital Melbourne; Royal Manchester Children's Hospital; University of Manchester; Nemours Alfred I. duPont Hospital for Children; University of Edinburgh	Murray, JE; Jackson, AP (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.; Murray, JE (corresponding author), Western Gen Hosp, South East Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland.	jennie.murray@igmm.ed.ac.uk; andrew.jackson@igmm.ed.ac.uk	Reijns, Martin/L-4355-2013; O'Rahilly, Stephen/ABF-6509-2020; Semple, Robert/AAB-2948-2019; Langlois, Sylvie/AAR-7978-2021; O'Connell, Susan Mary/ABC-7658-2021; Bicknell, Louise/AAL-8003-2020; Santoyo-Lopez, Javier/C-9714-2012; Bober, Michael/AAH-4553-2021; Bicknell, Louise/GLR-4215-2022; Santoyo-Lopez, Javier/AHE-5002-2022; Jackson, Andrew/D-3442-2009	Reijns, Martin/0000-0002-5048-2752; O'Rahilly, Stephen/0000-0003-2199-4449; O'Connell, Susan Mary/0000-0001-5604-9450; Santoyo-Lopez, Javier/0000-0003-1988-5059; Bicknell, Louise/0000-0001-6899-9322; Santoyo-Lopez, Javier/0000-0003-1988-5059; Bellelli, Roberto/0000-0002-2062-7113; Parry, David/0000-0003-0376-7736; Jackson, Andrew/0000-0002-8739-2646; Joyce, Caroline/0000-0001-7231-8331; Barroso, Ines/0000-0001-5800-4520; Bober, Michael/0000-0002-6178-1264; Aitman, Timothy/0000-0002-7875-4502; Semple, Robert Kenneth/0000-0001-6539-3069; NETCHINE, Irene/0000-0003-1324-3389	European Research Council ERC Starter Grant HumGenSize [281847]; ERC [788093]; UK Medical Research Council Human Genetics Unit core grant (MRC) [U127580972]; Scottish Genomes Partnership; Texas Scottish Rite Hospital for Children; Children's Medical Center Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]; Francis Crick Institute; Cancer Research UK [FC0010048]; UK Medical Research Council [FC0010048]; Wellcome Trust [FC0010048, 210752/Z/18/Z]; European Research Council (ERC) Advanced Investigator Grant (TelMetab); Chief Scientist Office of the Scottish Government Health Directorates [SGP/1]; Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative; MRC [MC_PC_15080, MC_UU_00007/16, MC_PC_U127580972, MR/N005902/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	European Research Council ERC Starter Grant HumGenSize; ERC(European Research Council (ERC)European Commission); UK Medical Research Council Human Genetics Unit core grant (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Genomes Partnership; Texas Scottish Rite Hospital for Children; Children's Medical Center Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) Advanced Investigator Grant (TelMetab)(European Research Council (ERC)); Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the families and clinicians for their involvement and participation; the Potentials Foundation and Walking with Giants Foundation; D. Fitzpatrick, N. Hastie, and W. Bickmore for discussions; E. Freyer for assistance with FACS analysis; IGMM core sequencing service; and Edinburgh Genomics (Clinical Division) for WGS sequencing. We thank Penny Jeggo for sharing cell lines. This work was supported by funding to the Jackson lab from European Research Council ERC Starter Grant HumGenSize, 281847; ERC Advanced Investigator Grant GrowCell, 788093; by a UK Medical Research Council Human Genetics Unit core grant (MRC, U127580972), and the Scottish Genomes Partnership. The Rios lab is supported by Texas Scottish Rite Hospital for Children and the Children's Medical Center Foundation. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Boulton lab work is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC0010048), the UK Medical Research Council (FC0010048), and the Wellcome Trust (FC0010048); a European Research Council (ERC) Advanced Investigator Grant (TelMetab); and Wellcome Trust Senior Investigator and Collaborative Grants. R.K.S. is funded by the Wellcome Trust (210752/Z/18/Z). The Scottish Genomes Partnership is funded by the Chief Scientist Office of the Scottish Government Health Directorates (SGP/1) and The Medical Research Council Whole Genome Sequencing for Health and Wealth Initiative.	Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; Bellelli R, 2018, MOL CELL, V70, P707, DOI 10.1016/j.molcel.2018.04.008; Bellido F, 2016, GENET MED, V18, P325, DOI 10.1038/gim.2015.75; Bennett J., 1993, IMAGE SYNDROM; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Borges KS, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0008-8; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Burrage LC, 2015, AM J HUM GENET, V97, P904, DOI 10.1016/j.ajhg.2015.11.006; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Cottineau J, 2017, J CLIN INVEST, V127, P1991, DOI 10.1172/JCI90727; Fenwick AL, 2016, AM J HUM GENET, V99, P125, DOI 10.1016/j.ajhg.2016.05.019; Frugoni F, 2016, J ALLERGY CLIN IMMUN, V137, P635, DOI 10.1016/j.jaci.2015.06.049; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hamajima N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075137; Hogg M., 2012, SUBCELL BIOCH, V62, P237, DOI [10.1007/978-94-007-4572-8_13, DOI 10.1007/978-94-007-4572-8_13]; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pedreira CC, 2004, J PEDIATR-US, V144, P274, DOI 10.1016/j.jpeds.2003.09.052; Schmid JP, 2012, J EXP MED, V209, P2323, DOI 10.1084/jem.20121303; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Tan TY, 2006, AM J MED GENET A, V140A, P1778, DOI 10.1002/ajmg.a.31365; Thiffault I, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0177-y	29	37	38	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					1038	1044		10.1016/j.ajhg.2018.10.024	http://dx.doi.org/10.1016/j.ajhg.2018.10.024			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30503519	Green Published, hybrid			2022-12-18	WOS:000452535600017
J	Guo, DC; Regalado, ES; Pinard, A; Chen, J; Lee, K; Rigelsky, C; Zilberberg, L; Hostetler, EM; Aldred, M; Wallace, SE; Prakash, SK; Leal, SM; Bamshad, MJ; Nickerson, DA; Natowicz, M; Rifkin, DB; Milewicz, DM				Guo, Dong-Chuan; Regalado, Ellen S.; Pinard, Amelie; Chen, Jiyuan; Lee, Kwanghyuk; Rigelsky, Christina; Zilberberg, Lior; Hostetler, Ellen M.; Aldred, Micheala; Wallace, Stephanie E.; Prakash, Siddharth K.; Leal, Suzanne M.; Bamshad, Michael J.; Nickerson, Deborah A.; Natowicz, Marvin; Rifkin, Daniel B.; Milewicz, Dianna M.		Univ Washington	LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-PROTEIN 3; TGF-BETA; MARFAN-SYNDROME; ANGIOTENSIN-II; MUTATIONS; DISEASE; MICE; OLIGODONTIA; FIBRILLINS	The major diseases affecting the thoracic aorta are aneurysms and acute dissections, and pathogenic variants in 11 genes are confirmed to lead to heritable thoracic aortic disease. However, many families in which multiple members have thoracic aortic disease do not have alterations in the known aortopathy genes. Genes highly expressed in the aorta were assessed for rare variants in exome sequencing data from such families, and compound rare heterozygous variants (p.Pro45Argfs*25 and p.Glu750*) in LTBP3 were identified in affected members of one family. A homozygous variant (p.Asn678_Gly681delinsThrCys) that introduces an additional cysteine into an epidermal growth factor (EGF)-like domain in the corresponding protein, latent TGF-beta binding protein (LTBP-3), was identified in a second family. Individuals with compound heterozygous or homozygous variants in these families have aneurysms and dissections of the thoracic aorta, as well as aneurysms of the abdominal aorta and other arteries, along with dental abnormalities and short stature. Heterozygous carriers of the p.Asn678_Gly681delinsThrCys variant have later onset of thoracic aortic disease, as well as dental abnormalities. In these families, LTBP3 variants segregated with thoracic aortic disease with a combined LOD score of 3.9. Additionally, heterozygous rare LTBP3 variants were found in individuals with early onset of acute aortic dissections, and some of these variants disrupted LTBP-3 levels or EGF-like domains. When compared to wild-type mice, Ltbp3(-/-) mice have enlarged aortic roots and ascending aortas. In summary, homozygous LTBP3 pathogenic variants predispose individuals to thoracic aortic aneurysms and dissections, along with the previously described skeletal and dental abnormalities.	[Guo, Dong-Chuan; Regalado, Ellen S.; Pinard, Amelie; Chen, Jiyuan; Hostetler, Ellen M.; Wallace, Stephanie E.; Prakash, Siddharth K.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, McGovern Med Sch, Houston, TX 77030 USA; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Rigelsky, Christina; Aldred, Micheala; Natowicz, Marvin] Cleveland Clin Fdn, Genom Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Zilberberg, Lior; Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Cleveland Clinic Foundation; New York University; University of Washington; University of Washington Seattle	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, McGovern Med Sch, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Pinard, Amelie/GVU-3835-2022; PINARD, Amelie/GVU-3886-2022	Pinard, Amelie/0000-0003-1882-5740; PINARD, Amelie/0000-0003-1882-5740; Regalado, Ellen/0000-0002-5859-218X; Hostetler, Ellen/0000-0002-9258-7827; Blue, Elizabeth/0000-0002-0633-0305; Lee, Kwanghyuk/0000-0003-1389-1220	National Heart, Lung, and Blood Institute [RO1 HL62594, P01HL110869-01]; John Ritter Foundation; NIH [UL1 RR024148]; National Human Genome Research Institute [1U54HG006493]; National Heart, Lung and Blood Institute Resequencing and Genotyping Service [HHSN268201100037C]; Marfan Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, R01HL109942, P01HL110869] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John Ritter Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute Resequencing and Genotyping Service; Marfan Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Heart, Lung, and Blood Institute (RO1 HL62594 and P01HL110869-01 to D.M.M.), the John Ritter Foundation, NIH UL1 RR024148 (through the Clinical and Translational Science Awards program), the National Human Genome Research Institute (1U54HG006493 to D.A.N., M.J.B., and S.M.L.), and the National Heart, Lung and Blood Institute Resequencing and Genotyping Service (HHSN268201100037C). Marfan Foundation (D.B.R.).	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Barbier M, 2014, AM J HUM GENET, V95, P736, DOI 10.1016/j.ajhg.2014.10.018; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Chen JY, 2017, CIRC RES, V120, P1903, DOI 10.1161/CIRCRESAHA.117.310563; Chen Y, 2002, FEBS LETT, V517, P277, DOI 10.1016/S0014-5793(02)02648-0; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; Dugan SL, 2015, AM J MED GENET A, V167, P1396, DOI 10.1002/ajmg.a.37049; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2017, J AM COLL CARDIOL, V70, P2728, DOI 10.1016/j.jacc.2017.09.1094; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Horbelt D, 2010, J CELL SCI, V123, P4340, DOI 10.1242/jcs.074773; Huckert M, 2015, HUM MOL GENET, V24, P3038, DOI 10.1093/hmg/ddv053; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Knipp BS, 2003, J SURG RES, V112, P97, DOI 10.1016/S0022-4804(03)00114-8; McInerney-Leo AM, 2016, J MED GENET, V53, P457, DOI 10.1136/jmedgenet-2015-103647; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Morkmued S, 2017, EUR J ORAL SCI, V125, P8, DOI 10.1111/eos.12328; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nistala H, 2010, HUM MOL GENET, V19, P4790, DOI 10.1093/hmg/ddq409; Noor A, 2009, AM J HUM GENET, V84, P519, DOI 10.1016/j.ajhg.2009.03.007; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721; Zilberberg L, 2015, P NATL ACAD SCI USA, V112, P14012, DOI 10.1073/pnas.1507652112; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	32	37	39	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					706	712		10.1016/j.ajhg.2018.03.002	http://dx.doi.org/10.1016/j.ajhg.2018.03.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29625025	Bronze, Green Published			2022-12-18	WOS:000429340800016
J	Verma, A; Lucas, A; Verma, SS; Zhang, Y; Josyula, N; Khan, A; Hartzel, DN; Lavage, DR; Leader, J; Ritchie, MD; Pendergrass, SA				Verma, Anurag; Lucas, Anastasia; Verma, Shefali S.; Zhang, Yu; Josyula, Navya; Khan, Anqa; Hartzel, Dustin N.; Lavage, Daniel R.; Leader, Joseph; Ritchie, Marylyn D.; Pendergrass, Sarah A.			PheWAS and Beyond: The Landscape of Associations with Medical Diagnoses and Clinical Measures across 38,662 Individuals from Geisinger	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN CELL-TYPES; RED-BLOOD-CELL; PHENOME-WIDE; RHEUMATOID-ARTHRITIS; GENETIC ASSOCIATION; KIDNEY-FUNCTION; RISK LOCI; VARIANTS; TRAITS	Most phenome-wide association studies (PheWASs) to date have used a small to moderate number of SNPs for association with phenotypic data. We performed a large-scale single-cohort PheWAS, using electronic health record (EHR)-derived case-control status for 541 diagnoses using International Classification of Disease version 9 (ICD-9) codes and 25 median clinical laboratory measures. We calculated associations between these diagnoses and traits with similar to 630,000 common frequency SNPs with minor allele frequency >0.01 for 38,662 individuals. In this landscape PheWAS, we explored results within diseases and traits, comparing results to those previously reported in genome-wide association studies (GWASs), as well as previously published PheWASs. We further leveraged the context of functional impact from protein-coding to regulatory regions, providing a deeper interpretation of these associations. The comprehensive nature of this PheWAS allows for novel hypothesis generation, the identification of phenotypes for further study for future phenotypic algorithm development, and identification of cross-phenotype associations.	[Josyula, Navya; Hartzel, Dustin N.; Lavage, Daniel R.; Leader, Joseph; Pendergrass, Sarah A.] Geisinger Hlth Syst, Biomed & Translat Informat Inst, Danville, PA 17822 USA; [Verma, Anurag; Lucas, Anastasia; Verma, Shefali S.; Ritchie, Marylyn D.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Verma, Anurag; Verma, Shefali S.; Ritchie, Marylyn D.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Zhang, Yu] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Khan, Anqa] Mt Holyoke Coll, S Hadley, MA 01075 USA	Geisinger Health System; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Mount Holyoke College	Pendergrass, SA (corresponding author), Geisinger Hlth Syst, Biomed & Translat Informat Inst, Danville, PA 17822 USA.	spendergrass@geisinger.edu	Josyula, Navya Shilpa/W-1030-2019	Josyula, Navya Shilpa/0000-0003-2782-8812; Pendergrass, Rion/0000-0002-0565-6522; Lavage, Dani/0000-0002-9570-2931; Verma, Anurag/0000-0002-5063-9107	Pennsylvania Department of Health [SAP 4100070267]	Pennsylvania Department of Health	This project is funded, in part, under a grant with the Pennsylvania Department of Health (#SAP 4100070267). The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Azghandi S, 2015, STROKE, V46, P197, DOI 10.1161/STROKEAHA.114.007213; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Canela-Xandri O, 2017, BIORXIV; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; de Rooy DPC, 2014, ANN RHEUM DIS, V73, P1163, DOI 10.1136/annrheumdis-2013-203375; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Doss J, 2017, ARTHRITIS RHEUMATOL, V69, P291, DOI 10.1002/art.39851; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Flisiak I, 2014, CLIN EXP DERMATOL, V39, P461, DOI 10.1111/ced.12356; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hall MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00802-2; Hall MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004678; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Hebbring SJ, 2015, BIOINFORMATICS, V31, P1981, DOI 10.1093/bioinformatics/btv076; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodonsky CJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006760; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Liu JX, 2016, J MED GENET, V53, P681, DOI 10.1136/jmedgenet-2016-103867; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Manichaikul A, 2016, HYPERTENSION, V68, P356, DOI 10.1161/HYPERTENSIONAHA.116.07564; Markus HS, 2013, STROKE, V44, P1220, DOI 10.1161/STROKEAHA.111.000217; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mero IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058352; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Nischwitz S, 2010, J NEUROIMMUNOL, V227, P162, DOI 10.1016/j.jneuroim.2010.06.003; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Sobota RS, 2015, ANN HUM GENET, V79, P136, DOI 10.1111/ahg.12095; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; van Rooij FJA, 2017, AM J HUM GENET, V100, P51, DOI 10.1016/j.ajhg.2016.11.016; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Verma A, 2017, BIORXIV; Verma A, 2016, BIOCOMPUT-PAC SYM, P168; Verma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160573; Verma A, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0191-8; Verma SS, 2017, BIOCOMPUT-PAC SYM, P533, DOI 10.1142/9789813207813_0049; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Wolf EJ, 2013, DEPRESS ANXIETY, V30, P1161, DOI 10.1002/da.22176; Wu Y, 2013, J LIPID RES, V54, P3198, DOI 10.1194/jlr.P042077; Ye Z, 2015, EUR J HUM GENET, V23, P523, DOI 10.1038/ejhg.2014.123; Zhang Y, 2017, NUCLEIC ACIDS RES, V45, P9823, DOI 10.1093/nar/gkx659; Zhang Y, 2016, NUCLEIC ACIDS RES, V44, P6721, DOI 10.1093/nar/gkw278	76	37	38	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					592	608		10.1016/j.ajhg.2018.02.017	http://dx.doi.org/10.1016/j.ajhg.2018.02.017			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29606303	Green Published, Bronze			2022-12-18	WOS:000429340800007
J	Straub, J; Konrad, EDH; Gruner, J; Toutain, A; Bok, LA; Cho, MT; Crawford, HP; Dubbs, H; Douglas, G; Jobling, R; Johnson, D; Krock, B; Mikati, MA; Nesbitt, A; Nicolai, J; Phillips, M; Poduri, A; Ortiz-Gonzalez, XR; Powis, Z; Santani, A; Smith, L; Stegmann, APA; Stumpel, C; Vreeburg, M; Fliedner, A; Gregor, A; Sticht, H; Zweier, C				Straub, Jonas; Konrad, Enrico D. H.; Gruener, Johanna; Toutain, Annick; Bok, Levinus A.; Cho, Megan T.; Crawford, Heather P.; Dubbs, Holly; Douglas, Ganka; Jobling, Rebekah; Johnson, Diana; Krock, Bryan; Mikati, Mohamad A.; Nesbitt, Addie; Nicolai, Joost; Phillips, Meredith; Poduri, Annapurna; Ortiz-Gonzalez, Xilma R.; Powis, Zoe; Santani, Avni; Smith, Lacey; Stegmann, Alexander P. A.; Stumpel, Constance; Vreeburg, Maaike; Fliedner, Anna; Gregor, Anne; Sticht, Heinrich; Zweier, Christiane		Deciphering Dev Disorders Study	Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; MUTATION ANALYSIS; RHO-GTPASES; RISK GENES; DBC2 GENE; AUTISM; EXPRESSION; IDENTIFICATION; ORGANIZATION; ARCHITECTURE	Although the role of typical Rho GTPases and other Rho-linked proteins in synaptic plasticity and cognitive function and dysfunction is widely acknowledged, the role of atypical Rho GTPases (such as RHOBTB2) in neurodevelopment has barely been characterized. We have now identified de novo missense variants clustering in the BTB-domain-encoding region of RHOBTB2 in ten individuals with a similar phenotype, including early-onset epilepsy, severe intellectual disability, postnatal microcephaly, and movement disorders. Three of the variants were recurrent. Upon transfection of HEK293 cells, we found that mutant RHOBTB2 was more abundant than the wildtype, most likely because of impaired degradation in the proteasome. Similarly, elevated amounts of the Drosophila ortholog RhoBTB in vivo were associated with seizure susceptibility and severe locomotor defects. Knockdown of RhoBTB in the Drosophila dendritic arborization neurons resulted in a decreased number of dendrites, thus suggesting a role of RhoBTB in dendritic development. We have established missense variants in the BTB-domain-encoding region of RHOBTB2 as causative for a developmental and epileptic encephalopathy and have elucidated the role of atypical Rho GTPase RhoBTB in Drosophila neurological function and possibly dendrite development.	[Straub, Jonas; Konrad, Enrico D. H.; Gruener, Johanna; Fliedner, Anna; Gregor, Anne; Zweier, Christiane] Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Toutain, Annick] CHU Tours, Serv Genet, F-37044 Tours, France; [Bok, Levinus A.] Maxima Med Ctr, Dept Pediat, NL-5504 DB Veldhoven, Netherlands; [Cho, Megan T.] GeneDx, Gaithersburg, MD 20877 USA; [Crawford, Heather P.; Phillips, Meredith] Cook Childrens Med Ctr, Clin & Metab Genet, Ft Worth, TX 76102 USA; [Dubbs, Holly; Ortiz-Gonzalez, Xilma R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Jobling, Rebekah] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Johnson, Diana] Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; [Krock, Bryan; Nesbitt, Addie; Santani, Avni] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Krock, Bryan; Santani, Avni] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mikati, Mohamad A.] Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC 27710 USA; [Nicolai, Joost] Maastricht Univ, Dept Neurol, Med Ctr, NL-6202 AZ Maastricht, Netherlands; [Poduri, Annapurna; Smith, Lacey] Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA 02115 USA; [Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Ortiz-Gonzalez, Xilma R.] Univ Penn, Pereleman Sch Med, Philadelphia, PA 19104 USA; [Powis, Zoe] Ambry Genet, Aliso Viejo, CA 92656 USA; [Stegmann, Alexander P. A.; Stumpel, Constance; Vreeburg, Maaike] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Stegmann, Alexander P. A.; Stumpel, Constance; Vreeburg, Maaike] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, NL-6202 AZ Maastricht, Netherlands; [Deciphering Dev Disorders Study] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; CHU Tours; Maxima Medical Center; Cook Children's Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Duke University; Maastricht University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Maastricht University; Maastricht University; Wellcome Trust Sanger Institute; University of Erlangen Nuremberg	Zweier, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	christiane.zweier@uk-erlangen.de	Ortiz-Gonzalez, Xilma/AAD-2211-2021; Zweier, Christiane/F-2202-2015	Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; Zweier, Christiane/0000-0001-8002-2020; Mikati, Mohamad/0000-0003-0363-8715; Sticht, Heinrich/0000-0001-5644-045X; Stegmann, Alexander/0000-0002-9736-7137; Toutain, Annick/0000-0002-5999-5300	German Ministry of Education and Research [01GS08160]; German Research Foundation [INST 410/91-1 FUGG, ZW184/1-2, ZW184/3-1, GRK2162]; Wellcome Trust; Drosophila Transgenic RNAi Project at Harvard Medical School (NIH National Institute of General Medical Sciences) [R01-GM084947]; Harold Amos Faculty Development Award of the Robert Wood Johnson Foundation; Boston Children's Hospital Translational Research Program; Interdisciplinary Center for Clinical Research in Erlangen [E26]; Bloomington Drosophila Stock Center [NIH P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Drosophila Transgenic RNAi Project at Harvard Medical School (NIH National Institute of General Medical Sciences); Harold Amos Faculty Development Award of the Robert Wood Johnson Foundation; Boston Children's Hospital Translational Research Program; Interdisciplinary Center for Clinical Research in Erlangen; Bloomington Drosophila Stock Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all affected individuals and their families for participating in this study. We thank Laila Distel, Christine Suchy, and Nicole Rachinger for excellent technical assistance; Jessica Panzer for providing clinical details; and Annette Schenck, Monique van der Voet, and Tom Koemans for providing fly lines and helping with the courtship conditioning assay. We also thank Andre Reis (supported by German Ministry of Education and Research 01GS08160), Arif Ekici, and Steffen Uebe from the next-generation sequencing core facility at the Institute of Human Genetics in Erlangen. We thank Felix Engel and Silvia Vergarajauregui for helping with confocal microscopy, which was supported by the German Research Foundation (INST 410/91-1 FUGG). This study made use of data generated by the DECIPHER community. A full list of centers that contributed to the generation of the data is available at http://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. Fly stocks were obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537), the Drosophila Transgenic RNAi Project at Harvard Medical School (NIH National Institute of General Medical Sciences R01-GM084947), and the Vienna Drosophila Resource Center (http://www.vdrc.at). Antibodies from the Developmental Studies Hybridoma Bank (created by the NIH National Institute of Child Health and Human Development) were used in this study. X.O.G. is supported by the Harold Amos Faculty Development Award of the Robert Wood Johnson Foundation, A.P. is supported by the Boston Children's Hospital Translational Research Program, and C.Z. is supported by grants from the German Research Foundation (ZW184/1-2, ZW184/3-1, and GRK2162) and by the Interdisciplinary Center for Clinical Research in Erlangen (E26).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Ba W, 2013, EXP CELL RES, V319, P2368, DOI 10.1016/j.yexcr.2013.05.033; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; BRAND AH, 1993, DEVELOPMENT, V118, P401; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Cho YG, 2008, ACTA ONCOL, V47, P366, DOI 10.1080/02841860701644094; Codina-Sola M, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0017-0; Crawley JN, 2016, TRENDS GENET, V32, P139, DOI 10.1016/j.tig.2016.01.001; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; Gregor A, 2014, HUM MUTAT, V35, P1495, DOI 10.1002/humu.22697; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Ji W, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020028; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lopes F, 2016, J MED GENET, V53, P190, DOI 10.1136/jmedgenet-2015-103568; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ohadi M, 2007, ACTA ONCOL, V46, P770, DOI 10.1080/02841860601047752; Palladino MJ, 2002, GENETICS, V161, P1197; PAVLIDIS P, 1995, J NEUROSCI, V15, P5810; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seco CZ, 2017, DIS MODEL MECH, V10, P105, DOI 10.1242/dmm.026476; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; St-Pierre B, 2004, GENE EXPR PATTERNS, V5, P245, DOI 10.1016/j.modgep.2004.07.009; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wilkins A, 2008, METHOD ENZYMOL, V439, P103, DOI 10.1016/S0076-6879(07)00408-9; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	58	37	39	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					44	57		10.1016/j.ajhg.2017.11.008	http://dx.doi.org/10.1016/j.ajhg.2017.11.008			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29276004	Green Published, Bronze			2022-12-18	WOS:000419305500004
J	Abadi, A; Alyass, A; du Pont, SR; Bolker, B; Singh, P; Mohan, V; Diaz, R; Engert, JC; Yusuf, S; Gerstein, HC; Anand, SS; Meyre, D				Abadi, Arkan; Alyass, Akram; du Pont, Sebastien Robiou; Bolker, Ben; Singh, Pardeep; Mohan, Viswanathan; Diaz, Rafael; Engert, James C.; Yusuf, Salim; Gerstein, Hertzel C.; Anand, Sonia S.; Meyre, David			Penetrance of Polygenic Obesity Susceptibility Loci across the Body Mass Index Distribution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-GENE INTERACTIONS; PHYSICAL-ACTIVITY; ENVIRONMENT INTERACTIONS; INDIVIDUALS REVEAL; QUALITY-CONTROL; DIETARY-INTAKE; EXACT TESTS; FAT MASS; FTO GENE	A growing number of single-nucleotide polymorphisms (SNPs) have been associated with body mass index (BMI) and obesity, but whether the effects of these obesity-susceptibility loci are uniform across the BMI distribution remains unclear. We studied the effects of 37 BMI-associated SNPs in 75,230 adults of European ancestry across BMI percentiles by using conditional quantile regression (CQR) and meta-regression (MR) models. The effects of nine SNPs (24%)-rs1421085 (FTO; p = 8.69 x 10(-15)), rs6235 (PCSK1; p = 7.11 x 10(-6)), rs7903146 (TCF7L2; p = 9.60 x 10(-6)), rs11873305 (MC4R; p = 5.08 x 10(-5)), rs12617233 (FANCL; p = 5.30 x 10(-5)), rs11672660 (GIPR; p = 1.64 x 10(-4)), rs997295 (MAP2K5; p = 3.25 x 10(-4)), rs6499653 (FTO; p = 6.23 x 10(-4)), and rs3824755 (NT5C2; p = 7.90 x 10(-4))-increased significantly across the sample BMI distribution. We showed that such increases stemmed from unadjusted gene interactions that enhanced the effects of SNPs in persons with a high BMI. When 125 height-associated SNPs were analyzed for comparison, only one (< 1%), rs6219 (IGF1, p = 1.80 x 10(-4)), showed effects that varied significantly across height percentiles. Cumulative gene scores of these SNPs (GS-BMI and GS-height) showed that only GS-BMI had effects that increased significantly across the sample distribution (BMI: p = 7.03 x 10(-37); height: p = 0.499). Overall, these findings underscore the importance of gene-gene and gene-environment interactions in shaping the genetic architecture of BMI and advance a method for detecting such interactions by using only the sample outcome distribution.	[Abadi, Arkan; Alyass, Akram; du Pont, Sebastien Robiou; Yusuf, Salim; Gerstein, Hertzel C.; Anand, Sonia S.; Meyre, David] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada; [Bolker, Ben] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4L8, Canada; [Singh, Pardeep; Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India; [Diaz, Rafael] Estudios Clin Latino Amer, Paraguay 160,S2000CVD, Rosario, Santa Fe, Argentina; [Engert, James C.] McGill Univ, Montreal, PQ H3A 0G4, Canada; [Yusuf, Salim; Gerstein, Hertzel C.; Anand, Sonia S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8S 4L8, Canada; [Yusuf, Salim; Gerstein, Hertzel C.; Anand, Sonia S.] Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON L8S 4L8, Canada; [Abadi, Arkan; Alyass, Akram] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University; McMaster University; Madras Diabetes Research Foundation; McGill University; McMaster University; Population Health Research Institute; McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada.	meyred@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013; Meyre, David/D-7315-2011	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Meyre, David/0000-0003-4850-7444; Engert, James/0000-0001-8411-4790; kumbara, arya/0000-0002-0395-1245; Yusuf, Salim/0000-0003-4776-5601	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	We thank Aihua Li for her assistance in database management and work using SPSS. Sebastien Robiou-du-Pont was supported by the Heart and Stroke Foundation of Ontario. Sonia S. Anand holds the Heart and Stroke Foundation of Ontario Michael G. DeGroote Chair in Population Health and a Canada Research Chair in Ethnicity and Cardiovascular Disease, Hertzel C. Gerstein holds the Aventis PHRI Chair in Diabetes, Salim Yusuf holds the Heart and Stroke Endowed Chair in Cardiovascular Research, and David Meyre holds a Canada Research Chair in Genetics of Obesity. Further acknowledgments are presented in the Supplemental Data.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abadi A., 2017, BIORXIV; Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Analytics R, 2014, DOPARALLEL FOREACH P; Anand SS, 2012, EUR J PREV CARDIOL, V19, P755, DOI 10.1177/1741826711409327; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019057; Borchers H. W., 2015, PRACMA PRACTICAL NUM; Borenstein M., 2009, INTRO METAANALYSIS; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Corella D, 2011, J NUTR, V141, P2219, DOI 10.3945/jn.111.143826; De R, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0074-0; Demerath EW, 2013, HUM HERED, V75, P175, DOI 10.1159/000351742; Dowle M., 2014, DATA TABLE EXTENSION; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gilbert-Diamond D., 2011, CURR PROTOC HUM GENE, P14; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; He XM, 2002, J AM STAT ASSOC, V97, P783, DOI 10.1198/016214502388618591; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hwang JY, 2015, DIABETES, V64, P291, DOI 10.2337/db14-0563; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kocherginsky M, 2005, J COMPUT GRAPH STAT, V14, P41, DOI 10.1198/106186005X27563; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KOENKER R, 1982, ECONOMETRICA, V50, P43, DOI 10.2307/1912528; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2013, QUANTREG QUANTILE RE; Koenker RW., 2005, QUANTILE REGRESSION, DOI [DOI 10.1017/CBO9780511754098, 10.1017/CBO9780511754098]; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lappalainen T, 2012, BRIT J NUTR, V108, P1859, DOI 10.1017/S0007114511007410; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mattei J, 2012, AM J CLIN NUTR, V96, P1129, DOI 10.3945/ajcn.112.038125; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Mitchell JA, 2013, OBESITY, V21, P1256, DOI 10.1002/oby.20319; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Pigeyre M, 2016, CLIN SCI, V130, P943, DOI 10.1042/CS20160136; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S., 2016, V190B34264BIT PLINK; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi QB, 2014, HUM MOL GENET, V23, P6961, DOI 10.1093/hmg/ddu411; R Core Team, 2019, R LANG ENV STAT COMP; Reddon H, 2016, CLIN SCI, V130, P1571, DOI 10.1042/CS20160221; Reddon H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18672; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rivera M, 2012, MOL PSYCHIATR, V17, P604, DOI 10.1038/mp.2011.45; Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; */* S  81, 2014, DIABETES CARE S1, V37, pS8, DOI DOI 10.2337/DC14-S081; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Sung YJ, 2014, GENET EPIDEMIOL, V38, P369, DOI 10.1002/gepi.21800; Taliun D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-10; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Warnes G.R., 2017, GDATA VARIOUS R PROG; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Wei Y, 2016, J AM STAT ASSOC, V111, P344, DOI 10.1080/01621459.2015.1008101; WHO (World Health Organization), 2000, OB PREV MAN GLOB EP; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Yaghootkar H, 2017, HUM MOL GENET, V26, P1018, DOI 10.1093/hmg/ddw433; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Young AI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12724; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC	96	37	37	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					925	938		10.1016/j.ajhg.2017.10.007	http://dx.doi.org/10.1016/j.ajhg.2017.10.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29220676	Bronze, Green Published			2022-12-18	WOS:000417644500005
J	Nguyen, TTM; Murakami, Y; Sheridan, E; Ehresmann, S; Rousseau, J; St-Denis, A; Chai, G; Ajeawung, NF; Fairbrother, L; Reimschisel, T; Bateman, A; Berry-Kravis, E; Xia, F; Tardif, J; Parry, DA; Logan, CV; Diggle, C; Bennett, CP; Hattingh, L; Rosenfeld, JA; Perry, MS; Parker, MJ; Le Deist, F; Zaki, MS; Ignatius, E; Isohanni, P; Lonnqvist, T; Carroll, CJ; Johnson, CA; Gleeson, JG; Kinoshita, T; Campeau, PM				Thi Tuyet Mai Nguyen; Murakami, Yoshiko; Sheridan, Eamonn; Ehresmann, Sophie; Rousseau, Justine; St-Denis, Anik; Chai, Guoliang; Ajeawung, Norbert F.; Fairbrother, Laura; Reimschisel, Tyler; Bateman, Alexandra; Berry-Kravis, Elizabeth; Xia, Fan; Tardif, Jessica; Parry, David A.; Logan, Clare V.; Diggle, Christine; Bennett, Christopher P.; Hattingh, Louise; Rosenfeld, Jill A.; Perry, Michael Scott; Parker, Michael J.; Le Deist, Francoise; Zaki, Maha S.; Ignatius, Erika; Isohanni, Pirjo; Lonnqvist, Tuula; Carroll, Christopher J.; Johnson, Colin A.; Gleeson, Joseph G.; Kinoshita, Taroh; Campeau, Philippe M.			Mutations in GPAA1, Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION SYNDROME; HYPOTONIA-SEIZURES SYNDROME; ANCHOR-SYNTHESIS PATHWAY; INTELLECTUAL DISABILITY; ALKALINE-PHOSPHATASE; CONGENITAL-ANOMALIES; GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; CAUSE HYPERPHOSPHATASIA; PIGV MUTATIONS; GENE	Approximately one in every 200 mammalian proteins is anchored to the cell membrane through a glycosylphosphatidylinositol (GPI) anchor. These proteins play important roles notably in neurological development and function. To date, more than 20 genes have been implicated in the biogenesis of GPI-anchored proteins. GPAA1 (glycosylphosphatidylinositol anchor attachment 1) is an essential component of the transamidase complex along with PIGK, PIGS, PIGT, and PIGU (phosphatidylinositol-glycan biosynthesis classes K, S, T, and U, respectively). This complex orchestrates the attachment of the GPI anchor to the C terminus of precursor proteins in the endoplasmic reticulum. Here, we report bi-allelic mutations in GPAA1 in ten individuals from five families. Using whole-exome sequencing, we identified two frameshift mutations (c.981_993del [p.Gln327Hisfs*102] and c.920delG [p.Gly307Alafs*11]), one intronic splicing mutation (c.1164_5C>T), and six missense mutations (c.152C>T [p.Ser51Leu], c.160_161delinsAA [p.Ala54Asn], c.527G>C [p.Trp176Ser], c.869T>C [p.Leu290Pro], c.872T>C [p.Leu291Pro], and c.1165G>C [p.Ala389Pro]). Most individuals presented with global developmental delay, hypotonia, early-onset seizures, cerebellar atrophy, and osteopenia. The splicing mutation was found to decrease GPAA1 mRNA. Moreover, flow-cytometry analysis of five available individual samples showed that several GPI-anchored proteins had decreased cell-surface abundance in leukocytes (FLAER, CD16, and CD59) or fibroblasts (CD73 and CD109). Transduction of fibroblasts with a lentivirus encoding the wild-type protein partially rescued the deficiency of GPI-anchored proteins. These findings highlight the role of the transamidase complex in the development and function of the cerebellum and the skeletal system.	[Thi Tuyet Mai Nguyen; Ehresmann, Sophie; Rousseau, Justine; St-Denis, Anik; Ajeawung, Norbert F.; Tardif, Jessica; Le Deist, Francoise; Campeau, Philippe M.] Univ Montreal, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Yabumoto Dept Intractable Dis Res, Osaka 5650871, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Sheridan, Eamonn; Parry, David A.; Logan, Clare V.; Diggle, Christine; Bennett, Christopher P.; Johnson, Colin A.] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Chai, Guoliang; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, San Diego, CA 92093 USA; [Fairbrother, Laura; Reimschisel, Tyler; Bateman, Alexandra] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Xia, Fan; Rosenfeld, Jill A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hattingh, Louise] Bradford Royal Infirm, Dept Radiol, Duckworth Lane, Bradford BD9 6RJ, W Yorkshire, England; [Perry, Michael Scott] Cook Childrens Med Ctr, Jane & John Justin Neurosci Ctr, Comprehens Epilepsy Program, Ft Worth, TX 76104 USA; [Parker, Michael J.] Sheffield Childrens Hosp NHS Fdn Trust, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Zaki, Maha S.] Natl Res Ctr, Clin Genet Dept, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Ignatius, Erika; Isohanni, Pirjo; Carroll, Christopher J.] Univ Helsinki, Mol Neurol, Res Programs Unit, FIN-00290 Helsinki, Finland; [Ignatius, Erika; Isohanni, Pirjo; Lonnqvist, Tuula] Univ Helsinki, Childrens Hosp, Dept Child Neurol, Helsinki 00029, Finland; [Ignatius, Erika; Isohanni, Pirjo; Lonnqvist, Tuula] Helsinki Univ Hosp, Hosp Dist Helsinki & Uusimaa, Helsinki 00029, Finland; [Carroll, Christopher J.] St Georges Univ London, Mol & Clin Sci Res Inst, Cranmer Terrace, London SW17 0RE, England; [Campeau, Philippe M.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Osaka University; Osaka University; University of Leeds; Howard Hughes Medical Institute; University of California System; University of California San Diego; Vanderbilt University; Rush University; Rush University; Rush University; Baylor College of Medicine; Bradford Royal Infirmary; Cook Children's Medical Center; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; St Georges University London; Universite de Montreal	Campeau, PM (corresponding author), Univ Montreal, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada.; Campeau, PM (corresponding author), Univ Montreal, Dept Pediat, Montreal, PQ H3T 1J4, Canada.	p.campeau@umontreal.ca	Carroll, Christopher/AAV-8023-2021; Kinoshita, Taroh/C-7353-2009; Campeau, Philippe/J-8614-2015; Carroll, Christopher/AAJ-6185-2021; Xia, Fan/GQP-4575-2022; Zaki, Maha S/B-9361-2013	Campeau, Philippe/0000-0001-9713-7107; Carroll, Christopher/0000-0002-2814-6955; Zaki, Maha/0000-0001-7840-0002; Parry, David/0000-0003-0376-7736; Rousseau, Justine/0000-0002-3554-2673; Johnson, Colin/0000-0002-2979-8234; Chai, Guoliang/0000-0001-9658-6381; Ehresmann, Sophie/0000-0002-4171-7222; Ignatius, Erika/0000-0002-3574-6510	Canadian Institutes of Health Research; Fonds de Recherche en Sante Quebec; Fondation du Grand Defi Pierre Lavoie; Wellcome Trust; Japanese Agency for Medical Research and Development; Ministry of Health, Labour, and Welfare [16ek0109052h0003]; Foundation for Pediatric Research; Helsinki University Hospital; Arvo and Lea Ylppo Foundation; Helsinki University; Sir Jules Thorn Charitable Trust Biomedical Award [JTA/09]; NIH [R01NS098004, R01NS048453]; Qatar National Research Fund; National Priorities Research Programme [6-1463-351]; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute; Yale Center for Mendelian Disorders [UMIHG008900, UMIHG006504]; MRC [MR/K011154/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS098004] Funding Source: NIH RePORTER; Medical Research Council [MR/K011154/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante Quebec; Fondation du Grand Defi Pierre Lavoie; Wellcome Trust(Wellcome Trust); Japanese Agency for Medical Research and Development; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Foundation for Pediatric Research; Helsinki University Hospital; Arvo and Lea Ylppo Foundation; Helsinki University; Sir Jules Thorn Charitable Trust Biomedical Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF)); National Priorities Research Programme; Simons Foundation Autism Research Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale Center for Mendelian Disorders; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	We acknowledge funding by the Canadian Institutes of Health Research, the Fonds de Recherche en Sante Quebec, and the Fondation du Grand Defi Pierre Lavoie. This study made use of data generated by the DECIPHER community. A full list of centers that contributed to the generation of the data is available at http://decipher.sanger.ac.uk and via decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. This study was also funded by grants from the Japanese Agency for Medical Research and Development and Ministry of Health, Labour, and Welfare (16ek0109052h0003 to Y.M.); grants from the Foundation for Pediatric Research, Helsinki University Hospital, Arvo and Lea Ylppo Foundation, and Helsinki University; and a Sir Jules Thorn Charitable Trust Biomedical Award (JTA/09 to E.S. and C.A.J.). The research was supported by the NIH (R01NS098004 and R01NS048453), Qatar National Research Fund, National Priorities Research Programme (6-1463-351), Simons Foundation Autism Research Initiative, and Howard Hughes Medical Institute (J.G.G.). We thank the Broad Institute and the Yale Center for Mendelian Disorders (UMIHG008900 to D. MacArthur and H. Rehm and UMIHG006504 to R. Lifton and M. Gunel). Sequence data for family 3 were deposited under dbGaP: phs000288 according to NIH guidelines. We thank Kana Miyanagi and Saori Umeshita for their technical assistance. We thank Dr. Irma Jarvela for help with obtaining photos.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Chen G, 2014, GENET MOL RES, V13, P499, DOI 10.4238/2014.January.21.19; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Edvardson S, 2017, J MED GENET, V54, P196, DOI 10.1136/jmedgenet-2016-104202; Eisenhaber B, 2014, CELL CYCLE, V13, P1912, DOI 10.4161/cc.28761; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hiroi Y, 1998, GENOMICS, V54, P354, DOI 10.1006/geno.1998.5490; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Johnstone DL, 2017, HUM MOL GENET, V26, P1706, DOI 10.1093/hmg/ddx077; Kinoshita T, 2014, CELL CYCLE, V13, P1838, DOI 10.4161/cc.29379; Kinoshita T, 2014, P JPN ACAD B-PHYS, V90, P130, DOI 10.2183/pjab.90.130; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Makrythanasis P, 2016, AM J HUM GENET, V98, P615, DOI 10.1016/j.ajhg.2016.02.007; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Nagpal JK, 2008, MODERN PATHOL, V21, P979, DOI 10.1038/modpathol.2008.76; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Nakashima M, 2014, NEUROGENETICS, V15, P193, DOI 10.1007/s10048-014-0408-y; Ng BG, 2015, J INHERIT METAB DIS, V38, P171, DOI 10.1007/s10545-014-9752-1; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Ohba C, 2014, NEUROGENETICS, V15, P85, DOI 10.1007/s10048-013-0384-7; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Pagnamenta AT, 2017, EUR J HUM GENET, V25, P669, DOI 10.1038/ejhg.2017.32; Skauli N, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120108; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thompson MD, 2006, PEDIATR NEUROL, V34, P303, DOI 10.1016/j.pediatrneurol.2005.08.020; van der Crabben SN, 2014, AM J MED GENET A, V164, P29, DOI 10.1002/ajmg.a.36184; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465	40	37	38	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					856	865		10.1016/j.ajhg.2017.09.020	http://dx.doi.org/10.1016/j.ajhg.2017.09.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100095	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000414251600016
J	Ng, M; Thakkar, D; Southam, L; Werker, P; Ophoff, R; Becker, K; Nothnagel, M; Franke, A; Nurnberg, P; Espirito-Santo, AI; Izadi, D; Hennies, HC; Nanchahal, J; Zeggini, E; Furniss, D				Ng, Michael; Thakkar, Dipti; Southam, Lorraine; Werker, Paul; Ophoff, Roel; Becker, Kerstin; Nothnagel, Michael; Franke, Andre; Nuernberg, Peter; Espirito-Santo, Ana Isabel; Izadi, David; Hennies, Hans Christian; Nanchahal, Jagdeep; Zeggini, Eleftheria; Furniss, Dominic			A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCOIDIN-DOMAIN RECEPTOR-2; EXTRACELLULAR-MATRIX; KINASE; EXPRESSION; COLLAGEN; OSTEOARTHRITIS; ACTIVATION; IMPUTATION; CELLS; PROLIFERATION	Individuals with Dupuytren disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue-specific fibroses. DD affects between 5% and 25% of people of European descent and is the most common inherited disease of connective tissue. We undertook the largest GWAS to date in individuals with a surgically validated diagnosis of DD from the UK, with replication in British, Dutch, and German individuals. We validated association at all nine previously described signals and discovered 17 additional variants with p <= 5 x 10(-8). As a proof of principle, we demonstrated correlation of the high-risk genotype at the statistically most strongly associated variant with decreased secretion of the soluble WNT-antagonist SFRP4, in surgical specimen-derived DD myofibroblasts. These results highlight important pathways involved in the pathogenesis of fibrosis, including WNT signaling, extracellular matrix modulation, and inflammation. In addition, many associated loci contain genes that were hitherto unrecognized as playing a role in fibrosis, opening up new avenues of research that may lead to novel treatments for DD and fibrosis more generally. DD represents an ideal human model disease for fibrosis research.	[Ng, Michael; Thakkar, Dipti; Espirito-Santo, Ana Isabel; Izadi, David; Nanchahal, Jagdeep; Furniss, Dominic] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Windmill Rd, Oxford OX3 7HE, England; [Southam, Lorraine; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Southam, Lorraine] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Werker, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Plast Surg, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Ophoff, Roel] UCLA, Ctr Neurobehav Genet, 695 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Becker, Kerstin; Nothnagel, Michael; Nuernberg, Peter; Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, Weyertal 115b, D-50931 Cologne, Germany; [Becker, Kerstin; Nuernberg, Peter; Hennies, Hans Christian] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Franke, Andre] Christian Albrechts Univ Kiel, Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Hennies, Hans Christian] Univ Huddersfield, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Nanchahal, Jagdeep; Furniss, Dominic] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England; [Furniss, Dominic] Univ Oxford, NIHR Biomed Res Ctr, Botnar Res Ctr, NDORMS, Windmill Rd, Oxford OX3 7HE, England	University of Oxford; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Groningen; University of California System; University of California Los Angeles; University of Cologne; University of Cologne; University of Kiel; Schleswig Holstein University Hospital; University of Huddersfield; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Furniss, D (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Windmill Rd, Oxford OX3 7HE, England.; Furniss, D (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England.; Furniss, D (corresponding author), Univ Oxford, NIHR Biomed Res Ctr, Botnar Res Ctr, NDORMS, Windmill Rd, Oxford OX3 7HE, England.	dominic.furniss@ndorms.ox.ac.uk	Furniss, Dominic/AAH-4447-2019; Nothnagel, Michael/G-6545-2014; Nothnagel, Michael/L-7187-2019; Hennies, Hans C/G-9424-2014; Werker, Paul/L-6293-2019; Franke, Andre/B-2151-2010	Nothnagel, Michael/0000-0001-8305-7114; Hennies, Hans C/0000-0001-7210-2389; Franke, Andre/0000-0003-1530-5811; Nanchahal, Jagdeep/0000-0002-9579-9411	Wellcome Trust [097152/Z/11/Z, 098051]; NIHR Biomedical Research Centre, Oxford; Deutsche Forschungsgemeinschaft through the Cluster of Excellence on Cellular Stress Responses in Aging-associated Diseases at the University of Cologne [EXC229]; Koln Fortune Program of the Faculty of Medicine, University of Cologne; Economic and Social Research Council; Economic and Social Research Council [ES/H029745/1] Funding Source: researchfish; ESRC [ES/H029745/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Deutsche Forschungsgemeinschaft through the Cluster of Excellence on Cellular Stress Responses in Aging-associated Diseases at the University of Cologne; Koln Fortune Program of the Faculty of Medicine, University of Cologne; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We are grateful to all affected and control individuals who participated in the study. We thank Dr. William Rayner (Wellcome Trust Centre for Human Genetics, Oxford University) for the use of scripts and Dr. Hoffman (University of Freiburg) for ELISA reagents. We wish to thank the collaborators of the BSSH-GODD group, the GODDAF group, and the German Dupuytren Study Group for recruitment of case subjects, Dr. Mohammed R. Toliat (Koln) for support in genotype analysis, and Ramona Casper for technical assistance. D.F. is supported by an Intermediate Clinical Fellowship from the Wellcome Trust (097152/Z/11/Z). This work was supported by the NIHR Biomedical Research Centre, Oxford. K.B., P.N., and H.C.H. are supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence on Cellular Stress Responses in Aging-associated Diseases at the University of Cologne (EXC229) and the Koln Fortune Program of the Faculty of Medicine, University of Cologne. E.Z. and L.S. were supported by the Wellcome Trust (098051). The UK Household Longitudinal Study is led by the Institute for Social and Economic Research at the University of Essex and funded by the Economic and Social Research Council. The survey was conducted by NatCen and the genome-wide scan data were analyzed and deposited by the Wellcome Trust Sanger Institute. Information on how to access the data can be found on the Understanding Society website.	Bebbington E, 2015, J PLAST RECONSTR AES, V68, P243, DOI 10.1016/j.bjps.2014.10.011; Becker K, 2015, CLIN GENET, V87, P483, DOI 10.1111/cge.12410; Capstick R, 2013, J HAND SURG-EUR VOL, V38E, P424, DOI 10.1177/1753193412453359; Cruciat C. M., 2013, BIOL, V5, DOI DOI 10.1101/CSHPERSPECT.A015081; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; Dolmans GH, 2011, NEW ENGL J MED, V365, P307, DOI 10.1056/NEJMoa1101029; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gregorio-King CC, 2002, GENE, V286, P249, DOI 10.1016/S0378-1119(02)00434-1; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hart MG, 2005, POSTGRAD MED J, V81, P425, DOI 10.1136/pgmj.2004.027425; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hoffmann MM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0155-2; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Hutchinson JW, 1998, J BONE JOINT SURG BR, V80B, P907, DOI 10.1302/0301-620X.80B5.8464; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Johnston P, 2007, J HAND SURG-AM, V32A, P343, DOI 10.1016/j.jhsa.2006.12.010; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; Lanting R, 2013, PLAST RECONSTR SURG, V132, P394, DOI 10.1097/PRS.0b013e3182958a33; Larsen S, 2015, J HAND SURG-EUR VOL, V40, P171, DOI 10.1177/1753193414535720; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Li YP, 2015, J MED CHEM, V58, P3287, DOI 10.1021/jm5012319; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nanchahal J., 2017, WELLCOME OPEN RES, V2, P37; Nimmrich I, 2001, CANCER LETT, V165, P71, DOI 10.1016/S0304-3835(01)00390-1; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Olaso E, 2011, AM J PATHOL, V179, P2894, DOI 10.1016/j.ajpath.2011.09.002; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Shi CS, 2006, MOL CELL BIOL, V26, P6511, DOI 10.1128/MCB.00209-06; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Townley WA, 2006, BRIT MED J, V332, P397, DOI 10.1136/bmj.332.7538.397; van Rijssen AL, 2012, PLAST RECONSTR SURG, V129, P469, DOI 10.1097/PRS.0b013e31823aea95; Verjee LS, 2013, P NATL ACAD SCI USA, V110, pE928, DOI 10.1073/pnas.1301100110; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wilburn J, 2013, J HAND SURG-AM, V38A, P1209, DOI 10.1016/j.jhsa.2013.03.036; Wilkinson JM, 2012, BBA-MOL BASIS DIS, V1822, P897, DOI 10.1016/j.bbadis.2012.02.001; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Xu L, 2010, ARTHRITIS RHEUM-US, V62, P2736, DOI 10.1002/art.27582; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang C, 2004, CELL BIOL INT, V28, P863, DOI 10.1016/j.cellbi.2004.09.003	57	37	38	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					417	427		10.1016/j.ajhg.2017.08.006	http://dx.doi.org/10.1016/j.ajhg.2017.08.006			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28886342	hybrid, Green Published			2022-12-18	WOS:000409530900008
J	Watson, LM; Bamber, E; Schnekenberg, RP; Williams, J; Bettencourt, C; Lickiss, J; Fawcett, K; Clokie, S; Wallis, Y; Clouston, P; Sims, D; Houlden, H; Becker, EBE; Nemeth, AH				Watson, Lauren M.; Bamber, Elizabeth; Schnekenberg, Ricardo Parolin; Williams, Jonathan; Bettencourt, Conceicao; Lickiss, Jennifer; Fawcett, Katherine; Clokie, Samuel; Wallis, Yvonne; Clouston, Penny; Sims, David; Houlden, Henry; Becker, Esther B. E.; Nemeth, Andrea H.			Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; MICE LACKING MGLUR1; CEREBELLAR-ATAXIA; MOTOR COORDINATION; ACTIVATION; MODEL; ASSOCIATION; MECHANISMS; PHENOTYPE	The metabotropic glutamate receptor 1 (mGluR1) is abundantly expressed in the mammalian central nervous system, where it regulates intracellular calcium homeostasis in response to excitatory signaling. Here, we describe heterozygous dominant mutations in GRM1, which encodes mGluR1, that are associated with distinct disease phenotypes: gain-of-function missense mutations, linked in two different families to adult-onset cerebellar ataxia, and a de novo truncation mutation resulting in a dominant-negative effect that is associated with juvenile-onset ataxia and intellectual disability. Crucially, the gain-of-function mutations could be pharmacologically modulated in vitro using an existing FDA-approved drug, Nitazoxanide, suggesting a possible avenue for treatment, which is currently unavailable for ataxias.	[Watson, Lauren M.; Bamber, Elizabeth; Becker, Esther B. E.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Schnekenberg, Ricardo Parolin; Nemeth, Andrea H.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, 6th Floor West Wing, Oxford OX3 9DU, England; [Williams, Jonathan; Clouston, Penny] Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LE, England; [Bettencourt, Conceicao; Houlden, Henry] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Bettencourt, Conceicao] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Lickiss, Jennifer; Clokie, Samuel; Wallis, Yvonne] Birmingham Womens & Childrens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [Fawcett, Katherine; Sims, David] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Computat Genom Anal & Training Programme, Oxford OX3 9DS, England; [Nemeth, Andrea H.] Oxford Univ Hosp NHS Trust, Oxford Ctr Genom Med, Oxford OX3 7HE, England	University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of London; University College London; University of Oxford; Oxford University Hospitals NHS Foundation Trust	Becker, EBE (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England.; Nemeth, AH (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, 6th Floor West Wing, Oxford OX3 9DU, England.; Nemeth, AH (corresponding author), Oxford Univ Hosp NHS Trust, Oxford Ctr Genom Med, Oxford OX3 7HE, England.	esther.becker@dpag.ox.ac.uk; andrea.nemeth@ndcn.ox.ac.uk	Houlden, Henry J/C-1532-2008; Schnekenberg, Ricardo Parolin/M-1194-2013	Houlden, Henry J/0000-0002-2866-7777; Schnekenberg, Ricardo Parolin/0000-0002-3374-8483; Bettencourt, Conceicao/0000-0001-9090-7690; Nemeth, Andrea/0000-0002-2941-7657; Clokie, Samuel/0000-0002-0025-3652; Becker, Esther B E/0000-0002-5238-4902; Fawcett, Katherine/0000-0002-6675-2112	European Union [699978]; John Fell OUP Fund; Action Medical Research; Henry Smith Charity; CNPq (National Council for Scientific and Technological Development), Brazil; Medical Research Council (UK) Computational Genomics Analysis and Training programme [G1000902]; Wellcome Trust in Equipment and Strategic Award [WT093205MA, WT104033AIA]; MRC [MC_UP_1502/3] Funding Source: UKRI; Medical Research Council [MC_UP_1502/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Rosetrees Trust [M584] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish; Action Medical Research [2063] Funding Source: researchfish; Brain Research UK [UCCHoulden] Funding Source: researchfish	European Union(European Commission); John Fell OUP Fund; Action Medical Research; Henry Smith Charity; CNPq (National Council for Scientific and Technological Development), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Medical Research Council (UK) Computational Genomics Analysis and Training programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust in Equipment and Strategic Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; Action Medical Research; Brain Research UK	Supported by the European Union's Horizon 2020 research and innovation programme (under the Marie Sklodowska-Curie grant agreement number 699978) (this publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein) (L.M.W.), the John Fell OUP Fund (A.H.N., E.B.E.B., L.M.W.), Action Medical Research, the Henry Smith Charity (A.H.N.), CNPq (National Council for Scientific and Technological Development), Brazil (R.P.S.), the Medical Research Council (UK) Computational Genomics Analysis and Training programme (G1000902) (K.F., D.S.), and the Wellcome Trust in Equipment and Strategic Award (Synaptopathies) funding (WT093205MA and WT104033AIA) (C.B., H.H.). We thank Dr. Gilad Barnea for the kind gift of HTLA cells, Prof. Bryan Roth for the GRM1-Tango plasmid, Hannah Sleven for her contributions, and the affected individuals and their families for their support of this research.	Ai N, 2015, PHARM RES-DORDR, V32, P2798, DOI 10.1007/s11095-015-1665-7; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bhattacharyya S, 2016, INT J BIOCHEM CELL B, V77, P205, DOI 10.1016/j.biocel.2016.03.003; Brody SA, 2003, EUR J NEUROSCI, V18, P3361, DOI 10.1111/j.1460-9568.2003.03073.x; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Choe ES, 2001, MOL BRAIN RES, V94, P75, DOI 10.1016/S0169-328X(01)00217-0; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Conti V, 2006, INT J MOL MED, V18, P593; Coutelier M, 2015, NEUROLOGY, V84, P1751, DOI 10.1212/WNL.0000000000001524; CURTIS DR, 1959, NATURE, V183, P611, DOI 10.1038/183611a0; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; Fogel BL, 2015, MOVEMENT DISORD, V30, P284, DOI 10.1002/mds.26096; Guergueltcheva V, 2012, AM J HUM GENET, V91, P553, DOI 10.1016/j.ajhg.2012.07.019; Hartmann Jana, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a006726; Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kammermeier PJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-1; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Liu J, 2009, J NEUROSCI, V29, P9148, DOI 10.1523/JNEUROSCI.0660-09.2009; Lohse MJ, 2014, CURR OPIN CELL BIOL, V27, P87, DOI 10.1016/j.ceb.2013.11.009; Lum JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34391; Maier A, 2014, MUSCLE NERVE, V49, P289, DOI 10.1002/mus.24096; Maltecca F, 2015, J CLIN INVEST, V125, P263, DOI 10.1172/JCI74770; Meera P, 2016, J PHYSIOL-LONDON, V594, P4653, DOI 10.1113/JP271897; Mencacci NE, 2015, AM J HUM GENET, V96, P938, DOI 10.1016/j.ajhg.2015.04.008; Nicoletti F, 2015, CURR OPIN PHARMACOL, V20, P89, DOI 10.1016/j.coph.2014.12.002; Ohtani Y, 2014, J NEUROSCI, V34, P2702, DOI 10.1523/JNEUROSCI.3542-13.2014; Power EM, 2016, J PHYSIOL-LONDON, V594, P4643, DOI 10.1113/JP271153; Power EM, 2016, J NEUROSCI, V36, P4910, DOI 10.1523/JNEUROSCI.3953-15.2016; Rossi PIA, 2013, CEREB CORTEX, V23, P2179, DOI 10.1093/cercor/bhs200; Rossi PIA, 2010, J NEUROL, V257, P598, DOI 10.1007/s00415-009-5380-3; Schnekenberg RP, 2015, BRAIN, V138, P1817, DOI 10.1093/brain/awv117; Utine GE, 2013, J CHILD NEUROL, V28, P926, DOI 10.1177/0883073813484967; Van Schil K, 2015, GENET MED, V17, P291, DOI 10.1038/gim.2014.95; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	41	37	37	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					451	458		10.1016/j.ajhg.2017.08.005	http://dx.doi.org/10.1016/j.ajhg.2017.08.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28886343	Green Published, hybrid			2022-12-18	WOS:000409530900011
J	Santiago-Sim, T; Burrage, LC; Ebstein, F; Tokita, MJ; Miller, M; Bi, W; Braxton, AA; Rosenfeld, JA; Shahrour, M; Lehmann, A; Cogne, B; Kury, S; Besnard, T; Isidor, B; Bezieau, S; Hazart, I; Nagakura, H; Immken, LL; Littlejohn, RO; Roeder, E; Caglayan, SH; Kara, B; Hardies, K; Weckhuysen, S; May, P; Lemke, JR; Elpeleg, O; Abu-Libdeh, B; James, KN; Silhavy, JL; Issa, MY; Zaki, MS; Gleeson, JG; Seavitt, JR; Dickinson, ME; Ljungberg, MC; Wells, S; Johnson, SJ; Teboul, L; Eng, CM; Yang, YP; Kloetzel, PM; Heaney, JD; Walkiewicz, MA				Santiago-Sim, Teresa; Burrage, Lindsay C.; Ebstein, Frederic; Tokita, Mari J.; Miller, Marcus; Bi, Weimin; Braxton, Alicia A.; Rosenfeld, Jill A.; Shahrour, Maher; Lehmann, Andrea; Cogne, Benjamin; Kuery, Sebastien; Besnard, Thomas; Isidor, Bertrand; Bezieau, Stephane; Hazart, Isabelle; Nagakura, Honey; Immken, LaDonna L.; Littlejohn, Rebecca O.; Roeder, Elizabeth; Caglayan, S. Hande; Kara, Bulent; Hardies, Katia; Weckhuysen, Sarah; May, Patrick; Lemke, Johannes R.; Elpeleg, Orly; Abu-Libdeh, Bassam; James, Kiely N.; Silhavy, Jennifer L.; Issa, Mahmoud Y.; Zaki, Maha S.; Gleeson, Joseph G.; Seavitt, John R.; Dickinson, Mary E.; Ljungberg, M. Cecilia; Wells, Sara; Johnson, Sara J.; Teboul, Lydia; Eng, Christine M.; Yang, Yaping; Kloetzel, Peter-Michael; Heaney, Jason D.; Walkiewicz, Magdalena A.		EuroEPINOMICS RES Consortium Autos	Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UBIQUITIN LIGASE; IMMUNOPROTEASOME SUBUNIT; PROTEASOME; MUTATION; DYSFUNCTION; ACTIVATION; PATHWAY; DEFECT; GENE	Ubiquitination is a posttranslational modification that regulates many cellular processes including protein degradation, intracellular trafficking, cell signaling, and protein-protein interactions. Deubiquitinating enzymes (DUBs), which reverse the process of ubiquitination, are important regulators of the ubiquitin system. OTUD6B encodes a member of the ovarian tumor domain(OTU)-containing subfamily of deubiquitinating enzymes. Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features. In subjects with predicted loss-of-function alleles, additional features include global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans. Analysis of peripheral blood mononuclear cells from an affected subject showed reduced incorporation of 19S subunits into 26S proteasomes, decreased chymotrypsin-like activity, and accumulation of ubiquitin-protein conjugates. Our findings suggest a role for OTUD6B in proteasome function, establish that defective OTUD6B function underlies a multisystemic human disorder, and provide additional evidence for the emerging relationship between the ubiquitin system and human disease.	[Santiago-Sim, Teresa; Burrage, Lindsay C.; Tokita, Mari J.; Miller, Marcus; Bi, Weimin; Braxton, Alicia A.; Rosenfeld, Jill A.; Roeder, Elizabeth; Seavitt, John R.; Dickinson, Mary E.; Eng, Christine M.; Yang, Yaping; Heaney, Jason D.; Walkiewicz, Magdalena A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Santiago-Sim, Teresa; Tokita, Mari J.; Miller, Marcus; Bi, Weimin; Braxton, Alicia A.; Eng, Christine M.; Yang, Yaping; Walkiewicz, Magdalena A.] Baylor Coll Med, Baylor Miraca Genet Labs, Houston, TX 77021 USA; [Burrage, Lindsay C.] Texas Childrens Hosp, Houston, TX 77030 USA; [Ebstein, Frederic; Lehmann, Andrea; Kloetzel, Peter-Michael] Charite Univ Med Berlin, Inst Biochem, Charite Pl 1-Virchowweg 6, D-10117 Berlin, Germany; [Shahrour, Maher; Abu-Libdeh, Bassam] Makassed Hosp, Dept Pediat, Jerusalem 91220, Palestine; [Shahrour, Maher; Abu-Libdeh, Bassam] Al Quds Univ, Jerusalem 91220, Palestine; [Cogne, Benjamin; Kuery, Sebastien; Besnard, Thomas; Isidor, Bertrand; Bezieau, Stephane] CHU Nantes, Serv Genet Med, F-44093 Nantes 1, France; [Isidor, Bertrand] INSERM, UMR S957, 1 Rue Gaston Veil, F-44035 Nantes, France; [Hazart, Isabelle] CHU Nantes, Serv Pediat, F-44093 Nantes 1, France; [Nagakura, Honey] Specially Children, Austin, TX 78723 USA; [Littlejohn, Rebecca O.; Roeder, Elizabeth] Baylor Coll Med, Dept Pediat, San Antonio, TX 78207 USA; [Caglayan, S. Hande] Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; [Kara, Bulent] Kocaeli Univ Med Fac, Dept Pediat, TR-41380 Kocaeli, Turkey; [Hardies, Katia; Weckhuysen, Sarah] VIB, Ctr Mol Neurol, Neurogenet Grp, B-2610 Antwerp, Belgium; [Hardies, Katia; Weckhuysen, Sarah] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Weckhuysen, Sarah] Univ Antwerp Hosp, Div Neurol, B-2610 Antwerp, Belgium; [May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette 4362, Luxembourg; [Lemke, Johannes R.] Univ Leipzig Hosp & Clin, Inst Human Genet, D-04103 Leipzig, Germany; [Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [James, Kiely N.; Silhavy, Jennifer L.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Lab Pediat Brain Dis, San Diego, CA 92093 USA; [Issa, Mahmoud Y.; Zaki, Maha S.] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo 12311, Egypt; [Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Ljungberg, M. Cecilia] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Ljungberg, M. Cecilia] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wells, Sara; Johnson, Sara J.; Teboul, Lydia] Med Res Council Harwell, Mammalian Genet Unit, Harwell OX11 0RD, Oxfordshire, England; [Kloetzel, Peter-Michael] Berlin Inst Hlth, D-10117 Berlin, Germany; [Heaney, Jason D.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Baylor College of Medicine; Bogazici University; Kocaeli University; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Luxembourg; Leipzig University; Hebrew University of Jerusalem; Howard Hughes Medical Institute; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Baylor College of Medicine; Baylor College of Medicine; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Berlin Institute of Health; Baylor College of Medicine	Heaney, JD; Walkiewicz, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Walkiewicz, MA (corresponding author), Baylor Coll Med, Baylor Miraca Genet Labs, Houston, TX 77021 USA.; Heaney, JD (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	heaney@bcm.edu; mwalkiew@bcm.edu	Isidor, Bertrand/AAJ-3456-2021; Teboul, Lydia/P-2428-2019; Muhle, Hiltrud/F-5715-2010; KÜRY, Sébastien/G-5971-2015; May, Patrick/B-1238-2010; Zaki, Maha S/B-9361-2013; Caglayan, Hande S/A-2368-2016; BESNARD, Thomas/D-1329-2018; May, Patrick/N-1019-2019; , WaNgtJ/AAR-7045-2020; Craiu, Dana/ABE-4886-2020; Issa, Mahmoud/AAL-5118-2020; Besnard, Thomas/L-2303-2019; Weckhuysen, Sarah/HGB-9957-2022; Baulac, Stéphanie/O-2099-2016; Marini, Carla/AAC-2413-2022; Zara, Federico/U-3477-2017	Isidor, Bertrand/0000-0001-6480-126X; Teboul, Lydia/0000-0002-2789-8637; KÜRY, Sébastien/0000-0001-5497-0465; May, Patrick/0000-0001-8698-3770; Caglayan, Hande S/0000-0001-6402-3306; BESNARD, Thomas/0000-0003-4804-5147; May, Patrick/0000-0001-8698-3770; Issa, Mahmoud/0000-0002-3899-2821; Besnard, Thomas/0000-0003-4804-5147; Weckhuysen, Sarah/0000-0003-2878-1147; Baulac, Stéphanie/0000-0001-6430-4693; Marini, Carla/0000-0002-9212-2691; Zaki, Maha/0000-0001-7840-0002; Johnson, Sara/0000-0001-6308-6401; Guerrini, Renzo/0000-0002-7272-7079; Klein, Karl Martin/0000-0002-6654-1665; Moller, Rikke S./0000-0002-9664-1448; Suls, Arvid/0000-0003-0328-198X; Serratosa, Jose/0000-0003-2239-8948; Balling, Rudi/0000-0003-2902-5650; Zara, Federico/0000-0001-9744-5222	NIH [K08DK106453, U42OD011174, U54HG006348, T32GM007526-39]; Trudy Mandel Louis Charitable Trust; International Coordination Action grant [G0E8614N]; Eurocores program of the European Science Foundation [G.A.136.11.N, HE5415/3-1]; TUBITAK within Euroepinomics-RES network [110S518]; Family Genomics group at the Institute for Systems Biology; MRC [MC_UP_1502/3] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348, UM1HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK106453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011174] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1502/3] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trudy Mandel Louis Charitable Trust; International Coordination Action grant; Eurocores program of the European Science Foundation; TUBITAK within Euroepinomics-RES network(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Family Genomics group at the Institute for Systems Biology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the subjects and their families for participating in our research study. This work was supported by NIH K08DK106453 (L.C.B.), NIH U42OD011174 and NIH U54HG006348 (J.D.H., M.E.D., J.R.S., S. Wells, S.J.J., L.T.), NIH T32GM007526-39 (M.J.T.), the Trudy Mandel Louis Charitable Trust (O.E.), and the International Coordination Action grant G0E8614N (S. Weckhuysen, K.H.). The Eurocores program of the European Science Foundation supported the EuroEPINOMICS-RES network (G.A.136.11.N, FWO/ESF-ECRP, and HE5415/3-1). S.H. Caglayan is granted by the TUBITAK project no 110S518 within the Euroepinomics-RES network. The Family Genomics group at the Institute for Systems Biology deserves thanks for their support and project management of the whole-genome sequencing data (family 6). We acknowledge the contribution of Peter De Rijk (University of Antwerp) and the HPC facilities of the University of Luxembourg for computational support. The Department of Molecular and Human Genetics at the Baylor College of Medicine derives revenue from molecular genetic testing offered at the Baylor Miraca Genetics Laboratories. Since mid-October 2015, K.H. is underemployment of UCB Pharma (Braine-l'Alleud, Belgium). The company had no part in this study.	Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Brehm A, 2015, J CLIN INVEST, V125, P4196, DOI 10.1172/JCI81260; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Cohen-Kaplan V, 2016, P NATL ACAD SCI USA, V113, pE7490, DOI 10.1073/pnas.1615455113; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Geetha TS, 2014, HUM MUTAT, V35, P41, DOI 10.1002/humu.22453; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kunimoto K, 2013, DERMATOLOGY, V227, P26, DOI 10.1159/000351323; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tomaic V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.572; Xu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014514; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	38	37	40	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					676	688		10.1016/j.ajhg.2017.03.001	http://dx.doi.org/10.1016/j.ajhg.2017.03.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28343629	Bronze, Green Published			2022-12-18	WOS:000398389600010
J	Oud, MM; Tuijnenburg, P; Hempel, M; van Vlies, N; Ren, ZM; Ferdinandusse, S; Jansen, MH; Santer, R; Johannsen, J; Bacchelli, C; Alders, M; Li, R; Davies, R; Dupuis, L; Cale, CM; Wanders, RJA; Pals, ST; Ocaka, L; James, C; Muller, I; Lehmberg, K; Strom, T; Engels, H; Williams, HJ; Beales, P; Roepmand, R; Dias, P; Brunner, HG; Cobben, JM; Hall, C; Hartley, T; Stabej, PL; Mendoza-Londono, R; Davies, EG; de Sousa, SB; Lesse, D; Arts, HH; Kuijpers, TW				Oud, Machteld M.; Tuijnenburg, Paul; Hempel, Maja; van Vlies, Naomi; Ren, Zemin; Ferdinandusse, Sacha; Jansen, Machiel H.; Santer, Rene; Johannsen, Jessika; Bacchelli, Chiara; Alders, MarieIle; Li, Rui; Davies, Rosalind; Dupuis, Lucie; Cale, Catherine M.; Wanders, Ronald J. A.; Pals, Steven T.; Ocaka, Louise; James, Chela; Mueller, Ingo; Lehmberg, Kai; Strom, Tim; Engels, Hartmut; Williams, Hywel J.; Beales, Phil; Roepmand, Ronald; Dias, Patricia; Brunner, Han G.; Cobben, Jan-Maarten; Hall, Christine; Hartley, Taila; Stabej, Polona Le Quesne; Mendoza-Londono, Roberto; Davies, E. Graham; de Sousa, Sergio B.; Lesse, Davor; Arts, Heleen H.; Kuijpers, Taco W.			Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TUMOR SUPPRESSORS EXT1; COPY-NUMBER VARIATION; EXOME SEQUENCE DATA; DE-NOVO MUTATIONS; GENE; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; MORPHOGENESIS	EXTL3 regulates the biosynthesis of heparan sulfate (HS), important for both skeletal development and hematopoiesis, through the formation of HS proteoglycans (HSPGs). By whole-exome sequencing, we identified homozygous missense mutations c.1382C>T, c.1537C>T, c.1970A>G, and c.2008T>G in EXTL3 in nine affected individuals from five unrelated families. Notably, we found the identical homozygous missense mutation c.1382C>T (p.Pro461Leu) in four affected individuals from two unrelated families. Affected individuals presented with variable skeletal abnormalities and neurodevelopmental defects. Severe combined immunodeficiency (SCID) with a complete absence of T cells was observed in three families. EXTL3 was most abundant in hematopoietic stem cells and early progenitor T cells, which is in line with a SCID phenotype at the level of early T cell development in the thymus. To provide further support for the hypothesis that mutations in EXTL3 cause a neuro-immuno-skeletal dysplasia syndrome, and to gain insight into the pathogenesis of the disorder, we analyzed the localization of EXTL3 in fibroblasts derived from affected individuals and determined glycosaminoglycan concentrations in these cells as well as in urine and blood. We observed abnormal glycosaminoglycan concentrations and increased concentrations of the non-sulfated chondroitin disaccharide D0a0 and the disaccharide D0a4 in serum and urine of all analyzed affected individuals. In summary, we show that biallelic mutations in EXTL3 disturb glycosaminoglycan synthesis and thus lead to a recognizable syndrome characterized by variable expression of skeletal, neurological, and immunological abnormalities.	[Oud, Machteld M.; Roepmand, Ronald; Brunner, Han G.; Arts, Heleen H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Radboud Inst Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Tuijnenburg, Paul; Jansen, Machiel H.; Kuijpers, Taco W.] Acad Med Ctr, Dept Expt Immunol, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Tuijnenburg, Paul; Jansen, Machiel H.] Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Hempel, Maja; Lesse, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [van Vlies, Naomi; Ferdinandusse, Sacha; Wanders, Ronald J. A.] Acad Med Ctr, Lab Genet Metab Dis, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Ren, Zemin; Pals, Steven T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Santer, Rene; Johannsen, Jessika] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Bacchelli, Chiara; Davies, Rosalind; Ocaka, Louise; James, Chela; Williams, Hywel J.; Beales, Phil; Stabej, Polona Le Quesne; Davies, E. Graham; de Sousa, Sergio B.] UCL, COSgene, Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Alders, MarieIle] Univ Amsterdam, Dept Clin Genet, Acad Med Ctr, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Li, Rui] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Li, Rui] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Li, Rui] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Dupuis, Lucie; Mendoza-Londono, Roberto] Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Dupuis, Lucie; Mendoza-Londono, Roberto] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Cale, Catherine M.; Davies, E. Graham] Great Ormond St Hosp Sick Children, Dept Immunol, London WC1N 3JH, England; [Mueller, Ingo; Lehmberg, Kai] Univ Med Ctr Hamburg Eppendorf, Div Pediat Stem Cell Transplantat & Immunol, D-20246 Hamburg, Germany; [Strom, Tim] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Engels, Hartmut] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Dias, Patricia] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Ctr Acad Med Lisboa, Serv Genet,Dept Pediat, P-1640035 Lisbon, Portugal; [Cobben, Jan-Maarten] Univ Hosp, Dept Pediat, Acad Med Ctr, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Cobben, Jan-Maarten] St Georges Univ Hosp, Dept Clin Genet, London SW19 0ER, England; [Hall, Christine] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England; [Hartley, Taila] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [de Sousa, Sergio B.] Ctr Hosp & Univ Coimbra, Med Genet Unit, Hosp Pediat, P-3000602 Coimbra, Portugal; [de Sousa, Sergio B.] Univ Beira Interior, Fac Hlth Sci, P-6200506 Covilha, Portugal; [Arts, Heleen H.] McMaster Univ, Dept Pathol & Mol Med, Med Ctr, Hamilton, ON L8S 4J9, Canada	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bonn; Universidade de Lisboa; Hospital Santa Maria; University of Amsterdam; Academic Medical Center Amsterdam; St Georges University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Ottawa; Children's Hospital of Eastern Ontario; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade da Beira Interior; McMaster University	Oud, MM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Radboud Inst Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.; Kuijpers, TW (corresponding author), Acad Med Ctr, Dept Expt Immunol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	machteld.oud@radboudumc.nl; t.w.kuijpers@amc.uva.nl	Roepman, Ronald/B-1339-2014; Oud, Machteld/P-6939-2015; Müller, Ingo/AAW-9025-2021; Williams, Hywel/AAL-2440-2021; Dias, Patrícia/HGT-6805-2022; Oud, Machteld/S-9062-2019; Lessel, Davor/ABD-6088-2021; arts, heleen/ACL-6040-2022	Roepman, Ronald/0000-0002-5178-8163; Oud, Machteld/0000-0003-4864-9346; Müller, Ingo/0000-0002-7477-6632; Williams, Hywel/0000-0001-7758-0312; Arts, Heleen/0000-0002-9860-3744; Le Quesne Stabej, Polona/0000-0002-9436-5857; Pals, Steven/0000-0002-1419-0939; Li, Rui/0000-0001-8353-6772; Lessel, Davor/0000-0003-4496-244X; Ferdinandusse, Sacha/0000-0002-7738-5709; james, chela/0000-0003-3996-0909	Dutch Kidney Foundation (KOUNCIL consortium) [CP11.18]; Netherlands Organization for Health Research and Development (ZonMW) [Veni-91613008]; Netherlands Organization for Scientific Research (NWO) [Vici-865.12.005]; Center of Immunodeficiencies Amsterdam; Fundacao para a Ciencia e Tecnologia [SFRH/BD/46778/2008]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; NIHR BRC; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; BBSRC [BB/M020991/1] Funding Source: UKRI; MRC [G0801843] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M020991/1] Funding Source: researchfish; Medical Research Council [G0801843] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10008] Funding Source: researchfish; The British Council [216377911] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1296] Funding Source: researchfish	Dutch Kidney Foundation (KOUNCIL consortium); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center of Immunodeficiencies Amsterdam; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; NIHR BRC; Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The British Council; Great Ormond Street Hospital Childrens Charity	We thank the families for participating in our study; all members of the clinical teams involved in the care of the described families; D. Braun, J. Lawson, and Dr. Hildebrandt for their screening effort; Dr. P. Meinecke for reviewing the X-rays; Dr. Dulce Quelhas and Dr. Lisa Woodbine for providing fibroblasts of affected individuals; Hanka Venselaar for helping with protein prediction models; and the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. This study was partly funded by the Dutch Kidney Foundation (KOUNCIL consortium project CP11.18 to H.H.A.), Netherlands Organization for Health Research and Development (ZonMW Veni-91613008 to H.H.A.), Netherlands Organization for Scientific Research (NWO Vici-865.12.005 to R.R.), Center of Immunodeficiencies Amsterdam, and Fundacao para a Ciencia e Tecnologia (SFRH/BD/46778/2008). GOSgene at the University College London (UCL) Institute of Child Health is supported by the National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Institute of Child Health. This report is of independent research by the NIHR BRC Funding Scheme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. Analysis of family C was performed by the Care4Rare Canada Consortium, funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children's Hospital of Eastern Ontario Foundation.	aan de Kerk DJ, 2013, J IMMUNOL, V190, P5012, DOI 10.4049/jimmunol.1201807; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bousfiha A, 2015, J CLIN IMMUNOL, V35, P727, DOI 10.1007/s10875-015-0198-5; BRUNO E, 1995, EXP HEMATOL, V23, P1212; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; de Ligt J, 2013, HUM MUTAT, V34, P1439, DOI 10.1002/humu.22387; Engels H, 2009, EUR J HUM GENET, V17, P1592, DOI 10.1038/ejhg.2009.90; Farhan SMK, 2015, J MED GENET, V52, P666, DOI 10.1136/jmedgenet-2015-103279; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Fromer M, 2014, CURR PROTOC HUM GENE, V81, DOI DOI 10.1002/0471142905.HG0723S81; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Izumikawa T, 2006, J BIOL CHEM, V281, P1929, DOI 10.1074/jbc.M509138200; Kaidonis X, 2010, EUR J HUM GENET, V18, P194, DOI 10.1038/ejhg.2009.143; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kingma SDK, 2014, J INHERIT METAB DIS, V37, P813, DOI 10.1007/s10545-014-9703-x; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kuijpers TW, 2013, HAEMATOLOGICA, V98, P1030, DOI 10.3324/haematol.2012.077511; Langereis EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138622; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mendoza-Londono R, 2015, AM J HUM GENET, V96, P979, DOI 10.1016/j.ajhg.2015.04.021; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; PETERSON HA, 1989, CLIN ORTHOP RELAT R, P222; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Srour M, 2015, AM J HUM GENET, V97, P744, DOI 10.1016/j.ajhg.2015.09.009; Stabej PL, 2016, EUR J HUM GENET, V24, P135, DOI 10.1038/ejhg.2015.107; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909	50	37	40	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					281	296		10.1016/j.ajhg.2017.01.013	http://dx.doi.org/10.1016/j.ajhg.2017.01.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132690	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000393352000009
J	Ait-El-Mkadem, S; Dayem-Quere, M; Gusic, M; Chaussenot, A; Bannwarth, S; Francois, B; Genin, EC; Fragaki, K; Volker-Touw, CLM; Vasnier, C; Serre, V; van Gassen, KLI; Lespinasse, F; Richter, S; Eisenhofer, G; Rouzier, C; Mochel, F; De Saint-Martin, A; Warde, MTA; de Sain-van der Velde, MGM; Jans, JJM; Amiel, J; Avsec, Z; Mertes, C; Haack, TB; Strom, T; Meitinger, T; Bonnen, PE; Taylor, RW; Gagneur, J; van Hasselt, PM; Rotig, A; Delahodde, A; Prokisch, H; Fuchs, SA; Paquis-Flucklinger, V				Ait-El-Mkadem, Samira; Dayem-Quere, Manal; Gusic, Mirjana; Chaussenot, Annabelle; Bannwarth, Sylvie; Francois, Berengere; Genin, Emmanuelle C.; Fragaki, Konstantina; Volker-Touw, Catharina L. M.; Vasnier, Christelle; Serre, Valerie; van Gassen, Koen L. I.; Lespinasse, Francoise; Richter, Susan; Eisenhofer, Graeme; Rouzier, Cecile; Mochel, Fanny; De Saint-Martin, Anne; Warde, Marie-Therese Abi; de Sain-van der Velde, Monique G. M.; Jans, Judith J. M.; Amiel, Jeanne; Avsec, Ziga; Mertes, Christian; Haack, Tobias B.; Strom, Tim; Meitinger, Thomas; Bonnen, Penelope E.; Taylor, Robert W.; Gagneur, Julien; van Hasselt, Peter M.; Rotig, Agnes; Delahodde, Agnes; Prokisch, Holger; Fuchs, Sabine A.; Paquis-Flucklinger, Veronique			Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX II DEFICIENCY; FUMARASE DEFICIENCY; MITOCHONDRIAL; EPILEPSY; DEFECTS; GENE; CHILDREN; SDHD	MDH2 encodes mitochondrial malate dehydrogenase (MDH), which is essential for the conversion of malate to oxaloacetate as part of the proper functioning of the Krebs cycle. We report bi-allelic pathogenic mutations in MDH2 in three unrelated subjects presenting with early-onset generalized hypotonia, psychomotor delay, refractory epilepsy, and elevated lactate in the blood and cerebrospinal fluid. Functional studies in fibroblasts from affected subjects showed both an apparently complete loss of MDH2 levels and MDH2 enzymatic activity close to null. Metabolomics analyses demonstrated a significant concomitant accumulation of the MDH substrate, malate, and fumarate, its immediate precursor in the Krebs cycle, in affected subjects' fibroblasts. Lentiviral complementation with wild-type MDH2 cDNA restored MDH2 levels and mitochondrial MDH activity. Additionally, introduction of the three missense mutations from the affected subjects into Saccharomyces cerevisiae provided functional evidence to support their pathogenicity. Disruption of the Krebs cycle is a hallmark of cancer, and MDH2 has been recently identified as a novel pheochromocytoma and paraganglioma susceptibility gene. We show that loss-of-function mutations in MDH2 are also associated with severe neurological clinical presentations in children.	[Ait-El-Mkadem, Samira; Dayem-Quere, Manal; Chaussenot, Annabelle; Bannwarth, Sylvie; Fragaki, Konstantina; Rouzier, Cecile; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, F-06202 Nice, France; [Ait-El-Mkadem, Samira; Dayem-Quere, Manal; Chaussenot, Annabelle; Bannwarth, Sylvie; Francois, Berengere; Genin, Emmanuelle C.; Fragaki, Konstantina; Lespinasse, Francoise; Rouzier, Cecile; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, CNRS UMR 7284, INSERM U1081, Inst Res Canc & Aging, F-06107 Nice, France; [Gusic, Mirjana; Haack, Tobias B.; Strom, Tim; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Gusic, Mirjana; Haack, Tobias B.; Strom, Tim; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Volker-Touw, Catharina L. M.; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Genet, NL-3584 Utrecht, Netherlands; [Vasnier, Christelle; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CNRS, Commissariat Energie Atom & Energies Alternat,I2B, F-91198 Gif Sur Yvette, France; [Serre, Valerie] Paris Diderot Univ, Inst Jacques Monod, CNRS UMR 7592, F-75205 Paris, France; [Richter, Susan; Eisenhofer, Graeme] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Med Fac Carl Gustav Carus, Inst Clin Chem & Lab Med, Fetscherstr 74, D-01307 Dresden, Germany; [Mochel, Fanny] Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, Pitie Salpetriere Univ Hosp,CNRS UMR 7225,UMR S11, Inst Cerveau & Moelle Epiniere,Dept Genet,INSERM, F-75013 Paris, France; [De Saint-Martin, Anne; Warde, Marie-Therese Abi] Ctr Hosp Univ Strasbourg, Ctr Reference Epilepsies Rares, Serv Neurol Pediat, F-67098 Strasbourg, France; [de Sain-van der Velde, Monique G. M.; Jans, Judith J. M.; Fuchs, Sabine A.] Univ Med Ctr Utrecht, Lab Metab Dis, NL-3584 Utrecht, Netherlands; [Amiel, Jeanne] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Avsec, Ziga; Mertes, Christian; Gagneur, Julien] Tech Univ Munich, Dept Informat, D-85748 Garching, Germany; [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [van Hasselt, Peter M.] Univ Med Ctr Utrecht, Dept Metab Dis, NL-3584 Utrecht, Netherlands; [Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, INSERM U1163, F-75015 Paris, France	CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Utrecht University; Utrecht University Medical Center; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich; Baylor College of Medicine; Newcastle University - UK; Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Paquis-Flucklinger, V (corresponding author), Nice Teaching Hosp, Natl Ctr Mitochondrial Dis, Dept Med Genet, F-06202 Nice, France.; Paquis-Flucklinger, V (corresponding author), Univ Nice Sophia Antipolis, CNRS UMR 7284, INSERM U1081, Inst Res Canc & Aging, F-06107 Nice, France.	paquis@hermes.unice.fr	amiel, jeanne/H-3501-2017; Rötig, Agnès/G-9592-2017; Eisenhofer, Graeme/AAU-9829-2021; Meitinger, Thomas/O-1318-2015; amiel, jeanne/AGX-1124-2022; Richter, Susan/AAP-1767-2020	amiel, jeanne/0000-0001-5973-4728; Rötig, Agnès/0000-0003-0589-0703; Eisenhofer, Graeme/0000-0002-8601-9903; Richter, Susan/0000-0002-3549-2477; van Gassen, Koen/0000-0001-7934-0662; Prokisch, Holger/0000-0003-2379-6286; Mertes, Christian/0000-0002-1091-205X; Meitinger, Thomas/0000-0002-8838-8403; LESPINASSE, francoise/0000-0001-7710-0649; Jans, Judith/0000-0003-0960-6263; Serre, Valerie/0000-0001-5277-1120; Gagneur, Julien/0000-0002-8924-8365; Gusic, Mirjana/0000-0002-9350-291X; Genin, Emmanuelle C./0000-0003-3039-7101; DE SAINT-MARTIN, ANNE/0000-0003-4666-5369	Fondation pour la Recherche Medicale; Fondation Maladies Rares; German Bundesministerium fur Bildung and Forschung (BMBF) through the E-Rare project GENOMIT [01GM1603]; BMBF through the Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; EU FP7 Mitochondrial European Educational Training Project [317433]; EU Horizon2020 Collaborative Research Project SOUND [633974]; Wellcome Trust Strategic Award [096919/Z/11/Z]; Medical Research Council Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; NIH National Institute of Neurological Disorders and Stroke [R01NS083726]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083726] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Maladies Rares; German Bundesministerium fur Bildung and Forschung (BMBF) through the E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); BMBF through the Juniorverbund in der Systemmedizin "mitOmics"(Federal Ministry of Education & Research (BMBF)); EU FP7 Mitochondrial European Educational Training Project; EU Horizon2020 Collaborative Research Project SOUND; Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge Charlotte Cochaud and Pascal Colosetti for technical help, Hiromi Sesaki for providing the lentiviral vectors, and Mercedes Robledo for helpful discussion. We also thank the Pasteur-IRCAN Cellular and Molecular Imaging platform. This work was made possible by grants from the Fondation pour la Recherche Medicale and Fondation Maladies Rares to V.P.-F. This study was supported by the German Bundesministerium fur Bildung and Forschung (BMBF) through the E-Rare project GENOMIT (01GM1603 to H.P. and A.R.). T.B.H. and J.G. were supported by the BMBF through the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C). H.P. was supported by the EU FP7 Mitochondrial European Educational Training Project (317433) and, together with J.G., by the EU Horizon2020 Collaborative Research Project SOUND (633974). R.W.T. was supported by a Wellcome Trust Strategic Award (096919/Z/11/Z), the Medical Research Council Centre for Neuromuscular Diseases (G0601943), the Lily Foundation, and the UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne. P.E.B. was supported by the NIH National Institute of Neurological Disorders and Stroke (R01NS083726).	Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Bayley JP, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-20; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cascon A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv053; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932; Jochmanova I, 2015, HORM CANCER-US, V6, P191, DOI 10.1007/s12672-015-0231-4; Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x; Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737; Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438; Ottolenghi C, 2011, HUM MUTAT, V32, P1046, DOI 10.1002/humu.21534; Pasca L, 2016, EUR J PEDIATR, V175, P1267, DOI 10.1007/s00431-016-2765-z; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414	24	37	41	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					151	159		10.1016/j.ajhg.2016.11.014	http://dx.doi.org/10.1016/j.ajhg.2016.11.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27989324	Green Published, hybrid			2022-12-18	WOS:000391910500013
J	Vince, N; Li, HC; Ramsuran, V; Naranbhai, V; Duh, FM; Fairfax, BP; Saleh, B; Knight, JC; Anderson, SK; Carrington, M				Vince, Nicolas; Li, Hongchuan; Ramsuran, Veron; Naranbhai, Vivek; Duh, Fuh-Mei; Fairfax, Benjamin P.; Saleh, Bahara; Knight, Julian C.; Anderson, Stephen K.; Carrington, Mary			HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; OCTAMER MOTIF; IMMUNOGLOBULIN; PROTEINS; ACTIVATION; INDUCTION; REVEALS	Differential HLA-C levels influence several human diseases, but the mechanisms responsible are incompletely characterized. Using a validated prediction algorithm, we imputed HLA-C cell surface levels in 228 individuals from the 1000 Genomes dataset. We tested 68,726 SNPs within the MHC for association with HLA-C level. The HLA-C promoter region variant, rs2395471, 800 bp upstream of the transcription start site, gave the most significant association with HLA-C levels (p = 4.2 x 10(-66)). This imputed expression quantitative trait locus, termed impeQTL, was also shown to associate with HLA-C expression in a genome-wide association study of 273 donors in which HLA-C mRNA expression levels were determined by quantitative PCR (qPCR) (p = 1.8 x 10(-20)) and in two cohorts where HLA-C cell surface levels were determined directly by flow cytometry (n = 369 combined, p < 10(-15)). rs2395471 is located in an Oct1 transcription factor consensus binding site motif where the A allele is predicted to have higher affinity for Oct1 than the G allele. Mobility shift electrophoresis demonstrated that Oct1 binds to both alleles in vitro, but decreased HLA-C promoter activity was observed in a luciferase reporter assay for rs2395471_G relative to rs2395471_A on a fixed promoter background. The rs2395471 variant accounts for up to 36% of the explained variation of HLA-C level. These data strengthen our understanding of HLA-C transcriptional regulation and provide a basis for understanding the potential consequences of manipulating HLA-C levels therapeutically.	[Vince, Nicolas; Li, Hongchuan; Ramsuran, Veron; Duh, Fuh-Mei; Saleh, Bahara; Anderson, Stephen K.; Carrington, Mary] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Vince, Nicolas; Ramsuran, Veron; Naranbhai, Vivek; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Naranbhai, Vivek; Fairfax, Benjamin P.; Knight, Julian C.] Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford OX3 7BN, England; [Naranbhai, Vivek] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, ZA-4091 Durban, South Africa	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Kwazulu Natal	Carrington, M (corresponding author), Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.; Carrington, M (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	carringm@mail.nih.gov	Vince, Nicolas/K-5882-2019; Knight, Julian Charles/W-2399-2019; Anderson, Stephen K/B-1727-2012	Vince, Nicolas/0000-0002-3767-6210; Knight, Julian Charles/0000-0002-0377-5536; Anderson, Stephen K/0000-0002-7856-4266; Fairfax, Benjamin/0000-0001-7413-5002; Ramsuran, Veron/0000-0003-1590-9893	Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the NIH; Frederick National Lab; Center for Cancer Research; European Research Council [281824]; NIHR Oxford Biomedical Research Centre; Wellcome Trust [090532/Z/09/Z, 074318, 088891]; European Research Council under the European Union [281824]; Medical Research Council [98082]; Rhodes Trust; MRC [G1001708] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL13-Fairfax] Funding Source: researchfish; Medical Research Council [G1001708] Funding Source: researchfish; National Institute for Health Research [CL-2012-13-004] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010792] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Lab; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council(European Research Council (ERC)European Commission); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); European Research Council under the European Union(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rhodes Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the Frederick National Laboratory for Cancer Research, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research. J.C.K. is supported by European Research Council funding (grant agreement no. 281824) and the NIHR Oxford Biomedical Research Centre and Wellcome Trust (core facilities grant 090532/Z/09/Z). The Oxford cohort was supported by the Wellcome Trust (grants 074318 [J.C.K.], 088891 [B.P.F.], and 090532/Z/09/Z [core facilities Wellcome Trust Centre for Human Genetics including High-Throughput Genomics Group]), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 281824 (J.C.K.), the Medical Research Council (98082 [J.C.K]), and the NIHR Oxford Biomedical Research Centre. V.N. was supported by the Rhodes Trust.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apps R, 2015, J IMMUNOL, V194, P3594, DOI 10.4049/jimmunol.1403234; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Draper N. R., 1998, APPL REGRESSION ANAL, V326; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferraris L, 2011, GENOME RES, V21, P1055, DOI 10.1101/gr.115824.110; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Grabe Niels, 2002, In Silico Biology, V2, pS1; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Hwang SS, 2016, BBA-GENE REGUL MECH, V1859, P825, DOI 10.1016/j.bbagrm.2016.04.006; Jeong SH, 2014, TUMOR BIOL, V35, P5501, DOI 10.1007/s13277-014-1724-4; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; KIM MH, 1995, J VIROL, V69, P4717, DOI 10.1128/JVI.69.8.4717-4726.1995; Kim YM, 1999, MOL CELLS, V9, P99; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Li H, 2016, GENES IMMUN, V17, P66, DOI 10.1038/gene.2015.56; Pance A, 2016, BBA-GENE REGUL MECH, V1859, P820, DOI 10.1016/j.bbagrm.2016.04.003; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; Vazquez-Arreguin K, 2016, BBA-GENE REGUL MECH, V1859, P792, DOI 10.1016/j.bbagrm.2016.02.007; Wang J, 2010, MED ONCOL, V27, P219, DOI 10.1007/s12032-009-9194-z; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Xie QW, 1997, J BIOL CHEM, V272, P14867, DOI 10.1074/jbc.272.23.14867	40	37	37	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1353	1358		10.1016/j.ajhg.2016.09.023	http://dx.doi.org/10.1016/j.ajhg.2016.09.023			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27817866	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000389148600010
J	Di Donato, N; Jean, YY; Maga, AM; Krewson, BD; Shupp, AB; Avrutsky, MI; Roy, A; Collins, S; Olds, C; Willert, RA; Czaja, AM; Johnson, R; Stover, JA; Gottlieb, S; Bartholdi, D; Rauch, A; Goldstein, A; Boyd-Kyle, V; Aldinger, KA; Mirzaa, GM; Nissen, A; Brigatti, KW; Puffenberger, EG; Millen, KJ; Strauss, KA; Dobyns, WB; Troy, CM; Jinks, RN				Di Donato, Nataliya; Jean, Ying Y.; Maga, A. Murat; Krewson, Briana D.; Shupp, Alison B.; Avrutsky, Maria I.; Roy, Achira; Collins, Sarah; Olds, Carissa; Willert, Rebecca A.; Czaja, Agnieszka M.; Johnson, Rachel; Stover, Jessi A.; Gottlieb, Steven; Bartholdi, Deborah; Rauch, Anita; Goldstein, Amy; Boyd-Kyle, Victoria; Aldinger, Kimberly A.; Mirzaa, Ghayda M.; Nissen, Anke; Brigatti, Karlla W.; Puffenberger, Erik G.; Millen, Kathleen J.; Strauss, Kevin A.; Dobyns, William B.; Troy, Carol M.; Jinks, Robert N.			Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR INVERSION PROBES; TROPHIC FACTOR WITHDRAWAL; HUMAN CEREBRAL-CORTEX; SYMPATHETIC NEURONS; CASPASE ACTIVATION; PC12 CELLS; BRAIN; DEATH; PROTEIN; PIDDOSOME	Lissencephaly is a malformation of cortical development typically caused by deficient neuronal migration resulting in cortical thickening and reduced gyration. Here we describe a "thin" lissencephaly (TLIS) variant characterized by megalencephaly, frontal predominant pachygyria, intellectual disability, and seizures. Trio-based whole-exome sequencing and targeted re-sequencing identified recessive mutations of CRADD in six individuals with TLIS from four unrelated families of diverse ethnic backgrounds. CRADD (also known as RAIDD) is a death-domain-containing adaptor protein that oligomerizes with PIDD and caspase-2 to initiate apoptosis. TLIS variants cluster in the CRADD death domain, a platform for interaction with other death-domain-containing proteins including PIDD. Although caspase-2 is expressed in the developing mammalian brain, little is known about its role in cortical development. CRADD/caspase-2 signaling is implicated in neurotrophic factor withdrawal- and amyloid-beta-induced dendritic spine collapse and neuronal apoptosis, suggesting a role in cortical sculpting and plasticity. TLIS-associated CRADD variants do not disrupt interactions with caspase-2 or PIDD in co-immunoprecipitation assays, but still abolish CRADD's ability to activate caspase-2, resulting in reduced neuronal apoptosis in vitro. Homozygous Cradd knockout mice display megalencephaly and seizures without obvious defects in cortical lamination, supporting a role for CRADD/caspase-2 signaling in mammalian brain development. Megalencephaly and lissencephaly associated with defective programmed cell death from loss of CRADD function in humans implicate reduced apoptosis as an important pathophysiological mechanism of cortical malformation. Our data suggest that CRADD/caspase-2 signaling is critical for normal gyration of the developing human neocortex and for normal cognitive ability.	[Di Donato, Nataliya] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-01307 Dresden, Germany; [Di Donato, Nataliya; Roy, Achira; Collins, Sarah; Olds, Carissa; Aldinger, Kimberly A.; Mirzaa, Ghayda M.; Millen, Kathleen J.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Jean, Ying Y.; Avrutsky, Maria I.; Troy, Carol M.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Maga, A. Murat] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98105 USA; [Maga, A. Murat] Univ Washington, Div Craniofacial Med, Dept Pediat, Seattle, WA 98105 USA; [Krewson, Briana D.; Shupp, Alison B.; Willert, Rebecca A.; Czaja, Agnieszka M.; Johnson, Rachel; Stover, Jessi A.; Boyd-Kyle, Victoria; Brigatti, Karlla W.; Puffenberger, Erik G.; Strauss, Kevin A.; Jinks, Robert N.] Franklin & Marshall Coll, Dept Biol, Biol Fdn Behav Program, Lancaster, PA 17604 USA; [Gottlieb, Steven] Alfred I DuPont Hosp Children, Div Pediat Neurol, Wilmington, DE 19803 USA; [Bartholdi, Deborah] Inselspital Bern, Dept Human Genet, CH-3010 Bern, Switzerland; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8952 Schlieren, Switzerland; [Goldstein, Amy] Univ Pittsburgh, Dept Pediat, Sch Med, Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15224 USA; [Mirzaa, Ghayda M.; Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Nissen, Anke] Ctr Med Genet, D-80335 Munich, Germany; [Brigatti, Karlla W.; Puffenberger, Erik G.; Strauss, Kevin A.] Clin Special Children, Strasburg, PA 17579 USA; [Strauss, Kevin A.] Lancaster Gen Hosp, Lancaster, PA 17602 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Troy, Carol M.] Columbia Univ, Taub Inst Res Alzheimer Dis & Aging Brain, Med Ctr, New York, NY 10032 USA; [Troy, Carol M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA	Technische Universitat Dresden; Seattle Children's Hospital; Columbia University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Franklin & Marshall College; Nemours Alfred I. duPont Hospital for Children; University of Bern; University Hospital of Bern; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; Columbia University	Di Donato, N (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-01307 Dresden, Germany.; Di Donato, N (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA.; Jinks, RN (corresponding author), Franklin & Marshall Coll, Dept Biol, Biol Fdn Behav Program, Lancaster, PA 17604 USA.	nataliya.didonato@unildinikum-dresden.de; rjinks@fandm.edu	Di Donato, Nataliya/G-2357-2019; Aldinger, Kimberly/ABB-1561-2020; Dobyns, William Brian/ABC-6525-2021; Troy, Carol/ABC-2771-2020; Dobyns, William/AAI-2768-2020; Roy, Achira/ABG-2660-2020; Rauch, Anita/C-5568-2014	Di Donato, Nataliya/0000-0001-9439-4677; Aldinger, Kimberly/0000-0002-5406-8911; Dobyns, William/0000-0002-7681-2844; Roy, Achira/0000-0002-6274-0667; Rauch, Anita/0000-0003-2930-3163; Puffenberger, Erik/0000-0002-6388-9148; Maga, A. Murat/0000-0002-7921-9018; Avrutsky, Maria/0000-0002-3477-0084; Millen, Kathleen/0000-0001-9978-675X	Deutsche Forschungsgemeinschaft [DI 2079/2-1, DI 2170/2-2]; HHMI Undergraduate Science Education Awards [52006294, 52007538]; Center for Research on Women and Newborn Health and ConnectCare3; National Eye Institute (NEI) of the NIH [T32 EY013933]; National Institute of Neurological Disorders and Stroke (NINDS) of the NIH [K08NS092898, R01NS081333, R01NS080390, R01NS092772]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY013933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092772, R01NS095733, K08NS092898, R01NS081333, R01NS080390] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HHMI Undergraduate Science Education Awards; Center for Research on Women and Newborn Health and ConnectCare3; National Eye Institute (NEI) of the NIH; National Institute of Neurological Disorders and Stroke (NINDS) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the Deutsche Forschungsgemeinschaft (DI 2079/2-1 and DI 2170/2-2 to N.D.D.), HHMI Undergraduate Science Education Awards (52006294 and 52007538 to Franklin & Marshall College, R.N.J., Principal Investigator), the Center for Research on Women and Newborn Health and ConnectCare3 (to R.N.J.), the National Eye Institute (NE,I) of the NIH (Vision Training Grant T32 EY013933 to M.I.A.), and the National Institute of Neurological Disorders and Stroke (NINDS) of the NIH (K08NS092898 to G.M.M., R01NS081333 to C.M.T., R01NS080390 to K.J.M., and R01NS092772 to W.B.D.). The Clinic for Special Children is funded by charitable contributions from private donors and the communities it serves. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other organizations listed above. The funding sources had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. All authors discussed and commented on the manuscript.	Ahmad M, 1997, CANCER RES, V57, P615; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Ando K, 2012, MOL CELL, V47, P681, DOI 10.1016/j.molcel.2012.06.024; Avela K, 2012, EUR J MED GENET, V55, P753, DOI 10.1016/j.ejmg.2012.09.007; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; Dawant B. M., 2012, LECT NOTES COMPUTER; Dekkers MPJ, 2013, J CELL BIOL, V203, P385, DOI 10.1083/jcb.201306136; Denault Jean-Bernard, 2008, V414, P191; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Doshi JJ., 2013, P MICCAI CHALL WORKS, P148; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gripp KW, 2010, AM J MED GENET A, V152A, P1161, DOI 10.1002/ajmg.a.33391; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Guzel A, 2007, AM J MED GENET A, V143A, P672, DOI 10.1002/ajmg.a.31640; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Jabado O, 2004, CELL DEATH DIFFER, V11, P618, DOI 10.1038/sj.cdd.4401397; Jamuar SS, 2015, PEDIATR CLIN N AM, V62, P571, DOI 10.1016/j.pcl.2015.03.002; Jang TH, 2013, APPL BIOCHEM BIOTECH, V170, P210, DOI 10.1007/s12010-013-0184-4; Jean YY, 2013, BIOCHEM J, V455, P15, DOI 10.1042/BJ20130556; Jinks RN, 2015, BRAIN, V138, P2173, DOI 10.1093/brain/awv153; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mirzaa GM, 2014, AM J MED GENET C, V166, P156, DOI 10.1002/ajmg.c.31401; Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67; Nematollahi LA, 2015, J MOL BIOL, V427, P737, DOI 10.1016/j.jmb.2014.11.021; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Phadke SR, 2007, NEUROL INDIA, V55, P57, DOI 10.4103/0028-3886.30429; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ramirez D, 2004, AM J MED GENET A, V124A, P231, DOI 10.1002/ajmg.a.20388; Ribe EM, 2012, BIOCHEM J, V444, P591, DOI 10.1042/BJ20111588; Sajan SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003823; Shalini S, 2012, CELL DEATH DIFFER, V19, P1370, DOI 10.1038/cdd.2012.13; Shearwin-Whyatt LM, 2000, CELL DEATH DIFFER, V7, P155, DOI 10.1038/sj.cdd.4400632; Teachey DT, 2010, BRIT J HAEMATOL, V148, P205, DOI 10.1111/j.1365-2141.2009.07991.x; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Troy CM, 2015, NEUROTHERAPEUTICS, V12, P42, DOI 10.1007/s13311-014-0307-9; Troy CM, 1997, J NEUROSCI, V17, P1911; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang Q, 2006, CELL DEATH DIFFER, V13, P75, DOI 10.1038/sj.cdd.4401690; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	65	37	37	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1117	1129		10.1016/j.ajhg.2016.09.010	http://dx.doi.org/10.1016/j.ajhg.2016.09.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27773430	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000387529600009
J	Parry, DA; Smith, CEL; El-Sayed, W; Poulter, JA; Shore, RC; Logan, CV; Mogi, C; Sato, K; Okajima, F; Harada, A; Zhang, H; Koruyucu, M; Seymen, F; Hu, JCC; Simmer, JP; Ahmed, M; Jafri, H; Johnson, CA; Inglehearn, CF; Mighell, AJ				Parry, David A.; Smith, Claire E. L.; El-Sayed, Walid; Poulter, James A.; Shore, Roger C.; Logan, Clare V.; Mogi, Chihiro; Sato, Koichi; Okajima, Fumikazu; Harada, Akihiro; Zhang, Hong; Koruyucu, Mine; Seymen, Figen; Hu, Jan C. -C.; Simmer, James P.; Ahmed, Mushtaq; Jafri, Hussain; Johnson, Colin A.; Inglehearn, Chris F.; Mighell, Alan J.			Mutations in the pH-Sensing G-protein-Coupled Receptor GPR68 Cause Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAT INCISOR ENAMEL; OGR1; AMELOBLASTS; EXCHANGER; EXPRESSION; DELETION; LINKAGE; MMP-20; CELLS; LAMB3	Amelogenesis is the process of dental enamel formation, leading to the deposition of the hardest tissue in the human body. This process requires the intricate regulation of ion transport and controlled changes to the pH of the developing enamel matrix. The means by which the enamel organ regulates pH during amelogenesis is largely unknown. We identified rare homozygous variants in GPR68 in three families with amelogenesis imperfecta, a genetically and phenotypically heterogeneous group of inherited conditions associated with abnormal enamel formation. Each of these homozygous variants (a large in-frame deletion, a frameshift deletion, and a missense variant) were predicted to result in loss of function. GPR68 encodes a proton-sensing G-protein-coupled receptor with sensitivity in the pH range that occurs in the developing enamel matrix during amelogenesis. Immunohistochemistry of rat mandibles confirmed localisation of GPR68 in the enamel organ at all stages of amelogenesis. Our data identify a role for GPR68 as a proton sensor that is required for proper enamel formation.	[Parry, David A.; Smith, Claire E. L.; El-Sayed, Walid; Poulter, James A.; Logan, Clare V.; Jafri, Hussain; Johnson, Colin A.; Inglehearn, Chris F.; Mighell, Alan J.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England; [Parry, David A.] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [El-Sayed, Walid; Shore, Roger C.; Mighell, Alan J.] Univ Leeds, St Jamess Univ Hosp, Sch Dent, Dept Oral Biol, Leeds LS9 7TF, W Yorkshire, England; [El-Sayed, Walid] Suez Canal Univ, Dept Oral Biol, Coll Dent, El Salam Dist 41611, Ismaileya, Egypt; [El-Sayed, Walid] Gulf Med Univ, Coll Dent, Oral Biol Dept, Al Jurf 3787, Ajman, U Arab Emirates; [Mogi, Chihiro; Sato, Koichi; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma 3718512, Japan; [Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka 5650871, Japan; [Zhang, Hong; Hu, Jan C. -C.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol Sci, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA; [Zhang, Hong; Hu, Jan C. -C.; Simmer, James P.] Univ Michigan, Sch Dent, Dept Mat Sci, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA; [Koruyucu, Mine; Seymen, Figen] Istanbul Univ, Dept Pedodont, Fac Dent, TR-34116 Istanbul, Turkey; [Ahmed, Mushtaq] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Jafri, Hussain] Gene Tech Lab 146 1, Shadman Jail Rd, Lahore 54000, Pakistan	Saint James's University Hospital; University of Leeds; University of Edinburgh; Saint James's University Hospital; University of Leeds; Egyptian Knowledge Bank (EKB); Suez Canal University; Gunma University; Osaka University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Istanbul University; Chapel Allerton Hospital; University of Leeds	Mighell, AJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England.; Mighell, AJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Dent, Dept Oral Biol, Leeds LS9 7TF, W Yorkshire, England.	a.j.mighell@leeds.ac.uk	Ahmed, Mushtaq/GSN-9818-2022; Koruyucu, M/AAC-6713-2020; Poulter, James A/A-8190-2013; Seymen, Figen/AAC-6736-2020; Inglehearn, Chris/GYD-9783-2022	Koruyucu, M/0000-0002-2077-5095; Poulter, James A/0000-0003-2048-5693; Seymen, Figen/0000-0001-7010-2035; El-Sayed, walid/0000-0002-6647-516X; Sato, Koichi/0000-0001-7694-4014; Johnson, Colin/0000-0002-2979-8234; Parry, David/0000-0003-0376-7736; Smith, Claire/0000-0001-8320-5105	Egyptian Government; Sir Jules Thom Charitable Trust [JTA/09]; Wellcome Trust [082448, 075945, 093113]; NIDCR/NIH [DE015846]; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	Egyptian Government; Sir Jules Thom Charitable Trust; Wellcome Trust(Wellcome TrustEuropean Commission); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); The Sir Jules Thorn Charitable Trust; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank the families for their participation, Sue Keat for assistance with immunohistochemistry, Professor Tim Wright, The University of North Carolina, Chapel Hill, USA for inclusion of samples in the family panel screened, and Mr. Stephen Fayle and Mrs. Helen Clark, Department of Child Dental Health, Leeds Dental Institute for clinical information. This work was funded by the Egyptian Government (WE.), the Sir Jules Thom Charitable Trust (grant number JTA/09), the Wellcome Trust (grant numbers 082448, 075945, and 093113), and NIDCR/NIH research grant DE015846.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barron MJ, 2008, HUM MOL GENET, V17, P3509, DOI 10.1093/hmg/ddn243; Brookes SJ, 1998, CONNECT TISSUE RES, V39, P89, DOI 10.3109/03008209809023915; Consortium EA, 2015, COLD SPRING HARBOR L; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Damkier HH, 2014, BONE, V60, P227, DOI 10.1016/j.bone.2013.12.018; de Valliere C, 2015, AM J PHYSIOL-GASTR L, V309, pG475, DOI 10.1152/ajpgi.00408.2014; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Frick KK, 2009, J BONE MINER RES, V24, P305, DOI 10.1359/JBMR.081015; GARANT PR, 1986, ANAT REC, V216, P1, DOI 10.1002/ar.1092160102; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; HALSE A, 1972, SCAND J DENT RES, V80, P428; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Kim JW, 2013, J DENT RES, V92, P899, DOI 10.1177/0022034513502054; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; Mohebbi N, 2012, CELL PHYSIOL BIOCHEM, V29, P313, DOI 10.1159/000338486; Moinichen CB, 1996, J ANAT, V189, P325; Nakakura T, 2012, ENDOCRINOLOGY, V153, P4171, DOI 10.1210/en.2012-1164; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Poulter JA, 2014, HUM MOL GENET, V23, P2189, DOI 10.1093/hmg/ddt616; Poulter JA, 2014, EUR J HUM GENET, V22, P132, DOI 10.1038/ejhg.2013.76; Prasad MK, 2016, J MED GENET, V53, P98, DOI 10.1136/jmedgenet-2015-103302; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Robinson C, 1997, CIBA F SYMP, V205, P156; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Sasaki T, 1989, Showa Shigakkai Zasshi, V9, P108; Sasaki T, 1997, CIBA F SYMP, V205, P32; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Takagi T, 1998, CONNECT TISSUE RES, V38, P181, DOI 10.3109/03008209809017035; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Tomura H, 2008, J BONE MINER RES, V23, P1129, DOI 10.1359/JBMR.080236; Wang SK, 2014, HUM MOL GENET, V23, P2157, DOI 10.1093/hmg/ddt611; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Yuen WY, 2012, ACTA DERM-VENEREOL, V92, P695, DOI 10.2340/00015555-1341	50	37	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					984	990		10.1016/j.ajhg.2016.08.020	http://dx.doi.org/10.1016/j.ajhg.2016.08.020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27693231	Green Published, hybrid			2022-12-18	WOS:000385333700019
J	Joshi, RS; Garg, P; Zaitlen, N; Lappalainen, T; Watson, CT; Azam, N; Ho, D; Li, X; Antonarakis, SE; Brunner, HG; Buiting, K; Cheung, SW; Coffee, B; Eggermann, T; Francis, D; Geraedts, JP; Gimelli, G; Jacobson, SG; Le Caignec, C; de Leeuw, N; Liehr, T; Mackay, DJ; Montgomery, SB; Pagnamenta, AT; Papenhausen, P; Robinson, DO; Ruivenkamp, C; Schwartz, C; Steiner, B; Stevenson, DA; Surti, U; Wassink, T; Sharp, AJ				Joshi, Ricky S.; Garg, Paras; Zaitlen, Noah; Lappalainen, Tuuli; Watson, Corey T.; Azam, Nidha; Ho, Daniel; Li, Xin; Antonarakis, Stylianos E.; Brunner, Han G.; Buiting, Karin; Cheung, Sau Wai; Coffee, Bradford; Eggermann, Thomas; Francis, David; Geraedts, Joep P.; Gimelli, Giorgio; Jacobson, Samuel G.; Le Caignec, Cedric; de Leeuw, Nicole; Liehr, Thomas; Mackay, Deborah J.; Montgomery, Stephen B.; Pagnamenta, Alistair T.; Papenhausen, Peter; Robinson, David O.; Ruivenkamp, Claudia; Schwartz, Charles; Steiner, Bernhard; Stevenson, David A.; Surti, Urvashi; Wassink, Thomas; Sharp, Andrew J.			DNA Methylation Profiling of Uniparental Disomy Subjects Provides a Map of Parental Epigenetic Bias in the Human Genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMPRINTING DISORDERS; ORIGIN; GENE; SEIZURES; REGIONS; LOCUS; RNA; INDIVIDUALS; ASSOCIATION; MECHANISMS	Genomic imprinting is a mechanism in which gene expression varies depending on parental origin. Imprinting occurs through differential epigenetic marks on the two parental alleles, with most imprinted loci marked by the presence of differentially methylated regions (DMRs). To identify sites of parental epigenetic bias, here we have profiled DNA methylation patterns in a cohort of 57 individuals with uniparental disomy (UPD) for 19 different chromosomes, defining imprinted DMRs as sites where the maternal and paternal methylation levels diverge significantly from the biparental mean. Using this approach we identified 77 DMR5, including nearly all those described in previous studies, in addition to 34 DMRs not previously reported. These include a DMR at TUBGCPS within the recurrent 15q11.2 microdeletion region, suggesting potential parent-of-origin effects associated with this genomic disorder. We also observed a modest parental bias in DNA methylation levels at every CpG analyzed across similar to 1.9 Mb of the 15q11-q13 Prader-Willi/Angelman syndrome region, demonstrating that the influence of imprinting is not limited to individual regulatory elements such as CpG islands, but can extend across entire chromosomal domains. Using RNA-seq data, we detected signatures consistent with imprinted expression associated with nine novel DMRs. Finally, using a population sample of 4,004 blood methylomes, we define patterns of epigenetic variation at DMR5, identifying rare individuals with global gain or loss of methylation across multiple imprinted loci. Our data provide a detailed map of parental epigenetic bias in the human genome, providing insights into potential parent-of-origin effects.	[Joshi, Ricky S.; Garg, Paras; Watson, Corey T.; Azam, Nidha; Ho, Daniel; Sharp, Andrew J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zaitlen, Noah] UCSF, Dept Med, MC2552,1700 4th St,Byers Hall,Suite 503C, San Francisco, CA 94158 USA; [Lappalainen, Tuuli] New York Genome Ctr, 101 Ave Amer,7th Floor, New York, NY 10013 USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Li, Xin; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Li, Xin; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Li, Xin; Montgomery, Stephen B.] Stanford Univ, Dept Comp Sci, Sch Med, Stanford, CA 94305 USA; [Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, 9th Floor,1 Rue Michel Servet, CH-1211 Geneva, Switzerland; [Brunner, Han G.; de Leeuw, Nicole] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Buiting, Karin] Univ Duisburg Essen, Inst Human Genet, Univ Hosp Essen, Hufelandstr 55, D-45122 Essen, Germany; [Cheung, Sau Wai] Baylor Univ, Dept Mol & Human Genet, Houston, TX 77030 USA; [Coffee, Bradford] Emory Univ, Emory Genet Lab, Atlanta, GA 30033 USA; [Eggermann, Thomas] Rhein Westfal TH Aachen, Inst Human Genet, Univ Hosp, D-52074 Aachen, Germany; [Francis, David] Royal Childrens Hosp, Victorian Clin Genet Serv, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Geraedts, Joep P.] Maastricht Univ, Fac Hlth Med & Life Sci, Res Inst GROW, Dept Genet & Cell Biol, POB 5800, NL-6202 AZ Maastricht, Netherlands; [Gimelli, Giorgio] Ist Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy; [Jacobson, Samuel G.] Univ Penn, Sch Med, Dept Ophthalmol, Scheie Eye Inst,Perelman Sch Med, 51 N 39th St, Philadelphia, PA 19104 USA; [Le Caignec, Cedric] CHU Nantes, Gen Med Serv, Inst Biol, 9 Quai Moncousu, F-44093 Nantes, France; [Le Caignec, Cedric] INSERM, UMR 957, F-44035 Nantes, France; [Le Caignec, Cedric] Univ Nantes, Nantes Atlantique Univ, Pathophysiol Bone Resorpt & Therapy Primary Bone, F-44035 Nantes, France; [Liehr, Thomas] Univ Jena, Jena Univ Hosp, Inst Human Genet, Kollegiengasse 10, D-07743 Jena, Germany; [Mackay, Deborah J.; Robinson, David O.] Wessex Reg Genet Lab Salisbury Dist Hosp, Salisbury SO2 8BJ, Wilts, England; [Pagnamenta, Alistair T.] Univ Oxford, Natl Inst Hlth Res Biomed Res Ctr, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Papenhausen, Peter] Ctr Mol Biol & Pathol, Cytogenet Div, LabCorp, Res Triangle Pk, NC 27709 USA; [Ruivenkamp, Claudia] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Schwartz, Charles] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Steiner, Bernhard] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Stevenson, David A.] Lucile Salter Packard Childrens Hosp, Div Med Genet, 300 Pasteur Dr,Boswell Bldg A097, Palo Alto, CA 94304 USA; [Surti, Urvashi] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Wassink, Thomas] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Ho, Daniel] Novartis Inst Biomed Res, 100 Technol Sq,8503C, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Columbia University; Stanford University; Stanford University; Stanford University; University of Geneva; Radboud University Nijmegen; University of Duisburg Essen; Baylor University; Emory University; RWTH Aachen University; RWTH Aachen University Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Maastricht University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Pennsylvania; Pennsylvania Medicine; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Friedrich Schiller University of Jena; Salisbury District Hospital; University of Oxford; Wellcome Centre for Human Genetics; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Greenwood Genetic Center; University of Zurich; Lucile Packard Children's Hospital (LPCH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; Novartis	Sharp, AJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	andrew.sharp@mssm.edu	Joshi, Ricky/AAP-6507-2020; Liehr, Thomas/H-2852-2019; Lappalainen, Tuuli/AAE-6532-2020; Antonarakis, Stylianos E/N-8866-2014; Mackay, Deborah JG/B-2879-2015	Joshi, Ricky/0000-0003-4463-0453; Liehr, Thomas/0000-0003-1672-3054; Lappalainen, Tuuli/0000-0002-7746-8109; Antonarakis, Stylianos E/0000-0001-8907-5823; Wassink, Thomas/0000-0002-0952-8333; Mackay, Deborah JG/0000-0003-3088-4401; Watson, Corey/0000-0001-7248-8787; Jacobson, Samuel/0000-0003-2122-169X; Montgomery, Stephen/0000-0002-5200-3903	NIH [DA033660, HG006696, HD073731, MH097018]; March of Dimes [6-FY13-92]; Beatriu de Pinos Postdoctoral Fellowship [2011BP-A00515]; Bundesministerium fur Bildung and Forschung (BMBF) [01GM1513A]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD073731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL121295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033660] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; MRC [MR/J000329/1] Funding Source: UKRI; Medical Research Council [MR/J000329/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Beatriu de Pinos Postdoctoral Fellowship; Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by NIH grants DA033660, HG006696, HD073731, and MH097018 and research grant 6-FY13-92 from the March of Dimes to A.J.S., a Beatriu de Pinos Postdoctoral Fellowship to R.S.J. (2011BP-A00515), and the Bundesministerium fur Bildung and Forschung to K.B. (BMBF; Imprinting diseases, grant No. 01GM1513A).	Alexander KA, 2015, CELL REP, V13, P1194, DOI 10.1016/j.celrep.2015.09.078; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; ANNEGERS JF, 1976, EPILEPSIA, V17, P1, DOI 10.1111/j.1528-1157.1976.tb03375.x; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Barbaux S, 2012, EPIGENETICS-US, V7, P1079, DOI 10.4161/epi.21495; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Docherty LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9086; Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116; Dockery L, 2009, EPIGENETICS-US, V4, P241, DOI 10.4161/epi.9021; Donovan GP, 1997, J NEUROSCI, V17, P4562; Doose H, 2001, EPILEPSY RES, V43, P103, DOI 10.1016/S0920-1211(00)00182-0; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dubertret C, 2004, J PSYCHIATR RES, V38, P371, DOI 10.1016/j.jpsychires.2004.01.002; Eggermann T, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0143-8; Hernando-Herraez I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003763; Iwata N, 2001, MOL PSYCHIATR, V6, P217, DOI 10.1038/sj.mp.4000829; Kotzot D, 2005, AM J MED GENET A, V136A, P287, DOI 10.1002/ajmg.a.30483; Li X, 2014, AM J HUM GENET, V95, P245, DOI 10.1016/j.ajhg.2014.08.004; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Metsalu T, 2014, EPIGENETICS-US, V9, P1397, DOI 10.4161/15592294.2014.970052; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Morcos L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r25; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Muranjan M, 2010, INDIAN PEDIATR, V47, P429, DOI 10.1007/s13312-010-0078-2; Nakabayashi K, 2011, HUM MOL GENET, V20, P3188, DOI 10.1093/hmg/ddr224; OTTMAN R, 1988, AM J HUM GENET, V43, P257; Pal DK, 2006, BRAIN DEV-JPN, V28, P92, DOI 10.1016/j.braindev.2005.05.009; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Robinson WP, 2000, BIOESSAYS, V22, P452; Romanelli V, 2014, EPIGENETICS-US, V9, P783, DOI 10.4161/epi.28323; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Sharp AJ, 2010, GENOME RES, V20, P1271, DOI 10.1101/gr.108597.110; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sun JN, 2014, NUCLEIC ACIDS RES, V42, P9588, DOI 10.1093/nar/gku549; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Wang X, 2013, P NATL ACAD SCI USA, V110, P10705, DOI 10.1073/pnas.1308998110; Wang X, 2011, GENETICS, V189, P109, DOI 10.1534/genetics.111.130088; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-10	49	37	38	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					555	566		10.1016/j.ajhg.2016.06.032	http://dx.doi.org/10.1016/j.ajhg.2016.06.032			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569549	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000383114800003
J	Siraj, AK; Masoodi, T; Bu, R; Beg, S; Al-Sobhi, SS; Al-Dayel, F; Al-Dawish, M; Alkuraya, FS; Al-Kuraya, KS				Siraj, Abdul K.; Masoodi, Tariq; Bu, Rong; Beg, Shaham; Al-Sobhi, Saif S.; Al-Dayel, Fouad; Al-Dawish, Mohammed; Alkuraya, Fowzan S.; Al-Kuraya, Khawla S.			Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATED RAS ONCOGENES; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; GENETIC ALTERATIONS; GERMLINE MUTATIONS; PIK3CA ALTERATIONS; POINT MUTATIONS; POOR-PROGNOSIS; BRAF MUTATIONS; PAPILLARY; MACC1	Papillary thyroid carcinoma (PTC) has a wide geographic variation in incidence; it is most common in Saudi Arabia, where it is only second to breast cancer as the most common cancer among females. Genomic profiling of PTC from Saudi Arabia has not been attempted previously. We performed whole-exome sequencing of 101 PTC samples and the corresponding genomic DNA to identify genes with recurrent somatic mutations, then sequenced these genes by using a next-generation gene-panel approach in an additional 785 samples. In addition to BRAF, N-RAS, and H-RAS, which have previously been shown to be recurrently mutated in PTC, our analysis highlights additional genes, including thyroglobulin (TG), which harbored somatic mutations in 3% of the entire cohort. Surprisingly, although TG mutations were not exclusive to mutations in the RAS-MAP kinase pathway, their presence was associated with a significantly worse clinical outcome, which suggests a pathogenic role beyond driving initial oncogenesis. Analysis of metastatic PTC tissue revealed significant enrichment for TG mutations (p < 0.001), including events of apparent clonal expansion. Our results suggest a previously unknown role of TG somatic mutations in the pathogenesis of PTC and its malignant evolution.	[Siraj, Abdul K.; Masoodi, Tariq; Bu, Rong; Beg, Shaham; Al-Kuraya, Khawla S.] King Faisal Specialist Hosp & Res Ctr, Human Canc Genom Res, Riyadh 11211, Saudi Arabia; [Al-Sobhi, Saif S.] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia; [Al-Dayel, Fouad] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia; [Al-Dawish, Mohammed] Prince Sultan Mil Med City, Dept Endocrinol & Diabet, Riyadh 11159, Saudi Arabia; [Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center; Alfaisal University	Al-Kuraya, KS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Human Canc Genom Res, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.	falkuraya@kfshrc.edu.sa; kkuraya@kfshrc.edu.sa	dawish, mohamed al/AAQ-5258-2020; Masoodi, Tariq/C-9843-2012	Masoodi, Tariq/0000-0002-9186-6349; Beg, Shaham/0000-0002-6068-1595	Saudi Government	Saudi Government	We thank the study subjects for their participation. This project was conducted by a generous fund from the Saudi Government to the Thyroid Cancer Genome Project as part of the International Cancer Genome Consortium (ICGC). Authors declare no conflict of interest.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Adjadj E, 2009, LANCET ONCOL, V10, P181, DOI 10.1016/S1470-2045(09)70020-8; Al-Kuraya K, 2006, HUM PATHOL, V37, P453, DOI 10.1016/j.humpath.2005.12.004; Al-Kuraya K, 2005, MODERN PATHOL, V18, P891, DOI 10.1038/modpathol.3800408; Albores-Saavedra J, 2007, ENDOCR PATHOL, V18, P1, DOI 10.1007/s12022-007-0002-z; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Cancer Genome Atlas Research Network Electronic address gue Cancer Genome Atlas Research N, 2014, CELL, V159, P676, DOI DOI 10.1016/J.CELL.2014.09.050; Cetta F, 2000, J CLIN ENDOCR METAB, V85, P286, DOI 10.1210/jc.85.1.286; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dal Maso L, 2011, ANN ONCOL, V22, P957, DOI 10.1093/annonc/mdq467; Dansonka-Mieszkowska A, 2006, ANN HUM GENET, V70, P594, DOI 10.1111/j.1469-1809.2006.00257.x; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Guo TK, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-121; Hagemann C, 2013, NEURO-ONCOLOGY, V15, P1696, DOI 10.1093/neuonc/not136; HAY ID, 1990, ENDOCRIN METAB CLIN, V19, P545, DOI 10.1016/S0889-8529(18)30310-4; Hishinuma A, 2005, THYROID, V15, P1079, DOI 10.1089/thy.2005.15.1079; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Hsiao SJ, 2014, ENDOCR-RELAT CANCER, V21, pT301, DOI 10.1530/ERC-14-0166; Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16; Huhn S, 2014, CANCER CAUSE CONTROL, V25, P759, DOI 10.1007/s10552-014-0379-1; Hussain Fazal, 2013, Hematol Oncol Stem Cell Ther, V6, P58, DOI 10.1016/j.hemonc.2013.05.004; Jang H, 2009, NAT STRUCT MOL BIOL, V16, P910, DOI 10.1038/nsmb.1657; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XH, 2008, ONCOL REP, V19, P157; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim MS, 2013, APMIS, V121, P85, DOI 10.1111/j.1600-0463.2012.02940.x; Kimura ET, 2003, CANCER RES, V63, P1454; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, CANCER RES, V48, P4459; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lin JD, 2008, CLIN CHIM ACTA, V388, P15, DOI 10.1016/j.cca.2007.11.002; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Loh KC, 1997, J CLIN ENDOCR METAB, V82, P3553, DOI 10.1210/jc.82.11.3553; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517; NAMBA H, 1990, MOL ENDOCRINOL, V4, P1474, DOI 10.1210/mend-4-10-1474; Ngeow J, 2011, J CLIN ENDOCR METAB, V96, pE2063, DOI 10.1210/jc.2011-1616; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Piersanti M, 2003, ENDOCR PATHOL, V14, P183, DOI 10.1385/EP:14:3:183; Schneider DF, 2013, CA-CANCER J CLIN, V63, P373, DOI 10.3322/caac.21195; Siironen P, 2005, TUMOR BIOL, V26, P57, DOI 10.1159/000085586; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Siraj AK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-168; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; SUAREZ HG, 1988, ONCOGENE, V2, P403; SUAREZ HG, 1990, ONCOGENE, V5, P565; Tavares C, 2016, EUR J ENDOCRINOL, V174, pR117, DOI 10.1530/EJE-15-0605; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZQ, 2015, J CANCER RES CLIN, V141, P1353, DOI 10.1007/s00432-014-1903-0; Watanabe T, 2009, CANCER, V115, P283, DOI 10.1002/cncr.24023; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Xie C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064235; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yehia L, 2015, AM J HUM GENET, V97, P661, DOI 10.1016/j.ajhg.2015.10.001; Zhang K, 2014, TUMOR BIOL, V35, P1343, DOI 10.1007/s13277-013-1180-6; Zhang Rui-tao, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1551; Zhu MC, 2013, PATHOL ONCOL RES, V19, P749, DOI 10.1007/s12253-013-9638-9	68	37	39	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1170	1180		10.1016/j.ajhg.2016.04.014	http://dx.doi.org/10.1016/j.ajhg.2016.04.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236916	Green Published, Bronze			2022-12-18	WOS:000377286000011
J	Broadaway, KA; Cutler, DJ; Duncan, R; Moore, JL; Ware, EB; Jhun, MA; Bielak, LF; Zhao, W; Smith, JA; Peyser, PA; Kardia, SLR; Ghosh, D; Epstein, MP				Broadaway, K. Alaine; Cutler, David J.; Duncan, Richard; Moore, Jacob L.; Ware, Erin B.; Jhun, Min A.; Bielak, Lawrence F.; Zhao, Wei; Smith, Jennifer A.; Peyser, Patricia A.; Kardia, Sharon L. R.; Ghosh, Debashis; Epstein, Michael P.			A Statistical Approach for Testing Cross-Phenotype Effects of Rare Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON SNPS EXPLAIN; P-SELECTIN GENE; QUANTITATIVE TRAITS; LARGE PROPORTION; ASSOCIATION; HERITABILITY; DISEASE; SET; PLEIOTROPY; REGRESSION	Increasing empirical evidence suggests that many genetic variants influence multiple distinct phenotypes. When cross-phenotype effects exist, multivariate association methods that consider pleiotropy are often more powerful than univariate methods that model each phenotype separately. Although several statistical approaches exist for testing cross-phenotype effects for common variants, there is a lack of similar tests for gene-based analysis of rare variants. In order to fill this important gap, we introduce a statistical method for cross-phenotype analysis of rare variants using a nonparametric distance-covariance approach that compares similarity in multivariate phenotypes to similarity in rare-variant genotypes across a gene. The approach can accommodate both binary and continuous phenotypes and further can adjust for covariates. Our approach yields a closed-form test whose significance can be evaluated analytically, thereby improving computational efficiency and permitting application on a genome-wide scale. We use simulated data to demonstrate that our method, which we refer to as the Gene Association with Multiple Traits (GAMuT) test, provides increased power over competing approaches. We also illustrate our approach using exome-chip data from the Genetic Epidemiology Network of Arteriopathy.	[Broadaway, K. Alaine; Cutler, David J.; Duncan, Richard; Epstein, Michael P.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Moore, Jacob L.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Ware, Erin B.; Jhun, Min A.; Bielak, Lawrence F.; Zhao, Wei; Smith, Jennifer A.; Peyser, Patricia A.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ware, Erin B.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48104 USA; [Ghosh, Debashis] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA	Emory University; University of California System; University of California Davis; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Colorado School of Public Health	Epstein, MP (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.	mpepste@emory.edu	Duncan, Richard/ABD-4099-2020; Duncan, Richard P/E-7899-2013	Duncan, Richard/0000-0003-2295-449X; Duncan, Richard P/0000-0003-2295-449X; Ghosh, Debashis/0000-0001-6618-1316; Smith, Jennifer Ann/0000-0002-3575-5468	NIH [HG007508, HL086694, HL119443, MH071537, GM117946, AR060893]; Div Of Biological Infrastructure [1457935] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL119443] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH071537, R01MH071537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants HG007508, HL086694, HL119443, MH071537, GM117946, and AR060893. For purposes of disclosing duality of interest, M.P.E. is a consultant for Amnion Laboratories.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032; Davi G, 1998, CIRCULATION, V97, P953; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; DAVIES R. B., 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Desachy G, 2015, MOL PSYCHIATR, V20, P170, DOI 10.1038/mp.2014.179; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gillespie J.H., 1994, CAUSES MOL EVOLUTION; Gretton A., 2008, ADV NEURAL INFORM PR, P585; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Hua WY, 2015, BIOMETRICS, V71, P812, DOI 10.1111/biom.12314; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; IKEDA H, 1995, CIRCULATION, V92, P1693, DOI 10.1161/01.CIR.92.7.1693; Jiang YX, 2014, GENET EPIDEMIOL, V38, P542, DOI 10.1002/gepi.21839; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kosorok MR, 2009, ANN APPL STAT, V3, P1270, DOI 10.1214/09-AOAS312B; Koyama H, 2003, CIRCULATION, V108, P524, DOI 10.1161/01.CIR.0000081765.88440.51; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lande R, 2007, GENET RES, V89, P373, DOI 10.1017/S0016672308009555; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lange LA, 2002, ARTERIOSCL THROM VAS, V22, P418, DOI 10.1161/hq0302.105721; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Maity A, 2012, GENET EPIDEMIOL, V36, P686, DOI 10.1002/gepi.21663; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ried JS, 2012, GENET EPIDEMIOL, V36, P244, DOI 10.1002/gepi.21617; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; Schork NJ, 2008, ADV GENET, V60, P195, DOI 10.1016/S0065-2660(07)00409-9; Simonson MA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-146; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Solomon DH, 2006, ANN RHEUM DIS, V65, P1608, DOI 10.1136/ard.2005.050377; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tregouet DA, 2002, HUM MOL GENET, V11, P2015, DOI 10.1093/hmg/11.17.2015; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wang YF, 2015, GENET EPIDEMIOL, V39, P259, DOI 10.1002/gepi.21895; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zapala Matthew A., 2012, Frontiers in Genetics, V3, P190, DOI 10.3389/fgene.2012.00190; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039; Zhang K., 2012, ARXIV12023775; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]	87	37	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					525	540		10.1016/j.ajhg.2016.01.017	http://dx.doi.org/10.1016/j.ajhg.2016.01.017			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942286	Bronze, Green Published			2022-12-18	WOS:000372383100015
J	Chong, JX; Burrage, LC; Beck, AE; Marvin, CT; McMillin, MJ; Shively, KM; Harrell, TM; Buckingham, KJ; Bacino, CA; Jain, M; Alanay, Y; Berry, SA; Carey, JC; Gibbs, RA; Lee, BH; Krakow, D; Shendure, J; Nickerson, DA; Bamshad, MJ				Chong, Jessica X.; Burrage, Lindsay C.; Beck, Anita E.; Marvin, Colby T.; McMillin, Margaret J.; Shively, Kathryn M.; Harrell, Tanya M.; Buckingham, Kati J.; Bacino, Carlos A.; Jain, Mahim; Alanay, Yasemin; Berry, Susan A.; Carey, John C.; Gibbs, Richard A.; Lee, Brendan H.; Krakow, Deborah; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.		Univ Washington	Autosomal-Dominant Multiple Pterygium Syndrome Is Caused by Mutations in MYH3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AKINESIA DEFORMATION SEQUENCE; FREEMAN-SHELDON-SYNDROME; DISTAL ARTHROGRYPOSIS; ESCOBAR SYNDROME; NATURAL-HISTORY; MECHANISMS; VARIANTS; SUBUNIT; MUSCLE	Multiple pterygium syndrome (MPS) is a phenotypically and genetically heterogeneous group of rare Mendelian conditions characterized by multiple pterygia, scoliosis, and congenital contractures of the limbs. MPS typically segregates as an autosomal-recessive disorder, but rare instances of autosomal-dominant transmission have been reported. Whereas several mutations causing recessive MPS have been identified, the genetic basis of dominant MPS remains unknown. We identified four families affected by dominantly transmitted MPS characterized by pterygia, camptodactyly of the hands, vertebral fusions, and scoliosis. Exome sequencing identified predicted protein-altering mutations in embryonic myosin heavy chain (MYH3) in three families. MYH3 mutations underlie distal arthrogryposis types 1, 2A, and 2B, but all mutations reported to date occur in the head and neck domains. In contrast, two of the mutations found to cause MPS in this study occurred in the tail domain. The phenotypic overlap among persons with MPS, coupled with physical findings distinct from other conditions caused by mutations in MYH3, suggests that the developmental mechanism underlying MPS differs from that of other conditions and/or that certain functions of embryonic myosin might be perturbed by disruption of specific residues and/or domains. Moreover, the vertebral fusions in persons with MPS, coupled with evidence of MYH3 expression in bone, suggest that embryonic myosin plays a role in skeletal development.	[Chong, Jessica X.; Beck, Anita E.; Marvin, Colby T.; McMillin, Margaret J.; Shively, Kathryn M.; Harrell, Tanya M.; Buckingham, Kati J.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Burrage, Lindsay C.; Bacino, Carlos A.; Jain, Mahim; Gibbs, Richard A.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Beck, Anita E.; Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Alanay, Yasemin] Acibadem Univ, Pediat Genet Unit, Dept Pediat, Sch Med, TR-34752 Istanbul, Turkey; [Berry, Susan A.] Univ Minnesota, Dept Pediat, Div Genet & Metab, Minneapolis, MN 55455 USA; [Carey, John C.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Gibbs, Richard A.; Lee, Brendan H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90048 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Orthoped Surg, Los Angeles, CA 90048 USA; [Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; Seattle Children's Hospital; Acibadem University; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA.	mbamshad@uw.edu	Beck, Anita E./AAS-8775-2021; Krakow, Deborah/B-5778-2009; Shendure, Jay/AAU-3684-2021; Alanay, Yasemin/A-1516-2016; Chong, Jessica/GZH-1625-2022; Kircher, Martin/H-6909-2019; Browning, Brian L/A-1178-2010	Beck, Anita E./0000-0002-7965-0326; Krakow, Deborah/0000-0001-9906-4968; Alanay, Yasemin/0000-0003-0683-9731; Kircher, Martin/0000-0001-9278-5471; Browning, Brian L/0000-0001-6454-6633; Blue, Elizabeth/0000-0002-0633-0305; Chong, Jessica/0000-0002-1616-2448; Berry, Susan/0000-0001-7970-688X	NIH National Human Genome Research Institute; NHLBI [1U54HG006493, 1RC2HG005608, 5R000HG004316]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD048895]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center - Eunice Kennedy Shriver NICHD [HD024064, U54HG003273, U54 U54HG006542, T32GM07526, P01HD070394]; Medical Genetics Training Award in Clinical Biochemical Genetics from Genzyme; Annual Clinical Genetics Meeting Foundation for Genetic and Genomic Medicine; National Urea Cycle Disorders Foundation Fellowship; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through Office of Rare Diseases Research [U54HD061221]; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through National Center for Advancing Translational Science [U54HD061221]; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through Eunice Kennedy Shriver NICHD [U54HD061221]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR066124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD048895, U54HD083092, U54HD061221, P01HD070394] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, UM1HG006493, U54HG003273, K99HG004316, U54HG006493, U54HG006542, R00HG004316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Life Sciences Discovery Fund; Washington Research Foundation; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center - Eunice Kennedy Shriver NICHD; Medical Genetics Training Award in Clinical Biochemical Genetics from Genzyme; Annual Clinical Genetics Meeting Foundation for Genetic and Genomic Medicine; National Urea Cycle Disorders Foundation Fellowship; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through Office of Rare Diseases Research; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through National Center for Advancing Translational Science; Urea Cycle Disorders Consortium part of the NIH Rare Disease Clinical Research Network through Eunice Kennedy Shriver NICHD; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the families for their participation and support; Christa Poel, Karynne Patterson, Jennifer Chin, Yuqing Chen, Alyssa Tran, Philippe Campeau, and James Lu for technical assistance; and Alice Ward Racca for helpful comments. Our work was supported in part by grants from the NIH National Human Genome Research Institute and NHLBI (1U54HG006493 to M.B., D.N., and J.S.; 1RC2HG005608 to M.B., D.N., and J.S.; 5R000HG004316 to H.K.T.), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; 1R01HD048895 to M.J.B.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation. This work was also supported by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (HD024064), funded by the Eunice Kennedy Shriver NICHD (U54HG003273 and U54 U54HG006542 to R.A.G.; T32GM07526 to M.J. and L.C.B.; P01HD070394 to B.L.). L.C.B. was also supported by the Medical Genetics Training Award in Clinical Biochemical Genetics from Genzyme and the Annual Clinical Genetics Meeting Foundation for Genetic and Genomic Medicine, the National Urea Cycle Disorders Foundation Fellowship, and a fellowship from the Urea Cycle Disorders Consortium (U54HD061221), which is a part of the NIH Rare Disease Clinical Research Network, supported through collaboration among the Office of Rare Diseases Research, the National Center for Advancing Translational Science, and the Eunice Kennedy Shriver NICHD. D.K. was supported by the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066124).	Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Armel TZ, 2009, P NATL ACAD SCI USA, V106, P6291, DOI 10.1073/pnas.0900107106; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Beck AE, 2014, AM J MED GENET A, V164, P2808, DOI 10.1002/ajmg.a.36762; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Frias J.L., 1973, EXCERPTA MED, V19; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; KAWIRA EL, 1985, AM J MED GENET, V20, P425, DOI 10.1002/ajmg.1320200302; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; MCKEOWN CME, 1988, J MED GENET, V25, P96, DOI 10.1136/jmg.25.2.96; Michalk A, 2008, AM J HUM GENET, V82, P464, DOI 10.1016/j.ajhg.2007.11.006; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; Prontera P, 2006, AM J MED GENET A, V140A, P2227, DOI 10.1002/ajmg.a.31428; Racca A.W., 2015, HUM MOL GENET; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Robinson KG, 2013, AM J MED GENET A, V161, P3042, DOI 10.1002/ajmg.a.36154; Stevenson DA, 2006, PEDIATRICS, V117, P754, DOI 10.1542/peds.2005-1219; Tajsharghi H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/s00401-012-1024-2; Takahashi M, 2002, EMBO REP, V3, P674, DOI 10.1093/embo-reports/kvf128; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Vogt J, 2009, J MED GENET, V46, P338, DOI 10.1136/jmg.2008.065425; Vogt J, 2008, AM J HUM GENET, V82, P222, DOI 10.1016/j.ajhg.2007.09.016; Vogt J, 2012, J MED GENET, V49, P21, DOI 10.1136/jmedgenet-2011-100378; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024486; Zhu XQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004589	31	37	39	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					841	849		10.1016/j.ajhg.2015.04.004	http://dx.doi.org/10.1016/j.ajhg.2015.04.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25957469	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000354189300015
J	Hayeck, TJ; Zaitlen, NA; Loh, PR; Vilhjalmsson, B; Pollack, S; Gusev, A; Yang, J; Chen, GB; Goddard, ME; Visscher, PM; Patterson, N; Price, AL				Hayeck, Tristan J.; Zaitlen, Noah A.; Loh, Po-Ru; Vilhjalmsson, Bjarni; Pollack, Samuela; Gusev, Alexander; Yang, Jian; Chen, Guo-Bo; Goddard, Michael E.; Visscher, Peter M.; Patterson, Nick; Price, Alkes L.			Mixed Model with Correction for Case-Control Ascertainment Increases Association Power	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS; STRUCTURED POPULATIONS; MULTIPLE-SCLEROSIS; HERITABILITY; VARIANTS; TRAITS; INHERITANCE; PROPORTION; REGRESSION	We introduce a liability-threshold mixed linear model (LTMLM) association statistic for case-control studies and show that it has a well-controlled false-positive rate and more power than existing mixed-model methods for diseases with low prevalence. Existing mixed-model methods suffer a loss in power under case-control ascertainment, but no solution has been proposed. Here, we solve this problem by using a chi(2) score statistic computed from posterior mean liabilities (PMLs) under the liability-threshold model. Each individual's PML is conditional not only on that individual's case-control status but also on every individual's case-control status and the genetic relationship matrix (GRM) obtained from the data. The PMLs are estimated with a multivariate Gibbs sampler; the liability-scale phenotypic covariance matrix is based on the GRM, and a heritability parameter is estimated via Haseman-Elston regression on case-control phenotypes and then transformed to the liability scale. In simulations of unrelated individuals, the LTMLM statistic was correctly calibrated and achieved higher power than existing mixed-model methods for diseases with low prevalence, and the magnitude of the improvement depended on sample size and severity of case-control ascertainment. In a Wellcome Trust Case Control Consortium 2 multiple sclerosis dataset with >10,000 samples, LTMLM was correctly calibrated and attained a 4.3% improvement (p = 0.005) in chi(2) statistics over existing mixed-model methods at 75 known associated SNPs, consistent with simulations. Larger increases in power are expected at larger sample sizes. In conclusion, case-control studies of diseases with low prevalence can achieve power higher than that in existing mixed-model methods.	[Hayeck, Tristan J.; Price, Alkes L.] Harvard Univ, Dept Biostat, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Hayeck, Tristan J.; Loh, Po-Ru; Vilhjalmsson, Bjarni; Pollack, Samuela; Gusev, Alexander; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Zaitlen, Noah A.] Univ Calif San Francisco, Sch Med, Lung Biol Ctr, San Francisco, CA 94158 USA; [Loh, Po-Ru; Vilhjalmsson, Bjarni; Pollack, Samuela; Gusev, Alexander; Price, Alkes L.] Harvard Univ, Dept Epidemiol, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Brisbane, Qld 4072, Australia; [Goddard, Michael E.] Univ Melbourne, Fac Land & Food Resources, Melbourne, Vic 3010, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; University of Queensland; University of Melbourne	Hayeck, TJ (corresponding author), Harvard Univ, Dept Biostat, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	tjh488@mail.harvard.edu; aprice@hsph.harvard.edu	Vilhjalmsson, Bjarni/K-3971-2014; Visscher, Peter/ABB-6151-2020; Vilhjálmsson, Bjarni/ABC-1369-2020; Yang, Jian/A-5852-2010; Chen, Guo-Bo/C-2435-2009	Vilhjalmsson, Bjarni/0000-0003-2277-9249; Visscher, Peter/0000-0002-2143-8760; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Yang, Jian/0000-0003-2001-2474; Chen, Guo-Bo/0000-0001-5475-8237; Goddard, Michael/0000-0001-9917-7946	NIH [R01 HG006399, T32 GM074897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL121295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, F32HG007805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1349449] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Golan and S. Rosset for helpful discussions. This research was funded by NIH grants R01 HG006399 and T32 GM074897. This study made use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available at http://www.wtccc.org.uk/.	Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Campbell DD, 2010, GENET EPIDEMIOL, V34, P159, DOI 10.1002/gepi.20446; Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Heyde C. C., 1997, QUASI LIKELIHOOD ITS; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mefford J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003096; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032; Zaitlen N, 2012, BIOINFORMATICS, V28, P1729, DOI 10.1093/bioinformatics/bts259; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	35	37	37	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					720	730		10.1016/j.ajhg.2015.03.004	http://dx.doi.org/10.1016/j.ajhg.2015.03.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25892111	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000354189300003
J	Carvalho, CMB; Pfundt, R; King, DA; Lindsay, SJ; Zuccherato, LW; Macville, MVE; Liu, PF; Johnson, D; Stankiewicz, P; Brown, CW; Shaw, CA; Hurles, ME; Ira, G; Hastings, PJ; Brunner, HG; Lupski, JR				Carvalho, Claudia M. B.; Pfundt, Rolph; King, Daniel A.; Lindsay, Sarah J.; Zuccherato, Luciana W.; Macville, Merryn V. E.; Liu, Pengfei; Johnson, Diana; Stankiewicz, Pawel; Brown, Chester W.; Shaw, Chad A.; Hurles, Matthew E.; Ira, Grzegorz; Hastings, P. J.; Brunner, Han G.; Lupski, James R.		DDD Study	Absence of Heterozygosity Due to Template Switching during Replicative Rearrangements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAK-INDUCED REPLICATION; LOW-COPY REPEATS; UNIPARENTAL DISOMY; DNA-REPLICATION; NONRECURRENT REARRANGEMENTS; GENOMIC REARRANGEMENTS; INVERTED REPEATS; MECHANISM; TRIPLICATION; RECOMBINATION	We investigated complex genomic rearrangements (CGRs) consisting of triplication copy-number variants (CNVs) that were accompanied by extended regions of copy-number-neutral absence of heterozygosity (AOH) in subjects with multiple congenital abnormalities. Molecular analyses provided observational evidence that in humans, post-zygotically generated CGRs can lead to regional uniparental disomy (UPD) due to template switches between homologs versus sister chromatids by using microhomology to prime DNA replication-a prediction of the replicative repair model, MMBIR. Our findings suggest that replication-based mechanisms might underlie the formation of diverse types of genomic alterations (CGRs and AOH) implicated in constitutional disorders.	[Carvalho, Claudia M. B.; Zuccherato, Luciana W.; Liu, Pengfei; Stankiewicz, Pawel; Brown, Chester W.; Shaw, Chad A.; Ira, Grzegorz; Hastings, P. J.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Carvalho, Claudia M. B.] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Pfundt, Rolph; Brunner, Han G.] Radboud Univ Nijmegen, Inst Mol Life Sci, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [King, Daniel A.; Lindsay, Sarah J.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Macville, Merryn V. E.; Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Johnson, Diana] Sheffield Childrens NHS Fdn Trust, Sheffield Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Brown, Chester W.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brown, Chester W.; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Fundacao Oswaldo Cruz; Radboud University Nijmegen; Wellcome Trust Sanger Institute; Maastricht University; Sheffield Children's NHS Foundation Trust; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Lindsay, Sarah/CAF-4613-2022; Liu, Pengfei/U-9743-2019; King, Daniel/AAM-8024-2021; Pfundt, Rolph/L-4576-2015; Brunner, Han/C-9928-2013; Stankiewicz, Paweł/AAP-7906-2021	Liu, Pengfei/0000-0002-4177-709X; King, Daniel/0000-0001-6451-712X; Stankiewicz, Paweł/0000-0002-6456-7490; Macville, Merryn/0000-0003-1675-2234; Lindsay, Sarah/0000-0002-0965-3070	US National Institute of Neurological Disorders and Stroke [R01NS058529]; National Institute of General Medical Sciences [RO1GM106373, R01GM080600]; National Human Genome Research Institute/National Heart Blood Lung Institute - Baylor Hopkins Center for Mendelian Genomics [U54HG006542, 402520/2012-2]; National Human Genome Research Institute/National Heart Blood Lung Institute - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [U54HG006542, 402520/2012-2]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Cambridge South REC [10/H0305/83]; National Institute for Health Research, through the Comprehensive Clinical Research Network; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106373, R01GM080600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute/National Heart Blood Lung Institute - Baylor Hopkins Center for Mendelian Genomics; National Human Genome Research Institute/National Heart Blood Lung Institute - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Cambridge South REC; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in the study. This work was supported in part by US National Institute of Neurological Disorders and Stroke (R01NS058529 to J.R.L.), the National Institute of General Medical Sciences (RO1GM106373 to P.J.H. and J.R.L. and R01GM080600 to G.I.), the National Human Genome Research Institute/National Heart Blood Lung Institute jointly funded Baylor Hopkins Center for Mendelian Genomics (U54HG006542 to J.R.L.), and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through the Young Investigator fellowship (Science without Borders Program) (grant 402520/2012-2 to C.M.B.C.). The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS, NHGRI/NHBLI, NIH, the Wellcome Trust, or the Department of Health. J.R.L. holds stock ownership in 23andMe, Inc., and Lasergen, Inc., is a paid consultant for Regeneron Pharmaceuticals, and is a co-inventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories.	Beri S, 2013, EUR J HUM GENET, V21, P757, DOI 10.1038/ejhg.2012.235; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Dittwald P, 2013, HUM MUTAT, V34, P210, DOI 10.1002/humu.22217; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Fujita A, 2013, AM J MED GENET A, V161, P1904, DOI 10.1002/ajmg.a.36026; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee PS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000410; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Liu PF, 2014, AM J HUM GENET, V94, P462, DOI 10.1016/j.ajhg.2014.01.017; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Sahoo T, 2015, EUR J HUM GENET, V23, P61, DOI 10.1038/ejhg.2014.53; Shimojima K, 2012, EUR J MED GENET, V55, P400, DOI 10.1016/j.ejmg.2012.02.013; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Soler-Alfonso C, 2014, EUR J HUM GENET, V22, P1071, DOI 10.1038/ejhg.2013.302; SPENCE JE, 1988, AM J HUM GENET, V42, P217; Stern C, 1936, GENETICS, V21, P625; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	36	37	37	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					555	564		10.1016/j.ajhg.2015.01.021	http://dx.doi.org/10.1016/j.ajhg.2015.01.021			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25799105	Green Published, Bronze			2022-12-18	WOS:000352212600004
J	Petrof, G; Nanda, A; Howden, J; Takeichi, T; McMillan, JR; Aristodemou, S; Ozoemena, L; Liu, L; South, AP; Pourreyron, C; Dafou, D; Proudfoot, LE; Al-Ajmi, H; Akiyama, M; McLean, WHI; Simpson, MA; Parsons, M; McGrath, JA				Petrof, Gabriela; Nanda, Arti; Howden, Jake; Takeichi, Takuya; McMillan, James R.; Aristodemou, Sophia; Ozoemena, Linda; Liu, Lu; South, Andrew P.; Pourreyron, Celine; Dafou, Dimitra; Proudfoot, Laura E.; Al-Ajmi, Hejab; Akiyama, Masashi; McLean, W. H. Irwin; Simpson, Michael A.; Parsons, Maddy; McGrath, John A.			Mutations in GRHL2 Result in an Autosomal-Recessive Ectodermal Dysplasia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRAINYHEAD-LIKE 2; TRANSCRIPTION FACTOR FAMILY; DOMINANT HEARING-LOSS; EXPRESSION; HEAD; GENE; MORPHOGENESIS; TFCP2L3; LOOP	Grainyhead-like 2, encoded by GRHL2, is a member of a highly conserved family of transcription factors that play essential roles during epithelial development. Haploinsufficiency for GRHL2 has been implicated in autosomal-dominant deafness, but mutations have not yet been associated with any skin pathology. We investigated two unrelated Kuwaiti families in which a total of six individuals have had lifelong ectodermal defects. The clinical features comprised nail dystrophy or nail loss, marginal palmoplantar keratoderma, hypodontia, enamel hypoplasia, oral hyperpigmentation, and dysphagia. In addition, three individuals had sensorineural deafness, and three had bronchial asthma. Taken together, the features were consistent with an unusual autosomal-recessive ectodermal dysplasia syndrome. Because of consanguinity in both families, we used whole-exome sequencing to search for novel homozygous DNA variants and found GRHL2 mutations common to both families: affected subjects in one family were homozygous for c.1192T>C (p.Tyr398His) in exon 9, and subjects in the other family were homozygous for c.1445T>A (p.Ile482Lys) in exon 11. Immortalized keratinocytes (p.I1e482Lys) showed altered cell morphology, impaired tight junctions, adhesion defects, and cytoplasmic translocation of GRHL2. Whole-skin transcriptomic analysis (p.Ile482Lys) disclosed changes in genes implicated in networks of cell-cell and cell-matrix adhesion. Our clinical findings of an autosomal-recessive ectodermal dysplasia syndrome provide insight into the role of GRHL2 in skin development, homeostasis, and human disease.	[Petrof, Gabriela; Takeichi, Takuya; Proudfoot, Laura E.; McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Nanda, Arti; Al-Ajmi, Hejab] Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait 13001, Kuwait; [Howden, Jake; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 9RT, England; [Takeichi, Takuya; Akiyama, Masashi] Nagoya Univ, Dept Dermatol, Grad Sch Med, Nagoya, Aichi 4668560, Japan; [McMillan, James R.; Aristodemou, Sophia; Ozoemena, Linda; Liu, Lu] St Thomas Hosp, Natl Diagnost Epidermolysis Bullosa Lab, London SE1 7EH, England; [South, Andrew P.; Pourreyron, Celine; McLean, W. H. Irwin; McGrath, John A.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [South, Andrew P.; Pourreyron, Celine; McLean, W. H. Irwin; McGrath, John A.] Univ Dundee, Coll Med Dent & Nursing, Dundee DD1 5EH, Scotland; [Dafou, Dimitra] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Simpson, Michael A.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; Guys Hosp, London SE1 9RT, England	University of London; King's College London; Al Sabah Hospital; University of London; King's College London; Nagoya University; Guy's & St Thomas' NHS Foundation Trust; University of Dundee; University of Dundee; Aristotle University of Thessaloniki; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	McGrath, JA (corresponding author), Kings Coll London, St Johns Inst Dermatol, Guys Campus, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	Akiyama, Masashi/I-1122-2012; Pourreyron, Celine/AAE-7362-2020; Parsons, Maddy/B-2203-2013; Nanda, Arti/H-8565-2019; McGrath, John/N-3529-2019; Petrof, Gabriela/AAO-1375-2021; Dafou, Dimitra/N-6094-2015; McGrath, John/D-6824-2012; Simpson, Michael/F-4737-2011	Parsons, Maddy/0000-0002-2021-8379; Petrof, Gabriela/0000-0001-8113-0373; Dafou, Dimitra/0000-0003-4170-0612; McGrath, John/0000-0002-3708-9964; Simpson, Michael/0000-0002-8539-8753; Nanda, Arti/0000-0002-1223-3181	Wellcome Trust [098439/Z/12/Z]; Biotechnology and Biological Sciences Research Council; Royal Society; UK National Institute for Health Research comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; DebRA UK; Great Britain Sasakawa Foundation [4314]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science [S2404]; Biotechnology and Biological Sciences Research Council [1413607] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); UK National Institute for Health Research comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; King's College London(General Electric); King's College Hospital NHS Foundation Trust; DebRA UK; Great Britain Sasakawa Foundation; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Centre for Dermatology and Genetic Medicine is supported by a Wellcome Trust Strategic Award (reference 098439/Z/12/Z). This work was supported by the Biotechnology and Biological Sciences Research Council, the Royal Society, and the UK National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London and King's College Hospital NHS Foundation Trust. This study was also supported, in part, by DebRA UK, the Great Britain Sasakawa Foundation (award 4314), and the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (S2404) from the Japan Society for the Promotion of Science. We also thank Venu Pullabhatla for assistance with transcriptomic data analysis and access.	Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Blaydon DC, 2013, AM J HUM GENET, V93, P330, DOI 10.1016/j.ajhg.2013.06.008; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Chen W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.190; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Han YC, 2011, HUM MOL GENET, V20, P3213, DOI 10.1093/hmg/ddr234; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Li X, 2013, IND HEALTH, V51, P612, DOI 10.2486/indhealth.2012-0084; Mlacki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089247; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Rifat Y, 2010, DEV BIOL, V345, P237, DOI 10.1016/j.ydbio.2010.07.017; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Tanimizu N, 2013, TISSUE BARRIERS, V1, DOI [10.4161/tisb.23495, 10.1091/mbc.E12-02-0097]; Terrinoni A, 2013, P NATL ACAD SCI USA, V110, P7300, DOI 10.1073/pnas.1214498110; Terrinoni A, 2010, BIOCHEM BIOPH RES CO, V395, P25, DOI 10.1016/j.bbrc.2010.03.098; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Varma S, 2014, AM J PHYSIOL-LUNG C, V306, pL405, DOI 10.1152/ajplung.00143.2013; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Vona B, 2013, AM J MED GENET A, V161, P2060, DOI 10.1002/ajmg.a.36017; Werner S, 2013, J BIOL CHEM, V288, P22993, DOI 10.1074/jbc.M113.456293; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Xiang JF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0714-5	30	37	42	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					308	314		10.1016/j.ajhg.2014.08.001	http://dx.doi.org/10.1016/j.ajhg.2014.08.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25152456	Green Published, hybrid			2022-12-18	WOS:000341404100007
J	Rosenthal, EA; Ranchalis, J; Crosslin, DR; Burt, A; Brunzell, JD; Motusky, AG; Nickerson, DA; Wijsman, EM; Jarvik, GP				Rosenthal, Elisabeth A.; Ranchalis, Jane; Crosslin, David R.; Burt, Amber; Brunzell, John D.; Motusky, Arno G.; Nickerson, Deborah A.; Wijsman, Ellen M.; Jarvik, Gail P.		NHLBI GO Exome Sequencing Project	Joint Linkage and Association Analysis with Exome Sequence Data Implicates SLC2SA40 in Hypertriglyceridemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-C-III; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; LARGE PEDIGREES; ARTERY-DISEASE; LIPID-LEVELS; A-V; RISK	Hypertriglyceridemia (HTG) is a heritable risk factor for cardiovascular disease. Investigating the genetics of HTG may identify new drug targets. There are similar to 35 known single-nucleotide variants (SNVs) that explain only similar to 10% of variation in triglyceride (TG) level. Because of the genetic heterogeneity of HTG, a family study design is optimal for identification of rare genetic variants with large effect size because the same mutation can be observed in many relatives and cosegregation with TG can be tested. We considered HTG in a five-generation family of European American descent (n = 121), ascertained for familial combined hyperlipidemia. By using Bayesian Markov chain Monte Carlo joint oligogenic linkage and association analysis, we detected linkage to chromosomes 7 and 17. Whole-exome sequence data revealed shared, highly conserved, private missense SNVs in both SLC25A40 on chr7 and PLD2 on chr17. Jointly, these SNVs explained 49% of the genetic variance in TG; however, only the SLC25A40 SNV was significantly associated with TG (p = 0.0001). This SNV, c.374A>G, causes a highly disruptive p.Tyr125Cys substitution just outside the second helical transmembrane region of the SLC25A40 inner mitochondrial membrane transport protein. Whole-gene testing in subjects from the Exome Sequencing Project confirmed the association between TG and SLC25A40 rare, highly conserved, coding variants (p = 0.03). These results suggest a previously undescribed pathway for HTG and illustrate the power of large pedigrees in the search for rare, causal variants.	[Rosenthal, Elisabeth A.; Ranchalis, Jane; Burt, Amber; Motusky, Arno G.; Wijsman, Ellen M.; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Crosslin, David R.; Motusky, Arno G.; Nickerson, Deborah A.; Wijsman, Ellen M.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Brunzell, John D.] Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rosenthal, EA (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	erosen@uw.edu	de Bakker, Paul IW/B-8730-2009; Barbalić, Maja/E-2161-2017; Jarvik, Gail P/N-6476-2014; Singleton, Andrew B/C-3010-2009	de Bakker, Paul IW/0000-0001-7735-7858; Barbalić, Maja/0000-0001-8914-1691; Jarvik, Gail P/0000-0002-6710-8708; O'Connor, Timothy/0000-0002-0276-1896; Shendure, Jay/0000-0002-1516-1865; Ballantyne, Christie/0000-0002-6432-1730; Seshadri, Sudha/0000-0001-6135-2622; Wijsman, Ellen/0000-0002-2725-6669; Akey, Joshua/0000-0002-4411-1330; Quinlan, Aaron/0000-0003-1756-0859; Bustamante, Carlos D./0000-0002-4187-7920; Turner, Emily/0000-0001-9040-9229; Caan, Bette/0000-0002-5803-310X	National Institutes of Health [P01 HL030086, T32 GM007454, R01 HL094976]; State of Washington Life Sciences Discovery Fund [265508]; National Heart, Lung, and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; National Heart, Lung, and Blood Institute [HHSN268201100037C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, RC2HL102924, RC2HL102923, P01HL030086, RC2HL102925, R01HL094976, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Washington Life Sciences Discovery Fund; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Thanks go to Peter Byers for his helpful comments. Funding for this analysis was provided by National Institutes of Health grants P01 HL030086, T32 GM007454, and R01 HL094976 and the State of Washington Life Sciences Discovery Fund award to the Northwest Institute of Genetic Medicine (grant 265508). The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI) and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Genotyping services were provided through the RS&G Service by the Northwest Genomics Center at the University of Washington, Department of Genome Sciences, under US Federal Government contract number HHSN268201100037C from the National Heart, Lung, and Blood Institute.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; Baroukh N, 2004, ARTERIOSCL THROM VAS, V24, P1297, DOI 10.1161/01.ATV.0000130463.68272.1d; Bi N, 2004, MOL GENET METAB, V83, P280, DOI 10.1016/j.ymgme.2004.06.017; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Bruckert E, 2011, J CARDIOVASC PHARM, V57, P267, DOI 10.1097/FJC.0b013e318202709f; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dallongeville J, 2006, INT J CARDIOL, V106, P152, DOI 10.1016/j.ijcard.2004.10.065; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; De La Vega FM, 2002, BIOTECHNIQUES, P48; Ford ES, 2009, ARCH INTERN MED, V169, P572, DOI 10.1001/archinternmed.2008.599; Gagnon F, 2005, HUM GENET, V117, P494, DOI 10.1007/s00439-005-1338-4; Gagnon F, 2003, HUM GENET, V113, P522, DOI 10.1007/s00439-003-1006-5; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; GOLDSTEIN JL, 1975, P NATL ACAD SCI USA, V72, P1092, DOI 10.1073/pnas.72.3.1092; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Kohli P, 2012, MED CLIN N AM, V96, P39, DOI 10.1016/j.mcna.2011.11.006; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lee M, 2011, ATHEROSCLEROSIS, V217, P492, DOI 10.1016/j.atherosclerosis.2011.04.020; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nilsson SK, 2011, ATHEROSCLEROSIS, V219, P15, DOI 10.1016/j.atherosclerosis.2011.07.019; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pontius J., 2003, NCBI HDB, P1; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rosenthal EA, 2011, J LIPID RES, V52, P1837, DOI 10.1194/jlr.P016576; Russo GT, 2001, ATHEROSCLEROSIS, V158, P173, DOI 10.1016/S0021-9150(01)00409-9; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; US Dept of Health and Human Services, 1980, LIP RES CLIN POP STU, V1; Vaessen SFC, 2006, J LIPID RES, V47, P2064, DOI 10.1194/jlr.M600233-JLR200; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Warnick G R, 1986, Methods Enzymol, V129, P101; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P270, DOI 10.1111/j.1742-1241.2011.02867.x; Wijsman EM, 2012, HUM GENET, V131, P1555, DOI 10.1007/s00439-012-1190-2; Wijsman EM, 2010, HUM GENET, V127, P705, DOI 10.1007/s00439-010-0819-2; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Yu D., 2003, THESIS U WASHINGTON	67	37	38	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1035	1045		10.1016/j.ajhg.2013.10.019	http://dx.doi.org/10.1016/j.ajhg.2013.10.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268658	Green Published, Bronze			2022-12-18	WOS:000328521300004
J	Aufenvenne, K; Larcher, F; Hausser, I; Duarte, B; Oji, V; Nikolenko, H; Del Rio, M; Dathe, M; Traupe, H				Aufenvenne, Karin; Larcher, Fernando; Hausser, Ingrid; Duarte, Blanca; Oji, Vinzenz; Nikolenko, Heike; Del Rio, Marcela; Dathe, Margitta; Traupe, Heiko			Topical Enzyme-Replacement Therapy Restores Transglutaminase 1 Activity and Corrects Architecture of Transglutaminase-1-Deficient Skin Grafts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E-DERIVED PEPTIDE; LAMELLAR ICHTHYOSIS; CELLULAR UPTAKE; MICE LACKING; GENE; DELIVERY; MUTATIONS; LIPOSOMES; MODEL; TAZAROTENE	Transglutaminase-1 (TG1)-deficient autosomal-recessive congenital ichthyosis (ARCI) is a rare and severe genetic skin disease caused by mutations in TGM1. It is characterized by collodion babies at birth, dramatically increased transepidermal water loss (TEWL), and lifelong pronounced scaling. The disease has a tremendous burden, including the problem of stigmatization. Currently, no therapy targeting the molecular cause is available, and the therapeutic situation is deplorable. In this study, we developed the basis for a causative therapy aiming at the delivery of the enzyme to the inner site of the keratinocytes' plasma membrane. We prepared sterically stabilized liposomes with encapsulated recombinant human TG1 (rhTG1) and equipped with a highly cationic lipopeptide vector to mediate cellular uptake. The liposomes overcame the problems of insufficient cutaneous delivery and membrane penetration and provided excellent availability and activity of rhTG1 in primary keratinocytes. To demonstrate the general feasibility of this therapeutic approach in a humanized context, we used a skin-humanized mouse model. Treatment with rhTG1 liposomes resulted in considerable improvement of the ichthyosis phenotype and in normalization of the regenerated ARCI skin: in situ monitoring showed a restoration of TG1 activity, and cholesterol clefts vanished ultrastructurally. Measurement of TEWL revealed a restoration of epidermal barrier function. We regard this aspect as a major advance over available nonspecific approaches making use of, for example, retinoid creams. We conclude that this topical approach is a promising strategy for restoring epidermal integrity and barrier function and provides a causal cure for individuals with TG1 deficiency.	[Aufenvenne, Karin; Oji, Vinzenz; Traupe, Heiko] Univ Hosp Munster, Dept Dermatol, D-48149 Munster, Germany; [Larcher, Fernando; Duarte, Blanca; Del Rio, Marcela] Ctr Invest Energet Medioambientales & Technol, Epithelial Biomed Div, Madrid 28040, Spain; [Larcher, Fernando; Duarte, Blanca; Del Rio, Marcela] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28040, Spain; [Hausser, Ingrid] Univ Heidelberg Hosp, Dept Dermatol, D-69120 Heidelberg, Germany; [Hausser, Ingrid] Heidelberg Univ, Electron Microscopy Core Facil, D-69120 Heidelberg, Germany; [Hausser, Ingrid] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Nikolenko, Heike; Dathe, Margitta] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Del Rio, Marcela] Univ Carlos III Madrid, Dept Biomed Engn, Madrid 28040, Spain	University of Munster; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Universidad Carlos III de Madrid	Traupe, H (corresponding author), Univ Hosp Munster, Dept Dermatol, D-48149 Munster, Germany.	karin_aufenvenne@yahoo.de; traupeh@ukmuenster.de	Larcher, Fernando/J-1527-2016; DEL RIO, MARCELA/H-2796-2015	Larcher, Fernando/0000-0002-6771-3561; DEL RIO, MARCELA/0000-0003-2910-7189; Oji, Vinzenz/0000-0003-1380-4828	Bundesministerium fur Bildung und Forschung as part of the Network for Ichthyosis and Related Keratinization Disorders (NIRK) [01GM0901, 01GM0902]; Foundation for Ichthyosis and Related Skin Types; Selbsthilfe Ichthyose e.V.; Instituto de Salud Carlos III [PI11/1225]; Ministerio de Ciencia y Innovacion [SAF2010-16976]; Deutsche Forschungsgemeinschaft [DA 324/9-1];  [S2010/BMD-2359]	Bundesministerium fur Bildung und Forschung as part of the Network for Ichthyosis and Related Keratinization Disorders (NIRK)(Federal Ministry of Education & Research (BMBF)); Foundation for Ichthyosis and Related Skin Types; Selbsthilfe Ichthyose e.V.; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia y Innovacion(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the Bundesministerium fur Bildung und Forschung as part of the Network for Ichthyosis and Related Keratinization Disorders (NIRK) (grants 01GM0901 and 01GM0902), the Foundation for Ichthyosis and Related Skin Types, and the Selbsthilfe Ichthyose e.V. F.L. was supported in part by the Instituto de Salud Carlos III (grant PI11/1225) and by grant S2010/BMD-2359 from C.M. M.D.R. was supported by the Ministerio de Ciencia y Innovacion (grant SAF2010-16976). The work of M.D. was partially supported by Deutsche Forschungsgemeinschaft (grant DA 324/9-1). We are very grateful to all individuals who participated in the study. Primary normal human keratinocytes for uptake studies were kindly provided by the Institute of Pharmacy of Freie Universitat Berlin. The excellent technical assistance of Androniki Kolovou is gratefully acknowledged, and Katrin Jordan is thanked very much for the biophysical characterization of the liposomal formulations. Very special thanks go to Brigitte Willis for her excellent work as the coordinator of the NIRK. The European commission has awarded an orphan drug designation for the therapeutic modality described in this article (http://www.ema.europa.eu/ema).	Aufenvenne K, 2012, J INVEST DERMATOL, V132, P1918, DOI 10.1038/jid.2012.65; Aufenvenne K, 2009, J INVEST DERMATOL, V129, P2068, DOI 10.1038/jid.2009.18; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Choate KA, 1997, HUM GENE THER, V8, P1659, DOI 10.1089/hum.1997.8.14-1659; Choate KA, 1996, NAT MED, V2, P1263, DOI 10.1038/nm1196-1263; DAMEN J, 1981, BIOCHIM BIOPHYS ACTA, V665, P538, DOI 10.1016/0005-2760(81)90268-X; de Leeuw J, 2009, J EUR ACAD DERMATOL, V23, P505, DOI 10.1111/j.1468-3083.2009.03100.x; DEDUVE C, 1964, J THEOR BIOL, V6, P33, DOI 10.1016/0022-5193(64)90065-7; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; DUPLESSIS J, 1992, ANTIVIR RES, V18, P259, DOI 10.1016/0166-3542(92)90059-E; Farasat S, 2009, J MED GENET, V46, P103, DOI 10.1136/jmg.2008.060905; Fireman S, 2011, DERMATOL THER, V24, P477, DOI 10.1111/j.1529-8019.2012.01464.x; GOLDSMITH LA, 1983, J INVEST DERMATOL, V80, pS39, DOI 10.1111/1523-1747.ep12537077; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Hofmann B, 1999, BRIT J DERMATOL, V141, P642; John S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034252; Kamalpour L, 2011, PEDIATR DERMATOL, V28, P512, DOI 10.1111/j.1525-1470.2011.01432.x; Keller S, 2005, ANGEW CHEM INT EDIT, V44, P5252, DOI 10.1002/anie.200500519; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI13563; Laiho E, 1999, EUR J HUM GENET, V7, P625, DOI 10.1038/sj.ejhg.5200353; Leupold E, 2009, BBA-BIOMEMBRANES, V1788, P442, DOI 10.1016/j.bbamem.2008.11.025; Leupold E, 2008, BBA-BIOMEMBRANES, V1778, P2781, DOI 10.1016/j.bbamem.2008.09.008; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Marulli GC, 2003, CLIN EXP DERMATOL, V28, P391, DOI 10.1046/j.1365-2230.2003.01318.x; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mufamadi MS, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/939851; Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Oji V, 2006, BRIT J DERMATOL, V154, P860, DOI 10.1111/j.1365-2133.2005.07109.x; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Okuyama T, 2010, MOL GENET METAB, V99, P18, DOI 10.1016/j.ymgme.2009.08.006; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; Raghunath M, 1998, ARCH DERMATOL RES, V290, P621, DOI 10.1007/s004030050362; RICE RH, 1990, BIOCHEM J, V265, P351, DOI 10.1042/bj2650351; Pierre MBR, 2011, ARCH DERMATOL RES, V303, P607, DOI 10.1007/s00403-011-1166-4; Rodriguez-Pazos L, 2011, BRIT J DERMATOL, V165, P906, DOI 10.1111/j.1365-2133.2011.10454.x; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sauer I, 2006, BBA-BIOMEMBRANES, V1758, P552, DOI 10.1016/j.bbamem.2006.03.017; Schaefer RM, 2009, DRUGS, V69, P2179, DOI 10.2165/11318300-000000000-00000; Steinert PM, 1996, BIOCHEM BIOPH RES CO, V221, P101, DOI 10.1006/bbrc.1996.0552; Tanaka N, 2001, INTERNAL MED, V40, P716, DOI 10.2169/internalmedicine.40.716	42	37	40	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					620	630		10.1016/j.ajhg.2013.08.003	http://dx.doi.org/10.1016/j.ajhg.2013.08.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24055110	Bronze, Green Published			2022-12-18	WOS:000326305600004
J	Delio, M; Guo, TW; McDonald-McGinn, DM; Zackai, E; Herman, S; Kaminetzky, M; Higgins, AM; Coleman, K; Chow, C; Jarlbrzkowski, M; Bearden, CE; Bailey, A; Vangkilde, A; Olsen, L; Olesen, C; Skovby, F; Werge, TM; Templin, L; Busa, T; Philip, N; Swillen, A; Vermeesch, JR; Devriendt, K; Schneider, M; Dahoun, S; Eliez, S; Schoch, K; Hooper, SR; Shashi, V; Samanich, J; Marion, R; van Amelsvoort, T; Boot, E; Klaassen, P; Duijff, SN; Vorstman, J; Yuen, T; Silversides, C; Chow, E; Bassett, A; Frisch, A; Weizman, A; Gothelf, D; Niarchou, M; van den Bree, M; Owen, MJ; Suner, DH; Andreo, JR; Armando, M; Vicari, S; Digilio, MC; Auton, A; Kates, WR; Wang, T; Shprintzen, RJ; Emanuel, BS; Morrow, BE				Delio, Maria; Guo, Tingwei; McDonald-McGinn, Donna M.; Zackai, Elaine; Herman, Sean; Kaminetzky, Mark; Higgins, Anne Marie; Coleman, Karlene; Chow, Carolyn; Jarlbrzkowski, Maria; Bearden, Carrie E.; Bailey, Alice; Vangkilde, Anders; Olsen, Line; Olesen, Charlotte; Skovby, Flemming; Werge, Thomas M.; Templin, Ludivine; Busa, Tiffany; Philip, Nicole; Swillen, Ann; Vermeesch, Joris R.; Devriendt, Koen; Schneider, Maude; Dahoun, Sophie; Eliez, Stephan; Schoch, Kelly; Hooper, Stephen R.; Shashi, Vandana; Samanich, Joy; Marion, Robert; van Amelsvoort, Therese; Boot, Erik; Klaassen, Petra; Duijff, Sasja N.; Vorstman, Jacob; Yuen, Tracy; Silversides, Candice; Chow, Eva; Bassett, Anne; Frisch, Amos; Weizman, Abraham; Gothelf, Doron; Niarchou, Maria; van den Bree, Marianne; Owen, Michael J.; Heine Suner, Damian; Rosell Andreo, Jordi; Armando, Marco; Vicari, Stefano; Digilio, Maria Cristina; Auton, Adam; Kates, Wendy R.; Wang, Tao; Shprintzen, Robert J.; Emanuel, Beverly S.; Morrow, Bernice E.		Int 22Q11 2 Consortium	Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; WILLIAMS-BEUREN-SYNDROME; COPY-NUMBER VARIANTS; GENETIC-LINKAGE MAP; CHROMOSOME 22Q11; HUMAN GENOME; INVERSION POLYMORPHISM; MOLECULAR DEFINITION; DEVELOPMENTAL DELAY; NF1 GENE	Velocardiofacial and DiGeorge syndromes, also known as 22q11.2 deletion syndrome (22q11DS), are congenital-anomaly disorders caused by a de novo hemizygous 22q11.2 deletion mediated by meiotic nonallelic homologous recombination events between low-copy repeats, also known as segmental duplications. Although previous studies exist, each was of small size, and it remains to be determined whether there are parent-of-origin biases for the de novo 22q11.2 deletion. To address this question, we genotyped a total of 389 DNA samples from 22q11DS-affected families. A total of 219 (56%) individuals with 22q11DS had maternal origin and 170 (44%) had paternal origin of the de novo deletion, which represents a statistically significant bias for maternal origin (p = 0.0151). Combined with many smaller, previous studies, 465 (57%) individuals had maternal origin and 345 (43%) had paternal origin, amounting to a ratio of 1.35 or a 35% increase in maternal compared to paternal origin (p = 0.000028). Among 1,892 probands with the de novo 22q11.2 deletion, the average maternal age at time of conception was 29.5, and this is similar to data for the general population in individual countries. Of interest, the female recombination rate in the 22q11.2 region was about 1.6-1.7 times greater than that for males, suggesting that for this region in the genome, enhanced meiotic recombination rates, as well as other as-of-yet undefined 22q11.2-specific features, could be responsible for the observed excess in maternal origin.	[Delio, Maria; Guo, Tingwei; Herman, Sean; Kaminetzky, Mark; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet Pediat & Obstet & Gynecol, Bronx, NY 10461 USA; [Delio, Maria; Guo, Tingwei; Herman, Sean; Kaminetzky, Mark; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY 10461 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine; Bailey, Alice; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine; Bailey, Alice; Emanuel, Beverly S.; Morrow, Bernice E.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Zackai, Elaine; Emanuel, Beverly S.; Morrow, Bernice E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Higgins, Anne Marie; Shprintzen, Robert J.] Virtual Ctr Velocardiofacial Syndrome, Manlius, NY 13104 USA; [Coleman, Karlene] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Coleman, Karlene] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Chow, Carolyn; Jarlbrzkowski, Maria; Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Chow, Carolyn; Jarlbrzkowski, Maria; Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Vangkilde, Anders; Olsen, Line; Werge, Thomas M.] Univ Copenhagen, Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, DK-4000 Copenhagen, Denmark; [Olesen, Charlotte] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Skovby, Flemming; Templin, Ludivine; Busa, Tiffany] Copenhagen Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Philip, Nicole] Hop Enfants La Timone, Assistance Publ Hop Marseille, F-13005 Marseille, France; [Swillen, Ann; Vermeesch, Joris R.; Devriendt, Koen] Katholieke Univ Leuven, Ctr Human Genet, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Schneider, Maude; Dahoun, Sophie; Eliez, Stephan] Univ Geneva, Off Medicopedag Res Unit, Sch Med, CH-1211 Geneva, Switzerland; [Schoch, Kelly; Shashi, Vandana] Duke Univ, Div Med Genet, Dept Pediat, Med Ctr, Durham, NC 27705 USA; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27514 USA; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27514 USA; [Hooper, Stephen R.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC 27705 USA; [Samanich, Joy; Marion, Robert] Montefiore Med Ctr, Dept Pediat, Bronx, NY 10461 USA; [van Amelsvoort, Therese] Univ Maastricht, Dept Psychiat & Psychol, NL-6211 Maastricht, Netherlands; [Boot, Erik] Acad Med Ctr, Dept Psychiat, NL-1100 Amsterdam, Netherlands; [Klaassen, Petra; Duijff, Sasja N.] Univ Med Ctr Utrecht, Dept Pediat Psychol, NL-3584 Utrecht, Netherlands; [Vorstman, Jacob] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 Utrecht, Netherlands; [Yuen, Tracy; Silversides, Candice; Chow, Eva; Bassett, Anne] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; [Frisch, Amos] Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Weizman, Abraham; Gothelf, Doron] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Niarchou, Maria; van den Bree, Marianne; Owen, Michael J.] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Cardiff CF14 4XN, S Glam, Wales; [Niarchou, Maria; van den Bree, Marianne; Owen, Michael J.] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF14 4XN, S Glam, Wales; [Heine Suner, Damian; Rosell Andreo, Jordi] Univ Hosp Son Espases, Mol Genet Lab, Dept Genet, Palma de Mallorca 07020, Spain; [Armando, Marco; Vicari, Stefano] Bambino Gesu Pediat Hosp, Child Neuropsychiat Unit, Dept Neurosci, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy; [Digilio, Maria Cristina] Bambino Gesu Pediat Hosp, Med Genet Unit, Dept Pediat, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy; [Auton, Adam] Albert Einstein Coll Med, Div Computat Genet, Dept Genet, Bronx, NY 10461 USA; [Kates, Wendy R.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Children's Healthcare of Atlanta (CHOA); Emory University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Copenhagen; Aarhus University; University of Copenhagen; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; KU Leuven; University Hospital Leuven; University of Geneva; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Maastricht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Cardiff University; Cardiff University; Hospital Universitari Son Espases; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Yeshiva University; Albert Einstein College of Medicine	Morrow, BE (corresponding author), Albert Einstein Coll Med, Dept Genet Pediat & Obstet & Gynecol, Bronx, NY 10461 USA.	bernice.morrow@einstein.yu.edu	Philip, Nicole/I-2881-2016; Vicari, Stefano/J-3008-2012; Digilio, Maria Cristina/AAI-2434-2019; Weizman, Abraham/AAK-6450-2020; McDonald-McGinn, Donna/L-8643-2019; Silversides, Candice K/D-8967-2017; Suñer, Damian Heine/AAW-9664-2020; Boot, Erik/AAV-8592-2021; Heine-Suñer, Damian/J-8045-2012; Hooper, Stephen/X-8171-2019; Niarchou, Maria/C-2275-2013	Weizman, Abraham/0000-0002-9765-8938; Suñer, Damian Heine/0000-0001-9374-1219; Boot, Erik/0000-0002-0593-1539; Heine-Suñer, Damian/0000-0001-9374-1219; McDonald-McGinn, Donna/0000-0003-4077-250X; Niarchou, Maria/0000-0002-8855-7393; Armando, Marco/0000-0001-7074-7212; Schneider, Maude/0000-0001-7147-8915; BUSA, Tiffany/0000-0003-4454-1979; Vermeesch, Joris/0000-0002-3071-1191; Bearden, Carrie/0000-0002-8516-923X; Morrow, Bernice/0000-0002-8076-4726; Swillen, Ann/0000-0003-4258-4537; van den Bree, Marianne/0000-0002-4426-3254; Vicari, Stefano/0000-0002-5395-2262	National Institutes of Health [HL84410, HD070454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085953, R01MH064824] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the individuals and family members for participating in this study. We also thank the many clinical support staff for their significant effort in obtaining informed consent and blood or saliva specimens. We appreciate technical assistance by Jidong Shan and Ms. Debbie Lewis in the Molecular Cytogenetics Core at the Albert Einstein College of Medicine. We appreciate the technical support from our summer student, Levi Teitz. We acknowledge Sylvie Laglois (BC Children's Hospital, Vancouver, BC, Candada), Sarah Dyack (IWK Health Centre, Halifax, NS, Canada), and Rosanna Weksberg (Hispital for Sick Children, Toronto, ON, Canada) for collaboration with Eva Chow. We also thank David Reynolds and Kevin Lau for performing Sequenom assays in the Genomics Core at the Albert Einstein College of Medicine. We acknowledge National Institutes of Health grants HL84410 and HD070454, which provided funds for this research.	Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Dutra RL, 2011, CLINICS, V66, P959, DOI 10.1590/S1807-59322011000600007; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Gebhardt GS, 2003, EUR J HUM GENET, V11, P109, DOI 10.1038/sj.ejhg.5200930; GILBERTDUSSARDIER B, 1995, AM J HUM GENET, V56, P542; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glaser Rivka L., 2009, P485, DOI 10.1007/978-1-59745-440-7_26; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; GUYER M, 1992, SCIENCE, V258, P67; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hobart HH, 2010, AM J MED GENET C, V154C, P220, DOI 10.1002/ajmg.c.30258; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kuczmarski JM, 2011, EXP BIOL MED, V236, P1085, DOI 10.1258/ebm.2011.011008; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Liu PF, 2011, AM J HUM GENET, V89, P580, DOI 10.1016/j.ajhg.2011.09.009; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; METSCH LR, 1995, J PSYCHOACTIVE DRUGS, V27, P73, DOI 10.1080/02791072.1995.10471675; MORROW B, 1995, AM J HUM GENET, V56, P1391; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Robinson WP, 1996, GENOMICS, V34, P17, DOI 10.1006/geno.1996.0237; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shprintzen RJ, 2005, CURR OPIN PEDIATR, V17, P725, DOI 10.1097/01.mop.0000184465.73833.0b; Sibbons C, 2012, EUR J HUM GENET, V20, P155, DOI 10.1038/ejhg.2011.182; Thomas NS, 2006, HUM GENET, V119, P444, DOI 10.1007/s00439-006-0157-6; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; Urban Z, 1996, AM J HUM GENET, V59, P958; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	44	37	44	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					439	447		10.1016/j.ajhg.2013.01.018	http://dx.doi.org/10.1016/j.ajhg.2013.01.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23453669	Green Published, Bronze			2022-12-18	WOS:000316161700018
J	Evans, BR; Mosig, RA; Lobl, M; Martignetti, CR; Camacho, C; Grum-Tokars, V; Glucksman, MJ; Martignetti, JA				Evans, Brad R.; Mosig, Rebecca A.; Lobl, Mollie; Martignetti, Chiara R.; Camacho, Catalina; Grum-Tokars, Valerie; Glucksman, Marc J.; Martignetti, John A.			Mutation of Membrane Type-1 Metalloproteinase, MT1-MMP, Causes the Multicentric Osteolysis and Arthritis Disease Winchester Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIGNAL PEPTIDE; MICE; SKELETAL; MATRIX	The "vanishing bone" syndromes represent a group of rare skeletal disorders characterized by osteolysis and joint destruction, which can mimic severe rheumatoid arthritis. Winchester syndrome was one of the first recognized autosomal-recessive, multicentric forms of the disorder. It was originally described nearly 50 years ago in two sisters with a severe crippling osteolysis. Using cultured fibroblasts from the proband, we have now identified homozygous mutations in membrane type-1 metalloproteinase (MT1-MMP or MMP14). We demonstrate that the resulting hydrophobic-region signal-peptide substitution (p.Thr17Arg) decreases MT1-MMP membrane localization with consequent impairment of pro-MMP2 activation, and we propose a structure-based mechanism for this effect.	[Evans, Brad R.; Mosig, Rebecca A.; Lobl, Mollie; Martignetti, Chiara R.; Camacho, Catalina; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Grum-Tokars, Valerie; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, N Chicago, IL USA; [Grum-Tokars, Valerie; Glucksman, Marc J.] Chicago Med Sch, N Chicago, IL USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; Chicago Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu			NCRR NIH HHS [P41 RR001646] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jarjanazi H, 2008, PROTEINS, V70, P394, DOI 10.1002/prot.21548; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Mosig R. A., 2008, INBORN ERRORS DEV MO, P1453; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Vu TH, 2001, NAT GENET, V28, P202, DOI 10.1038/90023; WINCHESTER P, 1969, AMER J ROENTGENOL RA, V106, P121, DOI 10.2214/ajr.106.1.121; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	11	37	39	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					572	576		10.1016/j.ajhg.2012.07.022	http://dx.doi.org/10.1016/j.ajhg.2012.07.022			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22922033	Bronze, Green Published			2022-12-18	WOS:000308683100019
J	Min, BJ; Kim, N; Chung, T; Kim, OH; Nishimura, G; Chung, CY; Song, HR; Kim, HW; Lee, HR; Kim, J; Kang, TH; Seo, ME; Yang, SD; Kim, DH; Lee, SB; Kim, JI; Seo, JS; Choi, JY; Kang, D; Kim, D; Park, WY; Cho, TJ				Min, Byung-Joo; Kim, Namshin; Chung, Taesu; Kim, Ok-Hwa; Nishimura, Gen; Chung, Chin Youb; Song, Hae Ryong; Kim, Hyun Woo; Lee, Hye Ran; Kim, Jiwoong; Kang, Tae-Hoon; Seo, Myung-Eui; Yang, San-Deok; Kim, Do-Hwan; Lee, Seung-Bok; Kim, Jong-Il; Seo, Jeong-Sun; Choi, Ji-Yeob; Kang, Daehee; Kim, Dongsup; Park, Woong-Yang; Cho, Tae-Joon			Whole-Exome Sequencing Identifies Mutations of KIF22 in Spondyloepimetaphyseal Dysplasia with Joint Laxity, Leptodactylic Type	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISLOCATIONS HALL TYPE; GENETIC SKELETAL DISORDERS; MULTIPLE DISLOCATIONS; DOMINANT INHERITANCE; DIAGNOSTIC FEATURE; DISTINCT FORM; KINESIN; DNA; CLASSIFICATION; ALIGNMENT	Spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL), leptodactylic (lepto-SEMDJL) or Hall type, is an autosomal-dominant skeletal dysplasia manifesting with short stature, joint laxity with dislocation(s), limb malalignment, and spinal deformity. Its causative gene mutation has not yet been discovered. We captured and sequenced the exomes of eight affected individuals in six unrelated kindreds (three individuals in a family and five simplex individuals). Five novel sequence variants in KIF22, which encodes a member of the kinesin-like protein family, were identified in seven individuals. Sanger sequencing of KIF22 confirmed that c.443C>T (p.Pro148Ser) cosegregated with the phenotype in the affected individuals in the family; c.442C>T (p.Pro148Leu) or c.446G>A (p.Arg149Gln) was present in four of five simplex individuals, but was absent in unaffected individuals in their family and 505 normal cohorts. KIF22 mRNA was detected in human bone, cartilage, joint capsule, ligament, skin, and primary cultured chondrocytes. In silico analysis of KIF22 protein structure indicates that Pro148 and Arg149 are important in maintaining hydrogen bonds in the ATP binding and motor domains of KIF22. We conclude that these mutations in KIF22 cause lepto-SEMDJL.	[Min, Byung-Joo; Kang, Tae-Hoon; Seo, Myung-Eui; Yang, San-Deok; Kim, Do-Hwan; Lee, Seung-Bok; Kim, Jong-Il; Seo, Jeong-Sun; Choi, Ji-Yeob; Kang, Daehee; Park, Woong-Yang] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul 110799, South Korea; [Chung, Chin Youb; Lee, Hye Ran; Cho, Tae-Joon] Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, Seoul 110799, South Korea; [Kim, Namshin; Kim, Jiwoong] Korea Res Inst Bioscience & Biotechnol, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Chung, Taesu; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Ok-Hwa] Ajou Univ Hosp, Dept Radiol, Suwon 443721, Kyunggi, South Korea; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo 2048567, Japan; [Song, Hae Ryong] Korea Univ, Dept Orthopaed Surg, Guro Hosp, Seoul 152703, South Korea; [Kim, Hyun Woo] Yonsei Univ, Dept Orthopaed Surg, Severance Childrens Hosp, Seoul 120752, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Ajou University; Ajou University Hospital; Tokyo Metropolitan Children's Medical Center; Korea University; Korea University Medicine (KU Medicine); Yonsei University	Park, WY (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul 110799, South Korea.	wypark@snu.ac.kr; tjcho@snu.ac.kr	Choi, Ji-Yeob/J-2796-2012; Chung, Chin Youb/J-5648-2012; Kim, Namshin/Q-6491-2017; Seo, Jeong-Sun/J-2763-2012; Kim, Dongsup/C-1612-2011; park, woongyang/D-5727-2012; Kang, Dae Hee/E-8631-2012; Cho, Tae-Joon/I-9355-2012; KIM, JONG-IL/D-1019-2011; Yang, San-Duk/GWZ-5491-2022	Kim, Namshin/0000-0001-6361-274X; Cho, Tae-Joon/0000-0001-8514-377X; KIM, JONG-IL/0000-0002-7240-3744; Seungbok, Lee/0000-0002-3145-8714; Yang, San-Duk/0000-0002-1276-365X; Kang, Daehee/0000-0003-4031-5878; Kang, Tae Hoon/0000-0003-0127-9456; Kim, Do-Hwan/0000-0003-4137-7130; Kim, Hyun Woo/0000-0001-8576-1877	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The authors deeply appreciate Andrea Superti-Furga and Sheila Unger for reviewing the affected individuals, Murim Choi and Charles Lee for reading the manuscript, and Soong Deok Lee for helping DNA preparation. This study was supported by a grant from the Korea Healthcare Technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (No A080588).	[Anonymous], PYMOL MOL GRAPH SYST; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Hall CM, 2002, J MED GENET, V39, P666, DOI 10.1136/jmg.39.9.666; Hall CM, 1998, J MED GENET, V35, P566, DOI 10.1136/jmg.35.7.566; Holder-Espinasse M, 2004, CLIN DYSMORPHOL, V13, P133, DOI 10.1097/01.mcd.0000130236.02981.c5; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim OH, 2009, SKELETAL RADIOL, V38, P803, DOI 10.1007/s00256-009-0671-4; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Megarbane A, 2003, AM J MED GENET A, V122A, P252, DOI 10.1002/ajmg.a.20262; Nishimura G, 2003, AM J MED GENET A, V117A, P147, DOI 10.1002/ajmg.a.10927; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Park SM, 2007, AM J MED GENET A, V143A, P2024, DOI 10.1002/ajmg.a.31857; Rossi M, 2005, CLIN DYSMORPHOL, V14, P13, DOI 10.1097/00019605-200501000-00003; SALL A, 1993, J MOL BIOL, V234, P779; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; *UCSC, 2009, UCSC DAT VERS HG19 N; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Zanders S, 2010, GENETICS, V186, P493, DOI 10.1534/genetics.110.120105; CONSENSUS CODING SEQ	30	37	43	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					760	766		10.1016/j.ajhg.2011.10.015	http://dx.doi.org/10.1016/j.ajhg.2011.10.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152677	Green Published, Bronze			2022-12-18	WOS:000298208700007
J	Pluzhnikov, A; Below, JE; Konkashbaev, A; Tikhomirov, A; Kistner-Griffin, E; Roe, CA; Nicolae, DL; Cox, NJ				Pluzhnikov, Anna; Below, Jennifer E.; Konkashbaev, Anuar; Tikhomirov, Anna; Kistner-Griffin, Emily; Roe, Cheryl A.; Nicolae, Dan L.; Cox, Nancy J.			Spoiling the Whole Bunch: Quality Control Aimed at Preserving the Integrity of High-Throughput Genotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-ASSOCIATION; ERROR RATE	False-positive or false-negative results attributable to undetected genotyping errors and confounding factors present a constant challenge for genome-wide association studies (GWAS) given the low signals associated with complex phenotypes and the noise associated with high-throughput genotyping. In the context of the genetics of kidneys in diabetes (GoKinD) study, we identify a source of error in genotype calling and demonstrate that a standard battery of quality-control (QC) measures is not sufficient to detect and/or correct it. We show that, if genotyping and calling are done by plate (batch), even a few DNA samples of marginally acceptable quality can profoundly alter the allele calls for other samples on the plate. In turn, this leads to significant differential bias in estimates of allele frequency between plates and, potentially, to false-positive associations, particularly when case and control samples are not sufficiently randomized to plates. This problem may become widespread as investigators tap into existing public databases for GWAS control samples. We describe how to detect and correct this bias by utilizing additional sources of information, including raw signal-intensity data.	[Pluzhnikov, Anna; Konkashbaev, Anuar; Tikhomirov, Anna; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Below, Jennifer E.; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Kistner-Griffin, Emily] Med Univ S Carolina, Dept Med, Hollings Canc Ctr, Charleston, SC 29425 USA; [Roe, Cheryl A.] SUNY Upstate Med Univ, Ctr Res & Evaluat, Syracuse, NY 13201 USA	University of Chicago; University of Chicago; University of Chicago; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cox, NJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ncox@bsd.uchicago.edu	Below, Jennifer E/W-2179-2018	Below, Jennifer E/0000-0002-1346-1872; Nicolae, Dan/0000-0002-0918-4630; Below, Jennifer/0000-0002-6372-6402	GAIN (Genetic Association Information Network); Juvenile Diabetes Research Foundation; CDC; Special Statutory Funding Program for Type 1 Diabetes Research;  [R01 DK077489];  [U01 HL084715];  [P60 DK20595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077489, P60DK020595] Funding Source: NIH RePORTER	GAIN (Genetic Association Information Network); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Special Statutory Funding Program for Type 1 Diabetes Research; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful for helpful comments from John Novembre, Anya Tsalenko, Simon Cawley, and Casey Gates; Anastasia Efstathiou, M.D. provided expert assistance in creating the GoKinD files used for analysis. This research was supported in part by awards R01 DK077489, U01 HL084715, and P60 DK20595 and by GAIN (Genetic Association Information Network). The Genetics of Kidneys in Diabetes (GoKinD) study was conducted by the GoKinD investigators and supported by the Juvenile Diabetes Research Foundation, the CDC, and the Special Statutory Funding Program for Type 1 Diabetes Research administered by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This manuscript was not prepared in collaboration with investigators of the GoKinD study and does not necessarily reflect the opinions or views of the GoKinD study or the NIDDK.	Ahn K, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1429; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Hao K, 2004, HUM HERED, V58, P154, DOI 10.1159/000083542; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tintle N, 2009, ANN HUM GENET, V73, P370, DOI 10.1111/j.1469-1809.2009.00516.x; Tintle NL, 2007, STAT APPL GENET MOL, V6; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398	17	37	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					123	128		10.1016/j.ajhg.2010.06.005	http://dx.doi.org/10.1016/j.ajhg.2010.06.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598280	Green Published, Bronze			2022-12-18	WOS:000280029200013
J	Fantes, JA; Boland, E; Ramsay, J; Donnai, D; Splitt, M; Goodship, JA; Stewart, H; Whiteford, M; Gautier, P; Harewood, L; Holloway, S; Sharkey, F; Maher, E; van Heyningen, V; Clayton-Smith, J; Fitzpatrick, DR; Black, GCM				Fantes, J. A.; Boland, E.; Ramsay, J.; Donnai, D.; Splitt, M.; Goodship, J. A.; Stewart, H.; Whiteford, M.; Gautier, P.; Harewood, L.; Holloway, S.; Sharkey, F.; Maher, E.; van Heyningen, V.; Clayton-Smith, J.; Fitzpatrick, D. R.; Black, G. C. M.			FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURAL REARRANGEMENTS; MENTAL-RETARDATION; TRANSLOCATIONS; BREAKPOINTS; GENE; ANOPHTHALMIA; DISEASE; CLONING; POINTS; MAP	We report fluorescence in situ hybridization (FISH) mapping of 152, mostly de novo, apparently balanced chromosomal rearrangement (ABCR) breakpoints in 76 individuals, 30 of whom had no obvious phenotypic abnormality (control group) and 46 of whom had an associated disease (case group). The aim of this study was to identify breakpoint characteristics that could discriminate between these groups and which might be of predictive value in de novo ABCR (DN-ABCR) cases detected antenatally. We found no difference in the proportion of breakpoints that interrupted a gene, although in three cases, direct interruption or deletion of known autosomal-dominant or X-linked recessive Mendelian disease genes was diagnostic. The only significant predictor of phenotypic abnormality in the group as a whole was the localization of one or both breakpoints to an R-positive (G-negative) band with estimated predictive values of 0.69 (95% CL 0.54-0.81) and 0.90 (95% CL 0.60-0.98), respectively. R-positive bands are known to contain more genes and have a higher guanine-cytosine (GC) content than do G-positive (R-negative) bands; however, whether a gene was interrupted by the breakpoint or the GC content in the 200kB around the breakpoint had no discriminant ability. Our results suggest that the large-scale genomic context of the breakpoint has prognostic utility and that the pathological mechanism of mapping to an R-band cannot be accounted for by direct gene inactivation.	[Fantes, J. A.; Ramsay, J.; Gautier, P.; Harewood, L.; Sharkey, F.; van Heyningen, V.; Fitzpatrick, D. R.] MRC, Human Genet Unit, Med & Dev Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Boland, E.; Donnai, D.; Clayton-Smith, J.; Black, G. C. M.] Cent Manchester& Manchester Childrens Univ Hosp, NHS Trust, St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Splitt, M.; Goodship, J. A.] Churchill Hosp, Dept Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Stewart, H.] Churchill Hosp, Dept Med Genet, Oxford OX3 7LJ, England; [Whiteford, M.] Yorkhill Hosp, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [Harewood, L.] Univ Lausanne, Ctr Integratif Genom, CH-1015 Lausanne, Switzerland; [Holloway, S.] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Sharkey, F.; Maher, E.] Western Gen Hosp, Reg Cytogenet Lab, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Manchester; University of Oxford; University of Lausanne; University of Edinburgh; University of Edinburgh	Fitzpatrick, DR (corresponding author), MRC, Human Genet Unit, Med & Dev Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk	Gautier, Philippe/D-4067-2011; van Heyningen, Veronica/B-8039-2008; FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; FitzPatrick, David R./0000-0003-4861-969X; Harewood, Louise/0000-0002-6398-6714	Medical Research Council [MC_U127527199, MC_U127561093] Funding Source: Medline; MRC [MC_U127561093, MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Astbury C, 2004, GENET MED, V6, P81, DOI 10.1097/01.GIM.0000117850.04443.C9; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; BREG WR, 1972, AM J DIS CHILD, V123, P561, DOI 10.1001/archpedi.1972.02110120085007; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; FRANCKE U, 1981, CYTOGENET CELL GENET, V31, P24, DOI 10.1159/000131622; FRYNS J P, 1991, Genetic Counseling, V2, P185; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; JACOBS PA, 1978, CLIN GENET, V13, P37; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MACGREGOR DJ, 1989, J MED GENET, V26, P590, DOI 10.1136/jmg.26.9.590; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; NAKAGOME Y, 1983, AM J HUM GENET, V35, P288; NAKAGOME Y, 1976, AM J HUM GENET, V28, P31; NIELSEN J, 1981, CLIN GENET, V20, P48; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; RG N, 2000, STAT CONFIDIENCE, P45; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; SAVAGE JRK, 1977, NATURE, V270, P513, DOI 10.1038/270513a0; SPEED RM, 1976, J MED GENET, V13, P295, DOI 10.1136/jmg.13.4.295; THARAPEL AT, 1977, CLIN GENET, V11, P255; WARBURTON D, 1991, AM J HUM GENET, V49, P995	32	37	38	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					916	926		10.1016/j.ajhg.2008.02.007	http://dx.doi.org/10.1016/j.ajhg.2008.02.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18374296	Green Published, Bronze			2022-12-18	WOS:000255103900010
J	Modamio-Hoybjor, S; Mencia, A; Goodyear, R; del Castillo, I; Richardson, G; Moreno, F; Moreno-Pelayo, MA				Modamio-Hoybjor, Silvia; Mencia, Angeles; Goodyear, Richard; del Castillo, Ignacio; Richardson, Guy; Moreno, Felipe; Moreno-Pelayo, Miguel Angel			A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER HAIR-CELLS; STRIA VASCULARIS; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; CANCER-CELLS; EXPRESSION; ORGAN; CORTI; DEAFNESS; DIFFERENTIATION	We previously mapped a novel autosomal dominant deafness locus, DFNA44, by studying a family with postlingual, progressive, nonsyndromic hearing loss. We report here on the identification of a mutation in CCDC50 as the cause of hearing loss in the family. CCDC50 encodes Ymer, an effector of epidermal growth factor (EGF)-mediated cell signaling that is ubiquitously expressed in different organs and has been suggested to inhibit down-regulation of the EGF receptor. We have examined its expression pattern in mouse inner ear. Western blotting and cell transfection results indicate that Ymer is a soluble, cytoplasmic protein, and immunostaining shows that Ymer is expressed in a complex spatiotemporal pattern during inner ear development. In adult inner ear, the expression of Ymer is restricted to the pillar cells of the cochlea, the stria vascularis, and the vestibular sensory epithelia, where it shows spatial overlap with the microtubule-based cytoskeleton. In dividing cells, Ymer colocalizes with microtubules of the mitotic apparatus. We suggest that DFNA44 hearing loss may result from a time-dependent disorganization of the microtubule-based cytoskeleton in the pillar cells and stria vascularis of the adult auditory system.	Hosp Ramon & Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Hospital Universitario Ramon y Cajal; University of Sussex	Moreno-Pelayo, MA (corresponding author), Hosp Ramon & Cajal, Unidad Genet Mol, Carretera Colmenar Km 9, E-28034 Madrid, Spain.	mmoreno.hrc@salud.madrid.org	Mencia, Angeles/AAE-4134-2021; Mencia, Angeles/H-8688-2017; del Castillo, Ignacio/B-4314-2013	del Castillo, Ignacio/0000-0003-1188-3665; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARIMA T, 1986, ACTA OTO-LARYNGOL, V102, P209, DOI 10.3109/00016488609108668; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; FORGE A, 1981, ACTA OTO-LARYNGOL, V92, P439, DOI 10.3109/00016488109133283; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Hallworth R, 2000, HEARING RES, V139, P31, DOI 10.1016/S0378-5955(99)00165-3; HENDERSON CG, 1995, J CELL SCI, V108, P37; ITO M, 1995, HEARING RES, V88, P107, DOI 10.1016/0378-5955(95)00106-E; JAMES R, 1984, ANNU REV BIOCHEM, V53, P259; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lee YW, 2004, ACTA OTO-LARYNGOL, V124, P558, DOI 10.1080/00016480410016577; Malgrange B, 2002, HEARING RES, V170, P48, DOI 10.1016/S0378-5955(02)00451-3; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Modamio-Hoybjor S, 2003, HUM GENET, V112, P24, DOI 10.1007/s00439-002-0836-x; Mueller KL, 2002, J NEUROSCI, V22, P9368; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Perry B, 2003, JARO-J ASSOC RES OTO, V4, P329, DOI 10.1007/s10162-002-2048-4; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x; PUJOL R, 1998, DEV AUDITORY SYSTEM, P146; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SAGARA T, 1995, HEARING RES, V83, P121, DOI 10.1016/0378-5955(94)00195-V; SANTOS-SACCHI J, 1982, HEARING RES, V6, P7, DOI 10.1016/0378-5955(82)90003-X; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SLEPECKY NB, 1996, COCHLEA, P44; Tannenbaum J, 1997, CELL MOTIL CYTOSKEL, V38, P146, DOI 10.1002/(SICI)1097-0169(1997)38:2<146::AID-CM4>3.0.CO;2-5; Tashiro K, 2006, J BIOL CHEM, V281, P24612, DOI 10.1074/jbc.M604184200; Vazza G, 2003, GENE, V314, P113, DOI 10.1016/S0378-1119(03)00710-8; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zine A, 2000, HEARING RES, V141, P19, DOI 10.1016/S0378-5955(99)00203-8; Zine A, 1999, J NEUROBIOL, V38, P313, DOI 10.1002/(SICI)1097-4695(19990215)38:3<313::AID-NEU2>3.0.CO;2-O	38	37	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1076	1089		10.1086/518311	http://dx.doi.org/10.1086/518311			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503326	Green Published, Bronze			2022-12-18	WOS:000246553800007
J	Kugler, S; Hahnewald, R; Garrido, M; Reiss, J				Kuegler, S.; Hahnewald, R.; Garrido, M.; Reiss, J.			Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINANT AAV VECTORS; XANTHINURIA TYPE-II; FACTOR-IX; SULFITE OXIDASE; IN-VIVO; TRANSDUCTION; LIVER; IDENTIFICATION; OXIDOREDUCTASE; BIOSYNTHESIS	Molybdenum cofactor (MoCo) deficiency is a progressive neurological disorder that inevitably leads to early childhood death because of the lack of any effective therapy. In a mouse model of MoCo deficiency type A, the most frequent form of this autosomal recessively inherited disease, the affected animals show the biochemical characteristics of sulphite and xanthine intoxication and do not survive 12 wk after birth. We have constructed a recombinant-expression cassette for the gene MOCS1, which, via alternative splicing, facilitates the expression of the proteins MOCS1A and MOCS1B, both of which are necessary for the formation of a first intermediate, cyclic pyranopterin monophosphate (cPMP), within the biosynthetic pathway leading to active MoCo. A recombinant adeno-associated virus (AAV) vector was used to express the artificial MOCS1 minigene, in an attempt to cure the lethal MOCS1-deficient phenotype. The vector was used to transduce Mocs1-deficient mice at both 1 and 4 d after birth or, after a pretreatment with purified cPMP, at 40 d after birth. We report here that all Mocs1-deficient animals injected with a control AAV-enhanced green fluorescent protein vector died similar to 8 d after birth or after withdrawal of cPMP supplementation, whereas AAV-MOCS1-transduced animals show significantly increased longevity. A single intrahepatic injection of AAV-MOCS1 resulted in fertile adult animals without any pathological phenotypes.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Univ Gottingen, Neurol Univ Klin, Abt Allgemeine Neurol, OFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Reiss, J (corresponding author), Univ Gottingen, Inst Human Genet, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	jreiss@gwdg.de						Bihun C, 2004, FERRETS RABBITS RODE, P286; Couto L, 2004, HUM GENE THER, V15, P287, DOI 10.1089/104303404322886138; GARRETT RM, 1995, BBA-GENE STRUCT EXPR, V1262, P147, DOI 10.1016/0167-4781(95)00068-R; Gross-Hardt S, 2002, MOL GENET METAB, V76, P340, DOI 10.1016/S1096-7192(02)00100-2; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; JOHNSON JL, 1993, ADV EXP MED BIOL, V338, P373; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; Lee HJ, 2002, HUM MOL GENET, V11, P3309, DOI 10.1093/hmg/11.26.3309; Malik JMI, 2005, MOL THER, V11, P373, DOI 10.1016/j.ymthe.2004.11.014; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Reiss J, 2005, MOL GENET METAB, V85, P12, DOI 10.1016/j.ymgme.2005.01.008; Reiss J, 2003, HUM MUTAT, V21, P569, DOI 10.1002/humu.10223; Rupar CA, 1996, NEUROPEDIATRICS, V27, P299, DOI 10.1055/s-2007-973798; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2004, HUM MOL GENET, V13, P1249, DOI 10.1093/hmg/ddh136; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Shimo T, 2005, TOXICOL SCI, V87, P267, DOI 10.1093/toxsci/kfi210; Tenenbaum L., 2003, Current Gene Therapy, V3, P545, DOI 10.2174/1566523034578131; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Yamamoto T, 2003, METABOLISM, V52, P1501, DOI 10.1016/S0026-0495(03)00272-5	25	37	39	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					291	297		10.1086/511281	http://dx.doi.org/10.1086/511281			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236133	Green Published, Bronze			2022-12-18	WOS:000243729500008
J	Jorgenson, E; Witte, JS				Jorgenson, E; Witte, JS			Coverage and power in genomewide association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POPULATIONS; PATTERNS	The ability of genomewide association studies to decipher genetic traits is driven in part by how well the measured single-nucleotide polymorphisms "cover" the unmeasured causal variants. Estimates of coverage based on standard linkage-disequilibrium measures, such as the average maximum squared correlation coefficient (r(2)), can lead to inaccurate and inflated estimates of the power of genomewide association studies. In contrast, use of the "cumulative r(2) adjusted power" measure presented here gives more-accurate estimates of power for genomewide association studies.	Univ Calif San Francisco, Ctr Human Genet, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Jorgenson, E (corresponding author), Univ Calif San Francisco, Ctr Human Genet, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	jorg@itsa.ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA088164, R01CA094211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390] Funding Source: NIH RePORTER; NCI NIH HHS [CA94211, CA88164, R01 CA088164, R01 CA094211] Funding Source: Medline; NIGMS NIH HHS [U01 GM061390, GM061390, U19 GM061390] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099	11	37	39	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					884	888		10.1086/503751	http://dx.doi.org/10.1086/503751			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642443	Green Published, Bronze			2022-12-18	WOS:000236756200014
J	Lohmueller, KE; Mauney, MM; Reich, D; Braverman, JM				Lohmueller, KE; Mauney, MM; Reich, D; Braverman, JM			Variants associated with common disease are not unusually differentiated in frequency across populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN ANGIOTENSINOGEN GENE; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; RHEUMATOID-ARTHRITIS; HAPLOTYPE STRUCTURE; ALZHEIMERS-DISEASE; DNA POLYMORPHISMS; NATURAL-SELECTION	Genetic variants that contribute to risk of common disease may differ in frequency across populations more than random variants in the genome do, perhaps because they have been exposed to population-specific natural selection. To assess this hypothesis empirically, we analyzed data from two groups of single-nucleotide polymorphisms ( SNPs) that have shown reproducible (n = 9) or reported (n = 39) associations with common diseases. We compared the frequency differentiation ( between Europeans and Africans) of the disease-associated SNPs with that of random SNPs in the genome. These common-disease-associated SNPs are not significantly more differentiated across populations than random SNPs. Thus, for the data examined here, ethnicity will not be a good predictor of genotype at many common-disease-associated SNPs, just as it is rarely a good predictor of genotype at random SNPs in the genome.	Georgetown Univ, Dept Biol, Washington, DC 20057 USA; Georgetown Univ, Dept Comp Sci, Washington, DC 20057 USA; Georgetown Univ, Inst Mol & Human Genet, Med Ctr, Washington, DC 20057 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02138 USA	Georgetown University; Georgetown University; Georgetown University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Braverman, JM (corresponding author), Georgetown Univ, Dept Biol, 3700 O St NW, Washington, DC 20057 USA.	jmb24@georgetown.edu						Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allebrandt KV, 2002, TOXICOL APPL PHARM, V180, P151, DOI 10.1006/taap.2002.9368; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Crocq MA, 1996, HUM HERED, V46, P58, DOI 10.1159/000154327; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Finckh U, 2003, NEUROGENETICS, V4, P213, DOI 10.1007/s10048-003-0157-9; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gonzalez-Conejero R, 1998, BLOOD, V92, P2771, DOI 10.1182/blood.V92.8.2771.420k28_2771_2776; Heinzmann A, 2003, J ALLERGY CLIN IMMUN, V112, P735, DOI 10.1016/S0091-6749(03)01887-6; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Hull J, 2001, AM J HUM GENET, V69, P413, DOI 10.1086/321291; Iwai C, 2003, AM HEART J, V146, P106, DOI 10.1016/S0002-8703(03)00110-8; Jiang ZW, 2001, HUM GENET, V109, P95, DOI 10.1007/s004390100553; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; Kohler HP, 1999, THROMB HAEMOSTASIS, V81, P511; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Moshfegh K, 1999, LANCET, V353, P351, DOI 10.1016/S0140-6736(98)06448-4; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nejentsev S, 2003, HUM IMMUNOL, V64, P345, DOI 10.1016/S0198-8859(02)00825-X; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Noguchi E, 1998, CLIN EXP ALLERGY, V28, P449; Norlund L, 1997, THROMB HAEMOSTASIS, V77, P248; Osei-Hyiaman D, 2001, DIABETES, V50, P2169, DOI 10.2337/diabetes.50.9.2169; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Ray JG, 2002, PATHOPHYSIOL HAEMO T, V32, P51, DOI 10.1159/000065076; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rotimi C, 1996, HYPERTENSION, V27, P558, DOI 10.1161/01.HYP.27.3.558; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Schneider JA, 1998, AM J HUM GENET, V62, P1258, DOI 10.1086/301836; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Soldevila Marta, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9157; Takei T, 2002, AM J HUM GENET, V70, P781, DOI 10.1086/339077; Taylor JG, 2002, BLOOD, V100, P4303, DOI 10.1182/blood-2001-12-0306; Thye T, 2003, AM J HUM GENET, V72, P448, DOI 10.1086/367714; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; VANERPOUWKRAAN TC, 1999, GENES IMMUN, V1, P61; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEIR BS, 1996, GENETIC DATA ANAL, V38, P1358; WENZEL K, 1994, HUM MOL GENET, V3, P1935, DOI 10.1093/hmg/3.11.1935; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Zhang P, 2003, NEUROSCI LETT, V349, P209, DOI 10.1016/S0304-3940(03)00837-1	69	37	37	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					130	136		10.1086/499287	http://dx.doi.org/10.1086/499287			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385456	Bronze, Green Published			2022-12-18	WOS:000233930400013
J	Wood, ET; Stover, DA; Slatkin, M; Nachman, MW; Hammer, MF				Wood, ET; Stover, DA; Slatkin, M; Nachman, MW; Hammer, MF			The beta-globin recombinational hotspot reduces the effects of strong selection around HbC, a recently arisen mutation providing resistance to malaria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOGLOBIN-C; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE DIVERSITY; MEIOTIC CROSSOVER; HUMAN GENOME; AFRICAN; VARIABILITY; POPULATION; ORIGIN; REGION	Recombination is expected to reduce the effect of selection on the extent of linkage disequilibrium (LD), but the impact that recombinational hotspots have on sites linked to selected mutations has not been investigated. We empirically determine chromosomal linkage phase for 5.2 kb spanning the beta-globin gene and hotspot. We estimate that the HbC mutation, which is positively selected because of malaria, originated < 5,000 years ago and that selection coefficients are 0.04-0.09. Despite strong selection and the recent origin of the HbC allele, recombination (crossing-over or gene conversion) is observed within 1 kb 5' of the selected site on more than one-third of the HbC chromosomes sampled. The rapid decay in LD upstream of the HbC allele demonstrates the large effect the beta-globin hotspot has in mitigating the effects of positive selection on linked variation.	Univ Arizona, Dept EEB, Tucson, AZ 85721 USA; Univ Arizona, Div Biotechnol, Tucson, AZ 85721 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Arizona; University of Arizona; University of California System; University of California Berkeley	Wood, ET (corresponding author), Univ Arizona, Dept EEB, Tucson, AZ 85721 USA.	ewood@u.arizona.edu		Stover, Daryn/0000-0002-4768-6308	NIGMS NIH HHS [R29 GM053566, R01 GM053566, GM-53566] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053566, R01GM053566] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; ALLISON AC, 1954, ANN HUM GENET, V19, P39, DOI 10.1111/j.1469-1809.1954.tb01261.x; ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Harding RM, 1997, AM J HUM GENET, V60, P772; Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LIVINGSTONE FB, 1976, HUM BIOL, V48, P487; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Rihet P, 2004, HUM MOL GENET, V13, P1, DOI 10.1093/hmg/ddh002; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2002, GENETICS, V162, P1849; SAUNDERS MA, 2005, GENETICS; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Slatkin M, 2001, GENETICS, V158, P865; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TRABUCHET G, 1991, HUM GENET, V87, P597; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	30	37	40	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					637	642		10.1086/491748	http://dx.doi.org/10.1086/491748			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175509	Bronze, Green Published			2022-12-18	WOS:000232106900011
J	Padhukasahasram, B; Marjoram, P; Nordborg, M				Padhukasahasram, B; Marjoram, P; Nordborg, M			Estimating the rate of gene conversion on human chromosome 21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RECOMBINATION RATES; POLYMORPHISM; INFERENCE; DIVERSITY; SEQUENCE; HISTORY; HUMANS	There is a growing recognition that gene conversion can be an important factor in shaping fine-scale patterns of linkage disequilibrium in the human genome. We devised simple multilocus summary statistics for estimating gene-conversion rates from genomewide polymorphism data sets. In addition to being computationally feasible for very large data sets, these summaries were designed to yield robust estimates of gene-conversion rates in the presence of variation in crossing-over rates. Using our summaries, we analyzed 21,840 biallelic single-nucleotide polymorphisms (SNPs) on human chromosome 21. Our results indicate that models including both crossing over and gene conversion fit the overall short-range data (0-5 kb) of chromosome 21 much better than do models including crossing over alone. The estimated ratio of gene-conversion rate to crossing-over rate has a range of 1.6-9.4, depending on the assumed conversion tract length (in the range of 500-50 bp). Removal of the 5,696 SNPs that occur in known mutational hotspots (CpG sites) did not significantly change our conclusions, suggesting that recurrent mutations alone cannot explain our data.	Univ So Calif, Keck Sch Med, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Div Biostat, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Padhukasahasram, B (corresponding author), Univ So Calif, Keck Sch Med, Program Mol & Computat Biol, SHS 172,835 W 37th St, Los Angeles, CA 90089 USA.	padhukas@usc.edu	Marjoram, Paul/A-3066-2008	Nordborg, Magnus/0000-0001-7178-9748	NHGRI NIH HHS [P50 HG002790, 1 P50 HG002790-01A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Andolfatto P, 1998, GENETICS, V148, P1397; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; CARPENTER ATC, 1984, COLD SPRING HARB SYM, V49, P23, DOI 10.1101/SQB.1984.049.01.005; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1985, GENETICS, V111, P147; Innan H, 2003, GENOME RES, V13, P1158, DOI 10.1101/gr.466303; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kuhner MK, 2000, GENETICS, V156, P1393; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Nielsen R, 2000, GENETICS, V154, P931; NORDBORG M, 2001, HDB STAT GENETICS, P213; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Wall JD, 2000, MOL BIOL EVOL, V17, P156, DOI 10.1093/oxfordjournals.molbev.a026228; Weiss G, 1998, GENETICS, V149, P1539; Wiehe T, 2000, GENET RES, V75, P61, DOI 10.1017/S0016672399004036; Wiuf C, 2000, GENETICS, V155, P451; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407	28	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					386	397		10.1086/423451	http://dx.doi.org/10.1086/423451			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15250027	Bronze, Green Published			2022-12-18	WOS:000223272200004
J	Ambrosius, WT; Lange, EM; Langefeld, CD				Ambrosius, WT; Lange, EM; Langefeld, CD			Power for genetic association studies with random allele frequencies and genotype distributions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; TRIALS; TRAITS; DESIGN; TESTS; TDT	One of the first and most important steps in planning a genetic association study is the accurate estimation of the statistical power under a proposed study design and sample size. In association studies for candidate genes or in fine-mapping applications, allele and genotype frequencies are often assumed to be known when, in fact, they are unknown (i.e., random variables from some distribution). For example, if we consider a diallelic marker with allele frequencies of 0.5 and 0.5 and Hardy-Weinberg proportions, the three genotype frequencies are often assumed to be 0.25, 0.50, and 0.25, and the statistical power is calculated. Unfortunately, ignoring this source of variation can inflate the estimated power of the study. In the present article, we propose averaging the estimates of power over the distribution of the genotype frequencies to calculate the true estimate of power for a fixed allele frequency. For the usual situation, in which allele frequencies in a population are not known, we propose placing a prior distribution on the allele frequency, taking advantage of any available genotype information. This Bayesian approach provides a more accurate estimate of power. We present examples for quantitative and qualitative traits in cohort studies of unrelated individuals and results from an extensive series of examples that show that ignoring the uncertainty in allele frequencies can inflate the estimated power of the study. We also present the results from case-control studies and show that standard methods may also overestimate power. As discussed in this article, the approach of fixing allele frequencies even if they are not known is the common approach to power calculations. We show that ignoring the sources of variation in allele frequencies tends to result in overestimates of power and, consequently, in studies that are underpowered. Software in C is available at http://www.ambrosius.net/Power/.	Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Biostat Sect, Winston Salem, NC 27157 USA	Wake Forest University	Ambrosius, WT (corresponding author), Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Biostat Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA.	wambrosi@wfubmc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035795, R01HL060944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR07122, M01 RR007122] Funding Source: Medline; NHLBI NIH HHS [R01-HL60944, R01 HL060944, R01-HL35795, R01 HL035795] Funding Source: Medline; NIAMS NIH HHS [P01-AR49084, P01 AR049084] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abramowitz M, 1965, HDB MATH FUNCTIONS F; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ambrosius WT, 1999, HYPERTENSION, V34, P631, DOI 10.1161/01.HYP.34.4.631; BROWN B, 1997, DCDFLIB LIB C ROUTIN; CHASALOW S, 2002, COMBINAT COMBINATORI; Deng HW, 2001, GENET RES, V78, P289, DOI 10.1017/S001667230100533X; Elashoff JD, 2000, NQUERY ADVISOR VERSI; Fleiss JL, 1981, STAT METHODS RATES P; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; LACHIN JM, 1977, BIOMETRICS, V33, P315, DOI 10.2307/2529781; Lalouel LM, 2002, AM J HYPERTENS, V15, P201, DOI 10.1016/S0895-7061(01)02285-3; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Long AD, 1999, GENOME RES, V9, P720; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; MEHTA C, 1999, PROCSTATXACT 4 SAS U; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Sahai H, 1996, STAT MED, V15, P1; Schork NJ, 2002, AM J HUM GENET, V70, P1480, DOI 10.1086/340788; SEARLE S, 1947, LINEAR MODELS; Shih MC, 2002, GENET EPIDEMIOL, V22, P128, DOI 10.1002/gepi.0151; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; WANG D, 2000, COMMUNICATIONS STA A, V5, P1129	23	37	39	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					683	693		10.1086/383282	http://dx.doi.org/10.1086/383282			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024689	Green Published, Bronze			2022-12-18	WOS:000220280800007
J	Zhang, K; Sun, FZ; Waterman, MS; Chen, T				Zhang, K; Sun, FZ; Waterman, MS; Chen, T			Haplotype block partition with limited resources and applications to human chromosome 21 haplotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; IDENTIFICATION; ALGORITHM	Recent studies have shown that the human genome has a haplotype block structure such that it can be decomposed into large blocks with high linkage disequilibrium (LD) and relatively limited haplotype diversity, separated by short regions of low LD. One of the practical implications of this observation is that only a small fraction of all the single-nucleotide polymorphisms (SNPs) (referred as "tag SNPs") can be chosen for mapping genes responsible for human complex diseases, which can significantly reduce genotyping effort, without much loss of power. Algorithms have been developed to partition haplotypes into blocks with the minimum number of tag SNPs for an entire chromosome. In practice, investigators may have limited resources, and only a certain number of SNPs can be genotyped. In the present article, we first formulate this problem as finding a block partition with a fixed number of tag SNPs that can cover the maximal percentage of the whole genome, and we then develop two dynamic programming algorithms to solve this problem. The algorithms are sufficiently flexible to permit knowledge of functional polymorphisms to be considered. We apply the algorithms to a data set of SNPs on human chromosome 21, combining the information of coding and noncoding regions. We study the density of SNPs in intergenic regions, introns, and exons, and we find that the SNP density in intergenic regions is similar to that in introns and is higher than that in exons, results that are consistent with previous studies. We also calculate the distribution of block break points in intergenic regions, genes, exons, and coding regions and do not find any significant differences.	Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Chen, T (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, 1042 W 36th Pl Drb-290, Los Angeles, CA 90089 USA.	tingchen@usc.edu	Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X	NCRR NIH HHS [R01 RR 16522-01, R01 RR016522] Funding Source: Medline; NIDDK NIH HHS [DK 53392] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK053392] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GUSFIELD D, 1994, ALGORITHMICA, V12, P312, DOI 10.1007/BF01185430; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Waterman M.S., 1995, INTRO COMPUTATIONAL; WATERMAN MS, 1992, P NATL ACAD SCI USA, V89, P6090, DOI 10.1073/pnas.89.13.6090; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	14	37	43	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					63	73		10.1086/376437	http://dx.doi.org/10.1086/376437			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12802783	Green Published, Bronze			2022-12-18	WOS:000183904900006
J	Cohn, DH; Ehtesham, N; Krakow, D; Unger, S; Shanske, A; Reinker, K; Powell, BR; Rimoin, DL				Cohn, DH; Ehtesham, N; Krakow, D; Unger, S; Shanske, A; Reinker, K; Powell, BR; Rimoin, DL			Mental retardation and abnormal skeletal development (Dyggve-Melchior-clausen dysplasia) due to mutations in a novel, evolutionarily conserved gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MCCORT-DYSPLASIA; PROTEOGLYCANS	Dyggve-Melchior-Clausen dysplasia (DMC) and Smith-McCort dysplasia (SMC) are similar, rare autosomal recessive osteochondrodysplasias. The radiographic features and cartilage histology in DMC and SMC are identical. However, patients with DMC exhibit significant developmental delay and mental retardation, the major features that distinguish the two conditions. Linkage studies localized the SMC and DMC disease genes to chromosome 18q12-21.1, providing evidence suggesting that they are allelic disorders. Sequence analysis of the coding exons of the FLJ90130 gene, a highly evolutionarily conserved gene within the recombination interval defined in the linkage study, identified mutations in SMC and DMC patients. The affected individuals in two consanguinous DMC families were homozygous for a stop codon mutation and a frameshift mutation, respectively, demonstrating that DMC represents the FLJ90130-null phenotype. The data confirm the hypothesis that SMC and DMC are allelic disorders and identify a gene necessary for normal skeletal development and brain function.	UCSF, Sch Med, Dept Pediat, Fresno, CA USA; Childrens Hosp Cent Calif, Madera, CA USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Childrens Hosp Montefiore, Ctr Congenital Disorders, Bronx, NY USA; Hosp Sick Children, Div Clin & Metab Genet, Dept Med Genet Metab, Toronto, ON M5G 1X8, Canada; Univ Calif Los Angeles, Dept Med, Geffen Sch Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Obstet & Gynecol, Geffen Sch Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Human Genet, Geffen Sch Med, Los Angeles, CA 90024 USA; Cedars Sinai Res Inst, Dept Obstet & Gynecol, Los Angeles, CA USA; Cedars Sinai Res Inst, Ahmanson Dept Pediat, Ctr Med Genet Birth Defects, Los Angeles, CA USA	University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of Texas System; University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, SSB-3,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	dan.cohn@cshs.org	unger, sheila/E-9177-2015; Reinker, Kent/R-5231-2019	Unger, Sheila/0000-0002-9539-8941	NICHD NIH HHS [HD22657, P01 HD022657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BURNS C, IN PRESS J PEDIAT OR; CHANDRASEKHAR S, 1984, COLLAGEN REL RES, V4, P323; DYGGVE HV, 1962, ARCH DIS CHILD, V37, P525, DOI 10.1136/adc.37.195.525; Ehtesham N, 2002, AM J HUM GENET, V71, P947, DOI 10.1086/342669; ENGFELDT B, 1983, ACTA PAEDIATR SCAND, V72, P269, DOI 10.1111/j.1651-2227.1983.tb09710.x; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; HORTON WA, 1982, J BONE JOINT SURG AM, V64, P408, DOI 10.2106/00004623-198264030-00011; KAUFMAN R L, 1971, Birth Defects Original Article Series, V7, P144; KUIJER R, 1988, CONNECT TISSUE RES, V17, P83, DOI 10.3109/03008208809015022; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Nakamura K, 1997, AM J MED GENET, V72, P11, DOI 10.1002/(SICI)1096-8628(19971003)72:1<11::AID-AJMG3>3.3.CO;2-0; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; SMITH R, 1958, Calif Med, V88, P55; SPRANGER J, 1976, HUM GENET, V33, P279, DOI 10.1007/BF00286853; Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Thauvin-Robinet C, 2002, J MED GENET, V39, P714, DOI 10.1136/jmg.39.10.714; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105	17	37	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					419	428		10.1086/346176	http://dx.doi.org/10.1086/346176			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12491225	Green Published, Bronze			2022-12-18	WOS:000180680000021
J	Dabora, SL; Roberts, P; Nieto, A; Perez, R; Jozwiak, S; Franz, D; Bissler, J; Thiele, EA; Sims, K; Kwiatkowski, DJ				Dabora, SL; Roberts, P; Nieto, A; Perez, R; Jozwiak, S; Franz, D; Bissler, J; Thiele, EA; Sims, K; Kwiatkowski, DJ			Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; RENAL-CELL CARCINOMA; FIRST INTRON; GENE; DISEASE; POLYMORPHISM; REPEAT; LYMPHANGIOLEIOMYOMATOSIS; DISEQUILIBRIUM; PATHOGENESIS	Tuberous sclerosis complex (TSC) is a familial hamartoma syndrome in which renal involvement is common and, at times, life threatening. We have investigated the potential effect of a non-TSC gene on renal disease in a cohort of 172 TSC patients with TSC2 mutations. Patients were genotyped for an interferon-gamma (IFN-gamma) microsatellite polymorphism, within intron 1, for which one common allele (allele 2, with 12 CA repeats) has been shown to have a higher expression of IFN-gamma. A chi(2) analysis was used to examine the association between IFN-gamma allele 2 and the development of kidney angiomyolipomas (KAMLs) in this TSC2 cohort. Because of the age-dependent development of KAMLs in TSC, we initially focused on the 127 patients who were >5 years old. Additional subgroup analyses were done to investigate the influence of age and gender. The transmission/disequilibrium test (TDT) was also performed in a subset of this cohort (46 probands) for whom parent and/or sibling samples were available for analysis. Both chi(2) analysis and TDT suggested an association between IFN-gamma allele 2 and the absence of KAMLs in patients who have known TSC2 mutations. Among the 127 patients who were >5 years old, KAMLs were present in 95 (75%) and were absent in 32 (25%). In the group with KAML present, the frequency of IFN-gamma allele 2 was 56%; in the group with KAML absent, the frequency of IFN-gamma allele 2 was significantly higher, at 78% (P = .02, by chi(2) analysis). The family-based TDT analysis gave similar results, with a TDT statistic (TDT chi(2) = 5.45) corresponding to a P value of .02. Subgroup analyses show that both age and gender may influence the impact of this association. Although these results should be replicated in other populations with TSC, the present study suggests that modifier genes play a role in the variable expression of TSC and also suggests a potential therapy for KAMLs in patients with TSC.	Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Div Neurol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Neurogenet Lab, Boston, MA 02114 USA; Childrens Mem Hosp, Dept Child Neurol, Warsaw, Poland; Childrens Hosp, Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Children's Memorial Health Institute; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dabora, SL (corresponding author), Brigham & Womens Hosp, Div Hematol, 221 Longwood Ave,LMRC 301, Boston, MA 02115 USA.			Bissler, John/0000-0001-9685-9183; Jozwiak, Sergiusz/0000-0003-3350-6326	NCI NIH HHS [R21 CA086248, R33 CA086248, CA86248] Funding Source: Medline; NINDS NIH HHS [R37 NS031535, NS31535, R01 NS031535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA086248, R21CA086248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031535, R37NS031535] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AULITZKY W, 1989, J CLIN ONCOL, V7, P1875, DOI 10.1200/JCO.1989.7.12.1875; Awad M, 1999, HUM IMMUNOL, V60, P343, DOI 10.1016/S0198-8859(98)00133-5; Becker C, 2001, NAT MED, V7, P1159, DOI 10.1038/nm1001-1159; Cavet J, 2001, BLOOD, V98, P1594, DOI 10.1182/blood.V98.5.1594; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; CURTIS D, 1995, AM J HUM GENET, V56, P811; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; ELLERHORST JA, 1994, J UROLOGY, V152, P841, DOI 10.1016/S0022-5347(17)32587-9; Ewalt DH, 1998, J UROLOGY, V160, P141, DOI 10.1016/S0022-5347(01)63072-6; EWENS WJ, 1999, CURR PROTOC HUM GENE; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Gleave ME, 1998, NEW ENGL J MED, V338, P1265, DOI 10.1056/NEJM199804303381804; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Henske EP, 1998, MODERN PATHOL, V11, P665; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Jozwiak S, 2000, J CHILD NEUROL, V15, P652, DOI 10.1177/088307380001501003; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; Khani-Hanjani A, 2000, LANCET, V356, P820, DOI 10.1016/S0140-6736(00)02657-X; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Kobayashi T, 1999, CANCER RES, V59, P1206; KWIATKOWSKI DJ, 1994, ARCH DERMATOL, V130, P348, DOI 10.1001/archderm.130.3.348; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee JK, 2000, J IMMUNOL, V164, P231, DOI 10.4049/jimmunol.164.1.231; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Perrey C, 1998, TRANSPL IMMUNOL, V6, P193, DOI 10.1016/S0966-3274(98)80045-2; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Pravica V, 1999, EUR J IMMUNOGENET, V26, P1, DOI 10.1046/j.1365-2370.1999.00122.x; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SMALLEY SL, 1994, J MED GENET, V31, P761, DOI 10.1136/jmg.31.10.761; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413	38	37	40	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					750	758		10.1086/342718	http://dx.doi.org/10.1086/342718			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12192641	Green Published, Bronze			2022-12-18	WOS:000178613800005
J	Hall, MA; Norman, PJ; Thiel, B; Tiwari, H; Peiffer, A; Vaughan, RW; Prescott, S; Leppert, M; Schork, NJ; Lanchbury, JS				Hall, MA; Norman, PJ; Thiel, B; Tiwari, H; Peiffer, A; Vaughan, RW; Prescott, S; Leppert, M; Schork, NJ; Lanchbury, JS			Quantitative-trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-CELL COUNT; IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR-BASIS; CD4-CD8 RATIO; HIV-INFECTION; LINKAGE; PREDICTORS; RECEPTOR; DISEASE; AIDS	Lymphocyte subpopulation levels are used for prognosis and monitoring of a variety of human diseases, especially those with an infectious etiology. As a primary step to defining the major gene variation underlying these phenotypes, we conducted the first whole-genome screen for quantitative variation in lymphocyte count, CD4 T cell, CD8 T cell, B cell, and natural killer cell numbers, as well as CD4: CD8 ratio. The screen was performed in 15 of the CEPH families that form the main human genome genetic project mapping resource. Quantitative-trait loci (QTLs) that account for significant proportions of the phenotypic variance of lymphocyte subpopulations were detected on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18. The most significant QTL found was for CD4 levels on chromosome 8 (empirical). Two regions of chromosome 4 showed significant linkage to CD4: CD8 ratio (empirical P=.00005 P=.00007 and P=.003). A QTL for the highly correlated measures of CD4 and CD19 levels colocalized at 18q21 (both P=.003). Similarly, a shared region of chromosome 1 was linked to CD8 and CD19 levels ( P=.001 and P=.0002, respectively). Several of the identified chromosome regions are likely to harbor polymorphic. candidate genes responsible for these important human phenotypes. Their discovery has important implications for understanding the generation of the immune repertoire and understanding immune-system homeostasis. More generally, these data show the power of an integrated human gene-mapping approach for heritable molecular phenotypes, using large pedigrees that have been extensively genotyped.	Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Rheumatol, Div Med,Mol Immunogenet Unit, London SE1 9RT, England; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; Univ Utah, WM Keck Fdn, Genet Reference Project, Salt Lake City, UT USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Case Western Reserve University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Hall, MA (corresponding author), Univ London Kings Coll, Guys Kings & St Thomas Hosp Sch Med, Dept Rheumatol, Div Med,Mol Immunogenet Unit, 5th Floor,Thomas Guys House,Guys Hosp Campus, London SE1 9RT, England.			Norman, Paul/0000-0001-8370-7703; Schork, Nicholas/0000-0003-0920-5013	NCRR NIH HHS [P41 RR003655, M01-RR00064, 1 P41 RR03655] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655, M01RR000064] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Ahmadi KR, 2001, GENES IMMUN, V2, P381, DOI 10.1038/sj.gene.6363796; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Amadori A, 1996, IMMUNOL TODAY, V17, P414, DOI 10.1016/0167-5699(96)10049-9; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BURCHAM J, 1991, AIDS, V5, P365, DOI 10.1097/00002030-199104000-00002; BUTTURINI A, 1990, LEUKEMIA, V4, P138; *CAS W RES U DEP E, 2001, SAGE STAT AN GEN EP, P37; Clementi M, 1999, HUM GENET, V105, P337, DOI 10.1007/s004390051111; COATES RA, 1992, J CLIN EPIDEMIOL, V45, P245, DOI 10.1016/0895-4356(92)90084-Z; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Elder ME, 1998, SEMIN HEMATOL, V35, P310; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; ENSRUD K, 1992, AM HEART J, V124, P207, DOI 10.1016/0002-8703(92)90942-O; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; George V, 1999, AM J HUM GENET, V65, P236, DOI 10.1086/302444; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; HANSEN LK, 1990, INT J EPIDEMIOL, V19, P881, DOI 10.1093/ije/19.4.881; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hawkins C J, 1997, Semin Immunol, V9, P25, DOI 10.1006/smim.1996.0052; HERSH EM, 1984, ANN NY ACAD SCI, V437, P364, DOI 10.1111/j.1749-6632.1984.tb37156.x; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE, V5th edition; Leonard WJ, 1996, ANNU REV MED, V47, P229; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Matsuzaki Y, 1997, BLOOD, V89, P853, DOI 10.1182/blood.V89.3.853; Mehrian R, 1998, ARTHRITIS RHEUM, V41, P596, DOI 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Pardoll D, 2001, NATURE, V411, P1010, DOI 10.1038/35082676; PUCK JM, 1994, HUM MOL GENET, V3, P1457, DOI 10.1093/hmg/3.suppl_1.1457; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; SAAH AJ, 1992, AM J EPIDEMIOL, V135, P1147, DOI 10.1093/oxfordjournals.aje.a116215; Schuster V, 2000, IMMUNOL REV, V178, P21, DOI 10.1034/j.1600-065X.2000.17819.x; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; SHETE S, 1999, GENET EPIDEMIOL, V17, P194; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386	47	37	42	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1172	1182		10.1086/340090	http://dx.doi.org/10.1086/340090			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11951176	Green Published, Bronze			2022-12-18	WOS:000175012400008
J	Province, MA				Province, MA			The significance of not finding a gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METAANALYSIS; LINKAGE	As more investigators conduct extensive whole-genome linkage scans for complex traits, interest is growing in meta-analysis as a way of integrating the weak or conflicting evidence from multiple studies. However, there is a bias in the most commonly used meta-analysis linkage technique (i.e., Fisher's [1925] method of combining of P values) when it is applied to many nonparametric (i.e., model free) linkage results. The bias arises in those methods (e.g., variance components, affected sib pair, extremely discordant sib pairs, etc.) that truncate all "negative evidence against linkage" into the single value of LOD = 0. If incorrectly handled, this bias can artificially inflate or deflate the combined meta-analysis linkage results for any given locus. This is an especially troublesome problem in the context of a genome scan, since LOD = 0 is expected to occur over half the unlinked genome. The bias can be overcome (nearly) completely by simply interpreting LOD = 0 as a P value of 1/2In(2) approximate to .72 in Fisher's formula.	Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL)	Province, MA (corresponding author), Washington Univ, Sch Med, Div Biostat, Box 8067,660 S Euclid, St Louis, MO 63110 USA.	mike@wubios.wustl.edu			NHLBI NIH HHS [U10 HL054473, U01 HL054473, HL54473] Funding Source: Medline; NIGMS NIH HHS [R01 GM028719, GM28719] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL054473, U01HL054473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1998, GENETICS, V148, P859; Fisher RA, 1925, STAT METHODS RES WOR; Glass GV., 1976, ED RES, V5, P3, DOI [10.2307/1174772ISSN0536-1036, 10.2307/1174772, DOI 10.3102/0013189X005010003, 10.3102/0013189X005010003, DOI 10.2307/1174772]; Guerra R, 1999, GENET EPIDEMIOL, V17, pS605; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; Ott J., 1991, ANAL HUMAN GENETIC L; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T	8	37	37	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					660	663		10.1086/323316	http://dx.doi.org/10.1086/323316			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11481587	Bronze, Green Published			2022-12-18	WOS:000170271400019
J	Leroy, JG; Seppala, R; Huizing, M; Dacremont, G; De Simpel, H; Van Coster, RN; Orvisky, E; Krasnewich, DM; Gahl, WA				Leroy, JG; Seppala, R; Huizing, M; Dacremont, G; De Simpel, H; Van Coster, RN; Orvisky, E; Krasnewich, DM; Gahl, WA			Dominant inheritance of sialuria, an inborn error of feedback inhibition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-ACETYLNEURAMINIC ACID; I-CELL DISEASE; SIALIC-ACID; FIBROBLASTS; 2-EPIMERASE; MUTATIONS; GENE	"French type" sialuria, a presumably dominant disorder that, until now, had been documented in only five patients, manifests with mildly coarse facies, slight motor delay, and urinary excretion of large quantities ( >1 g/d) of free N-acetylneuraminic acid (NeuAc). The basic defect consists of the very rare occurrence of failed feedback inhibition of a rate-limiting enzyme, in this case uridinediphosphate-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase, by a downstream product, in this case cytidine monophosphate (CMP)-NeuAc. We report a new patient with sialuria who has a heterozygous G -->A substitution in nucleotide 848 of the epimerase gene, which results in an R266Q change. The proband's other allele, as expected, had no mutation. However, the heterozygous R266Q mutation was detected in the patient's mother, who has similarly increased urinary levels of free NeuAc, thereby confirming, for the first time, the dominant mode of inheritance of this inborn error. The biochemical diagnosis of the proband was verified by the greatly increased level of free NeuAc in his cultured fibroblasts, the NeuAc distribution, mainly (59%) in the cytoplasm, and by the complete failure of 100 muM CMP-NeuAc to inhibit UDP-GlcNAc 2-epimerase activity in the mutant cells. These findings call for expansion of the phenotype to include adults and for more-extensive assaying of free NeuAc in the urine of children with mild developmental delay. The prevalence of sialuria is probably grossly underestimated.	State Univ Ghent, Sch Med, Dept Med Genet, B-9000 Ghent, Belgium; State Univ Ghent, Sch Med, Dept Pediat, B-9000 Ghent, Belgium; NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, Bethesda, MD 20892 USA; NIMH, Clin Neurosci Branch, Bethesda, MD 20892 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Ghent University; Ghent University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Leroy, JG (corresponding author), State Univ Ghent, Sch Med, Dept Med Genet, 185 De Pintelaan, B-9000 Ghent, Belgium.		Huizing, Marjan/AAR-8860-2020					AULA P, 2001, METABOLIC MOL BASES, P5109; CARDO PP, 1985, CLIN CHIM ACTA, V150, P129, DOI 10.1016/0009-8981(85)90263-3; DON NA, 1991, J INHERIT METAB DIS, V14, P942, DOI 10.1007/BF01800480; Ferreira H, 1999, MOL GENET METAB, V67, P131, DOI 10.1006/mgme.1999.2852; FONTAINE G, 1968, HELV PAEDIAT ACTA S, V17, P1; GAHL WA, 1996, HDB CLIN NEUROLOGY, V22, P353; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; KRASNEWICH DM, 1993, BIOCHEM MED METAB B, V49, P90, DOI 10.1006/bmmb.1993.1010; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; Leroy JG, 1998, AM J HUM GENET S, V63, pA269; MARTIN JJ, 1975, ACTA NEUROPATHOL, V33, P285, DOI 10.1007/BF00686161; MONTREUI.J, 1968, CLIN CHIM ACTA, V21, P61, DOI 10.1016/0009-8981(68)90011-9; Sambrook J, 1989, MOL CLONING LAB MANU; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; SEPPALA R, 1991, J BIOL CHEM, V266, P7456; SOMMAR KM, 1972, BIOCHIM BIOPHYS ACTA, V268, P581, DOI 10.1016/0005-2744(72)90355-5; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; THOMAS GH, 1985, PEDIATR RES, V19, P451, DOI 10.1203/00006450-198505000-00009; TIETZE F, 1989, J BIOL CHEM, V264, P15316; WEISS P, 1989, J BIOL CHEM, V264, P17635; WILCKEN B, 1987, J INHERIT METAB DIS, V10, P97, DOI 10.1007/BF01800030	21	37	39	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1419	1427		10.1086/320598	http://dx.doi.org/10.1086/320598			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326336	Bronze, Green Published			2022-12-18	WOS:000169094600012
J	Amos, CI; Frazier, ML; Wang, WF				Amos, CI; Frazier, ML; Wang, WF			DNA pooling in mutation detection with reference to sequence analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER	We discuss pooling methods of mutation detection for identifying rare mutations. We provide mathematical formulae for obtaining the optimal pool size as a function of the mutation frequency in the study population and the specificity of the test. The optimal pool size depends strongly on the specificity of the test. With a test that has 99% specificity, pooling can reduce the number of tests that need to be performed by 80%, whereas, with a test with 95% specificity, pooling reduces the number of samples that must be tested by only 50%. We used the software PHRED to call mutations after sequencing of pooled samples with known STK11 mutations. We found that, when the area under the curve for the less prominent peak was used to call mutations, we were able to pool pairs of samples and correctly identify mutations. Pooling of three samples did not lead to an adequately specific test for the basic automated allele-calling procedures that we used. We discuss methods by which the specificity may be improved to permit pooling of three or more samples when testing for mutations by sequencing.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Amos, CI (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd,Box 189, Houston, TX 77030 USA.				NCI NIH HHS [R01CA70759, P01CA34936] Funding Source: Medline; NIEHS NIH HHS [R01ES09912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070759, P01CA034936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; BRUNO WJ, 1995, GENOMICS, V26, P21, DOI 10.1016/0888-7543(95)80078-Z; Chen ZY, 1997, ANAL BIOCHEM, V244, P191, DOI 10.1006/abio.1996.9903; CHURCHILL GA, 1993, P NATL ACAD SCI USA, V90, P16, DOI 10.1073/pnas.90.1.16; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Coolbaugh-Murphy MI, 1999, AM J HUM GENET, V65, pA123; Daniels J, 1998, AM J HUM GENET, V62, P1189, DOI 10.1086/301816; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hartge P, 1999, AM J HUM GENET, V64, P963, DOI 10.1086/302320; Krook Anna, 1992, Human Molecular Genetics, V1, P391, DOI 10.1093/hmg/1.6.391; Mohrenweiser HW, 1998, MUTAT RES-FUND MOL M, V400, P15, DOI 10.1016/S0027-5107(98)00059-1; Shaw SH, 1998, GENOME RES, V8, P111, DOI 10.1101/gr.8.2.111; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; Taillon-Miller P, 1999, GENOME RES, V9, P499	15	37	47	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1689	1692		10.1086/302894	http://dx.doi.org/10.1086/302894			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10733464	Bronze, Green Published			2022-12-18	WOS:000088373700023
J	Lee, S; Wevrick, R				Lee, S; Wevrick, R			Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: Further evidence for regional imprinting control	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NECDIN GENE; NEUROENDOCRINE PROTEIN-7B2; OCULOCUTANEOUS ALBINISM; EXPRESSED TRANSCRIPT; POLYPEPTIDE 7B2; X-INACTIVATION; CANDIDATE GENE; ANTISENSE RNA; HUMAN GENOME; MOUSE MODEL	Deletions and other abnormalities of human chromosome 15q11-q13 are associated with two developmental disorders, Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Loss of expression of imprinted, paternally expressed genes has been implicated in PWS. However, the number of imprinted genes that contribute to PWS, and the range over which the imprinting signal acts to silence one copy of the gene in a parent-of-origin-specific manner, are unknown. To identify additional imprinted genes that could contribute to the PWS phenotype and to understand the regional control of imprinting in 15q11-q13, we have constructed an imprinted transcript map of the PWS-AS deletion interval. The imprinting status of 22 expressed sequence tags derived from the radiation-hybrid human transcript maps or physical maps was determined in a reverse transcriptase-PCR assay and correlated with the position of the transcripts on the physical map. Seven new paternally expressed transcripts localize to an similar to 1.5-Mb domain surrounding the SNRPN-associated imprinting center, which already includes four imprinted, paternally expressed genes. All other tested new transcripts in the deletion region were expressed from both alleles. A domain of exclusive paternal expression surrounding the imprinting center suggests strong regional control of the imprinting process. This study provides the means for further investigation of additional genes that cause or modify the phenotypes associated with rearrangements of 15q11-q13.	Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Alberta	Wevrick, R (corresponding author), Univ Alberta, Dept Med Genet, 842 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.			Wevrick, Rachel/0000-0002-3343-5794				Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Barlow DP, 1997, EMBO J, V16, P6899, DOI 10.1093/emboj/16.23.6899; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Christie WC, 1998, ENG COMPUTATION, V15, P35, DOI 10.1108/02644409810200677; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Dao D, 1998, HUM MOL GENET, V7, P597, DOI 10.1093/hmg/7.4.597; Dyomin VG, 1997, P NATL ACAD SCI USA, V94, P5728, DOI 10.1073/pnas.94.11.5728; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; Gabreels BATF, 1998, J CLIN ENDOCR METAB, V83, P591, DOI 10.1210/jc.83.2.591; GABREELS BATF, 1994, BRAIN RES, V657, P281, DOI 10.1016/0006-8993(94)90978-4; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; GRAHAM DA, 1992, AUST NZ J MED, V22, P455; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HOLM VA, 1993, PEDIATRICS, V91, P398; Horsthemke B, 1997, J CELL PHYSIOL, V173, P237, DOI 10.1002/(SICI)1097-4652(199711)173:2<237::AID-JCP28>3.0.CO;2-B; Huang B, 1997, HUM GENET, V99, P11; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; JOHNSON DK, 1995, GENETICS, V141, P1563; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MATTEI MG, 1990, GENOMICS, V6, P436, DOI 10.1016/0888-7543(90)90473-8; Meguro M, 1997, HUM MOL GENET, V6, P2127, DOI 10.1093/hmg/6.12.2127; Miller AP, 1998, P NATL ACAD SCI USA, V95, P8709, DOI 10.1073/pnas.95.15.8709; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Rougeulle C, 1998, NEUROGENETICS, V1, P229, DOI 10.1007/s100480050034; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SCHERER S, 1991, ADV TECHNIQUES CHROM; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wevrick R, 1996, LANCET, V348, P1068, DOI 10.1016/S0140-6736(96)04342-5; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	62	37	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					848	858		10.1086/302817	http://dx.doi.org/10.1086/302817			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712201	Green Published, Bronze			2022-12-18	WOS:000088373200009
J	Goldin, LR; Sgambati, M; Marti, GE; Fontaine, L; Ishibe, N; Caporaso, N				Goldin, LR; Sgambati, M; Marti, GE; Fontaine, L; Ishibe, N; Caporaso, N			Anticipation in familial chronic lymphocytic leukemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RELATIVES; HISTORY		NCI, Dov Canc Epidemiol & Genet, Genet Epidemiol Branch, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; Westat Res Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); Westat	Goldin, LR (corresponding author), NCI, Dov Canc Epidemiol & Genet, Genet Epidemiol Branch, 6120 Execut Blvd,Room 7008,MSC 7236, Bethesda, MD 20892 USA.							Allison P, 2010, SURVIVAL ANAL USING; CALL TG, 1994, MAYO CLIN PROC, V69, P323, DOI 10.1016/S0025-6196(12)62215-0; CAPORASO NE, 1991, LEUKEMIA LYMPHOMA, V3, P331, DOI 10.3109/10428199109070277; CARTWRIGHT RA, 1987, BRIT J CANCER, V56, P79, DOI 10.1038/bjc.1987.158; CUTTNER J, 1992, CANCER INVEST, V10, P103, DOI 10.3109/07357909209032771; DIGHIERO G, 1996, HEMATOL CELL THER S, V38, pS42; Fraser FC, 1997, LANCET, V350, P459, DOI 10.1016/S0140-6736(05)63077-2; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Hjalmar V, 1996, MED ONCOL, V13, P95, DOI 10.1007/BF02993859; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; Horwitz M, 1997, LEUKEMIA, V11, P1347, DOI 10.1038/sj.leu.2400707; Horwitz M, 1996, AM J HUM GENET, V59, P990; LaSpada AR, 1997, BRAIN PATHOL, V7, P943; LINET MS, 1989, AM J EPIDEMIOL, V130, P655, DOI 10.1093/oxfordjournals.aje.a115387; McInnis MG, 1996, AM J HUM GENET, V59, P973; RADOVANOVIC Z, 1994, EUR J EPIDEMIOL, V10, P211, DOI 10.1007/BF01730372; Rozman C, 1997, LEUKEMIA, V11, P775, DOI 10.1038/sj.leu.2400679; TRAVIS LB, 1992, JNCI-J NATL CANCER I, V84, P1422, DOI 10.1093/jnci/84.18.1422; Yuille MR, 1998, LEUKEMIA, V12, P1696, DOI 10.1038/sj.leu.2401176	19	37	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					265	269		10.1086/302458	http://dx.doi.org/10.1086/302458			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364544	Green Published, Bronze			2022-12-18	WOS:000081224300036
J	Huang, WJ; Lamb, DJ; Kim, ED; de Lara, J; Lin, WW; Lipshultz, LI; Bischoff, FZ				Huang, WJ; Lamb, DJ; Kim, ED; de Lara, J; Lin, WW; Lipshultz, LI; Bischoff, FZ			Germ-cell nondisjunction in testes biopsies of men with idiopathic infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	93rd Annual Meeting of the American-Urological-Association	MAY 30-JUN 04, 1998	SAN DIEGO, CA	Amer Urol Assoc			IN-SITU HYBRIDIZATION; INTRACYTOPLASMIC SPERM INJECTION; HUMAN-SPERMATOZOA; FOLLOW-UP; INSITU HYBRIDIZATION; MALE-STERILITY; CHILDREN BORN; CHROMOSOME-X; PATERNAL AGE; ANEUPLOIDY	Intracytoplasmic sperm; injection (ICSI) has been used in combination:with testicular sperm extraction to achieve pregnancies in couples:with severe male-factor infertility, yet many of the underlying genetic mechanisms remain largely unknown. To investigate nondisjunction in mitotic and meiotic germ cells, we performed three-color FISH to detect numeric chromosome aberrations in testicular tissue samples from infertile men confirmed to have impaired spermatogenesis of unknown cause. FISH was employed to determine the rate of sex-chromosome aneuploidy in germ cells. Nuclei were distinguished as haploid or diploid, respectively. The overall incidence of sex-chromosome aneuploidy in germ cells was found to be significantly higher (P <.00001) in all three abnormal histopathologic patterns (range 39.0%-43.5%) as compared with normal controls (29.1%). The relative ratio of normal to aneuploid nuclei in the diploid cells of patients with impaired spermatogenesis was similar to 1.0, a >300% decrease when compared with the 4.42 ratio detected in patients with normal spermatogenesis. These results provide direct evidence of an increased incidence of sex-chromosome aneuploidy observed in germ cells of men with severely impaired spermatogenesis who might be candidates:for ICSI with sperm obtained directly from the testis. The incidence of aneuploidy was significantly greater among the diploid nuclei, which suggests that chromosome instability is a result of altered genetic control during mitotic cell division and proliferation during spermatogenesis.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Urol, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Natl Yang Ming Univ, Sch Med, Vet Gen Hosp Taipei, Dept Surg,Div Urol, Taipei 112, Taiwan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Yang Ming Chiao Tung University	Bischoff, FZ (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 6550 Fannin,Suite 708B, Houston, TX 77030 USA.	bischoff@bcm.tmc.edu			NICHD NIH HHS [R01HD43203] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARR AB, 1971, J REPROD FERTIL, V25, P75; Bernardini L, 1997, MOL HUM REPROD, V3, P431, DOI 10.1093/molehr/3.5.431; Bischoff FZ, 1998, AM J OBSTET GYNECOL, V179, P203, DOI 10.1016/S0002-9378(98)70273-X; BISCHOFF FZ, 1994, CYTOGENET CELL GENET, V66, P237, DOI 10.1159/000133702; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bonduelle M, 1996, HUM REPROD, V11, P131, DOI 10.1093/humrep/11.suppl_4.131; Bonduelle M, 1996, HUM REPROD, V11, P1558; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; COONEN E, 1991, MOL REPROD DEV, V28, P18, DOI 10.1002/mrd.1080280104; DEVROEY P, 1995, HUM REPROD, V10, P1457, DOI 10.1093/HUMREP/10.6.1457; EGOZCUE J, 1983, HUM GENET, V65, P185, DOI 10.1007/BF00286660; Fishel S, 1997, HUM REPROD, V12, P336, DOI 10.1093/humrep/12.2.336; FISHEL S, 1995, LANCET, V345, P1641, DOI 10.1016/S0140-6736(95)90149-3; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Guttenbach M, 1997, HUM REPROD, V12, P468; Hilsenrath RE, 1997, FERTIL STERIL, V68, P510, DOI 10.1016/S0015-0282(97)00247-1; JOHNSON L, 1995, MICROSC RES TECHNIQ, V32, P385, DOI 10.1002/jemt.1070320504; JOHNSON L, 1982, FERTIL STERIL, V37, P811; JOSEPH AM, 1984, HUM GENET, V66, P234, DOI 10.1007/BF00286608; Kinakin B, 1997, CYTOGENET CELL GENET, V78, P116, DOI 10.1159/000134641; KURINCZUK J, 1996, B HUM GENET SOC AUST; Lahdetie J, 1997, AM J MED GENET, V71, P115; Lee JD, 1996, HUM REPROD, V11, P1942; Liebaers I, 1995, FERTILITY AND STERILITY, P409; Lin WW, 1997, FERTIL STERIL, V68, P1065, DOI 10.1016/S0015-0282(97)00372-5; LUCIANI JM, 1987, HUM GENET, V77, P246, DOI 10.1007/BF00284478; Mak V, 1996, J UROLOGY, V156, P1245, DOI 10.1016/S0022-5347(01)65561-7; MARTIN RH, 1988, MUTAT RES, V207, P159, DOI 10.1016/0165-1218(88)90235-2; MIHARU N, 1994, HUM GENET, V93, P502; MOOSANI N, 1995, FERTIL STERIL, V64, P811, DOI 10.1016/S0015-0282(16)57859-5; MULLER U, 1986, NUCLEIC ACIDS RES, V14, P6489, DOI 10.1093/nar/14.16.6489; Munne S, 1996, J ASSIST REPROD GEN, V13, P149, DOI 10.1007/BF02072537; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Office of Technology Assessment, 1988, OTABA358; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 1996, JAMA-J AM MED ASSOC, V276, P1893, DOI 10.1001/jama.276.23.1893; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; ROSENMANN A, 1985, CYTOGENET CELL GENET, V39, P19, DOI 10.1159/000132098; SILBER SJ, 1995, HUM REPROD, V10, P148, DOI 10.1093/humrep/10.1.148; Spriggs EL, 1996, AM J HUM GENET, V58, P356; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VELD PI, 1995, LANCET, V346, P773, DOI 10.1016/S0140-6736(95)91531-1; Yurov YB, 1996, MOL HUM REPROD, V2, P665, DOI 10.1093/molehr/2.9.665	45	37	38	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1638	1645		10.1086/302402	http://dx.doi.org/10.1086/302402			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Genetics & Heredity	203FA	10330350	Bronze, Green Published			2022-12-18	WOS:000080696200015
J	Martinsson, T; Darin, N; Kyllerman, M; Oldfors, A; Hallberg, B; Wahlstrom, J				Martinsson, T; Darin, N; Kyllerman, M; Oldfors, A; Hallberg, B; Wahlstrom, J			Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN HEAVY-CHAIN; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; DISTAL MYOPATHY; RIMMED VACUOLES; IRANIAN JEWS; HUMAN GENOME; MUTATIONS; LINKAGE; CARDIOMYOPATHY; QUADRICEPS	We recently described an autosomal dominant inclusion-body myopathy characterized by congenital joint contractures, external ophthalmoplegia, and predominantly proximal muscle weakness. A whole-genome scan, performed with 161 polymorphic markers and with DNA from 30 members of one family, indicated strong linkage for markers on chromosome 17p. After analyses with additional markers in the region and with DNA from eight additional family members, a maximum LOD score (Z(max)) was detected for marker D17S1303 (Z(max) = 7.38; recombination fraction (theta) = 0). Haplotype analyses showed that the locus (Genome Database locus name: IBM3) is flanked distally by marker D17S945 and proximally by marker D17S969. The positions of cytogenetically localized flanking markers suggest that the location of the IBM3 gene is in chromosome region 17p13.1. Radiation hybrid mapping showed that IBM3 is located in a 2-Mb chromosomal region and that the myosin heavy-chain (MHC) gene cluster, consisting of at least six genes, co-localizes to the same region. This localization raises the possibility that one of the MHC genes clustered in this region may be involved in this disorder.	Sahlgrens Univ Hosp, Dept Clin Genet, S-41685 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pediat, S-41685 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41685 Gothenburg, Sweden	Sahlgrenska University Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Martinsson, T (corresponding author), Sahlgrens Univ Hosp, Dept Clin Genet, S-41685 Gothenburg, Sweden.		Darin, Niklas/AAL-6345-2020; Martinsson, Tommy/J-4140-2013	Martinsson, Tommy/0000-0002-9403-3123; Oldfors, Anders/0000-0002-5758-7397				Argov Z, 1997, ANN NEUROL, V41, P548, DOI 10.1002/ana.410410419; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Askanas V, 1998, SCAND J RHEUMATOL, V27, P389; Askanas Valerie, 1998, Current Opinion in Rheumatology, V10, P530, DOI 10.1097/00002281-199811000-00005; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; COQUET M, 1990, NEUROPATH APPL NEURO, V16, P393, DOI 10.1111/j.1365-2990.1990.tb01275.x; Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FANANAPAZIR L, 1993, P NATL ACAD SCI USA, V90, P3993, DOI 10.1073/pnas.90.9.3993; FUKUHARA N, 1982, ACTA NEUROL SCAND, V65, P458, DOI 10.1111/j.1600-0404.1982.tb03103.x; FUKUHARA N, 1980, ACTA NEUROPATHOL, V51, P229, DOI 10.1007/BF00687390; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; KUMAMOTO T, 1982, ARCH NEUROL-CHICAGO, V39, P367, DOI 10.1001/archneur.1982.00510180045011; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEINWAND LA, 1983, SCIENCE, V221, P766, DOI 10.1126/science.6879174; LINDBERG C, 1991, J NEUROL SCI, V103, P76, DOI 10.1016/0022-510X(91)90287-H; MCKEE D, 1992, Neurology, V42, P302; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEVILLE HE, 1992, NEUROLOGY, V42, P897, DOI 10.1212/WNL.42.4.897; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; ROSENBAUM SM, 1996, HUM MOL GENET, V5, P159; SAEZ LJ, 1987, NUCLEIC ACIDS RES, V15, P5443, DOI 10.1093/nar/15.13.5443; Sivakumar K, 1996, NEUROLOGY, V47, P977, DOI 10.1212/WNL.47.4.977; SOUSSIYANICOSTAS N, 1993, HUM MOL GENET, V2, P563, DOI 10.1093/hmg/2.5.563; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; WHALEN RG, 1981, NATURE, V292, P805, DOI 10.1038/292805a0; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618; YOON SJ, 1992, P NATL ACAD SCI USA, V89, P12078, DOI 10.1073/pnas.89.24.12078	35	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1420	1426		10.1086/302375	http://dx.doi.org/10.1086/302375			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205275	Green Published, Bronze			2022-12-18	WOS:000080093000022
J	Greco, A; Villa, R; Tubino, B; Romano, L; Penso, D; Pierotti, MA				Greco, A; Villa, R; Tubino, B; Romano, L; Penso, D; Pierotti, MA			A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NERVE GROWTH-FACTOR; COILED-COIL DOMAIN; TRK-T3 ONCOGENE; RECEPTOR GENE; NEUROPATHIES; PRODUCT		Ist Nazl Tumori, Div Expt Oncol A, I-20133 Milan, Italy; Gaslini Inst, Dept Pediat, Genoa, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS Istituto Giannina Gaslini	Greco, A (corresponding author), Ist Nazl Tumori, Div Expt Oncol A, Via G Venezian 1, I-20133 Milan, Italy.		Pierotti, Marco Alessandro/AAC-4728-2022; Greco, Angela/C-1953-2017	Pierotti, Marco Alessandro/0000-0002-7431-8332; Greco, Angela/0000-0003-2994-0349; Villa, Riccardo/0000-0001-8385-800X	Telethon [E.0568] Funding Source: Medline	Telethon(Fondazione Telethon)		AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; AXELROD FB, 1996, PRINCIPLES PRACTICE, P397; Fagan AM, 1996, J NEUROSCI, V16, P6208; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Greco A, 1998, ONCOGENE, V16, P809, DOI 10.1038/sj.onc.1201596; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LANGER J, 1981, ACTA NEUROPATHOL, V54, P199, DOI 10.1007/BF00687742; ROSEMBERG S, 1994, PEDIATR NEUROL, V11, P50, DOI 10.1016/0887-8994(94)90091-4; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0	11	37	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1207	1210		10.1086/302319	http://dx.doi.org/10.1086/302319			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090906	Green Published, Bronze			2022-12-18	WOS:000079632900032
J	Andrew, LJ; Brancolini, V; de la Pena, LS; Devoto, M; Caeiro, F; Marchegiani, R; Reginato, A; Gaucher, A; Netter, P; Gillet, P; Loeuille, D; Prockop, DJ; Carr, A; Wordsworth, BF; Lathrop, M; Butcher, S; Considine, E; Everts, K; Nicod, A; Walsh, S; Williams, CJ				Andrew, LJ; Brancolini, V; de la Pena, LS; Devoto, M; Caeiro, F; Marchegiani, R; Reginato, A; Gaucher, A; Netter, P; Gillet, P; Loeuille, D; Prockop, DJ; Carr, A; Wordsworth, BF; Lathrop, M; Butcher, S; Considine, E; Everts, K; Nicod, A; Walsh, S; Williams, CJ			Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTICULAR CHONDROCALCINOSIS; HEREDITARY CHONDROCALCINOSIS; NTP PYROPHOSPHOHYDROLASE; SPONDYLOEPIPHYSEAL DYSPLASIA; PRECOCIOUS OSTEOARTHRITIS; INORGANIC PYROPHOSPHATE; CRYSTAL DEPOSITION; LINKAGE ANALYSIS; II GENE; CARTILAGE	Familial calcium pyrophosphate dihydrate deposition disease (CPPDD) is a disease of articular cartilage that is radiographically characterized by chondrocalcinosis due to the deposition of calcium-containing crystals in affected joints. We have documented the disease in an Argentinean kindred of northern Italian ancestry and in a French kindred from the Alsace region. Both families presented with a common phenotype including early age at onset and deposition of crystals of calcium pyrophosphate dihydrate in a similar pattern of affected joints. Affected family members were karyotypically normal. Linkage to the short arm of chromosome 5 was observed, consistent with a previous report of linkage of the CPPDD phenotype in a large British kindred to the 5p15 region. However, recombinants in the Argentinean kindred have enabled us to designate a region <1 cM in length between the markers D5S416 and D5S2114 as the CPPDD locus.	Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Mol Biol & Med, Philadelphia, PA 19107 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Wellcome Trust Ctr Human Ctr, Oxford, England; Hosp Privado, Cordoba, Argentina; Univ Med & Dent New Jersey, Div Rheumatol, Camden, NJ USA; Univ Henri Poincare & Clin Rhumatol, CNRS, Nancy, France	Jefferson University; Jefferson University; Rockefeller University; University of Oxford; Wellcome Centre for Human Genetics; Hospital Privado - Universitario de Cordoba; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Williams, CJ (corresponding author), Thomas Jefferson Univ, Dept Biochem, BLSB508,233 S 10th St, Philadelphia, PA 19107 USA.	Charlene.Williams@mail.tju.edu	Devoto, Marcella/AAP-7595-2021	DEVOTO, MARCELLA/0000-0002-4431-5114; Brancolini, Valeria/0000-0003-0871-537X	NIAMS NIH HHS [AR44360] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044360] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALDWIN CT, 1995, AM J HUM GENET, V56, P692; BALSA A, 1990, ANN RHEUM DIS, V49, P531, DOI 10.1136/ard.49.7.531; BJELLE A, 1982, ARTHRITIS RHEUM, V25, P66, DOI 10.1002/art.1780250111; BJELLE A, 1981, J RHEUMATOL, V8, P959; BJELLE AO, 1972, ANN RHEUM DIS, V31, P449, DOI 10.1136/ard.31.6.449; CHAN KWA, 1993, ARTHRITIS RHEUM-US, V36, P1691, DOI 10.1002/art.1780361207; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DIEPPE PA, 1982, ANN RHEUM DIS, V41, P371, DOI 10.1136/ard.41.4.371; DOHERTY M, 1991, BRIT J RHEUMATOL, V30, P10; ESHEL G, 1990, ANN RHEUM DIS, V49, P528, DOI 10.1136/ard.49.7.528; FELSON DT, 1989, J RHEUMATOL, V16, P1241; FERNANDEZDAPICA MP, 1986, J RHEUMATOL, V13, P631; GAUCHER A, 1977, SCAND J RHEUMATOL, V16, P217; GAUDREAU A, 1981, ARTHRITIS RHEUM, V24, P611, DOI 10.1002/art.1780240407; GERSH M, 1994, GENOMICS, V24, P577, DOI 10.1006/geno.1994.1668; HAMZA M, 1992, CLIN EXP RHEUMATOL, V10, P43; HOWELL DS, 1984, ARTHRITIS RHEUM, V27, P193, DOI 10.1002/art.1780270211; HUGHES AE, 1995, HUM MOL GENET, V4, P1225, DOI 10.1093/hmg/4.7.1225; LOUYOT P, 1964, REV RHUM, V31, P659; LUST G, 1981, ARTHRITIS RHEUM, V24, P1517, DOI 10.1002/art.1780241210; LUST G, 1981, SCIENCE, V214, P809, DOI 10.1126/science.6270793; Maniatis T., 1982, MOL CLONING LAB MANU; MCCARTY DJ, 1961, ANN INTERN MED, V54, P452, DOI 10.7326/0003-4819-54-3-452; MCCARTY DJ, 1975, B RHEUM DIS, V25, P804; MOSKOWITZ RW, 1964, JAMA-J AM MED ASSOC, V188, P867; MOSKOWITZ RW, 1993, TXB RHEUMATOLOGY, P1337; MUNIZ O, 1984, ARTHRITIS RHEUM, V27, P186, DOI 10.1002/art.1780270210; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; REGINATO AJ, 1994, ARTHRITIS RHEUM, V37, P1078, DOI 10.1002/art.1780370714; REGINATO AJ, 1975, ANN RHEUM DIS, V34, P260, DOI 10.1136/ard.34.3.260; RICHARDSON BC, 1983, ARTHRITIS RHEUM, V26, P1387, DOI 10.1002/art.1780261112; RIESTRA JL, 1988, CLIN EXP RHEUMATOL, V6, P369; RODRIGUEZVALVERDE V, 1988, AM J MED, V84, P101, DOI 10.1016/0002-9343(88)90015-0; Ryan Lawrence M., 1993, P1835; RYAN LM, 1986, J CLIN INVEST, V77, P1689, DOI 10.1172/JCI112487; RYAN LM, 1984, ARTHRITIS RHEUM, V27, P404, DOI 10.1002/art.1780270407; RYAN LM, 1985, ARTHRITIS RHEUM, V28, P413, DOI 10.1002/art.1780280409; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sakaguchi M, 1982, Ryumachi, V22, P4; SANMARTI R, 1993, ANN RHEUM DIS, V52, P418, DOI 10.1136/ard.52.6.418; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; VANDERKORST JK, 1974, AM J MED, V56, P307, DOI 10.1016/0002-9343(74)90612-3; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458; ZITNAN D, 1963, ANN RHEUM DIS, V22, P142, DOI 10.1136/ard.22.3.142; ZITNAN D, 1958, BRATISL LEK LISTY, V38, P217	46	37	38	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					136	145		10.1086/302186	http://dx.doi.org/10.1086/302186			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915952	Green Published, Bronze			2022-12-18	WOS:000078477400018
J	Bonafe, M; Olivieri, F; Mari, D; Baggio, G; Mattace, R; Sansoni, P; De Benedictis, G; De Luca, M; Bertolini, S; Barbi, C; Monti, D; Franceschi, C				Bonafe, M; Olivieri, F; Mari, D; Baggio, G; Mattace, R; Sansoni, P; De Benedictis, G; De Luca, M; Bertolini, S; Barbi, C; Monti, D; Franceschi, C			p53 variants predisposing to cancer are present in healthy centenarians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							BREAST-CANCER; LUNG-CANCER; POLYMORPHISMS; HAPLOTYPES; ASSOCIATIONS		Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; Italian Natl Res Ctr Aging, Ancona, Italy; Univ Milan, Maggiore Hosp, Sci Inst Care & Res, Inst Internal Med, Milan, Italy; Univ Sassari, Dept Internal Med, I-07100 Sassari, Italy; Univ Reggio Calabria, Chari Geriatr, Catanzaro, Italy; Univ Parma, Inst Internal Med & Med Therapy, I-43100 Parma, Italy; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; Univ Genoa, Dept Internal Med, Atherosclerosis Prevent Ctr, I-16126 Genoa, Italy; Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; Univ Florence, Inst Gen Pathol, Florence, Italy	University of Bologna; IRCCS INRCA; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Sassari; Universita Mediterranea di Reggio Calabria; University of Parma; University of Calabria; University of Genoa; Universita di Modena e Reggio Emilia; University of Florence	Franceschi, C (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	c.franceschi@inrca.it	Monti, Daniela/G-9556-2012; Mari, Daniela/K-5663-2016; Franceschi, Claudio/L-4484-2017; Olivieri, Fabiola/K-6465-2016; /V-4899-2019; , Otto/P-4127-2018	Monti, Daniela/0000-0001-8651-8123; Mari, Daniela/0000-0002-6950-0789; Franceschi, Claudio/0000-0001-9841-6386; Olivieri, Fabiola/0000-0002-9606-1144; , Otto/0000-0003-2101-4105				Baggio G, 1998, FASEB J, V12, P433, DOI 10.1096/fasebj.12.6.433; BIRGANDER R, 1995, CARCINOGENESIS, V16, P2233, DOI 10.1093/carcin/16.9.2233; Capurso A, 1997, ARCH GERONTOL GERIAT, V25, P149; De Benedictis G, 1998, ANN HUM GENET, V62, P115, DOI 10.1017/S0003480098006757; DeBenedictis G, 1997, HUM GENET, V99, P312; FRANCESCHI C, 1995, IMMUNOL TODAY, V16, P12, DOI 10.1016/0167-5699(95)80064-6; Mannucci PM, 1997, ARTERIOSCL THROM VAS, V17, P755, DOI 10.1161/01.ATV.17.4.755; Mari D, 1996, LANCET, V347, P1044, DOI 10.1016/S0140-6736(96)90181-6; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SJALANDER A, 1995, CARCINOGENESIS, V16, P1461, DOI 10.1093/carcin/16.7.1461; Sjalander A, 1996, CARCINOGENESIS, V17, P1313, DOI 10.1093/carcin/17.6.1313; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Toupance B, 1998, AM J HUM GENET, V62, P1525, DOI 10.1086/301865; Weston A, 1997, ENVIRON HEALTH PERSP, V105, P919, DOI 10.2307/3433304; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; YASIN A, 1998, J EPIDEMIOL BIOSTAT, V3, P289	16	37	39	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					292	295		10.1086/302196	http://dx.doi.org/10.1086/302196			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915969	Green Published, Bronze			2022-12-18	WOS:000078477400035
J	Anikster, Y; Nyhan, WL; Gahl, WA				Anikster, Y; Nyhan, WL; Gahl, WA			NTBC and alkaptonuria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TYROSINEMIA TYPE-I; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; INHIBITOR		NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Med Genet Branch, Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Diego	Gahl, WA (corresponding author), NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, 10 Ctr Dr,MSC 1830,Bldg 10,Room 9S-241, Bethesda, MD 20892 USA.							Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; GIBBS TC, 1993, J NEUROL NEUROSUR PS, V56, P1129, DOI 10.1136/jnnp.56.10.1129; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257; La Du BN, 1998, AM J HUM GENET, V62, P765, DOI 10.1086/301810; La Du BN, 1995, METABOLIC MOL BASES, P1371; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; MITCHELL GA, 1997, METABOLIC MOL BASES; Pronicka E, 1996, J INHERIT METAB DIS, V19, P234, DOI 10.1007/BF01799438; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K	10	37	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					920	921		10.1086/302027	http://dx.doi.org/10.1086/302027			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718357	Bronze, Green Published			2022-12-18	WOS:000075919000037
J	Makela-Bengs, P; Jarvinen, N; Vuopala, K; Suomalainen, A; Ignatius, J; Sipila, M; Herva, R; Palotie, A; Peltonen, L				Makela-Bengs, P; Jarvinen, N; Vuopala, K; Suomalainen, A; Ignatius, J; Sipila, M; Herva, R; Palotie, A; Peltonen, L			Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; MULTILOCUS LINKAGE ANALYSIS; GENE DELETION; ATAXIA LOCUS; DISEQUILIBRIUM; FINLAND; NOTCH; ARTHROGRYPOSIS; HYBRIDIZATION; POPULATIONS	Lethal congenital contracture syndrome (LCCS) is an autosomal recessive disease leading to death before the 32d gestational week. It is characterized by the fetal akinesia phenotype, with highly focused degeneration of motoneurons in the spinal cord as the main neuropathological finding. We report here the assignment of the LCCS locus to a defined region of chromosome 9q34, between markers D9S1825 and D3S1830, The initial genome scan was performed with the DNA samples of only five affected individuals from two unrelated LCCS families. The conventional linkage analysis performed with 20 affected individuals and their families was focused on those chromosomal regions in which the affected siblings were identical by descent in the initial scan. One core haplotype of 3 cM was observed in LCCS alleles, supporting the assumption of one major mutation underlying LCCS, and linkage disequilibrium analysis restricted the critical chromosomal region to <100 kb in the vicinity of marker D9S61. Two genes, NGAL (neutrophil gelatinase-associated lipocalin and NOTCH 1, were excluded as causative genes for LCCS.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; Lapland Cent Hosp, Dept Pathol, Rovaniemi, Finland; Jorvi Hosp, Dept Clin Neurophysiol, SF-02740 Espoo, Finland; Univ Oulu, Dept Pathol, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Oulu	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	leena.peltonen@ktl.fi		Palotie, Aarno/0000-0002-2527-5874; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; Burglen L, 1996, J CLIN INVEST, V98, P1130, DOI 10.1172/JCI118895; CARROLL AJ, 1987, BLOOD, V70, P1962; CHAN P, 1994, GENOMICS, V23, P145, DOI 10.1006/geno.1994.1470; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Devriendt K, 1996, ANN NEUROL, V40, P731, DOI 10.1002/ana.410400509; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; HASTBACKA J, 1992, NAT GENET, V2, P343; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEISKANEN M, 1994, BIOTECHNIQUES, V17, P928; Heiskanen M, 1996, GENET ANAL-BIOMOL E, V12, P179, DOI 10.1016/1050-3862(95)00134-4; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HERVA R, 1988, AM J MED GENET, V29, P67, DOI 10.1002/ajmg.1320290109; HERVA R, 1985, AM J MED GENET, V20, P431, DOI 10.1002/ajmg.1320200303; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; ISOLA J, 1994, AM J PATHOL, V145, P1301; Lardelli M, 1995, INT J DEV BIOL, V39, P769; LARSSON C, 1994, GENOMICS, V24, P253, DOI 10.1006/geno.1994.1613; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Luria SE, 1943, GENETICS, V28, P491; NIKALI K, 1995, AM J HUM GENET, V56, P1088; NORIO R, 1973, ANN CLIN RES, V5, P109; OTT J, 1986, GENET EPIDEMIOL, P251; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; RudnikSchoneborn S, 1996, NEUROPEDIATRICS, V27, P8, DOI 10.1055/s-2007-973741; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Solantie R., 1988, FENNOSCANDIA ARCHAEO, V5, P3; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Varilo T, 1996, AM J HUM GENET, V58, P506; Varilo T, 1996, GENOME RES, V6, P870, DOI 10.1101/gr.6.9.870; VUOPALA K, 1994, J MED GENET, V31, P521, DOI 10.1136/jmg.31.7.521; VUOPALA K, 1995, J MED GENET, V32, P36, DOI 10.1136/jmg.32.1.36; VUOPALA K, 1994, NEUROPEDIATRICS, V25, P308, DOI 10.1055/s-2008-1073045; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	46	37	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					506	516		10.1086/301968	http://dx.doi.org/10.1086/301968			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683599	Green Published, Bronze			2022-12-18	WOS:000075360800026
J	Wilson, A; Leclerc, D; Saberi, F; Campeau, E; Hwang, HY; Shane, B; Phillips, JA; Rosenblatt, DS; Gravel, RA				Wilson, A; Leclerc, D; Saberi, F; Campeau, E; Hwang, HY; Shane, B; Phillips, JA; Rosenblatt, DS; Gravel, RA			Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROGENEITY; COBALAMIN; CLONING	Methionine synthase (MS) catalyses the methylation of homocysteine to methionine and requires the vitamin B-12 derivative, methylcobalamin, as cofactor. We and others have recently cloned cDNAs for MS and described mutations associated with the cblG complementation group that correspond to MS deficiency. A subset of cblG, known as "cblG variant," shows no detectable MS activity and failure of [Co-57]CN cobalamin to incorporate into MS in patient fibroblasts. We report the mutations responsible for three cblG-variant patients, two of them siblings, who presented with neonatal seizures, severe developmental delay, and elevated plasma homocysteine. Cell lines from all three patients were negative by northern blotting, though trace MS mRNA could be detected by means of phosphorimage analysis. Reverse transcriptase-PCR, SSCP, and nucleotide sequence analysis revealed four mutations. All were functionally null, creating either a frameshift with a downstream stop codon or an insert containing an internal stop codon. Of the two mutations found in the siblings, one of them, intervening sequence (IVS)-166A-->G, generates a cryptic donor splice site at position -166 of an intron beginning after Leu113, resulting in a 165-bp insertion of intronic sequence at junction 339/340. The second is a 2-bp deletion, 2112delTC. Mutations in the third patient include a G-->A substitution, well within the intron after Lys203, which results in intronic inserts of 128 or 78 bp in the mRNA. The second mutation is a 1-bp insertion, 3378insA. We conclude that the absence of MS protein in these cblG variants is due to mutations causing premature translation termination and consequent mRNA instability.	McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Res Inst, Montreal, PQ, Canada; McGill Univ, Dept Biol, Montreal, PQ, Canada; McGill Univ, Dept Human Genet & Pediat, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Montreal Childrens Hosp, MRC, Grp Med Genet, Montreal, PQ H3H 1P3, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University; McGill University; University of California System; University of California Berkeley; Vanderbilt University; McGill University	Gravel, RA (corresponding author), Montreal Childrens Hosp, Res Inst, MUHC, 4060 St Catherine St W, Montreal, PQ H3Z 2Z3, Canada.		Leclerc, Daniel/AAB-4524-2021; Leclerc, Daniel/B-6375-2012	Leclerc, Daniel/0000-0002-9766-8941; 				Banerjee R, 1997, CHEM BIOL, V4, P175, DOI 10.1016/S1074-5521(97)90286-6; CARMEL R, 1988, NEW ENGL J MED, V318, P1738, DOI 10.1056/NEJM198806303182607; Chen LH, 1997, J BIOL CHEM, V272, P3628, DOI 10.1074/jbc.272.6.3628; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FENTON WA, 1995, METABOLIC MOL BASES, P3129; Gulati S, 1997, J BIOL CHEM, V272, P19171, DOI 10.1074/jbc.272.31.19171; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Harding CO, 1997, AM J MED GENET, V71, P384, DOI 10.1002/(SICI)1096-8628(19970905)71:4<384::AID-AJMG3>3.0.CO;2-U; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Ludwig ML, 1997, ANNU REV BIOCHEM, V66, P269, DOI 10.1146/annurev.biochem.66.1.269; Rosenblatt DS., 1995, METABOLIC MOL BASES, P3111; SILLAOTS SL, 1992, BIOCHEM MED METAB B, V47, P242, DOI 10.1016/0885-4505(92)90032-T; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; Wildin R. S., 1992, American Journal of Human Genetics, V51, pA357	16	37	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					409	414		10.1086/301976	http://dx.doi.org/10.1086/301976			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683607	Green Published, Bronze			2022-12-18	WOS:000075360800016
J	Sidransky, E; Burgess, C; Ikeuchi, T; Lindblad, K; Long, RT; Philibert, RA; Rapoport, J; Schalling, M; Tsuji, S; Ginns, EI				Sidransky, E; Burgess, C; Ikeuchi, T; Lindblad, K; Long, RT; Philibert, RA; Rapoport, J; Schalling, M; Tsuji, S; Ginns, EI			A triplet repeat on 17q accounts for most expansions detected by the repeat-expansion-detection technique	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHILDHOOD-ONSET SCHIZOPHRENIA; EXPANDED CAG REPEATS; DISORDER		NIMH, Clin Neurosci Branch, IRP, NIH, Bethesda, MD 20892 USA; NIMH, Child Psychiat Branch, IRP, NIH, Bethesda, MD 20892 USA; Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden; Niigata Univ, Dept Neurol, Brain Res Inst, Niigata, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet; Karolinska University Hospital; Niigata University	Sidransky, E (corresponding author), NIMH, Clin Neurosci Branch, IRP, NIH, Bldg 49,Room B1EE16,49 Convent Dr,MSC 4405, Bethesda, MD 20892 USA.		Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Philibert, Robert/0000-0001-7822-4977				Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; BURGESS CE, 1998, IN PRESS MOL PSYCHIA; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; GILLES D, 1997, NAT GENET, V17, P65; GORDON CT, 1994, SCHIZOPHRENIA BULL, V20, P697, DOI 10.1093/schbul/20.4.697; IKEUCHI T, 1998, IN PRESS GENOMICS; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Kumra S, 1998, J AM ACAD CHILD PSY, V37, P91, DOI 10.1097/00004583-199801000-00022; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; LINDBLAD K, 1995, NEUROBIOL DIS, V2, P55, DOI 10.1006/nbdi.1995.0006; MCKENNA K, 1994, J AM ACAD CHILD PSY, V33, P771, DOI 10.1097/00004583-199407000-00001; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; Nakamoto M, 1997, NAT GENET, V17, P385, DOI 10.1038/ng1297-385; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Zander C., 1997, P263	17	37	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1548	1551		10.1086/301876	http://dx.doi.org/10.1086/301876			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585604	Green Published, Bronze			2022-12-18	WOS:000074174700036
J	Bessant, DAR; Khaliq, S; Hameed, A; Anwar, K; Mehdi, SQ; Payne, AM; Bhattacharya, SS				Bessant, DAR; Khaliq, S; Hameed, A; Anwar, K; Mehdi, SQ; Payne, AM; Bhattacharya, SS			A locus for autosomal recessive congenital microphthalmia maps to chromosome 14q32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EYE; CATARACTS; GENES	Congenital microphthalmia (CMIC) (OMIM 309700) may occur in isolation or in association with a variety of systemic malformations. Isolated CMIC may be inherited as an autosomal dominant, an autosomal recessive, or an X-linked trait. On the basis of a whole-genome linkage analysis, we have mapped the first locus for isolated CMIC, in a five-generation consanguineous family with autosomal recessive inheritance, to chromosome 14q32. All affected individuals in this family have bilateral CMIC. Linkage analysis gave a maximum two-point LOD score of 3.55 for the marker D14S65. Surrounding this marker is a region of homozygosity of 7.3 cM, between the markers D14S987 and D14S267, within which the disease gene is predicted to lie. The genes for several eye-specific transcription factors are located on human chromosome 14q and in the syntenic region of mouse chromosome 12. However, both CHX10 (14q24.3), mutations of which give rise to CMIC in mouse models, and OTX2 (14q21-22) can be excluded as candidates for autosomal recessive congenital microphthalmia (arCMIC), since they map outside the critical disease region defined by recombination events. This suggests that arCMIC is caused by defects in a novel developmental gene that may be important or even essential in eye development.	UCL, Dept Mol Genet, Inst Ophthalmol, London EC1V 9EL, England; Dr AQ Khan Res Labs, Biomed & Genet Engn Div, Islamabad, Pakistan	University of London; University College London	Bhattacharya, SS (corresponding author), UCL, Dept Mol Genet, Inst Ophthalmol, London EC1V 9EL, England.	sbhatach@hgmp.mrc.ac.uk	Bhattacharya, Shom/N-2926-2016; Mehdi, Syed Qasim/L-2385-2015; Payne, annette/F-8877-2013; Khaliq, Shagufta/G-2337-2015	Bhattacharya, Shom/0000-0002-1601-6344; Payne, annette/0000-0002-2009-0141; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; DECHEN J, 1990, AM J HUM GENET, V47, pA102; ELLIOTT JH, 1985, ARCH OPHTHALMOL-CHIC, V103, P676; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; Graw J, 1996, DEV GENET, V18, P181, DOI 10.1002/(SICI)1520-6408(1996)18:3<181::AID-DVG1>3.0.CO;2-5; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Inglehearn CF, 1997, NAT GENET, V16, P15, DOI 10.1038/ng0597-15; Kallen B, 1996, INT J EPIDEMIOL, V25, P1009, DOI 10.1093/ije/25.5.1009; KASTURY K, 1994, GENOMICS, V22, P41, DOI 10.1006/geno.1994.1343; KOHN G, 1988, CLIN GENET, V33, P321; LABORDA J, 1993, J BIOL CHEM, V268, P3817; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MILLER BA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1053, DOI 10.1001/archopht.1992.01080200033015; MOROSS T, 1984, J MED GENET, V21, P52, DOI 10.1136/jmg.21.1.52; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PEARCE WG, 1986, CAN J OPHTHALMOL, V21, P291; STEPHENS FE, 1947, J HERED, V38, P307; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; VINGOLO EM, 1994, J MED GENET, V31, P721, DOI 10.1136/jmg.31.9.721; WARBURG M, 1993, J MED GENET, V30, P664, DOI 10.1136/jmg.30.8.664; ZLOTOGORA J, 1994, AM J MED GENET, V49, P261, DOI 10.1002/ajmg.1320490302	22	37	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1113	1116		10.1086/301843	http://dx.doi.org/10.1086/301843			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545413	Green Published, Bronze			2022-12-18	WOS:000073487000016
J	Bruggenwirth, HT; Boehmer, ALM; Ramnarain, S; VerleunMooijman, MCT; Satijn, DPE; Trapman, J; Grootegoed, JA; Brinkmann, AO				Bruggenwirth, HT; Boehmer, ALM; Ramnarain, S; VerleunMooijman, MCT; Satijn, DPE; Trapman, J; Grootegoed, JA; Brinkmann, AO			Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: An unusual type of intronic mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPLICE SITE SELECTION; PRE-MESSENGER-RNA; GLUCOCORTICOID RECEPTOR; THYROID-HORMONE; BINDING DOMAIN; PROTEIN; EXON; EXPRESSION; CELLS; DNA	In the coding part and the intron-exon boundaries of the androgen-receptor gene of a patient with partial androgen insensitivity, no mutation was found. The androgen receptor of this patient displayed normal ligand-binding parameters and migrated as a 110-112-kD doublet on SDS-PAGE in the absence of hormone. However, after culturing of the patient's genital skin fibroblasts in the presence of hormone, the slower-migrating 114-kD protein, which reflects hormone-dependent phosphorylation, was hardly detectable. Furthermore, receptor protein was undetectable in the nuclear fraction of the fibroblasts, after treatment with hormone, which is indicative of defective DNA binding. By sequencing part of intron 2, a T --> A mutation was found 11 bp upstream of exon 3. In our screening of 102 chromosomes from unrelated individuals, this basepair substitution was not found, indicating that it was not a polymorphism. mRNA analysis revealed that splicing involved a cryptic splice site, located 71/70 bp upstream of exon 3, resulting in generation of mRNA with an insert of 69 nucleotides. In addition, a small amount of a transcript with a deleted exon 3 and a very low level of wild-type transcript were detected. Translation of the extended transcript resulted in an androgen-receptor protein with 23 amino acid residues inserted between the two zinc clusters, displaying defective DNA binding and defective transcription activation.	ERASMUS UNIV ROTTERDAM, DEPT PATHOL, NL-3000 DR ROTTERDAM, NETHERLANDS; UNIV ROTTERDAM HOSP, DEPT PEDIAT, ROTTERDAM, NETHERLANDS; UNIV ROTTERDAM HOSP, DEPT CLIN GENET, ROTTERDAM, NETHERLANDS	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bruggenwirth, HT (corresponding author), ERASMUS UNIV ROTTERDAM, FAC MED & HLTH SCI, DEPT ENDOCRINOL & REPROD, POB 1738, NL-3000 DR ROTTERDAM, NETHERLANDS.							Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/edrv-17-6-587; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; Boehmer ALM, 1997, AM J HUM GENET, V60, P1003; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Bruggenwirth HT, 1996, J STEROID BIOCHEM, V58, P569, DOI 10.1016/0960-0760(96)00095-7; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DERUITER PE, 1995, MOL CELL ENDOCRINOL, V110, pR1, DOI 10.1016/0303-7207(95)03534-E; DUCOURET B, 1995, ENDOCRINOLOGY, V136, P3774, DOI 10.1210/en.136.9.3774; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; Gottlieb B, 1997, NUCLEIC ACIDS RES, V25, P158, DOI 10.1093/nar/25.1.158; Hiort O, 1996, AM J MED GENET, V63, P218, DOI 10.1002/(SICI)1096-8628(19960503)63:1<218::AID-AJMG38>3.0.CO;2-P; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; JENSTER G, 1994, BIOCHEMISTRY-US, V33, P14064, DOI 10.1021/bi00251a015; Kallio PJ, 1996, PROSTATE, P45; KUIL CW, 1995, J BIOL CHEM, V270, P27569, DOI 10.1074/jbc.270.46.27569; KUIPER GGJM, 1991, MOL CELL ENDOCRINOL, V80, P65, DOI 10.1016/0303-7207(91)90143-G; KUIPER GGJM, 1993, BIOCHEM J, V296, P161, DOI 10.1042/bj2960161; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MOREL Y, 1994, EUR J ENDOCRINOL, V130, P325, DOI 10.1530/eje.0.1300352; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; QUIGLEY A, 1992, MOL ENDOCRINOL, V6, P1103; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/edrv-16-3-271; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; RISSTALPERS C, 1994, AM J HUM GENET, V54, P609; RISSTALPERS C, 1991, MOL ENDOCRINOL, V5, P1562, DOI 10.1210/mend-5-10-1562; RISSTALPERS C, 1990, P NATL ACAD SCI USA, V87, P7866, DOI 10.1073/pnas.87.20.7866; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Weidemann W, 1996, CLIN ENDOCRINOL, V45, P733, DOI 10.1046/j.1365-2265.1996.8600869.x; Weiss RE, 1996, J CLIN ENDOCR METAB, V81, P4196, DOI 10.1210/jc.81.12.4196; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	39	37	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1067	1077		10.1086/301605	http://dx.doi.org/10.1086/301605			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345099	Bronze, Green Published			2022-12-18	WOS:A1997YH01700011
J	NeermanArbez, M; Antonarakis, SE; Blouin, JL; Zeinali, S; Akhtari, M; Afshar, Y; Tuddenham, EGD				NeermanArbez, M; Antonarakis, SE; Blouin, JL; Zeinali, S; Akhtari, M; Afshar, Y; Tuddenham, EGD			The locus for combined factor V factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-C INHIBITOR; HUMAN GENOME; LINKAGE; DISEASE; GENE	Combined factor V-factor VIII deficiency (F5F8D) is a rare, autosomal recessive coagulation disorder in which the levels of both coagulation factor V and coagulation factor VIII are diminished. In order to map and subsequently clone the gene responsible for this phenotype, DNAs from 19 families (16 from Iran, 2 from Pakistan, and 1 from Algeria) with a total of 32 affected individuals were collected for a genomewide linkage search using genotypes of highly informative DNA polymorphisms. All pedigrees except two contained at least one consanguineous marriage. A maximum LOD score (Z(max)) of 14.82 for theta =.02 was generated with marker D18S1129 in 18q21; LOD scores >9 were obtained for several other markers-D18S849, D18S1103, D18S64, and D18S862. Multipoint analysis resulted in Z(max) = 18.91 for the interval between D18S1129 and D18S64. Informative recombinants placed the locus for F5F8D between D18S849 and D18S1103, in an interval of similar to 1 cM. These results are similar to the recently reported linkage of this disease to chromosome 18q in Jewish families (Nichols et al. 1997) and provide evidence that the same gene is responsible for all F5F8D among human populations. The difference in clinical severity of the phenotype in unrelated families, as well as the failure to detect a specific haplotype of DNA polymorphisms in the consanguineous Iranian families, suggests the existence of different molecular defects in the F5F8D gene. There exists an apparently gap-free contig with CEPH YACs linking the two markers on either side of the critical region. Positional cloning efforts are now in progress to clone the F5F8D gene.	UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,DIV MED GENET,CH-1211 GENEVA,SWITZERLAND; CANTONAL HOSP GENEVA,DIV MED GENET,GENEVA,SWITZERLAND; INST PASTEUR,TEHRAN,IRAN; IMAM KHOMEINI HOSP,HAEMOPHILIA CTR,TEHRAN,IRAN; IMAM KHOMEINI HOSP,DEPT HAEMATOL,TEHRAN,IRAN; ROYAL POSTGRAD MED SCH,MRC,HAEMOSTASIS RES GRP,LONDON,ENGLAND	University of Geneva; University of Geneva; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Imperial College London			Tuddenham, Edward/AAS-6196-2020; Antonarakis, Stylianos E/N-8866-2014	Tuddenham, Edward/0000-0001-8955-2909; Antonarakis, Stylianos E/0000-0001-8907-5823; Neerman-Arbez, Marguerite/0000-0002-9351-4195	NHLBI NIH HHS [HL38165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038165] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAM KAR, 1985, SCAND J HAEMATOL, V34, P401; ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; CANFIELD WM, 1982, J CLIN INVEST, V70, P1260, DOI 10.1172/JCI110725; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; Dacie J.V., 1995, PRACTICAL HAEMATOLOG; GARDINER JE, 1984, THROMB RES, V36, P197, DOI 10.1016/0049-3848(84)90219-6; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MAZZONE D, 1982, ACTA HAEMATOL-BASEL, V68, P337, DOI 10.1159/000207005; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nichols W. C., 1996, Blood, V88, p656A; Nichols WC, 1997, J CLIN INVEST, V99, P596, DOI 10.1172/JCI119201; OZSOYLU S, 1983, ACTA HAEMATOL-BASEL, V70, P207, DOI 10.1159/000206726; SELIGSOHN U, 1984, THROMB RES, V33, P95, DOI 10.1016/0049-3848(84)90158-0; SELIGSOHN U, 1969, BRIT J HAEMATOL, V16, P475, DOI 10.1111/j.1365-2141.1969.tb00426.x; SELIGSOHN U, 1982, NEW ENGL J MED, V307, P1191, DOI 10.1056/NEJM198211043071907; Seligsohn U, 1989, FACTOR 8 VON WILLEBR, P89; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SUZUKI K, 1983, BLOOD, V62, P1266; ZIVELIN A, 1995, THROMB HAEMOSTASIS, V73, P1439	25	37	37	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					143	150		10.1086/513897	http://dx.doi.org/10.1086/513897			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245995	Bronze, Green Published			2022-12-18	WOS:A1997XM72800022
J	Reus, VI; Freimer, NB				Reus, VI; Freimer, NB			Understanding the genetic basis of mood disorders: Where do we stand?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; BIPOLAR AFFECTIVE-DISORDER; X-CHROMOSOME MARKERS; OLD ORDER AMISH; PSYCHIATRIC-DISORDERS; DNA MARKERS; LINKAGE; LOCUS				Reus, VI (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,CTR NEUROBIOL & PSYCHIAT,401 PARNASSUS AVE,SAN FRANCISCO,CA 94143, USA.		reus, victor i/I-7923-2015	reus, victor i/0000-0002-8193-5697				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; Blacker D, 1996, AM J MED GENET, V67, P445, DOI 10.1002/(SICI)1096-8628(19960920)67:5<445::AID-AJMG2>3.0.CO;2-J; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; BREIER A, 1984, ARCH GEN PSYCHIAT, V41, P1129; CORYELL W, 1988, AM J PSYCHIAT, V145, P293; Craddock N, 1997, AM J MED GENET, V74, P18, DOI 10.1002/(SICI)1096-8628(19970221)74:1<18::AID-AJMG4>3.0.CO;2-R; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ESCAMILLA MA, 1997, MOL GENETIC BASIS NE, P1343; EWALD H, 1995, PSYCHIATR GENET, V5, P71, DOI 10.1097/00041444-199522000-00005; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Goodwin F.K., 1990, MANIC DEPRESSIVE ILL; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Jamison KR, 1996, NAT MED, V2, P521, DOI 10.1038/nm0596-521; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; Kelsoe JR, 1996, AM J MED GENET, V67, P533, DOI 10.1002/(SICI)1096-8628(19961122)67:6<533::AID-AJMG4>3.0.CO;2-I; KENDLER KS, 1987, ARCH GEN PSYCHIAT, V44, P451; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; MCINNES LA, 1995, CURR OPIN GENET DEV, V5, P376, DOI 10.1016/0959-437X(95)80054-9; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; Morell V, 1996, SCIENCE, V272, P31, DOI 10.1126/science.272.5258.31; PAULS DL, 1995, AM J MED GENET, V60, P290, DOI 10.1002/ajmg.1320600406; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sherman SL, 1997, AM J HUM GENET, V60, P1265, DOI 10.1086/515473; Silverman GA, 1996, CYTOGENET CELL GENET, V75, P111, DOI 10.1159/000134462; Smith LB, 1996, J MED GENET, V33, P544, DOI 10.1136/jmg.33.7.544; SPENCE MA, 1995, AM J MED GENET, V60, P370, DOI 10.1002/ajmg.1320600505; Spence MA, 1997, AM J MED GENET, V74, P19, DOI 10.1002/(SICI)1096-8628(19970221)74:1<19::AID-AJMG5>3.0.CO;2-Q; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; Tsuang M, 1990, GENETICS MOOD DISORD; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P13	40	37	37	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1283	1288		10.1086/515482	http://dx.doi.org/10.1086/515482			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199547	Green Published, Bronze			2022-12-18	WOS:A1997XE29400004
J	Wang, CY; HawkinsLee, B; Ochoa, B; Walker, RD; She, JX				Wang, CY; HawkinsLee, B; Ochoa, B; Walker, RD; She, JX			Homozygosity and linkage-disequilibrium mapping of the urofacial (Ochoa) syndrome gene to a 1-cM interval on chromosome 10q23-q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POOLED DNA SAMPLES; ALLELE FREQUENCIES; LOCUS; MUTATIONS; MARKERS; MAPS	The urofacial (Ochoa) syndrome (UFS) is a rare autosomal recessive disease characterized by congenital obstructive uropathy and abnormal facial expression. The patients present with enuresis, urinary-tract infection, hydronephrosis, and voiding dysfunctions as a result of neurogenic bladders. To map the UFS gene, a genome screen using a combination of homozygosity-mapping and DNA-pooling strategies was performed in 20 selected patients, one patient pool, and three control pools (unaffected relatives). After analyses of 36 randomly chosen markers, D10S677 was identified as being linked to and associated with UFS, as suggested by a significant excess of homozygosity in patients compared with that in unaffected relatives (P < 10(-6)), as well as by the allelic-frequency differences between the patient pool and control pools. Ten additional markers flanking D10S677 and covering a 22-cM region then were analyzed to fine-map the UFS gene by use of haplotype (linkage disequilibrium) analysis. All 31 patients were found to be homozygous for two closely linked markers (D10S1726 and D10S198) located approximate to 5 cM telomeric to D10S677, whereas only 12% of the unaffected relatives were homozygous for both markers (P < 10(-19)). Several patients are heterozygous at two markers immediately flanking D10S1726/D10S198, one on the centromeric side (D10S1433) and the other on the telomeric side (D10S603). These recombinational events place the UFS gene near D10S1726/D10S198 and within a 1-cM interval defined by D10S1433 and D10S603 on chromosome 10q23-q24.	UNIV FLORIDA,COLL MED,DEPT PATHOL IMMUNOL & LAB MED,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT SURG,GAINESVILLE,FL 32610; UNIV ANTIOQUIA,HOSP SAN VICENTE DE PAUL,DEPT PEDIAT SURG,MEDELLIN,COLOMBIA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad de Antioquia				Wang, Cong-Yi/0000-0001-7914-168X				ARNHEIM N, 1985, P NATL ACAD SCI USA, V82, P6970, DOI 10.1073/pnas.82.20.6970; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; DARVASI A, 1994, GENETICS, V138, P1365; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fukai K, 1996, AM J HUM GENET, V59, P620; GELB BD, 1995, NAT GENET, V10, P235, DOI 10.1038/ng0695-235; GERMAN J, 1994, P NATL ACAD SCI USA, V91, P6669, DOI 10.1073/pnas.91.14.6669; Gschwend M, 1996, AM J HUM GENET, V59, P377; KHATIB H, 1994, PCR METH APPL, V4, P13; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; LUO DF, 1995, AUTOIMMUNITY, V21, P143, DOI 10.3109/08916939508993363; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; OCHOA B, 1992, J UROLOGY, V148, P580, DOI 10.1016/S0022-5347(17)36659-4; OCHOA B, 1987, AM J MED GENET, V27, P661, DOI 10.1002/ajmg.1320270320; Pacek P, 1993, PCR Methods Appl, V2, P313; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SMITH CAB, 1953, J R STAT SOC B, V15, P153; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; TEEBI AS, 1989, AM J MED GENET, V34, P608, DOI 10.1002/ajmg.1320340432; TEEBI AS, 1991, AM J MED GENET, V40, P199, DOI 10.1002/ajmg.1320400215; THOMAS PM, 1995, AM J HUM GENET, V56, P416; WANG GL, 1994, THEOR APPL GENET, V88, P355, DOI 10.1007/BF00223645; WAYN ES, 1996, HUM MOL GENET, V5, P1689; WILLIAMS JGK, 1993, NUCLEIC ACIDS RES, V21, P2697, DOI 10.1093/nar/21.11.2697	29	37	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1461	1467		10.1086/515469	http://dx.doi.org/10.1086/515469			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199567	Green Published			2022-12-18	WOS:A1997XE29400024
J	Richards, CS; Ward, PA; Roa, BB; Friedman, LC; Boyd, AA; Kuenzli, G; Dunn, JK; Plon, SE				Richards, CS; Ward, PA; Roa, BB; Friedman, LC; Boyd, AA; Kuenzli, G; Dunn, JK; Plon, SE			Screening for 185delAG in the Ashkenazim	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; OVARIAN-CANCER; BREAST-CANCER; BRCA1 MUTATIONS; INHERITED BREAST; FAMILIES; RISK; FREQUENCY; CARRIERS; ALLELES	A study was initiated to assess interest, educational effectiveness, and implications of genetic testing for the common BRCA1 mutation, 185delAG, in the Ashkenazim. Of 333 individuals who attended group sessions, 309 (92%) participated in the study. Participants were categorized as having negative family history (67%), positive family history (defined, by a relaxed criterion, as one first-degree relative or two second-degree relatives with breast [premenopausal] or ovarian cancer) (22%), positive personal history (7%), and both positive personal history and positive family history (4%). Group education was effective, as shown by the improvement in participant scores from pre- to posteducation tests. For the 289 individuals (94%) who requested testing, the major reasons included concern for their own risk, concern for the risk of their children, and desire to learn about surveillance options. The most common reason given by participants who declined testing was concern about health insurance. Six participants found to be heterozygous for the 185delAG mutation received results and were offered genetic counseling, Participants had consented for additional testing without receiving results and were screened for the 6174delT mutation in BRCA2, and seven were found to be positive. All identified carriers reported at least one first- or second-degree relative with a history of breast or ovarian cancer, although they did not all meet our study criteria for positive family history. Given these outcomes, we conclude that screening for breast and ovarian cancer susceptibility is most appropriate for individuals with a positive personal or positive family cancer history. We propose a guideline for future studies designed to identify individuals who may benefit from genetic testing for inherited breast and ovarian cancer.	BAYLOR COLL MED,BAYLOR DNA DIAGNOST LAB,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PSYCHIAT & BEHAV SCI,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT COMMUNITY MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,TEXAS CHILDRENS CANC CTR,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center	Richards, CS (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,T536,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							*AM SOC HUM GEN, 1994, AM J HUM GENET, V55, pR1; American Cancer Society (ACS), CANC FACTS FIG; Berman DB, 1996, AM J HUM GENET, V58, P1166; BIESECKER BB, 1995, MONOGR NCI, V17, P115; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHALIKI H, 1995, AM J PUBLIC HEALTH, V85, P1133, DOI 10.2105/AJPH.85.8_Pt_1.1133; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Collins FS, 1996, NEW ENGL J MED, V334, P186, DOI 10.1056/NEJM199601183340311; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409; DeMarchi JM, 1996, HUM MUTAT, V8, P116; EARLEY CL, 1995, AM J HUM GENET, V57, P727; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GELLER G, 1995, NAT GENET, V11, P364, DOI 10.1038/ng1295-364; GOLD RJM, 1974, ANN HUM GENET, V37, P315, DOI 10.1111/j.1469-1809.1974.tb01838.x; HELMRICH SP, 1983, AM J EPIDEMIOL, V117, P35, DOI 10.1093/oxfordjournals.aje.a113513; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KUSKA B, 1995, J NATL CANCER I, V87, P1578, DOI 10.1093/jnci/87.21.1578; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LERMAN C, 1994, J CLIN ONCOL, V12, P843, DOI 10.1200/JCO.1994.12.4.843; LERMAN C, 1995, AM J MED GENET, V57, P385, DOI 10.1002/ajmg.1320570304; Marks J H, 1989, Birth Defects Orig Artic Ser, V25, P1; Masood E, 1996, NATURE, V379, P389, DOI 10.1038/379389a0; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; *NAT ADV COUNC HUM, 1994, JAMA-J AM MED ASSOC, V271, P785; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; OFFIT K, 1994, J CLIN ONCOL, V12, P1724, DOI 10.1200/JCO.1994.12.8.1724; Peters J A, 1996, Oncology (Williston Park), V10, P159; Rebbeck TR, 1996, AM J HUM GENET, V59, P547; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; ROTHSTEIN MA, 1995, MONOGRAPH NCI, V17, P87; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TONIN P, 1995, AM J HUM GENET, V57, P189; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	54	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1085	1098						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150156				2022-12-18	WOS:A1997WX76000009
J	Rogus, JJ; Krolewski, AS				Rogus, JJ; Krolewski, AS			Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; DIABETIC NEPHROPATHY; LINKAGE STRATEGIES; PREVALENCE	A common approach for detecting genetic linkage using siblings is to collect affected sib pairs (ASPs) and to identify markers where allele sharing exceeds expectation. Alternatively, markers can be analyzed in discordant sih pairs (DSPs) for allele sharing below expectation. Relative to the ASP approach, according to Risch, the power of the DSP approach increases with sibling recurrence risk, the two approaches being equally effective at 50% recurrence risk. However, with many diseases associated with more moderate sibling recurrence risk, less emphasis has been placed on the use of DSPs and the development of the underlying theory. In this paper, we expand the work of Risch to provide a more general foundation for DSP studies, since power can be quite high under the appropriate conditions. For example, in some highly affected populations, such as the diabetes-prone Pima Indians, sibling recurrence risk can be very large and, thus, DSPs ideal. Similarly, as we show through simulation, DSPs are preferable for diabetic nephropathy due to a 70% recurrence rare among siblings with insulin-dependent diabetes mellitus. Following the diabetic nephropathy example, we consider more systematically the situations in which DSPs can provide an efficient alternative to ASPs.	HARVARD UNIV,SCH PUBL HLTH,PROGRAM POPULAT GENET,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02215	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Rogus, JJ (corresponding author), HARVARD UNIV,SCH MED,JOSLIN DIABET CTR,SECT EPIDEMIOL & GENET,1 JOSLIN PL,BOSTON,MA 02215, USA.				NIDDK NIH HHS [DK41256] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BORCHJOHNSEN K, 1992, KIDNEY INT, V41, P719, DOI 10.1038/ki.1992.112; CHAVERS BM, 1989, NEW ENGL J MED, V320, P966, DOI 10.1056/NEJM198904133201503; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; OSTERBY R, 1990, DIABETES, V39, P1057, DOI 10.2337/diabetes.39.9.1057; Quinn M, 1996, DIABETOLOGIA, V39, P940; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; VIBERTI G, 1994, JOSLINS DIABETES MEL, P691	17	37	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1376	1381						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940283				2022-12-18	WOS:A1996VV31500024
J	DEERE, M; BLANTON, SH; SCOTT, CI; LANGER, LO; PAULI, RM; HECHT, JT				DEERE, M; BLANTON, SH; SCOTT, CI; LANGER, LO; PAULI, RM; HECHT, JT			GENETIC-HETEROGENEITY IN MULTIPLE EPIPHYSEAL DYSPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	Multiple epiphyseal dysplasia (MED) comprises a group of hereditary chondrodysplasias in which there are major anatomic abnormalities of the long tubular bones. The Fairbank and Ribbing types are the most frequently cited types of MED. They are primarily defined radiographically and are autosomal dominant conditions. Recently, MED in one family was shown to map to the pericentromeric region of chromosome 19 and is probably allelic to pseudoachondroplasia. We have tested linkage with six short tandem repeat markers from chromosome 19 to autosomal dominant MED in one four-generation family and to MED in a unique family with three of seven siblings affected and with unaffected parents. Autosomal dominant MED in family 1 was linked with a maximum LOD score, at D19S212, of 3.22 at a recombination fraction (theta) of .00. Linkage to chromosome 19 was excluded with MED in the other family, under both autosomal recessive and autosomal dominant, with either reduced-penetrance or germ line-mosaicism models. Linkage to candidate genes COL9A1, COL9A2, and COL11A2 was tested and excluded for both genetic models in this family. COL11A1 was excluded under a recessive model. We have confirmed linkage of autosomal dominant Fairbank MED to chromosome 19 and have demonstrated that MED is genetically heterogeneous.	UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77225; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA; ALFRED I DUPONT INST,WILMINGTON,DE; UNIV MINNESOTA,MINNEAPOLIS,MN 55455; UNIV WISCONSIN,DEPT PEDIAT & MED GENET,MADISON,WI	University of Texas System; University of Virginia; Nemours Alfred I. duPont Hospital for Children; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison			Blanton, Susan Halloran/ABF-1323-2021					BRIGGS MD, 1994, AM J HUM GENET, V55, P678; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; GAMBOA I, 1974, CLIN GENET, V6, P15; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HUNT DD, 1967, J BONE JOINT SURG AM, VA 49, P1611, DOI 10.2106/00004623-196749080-00014; JUBERG RC, 1968, AM J HUM GENET, V20, P549; Kozlowski K, 1967, Clin Radiol, V18, P330, DOI 10.1016/S0009-9260(67)80083-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; Ribbing S, 1937, ACTA RADIOL S, V34, P7; Sambrook J., 1989, MOL CLONING LAB MANU; SPRANGER JW, 1974, CONE DYSPLASIAS ATLA; WAUGH W, 1952, J BONE JOINT SURG BR, V34, P82, DOI 10.1302/0301-620X.34B1.82; WEAVER EJ, 1993, AM J MED GENET, V45, P345, DOI 10.1002/ajmg.1320450312; WEBER JL, 1993, AM J HUM GENET, V53, P1079	16	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					698	704						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887425				2022-12-18	WOS:A1995QK91800020
J	JONSSON, JJ; ARONOVICH, EL; BRAUN, SE; WHITLEY, CB				JONSSON, JJ; ARONOVICH, EL; BRAUN, SE; WHITLEY, CB			MOLECULAR DIAGNOSIS OF MUCOPOLYSACCHARIDOSIS TYPE-II (HUNTER SYNDROME) BY AUTOMATED SEQUENCING AND COMPUTER-ASSISTED INTERPRETATION - TOWARD MUTATION MAPPING OF THE IDURONATE-2-SULFATASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDURONATE SULFATASE GENE; IDS GENE; CARRIER DETECTION; EXPRESSION; DISEASE; DNA; RNA; DELETIONS; CDNA; HETEROGENEITY	Virtually all mutations causing Hunter syndrome (mucopolysaccharidosis type II) are expected to be new mutations. Therefore, as a means of molecular diagnosis, we developed a rapid method to sequence the entire iduronate-2-sulfatase (IDS) coding region. PCR amplicons representing the IDS cDNA were sequenced with an automatic instrument, and output was analyzed by computer-assisted interpretation of tracings, using Staden programs on a Sun computer. Mutations were found in 10 of 11 patients studied. Unique missense mutations were identified in five patients: H229Y (685C-->T, severe phenotype); P358R (1073C-->G, severe); R468W (1402C-->T, mild); P469H (1406C-->A, mild); and Y523C (1568A-->G, mild). Nonsense mutations were identified in two patients: R172X (514C-->T, severe) and Q389X (1165C-->T, severe). Two other patients with severe disease had insertions of 1 and 14 bp, in exons 3 and 6, respectively. In another patient with severe disease, the predominant (>95%) IDS message resulted from aberrant splicing, which skipped exon 3. In this last case, consensus sequences for splice sites in exon 3 were intact, but a 395C-->G mutation was identified 24 bp upstream from the 3' splice site of exon 3. This mutation created a cryptic 5' splice site with a better consensus sequence for 5' splice sites than the natural 5' splice site of intron 3. A minor population of the IDS message was processed by using this cryptic splice site; however, no correctly spliced message was detected in leukocytes from this patient. The mutational topology of the IDS gene is presented.	UNIV MINNESOTA,SCH MED,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT GENET & CELL BIOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Aronovich, Elena/0000-0002-9713-8502	NIDDK NIH HHS [DK39891] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039891] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANNELLA T, 1993, HUM GENET, V92, P350, DOI 10.1007/BF01247333; BECK M, 1992, AM J MED GENET, V44, P100, DOI 10.1002/ajmg.1320440123; BRAUN SE, 1993, P NATL ACAD SCI USA, V90, P11830, DOI 10.1073/pnas.90.24.11830; BUNGE S, 1993, HUM MOL GENET, V2, P1871, DOI 10.1093/hmg/2.11.1871; Bunge Susanna, 1992, Human Molecular Genetics, V1, P335, DOI 10.1093/hmg/1.5.335; CHEHAB FF, 1993, HUM MUTAT, V2, P331, DOI 10.1002/humu.1380020502; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER DN, 1990, HUM GENET, V85, P55; Crotty Paul L., 1992, Human Molecular Genetics, V1, P755, DOI 10.1093/hmg/1.9.755; CROTTY PL, 1992, HUM GENET, V90, P285; DANIELE A, 1993, GENOMICS, V16, P755, DOI 10.1006/geno.1993.1259; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FLOMEN RH, 1993, HUM MOL GENET, V2, P5, DOI 10.1093/hmg/2.1.5; FLOMEN RH, 1992, GENOMICS, V13, P543, DOI 10.1016/0888-7543(92)90123-A; FROISART R, 1993, HUM MUTAT, V2, P138, DOI 10.1002/humu.1380020214; GAL A, 1992, J INHERIT METAB DIS, V15, P342, DOI 10.1007/BF02435972; GOLDENFUM S, 1993, 3RD INT S MUC REL DI; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; HOPWOOD JJ, 1993, HUM MUTAT, V2, P435, DOI 10.1002/humu.1380020603; KRAWCZAK M, 1992, HUM GENET, V90, P41; LANDEGREN U, 1992, GENET ANAL-BIOMOL E, V9, P3, DOI 10.1016/1050-3862(92)90023-X; LEGUERN E, 1990, GENOMICS, V7, P358, DOI 10.1016/0888-7543(90)90169-U; LICHTMAN MA, 1990, HEMATOLOGY, P1742; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PALMIERI G, 1992, GENOMICS, V12, P52, DOI 10.1016/0888-7543(92)90405-H; SCHRODER W, 1993, J MED GENET, V30, P210, DOI 10.1136/jmg.30.3.210; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STEENBONDESON ML, 1992, HUM MOL GENET, V1, P195, DOI 10.1093/hmg/1.3.195; SUKEGAWA K, 1992, BIOCHEM BIOPH RES CO, V183, P809, DOI 10.1016/0006-291X(92)90555-Y; SUKEGAWA K, 1993, 3RD INT S MUC REL DI; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406; WEHNERT M, 1992, HUM GENET, V89, P430; WHITLEY CB, 1993, HUM MUTAT, V2, P235, DOI 10.1002/humu.1380020313; WHITLEY CB, 1992, MCKUSICKS HERITABLE, P367; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WILSON PJ, 1993, GENOMICS, V17, P773, DOI 10.1006/geno.1993.1406; WILSON PJ, 1991, HUM GENET, V86, P505; WRAITH JE, 1991, HUM GENET, V87, P205, DOI 10.1007/BF00204183; YAMADA Y, 1993, HUM GENET, V92, P110; YOUNG ID, 1982, ARCH DIS CHILD, V57, P828, DOI 10.1136/adc.57.11.828; YOUNG ID, 1982, J MED GENET, V19, P408, DOI 10.1136/jmg.19.6.408; ZLOTOGORA J, 1984, AM J MED GENET, V17, P661, DOI 10.1002/ajmg.1320170317	46	37	39	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					597	607						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887413				2022-12-18	WOS:A1995QK91800007
J	LOESCH, DZ; HOPPER, JL; ROGUCKA, E; HUGGINS, RM				LOESCH, DZ; HOPPER, JL; ROGUCKA, E; HUGGINS, RM			TIMING AND GENETIC RAPPORT BETWEEN GROWTH IN SKELETAL MATURITY AND HEIGHT AROUND PUBERTY - SIMILARITIES AND DIFFERENCES BETWEEN GIRLS AND BOYS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE ANALYSIS; EXTENSIONS; CHILDREN; MODELS; ONSET; TWIN	We have analyzed longitudinal twin data by using a multivariate normal model to identify and quantify genetic effects over time on two main aspects of growth, height and skeletal maturity. The largest genetic contribution to the variance in both height and skeletal maturity coincided with the respective ages of peak growth velocity, The highest genetic covariance between these two traits coincided with the age of greatest acceleration of growth in height. These findings imply the existence of regulatory or structural genes that influence growth in both height and skeletal maturity. We also found sex differences in the rapport between velocities for height and skeletal maturity. These are consistent with a predominant role of estrogen in accelerating skeletal maturation in females, and the existence of additional mechanisms in males which may promote growth in height independently of the effects of gonadal sex steroids.	LA TROBE UNIV,DEPT STAT,BUNDOORA,VIC 3083,AUSTRALIA; UNIV MELBOURNE,DEPT PUBL HLTH & COMMUNITY MED,MELBOURNE,VIC,AUSTRALIA; POLISH ACAD SCI,INST ANTHROPOL,WROCLAW,POLAND	La Trobe University; University of Melbourne; Polish Academy of Sciences	LOESCH, DZ (corresponding author), LA TROBE UNIV,SCH PSYCHOL,BUNDOORA,VIC 3083,AUSTRALIA.			Loesch, Danuta/0000-0002-2180-2606				ACHESON RM, 1954, J ANAT, V88, P498; Becker RA, 1988, NEW S LANGUAGE; Bergmann P., 1988, MAT PRACE ANTROPOLOG, V108, P165; BEUNEN G, 1980, ANN HUM BIOL, V7, P155, DOI 10.1080/03014468000004181; BOURGUIGNON JP, 1988, ENDOCR REV, V9, P467, DOI 10.1210/edrv-9-4-467; BROOK CGD, 1974, ARCH DIS CHILD, V49, P789, DOI 10.1136/adc.49.10.789; CROCK P, 1990, TURNER SYNDROME GROW, P189; DELEMARREVANDEW.HA, 1992, INT GROWTH MONITOR, V2, P2; FISCHBEIN S, 1987, ACTA GENET MED GEMEL, V36, P171, DOI 10.1017/S0001566000004402; Fisher R. A., 1951, BR AGR B, V4, P217; HARRISON GA, 1978, HUM BIOL, P320; HAUSPIE R, 1991, ANN HUM BIOL, V18, P23, DOI 10.1080/03014469100001372; HEALY MJR, 1976, BIOMETRIKA, V63, P219, DOI 10.1093/biomet/63.2.219; Hopper J L, 1993, Stat Methods Med Res, V2, P199, DOI 10.1177/096228029300200302; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HOPPER JL, 1991, J APPL PHYSIOL, V70, P770, DOI 10.1152/jappl.1991.70.2.770; Hopper JL., 1994, AUST J STAT, V36, P153, DOI [10.1111/j.1467-842X.1994.tb00859.x, DOI 10.1111/J.1467-842X.1994.TB00859.X]; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; KOTLARZ K, 1988, MPA, V108, P51; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MARSHALL WA, 1974, ANN HUM BIOL, V1, P29, DOI 10.1080/03014467400000031; MARSHALL WA, 1986, HUMAN GROWTH, V2, P1; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; OGATA T, 1992, J MED GENET, V29, P539, DOI 10.1136/jmg.29.8.539; ORCZYKOWSKASWIA.Z, 1987, MATER PRACE ANTR, V108, P65; PHILLIPS K, 1990, ACTA GENET MED GEMEL, V39, P143, DOI 10.1017/S0001566000005389; PLOMIN R, 1986, BEHAV GENET, V16, P25, DOI 10.1007/BF01065477; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; RANKE MB, 1983, EUR J PEDIATR, V141, P81, DOI 10.1007/BF00496795; RANKE MB, 1991, INT GROWTH MONITOR, V1, P2; Tanner JM., 1986, HUMAN GROWTH, P25; Tanner JM., 1983, ASSESSMENT SKELETAL; Tanner JM, 1975, ASSESSMENT SKELETAL; VERSCHUER O, 1925, ARCH RASSEN GESELLSC, V17, P149; WYSLOUCHOWA B, 1969, Acta Medica Polona, V10, P187	36	37	41	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					753	759						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887431				2022-12-18	WOS:A1995QK91800026
J	STEPHENS, K; ZLOTOGORSKI, A; SMITH, L; EHRLICH, P; WIJSMAN, E; LIVINGSTON, RJ; SYBERT, VP				STEPHENS, K; ZLOTOGORSKI, A; SMITH, L; EHRLICH, P; WIJSMAN, E; LIVINGSTON, RJ; SYBERT, VP			EPIDERMOLYSIS-BULLOSA SIMPLEX - A KERATIN-5 MUTATION IS A FULLY DOMINANT ALLELE IN EPIDERMAL CYTOSKELETON FUNCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMPERFECTA TYPE-I; OSTEOGENESIS IMPERFECTA; COLLAGEN GENE; INTERMEDIATE FILAMENTS; FRAMESHIFT MUTATION; POINT MUTATIONS; DISEASE; ABNORMALITIES; EXPRESSION; DIAGNOSIS	To explore the relationship between abnormal keratin molecules, 10-nm intermediate filament (IF) organization, and epidermal fragility and blistering, we sought to determine the functional consequences of homozygosity for a dominant keratin defect. We describe a family with an autosomal dominant skin-blistering disorder, epidermolysis bullosa simplex, Koebner subtype (EBS-K), that has a novel point mutation, occurring in the keratin 5 gene (KRT5), that predicts the substitution of an evolutionarily conserved lysine by an asparagine residue (K173N). Unlike previous heterozygous mutations located within the initial segment of domain 1A of keratin molecules, K173N heterozygosity did not result in severe disease or clumping of keratin filaments. One family member was found to be homozygous for the K173N allele, having inherited it hem each of her affected first-cousin parents. Despite a lack of normal keratin 5 molecules, and an effective doubling of abnormal molecules, available for heterodimerization with keratin 14 during IF formation, there were no significant differences in the clinical severity or the ultrastructural organization of the keratin IF cytoskeleton of the homozygous individual. These data demonstrate that the K173N mutation behaves as a fully dominant allele and indicate that a limited number of abnormal keratin molecules are sufficient to impair cytoskeletal function and elicit epidermal fragility and blistering.	UNIV WASHINGTON,DEPT MED,DIV DERMATOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOL STRUCT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; CHILDRENS HOSP & MED CTR,SEATTLE,WA 98105; HADASSAH UNIV HOSP,DEPT DERMATOL,IL-91120 JERUSALEM,ISRAEL	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Hebrew University of Jerusalem	STEPHENS, K (corresponding author), UNIV WASHINGTON,DEPT MED,DIV MED GENET,RG-25,1959 NE PACIFIC ST,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR21557] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BRANDI ML, 1993, AM J HUM GENET, V53, P1167; CHAN YM, 1994, J CELL SCI, V107, P765; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; COHN DH, 1990, AM J HUM GENET, V46, P591; COMPTON JG, 1994, NAT GENET, V6, P6, DOI 10.1038/ng0194-6; COULOMBE PA, 1990, J CELL BIOL, V111, P3049, DOI 10.1083/jcb.111.6.3049; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; ECKERT RL, 1988, DNA-J MOLEC CELL BIO, V7, P337, DOI 10.1089/dna.1.1988.7.337; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; HACHAMZADEH S, 1988, J AM ACAD DERMATOL, V18, P702, DOI 10.1016/S0190-9622(88)70093-6; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOLMGREN G, 1992, CLIN GENET, V41, P39; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; KAYES LM, 1992, GENOMICS, V14, P369, DOI 10.1016/S0888-7543(05)80228-9; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; NIETZEL H, 1986, HUM GENET, V73, P320; OTT J, 1976, AM J HUM GENET, V28, P528; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; ROTHNAGEL JA, 1993, HUM MOL GENET, V2, P2147, DOI 10.1093/hmg/2.12.2147; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; RUGG EL, 1993, NAT GENET, V5, P294, DOI 10.1038/ng1193-294; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SMITH LT, 1990, J INVEST DERMATOL, V94, P261, DOI 10.1111/1523-1747.ep12874614; SPRITZ RA, 1992, AM J HUM GENET, V50, P261; STEINERT PM, 1993, J INVEST DERMATOL, V100, P729, DOI 10.1111/1523-1747.ep12475665; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; STEPHENS K, 1993, J INVEST DERMATOL, V101, P240, DOI 10.1111/1523-1747.ep12365079; TORCHARD D, 1994, NAT GENET, V6, P106, DOI 10.1038/ng0194-106; TRAUPE H, 1989, ICHTHYOSES; TYNER A, 1985, P NATL ACAD SCI USA, V76, P4350; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Weatherall DJ, 1994, MOL BASIS BLOOD DIS, P157; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1992, AM J HUM GENET, V51, P508; YAMANISHI K, 1994, HUM MOL GENET, V3, P1171, DOI 10.1093/hmg/3.7.1171; 1993, CELL, V72, P971	46	37	38	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					577	585						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7534039				2022-12-18	WOS:A1995QK91800004
J	STEVENS, G; VANBEUKERING, J; JENKINS, T; RAMSAY, M				STEVENS, G; VANBEUKERING, J; JENKINS, T; RAMSAY, M			AN INTRAGENIC DELETION OF THE P-GENE IS THE COMMON MUTATION CAUSING TYROSINASE-POSITIVE OCULOCUTANEOUS ALBINISM IN SOUTHERN AFRICAN NEGROIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EYED UNSTABLE MUTATION; LOCUS; MAPS; DNA	Tyrosinase-positive oculocutaneous albinism (OCA2), an autosomal recessive disorder of the melanin biosynthetic pathway, is the most common recessive disorder occurring in southern African Bantu-speaking Negroids, with an overall prevalence of 1/3,900. The OCA2 gene, P,has been mapped to chromosome 15q11-q13, and recently alterations in the P gene have been identified in OCA2 individuals. An intragenic deletion has been described and proposed to be of African origin because of its occurrence in four unrelated African American OCA2 individuals and in two individuals, one from Zaire and the other from Cameroon. This study shows that the intragenic deletion is a common cause of OCA2 in southern African Negroids (114/146 [.78]; OCA2 chromosomes) and is associated with one common haplotype (43/55 [.78]; OCA2 chromosomes), confirming the African origin of this allele. On the basis of haplotype data, it would appear that at least seven additional, less frequent OCA2 mutations occur in this population.	S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,JOHANNESBURG 2000,SOUTH AFRICA; UNIV WITWATERSRAND,JOHANNESBURG,SOUTH AFRICA	University of Witwatersrand				Ramsay, Michele/0000-0002-4156-4801				AQUARON R, 1990, OPHTHALMIC PAEDIAT G, V4, P255; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BEUTLER E, 1993, P NATL ACAD SCI USA, V90, P5384, DOI 10.1073/pnas.90.12.5384; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; CASTLE D, 1988, J MED GENET, V25, P835, DOI 10.1136/jmg.25.12.835; DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; KEDDA MA, 1994, AM J HUM GENET, V54, P1078; KROMBERG JGR, 1982, S AFR MED J, V61, P383; KROMBERG JGR, 1989, CLIN GENET, V36, P43; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEE ST, 1993, AM J HUM GENET, V53, P8; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RUSSELL ES, 1949, GENETICS, V34, P146; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SPRITZ RA, 1993, SEMIN DERMATOL, V12, P167; TRIPATHI RK, 1993, AM J HUM GENET S, V51, pA179; WALSH RJ, 1971, ANN HUM GENET, V34, P379, DOI 10.1111/j.1469-1809.1971.tb00250.x; [No title captured]	25	37	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					586	591						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887411				2022-12-18	WOS:A1995QK91800005
J	TILLER, GE; WEIS, MA; POLUMBO, PA; GRUBER, HE; RIMOIN, DL; COHN, DH; EYRE, DR				TILLER, GE; WEIS, MA; POLUMBO, PA; GRUBER, HE; RIMOIN, DL; COHN, DH; EYRE, DR			AN RNA-SPLICING MUTATION (G(+51VS20)) IN THE TYPE-II COLLAGEN GENE (COL2AI) IN A FAMILY WITH SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STICKLER SYNDROME ARTHROOPHTHALMOPATHY; SMALL NUCLEAR RNAS; MESSENGER-RNA; HERITABLE DISORDERS; SERINE SUBSTITUTION; PROCOLLAGEN COL2A1; CONNECTIVE-TISSUE; KNIEST DYSPLASIA; STRUDWICK TYPE; C-PROPEPTIDE	Defects in type II collagen have been demonstrated in a phenotypic continuum of chondrodysplasias that includes achondrogenesis II, hypochondrogenesis, spondyloepiphyseal dysplasia congenita (SEDC), Kniest dysplasia, and Stickler syndrome. We have determined that cartilage from a terminated fetus with an inherited form of SEDC contained both normal alpha 1(II) collagen chains and chains that lacked amino acids 256-273 of the triple-helical domain. PCR amplification of this region of COL2A1, from genomic DNA, yielded products of normal size, while amplification of cDNA yielded a normal sized species and a shorter fragment missing exon 20. Sequence analysis of genomic DNA from the fetus revealed a G-->T transversion at position +5 of intron 20; the affected father was also heterozygous for the mutation. Allele-specific PCR and heteroduplex analysis of a VNTR in COL2A1 independently confirmed the unaffected status of a fetus in a subsequent pregnancy. Thermodynamic calculations suggest that the mutation prevents normal splicing of exon 20 by interfering with binding of U-1 small-nuclear RNA to pre-mRNA, thus leading to skipping of exon 20 in transcripts from the mutant allele. Electron micrographs of diseased cartilage showed intracellular inclusion bodies, which were stained by an antibody to alpha 1(II) procollagen. Our findings support the hypothesis that alpha-chain length alterations that preserve the Gly-X-Y repeat motif of the triple helix result in partial intracellular retention of alpha 1(II) procollagen and produce mild to moderate chondrodysplasia phenotypes.	VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37212; UNIV WASHINGTON,DEPT ORTHOPED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; CEDARS SINAI MED CTR,STEVEN SPIELBERT PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT ORAL BIOL,LOS ANGELES,CA	Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	TILLER, GE (corresponding author), VANDERBILT UNIV,SCH MED,MED CTR,DEPT PEDIAT,DIV GENET,DD2205 MCN,NASHVILLE,TN 37232, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001925, R01AR037318, R37AR037318, R01AR036794] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR036794, AR37318, R37 AR037318, AR01925] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHMAD NN, 1993, AM J HUM GENET, V52, P39; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; ANDERSON CE, 1982, AM J MED GENET, V13, P243, DOI 10.1002/ajmg.1320130304; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1992, AM J MED GENET, V42, P431, DOI 10.1002/ajmg.1320420406; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; BOGAERT R, 1994, AM J HUM GENET, V55, P1128; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BOROCHOWITZ Z, 1986, AM J MED GENET, V24, P273, DOI 10.1002/ajmg.1320240208; CHAN D, 1991, J BIOL CHEM, V266, P12487; EYRE D, 1987, METHOD ENZYMOL, V144, P115; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GODFREY M, 1988, AM J HUM GENET, V43, P894; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; KORKKO J, 1993, AM J HUM GENET, V53, P55; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LEE B, 1991, J BIOL CHEM, V266, P5256; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LEE ER, 1990, J HISTOCHEM CYTOCHEM, V38, P659, DOI 10.1177/38.5.1692054; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MERCHENTHALER I, 1989, J HISTOCHEM CYTOCHEM, V37, P1563, DOI 10.1177/37.10.2674275; MILLER EJ, 1987, METHOD ENZYMOL, V144, P3; MURRAY LW, 1989, AM J HUM GENET, V45, P5; MURRAY LW, 1985, AM J HUM GENET S, V37, P13; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; RICHARDS AJ, 1994, HUM MOL GENET, V3, P1901, DOI 10.1093/hmg/3.10.1901; RIMOLN DL, 1990, PRINCIPLES PRACTICE, P835; RITVANIEMI P, 1994, HUM MUTAT, V3, P261, DOI 10.1002/humu.1380030314; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; Taybi H, 1990, RADIOLOGY SYNDROMES; TILLER GE, 1993, AM J HUM GENET, V53, P209; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; UGOZZOLI L, 1991, Methods (Orlando), V2, P42, DOI 10.1016/S1046-2023(05)80124-0; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VISSING H, 1989, J BIOL CHEM, V264, P18265; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; WILKIN DJ, 1993, GENOMICS, V15, P372, DOI 10.1006/geno.1993.1070; WILKIN DJ, 1993, AM J HUM GENET, V53, P210; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458; WINTERPACHT A, 1994, HUM MOL GENET, V3, P1891, DOI 10.1093/hmg/3.10.1891; WINTERPACHT A, 1993, NAT GENET, V3, P323, DOI 10.1038/ng0493-323	50	37	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					388	395						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847372				2022-12-18	WOS:A1995QF42300005
J	STEVANIN, G; CANCEL, G; DURR, A; CHNEIWEISS, H; DUBOURG, O; WEISSENBACH, J; CANN, HM; AGID, Y; BRICE, A				STEVANIN, G; CANCEL, G; DURR, A; CHNEIWEISS, H; DUBOURG, O; WEISSENBACH, J; CANN, HM; AGID, Y; BRICE, A			THE GENE FOR SPINAL CEREBELLAR-ATAXIA-3 (SCA3) IS LOCATED IN A REGION OF SIMILAR-TO-3-CM ON CHROMOSOME 14Q24.3-Q32.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAG REPEAT; SPINOCEREBELLAR; LOCUS; KINDREDS; TYPE-1; MAPS	SCA3, the gene for spinal cerebellar ataxia 3, was recently mapped to a 15-cM interval between D14S67 and D14S81 on chromosome 14q, by linkage analysis in two families of French ancestry. The SCA3 candidate region has now been refined by linkage analysis with four new microsatellite markers (D14S256, D14S291, D14S280, and AFM343vf1) in the same two families, in which 19 additional individuals were genotyped, and in a third French family. Combined two-point linkage analyses show that the new markers, D14S280 and AFM343vf1, are tightly linked to the SCA3 locus, with maximal lod scores, at recombination fraction, (theta)= .00, of 7.05 and 13.70, respectively. Combined multipoint and recombinant haplotype analyses localize the SCA3 locus to a 3-cM interval flanked by D14S291 and D14S81. The same allele for D14S280 segregates with the disease locus in the three kindreds. This allele is frequent in the French population, however, and linkage disequilibrium is not clearly established. The SCA3 locus remains within the 29-cM region on 14q24.3-q32.2 containing the gene for the Machado-Joseph disease, which is clinically related to the phenotype determined by SCA3, but it cannot yet be concluded that both diseases result from alterations of the same gene.	COLL FRANCE,INSERM,U114,F-75231 PARIS,FRANCE; CEPH,FDN JEAN DAUSSET,PARIS,FRANCE; GENETHON,EVRY,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Foundation Jean Dausset-CEPH	STEVANIN, G (corresponding author), HOP LA PITIE SALPETRIERE,INSERM,U289,47 BLVD HOP,F-75651 PARIS 13,FRANCE.		herve, chneiweiss/Q-6818-2019; Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	herve, chneiweiss/0000-0001-7675-5061; Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Cancel-Tassin, Geraldine/0000-0002-9583-6382				BELAL S, 1994, NEUROLOGY, V44, P1423, DOI 10.1212/WNL.44.8.1423; CANCEL G, 1994, NAT GENET, V6, P8, DOI 10.1038/ng0194-8; CANCEL G, IN PRESS AM J MED GE; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUBOURG O, IN PRESS ANN NEUROL; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; GARDNER K, 1994, NEUROLOGY S, V44, P921; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GIUNTI P, 1994, BRAIN, V117, P645, DOI 10.1093/brain/117.4.645; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, ADV NEUROL, V61, P1; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; KHATI C, 1993, NEUROLOGY, V43, P1131, DOI 10.1212/WNL.43.6.1131; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LATHROP GM, 1991, HDB STATISTICS, V8, P81; MATILLA T, 1993, HUM MOL GENET, V2, P2123, DOI 10.1093/hmg/2.12.2123; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RANUM LPW, 1991, AM J HUM GENET, V49, P31; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; VOLZ A, 1992, CYTOGENET CELL GENET, V60, P37, DOI 10.1159/000133291; WARNER TT, 1994, NAT GENET, V6, P225, DOI 10.1038/ng0394-225a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	30	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					193	201						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825578				2022-12-18	WOS:A1995QC10100025
J	BAMSHAD, M; WATKINS, WS; ZENGER, RK; BOHNSACK, JF; CAREY, JC; OTTERUD, B; KRAKOWIAK, PA; ROBERTSON, M; JORDE, LB				BAMSHAD, M; WATKINS, WS; ZENGER, RK; BOHNSACK, JF; CAREY, JC; OTTERUD, B; KRAKOWIAK, PA; ROBERTSON, M; JORDE, LB			A GENE FOR DISTAL ARTHROGRYPOSIS TYPE-I MAPS TO THE PERICENTROMERIC REGION OF CHROMOSOME-9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GORDON SYNDROME	Club foot is one of the most common human congenital malformations. Distal arthrogryposis type I (DA-1) is a frequent cause of dominantly inherited club foot. Performing a genomewide search using short tandem repeat (STR) polymorphisms, we have mapped a DA-1 gene to the pericentromeric region of chromosome 3 in a large kindred. Linkage analysis has generated a positive lod score of 5.90 at theta = 0, with the marker GS-4. Multiple recombinants bracketing the region have been identified, Analysis of an additional family demonstrated no linkage to the same locus, indicating likely locus heterogeneity. Of the autosomal congenital contracture disorders causing positional foot deformities, this is the first to be mapped.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT	Utah System of Higher Education; University of Utah	BAMSHAD, M (corresponding author), UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NCRR NIH HHS [RR-00064] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ATWOOD J, 1994, GENOMICS, V19, P203; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; DIETZ FR, 1993, MAY ANN M PED ORTH S; Freeman E A, 1938, Arch Dis Child, V13, P277; FUJITA R, 1992, HUM GENET, V89, P531, DOI 10.1007/BF00219179; GORDON H, 1969, Journal of Medical Genetics, V6, P266, DOI 10.1136/jmg.6.3.266; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALAL F, 1979, J MED GENET, V16, P149, DOI 10.1136/jmg.16.2.149; HALL JG, 1989, AM FAM PHYSICIAN, V39, P113; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; HALL JG, 1985, CLIN ORTHOP RELAT R, V194, P44; HALL JG, 1992, PRINCIPLES PRACTICE; HECHT F, 1969, Birth Defects Original Article Series, V5, P96; HUEBNER K, 1992, GENOMICS, V14, P220, DOI 10.1016/S0888-7543(05)80209-5; IOAN DM, 1993, CLIN GENET, V43, P300; Jorgenson R J, 1974, Birth Defects Orig Artic Ser, V10, P237; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MCKEOWN CME, 1988, J MED GENET, V25, P96, DOI 10.1136/jmg.25.2.96; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; MEYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144; OTT J, 1991, ANAL HUMAN LINKAGE; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; REED SD, 1985, CLIN GENET, V27, P353; SULISALO T, 1994, NAT GENET, V3, P338; TABIN CJ, 1992, DEVELOPMENT, V116, P289; VANDERBURGT I, 1991, AM J MED GENET, V41, P371; VANEK J, 1986, J MED GENET, V23, P231, DOI 10.1136/jmg.23.3.231; WANG JH, 1988, AM J HUM GENET, V42, P772; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	31	37	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1153	1158						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977374				2022-12-18	WOS:A1994QB68400011
J	DIZIER, MH; BABRON, MC; CLERGETDARPOUX, F				DIZIER, MH; BABRON, MC; CLERGETDARPOUX, F			INTERACTIVE EFFECT OF 2 CANDIDATE GENES IN A DISEASE - EXTENSION OF THE MARKER-ASSOCIATION-SEGREGATION CHI(2)-METHOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HUMAN INSULIN GENE; REGION; IDDM; SUSCEPTIBILITY; LOCUS; MODELS; HLA	For elucidating the genetic component of multifactorial diseases, it is important to investigate the effect of several factors and the possible interaction between them. In particular, for many diseases it is interesting to study the interactive effect of two genes. In this context, the marker-association-segregation chi(2) method (MASC), initially proposed to detect the involvement of a candidate gene in multifactorial diseases, is developed here to investigate the involvement of two candidate genes and to model the joint effect of these two genes. In particular, it is possible to precisely determine whether the joint effect of both genes is multiplicative. This extension simultaneously uses information on two markers, one for each candidate gene, at both the population and the familial segregation level. We show here that there can be an important gain of power to detect the effect of a second gene in a disease when information is used simultaneously on two markers instead of studying each marker separately. This extension of MASC is then applied on a sample of insulin-dependent diabetes (IDD) families typed for the markers of two candidate regions: HLA and that of the insulin gene (INS). This analysis allows us to confirm the involvement of INS in IDD, and the best-fitting model is a multiplicative (noninteractive) effect of HLA and INS, with a biallelic locus for INS and a complementation model for HLA.			DIZIER, MH (corresponding author), UNIV PARIS 07, INSERM,U155,BIOL ANTHROPOL LAB,CASE 7041, 2 PL JUSSIEU, F-75251 PARIS 05, FRANCE.		Dizier, Marie-Hélène/K-8463-2018; Clerget-Darpoux, Francoise/I-4825-2017	Dizier, Marie-Hélène/0000-0001-8460-7667; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Babron, Marie-Claude/0000-0002-4100-0299				BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BAUR MP, 1989, GENET EPIDEMIOL, V6, P15, DOI 10.1002/gepi.1370060105; BAUR MP, 1984, HISTOCOMPATIBILITY T, P677; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BORECKI IB, 1990, AM J HUM GENET, V47, P542; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; CLERGETDARPOUX F, 1986, GENET EPIDEMIOL, P313; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P247, DOI 10.1111/j.1469-1809.1988.tb01102.x; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; DIZIER MH, 1986, GENET EPIDEMIOL, V3, P343, DOI 10.1002/gepi.1370030507; DIZIER MH, 1990, TISSUE ANTIGENS, V36, P1, DOI 10.1111/j.1399-0039.1990.tb01790.x; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; OWERBACH D, 1982, DIABETES, V31, P275, DOI 10.2337/diabetes.31.3.275; RISCH N, 1984, AM J HUM GENET, V36, P363; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SVEJGAARD A, 1989, GENET EPIDEMIOL, V6, P1, DOI 10.1002/gepi.1370060104	21	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					1042	1049						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977341				2022-12-18	WOS:A1994QB68200024
J	HOWELL, N				HOWELL, N			MITOCHONDRIAL GENE-MUTATIONS AND HUMAN-DISEASES - A PROLEGOMENON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE EPISODES; ENERGY-METABOLISM; COMPLEX-I; DIABETES-MELLITUS; LACTIC-ACIDOSIS; DNA; NEURORETINOPATHY; ENCEPHALOPATHY; PEDIGREES		UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL F56,GALVESTON,TX 77555, USA.							BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1994, AM J HUM GENET, V55, P410; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1992, FASEB J, V6, P271; DEGOUL F, 1994, ANN NEUROL, V35, P365, DOI 10.1002/ana.410350321; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1993, GENETICS, V133, P133; HOWELL N, IN PRESS CLIN NEUROS; HOWELL N, 1993, AM J HUM GENET, V53, P3959; HOWELL N, UNPUB PHYLOGENETIC A; HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JOHNS DR, 1994, AM J HUM GENET, V55, P410; JONS DR, 1993, OPHTHALMOLOGY, V100, P495; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511; LERTRIT P, 1992, AM J HUM GENET, V51, P457; LUDOLPH AC, 1993, J INHERIT METAB DIS, V16, P716, DOI 10.1007/BF00711903; MACKEY DA, 1992, AUST NZ J OPHTHALMOL, V20, P177, DOI 10.1111/j.1442-9071.1992.tb00937.x; MACKEY DA, IN PRESS CLIN NEUROS; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN E, 1985, T OPHTHAL SOC UK, V104, P845; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; SAKUTA R, 1993, AM J HUM GENET, V53, P964; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; SMITH PR, 1994, J NEUROL SCI, V122, P80, DOI 10.1016/0022-510X(94)90055-8; SOKAL RR, 1991, ANNU REV ANTHROPOL, V20, P119, DOI 10.1146/annurev.an.20.100191.001003; TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	47	37	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					219	224						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037201				2022-12-18	WOS:A1994NZ33600001
J	CRANE, AM; LEDLEY, FD				CRANE, AM; LEDLEY, FD			CLUSTERING OF MUTATIONS IN METHYLMALONYL COA MUTASE ASSOCIATED WITH MUT(-) METHYLMALONIC ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-FIBROBLASTS; COBALAMIN METABOLISM; MOLECULAR-CLONING; INBORN-ERRORS; GENE-TRANSFER; EXPRESSION; ACIDURIA; LOCUS; ADENOSYLCOBALAMIN; HETEROGENEITY	Mutations have been described in human methylmalonyl CoA mutase (MCM) that exhibit partial defects in enzyme activity, including cobalamin-dependent (i.e., mut(-)) or interallelic complementation. This work describes mutations in cells from four patients, three of whom exhibit a cobalamin-dependent phenotype and all four of whom exhibit interallelic complementation. Four novel mutations (R694W, G648D, G630E, and G626C) are identified that cluster near the carboxyl terminus of the protein, a region close to another mut(-) mutation (G717V). Each of these mutations was shown to express a phenotype congruent with that of the parental cell line, after transfection into mut(0) fibroblasts, and each exhibits interallelic complementation in cotransfection assays with clones bearing a R93H mutation. The activity of mutant enzymes expressed in Saccharomyces cerevisiae parallels the residual activity of the parental cell lines and exhibits novel sensitivities to pH and salt. The clustering of these mutations identifies a region of MCM that most likely represents the cobalamin-binding domain. The location of this domain, as well as the pattern of sequence preservation between the homologous human and Probionobacterium shermanii enzymes, suggests a mechanism for interallelic complementation in which the cobalamin-binding defect is complemented in trans from the heterologous subunits of the dimer.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; GENEMED INC, HOUSTON, TX USA	Baylor College of Medicine; Baylor College of Medicine					NICHD NIH HHS [HD-24064, HD-24186] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD024186, R01HD024186] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREWS E, 1993, BIOCHEM MED METAB B, V50, P135, DOI 10.1006/bmmb.1993.1055; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRANE AM, 1992, HUM GENET, V89, P259; CRANE AM, 1992, J CLIN INVEST, V89, P385, DOI 10.1172/JCI115597; JANSEN R, 1990, AM J HUM GENET, V47, P808; KOLHOUSE JF, 1988, METHOD ENZYMOL, V166, P407; Kriegler M., 1990, GENE TRANSFER EXPRES; LEADLAY P, 1990, COBALAMIN 88, P343; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; LEDLEY FD, 1990, BIOESSAYS, V12, P335, DOI 10.1002/bies.950120706; LEDLEY FD, 1990, AM J HUM GENET, V46, P539; LEDLEY FD, 1990, P NATL ACAD SCI USA, V87, P3147, DOI 10.1073/pnas.87.8.3147; LEDLEY FD, 1991, BIOCHEM BIOPH RES CO, V177, P1076, DOI 10.1016/0006-291X(91)90648-Q; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MARSH EN, 1989, BIOCHEM J, V260, P353, DOI 10.1042/bj2600353; MCDONNELL DP, 1989, MOL CELL BIOL, V9, P3517, DOI 10.1128/MCB.9.8.3517; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1328; MORROW G, 1969, P NATL ACAD SCI USA, V63, P191, DOI 10.1073/pnas.63.1.191; NHAM SU, 1990, GENOMICS, V8, P710, DOI 10.1016/0888-7543(90)90259-W; QURESHI AA, IN PRESS CLIN INVEST; RAFF ML, 1991, J CLIN INVEST, V87, P203, DOI 10.1172/JCI114972; Retey J., 1982, B12, VII, P357; Rosenberg L.E., 1989, METABOLIC BASIS INHE, P822; SAIKI RK, 1988, SCIENCE, V233, P1076; Sambrook J., 1989, MOL CLONING; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; WILKEMEYER M, 1992, SOMAT CELL MOLEC GEN, V18, P493, DOI 10.1007/BF01232646; WILKEMEYER MF, 1991, J CLIN INVEST, V87, P915, DOI 10.1172/JCI115098; WILLARD HF, 1979, BIOCHEM GENET, V17, P57, DOI 10.1007/BF00484474; WILLARD HF, 1980, ARCH BIOCHEM BIOPHYS, V200, P130, DOI 10.1016/0003-9861(80)90339-2; WILLARD HF, 1977, BIOCHEM BIOPH RES CO, V78, P927, DOI 10.1016/0006-291X(77)90511-3; WILLARD HF, 1980, J CLIN INVEST, V65, P690, DOI 10.1172/JCI109715; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; WILLARD HF, 1979, METHODS STUDY INBORN, P297	35	37	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					42	50						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	7912889				2022-12-18	WOS:A1994NW46100007
J	TRIPATHI, RK; BUNDEY, S; MUSARELLA, MA; DROETTO, S; STRUNK, KM; HOLMES, SA; SPRITZ, RA				TRIPATHI, RK; BUNDEY, S; MUSARELLA, MA; DROETTO, S; STRUNK, KM; HOLMES, SA; SPRITZ, RA			MUTATIONS OF THE TYROSINASE GENE IN INDO-PAKISTANI PATIENTS WITH TYPE-I (TYROSINASE-DEFICIENT) OCULOCUTANEOUS ALBINISM (OCA)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA	Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by deficient synthesis of melanin pigment. Type I (tyrosinase-deficient) OCA results from mutations of the tyrosinase gene (TYR gene) encoding tyrosinase, the enzyme that catalyzes the first two steps of melanin biosynthesis. Mutations of the TYR gene have been identified in a large number of patients, most of Caucasian ethnic origin, with various forms of type I OCA. Here, we present an analysis of the TYR gene in eight Indo-Pakistani patients with type I OCA. We describe four novel TYR gene mutations and a fifth mutation previously observed in a Caucasian patient.	UNIV WISCONSIN,DEPT MED GENET,GENET LAB 317,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; UNIV BIRMINGHAM,BIRMINGHAM MATERN HOSP,DEPT PEDIAT,BIRMINGHAM,ENGLAND; UNIV BIRMINGHAM,BIRMINGHAM MATERN HOSP,DEPT CHILD HLTH,BIRMINGHAM,ENGLAND; HOSP SICK CHILDREN,RES INST,DEPT OPHTHALMOL,TORONTO,ON,CANADA; HOSP SICK CHILDREN,RES INST,DEPT PEDIAT,TORONTO,ON,CANADA; HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO,ON,CANADA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Birmingham; University of Birmingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)					NIAMS NIH HHS [AR 39892] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1991, GENOMICS, V9, P435, DOI 10.1016/0888-7543(91)90409-8; GIEBEL LB, 1991, J MED GENET, V28, P464, DOI 10.1136/jmg.28.7.464; KING RA, 1991, MOL BIOL MED, V8, P19; LEE ST, IN PRESS N ENGL J ME; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; SPRITZ RA, 1993, SEMIN DERMATOL, V12, P167; TRIPATHI RK, 1991, GENE EXPRESSION, V1, P103; TRIPATHI RK, 1992, J BIOL CHEM, V267, P23707; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; YAMAMOTO H, 1987, JPN J GENET, V62, P271, DOI 10.1266/jjg.62.271; [No title captured]	16	37	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1173	1179						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7902671				2022-12-18	WOS:A1993MJ81800003
J	JOHNS, DR; NEUFELD, MJ				JOHNS, DR; NEUFELD, MJ			PITFALLS IN THE MOLECULAR-GENETIC DIAGNOSIS OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX-I; MUTATION; NEURORETINOPATHY; PEDIGREES; SEQUENCE; VARIANT	Pathogenetic mutations in mtDNA are found in the majority of patients with Leber hereditary optic neuropathy (LHON), and molecular genetic techniques to detect them are important for the diagnosis. A false-positive molecular genetic error has adverse consequences for the diagnosis of this maternally inherited disease. We found a number of mtDNA polymorphisms that occur adjacent to known LHON-associated mutations and that confound their molecular genetic detection. These transition mutations occur at mtDNA nt 11779 (SfaNI site loss, 11778 mutation), nt 3459 (BsaHI site loss, 3460 mutation), nt 15258 (AccI site loss, 15257 mutation), nt 14485 (mismatch primer Sau3AI site loss, 14484 mutation), and nt 13707 (BstNI site loss, 13708 mutation). Molecular genetic detection of the most common pathogenetic mtDNA mutations in LHON, using a single restriction enzyme, may be confounded by adjacent polymorphisms that occur with a false-positive rate of 2%-7%.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University	JOHNS, DR (corresponding author), BETH ISRAEL HOSP,DEPT NEUROL,330 BROOKLINE AVE,LIBBEY 226,BOSTON,MA 02215, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001359] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 01359] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; BROWN MD, 1992, GENETICS, V130, P163; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1990, NEW ENGL J MED, V323, P1488; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; JOHNS DR, 1993, OPHTHALMOLOGY, V100, P981; JOHNS DR, 1992, AM J HUM GENET, V50, P872; MACKEY D, 1992, AM J HUM GENET, V51, P1218; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; STONE EM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1417, DOI 10.1001/archopht.1990.01070120065030; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	19	37	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					916	920						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213820				2022-12-18	WOS:A1993LY62700016
J	BLACK, DM; NICOLAI, H; BORROW, J; SOLOMON, E				BLACK, DM; NICOLAI, H; BORROW, J; SOLOMON, E			A SOMATIC-CELL HYBRID MAP OF THE LONG ARM OF HUMAN CHROMOSOME-17, CONTAINING THE FAMILIAL BREAST-CANCER LOCUS (BRCAI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; RETINOIC ACID RECEPTOR; GENE; TRANSLOCATION; AMPLIFICATION; ASSOCIATION; ONCOGENE; REGION	We describe a detailed somatic cell hybrid map of human chromosome 17q11.2-q23, containing the familial breast and ovarian cancer locus (BRCA1) and highly informative closely linked markers. An X-irradiation panel of 38 hamster/human and mouse/human hybrids with fragments of chromosome 17 was generated and characterized with 22 STS markers from this chromosome. A detailed map of 61 probes onto chromosome 17q, subdividing the chromosome arm into 25 regions, was done by using a panel of hybrids with well-defined breakpoints and nine chromosome-mediated gene transfectants. Our localization of RARA, TOP2, EDH17B1 and 2, and possibly WNT3, between THRA1 and D17S181, two markers known to flank BRCA1, suggests that any of these is a potential candidate for the BRCA1 locus. The marker D17S579 (Mfd188), which is believed to be very close to BRCA1, maps closest to the EDH17B genes.	IMPERIAL CANC RES FUND,SOMAT CELL GENET LAB,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK								BAI Y, 1982, ANN HUM GENET, V46, P337, DOI 10.1111/j.1469-1809.1982.tb01584.x; BARRETT JH, 1992, GENOMICS, V13, P95, DOI 10.1016/0888-7543(92)90207-9; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BEVILACQUA G, 1989, CANCER RES, V49, P5185; BORROW J, 1990, GENOMICS, V10, P477; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; COHN KH, 1991, LANCET, V338, P722, DOI 10.1016/0140-6736(91)91444-Y; COLLINS FS, 1989, TRENDS GENET, V5, P217, DOI 10.1016/0168-9525(89)90085-1; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; FAIN P R, 1992, Cytogenetics and Cell Genetics, V60, P177, DOI 10.1159/000133331; GHOMAS HJW, 1991, THESIS U LONDON LOND; GILLET GT, IN PRESS GENOMICS; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HEUBNER K, 1986, P NATL ACAD SCI USA, V83, P1403; IGGO R, 1989, P NATL ACAD SCI USA, V86, P6211, DOI 10.1073/pnas.86.16.6211; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LUU-THE V, 1990, Molecular Endocrinology, V4, P268; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MATTEI MG, 1988, HUM GENET, V80, P186, DOI 10.1007/BF00702866; NAROD SA, 1991, LANCET, V338, P82; RIDER SH, 1989, CYTOGENET CELL GENET, V51, P33; Sambrook J., 1989, MOL CLONING LAB MANU; SATO T, 1991, CANCER RES, V51, P5794; SHEER D, 1983, P NATL ACAD SCI-BIOL, V80, P5007, DOI 10.1073/pnas.80.16.5007; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLOMON E, 1991, CYTOGENET CELL GENET, V58, P686, DOI 10.1159/000133177; TUNNACLIFFE A, 1983, EMBO J, V2, P1577, DOI 10.1002/j.1460-2075.1983.tb01627.x; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; WEEKS DE, 1992, CYTOGENET CELL GENET, V57, P125; WHITE JJ, 1991, GENOMICS, V11, P228, DOI 10.1016/0888-7543(91)90126-Y; XU WM, 1988, P NATL ACAD SCI USA, V85, P8563, DOI 10.1073/pnas.85.22.8563; YAGLE MK, 1990, P NATL ACAD SCI USA, V87, P7255, DOI 10.1073/pnas.87.18.7255; YOKOTA J, 1986, LANCET, V1, P765	35	37	58	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					702	710						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460635				2022-12-18	WOS:A1993KY05900006
J	CHRISTENSEN, K; HOLM, NV; OLSEN, J; KOCK, K; FOGHANDERSEN, P				CHRISTENSEN, K; HOLM, NV; OLSEN, J; KOCK, K; FOGHANDERSEN, P			SELECTION BIAS IN GENETIC-EPIDEMIOLOGIC STUDIES OF CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-ALPHA; SEGREGATION ANALYSIS; ASSOCIATION; DANISH	The possible impact of selection bias in genetic and epidemiological studies of cleft lip and palate was studied, using three nationwide ascertainment sources and an autopsy study in a 10% sample of the Danish population. A total of 670 cases were identified. Two national record systems, when used together, were found suitable for ascertaining facial cleft in live births. More than 95% ascertainment was obtained by means of surgical files for cleft lip (with or without cleft palate) without associated malformations/syndromes. However, surgical files could be a poor source for studying isolated cleft palate (CP) (only a 60% and biased ascertainment), and they cannot be used to study the prevalence of associated malformations or syndromes in facial cleft cases. The male:female ratio was 0.88 in surgically treated cases of CP and was 1.5 in nonoperated CP cases, making the overall sex ratio for CP 1.1 (95 % confidence limits 0. 86-1.4) The sex ratio for CP without associated malformation was 1.1 (95% confidence limits 0.84-1.6). One of the major test criteria in CP multifactorial threshold models (higher CP liability among male CP relatives) must be reconsidered, if other investigations confirm that a CP sex-ratio reversal to male predominance occurs when high ascertainment is achieved.	ODENSE UNIV,UNIV CLIN,DEPT PATHOL,DK-5000 ODENSE,DENMARK	University of Southern Denmark	CHRISTENSEN, K (corresponding author), ODENSE UNIV,INST COMMUNITY HLTH,JB WINSLOWSVEJ 17,DK-5000 ODENSE,DENMARK.		Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292				ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEAR JC, 1983, CLIN GENET, V24, P407; Bishop Y. M. M., 1975, DISCRETE MULTIVARIAT, P229; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; Christensen K, 1992, Ugeskr Laeger, V154, P715; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DRONAMRAJU KR, 1982, JOHNS HOPKINS MED J, V151, P287; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1970, AM J HUM GENET, V22, P336; GREEN HG, 1979, CLEFT PALATE J, V16, P167; HECHT JT, 1991, AM J HUM GENET, V49, P682; KRAUS BS, 1963, AM J OBSTET GYNECOL, V86, P321, DOI 10.1016/0002-9378(63)90007-3; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MENEGOTTO BG, 1990, AM J MED GENET, V37, P539, DOI 10.1002/ajmg.1320370423; NISWANDER JD, 1972, LANCET, V2, P858; Olsen J, 1982, Ugeskr Laeger, V144, P1333; SHIELDS ED, 1981, CLIN GENET, V20, P13; SHPRINTZEN RJ, 1985, AM J MED GENET, V20, P585, DOI 10.1002/ajmg.1320200404; VANDERAS AP, 1987, CLEFT PALATE J, V24, P216; 1991, VITALSTATISTIK, V1, P28; 1988, VITALSTATISTIK, V1, P23	24	37	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					654	659						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496993				2022-12-18	WOS:A1992JJ82800022
J	CLARKE, JTR; WILSON, PJ; MORRIS, CP; HOPWOOD, JJ; RICHARDS, RI; SUTHERLAND, GR; RAY, PN				CLARKE, JTR; WILSON, PJ; MORRIS, CP; HOPWOOD, JJ; RICHARDS, RI; SUTHERLAND, GR; RAY, PN			CHARACTERIZATION OF A DELETION AT XQ27-Q28 ASSOCIATED WITH UNBALANCED INACTIVATION OF THE NONMUTANT X-CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-II; KARYOTYPICALLY NORMAL GIRL; FRAGILE-X; HUNTER SYNDROME; MENTAL-RETARDATION; DNA PROBES; REGION; MARKERS; FRAXA; FRAGMENTS	We report the results of studies on the characterization of the mutation associated with marked unbalanced expression of the mutant X chromosome in a karyotypically normal girl with Hunter disease (mucopolysaccharidosis type II). Southern analysis of DNA extracted from somatic cell hybrids containing only the mutant X chromosome showed deletion of the Xq27.3-q28 loci: DXS297 (VK23AC), DXS293 (VK16), FRAXA (pfxa3), DXS296 (VK21A), and the 3' end of the iduronatesulfatase (IDS) gene. The flanking loci-DXS52 (St14-1), DXS304 (U6.2), and DXS369 (RN1)-were intact. On the basis of these results, we concluded that the mutation was a simple deletion extending a maximum of 3-5 cM to the centromeric side of the IDS gene. Both Southern analysis of DNA from somatic cell hybrids, using short segments of IDS cDNA, and PCR of reverse-transcribed RNA from cultured skin fibroblasts indicated that the telomeric terminus of the deletion was localized to a region near the middle of the coding sequences of the gene.	UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	CLARKE, JTR (corresponding author), UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.		Richards, Robert/ABE-6423-2020; Sutherland, Grant Robert/D-2606-2012	Richards, Robert Ian/0000-0002-5978-6453; Morris, Phillip/0000-0001-8976-619X				ARVEILER B, 1988, AM J HUM GENET, V42, P380; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARKE JTR, 1990, CLIN GENET, V37, P355; CLARKE JTR, 1991, AM J HUM GENET, V49, P289; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HYLAND VJ, 1989, HUM GENET, V83, P61, DOI 10.1007/BF00274150; LITJENS T, 1991, BIOCHEM INT, V24, P209; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; OBERLE I, 1987, HUM GENET, V77, P60; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; ROBERTS SH, 1989, J MED GENET, V26, P309, DOI 10.1136/jmg.26.5.309; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SCHMIDT M, 1992, AM J MED GENET, V43, P279, DOI 10.1002/ajmg.1320430143; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WILSON PJ, 1991, HUM GENET, V86, P505; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	29	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					316	322						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642233				2022-12-18	WOS:A1992JF77600011
J	KUPKE, KG; GRAEBER, MB; MULLER, U				KUPKE, KG; GRAEBER, MB; MULLER, U			DYSTONIA-PARKINSONISM SYNDROME (XDP) LOCUS - FLANKING MARKERS IN XQ12-Q21.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN X-CHROMOSOME; TORSION DYSTONIA; Y-CHROMOSOME; LINKAGE ANALYSIS; DNA PROBES; GENE; DISEASE; RFLP; IDENTIFICATION; CHOROIDEREMIA	The study of rare genetic forms of dystonia and parkinsonism permits positional cloning of genes potentially involved in more common, multifactorial forms of these disease. One movement disorder amenable to molecular genetic analysis is the X-linked dystonia-parkinsonism syndrome (XDP). This disease is endemic to the Philippines where it originated by a genetic founder effect. Linkage analysis was performed with DNA from 14 XDP kindreds by using 12 polymorphic DNA sequences in Xp11-Xq22. Two-point analysis demonstrated maximum lod scores of 5.45, 4.95, 4.28, and 5.99 for DXS106, DXS159, PGK1, and DXS72, respectively, at recombination fractions of zero (DXS106 and DXS159), .01 (PGK1), and .04 (DXS72). Multipoint analysis resulted in a maximum-likelihood score (Z(max)) of 8.41 with a (Z(max) - 1) support interval of 9 cM between DXS159 and DXS72 (Xq12-q21.1). In 19 XDP kindreds significant linkage disequilibrium was found for loci DXS72 (DELTA = .47), PGK1 (DELTA = .36), DXS95 (DELTA = .30), DXS106 (DELTA = .28), and DXS159 (DELTA = .26). These data indicate that the gene mutated in XDP (locus DYT3) is located in Xq12-q21.1.	CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DIV NEWBORN MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School			Graeber, Manuel/H-3224-2011					Adams R.D, 1989, PRINCIPLES NEUROLOGY; ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ARVEILER B, 1987, NUCLEIC ACIDS RES, V15, P5903, DOI 10.1093/nar/15.14.5903; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DAVATELIS G, 1985, CYTOGENET CELL GENET, V40, P611; DAVATELIS G, 1987, NUCLEIC ACIDS RES, V15, P4694, DOI 10.1093/nar/15.11.4694; FACTOR SA, 1988, PROGR PARKINSON RES, P1; FAHN S, 1988, ANN NEUROL, V24, P179; FAHN S, 1987, MOVEMENT DISORD, V2, P332; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; HOFKER MH, 1987, AM J HUM GENET, V40, P312; JOHNSTON AW, 1963, 2ND P INT C HUM GEN, V3, P1652; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KEATS BJB, 1990, CYTOGENET CELL GENET, V55, P387, DOI 10.1159/000133023; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KOENIG M, 1985, CYTOGENET CELL GENET, V40, P670; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KUPKE KG, 1990, AM J MED GENET, V36, P237, DOI 10.1002/ajmg.1320360219; KUPKE KG, 1990, NEUROLOGY, V40, P1438, DOI 10.1212/WNL.40.9.1438; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lee L V, 1976, Adv Neurol, V14, P137; LEE LV, 1991, MEDICINE, V70, P179, DOI 10.1097/00005792-199105000-00002; MACDERMOT KD, 1987, HUM GENET, V77, P263, DOI 10.1007/BF00284482; MARSDEN CD, 1987, J NEUROL NEUROSUR PS, V50, P105, DOI 10.1136/jnnp.50.1.105; MARTTILA RJ, 1988, NEUROLOGY, V38, P1217, DOI 10.1212/WNL.38.8.1217; MCGEER PL, 1987, CAN J NEUROL SCI, V14, P363, DOI 10.1017/S0317167100037756; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MULLER U, 1986, NUCLEIC ACIDS RES, V14, P1325, DOI 10.1093/nar/14.3.1325; MULLER U, 1990, HUM GENET, V84, P107; Nygaard T G, 1988, Adv Neurol, V50, P377; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHMECKPEPER BJ, 1985, NUCLEIC ACIDS RES, V13, P5724, DOI 10.1093/nar/13.15.5724; SCHWARTZ M, 1988, HUM GENET, V78, P156, DOI 10.1007/BF00278188; SEGAWA M, 1986, ADV NEUROL, V45, P227; SMEAD DL, 1987, NUCLEIC ACIDS RES, V17, P7551; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WARD CD, 1983, NEUROLOGY, V33, P815, DOI 10.1212/WNL.33.7.815; WEINER WJ, 1989, MOVEMENT DISORDERS C; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203	52	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					808	815						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550125				2022-12-18	WOS:A1992HL84800017
J	MULES, EH; HAYFLICK, S; MILLER, CS; REYNOLDS, LW; THOMAS, GH				MULES, EH; HAYFLICK, S; MILLER, CS; REYNOLDS, LW; THOMAS, GH			6 NOVEL DELETERIOUS AND 3 NEUTRAL MUTATIONS IN THE GENE ENCODING THE ALPHA-SUBUNIT OF HEXOSAMINIDASE-A IN NON-JEWISH INDIVIDUALS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS DISEASE; ADULT GM2 GANGLIOSIDOSIS; BETA-HEXOSAMINIDASE; ASHKENAZI JEWS; GM2-GANGLIOSIDOSIS-B1 VARIANT; POINT MUTATION; CHAIN; DEFECT; DNA; ENZYME	Initial investigations demonstrated that only 3/34 "Tay-Sachs chromosomes" in 22 unrelated, non-Jewish patients or carriers of some form of G(M2)-gangliosidosis (7 black and 15 non-Jewish Caucasian) had either of the two mutations commonly found in the Jewish population. To determine the nature and incidence of the alterations in this non-Jewish population we have utilized PCR, single-strand conformation polymorphism analysis and sequencing to detect new mutations in genomic DNA. Fourteen primer sets have been utilized to analyze 80% of the coding region and 23/26 splice sites of the gene coding for the alpha chain of hexosaminidase A. Presumed deleterious mutations were discovered in 17/34 chromosomes believed to be carrying a beta-hexosaminidase A alpha-subunit gene mutation. Ten had abnormalities which have been described previously. In the remaining 24 Tay-Sachs disease alleles, six novel mutations predicted to be deleterious were discovered. These include two small deletions (a single-base frameshift and a three-base deletion removing an amino acid), two different nonsense mutations, an initiation codon mutation (ATG --> GTG), and a missense mutation (Arg499Cys) in a highly conserved residue. In addition, three presumed nondeleterious mutations were found.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205	Johns Hopkins University	MULES, EH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,KENNEDY INST,GENET LAB,707 N BROADWAY,BALTIMORE,MD 21205, USA.				NICHD NIH HHS [HD24061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AINSWORTH PJ, 1990, AM J HUM GENET, V47, pA206; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; CHARROW J, 1985, CLIN GENET, V27, P78; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FERNANDES M, 1991, AM J HUM GENET S, V49, pA405; GRAHAM TR, 1988, J BIOL CHEM, V263, P16823; GREBNER EE, 1991, AM J HUM GENET, V48, P604; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LAU MMH, 1989, J BIOL CHEM, V264, P21376; MULES EH, 1991, AM J HUM GENET, V48, P1181; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAKANO T, 1988, J NEUROCHEM, V51, P984, DOI 10.1111/j.1471-4159.1988.tb01836.x; NAKANO T, 1990, ANN NEUROL, V27, P465, DOI 10.1002/ana.410270503; NAVON R, 1991, AM J HUM GENET, V48, P412; NAVON R, 1990, AM J HUM GENET, V46, P817; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; OHNO K, 1988, J NEUROCHEM, V50, P316, DOI 10.1111/j.1471-4159.1988.tb13266.x; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1991, AM J HUM GENET, V48, P1139; PAW BH, 1990, J BIOL CHEM, V265, P9452; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; TANAKA A, 1990, AM J HUM GENET, V46, P329; TANAKA A, 1988, BIOCHEM BIOPH RES CO, V156, P1015, DOI 10.1016/S0006-291X(88)80945-8; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	33	37	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					834	841						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1532289				2022-12-18	WOS:A1992HL84800020
J	DUNLOP, MG; WYLLIE, AH; NAKAMURA, Y; STEEL, CM; EVANS, HJ; WHITE, RL; BIRD, CC				DUNLOP, MG; WYLLIE, AH; NAKAMURA, Y; STEEL, CM; EVANS, HJ; WHITE, RL; BIRD, CC			GENETIC-LINKAGE MAP OF 6 POLYMORPHIC DNA MARKERS AROUND THE GENE FOR FAMILIAL ADENOMATOUS POLYPOSIS ON CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV EDINBURGH,SCH MED,DEPT PATHOL,CRC LABS,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,TOKYO 170,JAPAN; UNIV UTAH,MED CTR,HOWARD HUGES MED INST,SALT LAKE CITY,UT 84112; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112	University of Edinburgh; Japanese Foundation for Cancer Research; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	DUNLOP, MG (corresponding author), WESTERN GEN HOSP,CNRS,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		Dunlop, Malcolm G/F-1973-2011	Dunlop, Malcolm G/0000-0002-3033-5851				ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BONELLI L, 1988, INT J CANCER, V41, P513; BULOW S, 1987, DAN MED BULL, V34, P1; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DUNCAN JL, 1982, GUT, V23, P169, DOI 10.1136/gut.23.2.169; DUNLOP MG, 1989, GENOMICS, V5, P350, DOI 10.1016/0888-7543(89)90068-2; KHAN PM, 1988, HUM GENET, V79, P183, DOI 10.1007/BF00280563; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LEPPERT M, 1990, NEW ENGL J MED, V322, P904, DOI 10.1056/NEJM199003293221306; LOVETT E, 1976, BRIT J SURG, V63, P13, DOI 10.1002/bjs.1800630103; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; MACKLIN MT, 1960, J NATL CANCER I, V24, P551, DOI 10.1093/jnci/24.3.551; MURDAY V, 1989, CYTOGENET CELL GENET, V5, P1049; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; REED TE, 1955, AM J HUM GENET, V7, P236; SASAKI M, 1989, CANCER RES, V49, P4402; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SONDERGAARD JO, 1985, SCAND J GASTROENTERO, V20, P759, DOI 10.3109/00365528509089209; SONDERGAARD JO, 1985, BRIT J CANCER, V52, P941, DOI 10.1038/bjc.1985.281; STEWART GD, 1987, NUCLEIC ACIDS RES, V15, P3939, DOI 10.1093/nar/15.9.3939; TOPS CMJ, 1989, LANCET, V2, P1361; VARESCO L, 1989, P NATL ACAD SCI USA, V86, P10118, DOI 10.1073/pnas.86.24.10118; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WOOLF CM, 1958, AM J HUM GENET, V10, P42; WYLLIE AH, 1989, 4TH INT S COL CANC K	28	37	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					982	987						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978564				2022-12-18	WOS:A1990EK40000015
J	JANSEN, R; LEDLEY, FD				JANSEN, R; LEDLEY, FD			HETEROZYGOUS MUTATIONS AT THE MUT LOCUS IN FIBROBLASTS WITH MUT0 METHYLMALONIC ACIDEMIA IDENTIFIED BY POLYMERASE-CHAIN-REACTION CDNA CLONING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV,HOWARD HUGHES MED INST,DEPT CELL BIOL,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR UNIV,HOWARD HUGHES MED INST,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor University; Howard Hughes Medical Institute; Baylor University; Howard Hughes Medical Institute					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024186, R29HD024186] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-24186, HD-24064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COOPER BA, 1987, ANNU REV NUTR, V7, P291, DOI 10.1146/annurev.nu.07.070187.001451; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; JANSEN R, IN PRESS NUCLEIC ACI; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEADLAY PF, 1989, COBALAMIN 88, P343; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; LEDLEY FD, 1990, AM J HUM GENET, V46, P539; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MARSH EN, 1989, BIOCHEM J, V260, P345, DOI 10.1042/bj2600345; NHAM SU, IN PRESS GENOMICS; Rosenberg L.E., 1989, METABOLIC BASIS INHE, P822; ROSENBLATT DS, 1984, J CLIN INVEST, V74, P2149, DOI 10.1172/JCI111641; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SCHERER, 1969, FUNDAMENTAL TECHNIQU, P413; SHIGEKAWA K, 1988, BIOTECHNIQUES, V6, P742; VRIELING H, 1988, MUTAT RES, V198, P107, DOI 10.1016/0027-5107(88)90046-2; WILKEMEYER M, IN PRESS BIOCH J; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; ZOGHBI HY, 1988, GENOMICS, V3, P396, DOI 10.1016/0888-7543(88)90135-8	22	37	39	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					808	814						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	1977311				2022-12-18	WOS:A1990EE94000007
J	MACKINNON, RN; HIRST, MC; BELL, MV; WATSON, JEV; CLAUSSEN, U; LUDECKE, HJ; SENGER, G; HORSTHEMKE, B; DAVIES, KE				MACKINNON, RN; HIRST, MC; BELL, MV; WATSON, JEV; CLAUSSEN, U; LUDECKE, HJ; SENGER, G; HORSTHEMKE, B; DAVIES, KE			MICRODISSECTION OF THE FRAGILE-X REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; UNIV ERLANGEN NURNBERG,INST HUMAN GENET,W-8520 ERLANGEN,GERMANY; UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,W-4300 ESSEN 1,GERMANY	University of Oxford; University of Erlangen Nuremberg; University of Duisburg Essen			MacKinnon, Ruth/E-6202-2011	MacKinnon, Ruth/0000-0003-0294-5051				BELL MV, 1989, HUM GENET, V82, P27, DOI 10.1007/BF00288266; BUITING K, 1990, GENOMICS, V6, P521, DOI 10.1016/0888-7543(90)90481-9; CLAUSSEN U, 1986, PRENATAL DIAG, V6, P401, DOI 10.1002/pd.1970060603; DAHL N, 1989, AM J HUM GENET, V45, P304; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRYNS JP, 1989, FRAGILE X SYNDROME, P1; HIRST MC, IN PRESS AM J MED GE; HOFKER MH, 1987, AM J HUM GENET, V40, P312; KAHKONEN M, 1987, HUM GENET, V77, P85; LEDBETTER SA, 1989, IN PRESS AM J MED GE; LUBS HA, 1969, AM J HUM GENET, V21, P231; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PATTERSON MN, 1989, GENOMICS, V4, P570, DOI 10.1016/0888-7543(89)90281-4; SCHWARTZ C, 1987, HUM GENET, V76, P54; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; VINCENT A, 1989, HUM GENET, V82, P85, DOI 10.1007/BF00288280; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; Wieringa B, 1988, Adv Neurol, V48, P47	24	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					181	187						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378345				2022-12-18	WOS:A1990DT87100002
J	BELL, MV; BLOOMFIELD, J; MCKINLEY, M; PATTERSON, MN; DARLISON, MG; BARNARD, EA; DAVIES, KE				BELL, MV; BLOOMFIELD, J; MCKINLEY, M; PATTERSON, MN; DARLISON, MG; BARNARD, EA; DAVIES, KE			PHYSICAL LINKAGE OF A GABAA RECEPTOR SUBUNIT GENE TO THE DXS374 LOCUS IN HUMAN XQ28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; UNIV CAMBRIDGE,SCH MED,MRC,NEUROBIOL UNIT,CAMBRIDGE,ENGLAND; ST MARYS HOSP,NW REG CYTOGENET LAB,MANCHESTER M13 0JH,LANCS,ENGLAND	University of Oxford; University of Cambridge; University of Manchester				Patterson, Mark/0000-0001-7237-0797				ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BUCKLE VJ, IN PRESS NEURON; CHEETHAM SC, 1988, BRAIN RES, V460, P114, DOI 10.1016/0006-8993(88)91211-5; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DELISI LE, 1988, SCHIZOPHR RES, V1, P277, DOI 10.1016/0920-9964(88)90004-7; FEINBERG AP, 1983, ANN BIOCH, V132, P16; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LLOYD KG, 1985, J PHARMACOL EXP THER, V235, P191; MENDLEWICZ J, 1987, LANCET, V1, P1230; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PATTERSON MN, 1989, GENOMICS, V4, P540; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; SUTHERS GK, IN PRESS CYTOGENET C	19	37	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					883	888						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2574000				2022-12-18	WOS:A1989CF40300007
J	LUCOTTE, G; GUERIN, P; HALLE, L; LOIRAT, F; HAZOUT, S				LUCOTTE, G; GUERIN, P; HALLE, L; LOIRAT, F; HAZOUT, S			Y-CHROMOSOME DNA POLYMORPHISMS IN 2 AFRICAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST NATL TRANSFUS SANGUINE,MOLEC GENET LAB,PARIS,FRANCE; INST NATL TRANSFUS SANGUINE,LAB IMMUNOL LEUCE PATELETS,PARIS,FRANCE; INSERM,U263,BIOSTAT LAB,F-75005 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	LUCOTTE, G (corresponding author), COLL FRANCE,ANTHROPOL PHYS LAB,11 PL MARCELIN BERTHELOT,PARIS 5,FRANCE.							ABBAS N, 1988, BIOCHEM SYST ECOL, V16, P105, DOI 10.1016/0305-1978(88)90123-8; BREUIL S, 1987, ANN GENET-PARIS, V30, P209; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; GUERIN P, 1988, NUCLEIC ACIDS RES, V16, P7759, DOI 10.1093/nar/16.15.7759; GUERIN P, 1988, REV FR TRANSFUS IMMU, V23, P513; HAZOUT S, 1987, ANN GENET, V29, P246; Hiernaux J., 1975, PEOPLE AFRICA; LUCOTTE G, 1985, NUCLEIC ACIDS RES, V13, P8285, DOI 10.1093/nar/13.22.8285; NGO KY, 1986, AM J HUM GENET, V38, P407; NGO KY, 1986, BIOCHEM SYST ECOL, V14, P141, DOI 10.1016/0305-1978(86)90099-2; QUACK B, 1988, CYTOGENET CELL GENET, V47, P232, DOI 10.1159/000132557; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0	15	37	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1989	45	1					16	20						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE779	2568089				2022-12-18	WOS:A1989AE77900003
J	PARTANEN, J; KOSKIMIES, S; SIPILA, I; LIPSANEN, V				PARTANEN, J; KOSKIMIES, S; SIPILA, I; LIPSANEN, V			MAJOR-HISTOCOMPATIBILITY-COMPLEX GENE MARKERS AND RESTRICTION-FRAGMENT ANALYSIS OF STEROID 21-HYDROXYLASE (CYP21) AND COMPLEMENT C-4 GENES IN CLASSICAL CONGENITAL ADRENAL-HYPERPLASIA PATIENTS IN A SINGLE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FINNISH RED CROSS,BLOOD TRANSFUS SERV,TISSUE TYPING LAB,HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,SF-00100 HELSINKI 10,FINLAND	University of Helsinki			Partanen, Jukka/B-7207-2014	Partanen, Jukka/0000-0001-6681-4734				BELT KT, 1984, CELL, V36, P907; CARLSSON B, 1987, HUM IMMUNOL, V20, P95, DOI 10.1016/0198-8859(87)90025-5; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; COULLIN P, 1982, TISSUE ANTIGENS, V19, P100; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; DUPONT B, 1977, LANCET, V2, P1309; DUPONT B, 1980, HISTOCOMPATIBILITY T, P693; DUPONT B, 1987, HISTOCOMPATIBILITY T; FLEISCHNICK E, 1983, LANCET, V1, P152; HARADA F, 1987, P NATL ACAD SCI USA, V84, P8091, DOI 10.1073/pnas.84.22.8091; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; KELLER E, 1987, IMMUNOGENETICS, V25, P123, DOI 10.1007/BF00364278; LAYRISSE Z, 1987, IMMUNOGENETICS, V25, P99, DOI 10.1007/BF00364274; LOKKI ML, 1982, TISSUE ANTIGENS, V20, P239; LONG EO, 1983, EMBO J, V2, P389, DOI 10.1002/j.1460-2075.1983.tb01435.x; MARCUS D, 1986, MANUAL CLIN LAB IMMU, P185; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; MILLER WL, 1987, J PEDIATR-US, V111, P1, DOI 10.1016/S0022-3476(87)80334-7; MORNET E, 1986, HUM GENET, V74, P402, DOI 10.1007/BF00280494; NEW MI, 1986, ENDOCR REV, V7, P331, DOI 10.1210/edrv-7-3-331; PARTANEN J, 1986, HUM HERED, V36, P269, DOI 10.1159/000153642; PARTANEN J, 1988, HUM GENET, V78, P372, DOI 10.1007/BF00291739; PARTANEN J, UNPUB DETERMINATION; PARTANEN J, 1987, THESIS U HELSINKI HE; PARTANEN J, 1988, J IMMUNOGENET, V14, P285; POLLACK MS, 1981, HUM GENET, V58, P331, DOI 10.1007/BF00294933; PRENTICE HL, 1986, IMMUNOGENETICS, V23, P274, DOI 10.1007/BF00373024; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; SCHNEIDER PM, 1988, IMMUNOGENETICS, V27, P225, DOI 10.1007/BF00346591; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; SCHOLZ S, 1984, HISTOCOMPATIBILITY T, P658; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x	38	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					660	670						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565078				2022-12-18	WOS:A1989U333800006
J	FISHER, JH; EMRIE, PA; DRABKIN, HA; KUSHNIK, T; GERBER, M; HOFMANN, T; JONES, C				FISHER, JH; EMRIE, PA; DRABKIN, HA; KUSHNIK, T; GERBER, M; HOFMANN, T; JONES, C			THE GENE ENCODING THE HYDROPHOBIC SURFACTANT PROTEIN SP-C IS LOCATED 8P AND IDENTIFIES ON ECORI RFLP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO, HLTH SCI CTR,DEPT MED,DIV PULM SCI,BOX C272, 4200 E 9TH AVE, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DIV MED ONCOL, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOCHEM BIOPHYS & GENET, DENVER, CO 80262 USA; ELEANOR ROOSEVELT INST CANC RES, DENVER, CO USA; WEBB WARING LUNG INST, DENVER, CO USA; E CAROLINA UNIV, SCH MED, GREENVILLE, NC 27834 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of North Carolina; East Carolina University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD002080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL027353] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL27353] Funding Source: Medline; NICHD NIH HHS [HD02080] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BORGAONOKAR DS, 1984, CHROMOSOMAL VARIATIO; CLAYPOOL WD, 1984, J CLIN INVEST, V74, P677, DOI 10.1172/JCI111483; de Grouchy J., 1984, CLIN ATLAS HUMAN CHR; DOBBS LG, 1987, P NATL ACAD SCI USA, V84, P1010, DOI 10.1073/pnas.84.4.1010; EMRIE PA, 1988, SOMAT CELL MOLEC GEN, V14, P105, DOI 10.1007/BF01535054; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER JH, 1987, AM J HUM GENET, V40, P503; GLASSER SW, 1987, P NATL ACAD SCI USA, V84, P4007, DOI 10.1073/pnas.84.12.4007; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; INUI K, 1985, HUM GENET, V69, P197, DOI 10.1007/BF00293023; JACOBS KA, 1987, J BIOL CHEM, V262, P9808; JONES C, 1985, SCIENCE, V228, P83, DOI 10.1126/science.3919444; JONES C, 1980, CYTOGENET CELL GENET, V28, P181, DOI 10.1159/000131529; JONES C, 1981, SOMAT CELL GENET, V7, P399, DOI 10.1007/BF01542985; KING RJ, 1982, J APPL PHYSIOL, V53, P1; KING RJ, 1975, J APPL PHYSIOL, V39, P735, DOI 10.1152/jappl.1975.39.5.735; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KUSHNICK T, 1984, AM J HUM GENET, V36, P615; MORSE HG, 1982, MAMM CHROMOSOME NEWS, V23, P127; PETTY TL, 1977, AM REV RESPIR DIS, V115, P531; POSSMAYER E, IN PRESS AM REV RESP; POSSMAYER F, 1987, FASEB J, V46, P2032; RODEWALD A, 1977, EUR J PEDIATR, V125, P45, DOI 10.1007/BF00470605; THAKUR NR, 1986, BIOCHEM J, V240, P679, DOI 10.1042/bj2400679; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915	27	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					436	441						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	2902783				2022-12-18	WOS:A1988Q473600010
J	BELL, CL; TENENHOUSE, HS; SCRIVER, CR				BELL, CL; TENENHOUSE, HS; SCRIVER, CR			PRIMARY CULTURES OF RENAL EPITHELIAL-CELLS FROM X-LINKED HYPOPHOSPHATEMIC (HYP) MICE EXPRESS DEFECTS IN PHOSPHATE-TRANSPORT AND VITAMIN-D METABOLISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV,MONTREAL CHILDRENS HOSP,MRC,GENET GRP,DABELLE LAB BIOCHEM GENET,2300 TUPPER ST,MONTREAL H3H 1P3,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 2T5,QUEBEC,CANADA	McGill University; McGill University; McGill University								AGUS ZS, 1983, KIDNEY INT, V24, P113, DOI 10.1038/ki.1983.133; Albright F, 1937, AM J DIS CHILD, V54, P529; BELL C L, 1986, American Journal of Human Genetics, V39, pA5; BELL CL, 1985, ANN NY ACAD SCI, V456, P398, DOI 10.1111/j.1749-6632.1985.tb14890.x; BELL CL, IN PRESS IN VITRO; BELL CL, 1986, THESIS MCGILL U; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOTH AG, 1974, BIOCH J, V159, P395; BRUNETTE MG, 1979, KIDNEY INT, V15, P357, DOI 10.1038/ki.1979.47; Carter-Su C, 1979, Am J Physiol, V237, pC67, DOI 10.1152/ajpcell.1979.237.1.C64; CHUNG SD, 1982, J CELL BIOL, V95, P118, DOI 10.1083/jcb.95.1.118; COLE DEC, 1984, BIOCH BIOPHYS ACTA, V776, P115; COWGILL LD, 1979, J CLIN INVEST, V63, P1203, DOI 10.1172/JCI109415; CUNNINGHAM J, 1983, ENDOCRINOLOGY, V112, P633, DOI 10.1210/endo-112-2-633; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; FUKASE M, 1984, ENDOCRINOLOGY, V114, P1203, DOI 10.1210/endo-114-4-1203; GIASSON SD, 1977, PFLUG ARCH EUR J PHY, V371, P33, DOI 10.1007/BF00580769; GOLDMAN H, 1982, DIABETES, V31, P897, DOI 10.2337/diab.31.10.897; JONES G, 1980, J CHROMATOGR, V221, P27, DOI 10.1016/S0378-4347(00)81004-X; KAWASHIMA H, 1981, P NATL ACAD SCI-BIOL, V78, P1199, DOI 10.1073/pnas.78.2.1199; KIEBZAK GM, 1981, MINER ELECTROL METAB, V6, P153; KIEBZAK GM, 1982, ENDOCRINOLOGY, V111, P650, DOI 10.1210/endo-111-2-650; Kimmich G. A., 1975, METHODS MEMBRANE BIO, V5, P51; KINOSHITA Y, 1987, BIOCHEM BIOPH RES CO, V144, P763, DOI 10.1016/S0006-291X(87)80030-X; LOBAUGH B, 1983, J CLIN INVEST, V71, P400, DOI 10.1172/JCI110783; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEYER RA, 1980, ENDOCRINOLOGY, V107, P1577, DOI 10.1210/endo-107-5-1577; NESBITT T, 1986, J CLIN INVEST, V77, P181, DOI 10.1172/JCI112274; POSILLICO JT, 1985, CALCIFIED TISSUE INT, V37, P418, DOI 10.1007/BF02553712; Rasmussen H., 1983, METABOLIC BASIS INHE, V5th, P1743; TAUB M, 1981, NY ACAD SCI, V372, P406; TENENHOUSE HS, 1978, KIDNEY INT, V14, P236, DOI 10.1038/ki.1978.115; TENENHOUSE HS, 1979, NATURE, V281, P225, DOI 10.1038/281225a0; TENENHOUSE HS, 1979, CAN J BIOCHEM CELL B, V57, P938, DOI 10.1139/o79-114; TENENHOUSE HS, 1987, ENDOCRINOLOGY, V120, P609, DOI 10.1210/endo-120-2-609; TENENHOUSE HS, 1984, CELL CALCIUM, V5, P43, DOI 10.1016/0143-4160(84)90153-2; TENENHOUSE HS, 1984, ENDOCRINOLOGY, V115, P634, DOI 10.1210/endo-115-2-634; TENENHOUSE HS, 1983, ENDOCRINOLOGY, V113, P816, DOI 10.1210/endo-113-2-816; TENENHOUSE HS, 1978, CAN J BIOCHEM CELL B, V56, P640, DOI 10.1139/o78-096; TRECHSEL U, 1979, J CLIN INVEST, V64, P206, DOI 10.1172/JCI109441; VESTERGAARDBOGI.B, 1964, SCAND J CLIN LAB INV, V16, P457, DOI 10.3109/00365516409060539; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; YAMAOKA K, 1986, MINER ELECTROL METAB, V12, P194	43	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					293	303						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3414685				2022-12-18	WOS:A1988P884100010
J	SANKARANARAYANAN, K				SANKARANARAYANAN, K			PREVALENCE OF GENETIC AND PARTIALLY GENETIC-DISEASES IN MAN AND THE ESTIMATION OF GENETIC RISKS OF EXPOSURE TO IONIZING-RADIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									STATE UNIV LEIDEN,DEPT RADIAT GENET & CHEM MUTAGENESIS,2312 AV LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC								ALEXANDER ML, 1954, GENETICS, V39, P409; AWA AA, 1987, CYTOGENETICS BASIC A, P166; BAIRD PA, 1988, AM J HUM GENET, V42, P677; BISHOP DT, 1983, PRINCIPLES PRACTICE, V1, P111; BRENT RL, 1986, CLIN PERINATOL, V13, P491, DOI 10.1016/S0095-5108(18)30807-8; CARTER C, 1982, PROGR MUTATION RES, V3, P1; CARTER CO, 1977, J MED GENET, V14, P316, DOI 10.1136/jmg.14.5.316; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; CROW JF, 1985, ADV HUM GENET, V14, P59; CROW JF, 1981, SCIENCE, V212, P888, DOI 10.1126/science.7233180; CZEIZEL A, 1984, MUTAT RES, V128, P73, DOI 10.1016/0027-5107(84)90049-6; CZEIZEL AE, 1984, AETIOLOGICAL STUDIES; DENNISTON C, 1982, ANNU REV GENET, V16, P329, DOI 10.1146/annurev.ge.16.120182.001553; DENNISTON C, 1983, ENVIRON HEALTH PERSP, V52, P41; EDWARDS JH, 1974, PROG MED GENET, V10, P1; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KLINE J, 1985, ANEUPLOIDY ETIOLOGY, P149; LUNING KG, 1971, MUTAT RES, V12, P291, DOI 10.1016/0027-5107(71)90017-0; McKusick V. A., 1986, MENDELIAN INHERITANC; MULLER HJ, 1954, ACTA RADIOL, V41, P5, DOI 10.3109/00016925409175829; MULLER HJ, 1951, SCIENCE PROGR, V7, P93; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1982, PROGR MUTATION RES, V3, P39; NEWCOMBE HB, 1973, CHEMICAL MUTAGENS PR, V3, P57; Roesch WC, 1987, US JAPAN JOINT REASS; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024; SANKARANARAYANA.K, IN PRESS BANBURY REP, V30; SANKARANARAYANAN K, 1979, MUTAT RES, V61, P1, DOI 10.1016/0027-5107(79)90003-4; SANKARANARAYANAN K, 1986, MUTAT RES, V160, P73, DOI 10.1016/0027-5107(86)90031-X; SANKARANARAYANAN K, 1986, J GENET, V65, P79, DOI 10.1007/BF02923538; SCHULL WJ, 1981, SCIENCE, V213, P1220, DOI 10.1126/science.7268429; SCHULL WJ, 1981, POPULATION BIOL ASPE, P277; SCHULL WJ, 1982, ENV MUTAGENS CARCINO, P687; Shapiro J. A., 1983, MOBILE GENETIC ELEME; SHOKEIR MHK, 1975, CLIN GENET, V7, P345; STEVENSON ALAN CARRUTH, 1959, RADIATION RES SUPPL, V1, P306, DOI 10.2307/3583647; STRAUME T, 1987, RADIAT RES, V111, P47, DOI 10.2307/3577020; SUTTON HE, 1975, MUTAT RES, V33, P17, DOI 10.1016/0027-5107(75)90038-X; TRIMBLE BK, 1974, ANN HUM GENET, V38, P199, DOI 10.1111/j.1469-1809.1974.tb01951.x; VOGEL F, 1984, CLIN GENET, V25, P381; VOGEL F, 1986, HUMAN GENETICS; 1962, 13TH GEN ASS OFF R S, V16; 1977, 32D GEN ASS OFF RE S, V40; 1987, INTERIM GUIDANCE IMP, P1; 1956, BIOL EFFECTS ATOMIC; [No title captured]; [No title captured]; 1958, 17TH GEN ASS OFF R S, V17; 1986, 41ST GEN ASS OFF R S, V16; 1972, 27TH GEN ASS OFF R S, V25; 1982, 37TH GEN ASS OFF R S, V45	51	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					651	662						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3282435				2022-12-18	WOS:A1988N143800001
J	LI, CC				LI, CC			A GENETIC MODEL FOR EMERGENESIS - IN MEMORY OF SNYDER,LAURENCE,H, 1901-86	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LI, CC (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT BIOSTAT,PITTSBURGH,PA 15261, USA.							LI CC, 1953, AM J HUM GENET, V5, P269; LI CC, 1976, 1ST COURSE POPULATIO; LYKKEN DT, 1982, PSYCHOPHYSIOLOGY, V19, P361, DOI 10.1111/j.1469-8986.1982.tb02489.x; SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436	4	37	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					517	523						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	3661558				2022-12-18	WOS:A1987K462100001
J	CAREY, G				CAREY, G			A GENERAL MULTIVARIATE APPROACH TO LINEAR MODELING IN HUMAN-GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,DEPT PSYCHOL,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder	CAREY, G (corresponding author), UNIV COLORADO,INST BEHAV GENET,CAMPUS BOX 447,BOULDER,CO 80309, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004954] Funding Source: NIH RePORTER; NIA NIH HHS [AG-04954] Funding Source: Medline; NIGMS NIH HHS [GM-30250, GM-32732] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken, 1934, P EDINBURGH MATH SOC, V4, P106, DOI [DOI 10.1017/S0013091500008063, 10.1017/S0013091500008063]; CAREY G, 1986, BEHAV GENET, V16, P319, DOI 10.1007/BF01071314; CAREY G, 1983, BEHAV GENET, V13, P43, DOI 10.1007/BF01071743; CLONINGER CR, 1979, AM J HUM GENET, V31, P176; CLONINGER CR, 1980, GENET RES, V36, P133, DOI 10.1017/S0016672300019765; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; FULKER DW, 1983, BRIT J MATH STAT PSY, V36, P175; HEATH AC, 1985, BEHAV GENET, V15, P15, DOI 10.1007/BF01071929; Joreskog K.G, 1973, STRUCTURAL EQUATION; JORESKOG KG, 1984, LISREL VI ANAL LINEA; LOEHLIN JC, 1978, BEHAV GENET, V8, P415, DOI 10.1007/BF01067938; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MCARDLE JJ, 1984, BRIT J MATH STAT PSY, V37, P234, DOI 10.1111/j.2044-8317.1984.tb00802.x; MCGUE M, 1983, GENET RES, V41, P117; PEARSON K, 1902, PHILOS T R SOC A, V200, P1; RAO DC, 1976, AM J HUM GENET, V28, P228; RICE J, 1978, AM J HUM GENET, V30, P618; van Eerdewegh, 1982, THESIS WASHINGTON U; VOGLER G P, 1985, Genetic Epidemiology, V2, P35, DOI 10.1002/gepi.1370020105	20	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					775	786						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3799597				2022-12-18	WOS:A1986F541400012
J	HARADA, F; SADA, M; KAMIYA, T; YANASE, Y; KAWASAKI, T; SASAZUKI, T				HARADA, F; SADA, M; KAMIYA, T; YANASE, Y; KAWASAKI, T; SASAZUKI, T			GENETIC-ANALYSIS OF KAWASAKI SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									JAPAN RED CROSS MED CTR,DEPT PEDIAT,TOKYO,JAPAN; NATL CARDIOVASC CTR,DEPT SURG RES,SUITA,OSAKA 565,JAPAN; NATL CARDIOVASC CTR,DEPT PEDIAT,SUITA,OSAKA 565,JAPAN	Japanese Red Cross Medical Center; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	HARADA, F (corresponding author), KYUSHU UNIV,MED INST BIOREGURAT,DEPT GENET,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.		Yanase, Yuhki/U-6082-2017					BELL DM, 1985, JAMA-J AM MED ASSOC, V254, P801, DOI 10.1001/jama.254.6.801; DEAN AG, 1982, J PEDIATR-US, V100, P552, DOI 10.1016/S0022-3476(82)80751-8; KATO S, 1978, PEDIATRICS, V61, P252; KLENSKY A, 1981, PEDIATRICS, V67, P741; THOMSON G, 1977, MEASURING SELECTION, P545; WEINBERG W, 1902, PFLUGERS ARCH GES PH, V88, P346	6	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					537	539						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	3766546				2022-12-18	WOS:A1986E706300011
J	JOHNSON, MJ; DELANGE, G; CAVALLISFORZA, LL				JOHNSON, MJ; DELANGE, G; CAVALLISFORZA, LL			IG-GAMMA RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS INDICATE AN ANCIENT SEPARATION OF CAUCASIAN HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; NEDERLANDSE RODE KRUIS, BLOEDTRANSFUSIEDIENST, CENT LAB, AMSTERDAM, NETHERLANDS	Stanford University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428, T32GM007790] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07790, GM-28428, GM-20457] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BOEHM CD, 1983, NEW ENGL J MED, V308, P1054, DOI 10.1056/NEJM198305053081803; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984; ELLISON J, 1981, DNA-J MOLEC CELL BIO, V1, P11, DOI 10.1089/dna.1.1981.1.11; ELLISON JW, 1982, NUCLEIC ACIDS RES, V10, P4071, DOI 10.1093/nar/10.13.4071; FEDER J, 1985, AM J HUM GENET, V37, P635; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Herzenberg L.A., 1978, HDB EXPT IMMUNOLOGY; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; HOWELL C, 1984, ORIGINS MODERN HUMAN; JOHNSON MJ, 1984, P NATL ACAD SCI-BIOL, V81, P7840, DOI 10.1073/pnas.81.24.7840; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; KRAWINKEL U, 1982, EMBO J, V1, P403, DOI 10.1002/j.1460-2075.1982.tb01182.x; LANGE GD, 1984, J IMMUNOGENET, V11, P173; LEFRANC MP, 1984, NUCLEIC ACIDS RES, V12, P1303, DOI 10.1093/nar/12.3.1303; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; LOGHEM EV, 1978, HDB EXPT IMMUNOLOGY; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; MILLER GF, 1962, P CAMB PHILOS SOC, V58, P588; NATVIG JB, 1967, COLD SPRING HARB SYM, V32, P173, DOI 10.1101/SQB.1967.032.01.025; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBERTSON A, 1962, GENETICS, V47, P1291; SCHANFIELD MS, 1985, HDB EXPT IMMUNOLOGY; SHANDER M, 1980, TRANSPL P, V12, P417; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; ZELASCHI D, 1983, P NATL ACAD SCI-BIOL, V80, P3762, DOI 10.1073/pnas.80.12.3762; ZELASCHI D, 1985, HDB EXPT IMMUNOLOGY	36	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					617	640						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3013003				2022-12-18	WOS:A1986C973000002
J	HUERREJEANPIERRE, C; MATTEI, MG; WEIL, D; GRZESCHIK, KH; CHU, ML; SANGIORGI, FO; SOBEL, ME; RAMIREZ, F; JUNIEN, C				HUERREJEANPIERRE, C; MATTEI, MG; WEIL, D; GRZESCHIK, KH; CHU, ML; SANGIORGI, FO; SOBEL, ME; RAMIREZ, F; JUNIEN, C			FURTHER EVIDENCE FOR THE DISPERSION OF THE HUMAN FIBRILLAR COLLAGEN GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MED & DENT NEW JERSEY,RUTGERS MED SCH,DEPT BIOCHEM,POB 101,PISCATAWAY,NJ 08854; INSERM,U242,CTR GENET MED,F-13385 MARSEILLE,FRANCE; INSERM,U12,UNITE RECH GENET MED,F-75730 PARIS,FRANCE; UNIV MUNSTER,INST HUMANGENET,D-4400 MUNSTER,FED REP GER; INSERM,U73,RECH BIOL PRENATALE GRP,F-75016 PARIS,FRANCE; NCI,PATHOL LAB,BETHESDA,MD 20205	Rutgers State University New Brunswick; Rutgers State University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Jeanpierre, cecile/H-3770-2017	Jeanpierre, cecile/0000-0002-3463-5907	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM032380] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-32380] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CHU ML, 1984, NATURE, V310, P337, DOI 10.1038/310337a0; CHU ML, 1985, J BIOL CHEM, V260, P4357; CHURCH RL, 1980, CYTOGENET CELL GENET, V27, P24, DOI 10.1159/000131460; DUTRILLAUX B, 1971, CR ACAD SCI D NAT, V272, P2638; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; HENDERSON AS, 1983, CYTOGENET CELL GENET, V36, P586, DOI 10.1159/000131978; HUERRE C, 1982, P NATL ACAD SCI-BIOL, V79, P6627, DOI 10.1073/pnas.79.21.6627; JUNIEN C, 1982, AM J HUM GENET, V34, P381; JUNIEN C, 1983, AM J HUM GENET, V35, P584; KEFALIDES NA, 1979, FED PROC, V38, P816; KENNETT RC, 1979, METHODS ENZYMOL, V63, P351; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; SMITHIES O, 1981, LEVELS GENETIC CONTR, P185; SOLOMON E, 1983, CYTOGENET CELL GENET, V35, P64, DOI 10.1159/000131838; STROM CM, 1984, SOMAT CELL MOLEC GEN, V10, P651, DOI 10.1007/BF01535232; TATE V, 1982, COLD SPRING HARB SYM, V47, P1039; TURLEAU C, 1977, HUM GENET, V37, P97, DOI 10.1007/BF00293779; WEIL D, 1980, ANN HUM GENET, V49, P11; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	23	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					26	37						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	3004202				2022-12-18	WOS:A1986AYP1700003
J	CHAABANI, H; BECHHANSEN, NT; COX, DW				CHAABANI, H; BECHHANSEN, NT; COX, DW			A MULTIGENE DELETION WITHIN THE IMMUNOGLOBULIN HEAVY-CHAIN REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,INST MED SCI,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	CHAABANI, H (corresponding author), FAC PHARM MONASTIR,MUNASTIR,TUNISIA.							BATTEY J, 1982, P NATL ACAD SCI-BIOL, V79, P5956, DOI 10.1073/pnas.79.19.5956; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; CHAABANI H, 1984, J IMMUNOGENET, V11, P107; ELLISON J, 1982, P NATL ACAD SCI-BIOL, V79, P1984, DOI 10.1073/pnas.79.6.1984; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; HELAL AN, 1982, THESIS FS TUNIS TUNI; KRAWINKEL U, 1982, EMBO J, V1, P403, DOI 10.1002/j.1460-2075.1982.tb01182.x; LEFRANC G, 1983, EUR J IMMUNOL, V13, P240, DOI 10.1002/eji.1830130312; LEFRANC MP, 1984, NUCLEIC ACIDS RES, V12, P1303, DOI 10.1093/nar/12.3.1303; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; LINSLEY PS, 1983, P NATL ACAD SCI-BIOL, V80, P1997, DOI 10.1073/pnas.80.7.1997; MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4; MIGONE N, 1985, AM J HUM GENET, V37, P1146; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; RAVETCH JV, 1980, P NATL ACAD SCI-BIOL, V77, P6734, DOI 10.1073/pnas.77.11.6734; ROPARTZ C, 1963, IMMUNOL TECH, V32, P1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANLOGHEM E, 1971, ANN NY ACAD SCI, V190, P136; VANLOGHEM E, 1984, VOX SANG, V46, P195	19	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1164	1171						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3002172				2022-12-18	WOS:A1985AXE3600012
J	CHAKRAVARTI, A; BUETOW, KH				CHAKRAVARTI, A; BUETOW, KH			A STRATEGY FOR USING MULTIPLE LINKED MARKERS FOR GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CHAKRAVARTI, A (corresponding author), UNIV PITTSBURGH, HUMAN GENET PROGRAM, DEPT BIOSTAT, PITTSBURGH, PA 15260 USA.				NIADDK NIH HHS [AM13983] Funding Source: Medline; NIGMS NIH HHS [GM33771] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM013983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; ASMUSSEN MA, 1982, AM J HUM GENET, V34, P369; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BOEHM CD, 1983, NEW ENGL J MED, V308, P1054, DOI 10.1056/NEJM198305053081803; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAKRAVARTI A, 1982, AM J HUM GENET, V34, P531; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1983, AM J HUM GENET, V35, P592; CHAKRAVARTI A, 1979, THESIS U TEXAS HOUST; EDGELL CJS, 1978, AM J HUM GENET, V30, P80; EDWARDS JH, 1956, LANCET, V270, P579; Feller W., 1968, INTRO PROBABILITY TH, V1; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; GIBSON SLM, 1980, CLIN GENET, V17, P443; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; HOOGVLIET B, 1942, GENETICA, V23, P93; KAN YW, 1978, LANCET, V2, P910; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1983, EVOLUTION GENES PROT; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; MCCURDY PR, 1971, NEW ENGL J MED, V285, P218, DOI 10.1056/NEJM197107222850409; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; Murphy EA, 1975, PRINCIPLES GENETIC C; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NEI M, 1979, JPN J HUM GENET, V24, P131, DOI 10.1007/BF01888684; NEI M, 1977, B INT STAT I, V47, P689; NEWMARK P, 1984, NATURE, V307, P11, DOI 10.1038/307011a0; ORKIN SH, 1982, NATURE, V296, P202, DOI 10.1038/296202a0; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; PHILLIPS JA, 1982, J CLIN INVEST, V70, P489, DOI 10.1172/JCI110640; RENWICK JH, 1969, LANCET, V2, P386; RIVAS ML, 1977, GENETIC COUNSELING, P447; SCHROTT HG, 1973, CLIN GENET, V4, P38; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	39	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					984	997						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	2996337				2022-12-18	WOS:A1985ASD5500016
J	PROVINCE, MA; RAO, DC				PROVINCE, MA; RAO, DC			PATH-ANALYSIS OF FAMILY RESEMBLANCE WITH TEMPORAL TRENDS - APPLICATIONS TO HEIGHT, WEIGHT, AND QUETELET INDEX IN NORTHEASTERN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)					NIGMS NIH HHS [GM28719] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH031302, P30MH031302] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAYLEY N, 1954, J EDUC PSYCHOL, V45, P1; BYARD PJ, 1984, AM J PHYS ANTHROPOL, V64, P97, DOI 10.1002/ajpa.1330640202; CLONINGER CR, 1980, GENET RES, V36, P133, DOI 10.1017/S0016672300019765; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1964, COLD SPRING HARB SYM, V29, P69, DOI 10.1101/SQB.1964.029.01.012; MUELLER WH, 1983, YEARB PHYS ANTHROPOL, V26, P215; NAMBOODIRI KK, UNPUB COLLABORATIVE; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P87; NANCE WE, 1984, GENETIC EPIDEMIOLOGY; NANCE WE, 1979, GENETIC ANAL COMMON; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1982, AM J HUM GENET, V34, P888; RAO DC, 1975, AM J HUM GENET, V27, P509; RAO DC, 1984, GENETIC EPIDEMIOLOGY, P193; RAO DC, 1984, HUMAN POPULATION GEN; RICE J, 1978, AM J HUM GENET, V30, P618	20	37	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					178	192						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AGY57	3976658				2022-12-18	WOS:A1985AGY5700018
J	SHAFER, DA; PRIEST, JH				SHAFER, DA; PRIEST, JH			REVERSAL OF DNA METHYLATION WITH 5-AZACYTIDINE ALTERS CHROMOSOME-REPLICATION PATTERNS IN HUMAN-LYMPHOCYTE AND FIBROBLAST-CULTURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EMORY UNIV,SCH MED,DEPT PSYCHIAT,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322	Emory University; Emory University	SHAFER, DA (corresponding author), GEORGIA MENTAL HLTH INST,HUMAN GENET RES LAB,ATLANTA,GA 30306, USA.							CHRISTMAN JK, 1983, CANCER RES, V43, P763; CLOUGH DW, 1982, SCIENCE, V216, P70, DOI 10.1126/science.6175023; FELSENFELD G, 1982, NATURE, V296, P602, DOI 10.1038/296602a0; GOTO K, 1975, CHROMOSOMA, V53, P223, DOI 10.1007/BF00329173; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; LATT SA, 1981, CANCER GENET CYTOGEN, V3, P171, DOI 10.1016/0165-4608(81)90073-X; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; PRIEST JH, 1967, J CELL BIOL, V35, P483, DOI 10.1083/jcb.35.2.483; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; SAGER R, 1982, P NATL ACAD SCI-BIOL, V79, P480, DOI 10.1073/pnas.79.2.480; SCHMIDT M, 1980, CHROMOSOMA, V76, P101, DOI 10.1007/BF00292230; SHAFER DA, 1982, AM J HUM GENET, V34, P307; SHAFER DA, 1979, MAMMALIAN CHROMOSOME, V20, P37; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352; WILLARD HF, 1977, CHROMOSOMA, V61, P61, DOI 10.1007/BF00292681	16	37	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					534	545						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6203402				2022-12-18	WOS:A1984SY11900004
J	KARLIN, S; CAMERON, EC; CHAKRABORTY, R				KARLIN, S; CAMERON, EC; CHAKRABORTY, R			PATH-ANALYSIS IN GENETIC EPIDEMIOLOGY - A CRITIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									UNIV TEXAS,HLTH SCI CTR,CTR DEMOG POPULAT GENET,HOUSTON,TX 77025	University of Texas System; University of Texas Health Science Center Houston	KARLIN, S (corresponding author), STANFORD UNIV,DEPT MATH,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010452] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-2161] Funding Source: Medline; NIGMS NIH HHS [IR01-GM28574-01, 5R01-GM10452-19] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aigner DJ, 1977, LATENT VARIABLES SOC; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTHAM PME, 1976, BIOMETRIKA, V63, P263, DOI 10.2307/2335618; AMEMIYA T, 1976, J AM STAT ASSOC, V71, P347, DOI 10.2307/2285311; Anderson T.W, 1958, INTRO MULTIVARIATE S; ARMSTRONG JS, 1978, J BUS, V51, P549, DOI 10.1086/296016; Belsley D., 1980, REGRESSION DIAGNOSTI; BICKEL PJ, 1981, J AM STAT ASSOC, V76, P296, DOI 10.2307/2287831; Blalock HM, 1964, CAUSAL INFERENCES NO; BOLT BA, 1978, J COMPUT PHYS, V29, P357, DOI 10.1016/0021-9991(78)90139-0; Bulmer MG., 1980, MATH THEORY QUANTITA; CHENG L, 1974, MAR FISH REV, V36, P1; CHRIST CF, 1975, INT ECON REV, V16, P54; CLONINGER CR, 1980, GENET RES, V36, P133, DOI 10.1017/S0016672300019765; Duncan O.D., 1975, INTRO STRUCTURAL EQU; DUNCAN OD, 1966, AM J SOCIOL, V72, P1, DOI 10.1086/224256; EAVES LJ, 1975, HEREDITY, V34, P132, DOI 10.1038/hdy.1975.14; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FORRESTER JW, 1980, J AM STAT ASSOC, V75, P555, DOI 10.2307/2287644; FREEDMAN D, 1982, DOE NRS P S VALIDATI; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P277, DOI 10.2307/2287825; FRISCH R, 1934, EC I PUBL, V5; GEWEKE JF, 1980, J AM STAT ASSOC, V75, P133, DOI 10.2307/2287400; GNANADESIKAN R, 1977, METHODS STATISTICAL; Goldberger A. S., 1978, GENETIC EPIDEMIOLOGY, P195; GOLDBERGER AS, 1978, HUM GENET, V30, P441; GULBRANDSEN CL, 1977, SOC BIOL, V24, P289, DOI 10.1080/19485565.1977.9988299; Harman H.H., 1976, MODERN FACTOR ANAL; HINKLEY DV, 1975, BIOMETRIKA, V62, P101, DOI 10.1093/biomet/62.1.101; HOLLAND PW, 1973, ANN STAT, V1, P84, DOI 10.1214/aos/1193342384; Intriligator M.D., 1978, ECONOMETRIC MODELS T; Jencks C, 1972, INEQUALITY REASSESSM; Jinks J, 1974, NATURE, V248, P287; Joreskog K.G, 1973, STRUCTURAL EQUATION; JORESKOG KG, 1981, DATA, V1, P1; JORESKOG KG, 1979, ADV FACTOR ANAL; KANG KM, 1980, DEV STATISTICS, V3, P217; KARLIN S, 1979, AM J HUM GENET, V31, P341; KARLIN S, 1981, AM J EPIDEMIOL, V113, P307, DOI 10.1093/oxfordjournals.aje.a113100; KARLIN S, 1979, THEOR POPUL BIOL, V15, P308, DOI 10.1016/0040-5809(79)90044-3; KHATRI CG, 1979, J MULTIVARIATE ANAL, V9, P589, DOI 10.1016/0047-259X(79)90060-5; KHATRI CG, 1976, J MULTIVARIATE ANAL, V6, P81, DOI 10.1016/0047-259X(76)90021-X; KIEFER J, 1979, MYCOLOGIA, V71, P343, DOI 10.2307/3759157; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Leamer E., 1978, SPECIFICATIONS SEARC; LEWONTIN RC, 1974, AM J HUM GENET, V26, P400; LOEHLIN JC, 1978, BEHAV GENET, V8, P415, DOI 10.1007/BF01067938; MACURDY TE, 1981, NBER14 STANF U TECH; MADANSKY A, 1976, F ECONOMETRICS; MORTON NE, 1980, HUM GENET, V53, P261; Nance W E, 1979, Prog Med Genet, V3, P73; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P195; NELSON CR, 1972, AM ECON REV, V62, P902; ODONALD P, 1980, SEXUAL SELECTION NAT; RAO DC, 1976, AM J HUM GENET, V28, P228; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1978, AM J HUM GENET, V30, P445; RAO DC, 1974, AM J HUM GENET, V26, P467; RAO DC, 1978, GENETIC EPIDEMIOLOGY, P145; RAO DC, 1980, CURRENT DEV ANTHR GE, P355; RICE J, 1980, BEHAV GENET, V10, P73, DOI 10.1007/BF01067320; STIGLER SM, 1977, ANN STAT, V5, P1055, DOI 10.1214/aos/1176343997; STONE CJ, 1981, ANN STAT, V9, P475, DOI 10.1214/aos/1176345452; TAVARE S, 1983, BIOMETRIKA, V70, P139; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Tukey JW, 1977, EXPLORATORY DATA ANA, Vxvi; VOGEL F, 1978, HUMAN GENETICS; WAGENER DK, 1976, THEOR POPUL BIOL, V10, P185, DOI 10.1016/0040-5809(76)90015-0; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; WILSON SR, 1973, ANN HUM GENET, V37, P289; Wright S, 1931, J AM STAT ASSOC, V26, P155; Wright S, 1921, J AGR RES, V7, P557; ZELLNER A, 1979, J AM STAT ASSOC, V74, P628, DOI 10.2307/2286981	74	37	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					695	732						38	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RG731	6349335				2022-12-18	WOS:A1983RG73100015
J	JACOBS, PA; HUNT, PA; MAYER, M; WANG, JC; BOSS, GR; ERBE, RW				JACOBS, PA; HUNT, PA; MAYER, M; WANG, JC; BOSS, GR; ERBE, RW			EXPRESSION OF THE MARKER(X)(Q28) IN LYMPHOBLASTOID CELL-LINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,CTR HUMAN GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,GENET UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	JACOBS, PA (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.			Boss, Gerry/0000-0002-9758-8714	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007878] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-07878, HD-06356] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BIRD GA, 1981, NATURE, V289, P300; Del Guidice RA, 1978, MYCOPLASMA INFECTION, P57; GLOVER TW, 1981, AM J HUM GENET, V33, P234; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; SLY WS, 1976, TISSUE ANTIGENS, V71, P165; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; TOMMERUP N, 1981, AM J MED GENET, V9, P263, DOI 10.1002/ajmg.1320090313; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X	10	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	4					552	557						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NY863	6213152				2022-12-18	WOS:A1982NY86300002
J	VARKI, A; REITMAN, ML; VANNIER, A; KORNFELD, S; GRUBB, JH; SLY, WS				VARKI, A; REITMAN, ML; VANNIER, A; KORNFELD, S; GRUBB, JH; SLY, WS			DEMONSTRATION OF THE HETEROZYGOUS STATE FOR I-CELL DISEASE AND PSEUDO-HURLER POLYDYSTROPHY BY ASSAY OF N-ACETYLGLUCOSAMINYLPHOSPHOTRANSFERASE IN WHITE BLOOD-CELLS AND FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110; WASHINGTON UNIV,ST LOUIS CHILDRENS HOSP,SCH MED,EDWARD MALLINCKRODT DEPT PEDIATR,DIV MED GENET,ST LOUIS,MO 63110	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	VARKI, A (corresponding author), WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110, USA.		Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475				BACH G, 1979, BIOCHEM BIOPH RES CO, V91, P976, DOI 10.1016/0006-291X(79)91975-2; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; DISTLER J, 1979, P NATL ACAD SCI USA, V76, P4235, DOI 10.1073/pnas.76.9.4235; GLASER JH, 1973, J LAB CLIN MED, V82, P969; GLASER JH, 1974, J PEDIATR-US, V85, P192, DOI 10.1016/S0022-3476(74)80391-4; HASILIK A, 1981, BIOCHEM BIOPH RES CO, V98, P761, DOI 10.1016/0006-291X(81)91177-3; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, P NATL ACAD SCI-BIOL, V77, P7074, DOI 10.1073/pnas.77.12.7074; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; JOLLY RD, 1979, AM J MED GENET, V4, P293, DOI 10.1002/ajmg.1320040313; KABACK MM, 1974, PROG MED GENET, V10, P103; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KELLY TE, 1975, JOHNS HOPKINS MED J, V137, P156; LEROY JG, 1973, HUMANGENETIK, V20, P119, DOI 10.1007/BF00284846; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKUSICK VA, METABOLIC BASIS INHE, P1299; MILLER AL, 1981, LYSOSOMES LYSOSOMAL, P271; NATOWICZ MR, 1979, P NATL ACAD SCI USA, V76, P4322, DOI 10.1073/pnas.76.9.4322; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; REITMAN ML, 1981, J BIOL CHEM, V256; TABAS I, 1980, J BIOL CHEM, V255, P6633; THOMAS GH, 1982, AM J HUM GENET, V34, P611; VANELSEN AF, 1976, HUM GENET, V31, P75, DOI 10.1007/BF00270402; VARKI A, 1981, J BIOL CHEM, V256, P9937; VARKI A, 1980, J BIOL CHEM, V255, P8389; VARKI AP, 1981, P NATL ACAD SCI-BIOL, V78, P7773, DOI 10.1073/pnas.78.12.7773; VARKI AP, 1980, J BIOL CHEM, V255; WAHEED A, 1981, J BIOL CHEM, V256, P4150; WAHEED A, 1981, J BIOL CHEM, V256, P5717	30	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					717	729						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	6289658				2022-12-18	WOS:A1982PH24200004
J	YOSHIDA, A; YAMAGUCHI, H; OKUBO, Y				YOSHIDA, A; YAMAGUCHI, H; OKUBO, Y			GENETIC MECHANISM OF CIS-AB INHERITANCE .1. A CASE ASSOCIATED WITH UNEQUAL CHROMOSOMAL CROSSING OVER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OSAKA RED CROSS HOSP, OSAKA, JAPAN; OSAKA RED CROSS BLOOD CTR, OSAKA, JAPAN	Osaka Red Cross Hospital; Osaka Red Cross Hospital	YOSHIDA, A (corresponding author), CITY HOPE NATL MED CTR, DEPT BIOCHEM GENET, DUARTE, CA 91010 USA.							BADET J, 1978, J IMMUNOGENET, V5, P221; BADET J, 1976, REV FR TRANSFUS IMMU, V19, P105, DOI 10.1016/S0338-4535(76)80091-8; HEARN VM, 1972, BIOCHEM BIOPH RES CO, V46, P948, DOI 10.1016/S0006-291X(72)80233-X; HEARN VM, 1968, BIOCHEM J, V109, P315, DOI 10.1042/bj1090315; KOBATA A, 1969, ARCH BIOCHEM BIOPHYS, V130, P509, DOI 10.1016/0003-9861(69)90063-0; KOMAI T, 1965, P JPN ACAD, V41, P316; KOSCIELAK J, 1975, VOX SANG, V28, P347; MADSEN G, 1968, VOX SANG, V14, P211, DOI 10.1111/j.1423-0410.1968.tb03406.x; NAGAI M, 1978, J BIOL CHEM, V253, P377; PACUSZKA T, 1975, VOX SANG, V29, P292, DOI 10.1111/j.1423-0410.1975.tb00510.x; RACE C, 1968, BIOCHEM J, V107, P733, DOI 10.1042/bj1070733; REVIRON J, 1968, NOUV REV FR HEMATOL, V8, P323; SABO BH, 1978, J IMMUNOGENET, V5, P87; SALMON C, 1973, BIOMEDICINE, V18, P375; SCHENKELBRUNNER H, 1969, NATURE, V223, P1272, DOI 10.1038/2231272a0; TUPPY H, 1969, EUR J BIOCHEM, V10, P152; WATKINS WM, 1978, REV FR TRANSFUS IMMU, V21, P201, DOI 10.1016/S0338-4535(78)80043-9; WHITEHEAD JS, 1974, J BIOL CHEM, V249, P3442; YAMAGUCHI H, 1970, JPN J HUM GENET, V15, P198; YAMAGUCHI H, 1965, P JPN ACAD, V41, P316, DOI 10.2183/pjab1945.41.316; YAMAGUCHI H, 1973, JPN J HUM GENET, V18, P1; YOSHIDA A, 1980, BLOOD, V55, P119; YOSHIDA A, 1979, BLOOD, V54, P344	23	37	37	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					332	338						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6770676				2022-12-18	WOS:A1980JX05900003
J	MCKUSICK, VA				MCKUSICK, VA			GENETIC NOSOLOGY - 3 APPROACHES - ALLAN,WILLIAM MEMORIAL AWARD LECTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine	MCKUSICK, VA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205, USA.							ADAM A, 1961, NATURE, V189, P636; BELL J, 1937, P R SOC MED, V123, P199; BERGSMA D, 1976, BIRTH DEFECTS OAS, V12, P54; BOYER SH, 1965, AM J HUM GENET, V17, P320; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHASE GA, 1972, AM J HUM GENET, V24, P339; Cooley TB, 1927, AM J DIS CHILD, V34, P347, DOI 10.1001/archpedi.1927.04130210022002; Dalton J.S., 1798, MANCHESTER LIT PHILO, V5, P28; DANES BS, 1965, SCIENCE, V149, P987, DOI 10.1126/science.149.3687.987; DICKIE MM, 1954, J NATL CANCER I, V15, P607; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; EPINETTE WW, 1973, ARCH DERMATOL, V107, P754; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; GOODMAN RM, 1978, GENETIC DISORDERS JE; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HALDANE JBS, 1915, J GENET, V5, P132; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; HORNER F, 1876, AMTL BER VERWALTUNG, P208; KAUFMAN R L, 1972, Birth Defects Original Article Series, V8, P85; Laberge C, 1976, Adv Hum Genet, V6, P323; McKusick V A, 1975, Birth Defects Orig Artic Ser, V11, P1; McKusick V A, 1968, JAMA, V204, P113; McKusick V.A., 1978, MENDELIAN INHERITANC; McKusick V.A., 1972, CLIN GENET; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; MCKUSICK VA, 1977, SCIENCE, V196, P390, DOI 10.1126/science.850784; MCKUSICK VA, 1964, JAMA-J AM MED ASSOC, V189, P813; MCKUSICK VA, 1973, AM J HUM GENET, V25, P446; MCKUSICK VA, 1975, ANN INTERN MED, V82, P585, DOI 10.7326/0003-4819-82-4-585; MCKUSICK VA, 1978, MEDICAL GENETIC STUD; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; MCKUSICK VA, 1965, B J HOPKINS HOSP, V116, P295; MOHR J, 1951, ACTA PATHOL MIC SC, V28, P207; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1973, ANN CLIN RES, V5, P109; OBRIEN JS, 1975, CLIN GENET, V8, P303; OBRIEN JS, 1977, AM J HUM GENET, V29, P184; PINSKY L, 1975, TERATOLOGY, V11, P227, DOI 10.1002/tera.1420110302; PINSKY L, 1974, TERATOLOGY, V9, P65, DOI 10.1002/tera.1420090109; PORTER IH, 1962, ANN HUM GENET, V26, P107, DOI 10.1111/j.1469-1809.1962.tb01316.x; RAO DC, 1973, AM J HUM GENET, V25, P594; RICCIUTI F, 1973, NATURE-NEW BIOL, V241, P180, DOI 10.1038/newbio241180a0; SINISCALCO M, 1960, ACCADEMIA NAZIONALE, V28, P1; Stewart R E, 1977, Birth Defects Orig Artic Ser, V13, P85; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249	46	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					105	122						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	418674				2022-12-18	WOS:A1978EV59500002
J	SENSABAUGH, GF; GOLDEN, VL				SENSABAUGH, GF; GOLDEN, VL			PHENOTYPE DEPENDENCE IN INHIBITION OF RED-CELL ACID-PHOSPHATASE (ACP) BY FOLATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SENSABAUGH, GF (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,DEPT BIOMED & ENVIRONM HLTH SCI,BERKELEY,CA 94720, USA.							BATTISTUZZI G, 1974, NATURE, V251, P711, DOI 10.1038/251711a0; BEUTLER E, 1969, J CLIN INVEST, V48, P1957, DOI 10.1172/JCI106162; BEUTLER E, 1969, EXPERIENTIA, V25, P804, DOI 10.1007/BF01897886; BOTTINI E, 1971, SCIENCE, V171, P409, DOI 10.1126/science.171.3969.409; BOTTINI E, 1973, J MED GENET, V10, P154, DOI 10.1136/jmg.10.2.154; BOTTINI E, 1976, LANCET, V1, P918; CHANARIN I, 1967, BIOCHEM J, V105, P633, DOI 10.1042/bj1050633; DIPIETRO DL, 1967, J BIOL CHEM, V242, P3391; EZE LC, 1974, ANN HUM GENET, V37, P333, DOI 10.1111/j.1469-1809.1974.tb01840.x; FILBURN CR, 1973, ARCH BIOCHEM BIOPHYS, V159, P683, DOI 10.1016/0003-9861(73)90508-0; GIBLETT ER, 1969, GENETIC MARKERS HUMA, P424; HARRIS H, 1975, PRINCIPLES HUMAN BIO; HEINRIKSON RL, 1969, J BIOL CHEM, V244, P299; HIBBARD ED, 1973, ARCH DIS CHILD, V48, P743, DOI 10.1136/adc.48.9.743; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; KEARNEY EB, 1951, J BIOL CHEM, V193, P821; LUFFMAN JE, 1967, ANN HUM GENET, V30, P387, DOI 10.1111/j.1469-1809.1967.tb00040.x; MANSFIELD E, 1977, LANCET, V2, P201; MANSFIELD E, 1978, RED CELL, P233; NORONHA JM, 1963, ARCH BIOCHEM BIOPHYS, V101, P445, DOI 10.1016/0003-9861(63)90501-0; RIVLIN R S, 1975, P393; SENSABAUGH GF, 1975, ISOENZYMES, V1, P367; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0; SWALLOW DM, 1973, ANN HUM GENET, V37, P31, DOI 10.1111/j.1469-1809.1973.tb01812.x; VALENTINE W, 1961, AM J CLIN PATHOL, V36, P328	26	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					553	560						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA288	736044				2022-12-18	WOS:A1978GA28800009
